data_2mf9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mf9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.595 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.388 0.613 . . . . 0.53000000000000003 110.856 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.71 109.76 4.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.2 -0.909 . . . . 1.1899999999999999 110.131 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.633 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.0 t70 -74.76 123.8 25.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 2.5099999999999998 110.818 174.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.494 HD11 HD12 ' A' ' 45' ' ' LEU . 8.8 mt -56.06 -36.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.711 -1.131 . . . . 1.1499999999999999 111.568 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -110.77 -2.39 16.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.208 0.528 . . . . 1.4299999999999999 110.473 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.17 24.75 67.51 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.33 -0.85 . . . . 0.65000000000000002 111.627 -173.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' H ' HD21 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -94.5 -22.37 18.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.858 0.361 . . . . 0.94999999999999996 111.669 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.496 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.0 -17.67 41.09 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.922 -0.656 . . . . 0.71999999999999997 112.125 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.792 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 1.1 mt -96.07 -24.23 16.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.673 0.273 . . . . 2.1600000000000001 110.912 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.494 HD12 HD11 ' A' ' 39' ' ' ILE . 19.5 tp -123.68 100.39 6.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.374 -0.376 . . . . 1.1200000000000001 111.854 -171.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -130.11 139.88 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.097 -0.377 . . . . 1.49 111.722 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HZ3' ' HG3' ' A' ' 106' ' ' MET . 10.3 ttpt -112.13 125.82 54.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.477 0.311 . . . . 1.1200000000000001 110.637 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.2 ttpp -116.54 120.73 39.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 1.6499999999999999 110.969 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 p -74.93 110.44 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.464 . . . . 1.03 111.646 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 ' HG3' ' A' ' 141' ' ' GLU . 9.0 mt -73.88 -52.0 14.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.827 -1.545 . . . . 1.0600000000000001 106.827 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.864 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.7 t -133.46 130.72 21.11 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 113.21 -1.814 . . . . 1.1399999999999999 106.752 170.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 22.7 Cg_endo -107.79 57.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.221 2.614 . . . . 0.56000000000000005 114.024 -176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.491 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 120.958 -0.639 . . . . 0.55000000000000004 112.848 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 122.003 0.906 . . . . 1.3600000000000001 113.252 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 16.5 m -146.71 140.0 25.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.582 -1.19 . . . . 1.8200000000000001 108.229 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 96.4 mtt180 -89.36 116.22 65.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 120.567 -0.453 . . . . 3.3900000000000001 109.831 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 10.0 Cg_endo -52.38 148.59 25.53 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.493 2.795 . . . . 0.42999999999999999 112.67 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.575 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -94.65 152.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 1.47 109.28 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.893 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 61.3 mttt -63.71 120.69 12.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 1.71 109.399 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.02 -41.92 1.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.06 -1.427 . . . . 0.41999999999999998 110.075 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.664 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -69.42 132.67 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.069 -0.715 . . . . 0.58999999999999997 109.069 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 17.9 m -84.45 118.64 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 122.142 0.973 . . . . 1.8600000000000001 108.727 175.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -115.65 144.84 22.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.93 -1.032 . . . . 1.0700000000000001 111.486 -171.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.97 HG21 HG21 ' A' ' 87' ' ' VAL . 43.5 p -88.86 113.99 25.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.535 -0.757 . . . . 1.0600000000000001 110.221 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG21 HD22 ' A' ' 99' ' ' LEU . 20.8 m -111.49 143.59 21.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.996 -0.682 . . . . 1.05 110.511 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -103.1 117.88 35.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.451 -1.314 . . . . 0.28999999999999998 107.451 168.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -118.96 137.79 53.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 118.92 -1.112 . . . . 1.1299999999999999 111.035 176.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.652 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.46 114.29 14.13 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.491 -2.041 . . . . 0.27000000000000002 105.491 166.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.65 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 60.3 m -105.45 132.61 51.41 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 114.976 -1.011 . . . . 1.04 111.831 -168.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 m -104.39 156.88 17.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.096 -0.956 . . . . 1.54 108.874 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 80' ' ' VAL . 10.8 mt -80.42 166.72 20.98 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 1.51 108.908 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.88 -14.54 15.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.915 0.339 . . . . 1.1399999999999999 111.915 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -93.28 -15.63 25.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.897 0.38 . . . . 2.1400000000000001 110.711 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.44 -3.92 19.93 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.813 -0.708 . . . . 0.51000000000000001 113.644 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.1 m -75.67 110.88 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.369 0.584 . . . . 1.1599999999999999 111.573 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.6 mtt180 -75.99 112.42 12.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.854 0.835 . . . . 0.54000000000000004 110.857 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.522 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.2 m -99.02 -13.8 7.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 113.992 -1.458 . . . . 1.0600000000000001 112.377 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.597 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.8 pt20 -157.06 136.58 12.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.81 0.338 . . . . 0.63 110.586 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.52 130.42 32.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.969 -0.559 . . . . 1.3400000000000001 109.687 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 4.8 tt0 -145.09 112.98 4.84 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.562 -0.745 . . . . 2.5899999999999999 109.815 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 15.2 Cg_exo -68.19 -15.77 43.27 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.501 2.801 . . . . 0.90000000000000002 113.315 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.555 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 26.5 tt0 -166.34 113.28 0.86 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.021 0.915 . . . . 1.3700000000000001 111.572 -175.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.445 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 49.7 tp -126.72 110.76 13.49 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.55 -1.659 . . . . 1.1399999999999999 108.737 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.97 HG21 HG21 ' A' ' 67' ' ' THR . 2.1 t -100.79 125.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.174 -0.676 . . . . 1.5900000000000001 109.174 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 p90 -145.56 160.71 41.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.25 111.44 -172.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 m -79.29 106.67 11.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.593 -0.73 . . . . 1.0700000000000001 110.4 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.893 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.02 134.54 57.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.213 -0.448 . . . . 1.3300000000000001 110.514 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.66 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 81.44 -5.63 67.63 Favored Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 120.824 -0.703 . . . . 0.37 113.293 173.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -107.17 15.54 25.04 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.534 -0.913 . . . . 0.93000000000000005 108.534 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 32.2 m 53.65 39.61 30.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.109 -1.405 . . . . 1.55 109.633 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.3 t0 -76.86 -2.79 35.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.563 1.173 . . . . 1.3300000000000001 108.383 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 6.2 m -140.04 -157.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 113.646 -1.616 . . . . 1.0800000000000001 110.757 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.5 pt -82.82 139.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.567 -1.272 . . . . 1.0600000000000001 107.567 173.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.477 HE21 ' HB3' ' A' ' 100' ' ' ASP . 6.3 tp60 -58.85 -31.51 68.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.351 -0.386 . . . . 0.40000000000000002 111.261 -171.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.91 79.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 1.0800000000000001 110.491 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.68 HD22 HG21 ' A' ' 68' ' ' VAL . 53.7 tp -75.5 -38.01 59.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.314 -0.857 . . . . 1.0700000000000001 110.551 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HB3' HE21 ' A' ' 97' ' ' GLN . 13.2 t70 -61.41 -29.82 70.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.97 -1.014 . . . . 0.26000000000000001 109.868 -175.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.496 HD23 ' HZ1' ' A' ' 62' ' ' LYS . 71.8 mt -90.55 -36.04 14.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.198 -0.91 . . . . 1.0600000000000001 111.969 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.8 t -64.91 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.676 -0.238 . . . . 1.53 111.191 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.625 ' HB ' ' HD3' ' A' ' 104' ' ' PRO . 76.1 t -65.55 -53.45 37.37 Favored Pre-proline 0 C--O 1.218 -0.578 0 CA-C-N 116.471 -0.332 . . . . 1.0600000000000001 111.888 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.767 ' HD3' HD13 ' A' ' 90' ' ' LEU . 64.5 Cg_exo -52.55 -28.83 38.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.992 1.795 . . . . 0.40999999999999998 112.706 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.56 -11.52 53.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.8 -0.636 . . . . 1.3500000000000001 111.279 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -100.43 142.07 32.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.27 -0.877 . . . . 1.3100000000000001 110.701 176.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -89.37 156.88 18.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.96999999999999997 108.781 172.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.3 p -66.04 126.47 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.935 0.874 . . . . 1.47 110.459 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.8 -2.3 45.17 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.337 -0.847 . . . . 0.28000000000000003 112.254 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.864 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 6.8 pt-20 -96.95 168.13 10.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.529 0.68 . . . . 0.40999999999999998 110.913 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.415 HG21 HD11 ' A' ' 50' ' ' LEU . 10.2 m -130.18 116.96 19.18 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.369 -0.974 . . . . 1.0700000000000001 108.369 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HB2' ' SD ' ' A' ' 106' ' ' MET . . . -115.21 135.28 54.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.314 -176.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttm -97.46 117.0 30.74 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.124 -1.436 . . . . 1.9399999999999999 107.124 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.62 130.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.584 -0.524 . . . . 1.0600000000000001 109.584 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.517 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 98.1 m -105.79 112.48 25.56 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.075 -1.083 . . . . 1.03 108.075 170.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.31 133.69 52.52 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.988 -1.46 . . . . 1.01 109.227 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.792 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 10.0 t70 -52.67 145.77 11.44 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.893 -0.78 . . . . 0.57999999999999996 108.893 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.8 t -52.74 -29.49 27.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.965 0.412 . . . . 1.04 110.125 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.695 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 7.0 ptpp? -56.73 -27.14 58.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.206 0.447 . . . . 1.4299999999999999 112.206 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.549 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 88.9 m-85 -99.4 0.99 43.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.3 0.571 . . . . 1.04 109.922 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -119.72 -92.03 0.54 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.816 -1.084 . . . . 0.87 109.994 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.0 m-85 -142.02 43.62 1.68 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 120.71 -0.396 . . . . 0.95999999999999996 111.761 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -49.29 -89.83 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 113.957 0.343 . . . . 0.25 113.957 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.65 15.27 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.639 2.226 . . . . 0.90000000000000002 110.707 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 33.0 mt-30 -104.3 -43.28 5.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.232 -0.895 . . . . 0.65000000000000002 109.672 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 75.85 144.99 1.44 Allowed Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.655 -1.157 . . . . 0.29999999999999999 112.673 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.672 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.3 t -92.08 159.91 15.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.417 -0.392 . . . . 0.90000000000000002 111.322 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.44 HH12 ' CD ' ' A' ' 83' ' ' GLU . 33.2 mtt180 -53.18 -57.0 11.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.329 -0.851 . . . . 3.6099999999999999 111.109 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.949 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.3 m -74.6 -64.31 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.833 -0.622 . . . . 1.52 110.553 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.949 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.6 Cg_endo -106.72 126.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.973 1.782 . . . . 0.44 112.132 174.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 34.3 t80 -58.85 98.02 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.153 -1.054 . . . . 1.6899999999999999 108.153 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.576 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.0 mm -65.97 132.33 94.66 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.448 -0.796 . . . . 1.0600000000000001 109.886 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.53 140.5 75.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.675 2.25 . . . . 1.03 112.436 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.44 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 48.2 Cg_exo -56.58 140.19 89.36 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.535 2.157 . . . . 0.89000000000000001 112.392 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.633 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 29.5 p80 47.59 28.76 1.27 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.398 1.079 . . . . 3.1899999999999999 113.145 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -86.19 134.2 33.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.374 -0.973 . . . . 1.04 108.374 169.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.81 113.32 15.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.306 -0.558 . . . . 1.05 110.326 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.65 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 2.5 tp -90.41 132.01 35.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.774 -0.648 . . . . 1.0600000000000001 110.015 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.8 t -115.56 100.38 8.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.308 -0.627 . . . . 1.8200000000000001 109.308 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 pp -113.36 136.36 52.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.002 -0.545 . . . . 1.1499999999999999 111.686 -171.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.652 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 46.9 tt0 -104.21 111.26 23.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.72 . . . . 1.05 109.213 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 99' ' ' LEU . 2.9 m -113.72 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.119 0.785 . . . . 1.0800000000000001 113.119 -173.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.6 m -88.6 108.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.636 -1.165 . . . . 1.0900000000000001 110.369 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.7 tp -81.75 93.05 6.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.326 -0.99 . . . . 1.0700000000000001 108.326 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 24.7 mtmt -90.13 -31.21 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.679 -0.691 . . . . 1.6899999999999999 110.754 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 m -148.67 151.46 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.961 0.41 . . . . 1.1200000000000001 111.293 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.507 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -139.78 128.11 22.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.98999999999999999 109.289 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.327 -0.384 0 C-N-CA 120.479 -0.488 . . . . 1.6200000000000001 110.245 -179.456 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.556 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.53000000000000003 110.528 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.7 tp -69.39 110.81 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.551 -0.749 . . . . 1.1899999999999999 109.618 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.624 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 11.6 t70 -75.71 128.56 35.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.202 -0.599 . . . . 2.5099999999999998 109.463 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.542 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 7.3 mt -65.13 -23.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.847 -1.069 . . . . 1.1499999999999999 110.839 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.3 mt -116.14 -5.5 11.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 1.4299999999999999 110.101 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 69.19 18.52 73.17 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.65000000000000002 112.361 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.28 -31.17 12.19 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.636 0.606 . . . . 0.94999999999999996 112.636 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.85 -0.83 21.46 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.473 -0.87 . . . . 0.71999999999999997 112.242 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.8 mp -99.13 -35.59 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.173 0.511 . . . . 2.1600000000000001 110.801 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.542 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 18.2 tp -122.68 101.62 7.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.132 -0.94 . . . . 1.1200000000000001 111.253 -172.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -133.89 140.33 46.76 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.124 -0.36 . . . . 1.49 111.472 -171.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HZ2' ' HA ' ' A' ' 106' ' ' MET . 14.2 ttpt -111.49 123.33 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 1.1200000000000001 110.696 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 11.2 ttmm -103.13 118.77 37.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.392 -0.225 . . . . 1.6499999999999999 110.392 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -76.71 96.09 4.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.486 -0.325 . . . . 1.03 110.577 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.486 HD21 ' HD2' ' A' ' 48' ' ' LYS . 10.6 mt -63.1 -49.47 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.304 -1.369 . . . . 1.0600000000000001 107.304 174.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.826 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 72.2 t -140.1 126.32 11.97 Favored Pre-proline 0 CA--C 1.499 -0.987 0 CA-C-N 112.617 -2.083 . . . . 1.1399999999999999 106.588 170.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -104.28 64.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.546 2.164 . . . . 0.56000000000000005 113.845 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.4 -0.818 . . . . 0.55000000000000004 113.888 173.608 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.444 -0.773 0 CA-C-O 120.947 0.403 . . . . 1.3600000000000001 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 t -152.48 136.05 16.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.787 -0.82 . . . . 1.8200000000000001 108.787 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 84.6 mtt180 -92.48 108.57 32.29 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.73 -0.47 . . . . 3.3900000000000001 109.73 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.581 ' HG3' HD22 ' A' ' 144' ' ' LEU . 5.3 Cg_endo -46.55 142.76 9.37 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.996 3.13 . . . . 0.42999999999999999 114.037 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.696 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -89.41 153.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.49 -0.777 . . . . 1.47 109.717 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.632 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -68.52 117.12 9.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.732 0.777 . . . . 1.71 110.956 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.7 -27.24 3.23 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.354 -1.293 . . . . 0.41999999999999998 110.423 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -75.65 140.94 42.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.58999999999999997 109.147 176.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.3 m -86.71 126.54 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.42 -1.326 . . . . 1.8600000000000001 107.42 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 33.3 m -120.6 146.41 25.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.174 -0.466 . . . . 1.0700000000000001 110.195 -173.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.44 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 31.3 p -96.37 111.71 23.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.822 -0.626 . . . . 1.0600000000000001 110.047 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.573 HG23 HD23 ' A' ' 99' ' ' LEU . 3.9 m -111.42 143.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.746 -0.661 . . . . 1.05 110.362 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.3 114.04 27.65 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.018 -1.475 . . . . 0.28999999999999998 107.018 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -114.67 135.47 54.12 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.301 -0.959 . . . . 1.1299999999999999 111.132 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.545 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -134.17 113.45 12.05 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.742 -1.947 . . . . 0.27000000000000002 105.742 165.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 140' ' ' LEU . 88.3 m -105.24 132.13 51.83 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.605 -1.18 . . . . 1.04 111.411 -168.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.799 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -110.46 156.61 20.61 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.297 -0.865 . . . . 1.54 109.131 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.72 165.64 21.77 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.828 -0.624 . . . . 1.51 109.807 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.7 -21.18 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 1.1399999999999999 111.266 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -91.3 -8.15 49.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.864 -0.607 . . . . 2.1400000000000001 110.61 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.44 -9.37 41.66 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.061 -0.59 . . . . 0.51000000000000001 112.702 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -74.23 109.41 7.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.72 0.267 . . . . 1.1599999999999999 111.72 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 23.3 mtt180 -75.71 124.37 27.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.254 0.55 . . . . 0.54000000000000004 110.532 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.558 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.0 m -112.76 -9.24 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.914 -1.039 . . . . 1.0600000000000001 112.777 -168.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.572 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.8 pt20 -159.4 132.5 7.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.475 -0.33 . . . . 0.63 110.137 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.457 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 63.1 tt0 -140.85 118.58 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 1.3400000000000001 110.644 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 3.0 tt0 -137.48 121.15 11.77 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.622 -0.717 . . . . 2.5899999999999999 110.313 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 8.9 Cg_exo -71.23 -13.63 31.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.627 2.885 . . . . 0.90000000000000002 113.274 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -161.5 105.58 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.048 0.928 . . . . 1.3700000000000001 111.784 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 68' ' ' VAL . 25.7 tp -114.88 109.97 18.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.443 -1.708 . . . . 1.1399999999999999 109.344 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.7 p -104.67 131.38 53.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.713 -0.477 . . . . 1.5900000000000001 109.713 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.675 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 46.1 p90 -150.98 158.67 44.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.568 -0.287 . . . . 0.25 111.111 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 m -77.07 109.48 10.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 1.0700000000000001 110.181 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.762 HD13 ' HD3' ' A' ' 104' ' ' PRO . 17.7 tp -62.05 133.96 55.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 1.3300000000000001 110.541 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 83.93 3.59 89.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.788 -0.72 . . . . 0.37 112.527 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -106.37 -2.68 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.42 . . . . 0.93000000000000005 110.021 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.412 ' C ' ' H ' ' A' ' 95' ' ' VAL . 35.3 m 59.46 35.91 22.98 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.775 -0.824 . . . . 1.55 108.775 -172.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -73.96 -2.86 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.26 1.028 . . . . 1.3300000000000001 108.48 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 93' ' ' CYS . 5.8 m -139.87 -153.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 113.767 -1.56 . . . . 1.0800000000000001 109.726 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.2 pt -82.94 138.04 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.265 -1.383 . . . . 1.0600000000000001 107.265 172.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.494 HE21 ' HB3' ' A' ' 100' ' ' ASP . 9.3 tp60 -57.65 -31.04 65.91 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.568 -0.287 . . . . 0.40000000000000002 111.071 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.63 -48.19 69.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 1.0800000000000001 110.863 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.597 HD12 HG13 ' A' ' 142' ' ' VAL . 46.9 tp -72.92 -38.11 66.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.367 -0.833 . . . . 1.0700000000000001 110.468 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.494 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.2 t70 -61.6 -30.04 70.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.824 -1.08 . . . . 0.26000000000000001 109.695 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 84.3 mt -89.92 -35.01 15.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.375 -0.83 . . . . 1.0600000000000001 111.63 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.7 t -63.57 -36.2 83.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 1.53 111.321 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.61 -55.87 34.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 112.772 0.656 . . . . 1.0600000000000001 112.772 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.762 ' HD3' HD13 ' A' ' 90' ' ' LEU . 25.7 Cg_endo -64.42 -19.57 65.45 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 121.887 1.725 . . . . 0.40999999999999998 112.114 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' CD1' HG21 ' A' ' 39' ' ' ILE . 12.8 mt -82.59 -13.62 56.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.016 -0.538 . . . . 1.3500000000000001 111.297 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.638 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.7 ptm -107.32 154.41 21.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.088 -0.505 . . . . 1.3100000000000001 110.72 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.71 152.75 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.96999999999999997 110.494 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.16 126.6 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.052 0.93 . . . . 1.47 110.116 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.54 12.37 57.13 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.661 -1.154 . . . . 0.28000000000000003 112.952 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.826 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.1 pt-20 -101.7 168.48 9.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.40999999999999998 110.736 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.467 HG22 HD12 ' A' ' 50' ' ' LEU . 9.5 m -129.63 119.08 22.98 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.653 -1.24 . . . . 1.0700000000000001 107.653 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.425 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.73 53.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.037 0.446 . . . . 1.0 111.018 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.9 ttm -97.96 116.71 30.73 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.9399999999999999 107.216 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.421 HG21 ' HG3' ' A' ' 47' ' ' LYS . 5.2 t -113.91 128.75 70.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.985 -0.376 . . . . 1.0600000000000001 109.985 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 62.7 m -104.67 113.73 27.5 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 108.187 -1.042 . . . . 1.03 108.187 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.511 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.63 141.92 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.01 -1.45 . . . . 1.01 108.749 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 6.6 t70 -57.76 156.37 8.8 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.223 -0.591 . . . . 0.57999999999999996 109.578 174.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.678 ' OG ' ' HA ' ' A' ' 135' ' ' HIS . 70.6 p -47.34 -43.4 22.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.996 -1.002 . . . . 1.04 110.739 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 14.4 ptpt -59.76 -28.97 67.85 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.907 -1.042 . . . . 1.4299999999999999 112.042 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.58 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 91.6 m-85 -94.81 2.63 55.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.364 0.602 . . . . 1.04 109.856 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.814 ' HB3' HD22 ' A' ' 138' ' ' LEU . 91.1 m -122.78 -92.34 0.54 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.623 -1.172 . . . . 0.87 110.271 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 3.8 m-85 -147.37 37.66 0.93 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 119.019 -0.515 . . . . 0.95999999999999996 111.85 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.542 ' CA ' ' HB2' ' A' ' 118' ' ' SER . . . -52.73 -83.5 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.597 -0.811 . . . . 0.25 112.998 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 7.36 4.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.551 2.167 . . . . 0.90000000000000002 111.692 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.512 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -104.22 -46.97 4.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.749 -0.66 . . . . 0.65000000000000002 110.66 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.596 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 80.73 142.06 3.07 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.954 -1.021 . . . . 0.29999999999999999 112.225 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.708 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.4 t -91.65 159.42 15.88 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.575 0.583 . . . . 0.90000000000000002 112.575 -174.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.534 ' HG3' ' H ' ' A' ' 129' ' ' SER . 9.6 ptp180 -48.97 -53.98 17.51 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.48 -1.236 . . . . 3.6099999999999999 112.259 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.949 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 3.5 m -82.4 -63.88 0.27 Allowed Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.895 -0.409 . . . . 1.52 109.895 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.949 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.1 Cg_endo -105.07 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.522 2.148 . . . . 0.44 112.262 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.656 ' HH ' ' HD3' ' A' ' 134' ' ' PRO . 26.1 t80 -55.57 97.45 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.674 -0.861 . . . . 1.6899999999999999 108.674 163.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.593 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.3 mm -66.77 122.57 82.86 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.75 -0.659 . . . . 1.0600000000000001 109.313 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.02 137.74 80.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.261 1.974 . . . . 1.03 111.965 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.656 ' HD3' ' HH ' ' A' ' 131' ' ' TYR . 38.4 Cg_exo -56.35 130.2 38.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.387 2.058 . . . . 0.89000000000000001 112.823 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.678 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 17.3 m80 74.39 23.82 1.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.577 -1.647 . . . . 3.1899999999999999 112.878 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.51 116.01 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.29 -1.004 . . . . 1.04 108.29 166.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.61 132.5 43.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.99 0.424 . . . . 1.05 110.039 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.814 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -104.05 132.37 50.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.918 -0.583 . . . . 1.0600000000000001 111.773 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.2 t -116.63 100.45 7.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.061 -0.718 . . . . 1.8200000000000001 109.061 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.6 pp -112.57 137.13 51.25 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.771 -0.65 . . . . 1.1499999999999999 111.579 -171.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.545 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 41.2 tt0 -106.8 116.2 31.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.891 -0.781 . . . . 1.05 108.891 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 99' ' ' LEU . 4.6 m -117.12 120.91 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.724 0.638 . . . . 1.0800000000000001 112.724 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 m -88.75 108.85 19.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.082 -0.963 . . . . 1.0900000000000001 110.737 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.638 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 55.7 tp -81.71 94.74 7.05 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.68 -0.859 . . . . 1.0700000000000001 108.68 172.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.9 mtmt -89.33 -25.1 21.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.141 -0.936 . . . . 1.6899999999999999 110.821 -171.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.44 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 22.0 m -160.84 148.12 15.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.664 0.269 . . . . 1.1200000000000001 111.174 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.475 ' HA ' HG11 ' A' ' 66' ' ' VAL . . . -124.43 127.96 48.31 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.193 -0.669 . . . . 0.98999999999999999 109.193 168.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 109.619 -0.511 . . . . 1.6200000000000001 109.619 -178.032 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.583 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.53000000000000003 110.625 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.05 118.26 12.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.585 -0.734 . . . . 1.1899999999999999 110.415 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.644 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.4 t70 -80.98 129.4 34.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.324 0.583 . . . . 2.5099999999999998 110.379 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.614 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.1 mt -65.51 -24.91 35.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.801 -1.091 . . . . 1.1499999999999999 111.088 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.66 0.7 10.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.55 . . . . 1.4299999999999999 110.47 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.25 22.37 65.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.436 -0.802 . . . . 0.65000000000000002 112.306 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.07 -28.24 15.83 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.137 0.421 . . . . 0.94999999999999996 112.137 -176.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 108.58 -1.01 32.41 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.818 -0.706 . . . . 0.71999999999999997 112.065 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.452 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 mp -105.42 -31.58 8.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.051 0.453 . . . . 2.1600000000000001 111.215 -176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 16.5 tp -122.31 101.33 7.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.4 -0.818 . . . . 1.1200000000000001 111.471 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' HG2' ' CA ' ' A' ' 38' ' ' ASP . 67.5 mtm180 -133.42 141.01 47.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.356 0.502 . . . . 1.49 112.356 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HZ1' ' HA ' ' A' ' 106' ' ' MET . 11.4 ttpt -114.28 126.09 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 1.1200000000000001 110.654 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.6 ttpt -112.03 128.56 56.22 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 121.062 -0.255 . . . . 1.6499999999999999 110.894 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 p -83.94 103.89 13.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.223 -0.444 . . . . 1.03 110.711 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG23 ' A' ' 111' ' ' THR . 8.0 mt -65.26 -52.94 51.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.832 -1.544 . . . . 1.0600000000000001 106.832 170.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.816 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 86.6 t -131.93 131.99 22.92 Favored Pre-proline 0 CA--C 1.501 -0.912 0 CA-C-N 113.28 -1.782 . . . . 1.1399999999999999 106.242 167.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.7 Cg_endo -104.61 53.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.935 2.423 . . . . 0.56000000000000005 113.023 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 CA-C-N 114.957 -1.02 . . . . 0.55000000000000004 112.807 178.269 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 121.543 0.687 . . . . 1.3600000000000001 111.901 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.728 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 50.5 m -116.59 133.61 55.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.32 -0.855 . . . . 1.8200000000000001 108.896 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 86.2 mtt180 -99.46 113.6 65.0 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-O 120.931 0.396 . . . . 3.3900000000000001 110.481 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.586 ' HG3' HD21 ' A' ' 144' ' ' LEU . 10.9 Cg_endo -53.77 145.78 48.34 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.43 2.754 . . . . 0.42999999999999999 113.382 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 17.6 t -97.19 152.68 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 1.47 109.396 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.948 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 89.1 mttt -71.34 120.84 17.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.454 0.645 . . . . 1.71 109.762 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.48 -26.97 4.27 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.872 -1.291 . . . . 0.41999999999999998 109.872 -172.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.632 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.06 139.73 30.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.455 -0.943 . . . . 0.58999999999999997 108.455 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.9 m -86.17 128.91 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 108.075 -1.083 . . . . 1.8600000000000001 108.075 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -124.91 146.46 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.175 -0.92 . . . . 1.0700000000000001 110.778 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.483 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 37.1 p -95.38 113.02 24.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.099 -0.501 . . . . 1.0600000000000001 110.572 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.669 HG21 HD23 ' A' ' 99' ' ' LEU . 30.3 m -110.65 143.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.037 -0.665 . . . . 1.05 109.846 173.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.598 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.52 116.29 32.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.701 -1.592 . . . . 0.28999999999999998 106.701 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.71 137.94 52.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.079 -1.049 . . . . 1.1299999999999999 111.024 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.52 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.74 114.56 14.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.788 -1.93 . . . . 0.27000000000000002 105.788 165.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.622 HG23 ' HB3' ' A' ' 140' ' ' LEU . 75.3 m -102.36 126.43 49.38 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.529 -1.214 . . . . 1.04 111.414 -166.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 13.1 t -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.464 -0.789 . . . . 1.54 109.498 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HG ' HG11 ' A' ' 80' ' ' VAL . 10.3 mt -82.32 164.89 20.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.368 -0.833 . . . . 1.51 109.863 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.69 -24.82 36.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.391 0.615 . . . . 1.1399999999999999 110.443 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -80.42 -12.81 59.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.344 -0.844 . . . . 2.1400000000000001 111.204 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.58 17.69 30.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.714 -0.755 . . . . 0.51000000000000001 112.039 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 m -102.55 110.05 21.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.581 0.229 . . . . 1.1599999999999999 111.525 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.696 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.2 mtt180 -74.87 115.41 14.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.523 0.678 . . . . 0.54000000000000004 110.083 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.643 ' HB ' ' CG ' ' A' ' 130' ' ' PRO . 27.0 m -99.51 -11.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.017 -0.992 . . . . 1.0600000000000001 111.989 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.589 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.6 pt20 -159.48 136.1 9.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.05 -0.523 . . . . 0.63 110.144 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 38.0 tt0 -133.43 123.94 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.999 0.428 . . . . 1.3400000000000001 109.849 173.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -136.96 116.85 10.62 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.344 -0.844 . . . . 2.5899999999999999 109.71 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.405 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 61.2 Cg_endo -72.09 -14.49 28.96 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.118 2.546 . . . . 0.90000000000000002 113.105 -170.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -164.94 110.83 0.95 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.181 0.991 . . . . 1.3700000000000001 111.029 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.09 103.25 8.88 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.179 -1.828 . . . . 1.1399999999999999 108.877 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.0 p -97.52 125.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.072 -0.513 . . . . 1.5900000000000001 109.834 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.809 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 43.3 p90 -147.19 159.58 43.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 0.25 110.952 -172.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 2.8 m -80.62 110.0 15.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.864 -0.607 . . . . 1.0700000000000001 110.176 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.948 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 13.8 tp -58.06 134.49 56.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 1.3300000000000001 110.955 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 74.47 11.54 82.54 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 121.043 -0.598 . . . . 0.37 112.375 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 27.0 t70 -112.58 8.56 19.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.192 -0.67 . . . . 0.93000000000000005 109.192 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 55.0 m 55.83 33.69 22.03 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.938 -1.028 . . . . 1.55 109.877 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 2.4 t0 -68.63 -14.6 63.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.393 1.092 . . . . 1.3300000000000001 108.693 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -133.96 -156.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.799 -1.546 . . . . 1.0800000000000001 110.539 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.5 pt -82.87 139.68 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.722 -1.214 . . . . 1.0600000000000001 107.722 175.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.515 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.4 tp60 -58.23 -30.53 66.58 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.244 -0.182 . . . . 0.40000000000000002 110.955 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.31 73.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.385 0.612 . . . . 1.0800000000000001 110.495 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.669 HD23 HG21 ' A' ' 68' ' ' VAL . 59.4 tp -77.88 -38.77 45.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.323 -0.853 . . . . 1.0700000000000001 110.665 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.68 -28.52 69.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.108 -0.951 . . . . 0.26000000000000001 109.585 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.612 HD22 ' HZ1' ' A' ' 62' ' ' LYS . 77.5 mt -90.47 -34.95 15.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.199 -0.91 . . . . 1.0600000000000001 111.883 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.4 t -64.17 -35.43 80.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 1.53 111.287 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HB ' ' CD ' ' A' ' 104' ' ' PRO . 54.6 t -63.32 -55.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.633 0.605 . . . . 1.0600000000000001 112.633 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.785 ' HD3' HD12 ' A' ' 90' ' ' LEU . 22.7 Cg_endo -63.16 -22.05 72.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.814 1.676 . . . . 0.40999999999999998 111.839 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.464 ' CD1' HG23 ' A' ' 39' ' ' ILE . 9.5 mt -81.68 -13.1 58.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 1.3500000000000001 111.271 173.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.668 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -106.42 157.19 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.959 -0.564 . . . . 1.3100000000000001 110.828 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.0 m-20 -96.37 153.56 17.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.96999999999999997 110.187 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.728 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -64.05 129.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.667 0.746 . . . . 1.47 110.728 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.66 7.47 61.57 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.536 -1.211 . . . . 0.28000000000000003 112.348 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.3 pt-20 -97.45 166.61 11.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.517 0.675 . . . . 0.40999999999999998 111.546 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.42 HG23 HD13 ' A' ' 50' ' ' LEU . 13.0 m -127.59 117.66 22.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.823 -1.177 . . . . 1.0700000000000001 107.823 172.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.521 ' HB1' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.24 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.944 0.402 . . . . 1.0 110.331 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.6 ttp -101.8 117.79 35.58 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.561 -1.274 . . . . 1.9399999999999999 107.561 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.478 HG22 ' HG3' ' A' ' 47' ' ' LYS . 10.5 t -112.67 135.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.296 -0.411 . . . . 1.0600000000000001 109.989 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.583 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 50.6 m -114.57 112.66 23.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.37 -0.974 . . . . 1.03 108.37 171.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . . . -125.16 136.56 53.72 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.399 -1.728 . . . . 1.01 109.688 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.683 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 11.1 t70 -53.05 149.5 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.112 -0.699 . . . . 0.57999999999999996 109.112 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.588 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.6 t -56.13 -28.06 56.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.191 0.52 . . . . 1.04 110.385 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.631 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.2 ptpt -55.33 -29.95 59.29 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 121.945 -0.472 . . . . 1.4299999999999999 111.498 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.562 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 72.6 m-85 -95.11 0.17 54.05 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.243 0.544 . . . . 1.04 110.271 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.633 ' HB3' HD23 ' A' ' 138' ' ' LEU . 61.8 m -122.56 -89.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.988 -1.005 . . . . 0.87 110.581 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.542 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.8 m-85 -143.88 40.67 1.4 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.004 0.372 . . . . 0.95999999999999996 112.004 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.04 -82.9 0.04 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 0.25 113.965 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.97 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.536 2.158 . . . . 0.90000000000000002 111.003 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 21.1 mt-30 -104.83 -51.5 3.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.376 -0.829 . . . . 0.65000000000000002 109.721 -174.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.605 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.05 141.74 3.14 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.401 -1.272 . . . . 0.29999999999999999 112.151 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.666 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.2 t -91.67 152.32 20.27 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.229 0.538 . . . . 0.90000000000000002 111.961 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -46.65 -48.32 20.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.464 -1.244 . . . . 3.6099999999999999 113.428 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 1.012 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 47.2 m -81.54 -65.95 0.24 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.124 -0.63 . . . . 1.52 109.896 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.012 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -107.01 127.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.295 1.997 . . . . 0.44 112.043 172.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.605 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -55.95 97.97 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.916 -1.142 . . . . 1.6899999999999999 107.916 164.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.589 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -66.5 126.49 92.26 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.678 -0.692 . . . . 1.0600000000000001 109.532 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.78 145.29 31.8 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.734 2.289 . . . . 1.03 112.189 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.574 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.7 Cg_endo -63.94 133.23 37.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.059 1.839 . . . . 0.89000000000000001 111.817 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.683 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 32.3 m170 71.77 8.3 6.07 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.018 -0.992 . . . . 3.1899999999999999 112.16 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -69.96 122.11 18.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.737 -0.838 . . . . 1.04 108.737 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.58 112.78 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 1.05 110.24 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.633 HD23 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -89.63 131.84 35.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.192 -0.913 . . . . 1.0600000000000001 110.285 -177.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 23.7 t -121.3 101.19 7.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.853 0.835 . . . . 1.8200000000000001 109.155 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.622 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -113.08 137.4 51.49 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.611 -1.177 . . . . 1.1499999999999999 111.61 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.52 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 42.4 tt0 -101.71 115.69 31.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.489 -0.778 . . . . 1.05 109.227 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.644 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -117.08 121.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.667 0.617 . . . . 1.0800000000000001 112.667 -175.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.8 m -92.75 109.02 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.243 -0.889 . . . . 1.0900000000000001 110.249 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.627 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 64.3 tp -81.85 98.63 8.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.493 -0.929 . . . . 1.0700000000000001 108.493 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -94.71 -27.86 15.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.33 -0.85 . . . . 1.6899999999999999 110.775 -170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.483 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 7.8 m -153.39 151.74 30.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.292 -0.413 . . . . 1.1200000000000001 111.458 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.495 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.58 128.5 27.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.565 -0.743 . . . . 0.98999999999999999 109.061 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.515 -0.39 0 CA-C-O 121.232 0.539 . . . . 1.6200000000000001 110.365 -178.588 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.63 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.564 0.697 . . . . 0.53000000000000003 112.138 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.7 125.02 28.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.706 -1.134 . . . . 1.1899999999999999 111.233 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' HB3' ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -77.17 123.55 26.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.131 -0.486 . . . . 2.5099999999999998 111.113 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.629 HD11 HD11 ' A' ' 45' ' ' LEU . 6.9 mt -62.54 -41.28 91.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.434 -0.803 . . . . 1.1499999999999999 110.959 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.446 HD23 HD13 ' A' ' 101' ' ' LEU . 89.1 mt -113.21 0.68 14.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.75 0.309 . . . . 1.4299999999999999 111.424 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.541 ' H ' ' HB3' ' A' ' 38' ' ' ASP . . . 68.65 24.15 75.38 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.4 -0.68 . . . . 0.65000000000000002 111.4 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.518 HD21 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -97.46 -24.74 15.46 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.94999999999999996 113.243 -177.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' HD21 ' A' ' 42' ' ' ASN . . . 102.32 -19.28 48.99 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 121.308 -0.472 . . . . 0.71999999999999997 112.372 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.74 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 2.8 mm? -90.12 -28.86 18.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.839 0.352 . . . . 2.1600000000000001 110.491 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 39' ' ' ILE . 20.9 tp -122.86 109.29 13.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 1.1200000000000001 111.865 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 71.2 mtm180 -139.38 140.46 37.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.987 0.366 . . . . 1.49 111.987 -173.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -113.23 123.44 50.18 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.985 0.514 . . . . 1.1200000000000001 110.137 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.63 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.2 ttpt -109.77 113.64 26.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 1.6499999999999999 110.708 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 p -74.07 100.66 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.347 -0.388 . . . . 1.03 111.328 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 111' ' ' THR . 7.8 mt -65.8 -49.55 67.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.427 -1.323 . . . . 1.0600000000000001 107.427 172.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.805 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.7 t -136.61 126.32 15.84 Favored Pre-proline 0 CA--C 1.505 -0.772 0 CA-C-N 113.007 -1.906 . . . . 1.1399999999999999 106.712 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -104.35 61.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.108 2.539 . . . . 0.56000000000000005 113.846 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-N 115.546 -0.752 . . . . 0.55000000000000004 113.634 177.001 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.889 0 CA-C-O 121.304 0.573 . . . . 1.3600000000000001 111.352 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.1 t -152.15 136.85 17.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.065 -1.087 . . . . 1.8200000000000001 108.065 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 10.4 ptp180 -91.68 113.48 58.87 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.528 -0.469 . . . . 3.3900000000000001 110.39 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.607 ' HD3' HG22 ' A' ' 108' ' ' VAL . 4.9 Cg_endo -47.47 142.21 13.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.985 3.123 . . . . 0.42999999999999999 113.653 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 16.9 t -92.05 156.86 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.386 -0.824 . . . . 1.47 109.645 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -63.53 111.92 2.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.132 0.491 . . . . 1.71 110.199 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.05 -33.44 2.31 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 114.827 -1.079 . . . . 0.41999999999999998 110.491 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -74.56 139.19 43.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.904 -0.776 . . . . 0.58999999999999997 108.904 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 2.7 m -89.25 131.33 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.696 -1.224 . . . . 1.8600000000000001 107.696 174.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.0 m -129.18 149.42 33.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.609 -0.723 . . . . 1.0700000000000001 110.718 -171.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.512 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 24.7 p -98.68 113.01 24.91 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.82 -0.627 . . . . 1.0600000000000001 110.041 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 99' ' ' LEU . 19.2 m -110.63 144.28 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 119.988 -0.685 . . . . 1.05 110.214 173.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.45 117.14 34.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.203 -1.406 . . . . 0.28999999999999998 107.203 170.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -121.17 134.83 55.23 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.384 -0.926 . . . . 1.1299999999999999 110.62 177.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -126.95 114.07 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.241 -2.133 . . . . 0.27000000000000002 105.241 167.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.613 HG22 ' HB3' ' A' ' 140' ' ' LEU . 59.0 m -106.13 123.59 48.25 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.317 -1.311 . . . . 1.04 111.057 -164.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.966 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.9 OUTLIER -104.81 170.99 7.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.821 -0.627 . . . . 1.54 109.448 -178.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt -97.12 165.4 12.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.433 -0.803 . . . . 1.51 109.249 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.26 -16.76 23.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.832 0.348 . . . . 1.1399999999999999 110.715 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -94.98 -14.7 24.15 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.364 -0.38 . . . . 2.1400000000000001 110.92 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.38 -24.44 6.91 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.544 -0.836 . . . . 0.51000000000000001 113.933 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.4 m -67.54 114.97 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.81 0.67 . . . . 1.1599999999999999 112.81 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.883 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.6 mtt180 -77.98 118.52 20.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.608 0.718 . . . . 0.54000000000000004 110.499 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.736 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.3 m -96.58 -9.08 9.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.613 -1.176 . . . . 1.0600000000000001 112.06 -170.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.565 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.7 pt20 -164.92 129.07 2.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.42 -0.355 . . . . 0.63 110.891 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -122.38 109.61 14.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.382 -0.599 . . . . 1.3400000000000001 109.382 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.25 113.75 25.99 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.59 -0.732 . . . . 2.5899999999999999 110.363 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 56.6 Cg_endo -71.26 -16.05 31.52 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.307 2.671 . . . . 0.90000000000000002 113.491 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -163.05 108.76 1.13 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.206 1.003 . . . . 1.3700000000000001 112.088 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 tp -118.49 105.98 12.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.086 -1.87 . . . . 1.1399999999999999 108.728 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -100.11 130.78 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.214 -0.448 . . . . 1.5900000000000001 109.842 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.4 p90 -151.74 157.78 42.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.691 0.281 . . . . 0.25 110.582 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.8 m -76.98 114.29 15.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.752 -0.658 . . . . 1.0700000000000001 109.711 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.858 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.7 tp -58.96 127.63 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 1.3300000000000001 111.376 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.81 4.22 90.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.997 -0.62 . . . . 0.37 112.344 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -89.72 -4.71 57.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.176 -1.046 . . . . 0.93000000000000005 108.176 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 19.5 m 56.95 32.88 22.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.57 -1.196 . . . . 1.55 109.92 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.61 -21.37 64.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.167 0.984 . . . . 1.3300000000000001 108.955 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 m -113.67 -158.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.714 -1.585 . . . . 1.0800000000000001 110.859 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.6 pt -78.44 137.25 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.317 -1.364 . . . . 1.0600000000000001 107.317 173.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -57.57 -30.35 65.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.471 -0.331 . . . . 0.40000000000000002 110.781 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.8 -46.83 81.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 1.0800000000000001 110.788 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.675 HD22 HG21 ' A' ' 68' ' ' VAL . 48.5 tp -71.26 -40.3 71.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 1.0700000000000001 110.728 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.07 -30.34 70.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.801 -1.09 . . . . 0.26000000000000001 109.977 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.446 HD13 HD23 ' A' ' 40' ' ' LEU . 82.2 mt -91.44 -33.36 15.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.353 -0.839 . . . . 1.0600000000000001 112.472 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.8 t -65.64 -32.11 73.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 1.53 111.119 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 99' ' ' LEU . 57.9 t -66.38 -52.83 34.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.767 0.654 . . . . 1.0600000000000001 112.767 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.858 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -62.81 -19.98 70.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.634 1.556 . . . . 0.40999999999999998 112.113 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.508 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.9 mt -83.18 -16.14 47.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.476 0.655 . . . . 1.3500000000000001 111.109 170.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.783 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 28.3 ttm -96.16 141.5 29.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.744 -1.116 . . . . 1.3100000000000001 111.572 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.92 151.08 19.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.914 -0.402 . . . . 0.96999999999999997 109.914 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.607 HG22 ' HD3' ' A' ' 60' ' ' PRO . 3.7 t -59.73 124.3 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 1.47 110.639 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.28 14.12 46.13 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.481 -0.782 . . . . 0.28000000000000003 112.787 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.805 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -104.31 168.23 9.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.615 0.708 . . . . 0.40999999999999998 110.574 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.443 HG22 HD12 ' A' ' 50' ' ' LEU . 17.9 m -133.65 117.97 17.62 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.923 -1.14 . . . . 1.0700000000000001 107.923 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.08 140.98 52.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.181 0.515 . . . . 1.0 110.805 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.419 ' HG2' ' CH2' ' A' ' 36' ' ' TRP . 16.9 ttt -98.12 117.88 33.49 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.297 -1.372 . . . . 1.9399999999999999 107.297 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.8 130.46 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.566 -0.531 . . . . 1.0600000000000001 109.566 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.566 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 99.3 m -108.3 114.45 28.33 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.652 -0.819 . . . . 1.03 109.023 173.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.61 134.17 53.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.017 -1.447 . . . . 1.01 110.063 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.74 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 9.6 t70 -52.31 147.5 7.81 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.57999999999999996 108.682 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.4 t -57.98 -25.68 61.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.232 0.539 . . . . 1.04 110.138 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.614 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 4.2 ptpp? -55.32 -29.79 58.95 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.111 -0.368 . . . . 1.4299999999999999 111.29 173.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.549 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 97.3 m-85 -98.51 3.0 48.13 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.219 0.533 . . . . 1.04 110.268 175.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.0 m -123.63 -91.59 0.54 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.148 -0.933 . . . . 0.87 110.701 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 12.3 m-85 -141.91 42.83 1.7 Allowed 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 112.15 0.426 . . . . 0.95999999999999996 112.15 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -51.58 -86.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.163 -0.542 . . . . 0.25 113.572 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.26 11.92 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.536 2.158 . . . . 0.90000000000000002 111.09 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.4 mt-30 -103.2 -46.75 4.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.6 -0.727 . . . . 0.65000000000000002 109.968 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.55 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.95 144.28 2.22 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.693 -1.139 . . . . 0.29999999999999999 112.188 -175.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.642 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.9 t -91.16 158.74 16.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.229 -0.486 . . . . 0.90000000000000002 112.09 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -47.05 -55.49 8.17 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.811 -1.086 . . . . 3.6099999999999999 111.943 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.917 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 22.9 t -80.92 -62.95 0.34 Allowed Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.534 -0.466 . . . . 1.52 110.158 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.917 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.7 Cg_endo -106.08 127.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.348 2.032 . . . . 0.44 112.11 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.55 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 49.2 t80 -55.91 98.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.346 -0.983 . . . . 1.6899999999999999 108.346 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.603 HG12 ' CB ' ' A' ' 127' ' ' SER . 32.3 mm -66.49 128.24 93.75 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.668 -0.697 . . . . 1.0600000000000001 109.917 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.59 139.29 75.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.572 2.181 . . . . 1.03 112.144 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.479 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 72.2 Cg_exo -52.54 129.06 30.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.815 2.343 . . . . 0.89000000000000001 112.918 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 66.3 m170 70.11 15.54 7.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.992 -1.004 . . . . 3.1899999999999999 112.508 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.92 123.79 26.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.87 -0.789 . . . . 1.04 108.87 170.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.11 115.96 14.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.328 0.585 . . . . 1.05 110.308 -173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.95 136.21 33.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.396 -0.82 . . . . 1.0600000000000001 111.007 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.966 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 30.7 p -119.54 98.56 6.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.037 0.922 . . . . 1.8200000000000001 110.026 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.613 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.5 OUTLIER -110.41 134.69 52.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.004 -0.998 . . . . 1.1499999999999999 111.647 -173.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.586 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 46.4 tt0 -100.78 111.73 24.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.799 . . . . 1.05 109.084 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.665 HG23 ' HE3' ' A' ' 106' ' ' MET . 1.3 m -112.17 117.05 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.516 0.674 . . . . 1.0800000000000001 112.716 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 4.0 m -89.91 114.03 25.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.945 -1.025 . . . . 1.0900000000000001 110.573 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.726 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.8 tp -85.82 96.07 9.63 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.962 -0.755 . . . . 1.0700000000000001 108.962 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.5 mtmt -91.85 -30.49 16.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.55 -0.75 . . . . 1.6899999999999999 110.8 -171.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.512 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 19.1 m -151.93 148.07 27.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.484 -0.326 . . . . 1.1200000000000001 111.167 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.92 128.79 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.244 -0.65 . . . . 0.98999999999999999 109.244 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 CA--C 1.514 -0.435 0 C-N-CA 119.568 -0.853 . . . . 1.6200000000000001 111.677 -178.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.533 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.3 m0 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.392 0.615 . . . . 0.53000000000000003 110.634 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.6 tp -83.49 115.22 21.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 1.1899999999999999 110.136 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.618 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -78.68 121.97 25.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.187 -0.671 . . . . 2.5099999999999998 109.187 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.622 HG22 HD12 ' A' ' 105' ' ' LEU . 13.5 mt -60.18 -35.91 64.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.188 -0.915 . . . . 1.1499999999999999 110.552 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.454 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 74.3 mt -102.54 -3.42 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.722 -0.672 . . . . 1.4299999999999999 110.565 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.05 27.9 65.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.65000000000000002 111.718 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' H ' HD21 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -111.66 -23.22 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.012 0.745 . . . . 0.94999999999999996 113.012 -175.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.435 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 109.24 30.73 3.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.95 -1.119 . . . . 0.71999999999999997 114.377 168.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -151.77 -9.26 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.985 0.392 . . . . 2.1600000000000001 110.784 175.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.587 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 3.2 tp -119.5 99.47 6.69 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.918 -0.583 . . . . 1.1200000000000001 109.975 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -139.14 136.58 35.28 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.014 -0.675 . . . . 1.49 112.065 -171.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 112' ' ' ALA . 11.2 ttpt -112.52 124.52 52.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.217 -0.447 . . . . 1.1200000000000001 110.361 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 28.9 ttpp -112.88 117.46 32.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.87 0.367 . . . . 1.6499999999999999 110.524 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.9 p -73.62 106.45 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.275 -0.421 . . . . 1.03 111.285 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD13 ' HG3' ' A' ' 141' ' ' GLU . 12.0 mt -68.66 -52.13 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.798 -1.556 . . . . 1.0600000000000001 106.798 170.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.874 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 93.0 t -131.37 135.42 27.02 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 113.143 -1.844 . . . . 1.1399999999999999 106.071 168.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -108.77 54.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.946 2.431 . . . . 0.56000000000000005 113.834 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.593 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 115.853 -0.612 . . . . 0.55000000000000004 113.319 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 121.507 0.67 . . . . 1.3600000000000001 111.439 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 23.0 t -159.09 130.67 6.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.936 -1.135 . . . . 1.8200000000000001 107.936 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 83.8 mtt180 -90.44 112.85 55.17 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 120.918 -0.313 . . . . 3.3900000000000001 110.313 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HG3' HD23 ' A' ' 144' ' ' LEU . 6.2 Cg_endo -47.3 152.99 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.831 3.021 . . . . 0.42999999999999999 114.142 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 11.4 t -102.67 151.56 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.211 -0.904 . . . . 1.47 109.774 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 62.7 mttt -64.24 108.78 1.67 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.02 0.914 . . . . 1.71 110.792 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.3 -31.5 2.34 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.772 -1.558 . . . . 0.41999999999999998 110.125 -174.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.643 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -71.89 140.19 49.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.21 0.529 . . . . 0.58999999999999997 109.89 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG22 ' A' ' 148' ' ' VAL . 65.4 t -84.68 119.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.598 -0.89 . . . . 1.8600000000000001 108.598 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.2 m -124.54 147.97 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.11 0.411 . . . . 1.0700000000000001 112.11 -170.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.506 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 30.0 p -102.26 116.52 32.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.923 -0.58 . . . . 1.0600000000000001 110.39 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.735 HG22 HD23 ' A' ' 99' ' ' LEU . 17.1 m -111.18 144.94 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.111 0.481 . . . . 1.05 110.06 172.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.604 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.9 t-160 -102.11 120.38 40.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.909 -1.515 . . . . 0.28999999999999998 106.909 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.553 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.9 OUTLIER -125.36 135.11 52.1 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 119.426 -0.91 . . . . 1.1299999999999999 110.474 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.854 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -127.52 114.97 18.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.902 -1.888 . . . . 0.27000000000000002 105.902 169.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.603 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 22.8 m -110.63 122.38 47.65 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.409 -1.268 . . . . 1.04 111.53 -165.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.969 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.7 OUTLIER -104.65 171.16 7.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.317 -0.856 . . . . 1.54 108.851 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.441 ' HG ' HG13 ' A' ' 80' ' ' VAL . 11.4 mt -97.53 167.46 10.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.537 -0.756 . . . . 1.51 109.936 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.62 -17.64 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.313 0.383 . . . . 1.1399999999999999 111.236 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.32 -14.64 20.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.674 0.273 . . . . 2.1400000000000001 110.921 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.08 7.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.637 -0.792 . . . . 0.51000000000000001 113.651 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 m -63.26 112.06 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.228 0.455 . . . . 1.1599999999999999 112.228 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.809 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.9 mtt180 -74.28 118.23 17.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.847 0.832 . . . . 0.54000000000000004 110.571 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.888 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.1 m -96.68 -9.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.452 -1.249 . . . . 1.0600000000000001 110.928 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.603 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.1 pt20 -166.55 146.76 5.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.606 -0.724 . . . . 0.63 109.753 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 15.2 tt0 -150.96 103.29 3.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.173 -1.047 . . . . 1.3400000000000001 108.173 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.502 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 4.7 mm-40 -126.72 113.81 22.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.541 -0.754 . . . . 2.5899999999999999 110.308 -170.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 37.7 Cg_endo -65.7 -12.32 34.64 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.014 2.476 . . . . 0.90000000000000002 112.982 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.628 ' CD ' ' HZ1' ' A' ' 145' ' ' LYS . 2.5 tp10 -151.94 112.02 4.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.366 0.603 . . . . 1.3700000000000001 110.724 -175.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' A' ' 68' ' ' VAL . 50.8 tp -130.11 106.99 8.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.835 -1.075 . . . . 1.1399999999999999 108.287 172.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.9 p -108.36 138.08 36.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.148 -0.478 . . . . 1.5900000000000001 109.825 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 30.1 p90 -160.97 166.54 28.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.25 110.868 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.1 m -86.0 115.07 23.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 1.0700000000000001 109.633 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.809 HD12 ' HD3' ' A' ' 104' ' ' PRO . 14.4 tp -60.54 126.64 28.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 1.3300000000000001 110.396 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 91.18 6.66 66.42 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.691 -0.766 . . . . 0.37 112.976 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.11 -8.62 21.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.93000000000000005 109.978 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.7 m 58.15 36.9 26.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 1.55 109.342 -172.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 22.1 t70 -70.75 -17.61 62.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.538 1.161 . . . . 1.3300000000000001 108.044 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.19 -154.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.323 -1.762 . . . . 1.0800000000000001 110.353 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.62 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.8 pt -83.0 138.81 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.647 -1.242 . . . . 1.0600000000000001 107.647 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.483 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 6.5 tp60 -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.904 -0.318 . . . . 0.40000000000000002 110.898 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.14 -42.25 72.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 1.0800000000000001 110.627 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.735 HD23 HG22 ' A' ' 68' ' ' VAL . 56.5 tp -75.72 -40.78 55.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.729 -0.668 . . . . 1.0700000000000001 110.551 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.441 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.9 t70 -61.14 -28.53 69.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.046 -0.979 . . . . 0.26000000000000001 109.883 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 76.1 mt -90.13 -36.59 14.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.006 -0.997 . . . . 1.0600000000000001 111.893 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.1 t -67.96 -28.18 67.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.751 -0.204 . . . . 1.53 111.275 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 99' ' ' LEU . 55.0 t -65.87 -55.8 20.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.401 0.519 . . . . 1.0600000000000001 112.401 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.809 ' HD3' HD12 ' A' ' 90' ' ' LEU . 22.1 Cg_endo -63.43 -18.77 66.07 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 121.998 1.799 . . . . 0.40999999999999998 111.906 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.622 HD12 HG22 ' A' ' 39' ' ' ILE . 13.1 mt -84.32 -14.21 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 1.3500000000000001 111.239 173.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.814 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 1.1 ttp -105.84 141.15 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.239 -0.437 . . . . 1.3100000000000001 110.934 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 m-20 -79.01 152.48 30.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.867 0.365 . . . . 0.96999999999999997 110.067 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -65.58 126.29 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.653 0.74 . . . . 1.47 109.789 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.81 10.71 56.23 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.117 -0.947 . . . . 0.28000000000000003 112.143 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.874 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.38 170.36 7.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.357 0.599 . . . . 0.40999999999999998 110.58 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.599 HG21 ' HG1' ' A' ' 143' ' ' THR . 10.3 m -133.19 119.25 19.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.473 -0.936 . . . . 1.0700000000000001 108.473 176.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . . . -117.1 139.65 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.663 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.5 ttt -97.8 117.09 31.34 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.654 -1.239 . . . . 1.9399999999999999 107.654 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.64 130.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.833 -0.622 . . . . 1.0600000000000001 109.359 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.511 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 91.8 m -107.16 114.09 27.93 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.38 -0.97 . . . . 1.03 108.38 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -123.12 135.43 54.36 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.0 -1.455 . . . . 1.01 109.651 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.7 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.1 t70 -55.71 148.86 15.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.767 -0.827 . . . . 0.57999999999999996 108.767 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.662 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -57.5 -27.21 62.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.376 0.608 . . . . 1.04 110.132 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.7 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 18.6 ptpt -55.26 -31.78 61.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.242 -0.435 . . . . 1.4299999999999999 111.167 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.62 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 95.9 m-85 -100.84 10.77 40.72 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 1.04 109.902 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.662 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 71.0 m -125.92 -93.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.87 110.521 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 6.8 m-85 -141.45 41.82 1.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.369 -0.532 . . . . 0.95999999999999996 112.076 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.709 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.72 -84.81 0.03 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.143 -0.551 . . . . 0.25 113.67 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.67 8.49 4.22 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.551 2.167 . . . . 0.90000000000000002 111.088 175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.6 mt-30 -104.13 -47.15 4.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.65000000000000002 110.216 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.76 144.18 2.12 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.873 -1.058 . . . . 0.29999999999999999 112.094 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.655 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 10.9 t -91.61 157.63 16.88 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.294 -0.453 . . . . 0.90000000000000002 111.461 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.502 ' NH2' ' HG3' ' A' ' 83' ' ' GLU . 21.0 ptt180 -57.0 -43.1 81.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.613 -0.721 . . . . 3.6099999999999999 112.102 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.629 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -80.38 -68.87 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.333 -0.547 . . . . 1.52 110.354 175.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.888 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -106.3 129.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.857 2.371 . . . . 0.44 112.145 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.577 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 33.6 t80 -55.17 99.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.135 -1.061 . . . . 1.6899999999999999 108.135 163.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.1 mm -65.92 131.79 94.62 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 115.953 -0.567 . . . . 1.0600000000000001 110.285 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.61 138.46 40.12 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.845 2.363 . . . . 1.03 111.908 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.709 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.9 Cg_endo -64.53 135.75 47.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.175 1.917 . . . . 0.89000000000000001 112.125 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.559 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 48.6 m-70 71.71 5.66 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.239 -0.891 . . . . 3.1899999999999999 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.02 125.63 28.08 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.595 -0.521 . . . . 1.04 109.595 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.93 113.72 11.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.393 -0.523 . . . . 1.05 110.181 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.608 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.23 133.0 34.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.515 -0.766 . . . . 1.0600000000000001 111.07 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.969 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 31.6 p -116.93 100.01 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.371 1.081 . . . . 1.8200000000000001 110.05 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 72' ' ' THR . 0.4 OUTLIER -115.17 137.71 51.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.886 -1.052 . . . . 1.1499999999999999 111.632 -172.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.854 ' HB3' HE22 ' A' ' 71' ' ' GLN . 26.4 tt0 -103.36 114.58 28.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.05 108.305 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.635 HG12 HD12 ' A' ' 99' ' ' LEU . 2.5 m -111.79 119.48 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.421 0.629 . . . . 1.0800000000000001 112.2 -174.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.599 ' HG1' HG21 ' A' ' 111' ' ' THR . 6.3 m -95.11 113.02 24.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.271 -0.877 . . . . 1.0900000000000001 110.156 174.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' A' ' 60' ' ' PRO . 60.4 tp -84.33 98.75 10.19 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.859 -0.793 . . . . 1.0700000000000001 108.859 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.628 ' HZ1' ' CD ' ' A' ' 85' ' ' GLU . 26.7 mtmt -97.75 -26.12 14.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.159 -0.928 . . . . 1.6899999999999999 111.253 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.506 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 23.9 m -153.63 150.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.901 0.381 . . . . 1.1200000000000001 111.773 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.504 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -143.78 128.3 18.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.659 -0.701 . . . . 0.98999999999999999 109.406 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.1 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 1.6200000000000001 110.344 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.578 ' NE1' ' HE2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.147 0.498 . . . . 0.53000000000000003 110.76 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.02 111.39 5.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.084 -0.962 . . . . 1.1899999999999999 110.551 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.661 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.1 t70 -73.18 125.55 27.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.367 -0.533 . . . . 2.5099999999999998 110.083 173.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.603 HG22 HD11 ' A' ' 105' ' ' LEU . 7.7 mt -56.3 -32.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.808 -1.087 . . . . 1.1499999999999999 111.656 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.32 -1.73 13.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.101 -0.499 . . . . 1.4299999999999999 110.32 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.661 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.98 26.61 65.81 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.169 -0.772 . . . . 0.65000000000000002 111.169 -172.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' OD1' HD22 ' A' ' 44' ' ' LEU . 1.1 p30 -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.366 -0.417 . . . . 0.94999999999999996 110.583 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.8 -4.15 21.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.939 -0.648 . . . . 0.71999999999999997 112.988 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 4.2 mm? -112.19 -27.41 8.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.869 0.322 . . . . 2.1600000000000001 111.869 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 39' ' ' ILE . 16.9 tp -120.62 100.66 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.3 -0.409 . . . . 1.1200000000000001 110.74 -170.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 89.7 mtm180 -133.18 141.44 48.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.6 0.222 . . . . 1.49 111.6 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.0 ttpt -114.09 123.8 50.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 110.244 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.578 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 18.2 ttmt -103.58 118.96 37.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.983 -0.377 . . . . 1.6499999999999999 109.983 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 52' ' ' PRO . 1.3 p -76.02 96.74 3.86 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.989 -0.55 . . . . 1.03 110.5 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 111' ' ' THR . 12.5 mt -63.66 -52.93 58.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.893 -1.521 . . . . 1.0600000000000001 106.893 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.882 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 85.1 t -132.84 127.1 20.15 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-N 113.038 -1.892 . . . . 1.1399999999999999 106.157 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 30.4 Cg_endo -106.66 56.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.956 2.437 . . . . 0.56000000000000005 114.502 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.718 0 C-N-CA 121.118 -0.563 . . . . 0.55000000000000004 113.201 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.435 -1.206 0 CA-C-O 121.292 0.568 . . . . 1.3600000000000001 111.26 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -153.86 144.35 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.786 -0.82 . . . . 1.8200000000000001 108.786 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.472 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 48.1 mtm180 -92.51 110.1 42.77 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.846 -0.428 . . . . 3.3900000000000001 109.846 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.728 ' HD3' HG22 ' A' ' 108' ' ' VAL . 5.8 Cg_endo -47.36 141.21 14.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.353 2.702 . . . . 0.42999999999999999 113.529 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.675 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.0 t -89.56 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.432 -0.804 . . . . 1.47 109.435 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.721 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 56.1 mttt -63.38 106.17 0.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.838 0.828 . . . . 1.71 110.85 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.89 -28.85 2.12 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.145 -1.388 . . . . 0.41999999999999998 110.199 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.675 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -79.28 128.0 32.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.859 -0.793 . . . . 0.58999999999999997 108.859 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.8 m -78.32 129.79 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.055 -1.091 . . . . 1.8600000000000001 108.055 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.9 m -125.99 146.65 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.997 -0.547 . . . . 1.0700000000000001 110.284 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.9 p -95.94 112.31 24.07 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.897 -0.592 . . . . 1.0600000000000001 109.825 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.678 HG21 HD22 ' A' ' 99' ' ' LEU . 7.4 m -110.5 142.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.849 -0.614 . . . . 1.05 110.074 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -100.76 116.42 32.61 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.721 -1.585 . . . . 0.28999999999999998 106.721 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.402 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.8 OUTLIER -117.79 136.94 53.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.285 1.041 . . . . 1.1299999999999999 111.336 178.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.08 113.3 12.6 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.003 -1.851 . . . . 0.27000000000000002 106.003 165.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.582 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.1 m -101.37 127.18 48.12 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.743 -1.117 . . . . 1.04 111.29 -168.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 17.1 t -104.89 160.46 14.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.309 -0.86 . . . . 1.54 109.626 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HG ' HG11 ' A' ' 80' ' ' VAL . 13.7 mt -89.64 166.06 13.85 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.521 -0.763 . . . . 1.51 109.795 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.26 -17.84 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.578 0.549 . . . . 1.1399999999999999 110.743 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -92.61 -8.68 43.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.641 -0.709 . . . . 2.1400000000000001 111.162 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.38 40.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.838 -0.696 . . . . 0.51000000000000001 111.855 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 m -98.17 109.91 22.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.878 0.371 . . . . 1.1599999999999999 111.469 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.7 mtt180 -76.04 116.42 16.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.54000000000000004 110.539 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.736 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -101.98 -8.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.561 -1.2 . . . . 1.0600000000000001 111.886 -168.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.582 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.2 pt20 -160.57 136.13 8.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.107 -0.497 . . . . 0.63 109.983 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -136.41 112.65 9.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.008 0.433 . . . . 1.3400000000000001 110.283 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.0 115.51 15.41 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.436 0.636 . . . . 2.5899999999999999 110.221 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 55.9 Cg_endo -71.05 -13.26 31.31 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.201 2.601 . . . . 0.90000000000000002 113.637 -172.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -160.16 110.41 1.84 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.292 1.044 . . . . 1.3700000000000001 111.571 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.497 ' HB3' HG22 ' A' ' 68' ' ' VAL . 21.1 tp -119.62 100.59 7.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.126 -1.852 . . . . 1.1399999999999999 108.756 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 10.7 p -95.73 132.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.275 -0.639 . . . . 1.5900000000000001 109.275 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.0 p90 -153.47 158.43 41.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.612 -0.267 . . . . 0.25 110.445 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.482 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 5.6 m -79.04 113.65 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.05 -0.523 . . . . 1.0700000000000001 109.788 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.785 HD12 ' HD3' ' A' ' 104' ' ' PRO . 16.4 tp -61.76 130.27 44.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.455 . . . . 1.3300000000000001 109.921 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.721 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 83.51 6.35 87.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.37 111.947 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.482 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 32.3 t70 -100.12 -5.62 27.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.12 -0.696 . . . . 0.93000000000000005 109.12 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.8 m 54.9 34.09 21.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.125 -0.943 . . . . 1.55 109.839 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.74 -9.13 58.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.445 1.117 . . . . 1.3300000000000001 108.765 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.3 m -125.26 -159.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 113.531 -1.668 . . . . 1.0800000000000001 110.711 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.5 pt -81.62 138.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.088 -1.449 . . . . 1.0600000000000001 107.088 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.548 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.6 tp60 -60.74 -28.68 68.87 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.835 -0.346 . . . . 0.40000000000000002 110.899 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.07 -37.32 69.14 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.079 0.466 . . . . 1.0800000000000001 110.679 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 68' ' ' VAL . 52.7 tp -81.84 -40.65 22.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.637 . . . . 1.0700000000000001 110.719 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' HE21 ' A' ' 97' ' ' GLN . 14.3 t70 -61.93 -27.91 69.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.434 -0.803 . . . . 0.26000000000000001 109.886 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 66.3 mt -90.97 -36.54 14.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.335 -0.848 . . . . 1.0600000000000001 112.355 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.521 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 p -72.03 -26.46 62.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.63 -0.428 . . . . 1.53 111.189 -173.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' LEU . 54.5 t -64.6 -55.74 27.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.457 0.539 . . . . 1.0600000000000001 112.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.785 ' HD3' HD12 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -61.09 -24.44 79.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.071 1.847 . . . . 0.40999999999999998 112.007 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.603 HD11 HG22 ' A' ' 39' ' ' ILE . 17.0 mt -73.1 -30.84 63.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.152 -0.477 . . . . 1.3500000000000001 111.155 172.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.807 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -92.07 152.72 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 1.3100000000000001 111.425 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.52 151.89 21.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.002 0.43 . . . . 0.96999999999999997 110.642 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.728 HG22 ' HD3' ' A' ' 60' ' ' PRO . 2.5 t -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.33 0.586 . . . . 1.47 110.337 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.63 43.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.362 -0.835 . . . . 0.28000000000000003 112.548 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.882 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.4 168.18 9.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.407 0.622 . . . . 0.40999999999999998 110.971 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.446 HG21 HD11 ' A' ' 50' ' ' LEU . 20.9 m -130.63 117.44 19.51 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.175 -1.046 . . . . 1.0700000000000001 108.175 174.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.35 138.27 53.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.032 0.444 . . . . 1.0 110.684 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.2 ttp -98.42 116.82 31.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.9399999999999999 107.216 173.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.651 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.9 t -112.25 132.04 62.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.661 -0.496 . . . . 1.0600000000000001 109.661 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.542 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 91.4 m -109.39 112.87 25.25 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.175 -1.046 . . . . 1.03 108.175 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.46 135.69 54.73 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.925 -1.489 . . . . 1.01 108.946 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.729 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.9 t70 -52.94 146.54 10.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.397 -0.964 . . . . 0.57999999999999996 108.397 172.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.64 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.6 t -55.94 -26.07 46.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.071 0.463 . . . . 1.04 110.439 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.687 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.5 ptpt -54.87 -29.75 56.28 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.103 -0.373 . . . . 1.4299999999999999 111.833 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.576 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.1 m-85 -97.15 2.31 50.95 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.042 0.448 . . . . 1.04 109.989 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 64.6 m -122.72 -89.91 0.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.141 -0.936 . . . . 0.87 110.665 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.4 m-85 -141.29 41.08 1.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.103 -0.475 . . . . 0.95999999999999996 112.176 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.94 -81.82 0.04 OUTLIER Glycine 0 C--N 1.343 0.943 0 N-CA-C 113.995 0.358 . . . . 0.25 113.995 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.98 15.46 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.525 2.15 . . . . 0.90000000000000002 110.924 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.7 mt-30 -103.51 -48.63 3.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.65000000000000002 110.071 -174.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.462 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.12 142.81 3.5 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 114.668 -1.151 . . . . 0.29999999999999999 112.051 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 14.1 t -90.68 165.03 13.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.577 0.584 . . . . 0.90000000000000002 112.577 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -62.36 -23.28 66.71 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 115.114 -0.948 . . . . 3.6099999999999999 112.728 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 1.044 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 18.3 t -105.51 -66.54 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.005 -0.739 . . . . 1.52 109.005 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.044 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 5.4 Cg_endo -99.07 129.63 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.937 2.425 . . . . 0.44 111.922 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.462 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -56.25 98.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.615 -1.254 . . . . 1.6899999999999999 107.615 158.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.642 HD11 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -65.22 130.44 94.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.317 -0.994 . . . . 1.0600000000000001 108.317 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.26 147.71 34.93 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.642 2.228 . . . . 1.03 112.587 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.71 137.93 83.14 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.473 2.115 . . . . 0.89000000000000001 113.105 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.729 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 10.9 p80 53.04 21.45 2.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.665 -1.152 . . . . 3.1899999999999999 113.342 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.632 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.78 132.88 40.72 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.983 -0.747 . . . . 1.04 108.983 172.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.9 113.82 12.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.141 0.496 . . . . 1.05 110.635 -171.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 115' ' ' THR . 1.3 tp -92.07 133.5 35.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.902 -0.59 . . . . 1.0600000000000001 110.516 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.4 t -118.53 100.69 7.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.334 -0.617 . . . . 1.8200000000000001 109.334 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 72' ' ' THR . 1.5 pp -112.53 136.55 51.92 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.868 -0.606 . . . . 1.1499999999999999 111.578 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.5 tt0 -105.0 114.49 28.72 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.481 -0.562 . . . . 1.05 109.481 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.621 HG13 HD11 ' A' ' 99' ' ' LEU . 3.6 m -115.76 119.87 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.013 0.745 . . . . 1.0800000000000001 113.013 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 4.1 m -90.46 111.71 23.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 1.0900000000000001 110.754 170.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.647 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.1 tp -84.1 93.87 8.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.6 -0.889 . . . . 1.0700000000000001 108.6 172.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.1 mtmt -88.1 -33.94 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.095 -0.957 . . . . 1.6899999999999999 110.547 -171.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.453 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.1 m -149.68 154.41 38.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.259 -0.428 . . . . 1.1200000000000001 111.729 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -137.95 128.26 26.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.299 -0.63 . . . . 0.98999999999999999 109.299 172.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 109.58 -0.526 . . . . 1.6200000000000001 109.58 179.02 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.673 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.274 -0.639 . . . . 0.53000000000000003 109.274 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.9 tp -73.31 110.61 7.73 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.672 -0.492 . . . . 1.1899999999999999 109.672 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -75.24 124.59 27.33 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.003 -0.74 . . . . 2.5099999999999998 109.003 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.561 HD12 HD12 ' A' ' 45' ' ' LEU . 14.4 mt -58.86 -31.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.872 -1.058 . . . . 1.1499999999999999 110.559 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.5 mt -116.13 -4.79 11.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.615 -0.72 . . . . 1.4299999999999999 110.64 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.85 23.31 72.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.057 -0.817 . . . . 0.65000000000000002 111.057 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.42 -15.57 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.482 0.549 . . . . 0.94999999999999996 112.482 -174.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.427 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 114.39 -13.79 20.92 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.575 -0.821 . . . . 0.71999999999999997 114.031 166.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -129.22 -2.21 5.06 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.057 0.762 . . . . 2.1600000000000001 113.057 -173.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.561 HD12 HD12 ' A' ' 39' ' ' ILE . 21.3 tp -122.34 100.25 6.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.008 -0.368 . . . . 1.1200000000000001 110.008 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -136.09 139.32 42.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.308 0.484 . . . . 1.49 112.308 -170.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HG3' HG21 ' A' ' 114' ' ' VAL . 12.8 ttpt -110.97 123.56 50.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.36 -0.382 . . . . 1.1200000000000001 110.004 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.673 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -108.3 125.86 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.571 0.224 . . . . 1.6499999999999999 110.603 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 p -81.93 103.1 11.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.159 0.504 . . . . 1.03 111.331 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 111' ' ' THR . 9.8 mt -69.47 -50.05 49.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.828 -1.545 . . . . 1.0600000000000001 106.828 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.845 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.0 t -140.04 126.14 11.93 Favored Pre-proline 0 CA--C 1.501 -0.907 0 CA-C-N 112.891 -1.959 . . . . 1.1399999999999999 106.688 170.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.4 Cg_endo -105.79 59.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.945 2.43 . . . . 0.56000000000000005 113.27 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.931 -0.577 . . . . 0.55000000000000004 112.762 178.147 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.492 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.832 -0.433 . . . . 1.3600000000000001 109.832 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.4 m -150.05 142.58 24.44 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.979 -0.748 . . . . 1.8200000000000001 108.979 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 36.7 mtm180 -90.14 116.45 66.4 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.402 -0.592 . . . . 3.3900000000000001 109.402 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.719 ' HD3' HG22 ' A' ' 108' ' ' VAL . 9.6 Cg_endo -50.86 146.86 20.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.569 2.846 . . . . 0.42999999999999999 112.902 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.578 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.2 t -96.24 151.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 1.47 109.582 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 90' ' ' LEU . 97.2 mttt -62.44 121.45 13.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.61 0.719 . . . . 1.71 109.42 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.45 -25.55 5.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.675 -1.148 . . . . 0.41999999999999998 111.114 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.663 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 134.62 34.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.033 -0.728 . . . . 0.58999999999999997 109.033 178.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 m -82.12 131.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 108.184 -1.043 . . . . 1.8600000000000001 108.184 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 28.1 m -128.04 148.03 32.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.362 -0.836 . . . . 1.0700000000000001 110.412 -171.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.513 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 34.0 p -97.95 112.88 24.64 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.129 0.49 . . . . 1.0600000000000001 110.118 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 86' ' ' LEU . 4.7 m -110.2 144.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.098 0.475 . . . . 1.05 110.246 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.632 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.54 117.4 34.84 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.001 -1.481 . . . . 0.28999999999999998 107.001 170.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 1.2 pt? -117.91 137.04 53.08 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.146 -1.022 . . . . 1.1299999999999999 111.018 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.625 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.42 114.22 11.94 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.308 -2.108 . . . . 0.27000000000000002 105.308 165.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.597 ' HB ' ' CG ' ' A' ' 81' ' ' GLN . 86.4 m -104.61 127.45 52.36 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.816 -1.083 . . . . 1.04 110.914 -166.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.794 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 4.2 t -105.52 159.94 15.55 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.442 -0.799 . . . . 1.54 109.206 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.404 ' HG ' HG12 ' A' ' 80' ' ' VAL . 13.9 mt -86.67 165.22 16.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 1.51 109.295 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.72 -23.92 54.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 1.1399999999999999 110.169 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -86.28 -4.18 59.12 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.695 -0.684 . . . . 2.1400000000000001 111.655 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.89 6.76 57.93 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.535 -0.84 . . . . 0.51000000000000001 113.392 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 89.2 m -91.52 112.88 24.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.514 0.657 . . . . 1.1599999999999999 111.947 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 32.9 mtt180 -74.76 117.11 16.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.793 0.806 . . . . 0.54000000000000004 110.634 176.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.515 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.8 m -101.86 -9.1 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.438 -1.255 . . . . 1.0600000000000001 112.491 -168.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.597 ' CG ' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -156.34 126.57 6.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.422 -0.354 . . . . 0.63 111.054 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -122.57 121.84 37.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 1.3400000000000001 109.953 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 7.3 tt0 -142.42 114.61 6.23 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.552 . . . . 2.5899999999999999 110.335 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -70.33 -18.68 34.18 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.538 2.826 . . . . 0.90000000000000002 113.063 -172.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.29 108.25 2.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.175 0.988 . . . . 1.3700000000000001 111.662 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.584 ' HB3' HG23 ' A' ' 68' ' ' VAL . 24.0 tp -117.41 106.45 13.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.484 -1.689 . . . . 1.1399999999999999 108.621 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -100.56 132.49 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.898 -0.408 . . . . 1.5900000000000001 109.898 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.4 p90 -156.81 162.99 39.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.336 -0.393 . . . . 0.25 110.534 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -88.92 117.45 27.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.185 -0.461 . . . . 1.0700000000000001 110.295 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.531 HD23 ' HD3' ' A' ' 104' ' ' PRO . 36.8 mt -60.83 136.59 58.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 1.3300000000000001 111.62 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.407 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 75.25 12.93 83.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.879 -0.677 . . . . 0.37 111.452 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.48 -3.37 14.44 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.082 -0.71 . . . . 0.93000000000000005 109.082 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.9 m 57.67 35.3 25.5 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.762 -1.108 . . . . 1.55 109.665 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.33 -9.0 58.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.126 0.965 . . . . 1.3300000000000001 108.484 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.7 -158.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.04 -1.436 . . . . 1.0800000000000001 110.747 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.9 pt -80.39 138.63 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 107.519 -1.289 . . . . 1.0600000000000001 107.519 174.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.3 tp60 -59.71 -30.22 68.66 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.052 -0.259 . . . . 0.40000000000000002 111.038 -172.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.82 71.81 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.161 0.505 . . . . 1.0800000000000001 110.484 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.564 ' O ' HG21 ' A' ' 103' ' ' VAL . 45.3 tp -79.55 -42.14 25.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.683 -0.69 . . . . 1.0700000000000001 110.567 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.423 ' HB3' HE21 ' A' ' 97' ' ' GLN . 22.0 t70 -59.64 -30.54 68.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.057 -0.974 . . . . 0.26000000000000001 110.068 -174.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.82 -36.07 14.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.197 -0.91 . . . . 1.0600000000000001 112.929 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.518 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 33.8 p -70.93 -29.54 65.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.143 0.496 . . . . 1.53 111.034 -171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 99' ' ' LEU . 80.5 t -64.74 -54.25 37.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.444 -0.798 . . . . 1.0600000000000001 112.957 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.531 ' HD3' HD23 ' A' ' 90' ' ' LEU . 21.2 Cg_endo -63.93 -20.41 68.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.737 1.625 . . . . 0.40999999999999998 111.661 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 39' ' ' ILE . 23.7 mt -78.47 -17.02 56.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.619 . . . . 1.3500000000000001 110.873 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.709 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -100.97 156.6 17.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.988 -0.551 . . . . 1.3100000000000001 110.59 -179.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -95.31 154.2 17.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.96999999999999997 110.817 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.719 HG22 ' HD3' ' A' ' 60' ' ' PRO . 2.4 t -62.43 123.89 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.454 0.645 . . . . 1.47 110.277 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.64 45.48 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.903 -1.044 . . . . 0.28000000000000003 112.754 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.845 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.7 pt-20 -105.14 167.62 9.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.464 0.649 . . . . 0.40999999999999998 111.011 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.439 HG21 HD13 ' A' ' 50' ' ' LEU . 13.7 m -129.16 116.99 20.05 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.974 -1.121 . . . . 1.0700000000000001 107.974 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.424 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . . . -118.32 136.78 53.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.81 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.9 ttm -98.34 117.14 32.07 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.22 -1.4 . . . . 1.9399999999999999 107.22 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.516 HG21 ' HG3' ' A' ' 47' ' ' LYS . 11.4 t -112.96 128.45 69.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.007 -0.368 . . . . 1.0600000000000001 110.007 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.522 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 73.8 m -107.45 112.6 25.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.401 -0.92 . . . . 1.03 108.759 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.441 ' HB1' ' SG ' ' A' ' 121' ' ' CYS . . . -121.67 134.32 54.97 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.944 -1.48 . . . . 1.01 109.229 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.727 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.2 t70 -52.61 145.44 11.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.647 -0.871 . . . . 0.57999999999999996 108.647 172.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.576 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -52.04 -26.65 11.38 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 123.416 0.448 . . . . 1.04 110.54 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.727 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 13.8 ptpt -54.33 -35.02 62.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.95 0.352 . . . . 1.4299999999999999 111.95 176.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 87.5 m-85 -95.93 2.21 53.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.094 0.473 . . . . 1.04 110.373 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 80.2 m -118.47 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.116 -0.947 . . . . 0.87 110.254 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.3 m-85 -144.41 40.71 1.33 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.34 -0.544 . . . . 0.95999999999999996 112.364 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.486 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.07 -83.08 0.04 OUTLIER Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.048 -0.596 . . . . 0.25 113.694 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.73 8.7 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.539 2.159 . . . . 0.90000000000000002 110.986 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.1 mt-30 -104.22 -51.4 3.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.624 0.726 . . . . 0.65000000000000002 110.216 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.66 143.71 4.19 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.478 -1.237 . . . . 0.29999999999999999 111.769 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t -91.77 156.75 17.32 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.62 0.6 . . . . 0.90000000000000002 112.62 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 129' ' ' SER . 7.4 ptm180 -43.1 -63.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.724 -1.125 . . . . 3.6099999999999999 112.159 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.994 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 17.2 m -72.56 -66.41 0.61 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 121.021 -0.271 . . . . 1.52 110.431 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.994 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -105.74 128.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.397 2.064 . . . . 0.44 112.31 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.0 t80 -57.31 98.24 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.41 -0.959 . . . . 1.6899999999999999 108.41 164.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.583 HG12 ' CB ' ' A' ' 127' ' ' SER . 26.9 mm -66.89 129.7 94.02 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.633 -0.506 . . . . 1.0600000000000001 109.633 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 11.6 Cg_endo -57.49 145.3 89.19 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.624 2.216 . . . . 1.03 112.574 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.486 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 39.6 Cg_exo -57.9 134.27 61.4 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.802 2.335 . . . . 0.89000000000000001 112.888 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 31.6 m170 66.88 10.97 8.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.74 -1.118 . . . . 3.1899999999999999 112.471 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -71.81 124.54 25.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.337 -0.986 . . . . 1.04 108.337 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.07 112.58 10.35 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.153 -0.619 . . . . 1.05 109.59 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 115' ' ' THR . 1.7 tp -90.14 131.64 35.88 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.546 -0.752 . . . . 1.0600000000000001 110.065 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.5 t -116.84 99.94 7.44 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.821 -0.807 . . . . 1.8200000000000001 108.821 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.3 pp -110.61 136.09 50.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.083 -0.508 . . . . 1.1499999999999999 111.106 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.625 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 34.5 tt0 -103.8 113.54 27.13 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.989 -0.745 . . . . 1.05 108.989 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.7 m -114.51 120.8 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.606 0.717 . . . . 1.0800000000000001 112.486 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.7 m -91.41 113.09 25.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.938 -1.028 . . . . 1.0900000000000001 110.139 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.709 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.0 tp -84.65 98.13 10.02 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.885 -0.783 . . . . 1.0700000000000001 108.885 173.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.453 ' C ' ' HG1' ' A' ' 146' ' ' THR . 27.6 mtmt -94.42 -28.6 15.41 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.096 -0.957 . . . . 1.6899999999999999 110.664 -171.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.513 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 24.5 m -153.72 147.44 25.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 1.1200000000000001 111.663 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 127.88 25.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.792 -0.448 . . . . 0.98999999999999999 109.792 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.225 -0.187 0 C-N-CA 120.643 -0.423 . . . . 1.6200000000000001 110.916 -177.596 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.671 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 110.193 -0.299 . . . . 0.53000000000000003 110.193 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.93 110.69 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.155 -0.475 . . . . 1.1899999999999999 110.903 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.727 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -71.03 99.94 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.637 -0.71 . . . . 2.5099999999999998 110.691 173.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 105' ' ' LEU . 15.8 mt -48.71 -48.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.973 -1.012 . . . . 1.1499999999999999 112.189 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 88.4 mt -105.93 4.64 29.76 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.612 -0.435 . . . . 1.4299999999999999 111.103 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.696 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 67.86 18.73 70.84 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.65000000000000002 112.416 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.691 HD21 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -98.03 -23.6 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.82 0.304 . . . . 0.94999999999999996 111.82 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.691 ' N ' HD21 ' A' ' 42' ' ' ASN . . . 105.18 -27.21 19.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.189 -1.005 . . . . 0.71999999999999997 113.722 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -94.26 -11.18 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.395 0.597 . . . . 2.1600000000000001 111.732 -174.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.3 tp -121.52 107.94 13.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 110.443 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 63.2 mtm180 -142.39 141.63 32.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.567 -0.288 . . . . 1.49 111.435 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.732 ' HG3' HG22 ' A' ' 114' ' ' VAL . 18.7 ttpt -111.04 129.6 55.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.951 -0.388 . . . . 1.1200000000000001 109.951 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 12.4 ttmt -108.05 128.52 54.75 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.773 0.32 . . . . 1.6499999999999999 110.778 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -80.56 101.33 9.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.949 -0.569 . . . . 1.03 110.91 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 HG22 ' A' ' 111' ' ' THR . 10.0 mt -68.25 -51.85 40.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.042 -1.466 . . . . 1.0600000000000001 107.042 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 79.3 t -138.63 126.0 13.35 Favored Pre-proline 0 CA--C 1.497 -1.075 0 CA-C-N 113.091 -1.868 . . . . 1.1399999999999999 106.574 169.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -103.12 64.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.818 2.345 . . . . 0.56000000000000005 113.491 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.872 0 CA-C-N 115.019 -0.991 . . . . 0.55000000000000004 113.085 175.558 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.44 -0.939 0 CA-C-O 121.299 0.571 . . . . 1.3600000000000001 110.977 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.702 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 9.8 m -153.08 127.07 8.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.646 -0.872 . . . . 1.8200000000000001 108.646 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 22.1 ptt180 -90.41 123.46 65.44 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 119.66 -0.816 . . . . 3.3900000000000001 110.809 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 147' ' ' ALA . 15.1 Cg_endo -56.39 155.22 26.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.909 3.073 . . . . 0.42999999999999999 113.741 -175.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.6 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.1 t -94.87 153.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.307 -0.861 . . . . 1.47 109.389 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.887 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 21.1 mtpt -67.59 119.35 12.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.496 0.665 . . . . 1.71 109.401 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.36 -23.5 5.14 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.2 -1.16 . . . . 0.41999999999999998 110.2 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.644 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.79 142.69 33.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.58999999999999997 109.263 176.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.73 121.49 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.577 -0.897 . . . . 1.8600000000000001 108.577 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.6 m -126.6 146.37 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 1.0700000000000001 111.895 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.442 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 28.9 p -104.22 114.05 28.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.381 -0.827 . . . . 1.0600000000000001 110.337 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.624 HG22 HD22 ' A' ' 99' ' ' LEU . 30.0 m -110.59 145.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.083 -0.647 . . . . 1.05 110.038 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -102.37 115.08 29.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.804 -1.554 . . . . 0.28999999999999998 106.804 169.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -116.19 136.36 53.08 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.149 -1.02 . . . . 1.1299999999999999 110.91 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.18 113.96 13.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.993 -1.854 . . . . 0.27000000000000002 105.993 166.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 61.0 m -104.24 125.71 50.74 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.683 -1.144 . . . . 1.04 111.186 -168.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.6 t -105.75 159.17 16.2 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.206 -0.906 . . . . 1.54 109.034 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.435 ' HG ' HG11 ' A' ' 80' ' ' VAL . 9.3 mt -86.34 165.2 16.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.792 -0.64 . . . . 1.51 110.017 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.93 -17.82 4.17 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.48 0.488 . . . . 1.1399999999999999 112.114 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -98.09 -15.2 20.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 2.1400000000000001 110.998 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.13 23.11 6.53 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.769 -0.729 . . . . 0.51000000000000001 113.357 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 m -101.42 109.58 21.43 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.302 -0.528 . . . . 1.1599999999999999 111.115 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 11.0 mtt180 -73.75 114.4 11.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.674 0.749 . . . . 0.54000000000000004 110.462 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.617 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.9 m -98.73 -9.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.529 -1.214 . . . . 1.0600000000000001 111.86 -171.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 8.4 pt20 -162.06 127.14 3.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.082 -0.508 . . . . 0.63 110.168 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.443 ' OE2' ' HG2' ' A' ' 71' ' ' GLN . 16.8 tt0 -130.52 106.85 8.79 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.641 -0.503 . . . . 1.3400000000000001 109.641 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 5.1 tt0 -126.91 117.98 22.27 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.444 -0.798 . . . . 2.5899999999999999 110.568 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 9.9 Cg_exo -71.39 -18.59 29.7 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.66 2.907 . . . . 0.90000000000000002 113.932 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -161.99 99.28 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.573 1.178 . . . . 1.3700000000000001 112.416 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.2 107.87 19.03 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.171 -1.831 . . . . 1.1399999999999999 108.7 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.6 p -104.6 137.12 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.753 -0.462 . . . . 1.5900000000000001 109.753 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.584 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 17.5 p90 -158.73 167.92 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.71 0.29 . . . . 0.25 111.332 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -88.63 112.09 22.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.263 -0.643 . . . . 1.0700000000000001 109.263 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.887 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 12.8 tp -53.44 121.55 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.116 -0.493 . . . . 1.3300000000000001 111.072 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.529 ' CA ' ' HE2' ' A' ' 62' ' ' LYS . . . 97.09 -3.21 61.95 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.444 -0.884 . . . . 0.37 113.383 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.7 10.4 41.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.97 -0.692 . . . . 0.93000000000000005 109.454 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.3 m 58.98 30.54 20.37 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 114.671 -1.15 . . . . 1.55 110.308 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 88' ' ' PHE . 18.1 m-20 -67.28 -11.29 57.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.816 0.817 . . . . 1.3300000000000001 109.835 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 m -131.66 -162.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.245 -1.343 . . . . 1.0800000000000001 110.026 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.527 HG13 ' H ' ' A' ' 99' ' ' LEU . 28.0 pt -76.11 141.27 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.668 -1.234 . . . . 1.0600000000000001 107.668 173.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -61.85 -28.61 69.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.555 -0.293 . . . . 0.40000000000000002 110.863 -173.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.9 80.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.988 0.423 . . . . 1.0800000000000001 110.226 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.624 HD22 HG22 ' A' ' 68' ' ' VAL . 57.2 tp -73.17 -40.98 64.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.479 -0.782 . . . . 1.0700000000000001 110.955 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.9 -31.36 69.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.08 -0.963 . . . . 0.26000000000000001 109.906 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.57 -34.49 15.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.127 -0.942 . . . . 1.0600000000000001 112.167 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 78.3 p -70.68 -28.64 64.92 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.918 -0.313 . . . . 1.53 110.911 -173.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 99' ' ' LEU . 55.6 t -64.47 -55.0 33.15 Favored Pre-proline 0 C--O 1.217 -0.648 0 CA-C-N 115.991 -0.549 . . . . 1.0600000000000001 112.227 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.872 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.0 Cg_endo -63.78 -17.79 61.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.95 1.766 . . . . 0.40999999999999998 111.873 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 39' ' ' ILE . 14.0 mt -82.75 -15.69 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.933 -0.576 . . . . 1.3500000000000001 111.136 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.744 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -103.77 148.57 25.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.144 -0.48 . . . . 1.3100000000000001 111.026 178.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.594 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -90.38 160.67 15.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.96999999999999997 110.786 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -66.97 129.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.544 0.687 . . . . 1.47 110.311 -176.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.94 66.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.239 -0.892 . . . . 0.28000000000000003 112.153 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -98.05 166.97 11.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.5 0.667 . . . . 0.40999999999999998 110.939 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.487 HG22 HD11 ' A' ' 50' ' ' LEU . 8.1 m -128.74 118.18 22.39 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.972 -1.121 . . . . 1.0700000000000001 107.972 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.32 136.61 54.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.602 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.1 ttp -101.89 117.04 34.01 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.667 -1.234 . . . . 1.9399999999999999 107.667 171.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.732 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.8 t -110.84 134.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.563 -0.532 . . . . 1.0600000000000001 109.563 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.547 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 89.5 m -107.66 114.06 27.78 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 119.202 -0.999 . . . . 1.03 108.491 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.16 130.7 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.958 -1.474 . . . . 1.01 109.022 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.762 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 5.8 t70 -53.06 147.31 9.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.437 -0.579 . . . . 0.57999999999999996 109.437 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.9 t -53.0 -29.27 28.25 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 121.027 0.441 . . . . 1.04 110.197 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.3 ptpt -55.26 -31.48 61.59 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.079 0.4 . . . . 1.4299999999999999 112.079 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.575 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.0 m-85 -95.44 -0.66 52.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.196 0.522 . . . . 1.04 110.148 175.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.587 ' HB3' HD21 ' A' ' 138' ' ' LEU . 77.3 m -118.24 -87.82 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.119 -0.946 . . . . 0.87 110.648 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.534 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.8 m-85 -144.94 36.2 1.14 Allowed 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.376 -0.53 . . . . 0.95999999999999996 112.063 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.89 -76.77 0.18 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.825 -0.702 . . . . 0.25 113.052 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.9 3.66 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.471 2.114 . . . . 0.90000000000000002 111.507 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -104.74 -51.92 2.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.506 0.67 . . . . 0.65000000000000002 109.91 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.527 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 83.92 141.83 4.94 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.592 -1.186 . . . . 0.29999999999999999 111.31 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.4 t -90.54 153.03 20.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.817 0.341 . . . . 0.90000000000000002 111.134 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -52.82 -42.48 65.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.386 -0.824 . . . . 3.6099999999999999 111.971 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.996 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 10.1 m -84.97 -66.06 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.266 -0.642 . . . . 1.52 109.266 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.996 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.0 Cg_endo -105.38 126.28 0.06 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.44 111.497 171.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -59.65 97.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.776 -1.194 . . . . 1.6899999999999999 107.776 167.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.563 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.9 mm -65.52 126.92 92.48 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.966 -0.561 . . . . 1.0600000000000001 109.633 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.89 142.45 42.73 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.639 2.226 . . . . 1.03 112.008 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.482 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 41.1 Cg_exo -57.03 134.42 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.352 2.035 . . . . 0.89000000000000001 112.0 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.441 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.8 OUTLIER 74.28 0.67 3.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.363 -0.835 . . . . 3.1899999999999999 111.422 174.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.6 119.41 12.32 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.193 -0.669 . . . . 1.04 109.193 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.24 113.81 10.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.195 -0.602 . . . . 1.05 110.54 -171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.3 mp -89.6 134.21 34.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.861 -0.609 . . . . 1.0600000000000001 111.708 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 t -118.0 100.47 7.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.025 -0.731 . . . . 1.8200000000000001 109.025 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 pp -111.02 137.05 49.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.609 -0.723 . . . . 1.1499999999999999 111.592 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.586 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 81.0 tt0 -103.53 124.79 49.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.703 -0.851 . . . . 1.05 108.703 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.616 HG21 ' HE3' ' A' ' 106' ' ' MET . 3.3 m -122.74 126.15 73.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.257 0.551 . . . . 1.0800000000000001 112.252 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 7.3 m -96.11 115.97 28.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.765 -0.652 . . . . 1.0900000000000001 110.219 170.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.737 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.8 tp -85.39 98.13 10.39 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.727 -0.842 . . . . 1.0700000000000001 108.727 172.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.44 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.5 mtmt -94.14 -30.3 14.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.336 -0.847 . . . . 1.6899999999999999 110.661 -169.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.5 m -150.92 146.14 26.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.128 0.49 . . . . 1.1200000000000001 111.814 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . . . -136.1 127.68 28.81 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.485 -0.932 . . . . 0.98999999999999999 108.485 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 121.18 0.514 . . . . 1.6200000000000001 111.13 -179.295 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.567 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.096 0.475 . . . . 0.53000000000000003 109.729 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.3 tp -73.01 110.33 7.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 1.1899999999999999 110.037 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.671 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -74.75 123.53 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.38 -0.528 . . . . 2.5099999999999998 109.831 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.569 HD13 HD11 ' A' ' 45' ' ' LEU . 8.4 mt -55.22 -33.21 29.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.985 -1.007 . . . . 1.1499999999999999 111.462 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -115.9 -1.39 12.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.014 -0.539 . . . . 1.4299999999999999 110.313 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.66 23.05 66.71 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.093 -0.803 . . . . 0.65000000000000002 111.093 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' OD1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -97.32 -17.67 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.622 0.601 . . . . 0.94999999999999996 112.622 -172.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.401 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.17 -15.43 18.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.446 -0.883 . . . . 0.71999999999999997 114.72 166.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -120.29 -7.79 9.74 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.972 0.73 . . . . 2.1600000000000001 112.972 -175.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.569 HD11 HD13 ' A' ' 39' ' ' ILE . 25.2 tp -121.75 100.07 6.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.578 0.228 . . . . 1.1200000000000001 110.624 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -134.86 139.23 44.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.697 0.258 . . . . 1.49 111.697 -171.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.7 ttpt -113.05 123.31 50.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.244 0.217 . . . . 1.1200000000000001 110.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.3 ttpp -111.07 117.69 33.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.832 0.349 . . . . 1.6499999999999999 111.253 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 2.2 p -74.1 98.89 3.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 1.03 111.656 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.44 HD22 ' HZ2' ' A' ' 48' ' ' LYS . 7.7 mt -67.01 -53.38 31.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.413 -1.329 . . . . 1.0600000000000001 107.413 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.799 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t -134.39 123.01 16.24 Favored Pre-proline 0 CA--C 1.498 -1.032 0 CA-C-N 112.908 -1.951 . . . . 1.1399999999999999 106.478 168.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 57.7 Cg_endo -108.37 72.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.521 2.148 . . . . 0.56000000000000005 114.578 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.55000000000000004 113.756 169.821 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.439 -0.978 0 CA-C-O 120.935 0.398 . . . . 1.3600000000000001 110.629 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -158.75 144.57 16.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.616 -0.883 . . . . 1.8200000000000001 108.616 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.452 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 49.5 mtm180 -94.13 111.38 53.06 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.659 -0.497 . . . . 3.3900000000000001 109.659 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.595 ' HG3' HD23 ' A' ' 144' ' ' LEU . 9.9 Cg_endo -49.96 149.55 11.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.693 2.928 . . . . 0.42999999999999999 113.657 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.665 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 20.2 t -96.22 153.05 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.364 -0.834 . . . . 1.47 109.531 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.886 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 98.5 mttt -68.78 119.61 13.42 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.523 0.678 . . . . 1.71 109.231 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 -28.5 3.82 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.836 -1.306 . . . . 0.41999999999999998 109.836 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -82.34 139.28 34.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.637 -0.875 . . . . 0.58999999999999997 108.637 177.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.3 m -88.69 125.74 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 108.024 -1.102 . . . . 1.8600000000000001 108.024 173.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.3 m -124.7 143.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.57 -0.741 . . . . 1.0700000000000001 111.468 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.796 HG23 HG22 ' A' ' 87' ' ' VAL . 69.4 p -90.11 113.03 24.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.423 -0.808 . . . . 1.0600000000000001 110.243 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 HD22 ' A' ' 99' ' ' LEU . 19.0 m -111.71 141.11 28.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 120.095 -0.642 . . . . 1.05 110.366 172.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.8 t-160 -101.67 119.13 38.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.848 -1.538 . . . . 0.28999999999999998 106.848 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -124.92 133.59 52.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 118.789 -1.164 . . . . 1.1299999999999999 111.297 177.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.566 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -125.45 115.13 19.77 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.082 -1.821 . . . . 0.27000000000000002 106.082 168.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.606 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 54.1 m -106.8 129.26 54.69 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.875 -1.057 . . . . 1.04 111.591 -168.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.56 155.46 18.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.192 -0.913 . . . . 1.54 109.159 177.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.499 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.0 mt -83.31 166.24 18.65 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.472 -0.785 . . . . 1.51 110.243 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -54.52 -19.18 5.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.01 -0.541 . . . . 1.1399999999999999 110.946 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -91.39 -3.59 56.54 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 110.947 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.4 10.23 62.33 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.319 -0.467 . . . . 0.51000000000000001 112.24 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.4 m -95.5 112.05 23.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 1.1599999999999999 111.441 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 14.5 mtt180 -74.38 120.02 19.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.518 0.675 . . . . 0.54000000000000004 110.609 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.5 m -108.48 -10.79 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.617 -1.174 . . . . 1.0600000000000001 112.272 -169.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.606 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.2 pt20 -159.72 125.63 4.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.288 -0.414 . . . . 0.63 109.961 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.541 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 73.4 tt0 -128.41 108.09 10.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 1.3400000000000001 109.972 174.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HB3' HD22 ' A' ' 70' ' ' LEU . 4.7 tp10 -119.18 111.56 36.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.922 -1.036 . . . . 2.5899999999999999 109.941 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 37.3 Cg_endo -66.48 -19.61 54.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.209 2.606 . . . . 0.90000000000000002 113.918 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 25.5 tt0 -165.18 101.47 0.74 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 122.364 1.078 . . . . 1.3700000000000001 112.479 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.1 tp -109.69 107.55 17.62 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.657 -1.61 . . . . 1.1399999999999999 108.786 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.796 HG22 HG23 ' A' ' 67' ' ' THR . 1.7 t -101.55 125.02 55.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.229 -0.656 . . . . 1.5900000000000001 109.229 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -144.95 161.63 38.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.586 -0.279 . . . . 0.25 110.381 -172.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -81.17 111.72 17.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.174 -0.467 . . . . 1.0700000000000001 109.774 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.886 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.1 tp -58.91 132.21 53.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 1.3300000000000001 110.161 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 84.2 2.65 89.24 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.128 -0.558 . . . . 0.37 112.415 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -99.38 -3.91 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.059 0.457 . . . . 0.93000000000000005 110.372 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.5 m 58.6 33.31 23.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.497 -0.774 . . . . 1.55 109.351 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.3 t70 -72.4 -10.68 60.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 122.534 1.159 . . . . 1.3300000000000001 108.891 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 15.5 m -130.24 -158.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.542 -1.663 . . . . 1.0800000000000001 109.665 -175.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.635 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.2 pt -80.3 137.73 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.954 -1.128 . . . . 1.0600000000000001 107.954 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.562 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.5 tp60 -59.53 -28.32 66.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.374 -0.376 . . . . 0.40000000000000002 110.408 -174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.62 93.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.133 0.492 . . . . 1.0800000000000001 110.655 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 HG13 ' A' ' 142' ' ' VAL . 58.2 tp -76.4 -38.69 55.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.706 -0.679 . . . . 1.0700000000000001 110.141 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.47 -29.09 69.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.965 -1.016 . . . . 0.26000000000000001 109.825 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 78.4 mt -91.12 -35.2 14.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.518 -0.764 . . . . 1.0600000000000001 112.533 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.553 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 23.3 p -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.088 -0.383 . . . . 1.53 111.312 -172.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 99' ' ' LEU . 54.5 t -62.23 -55.61 38.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.297 0.48 . . . . 1.0600000000000001 112.297 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.816 ' HD3' HD12 ' A' ' 90' ' ' LEU . 19.0 Cg_endo -62.6 -23.21 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.898 1.732 . . . . 0.40999999999999998 111.305 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 39' ' ' ILE . 16.8 mt -78.14 -15.62 58.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.55 . . . . 1.3500000000000001 111.707 173.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.6 ' HE1' HG23 ' A' ' 142' ' ' VAL . 2.9 ptm -106.93 154.9 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.497 -0.32 . . . . 1.3100000000000001 111.261 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.16 153.56 20.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.912 0.387 . . . . 0.96999999999999997 110.532 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -64.19 127.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.618 0.723 . . . . 1.47 109.972 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.58 58.4 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.128 -0.942 . . . . 0.28000000000000003 112.865 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.799 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.4 pt-20 -99.07 167.71 10.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.629 0.728 . . . . 0.40999999999999998 111.455 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.43 HG23 HD12 ' A' ' 50' ' ' LEU . 7.4 m -128.69 117.83 21.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.83 -1.174 . . . . 1.0700000000000001 107.83 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.72 139.01 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.995 0.426 . . . . 1.0 110.652 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.7 ttm -98.21 118.27 34.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.307 -1.368 . . . . 1.9399999999999999 107.307 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.4 t -115.35 128.2 72.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.781 -0.452 . . . . 1.0600000000000001 109.781 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.515 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 85.2 m -106.14 113.98 27.83 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.206 -1.035 . . . . 1.03 108.206 172.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.72 136.88 53.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.31 -1.314 . . . . 1.01 109.617 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.631 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.0 t70 -55.49 148.92 14.47 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.101 -0.703 . . . . 0.57999999999999996 109.101 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.632 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -56.32 -27.29 55.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.136 0.493 . . . . 1.04 110.453 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.631 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 15.1 ptpt -54.94 -32.63 61.54 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.215 -0.303 . . . . 1.4299999999999999 111.717 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.59 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 80.0 m-85 -96.44 0.44 50.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 120.998 0.428 . . . . 1.04 110.165 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.632 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.6 m -117.02 -92.01 0.53 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.076 -0.965 . . . . 0.87 110.382 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.523 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.2 m-85 -142.42 39.78 1.57 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.429 -0.508 . . . . 0.95999999999999996 112.233 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -53.2 -80.58 0.07 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 121.208 -0.52 . . . . 0.25 114.031 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.32 9.08 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.191 1.927 . . . . 0.90000000000000002 111.017 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.25 -50.43 3.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.065 -0.971 . . . . 0.65000000000000002 110.173 -173.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.563 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.91 143.94 4.46 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.912 -1.04 . . . . 0.29999999999999999 112.243 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.653 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.8 t -90.42 157.03 17.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.532 . . . . 0.90000000000000002 111.489 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -59.18 -34.83 72.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.287 -0.869 . . . . 3.6099999999999999 112.259 -172.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.99 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 48.2 m -89.45 -67.22 0.13 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.174 -0.61 . . . . 1.52 109.718 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.99 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -104.62 127.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.275 1.983 . . . . 0.44 111.95 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.563 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 36.5 t80 -56.91 97.87 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.194 -1.039 . . . . 1.6899999999999999 108.194 165.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -65.95 128.97 94.19 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.734 -0.666 . . . . 1.0600000000000001 109.577 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.6 Cg_exo -53.78 144.29 55.22 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.61 2.206 . . . . 1.03 112.033 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.539 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 33.2 Cg_exo -58.92 133.86 56.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.315 2.01 . . . . 0.89000000000000001 112.091 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.558 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER 73.61 0.12 3.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.232 -0.895 . . . . 3.1899999999999999 112.775 177.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -66.4 123.52 20.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.728 -0.471 . . . . 1.04 109.728 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.89 113.52 11.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.425 0.631 . . . . 1.05 110.41 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.0 OUTLIER -92.06 132.4 36.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.455 -0.793 . . . . 1.0600000000000001 111.214 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.0 t -116.6 100.65 7.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.182 -0.673 . . . . 1.8200000000000001 109.182 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -117.01 135.21 53.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.081 -0.509 . . . . 1.1499999999999999 111.664 -172.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.566 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 35.8 tt0 -99.63 117.47 34.06 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.451 -0.574 . . . . 1.05 109.451 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.827 HG13 HD13 ' A' ' 99' ' ' LEU . 5.3 m -110.51 124.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.608 . . . . 1.0800000000000001 111.95 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -99.91 108.88 21.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.36 -0.836 . . . . 1.0900000000000001 109.777 172.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.595 HD23 ' HG3' ' A' ' 60' ' ' PRO . 49.4 tp -82.59 96.91 8.23 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.384 -0.969 . . . . 1.0700000000000001 108.384 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -94.46 -25.13 17.02 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.583 -0.735 . . . . 1.6899999999999999 110.601 -170.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -154.66 146.25 23.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.876 -0.602 . . . . 1.1200000000000001 110.841 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.524 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -140.14 127.65 21.5 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.975 -0.75 . . . . 0.98999999999999999 108.975 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.288 -0.565 . . . . 1.6200000000000001 110.86 -177.506 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 7.6 m0 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.293 0.568 . . . . 0.53000000000000003 111.049 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.9 tp -81.24 111.71 17.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.333 -0.848 . . . . 1.1899999999999999 110.765 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.638 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -63.61 115.19 4.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.686 0.755 . . . . 2.5099999999999998 110.543 173.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.604 HD13 HD12 ' A' ' 45' ' ' LEU . 21.0 mt -66.86 -44.69 88.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.192 -0.913 . . . . 1.1499999999999999 111.152 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD23 HD12 ' A' ' 101' ' ' LEU . 93.0 mt -111.05 10.41 22.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 1.4299999999999999 110.14 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.638 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 77.22 -2.34 61.81 Favored Glycine 0 C--O 1.225 -0.46 0 CA-C-N 115.539 -0.755 . . . . 0.65000000000000002 112.137 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.717 HD21 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -83.74 -21.21 32.33 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.678 0.621 . . . . 0.94999999999999996 112.678 -174.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.717 ' N ' HD21 ' A' ' 42' ' ' ASN . . . 83.52 -22.67 7.23 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.413 -0.899 . . . . 0.71999999999999997 112.437 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.8 -32.84 72.85 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 122.109 0.957 . . . . 2.1600000000000001 108.948 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.604 HD12 HD13 ' A' ' 39' ' ' ILE . 21.3 tp -121.21 114.09 20.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.685 -1.598 . . . . 1.1200000000000001 110.292 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 49.8 mtm180 -142.32 143.43 32.77 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.296 0.372 . . . . 1.49 110.615 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HG3' HG21 ' A' ' 114' ' ' VAL . 23.0 ttpt -111.36 134.82 52.67 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.19 -0.3 . . . . 1.1200000000000001 110.19 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.1 ttpp -124.02 126.99 47.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.194 -0.299 . . . . 1.6499999999999999 110.194 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -79.89 116.53 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 1.03 111.223 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 ' HG3' ' A' ' 141' ' ' GLU . 7.5 mt -75.05 -49.28 20.28 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.507 -1.664 . . . . 1.0600000000000001 106.507 169.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.853 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 89.6 t -134.09 130.7 20.47 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 113.105 -1.861 . . . . 1.1399999999999999 106.287 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 20.6 Cg_endo -108.66 63.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.119 2.546 . . . . 0.56000000000000005 113.873 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.634 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-N 115.396 -0.82 . . . . 0.55000000000000004 113.685 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.445 -0.7 0 CA-C-O 121.038 0.447 . . . . 1.3600000000000001 111.13 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.13 153.19 41.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.224 -1.028 . . . . 1.8200000000000001 108.224 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -103.71 115.02 64.2 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 3.3900000000000001 110.098 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HD3' HG23 ' A' ' 108' ' ' VAL . 61.4 Cg_exo -37.26 135.66 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.827 3.018 . . . . 0.42999999999999999 113.982 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 18.9 t -90.73 150.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.092 -0.707 . . . . 1.47 109.092 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.697 ' HZ3' HD21 ' A' ' 101' ' ' LEU . 64.6 mttt -65.56 104.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.899 0.857 . . . . 1.71 111.117 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.18 -24.41 2.38 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 113.888 -1.505 . . . . 0.41999999999999998 110.113 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.679 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.044 0.449 . . . . 0.58999999999999997 109.948 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 76.1 t -83.51 117.03 28.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.313 -0.858 . . . . 1.8600000000000001 108.768 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.7 m -123.1 150.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.591 . . . . 1.0700000000000001 111.255 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.629 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 62.0 p -104.49 113.4 26.94 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.629 -0.714 . . . . 1.0600000000000001 110.085 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.611 HG22 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.3 145.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.331 -0.547 . . . . 1.05 109.977 175.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.34 114.46 28.76 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.188 -1.412 . . . . 0.28999999999999998 107.188 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.39 134.15 55.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.012 -1.075 . . . . 1.1299999999999999 111.075 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.553 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -129.94 114.72 16.19 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.902 -1.888 . . . . 0.27000000000000002 105.902 166.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.619 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 62.5 m -103.94 128.19 51.47 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.66 -1.155 . . . . 1.04 111.619 -168.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -105.01 151.21 24.22 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.914 -1.039 . . . . 1.54 108.653 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.27 165.46 25.0 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.97 -0.559 . . . . 1.51 109.604 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 6.4 pt-20 -55.77 -15.37 3.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.077 0.465 . . . . 1.1399999999999999 110.807 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -88.68 -16.71 31.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.699 -0.682 . . . . 2.1400000000000001 109.808 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.5 -4.71 37.44 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.656 -0.702 . . . . 0.51000000000000001 111.844 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -81.45 110.21 16.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.815 0.341 . . . . 1.1599999999999999 111.859 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 29.9 mtt180 -72.54 123.7 23.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.552 0.691 . . . . 0.54000000000000004 111.187 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.658 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.0 m -109.11 -15.73 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.832 -1.076 . . . . 1.0600000000000001 112.295 -170.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.616 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.9 pt20 -154.74 137.44 15.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.437 -0.579 . . . . 0.63 109.437 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.521 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 26.1 tt0 -144.41 105.69 4.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.171 0.51 . . . . 1.3400000000000001 110.152 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -119.73 121.41 29.85 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.539 -0.755 . . . . 2.5899999999999999 109.499 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.434 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 11.8 Cg_exo -69.0 -18.73 40.43 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.894 2.396 . . . . 0.90000000000000002 113.059 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.625 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 14.1 tt0 -166.56 96.3 0.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.089 0.947 . . . . 1.3700000000000001 111.53 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -98.38 102.94 14.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.485 -1.689 . . . . 1.1399999999999999 108.514 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.9 p -97.33 135.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.772 -0.455 . . . . 1.5900000000000001 109.772 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 31.2 p90 -157.42 169.06 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.25 111.417 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m -89.66 114.76 26.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.511 -0.768 . . . . 1.0700000000000001 109.648 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.878 HD13 ' HD3' ' A' ' 104' ' ' PRO . 16.3 tp -63.02 129.93 42.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.015 -0.538 . . . . 1.3300000000000001 110.65 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.484 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.06 6.18 86.83 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.885 -0.674 . . . . 0.37 112.083 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.65 -1.51 30.05 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.73 -0.47 . . . . 0.93000000000000005 109.73 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 40.0 m 56.16 33.99 23.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.662 -0.699 . . . . 1.55 109.727 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 17.7 t70 -71.47 -9.45 58.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 122.54 1.162 . . . . 1.3300000000000001 108.549 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.404 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 15.3 m -131.61 -162.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.497 -1.683 . . . . 1.0800000000000001 110.409 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.1 pt -77.6 139.64 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 107.67 -1.233 . . . . 1.0600000000000001 107.67 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.576 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 5.2 tp60 -60.05 -28.6 67.91 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.931 -0.308 . . . . 0.40000000000000002 110.941 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.05 82.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.179 0.514 . . . . 1.0800000000000001 110.262 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.611 HD21 HG22 ' A' ' 68' ' ' VAL . 47.4 tp -74.67 -40.48 61.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 1.0700000000000001 110.247 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.457 ' HB3' HE21 ' A' ' 97' ' ' GLN . 13.9 t70 -61.74 -28.06 69.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.906 -1.043 . . . . 0.26000000000000001 109.919 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.697 HD21 ' HZ3' ' A' ' 62' ' ' LYS . 65.8 mt -91.28 -36.75 13.7 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.282 -0.872 . . . . 1.0600000000000001 112.587 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.461 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 17.4 p -74.13 -23.6 59.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 1.53 110.972 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 99' ' ' LEU . 38.9 t -67.8 -55.27 14.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.709 -0.678 . . . . 1.0600000000000001 112.1 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.878 ' HD3' HD13 ' A' ' 90' ' ' LEU . 28.2 Cg_endo -62.69 -18.76 65.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.138 1.892 . . . . 0.40999999999999998 111.999 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.493 ' CD1' HG22 ' A' ' 39' ' ' ILE . 13.7 mt -83.43 -17.39 42.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.999 -0.546 . . . . 1.3500000000000001 111.713 172.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.73 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 10.4 ttp -97.37 142.71 28.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.354 -0.385 . . . . 1.3100000000000001 111.344 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -85.51 151.3 24.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.176 0.512 . . . . 0.96999999999999997 110.855 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.762 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -59.78 123.47 12.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.903 -0.589 . . . . 1.47 110.053 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.3 12.72 47.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.066 -0.97 . . . . 0.28000000000000003 112.871 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.853 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 8.4 pt-20 -114.24 169.19 9.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.2 0.524 . . . . 0.40999999999999998 110.64 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.6 m -129.32 120.9 26.42 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.651 -0.87 . . . . 1.0700000000000001 108.651 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.57 135.57 53.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.88 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.6 ttm -97.78 117.81 32.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.544 -1.28 . . . . 1.9399999999999999 107.544 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.689 HG21 ' HG3' ' A' ' 47' ' ' LYS . 5.4 t -115.1 133.06 62.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.531 -0.544 . . . . 1.0600000000000001 109.531 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 87.5 m -110.38 114.66 28.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.602 0.715 . . . . 1.03 109.077 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.17 137.02 54.15 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 1.01 110.41 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.589 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.81 147.35 9.07 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.737 -0.838 . . . . 0.57999999999999996 108.737 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.583 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.5 t -54.77 -27.16 39.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.04 0.447 . . . . 1.04 110.288 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 12.7 ptpt -55.19 -33.13 62.75 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.165 -0.334 . . . . 1.4299999999999999 111.511 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.555 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 83.9 m-85 -94.86 3.22 55.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.073 0.463 . . . . 1.04 110.1 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.597 ' HB3' HD21 ' A' ' 138' ' ' LEU . 72.3 m -123.16 -91.77 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.193 -0.912 . . . . 0.87 110.528 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 8.1 m-85 -142.59 41.08 1.58 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.153 -0.619 . . . . 0.95999999999999996 112.123 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.77 -88.57 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.486 -0.387 . . . . 0.25 113.909 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.49 11.69 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.396 2.064 . . . . 0.90000000000000002 111.168 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.04 -48.87 3.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.396 -0.82 . . . . 0.65000000000000002 109.884 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.634 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 79.13 143.63 2.64 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 114.616 -1.174 . . . . 0.29999999999999999 112.216 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.694 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.0 t -90.48 147.54 23.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.103 0.478 . . . . 0.90000000000000002 111.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HD2' ' H ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -54.87 -28.18 48.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.12 -0.945 . . . . 3.6099999999999999 112.485 -175.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 1.084 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 27.5 t -91.59 -70.03 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.891 -0.781 . . . . 1.52 108.891 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 1.084 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.4 Cg_endo -105.19 128.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.5 2.134 . . . . 0.44 111.998 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.634 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 22.3 t80 -55.72 97.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.32 -0.993 . . . . 1.6899999999999999 108.32 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' A' ' 127' ' ' SER . 28.6 mm -67.16 125.97 91.8 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.556 -0.747 . . . . 1.0600000000000001 109.31 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 136' ' ' ALA . 9.7 Cg_endo -53.47 135.99 62.52 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.321 2.014 . . . . 1.03 111.688 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.588 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 54.2 Cg_exo -53.33 129.01 31.53 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.491 2.127 . . . . 0.89000000000000001 112.304 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.557 ' H ' ' HB3' ' A' ' 118' ' ' SER . 70.3 m-70 74.69 11.09 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.69 -1.141 . . . . 3.1899999999999999 112.931 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.473 ' HB3' ' HG2' ' A' ' 133' ' ' PRO . . . -71.07 118.87 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.254 -1.017 . . . . 1.04 108.254 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.19 113.68 10.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.463 0.649 . . . . 1.05 109.902 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.619 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.37 131.98 34.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.153 -0.931 . . . . 1.0600000000000001 110.966 -174.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.1 t -115.18 99.74 7.64 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.891 -0.781 . . . . 1.8200000000000001 108.891 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -112.85 134.53 54.32 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.467 0.651 . . . . 1.1499999999999999 111.781 -173.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 39.9 tt0 -99.8 113.59 26.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.186 -0.916 . . . . 1.05 108.916 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 2.2 m -115.7 121.3 67.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.46 0.648 . . . . 1.0800000000000001 112.674 -175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 145' ' ' LYS . 8.1 m -88.05 121.67 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.18 -0.918 . . . . 1.0900000000000001 109.756 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.61 HD23 ' HG2' ' A' ' 60' ' ' PRO . 39.0 tp -93.89 93.33 7.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.401 -0.962 . . . . 1.0700000000000001 108.401 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.607 ' HG3' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -85.81 -30.83 22.69 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.898 -1.047 . . . . 1.6899999999999999 110.629 -172.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.629 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 85.2 m -157.14 145.09 19.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.813 -0.631 . . . . 1.1200000000000001 111.562 -168.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.612 ' HB1' ' HG3' ' A' ' 60' ' ' PRO . . . -137.55 128.32 27.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.74 -0.664 . . . . 0.98999999999999999 109.369 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 65' ' ' VAL . 11.2 m . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 109.563 -0.532 . . . . 1.6200000000000001 109.563 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.05 0.452 . . . . 0.53000000000000003 110.378 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.46 110.83 7.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 1.1899999999999999 110.409 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.642 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -75.0 127.15 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.332 0.587 . . . . 2.5099999999999998 110.612 174.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.538 HD12 HD13 ' A' ' 45' ' ' LEU . 8.4 mt -57.78 -35.55 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.586 -1.188 . . . . 1.1499999999999999 111.549 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.6 mt -111.12 -1.16 16.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.286 0.565 . . . . 1.4299999999999999 110.278 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.22 26.63 66.26 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.318 -0.855 . . . . 0.65000000000000002 111.746 -172.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.39 -29.09 14.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.65 0.241 . . . . 0.94999999999999996 111.65 -178.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.41 -9.14 30.72 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 121.114 -0.565 . . . . 0.71999999999999997 111.751 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 7.3 mp -97.4 -33.18 11.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.253 -0.474 . . . . 2.1600000000000001 110.971 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.538 HD13 HD12 ' A' ' 39' ' ' ILE . 19.8 tp -122.91 100.7 7.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 1.1200000000000001 111.352 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 66.7 mtm180 -132.23 140.73 48.78 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.178 -0.326 . . . . 1.49 111.163 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.654 ' HG2' ' HB3' ' A' ' 112' ' ' ALA . 13.4 ttpt -111.51 123.66 50.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.265 -0.272 . . . . 1.1200000000000001 110.265 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 20.1 ttmt -101.17 122.08 42.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.157 -0.312 . . . . 1.6499999999999999 110.157 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 52' ' ' PRO . 5.3 p -76.67 100.82 5.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.497 -0.319 . . . . 1.03 110.977 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 111' ' ' THR . 11.5 mt -68.71 -55.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.065 -1.457 . . . . 1.0600000000000001 107.065 171.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.787 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.5 t -129.82 126.35 22.52 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 113.024 -1.898 . . . . 1.1399999999999999 106.299 167.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 16.5 Cg_endo -104.48 60.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.832 2.355 . . . . 0.56000000000000005 113.477 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.959 -0.564 . . . . 0.55000000000000004 113.213 177.088 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 110.185 -0.302 . . . . 1.3600000000000001 110.185 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 t -152.81 127.93 9.75 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.04 -0.726 . . . . 1.8200000000000001 109.04 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.81 122.14 67.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.583 -0.447 . . . . 3.3900000000000001 110.946 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD3' HG21 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.6 153.24 11.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.789 2.992 . . . . 0.42999999999999999 114.13 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.7 t -100.08 155.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.004 -0.998 . . . . 1.47 109.449 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 95.4 mttt -64.34 106.86 1.19 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.386 0.613 . . . . 1.71 110.364 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.75 -24.73 2.44 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.28 -1.128 . . . . 0.41999999999999998 110.28 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.637 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.01 137.72 34.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.282 -0.636 . . . . 0.58999999999999997 109.282 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.5 m -81.05 133.54 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.064 -1.087 . . . . 1.8600000000000001 108.064 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.2 m -127.8 143.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.022 -0.535 . . . . 1.0700000000000001 110.92 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 45.9 p -94.11 112.61 24.44 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.309 -0.626 . . . . 1.0600000000000001 109.309 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.574 HG23 HD23 ' A' ' 99' ' ' LEU . 19.6 m -110.15 143.41 20.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.901 -0.72 . . . . 1.05 109.849 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.58 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.7 t-160 -102.33 116.11 31.95 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.824 -1.547 . . . . 0.28999999999999998 106.824 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 83' ' ' GLU . 1.2 pt? -122.5 137.95 54.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.462 -0.895 . . . . 1.1299999999999999 110.83 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.11 114.31 13.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.277 -2.12 . . . . 0.27000000000000002 105.277 166.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.629 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 71.0 m -105.04 129.69 53.42 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.6 -1.182 . . . . 1.04 111.016 -166.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 1.002 ' HB3' ' SG ' ' A' ' 139' ' ' CYS . 4.7 t -104.38 172.51 6.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.268 -0.878 . . . . 1.54 108.884 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' ' 80' ' ' VAL . 12.3 mt -101.48 165.54 11.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.517 -0.765 . . . . 1.51 109.178 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.18 -23.35 34.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.1 0.476 . . . . 1.1399999999999999 110.492 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.28 -8.49 53.28 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.776 -0.647 . . . . 2.1400000000000001 111.492 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.39 10.56 44.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.259 -0.972 . . . . 0.51000000000000001 113.568 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 92.1 m -98.64 113.0 24.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.311 0.555 . . . . 1.1599999999999999 112.332 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.883 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.4 mtt180 -69.91 125.56 27.12 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.54000000000000004 110.363 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.963 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.2 m -108.89 -20.17 6.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.004 -0.998 . . . . 1.0600000000000001 112.295 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.636 ' NE2' ' HG ' ' A' ' 127' ' ' SER . 9.2 pt20 -146.99 124.3 11.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.421 -0.354 . . . . 0.63 110.242 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -118.41 118.0 30.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.31 0.576 . . . . 1.3400000000000001 109.964 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.648 ' HB3' HD23 ' A' ' 70' ' ' LEU . 6.4 tp10 -135.8 107.58 9.85 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.589 -0.732 . . . . 2.5899999999999999 110.814 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.58 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 14.3 Cg_exo -68.12 -19.83 44.6 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.056 2.504 . . . . 0.90000000000000002 112.952 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -164.22 113.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.025 0.917 . . . . 1.3700000000000001 112.567 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.08 110.31 16.08 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.772 -1.558 . . . . 1.1399999999999999 108.763 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.8 p -100.17 137.03 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.569 -0.53 . . . . 1.5900000000000001 109.569 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.606 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -159.45 157.64 30.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 0.25 110.426 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 24.4 m -76.87 119.13 20.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.527 -0.546 . . . . 1.0700000000000001 109.527 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.856 HD13 ' HD3' ' A' ' 104' ' ' PRO . 17.4 tp -62.19 133.22 54.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 1.3300000000000001 110.544 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.71 -4.91 80.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 0.37 111.844 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.407 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 12.8 t70 -83.77 -15.06 49.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.165 -0.68 . . . . 0.93000000000000005 109.165 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.0 m 62.65 30.1 16.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.863 -1.062 . . . . 1.55 109.414 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 13.7 t70 -62.55 -26.36 68.53 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 122.367 1.079 . . . . 1.3300000000000001 108.45 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 m -114.46 -158.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 113.341 -1.754 . . . . 1.0800000000000001 110.834 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.7 pt -84.34 139.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.81 -1.182 . . . . 1.0600000000000001 107.81 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -60.17 -27.34 67.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.449 -0.341 . . . . 0.40000000000000002 110.966 -173.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.39 -42.95 78.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.324 0.583 . . . . 1.0800000000000001 110.286 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.574 HD23 HG23 ' A' ' 68' ' ' VAL . 53.0 tp -78.53 -40.49 34.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.131 -0.941 . . . . 1.0700000000000001 110.377 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB3' HE21 ' A' ' 97' ' ' GLN . 20.1 t70 -61.97 -29.72 70.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.794 -1.094 . . . . 0.26000000000000001 109.973 -174.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 57.6 mt -90.66 -33.64 15.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.44 -0.8 . . . . 1.0600000000000001 111.959 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.553 ' HG ' HG23 ' A' ' 114' ' ' VAL . 31.5 t -65.63 -34.54 78.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 1.53 110.769 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 99' ' ' LEU . 54.7 t -63.56 -53.29 52.78 Favored Pre-proline 0 C--O 1.22 -0.492 0 N-CA-C 113.129 0.789 . . . . 1.0600000000000001 113.129 -177.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.856 ' HD3' HD13 ' A' ' 90' ' ' LEU . 17.7 Cg_endo -62.03 -22.15 73.71 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.988 1.792 . . . . 0.40999999999999998 111.945 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.441 ' CD1' HG22 ' A' ' 39' ' ' ILE . 9.5 mt -83.82 -11.98 56.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.416 0.627 . . . . 1.3500000000000001 110.991 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.755 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 34.8 ttm -98.28 140.36 32.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.969 -1.014 . . . . 1.3100000000000001 111.635 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.13 153.11 19.56 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.485 -0.561 . . . . 0.96999999999999997 109.485 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' HD3' ' A' ' 60' ' ' PRO . 2.0 t -62.0 124.98 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 1.47 110.65 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 12.95 52.98 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.28000000000000003 112.723 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.787 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.6 pt-20 -105.43 168.63 8.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.478 0.639 . . . . 0.40999999999999998 110.432 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.484 HG22 HD13 ' A' ' 50' ' ' LEU . 24.4 m -132.83 119.8 20.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.402 -0.962 . . . . 1.0700000000000001 108.402 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.654 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . . . -117.54 137.45 52.57 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.483 -0.781 . . . . 1.0 110.718 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 ttt -96.85 116.03 28.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.872 -1.529 . . . . 1.9399999999999999 106.872 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.553 HG23 ' HG ' ' A' ' 102' ' ' SER . 3.4 t -113.34 132.96 60.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.53 -0.545 . . . . 1.0600000000000001 109.53 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.518 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 63.0 m -110.7 114.43 27.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.629 -0.828 . . . . 1.03 109.36 171.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.99 53.83 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.896 -1.502 . . . . 1.01 109.813 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.57 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.3 t70 -52.47 147.24 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.981 -0.748 . . . . 0.57999999999999996 108.981 173.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.615 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.1 t -55.78 -28.32 55.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 1.04 110.086 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.57 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 15.6 ptpt -55.48 -31.44 62.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.629 -0.259 . . . . 1.4299999999999999 111.634 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 78.5 m-85 -95.2 -1.55 51.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.147 0.499 . . . . 1.04 109.839 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 65.6 m -117.14 -93.47 0.51 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.061 -0.972 . . . . 0.87 110.371 -177.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.61 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.8 m-85 -140.78 39.71 1.83 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.207 -0.597 . . . . 0.95999999999999996 112.091 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -45.59 -83.03 0.02 OUTLIER Glycine 0 C--N 1.344 0.99 0 N-CA-C 114.242 0.457 . . . . 0.25 114.242 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HA ' ' HH ' ' A' ' 131' ' ' TYR . 74.0 Cg_endo -87.4 13.93 2.53 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.393 2.062 . . . . 0.90000000000000002 110.77 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.9 mt-30 -104.65 -49.28 3.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.978 -1.01 . . . . 0.65000000000000002 110.498 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.83 142.2 3.76 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 114.544 -1.207 . . . . 0.29999999999999999 112.622 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.636 ' HG ' ' NE2' ' A' ' 81' ' ' GLN . 30.4 t -91.93 165.99 12.94 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.091 0.404 . . . . 0.90000000000000002 112.091 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.574 ' HG3' ' N ' ' A' ' 129' ' ' SER . 6.9 ptp180 -52.87 -49.88 64.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.728 -0.669 . . . . 3.6099999999999999 112.219 -171.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.994 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 13.0 m -87.78 -62.72 0.22 Allowed Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.704 -0.48 . . . . 1.52 109.704 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.994 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 8.9 Cg_endo -101.08 127.7 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.592 2.195 . . . . 0.44 111.707 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.504 ' HH ' ' HA ' ' A' ' 124' ' ' PRO . 9.6 t80 -57.43 97.35 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.938 -1.504 . . . . 1.6899999999999999 106.938 159.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.601 HD13 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -64.87 124.66 87.13 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 107.965 -1.124 . . . . 1.0600000000000001 107.965 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.22 141.19 31.91 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.499 2.133 . . . . 1.03 112.301 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.533 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 55.0 Cg_exo -52.37 132.32 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.582 2.188 . . . . 0.89000000000000001 112.156 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.473 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 1.4 m-70 72.35 9.22 5.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.069 -0.969 . . . . 3.1899999999999999 113.015 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -74.09 123.84 25.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.162 -0.681 . . . . 1.04 109.162 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.82 112.28 9.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.351 0.596 . . . . 1.05 109.643 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 121' ' ' CYS . 2.0 tp -88.76 131.87 34.86 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.549 -0.751 . . . . 1.0600000000000001 110.586 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 1.002 ' SG ' ' HB3' ' A' ' 73' ' ' SER . 24.7 p -116.73 100.29 7.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.795 0.807 . . . . 1.8200000000000001 110.501 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -109.66 133.64 52.89 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.323 -0.853 . . . . 1.1499999999999999 111.491 -172.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.536 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.1 tt0 -98.33 109.09 21.9 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.508 -0.769 . . . . 1.05 109.212 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.632 HG21 ' HE3' ' A' ' 106' ' ' MET . 0.8 OUTLIER -113.35 116.46 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.463 0.649 . . . . 1.0800000000000001 112.39 -174.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 9.5 m -89.2 113.72 24.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 1.0900000000000001 111.034 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.751 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -84.8 93.55 8.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.773 -0.825 . . . . 1.0700000000000001 108.773 172.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -86.45 -32.61 20.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.111 -0.95 . . . . 1.6899999999999999 110.799 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.3 m -150.71 147.31 27.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.309 -0.405 . . . . 1.1200000000000001 111.197 -173.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.433 ' HA ' HG13 ' A' ' 66' ' ' VAL . . . -134.22 128.31 33.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.156 -0.683 . . . . 0.98999999999999999 109.156 171.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 110.063 -0.347 . . . . 1.6200000000000001 110.063 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.671 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.53000000000000003 110.995 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.75 110.99 5.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 1.1899999999999999 110.398 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.666 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -66.59 103.2 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 2.5099999999999998 110.963 175.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.724 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.2 mt -53.88 -48.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.66 -1.155 . . . . 1.1499999999999999 111.522 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.428 HD11 ' CE2' ' A' ' 120' ' ' TYR . 52.0 mt -105.68 12.79 30.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 1.4299999999999999 110.712 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.666 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 69.08 6.83 55.07 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.331 -0.849 . . . . 0.65000000000000002 113.332 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.402 ' H ' HD21 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -99.27 -12.76 20.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.676 0.275 . . . . 0.94999999999999996 111.468 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.32 -19.11 37.35 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.382 -0.913 . . . . 0.71999999999999997 112.832 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.5 mp -75.33 -24.47 57.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.039 0.923 . . . . 2.1600000000000001 109.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.724 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 tp -119.13 113.84 21.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.911 -1.495 . . . . 1.1200000000000001 110.145 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 46' ' ' ARG . 43.4 mtm180 -142.86 133.44 25.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.35 0.5 . . . . 1.49 112.35 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HZ2' ' HA ' ' A' ' 106' ' ' MET . 12.8 ttpt -109.97 125.04 52.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 1.1200000000000001 109.976 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 26.5 ttpp -114.4 121.6 44.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.146 0.498 . . . . 1.6499999999999999 111.046 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.586 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.3 p -74.68 103.45 4.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.198 -0.91 . . . . 1.03 111.713 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.428 HD22 ' HZ3' ' A' ' 48' ' ' LYS . 9.0 mt -69.09 -56.41 7.8 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.67 -1.604 . . . . 1.0600000000000001 106.67 171.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 56.0 t -131.97 123.89 19.28 Favored Pre-proline 0 CA--C 1.502 -0.9 0 CA-C-N 112.726 -2.034 . . . . 1.1399999999999999 106.719 168.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.627 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 73.5 Cg_endo -107.92 66.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 122.563 2.175 . . . . 0.56000000000000005 114.055 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.435 -0.802 . . . . 0.55000000000000004 113.394 173.34 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 121.108 0.48 . . . . 1.3600000000000001 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -149.82 147.21 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.912 -0.773 . . . . 1.8200000000000001 108.912 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 85.2 mtt180 -96.24 116.37 66.13 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.578 -0.449 . . . . 3.3900000000000001 110.116 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.785 ' HD3' HG22 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -49.47 144.48 18.42 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.756 2.971 . . . . 0.42999999999999999 112.975 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 9.0 t -89.25 145.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.18 -0.463 . . . . 1.47 110.031 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.922 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 97.9 mttt -65.72 104.42 1.05 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.639 0.733 . . . . 1.71 109.788 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.12 -29.92 2.16 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 114.394 -1.276 . . . . 0.41999999999999998 109.948 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.638 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -74.83 136.16 41.6 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.363 -0.977 . . . . 0.58999999999999997 108.363 175.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.3 m -84.16 115.23 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.951 -1.129 . . . . 1.8600000000000001 107.951 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -109.65 146.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.95 -1.023 . . . . 1.0700000000000001 110.853 -171.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.797 ' HB ' ' OE1' ' A' ' 85' ' ' GLU . 78.9 p -91.12 112.46 24.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.289 0.566 . . . . 1.0600000000000001 109.725 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.723 HG23 HD21 ' A' ' 99' ' ' LEU . 26.8 m -111.04 142.39 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 119.907 -0.717 . . . . 1.05 109.319 170.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -102.41 116.7 33.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.529 -1.656 . . . . 0.28999999999999998 106.529 169.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -116.86 135.15 53.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.98 -1.088 . . . . 1.1299999999999999 110.781 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.712 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -130.49 114.23 15.25 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.427 -2.064 . . . . 0.27000000000000002 105.427 167.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.552 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 86.8 m -106.43 127.27 53.16 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.229 -1.35 . . . . 1.04 111.145 -166.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.798 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -107.1 153.22 22.95 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.21 -0.905 . . . . 1.54 109.335 -178.246 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.438 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.7 mt -78.6 164.79 24.36 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.488 -0.778 . . . . 1.51 109.293 174.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.578 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 6.4 pt-20 -58.37 -14.21 7.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.436 0.636 . . . . 1.1399999999999999 110.507 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.664 ' N ' HD21 ' A' ' 76' ' ' ASN . 0.6 OUTLIER -87.25 -14.77 40.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.242 -0.89 . . . . 2.1400000000000001 109.895 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.33 -6.68 46.34 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.851 -0.613 . . . . 0.51000000000000001 111.763 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -81.42 110.05 16.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.926 0.343 . . . . 1.1599999999999999 111.926 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.798 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 37.5 mtt180 -74.11 116.75 15.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.511 0.672 . . . . 0.54000000000000004 110.394 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.1 m -99.33 -12.91 8.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 1.0600000000000001 112.314 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.51 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 28.9 pt20 -156.61 136.07 12.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.224 -0.444 . . . . 0.63 110.385 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 33.1 tt0 -135.13 116.54 14.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.962 -0.563 . . . . 1.3400000000000001 109.652 174.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 86' ' ' LEU . 5.2 tt0 -129.5 109.59 17.55 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.29 -0.868 . . . . 2.5899999999999999 109.795 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 16.5 Cg_exo -68.34 -13.57 38.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.736 2.957 . . . . 0.90000000000000002 113.256 -172.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OE1' ' HB ' ' A' ' 67' ' ' THR . 2.9 tp10 -157.96 101.94 1.8 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.037 0.923 . . . . 1.3700000000000001 110.711 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.469 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 28.1 tp -116.92 106.46 13.46 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.986 -1.461 . . . . 1.1399999999999999 108.65 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.5 p -101.97 132.08 48.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.252 -0.647 . . . . 1.5900000000000001 109.252 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.7 p90 -153.8 156.16 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.25 110.824 -174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.3 m -75.32 112.03 11.2 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.674 -0.693 . . . . 1.0700000000000001 109.66 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.922 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.8 tp -60.18 137.7 58.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.037 -0.528 . . . . 1.3300000000000001 110.21 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 77.61 5.98 86.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.37 112.264 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -103.3 -5.6 22.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.952 0.406 . . . . 0.93000000000000005 110.044 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 47.5 m 59.99 32.91 21.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.48 -0.782 . . . . 1.55 109.095 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 18.6 t70 -70.16 -16.52 63.1 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.424 1.107 . . . . 1.3300000000000001 108.758 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 11.7 m -121.76 -150.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 113.537 -1.665 . . . . 1.0800000000000001 110.253 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.1 pt -87.5 139.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.649 -1.241 . . . . 1.0600000000000001 107.649 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -58.68 -29.18 66.41 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 123.264 0.352 . . . . 0.40000000000000002 110.916 -173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.36 -48.34 74.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.362 0.601 . . . . 1.0800000000000001 110.664 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.723 HD21 HG23 ' A' ' 68' ' ' VAL . 56.5 tp -75.6 -36.22 60.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.443 -0.799 . . . . 1.0700000000000001 110.604 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.29 -30.63 71.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 0.26000000000000001 109.594 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 1.0600000000000001 112.296 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 t -63.75 -36.65 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 1.53 110.959 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 99' ' ' LEU . 77.2 t -62.97 -54.88 42.76 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.059 0.763 . . . . 1.0600000000000001 113.059 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.798 ' HD3' HD13 ' A' ' 90' ' ' LEU . 22.6 Cg_endo -62.54 -20.83 71.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.282 1.988 . . . . 0.40999999999999998 111.721 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.571 ' CD1' HG22 ' A' ' 39' ' ' ILE . 10.8 mt -83.96 -12.69 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 1.3500000000000001 111.29 173.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -106.98 155.94 19.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.268 -0.424 . . . . 1.3100000000000001 110.887 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.98 153.17 17.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 110.825 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.785 HG22 ' HD3' ' A' ' 60' ' ' PRO . 1.7 t -60.4 125.4 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.118 0.485 . . . . 1.47 110.403 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 18.58 41.98 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.103 -0.953 . . . . 0.28000000000000003 112.499 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.774 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.0 pt-20 -107.57 167.3 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.418 0.628 . . . . 0.40999999999999998 110.992 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 m -130.54 117.46 19.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.957 -1.127 . . . . 1.0700000000000001 107.957 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.28 138.89 52.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.115 0.483 . . . . 1.0 110.736 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.0 ttp -100.03 117.45 34.32 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.079 -1.452 . . . . 1.9399999999999999 107.079 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 t -114.74 131.0 68.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.764 -0.458 . . . . 1.0600000000000001 109.764 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.506 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 86.0 m -107.49 113.5 26.88 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.658 -0.867 . . . . 1.03 108.658 173.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.55 135.8 53.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.263 -1.335 . . . . 1.01 109.354 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.613 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.4 t70 -53.82 149.86 8.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.818 -0.808 . . . . 0.57999999999999996 108.818 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.619 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -56.66 -28.01 59.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.202 0.525 . . . . 1.04 110.059 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.9 ptpt -56.43 -31.94 64.41 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.902 -0.499 . . . . 1.4299999999999999 111.779 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.581 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.3 m-85 -94.87 4.22 54.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.31 0.576 . . . . 1.04 109.632 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 66.8 m -123.16 -92.76 0.53 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.067 -0.97 . . . . 0.87 110.489 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.527 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 6.5 m-85 -142.0 39.77 1.64 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 119.041 -0.504 . . . . 0.95999999999999996 112.135 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.16 -88.7 0.01 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 114.09 0.396 . . . . 0.25 114.09 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.96 10.63 3.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.015 1.81 . . . . 0.90000000000000002 111.434 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -103.49 -49.4 3.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.567 -0.742 . . . . 0.65000000000000002 109.924 -173.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.496 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 81.72 145.42 4.96 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.758 -1.11 . . . . 0.29999999999999999 111.698 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.5 t -90.49 162.54 15.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.405 -0.398 . . . . 0.90000000000000002 110.925 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -51.63 -58.74 5.49 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.892 0.745 . . . . 3.6099999999999999 110.733 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.835 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 59.6 m -77.48 -61.34 0.65 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.897 -0.592 . . . . 1.52 110.411 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.835 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.8 Cg_endo -106.04 125.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.09 1.86 . . . . 0.44 112.619 174.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.14 96.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.514 -0.921 . . . . 1.6899999999999999 108.514 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.565 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.9 123.87 87.2 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.536 -0.757 . . . . 1.0600000000000001 109.717 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.88 136.93 43.76 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.841 2.361 . . . . 1.03 112.459 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.646 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 Cg_endo -55.44 128.71 31.55 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.159 1.906 . . . . 0.89000000000000001 111.998 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.535 ' H ' ' HB3' ' A' ' 118' ' ' SER . 62.7 m170 74.13 12.97 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.98 -1.009 . . . . 3.1899999999999999 112.397 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -76.33 121.1 22.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.554 -0.906 . . . . 1.04 108.554 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.95 113.11 9.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 1.05 109.754 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.552 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.2 tp -88.45 131.45 34.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.572 -0.74 . . . . 1.0600000000000001 110.566 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.4 100.68 8.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.301 -1.0 . . . . 1.8200000000000001 108.301 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.1 pp -115.22 136.54 53.0 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.058 -0.519 . . . . 1.1499999999999999 111.734 -171.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.712 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.0 tt0 -102.71 117.14 34.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.479 -0.934 . . . . 1.05 108.479 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 99' ' ' LEU . 3.5 m -117.93 116.7 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.535 0.683 . . . . 1.0800000000000001 112.785 -174.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -89.73 108.77 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 1.0900000000000001 110.576 173.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.624 HD22 ' HG3' ' A' ' 60' ' ' PRO . 57.6 tp -85.44 97.78 10.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.379 -0.971 . . . . 1.0700000000000001 108.379 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 143' ' ' THR . 19.7 mtmm -103.39 -18.17 14.94 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.6899999999999999 110.702 -168.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m -156.16 145.36 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.913 -0.585 . . . . 1.1200000000000001 110.913 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.477 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -133.62 127.26 32.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.641 -0.874 . . . . 0.98999999999999999 108.641 169.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 65' ' ' VAL . 20.4 m . . . . . 0 C--N 1.323 -0.563 0 C-N-CA 120.203 -0.599 . . . . 1.6200000000000001 110.436 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.574 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 N-CA-C 109.864 -0.421 . . . . 0.53000000000000003 109.864 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.76 111.47 8.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.851 -0.613 . . . . 1.1899999999999999 110.3 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.73 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 11.0 t70 -75.14 126.65 31.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.779 -0.768 . . . . 2.5099999999999998 109.795 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 105' ' ' LEU . 5.0 mt -59.47 -30.22 43.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 1.1499999999999999 110.771 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.6 mt -113.21 -5.58 13.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.577 -0.738 . . . . 1.4299999999999999 110.572 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.71 21.8 71.32 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.428 -0.806 . . . . 0.65000000000000002 111.675 -174.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.18 -20.27 14.21 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.078 0.769 . . . . 0.94999999999999996 113.078 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 125.79 -26.43 5.38 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.036 -1.078 . . . . 0.71999999999999997 114.827 166.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -106.17 -11.47 16.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.124 0.787 . . . . 2.1600000000000001 113.124 -171.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.7 tp -123.11 100.99 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.505 -0.122 . . . . 1.1200000000000001 111.108 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.73 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 83.7 mtm180 -140.88 145.46 36.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.551 0.574 . . . . 1.49 112.551 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.612 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.7 ttpt -116.29 131.39 56.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.218 -0.447 . . . . 1.1200000000000001 110.259 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 4.2 ttmm -111.85 125.75 54.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.626 0.251 . . . . 1.6499999999999999 110.511 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 p -80.18 100.22 8.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.376 -0.375 . . . . 1.03 111.434 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 111' ' ' THR . 11.8 mt -63.94 -53.15 54.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.943 -1.503 . . . . 1.0600000000000001 106.943 170.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.9 t -136.35 129.36 17.72 Favored Pre-proline 0 CA--C 1.503 -0.844 0 CA-C-N 112.753 -2.021 . . . . 1.1399999999999999 106.638 170.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 38.7 Cg_endo -103.91 56.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 122.812 2.342 . . . . 0.56000000000000005 113.671 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.773 0 CA-C-N 115.303 -0.862 . . . . 0.55000000000000004 113.062 176.156 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 121.5 0.667 . . . . 1.3600000000000001 111.566 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -136.42 140.93 43.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.527 -0.916 . . . . 1.8200000000000001 108.527 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.467 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 97.7 mtt180 -101.13 114.1 65.79 Favored Pre-proline 0 C--N 1.311 -1.097 0 C-N-CA 120.786 -0.366 . . . . 3.3900000000000001 110.539 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HD3' HG22 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -47.29 142.1 12.77 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.875 3.05 . . . . 0.42999999999999999 113.735 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.681 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.1 t -95.67 152.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.486 -0.779 . . . . 1.47 109.564 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.565 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 40.4 mttp -66.51 106.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.569 0.699 . . . . 1.71 110.488 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.2 -23.14 2.57 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.96 -1.018 . . . . 0.41999999999999998 110.756 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.681 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -85.25 139.13 31.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.803 -0.814 . . . . 0.58999999999999997 108.803 177.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 10.7 m -87.28 129.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.677 -0.861 . . . . 1.8600000000000001 108.677 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 24.9 m -123.15 149.64 26.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.928 -1.033 . . . . 1.0700000000000001 110.502 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.462 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 20.2 p -97.82 112.85 24.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.748 -0.66 . . . . 1.0600000000000001 110.218 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 99' ' ' LEU . 24.4 m -110.93 147.01 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 120.376 -0.53 . . . . 1.05 110.375 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.78 114.84 29.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.988 -1.486 . . . . 0.28999999999999998 106.988 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.9 OUTLIER -120.33 138.16 53.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.387 -0.925 . . . . 1.1299999999999999 111.194 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.652 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.27 114.83 14.22 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.127 -1.805 . . . . 0.27000000000000002 106.127 167.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.645 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 32.6 m -103.14 118.99 38.02 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.867 -1.06 . . . . 1.04 111.848 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.728 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -105.65 135.05 47.75 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.477 -0.783 . . . . 1.54 109.248 176.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.536 HD13 ' CG1' ' A' ' 80' ' ' VAL . 4.2 mp -58.46 165.29 2.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.562 0.22 . . . . 1.51 111.26 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -52.45 -20.48 2.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.374 0.607 . . . . 1.1399999999999999 111.267 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -87.46 -14.73 39.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.706 -0.679 . . . . 2.1400000000000001 111.15 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.66 -10.57 38.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.35 -0.452 . . . . 0.51000000000000001 112.249 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -72.27 108.97 5.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.995 0.426 . . . . 1.1599999999999999 111.552 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 18.1 mtt180 -73.33 128.47 35.57 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.472 0.653 . . . . 0.54000000000000004 110.367 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.8 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.2 m -115.6 -8.17 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.683 -1.144 . . . . 1.0600000000000001 111.501 -171.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.645 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.7 pt20 -162.69 130.74 3.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.697 -0.683 . . . . 0.63 109.334 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 25.9 tt0 -141.84 105.92 4.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 1.3400000000000001 110.258 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 6.4 mm-40 -125.84 126.82 24.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.743 -0.662 . . . . 2.5899999999999999 109.754 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 10.9 Cg_exo -70.94 -17.06 32.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.424 2.083 . . . . 0.90000000000000002 112.639 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -159.66 122.9 3.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.99 0.9 . . . . 1.3700000000000001 111.923 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.6 tp -132.82 113.15 12.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.519 -1.673 . . . . 1.1399999999999999 108.774 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.9 p -104.94 132.58 51.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.756 -0.461 . . . . 1.5900000000000001 109.756 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.6 p90 -153.16 156.29 38.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.651 0.262 . . . . 0.25 110.638 -176.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -75.86 112.06 11.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 1.0700000000000001 110.172 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.761 HD13 ' HD3' ' A' ' 104' ' ' PRO . 14.5 tp -60.26 135.38 57.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 1.3300000000000001 110.427 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.565 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 81.01 5.43 90.16 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.708 -0.758 . . . . 0.37 112.069 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.82 -13.13 19.35 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.852 -0.425 . . . . 0.93000000000000005 109.852 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.7 m 62.32 35.04 15.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.556 -0.905 . . . . 1.55 108.556 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.27 -6.34 49.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.55 1.167 . . . . 1.3300000000000001 108.431 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 m -131.13 -156.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.375 -1.739 . . . . 1.0800000000000001 110.021 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -80.08 137.36 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 107.482 -1.303 . . . . 1.0600000000000001 107.482 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.474 HE21 ' HB3' ' A' ' 100' ' ' ASP . 8.0 tp60 -58.04 -29.16 65.13 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.583 -0.28 . . . . 0.40000000000000002 110.891 -173.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.91 78.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.019 -0.537 . . . . 1.0800000000000001 110.802 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.543 HD13 HG12 ' A' ' 142' ' ' VAL . 51.4 tp -72.51 -41.34 66.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 1.0700000000000001 110.503 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.474 ' HB3' HE21 ' A' ' 97' ' ' GLN . 15.7 t70 -61.11 -30.22 70.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.26000000000000001 109.911 -174.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.14 -33.77 16.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 1.0600000000000001 112.196 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.7 t -68.91 -29.11 67.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.593 -0.276 . . . . 1.53 111.111 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 99' ' ' LEU . 54.5 t -66.31 -55.11 21.34 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.659 0.615 . . . . 1.0600000000000001 112.659 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.761 ' HD3' HD13 ' A' ' 90' ' ' LEU . 20.7 Cg_endo -62.45 -23.62 75.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.921 1.747 . . . . 0.40999999999999998 111.818 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.634 HD11 HG22 ' A' ' 39' ' ' ILE . 20.2 mt -73.75 -26.12 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.738 -0.664 . . . . 1.3500000000000001 111.015 172.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.759 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -95.72 156.52 16.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.09 -0.505 . . . . 1.3100000000000001 111.082 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.03 151.54 21.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.055 0.455 . . . . 0.96999999999999997 110.923 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.646 HG22 ' HD3' ' A' ' 60' ' ' PRO . 1.3 t -60.07 125.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.461 0.648 . . . . 1.47 110.22 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.39 56.74 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.865 -1.061 . . . . 0.28000000000000003 112.803 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.0 pt-20 -103.14 167.93 9.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.40999999999999998 111.096 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 50' ' ' LEU . 7.2 m -129.41 117.19 20.16 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.716 -1.216 . . . . 1.0700000000000001 107.716 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . . . -120.74 134.35 55.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.717 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.4 ttp -98.39 117.93 33.9 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.759 -1.2 . . . . 1.9399999999999999 107.759 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.612 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.1 t -111.92 135.21 51.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.689 -0.687 . . . . 1.0600000000000001 109.431 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.574 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 87.8 m -114.32 113.68 24.89 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.616 -0.834 . . . . 1.03 108.795 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.64 54.94 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.18 -1.373 . . . . 1.01 109.796 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.699 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.79 148.79 6.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.004 -0.739 . . . . 0.57999999999999996 109.004 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.3 t -55.23 -28.5 53.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.116 0.484 . . . . 1.04 110.489 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.699 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.5 ptpt -54.77 -32.88 60.63 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.448 -0.342 . . . . 1.4299999999999999 111.535 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.622 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 98.3 m-85 -97.25 7.8 45.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.059 0.456 . . . . 1.04 110.04 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.61 ' HB3' HD21 ' A' ' 138' ' ' LEU . 61.4 m -123.7 -91.74 0.54 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.118 -0.946 . . . . 0.87 110.115 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.566 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 4.1 m-85 -144.56 41.57 1.34 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 119.272 -0.394 . . . . 0.95999999999999996 111.985 175.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.49 -84.01 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 121.449 -0.405 . . . . 0.25 113.836 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.76 12.07 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.32 2.013 . . . . 0.90000000000000002 111.088 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -104.45 -51.52 3.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.499 -0.773 . . . . 0.65000000000000002 110.176 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.54 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 83.27 142.46 4.77 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.606 -1.179 . . . . 0.29999999999999999 111.982 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.617 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.7 t -92.65 164.23 13.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.176 -0.512 . . . . 0.90000000000000002 112.074 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -50.59 -62.64 1.47 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.905 -1.043 . . . . 3.6099999999999999 111.905 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.947 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 30.9 t -72.09 -63.68 1.21 Allowed Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 1.52 110.067 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.9 Cg_endo -107.22 127.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 122.653 2.235 . . . . 0.44 112.315 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.54 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 42.1 t80 -55.97 98.6 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.861 -1.163 . . . . 1.6899999999999999 107.861 162.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.601 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.2 mm -66.44 128.82 94.05 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 115.713 -0.676 . . . . 1.0600000000000001 109.484 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.25 145.52 65.69 Favored 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.656 2.237 . . . . 1.03 111.839 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.656 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 34.8 Cg_endo -63.85 139.39 68.14 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.922 1.748 . . . . 0.89000000000000001 111.783 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.56 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 1.4 m80 68.75 6.97 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.129 -0.941 . . . . 3.1899999999999999 112.558 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -72.4 120.65 18.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.283 -0.636 . . . . 1.04 109.283 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.45 113.2 10.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.355 0.598 . . . . 1.05 109.904 -172.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' A' ' 121' ' ' CYS . 0.9 OUTLIER -87.95 131.32 34.65 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.567 -0.742 . . . . 1.0600000000000001 110.663 -177.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.8 t -115.73 99.94 7.67 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.901 -0.778 . . . . 1.8200000000000001 108.901 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.5 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.2 pp -115.23 134.32 55.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.116 -0.493 . . . . 1.1499999999999999 111.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.652 ' HB3' HE22 ' A' ' 71' ' ' GLN . 34.0 tt0 -98.86 122.04 41.59 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.223 -0.658 . . . . 1.05 109.223 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.661 HG22 ' HE2' ' A' ' 106' ' ' MET . 3.8 m -117.69 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.476 0.655 . . . . 1.0800000000000001 112.342 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 6.8 m -95.08 111.01 22.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.102 -0.954 . . . . 1.0900000000000001 110.06 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.599 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -83.6 99.19 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.66 -0.867 . . . . 1.0700000000000001 108.66 173.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 21.4 mtmt -94.69 -32.28 13.44 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.052 -0.976 . . . . 1.6899999999999999 110.598 -170.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.462 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.9 m -152.44 151.69 31.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.144 -0.48 . . . . 1.1200000000000001 111.019 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -139.25 129.35 25.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.249 -0.648 . . . . 0.98999999999999999 109.249 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.385 0.612 . . . . 1.6200000000000001 110.534 -178.609 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.527 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 2.0 m0 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 121.238 0.542 . . . . 0.53000000000000003 110.334 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 49.0 tp -80.04 109.99 15.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.17 0.51 . . . . 1.1899999999999999 110.661 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.701 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 2.8 p-10 -63.06 97.71 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.089 -0.959 . . . . 2.5099999999999998 110.696 171.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.796 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 12.0 mt -51.14 -49.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.021 -0.99 . . . . 1.1499999999999999 111.986 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' HG ' HD22 ' A' ' 45' ' ' LEU . 55.2 mt -102.33 3.84 38.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 1.4299999999999999 110.99 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.701 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 75.61 8.5 84.23 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.65000000000000002 112.314 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.649 HD21 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -98.12 -15.85 19.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.224 0.453 . . . . 0.94999999999999996 112.224 -177.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.649 ' N ' HD21 ' A' ' 42' ' ' ASN . . . 86.14 -26.87 5.86 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.71999999999999997 112.623 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.6 mp -69.15 -23.74 63.99 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 122.018 0.913 . . . . 2.1600000000000001 109.033 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.796 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.9 tp -120.24 112.39 19.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.133 -1.394 . . . . 1.1200000000000001 110.486 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 57.2 mtm180 -142.45 140.76 32.04 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 122.962 0.164 . . . . 1.49 111.229 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 114' ' ' VAL . 15.9 ttpt -115.53 127.04 54.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.801 -0.444 . . . . 1.1200000000000001 109.801 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.495 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 15.0 ttmt -107.16 122.42 46.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 110.216 -0.29 . . . . 1.6499999999999999 110.216 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.0 p -79.05 99.6 6.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.896 0.379 . . . . 1.03 111.063 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD13 HG21 ' A' ' 111' ' ' THR . 9.3 mt -67.8 -52.5 36.32 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.724 -1.584 . . . . 1.0600000000000001 106.724 173.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.824 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.3 t -134.68 126.66 18.15 Favored Pre-proline 0 CA--C 1.502 -0.88 0 CA-C-N 113.039 -1.891 . . . . 1.1399999999999999 106.196 168.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 65.7 Cg_endo -107.01 54.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.013 2.476 . . . . 0.56000000000000005 114.474 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.714 0 C-N-CA 120.849 -0.691 . . . . 0.55000000000000004 113.206 173.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 121.163 0.506 . . . . 1.3600000000000001 111.095 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 t -146.21 143.58 29.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.929 -0.767 . . . . 1.8200000000000001 108.929 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 69.1 mtm180 -94.16 116.84 66.92 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 120.449 -0.5 . . . . 3.3900000000000001 109.756 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.728 ' HD3' HG22 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -49.05 148.02 10.07 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.51 2.807 . . . . 0.42999999999999999 113.077 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 10.6 t -92.73 150.24 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.669 . . . . 1.47 109.195 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.875 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 66.1 mttt -71.33 120.26 16.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.709 0.766 . . . . 1.71 109.862 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.85 -26.8 4.74 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.175 -1.375 . . . . 0.41999999999999998 110.103 -172.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.659 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.1 135.88 35.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.86 -0.793 . . . . 0.58999999999999997 108.86 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 11.4 m -82.63 118.47 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.524 -0.917 . . . . 1.8600000000000001 108.524 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -112.96 146.06 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.249 -0.887 . . . . 1.0700000000000001 110.513 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.538 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.0 p -97.05 113.1 24.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.946 -0.57 . . . . 1.0600000000000001 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' THR . 27.1 m -111.05 150.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.767 -0.651 . . . . 1.05 110.187 174.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.73 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.52 -1.659 . . . . 0.28999999999999998 106.52 167.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 83' ' ' GLU . 1.8 pt? -125.0 141.62 52.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.901 0.858 . . . . 1.1299999999999999 110.88 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.644 HE22 ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -139.28 120.03 14.26 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.464 -2.05 . . . . 0.27000000000000002 105.464 167.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.57 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 43.3 m -112.26 121.66 45.55 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.382 -0.826 . . . . 1.04 111.808 -165.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -103.59 148.7 25.68 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.885 -0.598 . . . . 1.54 109.515 175.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.437 HD13 ' CG1' ' A' ' 80' ' ' VAL . 3.4 mp -71.56 165.6 23.56 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.955 -0.566 . . . . 1.51 111.067 170.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.34 -18.95 12.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.416 0.627 . . . . 1.1399999999999999 110.08 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.412 HD22 HD21 ' A' ' 74' ' ' LEU . 29.5 p30 -92.44 -5.07 52.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.366 -0.833 . . . . 2.1400000000000001 111.133 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.49 -10.74 53.89 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.248 -0.501 . . . . 0.51000000000000001 113.577 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.6 m -78.49 110.45 13.58 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.74 -0.27 . . . . 1.1599999999999999 111.697 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.671 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 33.9 mtt180 -71.19 122.25 19.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.476 0.655 . . . . 0.54000000000000004 110.253 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.68 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 32.8 m -108.18 -10.13 10.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.976 -1.011 . . . . 1.0600000000000001 111.625 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.57 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 29.4 pt20 -159.96 145.58 15.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.889 -0.596 . . . . 0.63 109.501 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 43.8 tt0 -148.96 105.57 3.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.195 0.521 . . . . 1.3400000000000001 109.902 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' HB2' HD23 ' A' ' 70' ' ' LEU . 7.1 mm-40 -122.27 117.57 29.28 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.693 -0.685 . . . . 2.5899999999999999 109.435 -175.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -66.5 -19.18 55.02 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.705 2.27 . . . . 0.90000000000000002 112.182 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -159.54 118.67 2.89 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.269 1.033 . . . . 1.3700000000000001 111.685 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.3 tp -126.07 99.65 6.0 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.174 -1.83 . . . . 1.1399999999999999 108.423 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.0 p -89.57 134.42 28.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.949 -0.76 . . . . 1.5900000000000001 108.949 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.66 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.5 p90 -153.56 162.7 41.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.11 0.481 . . . . 0.25 111.168 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.1 m -84.09 108.27 16.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.249 -0.887 . . . . 1.0700000000000001 110.063 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.875 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.24 132.52 54.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 1.3300000000000001 110.152 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.684 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 86.93 4.9 81.67 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.498 -0.858 . . . . 0.37 112.376 175.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -117.8 9.3 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.692 -0.485 . . . . 0.93000000000000005 109.692 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p 43.9 42.45 4.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.145 -0.934 . . . . 1.55 110.296 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 48.9 t0 -71.41 -12.29 61.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.766 1.27 . . . . 1.3300000000000001 108.166 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.409 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 4.1 m -123.48 -153.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 113.168 -1.833 . . . . 1.0800000000000001 109.558 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.601 HG13 ' H ' ' A' ' 99' ' ' LEU . 38.9 pt -81.67 142.85 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 107.541 -1.281 . . . . 1.0600000000000001 107.541 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.486 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 9.0 tp60 -59.96 -34.85 73.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.619 -0.264 . . . . 0.40000000000000002 111.08 -173.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.18 -48.79 67.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.204 0.526 . . . . 1.0800000000000001 110.759 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' H ' HG13 ' A' ' 96' ' ' ILE . 57.8 tp -67.68 -41.91 82.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.184 -0.916 . . . . 1.0700000000000001 110.534 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.443 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.8 t70 -60.54 -28.01 68.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.923 -1.035 . . . . 0.26000000000000001 109.913 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.686 HD22 ' HZ1' ' A' ' 62' ' ' LYS . 87.0 mt -89.66 -34.86 16.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.246 -0.888 . . . . 1.0600000000000001 111.893 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 60.3 p -70.82 -27.11 63.63 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.635 0.255 . . . . 1.53 110.768 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 99' ' ' LEU . 54.1 t -66.05 -55.33 21.92 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 112.48 0.548 . . . . 1.0600000000000001 112.48 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.626 ' HD3' HD12 ' A' ' 90' ' ' LEU . 21.9 Cg_endo -61.39 -24.64 78.84 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.806 1.67 . . . . 0.40999999999999998 112.112 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' A' ' 39' ' ' ILE . 11.9 mt -77.98 -13.25 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 1.3500000000000001 111.213 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.796 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -106.9 155.03 20.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.849 -0.614 . . . . 1.3100000000000001 111.077 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.74 155.61 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.711 0.291 . . . . 0.96999999999999997 110.619 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.728 HG22 ' HD3' ' A' ' 60' ' ' PRO . 2.1 t -60.5 125.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 1.47 110.659 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.01 5.86 56.19 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.201 -0.909 . . . . 0.28000000000000003 112.499 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.824 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -98.45 168.29 10.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.466 0.65 . . . . 0.40999999999999998 111.139 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 50' ' ' LEU . 31.6 m -132.69 117.42 17.85 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.995 -1.002 . . . . 1.0700000000000001 108.479 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.54 140.15 50.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.564 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 ttm -97.92 117.16 31.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.263 -1.384 . . . . 1.9399999999999999 107.263 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 47' ' ' LYS . 4.2 t -113.29 132.81 61.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.424 -0.584 . . . . 1.0600000000000001 109.424 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 79.4 m -112.71 113.75 26.01 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.133 0.968 . . . . 1.03 109.072 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.46 135.36 53.17 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.434 -1.712 . . . . 1.01 109.693 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.737 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.6 t70 -52.33 147.28 8.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.789 -0.819 . . . . 0.57999999999999996 108.789 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -55.8 -27.92 53.6 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 120.993 0.425 . . . . 1.04 110.234 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.607 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.6 ptpt -56.29 -29.28 60.99 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.894 -0.504 . . . . 1.4299999999999999 111.455 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.579 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 85.0 m-85 -97.35 1.72 49.74 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.196 0.522 . . . . 1.04 109.9 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.1 m -122.02 -90.71 0.57 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.954 -1.021 . . . . 0.87 110.66 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.664 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 8.1 m-85 -142.9 41.62 1.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.587 -0.445 . . . . 0.95999999999999996 111.921 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.44 -80.82 0.06 OUTLIER Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.09 -0.576 . . . . 0.25 113.4 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.26 10.36 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.478 2.119 . . . . 0.90000000000000002 111.003 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.664 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.2 mt-30 -102.83 -46.45 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.756 -1.111 . . . . 0.65000000000000002 109.876 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.554 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 79.21 142.58 2.42 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.181 -0.918 . . . . 0.29999999999999999 112.634 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.604 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.7 t -90.53 164.57 14.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.218 -0.491 . . . . 0.90000000000000002 111.558 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -56.16 -50.22 71.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.651 -0.704 . . . . 3.6099999999999999 112.065 -173.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.889 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 51.1 m -80.91 -62.4 0.36 Allowed Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.214 -0.594 . . . . 1.52 109.998 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.889 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 22.1 Cg_endo -107.19 127.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.892 2.395 . . . . 0.44 112.541 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.53 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 41.2 t80 -55.97 98.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.863 -1.162 . . . . 1.6899999999999999 107.863 162.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.578 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.2 mm -64.74 133.0 95.59 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.767 . . . . 1.0600000000000001 110.196 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 146.05 37.55 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.622 2.215 . . . . 1.03 112.14 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.518 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.3 Cg_endo -63.74 135.57 49.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.296 1.998 . . . . 0.89000000000000001 112.387 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.737 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER 70.75 -0.42 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.915 -1.038 . . . . 3.1899999999999999 112.744 178.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -61.12 118.97 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.129 -0.693 . . . . 1.04 109.129 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.92 113.09 10.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.422 0.63 . . . . 1.05 109.685 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 115' ' ' THR . 0.9 OUTLIER -88.83 131.07 35.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.86 . . . . 1.0600000000000001 110.982 -173.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.2 t -114.64 100.38 8.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.57 -0.9 . . . . 1.8200000000000001 108.57 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.548 ' HB3' HG21 ' A' ' 72' ' ' THR . 1.0 OUTLIER -121.32 135.46 55.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.008 -0.542 . . . . 1.1499999999999999 111.816 -174.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.644 ' HG2' HE22 ' A' ' 71' ' ' GLN . 4.8 tt0 -98.0 125.97 43.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.511 -0.768 . . . . 1.05 109.482 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.4 m -124.42 117.14 49.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.31 0.576 . . . . 1.0800000000000001 112.053 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 24.4 m -89.25 114.8 26.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.365 -0.834 . . . . 1.0900000000000001 110.391 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.682 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 62.0 tp -84.57 100.35 11.35 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.238 -0.653 . . . . 1.0700000000000001 109.238 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.509 ' C ' ' HG1' ' A' ' 146' ' ' THR . 25.8 mtmt -95.08 -25.8 16.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.528 -0.76 . . . . 1.6899999999999999 110.88 -170.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.538 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 14.2 m -157.37 155.25 30.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.115 0.413 . . . . 1.1200000000000001 112.115 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.512 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -140.49 127.9 21.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.28 -0.637 . . . . 0.98999999999999999 109.28 171.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 17.8 m . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.423 . . . . 1.6200000000000001 110.412 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.59 ' HB2' ' HB3' ' A' ' 46' ' ' ARG . 3.8 m0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.765 -0.457 . . . . 0.53000000000000003 109.765 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.07 109.58 4.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.304 -0.628 . . . . 1.1899999999999999 109.304 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.647 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.2 t70 -78.53 127.19 31.8 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.166 -0.614 . . . . 2.5099999999999998 109.852 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.514 HD11 HD12 ' A' ' 45' ' ' LEU . 3.3 mt -61.68 -31.1 49.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.702 -1.136 . . . . 1.1499999999999999 110.531 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -115.45 0.54 13.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.9 -0.591 . . . . 1.4299999999999999 110.546 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.647 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.2 25.27 64.36 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.522 -0.763 . . . . 0.65000000000000002 111.552 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -96.03 -26.56 15.49 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.936 0.347 . . . . 0.94999999999999996 111.936 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.471 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 105.45 0.86 40.54 Favored Glycine 0 CA--C 1.512 -0.122 0 C-N-CA 120.847 -0.692 . . . . 0.71999999999999997 111.871 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.1 mp -105.49 -32.73 8.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.037 0.446 . . . . 2.1600000000000001 110.873 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 HD11 ' A' ' 39' ' ' ILE . 19.0 tp -123.12 101.55 7.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 1.1200000000000001 111.572 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 66.4 mtm180 -137.35 148.31 46.18 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.152 -0.342 . . . . 1.49 111.449 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.673 ' HG3' HG21 ' A' ' 114' ' ' VAL . 25.3 ttpt -113.75 132.16 55.93 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.435 -0.209 . . . . 1.1200000000000001 110.435 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.6 ttpt -115.92 129.9 56.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.6499999999999999 110.219 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' OE1' ' A' ' 110' ' ' GLU . 5.9 p -82.43 107.67 15.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.163 -0.471 . . . . 1.03 111.549 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 111' ' ' THR . 6.7 mt -76.04 -54.76 6.37 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.344 -1.354 . . . . 1.0600000000000001 107.344 172.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.816 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 97.7 t -127.24 124.57 23.79 Favored Pre-proline 0 CA--C 1.501 -0.923 0 CA-C-N 113.06 -1.882 . . . . 1.1399999999999999 106.879 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.0 Cg_endo -111.56 88.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.932 2.421 . . . . 0.56000000000000005 114.252 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 CA--C 1.527 0.811 0 CA-C-N 116.387 -0.37 . . . . 0.55000000000000004 113.446 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 113.055 0.761 . . . . 1.3600000000000001 113.055 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -150.0 143.94 25.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.48 -1.304 . . . . 1.8200000000000001 107.48 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 6.8 mtm-85 -91.15 115.38 64.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.484 -0.486 . . . . 3.3900000000000001 110.638 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.773 ' HD3' HG22 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.23 140.26 42.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.98 2.453 . . . . 0.42999999999999999 113.598 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.7 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.3 t -90.91 156.99 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.531 -0.759 . . . . 1.47 109.845 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -66.26 107.89 2.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.408 0.623 . . . . 1.71 110.399 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.04 -27.12 2.56 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 110.534 -1.027 . . . . 0.41999999999999998 110.534 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.7 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -74.45 140.14 44.43 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.465 -0.569 . . . . 0.58999999999999997 109.465 178.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 148' ' ' VAL . 69.8 t -86.03 124.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.896 -0.779 . . . . 1.8600000000000001 108.896 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.6 m -127.79 146.82 32.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 112.296 0.48 . . . . 1.0700000000000001 112.296 -170.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.0 p -96.46 113.83 25.44 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.767 -0.651 . . . . 1.0600000000000001 110.008 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.499 HG23 HD21 ' A' ' 99' ' ' LEU . 24.5 m -110.68 142.05 24.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 120.071 -0.652 . . . . 1.05 109.803 172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.34 112.43 24.94 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.981 -1.859 . . . . 0.28999999999999998 105.981 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -119.21 133.69 55.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.318 1.056 . . . . 1.1299999999999999 111.097 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.667 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -129.09 114.12 15.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.109 -2.182 . . . . 0.27000000000000002 105.109 167.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.593 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 80.4 m -106.04 126.41 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.745 -1.116 . . . . 1.04 111.279 -166.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.8 t -106.89 157.21 17.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.341 -0.845 . . . . 1.54 109.504 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.38 167.12 15.02 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.613 -0.722 . . . . 1.51 110.65 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' OE1' ' HB3' ' A' ' 136' ' ' ALA . 4.6 pm0 -50.81 -24.97 3.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.106 -0.952 . . . . 1.1399999999999999 111.371 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -93.55 -10.25 35.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.036 -0.529 . . . . 2.1400000000000001 111.371 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.48 20.08 20.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.327 -0.94 . . . . 0.51000000000000001 112.492 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.1 m -96.29 109.6 22.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.628 0.251 . . . . 1.1599999999999999 110.72 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.671 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.9 mtt180 -76.03 109.94 10.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.736 0.779 . . . . 0.54000000000000004 110.004 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.711 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -95.1 -9.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.36 -1.291 . . . . 1.0600000000000001 111.833 -169.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.593 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 11.7 pt20 -159.69 148.65 17.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.63 109.597 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 28.7 tt0 -152.65 105.78 3.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.087 0.47 . . . . 1.3400000000000001 110.172 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -124.77 117.15 26.17 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.697 -0.683 . . . . 2.5899999999999999 110.072 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 30.0 Cg_endo -63.97 -17.96 61.85 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.592 2.194 . . . . 0.90000000000000002 112.103 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.74 106.72 2.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.161 0.982 . . . . 1.3700000000000001 111.699 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.4 tp -115.72 111.84 21.17 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.473 -1.694 . . . . 1.1399999999999999 107.635 170.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.3 p -109.17 131.05 61.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 110.041 -0.355 . . . . 1.5900000000000001 110.041 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.17 163.26 40.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.601 -0.272 . . . . 0.25 110.917 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.6 m -82.91 117.75 22.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.915 -0.584 . . . . 1.0700000000000001 109.628 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.844 HD13 ' HD3' ' A' ' 104' ' ' PRO . 13.8 tp -61.45 138.08 58.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 1.3300000000000001 110.843 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.29 -7.2 61.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.015 -0.612 . . . . 0.37 112.162 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.18 -9.14 55.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.93000000000000005 109.761 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.2 m 60.2 30.31 19.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.178 -0.919 . . . . 1.55 109.54 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.19 -20.63 63.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.542 1.163 . . . . 1.3300000000000001 108.302 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 m -112.88 -158.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 113.279 -1.782 . . . . 1.0800000000000001 110.38 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.573 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.8 pt -79.51 140.29 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.689 -1.226 . . . . 1.0600000000000001 107.689 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.513 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 5.9 tp60 -59.88 -30.97 69.36 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.267 0.355 . . . . 0.40000000000000002 110.821 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.16 -49.88 68.28 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.373 0.606 . . . . 1.0800000000000001 110.544 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.573 ' H ' HG13 ' A' ' 96' ' ' ILE . 58.4 tp -69.87 -41.68 74.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.832 -1.076 . . . . 1.0700000000000001 110.294 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HB3' HE21 ' A' ' 97' ' ' GLN . 19.9 t70 -60.72 -28.42 68.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.831 -1.077 . . . . 0.26000000000000001 109.963 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 80.9 mt -90.84 -34.81 15.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.394 -0.821 . . . . 1.0600000000000001 112.256 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 79.4 p -70.86 -24.63 62.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.538 -0.301 . . . . 1.53 111.143 -173.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 99' ' ' LEU . 53.3 t -72.42 -50.27 8.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 112.793 0.664 . . . . 1.0600000000000001 112.793 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.844 ' HD3' HD13 ' A' ' 90' ' ' LEU . 30.8 Cg_endo -65.01 -20.96 64.08 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 121.553 1.502 . . . . 0.40999999999999998 111.61 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 105' ' ' LEU . 15.9 mt -80.94 -18.62 46.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 1.3500000000000001 110.541 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.707 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 31.8 ttm -90.09 149.84 22.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 1.3100000000000001 111.104 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.37 147.45 23.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.96999999999999997 110.39 176.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.773 HG22 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -60.44 123.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.328 0.585 . . . . 1.47 110.68 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.27 56.89 Favored Glycine 0 C--N 1.314 -0.679 0 C-N-CA 120.784 -0.722 . . . . 0.28000000000000003 113.017 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -99.68 168.78 9.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.253 0.549 . . . . 0.40999999999999998 110.674 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.482 HG23 HD12 ' A' ' 50' ' ' LEU . 11.5 m -127.68 116.87 20.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.461 -1.311 . . . . 1.0700000000000001 107.461 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' HE1' ' A' ' 106' ' ' MET . . . -116.53 139.56 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.494 -174.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 ttm -98.44 117.02 31.91 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.328 -1.36 . . . . 1.9399999999999999 107.328 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.673 HG21 ' HG3' ' A' ' 47' ' ' LYS . 11.3 t -113.19 131.34 65.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 109.078 -0.712 . . . . 1.0600000000000001 109.078 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.546 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 41.6 m -115.81 113.93 24.06 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 119.278 -0.969 . . . . 1.03 109.068 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.42 139.03 53.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.038 -1.892 . . . . 1.01 109.739 -176.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 10.1 t70 -53.93 150.8 7.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.407 -0.59 . . . . 0.57999999999999996 109.407 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.586 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.9 t -54.81 -30.02 56.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 1.04 110.341 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.639 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -55.53 -30.13 60.15 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 122.229 -0.294 . . . . 1.4299999999999999 111.56 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.517 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 76.6 m-85 -95.87 2.03 53.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.231 0.538 . . . . 1.04 110.171 176.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.794 ' HB3' HD21 ' A' ' 138' ' ' LEU . 60.5 m -123.69 -91.05 0.56 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.156 -0.929 . . . . 0.87 110.654 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.813 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.9 m-85 -140.15 38.36 1.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.574 0.583 . . . . 0.95999999999999996 112.574 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.48 -78.82 0.08 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.474 0.579 . . . . 0.25 113.628 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -89.64 13.79 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.367 2.044 . . . . 0.90000000000000002 110.559 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.813 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 42.0 mt-30 -104.28 -49.02 3.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.97 -1.014 . . . . 0.65000000000000002 110.464 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.566 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 76.93 142.75 1.48 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.996 -1.002 . . . . 0.29999999999999999 112.905 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.601 ' HB3' HG12 ' A' ' 132' ' ' ILE . 10.3 t -90.68 159.62 16.28 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.042 -0.579 . . . . 0.90000000000000002 112.376 -175.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -52.45 -48.83 65.57 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.016 -0.993 . . . . 3.6099999999999999 111.968 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.986 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 34.6 m -80.59 -67.76 0.22 Allowed Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.453 -0.499 . . . . 1.52 109.946 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.986 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.4 Cg_endo -104.91 127.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.611 2.208 . . . . 0.44 112.091 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.566 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 39.4 t80 -55.67 99.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.194 -1.039 . . . . 1.6899999999999999 108.194 163.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 127' ' ' SER . 35.1 mm -65.63 129.58 94.37 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.282 -0.872 . . . . 1.0600000000000001 109.726 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.4 Cg_endo -53.52 141.78 61.51 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.828 2.352 . . . . 1.03 112.499 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.594 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 35.3 Cg_exo -58.28 131.35 42.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.467 2.111 . . . . 0.89000000000000001 112.52 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.577 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 32.2 m170 73.37 9.82 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.916 -1.038 . . . . 3.1899999999999999 112.35 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.68 127.75 33.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.215 -0.661 . . . . 1.04 109.215 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.69 111.58 10.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.074 0.464 . . . . 1.05 110.533 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.794 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.8 tp -88.4 130.97 35.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.684 -0.689 . . . . 1.0600000000000001 110.213 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.55 100.85 7.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.707 0.765 . . . . 1.8200000000000001 110.085 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -109.58 136.7 48.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.96 -1.018 . . . . 1.1499999999999999 112.067 -173.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.667 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 38.2 tt0 -101.14 118.19 36.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.74 -0.837 . . . . 1.05 108.74 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -121.43 118.15 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.092 0.775 . . . . 1.0800000000000001 113.092 -173.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 2.9 m -90.75 109.31 20.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.709 -0.678 . . . . 1.0900000000000001 110.539 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.707 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 38.3 tp -82.86 102.72 11.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.428 -0.952 . . . . 1.0700000000000001 108.428 172.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -103.53 -19.93 14.21 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.452 -0.795 . . . . 1.6899999999999999 110.901 -170.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 m -156.41 144.94 19.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.108 -0.496 . . . . 1.1200000000000001 111.152 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 66' ' ' VAL . . . -141.0 128.7 21.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.212 -0.662 . . . . 0.98999999999999999 109.212 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 65' ' ' VAL . 18.3 m . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.478 -0.489 . . . . 1.6200000000000001 110.7 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.666 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.622 . . . . 0.53000000000000003 110.663 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.75 110.91 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.684 -0.689 . . . . 1.1899999999999999 110.012 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.668 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.3 t70 -73.83 123.73 24.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.264 -0.574 . . . . 2.5099999999999998 110.086 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.586 HG22 HD13 ' A' ' 105' ' ' LEU . 9.4 mt -54.51 -37.82 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.053 -0.976 . . . . 1.1499999999999999 111.309 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -111.8 2.89 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.203 -0.453 . . . . 1.4299999999999999 110.617 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.668 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.11 22.7 60.91 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.57 -0.741 . . . . 0.65000000000000002 112.066 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.16 -27.8 17.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.146 0.424 . . . . 0.94999999999999996 112.146 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.52 2.69 37.76 Favored Glycine 0 N--CA 1.454 -0.136 0 C-N-CA 120.926 -0.655 . . . . 0.71999999999999997 112.271 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 3.8 mm? -112.72 -28.38 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.682 0.277 . . . . 2.1600000000000001 110.969 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.492 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 23.3 tp -122.06 100.33 6.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 1.1200000000000001 110.989 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -131.98 136.85 47.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.905 0.335 . . . . 1.49 111.905 -171.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 114' ' ' VAL . 12.8 ttpt -109.01 123.09 48.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.629 -0.508 . . . . 1.1200000000000001 109.629 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.666 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 24.4 ttpp -105.46 110.79 23.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.666 0.269 . . . . 1.6499999999999999 110.538 176.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -70.65 98.99 1.59 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 1.03 110.898 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 HG23 ' A' ' 111' ' ' THR . 10.7 mt -66.06 -52.54 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.724 -1.584 . . . . 1.0600000000000001 106.724 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.858 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 90.1 t -137.29 131.55 17.6 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 112.982 -1.917 . . . . 1.1399999999999999 106.483 169.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -105.65 52.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.704 2.269 . . . . 0.56000000000000005 113.798 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.924 -0.655 . . . . 0.55000000000000004 112.982 175.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.474 0.654 . . . . 1.3600000000000001 111.173 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -153.22 137.52 16.6 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.944 -1.132 . . . . 1.8200000000000001 107.944 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 106' ' ' MET . 40.3 mtm180 -91.67 110.61 44.57 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.696 -0.229 . . . . 3.3900000000000001 110.451 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HD3' HG23 ' A' ' 108' ' ' VAL . 12.1 Cg_endo -53.82 149.11 34.62 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.412 2.741 . . . . 0.42999999999999999 112.8 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 2.2 m -102.99 157.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.204 -0.665 . . . . 1.47 109.204 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.861 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 56.6 mttp -62.97 119.85 10.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.246 0.546 . . . . 1.71 109.749 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.72 -26.75 4.5 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.49 -1.044 . . . . 0.41999999999999998 110.49 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 3.1 mm-40 -83.88 127.14 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.884 -1.154 . . . . 0.58999999999999997 107.884 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -80.37 126.75 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.18 -1.044 . . . . 1.8600000000000001 108.18 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 18.2 m -121.89 145.9 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.066 -0.97 . . . . 1.0700000000000001 110.533 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.679 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 54.4 p -96.92 112.99 24.5 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.86 -0.609 . . . . 1.0600000000000001 109.778 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.735 HG23 HD23 ' A' ' 99' ' ' LEU . 17.1 m -110.91 145.6 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 C-N-CA 120.228 -0.589 . . . . 1.05 110.697 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.644 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.1 t-160 -102.03 114.87 29.37 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.014 -1.476 . . . . 0.28999999999999998 107.014 169.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -121.21 133.5 55.17 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.218 1.008 . . . . 1.1299999999999999 110.905 176.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.697 HE22 ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -128.79 113.59 15.5 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.372 -2.084 . . . . 0.27000000000000002 105.372 168.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 40.1 m -104.4 127.69 52.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.953 -1.021 . . . . 1.04 111.724 -168.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.9 m -103.16 162.17 13.19 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.291 -0.868 . . . . 1.54 109.308 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.22 166.14 15.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.739 -1.119 . . . . 1.51 109.904 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.97 -21.88 33.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.187 0.518 . . . . 1.1399999999999999 110.296 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.43 -4.47 55.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.909 -0.587 . . . . 2.1400000000000001 111.29 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.98 -23.07 28.46 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.658 -0.782 . . . . 0.51000000000000001 113.567 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 118.02 10.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.391 0.515 . . . . 1.1599999999999999 112.391 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.738 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.0 mtt180 -76.38 125.25 28.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.74 0.781 . . . . 0.54000000000000004 111.121 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.658 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -106.76 -9.09 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 1.0600000000000001 111.886 -170.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 8.6 pt20 -160.91 145.95 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.828 -0.624 . . . . 0.63 109.399 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HG2' ' CG ' ' A' ' 71' ' ' GLN . 1.2 tm-20 -150.56 105.53 3.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.347 -0.612 . . . . 1.3400000000000001 109.347 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -125.59 111.15 25.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 2.5899999999999999 110.069 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.413 ' HA ' ' CE1' ' A' ' 69' ' ' HIS . 24.6 Cg_exo -63.12 -16.63 55.62 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.137 2.558 . . . . 0.90000000000000002 113.192 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.48 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 11.6 tt0 -164.49 100.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.3 1.048 . . . . 1.3700000000000001 111.682 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.0 tp -109.11 110.35 21.57 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 1.1399999999999999 108.878 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.2 p -102.36 133.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.265 -0.643 . . . . 1.5900000000000001 109.265 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.2 p90 -153.31 157.29 39.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.695 0.283 . . . . 0.25 110.622 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -76.67 110.85 11.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.711 -0.677 . . . . 1.0700000000000001 109.646 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.861 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.3 tp -55.03 129.74 39.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.348 -0.387 . . . . 1.3300000000000001 110.862 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.12 2.02 90.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.918 -0.658 . . . . 0.37 112.368 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.16 -7.16 52.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.387 -0.598 . . . . 0.93000000000000005 109.387 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.8 m 60.65 28.77 18.48 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.207 -0.906 . . . . 1.55 110.019 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -63.87 -28.34 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.685 1.231 . . . . 1.3300000000000001 108.633 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 16.0 m -110.15 -153.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 113.329 -1.76 . . . . 1.0800000000000001 111.057 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.573 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.3 pt -89.04 139.47 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.548 -1.279 . . . . 1.0600000000000001 107.548 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.496 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -59.23 -29.35 67.46 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.458 -0.337 . . . . 0.40000000000000002 110.663 -174.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.02 -47.48 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.212 0.53 . . . . 1.0800000000000001 110.477 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.735 HD23 HG23 ' A' ' 68' ' ' VAL . 58.0 tp -78.04 -36.89 47.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.2 -0.909 . . . . 1.0700000000000001 110.259 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.49 -30.45 71.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.223 -0.899 . . . . 0.26000000000000001 109.588 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.2 mt -91.02 -33.32 15.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.418 -0.81 . . . . 1.0600000000000001 112.214 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 106' ' ' MET . 34.1 t -67.2 -31.92 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.58 -0.282 . . . . 1.53 111.1 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 99' ' ' LEU . 54.1 t -62.11 -55.45 40.57 Favored Pre-proline 0 C--O 1.219 -0.55 0 N-CA-C 112.309 0.485 . . . . 1.0600000000000001 112.309 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.837 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.9 Cg_endo -62.57 -20.64 71.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 121.747 1.632 . . . . 0.40999999999999998 111.75 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.586 HD13 HG22 ' A' ' 39' ' ' ILE . 12.1 mt -82.14 -15.15 54.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.584 . . . . 1.3500000000000001 111.299 173.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.746 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -107.41 146.41 31.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.925 -0.58 . . . . 1.3100000000000001 111.095 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.96 157.5 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.18 0.514 . . . . 0.96999999999999997 111.022 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.811 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.3 t -63.97 124.52 18.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.403 0.621 . . . . 1.47 110.169 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.68 16.39 45.81 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.067 -0.969 . . . . 0.28000000000000003 112.342 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.858 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.5 pt-20 -105.28 167.98 9.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.334 0.588 . . . . 0.40999999999999998 111.25 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.461 HG23 HD13 ' A' ' 50' ' ' LEU . 17.8 m -132.98 118.46 18.88 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.453 -0.943 . . . . 1.0700000000000001 108.453 173.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.13 140.19 52.84 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.327 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.6 ttp -100.61 118.26 36.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.506 -1.294 . . . . 1.9399999999999999 107.506 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.434 HG21 ' HG3' ' A' ' 47' ' ' LYS . 5.7 t -111.95 131.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.209 -0.45 . . . . 1.0600000000000001 110.086 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.521 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 96.1 m -108.16 112.98 25.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.364 -0.976 . . . . 1.03 108.364 172.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.62 135.17 52.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.378 -1.283 . . . . 1.01 109.399 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.634 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.8 t70 -54.25 149.35 9.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.1 -0.704 . . . . 0.57999999999999996 109.1 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.587 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -54.49 -28.49 45.25 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.407 0.442 . . . . 1.04 110.351 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.634 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.0 ptpt -54.68 -32.91 60.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.633 -0.258 . . . . 1.4299999999999999 111.463 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.566 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 82.8 m-85 -95.39 1.68 54.31 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.01 0.434 . . . . 1.04 110.279 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 70.8 m -120.74 -89.8 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.215 -0.902 . . . . 0.87 110.6 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.566 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.0 m-85 -144.04 38.78 1.32 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.066 -0.396 . . . . 0.95999999999999996 111.777 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.03 -79.39 0.08 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.215 -0.517 . . . . 0.25 113.636 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -85.02 9.51 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.197 1.931 . . . . 0.90000000000000002 111.044 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -104.0 -50.57 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.994 -1.003 . . . . 0.65000000000000002 109.81 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 79.87 141.53 2.51 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.602 -1.181 . . . . 0.29999999999999999 111.985 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.604 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.1 t -91.29 163.85 14.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.36 -0.42 . . . . 0.90000000000000002 111.374 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -48.82 -69.05 0.13 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.899 0.749 . . . . 3.6099999999999999 111.66 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.992 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.9 m -64.2 -66.37 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 115.675 -0.693 . . . . 1.52 110.608 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.992 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 28.5 Cg_endo -106.94 127.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.5 2.133 . . . . 0.44 112.259 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.554 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 23.5 t80 -57.15 97.34 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.978 -1.119 . . . . 1.6899999999999999 107.978 164.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.585 HG12 ' CB ' ' A' ' 127' ' ' SER . 31.8 mm -65.72 129.84 94.4 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 109.591 -0.522 . . . . 1.0600000000000001 109.591 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.76 140.88 66.61 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.59 2.194 . . . . 1.03 112.199 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 44.2 Cg_exo -57.8 131.28 43.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.234 1.956 . . . . 0.89000000000000001 112.292 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.499 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER 75.15 4.68 4.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.14 -0.936 . . . . 3.1899999999999999 112.356 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -70.05 123.3 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.281 -0.637 . . . . 1.04 109.281 176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.06 113.58 12.55 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.229 -0.588 . . . . 1.05 110.306 -172.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.603 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.3 tp -90.87 132.81 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.779 -0.646 . . . . 1.0600000000000001 110.918 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.78 100.75 7.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.183 0.516 . . . . 1.8200000000000001 109.696 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.559 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -116.19 136.16 53.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.138 -0.483 . . . . 1.1499999999999999 111.836 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.697 ' HG2' HE22 ' A' ' 71' ' ' GLN . 6.4 tt0 -102.05 121.8 42.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.224 -0.658 . . . . 1.05 109.224 178.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.694 HG13 HD12 ' A' ' 99' ' ' LEU . 3.7 m -118.14 117.56 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.682 0.753 . . . . 1.0800000000000001 112.52 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.72 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.3 m -87.8 115.36 25.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.971 -1.013 . . . . 1.0900000000000001 110.387 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.688 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 42.8 tp -88.87 100.73 13.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.223 -1.028 . . . . 1.0700000000000001 108.223 170.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.72 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -93.75 -23.27 18.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.191 -0.913 . . . . 1.6899999999999999 110.781 -173.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.679 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 94.7 m -159.84 144.91 15.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.763 -0.653 . . . . 1.1200000000000001 111.494 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.467 ' CB ' HG13 ' A' ' 66' ' ' VAL . . . -136.44 126.92 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.144 -0.688 . . . . 0.98999999999999999 109.144 170.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 121.126 0.489 . . . . 1.6200000000000001 110.455 -179.097 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.687 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.193 0.521 . . . . 0.53000000000000003 111.327 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 tp -69.4 112.94 6.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.454 -0.794 . . . . 1.1899999999999999 110.332 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.613 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 t70 -76.41 123.49 26.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.527 0.679 . . . . 2.5099999999999998 109.999 176.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.589 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 4.8 mt -64.18 -30.13 49.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.794 -1.094 . . . . 1.1499999999999999 110.667 -176.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.35 -8.43 19.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.118 -0.492 . . . . 1.4299999999999999 110.05 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.49 25.3 68.55 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.209 -0.905 . . . . 0.65000000000000002 111.654 -172.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' OD1' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -105.07 -26.95 11.91 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.359 0.503 . . . . 0.94999999999999996 112.359 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.497 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.66 7.51 25.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.308 -0.948 . . . . 0.71999999999999997 112.454 174.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD13 ' OD1' ' A' ' 42' ' ' ASN . 8.9 mp -110.2 -32.7 6.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.332 0.587 . . . . 2.1600000000000001 110.578 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 19.4 tp -122.55 104.04 9.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.11 -0.95 . . . . 1.1200000000000001 111.512 -170.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 77.9 mtm180 -134.63 144.91 48.14 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.942 -0.474 . . . . 1.49 112.197 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HG3' HG22 ' A' ' 114' ' ' VAL . 14.8 ttpt -115.34 129.08 56.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.271 -0.27 . . . . 1.1200000000000001 110.271 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.687 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -111.08 120.02 40.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.891 0.377 . . . . 1.6499999999999999 111.109 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 p -72.91 101.03 3.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.747 -0.66 . . . . 1.03 111.647 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.44 HD13 HG21 ' A' ' 111' ' ' THR . 10.9 mt -68.08 -51.39 47.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.895 -1.521 . . . . 1.0600000000000001 106.895 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.852 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 69.0 t -136.58 130.46 17.94 Favored Pre-proline 0 CA--C 1.501 -0.927 0 CA-C-N 112.898 -1.956 . . . . 1.1399999999999999 106.097 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 44.4 Cg_endo -104.21 56.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.743 2.295 . . . . 0.56000000000000005 113.451 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.725 0 CA-C-N 115.564 -0.744 . . . . 0.55000000000000004 112.637 177.442 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 120.941 0.4 . . . . 1.3600000000000001 110.811 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.486 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 19.4 m -145.85 138.02 25.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.745 -0.465 . . . . 1.8200000000000001 109.745 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 85.2 mtt180 -92.14 116.2 66.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 3.3900000000000001 109.626 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG3' HD22 ' A' ' 144' ' ' LEU . 9.1 Cg_endo -52.19 155.35 9.28 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.552 2.834 . . . . 0.42999999999999999 113.042 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.593 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 3.9 p -106.82 154.38 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 1.47 109.935 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.891 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 58.6 mttp -63.49 123.83 19.78 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.568 0.699 . . . . 1.71 109.54 178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.438 ' C ' HE21 ' A' ' 64' ' ' GLN . . . 118.24 -9.73 13.48 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 114.799 -1.091 . . . . 0.41999999999999998 110.562 -170.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.673 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.45 136.32 34.88 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.948 -0.736 . . . . 0.58999999999999997 109.698 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 p -82.87 115.7 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 108.445 -0.946 . . . . 1.8600000000000001 108.445 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.3 m -117.81 148.76 20.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.595 -0.729 . . . . 1.0700000000000001 111.156 -170.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.485 HG23 HG13 ' A' ' 87' ' ' VAL . 77.1 p -98.12 113.75 25.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.984 -0.553 . . . . 1.0600000000000001 110.09 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 99' ' ' LEU . 28.2 m -111.28 140.44 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 119.641 -0.824 . . . . 1.05 110.762 172.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.573 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.8 t-160 -102.29 115.27 30.21 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.891 -1.522 . . . . 0.28999999999999998 106.891 168.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 ' HB3' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -124.44 129.46 50.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 118.921 -1.112 . . . . 1.1299999999999999 111.608 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' CG ' ' HE2' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -121.79 114.9 21.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.865 -1.902 . . . . 0.27000000000000002 105.865 169.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.558 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 58.9 m -103.31 128.66 50.3 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.676 -1.147 . . . . 1.04 111.562 -167.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.695 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.8 m -103.51 156.8 17.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.129 -0.942 . . . . 1.54 108.869 176.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.69 165.34 19.02 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.199 -0.91 . . . . 1.51 109.431 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.06 -21.65 23.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.338 0.59 . . . . 1.1399999999999999 110.482 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.94 -5.15 58.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.379 -0.828 . . . . 2.1400000000000001 110.997 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.59 -6.4 57.39 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.979 -0.629 . . . . 0.51000000000000001 112.878 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -81.04 112.95 18.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.786 0.327 . . . . 1.1599999999999999 111.791 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 16.0 mtt180 -75.0 122.62 23.79 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.499 0.666 . . . . 0.54000000000000004 110.747 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -108.0 -9.93 10.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.695 -1.139 . . . . 1.0600000000000001 112.1 -169.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.558 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.0 pt20 -158.88 133.3 7.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.449 -0.341 . . . . 0.63 110.439 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.55 107.11 12.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.309 0.576 . . . . 1.3400000000000001 110.016 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.902 ' HB3' HD21 ' A' ' 70' ' ' LEU . 1.9 tp10 -111.29 105.68 57.0 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.237 -0.892 . . . . 2.5899999999999999 110.332 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.573 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 12.7 Cg_exo -67.91 -22.32 42.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.904 1.736 . . . . 0.90000000000000002 112.223 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.9 123.09 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.776 0.798 . . . . 1.3700000000000001 111.09 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.605 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 40.8 tp -131.38 105.78 7.83 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.806 -1.543 . . . . 1.1399999999999999 108.798 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 34.8 m -92.1 139.48 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-O 120.826 0.346 . . . . 1.5900000000000001 110.492 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 33.8 p90 -158.36 159.63 36.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.098 -0.501 . . . . 0.25 110.567 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 92' ' ' ASP . 7.4 m -77.63 115.99 17.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.607 -0.516 . . . . 1.0700000000000001 109.607 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.891 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.3 tp -56.76 131.41 49.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.558 -0.292 . . . . 1.3300000000000001 110.447 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.08 -3.66 86.85 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.908 -0.663 . . . . 0.37 112.55 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 12.6 t70 -86.34 -12.34 49.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.819 -0.438 . . . . 0.93000000000000005 109.819 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 m 60.38 33.73 20.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.902 -0.777 . . . . 1.55 108.902 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.8 t70 -72.67 -11.9 60.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.341 1.067 . . . . 1.3300000000000001 108.789 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.15 -158.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.502 -1.681 . . . . 1.0800000000000001 110.487 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -81.76 137.62 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.914 -1.143 . . . . 1.0600000000000001 107.914 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.482 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.0 tp60 -60.48 -28.78 68.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.829 -0.348 . . . . 0.40000000000000002 111.095 -173.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.37 70.56 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.32 0.581 . . . . 1.0800000000000001 110.472 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 68' ' ' VAL . 56.1 tp -80.08 -40.78 26.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.406 -0.815 . . . . 1.0700000000000001 110.941 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.482 ' HB3' HE21 ' A' ' 97' ' ' GLN . 16.3 t70 -60.58 -30.82 70.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.005 -0.998 . . . . 0.26000000000000001 110.018 -174.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.84 -33.24 15.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 1.0600000000000001 112.208 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.0 t -64.72 -35.32 80.66 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.76 0.314 . . . . 1.53 111.348 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 99' ' ' LEU . 65.7 t -60.72 -55.17 47.49 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.507 0.558 . . . . 1.0600000000000001 112.507 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.816 ' HD3' HD13 ' A' ' 90' ' ' LEU . 27.2 Cg_endo -64.51 -20.46 65.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.865 1.71 . . . . 0.40999999999999998 112.143 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.87 -12.72 59.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 1.3500000000000001 111.383 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.632 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 2.3 ptm -108.95 156.86 19.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 1.3100000000000001 110.625 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.96999999999999997 110.92 179.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.3 p -65.88 126.82 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.749 0.785 . . . . 1.47 110.29 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.37 7.4 62.04 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 114.75 -1.113 . . . . 0.28000000000000003 112.723 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.852 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.9 pt-20 -95.44 167.75 11.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.483 0.659 . . . . 0.40999999999999998 111.839 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.44 HG21 HD13 ' A' ' 50' ' ' LEU . 5.3 m -126.06 116.96 22.22 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.838 -1.171 . . . . 1.0700000000000001 107.838 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . . . -119.9 134.97 55.07 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.123 0.487 . . . . 1.0 110.813 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.1 ttm -97.54 117.88 32.79 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.381 -1.34 . . . . 1.9399999999999999 107.381 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.589 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.8 t -112.85 130.31 66.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.417 -0.586 . . . . 1.0600000000000001 109.417 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.553 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 78.9 m -110.29 112.75 24.9 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 119.146 -1.022 . . . . 1.03 108.365 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.23 135.04 52.16 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.963 -1.471 . . . . 1.01 109.91 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.624 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 9.6 t70 -52.36 147.94 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.819 -0.808 . . . . 0.57999999999999996 108.819 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.9 t -56.35 -26.29 52.18 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.013 0.435 . . . . 1.04 110.218 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.624 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -57.86 -29.96 65.43 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.762 -0.586 . . . . 1.4299999999999999 111.394 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 81.9 m-85 -93.46 -2.11 54.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.543 0.687 . . . . 1.04 110.221 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.652 ' HB3' HD21 ' A' ' 138' ' ' LEU . 64.7 m -119.53 -90.95 0.56 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.725 -1.125 . . . . 0.87 110.416 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.654 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.1 m-85 -145.81 43.06 1.25 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.337 -0.545 . . . . 0.95999999999999996 112.266 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -54.42 -87.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.056 -0.593 . . . . 0.25 113.361 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.14 10.38 2.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.373 2.048 . . . . 0.90000000000000002 111.046 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -103.47 -45.85 4.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.65000000000000002 110.245 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.53 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 76.01 143.39 1.28 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.911 -1.041 . . . . 0.29999999999999999 112.546 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 13.0 t -91.89 164.05 13.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.987 0.422 . . . . 0.90000000000000002 111.639 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -58.14 -45.64 87.02 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.249 -0.887 . . . . 3.6099999999999999 112.02 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.905 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 58.4 m -87.46 -60.26 0.26 Allowed Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 120.805 -0.358 . . . . 1.52 110.269 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.1 Cg_endo -107.58 126.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.541 2.161 . . . . 0.44 111.899 171.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.483 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 20.6 t80 -58.14 97.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.862 -1.162 . . . . 1.6899999999999999 107.862 165.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.578 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.1 mm -64.3 127.88 92.59 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.756 -0.656 . . . . 1.0600000000000001 110.013 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.0 Cg_endo -50.05 136.79 37.21 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.21 2.607 . . . . 1.03 111.87 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.55 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 31.2 Cg_exo -58.54 132.17 46.8 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.523 2.149 . . . . 0.89000000000000001 112.08 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.497 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 30.2 m170 77.0 0.21 3.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.912 -1.04 . . . . 3.1899999999999999 112.284 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.76 122.17 17.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.468 -0.493 . . . . 1.04 109.686 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.5 112.81 9.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.336 0.589 . . . . 1.05 109.634 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -88.05 132.32 34.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.605 -0.725 . . . . 1.0600000000000001 110.552 -176.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.6 t -115.08 99.54 7.52 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.755 -0.832 . . . . 1.8200000000000001 108.755 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.507 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.8 OUTLIER -113.95 134.12 55.04 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.289 0.566 . . . . 1.1499999999999999 111.599 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.512 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 57.6 tt0 -99.56 112.71 24.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 1.05 109.459 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.675 HG13 HD11 ' A' ' 99' ' ' LEU . 6.8 m -109.44 123.15 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.53 0.681 . . . . 1.0800000000000001 111.86 -177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -96.59 111.01 23.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.126 -0.943 . . . . 1.0900000000000001 110.167 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.632 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 58.1 tp -82.74 100.81 10.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.689 -0.856 . . . . 1.0700000000000001 108.689 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.43 ' C ' ' HG1' ' A' ' 146' ' ' THR . 32.1 mtmt -99.33 -21.38 16.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.631 -0.713 . . . . 1.6899999999999999 110.653 -170.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.43 ' HG1' ' C ' ' A' ' 145' ' ' LYS . 21.8 m -158.12 147.02 19.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.848 -0.341 . . . . 1.1200000000000001 111.408 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.74 127.68 33.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.98999999999999999 109.225 169.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 109.307 -0.627 . . . . 1.6200000000000001 109.307 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.515 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.198 0.523 . . . . 0.53000000000000003 110.932 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.1 tp -70.47 111.83 6.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.506 -0.77 . . . . 1.1899999999999999 110.621 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.594 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.7 t70 -73.06 131.88 42.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.586 0.708 . . . . 2.5099999999999998 110.678 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.5 mt -65.25 -34.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.612 -1.176 . . . . 1.1499999999999999 111.137 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.44 -2.35 20.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.503 0.668 . . . . 1.4299999999999999 109.71 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.88 24.26 68.21 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.879 -1.055 . . . . 0.65000000000000002 111.986 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.11 -30.36 11.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.436 0.532 . . . . 0.94999999999999996 112.436 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 116.38 -0.98 20.62 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.717 -0.754 . . . . 0.71999999999999997 112.303 172.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 44' ' ' LEU . 6.7 mp -100.98 -36.52 8.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.592 0.711 . . . . 2.1600000000000001 111.085 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.526 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 12.0 tp -122.22 104.82 9.71 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.838 -1.074 . . . . 1.1200000000000001 111.112 -169.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 46' ' ' ARG . 15.1 mtm180 -132.16 138.65 48.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 1.49 111.856 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -112.19 126.32 55.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.645 -0.252 . . . . 1.1200000000000001 110.54 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 39.0 ttpt -113.3 115.56 28.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 1.6499999999999999 110.885 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -74.17 103.11 4.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.025 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.459 HD11 HG23 ' A' ' 111' ' ' THR . 7.6 mt -68.92 -56.08 8.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.656 -1.609 . . . . 1.0600000000000001 106.656 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.829 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 64.8 t -128.85 125.81 23.06 Favored Pre-proline 0 CA--C 1.499 -1.013 0 CA-C-N 113.125 -1.852 . . . . 1.1399999999999999 106.62 168.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 45.9 Cg_endo -105.02 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.949 2.433 . . . . 0.56000000000000005 113.413 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.55000000000000004 113.328 177.074 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 121.177 0.513 . . . . 1.3600000000000001 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.513 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 23.7 m -135.62 127.17 28.8 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.004 -0.739 . . . . 1.8200000000000001 109.004 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 4.0 ptt-85 -91.07 108.77 30.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 120.906 0.384 . . . . 3.3900000000000001 109.991 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.2 Cg_endo -51.07 159.3 2.69 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.155 3.237 . . . . 0.42999999999999999 114.571 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.591 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.7 t -98.17 156.22 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.097 -0.956 . . . . 1.47 109.703 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.968 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -73.72 121.43 20.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.603 0.716 . . . . 1.71 109.632 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.71 -18.76 5.95 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.049 -1.221 . . . . 0.41999999999999998 110.049 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.44 141.05 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.445 -0.946 . . . . 0.58999999999999997 108.445 173.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 26.8 m -87.63 128.56 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.456 -0.898 . . . . 1.8600000000000001 108.658 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -123.1 145.8 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.804 -1.089 . . . . 1.0700000000000001 110.852 -173.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.9 p -89.84 115.81 27.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.013 0.435 . . . . 1.0600000000000001 110.117 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.928 HG22 HD23 ' A' ' 99' ' ' LEU . 18.1 m -109.36 144.06 18.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.597 -0.841 . . . . 1.05 109.283 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.0 t-160 -103.96 118.98 37.95 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.463 -1.68 . . . . 0.28999999999999998 106.463 169.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.8 OUTLIER -122.08 133.73 54.77 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 118.847 -1.141 . . . . 1.1299999999999999 111.026 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.574 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -127.75 113.57 16.16 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.419 -2.067 . . . . 0.27000000000000002 105.419 167.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 84.8 m -104.81 126.48 51.92 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.477 -1.238 . . . . 1.04 111.43 -166.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.77 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -107.24 147.71 29.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.147 -0.933 . . . . 1.54 109.511 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.71 165.79 24.09 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.732 -0.667 . . . . 1.51 110.013 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.89 -22.79 27.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 1.1399999999999999 110.5 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -83.03 -8.33 59.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.242 -0.89 . . . . 2.1400000000000001 110.884 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.38 60.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.959 -0.639 . . . . 0.51000000000000001 112.089 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.5 m -81.33 110.14 16.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.72 0.295 . . . . 1.1599999999999999 111.397 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.6 mtt180 -74.37 121.46 21.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.834 0.826 . . . . 0.54000000000000004 110.82 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.709 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.7 m -105.22 -9.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.359 -1.291 . . . . 1.0600000000000001 111.984 -169.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.566 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.4 pt20 -159.94 132.41 6.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.184 -0.462 . . . . 0.63 110.628 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.424 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 45.5 tt0 -127.78 109.52 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.484 . . . . 1.3400000000000001 109.828 171.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.45 109.1 26.39 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.576 -0.738 . . . . 2.5899999999999999 109.892 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 72.7 Cg_endo -68.19 -17.96 45.17 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.778 2.985 . . . . 0.90000000000000002 113.454 -172.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.34 111.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.167 0.984 . . . . 1.3700000000000001 111.04 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.9 tp -128.56 97.88 4.84 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.347 -1.751 . . . . 1.1399999999999999 109.043 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.6 p -89.73 130.96 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.336 -0.393 . . . . 1.5900000000000001 110.115 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.0 p90 -151.83 158.15 42.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.25 110.664 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.2 m -76.2 110.93 11.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.054 -0.521 . . . . 1.0700000000000001 110.283 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.968 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 14.1 tp -58.18 128.58 37.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.955 -0.566 . . . . 1.3300000000000001 110.382 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.637 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.68 7.92 83.61 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.716 -0.754 . . . . 0.37 112.419 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.6 6.0 23.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.577 -0.527 . . . . 0.93000000000000005 109.577 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.52 32.98 20.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.136 -0.938 . . . . 1.55 110.385 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 26.0 t0 -75.49 -4.21 38.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.341 1.067 . . . . 1.3300000000000001 109.335 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.2 m -135.24 -155.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.037 -1.438 . . . . 1.0800000000000001 110.602 -175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 34.4 pt -83.56 135.75 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.296 -1.372 . . . . 1.0600000000000001 107.296 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.521 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 6.6 tp60 -59.22 -31.19 68.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.472 -0.331 . . . . 0.40000000000000002 111.382 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.87 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.23 0.538 . . . . 1.0800000000000001 110.354 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.928 HD23 HG22 ' A' ' 68' ' ' VAL . 58.6 tp -73.64 -41.41 62.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 1.0700000000000001 110.496 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' HB3' HE21 ' A' ' 97' ' ' GLN . 12.7 t70 -61.95 -27.74 69.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.963 -1.017 . . . . 0.26000000000000001 110.098 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.785 HD21 ' HZ2' ' A' ' 62' ' ' LYS . 64.8 mt -90.13 -36.41 14.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.194 -0.912 . . . . 1.0600000000000001 111.91 176.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -37.58 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 1.53 111.107 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 99' ' ' LEU . 64.0 t -60.51 -55.79 41.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.0 0.741 . . . . 1.0600000000000001 113.0 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.745 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.1 Cg_endo -61.69 -25.06 78.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.092 1.862 . . . . 0.40999999999999998 111.849 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 39' ' ' ILE . 11.0 mt -80.06 -11.89 59.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 1.3500000000000001 111.593 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.667 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.2 153.81 23.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.307 -0.406 . . . . 1.3100000000000001 111.23 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.43 158.59 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 0.96999999999999997 110.593 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.5 p -66.16 128.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.84 0.829 . . . . 1.47 110.378 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.4 4.62 59.49 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.909 -1.041 . . . . 0.28000000000000003 112.15 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.829 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -98.06 165.12 12.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.383 0.611 . . . . 0.40999999999999998 111.534 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.459 HG23 HD11 ' A' ' 50' ' ' LEU . 54.6 m -130.76 117.95 20.15 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.739 -1.119 . . . . 1.0700000000000001 108.263 175.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.62 140.24 50.91 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.618 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.9 ttm -98.91 117.46 33.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.181 -1.415 . . . . 1.9399999999999999 107.181 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.46 128.78 74.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.66 -0.496 . . . . 1.0600000000000001 109.66 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 52.9 m -109.29 113.85 27.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.77 -0.772 . . . . 1.03 109.163 174.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.43 ' HB3' HD12 ' A' ' 45' ' ' LEU . . . -122.47 139.91 53.34 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.892 -1.504 . . . . 1.01 110.05 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.8 t70 -52.29 146.48 9.25 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.711 -0.848 . . . . 0.57999999999999996 108.711 171.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 3.2 t -55.18 -26.98 42.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 1.04 110.171 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.651 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.3 ptpt -55.3 -32.26 62.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.554 -0.294 . . . . 1.4299999999999999 111.426 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.7 m-85 -95.3 6.17 49.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.171 0.51 . . . . 1.04 110.196 176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -124.74 -90.82 0.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.831 -1.077 . . . . 0.87 110.489 -176.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.2 m-85 -143.75 37.72 1.33 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.978 0.353 . . . . 0.95999999999999996 111.831 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.11 -78.51 0.09 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.471 -0.395 . . . . 0.25 113.83 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.48 8.68 4.45 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.15 1.9 . . . . 0.90000000000000002 111.015 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -103.9 -50.12 3.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.435 -0.802 . . . . 0.65000000000000002 110.135 -172.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.594 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . 80.28 143.53 3.27 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.571 -1.195 . . . . 0.29999999999999999 111.753 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 12.1 t -89.82 158.4 17.5 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.505 -0.348 . . . . 0.90000000000000002 111.281 -177.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -58.81 -37.31 76.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.632 -0.713 . . . . 3.6099999999999999 111.738 -170.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.925 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 7.0 m -91.44 -60.71 0.21 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.598 -0.519 . . . . 1.52 109.598 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.925 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -107.41 126.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.808 2.339 . . . . 0.44 112.307 170.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.594 ' CD1' ' HA3' ' A' ' 126' ' ' GLY . 64.6 t80 -57.61 97.5 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.361 -0.977 . . . . 1.6899999999999999 108.361 164.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.583 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.43 128.36 93.81 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.441 -0.8 . . . . 1.0600000000000001 109.522 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.44 140.57 63.63 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.536 2.157 . . . . 1.03 112.286 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.536 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.9 Cg_exo -57.97 134.81 64.74 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.254 1.969 . . . . 0.89000000000000001 112.079 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 18.6 m80 70.42 5.18 5.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.0 -1.0 . . . . 3.1899999999999999 112.661 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -68.88 122.34 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.307 -0.627 . . . . 1.04 109.307 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.73 111.81 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.303 0.573 . . . . 1.05 109.583 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.66 131.32 36.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.834 -0.621 . . . . 1.0600000000000001 111.063 -175.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.7 t -117.44 101.61 8.53 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.844 0.831 . . . . 1.8200000000000001 109.55 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.9 OUTLIER -114.05 136.6 52.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.84 -1.073 . . . . 1.1499999999999999 111.702 -171.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.574 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 55.0 tt0 -101.28 117.11 34.32 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.082 -0.71 . . . . 1.05 109.082 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.758 HG12 HD12 ' A' ' 99' ' ' LEU . 5.5 m -116.15 121.95 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.367 0.603 . . . . 1.0800000000000001 112.31 -175.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 m -96.71 114.47 26.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.242 -0.89 . . . . 1.0900000000000001 111.281 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.633 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 52.0 tp -84.5 102.18 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.626 -0.879 . . . . 1.0700000000000001 108.626 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 84' ' ' PRO . 19.2 mtmm -105.06 -20.23 13.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.79 -0.641 . . . . 1.6899999999999999 111.019 -169.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.7 m -156.51 148.73 23.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.767 -0.651 . . . . 1.1200000000000001 110.599 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.507 ' CB ' HG13 ' A' ' 66' ' ' VAL . . . -145.61 128.47 16.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.761 -0.829 . . . . 0.98999999999999999 108.761 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 20.6 m . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 119.86 -0.736 . . . . 1.6200000000000001 111.715 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.677 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.594 0.711 . . . . 0.53000000000000003 112.422 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -69.09 111.93 5.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.026 -0.988 . . . . 1.1899999999999999 111.037 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.717 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -64.51 101.53 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.084 -0.962 . . . . 2.5099999999999998 110.599 173.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.585 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.9 mt -54.07 -44.08 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.141 -0.936 . . . . 1.1499999999999999 112.009 -174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.473 HD23 HD12 ' A' ' 101' ' ' LEU . 86.5 mt -109.84 12.64 23.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 1.4299999999999999 110.525 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 70.66 0.12 30.49 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.65000000000000002 113.02 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' OD1' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -81.06 -30.26 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.765 0.283 . . . . 0.94999999999999996 111.765 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.19 63.69 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.71999999999999997 112.311 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 2.3 mm? -79.04 -31.54 44.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.886 0.851 . . . . 2.1600000000000001 109.06 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.585 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 13.9 tp -119.31 114.01 21.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.087 -1.415 . . . . 1.1200000000000001 110.13 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 mtm180 -140.51 140.8 35.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.675 -0.239 . . . . 1.49 111.37 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HZ2' ' HA ' ' A' ' 106' ' ' MET . 11.1 ttpt -108.45 125.59 51.95 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.393 0.433 . . . . 1.1200000000000001 110.462 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.1 ttpt -107.63 113.67 27.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.164 -0.309 . . . . 1.6499999999999999 110.164 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -76.47 99.34 4.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.425 -0.352 . . . . 1.03 110.931 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.439 HD23 ' HE3' ' A' ' 48' ' ' LYS . 15.5 mt -63.84 -50.67 67.96 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.926 -1.509 . . . . 1.0600000000000001 106.926 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.868 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 82.0 t -139.38 133.73 16.11 Favored Pre-proline 0 CA--C 1.502 -0.869 0 CA-C-N 113.303 -1.771 . . . . 1.1399999999999999 106.389 169.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -107.63 64.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.749 2.299 . . . . 0.56000000000000005 113.446 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.07 0 CA-C-N 115.53 -0.759 . . . . 0.55000000000000004 112.504 178.746 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 108.872 -0.788 . . . . 1.3600000000000001 108.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.578 ' O ' HG23 ' A' ' 108' ' ' VAL . 17.9 t -128.22 -177.32 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.256 -1.016 . . . . 1.8200000000000001 108.256 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 14.1 mtm180 -130.91 120.55 18.48 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.562 -0.533 . . . . 3.3900000000000001 109.562 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.4 Cg_endo -51.15 138.08 45.06 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.247 2.631 . . . . 0.42999999999999999 113.306 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.655 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.8 t -90.1 154.93 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.597 -0.729 . . . . 1.47 109.196 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 59.1 mttt -66.64 108.55 2.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.452 0.644 . . . . 1.71 111.037 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.37 2.45 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.429 -1.259 . . . . 0.41999999999999998 110.287 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -76.27 138.71 40.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.855 -0.795 . . . . 0.58999999999999997 108.855 177.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -88.54 129.29 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.008 -1.108 . . . . 1.8600000000000001 108.008 172.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.7 m -125.79 147.86 30.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.43 -0.804 . . . . 1.0700000000000001 110.965 -171.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.506 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 26.6 p -96.32 113.37 24.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.979 -0.555 . . . . 1.0600000000000001 109.967 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.519 HG23 HD23 ' A' ' 99' ' ' LEU . 23.9 m -110.47 143.97 19.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.27 0.557 . . . . 1.05 110.336 174.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.58 112.1 24.7 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.106 -1.442 . . . . 0.28999999999999998 107.106 169.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 83' ' ' GLU . 1.7 pt? -116.06 136.59 52.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.93 0.872 . . . . 1.1299999999999999 110.808 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.574 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.21 116.58 14.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 105.702 -1.962 . . . . 0.27000000000000002 105.702 169.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.583 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 62.6 m -109.28 123.67 49.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.876 -1.056 . . . . 1.04 111.418 -165.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.62 149.49 25.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.429 -0.805 . . . . 1.54 109.276 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.546 ' HG ' HG11 ' A' ' 80' ' ' VAL . 8.0 mt -77.53 166.83 22.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.749 -0.659 . . . . 1.51 110.804 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.35 -23.89 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.493 0.663 . . . . 1.1399999999999999 110.4 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -82.55 -11.3 58.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.352 -0.84 . . . . 2.1400000000000001 110.76 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.43 59.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.142 -0.551 . . . . 0.51000000000000001 111.86 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 m -75.12 110.63 9.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.991 0.367 . . . . 1.1599999999999999 111.991 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.5 mtt180 -73.1 117.57 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.54000000000000004 110.804 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.645 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.7 m -98.96 -10.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.936 -1.029 . . . . 1.0600000000000001 112.081 -171.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.583 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.6 pt20 -159.99 141.25 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.677 -0.692 . . . . 0.63 109.31 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 14.4 tt0 -145.56 103.89 3.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.367 0.603 . . . . 1.3400000000000001 109.657 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.738 ' HB2' HD21 ' A' ' 70' ' ' LEU . 4.1 mm-40 -118.56 115.16 35.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.203 -0.908 . . . . 2.5899999999999999 109.887 -173.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 47.1 Cg_endo -69.06 -14.51 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.377 2.051 . . . . 0.90000000000000002 113.044 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -166.98 114.86 0.82 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.861 0.839 . . . . 1.3700000000000001 111.817 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.4 tp -123.97 112.18 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.604 -1.634 . . . . 1.1399999999999999 108.802 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.4 p -103.23 128.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.6 -0.518 . . . . 1.5900000000000001 109.6 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.786 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 47.2 p90 -148.75 159.83 43.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 0.25 111.698 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 1.7 m -78.45 109.07 12.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.839 . . . . 1.0700000000000001 110.546 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.776 HD12 ' HD3' ' A' ' 104' ' ' PRO . 15.4 tp -61.56 127.9 33.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.474 -0.33 . . . . 1.3300000000000001 110.661 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.645 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 83.91 11.72 78.55 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.835 -0.698 . . . . 0.37 112.689 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.447 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 34.3 t70 -115.44 10.0 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.331 0.586 . . . . 0.93000000000000005 109.605 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.5 m 54.39 39.15 30.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.202 -0.908 . . . . 1.55 109.438 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.786 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -70.63 -12.78 61.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.092 -1.077 . . . . 1.3300000000000001 108.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.0 m -137.61 -159.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 113.758 -1.565 . . . . 1.0800000000000001 110.578 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.7 pt -79.23 140.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.709 -1.219 . . . . 1.0600000000000001 107.709 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.2 tp60 -59.66 -31.2 69.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.407 -0.361 . . . . 0.40000000000000002 110.987 -173.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.96 -43.0 69.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.237 0.542 . . . . 1.0800000000000001 110.422 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.604 HD13 HG13 ' A' ' 142' ' ' VAL . 50.4 tp -78.01 -41.38 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.459 -0.791 . . . . 1.0700000000000001 110.897 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.458 ' HB3' HE21 ' A' ' 97' ' ' GLN . 11.1 t70 -60.28 -29.67 68.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.328 -0.851 . . . . 0.26000000000000001 110.123 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.583 HD22 ' HZ3' ' A' ' 62' ' ' LYS . 73.3 mt -90.03 -33.3 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.414 -0.812 . . . . 1.0600000000000001 111.92 176.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.0 t -66.28 -34.2 77.46 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.718 0.294 . . . . 1.53 110.888 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.409 ' HB ' ' CD ' ' A' ' 104' ' ' PRO . 54.3 t -64.0 -55.61 31.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.813 0.671 . . . . 1.0600000000000001 112.813 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.776 ' HD3' HD12 ' A' ' 90' ' ' LEU . 17.8 Cg_endo -62.5 -22.39 73.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.91 1.74 . . . . 0.40999999999999998 112.049 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 39' ' ' ILE . 11.5 mt -79.56 -16.89 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 1.3500000000000001 111.275 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -104.43 157.24 17.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.095 -0.502 . . . . 1.3100000000000001 111.315 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.5 m-20 -94.54 155.1 17.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.982 0.42 . . . . 0.96999999999999997 111.17 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 58' ' ' SER . 40.0 t -60.89 125.16 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.581 0.705 . . . . 1.47 110.394 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.47 14.74 56.65 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 115.172 -0.922 . . . . 0.28000000000000003 112.453 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.868 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -101.42 168.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.339 0.59 . . . . 0.40999999999999998 111.433 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.412 HG21 HD11 ' A' ' 50' ' ' LEU . 9.4 m -130.59 117.24 19.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.066 -1.087 . . . . 1.0700000000000001 108.066 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.475 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . . . -121.43 136.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.052 0.453 . . . . 1.0 110.653 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 ttm -99.49 116.86 32.61 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.528 -1.286 . . . . 1.9399999999999999 107.528 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.81 127.67 71.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.945 -0.761 . . . . 1.0600000000000001 108.945 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.677 HG21 ' SG ' ' A' ' 139' ' ' CYS . 38.6 m -107.14 114.19 28.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.345 -0.942 . . . . 1.03 108.94 175.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' A' ' 45' ' ' LEU . . . -122.14 136.43 54.91 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.749 -1.568 . . . . 1.01 109.93 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.3 t70 -53.33 149.33 7.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.792 -0.818 . . . . 0.57999999999999996 108.792 172.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.8 t -55.0 -27.24 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.258 0.551 . . . . 1.04 110.549 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.9 ptpt -54.15 -35.95 62.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.293 -0.412 . . . . 1.4299999999999999 111.515 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.541 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 99.2 m-85 -95.77 3.48 53.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 1.04 110.304 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.745 ' HB3' HD23 ' A' ' 138' ' ' LEU . 68.2 m -119.45 -91.03 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.033 -0.985 . . . . 0.87 110.572 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.691 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 7.6 m-85 -145.57 40.69 1.2 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.255 0.465 . . . . 0.95999999999999996 112.255 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -52.5 -84.41 0.03 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.341 0.518 . . . . 0.25 113.647 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -81.84 11.12 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.364 2.043 . . . . 0.90000000000000002 110.696 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.691 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.7 mt-30 -104.24 -50.19 3.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.203 -0.908 . . . . 0.65000000000000002 110.125 -174.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.03 141.6 3.09 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.731 -1.122 . . . . 0.29999999999999999 112.613 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.0 t -92.28 165.38 13.13 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.232 -0.484 . . . . 0.90000000000000002 111.373 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.708 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 2.6 mmp_? -54.79 -60.7 3.0 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.59 -0.732 . . . . 3.6099999999999999 112.197 -176.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.84 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 17.5 t -76.57 -58.06 1.19 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 116.142 -0.481 . . . . 1.52 109.871 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.84 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.4 Cg_endo -108.73 126.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.521 2.147 . . . . 0.44 112.25 171.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.615 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.9 t80 -57.0 99.37 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.59 -1.263 . . . . 1.6899999999999999 107.59 163.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.595 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.2 mm -65.61 128.54 93.88 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.023 -0.535 . . . . 1.0600000000000001 110.188 -177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.29 141.63 70.58 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.724 2.283 . . . . 1.03 112.051 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.543 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 39.5 Cg_exo -57.67 130.55 39.28 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.332 2.021 . . . . 0.89000000000000001 112.068 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.494 ' H ' ' HB3' ' A' ' 118' ' ' SER . 13.6 m-70 74.1 7.79 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.831 -1.077 . . . . 3.1899999999999999 113.105 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -68.9 120.59 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.503 -0.554 . . . . 1.04 109.503 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.32 113.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.171 0.51 . . . . 1.05 109.809 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 121' ' ' CYS . 2.2 mp -90.87 129.81 36.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.847 -0.615 . . . . 1.0600000000000001 111.009 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.677 ' SG ' HG21 ' A' ' 115' ' ' THR . 35.2 m -112.55 98.91 7.56 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.586 -0.894 . . . . 1.8200000000000001 108.586 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -108.46 134.96 50.52 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.793 -0.639 . . . . 1.1499999999999999 111.595 -174.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.574 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 43.2 tt0 -102.73 116.26 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.146 -0.687 . . . . 1.05 109.146 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.604 HG13 HD13 ' A' ' 99' ' ' LEU . 3.9 m -115.69 119.35 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.561 0.696 . . . . 1.0800000000000001 112.758 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.7 m -90.32 110.48 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 1.0900000000000001 110.271 171.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.557 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 61.7 tp -82.82 97.85 8.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.651 -0.87 . . . . 1.0700000000000001 108.651 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.454 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.2 mtmt -94.57 -29.11 15.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 1.6899999999999999 110.597 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.506 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.9 m -153.53 149.31 27.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.466 -0.334 . . . . 1.1200000000000001 111.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.476 ' HA ' HG11 ' A' ' 66' ' ' VAL . . . -140.12 127.99 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.27 -0.641 . . . . 0.98999999999999999 109.27 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.44 0.638 . . . . 1.6200000000000001 111.357 -178.032 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.616 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.087 -0.709 . . . . 0.53000000000000003 109.087 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.44 109.99 7.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.894 0.378 . . . . 1.1899999999999999 110.674 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.631 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -64.9 96.77 0.2 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.652 -0.704 . . . . 2.5099999999999998 111.499 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.707 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 15.1 mt -51.81 -53.08 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.203 -0.908 . . . . 1.1499999999999999 110.38 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.912 HD22 HD21 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -78.71 -16.98 56.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.15 -1.386 . . . . 1.4299999999999999 110.163 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.631 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 72.37 8.34 70.48 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.404 -0.816 . . . . 0.65000000000000002 111.674 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' ND2' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.41 -9.14 16.84 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.568 0.223 . . . . 0.94999999999999996 111.51 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.85 -22.38 28.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.346 -0.931 . . . . 0.71999999999999997 113.238 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 4.2 mm? -80.09 -22.51 42.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.577 0.704 . . . . 2.1600000000000001 109.235 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.912 HD21 HD22 ' A' ' 40' ' ' LEU . 26.3 tp -120.51 110.39 16.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 1.1200000000000001 110.679 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 42.8 mtm105 -143.75 140.41 29.93 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.223 0.327 . . . . 1.49 111.544 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.738 ' HG3' HG21 ' A' ' 114' ' ' VAL . 7.3 ttpp -116.95 127.8 54.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.16 0.184 . . . . 1.1200000000000001 110.553 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.616 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.9 ttpt -103.67 130.37 51.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.804 0.335 . . . . 1.6499999999999999 110.986 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.694 HG22 ' HZ3' ' A' ' 47' ' ' LYS . 1.5 p -80.49 94.67 6.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.847 -0.615 . . . . 1.03 110.381 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 111' ' ' THR . 12.5 mt -63.78 -52.77 58.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.014 -1.476 . . . . 1.0600000000000001 107.014 173.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.793 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 73.6 t -134.63 124.61 17.02 Favored Pre-proline 0 CA--C 1.494 -1.195 0 CA-C-N 113.362 -1.745 . . . . 1.1399999999999999 106.599 168.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 68.3 Cg_endo -105.6 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.623 2.215 . . . . 0.56000000000000005 113.593 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.532 ' HA3' ' OD2' ' A' ' 107' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.557 0 CA-C-N 115.201 -0.909 . . . . 0.55000000000000004 114.207 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 121.236 0.541 . . . . 1.3600000000000001 111.639 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.25 -0.886 . . . . 1.8200000000000001 108.791 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -91.06 119.14 68.89 Favored Pre-proline 0 C--N 1.319 -0.732 0 C-N-CA 120.792 -0.363 . . . . 3.3900000000000001 110.59 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.645 ' HD3' HG21 ' A' ' 108' ' ' VAL . 11.3 Cg_endo -53.16 149.43 28.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.603 2.869 . . . . 0.42999999999999999 113.318 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.6 t -100.02 151.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.974 -0.557 . . . . 1.47 109.737 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 59.7 mttt -61.72 112.83 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.652 0.739 . . . . 1.71 110.875 177.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.76 -30.0 2.91 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 114.165 -1.38 . . . . 0.41999999999999998 110.186 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.638 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -72.39 139.17 47.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.158 -0.617 . . . . 0.58999999999999997 110.202 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 148' ' ' VAL . 40.9 t -80.81 117.14 26.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.503 -0.925 . . . . 1.8600000000000001 108.503 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -125.47 150.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.782 0.66 . . . . 1.0700000000000001 112.782 -170.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' A' ' 145' ' ' LYS . 0.8 OUTLIER -98.43 121.8 40.81 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.696 -1.138 . . . . 1.0600000000000001 110.41 174.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.665 HG21 HD23 ' A' ' 99' ' ' LEU . 30.1 m -118.33 147.73 21.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.341 -0.543 . . . . 1.05 110.106 168.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.724 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.04 117.34 34.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.752 -1.573 . . . . 0.28999999999999998 106.752 167.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.506 ' CD2' ' HB3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -118.33 138.63 52.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.204 -0.999 . . . . 1.1299999999999999 111.004 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.692 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.77 113.91 11.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.194 -2.15 . . . . 0.27000000000000002 105.194 165.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.582 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 72.0 m -102.73 127.3 49.93 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.738 -1.119 . . . . 1.04 111.076 -167.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.716 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 t -109.04 159.44 16.84 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.396 -0.82 . . . . 1.54 109.358 -177.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.74 164.53 18.49 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.694 -0.684 . . . . 1.51 109.303 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -52.19 -24.12 6.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.518 0.675 . . . . 1.1399999999999999 110.58 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -94.46 -7.33 41.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.062 -0.972 . . . . 2.1400000000000001 111.98 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.48 -8.72 37.86 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.83 -0.7 . . . . 0.51000000000000001 113.981 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.3 m -75.55 110.69 10.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.448 0.624 . . . . 1.1599999999999999 111.718 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.716 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.8 mtt180 -77.68 110.64 12.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.947 0.88 . . . . 0.54000000000000004 110.298 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.481 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.2 m -91.36 -12.61 9.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.069 -1.423 . . . . 1.0600000000000001 111.936 -169.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.582 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -158.6 124.4 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.344 -0.389 . . . . 0.63 110.746 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.53 124.53 48.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.315 -0.624 . . . . 1.3400000000000001 109.315 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.506 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 8.6 tt0 -144.61 107.28 4.7 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-O 121.879 0.847 . . . . 2.5899999999999999 110.506 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 69' ' ' HIS . 53.1 Cg_endo -68.94 -19.2 40.43 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 123.35 2.7 . . . . 0.90000000000000002 113.871 -171.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -158.74 99.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.0 0.905 . . . . 1.3700000000000001 111.016 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.4 tp -113.04 116.02 29.27 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.31 -1.768 . . . . 1.1399999999999999 108.808 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.0 p -112.64 133.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.728 -0.471 . . . . 1.5900000000000001 109.728 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -154.86 164.74 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.884 0.373 . . . . 0.25 110.821 -172.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m -83.38 112.46 19.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.634 -0.712 . . . . 1.0700000000000001 109.495 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.937 HD13 ' HD3' ' A' ' 104' ' ' PRO . 14.2 tp -59.53 126.26 26.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.405 -0.361 . . . . 1.3300000000000001 110.919 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 62' ' ' LYS . . . 83.51 5.51 88.41 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.78 -0.724 . . . . 0.37 112.438 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -90.33 -7.34 53.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.565 -1.272 . . . . 0.93000000000000005 107.565 174.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 56.2 m 58.4 31.7 21.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.105 -1.407 . . . . 1.55 110.16 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.27 -18.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.256 1.026 . . . . 1.3300000000000001 109.168 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.38 -155.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.069 -1.423 . . . . 1.0800000000000001 110.454 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 28.8 pt -82.75 137.27 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.296 -1.372 . . . . 1.0600000000000001 107.296 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.577 HE21 ' HB3' ' A' ' 100' ' ' ASP . 12.4 tp60 -56.77 -30.03 63.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.468 -0.333 . . . . 0.40000000000000002 110.96 -173.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.77 78.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.163 0.506 . . . . 1.0800000000000001 110.746 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 68' ' ' VAL . 62.6 tp -77.88 -37.76 47.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.671 -0.695 . . . . 1.0700000000000001 110.678 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.577 ' HB3' HE21 ' A' ' 97' ' ' GLN . 22.9 t70 -61.9 -29.51 70.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 0.26000000000000001 109.59 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.3 -35.07 14.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.253 -0.885 . . . . 1.0600000000000001 112.275 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 106' ' ' MET . 21.3 t -65.81 -32.83 74.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 1.53 111.479 -174.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 104' ' ' PRO . 53.5 t -66.92 -54.91 18.43 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.519 0.563 . . . . 1.0600000000000001 112.519 -176.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.937 ' HD3' HD13 ' A' ' 90' ' ' LEU . 23.7 Cg_endo -63.76 -22.63 69.5 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.042 1.828 . . . . 0.40999999999999998 111.921 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.501 ' CD1' HG22 ' A' ' 39' ' ' ILE . 4.2 mt -77.38 -31.15 54.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 1.3500000000000001 111.336 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.3 ptm -88.52 157.23 18.69 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.936 -0.575 . . . . 1.3100000000000001 109.68 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.532 ' OD2' ' HA3' ' A' ' 53' ' ' GLY . 8.3 p-10 -103.49 158.39 16.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.337 0.589 . . . . 0.96999999999999997 111.713 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.645 HG21 ' HD3' ' A' ' 60' ' ' PRO . 2.8 t -61.37 125.82 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.524 -0.762 . . . . 1.47 111.464 -174.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.65 59.2 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 114.815 -1.084 . . . . 0.28000000000000003 112.819 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.793 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.4 pt-20 -97.0 167.87 10.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.195 0.522 . . . . 0.40999999999999998 110.625 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.498 HG23 HD13 ' A' ' 50' ' ' LEU . 21.5 m -128.07 117.4 21.58 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.048 -1.093 . . . . 1.0700000000000001 108.048 173.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . . . -118.35 131.52 56.31 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.963 -173.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.2 ttp -98.44 117.99 34.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.994 -1.113 . . . . 1.9399999999999999 107.994 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.738 HG21 ' HG3' ' A' ' 47' ' ' LYS . 12.7 t -109.1 137.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.878 -0.601 . . . . 1.0600000000000001 109.583 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.597 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 89.6 m -110.66 113.07 25.39 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.241 -1.022 . . . . 1.03 108.241 170.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -122.7 132.14 54.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.564 -1.198 . . . . 1.01 109.29 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.739 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.6 t70 -52.98 146.63 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.588 -0.893 . . . . 0.57999999999999996 108.588 171.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.5 t -52.32 -26.78 13.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.131 0.491 . . . . 1.04 110.48 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.739 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.7 ptpt -54.33 -33.54 59.16 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 122.062 -0.399 . . . . 1.4299999999999999 112.01 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.504 ' OH ' ' HG ' ' A' ' 40' ' ' LEU . 98.5 m-85 -96.4 3.08 53.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.352 0.596 . . . . 1.04 109.92 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.586 ' HB3' HD23 ' A' ' 138' ' ' LEU . 69.8 m -122.13 -90.46 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.034 . . . . 0.87 110.389 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.608 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 13.0 m-85 -144.39 39.62 1.3 Allowed 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.262 0.467 . . . . 0.95999999999999996 112.262 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -52.71 -83.26 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.188 -0.529 . . . . 0.25 113.744 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.74 7.66 4.72 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.405 2.07 . . . . 0.90000000000000002 111.259 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.0 mt-30 -104.45 -51.17 3.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.716 -0.674 . . . . 0.65000000000000002 110.498 -173.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.545 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 85.85 142.68 6.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.074 -0.966 . . . . 0.29999999999999999 112.419 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.628 ' HB3' HG12 ' A' ' 132' ' ' ILE . 6.9 t -91.35 162.22 14.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.187 -0.506 . . . . 0.90000000000000002 112.162 -175.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -52.89 -51.37 61.42 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 115.151 -0.931 . . . . 3.6099999999999999 112.238 -173.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.977 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 20.4 m -81.4 -64.7 0.27 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.438 . . . . 1.52 110.36 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.977 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 20.0 Cg_endo -105.24 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.401 2.067 . . . . 0.44 111.7 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.542 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 31.0 t80 -56.22 98.11 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.064 -1.087 . . . . 1.6899999999999999 108.064 163.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 127' ' ' SER . 33.5 mm -65.35 128.99 94.27 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.893 -0.594 . . . . 1.0600000000000001 109.639 -177.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -52.38 139.14 55.72 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.659 2.239 . . . . 1.03 112.282 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.553 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 40.7 Cg_exo -57.55 129.05 31.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.528 2.152 . . . . 0.89000000000000001 112.456 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.585 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 57.9 m80 75.36 12.16 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.936 -1.029 . . . . 3.1899999999999999 112.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.76 127.14 32.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.235 -0.654 . . . . 1.04 109.235 173.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.48 113.08 11.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.521 -0.472 . . . . 1.05 110.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.14 132.87 35.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.072 -0.513 . . . . 1.0600000000000001 110.97 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 5.2 t -118.11 100.07 7.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.012 -0.736 . . . . 1.8200000000000001 109.012 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.569 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 pp -109.5 136.71 48.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.651 -0.704 . . . . 1.1499999999999999 111.586 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.692 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 50.8 tt0 -101.85 118.44 36.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.175 -0.676 . . . . 1.05 109.175 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 4.2 m -119.67 123.3 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.435 0.636 . . . . 1.0800000000000001 112.555 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.439 ' HG1' HG22 ' A' ' 111' ' ' THR . 42.9 m -92.79 118.54 31.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.645 -0.707 . . . . 1.0900000000000001 109.362 170.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.693 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 37.4 tp -80.82 99.01 8.07 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.481 -0.933 . . . . 1.0700000000000001 108.481 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.603 ' HD3' ' HB ' ' A' ' 67' ' ' THR . 19.2 mtpt -79.91 -44.48 20.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.464 -1.244 . . . . 1.6899999999999999 110.328 -168.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.463 ' HG1' ' C ' ' A' ' 145' ' ' LYS . 4.4 m -158.48 160.0 36.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.969 -0.56 . . . . 1.1200000000000001 110.526 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.481 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.32 128.05 27.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.165 -0.68 . . . . 0.98999999999999999 109.165 170.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 65' ' ' VAL . 20.4 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 1.6200000000000001 110.06 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.991 -0.374 . . . . 50.460000000000001 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.98 -95.09 1.68 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.714 -0.755 . . . . 47.990000000000002 112.71 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -105.46 150.03 38.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.345 0.117 . . . . 46.439999999999998 110.805 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 23.5 Cg_exo -63.92 131.06 29.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.718 2.279 . . . . 45.219999999999999 111.514 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 14.1 Cg_exo -68.62 123.16 10.17 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.826 2.351 . . . . 44.450000000000003 112.499 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.1 16.96 3.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 42.710000000000001 110.447 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.97 119.58 39.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 41.5 110.479 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.76 157.85 22.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.0 -0.545 . . . . 40.329999999999998 109.568 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 -174.81 0.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.076 0.86 . . . . 39.390000000000001 111.146 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 11' ' ' GLN . 29.6 tt0 -127.26 -77.17 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 38.82 110.449 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.553 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 56.5 mt-30 -129.22 115.46 18.64 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 38.350000000000001 110.135 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.28 15.73 2.04 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.444 2.763 . . . . 37.039999999999999 112.031 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.02 -62.47 0.53 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.835 -0.698 . . . . 35.659999999999997 112.11 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.53 169.78 9.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.848 0.356 . . . . 35.149999999999999 110.803 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.01 -47.5 0.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 34.170000000000002 110.977 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 65.16 97.43 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.058 0.849 . . . . 32.950000000000003 111.409 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -81.86 179.2 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 32.299999999999997 111.193 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.45 61.06 0.66 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.72 -0.673 . . . . 31.239999999999998 110.789 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 31.2 t80 -80.79 -62.78 1.57 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.472 -0.786 . . . . 31.57 111.371 -174.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 19' ' ' PHE . 96.2 mt -112.65 110.76 21.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.861 0.362 . . . . 30.100000000000001 111.242 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.61 113.9 14.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.732 -0.667 . . . . 28.399999999999999 110.787 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.0 34.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.769 . . . . 26.969999999999999 109.575 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.4 ttp -122.01 15.27 10.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.373 -0.83 . . . . 27.66 109.8 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 3.0 mp0 -64.43 112.83 8.59 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.132 -0.94 . . . . 24.41 110.678 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 4.0 Cg_endo -86.19 93.5 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.306 2.671 . . . . 22.399999999999999 112.338 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.72 146.3 31.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.285 -0.416 . . . . 20.670000000000002 110.308 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.1 119.94 7.51 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.003 2.469 . . . . 18.75 112.45 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.41 28.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.744 -0.662 . . . . 14.960000000000001 110.384 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.59 157.47 55.24 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.713 2.276 . . . . 14.550000000000001 112.277 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.83 80.55 0.26 Allowed Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 124.097 0.873 . . . . 10.949999999999999 112.023 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.63 96.02 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.602 2.201 . . . . 10.6 112.181 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.03 130.96 22.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.788 -0.642 . . . . 6.1100000000000003 110.335 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.78 -19.67 46.82 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.578 2.186 . . . . 5.3600000000000003 112.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 71.2 -55.86 0.64 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.665 0.786 . . . . 4.1299999999999999 111.538 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.4 108.26 19.77 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.554 -0.536 . . . . 2.4500000000000002 109.554 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.595 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -95.71 -164.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 0.53000000000000003 110.856 -176.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.71 109.76 4.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.2 -0.909 . . . . 1.1899999999999999 110.131 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.633 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.0 t70 -74.76 123.8 25.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 2.5099999999999998 110.818 174.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.494 HD11 HD12 ' A' ' 45' ' ' LEU . 8.8 mt -56.06 -36.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.711 -1.131 . . . . 1.1499999999999999 111.568 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -110.77 -2.39 16.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.208 0.528 . . . . 1.4299999999999999 110.473 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.17 24.75 67.51 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.33 -0.85 . . . . 0.65000000000000002 111.627 -173.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' H ' HD21 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -94.5 -22.37 18.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.858 0.361 . . . . 0.94999999999999996 111.669 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.496 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.0 -17.67 41.09 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.922 -0.656 . . . . 0.71999999999999997 112.125 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.792 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 1.1 mt -96.07 -24.23 16.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.673 0.273 . . . . 2.1600000000000001 110.912 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.494 HD12 HD11 ' A' ' 39' ' ' ILE . 19.5 tp -123.68 100.39 6.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.374 -0.376 . . . . 1.1200000000000001 111.854 -171.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -130.11 139.88 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.097 -0.377 . . . . 1.49 111.722 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HZ3' ' HG3' ' A' ' 106' ' ' MET . 10.3 ttpt -112.13 125.82 54.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.477 0.311 . . . . 1.1200000000000001 110.637 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.2 ttpp -116.54 120.73 39.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 1.6499999999999999 110.969 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 p -74.93 110.44 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.464 . . . . 1.03 111.646 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 ' HG3' ' A' ' 141' ' ' GLU . 9.0 mt -73.88 -52.0 14.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.827 -1.545 . . . . 1.0600000000000001 106.827 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.864 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.7 t -133.46 130.72 21.11 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 113.21 -1.814 . . . . 1.1399999999999999 106.752 170.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 22.7 Cg_endo -107.79 57.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.221 2.614 . . . . 0.56000000000000005 114.024 -176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.491 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 81.61 94.12 0.49 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.958 -0.639 . . . . 0.55000000000000004 112.848 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.54 -48.13 16.39 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.198 2.599 . . . . 1.9099999999999999 114.671 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -94.49 -159.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.236 1.957 . . . . 2.5299999999999998 112.612 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 69.28 2.59 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 110.576 -1.01 . . . . 1.4199999999999999 110.576 173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 m -64.8 175.51 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.003 0.906 . . . . 1.3600000000000001 113.252 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 16.5 m -146.71 140.0 25.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.582 -1.19 . . . . 1.8200000000000001 108.229 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 96.4 mtt180 -89.36 116.22 65.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 120.567 -0.453 . . . . 3.3900000000000001 109.831 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 10.0 Cg_endo -52.38 148.59 25.53 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.493 2.795 . . . . 0.42999999999999999 112.67 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.575 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -94.65 152.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 1.47 109.28 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.893 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 61.3 mttt -63.71 120.69 12.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 1.71 109.399 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 129.02 -41.92 1.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.06 -1.427 . . . . 0.41999999999999998 110.075 -170.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.664 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -69.42 132.67 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.069 -0.715 . . . . 0.58999999999999997 109.069 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 17.9 m -84.45 118.64 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 122.142 0.973 . . . . 1.8600000000000001 108.727 175.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -115.65 144.84 22.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.93 -1.032 . . . . 1.0700000000000001 111.486 -171.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.97 HG21 HG21 ' A' ' 87' ' ' VAL . 43.5 p -88.86 113.99 25.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.535 -0.757 . . . . 1.0600000000000001 110.221 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG21 HD22 ' A' ' 99' ' ' LEU . 20.8 m -111.49 143.59 21.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.996 -0.682 . . . . 1.05 110.511 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -103.1 117.88 35.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.451 -1.314 . . . . 0.28999999999999998 107.451 168.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -118.96 137.79 53.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 118.92 -1.112 . . . . 1.1299999999999999 111.035 176.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.652 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.46 114.29 14.13 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.491 -2.041 . . . . 0.27000000000000002 105.491 166.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.65 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 60.3 m -105.45 132.61 51.41 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 114.976 -1.011 . . . . 1.04 111.831 -168.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 m -104.39 156.88 17.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.096 -0.956 . . . . 1.54 108.874 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 80' ' ' VAL . 10.8 mt -80.42 166.72 20.98 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 1.51 108.908 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.88 -14.54 15.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.915 0.339 . . . . 1.1399999999999999 111.915 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -93.28 -15.63 25.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.897 0.38 . . . . 2.1400000000000001 110.711 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.44 -3.92 19.93 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.813 -0.708 . . . . 0.51000000000000001 113.644 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.1 m -75.67 110.88 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.369 0.584 . . . . 1.1599999999999999 111.573 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.6 mtt180 -75.99 112.42 12.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.854 0.835 . . . . 0.54000000000000004 110.857 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.522 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.2 m -99.02 -13.8 7.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 113.992 -1.458 . . . . 1.0600000000000001 112.377 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.597 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.8 pt20 -157.06 136.58 12.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.81 0.338 . . . . 0.63 110.586 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.52 130.42 32.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.969 -0.559 . . . . 1.3400000000000001 109.687 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 4.8 tt0 -145.09 112.98 4.84 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.562 -0.745 . . . . 2.5899999999999999 109.815 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 15.2 Cg_exo -68.19 -15.77 43.27 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.501 2.801 . . . . 0.90000000000000002 113.315 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.555 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 26.5 tt0 -166.34 113.28 0.86 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.021 0.915 . . . . 1.3700000000000001 111.572 -175.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.445 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 49.7 tp -126.72 110.76 13.49 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.55 -1.659 . . . . 1.1399999999999999 108.737 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.97 HG21 HG21 ' A' ' 67' ' ' THR . 2.1 t -100.79 125.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.174 -0.676 . . . . 1.5900000000000001 109.174 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 p90 -145.56 160.71 41.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.25 111.44 -172.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 m -79.29 106.67 11.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.593 -0.73 . . . . 1.0700000000000001 110.4 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.893 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.02 134.54 57.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.213 -0.448 . . . . 1.3300000000000001 110.514 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.66 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 81.44 -5.63 67.63 Favored Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 120.824 -0.703 . . . . 0.37 113.293 173.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -107.17 15.54 25.04 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.534 -0.913 . . . . 0.93000000000000005 108.534 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 32.2 m 53.65 39.61 30.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.109 -1.405 . . . . 1.55 109.633 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.3 t0 -76.86 -2.79 35.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.563 1.173 . . . . 1.3300000000000001 108.383 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 6.2 m -140.04 -157.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 113.646 -1.616 . . . . 1.0800000000000001 110.757 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.5 pt -82.82 139.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.567 -1.272 . . . . 1.0600000000000001 107.567 173.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.477 HE21 ' HB3' ' A' ' 100' ' ' ASP . 6.3 tp60 -58.85 -31.51 68.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.351 -0.386 . . . . 0.40000000000000002 111.261 -171.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.91 79.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 1.0800000000000001 110.491 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.68 HD22 HG21 ' A' ' 68' ' ' VAL . 53.7 tp -75.5 -38.01 59.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.314 -0.857 . . . . 1.0700000000000001 110.551 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HB3' HE21 ' A' ' 97' ' ' GLN . 13.2 t70 -61.41 -29.82 70.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.97 -1.014 . . . . 0.26000000000000001 109.868 -175.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.496 HD23 ' HZ1' ' A' ' 62' ' ' LYS . 71.8 mt -90.55 -36.04 14.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.198 -0.91 . . . . 1.0600000000000001 111.969 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.8 t -64.91 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.676 -0.238 . . . . 1.53 111.191 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.625 ' HB ' ' HD3' ' A' ' 104' ' ' PRO . 76.1 t -65.55 -53.45 37.37 Favored Pre-proline 0 C--O 1.218 -0.578 0 CA-C-N 116.471 -0.332 . . . . 1.0600000000000001 111.888 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.767 ' HD3' HD13 ' A' ' 90' ' ' LEU . 64.5 Cg_exo -52.55 -28.83 38.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.992 1.795 . . . . 0.40999999999999998 112.706 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.56 -11.52 53.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.8 -0.636 . . . . 1.3500000000000001 111.279 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -100.43 142.07 32.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.27 -0.877 . . . . 1.3100000000000001 110.701 176.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -89.37 156.88 18.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.96999999999999997 108.781 172.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.3 p -66.04 126.47 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.935 0.874 . . . . 1.47 110.459 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.8 -2.3 45.17 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.337 -0.847 . . . . 0.28000000000000003 112.254 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.864 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 6.8 pt-20 -96.95 168.13 10.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.529 0.68 . . . . 0.40999999999999998 110.913 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.415 HG21 HD11 ' A' ' 50' ' ' LEU . 10.2 m -130.18 116.96 19.18 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.369 -0.974 . . . . 1.0700000000000001 108.369 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HB2' ' SD ' ' A' ' 106' ' ' MET . . . -115.21 135.28 54.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.314 -176.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttm -97.46 117.0 30.74 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.124 -1.436 . . . . 1.9399999999999999 107.124 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.62 130.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.584 -0.524 . . . . 1.0600000000000001 109.584 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.517 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 98.1 m -105.79 112.48 25.56 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.075 -1.083 . . . . 1.03 108.075 170.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.31 133.69 52.52 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.988 -1.46 . . . . 1.01 109.227 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.792 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 10.0 t70 -52.67 145.77 11.44 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.893 -0.78 . . . . 0.57999999999999996 108.893 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.8 t -52.74 -29.49 27.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.965 0.412 . . . . 1.04 110.125 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.695 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 7.0 ptpp? -56.73 -27.14 58.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.206 0.447 . . . . 1.4299999999999999 112.206 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.549 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 88.9 m-85 -99.4 0.99 43.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.3 0.571 . . . . 1.04 109.922 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -119.72 -92.03 0.54 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.816 -1.084 . . . . 0.87 109.994 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.0 m-85 -142.02 43.62 1.68 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 120.71 -0.396 . . . . 0.95999999999999996 111.761 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -49.29 -89.83 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 113.957 0.343 . . . . 0.25 113.957 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.65 15.27 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.639 2.226 . . . . 0.90000000000000002 110.707 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 33.0 mt-30 -104.3 -43.28 5.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.232 -0.895 . . . . 0.65000000000000002 109.672 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 75.85 144.99 1.44 Allowed Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.655 -1.157 . . . . 0.29999999999999999 112.673 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.672 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.3 t -92.08 159.91 15.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.417 -0.392 . . . . 0.90000000000000002 111.322 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.44 HH12 ' CD ' ' A' ' 83' ' ' GLU . 33.2 mtt180 -53.18 -57.0 11.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.329 -0.851 . . . . 3.6099999999999999 111.109 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.949 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.3 m -74.6 -64.31 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.833 -0.622 . . . . 1.52 110.553 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.949 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.6 Cg_endo -106.72 126.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.973 1.782 . . . . 0.44 112.132 174.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 34.3 t80 -58.85 98.02 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.153 -1.054 . . . . 1.6899999999999999 108.153 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.576 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.0 mm -65.97 132.33 94.66 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.448 -0.796 . . . . 1.0600000000000001 109.886 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.53 140.5 75.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.675 2.25 . . . . 1.03 112.436 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.44 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 48.2 Cg_exo -56.58 140.19 89.36 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.535 2.157 . . . . 0.89000000000000001 112.392 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.633 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 29.5 p80 47.59 28.76 1.27 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.398 1.079 . . . . 3.1899999999999999 113.145 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -86.19 134.2 33.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.374 -0.973 . . . . 1.04 108.374 169.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.81 113.32 15.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.306 -0.558 . . . . 1.05 110.326 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.65 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 2.5 tp -90.41 132.01 35.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.774 -0.648 . . . . 1.0600000000000001 110.015 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.8 t -115.56 100.38 8.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.308 -0.627 . . . . 1.8200000000000001 109.308 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 pp -113.36 136.36 52.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.002 -0.545 . . . . 1.1499999999999999 111.686 -171.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.652 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 46.9 tt0 -104.21 111.26 23.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.72 . . . . 1.05 109.213 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 99' ' ' LEU . 2.9 m -113.72 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.119 0.785 . . . . 1.0800000000000001 113.119 -173.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.6 m -88.6 108.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.636 -1.165 . . . . 1.0900000000000001 110.369 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.7 tp -81.75 93.05 6.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.326 -0.99 . . . . 1.0700000000000001 108.326 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 24.7 mtmt -90.13 -31.21 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.679 -0.691 . . . . 1.6899999999999999 110.754 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 m -148.67 151.46 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.961 0.41 . . . . 1.1200000000000001 111.293 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.507 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -139.78 128.11 22.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.98999999999999999 109.289 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.54 145.14 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.479 -0.488 . . . . 1.6200000000000001 110.245 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 10.0 t0 -91.98 118.41 30.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.147 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 tp -141.5 10.02 2.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.371 0.605 . . . . 2.5 109.845 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 7.1 tp10 -115.05 105.08 12.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 2.1400000000000001 110.183 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -143.05 16.98 1.93 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.641 . . . . 6.6299999999999999 110.082 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -112.49 145.1 40.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.812 0.339 . . . . 8.1899999999999995 111.098 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.8 m170 64.87 -172.27 0.18 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.701 -0.681 . . . . 9.0800000000000001 111.772 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -170.69 168.39 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.976 -1.12 . . . . 9.2400000000000002 107.976 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.51 143.85 29.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.513 -0.475 . . . . 12.779999999999999 111.056 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 117.953 -1.022 . . . . 14.109999999999999 109.11 179.575 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.825 0.345 . . . . 50.460000000000001 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.06 -23.25 5.89 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.039 -0.824 . . . . 47.990000000000002 111.039 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.654 HE21 ' HD2' ' A' ' 5' ' ' PRO . 24.2 tp60 -118.95 82.15 20.71 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 109.654 -0.499 . . . . 46.439999999999998 109.654 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.578 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 39.5 Cg_exo -60.24 -55.92 1.33 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.265 2.643 . . . . 45.219999999999999 114.382 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.654 ' HD2' HE21 ' A' ' 3' ' ' GLN . 8.6 Cg_exo -72.0 123.04 8.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.328 1.352 . . . . 44.450000000000003 111.884 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 2.27 43.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.397 0.618 . . . . 42.710000000000001 110.299 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 -8.63 59.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.164 -0.925 . . . . 41.5 111.453 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -87.91 22.91 2.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.902 0.382 . . . . 40.329999999999998 110.687 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.54 130.17 7.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 39.390000000000001 110.492 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -151.4 113.59 4.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.24 0.543 . . . . 38.82 109.658 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.71 86.99 6.05 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.674 0.749 . . . . 38.350000000000001 110.613 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.54 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.807 2.338 . . . . 37.039999999999999 112.285 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.33 53.15 0.47 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.769 -0.729 . . . . 35.659999999999997 112.161 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.6 32.63 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.727 0.299 . . . . 35.149999999999999 111.5 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.36 103.62 15.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.526 -0.306 . . . . 34.170000000000002 110.477 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.81 102.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.693 -0.484 . . . . 32.950000000000003 109.693 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.18 -166.69 2.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.016 -0.538 . . . . 32.299999999999997 110.57 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.42 119.56 19.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.039 -0.528 . . . . 31.239999999999998 110.674 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -119.31 -3.82 10.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.024 -0.534 . . . . 31.57 110.625 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.517 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.1 pt? -124.21 161.89 24.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.175 -0.466 . . . . 30.100000000000001 110.145 -174.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.52 -26.15 16.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.235 -0.439 . . . . 28.399999999999999 110.912 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.7 145.52 0.07 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.209 0.943 . . . . 26.969999999999999 111.711 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -95.85 -46.18 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.763 -0.653 . . . . 27.66 110.289 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -156.35 107.06 2.04 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.609 -0.723 . . . . 24.41 109.744 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.73 137.42 27.26 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.991 2.461 . . . . 22.399999999999999 112.008 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 44.6 mt-10 -79.29 133.32 60.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.054 -0.521 . . . . 20.670000000000002 110.364 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 34.5 Cg_exo -61.47 112.89 1.57 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.965 2.443 . . . . 18.75 113.356 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -119.96 126.68 26.75 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 14.960000000000001 109.952 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 23.6 Cg_exo -65.37 128.17 19.75 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.711 2.274 . . . . 14.550000000000001 112.533 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.588 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -171.03 -56.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 10.949999999999999 111.262 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 30' ' ' ALA . 89.0 Cg_endo -81.39 168.9 16.16 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.0 1.8 . . . . 10.6 112.568 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.93 145.69 37.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 6.1100000000000003 110.545 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.99 -16.51 50.3 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.232 2.621 . . . . 5.3600000000000003 113.203 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 5.8 mm-40 -96.94 1.19 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.5 . . . . 4.1299999999999999 110.984 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.446 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -99.58 78.47 2.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.144 -1.058 . . . . 2.4500000000000002 108.144 168.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.556 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -72.38 -175.36 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.53000000000000003 110.528 -173.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.7 tp -69.39 110.81 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.551 -0.749 . . . . 1.1899999999999999 109.618 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.624 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 11.6 t70 -75.71 128.56 35.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.202 -0.599 . . . . 2.5099999999999998 109.463 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.542 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 7.3 mt -65.13 -23.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.847 -1.069 . . . . 1.1499999999999999 110.839 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.3 mt -116.14 -5.5 11.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 1.4299999999999999 110.101 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 69.19 18.52 73.17 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.65000000000000002 112.361 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.28 -31.17 12.19 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.636 0.606 . . . . 0.94999999999999996 112.636 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.85 -0.83 21.46 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.473 -0.87 . . . . 0.71999999999999997 112.242 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.8 mp -99.13 -35.59 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.173 0.511 . . . . 2.1600000000000001 110.801 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.542 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 18.2 tp -122.68 101.62 7.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.132 -0.94 . . . . 1.1200000000000001 111.253 -172.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 71.3 mtm180 -133.89 140.33 46.76 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.124 -0.36 . . . . 1.49 111.472 -171.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HZ2' ' HA ' ' A' ' 106' ' ' MET . 14.2 ttpt -111.49 123.33 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 1.1200000000000001 110.696 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 11.2 ttmm -103.13 118.77 37.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.392 -0.225 . . . . 1.6499999999999999 110.392 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -76.71 96.09 4.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.486 -0.325 . . . . 1.03 110.577 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.486 HD21 ' HD2' ' A' ' 48' ' ' LYS . 10.6 mt -63.1 -49.47 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.304 -1.369 . . . . 1.0600000000000001 107.304 174.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.826 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 72.2 t -140.1 126.32 11.97 Favored Pre-proline 0 CA--C 1.499 -0.987 0 CA-C-N 112.617 -2.083 . . . . 1.1399999999999999 106.588 170.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -104.28 64.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.546 2.164 . . . . 0.56000000000000005 113.845 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.8 178.13 21.09 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.4 -0.818 . . . . 0.55000000000000004 113.888 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 98.4 Cg_endo -89.95 165.06 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.259 2.64 . . . . 1.9099999999999999 111.071 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.58 105.7 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.226 1.951 . . . . 2.5299999999999998 111.945 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.76 42.18 2.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.956 -0.64 . . . . 1.4199999999999999 112.015 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.616 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 2.3 p -83.65 -164.15 0.87 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.947 0.403 . . . . 1.3600000000000001 110.566 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 t -152.48 136.05 16.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.787 -0.82 . . . . 1.8200000000000001 108.787 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 84.6 mtt180 -92.48 108.57 32.29 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.73 -0.47 . . . . 3.3900000000000001 109.73 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.581 ' HG3' HD22 ' A' ' 144' ' ' LEU . 5.3 Cg_endo -46.55 142.76 9.37 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.996 3.13 . . . . 0.42999999999999999 114.037 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.696 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -89.41 153.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.49 -0.777 . . . . 1.47 109.717 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.632 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -68.52 117.12 9.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.732 0.777 . . . . 1.71 110.956 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.7 -27.24 3.23 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.354 -1.293 . . . . 0.41999999999999998 110.423 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -75.65 140.94 42.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.58999999999999997 109.147 176.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.3 m -86.71 126.54 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.42 -1.326 . . . . 1.8600000000000001 107.42 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 33.3 m -120.6 146.41 25.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.174 -0.466 . . . . 1.0700000000000001 110.195 -173.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.44 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 31.3 p -96.37 111.71 23.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.822 -0.626 . . . . 1.0600000000000001 110.047 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.573 HG23 HD23 ' A' ' 99' ' ' LEU . 3.9 m -111.42 143.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.746 -0.661 . . . . 1.05 110.362 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.3 114.04 27.65 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.018 -1.475 . . . . 0.28999999999999998 107.018 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -114.67 135.47 54.12 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.301 -0.959 . . . . 1.1299999999999999 111.132 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.545 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -134.17 113.45 12.05 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.742 -1.947 . . . . 0.27000000000000002 105.742 165.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 140' ' ' LEU . 88.3 m -105.24 132.13 51.83 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.605 -1.18 . . . . 1.04 111.411 -168.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.799 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -110.46 156.61 20.61 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.297 -0.865 . . . . 1.54 109.131 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.72 165.64 21.77 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.828 -0.624 . . . . 1.51 109.807 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.7 -21.18 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 1.1399999999999999 111.266 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -91.3 -8.15 49.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.864 -0.607 . . . . 2.1400000000000001 110.61 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.44 -9.37 41.66 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.061 -0.59 . . . . 0.51000000000000001 112.702 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -74.23 109.41 7.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.72 0.267 . . . . 1.1599999999999999 111.72 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 23.3 mtt180 -75.71 124.37 27.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.254 0.55 . . . . 0.54000000000000004 110.532 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.558 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.0 m -112.76 -9.24 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.914 -1.039 . . . . 1.0600000000000001 112.777 -168.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.572 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.8 pt20 -159.4 132.5 7.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.475 -0.33 . . . . 0.63 110.137 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.457 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 63.1 tt0 -140.85 118.58 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 1.3400000000000001 110.644 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 3.0 tt0 -137.48 121.15 11.77 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.622 -0.717 . . . . 2.5899999999999999 110.313 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 8.9 Cg_exo -71.23 -13.63 31.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.627 2.885 . . . . 0.90000000000000002 113.274 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -161.5 105.58 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.048 0.928 . . . . 1.3700000000000001 111.784 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 68' ' ' VAL . 25.7 tp -114.88 109.97 18.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.443 -1.708 . . . . 1.1399999999999999 109.344 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.7 p -104.67 131.38 53.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.713 -0.477 . . . . 1.5900000000000001 109.713 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.675 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 46.1 p90 -150.98 158.67 44.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.568 -0.287 . . . . 0.25 111.111 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 m -77.07 109.48 10.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 1.0700000000000001 110.181 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.762 HD13 ' HD3' ' A' ' 104' ' ' PRO . 17.7 tp -62.05 133.96 55.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 1.3300000000000001 110.541 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 83.93 3.59 89.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.788 -0.72 . . . . 0.37 112.527 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -106.37 -2.68 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.42 . . . . 0.93000000000000005 110.021 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.412 ' C ' ' H ' ' A' ' 95' ' ' VAL . 35.3 m 59.46 35.91 22.98 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.775 -0.824 . . . . 1.55 108.775 -172.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -73.96 -2.86 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.26 1.028 . . . . 1.3300000000000001 108.48 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 93' ' ' CYS . 5.8 m -139.87 -153.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 113.767 -1.56 . . . . 1.0800000000000001 109.726 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.2 pt -82.94 138.04 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.265 -1.383 . . . . 1.0600000000000001 107.265 172.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.494 HE21 ' HB3' ' A' ' 100' ' ' ASP . 9.3 tp60 -57.65 -31.04 65.91 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.568 -0.287 . . . . 0.40000000000000002 111.071 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.63 -48.19 69.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 1.0800000000000001 110.863 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.597 HD12 HG13 ' A' ' 142' ' ' VAL . 46.9 tp -72.92 -38.11 66.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.367 -0.833 . . . . 1.0700000000000001 110.468 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.494 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.2 t70 -61.6 -30.04 70.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.824 -1.08 . . . . 0.26000000000000001 109.695 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 84.3 mt -89.92 -35.01 15.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.375 -0.83 . . . . 1.0600000000000001 111.63 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.7 t -63.57 -36.2 83.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 1.53 111.321 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.61 -55.87 34.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 112.772 0.656 . . . . 1.0600000000000001 112.772 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.762 ' HD3' HD13 ' A' ' 90' ' ' LEU . 25.7 Cg_endo -64.42 -19.57 65.45 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 121.887 1.725 . . . . 0.40999999999999998 112.114 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' CD1' HG21 ' A' ' 39' ' ' ILE . 12.8 mt -82.59 -13.62 56.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.016 -0.538 . . . . 1.3500000000000001 111.297 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.638 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.7 ptm -107.32 154.41 21.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.088 -0.505 . . . . 1.3100000000000001 110.72 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.71 152.75 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.96999999999999997 110.494 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.16 126.6 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.052 0.93 . . . . 1.47 110.116 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.54 12.37 57.13 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.661 -1.154 . . . . 0.28000000000000003 112.952 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.826 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.1 pt-20 -101.7 168.48 9.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.40999999999999998 110.736 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.467 HG22 HD12 ' A' ' 50' ' ' LEU . 9.5 m -129.63 119.08 22.98 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.653 -1.24 . . . . 1.0700000000000001 107.653 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.425 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.73 53.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.037 0.446 . . . . 1.0 111.018 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.9 ttm -97.96 116.71 30.73 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.9399999999999999 107.216 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.421 HG21 ' HG3' ' A' ' 47' ' ' LYS . 5.2 t -113.91 128.75 70.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.985 -0.376 . . . . 1.0600000000000001 109.985 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 62.7 m -104.67 113.73 27.5 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 108.187 -1.042 . . . . 1.03 108.187 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.511 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.63 141.92 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.01 -1.45 . . . . 1.01 108.749 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 6.6 t70 -57.76 156.37 8.8 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.223 -0.591 . . . . 0.57999999999999996 109.578 174.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.678 ' OG ' ' HA ' ' A' ' 135' ' ' HIS . 70.6 p -47.34 -43.4 22.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.996 -1.002 . . . . 1.04 110.739 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 14.4 ptpt -59.76 -28.97 67.85 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.907 -1.042 . . . . 1.4299999999999999 112.042 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.58 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 91.6 m-85 -94.81 2.63 55.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.364 0.602 . . . . 1.04 109.856 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.814 ' HB3' HD22 ' A' ' 138' ' ' LEU . 91.1 m -122.78 -92.34 0.54 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.623 -1.172 . . . . 0.87 110.271 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.656 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 3.8 m-85 -147.37 37.66 0.93 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 119.019 -0.515 . . . . 0.95999999999999996 111.85 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.542 ' CA ' ' HB2' ' A' ' 118' ' ' SER . . . -52.73 -83.5 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.597 -0.811 . . . . 0.25 112.998 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 7.36 4.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.551 2.167 . . . . 0.90000000000000002 111.692 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.512 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -104.22 -46.97 4.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.749 -0.66 . . . . 0.65000000000000002 110.66 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.596 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 80.73 142.06 3.07 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.954 -1.021 . . . . 0.29999999999999999 112.225 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.708 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.4 t -91.65 159.42 15.88 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.575 0.583 . . . . 0.90000000000000002 112.575 -174.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.534 ' HG3' ' H ' ' A' ' 129' ' ' SER . 9.6 ptp180 -48.97 -53.98 17.51 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.48 -1.236 . . . . 3.6099999999999999 112.259 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.949 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 3.5 m -82.4 -63.88 0.27 Allowed Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.895 -0.409 . . . . 1.52 109.895 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.949 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.1 Cg_endo -105.07 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.522 2.148 . . . . 0.44 112.262 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.656 ' HH ' ' HD3' ' A' ' 134' ' ' PRO . 26.1 t80 -55.57 97.45 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.674 -0.861 . . . . 1.6899999999999999 108.674 163.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.593 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.3 mm -66.77 122.57 82.86 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.75 -0.659 . . . . 1.0600000000000001 109.313 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.02 137.74 80.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.261 1.974 . . . . 1.03 111.965 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.656 ' HD3' ' HH ' ' A' ' 131' ' ' TYR . 38.4 Cg_exo -56.35 130.2 38.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.387 2.058 . . . . 0.89000000000000001 112.823 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.678 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 17.3 m80 74.39 23.82 1.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.577 -1.647 . . . . 3.1899999999999999 112.878 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.51 116.01 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.29 -1.004 . . . . 1.04 108.29 166.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.61 132.5 43.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.99 0.424 . . . . 1.05 110.039 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.814 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -104.05 132.37 50.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.918 -0.583 . . . . 1.0600000000000001 111.773 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.2 t -116.63 100.45 7.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.061 -0.718 . . . . 1.8200000000000001 109.061 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.6 pp -112.57 137.13 51.25 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.771 -0.65 . . . . 1.1499999999999999 111.579 -171.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.545 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 41.2 tt0 -106.8 116.2 31.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.891 -0.781 . . . . 1.05 108.891 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 99' ' ' LEU . 4.6 m -117.12 120.91 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.724 0.638 . . . . 1.0800000000000001 112.724 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 m -88.75 108.85 19.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.082 -0.963 . . . . 1.0900000000000001 110.737 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.638 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 55.7 tp -81.71 94.74 7.05 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.68 -0.859 . . . . 1.0700000000000001 108.68 172.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.9 mtmt -89.33 -25.1 21.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.141 -0.936 . . . . 1.6899999999999999 110.821 -171.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.44 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 22.0 m -160.84 148.12 15.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.664 0.269 . . . . 1.1200000000000001 111.174 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.475 ' HA ' HG11 ' A' ' 66' ' ' VAL . . . -124.43 127.96 48.31 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.193 -0.669 . . . . 0.98999999999999999 109.193 168.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.2 t -119.93 121.09 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.619 -0.511 . . . . 1.6200000000000001 109.619 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.526 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 5.1 t0 -74.75 116.31 15.31 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.815 -0.809 . . . . 2.27 108.815 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -152.95 22.94 0.57 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.445 -0.798 . . . . 2.5 109.482 -169.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -72.83 -96.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.039 -1.097 . . . . 2.1400000000000001 108.039 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.435 ' C ' ' H ' ' A' ' 154' ' ' HIS . 82.0 m-70 37.53 68.32 0.3 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 124.184 0.928 . . . . 6.6299999999999999 111.791 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -67.47 8.75 0.3 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.407 0.521 . . . . 8.1899999999999995 112.407 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.435 ' H ' ' C ' ' A' ' 152' ' ' HIS . 56.0 t-80 -84.29 94.16 8.38 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.877 -0.416 . . . . 9.0800000000000001 109.877 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -140.28 138.72 35.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.568 -0.287 . . . . 9.2400000000000002 110.748 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -165.05 121.89 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 12.779999999999999 110.022 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 35.6 m170 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.42 -0.8 . . . . 14.109999999999999 110.051 175.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.968 -0.382 . . . . 50.460000000000001 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.22 -52.59 0.45 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.478 -0.867 . . . . 47.990000000000002 113.139 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -104.5 155.97 36.56 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.457 0.128 . . . . 46.439999999999998 110.72 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 61.1 Cg_exo -51.48 -50.11 15.01 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.09 2.526 . . . . 45.219999999999999 113.583 173.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 12.8 Cg_exo -71.45 122.63 8.8 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.501 1.467 . . . . 44.450000000000003 111.986 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 13.15 29.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.619 0.723 . . . . 42.710000000000001 109.704 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.77 -17.34 30.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.107 -0.951 . . . . 41.5 110.103 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.9 118.12 30.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.641 . . . . 40.329999999999998 110.941 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.22 127.99 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.93 -0.577 . . . . 39.390000000000001 110.831 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.6 25.76 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 38.82 109.707 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -98.67 120.91 57.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.554 0.692 . . . . 38.350000000000001 111.136 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.89 -60.56 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.45 2.767 . . . . 37.039999999999999 112.497 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.58 107.3 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.788 -0.525 . . . . 35.659999999999997 111.788 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 59.45 69.25 0.73 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.733 -0.469 . . . . 35.149999999999999 109.733 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 95.6 mt 69.13 -165.19 0.18 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.097 -0.956 . . . . 34.170000000000002 110.374 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.73 116.53 26.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.721 -0.844 . . . . 32.950000000000003 108.721 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 21.3 mmt180 -144.11 32.13 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.955 0.407 . . . . 32.299999999999997 111.496 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.89 92.53 0.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 31.239999999999998 109.751 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -66.54 -17.09 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.783 -0.644 . . . . 31.57 110.743 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.96 75.74 10.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 30.100000000000001 109.785 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.53 127.68 20.95 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.644 -0.707 . . . . 28.399999999999999 110.226 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.99 106.3 1.89 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 26.969999999999999 110.709 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.0 mtt -84.36 67.44 9.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.862 0.839 . . . . 27.66 110.417 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -133.07 93.53 22.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 114.693 -1.139 . . . . 24.41 108.813 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.15 137.82 58.64 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.674 2.249 . . . . 22.399999999999999 112.244 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 10.6 pt-20 -56.69 132.44 78.23 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 20.670000000000002 110.2 177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 53.1 Cg_exo -54.93 128.69 31.59 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.036 2.491 . . . . 18.75 112.655 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.32 147.5 36.91 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.623 -0.717 . . . . 14.960000000000001 110.981 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.73 128.16 22.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.52 2.147 . . . . 14.550000000000001 111.684 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.4 71.09 3.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.934 -0.575 . . . . 10.949999999999999 111.692 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.39 101.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.574 2.183 . . . . 10.6 111.63 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.78 138.8 21.18 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.219 -0.446 . . . . 6.1100000000000003 110.674 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.24 -44.74 17.83 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.682 2.255 . . . . 5.3600000000000003 112.051 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 179.54 -55.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.964 -0.754 . . . . 4.1299999999999999 108.964 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 69.33 110.35 0.05 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.982 -1.008 . . . . 2.4500000000000002 112.371 173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.583 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 0.8 OUTLIER -109.84 -157.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.53000000000000003 110.625 -175.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.05 118.26 12.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.585 -0.734 . . . . 1.1899999999999999 110.415 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.644 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.4 t70 -80.98 129.4 34.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.324 0.583 . . . . 2.5099999999999998 110.379 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.614 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.1 mt -65.51 -24.91 35.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.801 -1.091 . . . . 1.1499999999999999 111.088 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.66 0.7 10.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.55 . . . . 1.4299999999999999 110.47 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.25 22.37 65.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.436 -0.802 . . . . 0.65000000000000002 112.306 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.07 -28.24 15.83 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.137 0.421 . . . . 0.94999999999999996 112.137 -176.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 108.58 -1.01 32.41 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.818 -0.706 . . . . 0.71999999999999997 112.065 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 mp -105.42 -31.58 8.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.051 0.453 . . . . 2.1600000000000001 111.215 -176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 16.5 tp -122.31 101.33 7.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.4 -0.818 . . . . 1.1200000000000001 111.471 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' HG2' ' CA ' ' A' ' 38' ' ' ASP . 67.5 mtm180 -133.42 141.01 47.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.356 0.502 . . . . 1.49 112.356 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HZ1' ' HA ' ' A' ' 106' ' ' MET . 11.4 ttpt -114.28 126.09 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 1.1200000000000001 110.654 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.6 ttpt -112.03 128.56 56.22 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 121.062 -0.255 . . . . 1.6499999999999999 110.894 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 p -83.94 103.89 13.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.223 -0.444 . . . . 1.03 110.711 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG23 ' A' ' 111' ' ' THR . 8.0 mt -65.26 -52.94 51.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.832 -1.544 . . . . 1.0600000000000001 106.832 170.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.816 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 86.6 t -131.93 131.99 22.92 Favored Pre-proline 0 CA--C 1.501 -0.912 0 CA-C-N 113.28 -1.782 . . . . 1.1399999999999999 106.242 167.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.7 Cg_endo -104.61 53.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.935 2.423 . . . . 0.56000000000000005 113.023 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.27 169.98 29.81 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.957 -1.02 . . . . 0.55000000000000004 112.807 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.55 150.45 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.6 2.2 . . . . 1.9099999999999999 110.264 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.91 115.06 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.329 2.019 . . . . 2.5299999999999998 111.534 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.19 49.47 2.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.405 -0.902 . . . . 1.4199999999999999 111.724 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -81.89 170.93 15.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.543 0.687 . . . . 1.3600000000000001 111.901 -177.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.728 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 50.5 m -116.59 133.61 55.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.32 -0.855 . . . . 1.8200000000000001 108.896 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 86.2 mtt180 -99.46 113.6 65.0 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-O 120.931 0.396 . . . . 3.3900000000000001 110.481 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.586 ' HG3' HD21 ' A' ' 144' ' ' LEU . 10.9 Cg_endo -53.77 145.78 48.34 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.43 2.754 . . . . 0.42999999999999999 113.382 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 17.6 t -97.19 152.68 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 1.47 109.396 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.948 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 89.1 mttt -71.34 120.84 17.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.454 0.645 . . . . 1.71 109.762 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.48 -26.97 4.27 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.872 -1.291 . . . . 0.41999999999999998 109.872 -172.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.632 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.06 139.73 30.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.455 -0.943 . . . . 0.58999999999999997 108.455 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.9 m -86.17 128.91 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 108.075 -1.083 . . . . 1.8600000000000001 108.075 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -124.91 146.46 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.175 -0.92 . . . . 1.0700000000000001 110.778 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.483 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 37.1 p -95.38 113.02 24.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.099 -0.501 . . . . 1.0600000000000001 110.572 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.669 HG21 HD23 ' A' ' 99' ' ' LEU . 30.3 m -110.65 143.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.037 -0.665 . . . . 1.05 109.846 173.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.598 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.52 116.29 32.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.701 -1.592 . . . . 0.28999999999999998 106.701 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.71 137.94 52.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.079 -1.049 . . . . 1.1299999999999999 111.024 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.52 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.74 114.56 14.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.788 -1.93 . . . . 0.27000000000000002 105.788 165.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.622 HG23 ' HB3' ' A' ' 140' ' ' LEU . 75.3 m -102.36 126.43 49.38 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.529 -1.214 . . . . 1.04 111.414 -166.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 13.1 t -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.464 -0.789 . . . . 1.54 109.498 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HG ' HG11 ' A' ' 80' ' ' VAL . 10.3 mt -82.32 164.89 20.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.368 -0.833 . . . . 1.51 109.863 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.69 -24.82 36.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.391 0.615 . . . . 1.1399999999999999 110.443 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -80.42 -12.81 59.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.344 -0.844 . . . . 2.1400000000000001 111.204 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.58 17.69 30.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.714 -0.755 . . . . 0.51000000000000001 112.039 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 m -102.55 110.05 21.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.581 0.229 . . . . 1.1599999999999999 111.525 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.696 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.2 mtt180 -74.87 115.41 14.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.523 0.678 . . . . 0.54000000000000004 110.083 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.643 ' HB ' ' CG ' ' A' ' 130' ' ' PRO . 27.0 m -99.51 -11.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.017 -0.992 . . . . 1.0600000000000001 111.989 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.589 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.6 pt20 -159.48 136.1 9.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.05 -0.523 . . . . 0.63 110.144 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 38.0 tt0 -133.43 123.94 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.999 0.428 . . . . 1.3400000000000001 109.849 173.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -136.96 116.85 10.62 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.344 -0.844 . . . . 2.5899999999999999 109.71 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.405 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 61.2 Cg_endo -72.09 -14.49 28.96 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.118 2.546 . . . . 0.90000000000000002 113.105 -170.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -164.94 110.83 0.95 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.181 0.991 . . . . 1.3700000000000001 111.029 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.09 103.25 8.88 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.179 -1.828 . . . . 1.1399999999999999 108.877 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.0 p -97.52 125.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.072 -0.513 . . . . 1.5900000000000001 109.834 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.809 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 43.3 p90 -147.19 159.58 43.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 0.25 110.952 -172.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 2.8 m -80.62 110.0 15.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.864 -0.607 . . . . 1.0700000000000001 110.176 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.948 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 13.8 tp -58.06 134.49 56.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 1.3300000000000001 110.955 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 74.47 11.54 82.54 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 121.043 -0.598 . . . . 0.37 112.375 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 27.0 t70 -112.58 8.56 19.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.192 -0.67 . . . . 0.93000000000000005 109.192 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 55.0 m 55.83 33.69 22.03 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.938 -1.028 . . . . 1.55 109.877 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 2.4 t0 -68.63 -14.6 63.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.393 1.092 . . . . 1.3300000000000001 108.693 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -133.96 -156.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.799 -1.546 . . . . 1.0800000000000001 110.539 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.5 pt -82.87 139.68 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.722 -1.214 . . . . 1.0600000000000001 107.722 175.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.515 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.4 tp60 -58.23 -30.53 66.58 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.244 -0.182 . . . . 0.40000000000000002 110.955 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.31 73.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.385 0.612 . . . . 1.0800000000000001 110.495 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.669 HD23 HG21 ' A' ' 68' ' ' VAL . 59.4 tp -77.88 -38.77 45.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.323 -0.853 . . . . 1.0700000000000001 110.665 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.68 -28.52 69.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.108 -0.951 . . . . 0.26000000000000001 109.585 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.612 HD22 ' HZ1' ' A' ' 62' ' ' LYS . 77.5 mt -90.47 -34.95 15.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.199 -0.91 . . . . 1.0600000000000001 111.883 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.4 t -64.17 -35.43 80.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 1.53 111.287 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HB ' ' CD ' ' A' ' 104' ' ' PRO . 54.6 t -63.32 -55.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.633 0.605 . . . . 1.0600000000000001 112.633 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.785 ' HD3' HD12 ' A' ' 90' ' ' LEU . 22.7 Cg_endo -63.16 -22.05 72.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.814 1.676 . . . . 0.40999999999999998 111.839 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.464 ' CD1' HG23 ' A' ' 39' ' ' ILE . 9.5 mt -81.68 -13.1 58.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 1.3500000000000001 111.271 173.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.668 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -106.42 157.19 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.959 -0.564 . . . . 1.3100000000000001 110.828 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.0 m-20 -96.37 153.56 17.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.96999999999999997 110.187 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.728 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -64.05 129.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.667 0.746 . . . . 1.47 110.728 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.66 7.47 61.57 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.536 -1.211 . . . . 0.28000000000000003 112.348 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.3 pt-20 -97.45 166.61 11.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.517 0.675 . . . . 0.40999999999999998 111.546 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.42 HG23 HD13 ' A' ' 50' ' ' LEU . 13.0 m -127.59 117.66 22.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.823 -1.177 . . . . 1.0700000000000001 107.823 172.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.521 ' HB1' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.24 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.944 0.402 . . . . 1.0 110.331 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.6 ttp -101.8 117.79 35.58 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.561 -1.274 . . . . 1.9399999999999999 107.561 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.478 HG22 ' HG3' ' A' ' 47' ' ' LYS . 10.5 t -112.67 135.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.296 -0.411 . . . . 1.0600000000000001 109.989 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.583 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 50.6 m -114.57 112.66 23.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.37 -0.974 . . . . 1.03 108.37 171.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . . . -125.16 136.56 53.72 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.399 -1.728 . . . . 1.01 109.688 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.683 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 11.1 t70 -53.05 149.5 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.112 -0.699 . . . . 0.57999999999999996 109.112 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.588 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.6 t -56.13 -28.06 56.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.191 0.52 . . . . 1.04 110.385 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.631 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.2 ptpt -55.33 -29.95 59.29 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 121.945 -0.472 . . . . 1.4299999999999999 111.498 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.562 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 72.6 m-85 -95.11 0.17 54.05 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.243 0.544 . . . . 1.04 110.271 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.633 ' HB3' HD23 ' A' ' 138' ' ' LEU . 61.8 m -122.56 -89.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.988 -1.005 . . . . 0.87 110.581 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.542 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.8 m-85 -143.88 40.67 1.4 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.004 0.372 . . . . 0.95999999999999996 112.004 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.04 -82.9 0.04 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 0.25 113.965 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.97 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.536 2.158 . . . . 0.90000000000000002 111.003 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 21.1 mt-30 -104.83 -51.5 3.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.376 -0.829 . . . . 0.65000000000000002 109.721 -174.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.605 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.05 141.74 3.14 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.401 -1.272 . . . . 0.29999999999999999 112.151 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.666 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.2 t -91.67 152.32 20.27 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.229 0.538 . . . . 0.90000000000000002 111.961 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -46.65 -48.32 20.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.464 -1.244 . . . . 3.6099999999999999 113.428 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 1.012 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 47.2 m -81.54 -65.95 0.24 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.124 -0.63 . . . . 1.52 109.896 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.012 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -107.01 127.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.295 1.997 . . . . 0.44 112.043 172.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.605 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -55.95 97.97 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.916 -1.142 . . . . 1.6899999999999999 107.916 164.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.589 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -66.5 126.49 92.26 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.678 -0.692 . . . . 1.0600000000000001 109.532 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.78 145.29 31.8 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.734 2.289 . . . . 1.03 112.189 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.574 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.7 Cg_endo -63.94 133.23 37.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.059 1.839 . . . . 0.89000000000000001 111.817 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.683 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 32.3 m170 71.77 8.3 6.07 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.018 -0.992 . . . . 3.1899999999999999 112.16 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -69.96 122.11 18.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.737 -0.838 . . . . 1.04 108.737 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.58 112.78 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 1.05 110.24 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.633 HD23 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -89.63 131.84 35.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.192 -0.913 . . . . 1.0600000000000001 110.285 -177.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 23.7 t -121.3 101.19 7.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.853 0.835 . . . . 1.8200000000000001 109.155 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.622 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -113.08 137.4 51.49 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.611 -1.177 . . . . 1.1499999999999999 111.61 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.52 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 42.4 tt0 -101.71 115.69 31.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.489 -0.778 . . . . 1.05 109.227 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.644 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -117.08 121.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.667 0.617 . . . . 1.0800000000000001 112.667 -175.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.8 m -92.75 109.02 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.243 -0.889 . . . . 1.0900000000000001 110.249 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.627 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 64.3 tp -81.85 98.63 8.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.493 -0.929 . . . . 1.0700000000000001 108.493 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -94.71 -27.86 15.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.33 -0.85 . . . . 1.6899999999999999 110.775 -170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.483 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 7.8 m -153.39 151.74 30.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.292 -0.413 . . . . 1.1200000000000001 111.458 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.495 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.58 128.5 27.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.565 -0.743 . . . . 0.98999999999999999 109.061 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.11 130.51 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.232 0.539 . . . . 1.6200000000000001 110.365 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.45 133.64 43.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.789 -0.641 . . . . 2.27 109.339 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -161.45 25.44 0.13 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.554 -0.535 . . . . 2.5 109.554 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -71.72 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 2.1400000000000001 110.048 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.7 m170 69.16 -7.03 0.84 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.48 0.919 . . . . 6.6299999999999999 113.48 170.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -87.87 73.91 9.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.487 0.661 . . . . 8.1899999999999995 110.474 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -116.28 -24.13 8.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.562 -0.745 . . . . 9.0800000000000001 109.307 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 69.8 m-70 -147.13 159.3 43.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.276 -0.875 . . . . 9.2400000000000002 109.084 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 64.3 m-70 73.44 130.0 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.136 0.897 . . . . 12.779999999999999 109.517 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.059 -0.719 . . . . 14.109999999999999 109.059 -168.704 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.729 0.3 . . . . 50.460000000000001 110.586 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.46 -83.71 0.88 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.993 -0.623 . . . . 47.990000000000002 111.87 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -140.46 88.9 10.85 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 46.439999999999998 109.715 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.66 169.04 18.84 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.777 2.318 . . . . 45.219999999999999 112.104 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.18 124.42 16.23 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.667 2.244 . . . . 44.450000000000003 112.429 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.96 129.27 44.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.806 -0.634 . . . . 42.710000000000001 109.451 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -78.91 -37.32 40.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.937 -0.394 . . . . 41.5 109.937 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -157.47 -26.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 40.329999999999998 110.195 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.3 -88.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.807 -0.633 . . . . 39.390000000000001 111.23 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -163.04 -56.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.692 -0.231 . . . . 38.82 110.808 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -116.56 79.74 9.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.602 0.239 . . . . 38.350000000000001 111.571 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.15 2.36 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.581 2.187 . . . . 37.039999999999999 112.072 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.98 -142.09 4.26 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.751 . . . . 35.659999999999997 111.345 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.99 84.66 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.264 0.555 . . . . 35.149999999999999 110.907 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.17 -25.48 18.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.565 -0.743 . . . . 34.170000000000002 110.855 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 57.95 29.14 17.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.102 -0.499 . . . . 32.950000000000003 111.95 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 17' ' ' ARG . 14.9 tpt85 -90.83 25.83 2.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 32.299999999999997 110.787 -175.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.714 ' HG3' ' HD1' ' A' ' 19' ' ' PHE . 21.8 tp10 -59.48 -75.32 0.06 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.693 -0.685 . . . . 31.239999999999998 111.496 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.714 ' HD1' ' HG3' ' A' ' 18' ' ' GLU . 44.2 p90 -147.07 11.6 1.05 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.73 0.3 . . . . 31.57 111.648 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 20' ' ' LEU . 5.8 mp -80.87 -62.39 1.68 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 30.100000000000001 111.306 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.81 145.71 55.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.308 -0.405 . . . . 28.399999999999999 110.383 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 177.88 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.203 -0.453 . . . . 26.969999999999999 111.72 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.3 ttm 59.44 77.63 0.3 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.103 -0.953 . . . . 27.66 111.423 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 5.6 tp10 -166.66 109.96 0.68 Allowed Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.77 -0.826 . . . . 24.41 108.77 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 20.2 Cg_exo -66.13 143.3 71.04 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.2 2.6 . . . . 22.399999999999999 113.203 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -67.12 144.24 98.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.903 -0.59 . . . . 20.670000000000002 110.216 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.73 125.45 14.32 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.088 1.858 . . . . 18.75 111.418 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -114.7 120.49 37.49 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.87 0.367 . . . . 14.960000000000001 111.114 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.87 127.82 16.79 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.647 2.232 . . . . 14.550000000000001 111.57 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.09 80.99 70.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.129 -0.487 . . . . 10.949999999999999 111.241 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.16 105.39 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 10.6 111.544 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -71.22 139.35 84.68 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.825 -0.435 . . . . 6.1100000000000003 109.825 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.26 -25.95 64.46 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.669 2.246 . . . . 5.3600000000000003 112.858 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.86 -65.94 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 4.1299999999999999 111.268 -173.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 12.5 mm-40 -107.63 120.11 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 2.4500000000000002 109.713 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.63 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -109.06 -165.6 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.564 0.697 . . . . 0.53000000000000003 112.138 -170.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.7 125.02 28.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.706 -1.134 . . . . 1.1899999999999999 111.233 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' HB3' ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -77.17 123.55 26.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.131 -0.486 . . . . 2.5099999999999998 111.113 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.629 HD11 HD11 ' A' ' 45' ' ' LEU . 6.9 mt -62.54 -41.28 91.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.434 -0.803 . . . . 1.1499999999999999 110.959 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.446 HD23 HD13 ' A' ' 101' ' ' LEU . 89.1 mt -113.21 0.68 14.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.75 0.309 . . . . 1.4299999999999999 111.424 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.541 ' H ' ' HB3' ' A' ' 38' ' ' ASP . . . 68.65 24.15 75.38 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.4 -0.68 . . . . 0.65000000000000002 111.4 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.518 HD21 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -97.46 -24.74 15.46 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.94999999999999996 113.243 -177.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' HD21 ' A' ' 42' ' ' ASN . . . 102.32 -19.28 48.99 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 121.308 -0.472 . . . . 0.71999999999999997 112.372 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.74 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 2.8 mm? -90.12 -28.86 18.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.839 0.352 . . . . 2.1600000000000001 110.491 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 39' ' ' ILE . 20.9 tp -122.86 109.29 13.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 1.1200000000000001 111.865 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 71.2 mtm180 -139.38 140.46 37.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.987 0.366 . . . . 1.49 111.987 -173.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -113.23 123.44 50.18 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.985 0.514 . . . . 1.1200000000000001 110.137 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.63 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.2 ttpt -109.77 113.64 26.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 1.6499999999999999 110.708 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 p -74.07 100.66 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.347 -0.388 . . . . 1.03 111.328 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 111' ' ' THR . 7.8 mt -65.8 -49.55 67.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.427 -1.323 . . . . 1.0600000000000001 107.427 172.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.805 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.7 t -136.61 126.32 15.84 Favored Pre-proline 0 CA--C 1.505 -0.772 0 CA-C-N 113.007 -1.906 . . . . 1.1399999999999999 106.712 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -104.35 61.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.108 2.539 . . . . 0.56000000000000005 113.846 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 163.49 8.51 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.546 -0.752 . . . . 0.55000000000000004 113.634 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 97.5 Cg_endo -79.83 172.12 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.031 2.488 . . . . 1.9099999999999999 111.141 173.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.57 48.45 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.957 2.438 . . . . 2.5299999999999998 112.936 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.67 43.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.593 -0.603 . . . . 1.4199999999999999 111.593 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.675 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -95.69 -174.44 3.15 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.304 0.573 . . . . 1.3600000000000001 111.352 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.1 t -152.15 136.85 17.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.065 -1.087 . . . . 1.8200000000000001 108.065 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 10.4 ptp180 -91.68 113.48 58.87 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.528 -0.469 . . . . 3.3900000000000001 110.39 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.607 ' HD3' HG22 ' A' ' 108' ' ' VAL . 4.9 Cg_endo -47.47 142.21 13.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.985 3.123 . . . . 0.42999999999999999 113.653 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 16.9 t -92.05 156.86 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.386 -0.824 . . . . 1.47 109.645 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -63.53 111.92 2.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.132 0.491 . . . . 1.71 110.199 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 151' ' ' GLU . . . 137.05 -33.44 2.31 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 114.827 -1.079 . . . . 0.41999999999999998 110.491 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -74.56 139.19 43.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.904 -0.776 . . . . 0.58999999999999997 108.904 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 2.7 m -89.25 131.33 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.696 -1.224 . . . . 1.8600000000000001 107.696 174.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.0 m -129.18 149.42 33.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.609 -0.723 . . . . 1.0700000000000001 110.718 -171.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.512 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 24.7 p -98.68 113.01 24.91 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.82 -0.627 . . . . 1.0600000000000001 110.041 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 99' ' ' LEU . 19.2 m -110.63 144.28 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 119.988 -0.685 . . . . 1.05 110.214 173.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.45 117.14 34.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.203 -1.406 . . . . 0.28999999999999998 107.203 170.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -121.17 134.83 55.23 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.384 -0.926 . . . . 1.1299999999999999 110.62 177.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -126.95 114.07 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.241 -2.133 . . . . 0.27000000000000002 105.241 167.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.613 HG22 ' HB3' ' A' ' 140' ' ' LEU . 59.0 m -106.13 123.59 48.25 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.317 -1.311 . . . . 1.04 111.057 -164.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.966 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.9 OUTLIER -104.81 170.99 7.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.821 -0.627 . . . . 1.54 109.448 -178.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt -97.12 165.4 12.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.433 -0.803 . . . . 1.51 109.249 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.26 -16.76 23.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.832 0.348 . . . . 1.1399999999999999 110.715 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -94.98 -14.7 24.15 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.364 -0.38 . . . . 2.1400000000000001 110.92 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.38 -24.44 6.91 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.544 -0.836 . . . . 0.51000000000000001 113.933 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.4 m -67.54 114.97 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.81 0.67 . . . . 1.1599999999999999 112.81 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.883 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.6 mtt180 -77.98 118.52 20.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.608 0.718 . . . . 0.54000000000000004 110.499 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.736 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.3 m -96.58 -9.08 9.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.613 -1.176 . . . . 1.0600000000000001 112.06 -170.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.565 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.7 pt20 -164.92 129.07 2.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.42 -0.355 . . . . 0.63 110.891 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -122.38 109.61 14.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.382 -0.599 . . . . 1.3400000000000001 109.382 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.25 113.75 25.99 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.59 -0.732 . . . . 2.5899999999999999 110.363 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 56.6 Cg_endo -71.26 -16.05 31.52 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.307 2.671 . . . . 0.90000000000000002 113.491 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -163.05 108.76 1.13 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.206 1.003 . . . . 1.3700000000000001 112.088 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 tp -118.49 105.98 12.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.086 -1.87 . . . . 1.1399999999999999 108.728 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -100.11 130.78 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.214 -0.448 . . . . 1.5900000000000001 109.842 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.4 p90 -151.74 157.78 42.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.691 0.281 . . . . 0.25 110.582 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.8 m -76.98 114.29 15.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.752 -0.658 . . . . 1.0700000000000001 109.711 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.858 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.7 tp -58.96 127.63 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 1.3300000000000001 111.376 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.81 4.22 90.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.997 -0.62 . . . . 0.37 112.344 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -89.72 -4.71 57.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.176 -1.046 . . . . 0.93000000000000005 108.176 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 19.5 m 56.95 32.88 22.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.57 -1.196 . . . . 1.55 109.92 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.61 -21.37 64.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.167 0.984 . . . . 1.3300000000000001 108.955 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 m -113.67 -158.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.714 -1.585 . . . . 1.0800000000000001 110.859 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.6 pt -78.44 137.25 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.317 -1.364 . . . . 1.0600000000000001 107.317 173.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -57.57 -30.35 65.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.471 -0.331 . . . . 0.40000000000000002 110.781 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.8 -46.83 81.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 1.0800000000000001 110.788 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.675 HD22 HG21 ' A' ' 68' ' ' VAL . 48.5 tp -71.26 -40.3 71.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 1.0700000000000001 110.728 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.07 -30.34 70.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.801 -1.09 . . . . 0.26000000000000001 109.977 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.446 HD13 HD23 ' A' ' 40' ' ' LEU . 82.2 mt -91.44 -33.36 15.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.353 -0.839 . . . . 1.0600000000000001 112.472 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.8 t -65.64 -32.11 73.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 1.53 111.119 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 99' ' ' LEU . 57.9 t -66.38 -52.83 34.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.767 0.654 . . . . 1.0600000000000001 112.767 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.858 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -62.81 -19.98 70.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.634 1.556 . . . . 0.40999999999999998 112.113 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.508 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.9 mt -83.18 -16.14 47.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.476 0.655 . . . . 1.3500000000000001 111.109 170.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.783 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 28.3 ttm -96.16 141.5 29.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.744 -1.116 . . . . 1.3100000000000001 111.572 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.92 151.08 19.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.914 -0.402 . . . . 0.96999999999999997 109.914 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.607 HG22 ' HD3' ' A' ' 60' ' ' PRO . 3.7 t -59.73 124.3 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 1.47 110.639 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.28 14.12 46.13 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.481 -0.782 . . . . 0.28000000000000003 112.787 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.805 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -104.31 168.23 9.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.615 0.708 . . . . 0.40999999999999998 110.574 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.443 HG22 HD12 ' A' ' 50' ' ' LEU . 17.9 m -133.65 117.97 17.62 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.923 -1.14 . . . . 1.0700000000000001 107.923 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.08 140.98 52.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.181 0.515 . . . . 1.0 110.805 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.419 ' HG2' ' CH2' ' A' ' 36' ' ' TRP . 16.9 ttt -98.12 117.88 33.49 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.297 -1.372 . . . . 1.9399999999999999 107.297 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.8 130.46 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.566 -0.531 . . . . 1.0600000000000001 109.566 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.566 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 99.3 m -108.3 114.45 28.33 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.652 -0.819 . . . . 1.03 109.023 173.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.61 134.17 53.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.017 -1.447 . . . . 1.01 110.063 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.74 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 9.6 t70 -52.31 147.5 7.81 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.57999999999999996 108.682 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.4 t -57.98 -25.68 61.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.232 0.539 . . . . 1.04 110.138 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.614 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 4.2 ptpp? -55.32 -29.79 58.95 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.111 -0.368 . . . . 1.4299999999999999 111.29 173.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.549 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 97.3 m-85 -98.51 3.0 48.13 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.219 0.533 . . . . 1.04 110.268 175.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.0 m -123.63 -91.59 0.54 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.148 -0.933 . . . . 0.87 110.701 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 12.3 m-85 -141.91 42.83 1.7 Allowed 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 112.15 0.426 . . . . 0.95999999999999996 112.15 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -51.58 -86.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.163 -0.542 . . . . 0.25 113.572 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.26 11.92 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.536 2.158 . . . . 0.90000000000000002 111.09 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.4 mt-30 -103.2 -46.75 4.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.6 -0.727 . . . . 0.65000000000000002 109.968 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.55 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.95 144.28 2.22 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.693 -1.139 . . . . 0.29999999999999999 112.188 -175.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.642 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.9 t -91.16 158.74 16.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.229 -0.486 . . . . 0.90000000000000002 112.09 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -47.05 -55.49 8.17 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.811 -1.086 . . . . 3.6099999999999999 111.943 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.917 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 22.9 t -80.92 -62.95 0.34 Allowed Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.534 -0.466 . . . . 1.52 110.158 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.917 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.7 Cg_endo -106.08 127.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.348 2.032 . . . . 0.44 112.11 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.55 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 49.2 t80 -55.91 98.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.346 -0.983 . . . . 1.6899999999999999 108.346 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.603 HG12 ' CB ' ' A' ' 127' ' ' SER . 32.3 mm -66.49 128.24 93.75 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.668 -0.697 . . . . 1.0600000000000001 109.917 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.59 139.29 75.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.572 2.181 . . . . 1.03 112.144 178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.479 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 72.2 Cg_exo -52.54 129.06 30.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.815 2.343 . . . . 0.89000000000000001 112.918 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 66.3 m170 70.11 15.54 7.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.992 -1.004 . . . . 3.1899999999999999 112.508 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.92 123.79 26.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.87 -0.789 . . . . 1.04 108.87 170.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.11 115.96 14.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.328 0.585 . . . . 1.05 110.308 -173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.95 136.21 33.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.396 -0.82 . . . . 1.0600000000000001 111.007 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.966 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 30.7 p -119.54 98.56 6.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.037 0.922 . . . . 1.8200000000000001 110.026 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.613 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.5 OUTLIER -110.41 134.69 52.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.004 -0.998 . . . . 1.1499999999999999 111.647 -173.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.586 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 46.4 tt0 -100.78 111.73 24.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.799 . . . . 1.05 109.084 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.665 HG23 ' HE3' ' A' ' 106' ' ' MET . 1.3 m -112.17 117.05 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.516 0.674 . . . . 1.0800000000000001 112.716 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 4.0 m -89.91 114.03 25.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.945 -1.025 . . . . 1.0900000000000001 110.573 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.726 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.8 tp -85.82 96.07 9.63 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.962 -0.755 . . . . 1.0700000000000001 108.962 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.5 mtmt -91.85 -30.49 16.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.55 -0.75 . . . . 1.6899999999999999 110.8 -171.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.512 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 19.1 m -151.93 148.07 27.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.484 -0.326 . . . . 1.1200000000000001 111.167 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.92 128.79 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.244 -0.65 . . . . 0.98999999999999999 109.244 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 150' ' ' LEU . 36.0 m -128.93 135.89 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.568 -0.853 . . . . 1.6200000000000001 111.677 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -89.52 116.43 27.68 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.301 -0.863 . . . . 2.27 110.948 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 148' ' ' VAL . 2.6 pt? -158.14 -37.46 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.105 -0.952 . . . . 2.5 109.11 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.873 ' HG2' ' H ' ' A' ' 152' ' ' HIS . 9.9 tt0 60.83 -169.16 0.16 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.499 -1.682 . . . . 2.1400000000000001 111.253 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.873 ' H ' ' HG2' ' A' ' 151' ' ' GLU . 8.6 t-160 -152.45 12.98 0.55 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.701 0.286 . . . . 6.6299999999999999 110.858 -174.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -97.28 75.37 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 8.1899999999999995 110.578 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.3 m170 65.58 -99.36 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.149 -0.932 . . . . 9.0800000000000001 112.718 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -131.4 153.85 49.24 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.041 0.448 . . . . 9.2400000000000002 111.396 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.442 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 11.0 m170 -119.16 -45.67 2.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.923 -1.14 . . . . 12.779999999999999 107.923 169.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--O 1.247 0.96 0 CA-C-N 114.492 -1.231 . . . . 14.109999999999999 108.046 166.001 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.92 -0.4 . . . . 50.460000000000001 109.92 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.79 43.51 1.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.649 -0.786 . . . . 47.990000000000002 112.961 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.615 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.2 tm0? -164.59 -53.94 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.39 -0.338 . . . . 46.439999999999998 110.672 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.66 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 87.1 Cg_exo -48.33 -50.63 11.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.213 1.942 . . . . 45.219999999999999 113.994 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 10.8 Cg_exo -71.83 124.62 10.32 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.679 1.586 . . . . 44.450000000000003 111.345 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.95 146.51 45.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.782 0.325 . . . . 42.710000000000001 110.998 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.702 ' HG3' ' H ' ' A' ' 9' ' ' ALA . 9.9 tp10 -106.95 146.54 30.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 41.5 109.64 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.73 -7.58 49.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.28 -0.418 . . . . 40.329999999999998 110.868 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.702 ' H ' ' HG3' ' A' ' 7' ' ' GLU . . . -75.67 -28.96 58.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.167 -0.469 . . . . 39.390000000000001 110.818 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 63.11 93.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.517 -0.765 . . . . 38.82 111.745 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -169.84 79.01 0.65 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.417 -0.811 . . . . 38.350000000000001 110.296 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -88.01 -179.43 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.724 2.283 . . . . 37.039999999999999 112.13 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.87 129.38 10.77 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.64 -0.791 . . . . 35.659999999999997 111.975 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.7 116.59 29.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.696 0.284 . . . . 35.149999999999999 110.957 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.91 176.93 7.82 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.952 -0.388 . . . . 34.170000000000002 109.952 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 62.54 82.57 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.566 0.698 . . . . 32.950000000000003 110.457 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -131.25 156.53 45.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.492 -0.776 . . . . 32.299999999999997 109.82 -176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.03 78.45 8.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.755 0.788 . . . . 31.239999999999998 110.235 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -139.63 147.91 41.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.98 -1.009 . . . . 31.57 109.686 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.8 mt -71.65 103.69 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.292 -0.413 . . . . 30.100000000000001 110.143 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 24' ' ' GLU . . . -76.07 71.0 2.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.161 0.505 . . . . 28.399999999999999 111.049 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.75 -36.65 15.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.851 -0.613 . . . . 26.969999999999999 110.978 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.6 mtp -120.52 15.26 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.016 0.436 . . . . 27.66 110.768 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.592 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 34.8 mt-10 -138.78 117.11 9.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 24.41 110.663 175.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.12 159.21 26.85 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.503 2.135 . . . . 22.399999999999999 111.083 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.01 142.28 56.96 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.56 -0.291 . . . . 20.670000000000002 110.747 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.17 112.41 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.937 2.425 . . . . 18.75 112.232 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.34 147.18 68.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.853 -0.612 . . . . 14.960000000000001 110.561 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.83 128.76 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.587 2.191 . . . . 14.550000000000001 112.137 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.647 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -94.42 -51.49 0.25 Allowed Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.231 -0.44 . . . . 10.949999999999999 111.565 177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 5.2 Cg_exo -75.03 104.27 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.841 1.694 . . . . 10.6 111.665 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.468 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . . . -69.02 147.3 97.7 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.494 . . . . 6.1100000000000003 110.267 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.63 -2.36 12.57 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.537 2.158 . . . . 5.3600000000000003 112.864 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.29 150.9 51.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 4.1299999999999999 110.146 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.93 130.98 35.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.595 . . . . 2.4500000000000002 111.449 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.533 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.3 m0 -84.12 -168.93 2.35 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.392 0.615 . . . . 0.53000000000000003 110.634 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.6 tp -83.49 115.22 21.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 1.1899999999999999 110.136 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.618 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -78.68 121.97 25.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.187 -0.671 . . . . 2.5099999999999998 109.187 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.622 HG22 HD12 ' A' ' 105' ' ' LEU . 13.5 mt -60.18 -35.91 64.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.188 -0.915 . . . . 1.1499999999999999 110.552 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.454 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 74.3 mt -102.54 -3.42 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.722 -0.672 . . . . 1.4299999999999999 110.565 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.05 27.9 65.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.65000000000000002 111.718 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' H ' HD21 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -111.66 -23.22 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.012 0.745 . . . . 0.94999999999999996 113.012 -175.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.435 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 109.24 30.73 3.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.95 -1.119 . . . . 0.71999999999999997 114.377 168.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -151.77 -9.26 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.985 0.392 . . . . 2.1600000000000001 110.784 175.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.587 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 3.2 tp -119.5 99.47 6.69 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.918 -0.583 . . . . 1.1200000000000001 109.975 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -139.14 136.58 35.28 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.014 -0.675 . . . . 1.49 112.065 -171.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 112' ' ' ALA . 11.2 ttpt -112.52 124.52 52.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.217 -0.447 . . . . 1.1200000000000001 110.361 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 28.9 ttpp -112.88 117.46 32.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.87 0.367 . . . . 1.6499999999999999 110.524 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.9 p -73.62 106.45 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.275 -0.421 . . . . 1.03 111.285 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD13 ' HG3' ' A' ' 141' ' ' GLU . 12.0 mt -68.66 -52.13 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.798 -1.556 . . . . 1.0600000000000001 106.798 170.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.874 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 93.0 t -131.37 135.42 27.02 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 113.143 -1.844 . . . . 1.1399999999999999 106.071 168.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -108.77 54.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.946 2.431 . . . . 0.56000000000000005 113.834 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.593 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 79.31 157.9 12.94 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.853 -0.612 . . . . 0.55000000000000004 113.319 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 18.8 Cg_exo -67.11 163.14 35.25 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.535 2.156 . . . . 1.9099999999999999 109.945 170.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.07 -11.46 10.19 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.561 2.174 . . . . 2.5299999999999998 112.965 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -126.66 53.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.168 -0.539 . . . . 1.4199999999999999 112.016 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 9.3 p -84.81 -172.28 4.09 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.507 0.67 . . . . 1.3600000000000001 111.439 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 23.0 t -159.09 130.67 6.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.936 -1.135 . . . . 1.8200000000000001 107.936 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 83.8 mtt180 -90.44 112.85 55.17 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 120.918 -0.313 . . . . 3.3900000000000001 110.313 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HG3' HD23 ' A' ' 144' ' ' LEU . 6.2 Cg_endo -47.3 152.99 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.831 3.021 . . . . 0.42999999999999999 114.142 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 11.4 t -102.67 151.56 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.211 -0.904 . . . . 1.47 109.774 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 62.7 mttt -64.24 108.78 1.67 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.02 0.914 . . . . 1.71 110.792 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.3 -31.5 2.34 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.772 -1.558 . . . . 0.41999999999999998 110.125 -174.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.643 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -71.89 140.19 49.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.21 0.529 . . . . 0.58999999999999997 109.89 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG22 ' A' ' 148' ' ' VAL . 65.4 t -84.68 119.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.598 -0.89 . . . . 1.8600000000000001 108.598 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.2 m -124.54 147.97 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.11 0.411 . . . . 1.0700000000000001 112.11 -170.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.506 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 30.0 p -102.26 116.52 32.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.923 -0.58 . . . . 1.0600000000000001 110.39 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.735 HG22 HD23 ' A' ' 99' ' ' LEU . 17.1 m -111.18 144.94 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.111 0.481 . . . . 1.05 110.06 172.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.604 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.9 t-160 -102.11 120.38 40.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.909 -1.515 . . . . 0.28999999999999998 106.909 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.553 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.9 OUTLIER -125.36 135.11 52.1 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 119.426 -0.91 . . . . 1.1299999999999999 110.474 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.854 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -127.52 114.97 18.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.902 -1.888 . . . . 0.27000000000000002 105.902 169.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.603 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 22.8 m -110.63 122.38 47.65 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.409 -1.268 . . . . 1.04 111.53 -165.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.969 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.7 OUTLIER -104.65 171.16 7.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.317 -0.856 . . . . 1.54 108.851 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.441 ' HG ' HG13 ' A' ' 80' ' ' VAL . 11.4 mt -97.53 167.46 10.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.537 -0.756 . . . . 1.51 109.936 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.62 -17.64 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.313 0.383 . . . . 1.1399999999999999 111.236 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.32 -14.64 20.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.674 0.273 . . . . 2.1400000000000001 110.921 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.08 7.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.637 -0.792 . . . . 0.51000000000000001 113.651 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 m -63.26 112.06 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.228 0.455 . . . . 1.1599999999999999 112.228 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.809 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.9 mtt180 -74.28 118.23 17.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.847 0.832 . . . . 0.54000000000000004 110.571 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.888 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.1 m -96.68 -9.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.452 -1.249 . . . . 1.0600000000000001 110.928 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.603 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.1 pt20 -166.55 146.76 5.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.606 -0.724 . . . . 0.63 109.753 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 15.2 tt0 -150.96 103.29 3.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.173 -1.047 . . . . 1.3400000000000001 108.173 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 4.7 mm-40 -126.72 113.81 22.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.541 -0.754 . . . . 2.5899999999999999 110.308 -170.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 37.7 Cg_endo -65.7 -12.32 34.64 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.014 2.476 . . . . 0.90000000000000002 112.982 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.628 ' CD ' ' HZ1' ' A' ' 145' ' ' LYS . 2.5 tp10 -151.94 112.02 4.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.366 0.603 . . . . 1.3700000000000001 110.724 -175.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' A' ' 68' ' ' VAL . 50.8 tp -130.11 106.99 8.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.835 -1.075 . . . . 1.1399999999999999 108.287 172.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.9 p -108.36 138.08 36.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.148 -0.478 . . . . 1.5900000000000001 109.825 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 30.1 p90 -160.97 166.54 28.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.25 110.868 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.1 m -86.0 115.07 23.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 1.0700000000000001 109.633 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.809 HD12 ' HD3' ' A' ' 104' ' ' PRO . 14.4 tp -60.54 126.64 28.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 1.3300000000000001 110.396 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 91.18 6.66 66.42 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.691 -0.766 . . . . 0.37 112.976 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.11 -8.62 21.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.93000000000000005 109.978 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.7 m 58.15 36.9 26.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 1.55 109.342 -172.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 22.1 t70 -70.75 -17.61 62.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.538 1.161 . . . . 1.3300000000000001 108.044 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.7 m -119.19 -154.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.323 -1.762 . . . . 1.0800000000000001 110.353 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.62 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.8 pt -83.0 138.81 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.647 -1.242 . . . . 1.0600000000000001 107.647 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.483 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 6.5 tp60 -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.904 -0.318 . . . . 0.40000000000000002 110.898 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.14 -42.25 72.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 1.0800000000000001 110.627 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.735 HD23 HG22 ' A' ' 68' ' ' VAL . 56.5 tp -75.72 -40.78 55.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.729 -0.668 . . . . 1.0700000000000001 110.551 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.441 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.9 t70 -61.14 -28.53 69.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.046 -0.979 . . . . 0.26000000000000001 109.883 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 76.1 mt -90.13 -36.59 14.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.006 -0.997 . . . . 1.0600000000000001 111.893 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.1 t -67.96 -28.18 67.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.751 -0.204 . . . . 1.53 111.275 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 99' ' ' LEU . 55.0 t -65.87 -55.8 20.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.401 0.519 . . . . 1.0600000000000001 112.401 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.809 ' HD3' HD12 ' A' ' 90' ' ' LEU . 22.1 Cg_endo -63.43 -18.77 66.07 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 121.998 1.799 . . . . 0.40999999999999998 111.906 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.622 HD12 HG22 ' A' ' 39' ' ' ILE . 13.1 mt -84.32 -14.21 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 1.3500000000000001 111.239 173.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.814 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 1.1 ttp -105.84 141.15 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.239 -0.437 . . . . 1.3100000000000001 110.934 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 m-20 -79.01 152.48 30.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.867 0.365 . . . . 0.96999999999999997 110.067 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -65.58 126.29 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.653 0.74 . . . . 1.47 109.789 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.81 10.71 56.23 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.117 -0.947 . . . . 0.28000000000000003 112.143 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.874 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.38 170.36 7.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.357 0.599 . . . . 0.40999999999999998 110.58 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.599 HG21 ' HG1' ' A' ' 143' ' ' THR . 10.3 m -133.19 119.25 19.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.473 -0.936 . . . . 1.0700000000000001 108.473 176.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . . . -117.1 139.65 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.663 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.5 ttt -97.8 117.09 31.34 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.654 -1.239 . . . . 1.9399999999999999 107.654 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.64 130.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.833 -0.622 . . . . 1.0600000000000001 109.359 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.511 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 91.8 m -107.16 114.09 27.93 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.38 -0.97 . . . . 1.03 108.38 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -123.12 135.43 54.36 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.0 -1.455 . . . . 1.01 109.651 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.7 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.1 t70 -55.71 148.86 15.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.767 -0.827 . . . . 0.57999999999999996 108.767 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.662 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -57.5 -27.21 62.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.376 0.608 . . . . 1.04 110.132 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.7 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 18.6 ptpt -55.26 -31.78 61.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.242 -0.435 . . . . 1.4299999999999999 111.167 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.62 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 95.9 m-85 -100.84 10.77 40.72 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 1.04 109.902 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.662 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 71.0 m -125.92 -93.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.87 110.521 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 6.8 m-85 -141.45 41.82 1.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.369 -0.532 . . . . 0.95999999999999996 112.076 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.709 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.72 -84.81 0.03 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.143 -0.551 . . . . 0.25 113.67 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.67 8.49 4.22 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.551 2.167 . . . . 0.90000000000000002 111.088 175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.6 mt-30 -104.13 -47.15 4.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.65000000000000002 110.216 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.76 144.18 2.12 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.873 -1.058 . . . . 0.29999999999999999 112.094 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.655 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 10.9 t -91.61 157.63 16.88 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.294 -0.453 . . . . 0.90000000000000002 111.461 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.502 ' NH2' ' HG3' ' A' ' 83' ' ' GLU . 21.0 ptt180 -57.0 -43.1 81.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.613 -0.721 . . . . 3.6099999999999999 112.102 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.629 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -80.38 -68.87 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.333 -0.547 . . . . 1.52 110.354 175.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.888 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -106.3 129.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.857 2.371 . . . . 0.44 112.145 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.577 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 33.6 t80 -55.17 99.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.135 -1.061 . . . . 1.6899999999999999 108.135 163.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.1 mm -65.92 131.79 94.62 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 115.953 -0.567 . . . . 1.0600000000000001 110.285 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.61 138.46 40.12 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.845 2.363 . . . . 1.03 111.908 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.709 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.9 Cg_endo -64.53 135.75 47.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.175 1.917 . . . . 0.89000000000000001 112.125 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.559 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 48.6 m-70 71.71 5.66 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.239 -0.891 . . . . 3.1899999999999999 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.02 125.63 28.08 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.595 -0.521 . . . . 1.04 109.595 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.93 113.72 11.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.393 -0.523 . . . . 1.05 110.181 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.608 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.23 133.0 34.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.515 -0.766 . . . . 1.0600000000000001 111.07 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.969 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 31.6 p -116.93 100.01 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.371 1.081 . . . . 1.8200000000000001 110.05 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 72' ' ' THR . 0.4 OUTLIER -115.17 137.71 51.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.886 -1.052 . . . . 1.1499999999999999 111.632 -172.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.854 ' HB3' HE22 ' A' ' 71' ' ' GLN . 26.4 tt0 -103.36 114.58 28.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.05 108.305 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.635 HG12 HD12 ' A' ' 99' ' ' LEU . 2.5 m -111.79 119.48 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.421 0.629 . . . . 1.0800000000000001 112.2 -174.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.599 ' HG1' HG21 ' A' ' 111' ' ' THR . 6.3 m -95.11 113.02 24.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.271 -0.877 . . . . 1.0900000000000001 110.156 174.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' A' ' 60' ' ' PRO . 60.4 tp -84.33 98.75 10.19 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.859 -0.793 . . . . 1.0700000000000001 108.859 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.628 ' HZ1' ' CD ' ' A' ' 85' ' ' GLU . 26.7 mtmt -97.75 -26.12 14.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.159 -0.928 . . . . 1.6899999999999999 111.253 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.506 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 23.9 m -153.63 150.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.901 0.381 . . . . 1.1200000000000001 111.773 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.504 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -143.78 128.3 18.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.659 -0.701 . . . . 0.98999999999999999 109.406 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.1 m -126.22 138.23 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 1.6200000000000001 110.344 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.565 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 9.5 t70 -86.9 121.32 29.22 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.806 -0.357 . . . . 2.27 110.218 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.74 14.12 0.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.031 0.443 . . . . 2.5 110.23 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.16 146.44 52.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 2.1400000000000001 110.354 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -75.94 110.24 10.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 6.6299999999999999 110.147 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -90.94 -61.97 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 8.1899999999999995 110.285 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -153.69 115.74 4.31 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.859 -0.336 . . . . 9.0800000000000001 110.743 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -90.61 107.08 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 9.2400000000000002 110.023 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -76.18 145.16 40.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.755 0.312 . . . . 12.779999999999999 110.695 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.384 -0.817 . . . . 14.109999999999999 109.597 175.109 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.889 0.376 . . . . 50.460000000000001 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.51 -156.58 10.45 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.918 -0.658 . . . . 47.990000000000002 112.913 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -121.52 93.97 48.63 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.576 -0.528 . . . . 46.439999999999998 109.576 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.644 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 31.5 Cg_exo -57.97 -56.98 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.587 2.191 . . . . 45.219999999999999 113.906 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 87.5 Cg_endo -85.96 132.72 4.03 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.648 1.565 . . . . 44.450000000000003 113.065 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.95 5.72 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.626 0.727 . . . . 42.710000000000001 109.921 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.8 54.27 3.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.282 -0.872 . . . . 41.5 109.731 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.73 -5.76 49.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.773 -0.649 . . . . 40.329999999999998 112.086 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.36 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.594 -0.276 . . . . 39.390000000000001 111.338 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 74.53 -55.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.648 0.779 . . . . 38.82 110.352 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -138.95 96.53 9.16 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.663 -0.699 . . . . 38.350000000000001 109.507 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.54 176.92 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.392 2.728 . . . . 37.039999999999999 113.029 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.94 -175.46 22.61 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.122 -0.791 . . . . 35.659999999999997 111.122 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.26 -3.41 19.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.821 0.31 . . . . 35.149999999999999 110.197 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.9 mt 59.13 72.69 0.52 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.439 -0.801 . . . . 34.170000000000002 110.639 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.41 -38.21 7.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.322 -0.853 . . . . 32.950000000000003 110.447 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 59.41 83.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.951 0.782 . . . . 32.299999999999997 111.487 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -79.9 54.48 1.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.26 -0.427 . . . . 31.239999999999998 110.28 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -64.84 -38.72 91.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 31.57 110.72 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.3 tp -170.76 46.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.338 0.589 . . . . 30.100000000000001 109.842 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.34 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 28.399999999999999 110.247 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 71.06 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.201 0.938 . . . . 26.969999999999999 112.505 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.5 mmt -102.78 15.36 29.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 27.66 110.148 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 53.0 tt0 -103.78 125.73 33.85 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-N 115.476 -0.783 . . . . 24.41 109.541 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 9.3 Cg_endo -51.96 154.32 10.4 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 124.38 3.387 . . . . 22.399999999999999 112.638 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 81.8 mm-40 -53.12 141.49 39.92 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 116.033 -0.531 . . . . 20.670000000000002 110.238 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 11.4 Cg_exo -69.21 85.72 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.61 2.207 . . . . 18.75 112.276 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.84 93.6 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.384 -0.825 . . . . 14.960000000000001 109.127 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.06 127.4 14.89 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.706 2.271 . . . . 14.550000000000001 113.11 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.95 77.88 55.41 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.502 -0.772 . . . . 10.949999999999999 109.622 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 103.86 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.864 2.376 . . . . 10.6 111.684 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.68 61.53 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.579 -0.526 . . . . 6.1100000000000003 109.579 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.98 -10.3 21.19 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.658 2.239 . . . . 5.3600000000000003 112.874 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' HA ' ' HE1' ' A' ' 36' ' ' TRP . 35.8 mm-40 -95.69 5.82 50.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.435 . . . . 4.1299999999999999 111.742 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -98.29 84.41 3.23 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.081 -0.711 . . . . 2.4500000000000002 109.081 167.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.578 ' NE1' ' HE2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -83.71 -172.33 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.53000000000000003 110.76 -173.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.02 111.39 5.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.084 -0.962 . . . . 1.1899999999999999 110.551 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.661 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.1 t70 -73.18 125.55 27.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.367 -0.533 . . . . 2.5099999999999998 110.083 173.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.603 HG22 HD11 ' A' ' 105' ' ' LEU . 7.7 mt -56.3 -32.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.808 -1.087 . . . . 1.1499999999999999 111.656 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.32 -1.73 13.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.101 -0.499 . . . . 1.4299999999999999 110.32 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.661 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.98 26.61 65.81 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.169 -0.772 . . . . 0.65000000000000002 111.169 -172.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' OD1' HD22 ' A' ' 44' ' ' LEU . 1.1 p30 -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.366 -0.417 . . . . 0.94999999999999996 110.583 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.8 -4.15 21.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.939 -0.648 . . . . 0.71999999999999997 112.988 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 4.2 mm? -112.19 -27.41 8.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.869 0.322 . . . . 2.1600000000000001 111.869 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 39' ' ' ILE . 16.9 tp -120.62 100.66 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.3 -0.409 . . . . 1.1200000000000001 110.74 -170.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 89.7 mtm180 -133.18 141.44 48.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.6 0.222 . . . . 1.49 111.6 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.0 ttpt -114.09 123.8 50.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 110.244 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.578 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 18.2 ttmt -103.58 118.96 37.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.983 -0.377 . . . . 1.6499999999999999 109.983 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 52' ' ' PRO . 1.3 p -76.02 96.74 3.86 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.989 -0.55 . . . . 1.03 110.5 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 111' ' ' THR . 12.5 mt -63.66 -52.93 58.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.893 -1.521 . . . . 1.0600000000000001 106.893 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.882 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 85.1 t -132.84 127.1 20.15 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-N 113.038 -1.892 . . . . 1.1399999999999999 106.157 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 30.4 Cg_endo -106.66 56.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.956 2.437 . . . . 0.56000000000000005 114.502 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 82.58 129.44 1.31 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.118 -0.563 . . . . 0.55000000000000004 113.201 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 127.85 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.041 1.828 . . . . 1.9099999999999999 110.306 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -37.58 118.41 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.631 2.887 . . . . 2.5299999999999998 113.453 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.74 17.06 10.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.486 -0.779 . . . . 1.4199999999999999 111.919 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 p -80.96 -171.05 3.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.292 0.568 . . . . 1.3600000000000001 111.26 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -153.86 144.35 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.786 -0.82 . . . . 1.8200000000000001 108.786 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.472 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 48.1 mtm180 -92.51 110.1 42.77 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.846 -0.428 . . . . 3.3900000000000001 109.846 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.728 ' HD3' HG22 ' A' ' 108' ' ' VAL . 5.8 Cg_endo -47.36 141.21 14.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.353 2.702 . . . . 0.42999999999999999 113.529 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.675 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.0 t -89.56 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.432 -0.804 . . . . 1.47 109.435 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.721 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 56.1 mttt -63.38 106.17 0.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.838 0.828 . . . . 1.71 110.85 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.89 -28.85 2.12 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.145 -1.388 . . . . 0.41999999999999998 110.199 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.675 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -79.28 128.0 32.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.859 -0.793 . . . . 0.58999999999999997 108.859 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.8 m -78.32 129.79 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.055 -1.091 . . . . 1.8600000000000001 108.055 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.9 m -125.99 146.65 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.997 -0.547 . . . . 1.0700000000000001 110.284 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.9 p -95.94 112.31 24.07 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.897 -0.592 . . . . 1.0600000000000001 109.825 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.678 HG21 HD22 ' A' ' 99' ' ' LEU . 7.4 m -110.5 142.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.849 -0.614 . . . . 1.05 110.074 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -100.76 116.42 32.61 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.721 -1.585 . . . . 0.28999999999999998 106.721 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.402 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.8 OUTLIER -117.79 136.94 53.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.285 1.041 . . . . 1.1299999999999999 111.336 178.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.08 113.3 12.6 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.003 -1.851 . . . . 0.27000000000000002 106.003 165.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.582 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.1 m -101.37 127.18 48.12 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.743 -1.117 . . . . 1.04 111.29 -168.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 17.1 t -104.89 160.46 14.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.309 -0.86 . . . . 1.54 109.626 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HG ' HG11 ' A' ' 80' ' ' VAL . 13.7 mt -89.64 166.06 13.85 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.521 -0.763 . . . . 1.51 109.795 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.26 -17.84 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.578 0.549 . . . . 1.1399999999999999 110.743 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -92.61 -8.68 43.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.641 -0.709 . . . . 2.1400000000000001 111.162 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.38 40.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.838 -0.696 . . . . 0.51000000000000001 111.855 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 m -98.17 109.91 22.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.878 0.371 . . . . 1.1599999999999999 111.469 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.7 mtt180 -76.04 116.42 16.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.54000000000000004 110.539 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.736 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -101.98 -8.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.561 -1.2 . . . . 1.0600000000000001 111.886 -168.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.582 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.2 pt20 -160.57 136.13 8.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.107 -0.497 . . . . 0.63 109.983 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -136.41 112.65 9.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.008 0.433 . . . . 1.3400000000000001 110.283 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.0 115.51 15.41 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.436 0.636 . . . . 2.5899999999999999 110.221 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 55.9 Cg_endo -71.05 -13.26 31.31 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.201 2.601 . . . . 0.90000000000000002 113.637 -172.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -160.16 110.41 1.84 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.292 1.044 . . . . 1.3700000000000001 111.571 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.497 ' HB3' HG22 ' A' ' 68' ' ' VAL . 21.1 tp -119.62 100.59 7.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.126 -1.852 . . . . 1.1399999999999999 108.756 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 10.7 p -95.73 132.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.275 -0.639 . . . . 1.5900000000000001 109.275 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.0 p90 -153.47 158.43 41.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.612 -0.267 . . . . 0.25 110.445 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.482 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 5.6 m -79.04 113.65 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.05 -0.523 . . . . 1.0700000000000001 109.788 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.785 HD12 ' HD3' ' A' ' 104' ' ' PRO . 16.4 tp -61.76 130.27 44.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.455 . . . . 1.3300000000000001 109.921 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.721 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 83.51 6.35 87.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.37 111.947 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 32.3 t70 -100.12 -5.62 27.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.12 -0.696 . . . . 0.93000000000000005 109.12 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.8 m 54.9 34.09 21.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.125 -0.943 . . . . 1.55 109.839 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.74 -9.13 58.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.445 1.117 . . . . 1.3300000000000001 108.765 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.3 m -125.26 -159.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 113.531 -1.668 . . . . 1.0800000000000001 110.711 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.5 pt -81.62 138.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.088 -1.449 . . . . 1.0600000000000001 107.088 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.548 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.6 tp60 -60.74 -28.68 68.87 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.835 -0.346 . . . . 0.40000000000000002 110.899 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.07 -37.32 69.14 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.079 0.466 . . . . 1.0800000000000001 110.679 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.678 HD22 HG21 ' A' ' 68' ' ' VAL . 52.7 tp -81.84 -40.65 22.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.637 . . . . 1.0700000000000001 110.719 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' HE21 ' A' ' 97' ' ' GLN . 14.3 t70 -61.93 -27.91 69.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.434 -0.803 . . . . 0.26000000000000001 109.886 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 66.3 mt -90.97 -36.54 14.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.335 -0.848 . . . . 1.0600000000000001 112.355 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.521 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 p -72.03 -26.46 62.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.63 -0.428 . . . . 1.53 111.189 -173.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' LEU . 54.5 t -64.6 -55.74 27.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.457 0.539 . . . . 1.0600000000000001 112.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.785 ' HD3' HD12 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -61.09 -24.44 79.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.071 1.847 . . . . 0.40999999999999998 112.007 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.603 HD11 HG22 ' A' ' 39' ' ' ILE . 17.0 mt -73.1 -30.84 63.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.152 -0.477 . . . . 1.3500000000000001 111.155 172.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.807 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -92.07 152.72 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 1.3100000000000001 111.425 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.52 151.89 21.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.002 0.43 . . . . 0.96999999999999997 110.642 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.728 HG22 ' HD3' ' A' ' 60' ' ' PRO . 2.5 t -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.33 0.586 . . . . 1.47 110.337 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.63 43.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.362 -0.835 . . . . 0.28000000000000003 112.548 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.882 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.4 168.18 9.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.407 0.622 . . . . 0.40999999999999998 110.971 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.446 HG21 HD11 ' A' ' 50' ' ' LEU . 20.9 m -130.63 117.44 19.51 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.175 -1.046 . . . . 1.0700000000000001 108.175 174.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.35 138.27 53.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.032 0.444 . . . . 1.0 110.684 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.2 ttp -98.42 116.82 31.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.9399999999999999 107.216 173.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.651 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.9 t -112.25 132.04 62.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.661 -0.496 . . . . 1.0600000000000001 109.661 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.542 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 91.4 m -109.39 112.87 25.25 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.175 -1.046 . . . . 1.03 108.175 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.46 135.69 54.73 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.925 -1.489 . . . . 1.01 108.946 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.729 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.9 t70 -52.94 146.54 10.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.397 -0.964 . . . . 0.57999999999999996 108.397 172.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.64 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.6 t -55.94 -26.07 46.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.071 0.463 . . . . 1.04 110.439 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.687 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.5 ptpt -54.87 -29.75 56.28 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.103 -0.373 . . . . 1.4299999999999999 111.833 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.576 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.1 m-85 -97.15 2.31 50.95 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.042 0.448 . . . . 1.04 109.989 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 64.6 m -122.72 -89.91 0.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.141 -0.936 . . . . 0.87 110.665 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.4 m-85 -141.29 41.08 1.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.103 -0.475 . . . . 0.95999999999999996 112.176 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.94 -81.82 0.04 OUTLIER Glycine 0 C--N 1.343 0.943 0 N-CA-C 113.995 0.358 . . . . 0.25 113.995 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.98 15.46 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.525 2.15 . . . . 0.90000000000000002 110.924 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.7 mt-30 -103.51 -48.63 3.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.65000000000000002 110.071 -174.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.462 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.12 142.81 3.5 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 114.668 -1.151 . . . . 0.29999999999999999 112.051 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 14.1 t -90.68 165.03 13.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.577 0.584 . . . . 0.90000000000000002 112.577 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -62.36 -23.28 66.71 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 115.114 -0.948 . . . . 3.6099999999999999 112.728 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 1.044 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 18.3 t -105.51 -66.54 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.005 -0.739 . . . . 1.52 109.005 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.044 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 5.4 Cg_endo -99.07 129.63 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.937 2.425 . . . . 0.44 111.922 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.462 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -56.25 98.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.615 -1.254 . . . . 1.6899999999999999 107.615 158.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.642 HD11 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -65.22 130.44 94.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.317 -0.994 . . . . 1.0600000000000001 108.317 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.26 147.71 34.93 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.642 2.228 . . . . 1.03 112.587 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.71 137.93 83.14 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.473 2.115 . . . . 0.89000000000000001 113.105 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.729 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 10.9 p80 53.04 21.45 2.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.665 -1.152 . . . . 3.1899999999999999 113.342 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.632 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.78 132.88 40.72 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.983 -0.747 . . . . 1.04 108.983 172.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.9 113.82 12.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.141 0.496 . . . . 1.05 110.635 -171.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 115' ' ' THR . 1.3 tp -92.07 133.5 35.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.902 -0.59 . . . . 1.0600000000000001 110.516 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.4 t -118.53 100.69 7.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.334 -0.617 . . . . 1.8200000000000001 109.334 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HB3' HG21 ' A' ' 72' ' ' THR . 1.5 pp -112.53 136.55 51.92 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.868 -0.606 . . . . 1.1499999999999999 111.578 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.5 tt0 -105.0 114.49 28.72 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.481 -0.562 . . . . 1.05 109.481 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.621 HG13 HD11 ' A' ' 99' ' ' LEU . 3.6 m -115.76 119.87 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.013 0.745 . . . . 1.0800000000000001 113.013 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 4.1 m -90.46 111.71 23.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 1.0900000000000001 110.754 170.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.647 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.1 tp -84.1 93.87 8.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.6 -0.889 . . . . 1.0700000000000001 108.6 172.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.1 mtmt -88.1 -33.94 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.095 -0.957 . . . . 1.6899999999999999 110.547 -171.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.453 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.1 m -149.68 154.41 38.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.259 -0.428 . . . . 1.1200000000000001 111.729 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -137.95 128.26 26.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.299 -0.63 . . . . 0.98999999999999999 109.299 172.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.85 111.56 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.58 -0.526 . . . . 1.6200000000000001 109.58 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.16 114.82 25.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.471 0.653 . . . . 2.27 109.658 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -140.42 -8.51 1.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.515 -0.766 . . . . 2.5 111.079 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.18 -57.79 2.18 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.978 -1.01 . . . . 2.1400000000000001 109.813 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 65.46 -93.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.241 -0.891 . . . . 6.6299999999999999 110.539 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -177.06 115.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.093 -0.706 . . . . 8.1899999999999995 109.093 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -102.66 105.69 16.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.341 0.591 . . . . 9.0800000000000001 111.201 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -80.22 116.84 20.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 9.2400000000000002 111.35 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -136.74 140.99 42.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.911 -0.586 . . . . 12.779999999999999 110.001 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.245 0.83 0 CA-C-O 118.378 -0.82 . . . . 14.109999999999999 109.918 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.081 0.467 . . . . 50.460000000000001 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.67 -139.33 2.71 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.337 -0.935 . . . . 47.990000000000002 112.956 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 65.16 94.36 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.466 0.651 . . . . 46.439999999999998 110.417 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.928 2.419 . . . . 45.219999999999999 111.919 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.27 130.09 27.64 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.66 2.24 . . . . 44.450000000000003 112.364 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.8 166.13 11.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.195 -0.457 . . . . 42.710000000000001 110.609 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 67.95 120.44 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 O-C-N 124.024 0.828 . . . . 41.5 111.472 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.54 -17.59 64.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.062 -0.972 . . . . 40.329999999999998 111.615 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.83 42.87 15.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.151 0.5 . . . . 39.390000000000001 110.089 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -59.03 -39.23 81.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.194 -0.912 . . . . 38.82 110.732 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.6 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 78.7 mt-30 -110.89 94.15 19.39 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.473 . . . . 38.350000000000001 110.12 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 10' ' ' GLU . 13.7 Cg_exo -70.22 -28.85 22.51 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.676 2.25 . . . . 37.039999999999999 111.997 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.1 -82.47 0.76 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.8 -0.636 . . . . 35.659999999999997 112.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -178.81 -65.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.046 0.539 . . . . 35.149999999999999 109.642 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tt -163.79 -54.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 34.170000000000002 109.403 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.1 -94.6 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 32.950000000000003 110.543 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 58.23 20.82 7.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.752 0.421 . . . . 32.299999999999997 111.541 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -85.27 -20.16 30.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 31.239999999999998 110.036 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' HD2' ' HB1' ' A' ' 22' ' ' ALA . 16.3 t80 71.55 169.9 0.32 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.871 -1.059 . . . . 31.57 110.09 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -82.93 96.76 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.114 -0.328 . . . . 30.100000000000001 110.114 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.68 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.539 -0.755 . . . . 28.399999999999999 110.536 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB1' ' HD2' ' A' ' 19' ' ' PHE . . . 51.47 -143.16 0.67 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.329 0.393 . . . . 26.969999999999999 111.323 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.485 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 65.0 mtt 72.38 -21.47 0.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.563 0.745 . . . . 27.66 112.385 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 22' ' ' ALA . 67.8 mm-40 -90.34 108.07 24.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.929 -0.397 . . . . 24.41 109.929 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 23' ' ' MET . 45.5 Cg_endo -98.0 100.69 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.389 2.726 . . . . 22.399999999999999 112.462 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 12.9 pt-20 -81.37 127.27 74.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.882 0.372 . . . . 20.670000000000002 110.192 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 2.8 Cg_exo -75.72 97.13 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.735 2.29 . . . . 18.75 111.637 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.3 111.0 53.57 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.631 -0.507 . . . . 14.960000000000001 109.631 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.17 126.67 23.14 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.693 2.262 . . . . 14.550000000000001 112.515 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.32 75.92 19.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.271 -0.877 . . . . 10.949999999999999 109.448 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.29 130.05 24.4 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.802 2.335 . . . . 10.6 111.933 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.8 124.25 75.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.41 -0.589 . . . . 6.1100000000000003 109.41 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.87 -36.77 59.18 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.541 2.161 . . . . 5.3600000000000003 112.73 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -103.09 -29.54 11.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.126 0.489 . . . . 4.1299999999999999 111.108 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.33 97.39 11.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 2.4500000000000002 110.51 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.673 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 -84.08 -164.72 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.274 -0.639 . . . . 0.53000000000000003 109.274 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.9 tp -73.31 110.61 7.73 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.672 -0.492 . . . . 1.1899999999999999 109.672 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -75.24 124.59 27.33 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.003 -0.74 . . . . 2.5099999999999998 109.003 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.561 HD12 HD12 ' A' ' 45' ' ' LEU . 14.4 mt -58.86 -31.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.872 -1.058 . . . . 1.1499999999999999 110.559 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.5 mt -116.13 -4.79 11.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.615 -0.72 . . . . 1.4299999999999999 110.64 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.85 23.31 72.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.057 -0.817 . . . . 0.65000000000000002 111.057 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.42 -15.57 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.482 0.549 . . . . 0.94999999999999996 112.482 -174.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.427 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 114.39 -13.79 20.92 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.575 -0.821 . . . . 0.71999999999999997 114.031 166.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -129.22 -2.21 5.06 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.057 0.762 . . . . 2.1600000000000001 113.057 -173.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.561 HD12 HD12 ' A' ' 39' ' ' ILE . 21.3 tp -122.34 100.25 6.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.008 -0.368 . . . . 1.1200000000000001 110.008 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -136.09 139.32 42.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.308 0.484 . . . . 1.49 112.308 -170.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HG3' HG21 ' A' ' 114' ' ' VAL . 12.8 ttpt -110.97 123.56 50.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.36 -0.382 . . . . 1.1200000000000001 110.004 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.673 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -108.3 125.86 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.571 0.224 . . . . 1.6499999999999999 110.603 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 p -81.93 103.1 11.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.159 0.504 . . . . 1.03 111.331 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 111' ' ' THR . 9.8 mt -69.47 -50.05 49.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.828 -1.545 . . . . 1.0600000000000001 106.828 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.845 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.0 t -140.04 126.14 11.93 Favored Pre-proline 0 CA--C 1.501 -0.907 0 CA-C-N 112.891 -1.959 . . . . 1.1399999999999999 106.688 170.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.4 Cg_endo -105.79 59.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.945 2.43 . . . . 0.56000000000000005 113.27 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.19 160.96 8.68 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.931 -0.577 . . . . 0.55000000000000004 112.762 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.09 175.07 8.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.612 2.208 . . . . 1.9099999999999999 110.779 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.82 75.19 1.26 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.089 1.86 . . . . 2.5299999999999998 112.375 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.71 48.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.954 -0.641 . . . . 1.4199999999999999 113.015 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.492 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -96.14 -163.7 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.832 -0.433 . . . . 1.3600000000000001 109.832 178.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.4 m -150.05 142.58 24.44 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.979 -0.748 . . . . 1.8200000000000001 108.979 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 36.7 mtm180 -90.14 116.45 66.4 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.402 -0.592 . . . . 3.3900000000000001 109.402 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.719 ' HD3' HG22 ' A' ' 108' ' ' VAL . 9.6 Cg_endo -50.86 146.86 20.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.569 2.846 . . . . 0.42999999999999999 112.902 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.578 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.2 t -96.24 151.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 1.47 109.582 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 90' ' ' LEU . 97.2 mttt -62.44 121.45 13.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.61 0.719 . . . . 1.71 109.42 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.45 -25.55 5.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.675 -1.148 . . . . 0.41999999999999998 111.114 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.663 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 134.62 34.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.033 -0.728 . . . . 0.58999999999999997 109.033 178.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 m -82.12 131.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 108.184 -1.043 . . . . 1.8600000000000001 108.184 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 28.1 m -128.04 148.03 32.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.362 -0.836 . . . . 1.0700000000000001 110.412 -171.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.513 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 34.0 p -97.95 112.88 24.64 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.129 0.49 . . . . 1.0600000000000001 110.118 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 86' ' ' LEU . 4.7 m -110.2 144.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.098 0.475 . . . . 1.05 110.246 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.632 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.54 117.4 34.84 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.001 -1.481 . . . . 0.28999999999999998 107.001 170.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.439 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 1.2 pt? -117.91 137.04 53.08 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.146 -1.022 . . . . 1.1299999999999999 111.018 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.625 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.42 114.22 11.94 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.308 -2.108 . . . . 0.27000000000000002 105.308 165.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.597 ' HB ' ' CG ' ' A' ' 81' ' ' GLN . 86.4 m -104.61 127.45 52.36 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.816 -1.083 . . . . 1.04 110.914 -166.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.794 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 4.2 t -105.52 159.94 15.55 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.442 -0.799 . . . . 1.54 109.206 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.404 ' HG ' HG12 ' A' ' 80' ' ' VAL . 13.9 mt -86.67 165.22 16.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 1.51 109.295 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.72 -23.92 54.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 1.1399999999999999 110.169 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -86.28 -4.18 59.12 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.695 -0.684 . . . . 2.1400000000000001 111.655 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.89 6.76 57.93 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.535 -0.84 . . . . 0.51000000000000001 113.392 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 89.2 m -91.52 112.88 24.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.514 0.657 . . . . 1.1599999999999999 111.947 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 32.9 mtt180 -74.76 117.11 16.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.793 0.806 . . . . 0.54000000000000004 110.634 176.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.515 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.8 m -101.86 -9.1 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.438 -1.255 . . . . 1.0600000000000001 112.491 -168.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.597 ' CG ' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -156.34 126.57 6.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.422 -0.354 . . . . 0.63 111.054 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -122.57 121.84 37.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 1.3400000000000001 109.953 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 7.3 tt0 -142.42 114.61 6.23 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.552 . . . . 2.5899999999999999 110.335 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -70.33 -18.68 34.18 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.538 2.826 . . . . 0.90000000000000002 113.063 -172.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.29 108.25 2.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.175 0.988 . . . . 1.3700000000000001 111.662 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.584 ' HB3' HG23 ' A' ' 68' ' ' VAL . 24.0 tp -117.41 106.45 13.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.484 -1.689 . . . . 1.1399999999999999 108.621 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -100.56 132.49 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.898 -0.408 . . . . 1.5900000000000001 109.898 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.4 p90 -156.81 162.99 39.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.336 -0.393 . . . . 0.25 110.534 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -88.92 117.45 27.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.185 -0.461 . . . . 1.0700000000000001 110.295 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.531 HD23 ' HD3' ' A' ' 104' ' ' PRO . 36.8 mt -60.83 136.59 58.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 1.3300000000000001 111.62 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 75.25 12.93 83.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.879 -0.677 . . . . 0.37 111.452 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.48 -3.37 14.44 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.082 -0.71 . . . . 0.93000000000000005 109.082 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.9 m 57.67 35.3 25.5 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.762 -1.108 . . . . 1.55 109.665 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.33 -9.0 58.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.126 0.965 . . . . 1.3300000000000001 108.484 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.7 -158.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.04 -1.436 . . . . 1.0800000000000001 110.747 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.9 pt -80.39 138.63 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 107.519 -1.289 . . . . 1.0600000000000001 107.519 174.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.3 tp60 -59.71 -30.22 68.66 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.052 -0.259 . . . . 0.40000000000000002 111.038 -172.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.82 71.81 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.161 0.505 . . . . 1.0800000000000001 110.484 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.564 ' O ' HG21 ' A' ' 103' ' ' VAL . 45.3 tp -79.55 -42.14 25.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.683 -0.69 . . . . 1.0700000000000001 110.567 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.423 ' HB3' HE21 ' A' ' 97' ' ' GLN . 22.0 t70 -59.64 -30.54 68.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.057 -0.974 . . . . 0.26000000000000001 110.068 -174.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -90.82 -36.07 14.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.197 -0.91 . . . . 1.0600000000000001 112.929 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.518 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 33.8 p -70.93 -29.54 65.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.143 0.496 . . . . 1.53 111.034 -171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 99' ' ' LEU . 80.5 t -64.74 -54.25 37.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.444 -0.798 . . . . 1.0600000000000001 112.957 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.531 ' HD3' HD23 ' A' ' 90' ' ' LEU . 21.2 Cg_endo -63.93 -20.41 68.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.737 1.625 . . . . 0.40999999999999998 111.661 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 39' ' ' ILE . 23.7 mt -78.47 -17.02 56.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.619 . . . . 1.3500000000000001 110.873 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.709 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -100.97 156.6 17.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.988 -0.551 . . . . 1.3100000000000001 110.59 -179.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -95.31 154.2 17.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.96999999999999997 110.817 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.719 HG22 ' HD3' ' A' ' 60' ' ' PRO . 2.4 t -62.43 123.89 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.454 0.645 . . . . 1.47 110.277 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.64 45.48 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.903 -1.044 . . . . 0.28000000000000003 112.754 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.845 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.7 pt-20 -105.14 167.62 9.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.464 0.649 . . . . 0.40999999999999998 111.011 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.439 HG21 HD13 ' A' ' 50' ' ' LEU . 13.7 m -129.16 116.99 20.05 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.974 -1.121 . . . . 1.0700000000000001 107.974 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.424 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . . . -118.32 136.78 53.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.81 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.9 ttm -98.34 117.14 32.07 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.22 -1.4 . . . . 1.9399999999999999 107.22 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.516 HG21 ' HG3' ' A' ' 47' ' ' LYS . 11.4 t -112.96 128.45 69.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.007 -0.368 . . . . 1.0600000000000001 110.007 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.522 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 73.8 m -107.45 112.6 25.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.401 -0.92 . . . . 1.03 108.759 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.441 ' HB1' ' SG ' ' A' ' 121' ' ' CYS . . . -121.67 134.32 54.97 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.944 -1.48 . . . . 1.01 109.229 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.727 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.2 t70 -52.61 145.44 11.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.647 -0.871 . . . . 0.57999999999999996 108.647 172.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.576 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -52.04 -26.65 11.38 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 123.416 0.448 . . . . 1.04 110.54 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.727 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 13.8 ptpt -54.33 -35.02 62.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.95 0.352 . . . . 1.4299999999999999 111.95 176.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 87.5 m-85 -95.93 2.21 53.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.094 0.473 . . . . 1.04 110.373 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 80.2 m -118.47 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.116 -0.947 . . . . 0.87 110.254 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.3 m-85 -144.41 40.71 1.33 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.34 -0.544 . . . . 0.95999999999999996 112.364 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.486 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.07 -83.08 0.04 OUTLIER Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.048 -0.596 . . . . 0.25 113.694 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.73 8.7 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.539 2.159 . . . . 0.90000000000000002 110.986 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.1 mt-30 -104.22 -51.4 3.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.624 0.726 . . . . 0.65000000000000002 110.216 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.66 143.71 4.19 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.478 -1.237 . . . . 0.29999999999999999 111.769 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t -91.77 156.75 17.32 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.62 0.6 . . . . 0.90000000000000002 112.62 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 129' ' ' SER . 7.4 ptm180 -43.1 -63.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.724 -1.125 . . . . 3.6099999999999999 112.159 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.994 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 17.2 m -72.56 -66.41 0.61 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 121.021 -0.271 . . . . 1.52 110.431 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.994 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -105.74 128.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.397 2.064 . . . . 0.44 112.31 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.0 t80 -57.31 98.24 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.41 -0.959 . . . . 1.6899999999999999 108.41 164.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.583 HG12 ' CB ' ' A' ' 127' ' ' SER . 26.9 mm -66.89 129.7 94.02 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.633 -0.506 . . . . 1.0600000000000001 109.633 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 11.6 Cg_endo -57.49 145.3 89.19 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.624 2.216 . . . . 1.03 112.574 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.486 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 39.6 Cg_exo -57.9 134.27 61.4 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.802 2.335 . . . . 0.89000000000000001 112.888 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 31.6 m170 66.88 10.97 8.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.74 -1.118 . . . . 3.1899999999999999 112.471 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -71.81 124.54 25.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.337 -0.986 . . . . 1.04 108.337 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.07 112.58 10.35 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.153 -0.619 . . . . 1.05 109.59 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 115' ' ' THR . 1.7 tp -90.14 131.64 35.88 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.546 -0.752 . . . . 1.0600000000000001 110.065 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.5 t -116.84 99.94 7.44 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.821 -0.807 . . . . 1.8200000000000001 108.821 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.3 pp -110.61 136.09 50.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.083 -0.508 . . . . 1.1499999999999999 111.106 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.625 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 34.5 tt0 -103.8 113.54 27.13 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.989 -0.745 . . . . 1.05 108.989 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.7 m -114.51 120.8 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.606 0.717 . . . . 1.0800000000000001 112.486 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.7 m -91.41 113.09 25.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.938 -1.028 . . . . 1.0900000000000001 110.139 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.709 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.0 tp -84.65 98.13 10.02 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.885 -0.783 . . . . 1.0700000000000001 108.885 173.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.453 ' C ' ' HG1' ' A' ' 146' ' ' THR . 27.6 mtmt -94.42 -28.6 15.41 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.096 -0.957 . . . . 1.6899999999999999 110.664 -171.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.513 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 24.5 m -153.72 147.44 25.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 1.1200000000000001 111.663 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 127.88 25.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.792 -0.448 . . . . 0.98999999999999999 109.792 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.13 141.96 34.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 C-N-CA 120.643 -0.423 . . . . 1.6200000000000001 110.916 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.549 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 10.6 t70 -74.52 119.4 18.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.44 -0.346 . . . . 2.27 110.745 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.556 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -152.77 37.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.988 -0.745 . . . . 2.5 108.988 -176.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 156.99 36.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 2.1400000000000001 110.296 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.38 -42.84 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.721 0.637 . . . . 6.6299999999999999 112.721 -169.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -150.55 105.96 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.72 0.295 . . . . 8.1899999999999995 110.637 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -66.97 100.18 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 9.0800000000000001 110.739 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -116.63 6.61 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.692 -0.231 . . . . 9.2400000000000002 111.538 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -150.89 151.74 32.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.514 0.197 . . . . 12.779999999999999 110.754 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.531 -0.747 . . . . 14.109999999999999 110.005 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 tpp . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.798 0.332 . . . . 50.460000000000001 110.958 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.6 41.33 0.57 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.961 -0.638 . . . . 47.990000000000002 111.515 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 20.5 mt-30 -79.97 152.63 74.52 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.174 . . . . 46.439999999999998 110.796 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' GLN . 16.2 Cg_exo -69.43 151.06 70.94 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.901 2.401 . . . . 45.219999999999999 111.729 176.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.35 153.41 66.24 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.581 2.187 . . . . 44.450000000000003 112.227 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 69.14 -170.03 0.18 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.011 -0.541 . . . . 42.710000000000001 112.171 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 9' ' ' ALA . 7.8 tp10 -134.7 140.59 46.09 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.178 -0.465 . . . . 41.5 109.747 -176.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -113.05 18.89 17.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.503 -0.317 . . . . 40.329999999999998 110.947 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.564 ' H ' ' HG3' ' A' ' 7' ' ' GLU . . . 80.1 162.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.03 -0.986 . . . . 39.390000000000001 112.003 173.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -130.44 -69.03 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.019 -0.991 . . . . 38.82 110.396 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 3.6 pt20 -98.6 121.69 55.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 38.350000000000001 111.169 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 11' ' ' GLN . 7.3 Cg_exo -73.08 125.4 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.782 2.321 . . . . 37.039999999999999 111.238 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.29 33.6 0.57 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.697 -0.763 . . . . 35.659999999999997 112.047 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.77 140.95 49.36 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.696 -0.296 . . . . 35.149999999999999 110.428 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -133.22 131.63 40.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.635 -0.505 . . . . 34.170000000000002 109.635 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.8 22.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.662 0.245 . . . . 32.950000000000003 111.662 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.545 ' HD2' ' C ' ' A' ' 17' ' ' ARG . 1.7 ppt_? -139.52 5.04 2.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.765 0.317 . . . . 32.299999999999997 111.206 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.31 -62.18 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.581 -0.736 . . . . 31.239999999999998 112.961 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.92 145.89 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.45 0.643 . . . . 31.57 111.937 -167.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.783 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.4 pt? -82.31 83.48 7.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 30.100000000000001 110.388 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.39 76.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.794 -0.639 . . . . 28.399999999999999 110.268 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.01 -53.59 2.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.764 -0.653 . . . . 26.969999999999999 110.375 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.6 ttm -158.15 66.71 0.46 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 27.66 109.838 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.82 107.91 61.1 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.505 -0.77 . . . . 24.41 109.29 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.77 -178.25 4.41 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.869 2.379 . . . . 22.399999999999999 113.336 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 91.2 mt-10 -94.7 137.02 22.57 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 115.632 -0.713 . . . . 20.670000000000002 110.012 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 22.0 Cg_exo -66.1 105.01 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.544 2.163 . . . . 18.75 111.404 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.72 141.35 92.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 14.960000000000001 110.306 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.16 127.77 27.01 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.495 2.13 . . . . 14.550000000000001 112.339 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.15 70.75 6.32 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.669 -0.696 . . . . 10.949999999999999 110.894 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.1 67.26 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.612 2.208 . . . . 10.6 112.137 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.78 135.24 20.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 6.1100000000000003 109.962 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.87 -43.74 54.21 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.986 2.457 . . . . 5.3600000000000003 111.956 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -157.2 146.96 20.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.58 -0.736 . . . . 4.1299999999999999 109.244 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -114.17 106.28 14.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.063 0.459 . . . . 2.4500000000000002 110.801 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.671 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -92.4 -160.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.672 -0.694 . . . . 0.53000000000000003 110.193 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.93 110.69 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.155 -0.475 . . . . 1.1899999999999999 110.903 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.727 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -71.03 99.94 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.637 -0.71 . . . . 2.5099999999999998 110.691 173.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 105' ' ' LEU . 15.8 mt -48.71 -48.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.973 -1.012 . . . . 1.1499999999999999 112.189 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 88.4 mt -105.93 4.64 29.76 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.612 -0.435 . . . . 1.4299999999999999 111.103 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.696 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 67.86 18.73 70.84 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.65000000000000002 112.416 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.691 HD21 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -98.03 -23.6 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.82 0.304 . . . . 0.94999999999999996 111.82 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.691 ' N ' HD21 ' A' ' 42' ' ' ASN . . . 105.18 -27.21 19.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.189 -1.005 . . . . 0.71999999999999997 113.722 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -94.26 -11.18 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.395 0.597 . . . . 2.1600000000000001 111.732 -174.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.3 tp -121.52 107.94 13.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 110.443 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 63.2 mtm180 -142.39 141.63 32.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.567 -0.288 . . . . 1.49 111.435 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.732 ' HG3' HG22 ' A' ' 114' ' ' VAL . 18.7 ttpt -111.04 129.6 55.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.951 -0.388 . . . . 1.1200000000000001 109.951 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 12.4 ttmt -108.05 128.52 54.75 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.773 0.32 . . . . 1.6499999999999999 110.778 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -80.56 101.33 9.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.949 -0.569 . . . . 1.03 110.91 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.487 HD11 HG22 ' A' ' 111' ' ' THR . 10.0 mt -68.25 -51.85 40.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.042 -1.466 . . . . 1.0600000000000001 107.042 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.81 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 79.3 t -138.63 126.0 13.35 Favored Pre-proline 0 CA--C 1.497 -1.075 0 CA-C-N 113.091 -1.868 . . . . 1.1399999999999999 106.574 169.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -103.12 64.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.818 2.345 . . . . 0.56000000000000005 113.491 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.67 169.14 32.59 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.019 -0.991 . . . . 0.55000000000000004 113.085 175.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 73.4 Cg_endo -77.42 168.95 21.99 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.355 2.036 . . . . 1.9099999999999999 110.492 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.19 84.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.457 2.105 . . . . 2.5299999999999998 111.941 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.19 48.07 0.33 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.992 -0.549 . . . . 1.4199999999999999 112.17 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.688 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 3.4 p -87.22 -172.39 3.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.299 0.571 . . . . 1.3600000000000001 110.977 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.702 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 9.8 m -153.08 127.07 8.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.646 -0.872 . . . . 1.8200000000000001 108.646 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 22.1 ptt180 -90.41 123.46 65.44 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 119.66 -0.816 . . . . 3.3900000000000001 110.809 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 147' ' ' ALA . 15.1 Cg_endo -56.39 155.22 26.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.909 3.073 . . . . 0.42999999999999999 113.741 -175.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.6 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.1 t -94.87 153.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.307 -0.861 . . . . 1.47 109.389 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.887 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 21.1 mtpt -67.59 119.35 12.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.496 0.665 . . . . 1.71 109.401 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.36 -23.5 5.14 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.2 -1.16 . . . . 0.41999999999999998 110.2 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.644 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.79 142.69 33.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.58999999999999997 109.263 176.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.73 121.49 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.577 -0.897 . . . . 1.8600000000000001 108.577 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.6 m -126.6 146.37 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 1.0700000000000001 111.895 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.442 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 28.9 p -104.22 114.05 28.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.381 -0.827 . . . . 1.0600000000000001 110.337 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.624 HG22 HD22 ' A' ' 99' ' ' LEU . 30.0 m -110.59 145.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.083 -0.647 . . . . 1.05 110.038 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -102.37 115.08 29.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.804 -1.554 . . . . 0.28999999999999998 106.804 169.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -116.19 136.36 53.08 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.149 -1.02 . . . . 1.1299999999999999 110.91 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.586 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.18 113.96 13.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.993 -1.854 . . . . 0.27000000000000002 105.993 166.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 61.0 m -104.24 125.71 50.74 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.683 -1.144 . . . . 1.04 111.186 -168.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.6 t -105.75 159.17 16.2 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.206 -0.906 . . . . 1.54 109.034 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.435 ' HG ' HG11 ' A' ' 80' ' ' VAL . 9.3 mt -86.34 165.2 16.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.792 -0.64 . . . . 1.51 110.017 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.93 -17.82 4.17 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.48 0.488 . . . . 1.1399999999999999 112.114 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -98.09 -15.2 20.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 2.1400000000000001 110.998 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.13 23.11 6.53 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.769 -0.729 . . . . 0.51000000000000001 113.357 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 m -101.42 109.58 21.43 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.302 -0.528 . . . . 1.1599999999999999 111.115 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 11.0 mtt180 -73.75 114.4 11.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.674 0.749 . . . . 0.54000000000000004 110.462 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.617 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.9 m -98.73 -9.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.529 -1.214 . . . . 1.0600000000000001 111.86 -171.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 8.4 pt20 -162.06 127.14 3.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.082 -0.508 . . . . 0.63 110.168 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.443 ' OE2' ' HG2' ' A' ' 71' ' ' GLN . 16.8 tt0 -130.52 106.85 8.79 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.641 -0.503 . . . . 1.3400000000000001 109.641 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 5.1 tt0 -126.91 117.98 22.27 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.444 -0.798 . . . . 2.5899999999999999 110.568 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 9.9 Cg_exo -71.39 -18.59 29.7 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.66 2.907 . . . . 0.90000000000000002 113.932 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -161.99 99.28 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.573 1.178 . . . . 1.3700000000000001 112.416 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.2 107.87 19.03 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.171 -1.831 . . . . 1.1399999999999999 108.7 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.6 p -104.6 137.12 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.753 -0.462 . . . . 1.5900000000000001 109.753 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.584 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 17.5 p90 -158.73 167.92 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.71 0.29 . . . . 0.25 111.332 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -88.63 112.09 22.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.263 -0.643 . . . . 1.0700000000000001 109.263 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.887 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 12.8 tp -53.44 121.55 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.116 -0.493 . . . . 1.3300000000000001 111.072 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.529 ' CA ' ' HE2' ' A' ' 62' ' ' LYS . . . 97.09 -3.21 61.95 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.444 -0.884 . . . . 0.37 113.383 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.7 10.4 41.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.97 -0.692 . . . . 0.93000000000000005 109.454 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.3 m 58.98 30.54 20.37 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 114.671 -1.15 . . . . 1.55 110.308 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 88' ' ' PHE . 18.1 m-20 -67.28 -11.29 57.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.816 0.817 . . . . 1.3300000000000001 109.835 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 m -131.66 -162.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.245 -1.343 . . . . 1.0800000000000001 110.026 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.527 HG13 ' H ' ' A' ' 99' ' ' LEU . 28.0 pt -76.11 141.27 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.668 -1.234 . . . . 1.0600000000000001 107.668 173.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -61.85 -28.61 69.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.555 -0.293 . . . . 0.40000000000000002 110.863 -173.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.9 80.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.988 0.423 . . . . 1.0800000000000001 110.226 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.624 HD22 HG22 ' A' ' 68' ' ' VAL . 57.2 tp -73.17 -40.98 64.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.479 -0.782 . . . . 1.0700000000000001 110.955 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.9 -31.36 69.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.08 -0.963 . . . . 0.26000000000000001 109.906 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.57 -34.49 15.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.127 -0.942 . . . . 1.0600000000000001 112.167 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 78.3 p -70.68 -28.64 64.92 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.918 -0.313 . . . . 1.53 110.911 -173.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 99' ' ' LEU . 55.6 t -64.47 -55.0 33.15 Favored Pre-proline 0 C--O 1.217 -0.648 0 CA-C-N 115.991 -0.549 . . . . 1.0600000000000001 112.227 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.872 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.0 Cg_endo -63.78 -17.79 61.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.95 1.766 . . . . 0.40999999999999998 111.873 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 39' ' ' ILE . 14.0 mt -82.75 -15.69 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.933 -0.576 . . . . 1.3500000000000001 111.136 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.744 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -103.77 148.57 25.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.144 -0.48 . . . . 1.3100000000000001 111.026 178.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.594 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -90.38 160.67 15.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.96999999999999997 110.786 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -66.97 129.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.544 0.687 . . . . 1.47 110.311 -176.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.94 66.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.239 -0.892 . . . . 0.28000000000000003 112.153 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -98.05 166.97 11.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.5 0.667 . . . . 0.40999999999999998 110.939 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.487 HG22 HD11 ' A' ' 50' ' ' LEU . 8.1 m -128.74 118.18 22.39 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.972 -1.121 . . . . 1.0700000000000001 107.972 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.32 136.61 54.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.602 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.1 ttp -101.89 117.04 34.01 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.667 -1.234 . . . . 1.9399999999999999 107.667 171.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.732 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.8 t -110.84 134.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.563 -0.532 . . . . 1.0600000000000001 109.563 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.547 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 89.5 m -107.66 114.06 27.78 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 119.202 -0.999 . . . . 1.03 108.491 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.16 130.7 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.958 -1.474 . . . . 1.01 109.022 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.762 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 5.8 t70 -53.06 147.31 9.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.437 -0.579 . . . . 0.57999999999999996 109.437 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.9 t -53.0 -29.27 28.25 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 121.027 0.441 . . . . 1.04 110.197 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.3 ptpt -55.26 -31.48 61.59 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.079 0.4 . . . . 1.4299999999999999 112.079 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.575 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.0 m-85 -95.44 -0.66 52.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.196 0.522 . . . . 1.04 110.148 175.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.587 ' HB3' HD21 ' A' ' 138' ' ' LEU . 77.3 m -118.24 -87.82 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.119 -0.946 . . . . 0.87 110.648 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.534 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.8 m-85 -144.94 36.2 1.14 Allowed 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.376 -0.53 . . . . 0.95999999999999996 112.063 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.89 -76.77 0.18 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.825 -0.702 . . . . 0.25 113.052 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.9 3.66 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.471 2.114 . . . . 0.90000000000000002 111.507 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -104.74 -51.92 2.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.506 0.67 . . . . 0.65000000000000002 109.91 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.527 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 83.92 141.83 4.94 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.592 -1.186 . . . . 0.29999999999999999 111.31 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.4 t -90.54 153.03 20.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.817 0.341 . . . . 0.90000000000000002 111.134 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -52.82 -42.48 65.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.386 -0.824 . . . . 3.6099999999999999 111.971 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.996 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 10.1 m -84.97 -66.06 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.266 -0.642 . . . . 1.52 109.266 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.996 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.0 Cg_endo -105.38 126.28 0.06 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.44 111.497 171.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -59.65 97.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.776 -1.194 . . . . 1.6899999999999999 107.776 167.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.563 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.9 mm -65.52 126.92 92.48 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.966 -0.561 . . . . 1.0600000000000001 109.633 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.89 142.45 42.73 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.639 2.226 . . . . 1.03 112.008 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.482 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 41.1 Cg_exo -57.03 134.42 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.352 2.035 . . . . 0.89000000000000001 112.0 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.441 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.8 OUTLIER 74.28 0.67 3.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.363 -0.835 . . . . 3.1899999999999999 111.422 174.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.6 119.41 12.32 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.193 -0.669 . . . . 1.04 109.193 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.24 113.81 10.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.195 -0.602 . . . . 1.05 110.54 -171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.3 mp -89.6 134.21 34.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.861 -0.609 . . . . 1.0600000000000001 111.708 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 t -118.0 100.47 7.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.025 -0.731 . . . . 1.8200000000000001 109.025 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 pp -111.02 137.05 49.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.609 -0.723 . . . . 1.1499999999999999 111.592 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.586 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 81.0 tt0 -103.53 124.79 49.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.703 -0.851 . . . . 1.05 108.703 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.616 HG21 ' HE3' ' A' ' 106' ' ' MET . 3.3 m -122.74 126.15 73.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.257 0.551 . . . . 1.0800000000000001 112.252 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 7.3 m -96.11 115.97 28.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.765 -0.652 . . . . 1.0900000000000001 110.219 170.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.737 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.8 tp -85.39 98.13 10.39 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.727 -0.842 . . . . 1.0700000000000001 108.727 172.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.44 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.5 mtmt -94.14 -30.3 14.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.336 -0.847 . . . . 1.6899999999999999 110.661 -169.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.5 m -150.92 146.14 26.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.128 0.49 . . . . 1.1200000000000001 111.814 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . . . -136.1 127.68 28.81 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.485 -0.932 . . . . 0.98999999999999999 108.485 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.31 125.29 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.18 0.514 . . . . 1.6200000000000001 111.13 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.563 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.7 t70 -67.73 121.45 15.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 2.27 110.163 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.85 12.53 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 2.5 111.299 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.27 169.99 13.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.208 -0.597 . . . . 2.1400000000000001 109.993 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -108.02 -179.58 3.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.725 -0.67 . . . . 6.6299999999999999 111.593 -167.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -95.9 9.92 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.759 -0.655 . . . . 8.1899999999999995 110.084 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -135.63 96.61 3.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.318 -0.855 . . . . 9.0800000000000001 108.698 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.09 148.97 42.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.765 -0.652 . . . . 9.2400000000000002 111.853 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -92.71 -32.45 14.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 12.779999999999999 109.998 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 37.8 m80 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.085 -0.959 . . . . 14.109999999999999 109.419 -179.494 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 121.01 0.433 . . . . 50.460000000000001 110.283 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.89 54.48 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.707 -0.957 . . . . 47.990000000000002 110.707 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -75.84 145.42 77.96 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 110.374 -0.232 . . . . 46.439999999999998 110.374 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.27 121.36 9.79 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.781 2.321 . . . . 45.219999999999999 112.148 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.28 135.86 61.15 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.27 2.647 . . . . 44.450000000000003 113.136 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.84 136.07 53.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.743 -0.662 . . . . 42.710000000000001 109.641 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 58.1 72.94 0.49 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.582 0.551 . . . . 41.5 110.23 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.31 127.25 32.14 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.426 -0.583 . . . . 40.329999999999998 109.426 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.45 -57.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.81 -0.177 . . . . 39.390000000000001 111.432 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 64.7 103.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.756 0.66 . . . . 38.82 112.081 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 61.99 70.41 0.85 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 114.907 -1.042 . . . . 38.350000000000001 111.538 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.62 174.93 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.392 2.728 . . . . 37.039999999999999 112.562 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.25 -122.8 5.94 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 35.659999999999997 111.973 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.94 166.57 23.13 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.135 -0.32 . . . . 35.149999999999999 110.135 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.46 83.25 2.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.023 0.44 . . . . 34.170000000000002 110.994 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.39 97.78 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.705 -0.85 . . . . 32.950000000000003 108.705 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -117.45 166.98 11.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.96 -0.563 . . . . 32.299999999999997 111.23 -172.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -96.18 142.16 28.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.268 -0.878 . . . . 31.239999999999998 110.437 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -86.13 11.4 11.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.599 -0.728 . . . . 31.57 110.65 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -88.58 8.8 26.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.661 -0.7 . . . . 30.100000000000001 111.12 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.59 -168.63 0.21 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.743 -0.662 . . . . 28.399999999999999 111.371 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.29 49.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 26.969999999999999 110.535 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 58.8 mtt -90.88 35.39 0.9 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 27.66 110.423 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 34.7 tt0 67.29 112.09 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.39 -0.823 . . . . 24.41 110.808 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 12.0 Cg_exo -71.13 173.74 11.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.231 2.62 . . . . 22.399999999999999 113.197 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -73.14 144.04 84.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 20.670000000000002 110.595 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.64 137.08 37.92 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.543 2.162 . . . . 18.75 112.205 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -80.62 148.22 65.16 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 14.960000000000001 110.323 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 21.7 Cg_exo -64.85 128.02 19.93 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 122.688 2.258 . . . . 14.550000000000001 111.723 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 32' ' ' ALA . . . -141.66 77.16 19.49 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.863 -0.608 . . . . 10.949999999999999 111.169 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.34 35.55 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.059 2.506 . . . . 10.6 112.564 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 30' ' ' ALA . . . -112.33 117.02 48.12 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.773 -0.649 . . . . 6.1100000000000003 110.468 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 25.5 Cg_exo -63.75 -28.05 68.28 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.792 2.328 . . . . 5.3600000000000003 112.783 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.98 -54.04 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.464 -0.334 . . . . 4.1299999999999999 111.216 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' HA ' HH11 ' A' ' 46' ' ' ARG . 9.6 pt-20 -54.99 125.11 19.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 2.4500000000000002 112.42 -174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.567 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -86.94 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.556 -0.747 . . . . 0.53000000000000003 109.729 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.3 tp -73.01 110.33 7.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 1.1899999999999999 110.037 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.671 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -74.75 123.53 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.38 -0.528 . . . . 2.5099999999999998 109.831 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.569 HD13 HD11 ' A' ' 45' ' ' LEU . 8.4 mt -55.22 -33.21 29.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.985 -1.007 . . . . 1.1499999999999999 111.462 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -115.9 -1.39 12.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.014 -0.539 . . . . 1.4299999999999999 110.313 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.66 23.05 66.71 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.093 -0.803 . . . . 0.65000000000000002 111.093 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' OD1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -97.32 -17.67 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.622 0.601 . . . . 0.94999999999999996 112.622 -172.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.401 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.17 -15.43 18.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.446 -0.883 . . . . 0.71999999999999997 114.72 166.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -120.29 -7.79 9.74 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.972 0.73 . . . . 2.1600000000000001 112.972 -175.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.569 HD11 HD13 ' A' ' 39' ' ' ILE . 25.2 tp -121.75 100.07 6.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.578 0.228 . . . . 1.1200000000000001 110.624 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.525 HH11 ' HA ' ' A' ' 35' ' ' GLU . 81.2 mtm180 -134.86 139.23 44.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.697 0.258 . . . . 1.49 111.697 -171.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.7 ttpt -113.05 123.31 50.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.244 0.217 . . . . 1.1200000000000001 110.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.3 ttpp -111.07 117.69 33.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.832 0.349 . . . . 1.6499999999999999 111.253 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 2.2 p -74.1 98.89 3.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 1.03 111.656 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.44 HD22 ' HZ2' ' A' ' 48' ' ' LYS . 7.7 mt -67.01 -53.38 31.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.413 -1.329 . . . . 1.0600000000000001 107.413 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.799 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t -134.39 123.01 16.24 Favored Pre-proline 0 CA--C 1.498 -1.032 0 CA-C-N 112.908 -1.951 . . . . 1.1399999999999999 106.478 168.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 57.7 Cg_endo -108.37 72.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.521 2.148 . . . . 0.56000000000000005 114.578 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 54' ' ' PRO . . . 81.23 140.65 2.94 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.55000000000000004 113.756 169.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 11.6 Cg_exo -70.71 148.71 59.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.411 2.074 . . . . 1.9099999999999999 110.134 169.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.33 110.38 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.756 2.304 . . . . 2.5299999999999998 112.711 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.72 44.65 2.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.818 -0.706 . . . . 1.4199999999999999 112.053 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -89.93 -165.34 1.32 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.935 0.398 . . . . 1.3600000000000001 110.629 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -158.75 144.57 16.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.616 -0.883 . . . . 1.8200000000000001 108.616 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.452 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 49.5 mtm180 -94.13 111.38 53.06 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.659 -0.497 . . . . 3.3900000000000001 109.659 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.595 ' HG3' HD23 ' A' ' 144' ' ' LEU . 9.9 Cg_endo -49.96 149.55 11.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.693 2.928 . . . . 0.42999999999999999 113.657 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.665 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 20.2 t -96.22 153.05 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.364 -0.834 . . . . 1.47 109.531 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.886 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 98.5 mttt -68.78 119.61 13.42 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.523 0.678 . . . . 1.71 109.231 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 -28.5 3.82 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.836 -1.306 . . . . 0.41999999999999998 109.836 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -82.34 139.28 34.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.637 -0.875 . . . . 0.58999999999999997 108.637 177.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.3 m -88.69 125.74 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 108.024 -1.102 . . . . 1.8600000000000001 108.024 173.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.3 m -124.7 143.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.57 -0.741 . . . . 1.0700000000000001 111.468 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.796 HG23 HG22 ' A' ' 87' ' ' VAL . 69.4 p -90.11 113.03 24.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.423 -0.808 . . . . 1.0600000000000001 110.243 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 HD22 ' A' ' 99' ' ' LEU . 19.0 m -111.71 141.11 28.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 120.095 -0.642 . . . . 1.05 110.366 172.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.544 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.8 t-160 -101.67 119.13 38.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.848 -1.538 . . . . 0.28999999999999998 106.848 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -124.92 133.59 52.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 118.789 -1.164 . . . . 1.1299999999999999 111.297 177.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.566 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -125.45 115.13 19.77 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.082 -1.821 . . . . 0.27000000000000002 106.082 168.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.606 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 54.1 m -106.8 129.26 54.69 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.875 -1.057 . . . . 1.04 111.591 -168.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.56 155.46 18.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.192 -0.913 . . . . 1.54 109.159 177.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.499 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.0 mt -83.31 166.24 18.65 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.472 -0.785 . . . . 1.51 110.243 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -54.52 -19.18 5.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.01 -0.541 . . . . 1.1399999999999999 110.946 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -91.39 -3.59 56.54 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 110.947 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.4 10.23 62.33 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.319 -0.467 . . . . 0.51000000000000001 112.24 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.4 m -95.5 112.05 23.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 1.1599999999999999 111.441 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 14.5 mtt180 -74.38 120.02 19.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.518 0.675 . . . . 0.54000000000000004 110.609 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.5 m -108.48 -10.79 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.617 -1.174 . . . . 1.0600000000000001 112.272 -169.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.606 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.2 pt20 -159.72 125.63 4.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.288 -0.414 . . . . 0.63 109.961 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.541 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 73.4 tt0 -128.41 108.09 10.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 1.3400000000000001 109.972 174.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HB3' HD22 ' A' ' 70' ' ' LEU . 4.7 tp10 -119.18 111.56 36.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.922 -1.036 . . . . 2.5899999999999999 109.941 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 37.3 Cg_endo -66.48 -19.61 54.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.209 2.606 . . . . 0.90000000000000002 113.918 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 25.5 tt0 -165.18 101.47 0.74 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 122.364 1.078 . . . . 1.3700000000000001 112.479 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.1 tp -109.69 107.55 17.62 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.657 -1.61 . . . . 1.1399999999999999 108.786 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.796 HG22 HG23 ' A' ' 67' ' ' THR . 1.7 t -101.55 125.02 55.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.229 -0.656 . . . . 1.5900000000000001 109.229 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -144.95 161.63 38.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.586 -0.279 . . . . 0.25 110.381 -172.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -81.17 111.72 17.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.174 -0.467 . . . . 1.0700000000000001 109.774 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.886 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.1 tp -58.91 132.21 53.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 1.3300000000000001 110.161 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 84.2 2.65 89.24 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.128 -0.558 . . . . 0.37 112.415 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -99.38 -3.91 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.059 0.457 . . . . 0.93000000000000005 110.372 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.5 m 58.6 33.31 23.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.497 -0.774 . . . . 1.55 109.351 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.3 t70 -72.4 -10.68 60.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 122.534 1.159 . . . . 1.3300000000000001 108.891 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 15.5 m -130.24 -158.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.542 -1.663 . . . . 1.0800000000000001 109.665 -175.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.635 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.2 pt -80.3 137.73 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.954 -1.128 . . . . 1.0600000000000001 107.954 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.562 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.5 tp60 -59.53 -28.32 66.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.374 -0.376 . . . . 0.40000000000000002 110.408 -174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.62 93.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.133 0.492 . . . . 1.0800000000000001 110.655 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.827 HD13 HG13 ' A' ' 142' ' ' VAL . 58.2 tp -76.4 -38.69 55.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.706 -0.679 . . . . 1.0700000000000001 110.141 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.47 -29.09 69.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.965 -1.016 . . . . 0.26000000000000001 109.825 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 78.4 mt -91.12 -35.2 14.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.518 -0.764 . . . . 1.0600000000000001 112.533 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.553 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 23.3 p -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.088 -0.383 . . . . 1.53 111.312 -172.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 99' ' ' LEU . 54.5 t -62.23 -55.61 38.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.297 0.48 . . . . 1.0600000000000001 112.297 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.816 ' HD3' HD12 ' A' ' 90' ' ' LEU . 19.0 Cg_endo -62.6 -23.21 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.898 1.732 . . . . 0.40999999999999998 111.305 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 39' ' ' ILE . 16.8 mt -78.14 -15.62 58.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.55 . . . . 1.3500000000000001 111.707 173.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.6 ' HE1' HG23 ' A' ' 142' ' ' VAL . 2.9 ptm -106.93 154.9 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.497 -0.32 . . . . 1.3100000000000001 111.261 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.16 153.56 20.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.912 0.387 . . . . 0.96999999999999997 110.532 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -64.19 127.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.618 0.723 . . . . 1.47 109.972 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.58 58.4 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.128 -0.942 . . . . 0.28000000000000003 112.865 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.799 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.4 pt-20 -99.07 167.71 10.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.629 0.728 . . . . 0.40999999999999998 111.455 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.43 HG23 HD12 ' A' ' 50' ' ' LEU . 7.4 m -128.69 117.83 21.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.83 -1.174 . . . . 1.0700000000000001 107.83 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.72 139.01 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.995 0.426 . . . . 1.0 110.652 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.7 ttm -98.21 118.27 34.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.307 -1.368 . . . . 1.9399999999999999 107.307 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.4 t -115.35 128.2 72.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.781 -0.452 . . . . 1.0600000000000001 109.781 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.515 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 85.2 m -106.14 113.98 27.83 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.206 -1.035 . . . . 1.03 108.206 172.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.72 136.88 53.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.31 -1.314 . . . . 1.01 109.617 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.631 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.0 t70 -55.49 148.92 14.47 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.101 -0.703 . . . . 0.57999999999999996 109.101 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.632 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -56.32 -27.29 55.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.136 0.493 . . . . 1.04 110.453 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.631 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 15.1 ptpt -54.94 -32.63 61.54 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.215 -0.303 . . . . 1.4299999999999999 111.717 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.59 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 80.0 m-85 -96.44 0.44 50.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 120.998 0.428 . . . . 1.04 110.165 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.632 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.6 m -117.02 -92.01 0.53 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.076 -0.965 . . . . 0.87 110.382 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.523 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.2 m-85 -142.42 39.78 1.57 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.429 -0.508 . . . . 0.95999999999999996 112.233 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -53.2 -80.58 0.07 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 121.208 -0.52 . . . . 0.25 114.031 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.32 9.08 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.191 1.927 . . . . 0.90000000000000002 111.017 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.25 -50.43 3.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.065 -0.971 . . . . 0.65000000000000002 110.173 -173.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.563 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.91 143.94 4.46 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.912 -1.04 . . . . 0.29999999999999999 112.243 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.653 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.8 t -90.42 157.03 17.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.532 . . . . 0.90000000000000002 111.489 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -59.18 -34.83 72.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.287 -0.869 . . . . 3.6099999999999999 112.259 -172.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.99 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 48.2 m -89.45 -67.22 0.13 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.174 -0.61 . . . . 1.52 109.718 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.99 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -104.62 127.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.275 1.983 . . . . 0.44 111.95 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.563 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 36.5 t80 -56.91 97.87 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.194 -1.039 . . . . 1.6899999999999999 108.194 165.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -65.95 128.97 94.19 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.734 -0.666 . . . . 1.0600000000000001 109.577 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.6 Cg_exo -53.78 144.29 55.22 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.61 2.206 . . . . 1.03 112.033 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.539 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 33.2 Cg_exo -58.92 133.86 56.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.315 2.01 . . . . 0.89000000000000001 112.091 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.558 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER 73.61 0.12 3.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.232 -0.895 . . . . 3.1899999999999999 112.775 177.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -66.4 123.52 20.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.728 -0.471 . . . . 1.04 109.728 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.89 113.52 11.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.425 0.631 . . . . 1.05 110.41 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.605 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.0 OUTLIER -92.06 132.4 36.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.455 -0.793 . . . . 1.0600000000000001 111.214 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.0 t -116.6 100.65 7.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.182 -0.673 . . . . 1.8200000000000001 109.182 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -117.01 135.21 53.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.081 -0.509 . . . . 1.1499999999999999 111.664 -172.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.566 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 35.8 tt0 -99.63 117.47 34.06 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.451 -0.574 . . . . 1.05 109.451 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.827 HG13 HD13 ' A' ' 99' ' ' LEU . 5.3 m -110.51 124.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.608 . . . . 1.0800000000000001 111.95 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -99.91 108.88 21.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.36 -0.836 . . . . 1.0900000000000001 109.777 172.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.595 HD23 ' HG3' ' A' ' 60' ' ' PRO . 49.4 tp -82.59 96.91 8.23 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.384 -0.969 . . . . 1.0700000000000001 108.384 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -94.46 -25.13 17.02 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.583 -0.735 . . . . 1.6899999999999999 110.601 -170.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -154.66 146.25 23.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.876 -0.602 . . . . 1.1200000000000001 110.841 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.524 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -140.14 127.65 21.5 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.975 -0.75 . . . . 0.98999999999999999 108.975 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.83 139.34 44.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.288 -0.565 . . . . 1.6200000000000001 110.86 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.505 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 8.8 t70 -78.62 122.0 25.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.691 -0.485 . . . . 2.27 109.691 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.4 tp -152.76 22.33 0.6 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.141 -0.481 . . . . 2.5 110.675 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.81 151.71 31.78 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.543 -0.91 . . . . 2.1400000000000001 108.543 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.586 ' O ' ' HB2' ' A' ' 153' ' ' HIS . 3.7 t60 -61.84 -55.56 28.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.661 -0.496 . . . . 6.6299999999999999 109.661 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.586 ' HB2' ' O ' ' A' ' 152' ' ' HIS . 0.9 OUTLIER 157.73 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.52 1.138 . . . . 8.1899999999999995 109.72 176.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -146.07 54.34 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 9.0800000000000001 110.543 -170.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -70.87 86.44 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 9.2400000000000002 110.093 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 27.2 t60 -178.38 -27.2 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.807 -0.633 . . . . 12.779999999999999 110.619 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 31.8 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 117.847 -1.073 . . . . 14.109999999999999 109.811 -172.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.85 0.357 . . . . 50.460000000000001 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.43 157.19 29.56 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.315 -0.714 . . . . 47.990000000000002 111.315 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 26.9 pt20 -113.61 144.63 31.75 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 110.238 -0.282 . . . . 46.439999999999998 110.238 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 3' ' ' GLN . 25.0 Cg_exo -63.01 118.92 5.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.032 2.488 . . . . 45.219999999999999 112.686 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.78 165.22 24.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.714 2.276 . . . . 44.450000000000003 111.804 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.59 113.4 25.5 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.46 -0.336 . . . . 42.710000000000001 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 72.98 130.17 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.149 0.906 . . . . 41.5 113.004 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.2 127.23 33.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.656 -0.702 . . . . 40.329999999999998 109.133 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.52 11.48 2.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.571 -0.286 . . . . 39.390000000000001 111.345 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.75 -46.76 68.01 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.316 0.579 . . . . 38.82 109.663 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -125.83 97.13 36.32 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.7 -0.682 . . . . 38.350000000000001 109.85 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.84 98.37 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.718 2.279 . . . . 37.039999999999999 111.87 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.25 -166.76 11.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.044 -0.598 . . . . 35.659999999999997 112.223 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.61 176.32 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 35.149999999999999 109.583 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -74.79 -68.21 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.649 -0.5 . . . . 34.170000000000002 109.649 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 52.47 26.7 4.39 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.259 0.837 . . . . 32.950000000000003 113.259 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -105.9 -9.39 17.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 32.299999999999997 110.586 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 45.8 tt0 -77.09 106.11 8.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.407 -0.59 . . . . 31.239999999999998 109.407 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 6.2 t80 74.13 -36.45 0.33 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.079 0.862 . . . . 31.57 112.454 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.06 92.83 0.55 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.407 0.623 . . . . 30.100000000000001 111.473 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.88 167.09 10.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.362 -0.835 . . . . 28.399999999999999 110.412 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' OE1' ' A' ' 24' ' ' GLU . . . -121.21 176.96 5.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.409 -0.359 . . . . 26.969999999999999 111.307 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 47.0 ttm -133.63 -72.09 0.5 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.569 -0.9 . . . . 27.66 108.569 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' OE1' ' HB2' ' A' ' 22' ' ' ALA . 1.7 mp0 44.97 88.05 0.11 Allowed Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 124.514 1.134 . . . . 24.41 112.874 171.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -55.78 112.75 1.15 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.974 2.449 . . . . 22.399999999999999 112.236 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.84 127.5 93.12 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.839 -0.619 . . . . 20.670000000000002 110.657 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.02 154.72 62.61 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.395 2.73 . . . . 18.75 112.117 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -120.05 134.26 24.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.518 . . . . 14.960000000000001 111.038 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.98 146.26 94.62 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.718 2.278 . . . . 14.550000000000001 111.52 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.61 79.78 16.4 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 120.87 -0.332 . . . . 10.949999999999999 111.694 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.63 122.46 11.07 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.68 2.253 . . . . 10.6 111.116 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.51 121.95 70.84 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.194 -0.457 . . . . 6.1100000000000003 111.133 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.72 -5.33 8.04 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.742 2.295 . . . . 5.3600000000000003 112.298 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.48 118.5 21.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 4.1299999999999999 111.347 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 9.6 tp10 -82.33 103.72 12.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.518 -0.764 . . . . 2.4500000000000002 109.408 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 7.6 m0 -79.38 -161.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.53000000000000003 111.049 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.9 tp -81.24 111.71 17.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.333 -0.848 . . . . 1.1899999999999999 110.765 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.638 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -63.61 115.19 4.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.686 0.755 . . . . 2.5099999999999998 110.543 173.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.604 HD13 HD12 ' A' ' 45' ' ' LEU . 21.0 mt -66.86 -44.69 88.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.192 -0.913 . . . . 1.1499999999999999 111.152 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD23 HD12 ' A' ' 101' ' ' LEU . 93.0 mt -111.05 10.41 22.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 1.4299999999999999 110.14 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.638 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 77.22 -2.34 61.81 Favored Glycine 0 C--O 1.225 -0.46 0 CA-C-N 115.539 -0.755 . . . . 0.65000000000000002 112.137 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.717 HD21 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -83.74 -21.21 32.33 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.678 0.621 . . . . 0.94999999999999996 112.678 -174.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.717 ' N ' HD21 ' A' ' 42' ' ' ASN . . . 83.52 -22.67 7.23 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.413 -0.899 . . . . 0.71999999999999997 112.437 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.8 -32.84 72.85 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 122.109 0.957 . . . . 2.1600000000000001 108.948 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.604 HD12 HD13 ' A' ' 39' ' ' ILE . 21.3 tp -121.21 114.09 20.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.685 -1.598 . . . . 1.1200000000000001 110.292 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 49.8 mtm180 -142.32 143.43 32.77 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.296 0.372 . . . . 1.49 110.615 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HG3' HG21 ' A' ' 114' ' ' VAL . 23.0 ttpt -111.36 134.82 52.67 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.19 -0.3 . . . . 1.1200000000000001 110.19 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.1 ttpp -124.02 126.99 47.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.194 -0.299 . . . . 1.6499999999999999 110.194 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -79.89 116.53 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 1.03 111.223 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 ' HG3' ' A' ' 141' ' ' GLU . 7.5 mt -75.05 -49.28 20.28 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.507 -1.664 . . . . 1.0600000000000001 106.507 169.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.853 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 89.6 t -134.09 130.7 20.47 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 113.105 -1.861 . . . . 1.1399999999999999 106.287 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 20.6 Cg_endo -108.66 63.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.119 2.546 . . . . 0.56000000000000005 113.873 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.634 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 68.03 170.49 5.5 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.396 -0.82 . . . . 0.55000000000000004 113.685 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.697 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 93.8 Cg_endo -87.27 175.32 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.235 2.624 . . . . 1.9099999999999999 111.451 172.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.82 65.98 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.404 2.069 . . . . 2.5299999999999998 112.801 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.74 56.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.028 -0.606 . . . . 1.4199999999999999 112.796 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.697 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.9 p -99.84 -171.92 2.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.038 0.447 . . . . 1.3600000000000001 111.13 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.13 153.19 41.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.224 -1.028 . . . . 1.8200000000000001 108.224 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -103.71 115.02 64.2 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 3.3900000000000001 110.098 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HD3' HG23 ' A' ' 108' ' ' VAL . 61.4 Cg_exo -37.26 135.66 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.827 3.018 . . . . 0.42999999999999999 113.982 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 18.9 t -90.73 150.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.092 -0.707 . . . . 1.47 109.092 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.697 ' HZ3' HD21 ' A' ' 101' ' ' LEU . 64.6 mttt -65.56 104.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.899 0.857 . . . . 1.71 111.117 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.462 ' HA3' ' CG ' ' A' ' 151' ' ' GLU . . . 142.18 -24.41 2.38 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 113.888 -1.505 . . . . 0.41999999999999998 110.113 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.679 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.044 0.449 . . . . 0.58999999999999997 109.948 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 76.1 t -83.51 117.03 28.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.313 -0.858 . . . . 1.8600000000000001 108.768 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.7 m -123.1 150.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.591 . . . . 1.0700000000000001 111.255 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.629 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 62.0 p -104.49 113.4 26.94 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.629 -0.714 . . . . 1.0600000000000001 110.085 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.611 HG22 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.3 145.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.331 -0.547 . . . . 1.05 109.977 175.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.34 114.46 28.76 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.188 -1.412 . . . . 0.28999999999999998 107.188 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.39 134.15 55.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.012 -1.075 . . . . 1.1299999999999999 111.075 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.553 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -129.94 114.72 16.19 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.902 -1.888 . . . . 0.27000000000000002 105.902 166.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.619 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 62.5 m -103.94 128.19 51.47 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.66 -1.155 . . . . 1.04 111.619 -168.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -105.01 151.21 24.22 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.914 -1.039 . . . . 1.54 108.653 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.27 165.46 25.0 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.97 -0.559 . . . . 1.51 109.604 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 6.4 pt-20 -55.77 -15.37 3.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.077 0.465 . . . . 1.1399999999999999 110.807 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.554 ' ND2' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -88.68 -16.71 31.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.699 -0.682 . . . . 2.1400000000000001 109.808 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.5 -4.71 37.44 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.656 -0.702 . . . . 0.51000000000000001 111.844 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -81.45 110.21 16.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.815 0.341 . . . . 1.1599999999999999 111.859 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 29.9 mtt180 -72.54 123.7 23.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.552 0.691 . . . . 0.54000000000000004 111.187 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.658 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.0 m -109.11 -15.73 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.832 -1.076 . . . . 1.0600000000000001 112.295 -170.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.616 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.9 pt20 -154.74 137.44 15.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.437 -0.579 . . . . 0.63 109.437 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 26.1 tt0 -144.41 105.69 4.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.171 0.51 . . . . 1.3400000000000001 110.152 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -119.73 121.41 29.85 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.539 -0.755 . . . . 2.5899999999999999 109.499 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.434 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 11.8 Cg_exo -69.0 -18.73 40.43 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.894 2.396 . . . . 0.90000000000000002 113.059 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.625 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 14.1 tt0 -166.56 96.3 0.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.089 0.947 . . . . 1.3700000000000001 111.53 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -98.38 102.94 14.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.485 -1.689 . . . . 1.1399999999999999 108.514 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.9 p -97.33 135.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.772 -0.455 . . . . 1.5900000000000001 109.772 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 31.2 p90 -157.42 169.06 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.25 111.417 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m -89.66 114.76 26.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.511 -0.768 . . . . 1.0700000000000001 109.648 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.878 HD13 ' HD3' ' A' ' 104' ' ' PRO . 16.3 tp -63.02 129.93 42.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.015 -0.538 . . . . 1.3300000000000001 110.65 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.484 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.06 6.18 86.83 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.885 -0.674 . . . . 0.37 112.083 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.65 -1.51 30.05 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.73 -0.47 . . . . 0.93000000000000005 109.73 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 40.0 m 56.16 33.99 23.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.662 -0.699 . . . . 1.55 109.727 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 17.7 t70 -71.47 -9.45 58.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 122.54 1.162 . . . . 1.3300000000000001 108.549 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.404 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 15.3 m -131.61 -162.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.497 -1.683 . . . . 1.0800000000000001 110.409 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.1 pt -77.6 139.64 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 107.67 -1.233 . . . . 1.0600000000000001 107.67 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.576 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 5.2 tp60 -60.05 -28.6 67.91 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.931 -0.308 . . . . 0.40000000000000002 110.941 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.05 82.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.179 0.514 . . . . 1.0800000000000001 110.262 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD21 HG22 ' A' ' 68' ' ' VAL . 47.4 tp -74.67 -40.48 61.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 1.0700000000000001 110.247 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.457 ' HB3' HE21 ' A' ' 97' ' ' GLN . 13.9 t70 -61.74 -28.06 69.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.906 -1.043 . . . . 0.26000000000000001 109.919 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.697 HD21 ' HZ3' ' A' ' 62' ' ' LYS . 65.8 mt -91.28 -36.75 13.7 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.282 -0.872 . . . . 1.0600000000000001 112.587 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.461 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 17.4 p -74.13 -23.6 59.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 1.53 110.972 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 99' ' ' LEU . 38.9 t -67.8 -55.27 14.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.709 -0.678 . . . . 1.0600000000000001 112.1 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.878 ' HD3' HD13 ' A' ' 90' ' ' LEU . 28.2 Cg_endo -62.69 -18.76 65.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.138 1.892 . . . . 0.40999999999999998 111.999 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.493 ' CD1' HG22 ' A' ' 39' ' ' ILE . 13.7 mt -83.43 -17.39 42.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.999 -0.546 . . . . 1.3500000000000001 111.713 172.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.73 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 10.4 ttp -97.37 142.71 28.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.354 -0.385 . . . . 1.3100000000000001 111.344 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -85.51 151.3 24.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.176 0.512 . . . . 0.96999999999999997 110.855 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.762 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -59.78 123.47 12.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.903 -0.589 . . . . 1.47 110.053 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.3 12.72 47.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.066 -0.97 . . . . 0.28000000000000003 112.871 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.853 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 8.4 pt-20 -114.24 169.19 9.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.2 0.524 . . . . 0.40999999999999998 110.64 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.6 m -129.32 120.9 26.42 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.651 -0.87 . . . . 1.0700000000000001 108.651 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.57 135.57 53.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.88 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.6 ttm -97.78 117.81 32.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.544 -1.28 . . . . 1.9399999999999999 107.544 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.689 HG21 ' HG3' ' A' ' 47' ' ' LYS . 5.4 t -115.1 133.06 62.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.531 -0.544 . . . . 1.0600000000000001 109.531 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 87.5 m -110.38 114.66 28.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.602 0.715 . . . . 1.03 109.077 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.17 137.02 54.15 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 1.01 110.41 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.589 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.81 147.35 9.07 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.737 -0.838 . . . . 0.57999999999999996 108.737 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.583 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.5 t -54.77 -27.16 39.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.04 0.447 . . . . 1.04 110.288 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 12.7 ptpt -55.19 -33.13 62.75 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.165 -0.334 . . . . 1.4299999999999999 111.511 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.555 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 83.9 m-85 -94.86 3.22 55.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.073 0.463 . . . . 1.04 110.1 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.597 ' HB3' HD21 ' A' ' 138' ' ' LEU . 72.3 m -123.16 -91.77 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.193 -0.912 . . . . 0.87 110.528 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 8.1 m-85 -142.59 41.08 1.58 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.153 -0.619 . . . . 0.95999999999999996 112.123 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.77 -88.57 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.486 -0.387 . . . . 0.25 113.909 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.49 11.69 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.396 2.064 . . . . 0.90000000000000002 111.168 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.04 -48.87 3.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.396 -0.82 . . . . 0.65000000000000002 109.884 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.634 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 79.13 143.63 2.64 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 114.616 -1.174 . . . . 0.29999999999999999 112.216 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.694 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.0 t -90.48 147.54 23.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.103 0.478 . . . . 0.90000000000000002 111.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HD2' ' H ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -54.87 -28.18 48.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.12 -0.945 . . . . 3.6099999999999999 112.485 -175.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 1.084 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 27.5 t -91.59 -70.03 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.891 -0.781 . . . . 1.52 108.891 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 1.084 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.4 Cg_endo -105.19 128.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.5 2.134 . . . . 0.44 111.998 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.634 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 22.3 t80 -55.72 97.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.32 -0.993 . . . . 1.6899999999999999 108.32 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' A' ' 127' ' ' SER . 28.6 mm -67.16 125.97 91.8 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.556 -0.747 . . . . 1.0600000000000001 109.31 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 136' ' ' ALA . 9.7 Cg_endo -53.47 135.99 62.52 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.321 2.014 . . . . 1.03 111.688 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.588 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 54.2 Cg_exo -53.33 129.01 31.53 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.491 2.127 . . . . 0.89000000000000001 112.304 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.557 ' H ' ' HB3' ' A' ' 118' ' ' SER . 70.3 m-70 74.69 11.09 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.69 -1.141 . . . . 3.1899999999999999 112.931 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.473 ' HB3' ' HG2' ' A' ' 133' ' ' PRO . . . -71.07 118.87 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.254 -1.017 . . . . 1.04 108.254 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.19 113.68 10.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.463 0.649 . . . . 1.05 109.902 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.619 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.37 131.98 34.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.153 -0.931 . . . . 1.0600000000000001 110.966 -174.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.1 t -115.18 99.74 7.64 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.891 -0.781 . . . . 1.8200000000000001 108.891 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -112.85 134.53 54.32 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.467 0.651 . . . . 1.1499999999999999 111.781 -173.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 39.9 tt0 -99.8 113.59 26.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.186 -0.916 . . . . 1.05 108.916 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 2.2 m -115.7 121.3 67.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.46 0.648 . . . . 1.0800000000000001 112.674 -175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 145' ' ' LYS . 8.1 m -88.05 121.67 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.18 -0.918 . . . . 1.0900000000000001 109.756 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.61 HD23 ' HG2' ' A' ' 60' ' ' PRO . 39.0 tp -93.89 93.33 7.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.401 -0.962 . . . . 1.0700000000000001 108.401 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.607 ' HG3' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -85.81 -30.83 22.69 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.898 -1.047 . . . . 1.6899999999999999 110.629 -172.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.629 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 85.2 m -157.14 145.09 19.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.813 -0.631 . . . . 1.1200000000000001 111.562 -168.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.612 ' HB1' ' HG3' ' A' ' 60' ' ' PRO . . . -137.55 128.32 27.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.74 -0.664 . . . . 0.98999999999999999 109.369 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 65' ' ' VAL . 11.2 m -132.12 145.66 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.563 -0.532 . . . . 1.6200000000000001 109.563 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 4.4 t70 -84.33 118.29 24.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.366 -0.533 . . . . 2.27 110.105 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.435 ' HB3' HG21 ' A' ' 65' ' ' VAL . 13.1 tp -137.55 16.33 2.93 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.667 -0.864 . . . . 2.5 108.667 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.462 ' CG ' ' HA3' ' A' ' 63' ' ' GLY . 2.0 tm-20 -72.82 -41.85 64.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.64 -1.164 . . . . 2.1400000000000001 108.632 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -77.24 61.74 2.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.913 -1.039 . . . . 6.6299999999999999 110.518 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -71.52 129.45 38.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.953 -1.021 . . . . 8.1899999999999995 110.703 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -135.2 149.29 49.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.003 -0.544 . . . . 9.0800000000000001 110.237 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -75.06 131.2 40.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.772 -0.649 . . . . 9.2400000000000002 110.827 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -127.82 162.53 26.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.973 -0.751 . . . . 12.779999999999999 108.973 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.408 -0.806 . . . . 14.109999999999999 110.445 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 ttm . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.936 0.398 . . . . 50.460000000000001 110.182 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.97 163.97 12.21 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.065 -0.814 . . . . 47.990000000000002 111.065 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 65.08 87.24 0.12 Allowed Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 121.18 0.514 . . . . 46.439999999999998 111.212 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 74.3 Cg_endo -73.7 152.29 47.56 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 123.008 2.472 . . . . 45.219999999999999 112.431 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 12.5 Cg_exo -70.57 145.26 51.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.488 2.125 . . . . 44.450000000000003 111.482 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 71.81 102.17 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.925 0.766 . . . . 42.710000000000001 111.941 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.11 170.14 8.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 41.5 109.798 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.91 175.4 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 40.329999999999998 110.906 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.06 42.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.648 . . . . 39.390000000000001 109.554 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -88.82 -78.85 0.33 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.212 0.53 . . . . 38.82 109.92 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -114.69 124.0 31.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 38.350000000000001 110.727 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 -27.36 84.72 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.3 2.0 . . . . 37.039999999999999 111.277 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.59 31.79 7.66 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.847 -0.615 . . . . 35.659999999999997 112.079 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 56.08 -96.02 0.06 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.092 0.525 . . . . 35.149999999999999 110.335 -174.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 35.4 tp 174.08 -88.68 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 123.95 0.781 . . . . 34.170000000000002 109.379 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 171.56 -40.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.396 -0.82 . . . . 32.950000000000003 109.085 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -124.62 117.04 23.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.97 -1.014 . . . . 32.299999999999997 110.182 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 19' ' ' PHE . 4.4 pt-20 -103.14 -49.13 3.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 31.239999999999998 110.981 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 62.6 t80 -152.32 -60.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.435 . . . . 31.57 110.455 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HG ' ' CD2' ' A' ' 19' ' ' PHE . 89.1 mt -121.81 -174.25 2.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.635 0.255 . . . . 30.100000000000001 110.318 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.94 -164.84 1.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.978 -0.556 . . . . 28.399999999999999 110.059 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.65 160.84 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.483 0.182 . . . . 26.969999999999999 110.829 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.2 mmt 72.28 5.55 5.31 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.841 0.713 . . . . 27.66 112.357 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -133.41 91.64 26.34 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.19 -0.671 . . . . 24.41 109.19 173.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -83.63 154.64 13.7 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.759 2.306 . . . . 22.399999999999999 112.671 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 16.1 pt-20 -96.79 145.17 29.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 20.670000000000002 109.797 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 18.4 Cg_exo -66.54 137.18 45.52 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.832 2.355 . . . . 18.75 112.747 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.17 137.03 35.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 14.960000000000001 110.172 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.26 127.7 21.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.239 1.959 . . . . 14.550000000000001 112.04 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.29 65.22 10.37 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.999 -0.546 . . . . 10.949999999999999 110.869 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.57 118.92 5.87 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.432 2.088 . . . . 10.6 111.463 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.62 116.73 64.64 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.415 -0.357 . . . . 6.1100000000000003 110.875 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.1 -0.53 10.77 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.2 2.6 . . . . 5.3600000000000003 111.58 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -98.63 146.72 25.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 4.1299999999999999 109.434 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -85.07 121.5 27.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.705 0.288 . . . . 2.4500000000000002 110.236 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -80.44 -166.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.17 -0.468 . . . . 0.53000000000000003 110.378 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.46 110.83 7.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 1.1899999999999999 110.409 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.642 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -75.0 127.15 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.332 0.587 . . . . 2.5099999999999998 110.612 174.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.538 HD12 HD13 ' A' ' 45' ' ' LEU . 8.4 mt -57.78 -35.55 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.586 -1.188 . . . . 1.1499999999999999 111.549 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.6 mt -111.12 -1.16 16.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.286 0.565 . . . . 1.4299999999999999 110.278 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.22 26.63 66.26 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.318 -0.855 . . . . 0.65000000000000002 111.746 -172.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.39 -29.09 14.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.65 0.241 . . . . 0.94999999999999996 111.65 -178.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.41 -9.14 30.72 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 121.114 -0.565 . . . . 0.71999999999999997 111.751 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 7.3 mp -97.4 -33.18 11.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.253 -0.474 . . . . 2.1600000000000001 110.971 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.538 HD13 HD12 ' A' ' 39' ' ' ILE . 19.8 tp -122.91 100.7 7.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 1.1200000000000001 111.352 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 66.7 mtm180 -132.23 140.73 48.78 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.178 -0.326 . . . . 1.49 111.163 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.654 ' HG2' ' HB3' ' A' ' 112' ' ' ALA . 13.4 ttpt -111.51 123.66 50.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.265 -0.272 . . . . 1.1200000000000001 110.265 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 20.1 ttmt -101.17 122.08 42.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.157 -0.312 . . . . 1.6499999999999999 110.157 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 52' ' ' PRO . 5.3 p -76.67 100.82 5.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.497 -0.319 . . . . 1.03 110.977 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 111' ' ' THR . 11.5 mt -68.71 -55.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.065 -1.457 . . . . 1.0600000000000001 107.065 171.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.787 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.5 t -129.82 126.35 22.52 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 113.024 -1.898 . . . . 1.1399999999999999 106.299 167.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 16.5 Cg_endo -104.48 60.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.832 2.355 . . . . 0.56000000000000005 113.477 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.81 151.89 4.35 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.959 -0.564 . . . . 0.55000000000000004 113.213 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 38.0 Cg_endo -68.39 163.28 37.12 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.176 1.918 . . . . 1.9099999999999999 110.466 172.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.24 98.65 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.375 2.05 . . . . 2.5299999999999998 112.009 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.04 51.37 2.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.134 -0.555 . . . . 1.4199999999999999 112.674 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -83.09 -162.97 0.66 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 110.185 -0.302 . . . . 1.3600000000000001 110.185 174.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 t -152.81 127.93 9.75 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.04 -0.726 . . . . 1.8200000000000001 109.04 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.81 122.14 67.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.583 -0.447 . . . . 3.3900000000000001 110.946 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD3' HG21 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.6 153.24 11.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.789 2.992 . . . . 0.42999999999999999 114.13 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.7 t -100.08 155.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.004 -0.998 . . . . 1.47 109.449 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 95.4 mttt -64.34 106.86 1.19 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.386 0.613 . . . . 1.71 110.364 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 141.75 -24.73 2.44 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.28 -1.128 . . . . 0.41999999999999998 110.28 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.637 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.01 137.72 34.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.282 -0.636 . . . . 0.58999999999999997 109.282 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.5 m -81.05 133.54 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.064 -1.087 . . . . 1.8600000000000001 108.064 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.2 m -127.8 143.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.022 -0.535 . . . . 1.0700000000000001 110.92 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 45.9 p -94.11 112.61 24.44 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.309 -0.626 . . . . 1.0600000000000001 109.309 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.574 HG23 HD23 ' A' ' 99' ' ' LEU . 19.6 m -110.15 143.41 20.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.901 -0.72 . . . . 1.05 109.849 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.58 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.7 t-160 -102.33 116.11 31.95 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.824 -1.547 . . . . 0.28999999999999998 106.824 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 83' ' ' GLU . 1.2 pt? -122.5 137.95 54.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.462 -0.895 . . . . 1.1299999999999999 110.83 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.11 114.31 13.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.277 -2.12 . . . . 0.27000000000000002 105.277 166.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.629 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 71.0 m -105.04 129.69 53.42 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.6 -1.182 . . . . 1.04 111.016 -166.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 1.002 ' HB3' ' SG ' ' A' ' 139' ' ' CYS . 4.7 t -104.38 172.51 6.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.268 -0.878 . . . . 1.54 108.884 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' ' 80' ' ' VAL . 12.3 mt -101.48 165.54 11.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.517 -0.765 . . . . 1.51 109.178 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.18 -23.35 34.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.1 0.476 . . . . 1.1399999999999999 110.492 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.28 -8.49 53.28 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.776 -0.647 . . . . 2.1400000000000001 111.492 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.39 10.56 44.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.259 -0.972 . . . . 0.51000000000000001 113.568 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 92.1 m -98.64 113.0 24.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.311 0.555 . . . . 1.1599999999999999 112.332 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.883 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.4 mtt180 -69.91 125.56 27.12 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.54000000000000004 110.363 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.963 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.2 m -108.89 -20.17 6.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.004 -0.998 . . . . 1.0600000000000001 112.295 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.636 ' NE2' ' HG ' ' A' ' 127' ' ' SER . 9.2 pt20 -146.99 124.3 11.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.421 -0.354 . . . . 0.63 110.242 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -118.41 118.0 30.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.31 0.576 . . . . 1.3400000000000001 109.964 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.648 ' HB3' HD23 ' A' ' 70' ' ' LEU . 6.4 tp10 -135.8 107.58 9.85 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.589 -0.732 . . . . 2.5899999999999999 110.814 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.58 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 14.3 Cg_exo -68.12 -19.83 44.6 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.056 2.504 . . . . 0.90000000000000002 112.952 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -164.22 113.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.025 0.917 . . . . 1.3700000000000001 112.567 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.08 110.31 16.08 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.772 -1.558 . . . . 1.1399999999999999 108.763 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.8 p -100.17 137.03 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.569 -0.53 . . . . 1.5900000000000001 109.569 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.606 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -159.45 157.64 30.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 0.25 110.426 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 24.4 m -76.87 119.13 20.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.527 -0.546 . . . . 1.0700000000000001 109.527 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.856 HD13 ' HD3' ' A' ' 104' ' ' PRO . 17.4 tp -62.19 133.22 54.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 1.3300000000000001 110.544 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.71 -4.91 80.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 0.37 111.844 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.407 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 12.8 t70 -83.77 -15.06 49.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.165 -0.68 . . . . 0.93000000000000005 109.165 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.0 m 62.65 30.1 16.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.863 -1.062 . . . . 1.55 109.414 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 13.7 t70 -62.55 -26.36 68.53 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 122.367 1.079 . . . . 1.3300000000000001 108.45 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 m -114.46 -158.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 113.341 -1.754 . . . . 1.0800000000000001 110.834 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.7 pt -84.34 139.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.81 -1.182 . . . . 1.0600000000000001 107.81 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -60.17 -27.34 67.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.449 -0.341 . . . . 0.40000000000000002 110.966 -173.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.39 -42.95 78.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.324 0.583 . . . . 1.0800000000000001 110.286 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.574 HD23 HG23 ' A' ' 68' ' ' VAL . 53.0 tp -78.53 -40.49 34.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.131 -0.941 . . . . 1.0700000000000001 110.377 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB3' HE21 ' A' ' 97' ' ' GLN . 20.1 t70 -61.97 -29.72 70.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.794 -1.094 . . . . 0.26000000000000001 109.973 -174.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 57.6 mt -90.66 -33.64 15.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.44 -0.8 . . . . 1.0600000000000001 111.959 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.553 ' HG ' HG23 ' A' ' 114' ' ' VAL . 31.5 t -65.63 -34.54 78.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 1.53 110.769 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 99' ' ' LEU . 54.7 t -63.56 -53.29 52.78 Favored Pre-proline 0 C--O 1.22 -0.492 0 N-CA-C 113.129 0.789 . . . . 1.0600000000000001 113.129 -177.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.856 ' HD3' HD13 ' A' ' 90' ' ' LEU . 17.7 Cg_endo -62.03 -22.15 73.71 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.988 1.792 . . . . 0.40999999999999998 111.945 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.441 ' CD1' HG22 ' A' ' 39' ' ' ILE . 9.5 mt -83.82 -11.98 56.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.416 0.627 . . . . 1.3500000000000001 110.991 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.755 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 34.8 ttm -98.28 140.36 32.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.969 -1.014 . . . . 1.3100000000000001 111.635 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.13 153.11 19.56 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.485 -0.561 . . . . 0.96999999999999997 109.485 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' HD3' ' A' ' 60' ' ' PRO . 2.0 t -62.0 124.98 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 1.47 110.65 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 12.95 52.98 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.28000000000000003 112.723 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.787 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.6 pt-20 -105.43 168.63 8.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.478 0.639 . . . . 0.40999999999999998 110.432 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.484 HG22 HD13 ' A' ' 50' ' ' LEU . 24.4 m -132.83 119.8 20.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.402 -0.962 . . . . 1.0700000000000001 108.402 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.654 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . . . -117.54 137.45 52.57 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.483 -0.781 . . . . 1.0 110.718 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 ttt -96.85 116.03 28.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.872 -1.529 . . . . 1.9399999999999999 106.872 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.553 HG23 ' HG ' ' A' ' 102' ' ' SER . 3.4 t -113.34 132.96 60.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.53 -0.545 . . . . 1.0600000000000001 109.53 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.518 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 63.0 m -110.7 114.43 27.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.629 -0.828 . . . . 1.03 109.36 171.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.99 53.83 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.896 -1.502 . . . . 1.01 109.813 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.57 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.3 t70 -52.47 147.24 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.981 -0.748 . . . . 0.57999999999999996 108.981 173.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.615 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.1 t -55.78 -28.32 55.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 1.04 110.086 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.57 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 15.6 ptpt -55.48 -31.44 62.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.629 -0.259 . . . . 1.4299999999999999 111.634 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 78.5 m-85 -95.2 -1.55 51.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.147 0.499 . . . . 1.04 109.839 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 65.6 m -117.14 -93.47 0.51 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.061 -0.972 . . . . 0.87 110.371 -177.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.61 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.8 m-85 -140.78 39.71 1.83 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.207 -0.597 . . . . 0.95999999999999996 112.091 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -45.59 -83.03 0.02 OUTLIER Glycine 0 C--N 1.344 0.99 0 N-CA-C 114.242 0.457 . . . . 0.25 114.242 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HA ' ' HH ' ' A' ' 131' ' ' TYR . 74.0 Cg_endo -87.4 13.93 2.53 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.393 2.062 . . . . 0.90000000000000002 110.77 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.9 mt-30 -104.65 -49.28 3.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.978 -1.01 . . . . 0.65000000000000002 110.498 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.83 142.2 3.76 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 114.544 -1.207 . . . . 0.29999999999999999 112.622 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.636 ' HG ' ' NE2' ' A' ' 81' ' ' GLN . 30.4 t -91.93 165.99 12.94 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.091 0.404 . . . . 0.90000000000000002 112.091 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.574 ' HG3' ' N ' ' A' ' 129' ' ' SER . 6.9 ptp180 -52.87 -49.88 64.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.728 -0.669 . . . . 3.6099999999999999 112.219 -171.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.994 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 13.0 m -87.78 -62.72 0.22 Allowed Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.704 -0.48 . . . . 1.52 109.704 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.994 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 8.9 Cg_endo -101.08 127.7 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.592 2.195 . . . . 0.44 111.707 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.504 ' HH ' ' HA ' ' A' ' 124' ' ' PRO . 9.6 t80 -57.43 97.35 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.938 -1.504 . . . . 1.6899999999999999 106.938 159.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.601 HD13 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -64.87 124.66 87.13 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 107.965 -1.124 . . . . 1.0600000000000001 107.965 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.22 141.19 31.91 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.499 2.133 . . . . 1.03 112.301 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.533 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 55.0 Cg_exo -52.37 132.32 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.582 2.188 . . . . 0.89000000000000001 112.156 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.473 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 1.4 m-70 72.35 9.22 5.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.069 -0.969 . . . . 3.1899999999999999 113.015 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -74.09 123.84 25.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.162 -0.681 . . . . 1.04 109.162 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.82 112.28 9.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.351 0.596 . . . . 1.05 109.643 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 121' ' ' CYS . 2.0 tp -88.76 131.87 34.86 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.549 -0.751 . . . . 1.0600000000000001 110.586 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 1.002 ' SG ' ' HB3' ' A' ' 73' ' ' SER . 24.7 p -116.73 100.29 7.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.795 0.807 . . . . 1.8200000000000001 110.501 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -109.66 133.64 52.89 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.323 -0.853 . . . . 1.1499999999999999 111.491 -172.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.536 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.1 tt0 -98.33 109.09 21.9 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.508 -0.769 . . . . 1.05 109.212 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.632 HG21 ' HE3' ' A' ' 106' ' ' MET . 0.8 OUTLIER -113.35 116.46 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.463 0.649 . . . . 1.0800000000000001 112.39 -174.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 9.5 m -89.2 113.72 24.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 1.0900000000000001 111.034 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.751 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -84.8 93.55 8.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.773 -0.825 . . . . 1.0700000000000001 108.773 172.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -86.45 -32.61 20.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.111 -0.95 . . . . 1.6899999999999999 110.799 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.3 m -150.71 147.31 27.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.309 -0.405 . . . . 1.1200000000000001 111.197 -173.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.433 ' HA ' HG13 ' A' ' 66' ' ' VAL . . . -134.22 128.31 33.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.156 -0.683 . . . . 0.98999999999999999 109.156 171.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.83 125.39 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 110.063 -0.347 . . . . 1.6200000000000001 110.063 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.429 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 2.3 p-10 -70.67 117.15 11.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 120.335 -0.546 . . . . 2.27 109.961 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.59 25.07 1.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.777 . . . . 2.5 109.168 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -92.06 116.26 28.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.07 -0.715 . . . . 2.1400000000000001 109.07 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -134.92 74.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.108 -0.701 . . . . 6.6299999999999999 109.108 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -51.97 110.57 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.699 -1.137 . . . . 8.1899999999999995 111.57 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -136.43 -65.99 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.952 -0.759 . . . . 9.0800000000000001 108.952 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -157.4 25.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.752 0.787 . . . . 9.2400000000000002 109.472 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 61.0 t-80 -130.09 53.36 1.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.932 -1.507 . . . . 12.779999999999999 106.932 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 33.6 m170 . . . . . 0 C--O 1.24 0.595 0 CA-C-N 114.483 -1.235 . . . . 14.109999999999999 109.082 -163.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.167 -0.309 . . . . 50.460000000000001 110.167 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.0 36.4 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.481 -0.648 . . . . 47.990000000000002 111.481 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.688 HE21 ' HA ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -145.04 98.83 4.69 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 109.791 -0.448 . . . . 46.439999999999998 109.791 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.07 134.45 42.87 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.711 2.274 . . . . 45.219999999999999 111.443 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.79 123.82 14.68 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.126 2.551 . . . . 44.450000000000003 113.19 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.87 82.39 2.0 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.435 -0.802 . . . . 42.710000000000001 109.001 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.686 ' HG3' ' H ' ' A' ' 8' ' ' GLU . 5.3 pt-20 -153.35 -69.79 0.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.714 -0.675 . . . . 41.5 111.496 -170.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.686 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 41.4 tt0 64.11 89.82 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.701 0.625 . . . . 40.329999999999998 110.164 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.91 -168.82 0.14 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.574 -0.739 . . . . 39.390000000000001 110.893 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -44.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.192 -0.458 . . . . 38.82 110.774 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -151.06 106.14 3.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 38.350000000000001 111.186 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.27 154.19 61.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.239 2.626 . . . . 37.039999999999999 111.85 175.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.81 -138.92 2.52 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.843 -0.694 . . . . 35.659999999999997 112.682 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 73.02 -64.55 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.024 0.93 . . . . 35.149999999999999 111.967 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 tt -94.09 133.24 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.418 -0.355 . . . . 34.170000000000002 110.344 -174.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 135.59 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 32.950000000000003 110.377 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -144.04 163.01 34.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.358 -0.383 . . . . 32.299999999999997 110.477 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -92.61 115.49 28.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.979 0.419 . . . . 31.239999999999998 110.754 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -85.82 0.94 51.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.151 -0.477 . . . . 31.57 110.429 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 21' ' ' ALA . 1.4 pp -129.09 -20.65 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 30.100000000000001 111.659 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 57.36 90.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.995 0.518 . . . . 28.399999999999999 111.858 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.5 10.62 3.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.981 0.419 . . . . 26.969999999999999 111.734 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.52 2.71 56.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.154 -0.476 . . . . 27.66 110.621 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 9.8 tp10 -81.56 -47.55 1.04 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.816 -0.629 . . . . 24.41 111.465 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 36.5 Cg_exo -62.72 -169.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.353 2.035 . . . . 22.399999999999999 112.777 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.46 ' OE2' ' HD2' ' A' ' 27' ' ' PRO . 10.0 tp10 -58.54 119.7 38.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 20.670000000000002 110.596 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD2' ' OE2' ' A' ' 26' ' ' GLU . 28.5 Cg_endo -63.41 131.64 32.73 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 18.75 112.957 -176.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.85 153.78 37.59 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.689 -0.687 . . . . 14.960000000000001 109.564 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.11 128.22 27.94 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.416 2.077 . . . . 14.550000000000001 112.525 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.773 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -144.68 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.701 -0.681 . . . . 10.949999999999999 110.311 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 30' ' ' ALA . 17.1 Cg_exo -68.19 132.15 25.31 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.924 1.749 . . . . 10.6 110.502 170.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.22 148.06 35.87 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 121.023 -0.271 . . . . 6.1100000000000003 110.863 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.33 -19.57 65.72 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.384 2.056 . . . . 5.3600000000000003 111.251 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.39 -54.21 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.351 -0.84 . . . . 4.1299999999999999 109.848 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 34.9 mm-40 -97.44 99.2 10.62 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.399 -0.364 . . . . 2.4500000000000002 110.113 176.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.671 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -83.18 -158.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.81 -0.632 . . . . 0.53000000000000003 110.995 -175.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.75 110.99 5.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 1.1899999999999999 110.398 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.666 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -66.59 103.2 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 2.5099999999999998 110.963 175.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.724 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.2 mt -53.88 -48.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.66 -1.155 . . . . 1.1499999999999999 111.522 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.428 HD11 ' CE2' ' A' ' 120' ' ' TYR . 52.0 mt -105.68 12.79 30.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 1.4299999999999999 110.712 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.666 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 69.08 6.83 55.07 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.331 -0.849 . . . . 0.65000000000000002 113.332 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' H ' HD21 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -99.27 -12.76 20.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.676 0.275 . . . . 0.94999999999999996 111.468 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.32 -19.11 37.35 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.382 -0.913 . . . . 0.71999999999999997 112.832 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.5 mp -75.33 -24.47 57.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.039 0.923 . . . . 2.1600000000000001 109.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.724 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 tp -119.13 113.84 21.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.911 -1.495 . . . . 1.1200000000000001 110.145 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.416 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 43.4 mtm180 -142.86 133.44 25.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.35 0.5 . . . . 1.49 112.35 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HZ2' ' HA ' ' A' ' 106' ' ' MET . 12.8 ttpt -109.97 125.04 52.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 1.1200000000000001 109.976 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 26.5 ttpp -114.4 121.6 44.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.146 0.498 . . . . 1.6499999999999999 111.046 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.586 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.3 p -74.68 103.45 4.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.198 -0.91 . . . . 1.03 111.713 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.428 HD22 ' HZ3' ' A' ' 48' ' ' LYS . 9.0 mt -69.09 -56.41 7.8 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.67 -1.604 . . . . 1.0600000000000001 106.67 171.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 56.0 t -131.97 123.89 19.28 Favored Pre-proline 0 CA--C 1.502 -0.9 0 CA-C-N 112.726 -2.034 . . . . 1.1399999999999999 106.719 168.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.627 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 73.5 Cg_endo -107.92 66.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 122.563 2.175 . . . . 0.56000000000000005 114.055 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.48 157.68 5.58 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.435 -0.802 . . . . 0.55000000000000004 113.394 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 97.0 Cg_endo -78.75 161.0 27.71 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.536 2.157 . . . . 1.9099999999999999 110.927 172.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.38 98.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.176 1.917 . . . . 2.5299999999999998 111.865 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.0 47.15 0.97 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.599 -0.81 . . . . 1.4199999999999999 112.153 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.1 p -90.34 -165.81 1.44 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.108 0.48 . . . . 1.3600000000000001 110.601 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -149.82 147.21 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.912 -0.773 . . . . 1.8200000000000001 108.912 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 85.2 mtt180 -96.24 116.37 66.13 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.578 -0.449 . . . . 3.3900000000000001 110.116 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.785 ' HD3' HG22 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -49.47 144.48 18.42 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.756 2.971 . . . . 0.42999999999999999 112.975 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 9.0 t -89.25 145.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.18 -0.463 . . . . 1.47 110.031 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.922 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 97.9 mttt -65.72 104.42 1.05 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.639 0.733 . . . . 1.71 109.788 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 142.12 -29.92 2.16 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 114.394 -1.276 . . . . 0.41999999999999998 109.948 -174.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.638 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -74.83 136.16 41.6 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.363 -0.977 . . . . 0.58999999999999997 108.363 175.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.3 m -84.16 115.23 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.951 -1.129 . . . . 1.8600000000000001 107.951 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -109.65 146.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.95 -1.023 . . . . 1.0700000000000001 110.853 -171.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.797 ' HB ' ' OE1' ' A' ' 85' ' ' GLU . 78.9 p -91.12 112.46 24.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.289 0.566 . . . . 1.0600000000000001 109.725 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.723 HG23 HD21 ' A' ' 99' ' ' LEU . 26.8 m -111.04 142.39 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 119.907 -0.717 . . . . 1.05 109.319 170.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -102.41 116.7 33.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.529 -1.656 . . . . 0.28999999999999998 106.529 169.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -116.86 135.15 53.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.98 -1.088 . . . . 1.1299999999999999 110.781 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.712 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -130.49 114.23 15.25 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.427 -2.064 . . . . 0.27000000000000002 105.427 167.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.552 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 86.8 m -106.43 127.27 53.16 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.229 -1.35 . . . . 1.04 111.145 -166.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.798 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -107.1 153.22 22.95 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.21 -0.905 . . . . 1.54 109.335 -178.246 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.7 mt -78.6 164.79 24.36 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.488 -0.778 . . . . 1.51 109.293 174.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.578 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 6.4 pt-20 -58.37 -14.21 7.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.436 0.636 . . . . 1.1399999999999999 110.507 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.664 ' N ' HD21 ' A' ' 76' ' ' ASN . 0.6 OUTLIER -87.25 -14.77 40.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.242 -0.89 . . . . 2.1400000000000001 109.895 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.33 -6.68 46.34 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.851 -0.613 . . . . 0.51000000000000001 111.763 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -81.42 110.05 16.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.926 0.343 . . . . 1.1599999999999999 111.926 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.798 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 37.5 mtt180 -74.11 116.75 15.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.511 0.672 . . . . 0.54000000000000004 110.394 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.1 m -99.33 -12.91 8.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 1.0600000000000001 112.314 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.51 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 28.9 pt20 -156.61 136.07 12.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.224 -0.444 . . . . 0.63 110.385 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 33.1 tt0 -135.13 116.54 14.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.962 -0.563 . . . . 1.3400000000000001 109.652 174.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 86' ' ' LEU . 5.2 tt0 -129.5 109.59 17.55 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.29 -0.868 . . . . 2.5899999999999999 109.795 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 16.5 Cg_exo -68.34 -13.57 38.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.736 2.957 . . . . 0.90000000000000002 113.256 -172.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OE1' ' HB ' ' A' ' 67' ' ' THR . 2.9 tp10 -157.96 101.94 1.8 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.037 0.923 . . . . 1.3700000000000001 110.711 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.469 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 28.1 tp -116.92 106.46 13.46 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.986 -1.461 . . . . 1.1399999999999999 108.65 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.5 p -101.97 132.08 48.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.252 -0.647 . . . . 1.5900000000000001 109.252 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.7 p90 -153.8 156.16 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.25 110.824 -174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.3 m -75.32 112.03 11.2 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.674 -0.693 . . . . 1.0700000000000001 109.66 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.922 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.8 tp -60.18 137.7 58.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.037 -0.528 . . . . 1.3300000000000001 110.21 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 77.61 5.98 86.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.37 112.264 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -103.3 -5.6 22.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.952 0.406 . . . . 0.93000000000000005 110.044 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 47.5 m 59.99 32.91 21.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.48 -0.782 . . . . 1.55 109.095 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 18.6 t70 -70.16 -16.52 63.1 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.424 1.107 . . . . 1.3300000000000001 108.758 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 11.7 m -121.76 -150.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 113.537 -1.665 . . . . 1.0800000000000001 110.253 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.1 pt -87.5 139.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.649 -1.241 . . . . 1.0600000000000001 107.649 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -58.68 -29.18 66.41 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 123.264 0.352 . . . . 0.40000000000000002 110.916 -173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.36 -48.34 74.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.362 0.601 . . . . 1.0800000000000001 110.664 174.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.723 HD21 HG23 ' A' ' 68' ' ' VAL . 56.5 tp -75.6 -36.22 60.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.443 -0.799 . . . . 1.0700000000000001 110.604 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.29 -30.63 71.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 0.26000000000000001 109.594 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 1.0600000000000001 112.296 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 t -63.75 -36.65 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 1.53 110.959 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 99' ' ' LEU . 77.2 t -62.97 -54.88 42.76 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.059 0.763 . . . . 1.0600000000000001 113.059 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.798 ' HD3' HD13 ' A' ' 90' ' ' LEU . 22.6 Cg_endo -62.54 -20.83 71.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.282 1.988 . . . . 0.40999999999999998 111.721 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.571 ' CD1' HG22 ' A' ' 39' ' ' ILE . 10.8 mt -83.96 -12.69 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 1.3500000000000001 111.29 173.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -106.98 155.94 19.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.268 -0.424 . . . . 1.3100000000000001 110.887 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.98 153.17 17.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 110.825 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.785 HG22 ' HD3' ' A' ' 60' ' ' PRO . 1.7 t -60.4 125.4 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.118 0.485 . . . . 1.47 110.403 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 18.58 41.98 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.103 -0.953 . . . . 0.28000000000000003 112.499 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.774 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.0 pt-20 -107.57 167.3 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.418 0.628 . . . . 0.40999999999999998 110.992 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 m -130.54 117.46 19.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.957 -1.127 . . . . 1.0700000000000001 107.957 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.28 138.89 52.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.115 0.483 . . . . 1.0 110.736 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.0 ttp -100.03 117.45 34.32 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.079 -1.452 . . . . 1.9399999999999999 107.079 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 t -114.74 131.0 68.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.764 -0.458 . . . . 1.0600000000000001 109.764 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.506 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 86.0 m -107.49 113.5 26.88 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.658 -0.867 . . . . 1.03 108.658 173.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.55 135.8 53.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.263 -1.335 . . . . 1.01 109.354 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.613 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.4 t70 -53.82 149.86 8.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.818 -0.808 . . . . 0.57999999999999996 108.818 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.619 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -56.66 -28.01 59.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.202 0.525 . . . . 1.04 110.059 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.9 ptpt -56.43 -31.94 64.41 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.902 -0.499 . . . . 1.4299999999999999 111.779 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.581 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.3 m-85 -94.87 4.22 54.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.31 0.576 . . . . 1.04 109.632 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 66.8 m -123.16 -92.76 0.53 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.067 -0.97 . . . . 0.87 110.489 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.527 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 6.5 m-85 -142.0 39.77 1.64 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 119.041 -0.504 . . . . 0.95999999999999996 112.135 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.16 -88.7 0.01 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 114.09 0.396 . . . . 0.25 114.09 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.96 10.63 3.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.015 1.81 . . . . 0.90000000000000002 111.434 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -103.49 -49.4 3.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.567 -0.742 . . . . 0.65000000000000002 109.924 -173.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.496 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 81.72 145.42 4.96 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.758 -1.11 . . . . 0.29999999999999999 111.698 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.5 t -90.49 162.54 15.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.405 -0.398 . . . . 0.90000000000000002 110.925 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -51.63 -58.74 5.49 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.892 0.745 . . . . 3.6099999999999999 110.733 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.835 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 59.6 m -77.48 -61.34 0.65 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.897 -0.592 . . . . 1.52 110.411 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.835 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.8 Cg_endo -106.04 125.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.09 1.86 . . . . 0.44 112.619 174.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.14 96.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.514 -0.921 . . . . 1.6899999999999999 108.514 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.565 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.9 123.87 87.2 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.536 -0.757 . . . . 1.0600000000000001 109.717 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.88 136.93 43.76 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.841 2.361 . . . . 1.03 112.459 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.646 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 Cg_endo -55.44 128.71 31.55 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.159 1.906 . . . . 0.89000000000000001 111.998 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.535 ' H ' ' HB3' ' A' ' 118' ' ' SER . 62.7 m170 74.13 12.97 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.98 -1.009 . . . . 3.1899999999999999 112.397 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -76.33 121.1 22.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.554 -0.906 . . . . 1.04 108.554 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.95 113.11 9.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 1.05 109.754 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.552 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.2 tp -88.45 131.45 34.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.572 -0.74 . . . . 1.0600000000000001 110.566 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.4 100.68 8.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.301 -1.0 . . . . 1.8200000000000001 108.301 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.1 pp -115.22 136.54 53.0 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.058 -0.519 . . . . 1.1499999999999999 111.734 -171.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.712 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.0 tt0 -102.71 117.14 34.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.479 -0.934 . . . . 1.05 108.479 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 99' ' ' LEU . 3.5 m -117.93 116.7 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.535 0.683 . . . . 1.0800000000000001 112.785 -174.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -89.73 108.77 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 1.0900000000000001 110.576 173.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.624 HD22 ' HG3' ' A' ' 60' ' ' PRO . 57.6 tp -85.44 97.78 10.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.379 -0.971 . . . . 1.0700000000000001 108.379 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 143' ' ' THR . 19.7 mtmm -103.39 -18.17 14.94 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.6899999999999999 110.702 -168.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m -156.16 145.36 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.913 -0.585 . . . . 1.1200000000000001 110.913 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.477 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -133.62 127.26 32.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.641 -0.874 . . . . 0.98999999999999999 108.641 169.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 65' ' ' VAL . 20.4 m -131.29 137.87 54.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.203 -0.599 . . . . 1.6200000000000001 110.436 -178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.512 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 7.6 t70 -79.61 117.96 21.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.918 -0.583 . . . . 2.27 110.04 -176.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.9 5.3 3.08 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.808 -0.633 . . . . 2.5 109.764 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -85.68 85.78 7.39 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.522 0.677 . . . . 2.1400000000000001 110.194 -175.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.07 79.02 1.45 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.538 -1.21 . . . . 6.6299999999999999 108.407 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -52.02 143.52 13.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.611 -1.177 . . . . 8.1899999999999995 110.539 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -45.27 7.88 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.476 0.917 . . . . 9.0800000000000001 113.476 -166.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -116.08 32.65 5.97 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.533 -0.467 . . . . 9.2400000000000002 111.826 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 42.1 m80 63.35 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.537 0.523 . . . . 12.779999999999999 110.978 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.136 -0.935 . . . . 14.109999999999999 109.38 179.833 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.633 0.254 . . . . 50.460000000000001 110.515 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.53 -43.69 2.62 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.717 -0.754 . . . . 47.990000000000002 111.363 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -89.91 122.52 67.79 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.24 -0.652 . . . . 46.439999999999998 109.24 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 72.3 Cg_exo -47.49 -51.72 9.17 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.284 2.656 . . . . 45.219999999999999 114.5 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 1.8 Cg_endo -83.65 120.61 2.79 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.346 1.364 . . . . 44.450000000000003 112.025 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 -0.96 2.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.605 -0.725 . . . . 42.710000000000001 110.217 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -132.83 148.03 52.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.343 -0.844 . . . . 41.5 109.938 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -122.18 107.97 12.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.116 -0.493 . . . . 40.329999999999998 109.689 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.29 -65.41 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.093 0.87 . . . . 39.390000000000001 111.27 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 179.07 -59.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.222 0.534 . . . . 38.82 110.022 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.14 76.74 0.44 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.805 -1.089 . . . . 38.350000000000001 109.978 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -95.8 -172.17 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.232 2.621 . . . . 37.039999999999999 112.1 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.52 -25.92 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.628 -0.796 . . . . 35.659999999999997 112.591 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.23 9.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.728 0.299 . . . . 35.149999999999999 110.562 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp 67.04 167.06 0.23 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.243 -0.89 . . . . 34.170000000000002 110.197 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 54.59 68.43 0.86 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.431 0.634 . . . . 32.950000000000003 110.601 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -76.49 24.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.584 -0.735 . . . . 32.299999999999997 112.523 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 54.86 74.63 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.061 0.458 . . . . 31.239999999999998 109.824 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.553 ' HD2' ' HG ' ' A' ' 20' ' ' LEU . 39.0 t80 -163.44 -60.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.097 0.475 . . . . 31.57 110.128 -177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.553 ' HG ' ' HD2' ' A' ' 19' ' ' PHE . 96.1 mt -121.29 163.21 18.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 30.100000000000001 110.479 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.02 170.25 8.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.09 -0.505 . . . . 28.399999999999999 110.302 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.11 99.45 9.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 26.969999999999999 111.063 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 52.5 tpp -105.14 79.56 1.51 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.072 -0.714 . . . . 27.66 109.072 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -105.64 121.11 47.08 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.673 -0.694 . . . . 24.41 110.933 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.05 111.4 3.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.717 2.278 . . . . 22.399999999999999 111.485 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.99 145.34 91.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 20.670000000000002 110.438 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.82 96.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.479 2.786 . . . . 18.75 113.925 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -120.61 142.16 33.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.61 . . . . 14.960000000000001 110.114 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 3.7 Cg_exo -80.84 163.29 20.88 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.994 2.463 . . . . 14.550000000000001 111.542 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.15 67.98 1.76 Allowed Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 123.961 0.788 . . . . 10.949999999999999 110.9 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.37 67.58 6.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.184 2.589 . . . . 10.6 110.963 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 145.38 73.29 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.526 -0.761 . . . . 6.1100000000000003 110.402 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.89 -25.11 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.325 2.017 . . . . 5.3600000000000003 112.374 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.15 122.51 19.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 4.1299999999999999 111.186 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -93.08 103.63 15.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.886 -0.597 . . . . 2.4500000000000002 109.575 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.574 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 1.0 OUTLIER -87.99 -170.41 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.53000000000000003 109.864 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.76 111.47 8.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.851 -0.613 . . . . 1.1899999999999999 110.3 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.73 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 11.0 t70 -75.14 126.65 31.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.779 -0.768 . . . . 2.5099999999999998 109.795 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 105' ' ' LEU . 5.0 mt -59.47 -30.22 43.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 1.1499999999999999 110.771 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.6 mt -113.21 -5.58 13.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.577 -0.738 . . . . 1.4299999999999999 110.572 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.71 21.8 71.32 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.428 -0.806 . . . . 0.65000000000000002 111.675 -174.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.18 -20.27 14.21 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.078 0.769 . . . . 0.94999999999999996 113.078 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 125.79 -26.43 5.38 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.036 -1.078 . . . . 0.71999999999999997 114.827 166.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -106.17 -11.47 16.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.124 0.787 . . . . 2.1600000000000001 113.124 -171.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.7 tp -123.11 100.99 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.505 -0.122 . . . . 1.1200000000000001 111.108 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.73 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 83.7 mtm180 -140.88 145.46 36.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.551 0.574 . . . . 1.49 112.551 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.612 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.7 ttpt -116.29 131.39 56.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.218 -0.447 . . . . 1.1200000000000001 110.259 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 4.2 ttmm -111.85 125.75 54.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.626 0.251 . . . . 1.6499999999999999 110.511 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 p -80.18 100.22 8.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.376 -0.375 . . . . 1.03 111.434 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 111' ' ' THR . 11.8 mt -63.94 -53.15 54.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.943 -1.503 . . . . 1.0600000000000001 106.943 170.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.9 t -136.35 129.36 17.72 Favored Pre-proline 0 CA--C 1.503 -0.844 0 CA-C-N 112.753 -2.021 . . . . 1.1399999999999999 106.638 170.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 38.7 Cg_endo -103.91 56.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 122.812 2.342 . . . . 0.56000000000000005 113.671 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.42 170.71 44.25 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.303 -0.862 . . . . 0.55000000000000004 113.062 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.4 172.41 14.58 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.655 2.237 . . . . 1.9099999999999999 110.93 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.56 103.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.362 2.041 . . . . 2.5299999999999998 112.254 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.89 56.68 1.59 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.023 -0.608 . . . . 1.4199999999999999 112.51 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.61 -173.85 4.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.5 0.667 . . . . 1.3600000000000001 111.566 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -136.42 140.93 43.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.527 -0.916 . . . . 1.8200000000000001 108.527 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.467 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 97.7 mtt180 -101.13 114.1 65.79 Favored Pre-proline 0 C--N 1.311 -1.097 0 C-N-CA 120.786 -0.366 . . . . 3.3900000000000001 110.539 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HD3' HG22 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -47.29 142.1 12.77 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.875 3.05 . . . . 0.42999999999999999 113.735 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.681 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.1 t -95.67 152.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.486 -0.779 . . . . 1.47 109.564 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.565 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 40.4 mttp -66.51 106.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.569 0.699 . . . . 1.71 110.488 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.2 -23.14 2.57 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.96 -1.018 . . . . 0.41999999999999998 110.756 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.681 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -85.25 139.13 31.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.803 -0.814 . . . . 0.58999999999999997 108.803 177.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.72 HG12 HD13 ' A' ' 150' ' ' LEU . 10.7 m -87.28 129.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.677 -0.861 . . . . 1.8600000000000001 108.677 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 24.9 m -123.15 149.64 26.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.928 -1.033 . . . . 1.0700000000000001 110.502 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.462 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 20.2 p -97.82 112.85 24.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.748 -0.66 . . . . 1.0600000000000001 110.218 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 99' ' ' LEU . 24.4 m -110.93 147.01 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 120.376 -0.53 . . . . 1.05 110.375 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.78 114.84 29.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.988 -1.486 . . . . 0.28999999999999998 106.988 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.9 OUTLIER -120.33 138.16 53.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.387 -0.925 . . . . 1.1299999999999999 111.194 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.652 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.27 114.83 14.22 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.127 -1.805 . . . . 0.27000000000000002 106.127 167.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.645 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 32.6 m -103.14 118.99 38.02 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.867 -1.06 . . . . 1.04 111.848 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.728 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -105.65 135.05 47.75 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.477 -0.783 . . . . 1.54 109.248 176.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.536 HD13 ' CG1' ' A' ' 80' ' ' VAL . 4.2 mp -58.46 165.29 2.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.562 0.22 . . . . 1.51 111.26 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -52.45 -20.48 2.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.374 0.607 . . . . 1.1399999999999999 111.267 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -87.46 -14.73 39.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.706 -0.679 . . . . 2.1400000000000001 111.15 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.66 -10.57 38.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.35 -0.452 . . . . 0.51000000000000001 112.249 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -72.27 108.97 5.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.995 0.426 . . . . 1.1599999999999999 111.552 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 18.1 mtt180 -73.33 128.47 35.57 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.472 0.653 . . . . 0.54000000000000004 110.367 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.8 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.2 m -115.6 -8.17 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.683 -1.144 . . . . 1.0600000000000001 111.501 -171.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.645 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.7 pt20 -162.69 130.74 3.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.697 -0.683 . . . . 0.63 109.334 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 25.9 tt0 -141.84 105.92 4.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 1.3400000000000001 110.258 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 6.4 mm-40 -125.84 126.82 24.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.743 -0.662 . . . . 2.5899999999999999 109.754 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 10.9 Cg_exo -70.94 -17.06 32.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.424 2.083 . . . . 0.90000000000000002 112.639 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -159.66 122.9 3.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.99 0.9 . . . . 1.3700000000000001 111.923 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.6 tp -132.82 113.15 12.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.519 -1.673 . . . . 1.1399999999999999 108.774 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.9 p -104.94 132.58 51.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.756 -0.461 . . . . 1.5900000000000001 109.756 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.6 p90 -153.16 156.29 38.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.651 0.262 . . . . 0.25 110.638 -176.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -75.86 112.06 11.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 1.0700000000000001 110.172 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.761 HD13 ' HD3' ' A' ' 104' ' ' PRO . 14.5 tp -60.26 135.38 57.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 1.3300000000000001 110.427 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.565 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 81.01 5.43 90.16 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.708 -0.758 . . . . 0.37 112.069 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.82 -13.13 19.35 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.852 -0.425 . . . . 0.93000000000000005 109.852 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.7 m 62.32 35.04 15.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.556 -0.905 . . . . 1.55 108.556 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.27 -6.34 49.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.55 1.167 . . . . 1.3300000000000001 108.431 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 m -131.13 -156.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.375 -1.739 . . . . 1.0800000000000001 110.021 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -80.08 137.36 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 107.482 -1.303 . . . . 1.0600000000000001 107.482 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.474 HE21 ' HB3' ' A' ' 100' ' ' ASP . 8.0 tp60 -58.04 -29.16 65.13 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.583 -0.28 . . . . 0.40000000000000002 110.891 -173.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.91 78.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.019 -0.537 . . . . 1.0800000000000001 110.802 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.543 HD13 HG12 ' A' ' 142' ' ' VAL . 51.4 tp -72.51 -41.34 66.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 1.0700000000000001 110.503 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.474 ' HB3' HE21 ' A' ' 97' ' ' GLN . 15.7 t70 -61.11 -30.22 70.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.26000000000000001 109.911 -174.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.14 -33.77 16.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 1.0600000000000001 112.196 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.7 t -68.91 -29.11 67.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.593 -0.276 . . . . 1.53 111.111 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 99' ' ' LEU . 54.5 t -66.31 -55.11 21.34 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.659 0.615 . . . . 1.0600000000000001 112.659 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.761 ' HD3' HD13 ' A' ' 90' ' ' LEU . 20.7 Cg_endo -62.45 -23.62 75.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.921 1.747 . . . . 0.40999999999999998 111.818 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.634 HD11 HG22 ' A' ' 39' ' ' ILE . 20.2 mt -73.75 -26.12 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.738 -0.664 . . . . 1.3500000000000001 111.015 172.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.759 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -95.72 156.52 16.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.09 -0.505 . . . . 1.3100000000000001 111.082 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.03 151.54 21.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.055 0.455 . . . . 0.96999999999999997 110.923 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.646 HG22 ' HD3' ' A' ' 60' ' ' PRO . 1.3 t -60.07 125.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.461 0.648 . . . . 1.47 110.22 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.39 56.74 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.865 -1.061 . . . . 0.28000000000000003 112.803 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.0 pt-20 -103.14 167.93 9.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.40999999999999998 111.096 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 50' ' ' LEU . 7.2 m -129.41 117.19 20.16 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.716 -1.216 . . . . 1.0700000000000001 107.716 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . . . -120.74 134.35 55.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.717 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.4 ttp -98.39 117.93 33.9 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.759 -1.2 . . . . 1.9399999999999999 107.759 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.612 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.1 t -111.92 135.21 51.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.689 -0.687 . . . . 1.0600000000000001 109.431 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.574 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 87.8 m -114.32 113.68 24.89 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.616 -0.834 . . . . 1.03 108.795 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.64 54.94 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.18 -1.373 . . . . 1.01 109.796 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.699 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.79 148.79 6.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.004 -0.739 . . . . 0.57999999999999996 109.004 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.59 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.3 t -55.23 -28.5 53.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.116 0.484 . . . . 1.04 110.489 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.699 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.5 ptpt -54.77 -32.88 60.63 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.448 -0.342 . . . . 1.4299999999999999 111.535 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.622 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 98.3 m-85 -97.25 7.8 45.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.059 0.456 . . . . 1.04 110.04 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.61 ' HB3' HD21 ' A' ' 138' ' ' LEU . 61.4 m -123.7 -91.74 0.54 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.118 -0.946 . . . . 0.87 110.115 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.566 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 4.1 m-85 -144.56 41.57 1.34 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 119.272 -0.394 . . . . 0.95999999999999996 111.985 175.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.49 -84.01 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 121.449 -0.405 . . . . 0.25 113.836 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.76 12.07 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.32 2.013 . . . . 0.90000000000000002 111.088 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -104.45 -51.52 3.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.499 -0.773 . . . . 0.65000000000000002 110.176 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.54 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 83.27 142.46 4.77 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.606 -1.179 . . . . 0.29999999999999999 111.982 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.617 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.7 t -92.65 164.23 13.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.176 -0.512 . . . . 0.90000000000000002 112.074 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -50.59 -62.64 1.47 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.905 -1.043 . . . . 3.6099999999999999 111.905 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.947 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 30.9 t -72.09 -63.68 1.21 Allowed Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 1.52 110.067 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.9 Cg_endo -107.22 127.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 122.653 2.235 . . . . 0.44 112.315 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.54 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 42.1 t80 -55.97 98.6 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.861 -1.163 . . . . 1.6899999999999999 107.861 162.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.601 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.2 mm -66.44 128.82 94.05 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 115.713 -0.676 . . . . 1.0600000000000001 109.484 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.25 145.52 65.69 Favored 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.656 2.237 . . . . 1.03 111.839 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.656 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 34.8 Cg_endo -63.85 139.39 68.14 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.922 1.748 . . . . 0.89000000000000001 111.783 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.56 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 1.4 m80 68.75 6.97 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.129 -0.941 . . . . 3.1899999999999999 112.558 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -72.4 120.65 18.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.283 -0.636 . . . . 1.04 109.283 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.45 113.2 10.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.355 0.598 . . . . 1.05 109.904 -172.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' A' ' 121' ' ' CYS . 0.9 OUTLIER -87.95 131.32 34.65 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.567 -0.742 . . . . 1.0600000000000001 110.663 -177.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.8 t -115.73 99.94 7.67 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.901 -0.778 . . . . 1.8200000000000001 108.901 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.5 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.2 pp -115.23 134.32 55.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.116 -0.493 . . . . 1.1499999999999999 111.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.652 ' HB3' HE22 ' A' ' 71' ' ' GLN . 34.0 tt0 -98.86 122.04 41.59 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.223 -0.658 . . . . 1.05 109.223 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.661 HG22 ' HE2' ' A' ' 106' ' ' MET . 3.8 m -117.69 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.476 0.655 . . . . 1.0800000000000001 112.342 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 6.8 m -95.08 111.01 22.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.102 -0.954 . . . . 1.0900000000000001 110.06 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.599 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -83.6 99.19 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.66 -0.867 . . . . 1.0700000000000001 108.66 173.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 21.4 mtmt -94.69 -32.28 13.44 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.052 -0.976 . . . . 1.6899999999999999 110.598 -170.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.462 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.9 m -152.44 151.69 31.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.144 -0.48 . . . . 1.1200000000000001 111.019 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -139.25 129.35 25.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.249 -0.648 . . . . 0.98999999999999999 109.249 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.55 128.73 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.385 0.612 . . . . 1.6200000000000001 110.534 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.47 125.57 34.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.644 -0.707 . . . . 2.27 110.615 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.72 HD13 HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.2 -1.24 1.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.674 -0.694 . . . . 2.5 110.514 178.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -80.82 98.15 7.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.661 . . . . 2.1400000000000001 109.796 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 70.24 -1.53 2.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.56 -0.745 . . . . 6.6299999999999999 111.022 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.422 ' H ' ' C ' ' A' ' 151' ' ' GLU . 21.6 m-70 69.72 137.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.71 0.804 . . . . 8.1899999999999995 112.421 174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -46.6 115.14 0.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.967 -1.015 . . . . 9.0800000000000001 111.597 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -91.98 -12.03 34.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.486 -0.561 . . . . 9.2400000000000002 109.486 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -76.74 87.64 3.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.593 -0.891 . . . . 12.779999999999999 108.593 167.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.6 m170 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 114.995 -1.002 . . . . 14.109999999999999 110.203 -174.472 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.134 -0.321 . . . . 50.460000000000001 110.134 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.65 -159.82 9.25 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.153 -0.779 . . . . 47.990000000000002 111.153 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -117.2 137.76 24.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.996 0.398 . . . . 46.439999999999998 110.092 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.11 144.34 99.49 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.276 1.984 . . . . 45.219999999999999 111.441 172.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.02 127.37 19.24 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.577 2.185 . . . . 44.450000000000003 112.214 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.86 -168.44 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 42.710000000000001 110.517 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 59.83 88.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.844 -0.798 . . . . 41.5 108.844 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -68.81 135.29 50.95 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.275 0.843 . . . . 40.329999999999998 113.275 -166.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.25 5.55 12.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.917 -1.038 . . . . 39.390000000000001 109.746 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -90.01 -63.89 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 38.82 109.519 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.83 86.35 43.93 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.031 -0.531 . . . . 38.350000000000001 109.909 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -86.19 -177.27 2.39 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.779 2.32 . . . . 37.039999999999999 111.407 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.79 70.45 0.68 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.174 -1.012 . . . . 35.659999999999997 112.319 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.05 95.4 2.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.024 0.44 . . . . 35.149999999999999 110.468 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.9 -53.64 3.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.941 -0.572 . . . . 34.170000000000002 110.241 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.79 77.83 6.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.046 -0.524 . . . . 32.950000000000003 110.622 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -87.88 -7.12 57.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 32.299999999999997 111.351 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 70.74 114.79 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.789 0.68 . . . . 31.239999999999998 111.117 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.666 ' HD2' ' HG ' ' A' ' 20' ' ' LEU . 26.5 p90 -164.09 164.59 22.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 31.57 110.712 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.666 ' HG ' ' HD2' ' A' ' 19' ' ' PHE . 67.1 mt 66.44 71.61 0.39 Allowed 'General case' 0 C--O 1.239 0.512 0 O-C-N 124.143 0.902 . . . . 30.100000000000001 111.311 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.01 -110.82 0.56 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.864 -1.062 . . . . 28.399999999999999 110.987 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.81 -48.44 2.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.803 0.335 . . . . 26.969999999999999 110.403 175.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.4 mtm -138.34 16.42 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.35 . . . . 27.66 111.673 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 57.45 98.85 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.685 0.616 . . . . 24.41 110.895 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.78 101.09 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.58 2.186 . . . . 22.399999999999999 112.797 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.92 149.56 42.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.021 -0.536 . . . . 20.670000000000002 109.77 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.59 122.66 11.61 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.734 2.29 . . . . 18.75 111.984 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.19 155.98 92.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 14.960000000000001 110.515 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.06 134.96 51.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.845 2.363 . . . . 14.550000000000001 112.576 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.705 ' HB1' ' HD3' ' A' ' 31' ' ' PRO . . . -73.81 -52.85 4.45 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.102 -0.499 . . . . 10.949999999999999 111.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.705 ' HD3' ' HB1' ' A' ' 30' ' ' ALA . 5.5 Cg_exo -78.8 115.52 3.6 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.063 1.842 . . . . 10.6 111.343 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.5 112.63 6.88 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.452 -0.34 . . . . 6.1100000000000003 111.242 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -93.04 29.69 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.116 2.544 . . . . 5.3600000000000003 111.965 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 65.68 41.87 3.81 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.438 -0.801 . . . . 4.1299999999999999 110.617 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -84.79 92.97 8.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.527 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 2.0 m0 -72.56 -161.21 0.08 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.53000000000000003 110.334 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 49.0 tp -80.04 109.99 15.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.17 0.51 . . . . 1.1899999999999999 110.661 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.701 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 2.8 p-10 -63.06 97.71 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.089 -0.959 . . . . 2.5099999999999998 110.696 171.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.796 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 12.0 mt -51.14 -49.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.021 -0.99 . . . . 1.1499999999999999 111.986 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' HG ' HD22 ' A' ' 45' ' ' LEU . 55.2 mt -102.33 3.84 38.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 1.4299999999999999 110.99 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.701 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 75.61 8.5 84.23 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.65000000000000002 112.314 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.649 HD21 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -98.12 -15.85 19.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.224 0.453 . . . . 0.94999999999999996 112.224 -177.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.649 ' N ' HD21 ' A' ' 42' ' ' ASN . . . 86.14 -26.87 5.86 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.71999999999999997 112.623 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.6 mp -69.15 -23.74 63.99 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 122.018 0.913 . . . . 2.1600000000000001 109.033 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.796 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.9 tp -120.24 112.39 19.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.133 -1.394 . . . . 1.1200000000000001 110.486 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 57.2 mtm180 -142.45 140.76 32.04 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 122.962 0.164 . . . . 1.49 111.229 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 114' ' ' VAL . 15.9 ttpt -115.53 127.04 54.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.801 -0.444 . . . . 1.1200000000000001 109.801 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.495 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 15.0 ttmt -107.16 122.42 46.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 110.216 -0.29 . . . . 1.6499999999999999 110.216 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.0 p -79.05 99.6 6.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.896 0.379 . . . . 1.03 111.063 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD13 HG21 ' A' ' 111' ' ' THR . 9.3 mt -67.8 -52.5 36.32 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.724 -1.584 . . . . 1.0600000000000001 106.724 173.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.824 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.3 t -134.68 126.66 18.15 Favored Pre-proline 0 CA--C 1.502 -0.88 0 CA-C-N 113.039 -1.891 . . . . 1.1399999999999999 106.196 168.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 65.7 Cg_endo -107.01 54.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.013 2.476 . . . . 0.56000000000000005 114.474 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 87.43 140.73 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.849 -0.691 . . . . 0.55000000000000004 113.206 173.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.0 153.73 71.93 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.76 2.307 . . . . 1.9099999999999999 110.695 173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -50.31 108.69 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.593 2.195 . . . . 2.5299999999999998 112.469 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.81 43.47 2.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.827 -0.701 . . . . 1.4199999999999999 112.205 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -87.11 -172.23 3.87 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.163 0.506 . . . . 1.3600000000000001 111.095 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 t -146.21 143.58 29.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.929 -0.767 . . . . 1.8200000000000001 108.929 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 69.1 mtm180 -94.16 116.84 66.92 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 120.449 -0.5 . . . . 3.3900000000000001 109.756 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.728 ' HD3' HG22 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -49.05 148.02 10.07 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.51 2.807 . . . . 0.42999999999999999 113.077 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 10.6 t -92.73 150.24 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.669 . . . . 1.47 109.195 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.875 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 66.1 mttt -71.33 120.26 16.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.709 0.766 . . . . 1.71 109.862 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.85 -26.8 4.74 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.175 -1.375 . . . . 0.41999999999999998 110.103 -172.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.659 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.1 135.88 35.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.86 -0.793 . . . . 0.58999999999999997 108.86 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 11.4 m -82.63 118.47 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.524 -0.917 . . . . 1.8600000000000001 108.524 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -112.96 146.06 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.249 -0.887 . . . . 1.0700000000000001 110.513 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.538 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.0 p -97.05 113.1 24.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.946 -0.57 . . . . 1.0600000000000001 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' THR . 27.1 m -111.05 150.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.767 -0.651 . . . . 1.05 110.187 174.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.73 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.52 -1.659 . . . . 0.28999999999999998 106.52 167.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 83' ' ' GLU . 1.8 pt? -125.0 141.62 52.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.901 0.858 . . . . 1.1299999999999999 110.88 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.644 HE22 ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -139.28 120.03 14.26 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.464 -2.05 . . . . 0.27000000000000002 105.464 167.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.57 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 43.3 m -112.26 121.66 45.55 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.382 -0.826 . . . . 1.04 111.808 -165.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -103.59 148.7 25.68 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.885 -0.598 . . . . 1.54 109.515 175.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.437 HD13 ' CG1' ' A' ' 80' ' ' VAL . 3.4 mp -71.56 165.6 23.56 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.955 -0.566 . . . . 1.51 111.067 170.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.34 -18.95 12.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.416 0.627 . . . . 1.1399999999999999 110.08 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.412 HD22 HD21 ' A' ' 74' ' ' LEU . 29.5 p30 -92.44 -5.07 52.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.366 -0.833 . . . . 2.1400000000000001 111.133 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.49 -10.74 53.89 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.248 -0.501 . . . . 0.51000000000000001 113.577 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.6 m -78.49 110.45 13.58 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.74 -0.27 . . . . 1.1599999999999999 111.697 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.671 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 33.9 mtt180 -71.19 122.25 19.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.476 0.655 . . . . 0.54000000000000004 110.253 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.68 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 32.8 m -108.18 -10.13 10.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.976 -1.011 . . . . 1.0600000000000001 111.625 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.57 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 29.4 pt20 -159.96 145.58 15.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.889 -0.596 . . . . 0.63 109.501 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 43.8 tt0 -148.96 105.57 3.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.195 0.521 . . . . 1.3400000000000001 109.902 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' HB2' HD23 ' A' ' 70' ' ' LEU . 7.1 mm-40 -122.27 117.57 29.28 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.693 -0.685 . . . . 2.5899999999999999 109.435 -175.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -66.5 -19.18 55.02 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.705 2.27 . . . . 0.90000000000000002 112.182 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -159.54 118.67 2.89 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.269 1.033 . . . . 1.3700000000000001 111.685 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.3 tp -126.07 99.65 6.0 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.174 -1.83 . . . . 1.1399999999999999 108.423 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.0 p -89.57 134.42 28.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.949 -0.76 . . . . 1.5900000000000001 108.949 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.66 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.5 p90 -153.56 162.7 41.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.11 0.481 . . . . 0.25 111.168 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.1 m -84.09 108.27 16.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.249 -0.887 . . . . 1.0700000000000001 110.063 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.875 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.24 132.52 54.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 1.3300000000000001 110.152 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.684 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 86.93 4.9 81.67 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.498 -0.858 . . . . 0.37 112.376 175.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -117.8 9.3 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.692 -0.485 . . . . 0.93000000000000005 109.692 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p 43.9 42.45 4.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.145 -0.934 . . . . 1.55 110.296 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 48.9 t0 -71.41 -12.29 61.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.766 1.27 . . . . 1.3300000000000001 108.166 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.409 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 4.1 m -123.48 -153.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 113.168 -1.833 . . . . 1.0800000000000001 109.558 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.601 HG13 ' H ' ' A' ' 99' ' ' LEU . 38.9 pt -81.67 142.85 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 107.541 -1.281 . . . . 1.0600000000000001 107.541 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.486 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 9.0 tp60 -59.96 -34.85 73.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.619 -0.264 . . . . 0.40000000000000002 111.08 -173.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.18 -48.79 67.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.204 0.526 . . . . 1.0800000000000001 110.759 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' H ' HG13 ' A' ' 96' ' ' ILE . 57.8 tp -67.68 -41.91 82.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.184 -0.916 . . . . 1.0700000000000001 110.534 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.443 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.8 t70 -60.54 -28.01 68.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.923 -1.035 . . . . 0.26000000000000001 109.913 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.686 HD22 ' HZ1' ' A' ' 62' ' ' LYS . 87.0 mt -89.66 -34.86 16.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.246 -0.888 . . . . 1.0600000000000001 111.893 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 60.3 p -70.82 -27.11 63.63 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.635 0.255 . . . . 1.53 110.768 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 99' ' ' LEU . 54.1 t -66.05 -55.33 21.92 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 112.48 0.548 . . . . 1.0600000000000001 112.48 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.626 ' HD3' HD12 ' A' ' 90' ' ' LEU . 21.9 Cg_endo -61.39 -24.64 78.84 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.806 1.67 . . . . 0.40999999999999998 112.112 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' A' ' 39' ' ' ILE . 11.9 mt -77.98 -13.25 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 1.3500000000000001 111.213 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.796 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -106.9 155.03 20.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.849 -0.614 . . . . 1.3100000000000001 111.077 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.74 155.61 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.711 0.291 . . . . 0.96999999999999997 110.619 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.728 HG22 ' HD3' ' A' ' 60' ' ' PRO . 2.1 t -60.5 125.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 1.47 110.659 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.01 5.86 56.19 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.201 -0.909 . . . . 0.28000000000000003 112.499 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.824 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -98.45 168.29 10.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.466 0.65 . . . . 0.40999999999999998 111.139 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 50' ' ' LEU . 31.6 m -132.69 117.42 17.85 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.995 -1.002 . . . . 1.0700000000000001 108.479 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.54 140.15 50.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.564 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 ttm -97.92 117.16 31.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.263 -1.384 . . . . 1.9399999999999999 107.263 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 47' ' ' LYS . 4.2 t -113.29 132.81 61.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.424 -0.584 . . . . 1.0600000000000001 109.424 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 79.4 m -112.71 113.75 26.01 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.133 0.968 . . . . 1.03 109.072 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.46 135.36 53.17 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.434 -1.712 . . . . 1.01 109.693 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.737 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.6 t70 -52.33 147.28 8.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.789 -0.819 . . . . 0.57999999999999996 108.789 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -55.8 -27.92 53.6 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 120.993 0.425 . . . . 1.04 110.234 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.607 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.6 ptpt -56.29 -29.28 60.99 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.894 -0.504 . . . . 1.4299999999999999 111.455 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.579 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 85.0 m-85 -97.35 1.72 49.74 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.196 0.522 . . . . 1.04 109.9 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.1 m -122.02 -90.71 0.57 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.954 -1.021 . . . . 0.87 110.66 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.664 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 8.1 m-85 -142.9 41.62 1.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.587 -0.445 . . . . 0.95999999999999996 111.921 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.44 -80.82 0.06 OUTLIER Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.09 -0.576 . . . . 0.25 113.4 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.26 10.36 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.478 2.119 . . . . 0.90000000000000002 111.003 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.664 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.2 mt-30 -102.83 -46.45 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.756 -1.111 . . . . 0.65000000000000002 109.876 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.554 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 79.21 142.58 2.42 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.181 -0.918 . . . . 0.29999999999999999 112.634 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.604 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.7 t -90.53 164.57 14.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.218 -0.491 . . . . 0.90000000000000002 111.558 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -56.16 -50.22 71.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.651 -0.704 . . . . 3.6099999999999999 112.065 -173.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.889 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 51.1 m -80.91 -62.4 0.36 Allowed Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.214 -0.594 . . . . 1.52 109.998 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.889 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 22.1 Cg_endo -107.19 127.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.892 2.395 . . . . 0.44 112.541 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.53 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 41.2 t80 -55.97 98.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.863 -1.162 . . . . 1.6899999999999999 107.863 162.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.578 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.2 mm -64.74 133.0 95.59 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.767 . . . . 1.0600000000000001 110.196 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 146.05 37.55 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.622 2.215 . . . . 1.03 112.14 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.518 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.3 Cg_endo -63.74 135.57 49.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.296 1.998 . . . . 0.89000000000000001 112.387 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.737 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER 70.75 -0.42 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.915 -1.038 . . . . 3.1899999999999999 112.744 178.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -61.12 118.97 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.129 -0.693 . . . . 1.04 109.129 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.92 113.09 10.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.422 0.63 . . . . 1.05 109.685 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 115' ' ' THR . 0.9 OUTLIER -88.83 131.07 35.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.86 . . . . 1.0600000000000001 110.982 -173.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.2 t -114.64 100.38 8.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.57 -0.9 . . . . 1.8200000000000001 108.57 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.548 ' HB3' HG21 ' A' ' 72' ' ' THR . 1.0 OUTLIER -121.32 135.46 55.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.008 -0.542 . . . . 1.1499999999999999 111.816 -174.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.644 ' HG2' HE22 ' A' ' 71' ' ' GLN . 4.8 tt0 -98.0 125.97 43.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.511 -0.768 . . . . 1.05 109.482 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.4 m -124.42 117.14 49.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.31 0.576 . . . . 1.0800000000000001 112.053 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 24.4 m -89.25 114.8 26.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.365 -0.834 . . . . 1.0900000000000001 110.391 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.682 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 62.0 tp -84.57 100.35 11.35 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.238 -0.653 . . . . 1.0700000000000001 109.238 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.509 ' C ' ' HG1' ' A' ' 146' ' ' THR . 25.8 mtmt -95.08 -25.8 16.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.528 -0.76 . . . . 1.6899999999999999 110.88 -170.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.538 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 14.2 m -157.37 155.25 30.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.115 0.413 . . . . 1.1200000000000001 112.115 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.512 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -140.49 127.9 21.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.28 -0.637 . . . . 0.98999999999999999 109.28 171.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 17.8 m -136.32 142.44 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.423 . . . . 1.6200000000000001 110.412 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.501 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.9 t0 -79.85 118.66 21.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.242 0.544 . . . . 2.27 110.335 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.412 ' HB3' HG11 ' A' ' 65' ' ' VAL . 12.6 tp -137.07 16.36 3.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.532 -0.914 . . . . 2.5 108.532 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.83 -47.04 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.535 -1.212 . . . . 2.1400000000000001 108.198 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -90.11 62.07 5.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.904 -1.044 . . . . 6.6299999999999999 110.122 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -61.54 159.73 12.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.669 -1.15 . . . . 8.1899999999999995 110.932 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -72.03 145.79 48.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.423 -0.353 . . . . 9.0800000000000001 110.267 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.3 t60 66.29 107.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.0 0.812 . . . . 9.2400000000000002 111.679 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -107.99 175.88 5.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.062 -0.517 . . . . 12.779999999999999 110.616 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 C--O 1.244 0.804 0 N-CA-C 108.196 -1.039 . . . . 14.109999999999999 108.196 172.134 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.425 -0.213 . . . . 50.460000000000001 110.425 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.38 6.76 55.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 47.990000000000002 112.743 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -132.64 121.98 17.54 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 122.531 -0.394 . . . . 46.439999999999998 110.681 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 13.8 Cg_exo -70.52 146.7 56.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.721 2.28 . . . . 45.219999999999999 111.394 173.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 27.9 Cg_exo -62.27 150.24 87.71 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.019 2.479 . . . . 44.450000000000003 112.488 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.1 98.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 42.710000000000001 110.927 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.5 129.65 47.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.003 0.43 . . . . 41.5 110.307 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.27 164.71 12.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 40.329999999999998 111.091 -171.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.72 143.33 26.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.186 -0.461 . . . . 39.390000000000001 110.713 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.13 -11.05 60.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 38.82 110.617 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.99 97.58 26.16 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.361 0.6 . . . . 38.350000000000001 110.084 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.46 -33.1 30.32 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.956 2.437 . . . . 37.039999999999999 113.164 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.12 3.65 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.614 -0.803 . . . . 35.659999999999997 112.847 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.88 -152.03 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.44 -0.207 . . . . 35.149999999999999 110.44 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.11 94.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.985 0.421 . . . . 34.170000000000002 110.353 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.13 94.83 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 32.950000000000003 111.03 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 17' ' ' ARG . 1.7 ptp85 -100.74 150.09 23.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.593 -0.73 . . . . 32.299999999999997 109.041 172.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -104.83 160.42 15.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.794 0.807 . . . . 31.239999999999998 111.417 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -144.81 20.51 1.64 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.46 -1.245 . . . . 31.57 108.374 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.01 -51.95 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.565 -1.198 . . . . 30.100000000000001 110.592 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.8 -64.16 1.33 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.851 -0.613 . . . . 28.399999999999999 109.802 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HB1' ' HG3' ' A' ' 24' ' ' GLU . . . 56.53 11.6 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.571 -0.74 . . . . 26.969999999999999 112.4 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt 58.26 24.77 11.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.148 0.579 . . . . 27.66 111.296 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' HG3' ' HB1' ' A' ' 22' ' ' ALA . 46.7 mt-10 -77.86 -53.26 1.49 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.334 -0.393 . . . . 24.41 111.611 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 24' ' ' GLU . 11.4 Cg_endo -54.93 129.06 33.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.474 2.116 . . . . 22.399999999999999 112.332 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.73 145.94 90.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.036 -0.529 . . . . 20.670000000000002 111.322 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.72 165.88 30.62 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.962 2.441 . . . . 18.75 112.9 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.16 139.34 20.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 14.960000000000001 110.311 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.761 ' HG2' ' HB2' ' A' ' 32' ' ' ALA . 13.2 Cg_endo -60.38 157.27 36.68 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.513 2.142 . . . . 14.550000000000001 112.738 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -72.44 -48.46 9.49 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.151 -0.477 . . . . 10.949999999999999 112.219 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 30' ' ' ALA . 6.3 Cg_exo -80.27 42.63 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.212 1.941 . . . . 10.6 112.179 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . . . -101.75 148.94 35.99 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 6.1100000000000003 110.55 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 22.0 Cg_exo -65.34 -31.17 53.09 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.568 2.178 . . . . 5.3600000000000003 112.053 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 73.07 168.19 0.31 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.079 0.862 . . . . 4.1299999999999999 111.089 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 2.0 mp0 -83.74 104.41 13.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.853 -0.612 . . . . 2.4500000000000002 110.011 176.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.59 ' HB2' ' HB3' ' A' ' 46' ' ' ARG . 3.8 m0 -74.65 -170.0 0.96 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.124 -0.489 . . . . 0.53000000000000003 109.765 174.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.07 109.58 4.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.304 -0.628 . . . . 1.1899999999999999 109.304 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.647 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.2 t70 -78.53 127.19 31.8 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.166 -0.614 . . . . 2.5099999999999998 109.852 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.514 HD11 HD12 ' A' ' 45' ' ' LEU . 3.3 mt -61.68 -31.1 49.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.702 -1.136 . . . . 1.1499999999999999 110.531 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -115.45 0.54 13.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.9 -0.591 . . . . 1.4299999999999999 110.546 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.647 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.2 25.27 64.36 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.522 -0.763 . . . . 0.65000000000000002 111.552 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -96.03 -26.56 15.49 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.936 0.347 . . . . 0.94999999999999996 111.936 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.471 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 105.45 0.86 40.54 Favored Glycine 0 CA--C 1.512 -0.122 0 C-N-CA 120.847 -0.692 . . . . 0.71999999999999997 111.871 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.1 mp -105.49 -32.73 8.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.037 0.446 . . . . 2.1600000000000001 110.873 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD12 HD11 ' A' ' 39' ' ' ILE . 19.0 tp -123.12 101.55 7.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 1.1200000000000001 111.572 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 66.4 mtm180 -137.35 148.31 46.18 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.152 -0.342 . . . . 1.49 111.449 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.673 ' HG3' HG21 ' A' ' 114' ' ' VAL . 25.3 ttpt -113.75 132.16 55.93 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.435 -0.209 . . . . 1.1200000000000001 110.435 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.6 ttpt -115.92 129.9 56.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.6499999999999999 110.219 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' OE1' ' A' ' 110' ' ' GLU . 5.9 p -82.43 107.67 15.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.163 -0.471 . . . . 1.03 111.549 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.482 HD12 HG23 ' A' ' 111' ' ' THR . 6.7 mt -76.04 -54.76 6.37 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.344 -1.354 . . . . 1.0600000000000001 107.344 172.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.816 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 97.7 t -127.24 124.57 23.79 Favored Pre-proline 0 CA--C 1.501 -0.923 0 CA-C-N 113.06 -1.882 . . . . 1.1399999999999999 106.879 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.0 Cg_endo -111.56 88.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.932 2.421 . . . . 0.56000000000000005 114.252 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' A' ' 110' ' ' GLU . . . 50.48 76.95 0.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.387 -0.37 . . . . 0.55000000000000004 113.446 174.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 51.6 Cg_exo -50.93 -59.33 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.455 2.77 . . . . 1.9099999999999999 115.439 -170.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 12.5 Cg_endo -91.65 -4.2 4.11 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.48 2.12 . . . . 2.5299999999999998 114.248 -170.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.82 90.35 0.91 Allowed Glycine 0 CA--C 1.509 -0.336 0 C-N-CA 120.479 -0.867 . . . . 1.4199999999999999 111.107 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 2.1 p -96.58 -171.87 2.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.055 0.761 . . . . 1.3600000000000001 113.055 -170.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -150.0 143.94 25.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.48 -1.304 . . . . 1.8200000000000001 107.48 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 6.8 mtm-85 -91.15 115.38 64.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.484 -0.486 . . . . 3.3900000000000001 110.638 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.773 ' HD3' HG22 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.23 140.26 42.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.98 2.453 . . . . 0.42999999999999999 113.598 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.7 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.3 t -90.91 156.99 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.531 -0.759 . . . . 1.47 109.845 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -66.26 107.89 2.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.408 0.623 . . . . 1.71 110.399 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.04 -27.12 2.56 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 110.534 -1.027 . . . . 0.41999999999999998 110.534 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.7 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -74.45 140.14 44.43 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.465 -0.569 . . . . 0.58999999999999997 109.465 178.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.576 HG23 HD12 ' A' ' 150' ' ' LEU . 69.8 t -86.03 124.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.896 -0.779 . . . . 1.8600000000000001 108.896 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.6 m -127.79 146.82 32.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 112.296 0.48 . . . . 1.0700000000000001 112.296 -170.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.0 p -96.46 113.83 25.44 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.767 -0.651 . . . . 1.0600000000000001 110.008 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.499 HG23 HD21 ' A' ' 99' ' ' LEU . 24.5 m -110.68 142.05 24.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 120.071 -0.652 . . . . 1.05 109.803 172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.616 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.34 112.43 24.94 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.981 -1.859 . . . . 0.28999999999999998 105.981 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -119.21 133.69 55.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.318 1.056 . . . . 1.1299999999999999 111.097 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.667 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -129.09 114.12 15.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.109 -2.182 . . . . 0.27000000000000002 105.109 167.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.593 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 80.4 m -106.04 126.41 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.745 -1.116 . . . . 1.04 111.279 -166.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.8 t -106.89 157.21 17.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.341 -0.845 . . . . 1.54 109.504 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.38 167.12 15.02 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.613 -0.722 . . . . 1.51 110.65 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' OE1' ' HB3' ' A' ' 136' ' ' ALA . 4.6 pm0 -50.81 -24.97 3.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.106 -0.952 . . . . 1.1399999999999999 111.371 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -93.55 -10.25 35.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.036 -0.529 . . . . 2.1400000000000001 111.371 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.48 20.08 20.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.327 -0.94 . . . . 0.51000000000000001 112.492 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.1 m -96.29 109.6 22.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.628 0.251 . . . . 1.1599999999999999 110.72 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.671 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.9 mtt180 -76.03 109.94 10.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.736 0.779 . . . . 0.54000000000000004 110.004 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.711 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -95.1 -9.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.36 -1.291 . . . . 1.0600000000000001 111.833 -169.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.593 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 11.7 pt20 -159.69 148.65 17.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.63 109.597 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 28.7 tt0 -152.65 105.78 3.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.087 0.47 . . . . 1.3400000000000001 110.172 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -124.77 117.15 26.17 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.697 -0.683 . . . . 2.5899999999999999 110.072 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 30.0 Cg_endo -63.97 -17.96 61.85 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.592 2.194 . . . . 0.90000000000000002 112.103 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.74 106.72 2.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.161 0.982 . . . . 1.3700000000000001 111.699 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.4 tp -115.72 111.84 21.17 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.473 -1.694 . . . . 1.1399999999999999 107.635 170.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.3 p -109.17 131.05 61.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 110.041 -0.355 . . . . 1.5900000000000001 110.041 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -154.17 163.26 40.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.601 -0.272 . . . . 0.25 110.917 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.6 m -82.91 117.75 22.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.915 -0.584 . . . . 1.0700000000000001 109.628 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.844 HD13 ' HD3' ' A' ' 104' ' ' PRO . 13.8 tp -61.45 138.08 58.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 1.3300000000000001 110.843 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.29 -7.2 61.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.015 -0.612 . . . . 0.37 112.162 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.18 -9.14 55.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.93000000000000005 109.761 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.2 m 60.2 30.31 19.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.178 -0.919 . . . . 1.55 109.54 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.19 -20.63 63.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.542 1.163 . . . . 1.3300000000000001 108.302 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 m -112.88 -158.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 113.279 -1.782 . . . . 1.0800000000000001 110.38 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.573 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.8 pt -79.51 140.29 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.689 -1.226 . . . . 1.0600000000000001 107.689 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.513 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 5.9 tp60 -59.88 -30.97 69.36 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.267 0.355 . . . . 0.40000000000000002 110.821 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.16 -49.88 68.28 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.373 0.606 . . . . 1.0800000000000001 110.544 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.573 ' H ' HG13 ' A' ' 96' ' ' ILE . 58.4 tp -69.87 -41.68 74.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.832 -1.076 . . . . 1.0700000000000001 110.294 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HB3' HE21 ' A' ' 97' ' ' GLN . 19.9 t70 -60.72 -28.42 68.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.831 -1.077 . . . . 0.26000000000000001 109.963 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 80.9 mt -90.84 -34.81 15.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.394 -0.821 . . . . 1.0600000000000001 112.256 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 79.4 p -70.86 -24.63 62.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.538 -0.301 . . . . 1.53 111.143 -173.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 99' ' ' LEU . 53.3 t -72.42 -50.27 8.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 112.793 0.664 . . . . 1.0600000000000001 112.793 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.844 ' HD3' HD13 ' A' ' 90' ' ' LEU . 30.8 Cg_endo -65.01 -20.96 64.08 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 121.553 1.502 . . . . 0.40999999999999998 111.61 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 105' ' ' LEU . 15.9 mt -80.94 -18.62 46.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 1.3500000000000001 110.541 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.707 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 31.8 ttm -90.09 149.84 22.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 1.3100000000000001 111.104 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.37 147.45 23.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.96999999999999997 110.39 176.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.773 HG22 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -60.44 123.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.328 0.585 . . . . 1.47 110.68 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.27 56.89 Favored Glycine 0 C--N 1.314 -0.679 0 C-N-CA 120.784 -0.722 . . . . 0.28000000000000003 113.017 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -99.68 168.78 9.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.253 0.549 . . . . 0.40999999999999998 110.674 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.482 HG23 HD12 ' A' ' 50' ' ' LEU . 11.5 m -127.68 116.87 20.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.461 -1.311 . . . . 1.0700000000000001 107.461 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.503 ' HB1' ' HE1' ' A' ' 106' ' ' MET . . . -116.53 139.56 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.494 -174.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 ttm -98.44 117.02 31.91 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.328 -1.36 . . . . 1.9399999999999999 107.328 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.673 HG21 ' HG3' ' A' ' 47' ' ' LYS . 11.3 t -113.19 131.34 65.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 109.078 -0.712 . . . . 1.0600000000000001 109.078 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.546 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 41.6 m -115.81 113.93 24.06 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 119.278 -0.969 . . . . 1.03 109.068 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.42 139.03 53.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.038 -1.892 . . . . 1.01 109.739 -176.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 10.1 t70 -53.93 150.8 7.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.407 -0.59 . . . . 0.57999999999999996 109.407 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.586 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.9 t -54.81 -30.02 56.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 1.04 110.341 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.639 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -55.53 -30.13 60.15 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 122.229 -0.294 . . . . 1.4299999999999999 111.56 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.517 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 76.6 m-85 -95.87 2.03 53.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.231 0.538 . . . . 1.04 110.171 176.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.794 ' HB3' HD21 ' A' ' 138' ' ' LEU . 60.5 m -123.69 -91.05 0.56 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.156 -0.929 . . . . 0.87 110.654 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.813 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.9 m-85 -140.15 38.36 1.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.574 0.583 . . . . 0.95999999999999996 112.574 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.48 -78.82 0.08 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.474 0.579 . . . . 0.25 113.628 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -89.64 13.79 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.367 2.044 . . . . 0.90000000000000002 110.559 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.813 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 42.0 mt-30 -104.28 -49.02 3.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.97 -1.014 . . . . 0.65000000000000002 110.464 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.566 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 76.93 142.75 1.48 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.996 -1.002 . . . . 0.29999999999999999 112.905 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.601 ' HB3' HG12 ' A' ' 132' ' ' ILE . 10.3 t -90.68 159.62 16.28 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.042 -0.579 . . . . 0.90000000000000002 112.376 -175.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -52.45 -48.83 65.57 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.016 -0.993 . . . . 3.6099999999999999 111.968 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.986 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 34.6 m -80.59 -67.76 0.22 Allowed Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.453 -0.499 . . . . 1.52 109.946 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.986 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.4 Cg_endo -104.91 127.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.611 2.208 . . . . 0.44 112.091 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.566 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 39.4 t80 -55.67 99.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.194 -1.039 . . . . 1.6899999999999999 108.194 163.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 127' ' ' SER . 35.1 mm -65.63 129.58 94.37 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.282 -0.872 . . . . 1.0600000000000001 109.726 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.4 Cg_endo -53.52 141.78 61.51 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.828 2.352 . . . . 1.03 112.499 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.594 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 35.3 Cg_exo -58.28 131.35 42.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.467 2.111 . . . . 0.89000000000000001 112.52 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.577 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 32.2 m170 73.37 9.82 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.916 -1.038 . . . . 3.1899999999999999 112.35 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.68 127.75 33.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.215 -0.661 . . . . 1.04 109.215 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.69 111.58 10.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.074 0.464 . . . . 1.05 110.533 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.794 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.8 tp -88.4 130.97 35.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.684 -0.689 . . . . 1.0600000000000001 110.213 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.55 100.85 7.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.707 0.765 . . . . 1.8200000000000001 110.085 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -109.58 136.7 48.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.96 -1.018 . . . . 1.1499999999999999 112.067 -173.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.667 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 38.2 tt0 -101.14 118.19 36.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.74 -0.837 . . . . 1.05 108.74 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -121.43 118.15 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.092 0.775 . . . . 1.0800000000000001 113.092 -173.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 2.9 m -90.75 109.31 20.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.709 -0.678 . . . . 1.0900000000000001 110.539 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.707 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 38.3 tp -82.86 102.72 11.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.428 -0.952 . . . . 1.0700000000000001 108.428 172.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -103.53 -19.93 14.21 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.452 -0.795 . . . . 1.6899999999999999 110.901 -170.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 m -156.41 144.94 19.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.108 -0.496 . . . . 1.1200000000000001 111.152 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 66' ' ' VAL . . . -141.0 128.7 21.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.212 -0.662 . . . . 0.98999999999999999 109.212 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 65' ' ' VAL . 18.3 m -124.37 127.31 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.478 -0.489 . . . . 1.6200000000000001 110.7 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.529 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 7.5 t70 -87.43 121.67 30.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.416 -0.356 . . . . 2.27 110.751 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.576 HD12 HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -144.37 -1.21 0.93 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.812 0.339 . . . . 2.5 111.428 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.99 -71.1 0.72 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 2.1400000000000001 111.767 -172.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.33 122.07 11.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 6.6299999999999999 111.299 -173.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -72.39 107.55 5.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 8.1899999999999995 109.524 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -51.85 127.2 20.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.682 -0.69 . . . . 9.0800000000000001 111.808 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -151.03 176.9 10.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 9.2400000000000002 110.149 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 59.7 m-70 -110.9 118.21 35.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.09 0.404 . . . . 12.779999999999999 112.09 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 36.1 t60 . . . . . 0 C--O 1.243 0.715 0 CA-C-O 118.292 -0.861 . . . . 14.109999999999999 109.222 170.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.67 0.271 . . . . 50.460000000000001 110.362 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.66 128.71 1.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.003 -0.618 . . . . 47.990000000000002 111.865 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 36.8 mt-30 -82.9 129.23 62.52 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.484 0.183 . . . . 46.439999999999998 110.55 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 8' ' ' GLU . 3.8 Cg_exo -78.32 130.17 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.879 2.386 . . . . 45.219999999999999 111.569 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.73 141.74 43.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.923 2.416 . . . . 44.450000000000003 111.933 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.97 -82.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.956 0.785 . . . . 42.710000000000001 110.471 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.06 161.96 34.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.755 0.312 . . . . 41.5 110.315 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.533 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 35.0 tt0 -81.18 96.76 7.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.498 -0.927 . . . . 40.329999999999998 108.498 173.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.03 -166.99 1.31 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.811 -0.631 . . . . 39.390000000000001 111.765 -171.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 11' ' ' GLN . 12.8 pt-20 -129.73 -58.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.6 . . . . 38.82 112.322 -171.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.473 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 31.3 mm-40 65.76 74.91 0.36 Allowed Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 123.141 0.576 . . . . 38.350000000000001 110.235 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.05 128.54 18.83 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.112 2.541 . . . . 37.039999999999999 112.253 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.17 -170.28 35.5 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.677 -0.569 . . . . 35.659999999999997 111.677 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.36 95.11 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 35.149999999999999 110.347 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 17' ' ' ARG . 52.0 tp -117.93 -10.49 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.866 -0.606 . . . . 34.170000000000002 110.286 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 72.34 -41.61 0.51 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.479 0.712 . . . . 32.950000000000003 110.901 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 15' ' ' LEU . 29.2 ttm180 -85.68 96.6 9.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.423 -0.353 . . . . 32.299999999999997 110.394 176.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -76.46 -27.62 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.442 -0.577 . . . . 31.239999999999998 109.442 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.1 t80 71.37 120.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.801 -1.09 . . . . 31.57 112.337 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.93 68.99 0.76 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.967 -1.015 . . . . 30.100000000000001 110.929 172.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.57 98.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.279 -0.873 . . . . 28.399999999999999 111.643 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.15 129.55 12.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.918 -0.313 . . . . 26.969999999999999 111.06 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 tpt -174.58 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.445 -0.946 . . . . 27.66 108.445 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 39.3 tt0 -103.74 120.06 52.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.579 -1.192 . . . . 24.41 108.816 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 19.8 Cg_exo -66.39 136.98 45.39 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.047 2.498 . . . . 22.399999999999999 112.947 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 12.4 pt-20 -91.92 136.68 25.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 20.670000000000002 110.199 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 8.3 Cg_exo -73.14 131.85 17.24 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.846 2.364 . . . . 18.75 111.843 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.84 147.42 70.54 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 14.960000000000001 110.39 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 162.99 40.39 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.499 2.132 . . . . 14.550000000000001 112.121 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.96 68.89 1.7 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.365 -0.834 . . . . 10.949999999999999 111.107 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.35 126.51 8.46 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.381 2.054 . . . . 10.6 112.724 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.4 134.96 94.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 6.1100000000000003 110.764 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 57.6 Cg_endo -72.13 -13.14 28.47 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.859 2.372 . . . . 5.3600000000000003 113.039 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mm-40 76.78 -7.18 1.89 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.628 0.771 . . . . 4.1299999999999999 111.64 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 52.54 89.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.958 0.787 . . . . 2.4500000000000002 111.74 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.666 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 -85.89 -164.44 1.03 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.405 0.622 . . . . 0.53000000000000003 110.663 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.75 110.91 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.684 -0.689 . . . . 1.1899999999999999 110.012 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.668 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.3 t70 -73.83 123.73 24.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.264 -0.574 . . . . 2.5099999999999998 110.086 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.586 HG22 HD13 ' A' ' 105' ' ' LEU . 9.4 mt -54.51 -37.82 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.053 -0.976 . . . . 1.1499999999999999 111.309 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -111.8 2.89 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.203 -0.453 . . . . 1.4299999999999999 110.617 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.668 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.11 22.7 60.91 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.57 -0.741 . . . . 0.65000000000000002 112.066 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.16 -27.8 17.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.146 0.424 . . . . 0.94999999999999996 112.146 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.52 2.69 37.76 Favored Glycine 0 N--CA 1.454 -0.136 0 C-N-CA 120.926 -0.655 . . . . 0.71999999999999997 112.271 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 3.8 mm? -112.72 -28.38 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.682 0.277 . . . . 2.1600000000000001 110.969 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.492 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 23.3 tp -122.06 100.33 6.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 1.1200000000000001 110.989 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -131.98 136.85 47.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.905 0.335 . . . . 1.49 111.905 -171.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 114' ' ' VAL . 12.8 ttpt -109.01 123.09 48.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.629 -0.508 . . . . 1.1200000000000001 109.629 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.666 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 24.4 ttpp -105.46 110.79 23.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.666 0.269 . . . . 1.6499999999999999 110.538 176.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -70.65 98.99 1.59 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 1.03 110.898 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 HG23 ' A' ' 111' ' ' THR . 10.7 mt -66.06 -52.54 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.724 -1.584 . . . . 1.0600000000000001 106.724 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.858 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 90.1 t -137.29 131.55 17.6 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 112.982 -1.917 . . . . 1.1399999999999999 106.483 169.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -105.65 52.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.704 2.269 . . . . 0.56000000000000005 113.798 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.92 148.99 12.01 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.924 -0.655 . . . . 0.55000000000000004 112.982 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.08 147.9 68.25 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.379 2.053 . . . . 1.9099999999999999 110.484 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.77 107.35 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.869 2.379 . . . . 2.5299999999999998 112.455 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.67 30.98 4.1 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.657 -0.701 . . . . 1.4199999999999999 112.168 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -167.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.474 0.654 . . . . 1.3600000000000001 111.173 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -153.22 137.52 16.6 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.944 -1.132 . . . . 1.8200000000000001 107.944 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 106' ' ' MET . 40.3 mtm180 -91.67 110.61 44.57 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.696 -0.229 . . . . 3.3900000000000001 110.451 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HD3' HG23 ' A' ' 108' ' ' VAL . 12.1 Cg_endo -53.82 149.11 34.62 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.412 2.741 . . . . 0.42999999999999999 112.8 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 2.2 m -102.99 157.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.204 -0.665 . . . . 1.47 109.204 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.861 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 56.6 mttp -62.97 119.85 10.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.246 0.546 . . . . 1.71 109.749 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.72 -26.75 4.5 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.49 -1.044 . . . . 0.41999999999999998 110.49 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.675 ' OE1' ' HB2' ' A' ' 149' ' ' ASP . 3.1 mm-40 -83.88 127.14 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.884 -1.154 . . . . 0.58999999999999997 107.884 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -80.37 126.75 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.18 -1.044 . . . . 1.8600000000000001 108.18 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 18.2 m -121.89 145.9 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.066 -0.97 . . . . 1.0700000000000001 110.533 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.679 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 54.4 p -96.92 112.99 24.5 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.86 -0.609 . . . . 1.0600000000000001 109.778 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.735 HG23 HD23 ' A' ' 99' ' ' LEU . 17.1 m -110.91 145.6 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 C-N-CA 120.228 -0.589 . . . . 1.05 110.697 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.644 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.1 t-160 -102.03 114.87 29.37 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.014 -1.476 . . . . 0.28999999999999998 107.014 169.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -121.21 133.5 55.17 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.218 1.008 . . . . 1.1299999999999999 110.905 176.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.697 HE22 ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -128.79 113.59 15.5 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.372 -2.084 . . . . 0.27000000000000002 105.372 168.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 40.1 m -104.4 127.69 52.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.953 -1.021 . . . . 1.04 111.724 -168.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.9 m -103.16 162.17 13.19 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.291 -0.868 . . . . 1.54 109.308 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.22 166.14 15.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.739 -1.119 . . . . 1.51 109.904 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.97 -21.88 33.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.187 0.518 . . . . 1.1399999999999999 110.296 174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.43 -4.47 55.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.909 -0.587 . . . . 2.1400000000000001 111.29 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.98 -23.07 28.46 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.658 -0.782 . . . . 0.51000000000000001 113.567 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 118.02 10.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.391 0.515 . . . . 1.1599999999999999 112.391 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.738 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.0 mtt180 -76.38 125.25 28.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.74 0.781 . . . . 0.54000000000000004 111.121 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.658 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -106.76 -9.09 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 1.0600000000000001 111.886 -170.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 8.6 pt20 -160.91 145.95 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.828 -0.624 . . . . 0.63 109.399 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HG2' ' CG ' ' A' ' 71' ' ' GLN . 1.2 tm-20 -150.56 105.53 3.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.347 -0.612 . . . . 1.3400000000000001 109.347 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -125.59 111.15 25.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 2.5899999999999999 110.069 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.413 ' HA ' ' CE1' ' A' ' 69' ' ' HIS . 24.6 Cg_exo -63.12 -16.63 55.62 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.137 2.558 . . . . 0.90000000000000002 113.192 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.48 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 11.6 tt0 -164.49 100.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.3 1.048 . . . . 1.3700000000000001 111.682 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.0 tp -109.11 110.35 21.57 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 1.1399999999999999 108.878 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.2 p -102.36 133.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.265 -0.643 . . . . 1.5900000000000001 109.265 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.2 p90 -153.31 157.29 39.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.695 0.283 . . . . 0.25 110.622 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -76.67 110.85 11.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.711 -0.677 . . . . 1.0700000000000001 109.646 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.861 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.3 tp -55.03 129.74 39.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.348 -0.387 . . . . 1.3300000000000001 110.862 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.12 2.02 90.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.918 -0.658 . . . . 0.37 112.368 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.16 -7.16 52.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.387 -0.598 . . . . 0.93000000000000005 109.387 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.8 m 60.65 28.77 18.48 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.207 -0.906 . . . . 1.55 110.019 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -63.87 -28.34 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.685 1.231 . . . . 1.3300000000000001 108.633 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 16.0 m -110.15 -153.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 113.329 -1.76 . . . . 1.0800000000000001 111.057 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.573 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.3 pt -89.04 139.47 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.548 -1.279 . . . . 1.0600000000000001 107.548 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.496 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -59.23 -29.35 67.46 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.458 -0.337 . . . . 0.40000000000000002 110.663 -174.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.02 -47.48 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.212 0.53 . . . . 1.0800000000000001 110.477 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.735 HD23 HG23 ' A' ' 68' ' ' VAL . 58.0 tp -78.04 -36.89 47.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.2 -0.909 . . . . 1.0700000000000001 110.259 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.49 -30.45 71.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.223 -0.899 . . . . 0.26000000000000001 109.588 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.2 mt -91.02 -33.32 15.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.418 -0.81 . . . . 1.0600000000000001 112.214 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 106' ' ' MET . 34.1 t -67.2 -31.92 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.58 -0.282 . . . . 1.53 111.1 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 99' ' ' LEU . 54.1 t -62.11 -55.45 40.57 Favored Pre-proline 0 C--O 1.219 -0.55 0 N-CA-C 112.309 0.485 . . . . 1.0600000000000001 112.309 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.837 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.9 Cg_endo -62.57 -20.64 71.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 121.747 1.632 . . . . 0.40999999999999998 111.75 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.586 HD13 HG22 ' A' ' 39' ' ' ILE . 12.1 mt -82.14 -15.15 54.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.584 . . . . 1.3500000000000001 111.299 173.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.746 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -107.41 146.41 31.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.925 -0.58 . . . . 1.3100000000000001 111.095 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.96 157.5 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.18 0.514 . . . . 0.96999999999999997 111.022 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.811 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.3 t -63.97 124.52 18.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.403 0.621 . . . . 1.47 110.169 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.68 16.39 45.81 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.067 -0.969 . . . . 0.28000000000000003 112.342 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.858 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.5 pt-20 -105.28 167.98 9.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.334 0.588 . . . . 0.40999999999999998 111.25 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.461 HG23 HD13 ' A' ' 50' ' ' LEU . 17.8 m -132.98 118.46 18.88 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.453 -0.943 . . . . 1.0700000000000001 108.453 173.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.13 140.19 52.84 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.327 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.6 ttp -100.61 118.26 36.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.506 -1.294 . . . . 1.9399999999999999 107.506 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.434 HG21 ' HG3' ' A' ' 47' ' ' LYS . 5.7 t -111.95 131.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.209 -0.45 . . . . 1.0600000000000001 110.086 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.521 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 96.1 m -108.16 112.98 25.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.364 -0.976 . . . . 1.03 108.364 172.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.62 135.17 52.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.378 -1.283 . . . . 1.01 109.399 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.634 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.8 t70 -54.25 149.35 9.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.1 -0.704 . . . . 0.57999999999999996 109.1 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.587 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -54.49 -28.49 45.25 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.407 0.442 . . . . 1.04 110.351 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.634 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.0 ptpt -54.68 -32.91 60.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.633 -0.258 . . . . 1.4299999999999999 111.463 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.566 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 82.8 m-85 -95.39 1.68 54.31 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.01 0.434 . . . . 1.04 110.279 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 70.8 m -120.74 -89.8 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.215 -0.902 . . . . 0.87 110.6 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.566 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.0 m-85 -144.04 38.78 1.32 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.066 -0.396 . . . . 0.95999999999999996 111.777 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.03 -79.39 0.08 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.215 -0.517 . . . . 0.25 113.636 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -85.02 9.51 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.197 1.931 . . . . 0.90000000000000002 111.044 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -104.0 -50.57 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.994 -1.003 . . . . 0.65000000000000002 109.81 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 79.87 141.53 2.51 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.602 -1.181 . . . . 0.29999999999999999 111.985 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.604 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.1 t -91.29 163.85 14.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.36 -0.42 . . . . 0.90000000000000002 111.374 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -48.82 -69.05 0.13 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.899 0.749 . . . . 3.6099999999999999 111.66 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.992 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.9 m -64.2 -66.37 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 115.675 -0.693 . . . . 1.52 110.608 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.992 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 28.5 Cg_endo -106.94 127.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.5 2.133 . . . . 0.44 112.259 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.554 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 23.5 t80 -57.15 97.34 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.978 -1.119 . . . . 1.6899999999999999 107.978 164.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.585 HG12 ' CB ' ' A' ' 127' ' ' SER . 31.8 mm -65.72 129.84 94.4 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 109.591 -0.522 . . . . 1.0600000000000001 109.591 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.76 140.88 66.61 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.59 2.194 . . . . 1.03 112.199 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 44.2 Cg_exo -57.8 131.28 43.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.234 1.956 . . . . 0.89000000000000001 112.292 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.499 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER 75.15 4.68 4.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.14 -0.936 . . . . 3.1899999999999999 112.356 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -70.05 123.3 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.281 -0.637 . . . . 1.04 109.281 176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.06 113.58 12.55 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.229 -0.588 . . . . 1.05 110.306 -172.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.603 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.3 tp -90.87 132.81 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.779 -0.646 . . . . 1.0600000000000001 110.918 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.78 100.75 7.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.183 0.516 . . . . 1.8200000000000001 109.696 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.559 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -116.19 136.16 53.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.138 -0.483 . . . . 1.1499999999999999 111.836 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.697 ' HG2' HE22 ' A' ' 71' ' ' GLN . 6.4 tt0 -102.05 121.8 42.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.224 -0.658 . . . . 1.05 109.224 178.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.694 HG13 HD12 ' A' ' 99' ' ' LEU . 3.7 m -118.14 117.56 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.682 0.753 . . . . 1.0800000000000001 112.52 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.72 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.3 m -87.8 115.36 25.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.971 -1.013 . . . . 1.0900000000000001 110.387 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.688 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 42.8 tp -88.87 100.73 13.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.223 -1.028 . . . . 1.0700000000000001 108.223 170.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.72 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -93.75 -23.27 18.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.191 -0.913 . . . . 1.6899999999999999 110.781 -173.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.679 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 94.7 m -159.84 144.91 15.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.763 -0.653 . . . . 1.1200000000000001 111.494 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.467 ' CB ' HG13 ' A' ' 66' ' ' VAL . . . -136.44 126.92 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.144 -0.688 . . . . 0.98999999999999999 109.144 170.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.0 m -135.41 131.07 51.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.126 0.489 . . . . 1.6200000000000001 110.455 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.675 ' HB2' ' OE1' ' A' ' 64' ' ' GLN . 8.5 t70 -69.69 119.11 13.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.317 -0.401 . . . . 2.27 110.783 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.35 31.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.033 -0.728 . . . . 2.5 109.033 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.578 -0.737 . . . . 2.1400000000000001 109.756 -176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -113.43 112.45 23.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.478 . . . . 6.6299999999999999 110.677 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -91.09 51.27 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.998 -0.742 . . . . 8.1899999999999995 108.998 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -83.66 -15.75 47.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 9.0800000000000001 110.541 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -66.59 153.17 43.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 9.2400000000000002 110.876 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 67.47 27.61 7.93 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.972 0.795 . . . . 12.779999999999999 110.619 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.486 -0.769 . . . . 14.109999999999999 109.139 176.685 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.699 -0.482 . . . . 50.460000000000001 109.699 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.543 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . 62.91 54.36 33.93 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.13 -0.788 . . . . 47.990000000000002 111.13 -172.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -102.36 103.31 30.36 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.825 0.345 . . . . 46.439999999999998 111.618 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 2' ' ' GLY . 55.3 Cg_endo -95.2 117.86 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.006 2.471 . . . . 45.219999999999999 111.455 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.72 121.31 9.51 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.858 1.705 . . . . 44.450000000000003 111.269 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.88 -55.34 3.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 42.710000000000001 110.432 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -125.6 82.23 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 41.5 110.498 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.37 121.01 25.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.362 -0.607 . . . . 40.329999999999998 109.362 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.73 158.47 33.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 39.390000000000001 111.393 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -78.23 -32.79 49.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.494 -0.775 . . . . 38.82 109.623 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -124.56 92.29 48.17 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.225 -0.898 . . . . 38.350000000000001 111.3 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.01 114.83 3.89 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.446 2.097 . . . . 37.039999999999999 111.616 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.57 -21.08 4.3 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.528 -0.844 . . . . 35.659999999999997 112.389 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.56 -67.97 0.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.651 0.262 . . . . 35.149999999999999 110.34 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 tp 62.88 98.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.585 -0.734 . . . . 34.170000000000002 112.296 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.63 101.73 11.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.156 -0.683 . . . . 32.950000000000003 109.156 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HE ' ' C ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -98.19 162.92 12.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.324 0.49 . . . . 32.299999999999997 112.324 -174.13 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.41 173.25 7.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 31.239999999999998 109.179 171.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 26.0 p90 -155.12 159.15 39.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.028 -0.269 . . . . 31.57 110.719 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 7.5 mt -173.41 -55.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.042 0.839 . . . . 30.100000000000001 109.516 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.41 102.49 4.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.016 -0.538 . . . . 28.399999999999999 109.831 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.68 -80.53 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.331 -0.395 . . . . 26.969999999999999 110.684 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ptm -120.04 -9.93 9.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.905 0.383 . . . . 27.66 111.108 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 6.5 tp10 -150.09 121.31 4.0 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.401 -0.363 . . . . 24.41 110.526 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 4.7 Cg_exo -76.49 -173.39 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.71 2.274 . . . . 22.399999999999999 110.834 173.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.59 131.09 22.1 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.797 -0.445 . . . . 20.670000000000002 109.797 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.05 115.1 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.033 2.489 . . . . 18.75 112.135 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -92.01 126.75 52.2 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 14.960000000000001 110.989 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 15.0 Cg_exo -70.71 129.29 16.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.953 2.436 . . . . 14.550000000000001 111.896 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.586 ' HB1' ' HD3' ' A' ' 31' ' ' PRO . . . -90.33 -52.59 0.32 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.395 -0.366 . . . . 10.949999999999999 111.888 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.586 ' HD3' ' HB1' ' A' ' 30' ' ' ALA . 4.3 Cg_exo -77.39 48.03 2.44 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.753 2.302 . . . . 10.6 112.156 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -100.26 140.89 21.81 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 6.1100000000000003 110.41 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 19.2 Cg_exo -66.79 -24.94 46.41 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.873 2.382 . . . . 5.3600000000000003 112.096 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 45.1 tt0 80.17 144.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.308 1.005 . . . . 4.1299999999999999 110.681 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.59 90.89 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.438 0.637 . . . . 2.4500000000000002 110.162 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.687 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -73.73 -169.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.884 -1.053 . . . . 0.53000000000000003 111.327 -176.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 tp -69.4 112.94 6.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.454 -0.794 . . . . 1.1899999999999999 110.332 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.613 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 t70 -76.41 123.49 26.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.527 0.679 . . . . 2.5099999999999998 109.999 176.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.589 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 4.8 mt -64.18 -30.13 49.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.794 -1.094 . . . . 1.1499999999999999 110.667 -176.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.35 -8.43 19.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.118 -0.492 . . . . 1.4299999999999999 110.05 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.49 25.3 68.55 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.209 -0.905 . . . . 0.65000000000000002 111.654 -172.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' OD1' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -105.07 -26.95 11.91 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.359 0.503 . . . . 0.94999999999999996 112.359 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.497 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.66 7.51 25.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.308 -0.948 . . . . 0.71999999999999997 112.454 174.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD13 ' OD1' ' A' ' 42' ' ' ASN . 8.9 mp -110.2 -32.7 6.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.332 0.587 . . . . 2.1600000000000001 110.578 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 19.4 tp -122.55 104.04 9.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.11 -0.95 . . . . 1.1200000000000001 111.512 -170.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 77.9 mtm180 -134.63 144.91 48.14 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.942 -0.474 . . . . 1.49 112.197 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HG3' HG22 ' A' ' 114' ' ' VAL . 14.8 ttpt -115.34 129.08 56.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.271 -0.27 . . . . 1.1200000000000001 110.271 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.687 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -111.08 120.02 40.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.891 0.377 . . . . 1.6499999999999999 111.109 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 p -72.91 101.03 3.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.747 -0.66 . . . . 1.03 111.647 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.44 HD13 HG21 ' A' ' 111' ' ' THR . 10.9 mt -68.08 -51.39 47.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.895 -1.521 . . . . 1.0600000000000001 106.895 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.852 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 69.0 t -136.58 130.46 17.94 Favored Pre-proline 0 CA--C 1.501 -0.927 0 CA-C-N 112.898 -1.956 . . . . 1.1399999999999999 106.097 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 44.4 Cg_endo -104.21 56.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.743 2.295 . . . . 0.56000000000000005 113.451 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.99 174.34 33.75 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.564 -0.744 . . . . 0.55000000000000004 112.637 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.02 151.72 45.08 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.205 1.936 . . . . 1.9099999999999999 110.685 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.21 97.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.448 2.098 . . . . 2.5299999999999998 111.978 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.35 39.12 1.05 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.864 -0.607 . . . . 1.4199999999999999 111.93 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -86.73 -168.78 2.36 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.941 0.4 . . . . 1.3600000000000001 110.811 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.486 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 19.4 m -145.85 138.02 25.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.745 -0.465 . . . . 1.8200000000000001 109.745 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 85.2 mtt180 -92.14 116.2 66.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 3.3900000000000001 109.626 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG3' HD22 ' A' ' 144' ' ' LEU . 9.1 Cg_endo -52.19 155.35 9.28 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.552 2.834 . . . . 0.42999999999999999 113.042 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.593 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 3.9 p -106.82 154.38 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 1.47 109.935 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.891 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 58.6 mttp -63.49 123.83 19.78 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.568 0.699 . . . . 1.71 109.54 178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 151' ' ' GLU . . . 118.24 -9.73 13.48 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 114.799 -1.091 . . . . 0.41999999999999998 110.562 -170.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.673 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.45 136.32 34.88 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.948 -0.736 . . . . 0.58999999999999997 109.698 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 p -82.87 115.7 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 108.445 -0.946 . . . . 1.8600000000000001 108.445 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.3 m -117.81 148.76 20.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.595 -0.729 . . . . 1.0700000000000001 111.156 -170.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.485 HG23 HG13 ' A' ' 87' ' ' VAL . 77.1 p -98.12 113.75 25.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.984 -0.553 . . . . 1.0600000000000001 110.09 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 99' ' ' LEU . 28.2 m -111.28 140.44 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 119.641 -0.824 . . . . 1.05 110.762 172.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.573 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.8 t-160 -102.29 115.27 30.21 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.891 -1.522 . . . . 0.28999999999999998 106.891 168.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 ' HB3' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -124.44 129.46 50.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 118.921 -1.112 . . . . 1.1299999999999999 111.608 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' CG ' ' HE2' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -121.79 114.9 21.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.865 -1.902 . . . . 0.27000000000000002 105.865 169.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.558 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 58.9 m -103.31 128.66 50.3 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.676 -1.147 . . . . 1.04 111.562 -167.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.695 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.8 m -103.51 156.8 17.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.129 -0.942 . . . . 1.54 108.869 176.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.69 165.34 19.02 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.199 -0.91 . . . . 1.51 109.431 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.06 -21.65 23.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.338 0.59 . . . . 1.1399999999999999 110.482 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.94 -5.15 58.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.379 -0.828 . . . . 2.1400000000000001 110.997 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.59 -6.4 57.39 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.979 -0.629 . . . . 0.51000000000000001 112.878 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -81.04 112.95 18.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.786 0.327 . . . . 1.1599999999999999 111.791 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 16.0 mtt180 -75.0 122.62 23.79 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.499 0.666 . . . . 0.54000000000000004 110.747 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -108.0 -9.93 10.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.695 -1.139 . . . . 1.0600000000000001 112.1 -169.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.558 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.0 pt20 -158.88 133.3 7.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.449 -0.341 . . . . 0.63 110.439 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.55 107.11 12.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.309 0.576 . . . . 1.3400000000000001 110.016 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.902 ' HB3' HD21 ' A' ' 70' ' ' LEU . 1.9 tp10 -111.29 105.68 57.0 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.237 -0.892 . . . . 2.5899999999999999 110.332 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.573 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 12.7 Cg_exo -67.91 -22.32 42.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.904 1.736 . . . . 0.90000000000000002 112.223 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.9 123.09 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.776 0.798 . . . . 1.3700000000000001 111.09 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.605 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 40.8 tp -131.38 105.78 7.83 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.806 -1.543 . . . . 1.1399999999999999 108.798 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 34.8 m -92.1 139.48 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-O 120.826 0.346 . . . . 1.5900000000000001 110.492 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 33.8 p90 -158.36 159.63 36.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.098 -0.501 . . . . 0.25 110.567 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 92' ' ' ASP . 7.4 m -77.63 115.99 17.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.607 -0.516 . . . . 1.0700000000000001 109.607 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.891 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.3 tp -56.76 131.41 49.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.558 -0.292 . . . . 1.3300000000000001 110.447 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.08 -3.66 86.85 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.908 -0.663 . . . . 0.37 112.55 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 12.6 t70 -86.34 -12.34 49.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.819 -0.438 . . . . 0.93000000000000005 109.819 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 m 60.38 33.73 20.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.902 -0.777 . . . . 1.55 108.902 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.8 t70 -72.67 -11.9 60.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.341 1.067 . . . . 1.3300000000000001 108.789 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.15 -158.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.502 -1.681 . . . . 1.0800000000000001 110.487 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -81.76 137.62 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.914 -1.143 . . . . 1.0600000000000001 107.914 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.482 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.0 tp60 -60.48 -28.78 68.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.829 -0.348 . . . . 0.40000000000000002 111.095 -173.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.37 70.56 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.32 0.581 . . . . 1.0800000000000001 110.472 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 68' ' ' VAL . 56.1 tp -80.08 -40.78 26.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.406 -0.815 . . . . 1.0700000000000001 110.941 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.482 ' HB3' HE21 ' A' ' 97' ' ' GLN . 16.3 t70 -60.58 -30.82 70.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.005 -0.998 . . . . 0.26000000000000001 110.018 -174.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.84 -33.24 15.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 1.0600000000000001 112.208 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.0 t -64.72 -35.32 80.66 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.76 0.314 . . . . 1.53 111.348 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 99' ' ' LEU . 65.7 t -60.72 -55.17 47.49 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.507 0.558 . . . . 1.0600000000000001 112.507 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.816 ' HD3' HD13 ' A' ' 90' ' ' LEU . 27.2 Cg_endo -64.51 -20.46 65.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.865 1.71 . . . . 0.40999999999999998 112.143 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.87 -12.72 59.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 1.3500000000000001 111.383 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.632 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 2.3 ptm -108.95 156.86 19.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 1.3100000000000001 110.625 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.96999999999999997 110.92 179.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.3 p -65.88 126.82 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.749 0.785 . . . . 1.47 110.29 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.37 7.4 62.04 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 114.75 -1.113 . . . . 0.28000000000000003 112.723 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.852 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.9 pt-20 -95.44 167.75 11.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.483 0.659 . . . . 0.40999999999999998 111.839 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.44 HG21 HD13 ' A' ' 50' ' ' LEU . 5.3 m -126.06 116.96 22.22 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.838 -1.171 . . . . 1.0700000000000001 107.838 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . . . -119.9 134.97 55.07 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.123 0.487 . . . . 1.0 110.813 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.1 ttm -97.54 117.88 32.79 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.381 -1.34 . . . . 1.9399999999999999 107.381 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.589 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.8 t -112.85 130.31 66.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.417 -0.586 . . . . 1.0600000000000001 109.417 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.553 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 78.9 m -110.29 112.75 24.9 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 119.146 -1.022 . . . . 1.03 108.365 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.23 135.04 52.16 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.963 -1.471 . . . . 1.01 109.91 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.624 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 9.6 t70 -52.36 147.94 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.819 -0.808 . . . . 0.57999999999999996 108.819 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.624 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.9 t -56.35 -26.29 52.18 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.013 0.435 . . . . 1.04 110.218 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.624 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -57.86 -29.96 65.43 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.762 -0.586 . . . . 1.4299999999999999 111.394 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 81.9 m-85 -93.46 -2.11 54.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.543 0.687 . . . . 1.04 110.221 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.652 ' HB3' HD21 ' A' ' 138' ' ' LEU . 64.7 m -119.53 -90.95 0.56 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.725 -1.125 . . . . 0.87 110.416 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.654 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.1 m-85 -145.81 43.06 1.25 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.337 -0.545 . . . . 0.95999999999999996 112.266 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -54.42 -87.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.056 -0.593 . . . . 0.25 113.361 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.14 10.38 2.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.373 2.048 . . . . 0.90000000000000002 111.046 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -103.47 -45.85 4.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.65000000000000002 110.245 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.53 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 76.01 143.39 1.28 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.911 -1.041 . . . . 0.29999999999999999 112.546 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 13.0 t -91.89 164.05 13.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.987 0.422 . . . . 0.90000000000000002 111.639 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -58.14 -45.64 87.02 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.249 -0.887 . . . . 3.6099999999999999 112.02 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.905 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 58.4 m -87.46 -60.26 0.26 Allowed Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 120.805 -0.358 . . . . 1.52 110.269 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.1 Cg_endo -107.58 126.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.541 2.161 . . . . 0.44 111.899 171.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.483 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 20.6 t80 -58.14 97.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.862 -1.162 . . . . 1.6899999999999999 107.862 165.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.578 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.1 mm -64.3 127.88 92.59 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.756 -0.656 . . . . 1.0600000000000001 110.013 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.0 Cg_endo -50.05 136.79 37.21 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.21 2.607 . . . . 1.03 111.87 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.55 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 31.2 Cg_exo -58.54 132.17 46.8 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.523 2.149 . . . . 0.89000000000000001 112.08 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.497 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 30.2 m170 77.0 0.21 3.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.912 -1.04 . . . . 3.1899999999999999 112.284 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.76 122.17 17.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.468 -0.493 . . . . 1.04 109.686 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.5 112.81 9.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.336 0.589 . . . . 1.05 109.634 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -88.05 132.32 34.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.605 -0.725 . . . . 1.0600000000000001 110.552 -176.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.6 t -115.08 99.54 7.52 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.755 -0.832 . . . . 1.8200000000000001 108.755 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.507 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.8 OUTLIER -113.95 134.12 55.04 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.289 0.566 . . . . 1.1499999999999999 111.599 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.512 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 57.6 tt0 -99.56 112.71 24.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 1.05 109.459 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.675 HG13 HD11 ' A' ' 99' ' ' LEU . 6.8 m -109.44 123.15 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.53 0.681 . . . . 1.0800000000000001 111.86 -177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -96.59 111.01 23.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.126 -0.943 . . . . 1.0900000000000001 110.167 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.632 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 58.1 tp -82.74 100.81 10.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.689 -0.856 . . . . 1.0700000000000001 108.689 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.43 ' C ' ' HG1' ' A' ' 146' ' ' THR . 32.1 mtmt -99.33 -21.38 16.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.631 -0.713 . . . . 1.6899999999999999 110.653 -170.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.43 ' HG1' ' C ' ' A' ' 145' ' ' LYS . 21.8 m -158.12 147.02 19.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.848 -0.341 . . . . 1.1200000000000001 111.408 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.74 127.68 33.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.98999999999999999 109.225 169.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -124.12 147.57 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.307 -0.627 . . . . 1.6200000000000001 109.307 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.611 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.8 p-10 -97.24 128.15 43.85 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 110.21 -0.293 . . . . 2.27 110.21 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 150' ' ' LEU . 1.3 tm? -135.13 -38.11 0.78 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.741 0.781 . . . . 2.5 110.21 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.598 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 4.8 tp10 -82.66 -34.89 27.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.468 -1.242 . . . . 2.1400000000000001 111.593 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 149' ' ' ASP . 0.1 OUTLIER -71.59 154.75 41.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 6.6299999999999999 111.106 -173.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.7 t60 62.88 20.12 11.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.9 -0.591 . . . . 8.1899999999999995 112.048 170.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -105.37 142.05 35.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.111 -0.329 . . . . 9.0800000000000001 110.111 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 60.18 77.3 0.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.79 0.681 . . . . 9.2400000000000002 111.277 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -112.5 128.92 56.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.119 -0.492 . . . . 12.779999999999999 110.683 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.167 -0.921 . . . . 14.109999999999999 109.267 175.434 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.449 0.166 . . . . 50.460000000000001 110.649 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.02 -17.65 5.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.207 -0.997 . . . . 47.990000000000002 113.365 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -137.91 121.93 11.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.091 0.445 . . . . 46.439999999999998 110.787 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.6 Cg_endo -76.96 150.45 30.02 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.682 2.255 . . . . 45.219999999999999 112.254 177.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 17.0 Cg_exo -68.67 123.41 10.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.543 2.162 . . . . 44.450000000000003 111.982 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.29 152.76 47.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 42.710000000000001 111.32 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.41 144.25 51.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.303 -0.629 . . . . 41.5 109.303 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -86.75 149.74 24.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 40.329999999999998 110.8 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.33 137.36 53.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.106 -0.497 . . . . 39.390000000000001 111.305 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -126.6 -60.85 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 38.82 109.034 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -127.44 90.28 49.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.593 -0.731 . . . . 38.350000000000001 109.59 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.61 -64.88 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.753 2.302 . . . . 37.039999999999999 112.675 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.58 159.5 13.89 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.806 -0.712 . . . . 35.659999999999997 112.114 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.8 -53.54 7.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 35.149999999999999 110.568 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tt -125.35 103.71 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 34.170000000000002 109.577 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.02 124.91 50.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.572 . . . . 32.950000000000003 110.093 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -127.79 142.51 51.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.974 0.416 . . . . 32.299999999999997 111.313 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -77.76 -33.72 52.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.657 -0.701 . . . . 31.239999999999998 110.82 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -93.81 158.9 15.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 31.57 110.349 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.94 173.54 12.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 30.100000000000001 111.352 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.8 94.02 9.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 28.399999999999999 110.455 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.62 152.63 33.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.619 . . . . 26.969999999999999 109.33 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -104.27 -64.66 1.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.579 0.228 . . . . 27.66 110.848 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.523 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 37.4 tt0 -173.11 -49.76 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.43 0.529 . . . . 24.41 112.43 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 11.2 Cg_exo -72.18 52.68 1.92 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.45 2.1 . . . . 22.399999999999999 112.989 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -71.45 126.75 91.71 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.781 -0.645 . . . . 20.670000000000002 110.603 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.2 146.66 64.41 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.595 2.196 . . . . 18.75 111.831 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.37 131.87 74.02 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 14.960000000000001 110.726 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.78 129.34 32.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.98 2.453 . . . . 14.550000000000001 112.039 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.579 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -149.91 -51.96 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.614 0.598 . . . . 10.949999999999999 112.614 -175.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 30' ' ' ALA . 3.3 Cg_exo -81.83 173.03 11.57 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.659 2.239 . . . . 10.6 112.456 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -101.09 113.95 65.8 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.664 . . . . 6.1100000000000003 109.822 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.657 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 32.2 Cg_endo -93.56 -0.89 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.299 2.666 . . . . 5.3600000000000003 114.4 -173.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.0 28.34 12.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.894 0.378 . . . . 4.1299999999999999 110.633 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 33.0 mt-10 -101.24 95.47 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.319 0.581 . . . . 2.4500000000000002 110.03 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.515 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -81.16 -156.4 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.827 -1.079 . . . . 0.53000000000000003 110.932 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.1 tp -70.47 111.83 6.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.506 -0.77 . . . . 1.1899999999999999 110.621 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.594 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.7 t70 -73.06 131.88 42.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.586 0.708 . . . . 2.5099999999999998 110.678 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.5 mt -65.25 -34.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.612 -1.176 . . . . 1.1499999999999999 111.137 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.44 -2.35 20.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.503 0.668 . . . . 1.4299999999999999 109.71 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.88 24.26 68.21 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.879 -1.055 . . . . 0.65000000000000002 111.986 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.11 -30.36 11.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.436 0.532 . . . . 0.94999999999999996 112.436 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 116.38 -0.98 20.62 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.717 -0.754 . . . . 0.71999999999999997 112.303 172.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 44' ' ' LEU . 6.7 mp -100.98 -36.52 8.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.592 0.711 . . . . 2.1600000000000001 111.085 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 12.0 tp -122.22 104.82 9.71 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.838 -1.074 . . . . 1.1200000000000001 111.112 -169.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' NH1' ' HG2' ' A' ' 35' ' ' GLU . 15.1 mtm180 -132.16 138.65 48.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 1.49 111.856 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -112.19 126.32 55.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.645 -0.252 . . . . 1.1200000000000001 110.54 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 39.0 ttpt -113.3 115.56 28.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 1.6499999999999999 110.885 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -74.17 103.11 4.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.025 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.459 HD11 HG23 ' A' ' 111' ' ' THR . 7.6 mt -68.92 -56.08 8.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.656 -1.609 . . . . 1.0600000000000001 106.656 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.829 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 64.8 t -128.85 125.81 23.06 Favored Pre-proline 0 CA--C 1.499 -1.013 0 CA-C-N 113.125 -1.852 . . . . 1.1399999999999999 106.62 168.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 45.9 Cg_endo -105.02 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.949 2.433 . . . . 0.56000000000000005 113.413 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.32 149.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.55000000000000004 113.328 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.19 151.71 84.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.572 2.181 . . . . 1.9099999999999999 110.591 169.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.97 109.58 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.352 2.035 . . . . 2.5299999999999998 111.967 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 33.42 2.98 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.664 -0.698 . . . . 1.4199999999999999 112.765 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m -85.18 178.74 7.41 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.177 0.513 . . . . 1.3600000000000001 110.84 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.513 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 23.7 m -135.62 127.17 28.8 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.004 -0.739 . . . . 1.8200000000000001 109.004 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 4.0 ptt-85 -91.07 108.77 30.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 120.906 0.384 . . . . 3.3900000000000001 109.991 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.2 Cg_endo -51.07 159.3 2.69 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.155 3.237 . . . . 0.42999999999999999 114.571 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.591 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.7 t -98.17 156.22 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.097 -0.956 . . . . 1.47 109.703 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.968 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -73.72 121.43 20.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.603 0.716 . . . . 1.71 109.632 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' CA ' ' HG2' ' A' ' 151' ' ' GLU . . . 127.71 -18.76 5.95 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.049 -1.221 . . . . 0.41999999999999998 110.049 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.44 141.05 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.445 -0.946 . . . . 0.58999999999999997 108.445 173.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.869 HG13 HD22 ' A' ' 150' ' ' LEU . 26.8 m -87.63 128.56 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.456 -0.898 . . . . 1.8600000000000001 108.658 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -123.1 145.8 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.804 -1.089 . . . . 1.0700000000000001 110.852 -173.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.9 p -89.84 115.81 27.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.013 0.435 . . . . 1.0600000000000001 110.117 176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.928 HG22 HD23 ' A' ' 99' ' ' LEU . 18.1 m -109.36 144.06 18.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.597 -0.841 . . . . 1.05 109.283 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.0 t-160 -103.96 118.98 37.95 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.463 -1.68 . . . . 0.28999999999999998 106.463 169.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.8 OUTLIER -122.08 133.73 54.77 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 118.847 -1.141 . . . . 1.1299999999999999 111.026 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.574 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -127.75 113.57 16.16 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.419 -2.067 . . . . 0.27000000000000002 105.419 167.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 84.8 m -104.81 126.48 51.92 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.477 -1.238 . . . . 1.04 111.43 -166.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.77 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -107.24 147.71 29.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.147 -0.933 . . . . 1.54 109.511 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.71 165.79 24.09 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.732 -0.667 . . . . 1.51 110.013 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.89 -22.79 27.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 1.1399999999999999 110.5 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -83.03 -8.33 59.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.242 -0.89 . . . . 2.1400000000000001 110.884 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.38 60.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.959 -0.639 . . . . 0.51000000000000001 112.089 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.5 m -81.33 110.14 16.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.72 0.295 . . . . 1.1599999999999999 111.397 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.6 mtt180 -74.37 121.46 21.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.834 0.826 . . . . 0.54000000000000004 110.82 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.709 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.7 m -105.22 -9.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.359 -1.291 . . . . 1.0600000000000001 111.984 -169.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.566 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.4 pt20 -159.94 132.41 6.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.184 -0.462 . . . . 0.63 110.628 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.424 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 45.5 tt0 -127.78 109.52 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.484 . . . . 1.3400000000000001 109.828 171.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.45 109.1 26.39 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.576 -0.738 . . . . 2.5899999999999999 109.892 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 72.7 Cg_endo -68.19 -17.96 45.17 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.778 2.985 . . . . 0.90000000000000002 113.454 -172.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.34 111.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.167 0.984 . . . . 1.3700000000000001 111.04 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.9 tp -128.56 97.88 4.84 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.347 -1.751 . . . . 1.1399999999999999 109.043 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.6 p -89.73 130.96 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.336 -0.393 . . . . 1.5900000000000001 110.115 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.0 p90 -151.83 158.15 42.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.25 110.664 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.2 m -76.2 110.93 11.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.054 -0.521 . . . . 1.0700000000000001 110.283 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.968 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 14.1 tp -58.18 128.58 37.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.955 -0.566 . . . . 1.3300000000000001 110.382 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.637 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.68 7.92 83.61 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.716 -0.754 . . . . 0.37 112.419 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.6 6.0 23.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.577 -0.527 . . . . 0.93000000000000005 109.577 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.52 32.98 20.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.136 -0.938 . . . . 1.55 110.385 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 26.0 t0 -75.49 -4.21 38.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.341 1.067 . . . . 1.3300000000000001 109.335 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.2 m -135.24 -155.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.037 -1.438 . . . . 1.0800000000000001 110.602 -175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 34.4 pt -83.56 135.75 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.296 -1.372 . . . . 1.0600000000000001 107.296 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.521 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 6.6 tp60 -59.22 -31.19 68.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.472 -0.331 . . . . 0.40000000000000002 111.382 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.87 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.23 0.538 . . . . 1.0800000000000001 110.354 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.928 HD23 HG22 ' A' ' 68' ' ' VAL . 58.6 tp -73.64 -41.41 62.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 1.0700000000000001 110.496 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' HB3' HE21 ' A' ' 97' ' ' GLN . 12.7 t70 -61.95 -27.74 69.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.963 -1.017 . . . . 0.26000000000000001 110.098 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.785 HD21 ' HZ2' ' A' ' 62' ' ' LYS . 64.8 mt -90.13 -36.41 14.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.194 -0.912 . . . . 1.0600000000000001 111.91 176.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -37.58 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 1.53 111.107 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 99' ' ' LEU . 64.0 t -60.51 -55.79 41.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.0 0.741 . . . . 1.0600000000000001 113.0 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.745 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.1 Cg_endo -61.69 -25.06 78.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.092 1.862 . . . . 0.40999999999999998 111.849 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 39' ' ' ILE . 11.0 mt -80.06 -11.89 59.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 1.3500000000000001 111.593 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.667 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.2 153.81 23.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.307 -0.406 . . . . 1.3100000000000001 111.23 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.43 158.59 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 0.96999999999999997 110.593 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.5 p -66.16 128.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.84 0.829 . . . . 1.47 110.378 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.4 4.62 59.49 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.909 -1.041 . . . . 0.28000000000000003 112.15 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.829 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -98.06 165.12 12.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.383 0.611 . . . . 0.40999999999999998 111.534 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.459 HG23 HD11 ' A' ' 50' ' ' LEU . 54.6 m -130.76 117.95 20.15 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.739 -1.119 . . . . 1.0700000000000001 108.263 175.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.62 140.24 50.91 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.618 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.9 ttm -98.91 117.46 33.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.181 -1.415 . . . . 1.9399999999999999 107.181 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.46 128.78 74.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.66 -0.496 . . . . 1.0600000000000001 109.66 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 52.9 m -109.29 113.85 27.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.77 -0.772 . . . . 1.03 109.163 174.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.43 ' HB3' HD12 ' A' ' 45' ' ' LEU . . . -122.47 139.91 53.34 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.892 -1.504 . . . . 1.01 110.05 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.651 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.8 t70 -52.29 146.48 9.25 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.711 -0.848 . . . . 0.57999999999999996 108.711 171.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 3.2 t -55.18 -26.98 42.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 1.04 110.171 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.651 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.3 ptpt -55.3 -32.26 62.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.554 -0.294 . . . . 1.4299999999999999 111.426 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.7 m-85 -95.3 6.17 49.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.171 0.51 . . . . 1.04 110.196 176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -124.74 -90.82 0.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.831 -1.077 . . . . 0.87 110.489 -176.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.2 m-85 -143.75 37.72 1.33 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.978 0.353 . . . . 0.95999999999999996 111.831 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.11 -78.51 0.09 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.471 -0.395 . . . . 0.25 113.83 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.48 8.68 4.45 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.15 1.9 . . . . 0.90000000000000002 111.015 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -103.9 -50.12 3.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.435 -0.802 . . . . 0.65000000000000002 110.135 -172.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.594 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . 80.28 143.53 3.27 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.571 -1.195 . . . . 0.29999999999999999 111.753 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.645 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 12.1 t -89.82 158.4 17.5 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.505 -0.348 . . . . 0.90000000000000002 111.281 -177.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -58.81 -37.31 76.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.632 -0.713 . . . . 3.6099999999999999 111.738 -170.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.925 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 7.0 m -91.44 -60.71 0.21 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.598 -0.519 . . . . 1.52 109.598 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.925 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -107.41 126.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.808 2.339 . . . . 0.44 112.307 170.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.594 ' CD1' ' HA3' ' A' ' 126' ' ' GLY . 64.6 t80 -57.61 97.5 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.361 -0.977 . . . . 1.6899999999999999 108.361 164.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.583 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.43 128.36 93.81 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.441 -0.8 . . . . 1.0600000000000001 109.522 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.44 140.57 63.63 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.536 2.157 . . . . 1.03 112.286 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.536 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.9 Cg_exo -57.97 134.81 64.74 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.254 1.969 . . . . 0.89000000000000001 112.079 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 18.6 m80 70.42 5.18 5.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.0 -1.0 . . . . 3.1899999999999999 112.661 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -68.88 122.34 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.307 -0.627 . . . . 1.04 109.307 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.73 111.81 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.303 0.573 . . . . 1.05 109.583 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.66 131.32 36.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.834 -0.621 . . . . 1.0600000000000001 111.063 -175.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.7 t -117.44 101.61 8.53 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.844 0.831 . . . . 1.8200000000000001 109.55 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.9 OUTLIER -114.05 136.6 52.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.84 -1.073 . . . . 1.1499999999999999 111.702 -171.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.574 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 55.0 tt0 -101.28 117.11 34.32 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.082 -0.71 . . . . 1.05 109.082 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.758 HG12 HD12 ' A' ' 99' ' ' LEU . 5.5 m -116.15 121.95 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.367 0.603 . . . . 1.0800000000000001 112.31 -175.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 m -96.71 114.47 26.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.242 -0.89 . . . . 1.0900000000000001 111.281 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.633 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 52.0 tp -84.5 102.18 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.626 -0.879 . . . . 1.0700000000000001 108.626 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 84' ' ' PRO . 19.2 mtmm -105.06 -20.23 13.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.79 -0.641 . . . . 1.6899999999999999 111.019 -169.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.7 m -156.51 148.73 23.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.767 -0.651 . . . . 1.1200000000000001 110.599 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.507 ' CB ' HG13 ' A' ' 66' ' ' VAL . . . -145.61 128.47 16.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.761 -0.829 . . . . 0.98999999999999999 108.761 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 20.6 m -134.35 133.77 55.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.86 -0.736 . . . . 1.6200000000000001 111.715 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.501 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.9 p-10 -80.4 123.4 28.0 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.022 -0.99 . . . . 2.27 110.807 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.869 HD22 HG13 ' A' ' 65' ' ' VAL . 1.5 pt? -153.11 13.14 0.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.319 -0.4 . . . . 2.5 110.986 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.452 ' HG2' ' CA ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -54.05 -72.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.624 0.577 . . . . 2.1400000000000001 110.918 -172.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -122.06 101.23 7.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 6.6299999999999999 112.188 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -54.81 121.15 7.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.022 -0.99 . . . . 8.1899999999999995 110.173 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -76.78 55.72 1.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.591 0.589 . . . . 9.0800000000000001 112.591 -172.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 56.72 30.13 17.07 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.691 0.396 . . . . 9.2400000000000002 111.508 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -134.73 156.33 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.975 0.417 . . . . 12.779999999999999 110.789 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m80 . . . . . 0 C--O 1.245 0.827 0 CA-C-N 115.508 -0.769 . . . . 14.109999999999999 109.466 173.576 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 mmt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.155 -0.683 . . . . 50.460000000000001 109.155 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.72 28.11 1.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.392 -0.908 . . . . 47.990000000000002 112.777 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -97.94 142.99 25.45 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 122.748 -0.266 . . . . 46.439999999999998 110.336 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.674 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 64.4 Cg_exo -50.93 -48.09 22.51 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.726 2.284 . . . . 45.219999999999999 112.682 174.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 2.9 Cg_endo -82.94 122.33 3.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.825 1.683 . . . . 44.450000000000003 110.928 169.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.27 -21.66 15.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.873 0.368 . . . . 42.710000000000001 110.928 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 9' ' ' ALA . 10.6 tp10 -157.48 139.17 14.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 41.5 109.628 -177.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.44 -40.77 18.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.677 -0.49 . . . . 40.329999999999998 109.677 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 7' ' ' GLU . . . 51.66 39.85 26.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.37 -0.832 . . . . 39.390000000000001 112.156 174.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -88.84 -76.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.427 -0.352 . . . . 38.82 110.904 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 55.18 81.86 0.25 Allowed Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.658 -0.701 . . . . 38.350000000000001 110.08 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.06 -176.51 3.28 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.08 2.52 . . . . 37.039999999999999 113.643 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.08 -12.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.877 -0.677 . . . . 35.659999999999997 112.464 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.98 -84.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.361 0.664 . . . . 35.149999999999999 111.57 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -170.65 -70.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.307 . . . . 34.170000000000002 110.611 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 177.59 -60.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.618 0.723 . . . . 32.950000000000003 109.528 -174.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -120.96 -11.68 8.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 32.299999999999997 110.379 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 62.41 -84.68 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.865 0.728 . . . . 31.239999999999998 111.167 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -146.02 144.88 30.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.863 -0.421 . . . . 31.57 109.863 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.747 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.4 pt? -99.25 10.13 42.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 30.100000000000001 111.992 -172.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.79 87.3 6.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 28.399999999999999 110.39 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 -12.59 21.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.797 -0.638 . . . . 26.969999999999999 110.452 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 52.3 mtt -90.44 0.32 57.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 27.66 110.717 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -114.23 96.96 44.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.484 -0.561 . . . . 24.41 109.484 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -91.34 112.62 0.36 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.958 2.439 . . . . 22.399999999999999 113.018 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -100.26 150.02 36.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.723 -0.473 . . . . 20.670000000000002 109.723 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.53 126.82 22.48 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.595 2.196 . . . . 18.75 111.715 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.17 132.65 93.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 14.960000000000001 110.994 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.67 143.18 70.52 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.215 2.61 . . . . 14.550000000000001 113.319 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.08 65.16 18.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 10.949999999999999 110.355 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.8 166.26 19.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.775 2.317 . . . . 10.6 112.582 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . . . -111.13 142.71 26.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.293 -0.412 . . . . 6.1100000000000003 110.552 176.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 22.4 Cg_exo -66.78 -24.0 47.6 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.215 2.61 . . . . 5.3600000000000003 113.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -144.7 105.96 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.084 -0.71 . . . . 4.1299999999999999 109.084 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.676 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 24.2 mt-10 -105.89 113.99 27.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.745 -0.661 . . . . 2.4500000000000002 109.738 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.677 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -68.13 -166.85 0.07 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.066 -0.97 . . . . 0.53000000000000003 112.422 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -69.09 111.93 5.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.026 -0.988 . . . . 1.1899999999999999 111.037 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.717 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -64.51 101.53 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.084 -0.962 . . . . 2.5099999999999998 110.599 173.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.585 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.9 mt -54.07 -44.08 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.141 -0.936 . . . . 1.1499999999999999 112.009 -174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.473 HD23 HD12 ' A' ' 101' ' ' LEU . 86.5 mt -109.84 12.64 23.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 1.4299999999999999 110.525 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 70.66 0.12 30.49 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.65000000000000002 113.02 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' OD1' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -81.06 -30.26 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.765 0.283 . . . . 0.94999999999999996 111.765 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.19 63.69 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.71999999999999997 112.311 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 2.3 mm? -79.04 -31.54 44.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.886 0.851 . . . . 2.1600000000000001 109.06 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.585 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 13.9 tp -119.31 114.01 21.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.087 -1.415 . . . . 1.1200000000000001 110.13 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 mtm180 -140.51 140.8 35.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.675 -0.239 . . . . 1.49 111.37 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HZ2' ' HA ' ' A' ' 106' ' ' MET . 11.1 ttpt -108.45 125.59 51.95 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.393 0.433 . . . . 1.1200000000000001 110.462 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.1 ttpt -107.63 113.67 27.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.164 -0.309 . . . . 1.6499999999999999 110.164 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -76.47 99.34 4.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.425 -0.352 . . . . 1.03 110.931 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.439 HD23 ' HE3' ' A' ' 48' ' ' LYS . 15.5 mt -63.84 -50.67 67.96 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.926 -1.509 . . . . 1.0600000000000001 106.926 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.868 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 82.0 t -139.38 133.73 16.11 Favored Pre-proline 0 CA--C 1.502 -0.869 0 CA-C-N 113.303 -1.771 . . . . 1.1399999999999999 106.389 169.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -107.63 64.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.749 2.299 . . . . 0.56000000000000005 113.446 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.89 142.13 1.77 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.53 -0.759 . . . . 0.55000000000000004 112.504 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.48 145.94 96.52 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.943 1.762 . . . . 1.9099999999999999 109.63 168.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -46.88 99.09 0.03 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.686 2.257 . . . . 2.5299999999999998 112.351 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.4 60.64 0.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.669 -0.696 . . . . 1.4199999999999999 112.491 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -116.57 -172.35 2.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.872 -0.788 . . . . 1.3600000000000001 108.872 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.578 ' O ' HG23 ' A' ' 108' ' ' VAL . 17.9 t -128.22 -177.32 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.256 -1.016 . . . . 1.8200000000000001 108.256 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 14.1 mtm180 -130.91 120.55 18.48 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.562 -0.533 . . . . 3.3900000000000001 109.562 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.4 Cg_endo -51.15 138.08 45.06 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.247 2.631 . . . . 0.42999999999999999 113.306 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.655 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.8 t -90.1 154.93 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.597 -0.729 . . . . 1.47 109.196 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 59.1 mttt -66.64 108.55 2.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.452 0.644 . . . . 1.71 111.037 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 140.44 -28.37 2.45 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.429 -1.259 . . . . 0.41999999999999998 110.287 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -76.27 138.71 40.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.855 -0.795 . . . . 0.58999999999999997 108.855 177.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -88.54 129.29 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.008 -1.108 . . . . 1.8600000000000001 108.008 172.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.7 m -125.79 147.86 30.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.43 -0.804 . . . . 1.0700000000000001 110.965 -171.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.506 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 26.6 p -96.32 113.37 24.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.979 -0.555 . . . . 1.0600000000000001 109.967 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.519 HG23 HD23 ' A' ' 99' ' ' LEU . 23.9 m -110.47 143.97 19.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.27 0.557 . . . . 1.05 110.336 174.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.58 112.1 24.7 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.106 -1.442 . . . . 0.28999999999999998 107.106 169.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 83' ' ' GLU . 1.7 pt? -116.06 136.59 52.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.93 0.872 . . . . 1.1299999999999999 110.808 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.574 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.21 116.58 14.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 105.702 -1.962 . . . . 0.27000000000000002 105.702 169.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.583 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 62.6 m -109.28 123.67 49.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.876 -1.056 . . . . 1.04 111.418 -165.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.62 149.49 25.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.429 -0.805 . . . . 1.54 109.276 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.546 ' HG ' HG11 ' A' ' 80' ' ' VAL . 8.0 mt -77.53 166.83 22.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.749 -0.659 . . . . 1.51 110.804 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.35 -23.89 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.493 0.663 . . . . 1.1399999999999999 110.4 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -82.55 -11.3 58.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.352 -0.84 . . . . 2.1400000000000001 110.76 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.43 59.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.142 -0.551 . . . . 0.51000000000000001 111.86 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 m -75.12 110.63 9.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.991 0.367 . . . . 1.1599999999999999 111.991 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.5 mtt180 -73.1 117.57 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.54000000000000004 110.804 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.645 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.7 m -98.96 -10.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.936 -1.029 . . . . 1.0600000000000001 112.081 -171.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.583 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.6 pt20 -159.99 141.25 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.677 -0.692 . . . . 0.63 109.31 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 14.4 tt0 -145.56 103.89 3.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.367 0.603 . . . . 1.3400000000000001 109.657 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.738 ' HB2' HD21 ' A' ' 70' ' ' LEU . 4.1 mm-40 -118.56 115.16 35.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.203 -0.908 . . . . 2.5899999999999999 109.887 -173.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 47.1 Cg_endo -69.06 -14.51 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.377 2.051 . . . . 0.90000000000000002 113.044 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -166.98 114.86 0.82 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.861 0.839 . . . . 1.3700000000000001 111.817 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.4 tp -123.97 112.18 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.604 -1.634 . . . . 1.1399999999999999 108.802 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.4 p -103.23 128.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.6 -0.518 . . . . 1.5900000000000001 109.6 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.786 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 47.2 p90 -148.75 159.83 43.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 0.25 111.698 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 1.7 m -78.45 109.07 12.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.839 . . . . 1.0700000000000001 110.546 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.776 HD12 ' HD3' ' A' ' 104' ' ' PRO . 15.4 tp -61.56 127.9 33.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.474 -0.33 . . . . 1.3300000000000001 110.661 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.645 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 83.91 11.72 78.55 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.835 -0.698 . . . . 0.37 112.689 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.447 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 34.3 t70 -115.44 10.0 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.331 0.586 . . . . 0.93000000000000005 109.605 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.5 m 54.39 39.15 30.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.202 -0.908 . . . . 1.55 109.438 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.786 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -70.63 -12.78 61.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.092 -1.077 . . . . 1.3300000000000001 108.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.0 m -137.61 -159.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 113.758 -1.565 . . . . 1.0800000000000001 110.578 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.7 pt -79.23 140.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.709 -1.219 . . . . 1.0600000000000001 107.709 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.2 tp60 -59.66 -31.2 69.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.407 -0.361 . . . . 0.40000000000000002 110.987 -173.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.96 -43.0 69.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.237 0.542 . . . . 1.0800000000000001 110.422 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.604 HD13 HG13 ' A' ' 142' ' ' VAL . 50.4 tp -78.01 -41.38 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.459 -0.791 . . . . 1.0700000000000001 110.897 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.458 ' HB3' HE21 ' A' ' 97' ' ' GLN . 11.1 t70 -60.28 -29.67 68.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.328 -0.851 . . . . 0.26000000000000001 110.123 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.583 HD22 ' HZ3' ' A' ' 62' ' ' LYS . 73.3 mt -90.03 -33.3 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.414 -0.812 . . . . 1.0600000000000001 111.92 176.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.0 t -66.28 -34.2 77.46 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.718 0.294 . . . . 1.53 110.888 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.409 ' HB ' ' CD ' ' A' ' 104' ' ' PRO . 54.3 t -64.0 -55.61 31.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.813 0.671 . . . . 1.0600000000000001 112.813 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.776 ' HD3' HD12 ' A' ' 90' ' ' LEU . 17.8 Cg_endo -62.5 -22.39 73.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.91 1.74 . . . . 0.40999999999999998 112.049 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 39' ' ' ILE . 11.5 mt -79.56 -16.89 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 1.3500000000000001 111.275 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -104.43 157.24 17.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.095 -0.502 . . . . 1.3100000000000001 111.315 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.5 m-20 -94.54 155.1 17.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.982 0.42 . . . . 0.96999999999999997 111.17 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 58' ' ' SER . 40.0 t -60.89 125.16 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.581 0.705 . . . . 1.47 110.394 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.47 14.74 56.65 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 115.172 -0.922 . . . . 0.28000000000000003 112.453 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.868 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -101.42 168.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.339 0.59 . . . . 0.40999999999999998 111.433 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.412 HG21 HD11 ' A' ' 50' ' ' LEU . 9.4 m -130.59 117.24 19.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.066 -1.087 . . . . 1.0700000000000001 108.066 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.475 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . . . -121.43 136.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.052 0.453 . . . . 1.0 110.653 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 ttm -99.49 116.86 32.61 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.528 -1.286 . . . . 1.9399999999999999 107.528 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.81 127.67 71.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.945 -0.761 . . . . 1.0600000000000001 108.945 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.677 HG21 ' SG ' ' A' ' 139' ' ' CYS . 38.6 m -107.14 114.19 28.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.345 -0.942 . . . . 1.03 108.94 175.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' A' ' 45' ' ' LEU . . . -122.14 136.43 54.91 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.749 -1.568 . . . . 1.01 109.93 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.3 t70 -53.33 149.33 7.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.792 -0.818 . . . . 0.57999999999999996 108.792 172.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.8 t -55.0 -27.24 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.258 0.551 . . . . 1.04 110.549 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.9 ptpt -54.15 -35.95 62.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.293 -0.412 . . . . 1.4299999999999999 111.515 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.541 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 99.2 m-85 -95.77 3.48 53.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 1.04 110.304 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.745 ' HB3' HD23 ' A' ' 138' ' ' LEU . 68.2 m -119.45 -91.03 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.033 -0.985 . . . . 0.87 110.572 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.691 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 7.6 m-85 -145.57 40.69 1.2 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.255 0.465 . . . . 0.95999999999999996 112.255 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -52.5 -84.41 0.03 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.341 0.518 . . . . 0.25 113.647 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -81.84 11.12 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.364 2.043 . . . . 0.90000000000000002 110.696 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.691 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.7 mt-30 -104.24 -50.19 3.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.203 -0.908 . . . . 0.65000000000000002 110.125 -174.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.03 141.6 3.09 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.731 -1.122 . . . . 0.29999999999999999 112.613 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.0 t -92.28 165.38 13.13 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.232 -0.484 . . . . 0.90000000000000002 111.373 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.708 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 2.6 mmp_? -54.79 -60.7 3.0 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.59 -0.732 . . . . 3.6099999999999999 112.197 -176.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.84 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 17.5 t -76.57 -58.06 1.19 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 116.142 -0.481 . . . . 1.52 109.871 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.84 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.4 Cg_endo -108.73 126.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.521 2.147 . . . . 0.44 112.25 171.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.615 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.9 t80 -57.0 99.37 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.59 -1.263 . . . . 1.6899999999999999 107.59 163.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.595 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.2 mm -65.61 128.54 93.88 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.023 -0.535 . . . . 1.0600000000000001 110.188 -177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.29 141.63 70.58 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.724 2.283 . . . . 1.03 112.051 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.543 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 39.5 Cg_exo -57.67 130.55 39.28 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.332 2.021 . . . . 0.89000000000000001 112.068 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.494 ' H ' ' HB3' ' A' ' 118' ' ' SER . 13.6 m-70 74.1 7.79 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.831 -1.077 . . . . 3.1899999999999999 113.105 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -68.9 120.59 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.503 -0.554 . . . . 1.04 109.503 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.32 113.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.171 0.51 . . . . 1.05 109.809 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.745 HD23 ' HB3' ' A' ' 121' ' ' CYS . 2.2 mp -90.87 129.81 36.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.847 -0.615 . . . . 1.0600000000000001 111.009 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.677 ' SG ' HG21 ' A' ' 115' ' ' THR . 35.2 m -112.55 98.91 7.56 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.586 -0.894 . . . . 1.8200000000000001 108.586 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -108.46 134.96 50.52 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.793 -0.639 . . . . 1.1499999999999999 111.595 -174.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.574 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 43.2 tt0 -102.73 116.26 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.146 -0.687 . . . . 1.05 109.146 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.604 HG13 HD13 ' A' ' 99' ' ' LEU . 3.9 m -115.69 119.35 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.561 0.696 . . . . 1.0800000000000001 112.758 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.7 m -90.32 110.48 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 1.0900000000000001 110.271 171.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.557 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 61.7 tp -82.82 97.85 8.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.651 -0.87 . . . . 1.0700000000000001 108.651 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.454 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.2 mtmt -94.57 -29.11 15.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 1.6899999999999999 110.597 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.506 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.9 m -153.53 149.31 27.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.466 -0.334 . . . . 1.1200000000000001 111.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.476 ' HA ' HG11 ' A' ' 66' ' ' VAL . . . -140.12 127.99 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.27 -0.641 . . . . 0.98999999999999999 109.27 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.12 140.35 49.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.44 0.638 . . . . 1.6200000000000001 111.357 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.524 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.5 t70 -90.43 121.12 32.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 2.27 110.076 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.7 mt -153.65 15.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 2.5 110.765 -171.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 152' ' ' HIS . 6.5 tp10 -97.13 -84.02 0.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 2.1400000000000001 110.43 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.581 ' CD2' ' HG3' ' A' ' 151' ' ' GLU . 34.5 p80 -150.28 139.95 21.67 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.236 -0.586 . . . . 6.6299999999999999 111.615 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -118.77 12.23 12.92 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.491 0.663 . . . . 8.1899999999999995 109.243 169.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.87 127.15 33.63 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.864 -1.062 . . . . 9.0800000000000001 109.061 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 64.23 -176.9 0.16 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.851 0.719 . . . . 9.2400000000000002 111.682 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -115.22 11.73 16.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.44 -0.578 . . . . 12.779999999999999 109.44 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.402 -0.809 . . . . 14.109999999999999 109.53 -174.648 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.758 0.314 . . . . 50.460000000000001 110.821 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.93 134.59 6.86 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.733 -0.746 . . . . 47.990000000000002 112.123 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -111.22 158.78 35.08 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.405 -0.22 . . . . 46.439999999999998 110.405 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 29.4 Cg_endo -65.57 134.18 37.26 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.182 1.921 . . . . 45.219999999999999 110.809 169.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 33.5 Cg_exo -61.35 142.77 96.91 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.82 2.347 . . . . 44.450000000000003 112.771 -176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 73.14 -77.29 0.06 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.08 -0.963 . . . . 42.710000000000001 112.554 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.58 162.4 41.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 41.5 111.426 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 9' ' ' ALA . 3.7 pt-20 -127.16 -31.57 2.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 40.329999999999998 110.711 173.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 8' ' ' GLU . . . -166.21 105.35 0.66 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.889 0.376 . . . . 39.390000000000001 111.958 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -175.03 146.57 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.62 -0.882 . . . . 38.82 108.62 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 61.06 75.1 0.47 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.329 -0.619 . . . . 38.350000000000001 109.329 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.61 -18.98 58.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.19 2.593 . . . . 37.039999999999999 112.826 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.43 73.22 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.445 -0.883 . . . . 35.659999999999997 111.961 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.65 -21.53 66.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.259 . . . . 35.149999999999999 111.03 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt 66.82 -172.62 0.19 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.629 -0.714 . . . . 34.170000000000002 111.418 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.81 -81.04 0.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 32.950000000000003 109.748 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -103.08 -2.29 27.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.089 -0.505 . . . . 32.299999999999997 110.595 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 55.58 89.8 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.385 0.612 . . . . 31.239999999999998 110.84 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 10.13 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.285 -0.416 . . . . 31.57 111.971 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp -144.8 17.2 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.719 0.295 . . . . 30.100000000000001 111.772 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.02 113.84 20.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.735 -0.211 . . . . 28.399999999999999 110.811 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.69 -179.78 0.23 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.041 0.838 . . . . 26.969999999999999 111.54 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.2 13.88 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 27.66 110.338 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 56.64 91.54 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 124.067 0.854 . . . . 24.41 110.95 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.83 149.93 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.889 2.392 . . . . 22.399999999999999 112.456 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 24.1 mm-40 -62.91 132.94 95.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.856 -0.611 . . . . 20.670000000000002 110.066 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 16.5 Cg_exo -68.08 131.89 24.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.571 2.181 . . . . 18.75 111.361 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 144.85 84.88 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.294 -0.262 . . . . 14.960000000000001 110.294 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 140.82 22.37 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 14.550000000000001 113.908 -174.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -97.67 -44.53 0.24 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.45 -0.795 . . . . 10.949999999999999 111.876 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 45.1 Cg_exo -57.96 128.22 28.07 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.821 1.681 . . . . 10.6 112.19 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.01 112.48 55.52 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.272 -0.422 . . . . 6.1100000000000003 110.481 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.22 -36.95 77.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.606 2.204 . . . . 5.3600000000000003 112.035 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -168.83 110.4 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.392 -0.822 . . . . 4.1299999999999999 109.093 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -87.27 114.01 23.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.827 0.823 . . . . 2.4500000000000002 111.592 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.616 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -96.87 -163.52 1.06 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 0.53000000000000003 109.087 173.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.44 109.99 7.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.894 0.378 . . . . 1.1899999999999999 110.674 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.631 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -64.9 96.77 0.2 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.652 -0.704 . . . . 2.5099999999999998 111.499 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.707 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 15.1 mt -51.81 -53.08 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.203 -0.908 . . . . 1.1499999999999999 110.38 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.912 HD22 HD21 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -78.71 -16.98 56.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.15 -1.386 . . . . 1.4299999999999999 110.163 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.631 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 72.37 8.34 70.48 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.404 -0.816 . . . . 0.65000000000000002 111.674 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' ND2' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.41 -9.14 16.84 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.568 0.223 . . . . 0.94999999999999996 111.51 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.85 -22.38 28.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.346 -0.931 . . . . 0.71999999999999997 113.238 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 4.2 mm? -80.09 -22.51 42.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.577 0.704 . . . . 2.1600000000000001 109.235 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.912 HD21 HD22 ' A' ' 40' ' ' LEU . 26.3 tp -120.51 110.39 16.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 1.1200000000000001 110.679 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 42.8 mtm105 -143.75 140.41 29.93 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.223 0.327 . . . . 1.49 111.544 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.738 ' HG3' HG21 ' A' ' 114' ' ' VAL . 7.3 ttpp -116.95 127.8 54.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.16 0.184 . . . . 1.1200000000000001 110.553 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.616 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.9 ttpt -103.67 130.37 51.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.804 0.335 . . . . 1.6499999999999999 110.986 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.694 HG22 ' HZ3' ' A' ' 47' ' ' LYS . 1.5 p -80.49 94.67 6.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.847 -0.615 . . . . 1.03 110.381 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 111' ' ' THR . 12.5 mt -63.78 -52.77 58.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.014 -1.476 . . . . 1.0600000000000001 107.014 173.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.793 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 73.6 t -134.63 124.61 17.02 Favored Pre-proline 0 CA--C 1.494 -1.195 0 CA-C-N 113.362 -1.745 . . . . 1.1399999999999999 106.599 168.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 68.3 Cg_endo -105.6 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.623 2.215 . . . . 0.56000000000000005 113.593 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.532 ' HA3' ' OD2' ' A' ' 107' ' ' ASP . . . 60.71 173.93 1.05 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.201 -0.909 . . . . 0.55000000000000004 114.207 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.816 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 71.9 Cg_endo -77.82 178.98 6.95 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.52 2.147 . . . . 1.9099999999999999 109.475 164.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 50.9 Cg_endo -71.22 36.52 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.922 1.748 . . . . 2.5299999999999998 112.656 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 54' ' ' PRO . . . 177.4 53.35 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.275 -0.421 . . . . 1.4199999999999999 112.073 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.816 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -95.66 -174.78 3.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.236 0.541 . . . . 1.3600000000000001 111.639 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.25 -0.886 . . . . 1.8200000000000001 108.791 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -91.06 119.14 68.89 Favored Pre-proline 0 C--N 1.319 -0.732 0 C-N-CA 120.792 -0.363 . . . . 3.3900000000000001 110.59 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.645 ' HD3' HG21 ' A' ' 108' ' ' VAL . 11.3 Cg_endo -53.16 149.43 28.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.603 2.869 . . . . 0.42999999999999999 113.318 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.6 t -100.02 151.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.974 -0.557 . . . . 1.47 109.737 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 59.7 mttt -61.72 112.83 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.652 0.739 . . . . 1.71 110.875 177.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 134.76 -30.0 2.91 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 114.165 -1.38 . . . . 0.41999999999999998 110.186 -174.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.638 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -72.39 139.17 47.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.158 -0.617 . . . . 0.58999999999999997 110.202 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 148' ' ' VAL . 40.9 t -80.81 117.14 26.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.503 -0.925 . . . . 1.8600000000000001 108.503 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -125.47 150.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.782 0.66 . . . . 1.0700000000000001 112.782 -170.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' A' ' 145' ' ' LYS . 0.8 OUTLIER -98.43 121.8 40.81 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.696 -1.138 . . . . 1.0600000000000001 110.41 174.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.665 HG21 HD23 ' A' ' 99' ' ' LEU . 30.1 m -118.33 147.73 21.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.341 -0.543 . . . . 1.05 110.106 168.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.724 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.04 117.34 34.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.752 -1.573 . . . . 0.28999999999999998 106.752 167.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.506 ' CD2' ' HB3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -118.33 138.63 52.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.204 -0.999 . . . . 1.1299999999999999 111.004 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.692 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.77 113.91 11.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.194 -2.15 . . . . 0.27000000000000002 105.194 165.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.582 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 72.0 m -102.73 127.3 49.93 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.738 -1.119 . . . . 1.04 111.076 -167.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.716 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 t -109.04 159.44 16.84 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.396 -0.82 . . . . 1.54 109.358 -177.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.74 164.53 18.49 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.694 -0.684 . . . . 1.51 109.303 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -52.19 -24.12 6.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.518 0.675 . . . . 1.1399999999999999 110.58 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -94.46 -7.33 41.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.062 -0.972 . . . . 2.1400000000000001 111.98 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.48 -8.72 37.86 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.83 -0.7 . . . . 0.51000000000000001 113.981 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.3 m -75.55 110.69 10.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.448 0.624 . . . . 1.1599999999999999 111.718 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.716 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.8 mtt180 -77.68 110.64 12.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.947 0.88 . . . . 0.54000000000000004 110.298 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.481 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.2 m -91.36 -12.61 9.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.069 -1.423 . . . . 1.0600000000000001 111.936 -169.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.582 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -158.6 124.4 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.344 -0.389 . . . . 0.63 110.746 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.53 124.53 48.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.315 -0.624 . . . . 1.3400000000000001 109.315 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.506 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 8.6 tt0 -144.61 107.28 4.7 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-O 121.879 0.847 . . . . 2.5899999999999999 110.506 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 69' ' ' HIS . 53.1 Cg_endo -68.94 -19.2 40.43 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 123.35 2.7 . . . . 0.90000000000000002 113.871 -171.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -158.74 99.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.0 0.905 . . . . 1.3700000000000001 111.016 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.4 tp -113.04 116.02 29.27 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.31 -1.768 . . . . 1.1399999999999999 108.808 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.0 p -112.64 133.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.728 -0.471 . . . . 1.5900000000000001 109.728 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -154.86 164.74 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.884 0.373 . . . . 0.25 110.821 -172.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m -83.38 112.46 19.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.634 -0.712 . . . . 1.0700000000000001 109.495 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.937 HD13 ' HD3' ' A' ' 104' ' ' PRO . 14.2 tp -59.53 126.26 26.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.405 -0.361 . . . . 1.3300000000000001 110.919 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 62' ' ' LYS . . . 83.51 5.51 88.41 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.78 -0.724 . . . . 0.37 112.438 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -90.33 -7.34 53.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.565 -1.272 . . . . 0.93000000000000005 107.565 174.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 56.2 m 58.4 31.7 21.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.105 -1.407 . . . . 1.55 110.16 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.27 -18.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.256 1.026 . . . . 1.3300000000000001 109.168 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.38 -155.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.069 -1.423 . . . . 1.0800000000000001 110.454 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 28.8 pt -82.75 137.27 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.296 -1.372 . . . . 1.0600000000000001 107.296 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.577 HE21 ' HB3' ' A' ' 100' ' ' ASP . 12.4 tp60 -56.77 -30.03 63.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.468 -0.333 . . . . 0.40000000000000002 110.96 -173.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.77 78.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.163 0.506 . . . . 1.0800000000000001 110.746 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 68' ' ' VAL . 62.6 tp -77.88 -37.76 47.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.671 -0.695 . . . . 1.0700000000000001 110.678 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.577 ' HB3' HE21 ' A' ' 97' ' ' GLN . 22.9 t70 -61.9 -29.51 70.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 0.26000000000000001 109.59 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.3 -35.07 14.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.253 -0.885 . . . . 1.0600000000000001 112.275 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 106' ' ' MET . 21.3 t -65.81 -32.83 74.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 1.53 111.479 -174.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 104' ' ' PRO . 53.5 t -66.92 -54.91 18.43 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.519 0.563 . . . . 1.0600000000000001 112.519 -176.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.937 ' HD3' HD13 ' A' ' 90' ' ' LEU . 23.7 Cg_endo -63.76 -22.63 69.5 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.042 1.828 . . . . 0.40999999999999998 111.921 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.501 ' CD1' HG22 ' A' ' 39' ' ' ILE . 4.2 mt -77.38 -31.15 54.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 1.3500000000000001 111.336 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.3 ptm -88.52 157.23 18.69 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.936 -0.575 . . . . 1.3100000000000001 109.68 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.532 ' OD2' ' HA3' ' A' ' 53' ' ' GLY . 8.3 p-10 -103.49 158.39 16.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.337 0.589 . . . . 0.96999999999999997 111.713 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.645 HG21 ' HD3' ' A' ' 60' ' ' PRO . 2.8 t -61.37 125.82 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.524 -0.762 . . . . 1.47 111.464 -174.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.65 59.2 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 114.815 -1.084 . . . . 0.28000000000000003 112.819 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.793 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.4 pt-20 -97.0 167.87 10.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.195 0.522 . . . . 0.40999999999999998 110.625 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.498 HG23 HD13 ' A' ' 50' ' ' LEU . 21.5 m -128.07 117.4 21.58 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.048 -1.093 . . . . 1.0700000000000001 108.048 173.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 47' ' ' LYS . . . -118.35 131.52 56.31 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.963 -173.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.2 ttp -98.44 117.99 34.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.994 -1.113 . . . . 1.9399999999999999 107.994 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.738 HG21 ' HG3' ' A' ' 47' ' ' LYS . 12.7 t -109.1 137.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.878 -0.601 . . . . 1.0600000000000001 109.583 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.597 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 89.6 m -110.66 113.07 25.39 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.241 -1.022 . . . . 1.03 108.241 170.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -122.7 132.14 54.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.564 -1.198 . . . . 1.01 109.29 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.739 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.6 t70 -52.98 146.63 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.588 -0.893 . . . . 0.57999999999999996 108.588 171.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.568 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.5 t -52.32 -26.78 13.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.131 0.491 . . . . 1.04 110.48 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.739 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.7 ptpt -54.33 -33.54 59.16 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 122.062 -0.399 . . . . 1.4299999999999999 112.01 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' OH ' ' HG ' ' A' ' 40' ' ' LEU . 98.5 m-85 -96.4 3.08 53.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.352 0.596 . . . . 1.04 109.92 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.586 ' HB3' HD23 ' A' ' 138' ' ' LEU . 69.8 m -122.13 -90.46 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.034 . . . . 0.87 110.389 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.608 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 13.0 m-85 -144.39 39.62 1.3 Allowed 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.262 0.467 . . . . 0.95999999999999996 112.262 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -52.71 -83.26 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.188 -0.529 . . . . 0.25 113.744 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.74 7.66 4.72 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.405 2.07 . . . . 0.90000000000000002 111.259 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.0 mt-30 -104.45 -51.17 3.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.716 -0.674 . . . . 0.65000000000000002 110.498 -173.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 85.85 142.68 6.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.074 -0.966 . . . . 0.29999999999999999 112.419 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.628 ' HB3' HG12 ' A' ' 132' ' ' ILE . 6.9 t -91.35 162.22 14.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.187 -0.506 . . . . 0.90000000000000002 112.162 -175.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -52.89 -51.37 61.42 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 115.151 -0.931 . . . . 3.6099999999999999 112.238 -173.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.977 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 20.4 m -81.4 -64.7 0.27 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.438 . . . . 1.52 110.36 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.977 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 20.0 Cg_endo -105.24 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.401 2.067 . . . . 0.44 111.7 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.542 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 31.0 t80 -56.22 98.11 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.064 -1.087 . . . . 1.6899999999999999 108.064 163.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 127' ' ' SER . 33.5 mm -65.35 128.99 94.27 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.893 -0.594 . . . . 1.0600000000000001 109.639 -177.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -52.38 139.14 55.72 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.659 2.239 . . . . 1.03 112.282 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.553 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 40.7 Cg_exo -57.55 129.05 31.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.528 2.152 . . . . 0.89000000000000001 112.456 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.585 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 57.9 m80 75.36 12.16 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.936 -1.029 . . . . 3.1899999999999999 112.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.76 127.14 32.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.235 -0.654 . . . . 1.04 109.235 173.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.48 113.08 11.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.521 -0.472 . . . . 1.05 110.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.14 132.87 35.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.072 -0.513 . . . . 1.0600000000000001 110.97 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 5.2 t -118.11 100.07 7.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.012 -0.736 . . . . 1.8200000000000001 109.012 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.569 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 pp -109.5 136.71 48.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.651 -0.704 . . . . 1.1499999999999999 111.586 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.692 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 50.8 tt0 -101.85 118.44 36.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.175 -0.676 . . . . 1.05 109.175 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 4.2 m -119.67 123.3 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.435 0.636 . . . . 1.0800000000000001 112.555 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.439 ' HG1' HG22 ' A' ' 111' ' ' THR . 42.9 m -92.79 118.54 31.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.645 -0.707 . . . . 1.0900000000000001 109.362 170.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.693 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 37.4 tp -80.82 99.01 8.07 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.481 -0.933 . . . . 1.0700000000000001 108.481 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.603 ' HD3' ' HB ' ' A' ' 67' ' ' THR . 19.2 mtpt -79.91 -44.48 20.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.464 -1.244 . . . . 1.6899999999999999 110.328 -168.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.463 ' HG1' ' C ' ' A' ' 145' ' ' LYS . 4.4 m -158.48 160.0 36.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.969 -0.56 . . . . 1.1200000000000001 110.526 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.481 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.32 128.05 27.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.165 -0.68 . . . . 0.98999999999999999 109.165 170.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 65' ' ' VAL . 20.4 m -126.19 140.23 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 1.6200000000000001 110.06 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.482 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 7.7 t70 -86.36 117.76 25.36 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.509 -0.476 . . . . 2.27 110.55 -176.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.5 tp -136.25 6.9 3.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.878 -0.601 . . . . 2.5 109.793 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -109.07 117.87 35.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.496 -0.775 . . . . 2.1400000000000001 109.198 -178.097 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -128.97 73.95 1.55 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.363 0.602 . . . . 6.6299999999999999 109.745 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -71.29 120.57 17.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 8.1899999999999995 110.897 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -84.34 -29.21 26.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 9.0800000000000001 111.104 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -125.95 82.13 2.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.693 0.282 . . . . 9.2400000000000002 110.999 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.0 m80 61.5 -89.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.695 -0.684 . . . . 12.779999999999999 111.385 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 . . . . . 0 C--O 1.244 0.798 0 N-CA-C 109.132 -0.692 . . . . 14.109999999999999 109.132 176.037 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.609 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.388 0.613 . . . . 0.53000000000000003 110.856 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.71 109.76 4.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.5 110.131 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.623 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.0 t70 -74.76 123.8 25.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 2.5099999999999998 110.818 174.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.506 HD12 HD11 ' A' ' 45' ' ' LEU . 8.8 mt -56.06 -36.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.711 -1.131 . . . . 0.46000000000000002 111.568 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -110.77 -2.39 16.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.208 0.528 . . . . 0.71999999999999997 110.473 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.17 24.75 67.51 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.33 -0.85 . . . . 0.52000000000000002 111.627 -173.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.525 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -94.5 -22.37 18.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.858 0.361 . . . . 0.94999999999999996 111.669 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.548 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.0 -17.67 41.09 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.922 -0.656 . . . . 0.71999999999999997 112.125 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.817 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 1.1 mt -96.07 -24.23 16.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.673 0.273 . . . . 1.5600000000000001 110.912 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 39' ' ' ILE . 19.5 tp -123.68 100.39 6.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.374 -0.376 . . . . 0.32000000000000001 111.854 -171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -130.11 139.88 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.097 -0.377 . . . . 1.1399999999999999 111.722 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 10.3 ttpt -112.13 125.82 54.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.477 0.311 . . . . 0.34999999999999998 110.637 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.2 ttpp -116.54 120.73 39.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 1.0700000000000001 110.969 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 p -74.93 110.44 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.464 . . . . 0.33000000000000002 111.646 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD11 ' HG3' ' A' ' 141' ' ' GLU . 9.0 mt -73.88 -52.0 14.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.827 -1.545 . . . . 0.28000000000000003 106.827 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.866 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.7 t -133.46 130.72 21.11 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 113.21 -1.814 . . . . 0.35999999999999999 106.752 170.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 22.7 Cg_endo -107.79 57.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.221 2.614 . . . . 0.54000000000000004 114.024 -176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 120.958 -0.639 . . . . 0.55000000000000004 112.848 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 122.003 0.906 . . . . 0.98999999999999999 113.252 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 108' ' ' VAL . 16.5 m -146.71 140.0 25.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.582 -1.19 . . . . 1.28 108.229 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 96.4 mtt180 -89.36 116.22 65.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 120.567 -0.453 . . . . 2.8100000000000001 109.831 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 10.0 Cg_endo -52.38 148.59 25.53 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.493 2.795 . . . . 0.29999999999999999 112.67 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -94.65 152.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 0.88 109.28 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 61.3 mttt -63.71 120.69 12.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 1.1699999999999999 109.399 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.02 -41.92 1.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.06 -1.427 . . . . 0.41999999999999998 110.075 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.5 mm-40 -69.42 132.67 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.069 -0.715 . . . . 0.58999999999999997 109.069 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 17.9 m -84.45 118.64 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 122.142 0.973 . . . . 1.22 108.727 175.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -115.65 144.84 22.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.93 -1.032 . . . . 0.25 111.486 -171.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.973 HG22 HG22 ' A' ' 87' ' ' VAL . 43.5 p -88.86 113.99 25.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.535 -0.757 . . . . 0.28999999999999998 110.221 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 99' ' ' LEU . 20.8 m -111.49 143.59 21.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.996 -0.682 . . . . 0.19 110.511 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -103.1 117.88 35.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.451 -1.314 . . . . 0.19 107.451 168.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -118.96 137.79 53.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 118.92 -1.112 . . . . 0.39000000000000001 111.035 176.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.501 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 2.0 mp0 -132.46 114.29 14.13 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.491 -2.041 . . . . 0.27000000000000002 105.491 166.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.662 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 60.3 m -105.45 132.61 51.41 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 114.976 -1.011 . . . . 0.19 111.831 -168.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 m -104.39 156.88 17.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.096 -0.956 . . . . 1.0600000000000001 108.874 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.419 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.8 mt -80.42 166.72 20.98 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 0.83999999999999997 108.908 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 11.1 pt-20 -59.88 -14.54 15.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.915 0.339 . . . . 1.1399999999999999 111.915 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.28 -15.63 25.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.897 0.38 . . . . 2.1400000000000001 110.711 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.44 -3.92 19.93 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.813 -0.708 . . . . 0.51000000000000001 113.644 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.1 m -75.67 110.88 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.369 0.584 . . . . 0.46000000000000002 111.573 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.6 mtt180 -75.99 112.42 12.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.854 0.835 . . . . 0.46999999999999997 110.857 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.573 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.2 m -99.02 -13.8 7.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 113.992 -1.458 . . . . 0.27000000000000002 112.377 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.611 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 19.1 pt20 -157.06 136.58 12.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.81 0.338 . . . . 0.58999999999999997 110.586 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.52 130.42 32.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.969 -0.559 . . . . 1.3400000000000001 109.687 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 4.8 tt0 -145.09 112.98 4.84 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.562 -0.745 . . . . 2.5899999999999999 109.815 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 15.2 Cg_exo -68.19 -15.77 43.27 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.501 2.801 . . . . 0.5 113.315 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.578 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 26.5 tt0 -166.34 113.28 0.86 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.021 0.915 . . . . 1.3700000000000001 111.572 -175.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.455 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 49.7 tp -126.72 110.76 13.49 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.55 -1.659 . . . . 0.38 108.737 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.973 HG22 HG22 ' A' ' 67' ' ' THR . 2.1 t -100.79 125.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 p90 -145.56 160.71 41.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.23000000000000001 111.44 -172.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 m -79.29 106.67 11.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.593 -0.73 . . . . 0.41999999999999998 110.4 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.856 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.02 134.54 57.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.213 -0.448 . . . . 0.59999999999999998 110.514 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 81.44 -5.63 67.63 Favored Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 120.824 -0.703 . . . . 0.37 113.293 173.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -107.17 15.54 25.04 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.534 -0.913 . . . . 0.93000000000000005 108.534 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 32.2 m 53.65 39.61 30.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.109 -1.405 . . . . 0.62 109.633 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.3 t0 -76.86 -2.79 35.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.563 1.173 . . . . 1.3300000000000001 108.383 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 6.2 m -140.04 -157.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 113.646 -1.616 . . . . 0.23000000000000001 110.757 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.5 pt -82.82 139.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.567 -1.272 . . . . 0.28999999999999998 107.567 173.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -58.85 -31.51 68.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.351 -0.386 . . . . 0.40000000000000002 111.261 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.91 79.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 0.20000000000000001 110.491 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 68' ' ' VAL . 53.7 tp -75.5 -38.01 59.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.314 -0.857 . . . . 0.22 110.551 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.41 -29.82 70.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.97 -1.014 . . . . 0.26000000000000001 109.868 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.55 -36.04 14.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.198 -0.91 . . . . 0.25 111.969 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.8 t -64.91 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.676 -0.238 . . . . 1.01 111.191 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 104' ' ' PRO . 76.1 t -65.55 -53.45 37.37 Favored Pre-proline 0 C--O 1.218 -0.578 0 CA-C-N 116.471 -0.332 . . . . 0.20999999999999999 111.888 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.802 ' HD3' HD11 ' A' ' 90' ' ' LEU . 64.5 Cg_exo -52.55 -28.83 38.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.992 1.795 . . . . 0.27000000000000002 112.706 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.56 -11.52 53.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.8 -0.636 . . . . 0.64000000000000001 111.279 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -100.43 142.07 32.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.27 -0.877 . . . . 0.78000000000000003 110.701 176.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.576 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -89.37 156.88 18.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.96999999999999997 108.781 172.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 58' ' ' SER . 1.3 p -66.04 126.47 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.935 0.874 . . . . 0.80000000000000004 110.459 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.8 -2.3 45.17 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.337 -0.847 . . . . 0.28000000000000003 112.254 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.866 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 6.8 pt-20 -96.95 168.13 10.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.529 0.68 . . . . 0.40999999999999998 110.913 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.438 HG22 HD12 ' A' ' 50' ' ' LEU . 10.2 m -130.18 116.96 19.18 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.369 -0.974 . . . . 0.22 108.369 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.595 ' HB3' ' SD ' ' A' ' 106' ' ' MET . . . -115.21 135.28 54.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.878 -0.601 . . . . 0.17999999999999999 110.314 -176.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttm -97.46 117.0 30.74 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.124 -1.436 . . . . 1.3200000000000001 107.124 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.62 130.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.584 -0.524 . . . . 0.17999999999999999 109.584 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.512 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 98.1 m -105.79 112.48 25.56 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.075 -1.083 . . . . 0.20999999999999999 108.075 170.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.31 133.69 52.52 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.988 -1.46 . . . . 0.14999999999999999 109.227 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.817 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 10.0 t70 -52.67 145.77 11.44 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.893 -0.78 . . . . 0.57999999999999996 108.893 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.8 t -52.74 -29.49 27.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.965 0.412 . . . . 0.81999999999999995 110.125 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.693 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 7.0 ptpp? -56.73 -27.14 58.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.206 0.447 . . . . 0.81000000000000005 112.206 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.564 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 88.9 m-85 -99.4 0.99 43.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.3 0.571 . . . . 0.41999999999999998 109.922 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -119.72 -92.03 0.54 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.816 -1.084 . . . . 0.17999999999999999 109.994 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.0 m-85 -142.02 43.62 1.68 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 111.761 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.29 -89.83 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 113.957 0.343 . . . . 0.25 113.957 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.65 15.27 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.639 2.226 . . . . 0.57999999999999996 110.707 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 33.0 mt-30 -104.3 -43.28 5.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.232 -0.895 . . . . 0.65000000000000002 109.672 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.595 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 75.85 144.99 1.44 Allowed Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.655 -1.157 . . . . 0.29999999999999999 112.673 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.678 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.3 t -92.08 159.91 15.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.417 -0.392 . . . . 0.33000000000000002 111.322 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.449 HH12 ' CD ' ' A' ' 83' ' ' GLU . 33.2 mtt180 -53.18 -57.0 11.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.329 -0.851 . . . . 3.1699999999999999 111.109 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.96 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.3 m -74.6 -64.31 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.833 -0.622 . . . . 1.23 110.553 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.96 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.6 Cg_endo -106.72 126.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.973 1.782 . . . . 0.37 112.132 174.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 34.3 t80 -58.85 98.02 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.153 -1.054 . . . . 1.1399999999999999 108.153 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.0 mm -65.97 132.33 94.66 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.39000000000000001 109.886 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 52.7 Cg_exo -54.53 140.5 75.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.675 2.25 . . . . 0.60999999999999999 112.436 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.477 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 48.2 Cg_exo -56.58 140.19 89.36 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.535 2.157 . . . . 0.52000000000000002 112.392 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.637 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 29.5 p80 47.59 28.76 1.27 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.398 1.079 . . . . 2.3799999999999999 113.145 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -86.19 134.2 33.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.374 -0.973 . . . . 0.26000000000000001 108.374 169.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -77.81 113.32 15.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.306 -0.558 . . . . 0.22 110.326 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.662 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 2.5 tp -90.41 132.01 35.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.774 -0.648 . . . . 0.22 110.015 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.8 t -115.56 100.38 8.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.308 -0.627 . . . . 1.2 109.308 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 pp -113.36 136.36 52.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.002 -0.545 . . . . 0.32000000000000001 111.686 -171.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 46.9 tt0 -104.21 111.26 23.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.72 . . . . 1.05 109.213 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.682 HG11 HD13 ' A' ' 99' ' ' LEU . 2.9 m -113.72 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.119 0.785 . . . . 0.19 113.119 -173.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.6 m -88.6 108.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.636 -1.165 . . . . 0.28000000000000003 110.369 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.407 HD21 ' HG3' ' A' ' 60' ' ' PRO . 61.7 tp -81.75 93.05 6.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.326 -0.99 . . . . 0.14999999999999999 108.326 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.472 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 24.7 mtmt -90.13 -31.21 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.679 -0.691 . . . . 1.0800000000000001 110.754 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 m -148.67 151.46 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.961 0.41 . . . . 0.37 111.293 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -139.78 128.11 22.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.25 109.289 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.327 -0.384 0 C-N-CA 120.479 -0.488 . . . . 0.92000000000000004 110.245 -179.456 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.594 ' HZ3' ' H ' ' A' ' 115' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.53000000000000003 110.528 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.7 tp -69.39 110.81 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.551 -0.749 . . . . 0.5 109.618 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.621 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 11.6 t70 -75.71 128.56 35.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.202 -0.599 . . . . 2.5099999999999998 109.463 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.544 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 7.3 mt -65.13 -23.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.847 -1.069 . . . . 0.46000000000000002 110.839 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.3 mt -116.14 -5.5 11.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.71999999999999997 110.101 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 69.19 18.52 73.17 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.52000000000000002 112.361 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' ND2' HD13 ' A' ' 44' ' ' LEU . 19.1 p-10 -98.28 -31.17 12.19 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.636 0.606 . . . . 0.94999999999999996 112.636 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.516 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.85 -0.83 21.46 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.473 -0.87 . . . . 0.71999999999999997 112.242 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.522 HD13 ' ND2' ' A' ' 42' ' ' ASN . 7.8 mp -99.13 -35.59 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.173 0.511 . . . . 1.5600000000000001 110.801 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 18.2 tp -122.68 101.62 7.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.132 -0.94 . . . . 0.32000000000000001 111.253 -172.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -133.89 140.33 46.76 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.124 -0.36 . . . . 1.1399999999999999 111.472 -171.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HZ3' ' HA ' ' A' ' 106' ' ' MET . 14.2 ttpt -111.49 123.33 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.34999999999999998 110.696 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 11.2 ttmm -103.13 118.77 37.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.392 -0.225 . . . . 1.0700000000000001 110.392 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -76.71 96.09 4.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.486 -0.325 . . . . 0.33000000000000002 110.577 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 111' ' ' THR . 10.6 mt -63.1 -49.47 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.304 -1.369 . . . . 0.28000000000000003 107.304 174.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 72.2 t -140.1 126.32 11.97 Favored Pre-proline 0 CA--C 1.499 -0.987 0 CA-C-N 112.617 -2.083 . . . . 0.35999999999999999 106.588 170.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -104.28 64.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.546 2.164 . . . . 0.54000000000000004 113.845 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.4 -0.818 . . . . 0.55000000000000004 113.888 173.608 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.444 -0.773 0 CA-C-O 120.947 0.403 . . . . 0.98999999999999999 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.432 ' H ' HG12 ' A' ' 108' ' ' VAL . 10.6 t -152.48 136.05 16.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.787 -0.82 . . . . 1.28 108.787 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 84.6 mtt180 -92.48 108.57 32.29 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.73 -0.47 . . . . 2.8100000000000001 109.73 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 144' ' ' LEU . 5.3 Cg_endo -46.55 142.76 9.37 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.996 3.13 . . . . 0.29999999999999999 114.037 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -89.41 153.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.49 -0.777 . . . . 0.88 109.717 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.653 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -68.52 117.12 9.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.732 0.777 . . . . 1.1699999999999999 110.956 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.7 -27.24 3.23 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.354 -1.293 . . . . 0.41999999999999998 110.423 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -75.65 140.94 42.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.58999999999999997 109.147 176.563 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.3 m -86.71 126.54 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.42 -1.326 . . . . 1.22 107.42 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 33.3 m -120.6 146.41 25.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.174 -0.466 . . . . 0.25 110.195 -173.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.446 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 31.3 p -96.37 111.71 23.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.822 -0.626 . . . . 0.28999999999999998 110.047 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG21 HD21 ' A' ' 99' ' ' LEU . 3.9 m -111.42 143.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.746 -0.661 . . . . 0.19 110.362 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.3 114.04 27.65 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.018 -1.475 . . . . 0.19 107.018 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -114.67 135.47 54.12 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.301 -0.959 . . . . 0.39000000000000001 111.132 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' HB2' ' NH1' ' A' ' 79' ' ' ARG . 1.2 mp0 -134.17 113.45 12.05 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.742 -1.947 . . . . 0.27000000000000002 105.742 165.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 88.3 m -105.24 132.13 51.83 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.605 -1.18 . . . . 0.19 111.411 -168.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.791 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -110.46 156.61 20.61 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.297 -0.865 . . . . 1.0600000000000001 109.131 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.72 165.64 21.77 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.828 -0.624 . . . . 0.83999999999999997 109.807 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.7 -21.18 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 1.1399999999999999 111.266 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -91.3 -8.15 49.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.864 -0.607 . . . . 2.1400000000000001 110.61 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.44 -9.37 41.66 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.061 -0.59 . . . . 0.51000000000000001 112.702 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -74.23 109.41 7.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.72 0.267 . . . . 0.46000000000000002 111.72 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 23.3 mtt180 -75.71 124.37 27.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.254 0.55 . . . . 0.46999999999999997 110.532 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.0 m -112.76 -9.24 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.914 -1.039 . . . . 0.27000000000000002 112.777 -168.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.1 pt20 -159.4 132.5 7.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.475 -0.33 . . . . 0.58999999999999997 110.137 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.465 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 63.1 tt0 -140.85 118.58 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 1.3400000000000001 110.644 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 3.0 tt0 -137.48 121.15 11.77 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.622 -0.717 . . . . 2.5899999999999999 110.313 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 8.9 Cg_exo -71.23 -13.63 31.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.627 2.885 . . . . 0.5 113.274 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -161.5 105.58 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.048 0.928 . . . . 1.3700000000000001 111.784 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.558 ' HB3' HG23 ' A' ' 68' ' ' VAL . 25.7 tp -114.88 109.97 18.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.443 -1.708 . . . . 0.38 109.344 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.7 p -104.67 131.38 53.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.68 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 46.1 p90 -150.98 158.67 44.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.568 -0.287 . . . . 0.23000000000000001 111.111 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 m -77.07 109.48 10.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.41999999999999998 110.181 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.814 HD11 ' HD3' ' A' ' 104' ' ' PRO . 17.7 tp -62.05 133.96 55.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.59999999999999998 110.541 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 83.93 3.59 89.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.788 -0.72 . . . . 0.37 112.527 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -106.37 -2.68 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.42 . . . . 0.93000000000000005 110.021 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.3 m 59.46 35.91 22.98 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.775 -0.824 . . . . 0.62 108.775 -172.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -73.96 -2.86 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.26 1.028 . . . . 1.3300000000000001 108.48 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.465 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 5.8 m -139.87 -153.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 113.767 -1.56 . . . . 0.23000000000000001 109.726 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.2 pt -82.94 138.04 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.265 -1.383 . . . . 0.28999999999999998 107.265 172.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.428 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 3.0 tp-100 -57.65 -31.04 65.91 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.568 -0.287 . . . . 0.40000000000000002 111.071 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.63 -48.19 69.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.20000000000000001 110.863 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 68' ' ' VAL . 46.9 tp -72.92 -38.11 66.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.367 -0.833 . . . . 0.22 110.468 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.6 -30.04 70.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.824 -1.08 . . . . 0.26000000000000001 109.695 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 84.3 mt -89.92 -35.01 15.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.375 -0.83 . . . . 0.25 111.63 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.7 t -63.57 -36.2 83.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 1.01 111.321 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.532 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 46.6 t -62.61 -55.87 34.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 112.772 0.656 . . . . 0.20999999999999999 112.772 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.814 ' HD3' HD11 ' A' ' 90' ' ' LEU . 25.7 Cg_endo -64.42 -19.57 65.45 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 121.887 1.725 . . . . 0.27000000000000002 112.114 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 39' ' ' ILE . 12.8 mt -82.59 -13.62 56.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.016 -0.538 . . . . 0.64000000000000001 111.297 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.654 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.7 ptm -107.32 154.41 21.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.088 -0.505 . . . . 0.78000000000000003 110.72 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.71 152.75 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.96999999999999997 110.494 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 58' ' ' SER . 2.1 p -63.16 126.6 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.052 0.93 . . . . 0.80000000000000004 110.116 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.54 12.37 57.13 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.661 -1.154 . . . . 0.28000000000000003 112.952 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.823 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.1 pt-20 -101.7 168.48 9.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.40999999999999998 110.736 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.495 HG22 HD12 ' A' ' 50' ' ' LEU . 9.5 m -129.63 119.08 22.98 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.653 -1.24 . . . . 0.22 107.653 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.73 53.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.037 0.446 . . . . 0.17999999999999999 111.018 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.9 ttm -97.96 116.71 30.73 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.3200000000000001 107.216 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.2 t -113.91 128.75 70.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.985 -0.376 . . . . 0.17999999999999999 109.985 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.594 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 62.7 m -104.67 113.73 27.5 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 108.187 -1.042 . . . . 0.20999999999999999 108.187 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.63 141.92 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.01 -1.45 . . . . 0.14999999999999999 108.749 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 6.6 t70 -57.76 156.37 8.8 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.223 -0.591 . . . . 0.57999999999999996 109.578 174.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 135' ' ' HIS . 70.6 p -47.34 -43.4 22.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.996 -1.002 . . . . 0.81999999999999995 110.739 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 14.4 ptpt -59.76 -28.97 67.85 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.907 -1.042 . . . . 0.81000000000000005 112.042 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.592 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 91.6 m-85 -94.81 2.63 55.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.364 0.602 . . . . 0.41999999999999998 109.856 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.792 ' HB3' HD22 ' A' ' 138' ' ' LEU . 91.1 m -122.78 -92.34 0.54 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.623 -1.172 . . . . 0.17999999999999999 110.271 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.661 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 3.8 m-85 -147.37 37.66 0.93 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 119.019 -0.515 . . . . 0.23999999999999999 111.85 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 118' ' ' SER . . . -52.73 -83.5 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.597 -0.811 . . . . 0.25 112.998 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 7.36 4.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.551 2.167 . . . . 0.57999999999999996 111.692 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -104.22 -46.97 4.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.749 -0.66 . . . . 0.65000000000000002 110.66 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.608 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 80.73 142.06 3.07 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.954 -1.021 . . . . 0.29999999999999999 112.225 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.712 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.4 t -91.65 159.42 15.88 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.575 0.583 . . . . 0.33000000000000002 112.575 -174.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 129' ' ' SER . 9.6 ptp180 -48.97 -53.98 17.51 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.48 -1.236 . . . . 3.1699999999999999 112.259 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.957 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 3.5 m -82.4 -63.88 0.27 Allowed Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.895 -0.409 . . . . 1.23 109.895 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.957 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.1 Cg_endo -105.07 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.522 2.148 . . . . 0.37 112.262 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.608 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 26.1 t80 -55.57 97.45 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.674 -0.861 . . . . 1.1399999999999999 108.674 163.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.595 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.3 mm -66.77 122.57 82.86 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.75 -0.659 . . . . 0.39000000000000001 109.313 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 47.2 Cg_exo -56.02 137.74 80.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.261 1.974 . . . . 0.60999999999999999 111.965 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.501 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 38.4 Cg_exo -56.35 130.2 38.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.387 2.058 . . . . 0.52000000000000002 112.823 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.672 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 17.3 m80 74.39 23.82 1.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.577 -1.647 . . . . 2.3799999999999999 112.878 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.51 116.01 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.29 -1.004 . . . . 0.26000000000000001 108.29 166.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.61 132.5 43.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.99 0.424 . . . . 0.22 110.039 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -104.05 132.37 50.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.918 -0.583 . . . . 0.22 111.773 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.2 t -116.63 100.45 7.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.061 -0.718 . . . . 1.2 109.061 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.6 pp -112.57 137.13 51.25 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.771 -0.65 . . . . 0.32000000000000001 111.579 -171.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 41.2 tt0 -106.8 116.2 31.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.891 -0.781 . . . . 1.05 108.891 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 99' ' ' LEU . 4.6 m -117.12 120.91 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.724 0.638 . . . . 0.19 112.724 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 m -88.75 108.85 19.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.082 -0.963 . . . . 0.28000000000000003 110.737 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.654 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 55.7 tp -81.71 94.74 7.05 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.68 -0.859 . . . . 0.14999999999999999 108.68 172.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.9 mtmt -89.33 -25.1 21.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.141 -0.936 . . . . 1.0800000000000001 110.821 -171.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.446 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 22.0 m -160.84 148.12 15.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.664 0.269 . . . . 0.37 111.174 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -124.43 127.96 48.31 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.193 -0.669 . . . . 0.25 109.193 168.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.92000000000000004 109.619 -178.032 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.584 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.53000000000000003 110.625 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.05 118.26 12.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.585 -0.734 . . . . 0.5 110.415 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.64 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.4 t70 -80.98 129.4 34.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.324 0.583 . . . . 2.5099999999999998 110.379 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.606 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.1 mt -65.51 -24.91 35.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.801 -1.091 . . . . 0.46000000000000002 111.088 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.66 0.7 10.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.55 . . . . 0.71999999999999997 110.47 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.25 22.37 65.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.436 -0.802 . . . . 0.52000000000000002 112.306 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.07 -28.24 15.83 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.137 0.421 . . . . 0.94999999999999996 112.137 -176.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 108.58 -1.01 32.41 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.818 -0.706 . . . . 0.71999999999999997 112.065 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.51 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 mp -105.42 -31.58 8.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.051 0.453 . . . . 1.5600000000000001 111.215 -176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 16.5 tp -122.31 101.33 7.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.4 -0.818 . . . . 0.32000000000000001 111.471 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HG2' ' CA ' ' A' ' 38' ' ' ASP . 67.5 mtm180 -133.42 141.01 47.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.356 0.502 . . . . 1.1399999999999999 112.356 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' HG3' HG22 ' A' ' 114' ' ' VAL . 11.4 ttpt -114.28 126.09 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.34999999999999998 110.654 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.6 ttpt -112.03 128.56 56.22 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 121.062 -0.255 . . . . 1.0700000000000001 110.894 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 p -83.94 103.89 13.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.223 -0.444 . . . . 0.33000000000000002 110.711 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 111' ' ' THR . 8.0 mt -65.26 -52.94 51.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.832 -1.544 . . . . 0.28000000000000003 106.832 170.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.815 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 86.6 t -131.93 131.99 22.92 Favored Pre-proline 0 CA--C 1.501 -0.912 0 CA-C-N 113.28 -1.782 . . . . 0.35999999999999999 106.242 167.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.7 Cg_endo -104.61 53.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.935 2.423 . . . . 0.54000000000000004 113.023 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 CA-C-N 114.957 -1.02 . . . . 0.55000000000000004 112.807 178.269 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 121.543 0.687 . . . . 0.98999999999999999 111.901 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.746 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 50.5 m -116.59 133.61 55.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.32 -0.855 . . . . 1.28 108.896 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 86.2 mtt180 -99.46 113.6 65.0 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-O 120.931 0.396 . . . . 2.8100000000000001 110.481 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.658 ' HG3' HD21 ' A' ' 144' ' ' LEU . 10.9 Cg_endo -53.77 145.78 48.34 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.43 2.754 . . . . 0.29999999999999999 113.382 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 17.6 t -97.19 152.68 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.88 109.396 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.976 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 89.1 mttt -71.34 120.84 17.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.454 0.645 . . . . 1.1699999999999999 109.762 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.48 -26.97 4.27 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.872 -1.291 . . . . 0.41999999999999998 109.872 -172.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.6 OUTLIER -86.06 139.73 30.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.455 -0.943 . . . . 0.58999999999999997 108.455 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.9 m -86.17 128.91 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 108.075 -1.083 . . . . 1.22 108.075 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -124.91 146.46 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.175 -0.92 . . . . 0.25 110.778 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.478 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 37.1 p -95.38 113.02 24.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.099 -0.501 . . . . 0.28999999999999998 110.572 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.682 HG21 HD21 ' A' ' 99' ' ' LEU . 30.3 m -110.65 143.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.037 -0.665 . . . . 0.19 109.846 173.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.52 116.29 32.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.701 -1.592 . . . . 0.19 106.701 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.71 137.94 52.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.079 -1.049 . . . . 0.39000000000000001 111.024 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.478 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.2 mp0 -132.74 114.56 14.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.788 -1.93 . . . . 0.27000000000000002 105.788 165.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.628 HG23 ' HB3' ' A' ' 140' ' ' LEU . 75.3 m -102.36 126.43 49.38 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.529 -1.214 . . . . 0.19 111.414 -166.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 13.1 t -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.464 -0.789 . . . . 1.0600000000000001 109.498 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.3 mt -82.32 164.89 20.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.368 -0.833 . . . . 0.83999999999999997 109.863 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.69 -24.82 36.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.391 0.615 . . . . 1.1399999999999999 110.443 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -80.42 -12.81 59.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.344 -0.844 . . . . 2.1400000000000001 111.204 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.58 17.69 30.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.714 -0.755 . . . . 0.51000000000000001 112.039 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 m -102.55 110.05 21.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.581 0.229 . . . . 0.46000000000000002 111.525 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.2 mtt180 -74.87 115.41 14.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.523 0.678 . . . . 0.46999999999999997 110.083 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.659 ' HB ' ' CG ' ' A' ' 130' ' ' PRO . 27.0 m -99.51 -11.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.017 -0.992 . . . . 0.27000000000000002 111.989 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.618 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.6 pt20 -159.48 136.1 9.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.05 -0.523 . . . . 0.58999999999999997 110.144 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 38.0 tt0 -133.43 123.94 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.999 0.428 . . . . 1.3400000000000001 109.849 173.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -136.96 116.85 10.62 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.344 -0.844 . . . . 2.5899999999999999 109.71 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.418 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 61.2 Cg_endo -72.09 -14.49 28.96 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.118 2.546 . . . . 0.5 113.105 -170.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 22.7 tt0 -164.94 110.83 0.95 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.181 0.991 . . . . 1.3700000000000001 111.029 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.09 103.25 8.88 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.179 -1.828 . . . . 0.38 108.877 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.0 p -97.52 125.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.834 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.817 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 43.3 p90 -147.19 159.58 43.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 0.23000000000000001 110.952 -172.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 2.8 m -80.62 110.0 15.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.864 -0.607 . . . . 0.41999999999999998 110.176 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.976 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 13.8 tp -58.06 134.49 56.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.59999999999999998 110.955 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 74.47 11.54 82.54 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 121.043 -0.598 . . . . 0.37 112.375 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 27.0 t70 -112.58 8.56 19.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.192 -0.67 . . . . 0.93000000000000005 109.192 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 55.0 m 55.83 33.69 22.03 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.938 -1.028 . . . . 0.62 109.877 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.817 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 2.4 t0 -68.63 -14.6 63.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.393 1.092 . . . . 1.3300000000000001 108.693 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -133.96 -156.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.799 -1.546 . . . . 0.23000000000000001 110.539 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.5 pt -82.87 139.68 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.722 -1.214 . . . . 0.28999999999999998 107.722 175.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.524 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.3 tp-100 -58.23 -30.53 66.58 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.244 -0.182 . . . . 0.40000000000000002 110.955 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -54.5 -45.31 73.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.385 0.612 . . . . 0.20000000000000001 110.495 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 68' ' ' VAL . 59.4 tp -77.88 -38.77 45.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.323 -0.853 . . . . 0.22 110.665 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.68 -28.52 69.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.108 -0.951 . . . . 0.26000000000000001 109.585 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 77.5 mt -90.47 -34.95 15.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.199 -0.91 . . . . 0.25 111.883 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.4 t -64.17 -35.43 80.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 1.01 111.287 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.565 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.6 t -63.32 -55.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.633 0.605 . . . . 0.20999999999999999 112.633 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.845 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.7 Cg_endo -63.16 -22.05 72.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.814 1.676 . . . . 0.27000000000000002 111.839 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 39' ' ' ILE . 9.5 mt -81.68 -13.1 58.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.64000000000000001 111.271 173.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.671 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -106.42 157.19 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.959 -0.564 . . . . 0.78000000000000003 110.828 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.0 m-20 -96.37 153.56 17.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.96999999999999997 110.187 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.746 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -64.05 129.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.667 0.746 . . . . 0.80000000000000004 110.728 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.66 7.47 61.57 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.536 -1.211 . . . . 0.28000000000000003 112.348 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.815 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.3 pt-20 -97.45 166.61 11.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.517 0.675 . . . . 0.40999999999999998 111.546 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.419 HG22 HD12 ' A' ' 50' ' ' LEU . 13.0 m -127.59 117.66 22.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.823 -1.177 . . . . 0.22 107.823 172.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.24 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.944 0.402 . . . . 0.17999999999999999 110.331 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.6 ttp -101.8 117.79 35.58 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.561 -1.274 . . . . 1.3200000000000001 107.561 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.517 HG22 ' HG3' ' A' ' 47' ' ' LYS . 10.5 t -112.67 135.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.296 -0.411 . . . . 0.17999999999999999 109.989 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 50.6 m -114.57 112.66 23.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.37 -0.974 . . . . 0.20999999999999999 108.37 171.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.16 136.56 53.72 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.399 -1.728 . . . . 0.14999999999999999 109.688 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.689 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 11.1 t70 -53.05 149.5 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.112 -0.699 . . . . 0.57999999999999996 109.112 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.6 t -56.13 -28.06 56.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.191 0.52 . . . . 0.81999999999999995 110.385 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.627 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.2 ptpt -55.33 -29.95 59.29 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 121.945 -0.472 . . . . 0.81000000000000005 111.498 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 72.6 m-85 -95.11 0.17 54.05 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.243 0.544 . . . . 0.41999999999999998 110.271 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.66 ' HB3' HD22 ' A' ' 138' ' ' LEU . 61.8 m -122.56 -89.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.988 -1.005 . . . . 0.17999999999999999 110.581 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.8 m-85 -143.88 40.67 1.4 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.004 0.372 . . . . 0.23999999999999999 112.004 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.04 -82.9 0.04 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 0.25 113.965 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.97 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.536 2.158 . . . . 0.57999999999999996 111.003 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -104.83 -51.5 3.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.376 -0.829 . . . . 0.65000000000000002 109.721 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.618 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.05 141.74 3.14 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.401 -1.272 . . . . 0.29999999999999999 112.151 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.2 t -91.67 152.32 20.27 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.229 0.538 . . . . 0.33000000000000002 111.961 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -46.65 -48.32 20.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.464 -1.244 . . . . 3.1699999999999999 113.428 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . 1.044 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 47.2 m -81.54 -65.95 0.24 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.124 -0.63 . . . . 1.23 109.896 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.044 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -107.01 127.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.295 1.997 . . . . 0.37 112.043 172.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -55.95 97.97 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.916 -1.142 . . . . 1.1399999999999999 107.916 164.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.599 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -66.5 126.49 92.26 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.678 -0.692 . . . . 0.39000000000000001 109.532 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.78 145.29 31.8 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.734 2.289 . . . . 0.60999999999999999 112.189 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.608 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.7 Cg_endo -63.94 133.23 37.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.059 1.839 . . . . 0.52000000000000002 111.817 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.689 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 32.3 m170 71.77 8.3 6.07 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.018 -0.992 . . . . 2.3799999999999999 112.16 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -69.96 122.11 18.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.737 -0.838 . . . . 0.26000000000000001 108.737 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.58 112.78 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 0.22 110.24 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -89.63 131.84 35.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.192 -0.913 . . . . 0.22 110.285 -177.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 23.7 t -121.3 101.19 7.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.853 0.835 . . . . 1.2 109.155 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -113.08 137.4 51.49 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.611 -1.177 . . . . 0.32000000000000001 111.61 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -101.71 115.69 31.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.489 -0.778 . . . . 1.05 109.227 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -117.08 121.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.667 0.617 . . . . 0.19 112.667 -175.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.8 m -92.75 109.02 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.243 -0.889 . . . . 0.28000000000000003 110.249 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 60' ' ' PRO . 64.3 tp -81.85 98.63 8.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.493 -0.929 . . . . 0.14999999999999999 108.493 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -94.71 -27.86 15.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.33 -0.85 . . . . 1.0800000000000001 110.775 -170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.478 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 7.8 m -153.39 151.74 30.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.292 -0.413 . . . . 0.37 111.458 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.58 128.5 27.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.565 -0.743 . . . . 0.25 109.061 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.515 -0.39 0 CA-C-O 121.232 0.539 . . . . 0.92000000000000004 110.365 -178.588 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.649 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.564 0.697 . . . . 0.53000000000000003 112.138 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.7 125.02 28.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.706 -1.134 . . . . 0.5 111.233 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.629 ' HB3' ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -77.17 123.55 26.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.131 -0.486 . . . . 2.5099999999999998 111.113 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.63 HD12 HD11 ' A' ' 45' ' ' LEU . 6.9 mt -62.54 -41.28 91.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.46000000000000002 110.959 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.555 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 89.1 mt -113.21 0.68 14.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.75 0.309 . . . . 0.71999999999999997 111.424 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 38' ' ' ASP . . . 68.65 24.15 75.38 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.4 -0.68 . . . . 0.52000000000000002 111.4 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 40' ' ' LEU . 7.2 p30 -97.46 -24.74 15.46 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.94999999999999996 113.243 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.32 -19.28 48.99 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 121.308 -0.472 . . . . 0.71999999999999997 112.372 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 2.8 mm? -90.12 -28.86 18.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.839 0.352 . . . . 1.5600000000000001 110.491 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 39' ' ' ILE . 20.9 tp -122.86 109.29 13.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.32000000000000001 111.865 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 71.2 mtm180 -139.38 140.46 37.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.987 0.366 . . . . 1.1399999999999999 111.987 -173.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -113.23 123.44 50.18 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.985 0.514 . . . . 0.34999999999999998 110.137 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.2 ttpt -109.77 113.64 26.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 1.0700000000000001 110.708 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 p -74.07 100.66 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.347 -0.388 . . . . 0.33000000000000002 111.328 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 111' ' ' THR . 7.8 mt -65.8 -49.55 67.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.427 -1.323 . . . . 0.28000000000000003 107.427 172.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.806 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.7 t -136.61 126.32 15.84 Favored Pre-proline 0 CA--C 1.505 -0.772 0 CA-C-N 113.007 -1.906 . . . . 0.35999999999999999 106.712 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 19.5 Cg_endo -104.35 61.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.108 2.539 . . . . 0.54000000000000004 113.846 -177.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-N 115.546 -0.752 . . . . 0.55000000000000004 113.634 177.001 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.98999999999999999 111.352 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.1 t -152.15 136.85 17.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.065 -1.087 . . . . 1.28 108.065 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 10.4 ptp180 -91.68 113.48 58.87 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.528 -0.469 . . . . 2.8100000000000001 110.39 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD3' HG23 ' A' ' 108' ' ' VAL . 4.9 Cg_endo -47.47 142.21 13.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.985 3.123 . . . . 0.29999999999999999 113.653 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.715 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 16.9 t -92.05 156.86 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.386 -0.824 . . . . 0.88 109.645 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -63.53 111.92 2.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.132 0.491 . . . . 1.1699999999999999 110.199 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.05 -33.44 2.31 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 114.827 -1.079 . . . . 0.41999999999999998 110.491 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.6 OUTLIER -74.56 139.19 43.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.904 -0.776 . . . . 0.58999999999999997 108.904 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 2.7 m -89.25 131.33 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.696 -1.224 . . . . 1.22 107.696 174.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.0 m -129.18 149.42 33.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.609 -0.723 . . . . 0.25 110.718 -171.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 24.7 p -98.68 113.01 24.91 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.82 -0.627 . . . . 0.28999999999999998 110.041 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.676 HG21 HD21 ' A' ' 99' ' ' LEU . 19.2 m -110.63 144.28 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 119.988 -0.685 . . . . 0.19 110.214 173.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.572 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.45 117.14 34.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.203 -1.406 . . . . 0.19 107.203 170.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -121.17 134.83 55.23 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.384 -0.926 . . . . 0.39000000000000001 110.62 177.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 2.3 mp0 -126.95 114.07 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.241 -2.133 . . . . 0.27000000000000002 105.241 167.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 140' ' ' LEU . 59.0 m -106.13 123.59 48.25 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.317 -1.311 . . . . 0.19 111.057 -164.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.958 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.9 OUTLIER -104.81 170.99 7.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.821 -0.627 . . . . 1.0600000000000001 109.448 -178.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt -97.12 165.4 12.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.433 -0.803 . . . . 0.83999999999999997 109.249 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 12.7 pt-20 -59.26 -16.76 23.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.832 0.348 . . . . 1.1399999999999999 110.715 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -94.98 -14.7 24.15 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.364 -0.38 . . . . 2.1400000000000001 110.92 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.38 -24.44 6.91 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.544 -0.836 . . . . 0.51000000000000001 113.933 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.4 m -67.54 114.97 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.81 0.67 . . . . 0.46000000000000002 112.81 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.89 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.6 mtt180 -77.98 118.52 20.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.608 0.718 . . . . 0.46999999999999997 110.499 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.776 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.3 m -96.58 -9.08 9.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.613 -1.176 . . . . 0.27000000000000002 112.06 -170.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.595 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.7 pt20 -164.92 129.07 2.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.42 -0.355 . . . . 0.58999999999999997 110.891 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -122.38 109.61 14.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.382 -0.599 . . . . 1.3400000000000001 109.382 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.25 113.75 25.99 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.59 -0.732 . . . . 2.5899999999999999 110.363 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 56.6 Cg_endo -71.26 -16.05 31.52 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.307 2.671 . . . . 0.5 113.491 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -163.05 108.76 1.13 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.206 1.003 . . . . 1.3700000000000001 112.088 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 tp -118.49 105.98 12.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.086 -1.87 . . . . 0.38 108.728 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -100.11 130.78 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.214 -0.448 . . . . 1.0 109.842 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.667 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 31.4 p90 -151.74 157.78 42.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.691 0.281 . . . . 0.23000000000000001 110.582 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.8 m -76.98 114.29 15.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.752 -0.658 . . . . 0.41999999999999998 109.711 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.903 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.7 tp -58.96 127.63 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.59999999999999998 111.376 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.81 4.22 90.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.997 -0.62 . . . . 0.37 112.344 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -89.72 -4.71 57.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.176 -1.046 . . . . 0.93000000000000005 108.176 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 19.5 m 56.95 32.88 22.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.57 -1.196 . . . . 0.62 109.92 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.61 -21.37 64.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.167 0.984 . . . . 1.3300000000000001 108.955 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 m -113.67 -158.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.714 -1.585 . . . . 0.23000000000000001 110.859 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 99' ' ' LEU . 32.6 pt -78.44 137.25 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.317 -1.364 . . . . 0.28999999999999998 107.317 173.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -57.57 -30.35 65.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.471 -0.331 . . . . 0.40000000000000002 110.781 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.8 -46.83 81.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.20000000000000001 110.788 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 68' ' ' VAL . 48.5 tp -71.26 -40.3 71.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.22 110.728 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.07 -30.34 70.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.801 -1.09 . . . . 0.26000000000000001 109.977 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 40' ' ' LEU . 82.2 mt -91.44 -33.36 15.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.353 -0.839 . . . . 0.25 112.472 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.8 t -65.64 -32.11 73.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 1.01 111.119 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.667 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 57.9 t -66.38 -52.83 34.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.767 0.654 . . . . 0.20999999999999999 112.767 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -62.81 -19.98 70.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.634 1.556 . . . . 0.27000000000000002 112.113 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.518 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.9 mt -83.18 -16.14 47.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.476 0.655 . . . . 0.64000000000000001 111.109 170.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.797 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 28.3 ttm -96.16 141.5 29.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.744 -1.116 . . . . 0.78000000000000003 111.572 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.92 151.08 19.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.914 -0.402 . . . . 0.96999999999999997 109.914 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.654 HG23 ' HD3' ' A' ' 60' ' ' PRO . 3.7 t -59.73 124.3 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.80000000000000004 110.639 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.28 14.12 46.13 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.481 -0.782 . . . . 0.28000000000000003 112.787 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.806 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -104.31 168.23 9.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.615 0.708 . . . . 0.40999999999999998 110.574 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.443 HG22 HD12 ' A' ' 50' ' ' LEU . 17.9 m -133.65 117.97 17.62 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.923 -1.14 . . . . 0.22 107.923 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.08 140.98 52.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.181 0.515 . . . . 0.17999999999999999 110.805 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.423 ' HG2' ' CH2' ' A' ' 36' ' ' TRP . 16.9 ttt -98.12 117.88 33.49 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.297 -1.372 . . . . 1.3200000000000001 107.297 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.8 130.46 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.566 -0.531 . . . . 0.17999999999999999 109.566 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 99.3 m -108.3 114.45 28.33 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.652 -0.819 . . . . 0.20999999999999999 109.023 173.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -124.61 134.17 53.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.017 -1.447 . . . . 0.14999999999999999 110.063 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.749 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 9.6 t70 -52.31 147.5 7.81 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.57999999999999996 108.682 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.663 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.4 t -57.98 -25.68 61.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.232 0.539 . . . . 0.81999999999999995 110.138 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.624 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 4.2 ptpp? -55.32 -29.79 58.95 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.111 -0.368 . . . . 0.81000000000000005 111.29 173.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.56 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 97.3 m-85 -98.51 3.0 48.13 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.219 0.533 . . . . 0.41999999999999998 110.268 175.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.0 m -123.63 -91.59 0.54 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.148 -0.933 . . . . 0.17999999999999999 110.701 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 12.3 m-85 -141.91 42.83 1.7 Allowed 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 112.15 0.426 . . . . 0.23999999999999999 112.15 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.58 -86.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.163 -0.542 . . . . 0.25 113.572 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.26 11.92 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.536 2.158 . . . . 0.57999999999999996 111.09 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.4 mt-30 -103.2 -46.75 4.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.6 -0.727 . . . . 0.65000000000000002 109.968 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.559 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.95 144.28 2.22 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.693 -1.139 . . . . 0.29999999999999999 112.188 -175.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.649 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.9 t -91.16 158.74 16.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.229 -0.486 . . . . 0.33000000000000002 112.09 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -47.05 -55.49 8.17 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.811 -1.086 . . . . 3.1699999999999999 111.943 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.915 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 22.9 t -80.92 -62.95 0.34 Allowed Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.534 -0.466 . . . . 1.23 110.158 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.915 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.7 Cg_endo -106.08 127.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.348 2.032 . . . . 0.37 112.11 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.559 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 49.2 t80 -55.91 98.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.346 -0.983 . . . . 1.1399999999999999 108.346 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.612 HG12 ' CB ' ' A' ' 127' ' ' SER . 32.3 mm -66.49 128.24 93.75 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.668 -0.697 . . . . 0.39000000000000001 109.917 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.7 Cg_endo -54.59 139.29 75.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.572 2.181 . . . . 0.60999999999999999 112.144 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.527 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 72.2 Cg_exo -52.54 129.06 30.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.815 2.343 . . . . 0.52000000000000002 112.918 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.633 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 66.3 m170 70.11 15.54 7.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.992 -1.004 . . . . 2.3799999999999999 112.508 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.92 123.79 26.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.87 -0.789 . . . . 0.26000000000000001 108.87 170.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -74.11 115.96 14.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.328 0.585 . . . . 0.22 110.308 -173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.654 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.95 136.21 33.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.007 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.958 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 30.7 p -119.54 98.56 6.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.037 0.922 . . . . 1.2 110.026 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -110.41 134.69 52.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.004 -0.998 . . . . 0.32000000000000001 111.647 -173.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 46.4 tt0 -100.78 111.73 24.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.799 . . . . 1.05 109.084 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.621 HG11 HD13 ' A' ' 99' ' ' LEU . 1.3 m -112.17 117.05 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.516 0.674 . . . . 0.19 112.716 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.0 m -89.91 114.03 25.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.945 -1.025 . . . . 0.28000000000000003 110.573 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.741 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.8 tp -85.82 96.07 9.63 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.962 -0.755 . . . . 0.14999999999999999 108.962 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.5 mtmt -91.85 -30.49 16.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.55 -0.75 . . . . 1.0800000000000001 110.8 -171.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.508 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 19.1 m -151.93 148.07 27.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.484 -0.326 . . . . 0.37 111.167 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.92 128.79 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.244 -0.65 . . . . 0.25 109.244 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 CA--C 1.514 -0.435 0 C-N-CA 119.568 -0.853 . . . . 0.92000000000000004 111.677 -178.0 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.548 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.3 m0 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.392 0.615 . . . . 0.53000000000000003 110.634 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.6 tp -83.49 115.22 21.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.5 110.136 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.617 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -78.68 121.97 25.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.187 -0.671 . . . . 2.5099999999999998 109.187 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.643 HG23 HD11 ' A' ' 105' ' ' LEU . 13.5 mt -60.18 -35.91 64.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.188 -0.915 . . . . 0.46000000000000002 110.552 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 74.3 mt -102.54 -3.42 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.71999999999999997 110.565 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.05 27.9 65.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.52000000000000002 111.718 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.604 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -111.66 -23.22 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.012 0.745 . . . . 0.94999999999999996 113.012 -175.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 109.24 30.73 3.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.95 -1.119 . . . . 0.71999999999999997 114.377 168.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -151.77 -9.26 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.985 0.392 . . . . 1.5600000000000001 110.784 175.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.607 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 3.2 tp -119.5 99.47 6.69 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.32000000000000001 109.975 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 62.0 mtm180 -139.14 136.58 35.28 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.014 -0.675 . . . . 1.1399999999999999 112.065 -171.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 11.2 ttpt -112.52 124.52 52.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.217 -0.447 . . . . 0.34999999999999998 110.361 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 28.9 ttpp -112.88 117.46 32.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.87 0.367 . . . . 1.0700000000000001 110.524 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.9 p -73.62 106.45 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.275 -0.421 . . . . 0.33000000000000002 111.285 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 141' ' ' GLU . 12.0 mt -68.66 -52.13 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.798 -1.556 . . . . 0.28000000000000003 106.798 170.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.873 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 93.0 t -131.37 135.42 27.02 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 113.143 -1.844 . . . . 0.35999999999999999 106.071 168.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 40.3 Cg_endo -108.77 54.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.946 2.431 . . . . 0.54000000000000004 113.834 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.601 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 115.853 -0.612 . . . . 0.55000000000000004 113.319 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 9.3 p . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 121.507 0.67 . . . . 0.98999999999999999 111.439 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.631 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 23.0 t -159.09 130.67 6.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.936 -1.135 . . . . 1.28 107.936 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 83.8 mtt180 -90.44 112.85 55.17 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 120.918 -0.313 . . . . 2.8100000000000001 110.313 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HG3' HD21 ' A' ' 144' ' ' LEU . 6.2 Cg_endo -47.3 152.99 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.831 3.021 . . . . 0.29999999999999999 114.142 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 11.4 t -102.67 151.56 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.211 -0.904 . . . . 0.88 109.774 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 62.7 mttt -64.24 108.78 1.67 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.02 0.914 . . . . 1.1699999999999999 110.792 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.3 -31.5 2.34 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.772 -1.558 . . . . 0.41999999999999998 110.125 -174.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.8 mm-40 -71.89 140.19 49.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.21 0.529 . . . . 0.58999999999999997 109.89 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 148' ' ' VAL . 65.4 t -84.68 119.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.598 -0.89 . . . . 1.22 108.598 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.2 m -124.54 147.97 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.11 0.411 . . . . 0.25 112.11 -170.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 30.0 p -102.26 116.52 32.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.923 -0.58 . . . . 0.28999999999999998 110.39 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.753 HG21 HD21 ' A' ' 99' ' ' LEU . 17.1 m -111.18 144.94 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.111 0.481 . . . . 0.19 110.06 172.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.9 t-160 -102.11 120.38 40.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.909 -1.515 . . . . 0.19 106.909 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.548 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.9 OUTLIER -125.36 135.11 52.1 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 119.426 -0.91 . . . . 0.39000000000000001 110.474 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.652 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 1.1 mp0 -127.52 114.97 18.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.902 -1.888 . . . . 0.27000000000000002 105.902 169.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.626 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 22.8 m -110.63 122.38 47.65 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.409 -1.268 . . . . 0.19 111.53 -165.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.967 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.7 OUTLIER -104.65 171.16 7.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.317 -0.856 . . . . 1.0600000000000001 108.851 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 80' ' ' VAL . 11.4 mt -97.53 167.46 10.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.537 -0.756 . . . . 0.83999999999999997 109.936 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.62 -17.64 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.313 0.383 . . . . 1.1399999999999999 111.236 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.32 -14.64 20.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.674 0.273 . . . . 2.1400000000000001 110.921 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.08 7.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.637 -0.792 . . . . 0.51000000000000001 113.651 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 m -63.26 112.06 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.228 0.455 . . . . 0.46000000000000002 112.228 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.9 mtt180 -74.28 118.23 17.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.847 0.832 . . . . 0.46999999999999997 110.571 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.928 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.1 m -96.68 -9.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.452 -1.249 . . . . 0.27000000000000002 110.928 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.626 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 18.1 pt20 -166.55 146.76 5.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.606 -0.724 . . . . 0.58999999999999997 109.753 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 71' ' ' GLN . 15.2 tt0 -150.96 103.29 3.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.173 -1.047 . . . . 1.3400000000000001 108.173 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 4.7 mm-40 -126.72 113.81 22.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.541 -0.754 . . . . 2.5899999999999999 110.308 -170.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 37.7 Cg_endo -65.7 -12.32 34.64 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.014 2.476 . . . . 0.5 112.982 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -151.94 112.02 4.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.366 0.603 . . . . 1.3700000000000001 110.724 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.428 ' HB3' HG23 ' A' ' 68' ' ' VAL . 50.8 tp -130.11 106.99 8.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.835 -1.075 . . . . 0.38 108.287 172.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.9 p -108.36 138.08 36.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.825 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 30.1 p90 -160.97 166.54 28.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.23000000000000001 110.868 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.1 m -86.0 115.07 23.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 0.41999999999999998 109.633 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.85 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.4 tp -60.54 126.64 28.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.59999999999999998 110.396 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 91.18 6.66 66.42 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.691 -0.766 . . . . 0.37 112.976 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.11 -8.62 21.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.93000000000000005 109.978 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.7 m 58.15 36.9 26.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.62 109.342 -172.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 22.1 t70 -70.75 -17.61 62.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.538 1.161 . . . . 1.3300000000000001 108.044 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.7 m -119.19 -154.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.323 -1.762 . . . . 0.23000000000000001 110.353 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.8 pt -83.0 138.81 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.647 -1.242 . . . . 0.28999999999999998 107.647 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.4 tp-100 -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.904 -0.318 . . . . 0.40000000000000002 110.898 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.14 -42.25 72.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.20000000000000001 110.627 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.753 HD21 HG21 ' A' ' 68' ' ' VAL . 56.5 tp -75.72 -40.78 55.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.729 -0.668 . . . . 0.22 110.551 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.14 -28.53 69.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.046 -0.979 . . . . 0.26000000000000001 109.883 -176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 76.1 mt -90.13 -36.59 14.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.006 -0.997 . . . . 0.25 111.893 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.1 t -67.96 -28.18 67.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.751 -0.204 . . . . 1.01 111.275 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.571 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 55.0 t -65.87 -55.8 20.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.401 0.519 . . . . 0.20999999999999999 112.401 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.85 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.1 Cg_endo -63.43 -18.77 66.07 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 121.998 1.799 . . . . 0.27000000000000002 111.906 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 39' ' ' ILE . 13.1 mt -84.32 -14.21 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.64000000000000001 111.239 173.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.811 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 1.1 ttp -105.84 141.15 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.239 -0.437 . . . . 0.78000000000000003 110.934 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 m-20 -79.01 152.48 30.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.867 0.365 . . . . 0.96999999999999997 110.067 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -65.58 126.29 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.653 0.74 . . . . 0.80000000000000004 109.789 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.81 10.71 56.23 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.117 -0.947 . . . . 0.28000000000000003 112.143 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.873 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.38 170.36 7.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.357 0.599 . . . . 0.40999999999999998 110.58 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.3 m -133.19 119.25 19.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.473 -0.936 . . . . 0.22 108.473 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.436 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -117.1 139.65 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.817 -0.629 . . . . 0.17999999999999999 110.663 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.5 ttt -97.8 117.09 31.34 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.654 -1.239 . . . . 1.3200000000000001 107.654 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.64 130.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.833 -0.622 . . . . 0.17999999999999999 109.359 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 91.8 m -107.16 114.09 27.93 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.38 -0.97 . . . . 0.20999999999999999 108.38 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -123.12 135.43 54.36 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.0 -1.455 . . . . 0.14999999999999999 109.651 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.1 t70 -55.71 148.86 15.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.767 -0.827 . . . . 0.57999999999999996 108.767 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -57.5 -27.21 62.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.376 0.608 . . . . 0.81999999999999995 110.132 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 18.6 ptpt -55.26 -31.78 61.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.242 -0.435 . . . . 0.81000000000000005 111.167 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.638 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 95.9 m-85 -100.84 10.77 40.72 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.41999999999999998 109.902 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.675 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 71.0 m -125.92 -93.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.17999999999999999 110.521 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.556 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 6.8 m-85 -141.45 41.82 1.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.369 -0.532 . . . . 0.23999999999999999 112.076 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.72 -84.81 0.03 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.143 -0.551 . . . . 0.25 113.67 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.67 8.49 4.22 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.551 2.167 . . . . 0.57999999999999996 111.088 175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.6 mt-30 -104.13 -47.15 4.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.65000000000000002 110.216 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.76 144.18 2.12 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.873 -1.058 . . . . 0.29999999999999999 112.094 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 10.9 t -91.61 157.63 16.88 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.294 -0.453 . . . . 0.33000000000000002 111.461 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.508 ' NH2' ' HG3' ' A' ' 83' ' ' GLU . 21.0 ptt180 -57.0 -43.1 81.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.613 -0.721 . . . . 3.1699999999999999 112.102 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.629 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -80.38 -68.87 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.333 -0.547 . . . . 1.23 110.354 175.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.928 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -106.3 129.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.857 2.371 . . . . 0.37 112.145 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 33.6 t80 -55.17 99.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.135 -1.061 . . . . 1.1399999999999999 108.135 163.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.1 mm -65.92 131.79 94.62 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 115.953 -0.567 . . . . 0.39000000000000001 110.285 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.61 138.46 40.12 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.845 2.363 . . . . 0.60999999999999999 111.908 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.743 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.9 Cg_endo -64.53 135.75 47.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.175 1.917 . . . . 0.52000000000000002 112.125 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.557 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 48.6 m-70 71.71 5.66 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.239 -0.891 . . . . 2.3799999999999999 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.02 125.63 28.08 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.595 -0.521 . . . . 0.26000000000000001 109.595 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.93 113.72 11.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.393 -0.523 . . . . 0.22 110.181 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.626 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.23 133.0 34.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.515 -0.766 . . . . 0.22 111.07 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.967 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 31.6 p -116.93 100.01 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.371 1.081 . . . . 1.2 110.05 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.59 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.4 OUTLIER -115.17 137.71 51.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.886 -1.052 . . . . 0.32000000000000001 111.632 -172.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.652 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 26.4 tt0 -103.36 114.58 28.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.05 108.305 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 99' ' ' LEU . 2.5 m -111.79 119.48 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.421 0.629 . . . . 0.19 112.2 -174.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 6.3 m -95.11 113.02 24.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.271 -0.877 . . . . 0.28000000000000003 110.156 174.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.589 HD21 ' HG3' ' A' ' 60' ' ' PRO . 60.4 tp -84.33 98.75 10.19 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.859 -0.793 . . . . 0.14999999999999999 108.859 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.7 mtmt -97.75 -26.12 14.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.159 -0.928 . . . . 1.0800000000000001 111.253 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.503 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 23.9 m -153.63 150.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.901 0.381 . . . . 0.37 111.773 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -143.78 128.3 18.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.659 -0.701 . . . . 0.25 109.406 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.1 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.92000000000000004 110.344 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.593 ' NE1' ' HE2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.147 0.498 . . . . 0.53000000000000003 110.76 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.02 111.39 5.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.084 -0.962 . . . . 0.5 110.551 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.655 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.1 t70 -73.18 125.55 27.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.367 -0.533 . . . . 2.5099999999999998 110.083 173.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.652 HG23 HD11 ' A' ' 105' ' ' LEU . 7.7 mt -56.3 -32.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.808 -1.087 . . . . 0.46000000000000002 111.656 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.32 -1.73 13.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.101 -0.499 . . . . 0.71999999999999997 110.32 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.98 26.61 65.81 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.169 -0.772 . . . . 0.52000000000000002 111.169 -172.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' HD23 ' A' ' 44' ' ' LEU . 1.1 p30 -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.366 -0.417 . . . . 0.94999999999999996 110.583 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.478 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.8 -4.15 21.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.939 -0.648 . . . . 0.71999999999999997 112.988 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 4.2 mm? -112.19 -27.41 8.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.869 0.322 . . . . 1.5600000000000001 111.869 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.561 HD11 HD12 ' A' ' 39' ' ' ILE . 16.9 tp -120.62 100.66 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.3 -0.409 . . . . 0.32000000000000001 110.74 -170.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 89.7 mtm180 -133.18 141.44 48.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.6 0.222 . . . . 1.1399999999999999 111.6 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.0 ttpt -114.09 123.8 50.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.421 -0.354 . . . . 0.34999999999999998 110.244 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 18.2 ttmt -103.58 118.96 37.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.983 -0.377 . . . . 1.0700000000000001 109.983 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.441 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 1.3 p -76.02 96.74 3.86 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.989 -0.55 . . . . 0.33000000000000002 110.5 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD12 HG22 ' A' ' 111' ' ' THR . 12.5 mt -63.66 -52.93 58.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.893 -1.521 . . . . 0.28000000000000003 106.893 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.881 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 85.1 t -132.84 127.1 20.15 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-N 113.038 -1.892 . . . . 0.35999999999999999 106.157 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HB3' ' CG2' ' A' ' 49' ' ' THR . 30.4 Cg_endo -106.66 56.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.956 2.437 . . . . 0.54000000000000004 114.502 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.718 0 C-N-CA 121.118 -0.563 . . . . 0.55000000000000004 113.201 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.435 -1.206 0 CA-C-O 121.292 0.568 . . . . 0.98999999999999999 111.26 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -153.86 144.35 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.786 -0.82 . . . . 1.28 108.786 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.499 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 48.1 mtm180 -92.51 110.1 42.77 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.846 -0.428 . . . . 2.8100000000000001 109.846 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.755 ' HD3' HG23 ' A' ' 108' ' ' VAL . 5.8 Cg_endo -47.36 141.21 14.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.353 2.702 . . . . 0.29999999999999999 113.529 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.682 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.0 t -89.56 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.432 -0.804 . . . . 0.88 109.435 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.726 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 56.1 mttt -63.38 106.17 0.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.838 0.828 . . . . 1.1699999999999999 110.85 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.89 -28.85 2.12 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.145 -1.388 . . . . 0.41999999999999998 110.199 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.6 OUTLIER -79.28 128.0 32.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.859 -0.793 . . . . 0.58999999999999997 108.859 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.8 m -78.32 129.79 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.055 -1.091 . . . . 1.22 108.055 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.9 m -125.99 146.65 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.997 -0.547 . . . . 0.25 110.284 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.9 p -95.94 112.31 24.07 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.897 -0.592 . . . . 0.28999999999999998 109.825 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.713 HG21 HD21 ' A' ' 99' ' ' LEU . 7.4 m -110.5 142.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.849 -0.614 . . . . 0.19 110.074 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -100.76 116.42 32.61 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.721 -1.585 . . . . 0.19 106.721 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 136.94 53.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.285 1.041 . . . . 0.39000000000000001 111.336 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.429 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -133.08 113.3 12.6 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.003 -1.851 . . . . 0.27000000000000002 106.003 165.429 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.617 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.1 m -101.37 127.18 48.12 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.743 -1.117 . . . . 0.19 111.29 -168.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 17.1 t -104.89 160.46 14.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.309 -0.86 . . . . 1.0600000000000001 109.626 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.444 HD21 HG11 ' A' ' 80' ' ' VAL . 13.7 mt -89.64 166.06 13.85 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.521 -0.763 . . . . 0.83999999999999997 109.795 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.26 -17.84 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.578 0.549 . . . . 1.1399999999999999 110.743 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -92.61 -8.68 43.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.641 -0.709 . . . . 2.1400000000000001 111.162 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.38 40.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.838 -0.696 . . . . 0.51000000000000001 111.855 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 m -98.17 109.91 22.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.878 0.371 . . . . 0.46000000000000002 111.469 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.7 mtt180 -76.04 116.42 16.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.46999999999999997 110.539 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.765 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -101.98 -8.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.561 -1.2 . . . . 0.27000000000000002 111.886 -168.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.617 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.2 pt20 -160.57 136.13 8.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.107 -0.497 . . . . 0.58999999999999997 109.983 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -136.41 112.65 9.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.008 0.433 . . . . 1.3400000000000001 110.283 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.0 115.51 15.41 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.436 0.636 . . . . 2.5899999999999999 110.221 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 55.9 Cg_endo -71.05 -13.26 31.31 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.201 2.601 . . . . 0.5 113.637 -172.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -160.16 110.41 1.84 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.292 1.044 . . . . 1.3700000000000001 111.571 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 68' ' ' VAL . 21.1 tp -119.62 100.59 7.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.126 -1.852 . . . . 0.38 108.756 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 10.7 p -95.73 132.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.0 p90 -153.47 158.43 41.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.612 -0.267 . . . . 0.23000000000000001 110.445 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.493 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 5.6 m -79.04 113.65 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 109.788 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.827 HD11 ' HD3' ' A' ' 104' ' ' PRO . 16.4 tp -61.76 130.27 44.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.455 . . . . 0.59999999999999998 109.921 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.726 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 83.51 6.35 87.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.37 111.947 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 32.3 t70 -100.12 -5.62 27.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.12 -0.696 . . . . 0.93000000000000005 109.12 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.8 m 54.9 34.09 21.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.125 -0.943 . . . . 0.62 109.839 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.74 -9.13 58.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.445 1.117 . . . . 1.3300000000000001 108.765 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.3 m -125.26 -159.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 113.531 -1.668 . . . . 0.23000000000000001 110.711 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.5 pt -81.62 138.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.088 -1.449 . . . . 0.28999999999999998 107.088 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.482 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.8 tp-100 -60.74 -28.68 68.87 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.835 -0.346 . . . . 0.40000000000000002 110.899 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.07 -37.32 69.14 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.079 0.466 . . . . 0.20000000000000001 110.679 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 68' ' ' VAL . 52.7 tp -81.84 -40.65 22.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.637 . . . . 0.22 110.719 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -61.93 -27.91 69.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.434 -0.803 . . . . 0.26000000000000001 109.886 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 66.3 mt -90.97 -36.54 14.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.335 -0.848 . . . . 0.25 112.355 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.542 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 p -72.03 -26.46 62.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.63 -0.428 . . . . 1.01 111.189 -173.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.513 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -64.6 -55.74 27.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.457 0.539 . . . . 0.20999999999999999 112.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.827 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -61.09 -24.44 79.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.071 1.847 . . . . 0.27000000000000002 112.007 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.652 HD11 HG23 ' A' ' 39' ' ' ILE . 17.0 mt -73.1 -30.84 63.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.152 -0.477 . . . . 0.64000000000000001 111.155 172.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.82 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -92.07 152.72 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.78000000000000003 111.425 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -90.52 151.89 21.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.002 0.43 . . . . 0.96999999999999997 110.642 178.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.755 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.5 t -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.33 0.586 . . . . 0.80000000000000004 110.337 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.63 43.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.362 -0.835 . . . . 0.28000000000000003 112.548 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.881 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.4 168.18 9.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.407 0.622 . . . . 0.40999999999999998 110.971 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 50' ' ' LEU . 20.9 m -130.63 117.44 19.51 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.175 -1.046 . . . . 0.22 108.175 174.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.35 138.27 53.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.032 0.444 . . . . 0.17999999999999999 110.684 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.2 ttp -98.42 116.82 31.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.3200000000000001 107.216 173.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.647 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.9 t -112.25 132.04 62.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.661 -0.496 . . . . 0.17999999999999999 109.661 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.544 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 91.4 m -109.39 112.87 25.25 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.175 -1.046 . . . . 0.20999999999999999 108.175 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.46 135.69 54.73 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.925 -1.489 . . . . 0.14999999999999999 108.946 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.734 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.9 t70 -52.94 146.54 10.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.397 -0.964 . . . . 0.57999999999999996 108.397 172.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.649 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.6 t -55.94 -26.07 46.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.071 0.463 . . . . 0.81999999999999995 110.439 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.684 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.5 ptpt -54.87 -29.75 56.28 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.103 -0.373 . . . . 0.81000000000000005 111.833 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.594 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.1 m-85 -97.15 2.31 50.95 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.41999999999999998 109.989 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 64.6 m -122.72 -89.91 0.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.141 -0.936 . . . . 0.17999999999999999 110.665 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.4 m-85 -141.29 41.08 1.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.103 -0.475 . . . . 0.23999999999999999 112.176 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.94 -81.82 0.04 OUTLIER Glycine 0 C--N 1.343 0.943 0 N-CA-C 113.995 0.358 . . . . 0.25 113.995 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.98 15.46 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.525 2.15 . . . . 0.57999999999999996 110.924 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.2 mt-30 -103.51 -48.63 3.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.65000000000000002 110.071 -174.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.471 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.12 142.81 3.5 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 114.668 -1.151 . . . . 0.29999999999999999 112.051 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 14.1 t -90.68 165.03 13.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.577 0.584 . . . . 0.33000000000000002 112.577 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -62.36 -23.28 66.71 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 115.114 -0.948 . . . . 3.1699999999999999 112.728 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . 1.048 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 18.3 t -105.51 -66.54 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.005 -0.739 . . . . 1.23 109.005 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.048 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 5.4 Cg_endo -99.07 129.63 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.937 2.425 . . . . 0.37 111.922 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.471 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -56.25 98.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.615 -1.254 . . . . 1.1399999999999999 107.615 158.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.668 HD13 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -65.22 130.44 94.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.317 -0.994 . . . . 0.39000000000000001 108.317 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.26 147.71 34.93 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.642 2.228 . . . . 0.60999999999999999 112.587 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.71 137.93 83.14 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.473 2.115 . . . . 0.52000000000000002 113.105 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.734 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 10.9 p80 53.04 21.45 2.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.665 -1.152 . . . . 2.3799999999999999 113.342 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.78 132.88 40.72 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.983 -0.747 . . . . 0.26000000000000001 108.983 172.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.9 113.82 12.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.141 0.496 . . . . 0.22 110.635 -171.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -92.07 133.5 35.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.902 -0.59 . . . . 0.22 110.516 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.4 t -118.53 100.69 7.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.334 -0.617 . . . . 1.2 109.334 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.598 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -112.53 136.55 51.92 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.868 -0.606 . . . . 0.32000000000000001 111.578 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.429 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 40.5 tt0 -105.0 114.49 28.72 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.481 -0.562 . . . . 1.05 109.481 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.665 HG11 HD13 ' A' ' 99' ' ' LEU . 3.6 m -115.76 119.87 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.013 0.745 . . . . 0.19 113.013 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 4.1 m -90.46 111.71 23.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.28000000000000003 110.754 170.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.1 tp -84.1 93.87 8.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.6 -0.889 . . . . 0.14999999999999999 108.6 172.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.1 mtmt -88.1 -33.94 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.095 -0.957 . . . . 1.0800000000000001 110.547 -171.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.454 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.1 m -149.68 154.41 38.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.37 111.729 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 128.26 26.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.299 -0.63 . . . . 0.25 109.299 172.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 109.58 -0.526 . . . . 0.92000000000000004 109.58 179.02 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.685 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.274 -0.639 . . . . 0.53000000000000003 109.274 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.9 tp -73.31 110.61 7.73 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.5 109.672 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -75.24 124.59 27.33 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.003 -0.74 . . . . 2.5099999999999998 109.003 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 45' ' ' LEU . 14.4 mt -58.86 -31.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.872 -1.058 . . . . 0.46000000000000002 110.559 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.5 mt -116.13 -4.79 11.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.615 -0.72 . . . . 0.71999999999999997 110.64 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.85 23.31 72.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.057 -0.817 . . . . 0.52000000000000002 111.057 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.402 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -96.42 -15.57 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.482 0.549 . . . . 0.94999999999999996 112.482 -174.13 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.47 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 114.39 -13.79 20.92 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.575 -0.821 . . . . 0.71999999999999997 114.031 166.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -129.22 -2.21 5.06 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.057 0.762 . . . . 1.5600000000000001 113.057 -173.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 39' ' ' ILE . 21.3 tp -122.34 100.25 6.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.008 -0.368 . . . . 0.32000000000000001 110.008 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -136.09 139.32 42.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.308 0.484 . . . . 1.1399999999999999 112.308 -170.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.8 ttpt -110.97 123.56 50.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.36 -0.382 . . . . 0.34999999999999998 110.004 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.685 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -108.3 125.86 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.571 0.224 . . . . 1.0700000000000001 110.603 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 p -81.93 103.1 11.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.159 0.504 . . . . 0.33000000000000002 111.331 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 111' ' ' THR . 9.8 mt -69.47 -50.05 49.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.828 -1.545 . . . . 0.28000000000000003 106.828 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.845 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.0 t -140.04 126.14 11.93 Favored Pre-proline 0 CA--C 1.501 -0.907 0 CA-C-N 112.891 -1.959 . . . . 0.35999999999999999 106.688 170.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.4 Cg_endo -105.79 59.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.945 2.43 . . . . 0.54000000000000004 113.27 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.931 -0.577 . . . . 0.55000000000000004 112.762 178.147 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.832 -0.433 . . . . 0.98999999999999999 109.832 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.4 m -150.05 142.58 24.44 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.979 -0.748 . . . . 1.28 108.979 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 36.7 mtm180 -90.14 116.45 66.4 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.402 -0.592 . . . . 2.8100000000000001 109.402 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.742 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.6 Cg_endo -50.86 146.86 20.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.569 2.846 . . . . 0.29999999999999999 112.902 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.2 t -96.24 151.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.88 109.582 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 90' ' ' LEU . 97.2 mttt -62.44 121.45 13.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.61 0.719 . . . . 1.1699999999999999 109.42 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.45 -25.55 5.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.675 -1.148 . . . . 0.41999999999999998 111.114 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.2 mm-40 -84.93 134.62 34.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.033 -0.728 . . . . 0.58999999999999997 109.033 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 m -82.12 131.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 108.184 -1.043 . . . . 1.22 108.184 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 28.1 m -128.04 148.03 32.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.362 -0.836 . . . . 0.25 110.412 -171.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.515 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 34.0 p -97.95 112.88 24.64 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.129 0.49 . . . . 0.28999999999999998 110.118 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 86' ' ' LEU . 4.7 m -110.2 144.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.098 0.475 . . . . 0.19 110.246 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.54 117.4 34.84 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.001 -1.481 . . . . 0.19 107.001 170.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 1.2 pt? -117.91 137.04 53.08 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.146 -1.022 . . . . 0.39000000000000001 111.018 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' GLN . 1.1 mp0 -135.42 114.22 11.94 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.308 -2.108 . . . . 0.27000000000000002 105.308 165.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.62 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.4 m -104.61 127.45 52.36 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.816 -1.083 . . . . 0.19 110.914 -166.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.783 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 4.2 t -105.52 159.94 15.55 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.442 -0.799 . . . . 1.0600000000000001 109.206 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.4 ' HG ' HG13 ' A' ' 80' ' ' VAL . 13.9 mt -86.67 165.22 16.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.83999999999999997 109.295 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.72 -23.92 54.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 1.1399999999999999 110.169 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -86.28 -4.18 59.12 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.695 -0.684 . . . . 2.1400000000000001 111.655 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.89 6.76 57.93 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.535 -0.84 . . . . 0.51000000000000001 113.392 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 89.2 m -91.52 112.88 24.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.514 0.657 . . . . 0.46000000000000002 111.947 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.783 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 32.9 mtt180 -74.76 117.11 16.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.793 0.806 . . . . 0.46999999999999997 110.634 176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.8 m -101.86 -9.1 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.438 -1.255 . . . . 0.27000000000000002 112.491 -168.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -156.34 126.57 6.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.422 -0.354 . . . . 0.58999999999999997 111.054 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -122.57 121.84 37.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 1.3400000000000001 109.953 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.532 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 7.3 tt0 -142.42 114.61 6.23 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.552 . . . . 2.5899999999999999 110.335 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -70.33 -18.68 34.18 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.538 2.826 . . . . 0.5 113.063 -172.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.29 108.25 2.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.175 0.988 . . . . 1.3700000000000001 111.662 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.559 ' HB3' HG23 ' A' ' 68' ' ' VAL . 24.0 tp -117.41 106.45 13.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.484 -1.689 . . . . 0.38 108.621 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -100.56 132.49 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.4 p90 -156.81 162.99 39.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.336 -0.393 . . . . 0.23000000000000001 110.534 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -88.92 117.45 27.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.185 -0.461 . . . . 0.41999999999999998 110.295 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.542 HD22 ' HD3' ' A' ' 104' ' ' PRO . 36.8 mt -60.83 136.59 58.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.59999999999999998 111.62 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 75.25 12.93 83.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.879 -0.677 . . . . 0.37 111.452 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.48 -3.37 14.44 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.082 -0.71 . . . . 0.93000000000000005 109.082 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.9 m 57.67 35.3 25.5 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.762 -1.108 . . . . 0.62 109.665 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.9 t70 -74.33 -9.0 58.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.126 0.965 . . . . 1.3300000000000001 108.484 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.7 -158.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.04 -1.436 . . . . 0.23000000000000001 110.747 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.9 pt -80.39 138.63 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 107.519 -1.289 . . . . 0.28999999999999998 107.519 174.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -59.71 -30.22 68.66 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.052 -0.259 . . . . 0.40000000000000002 111.038 -172.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.82 71.81 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.161 0.505 . . . . 0.20000000000000001 110.484 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 68' ' ' VAL . 45.3 tp -79.55 -42.14 25.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.683 -0.69 . . . . 0.22 110.567 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.64 -30.54 68.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.057 -0.974 . . . . 0.26000000000000001 110.068 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 86.5 mt -90.82 -36.07 14.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.197 -0.91 . . . . 0.25 112.929 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.8 p -70.93 -29.54 65.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.143 0.496 . . . . 1.01 111.034 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.584 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 80.5 t -64.74 -54.25 37.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.444 -0.798 . . . . 0.20999999999999999 112.957 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.542 ' HD3' HD22 ' A' ' 90' ' ' LEU . 21.2 Cg_endo -63.93 -20.41 68.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.737 1.625 . . . . 0.27000000000000002 111.661 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 39' ' ' ILE . 23.7 mt -78.47 -17.02 56.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.619 . . . . 0.64000000000000001 110.873 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.723 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -100.97 156.6 17.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.988 -0.551 . . . . 0.78000000000000003 110.59 -179.258 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -95.31 154.2 17.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.96999999999999997 110.817 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.742 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.4 t -62.43 123.89 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.454 0.645 . . . . 0.80000000000000004 110.277 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.64 45.48 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.903 -1.044 . . . . 0.28000000000000003 112.754 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.845 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.7 pt-20 -105.14 167.62 9.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.464 0.649 . . . . 0.40999999999999998 111.011 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.513 HG22 HD12 ' A' ' 50' ' ' LEU . 13.7 m -129.16 116.99 20.05 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.974 -1.121 . . . . 0.22 107.974 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -118.32 136.78 53.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.161 -0.472 . . . . 0.17999999999999999 110.81 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.9 ttm -98.34 117.14 32.07 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.22 -1.4 . . . . 1.3200000000000001 107.22 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.4 t -112.96 128.45 69.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.007 -0.368 . . . . 0.17999999999999999 110.007 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 73.8 m -107.45 112.6 25.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.401 -0.92 . . . . 0.20999999999999999 108.759 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.442 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.67 134.32 54.97 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.944 -1.48 . . . . 0.14999999999999999 109.229 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.2 t70 -52.61 145.44 11.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.647 -0.871 . . . . 0.57999999999999996 108.647 172.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -52.04 -26.65 11.38 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 123.416 0.448 . . . . 0.81999999999999995 110.54 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.725 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 13.8 ptpt -54.33 -35.02 62.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.95 0.352 . . . . 0.81000000000000005 111.95 176.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.554 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 87.5 m-85 -95.93 2.21 53.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.41999999999999998 110.373 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 80.2 m -118.47 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.116 -0.947 . . . . 0.17999999999999999 110.254 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.63 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.3 m-85 -144.41 40.71 1.33 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.34 -0.544 . . . . 0.23999999999999999 112.364 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.485 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.07 -83.08 0.04 OUTLIER Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.048 -0.596 . . . . 0.25 113.694 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.73 8.7 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.539 2.159 . . . . 0.57999999999999996 110.986 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.1 mt-30 -104.22 -51.4 3.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.624 0.726 . . . . 0.65000000000000002 110.216 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.66 143.71 4.19 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.478 -1.237 . . . . 0.29999999999999999 111.769 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t -91.77 156.75 17.32 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.62 0.6 . . . . 0.33000000000000002 112.62 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 129' ' ' SER . 7.4 ptm180 -43.1 -63.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.724 -1.125 . . . . 3.1699999999999999 112.159 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.984 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 17.2 m -72.56 -66.41 0.61 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 121.021 -0.271 . . . . 1.23 110.431 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.984 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -105.74 128.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.397 2.064 . . . . 0.37 112.31 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.597 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.0 t80 -57.31 98.24 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.41 -0.959 . . . . 1.1399999999999999 108.41 164.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.591 HG12 ' CB ' ' A' ' 127' ' ' SER . 26.9 mm -66.89 129.7 94.02 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.633 -0.506 . . . . 0.39000000000000001 109.633 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 11.6 Cg_endo -57.49 145.3 89.19 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.624 2.216 . . . . 0.60999999999999999 112.574 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.485 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 39.6 Cg_exo -57.9 134.27 61.4 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.802 2.335 . . . . 0.52000000000000002 112.888 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 31.6 m170 66.88 10.97 8.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.74 -1.118 . . . . 2.3799999999999999 112.471 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -71.81 124.54 25.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.337 -0.986 . . . . 0.26000000000000001 108.337 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.07 112.58 10.35 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.153 -0.619 . . . . 0.22 109.59 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 115' ' ' THR . 1.7 tp -90.14 131.64 35.88 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.546 -0.752 . . . . 0.22 110.065 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.5 t -116.84 99.94 7.44 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.821 -0.807 . . . . 1.2 108.821 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.3 pp -110.61 136.09 50.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.083 -0.508 . . . . 0.32000000000000001 111.106 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.473 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 34.5 tt0 -103.8 113.54 27.13 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.989 -0.745 . . . . 1.05 108.989 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.7 m -114.51 120.8 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.606 0.717 . . . . 0.19 112.486 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.7 m -91.41 113.09 25.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.938 -1.028 . . . . 0.28000000000000003 110.139 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.723 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.0 tp -84.65 98.13 10.02 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.885 -0.783 . . . . 0.14999999999999999 108.885 173.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 27.6 mtmt -94.42 -28.6 15.41 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.096 -0.957 . . . . 1.0800000000000001 110.664 -171.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.515 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 24.5 m -153.72 147.44 25.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 0.37 111.663 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.634 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 127.88 25.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.792 -0.448 . . . . 0.25 109.792 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.225 -0.187 0 C-N-CA 120.643 -0.423 . . . . 0.92000000000000004 110.916 -177.596 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.675 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 110.193 -0.299 . . . . 0.53000000000000003 110.193 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.93 110.69 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.5 110.903 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.752 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -71.03 99.94 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.637 -0.71 . . . . 2.5099999999999998 110.691 173.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.614 HG23 HD11 ' A' ' 105' ' ' LEU . 15.8 mt -48.71 -48.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.973 -1.012 . . . . 0.46000000000000002 112.189 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.567 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 88.4 mt -105.93 4.64 29.76 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.612 -0.435 . . . . 0.71999999999999997 111.103 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.71 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 67.86 18.73 70.84 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.52000000000000002 112.416 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 40' ' ' LEU . 13.1 p30 -98.03 -23.6 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.82 0.304 . . . . 0.94999999999999996 111.82 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.18 -27.21 19.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.189 -1.005 . . . . 0.71999999999999997 113.722 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -94.26 -11.18 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.395 0.597 . . . . 1.5600000000000001 111.732 -174.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.3 tp -121.52 107.94 13.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.021 -0.536 . . . . 0.32000000000000001 110.443 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 63.2 mtm180 -142.39 141.63 32.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.567 -0.288 . . . . 1.1399999999999999 111.435 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' HG22 ' A' ' 114' ' ' VAL . 18.7 ttpt -111.04 129.6 55.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.951 -0.388 . . . . 0.34999999999999998 109.951 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.675 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 12.4 ttmt -108.05 128.52 54.75 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.773 0.32 . . . . 1.0700000000000001 110.778 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -80.56 101.33 9.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.949 -0.569 . . . . 0.33000000000000002 110.91 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 111' ' ' THR . 10.0 mt -68.25 -51.85 40.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.042 -1.466 . . . . 0.28000000000000003 107.042 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 79.3 t -138.63 126.0 13.35 Favored Pre-proline 0 CA--C 1.497 -1.075 0 CA-C-N 113.091 -1.868 . . . . 0.35999999999999999 106.574 169.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -103.12 64.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.818 2.345 . . . . 0.54000000000000004 113.491 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.872 0 CA-C-N 115.019 -0.991 . . . . 0.55000000000000004 113.085 175.558 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.44 -0.939 0 CA-C-O 121.299 0.571 . . . . 0.98999999999999999 110.977 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.72 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 9.8 m -153.08 127.07 8.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.646 -0.872 . . . . 1.28 108.646 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 22.1 ptt180 -90.41 123.46 65.44 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 119.66 -0.816 . . . . 2.8100000000000001 110.809 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.469 ' HB3' ' HB1' ' A' ' 147' ' ' ALA . 15.1 Cg_endo -56.39 155.22 26.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.909 3.073 . . . . 0.29999999999999999 113.741 -175.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.1 t -94.87 153.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.307 -0.861 . . . . 0.88 109.389 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.895 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 21.1 mtpt -67.59 119.35 12.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.496 0.665 . . . . 1.1699999999999999 109.401 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.36 -23.5 5.14 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.2 -1.16 . . . . 0.41999999999999998 110.2 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 2.7 mm-40 -80.79 142.69 33.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.58999999999999997 109.263 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.73 121.49 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.577 -0.897 . . . . 1.22 108.577 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.6 m -126.6 146.37 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.25 111.895 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.442 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 28.9 p -104.22 114.05 28.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.381 -0.827 . . . . 0.28999999999999998 110.337 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.652 HG21 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.59 145.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.083 -0.647 . . . . 0.19 110.038 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.624 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -102.37 115.08 29.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.804 -1.554 . . . . 0.19 106.804 169.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -116.19 136.36 53.08 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.149 -1.02 . . . . 0.39000000000000001 110.91 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HG2' ' OE2' ' A' ' 82' ' ' GLU . 1.9 mp0 -132.18 113.96 13.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.993 -1.854 . . . . 0.27000000000000002 105.993 166.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.636 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 61.0 m -104.24 125.71 50.74 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.683 -1.144 . . . . 0.19 111.186 -168.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.6 t -105.75 159.17 16.2 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.206 -0.906 . . . . 1.0600000000000001 109.034 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.436 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.3 mt -86.34 165.2 16.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.792 -0.64 . . . . 0.83999999999999997 110.017 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 9.5 pt-20 -54.93 -17.82 4.17 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.48 0.488 . . . . 1.1399999999999999 112.114 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.09 -15.2 20.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 2.1400000000000001 110.998 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.13 23.11 6.53 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.769 -0.729 . . . . 0.51000000000000001 113.357 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 m -101.42 109.58 21.43 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.302 -0.528 . . . . 0.46000000000000002 111.115 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 11.0 mtt180 -73.75 114.4 11.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.674 0.749 . . . . 0.46999999999999997 110.462 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.663 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.9 m -98.73 -9.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.529 -1.214 . . . . 0.27000000000000002 111.86 -171.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.636 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.5 pt20 -162.06 127.14 3.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.082 -0.508 . . . . 0.58999999999999997 110.168 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 71' ' ' GLN . 16.8 tt0 -130.52 106.85 8.79 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.641 -0.503 . . . . 1.3400000000000001 109.641 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 5.1 tt0 -126.91 117.98 22.27 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.444 -0.798 . . . . 2.5899999999999999 110.568 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 9.9 Cg_exo -71.39 -18.59 29.7 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.66 2.907 . . . . 0.5 113.932 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -161.99 99.28 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.573 1.178 . . . . 1.3700000000000001 112.416 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.2 107.87 19.03 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.171 -1.831 . . . . 0.38 108.7 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.6 p -104.6 137.12 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 17.5 p90 -158.73 167.92 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.71 0.29 . . . . 0.23000000000000001 111.332 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -88.63 112.09 22.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.263 -0.643 . . . . 0.41999999999999998 109.263 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.895 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 12.8 tp -53.44 121.55 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.116 -0.493 . . . . 0.59999999999999998 111.072 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.53 ' CA ' ' HE2' ' A' ' 62' ' ' LYS . . . 97.09 -3.21 61.95 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.444 -0.884 . . . . 0.37 113.383 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.7 10.4 41.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.97 -0.692 . . . . 0.93000000000000005 109.454 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.3 m 58.98 30.54 20.37 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 114.671 -1.15 . . . . 0.62 110.308 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 88' ' ' PHE . 18.1 m-20 -67.28 -11.29 57.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.816 0.817 . . . . 1.3300000000000001 109.835 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 m -131.66 -162.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.245 -1.343 . . . . 0.23000000000000001 110.026 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.61 HG13 ' H ' ' A' ' 99' ' ' LEU . 28.0 pt -76.11 141.27 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.668 -1.234 . . . . 0.28999999999999998 107.668 173.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.85 -28.61 69.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.555 -0.293 . . . . 0.40000000000000002 110.863 -173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.9 80.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.988 0.423 . . . . 0.20000000000000001 110.226 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.652 HD21 HG21 ' A' ' 68' ' ' VAL . 57.2 tp -73.17 -40.98 64.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.479 -0.782 . . . . 0.22 110.955 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.9 -31.36 69.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.08 -0.963 . . . . 0.26000000000000001 109.906 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.57 -34.49 15.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.127 -0.942 . . . . 0.25 112.167 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 78.3 p -70.68 -28.64 64.92 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.918 -0.313 . . . . 1.01 110.911 -173.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.429 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 55.6 t -64.47 -55.0 33.15 Favored Pre-proline 0 C--O 1.217 -0.648 0 CA-C-N 115.991 -0.549 . . . . 0.20999999999999999 112.227 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.888 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.0 Cg_endo -63.78 -17.79 61.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.95 1.766 . . . . 0.27000000000000002 111.873 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.614 HD11 HG23 ' A' ' 39' ' ' ILE . 14.0 mt -82.75 -15.69 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.933 -0.576 . . . . 0.64000000000000001 111.136 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -103.77 148.57 25.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.144 -0.48 . . . . 0.78000000000000003 111.026 178.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -90.38 160.67 15.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.96999999999999997 110.786 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -66.97 129.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.544 0.687 . . . . 0.80000000000000004 110.311 -176.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.94 66.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.239 -0.892 . . . . 0.28000000000000003 112.153 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -98.05 166.97 11.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.5 0.667 . . . . 0.40999999999999998 110.939 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.516 HG22 HD12 ' A' ' 50' ' ' LEU . 8.1 m -128.74 118.18 22.39 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.972 -1.121 . . . . 0.22 107.972 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.501 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.32 136.61 54.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.277 -0.419 . . . . 0.17999999999999999 110.602 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.1 ttp -101.89 117.04 34.01 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.667 -1.234 . . . . 1.3200000000000001 107.667 171.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.749 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.8 t -110.84 134.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.563 -0.532 . . . . 0.17999999999999999 109.563 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.552 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 89.5 m -107.66 114.06 27.78 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 119.202 -0.999 . . . . 0.20999999999999999 108.491 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.16 130.7 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.958 -1.474 . . . . 0.14999999999999999 109.022 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.777 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 5.8 t70 -53.06 147.31 9.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.437 -0.579 . . . . 0.57999999999999996 109.437 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.9 t -53.0 -29.27 28.25 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.81999999999999995 110.197 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.777 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.3 ptpt -55.26 -31.48 61.59 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.079 0.4 . . . . 0.81000000000000005 112.079 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.592 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.0 m-85 -95.44 -0.66 52.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.196 0.522 . . . . 0.41999999999999998 110.148 175.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 77.3 m -118.24 -87.82 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.119 -0.946 . . . . 0.17999999999999999 110.648 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.54 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.8 m-85 -144.94 36.2 1.14 Allowed 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.376 -0.53 . . . . 0.23999999999999999 112.063 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.89 -76.77 0.18 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.825 -0.702 . . . . 0.25 113.052 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.9 3.66 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.471 2.114 . . . . 0.57999999999999996 111.507 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -104.74 -51.92 2.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.506 0.67 . . . . 0.65000000000000002 109.91 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.54 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 83.92 141.83 4.94 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.592 -1.186 . . . . 0.29999999999999999 111.31 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.69 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.4 t -90.54 153.03 20.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.817 0.341 . . . . 0.33000000000000002 111.134 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -52.82 -42.48 65.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.386 -0.824 . . . . 3.1699999999999999 111.971 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 1.001 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 10.1 m -84.97 -66.06 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.266 -0.642 . . . . 1.23 109.266 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.001 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.0 Cg_endo -105.38 126.28 0.06 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.37 111.497 171.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.411 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 12.9 t80 -59.65 97.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.776 -1.194 . . . . 1.1399999999999999 107.776 167.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.569 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.9 mm -65.52 126.92 92.48 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.966 -0.561 . . . . 0.39000000000000001 109.633 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 53.2 Cg_exo -51.89 142.45 42.73 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.639 2.226 . . . . 0.60999999999999999 112.008 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 41.1 Cg_exo -57.03 134.42 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.352 2.035 . . . . 0.52000000000000002 112.0 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.448 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.8 OUTLIER 74.28 0.67 3.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.363 -0.835 . . . . 2.3799999999999999 111.422 174.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.6 119.41 12.32 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.193 -0.669 . . . . 0.26000000000000001 109.193 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -73.24 113.81 10.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.195 -0.602 . . . . 0.22 110.54 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.597 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 mp -89.6 134.21 34.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.861 -0.609 . . . . 0.22 111.708 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 t -118.0 100.47 7.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.025 -0.731 . . . . 1.2 109.025 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.594 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.4 pp -111.02 137.05 49.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.609 -0.723 . . . . 0.32000000000000001 111.592 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 81.0 tt0 -103.53 124.79 49.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.703 -0.851 . . . . 1.05 108.703 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' HE3' ' A' ' 106' ' ' MET . 3.3 m -122.74 126.15 73.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.257 0.551 . . . . 0.19 112.252 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 7.3 m -96.11 115.97 28.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.28000000000000003 110.219 170.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.752 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.8 tp -85.39 98.13 10.39 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.727 -0.842 . . . . 0.14999999999999999 108.727 172.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.443 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.5 mtmt -94.14 -30.3 14.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.336 -0.847 . . . . 1.0800000000000001 110.661 -169.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.5 m -150.92 146.14 26.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.128 0.49 . . . . 0.37 111.814 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.508 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -136.1 127.68 28.81 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.485 -0.932 . . . . 0.25 108.485 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 121.18 0.514 . . . . 0.92000000000000004 111.13 -179.295 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.583 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.096 0.475 . . . . 0.53000000000000003 109.729 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.3 tp -73.01 110.33 7.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.5 110.037 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.664 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -74.75 123.53 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.38 -0.528 . . . . 2.5099999999999998 109.831 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.639 HG23 HD11 ' A' ' 105' ' ' LEU . 8.4 mt -55.22 -33.21 29.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.985 -1.007 . . . . 0.46000000000000002 111.462 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -115.9 -1.39 12.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.014 -0.539 . . . . 0.71999999999999997 110.313 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.66 23.05 66.71 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.093 -0.803 . . . . 0.52000000000000002 111.093 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.497 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -97.32 -17.67 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.622 0.601 . . . . 0.94999999999999996 112.622 -172.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.17 -15.43 18.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.446 -0.883 . . . . 0.71999999999999997 114.72 166.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -120.29 -7.79 9.74 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.972 0.73 . . . . 1.5600000000000001 112.972 -175.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 39' ' ' ILE . 25.2 tp -121.75 100.07 6.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.578 0.228 . . . . 0.32000000000000001 110.624 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -134.86 139.23 44.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.697 0.258 . . . . 1.1399999999999999 111.697 -171.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.7 ttpt -113.05 123.31 50.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.244 0.217 . . . . 0.34999999999999998 110.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.3 ttpp -111.07 117.69 33.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.832 0.349 . . . . 1.0700000000000001 111.253 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.547 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 2.2 p -74.1 98.89 3.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.33000000000000002 111.656 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 111' ' ' THR . 7.7 mt -67.01 -53.38 31.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.413 -1.329 . . . . 0.28000000000000003 107.413 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.801 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t -134.39 123.01 16.24 Favored Pre-proline 0 CA--C 1.498 -1.032 0 CA-C-N 112.908 -1.951 . . . . 0.35999999999999999 106.478 168.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 57.7 Cg_endo -108.37 72.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.521 2.148 . . . . 0.54000000000000004 114.578 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.55000000000000004 113.756 169.821 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.439 -0.978 0 CA-C-O 120.935 0.398 . . . . 0.98999999999999999 110.629 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -158.75 144.57 16.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.616 -0.883 . . . . 1.28 108.616 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 49.5 mtm180 -94.13 111.38 53.06 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.659 -0.497 . . . . 2.8100000000000001 109.659 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.65 ' HG3' HD21 ' A' ' 144' ' ' LEU . 9.9 Cg_endo -49.96 149.55 11.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.693 2.928 . . . . 0.29999999999999999 113.657 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.676 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 20.2 t -96.22 153.05 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.88 109.531 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.853 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 98.5 mttt -68.78 119.61 13.42 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.523 0.678 . . . . 1.1699999999999999 109.231 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 -28.5 3.82 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.836 -1.306 . . . . 0.41999999999999998 109.836 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.1 mm-40 -82.34 139.28 34.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.637 -0.875 . . . . 0.58999999999999997 108.637 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.3 m -88.69 125.74 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 108.024 -1.102 . . . . 1.22 108.024 173.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.3 m -124.7 143.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.57 -0.741 . . . . 0.25 111.468 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.867 HG22 HG22 ' A' ' 87' ' ' VAL . 69.4 p -90.11 113.03 24.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.423 -0.808 . . . . 0.28999999999999998 110.243 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.823 HG21 HD21 ' A' ' 99' ' ' LEU . 19.0 m -111.71 141.11 28.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 120.095 -0.642 . . . . 0.19 110.366 172.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.8 t-160 -101.67 119.13 38.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.848 -1.538 . . . . 0.19 106.848 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -124.92 133.59 52.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 118.789 -1.164 . . . . 0.39000000000000001 111.297 177.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 2.4 mp0 -125.45 115.13 19.77 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.082 -1.821 . . . . 0.27000000000000002 106.082 168.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.627 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 54.1 m -106.8 129.26 54.69 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.875 -1.057 . . . . 0.19 111.591 -168.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.705 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.56 155.46 18.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.192 -0.913 . . . . 1.0600000000000001 109.159 177.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.484 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.0 mt -83.31 166.24 18.65 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.472 -0.785 . . . . 0.83999999999999997 110.243 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -54.52 -19.18 5.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.01 -0.541 . . . . 1.1399999999999999 110.946 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -91.39 -3.59 56.54 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 110.947 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.4 10.23 62.33 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.319 -0.467 . . . . 0.51000000000000001 112.24 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.4 m -95.5 112.05 23.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.46000000000000002 111.441 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 14.5 mtt180 -74.38 120.02 19.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.518 0.675 . . . . 0.46999999999999997 110.609 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.614 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.5 m -108.48 -10.79 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.617 -1.174 . . . . 0.27000000000000002 112.272 -169.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.627 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 18.1 pt20 -159.72 125.63 4.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.288 -0.414 . . . . 0.58999999999999997 109.961 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.541 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 73.4 tt0 -128.41 108.09 10.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 1.3400000000000001 109.972 174.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.544 ' HB3' HD23 ' A' ' 70' ' ' LEU . 4.7 tp10 -119.18 111.56 36.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.922 -1.036 . . . . 2.5899999999999999 109.941 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 37.3 Cg_endo -66.48 -19.61 54.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.209 2.606 . . . . 0.5 113.918 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.582 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 25.5 tt0 -165.18 101.47 0.74 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 122.364 1.078 . . . . 1.3700000000000001 112.479 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.1 tp -109.69 107.55 17.62 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.657 -1.61 . . . . 0.38 108.786 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.867 HG22 HG22 ' A' ' 67' ' ' THR . 1.7 t -101.55 125.02 55.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -144.95 161.63 38.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.586 -0.279 . . . . 0.23000000000000001 110.381 -172.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -81.17 111.72 17.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.174 -0.467 . . . . 0.41999999999999998 109.774 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.853 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.1 tp -58.91 132.21 53.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.59999999999999998 110.161 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 84.2 2.65 89.24 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.128 -0.558 . . . . 0.37 112.415 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -99.38 -3.91 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.059 0.457 . . . . 0.93000000000000005 110.372 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.5 m 58.6 33.31 23.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.497 -0.774 . . . . 0.62 109.351 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.3 t70 -72.4 -10.68 60.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 122.534 1.159 . . . . 1.3300000000000001 108.891 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.24 -158.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.542 -1.663 . . . . 0.23000000000000001 109.665 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.711 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.2 pt -80.3 137.73 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.954 -1.128 . . . . 0.28999999999999998 107.954 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.5 tp-100 -59.53 -28.32 66.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.374 -0.376 . . . . 0.40000000000000002 110.408 -174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.62 93.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.133 0.492 . . . . 0.20000000000000001 110.655 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.823 HD21 HG21 ' A' ' 68' ' ' VAL . 58.2 tp -76.4 -38.69 55.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.706 -0.679 . . . . 0.22 110.141 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.47 -29.09 69.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.965 -1.016 . . . . 0.26000000000000001 109.825 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 78.4 mt -91.12 -35.2 14.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.518 -0.764 . . . . 0.25 112.533 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 23.3 p -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.088 -0.383 . . . . 1.01 111.312 -172.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.558 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -62.23 -55.61 38.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.297 0.48 . . . . 0.20999999999999999 112.297 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.846 ' HD3' HD11 ' A' ' 90' ' ' LEU . 19.0 Cg_endo -62.6 -23.21 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.898 1.732 . . . . 0.27000000000000002 111.305 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.639 HD11 HG23 ' A' ' 39' ' ' ILE . 16.8 mt -78.14 -15.62 58.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.55 . . . . 0.64000000000000001 111.707 173.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.54 ' HE3' HG23 ' A' ' 142' ' ' VAL . 2.9 ptm -106.93 154.9 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.497 -0.32 . . . . 0.78000000000000003 111.261 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.16 153.56 20.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.912 0.387 . . . . 0.96999999999999997 110.532 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -64.19 127.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.618 0.723 . . . . 0.80000000000000004 109.972 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.58 58.4 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.128 -0.942 . . . . 0.28000000000000003 112.865 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.801 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.4 pt-20 -99.07 167.71 10.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.629 0.728 . . . . 0.40999999999999998 111.455 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 50' ' ' LEU . 7.4 m -128.69 117.83 21.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.83 -1.174 . . . . 0.22 107.83 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.72 139.01 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.995 0.426 . . . . 0.17999999999999999 110.652 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.7 ttm -98.21 118.27 34.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.307 -1.368 . . . . 1.3200000000000001 107.307 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.4 t -115.35 128.2 72.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.781 -0.452 . . . . 0.17999999999999999 109.781 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.511 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 85.2 m -106.14 113.98 27.83 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.206 -1.035 . . . . 0.20999999999999999 108.206 172.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.72 136.88 53.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.31 -1.314 . . . . 0.14999999999999999 109.617 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.0 t70 -55.49 148.92 14.47 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.101 -0.703 . . . . 0.57999999999999996 109.101 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.643 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -56.32 -27.29 55.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.136 0.493 . . . . 0.81999999999999995 110.453 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 15.1 ptpt -54.94 -32.63 61.54 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.215 -0.303 . . . . 0.81000000000000005 111.717 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.604 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 80.0 m-85 -96.44 0.44 50.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 120.998 0.428 . . . . 0.41999999999999998 110.165 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.6 m -117.02 -92.01 0.53 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.076 -0.965 . . . . 0.17999999999999999 110.382 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.2 m-85 -142.42 39.78 1.57 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.429 -0.508 . . . . 0.23999999999999999 112.233 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.2 -80.58 0.07 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 121.208 -0.52 . . . . 0.25 114.031 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.32 9.08 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 111.017 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.25 -50.43 3.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.065 -0.971 . . . . 0.65000000000000002 110.173 -173.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.574 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.91 143.94 4.46 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.912 -1.04 . . . . 0.29999999999999999 112.243 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.8 t -90.42 157.03 17.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.532 . . . . 0.33000000000000002 111.489 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -59.18 -34.83 72.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.287 -0.869 . . . . 3.1699999999999999 112.259 -172.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 1.033 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 48.2 m -89.45 -67.22 0.13 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.174 -0.61 . . . . 1.23 109.718 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.033 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -104.62 127.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.275 1.983 . . . . 0.37 111.95 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.574 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 36.5 t80 -56.91 97.87 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.194 -1.039 . . . . 1.1399999999999999 108.194 165.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -65.95 128.97 94.19 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.734 -0.666 . . . . 0.39000000000000001 109.577 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.6 Cg_exo -53.78 144.29 55.22 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.61 2.206 . . . . 0.60999999999999999 112.033 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.2 Cg_exo -58.92 133.86 56.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.315 2.01 . . . . 0.52000000000000002 112.091 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.565 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER 73.61 0.12 3.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.232 -0.895 . . . . 2.3799999999999999 112.775 177.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -66.4 123.52 20.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.728 -0.471 . . . . 0.26000000000000001 109.728 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.89 113.52 11.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.425 0.631 . . . . 0.22 110.41 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.621 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.0 OUTLIER -92.06 132.4 36.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.455 -0.793 . . . . 0.22 111.214 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.0 t -116.6 100.65 7.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.182 -0.673 . . . . 1.2 109.182 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -117.01 135.21 53.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.081 -0.509 . . . . 0.32000000000000001 111.664 -172.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 35.8 tt0 -99.63 117.47 34.06 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.451 -0.574 . . . . 1.05 109.451 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.818 HG11 HD13 ' A' ' 99' ' ' LEU . 5.3 m -110.51 124.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.608 . . . . 0.19 111.95 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -99.91 108.88 21.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.36 -0.836 . . . . 0.28000000000000003 109.777 172.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 60' ' ' PRO . 49.4 tp -82.59 96.91 8.23 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.384 -0.969 . . . . 0.14999999999999999 108.384 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -94.46 -25.13 17.02 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.583 -0.735 . . . . 1.0800000000000001 110.601 -170.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -154.66 146.25 23.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.876 -0.602 . . . . 0.37 110.841 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.14 127.65 21.5 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.975 -0.75 . . . . 0.25 108.975 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.288 -0.565 . . . . 0.92000000000000004 110.86 -177.506 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.56 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 7.6 m0 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.293 0.568 . . . . 0.53000000000000003 111.049 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.9 tp -81.24 111.71 17.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.333 -0.848 . . . . 0.5 110.765 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.65 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -63.61 115.19 4.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.686 0.755 . . . . 2.5099999999999998 110.543 173.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.628 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 21.0 mt -66.86 -44.69 88.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.192 -0.913 . . . . 0.46000000000000002 111.152 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 101' ' ' LEU . 93.0 mt -111.05 10.41 22.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 0.71999999999999997 110.14 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.65 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 77.22 -2.34 61.81 Favored Glycine 0 C--O 1.225 -0.46 0 CA-C-N 115.539 -0.755 . . . . 0.52000000000000002 112.137 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 40' ' ' LEU . 25.5 p30 -83.74 -21.21 32.33 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.678 0.621 . . . . 0.94999999999999996 112.678 -174.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.52 -22.67 7.23 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.413 -0.899 . . . . 0.71999999999999997 112.437 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.8 -32.84 72.85 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 122.109 0.957 . . . . 1.5600000000000001 108.948 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 21.3 tp -121.21 114.09 20.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.685 -1.598 . . . . 0.32000000000000001 110.292 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 49.8 mtm180 -142.32 143.43 32.77 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.296 0.372 . . . . 1.1399999999999999 110.615 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 114' ' ' VAL . 23.0 ttpt -111.36 134.82 52.67 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.19 -0.3 . . . . 0.34999999999999998 110.19 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.1 ttpp -124.02 126.99 47.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.194 -0.299 . . . . 1.0700000000000001 110.194 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -79.89 116.53 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.33000000000000002 111.223 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 141' ' ' GLU . 7.5 mt -75.05 -49.28 20.28 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.507 -1.664 . . . . 0.28000000000000003 106.507 169.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.863 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 89.6 t -134.09 130.7 20.47 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 113.105 -1.861 . . . . 0.35999999999999999 106.287 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 20.6 Cg_endo -108.66 63.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.119 2.546 . . . . 0.54000000000000004 113.873 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.646 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-N 115.396 -0.82 . . . . 0.55000000000000004 113.685 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.445 -0.7 0 CA-C-O 121.038 0.447 . . . . 0.98999999999999999 111.13 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.13 153.19 41.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.224 -1.028 . . . . 1.28 108.224 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -103.71 115.02 64.2 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 2.8100000000000001 110.098 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.786 ' HD3' HG23 ' A' ' 108' ' ' VAL . 61.4 Cg_exo -37.26 135.66 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.827 3.018 . . . . 0.29999999999999999 113.982 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.542 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 18.9 t -90.73 150.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.092 -0.707 . . . . 0.88 109.092 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.588 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 64.6 mttt -65.56 104.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.899 0.857 . . . . 1.1699999999999999 111.117 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.18 -24.41 2.38 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 113.888 -1.505 . . . . 0.41999999999999998 110.113 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.7 mm-40 -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.044 0.449 . . . . 0.58999999999999997 109.948 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 76.1 t -83.51 117.03 28.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.313 -0.858 . . . . 1.22 108.768 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.7 m -123.1 150.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.591 . . . . 0.25 111.255 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.649 ' HB ' ' HG3' ' A' ' 85' ' ' GLU . 62.0 p -104.49 113.4 26.94 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.28999999999999998 110.085 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.623 HG21 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.3 145.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.331 -0.547 . . . . 0.19 109.977 175.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.675 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.34 114.46 28.76 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.188 -1.412 . . . . 0.19 107.188 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.39 134.15 55.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.012 -1.075 . . . . 0.39000000000000001 111.075 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.524 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.3 mp0 -129.94 114.72 16.19 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.902 -1.888 . . . . 0.27000000000000002 105.902 166.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 62.5 m -103.94 128.19 51.47 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.66 -1.155 . . . . 0.19 111.619 -168.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -105.01 151.21 24.22 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.914 -1.039 . . . . 1.0600000000000001 108.653 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.27 165.46 25.0 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.97 -0.559 . . . . 0.83999999999999997 109.604 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 6.4 pt-20 -55.77 -15.37 3.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.077 0.465 . . . . 1.1399999999999999 110.807 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.422 ' OD1' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -88.68 -16.71 31.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.699 -0.682 . . . . 2.1400000000000001 109.808 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.5 -4.71 37.44 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.656 -0.702 . . . . 0.51000000000000001 111.844 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -81.45 110.21 16.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.815 0.341 . . . . 0.46000000000000002 111.859 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 29.9 mtt180 -72.54 123.7 23.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.552 0.691 . . . . 0.46999999999999997 111.187 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.0 m -109.11 -15.73 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.832 -1.076 . . . . 0.27000000000000002 112.295 -170.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.636 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.4 pt20 -154.74 137.44 15.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.437 -0.579 . . . . 0.58999999999999997 109.437 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 26.1 tt0 -144.41 105.69 4.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.171 0.51 . . . . 1.3400000000000001 110.152 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -119.73 121.41 29.85 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.539 -0.755 . . . . 2.5899999999999999 109.499 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 11.8 Cg_exo -69.0 -18.73 40.43 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.894 2.396 . . . . 0.5 113.059 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.649 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 14.1 tt0 -166.56 96.3 0.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.089 0.947 . . . . 1.3700000000000001 111.53 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -98.38 102.94 14.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.485 -1.689 . . . . 0.38 108.514 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.9 p -97.33 135.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.636 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 31.2 p90 -157.42 169.06 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.23000000000000001 111.417 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m -89.66 114.76 26.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.41999999999999998 109.648 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.903 HD11 ' HD3' ' A' ' 104' ' ' PRO . 16.3 tp -63.02 129.93 42.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.015 -0.538 . . . . 0.59999999999999998 110.65 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.49 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.06 6.18 86.83 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.885 -0.674 . . . . 0.37 112.083 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.65 -1.51 30.05 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.73 -0.47 . . . . 0.93000000000000005 109.73 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 40.0 m 56.16 33.99 23.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.62 109.727 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 17.7 t70 -71.47 -9.45 58.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 122.54 1.162 . . . . 1.3300000000000001 108.549 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.61 -162.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.497 -1.683 . . . . 0.23000000000000001 110.409 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.1 pt -77.6 139.64 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 107.67 -1.233 . . . . 0.28999999999999998 107.67 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.583 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.8 tp-100 -60.05 -28.6 67.91 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.931 -0.308 . . . . 0.40000000000000002 110.941 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -57.13 -43.05 82.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.179 0.514 . . . . 0.20000000000000001 110.262 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.623 HD21 HG21 ' A' ' 68' ' ' VAL . 47.4 tp -74.67 -40.48 61.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.22 110.247 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.74 -28.06 69.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.906 -1.043 . . . . 0.26000000000000001 109.919 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.8 mt -91.28 -36.75 13.7 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.282 -0.872 . . . . 0.25 112.587 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.476 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 17.4 p -74.13 -23.6 59.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 1.01 110.972 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.592 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 38.9 t -67.8 -55.27 14.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.20999999999999999 112.1 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' HD11 ' A' ' 90' ' ' LEU . 28.2 Cg_endo -62.69 -18.76 65.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.138 1.892 . . . . 0.27000000000000002 111.999 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.481 ' CD1' HG23 ' A' ' 39' ' ' ILE . 13.7 mt -83.43 -17.39 42.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.999 -0.546 . . . . 0.64000000000000001 111.713 172.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.732 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 10.4 ttp -97.37 142.71 28.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.354 -0.385 . . . . 0.78000000000000003 111.344 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -85.51 151.3 24.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.176 0.512 . . . . 0.96999999999999997 110.855 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.786 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -59.78 123.47 12.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.903 -0.589 . . . . 0.80000000000000004 110.053 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.3 12.72 47.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.066 -0.97 . . . . 0.28000000000000003 112.871 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.863 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 8.4 pt-20 -114.24 169.19 9.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.2 0.524 . . . . 0.40999999999999998 110.64 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.402 HG22 HD12 ' A' ' 50' ' ' LEU . 10.6 m -129.32 120.9 26.42 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.651 -0.87 . . . . 0.22 108.651 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.57 135.57 53.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.693 -0.685 . . . . 0.17999999999999999 110.88 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.6 ttm -97.78 117.81 32.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.544 -1.28 . . . . 1.3200000000000001 107.544 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.706 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.4 t -115.1 133.06 62.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.531 -0.544 . . . . 0.17999999999999999 109.531 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 87.5 m -110.38 114.66 28.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.602 0.715 . . . . 0.20999999999999999 109.077 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.521 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -125.17 137.02 54.15 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 0.14999999999999999 110.41 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.595 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.81 147.35 9.07 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.737 -0.838 . . . . 0.57999999999999996 108.737 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 2.5 t -54.77 -27.16 39.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.04 0.447 . . . . 0.81999999999999995 110.288 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.595 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 12.7 ptpt -55.19 -33.13 62.75 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.165 -0.334 . . . . 0.81000000000000005 111.511 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.574 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 83.9 m-85 -94.86 3.22 55.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.073 0.463 . . . . 0.41999999999999998 110.1 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 72.3 m -123.16 -91.77 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.193 -0.912 . . . . 0.17999999999999999 110.528 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 8.1 m-85 -142.59 41.08 1.58 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.153 -0.619 . . . . 0.23999999999999999 112.123 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.77 -88.57 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.486 -0.387 . . . . 0.25 113.909 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.49 11.69 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.396 2.064 . . . . 0.57999999999999996 111.168 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.04 -48.87 3.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.396 -0.82 . . . . 0.65000000000000002 109.884 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.637 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 79.13 143.63 2.64 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 114.616 -1.174 . . . . 0.29999999999999999 112.216 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.695 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.0 t -90.48 147.54 23.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.103 0.478 . . . . 0.33000000000000002 111.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.593 ' HD2' ' H ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -54.87 -28.18 48.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.12 -0.945 . . . . 3.1699999999999999 112.485 -175.384 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 1.089 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 27.5 t -91.59 -70.03 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.891 -0.781 . . . . 1.23 108.891 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.089 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.4 Cg_endo -105.19 128.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.5 2.134 . . . . 0.37 111.998 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.637 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 22.3 t80 -55.72 97.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.32 -0.993 . . . . 1.1399999999999999 108.32 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 127' ' ' SER . 28.6 mm -67.16 125.97 91.8 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.556 -0.747 . . . . 0.39000000000000001 109.31 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' A' ' 136' ' ' ALA . 9.7 Cg_endo -53.47 135.99 62.52 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.321 2.014 . . . . 0.60999999999999999 111.688 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.633 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 54.2 Cg_exo -53.33 129.01 31.53 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.491 2.127 . . . . 0.52000000000000002 112.304 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.621 ' H ' ' HB3' ' A' ' 118' ' ' SER . 70.3 m-70 74.69 11.09 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.69 -1.141 . . . . 2.3799999999999999 112.931 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 133' ' ' PRO . . . -71.07 118.87 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.254 -1.017 . . . . 0.26000000000000001 108.254 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.19 113.68 10.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.463 0.649 . . . . 0.22 109.902 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.637 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.37 131.98 34.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.153 -0.931 . . . . 0.22 110.966 -174.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.1 t -115.18 99.74 7.64 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.891 -0.781 . . . . 1.2 108.891 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -112.85 134.53 54.32 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.467 0.651 . . . . 0.32000000000000001 111.781 -173.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.484 ' HG3' HD11 ' A' ' 50' ' ' LEU . 39.9 tt0 -99.8 113.59 26.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.186 -0.916 . . . . 1.05 108.916 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 2.2 m -115.7 121.3 67.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.46 0.648 . . . . 0.19 112.674 -175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.1 m -88.05 121.67 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.18 -0.918 . . . . 0.28000000000000003 109.756 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 60' ' ' PRO . 39.0 tp -93.89 93.33 7.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.401 -0.962 . . . . 0.14999999999999999 108.401 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.535 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -85.81 -30.83 22.69 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.898 -1.047 . . . . 1.0800000000000001 110.629 -172.246 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.625 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 85.2 m -157.14 145.09 19.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.813 -0.631 . . . . 0.37 111.562 -168.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.619 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . . . -137.55 128.32 27.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.74 -0.664 . . . . 0.25 109.369 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 65' ' ' VAL . 11.2 m . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 109.563 -0.532 . . . . 0.92000000000000004 109.563 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.534 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.05 0.452 . . . . 0.53000000000000003 110.378 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.46 110.83 7.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.5 110.409 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.633 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -75.0 127.15 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.332 0.587 . . . . 2.5099999999999998 110.612 174.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 45' ' ' LEU . 8.4 mt -57.78 -35.55 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.586 -1.188 . . . . 0.46000000000000002 111.549 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.6 mt -111.12 -1.16 16.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.286 0.565 . . . . 0.71999999999999997 110.278 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.22 26.63 66.26 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.318 -0.855 . . . . 0.52000000000000002 111.746 -172.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.39 -29.09 14.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.65 0.241 . . . . 0.94999999999999996 111.65 -178.156 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.541 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.41 -9.14 30.72 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 121.114 -0.565 . . . . 0.71999999999999997 111.751 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 7.3 mp -97.4 -33.18 11.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.253 -0.474 . . . . 1.5600000000000001 110.971 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.573 HD11 HD12 ' A' ' 39' ' ' ILE . 19.8 tp -122.91 100.7 7.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.32000000000000001 111.352 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 66.7 mtm180 -132.23 140.73 48.78 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.178 -0.326 . . . . 1.1399999999999999 111.163 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 13.4 ttpt -111.51 123.66 50.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.265 -0.272 . . . . 0.34999999999999998 110.265 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 20.1 ttmt -101.17 122.08 42.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.157 -0.312 . . . . 1.0700000000000001 110.157 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' PRO . 5.3 p -76.67 100.82 5.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.497 -0.319 . . . . 0.33000000000000002 110.977 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD12 HG22 ' A' ' 111' ' ' THR . 11.5 mt -68.71 -55.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.065 -1.457 . . . . 0.28000000000000003 107.065 171.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.784 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.5 t -129.82 126.35 22.52 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 113.024 -1.898 . . . . 0.35999999999999999 106.299 167.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 16.5 Cg_endo -104.48 60.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.832 2.355 . . . . 0.54000000000000004 113.477 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.959 -0.564 . . . . 0.55000000000000004 113.213 177.088 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 110.185 -0.302 . . . . 0.98999999999999999 110.185 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 t -152.81 127.93 9.75 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.04 -0.726 . . . . 1.28 109.04 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.81 122.14 67.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.583 -0.447 . . . . 2.8100000000000001 110.946 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.6 153.24 11.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.789 2.992 . . . . 0.29999999999999999 114.13 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.7 t -100.08 155.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.004 -0.998 . . . . 0.88 109.449 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 95.4 mttt -64.34 106.86 1.19 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.386 0.613 . . . . 1.1699999999999999 110.364 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.75 -24.73 2.44 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.28 -1.128 . . . . 0.41999999999999998 110.28 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.1 mm-40 -83.01 137.72 34.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.282 -0.636 . . . . 0.58999999999999997 109.282 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.5 m -81.05 133.54 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.064 -1.087 . . . . 1.22 108.064 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.2 m -127.8 143.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.022 -0.535 . . . . 0.25 110.92 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 45.9 p -94.11 112.61 24.44 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.309 -0.626 . . . . 0.28999999999999998 109.309 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.59 HG21 HD21 ' A' ' 99' ' ' LEU . 19.6 m -110.15 143.41 20.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.901 -0.72 . . . . 0.19 109.849 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.596 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.7 t-160 -102.33 116.11 31.95 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.824 -1.547 . . . . 0.19 106.824 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 83' ' ' GLU . 1.2 pt? -122.5 137.95 54.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.462 -0.895 . . . . 0.39000000000000001 110.83 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HB2' ' NH1' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -133.11 114.31 13.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.277 -2.12 . . . . 0.27000000000000002 105.277 166.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.654 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 71.0 m -105.04 129.69 53.42 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.6 -1.182 . . . . 0.19 111.016 -166.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.993 ' HB3' ' SG ' ' A' ' 139' ' ' CYS . 4.7 t -104.38 172.51 6.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.268 -0.878 . . . . 1.0600000000000001 108.884 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 80' ' ' VAL . 12.3 mt -101.48 165.54 11.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.517 -0.765 . . . . 0.83999999999999997 109.178 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.18 -23.35 34.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.1 0.476 . . . . 1.1399999999999999 110.492 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.28 -8.49 53.28 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.776 -0.647 . . . . 2.1400000000000001 111.492 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.39 10.56 44.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.259 -0.972 . . . . 0.51000000000000001 113.568 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 92.1 m -98.64 113.0 24.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.311 0.555 . . . . 0.46000000000000002 112.332 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.894 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.4 mtt180 -69.91 125.56 27.12 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.46999999999999997 110.363 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.012 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.2 m -108.89 -20.17 6.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.004 -0.998 . . . . 0.27000000000000002 112.295 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.654 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.4 pt20 -146.99 124.3 11.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.421 -0.354 . . . . 0.58999999999999997 110.242 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -118.41 118.0 30.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.31 0.576 . . . . 1.3400000000000001 109.964 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.563 ' HB3' HD23 ' A' ' 70' ' ' LEU . 6.4 tp10 -135.8 107.58 9.85 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.589 -0.732 . . . . 2.5899999999999999 110.814 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.596 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 14.3 Cg_exo -68.12 -19.83 44.6 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.056 2.504 . . . . 0.5 112.952 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -164.22 113.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.025 0.917 . . . . 1.3700000000000001 112.567 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.08 110.31 16.08 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.772 -1.558 . . . . 0.38 108.763 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.8 p -100.17 137.03 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -159.45 157.64 30.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 0.23000000000000001 110.426 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 24.4 m -76.87 119.13 20.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.527 -0.546 . . . . 0.41999999999999998 109.527 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.915 HD11 ' HD3' ' A' ' 104' ' ' PRO . 17.4 tp -62.19 133.22 54.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 0.59999999999999998 110.544 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.71 -4.91 80.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 0.37 111.844 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 12.8 t70 -83.77 -15.06 49.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.165 -0.68 . . . . 0.93000000000000005 109.165 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.0 m 62.65 30.1 16.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.863 -1.062 . . . . 0.62 109.414 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 13.7 t70 -62.55 -26.36 68.53 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 122.367 1.079 . . . . 1.3300000000000001 108.45 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 15.1 m -114.46 -158.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 113.341 -1.754 . . . . 0.23000000000000001 110.834 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.7 pt -84.34 139.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.81 -1.182 . . . . 0.28999999999999998 107.81 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.512 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -60.17 -27.34 67.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.449 -0.341 . . . . 0.40000000000000002 110.966 -173.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -56.39 -42.95 78.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.324 0.583 . . . . 0.20000000000000001 110.286 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 68' ' ' VAL . 53.0 tp -78.53 -40.49 34.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.131 -0.941 . . . . 0.22 110.377 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.97 -29.72 70.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.794 -1.094 . . . . 0.26000000000000001 109.973 -174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 57.6 mt -90.66 -33.64 15.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.44 -0.8 . . . . 0.25 111.959 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.5 t -65.63 -34.54 78.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 1.01 110.769 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.7 t -63.56 -53.29 52.78 Favored Pre-proline 0 C--O 1.22 -0.492 0 N-CA-C 113.129 0.789 . . . . 0.20999999999999999 113.129 -177.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.915 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.7 Cg_endo -62.03 -22.15 73.71 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.988 1.792 . . . . 0.27000000000000002 111.945 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' A' ' 39' ' ' ILE . 9.5 mt -83.82 -11.98 56.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.416 0.627 . . . . 0.64000000000000001 110.991 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.771 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 34.8 ttm -98.28 140.36 32.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.969 -1.014 . . . . 0.78000000000000003 111.635 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.13 153.11 19.56 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.485 -0.561 . . . . 0.96999999999999997 109.485 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.588 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.0 t -62.0 124.98 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 0.80000000000000004 110.65 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 12.95 52.98 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.28000000000000003 112.723 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.784 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.6 pt-20 -105.43 168.63 8.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.478 0.639 . . . . 0.40999999999999998 110.432 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.49 HG22 HD12 ' A' ' 50' ' ' LEU . 24.4 m -132.83 119.8 20.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.402 -0.962 . . . . 0.22 108.402 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.68 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -117.54 137.45 52.57 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.483 -0.781 . . . . 0.17999999999999999 110.718 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 ttt -96.85 116.03 28.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.872 -1.529 . . . . 1.3200000000000001 106.872 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.506 HG22 ' HG3' ' A' ' 47' ' ' LYS . 3.4 t -113.34 132.96 60.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.53 -0.545 . . . . 0.17999999999999999 109.53 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.525 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 63.0 m -110.7 114.43 27.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.629 -0.828 . . . . 0.20999999999999999 109.36 171.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.99 53.83 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.896 -1.502 . . . . 0.14999999999999999 109.813 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.576 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.3 t70 -52.47 147.24 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.981 -0.748 . . . . 0.57999999999999996 108.981 173.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.627 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.1 t -55.78 -28.32 55.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 0.81999999999999995 110.086 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.58 ' HG3' ' CD1' ' A' ' 120' ' ' TYR . 15.6 ptpt -55.48 -31.44 62.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.629 -0.259 . . . . 0.81000000000000005 111.634 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.58 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 78.5 m-85 -95.2 -1.55 51.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.147 0.499 . . . . 0.41999999999999998 109.839 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 65.6 m -117.14 -93.47 0.51 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.061 -0.972 . . . . 0.17999999999999999 110.371 -177.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.609 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.8 m-85 -140.78 39.71 1.83 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.207 -0.597 . . . . 0.23999999999999999 112.091 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -45.59 -83.03 0.02 OUTLIER Glycine 0 C--N 1.344 0.99 0 N-CA-C 114.242 0.457 . . . . 0.25 114.242 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.4 13.93 2.53 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.393 2.062 . . . . 0.57999999999999996 110.77 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.4 mt-30 -104.65 -49.28 3.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.978 -1.01 . . . . 0.65000000000000002 110.498 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 131' ' ' TYR . . . 81.83 142.2 3.76 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 114.544 -1.207 . . . . 0.29999999999999999 112.622 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.609 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 30.4 t -91.93 165.99 12.94 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.091 0.404 . . . . 0.33000000000000002 112.091 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.579 ' HG3' ' N ' ' A' ' 129' ' ' SER . 6.9 ptp180 -52.87 -49.88 64.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.728 -0.669 . . . . 3.1699999999999999 112.219 -171.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.986 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 13.0 m -87.78 -62.72 0.22 Allowed Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.704 -0.48 . . . . 1.23 109.704 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.012 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 8.9 Cg_endo -101.08 127.7 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.592 2.195 . . . . 0.37 111.707 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.44 ' HA ' ' CA ' ' A' ' 126' ' ' GLY . 9.6 t80 -57.43 97.35 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.938 -1.504 . . . . 1.1399999999999999 106.938 159.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -64.87 124.66 87.13 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 107.965 -1.124 . . . . 0.39000000000000001 107.965 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.22 141.19 31.91 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.499 2.133 . . . . 0.60999999999999999 112.301 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 55.0 Cg_exo -52.37 132.32 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.582 2.188 . . . . 0.52000000000000002 112.156 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.515 ' H ' ' HB3' ' A' ' 118' ' ' SER . 1.4 m-70 72.35 9.22 5.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.069 -0.969 . . . . 2.3799999999999999 113.015 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -74.09 123.84 25.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.162 -0.681 . . . . 0.26000000000000001 109.162 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.82 112.28 9.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.351 0.596 . . . . 0.22 109.643 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 121' ' ' CYS . 2.0 tp -88.76 131.87 34.86 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.549 -0.751 . . . . 0.22 110.586 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.993 ' SG ' ' HB3' ' A' ' 73' ' ' SER . 24.7 p -116.73 100.29 7.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.795 0.807 . . . . 1.2 110.501 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -109.66 133.64 52.89 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.323 -0.853 . . . . 0.32000000000000001 111.491 -172.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 40.1 tt0 -98.33 109.09 21.9 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.508 -0.769 . . . . 1.05 109.212 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.654 HG23 ' HE1' ' A' ' 106' ' ' MET . 0.8 OUTLIER -113.35 116.46 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.463 0.649 . . . . 0.19 112.39 -174.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 9.5 m -89.2 113.72 24.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 0.28000000000000003 111.034 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.771 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -84.8 93.55 8.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.773 -0.825 . . . . 0.14999999999999999 108.773 172.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -86.45 -32.61 20.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.111 -0.95 . . . . 1.0800000000000001 110.799 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.3 m -150.71 147.31 27.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.309 -0.405 . . . . 0.37 111.197 -173.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -134.22 128.31 33.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.156 -0.683 . . . . 0.25 109.156 171.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 110.063 -0.347 . . . . 0.92000000000000004 110.063 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.686 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.53000000000000003 110.995 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.75 110.99 5.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.5 110.398 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.676 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -66.59 103.2 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 2.5099999999999998 110.963 175.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.742 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.2 mt -53.88 -48.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.66 -1.155 . . . . 0.46000000000000002 111.522 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 45' ' ' LEU . 52.0 mt -105.68 12.79 30.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 0.71999999999999997 110.712 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.676 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 69.08 6.83 55.07 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.331 -0.849 . . . . 0.52000000000000002 113.332 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.541 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -99.27 -12.76 20.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.676 0.275 . . . . 0.94999999999999996 111.468 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.32 -19.11 37.35 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.382 -0.913 . . . . 0.71999999999999997 112.832 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.5 mp -75.33 -24.47 57.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.039 0.923 . . . . 1.5600000000000001 109.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 tp -119.13 113.84 21.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.911 -1.495 . . . . 0.32000000000000001 110.145 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 46' ' ' ARG . 43.4 mtm180 -142.86 133.44 25.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.35 0.5 . . . . 1.1399999999999999 112.35 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB2' HD11 ' A' ' 39' ' ' ILE . 12.8 ttpt -109.97 125.04 52.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.34999999999999998 109.976 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.686 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 26.5 ttpp -114.4 121.6 44.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.146 0.498 . . . . 1.0700000000000001 111.046 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.612 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.3 p -74.68 103.45 4.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.198 -0.91 . . . . 0.33000000000000002 111.713 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.09 -56.41 7.8 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.67 -1.604 . . . . 0.28000000000000003 106.67 171.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 56.0 t -131.97 123.89 19.28 Favored Pre-proline 0 CA--C 1.502 -0.9 0 CA-C-N 112.726 -2.034 . . . . 0.35999999999999999 106.719 168.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.708 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 73.5 Cg_endo -107.92 66.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 122.563 2.175 . . . . 0.54000000000000004 114.055 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.435 -0.802 . . . . 0.55000000000000004 113.394 173.34 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 121.108 0.48 . . . . 0.98999999999999999 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -149.82 147.21 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.912 -0.773 . . . . 1.28 108.912 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 85.2 mtt180 -96.24 116.37 66.13 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.578 -0.449 . . . . 2.8100000000000001 110.116 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.801 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -49.47 144.48 18.42 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.756 2.971 . . . . 0.29999999999999999 112.975 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 9.0 t -89.25 145.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.18 -0.463 . . . . 0.88 110.031 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.902 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 97.9 mttt -65.72 104.42 1.05 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.639 0.733 . . . . 1.1699999999999999 109.788 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.12 -29.92 2.16 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 114.394 -1.276 . . . . 0.41999999999999998 109.948 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.9 mm-40 -74.83 136.16 41.6 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.363 -0.977 . . . . 0.58999999999999997 108.363 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.3 m -84.16 115.23 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.951 -1.129 . . . . 1.22 107.951 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -109.65 146.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.95 -1.023 . . . . 0.25 110.853 -171.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.797 ' HB ' ' OE1' ' A' ' 85' ' ' GLU . 78.9 p -91.12 112.46 24.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.289 0.566 . . . . 0.28999999999999998 109.725 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.739 HG21 HD21 ' A' ' 99' ' ' LEU . 26.8 m -111.04 142.39 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 119.907 -0.717 . . . . 0.19 109.319 170.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -102.41 116.7 33.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.529 -1.656 . . . . 0.19 106.529 169.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -116.86 135.15 53.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.98 -1.088 . . . . 0.39000000000000001 110.781 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.572 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 2.9 mp0 -130.49 114.23 15.25 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.427 -2.064 . . . . 0.27000000000000002 105.427 167.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.563 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 86.8 m -106.43 127.27 53.16 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.229 -1.35 . . . . 0.19 111.145 -166.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.789 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -107.1 153.22 22.95 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.21 -0.905 . . . . 1.0600000000000001 109.335 -178.246 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.7 mt -78.6 164.79 24.36 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.488 -0.778 . . . . 0.83999999999999997 109.293 174.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 6.4 pt-20 -58.37 -14.21 7.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.436 0.636 . . . . 1.1399999999999999 110.507 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.442 ' OD1' ' HG3' ' A' ' 75' ' ' GLU . 2.0 m-20 -87.25 -14.77 40.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.242 -0.89 . . . . 2.1400000000000001 109.895 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.33 -6.68 46.34 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.851 -0.613 . . . . 0.51000000000000001 111.763 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -81.42 110.05 16.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.926 0.343 . . . . 0.46000000000000002 111.926 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 37.5 mtt180 -74.11 116.75 15.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.511 0.672 . . . . 0.46999999999999997 110.394 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.1 m -99.33 -12.91 8.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.27000000000000002 112.314 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.536 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 28.9 pt20 -156.61 136.07 12.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.224 -0.444 . . . . 0.58999999999999997 110.385 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 33.1 tt0 -135.13 116.54 14.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.962 -0.563 . . . . 1.3400000000000001 109.652 174.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 86' ' ' LEU . 5.2 tt0 -129.5 109.59 17.55 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.29 -0.868 . . . . 2.5899999999999999 109.795 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 16.5 Cg_exo -68.34 -13.57 38.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.736 2.957 . . . . 0.5 113.256 -172.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OE1' ' HB ' ' A' ' 67' ' ' THR . 2.9 tp10 -157.96 101.94 1.8 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.037 0.923 . . . . 1.3700000000000001 110.711 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.478 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 28.1 tp -116.92 106.46 13.46 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.986 -1.461 . . . . 0.38 108.65 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.5 p -101.97 132.08 48.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.7 p90 -153.8 156.16 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.23000000000000001 110.824 -174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 5.3 m -75.32 112.03 11.2 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.674 -0.693 . . . . 0.41999999999999998 109.66 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.902 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.8 tp -60.18 137.7 58.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.037 -0.528 . . . . 0.59999999999999998 110.21 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 77.61 5.98 86.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.37 112.264 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.421 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 29.5 t70 -103.3 -5.6 22.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.952 0.406 . . . . 0.93000000000000005 110.044 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 47.5 m 59.99 32.91 21.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.48 -0.782 . . . . 0.62 109.095 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 18.6 t70 -70.16 -16.52 63.1 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.424 1.107 . . . . 1.3300000000000001 108.758 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.76 -150.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 113.537 -1.665 . . . . 0.23000000000000001 110.253 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.6 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.1 pt -87.5 139.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.649 -1.241 . . . . 0.28999999999999998 107.649 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -58.68 -29.18 66.41 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 123.264 0.352 . . . . 0.40000000000000002 110.916 -173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -55.36 -48.34 74.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.362 0.601 . . . . 0.20000000000000001 110.664 174.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 68' ' ' VAL . 56.5 tp -75.6 -36.22 60.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.443 -0.799 . . . . 0.22 110.604 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.29 -30.63 71.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 0.26000000000000001 109.594 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 0.25 112.296 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 t -63.75 -36.65 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 1.01 110.959 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.554 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 77.2 t -62.97 -54.88 42.76 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.059 0.763 . . . . 0.20999999999999999 113.059 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.838 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.6 Cg_endo -62.54 -20.83 71.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.282 1.988 . . . . 0.27000000000000002 111.721 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.584 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.8 mt -83.96 -12.69 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.64000000000000001 111.29 173.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -106.98 155.94 19.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.268 -0.424 . . . . 0.78000000000000003 110.887 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.98 153.17 17.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 110.825 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.801 HG23 ' HD3' ' A' ' 60' ' ' PRO . 1.7 t -60.4 125.4 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.118 0.485 . . . . 0.80000000000000004 110.403 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 18.58 41.98 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.103 -0.953 . . . . 0.28000000000000003 112.499 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.774 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.0 pt-20 -107.57 167.3 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.418 0.628 . . . . 0.40999999999999998 110.992 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 m -130.54 117.46 19.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.957 -1.127 . . . . 0.22 107.957 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.28 138.89 52.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.115 0.483 . . . . 0.17999999999999999 110.736 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.0 ttp -100.03 117.45 34.32 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.079 -1.452 . . . . 1.3200000000000001 107.079 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 47' ' ' LYS . 9.8 t -114.74 131.0 68.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.764 -0.458 . . . . 0.17999999999999999 109.764 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.516 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 86.0 m -107.49 113.5 26.88 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.658 -0.867 . . . . 0.20999999999999999 108.658 173.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.55 135.8 53.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.263 -1.335 . . . . 0.14999999999999999 109.354 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.614 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.4 t70 -53.82 149.86 8.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.818 -0.808 . . . . 0.57999999999999996 108.818 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -56.66 -28.01 59.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.202 0.525 . . . . 0.81999999999999995 110.059 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.9 ptpt -56.43 -31.94 64.41 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.902 -0.499 . . . . 0.81000000000000005 111.779 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.593 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.3 m-85 -94.87 4.22 54.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.41999999999999998 109.632 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 66.8 m -123.16 -92.76 0.53 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.067 -0.97 . . . . 0.17999999999999999 110.489 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 6.5 m-85 -142.0 39.77 1.64 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 119.041 -0.504 . . . . 0.23999999999999999 112.135 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.16 -88.7 0.01 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 114.09 0.396 . . . . 0.25 114.09 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.96 10.63 3.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.015 1.81 . . . . 0.57999999999999996 111.434 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -103.49 -49.4 3.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.567 -0.742 . . . . 0.65000000000000002 109.924 -173.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.515 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 81.72 145.42 4.96 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.758 -1.11 . . . . 0.29999999999999999 111.698 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.687 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.5 t -90.49 162.54 15.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.405 -0.398 . . . . 0.33000000000000002 110.925 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -51.63 -58.74 5.49 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.892 0.745 . . . . 3.1699999999999999 110.733 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.849 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 59.6 m -77.48 -61.34 0.65 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.897 -0.592 . . . . 1.23 110.411 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.849 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.8 Cg_endo -106.04 125.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.09 1.86 . . . . 0.37 112.619 174.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.14 96.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.514 -0.921 . . . . 1.1399999999999999 108.514 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.573 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.9 123.87 87.2 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.536 -0.757 . . . . 0.39000000000000001 109.717 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.88 136.93 43.76 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.841 2.361 . . . . 0.60999999999999999 112.459 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.672 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 Cg_endo -55.44 128.71 31.55 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.159 1.906 . . . . 0.52000000000000002 111.998 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.593 ' H ' ' HB3' ' A' ' 118' ' ' SER . 62.7 m170 74.13 12.97 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.98 -1.009 . . . . 2.3799999999999999 112.397 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -76.33 121.1 22.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.554 -0.906 . . . . 0.26000000000000001 108.554 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -72.95 113.11 9.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.22 109.754 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.563 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.2 tp -88.45 131.45 34.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.572 -0.74 . . . . 0.22 110.566 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.4 100.68 8.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.301 -1.0 . . . . 1.2 108.301 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.536 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.1 pp -115.22 136.54 53.0 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.058 -0.519 . . . . 0.32000000000000001 111.734 -171.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.572 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 40.0 tt0 -102.71 117.14 34.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.479 -0.934 . . . . 1.05 108.479 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 99' ' ' LEU . 3.5 m -117.93 116.7 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.535 0.683 . . . . 0.19 112.785 -174.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -89.73 108.77 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 0.28000000000000003 110.576 173.774 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.652 HD21 ' HG3' ' A' ' 60' ' ' PRO . 57.6 tp -85.44 97.78 10.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.379 -0.971 . . . . 0.14999999999999999 108.379 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 143' ' ' THR . 19.7 mtmm -103.39 -18.17 14.94 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.0800000000000001 110.702 -168.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m -156.16 145.36 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.913 -0.585 . . . . 0.37 110.913 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.531 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.62 127.26 32.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.641 -0.874 . . . . 0.25 108.641 169.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 65' ' ' VAL . 20.4 m . . . . . 0 C--N 1.323 -0.563 0 C-N-CA 120.203 -0.599 . . . . 0.92000000000000004 110.436 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.565 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 N-CA-C 109.864 -0.421 . . . . 0.53000000000000003 109.864 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.76 111.47 8.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.851 -0.613 . . . . 0.5 110.3 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.797 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 11.0 t70 -75.14 126.65 31.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.779 -0.768 . . . . 2.5099999999999998 109.795 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 105' ' ' LEU . 5.0 mt -59.47 -30.22 43.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.46000000000000002 110.771 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.6 mt -113.21 -5.58 13.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.577 -0.738 . . . . 0.71999999999999997 110.572 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.676 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.71 21.8 71.32 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.428 -0.806 . . . . 0.52000000000000002 111.675 -174.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.509 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -103.18 -20.27 14.21 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.078 0.769 . . . . 0.94999999999999996 113.078 -175.137 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.491 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 125.79 -26.43 5.38 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.036 -1.078 . . . . 0.71999999999999997 114.827 166.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -106.17 -11.47 16.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.124 0.787 . . . . 1.5600000000000001 113.124 -171.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.7 tp -123.11 100.99 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.505 -0.122 . . . . 0.32000000000000001 111.108 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.797 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 83.7 mtm180 -140.88 145.46 36.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.551 0.574 . . . . 1.1399999999999999 112.551 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.652 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.7 ttpt -116.29 131.39 56.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.218 -0.447 . . . . 0.34999999999999998 110.259 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 4.2 ttmm -111.85 125.75 54.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.626 0.251 . . . . 1.0700000000000001 110.511 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 p -80.18 100.22 8.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.376 -0.375 . . . . 0.33000000000000002 111.434 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.464 HD12 HG22 ' A' ' 111' ' ' THR . 11.8 mt -63.94 -53.15 54.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.943 -1.503 . . . . 0.28000000000000003 106.943 170.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.8 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.9 t -136.35 129.36 17.72 Favored Pre-proline 0 CA--C 1.503 -0.844 0 CA-C-N 112.753 -2.021 . . . . 0.35999999999999999 106.638 170.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 38.7 Cg_endo -103.91 56.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 122.812 2.342 . . . . 0.54000000000000004 113.671 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.773 0 CA-C-N 115.303 -0.862 . . . . 0.55000000000000004 113.062 176.156 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 121.5 0.667 . . . . 0.98999999999999999 111.566 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -136.42 140.93 43.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.527 -0.916 . . . . 1.28 108.527 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 97.7 mtt180 -101.13 114.1 65.79 Favored Pre-proline 0 C--N 1.311 -1.097 0 C-N-CA 120.786 -0.366 . . . . 2.8100000000000001 110.539 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.685 ' HD3' HG23 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -47.29 142.1 12.77 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.875 3.05 . . . . 0.29999999999999999 113.735 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.69 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.1 t -95.67 152.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.486 -0.779 . . . . 0.88 109.564 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 40.4 mttp -66.51 106.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.569 0.699 . . . . 1.1699999999999999 110.488 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.2 -23.14 2.57 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.96 -1.018 . . . . 0.41999999999999998 110.756 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.2 OUTLIER -85.25 139.13 31.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.803 -0.814 . . . . 0.58999999999999997 108.803 177.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 10.7 m -87.28 129.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.677 -0.861 . . . . 1.22 108.677 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 24.9 m -123.15 149.64 26.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.928 -1.033 . . . . 0.25 110.502 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 20.2 p -97.82 112.85 24.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.748 -0.66 . . . . 0.28999999999999998 110.218 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 99' ' ' LEU . 24.4 m -110.93 147.01 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 120.376 -0.53 . . . . 0.19 110.375 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.611 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.78 114.84 29.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.988 -1.486 . . . . 0.19 106.988 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.9 OUTLIER -120.33 138.16 53.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.387 -0.925 . . . . 0.39000000000000001 111.194 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.477 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 mp0 -133.27 114.83 14.22 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.127 -1.805 . . . . 0.27000000000000002 106.127 167.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.675 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 32.6 m -103.14 118.99 38.02 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.867 -1.06 . . . . 0.19 111.848 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -105.65 135.05 47.75 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.477 -0.783 . . . . 1.0600000000000001 109.248 176.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.531 HD13 ' CG1' ' A' ' 80' ' ' VAL . 4.2 mp -58.46 165.29 2.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.562 0.22 . . . . 0.83999999999999997 111.26 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 8.1 pt-20 -52.45 -20.48 2.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.374 0.607 . . . . 1.1399999999999999 111.267 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -87.46 -14.73 39.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.706 -0.679 . . . . 2.1400000000000001 111.15 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.66 -10.57 38.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.35 -0.452 . . . . 0.51000000000000001 112.249 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -72.27 108.97 5.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.995 0.426 . . . . 0.46000000000000002 111.552 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 18.1 mtt180 -73.33 128.47 35.57 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.472 0.653 . . . . 0.46999999999999997 110.367 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.851 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.2 m -115.6 -8.17 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.683 -1.144 . . . . 0.27000000000000002 111.501 -171.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.675 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.8 pt20 -162.69 130.74 3.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.697 -0.683 . . . . 0.58999999999999997 109.334 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 25.9 tt0 -141.84 105.92 4.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 1.3400000000000001 110.258 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 6.4 mm-40 -125.84 126.82 24.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.743 -0.662 . . . . 2.5899999999999999 109.754 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.492 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 10.9 Cg_exo -70.94 -17.06 32.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.424 2.083 . . . . 0.5 112.639 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -159.66 122.9 3.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.99 0.9 . . . . 1.3700000000000001 111.923 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.6 tp -132.82 113.15 12.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.519 -1.673 . . . . 0.38 108.774 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.9 p -104.94 132.58 51.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.6 p90 -153.16 156.29 38.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.651 0.262 . . . . 0.23000000000000001 110.638 -176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -75.86 112.06 11.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.41999999999999998 110.172 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.84 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.5 tp -60.26 135.38 57.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.59999999999999998 110.427 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.573 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 81.01 5.43 90.16 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.708 -0.758 . . . . 0.37 112.069 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.82 -13.13 19.35 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.852 -0.425 . . . . 0.93000000000000005 109.852 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.7 m 62.32 35.04 15.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.556 -0.905 . . . . 0.62 108.556 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.27 -6.34 49.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.55 1.167 . . . . 1.3300000000000001 108.431 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 7.8 m -131.13 -156.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.375 -1.739 . . . . 0.23000000000000001 110.021 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -80.08 137.36 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 107.482 -1.303 . . . . 0.28999999999999998 107.482 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -58.04 -29.16 65.13 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.583 -0.28 . . . . 0.40000000000000002 110.891 -173.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.91 78.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.20000000000000001 110.802 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.565 ' H ' HG13 ' A' ' 96' ' ' ILE . 51.4 tp -72.51 -41.34 66.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.22 110.503 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.11 -30.22 70.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.26000000000000001 109.911 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.14 -33.77 16.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.25 112.196 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.7 t -68.91 -29.11 67.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.593 -0.276 . . . . 1.01 111.111 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.602 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -66.31 -55.11 21.34 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.659 0.615 . . . . 0.20999999999999999 112.659 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.84 ' HD3' HD11 ' A' ' 90' ' ' LEU . 20.7 Cg_endo -62.45 -23.62 75.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.921 1.747 . . . . 0.27000000000000002 111.818 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 39' ' ' ILE . 20.2 mt -73.75 -26.12 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.738 -0.664 . . . . 0.64000000000000001 111.015 172.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.767 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -95.72 156.52 16.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.09 -0.505 . . . . 0.78000000000000003 111.082 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.03 151.54 21.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.055 0.455 . . . . 0.96999999999999997 110.923 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.685 HG23 ' HD3' ' A' ' 60' ' ' PRO . 1.3 t -60.07 125.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.461 0.648 . . . . 0.80000000000000004 110.22 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.39 56.74 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.865 -1.061 . . . . 0.28000000000000003 112.803 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.8 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.0 pt-20 -103.14 167.93 9.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.40999999999999998 111.096 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.464 HG22 HD12 ' A' ' 50' ' ' LEU . 7.2 m -129.41 117.19 20.16 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.716 -1.216 . . . . 0.22 107.716 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.74 134.35 55.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.049 -0.523 . . . . 0.17999999999999999 110.717 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.4 ttp -98.39 117.93 33.9 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.759 -1.2 . . . . 1.3200000000000001 107.759 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.652 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.1 t -111.92 135.21 51.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.689 -0.687 . . . . 0.17999999999999999 109.431 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.565 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 87.8 m -114.32 113.68 24.89 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.616 -0.834 . . . . 0.20999999999999999 108.795 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.64 54.94 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.18 -1.373 . . . . 0.14999999999999999 109.796 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.706 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.79 148.79 6.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.004 -0.739 . . . . 0.57999999999999996 109.004 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.3 t -55.23 -28.5 53.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.116 0.484 . . . . 0.81999999999999995 110.489 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.706 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.5 ptpt -54.77 -32.88 60.63 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.448 -0.342 . . . . 0.81000000000000005 111.535 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.636 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 98.3 m-85 -97.25 7.8 45.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.41999999999999998 110.04 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.667 ' HB3' HD22 ' A' ' 138' ' ' LEU . 61.4 m -123.7 -91.74 0.54 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.118 -0.946 . . . . 0.17999999999999999 110.115 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 4.1 m-85 -144.56 41.57 1.34 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 119.272 -0.394 . . . . 0.23999999999999999 111.985 175.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.692 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.49 -84.01 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 121.449 -0.405 . . . . 0.25 113.836 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.76 12.07 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.32 2.013 . . . . 0.57999999999999996 111.088 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -104.45 -51.52 3.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.499 -0.773 . . . . 0.65000000000000002 110.176 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.558 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 83.27 142.46 4.77 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.606 -1.179 . . . . 0.29999999999999999 111.982 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.618 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.7 t -92.65 164.23 13.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.176 -0.512 . . . . 0.33000000000000002 112.074 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 128' ' ' ARG . 44.6 mtm180 -50.59 -62.64 1.47 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.905 -1.043 . . . . 3.1699999999999999 111.905 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.939 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 30.9 t -72.09 -63.68 1.21 Allowed Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 1.23 110.067 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.9 Cg_endo -107.22 127.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 122.653 2.235 . . . . 0.37 112.315 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.558 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 42.1 t80 -55.97 98.6 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.861 -1.163 . . . . 1.1399999999999999 107.861 162.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.612 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.2 mm -66.44 128.82 94.05 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 115.713 -0.676 . . . . 0.39000000000000001 109.484 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.25 145.52 65.69 Favored 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.656 2.237 . . . . 0.60999999999999999 111.839 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.692 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 34.8 Cg_endo -63.85 139.39 68.14 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.922 1.748 . . . . 0.52000000000000002 111.783 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.565 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 4.9 m-70 68.75 6.97 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.129 -0.941 . . . . 2.3799999999999999 112.558 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -72.4 120.65 18.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.283 -0.636 . . . . 0.26000000000000001 109.283 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -73.45 113.2 10.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.355 0.598 . . . . 0.22 109.904 -172.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 121' ' ' CYS . 0.9 OUTLIER -87.95 131.32 34.65 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.567 -0.742 . . . . 0.22 110.663 -177.151 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.8 t -115.73 99.94 7.67 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.901 -0.778 . . . . 1.2 108.901 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.2 pp -115.23 134.32 55.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.116 -0.493 . . . . 0.32000000000000001 111.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 34.0 tt0 -98.86 122.04 41.59 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.223 -0.658 . . . . 1.05 109.223 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.8 m -117.69 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.476 0.655 . . . . 0.19 112.342 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 6.8 m -95.08 111.01 22.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.102 -0.954 . . . . 0.28000000000000003 110.06 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.619 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -83.6 99.19 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.66 -0.867 . . . . 0.14999999999999999 108.66 173.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.424 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 21.4 mtmt -94.69 -32.28 13.44 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.052 -0.976 . . . . 1.0800000000000001 110.598 -170.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.463 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.9 m -152.44 151.69 31.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.37 111.019 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -139.25 129.35 25.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.249 -0.648 . . . . 0.25 109.249 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.385 0.612 . . . . 0.92000000000000004 110.534 -178.609 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.523 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 2.0 m0 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 121.238 0.542 . . . . 0.53000000000000003 110.334 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 49.0 tp -80.04 109.99 15.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.5 110.661 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.713 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 2.8 p-10 -63.06 97.71 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.089 -0.959 . . . . 2.5099999999999998 110.696 171.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.817 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 12.0 mt -51.14 -49.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.021 -0.99 . . . . 0.46000000000000002 111.986 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 45' ' ' LEU . 55.2 mt -102.33 3.84 38.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.71999999999999997 110.99 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.713 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 75.61 8.5 84.23 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.52000000000000002 112.314 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -98.12 -15.85 19.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.224 0.453 . . . . 0.94999999999999996 112.224 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.14 -26.87 5.86 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.71999999999999997 112.623 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.6 mp -69.15 -23.74 63.99 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 122.018 0.913 . . . . 1.5600000000000001 109.033 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.817 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.9 tp -120.24 112.39 19.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.133 -1.394 . . . . 0.32000000000000001 110.486 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 57.2 mtm180 -142.45 140.76 32.04 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 122.962 0.164 . . . . 1.1399999999999999 111.229 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HG3' HG22 ' A' ' 114' ' ' VAL . 15.9 ttpt -115.53 127.04 54.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.801 -0.444 . . . . 0.34999999999999998 109.801 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 15.0 ttmt -107.16 122.42 46.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 110.216 -0.29 . . . . 1.0700000000000001 110.216 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.0 p -79.05 99.6 6.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.896 0.379 . . . . 0.33000000000000002 111.063 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 111' ' ' THR . 9.3 mt -67.8 -52.5 36.32 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.724 -1.584 . . . . 0.28000000000000003 106.724 173.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.819 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.3 t -134.68 126.66 18.15 Favored Pre-proline 0 CA--C 1.502 -0.88 0 CA-C-N 113.039 -1.891 . . . . 0.35999999999999999 106.196 168.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 65.7 Cg_endo -107.01 54.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.013 2.476 . . . . 0.54000000000000004 114.474 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.452 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.714 0 C-N-CA 120.849 -0.691 . . . . 0.55000000000000004 113.206 173.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 121.163 0.506 . . . . 0.98999999999999999 111.095 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 t -146.21 143.58 29.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.929 -0.767 . . . . 1.28 108.929 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 69.1 mtm180 -94.16 116.84 66.92 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 120.449 -0.5 . . . . 2.8100000000000001 109.756 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.778 ' HD3' HG23 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -49.05 148.02 10.07 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.51 2.807 . . . . 0.29999999999999999 113.077 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 10.6 t -92.73 150.24 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.669 . . . . 0.88 109.195 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 66.1 mttt -71.33 120.26 16.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.709 0.766 . . . . 1.1699999999999999 109.862 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.85 -26.8 4.74 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.175 -1.375 . . . . 0.41999999999999998 110.103 -172.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.3 mm-40 -82.1 135.88 35.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.86 -0.793 . . . . 0.58999999999999997 108.86 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 11.4 m -82.63 118.47 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.524 -0.917 . . . . 1.22 108.524 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -112.96 146.06 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.249 -0.887 . . . . 0.25 110.513 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.0 p -97.05 113.1 24.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.946 -0.57 . . . . 0.28999999999999998 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.446 HG21 HD21 ' A' ' 99' ' ' LEU . 27.1 m -111.05 150.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.767 -0.651 . . . . 0.19 110.187 174.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.734 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.52 -1.659 . . . . 0.19 106.52 167.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pt? -125.0 141.62 52.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.901 0.858 . . . . 0.39000000000000001 110.88 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 mp0 -139.28 120.03 14.26 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.464 -2.05 . . . . 0.27000000000000002 105.464 167.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 43.3 m -112.26 121.66 45.55 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.382 -0.826 . . . . 0.19 111.808 -165.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -103.59 148.7 25.68 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.885 -0.598 . . . . 1.0600000000000001 109.515 175.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD23 HD21 ' A' ' 76' ' ' ASN . 3.4 mp -71.56 165.6 23.56 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.955 -0.566 . . . . 0.83999999999999997 111.067 170.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.34 -18.95 12.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.416 0.627 . . . . 1.1399999999999999 110.08 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.496 HD21 HD23 ' A' ' 74' ' ' LEU . 29.5 p30 -92.44 -5.07 52.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.366 -0.833 . . . . 2.1400000000000001 111.133 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.49 -10.74 53.89 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.248 -0.501 . . . . 0.51000000000000001 113.577 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.6 m -78.49 110.45 13.58 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.74 -0.27 . . . . 0.46000000000000002 111.697 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 33.9 mtt180 -71.19 122.25 19.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.476 0.655 . . . . 0.46999999999999997 110.253 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.735 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 32.8 m -108.18 -10.13 10.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.976 -1.011 . . . . 0.27000000000000002 111.625 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 4.5 pt20 -159.96 145.58 15.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.889 -0.596 . . . . 0.58999999999999997 109.501 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 43.8 tt0 -148.96 105.57 3.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.195 0.521 . . . . 1.3400000000000001 109.902 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HB2' HD23 ' A' ' 70' ' ' LEU . 7.1 mm-40 -122.27 117.57 29.28 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.693 -0.685 . . . . 2.5899999999999999 109.435 -175.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -66.5 -19.18 55.02 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.705 2.27 . . . . 0.5 112.182 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -159.54 118.67 2.89 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.269 1.033 . . . . 1.3700000000000001 111.685 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.3 tp -126.07 99.65 6.0 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.174 -1.83 . . . . 0.38 108.423 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.0 p -89.57 134.42 28.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.5 p90 -153.56 162.7 41.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.11 0.481 . . . . 0.23000000000000001 111.168 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 5.1 m -84.09 108.27 16.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.249 -0.887 . . . . 0.41999999999999998 110.063 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.859 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.24 132.52 54.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.59999999999999998 110.152 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.692 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 86.93 4.9 81.67 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.498 -0.858 . . . . 0.37 112.376 175.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 31.4 t70 -117.8 9.3 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.692 -0.485 . . . . 0.93000000000000005 109.692 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p 43.9 42.45 4.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.145 -0.934 . . . . 0.62 110.296 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 48.9 t0 -71.41 -12.29 61.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.766 1.27 . . . . 1.3300000000000001 108.166 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.471 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 4.1 m -123.48 -153.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 113.168 -1.833 . . . . 0.23000000000000001 109.558 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.682 HG13 ' H ' ' A' ' 99' ' ' LEU . 38.9 pt -81.67 142.85 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 107.541 -1.281 . . . . 0.28999999999999998 107.541 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.494 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 3.1 tp-100 -59.96 -34.85 73.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.619 -0.264 . . . . 0.40000000000000002 111.08 -173.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -53.18 -48.79 67.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.204 0.526 . . . . 0.20000000000000001 110.759 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.682 ' H ' HG13 ' A' ' 96' ' ' ILE . 57.8 tp -67.68 -41.91 82.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.184 -0.916 . . . . 0.22 110.534 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.54 -28.01 68.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.923 -1.035 . . . . 0.26000000000000001 109.913 -176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 87.0 mt -89.66 -34.86 16.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.246 -0.888 . . . . 0.25 111.893 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.477 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 60.3 p -70.82 -27.11 63.63 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.635 0.255 . . . . 1.01 110.768 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.613 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.1 t -66.05 -55.33 21.92 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 112.48 0.548 . . . . 0.20999999999999999 112.48 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.676 ' HD3' HD11 ' A' ' 90' ' ' LEU . 21.9 Cg_endo -61.39 -24.64 78.84 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.806 1.67 . . . . 0.27000000000000002 112.112 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.9 mt -77.98 -13.25 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.64000000000000001 111.213 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.799 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -106.9 155.03 20.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.849 -0.614 . . . . 0.78000000000000003 111.077 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.74 155.61 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.711 0.291 . . . . 0.96999999999999997 110.619 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.778 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.1 t -60.5 125.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.80000000000000004 110.659 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.01 5.86 56.19 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.201 -0.909 . . . . 0.28000000000000003 112.499 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -98.45 168.29 10.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.466 0.65 . . . . 0.40999999999999998 111.139 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.524 HG22 HD12 ' A' ' 50' ' ' LEU . 31.6 m -132.69 117.42 17.85 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.995 -1.002 . . . . 0.22 108.479 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -118.54 140.15 50.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.917 -0.583 . . . . 0.17999999999999999 110.564 -176.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 ttm -97.92 117.16 31.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.263 -1.384 . . . . 1.3200000000000001 107.263 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.476 HG22 ' HG3' ' A' ' 47' ' ' LYS . 4.2 t -113.29 132.81 61.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.424 -0.584 . . . . 0.17999999999999999 109.424 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 79.4 m -112.71 113.75 26.01 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.133 0.968 . . . . 0.20999999999999999 109.072 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.46 135.36 53.17 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.434 -1.712 . . . . 0.14999999999999999 109.693 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.75 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.6 t70 -52.33 147.28 8.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.789 -0.819 . . . . 0.57999999999999996 108.789 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.639 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -55.8 -27.92 53.6 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 120.993 0.425 . . . . 0.81999999999999995 110.234 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.599 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.6 ptpt -56.29 -29.28 60.99 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.894 -0.504 . . . . 0.81000000000000005 111.455 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.593 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 85.0 m-85 -97.35 1.72 49.74 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.196 0.522 . . . . 0.41999999999999998 109.9 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.639 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.1 m -122.02 -90.71 0.57 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.954 -1.021 . . . . 0.17999999999999999 110.66 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.659 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 8.1 m-85 -142.9 41.62 1.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.587 -0.445 . . . . 0.23999999999999999 111.921 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.44 -80.82 0.06 OUTLIER Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.09 -0.576 . . . . 0.25 113.4 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.26 10.36 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.478 2.119 . . . . 0.57999999999999996 111.003 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.659 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.2 mt-30 -102.83 -46.45 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.756 -1.111 . . . . 0.65000000000000002 109.876 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.571 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 79.21 142.58 2.42 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.181 -0.918 . . . . 0.29999999999999999 112.634 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.607 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.7 t -90.53 164.57 14.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.218 -0.491 . . . . 0.33000000000000002 111.558 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -56.16 -50.22 71.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.651 -0.704 . . . . 3.1699999999999999 112.065 -173.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.895 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 51.1 m -80.91 -62.4 0.36 Allowed Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.214 -0.594 . . . . 1.23 109.998 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.895 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 22.1 Cg_endo -107.19 127.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.892 2.395 . . . . 0.37 112.541 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.543 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 41.2 t80 -55.97 98.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.863 -1.162 . . . . 1.1399999999999999 107.863 162.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.589 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.2 mm -64.74 133.0 95.59 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.767 . . . . 0.39000000000000001 110.196 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 146.05 37.55 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.622 2.215 . . . . 0.60999999999999999 112.14 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.3 Cg_endo -63.74 135.57 49.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.296 1.998 . . . . 0.52000000000000002 112.387 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.75 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER 70.75 -0.42 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.915 -1.038 . . . . 2.3799999999999999 112.744 178.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -61.12 118.97 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.129 -0.693 . . . . 0.26000000000000001 109.129 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.92 113.09 10.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.422 0.63 . . . . 0.22 109.685 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 115' ' ' THR . 0.9 OUTLIER -88.83 131.07 35.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.86 . . . . 0.22 110.982 -173.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.2 t -114.64 100.38 8.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.57 -0.9 . . . . 1.2 108.57 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.571 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.0 OUTLIER -121.32 135.46 55.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.008 -0.542 . . . . 0.32000000000000001 111.816 -174.358 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 4.8 tt0 -98.0 125.97 43.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.511 -0.768 . . . . 1.05 109.482 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.4 m -124.42 117.14 49.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.31 0.576 . . . . 0.19 112.053 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 24.4 m -89.25 114.8 26.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.365 -0.834 . . . . 0.28000000000000003 110.391 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.697 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 62.0 tp -84.57 100.35 11.35 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.238 -0.653 . . . . 0.14999999999999999 109.238 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 25.8 mtmt -95.08 -25.8 16.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.528 -0.76 . . . . 1.0800000000000001 110.88 -170.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.536 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 14.2 m -157.37 155.25 30.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.115 0.413 . . . . 0.37 112.115 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.564 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.49 127.9 21.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.28 -0.637 . . . . 0.25 109.28 171.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 17.8 m . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.423 . . . . 0.92000000000000004 110.412 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 46' ' ' ARG . 3.8 m0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.765 -0.457 . . . . 0.53000000000000003 109.765 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.07 109.58 4.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.304 -0.628 . . . . 0.5 109.304 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.645 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.2 t70 -78.53 127.19 31.8 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.166 -0.614 . . . . 2.5099999999999998 109.852 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 45' ' ' LEU . 3.3 mt -61.68 -31.1 49.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.702 -1.136 . . . . 0.46000000000000002 110.531 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -115.45 0.54 13.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.9 -0.591 . . . . 0.71999999999999997 110.546 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.645 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.2 25.27 64.36 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.522 -0.763 . . . . 0.52000000000000002 111.552 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -96.03 -26.56 15.49 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.936 0.347 . . . . 0.94999999999999996 111.936 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 105.45 0.86 40.54 Favored Glycine 0 CA--C 1.512 -0.122 0 C-N-CA 120.847 -0.692 . . . . 0.71999999999999997 111.871 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.1 mp -105.49 -32.73 8.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.037 0.446 . . . . 1.5600000000000001 110.873 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 39' ' ' ILE . 19.0 tp -123.12 101.55 7.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 0.32000000000000001 111.572 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 66.4 mtm180 -137.35 148.31 46.18 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.152 -0.342 . . . . 1.1399999999999999 111.449 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HG3' HG22 ' A' ' 114' ' ' VAL . 25.3 ttpt -113.75 132.16 55.93 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.435 -0.209 . . . . 0.34999999999999998 110.435 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.6 ttpt -115.92 129.9 56.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.0700000000000001 110.219 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.466 HG22 ' OE1' ' A' ' 110' ' ' GLU . 5.9 p -82.43 107.67 15.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.163 -0.471 . . . . 0.33000000000000002 111.549 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.486 HD12 HG22 ' A' ' 111' ' ' THR . 6.7 mt -76.04 -54.76 6.37 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.344 -1.354 . . . . 0.28000000000000003 107.344 172.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.814 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 97.7 t -127.24 124.57 23.79 Favored Pre-proline 0 CA--C 1.501 -0.923 0 CA-C-N 113.06 -1.882 . . . . 0.35999999999999999 106.879 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.0 Cg_endo -111.56 88.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.932 2.421 . . . . 0.54000000000000004 114.252 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 CA--C 1.527 0.811 0 CA-C-N 116.387 -0.37 . . . . 0.55000000000000004 113.446 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 113.055 0.761 . . . . 0.98999999999999999 113.055 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -150.0 143.94 25.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.48 -1.304 . . . . 1.28 107.48 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 6.8 mtm-85 -91.15 115.38 64.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.484 -0.486 . . . . 2.8100000000000001 110.638 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.79 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.23 140.26 42.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.98 2.453 . . . . 0.29999999999999999 113.598 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.711 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.3 t -90.91 156.99 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.531 -0.759 . . . . 0.88 109.845 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -66.26 107.89 2.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.408 0.623 . . . . 1.1699999999999999 110.399 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.04 -27.12 2.56 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 110.534 -1.027 . . . . 0.41999999999999998 110.534 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.711 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.1 mm-40 -74.45 140.14 44.43 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.465 -0.569 . . . . 0.58999999999999997 109.465 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.517 ' O ' HG22 ' A' ' 148' ' ' VAL . 69.8 t -86.03 124.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.896 -0.779 . . . . 1.22 108.896 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.6 m -127.79 146.82 32.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 112.296 0.48 . . . . 0.25 112.296 -170.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.0 p -96.46 113.83 25.44 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.767 -0.651 . . . . 0.28999999999999998 110.008 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 99' ' ' LEU . 24.5 m -110.68 142.05 24.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 120.071 -0.652 . . . . 0.19 109.803 172.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.34 112.43 24.94 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.981 -1.859 . . . . 0.19 105.981 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -119.21 133.69 55.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.318 1.056 . . . . 0.39000000000000001 111.097 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.522 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 1.2 mp0 -129.09 114.12 15.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.109 -2.182 . . . . 0.27000000000000002 105.109 167.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.61 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 80.4 m -106.04 126.41 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.745 -1.116 . . . . 0.19 111.279 -166.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.8 t -106.89 157.21 17.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.341 -0.845 . . . . 1.0600000000000001 109.504 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.38 167.12 15.02 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.613 -0.722 . . . . 0.83999999999999997 110.65 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE1' ' HB1' ' A' ' 136' ' ' ALA . 4.6 pm0 -50.81 -24.97 3.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.106 -0.952 . . . . 1.1399999999999999 111.371 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -93.55 -10.25 35.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.036 -0.529 . . . . 2.1400000000000001 111.371 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.48 20.08 20.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.327 -0.94 . . . . 0.51000000000000001 112.492 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.1 m -96.29 109.6 22.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.628 0.251 . . . . 0.46000000000000002 110.72 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.9 mtt180 -76.03 109.94 10.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.736 0.779 . . . . 0.46999999999999997 110.004 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.744 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -95.1 -9.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.36 -1.291 . . . . 0.27000000000000002 111.833 -169.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.61 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 11.7 pt20 -159.69 148.65 17.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.58999999999999997 109.597 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 71' ' ' GLN . 28.7 tt0 -152.65 105.78 3.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.087 0.47 . . . . 1.3400000000000001 110.172 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -124.77 117.15 26.17 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.697 -0.683 . . . . 2.5899999999999999 110.072 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 30.0 Cg_endo -63.97 -17.96 61.85 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.592 2.194 . . . . 0.5 112.103 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.74 106.72 2.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.161 0.982 . . . . 1.3700000000000001 111.699 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.4 tp -115.72 111.84 21.17 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.473 -1.694 . . . . 0.38 107.635 170.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.3 p -109.17 131.05 61.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 110.041 -0.355 . . . . 1.0 110.041 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 31.0 p90 -154.17 163.26 40.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.601 -0.272 . . . . 0.23000000000000001 110.917 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.6 m -82.91 117.75 22.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.915 -0.584 . . . . 0.41999999999999998 109.628 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.945 HD11 ' HD3' ' A' ' 104' ' ' PRO . 13.8 tp -61.45 138.08 58.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.59999999999999998 110.843 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.29 -7.2 61.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.015 -0.612 . . . . 0.37 112.162 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.18 -9.14 55.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.93000000000000005 109.761 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.2 m 60.2 30.31 19.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.178 -0.919 . . . . 0.62 109.54 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.19 -20.63 63.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.542 1.163 . . . . 1.3300000000000001 108.302 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 m -112.88 -158.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 113.279 -1.782 . . . . 0.23000000000000001 110.38 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.654 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.8 pt -79.51 140.29 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.689 -1.226 . . . . 0.28999999999999998 107.689 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.521 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.1 tp-100 -59.88 -30.97 69.36 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.267 0.355 . . . . 0.40000000000000002 110.821 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -54.16 -49.88 68.28 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.373 0.606 . . . . 0.20000000000000001 110.544 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.654 ' H ' HG13 ' A' ' 96' ' ' ILE . 58.4 tp -69.87 -41.68 74.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.832 -1.076 . . . . 0.22 110.294 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.72 -28.42 68.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.831 -1.077 . . . . 0.26000000000000001 109.963 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 80.9 mt -90.84 -34.81 15.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.394 -0.821 . . . . 0.25 112.256 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 79.4 p -70.86 -24.63 62.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.538 -0.301 . . . . 1.01 111.143 -173.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.581 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 53.3 t -72.42 -50.27 8.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 112.793 0.664 . . . . 0.20999999999999999 112.793 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.945 ' HD3' HD11 ' A' ' 90' ' ' LEU . 30.8 Cg_endo -65.01 -20.96 64.08 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 121.553 1.502 . . . . 0.27000000000000002 111.61 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.454 HD11 HG23 ' A' ' 39' ' ' ILE . 15.9 mt -80.94 -18.62 46.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.64000000000000001 110.541 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.724 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 31.8 ttm -90.09 149.84 22.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.78000000000000003 111.104 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.37 147.45 23.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.96999999999999997 110.39 176.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.79 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -60.44 123.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.328 0.585 . . . . 0.80000000000000004 110.68 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.27 56.89 Favored Glycine 0 C--N 1.314 -0.679 0 C-N-CA 120.784 -0.722 . . . . 0.28000000000000003 113.017 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.814 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -99.68 168.78 9.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.253 0.549 . . . . 0.40999999999999998 110.674 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.486 HG22 HD12 ' A' ' 50' ' ' LEU . 11.5 m -127.68 116.87 20.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.461 -1.311 . . . . 0.22 107.461 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.53 139.56 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.076 -0.511 . . . . 0.17999999999999999 110.494 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 ttm -98.44 117.02 31.91 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.328 -1.36 . . . . 1.3200000000000001 107.328 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.683 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.3 t -113.19 131.34 65.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 109.078 -0.712 . . . . 0.17999999999999999 109.078 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.542 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 41.6 m -115.81 113.93 24.06 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 119.278 -0.969 . . . . 0.20999999999999999 109.068 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.42 139.03 53.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.038 -1.892 . . . . 0.14999999999999999 109.739 -176.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 10.1 t70 -53.93 150.8 7.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.407 -0.59 . . . . 0.57999999999999996 109.407 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.595 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 1.9 t -54.81 -30.02 56.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.81999999999999995 110.341 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.639 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -55.53 -30.13 60.15 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 122.229 -0.294 . . . . 0.81000000000000005 111.56 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.532 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 76.6 m-85 -95.87 2.03 53.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.231 0.538 . . . . 0.41999999999999998 110.171 176.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.827 ' HB3' HD22 ' A' ' 138' ' ' LEU . 60.5 m -123.69 -91.05 0.56 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.156 -0.929 . . . . 0.17999999999999999 110.654 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.803 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.9 m-85 -140.15 38.36 1.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.574 0.583 . . . . 0.23999999999999999 112.574 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.48 -78.82 0.08 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.474 0.579 . . . . 0.25 113.628 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -89.64 13.79 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.367 2.044 . . . . 0.57999999999999996 110.559 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.803 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 42.0 mt-30 -104.28 -49.02 3.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.97 -1.014 . . . . 0.65000000000000002 110.464 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.586 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 76.93 142.75 1.48 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.996 -1.002 . . . . 0.29999999999999999 112.905 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.608 ' CB ' HG12 ' A' ' 132' ' ' ILE . 10.3 t -90.68 159.62 16.28 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.042 -0.579 . . . . 0.33000000000000002 112.376 -175.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -52.45 -48.83 65.57 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.016 -0.993 . . . . 3.1699999999999999 111.968 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.966 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 34.6 m -80.59 -67.76 0.22 Allowed Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.453 -0.499 . . . . 1.23 109.946 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.966 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.4 Cg_endo -104.91 127.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.611 2.208 . . . . 0.37 112.091 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.586 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 39.4 t80 -55.67 99.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.194 -1.039 . . . . 1.1399999999999999 108.194 163.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.608 HG12 ' CB ' ' A' ' 127' ' ' SER . 35.1 mm -65.63 129.58 94.37 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.282 -0.872 . . . . 0.39000000000000001 109.726 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.4 Cg_endo -53.52 141.78 61.51 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.828 2.352 . . . . 0.60999999999999999 112.499 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.645 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 35.3 Cg_exo -58.28 131.35 42.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.467 2.111 . . . . 0.52000000000000002 112.52 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.595 ' H ' ' HB3' ' A' ' 118' ' ' SER . 32.2 m170 73.37 9.82 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.916 -1.038 . . . . 2.3799999999999999 112.35 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.68 127.75 33.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.215 -0.661 . . . . 0.26000000000000001 109.215 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.69 111.58 10.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.074 0.464 . . . . 0.22 110.533 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.8 tp -88.4 130.97 35.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.684 -0.689 . . . . 0.22 110.213 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.55 100.85 7.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.707 0.765 . . . . 1.2 110.085 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -109.58 136.7 48.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.96 -1.018 . . . . 0.32000000000000001 112.067 -173.459 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 38.2 tt0 -101.14 118.19 36.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.74 -0.837 . . . . 1.05 108.74 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -121.43 118.15 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.092 0.775 . . . . 0.19 113.092 -173.406 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 2.9 m -90.75 109.31 20.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.709 -0.678 . . . . 0.28000000000000003 110.539 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.724 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 38.3 tp -82.86 102.72 11.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.428 -0.952 . . . . 0.14999999999999999 108.428 172.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -103.53 -19.93 14.21 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.452 -0.795 . . . . 1.0800000000000001 110.901 -170.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 m -156.41 144.94 19.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.37 111.152 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -141.0 128.7 21.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.212 -0.662 . . . . 0.25 109.212 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 65' ' ' VAL . 18.3 m . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.478 -0.489 . . . . 0.92000000000000004 110.7 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.676 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.622 . . . . 0.53000000000000003 110.663 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.75 110.91 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.684 -0.689 . . . . 0.5 110.012 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.665 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.3 t70 -73.83 123.73 24.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.264 -0.574 . . . . 2.5099999999999998 110.086 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 105' ' ' LEU . 9.4 mt -54.51 -37.82 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.053 -0.976 . . . . 0.46000000000000002 111.309 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -111.8 2.89 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.203 -0.453 . . . . 0.71999999999999997 110.617 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.11 22.7 60.91 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.57 -0.741 . . . . 0.52000000000000002 112.066 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -92.16 -27.8 17.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.146 0.424 . . . . 0.94999999999999996 112.146 -176.562 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.52 2.69 37.76 Favored Glycine 0 N--CA 1.454 -0.136 0 C-N-CA 120.926 -0.655 . . . . 0.71999999999999997 112.271 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 3.8 mm? -112.72 -28.38 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.682 0.277 . . . . 1.5600000000000001 110.969 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 39' ' ' ILE . 23.3 tp -122.06 100.33 6.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.32000000000000001 110.989 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -131.98 136.85 47.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.905 0.335 . . . . 1.1399999999999999 111.905 -171.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.8 ttpt -109.01 123.09 48.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.629 -0.508 . . . . 0.34999999999999998 109.629 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.676 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 24.4 ttpp -105.46 110.79 23.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.666 0.269 . . . . 1.0700000000000001 110.538 176.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -70.65 98.99 1.59 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.33000000000000002 110.898 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 111' ' ' THR . 10.7 mt -66.06 -52.54 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.724 -1.584 . . . . 0.28000000000000003 106.724 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.855 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 90.1 t -137.29 131.55 17.6 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 112.982 -1.917 . . . . 0.35999999999999999 106.483 169.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 33.6 Cg_endo -105.65 52.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.704 2.269 . . . . 0.54000000000000004 113.798 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.924 -0.655 . . . . 0.55000000000000004 112.982 175.958 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.474 0.654 . . . . 0.98999999999999999 111.173 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -153.22 137.52 16.6 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.944 -1.132 . . . . 1.28 107.944 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 106' ' ' MET . 40.3 mtm180 -91.67 110.61 44.57 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.696 -0.229 . . . . 2.8100000000000001 110.451 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.842 ' HD3' HG23 ' A' ' 108' ' ' VAL . 12.1 Cg_endo -53.82 149.11 34.62 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.412 2.741 . . . . 0.29999999999999999 112.8 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 2.2 m -102.99 157.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.204 -0.665 . . . . 0.88 109.204 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 56.6 mttp -62.97 119.85 10.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.246 0.546 . . . . 1.1699999999999999 109.749 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.72 -26.75 4.5 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.49 -1.044 . . . . 0.41999999999999998 110.49 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 3.2 mm100 -83.88 127.14 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.884 -1.154 . . . . 0.58999999999999997 107.884 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -80.37 126.75 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.18 -1.044 . . . . 1.22 108.18 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 147' ' ' ALA . 18.2 m -121.89 145.9 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.066 -0.97 . . . . 0.25 110.533 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.675 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 54.4 p -96.92 112.99 24.5 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.28999999999999998 109.778 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.754 HG21 HD21 ' A' ' 99' ' ' LEU . 17.1 m -110.91 145.6 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 C-N-CA 120.228 -0.589 . . . . 0.19 110.697 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.654 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.1 t-160 -102.03 114.87 29.37 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.014 -1.476 . . . . 0.19 107.014 169.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -121.21 133.5 55.17 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.218 1.008 . . . . 0.39000000000000001 110.905 176.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CG ' ' HG2' ' A' ' 82' ' ' GLU . 2.1 mp0 -128.79 113.59 15.5 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.372 -2.084 . . . . 0.27000000000000002 105.372 168.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.635 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 40.1 m -104.4 127.69 52.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.953 -1.021 . . . . 0.19 111.724 -168.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.9 m -103.16 162.17 13.19 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.291 -0.868 . . . . 1.0600000000000001 109.308 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.22 166.14 15.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.739 -1.119 . . . . 0.83999999999999997 109.904 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 9.8 pt-20 -56.97 -21.88 33.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.187 0.518 . . . . 1.1399999999999999 110.296 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.43 -4.47 55.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.909 -0.587 . . . . 2.1400000000000001 111.29 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.98 -23.07 28.46 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.658 -0.782 . . . . 0.51000000000000001 113.567 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 118.02 10.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.391 0.515 . . . . 0.46000000000000002 112.391 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.0 mtt180 -76.38 125.25 28.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.74 0.781 . . . . 0.46999999999999997 111.121 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.702 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -106.76 -9.09 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 0.27000000000000002 111.886 -170.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.635 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.7 pt20 -160.91 145.95 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.828 -0.624 . . . . 0.58999999999999997 109.399 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 71' ' ' GLN . 1.2 tm-20 -150.56 105.53 3.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.347 -0.612 . . . . 1.3400000000000001 109.347 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -125.59 111.15 25.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 2.5899999999999999 110.069 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 24.6 Cg_exo -63.12 -16.63 55.62 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.137 2.558 . . . . 0.5 113.192 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 11.6 tt0 -164.49 100.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.3 1.048 . . . . 1.3700000000000001 111.682 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.0 tp -109.11 110.35 21.57 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 0.38 108.878 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.2 p -102.36 133.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.2 p90 -153.31 157.29 39.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.695 0.283 . . . . 0.23000000000000001 110.622 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -76.67 110.85 11.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.711 -0.677 . . . . 0.41999999999999998 109.646 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.874 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.3 tp -55.03 129.74 39.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.348 -0.387 . . . . 0.59999999999999998 110.862 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.12 2.02 90.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.918 -0.658 . . . . 0.37 112.368 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.16 -7.16 52.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.387 -0.598 . . . . 0.93000000000000005 109.387 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.8 m 60.65 28.77 18.48 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.207 -0.906 . . . . 0.62 110.019 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -63.87 -28.34 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.685 1.231 . . . . 1.3300000000000001 108.633 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 16.0 m -110.15 -153.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 113.329 -1.76 . . . . 0.23000000000000001 111.057 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.3 pt -89.04 139.47 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.548 -1.279 . . . . 0.28999999999999998 107.548 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -59.23 -29.35 67.46 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.458 -0.337 . . . . 0.40000000000000002 110.663 -174.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -55.02 -47.48 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.212 0.53 . . . . 0.20000000000000001 110.477 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.754 HD21 HG21 ' A' ' 68' ' ' VAL . 58.0 tp -78.04 -36.89 47.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.2 -0.909 . . . . 0.22 110.259 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.49 -30.45 71.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.223 -0.899 . . . . 0.26000000000000001 109.588 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.2 mt -91.02 -33.32 15.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.418 -0.81 . . . . 0.25 112.214 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 106' ' ' MET . 34.1 t -67.2 -31.92 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.58 -0.282 . . . . 1.01 111.1 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.534 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.1 t -62.11 -55.45 40.57 Favored Pre-proline 0 C--O 1.219 -0.55 0 N-CA-C 112.309 0.485 . . . . 0.20999999999999999 112.309 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.874 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.9 Cg_endo -62.57 -20.64 71.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 121.747 1.632 . . . . 0.27000000000000002 111.75 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 39' ' ' ILE . 12.1 mt -82.14 -15.15 54.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.584 . . . . 0.64000000000000001 111.299 173.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.759 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -107.41 146.41 31.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.925 -0.58 . . . . 0.78000000000000003 111.095 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.96 157.5 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.18 0.514 . . . . 0.96999999999999997 111.022 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.842 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.3 t -63.97 124.52 18.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.403 0.621 . . . . 0.80000000000000004 110.169 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.68 16.39 45.81 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.067 -0.969 . . . . 0.28000000000000003 112.342 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.855 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.5 pt-20 -105.28 167.98 9.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.334 0.588 . . . . 0.40999999999999998 111.25 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 50' ' ' LEU . 17.8 m -132.98 118.46 18.88 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 173.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.13 140.19 52.84 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.885 -0.598 . . . . 0.17999999999999999 110.327 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.6 ttp -100.61 118.26 36.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.506 -1.294 . . . . 1.3200000000000001 107.506 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.7 t -111.95 131.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.209 -0.45 . . . . 0.17999999999999999 110.086 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 96.1 m -108.16 112.98 25.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.364 -0.976 . . . . 0.20999999999999999 108.364 172.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.62 135.17 52.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.378 -1.283 . . . . 0.14999999999999999 109.399 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.647 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.8 t70 -54.25 149.35 9.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.1 -0.704 . . . . 0.57999999999999996 109.1 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -54.49 -28.49 45.25 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.407 0.442 . . . . 0.81999999999999995 110.351 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.647 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.0 ptpt -54.68 -32.91 60.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.633 -0.258 . . . . 0.81000000000000005 111.463 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.582 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 82.8 m-85 -95.39 1.68 54.31 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.01 0.434 . . . . 0.41999999999999998 110.279 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 70.8 m -120.74 -89.8 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.215 -0.902 . . . . 0.17999999999999999 110.6 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.0 m-85 -144.04 38.78 1.32 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.066 -0.396 . . . . 0.23999999999999999 111.777 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.03 -79.39 0.08 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.215 -0.517 . . . . 0.25 113.636 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -85.02 9.51 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.197 1.931 . . . . 0.57999999999999996 111.044 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -104.0 -50.57 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.994 -1.003 . . . . 0.65000000000000002 109.81 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 79.87 141.53 2.51 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.602 -1.181 . . . . 0.29999999999999999 111.985 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.607 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.1 t -91.29 163.85 14.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.36 -0.42 . . . . 0.33000000000000002 111.374 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -48.82 -69.05 0.13 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.899 0.749 . . . . 3.1699999999999999 111.66 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.987 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.9 m -64.2 -66.37 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 115.675 -0.693 . . . . 1.23 110.608 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.987 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 28.5 Cg_endo -106.94 127.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.5 2.133 . . . . 0.37 112.259 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.572 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 23.5 t80 -57.15 97.34 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.978 -1.119 . . . . 1.1399999999999999 107.978 164.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.593 HG12 ' CB ' ' A' ' 127' ' ' SER . 31.8 mm -65.72 129.84 94.4 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 109.591 -0.522 . . . . 0.39000000000000001 109.591 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.5 Cg_exo -53.76 140.88 66.61 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.59 2.194 . . . . 0.60999999999999999 112.199 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.602 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 44.2 Cg_exo -57.8 131.28 43.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.234 1.956 . . . . 0.52000000000000002 112.292 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.523 ' H ' ' HB3' ' A' ' 118' ' ' SER . 0.2 OUTLIER 75.15 4.68 4.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.14 -0.936 . . . . 2.3799999999999999 112.356 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -70.05 123.3 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.281 -0.637 . . . . 0.26000000000000001 109.281 176.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -75.06 113.58 12.55 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.229 -0.588 . . . . 0.22 110.306 -172.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.614 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.3 tp -90.87 132.81 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.779 -0.646 . . . . 0.22 110.918 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.78 100.75 7.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.183 0.516 . . . . 1.2 109.696 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.583 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -116.19 136.16 53.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.138 -0.483 . . . . 0.32000000000000001 111.836 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 6.4 tt0 -102.05 121.8 42.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.224 -0.658 . . . . 1.05 109.224 178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -118.14 117.56 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.682 0.753 . . . . 0.19 112.52 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.3 m -87.8 115.36 25.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.971 -1.013 . . . . 0.28000000000000003 110.387 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.701 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 42.8 tp -88.87 100.73 13.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.223 -1.028 . . . . 0.14999999999999999 108.223 170.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.622 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -93.75 -23.27 18.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.191 -0.913 . . . . 1.0800000000000001 110.781 -173.103 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.675 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 94.7 m -159.84 144.91 15.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.763 -0.653 . . . . 0.37 111.494 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -136.44 126.92 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.144 -0.688 . . . . 0.25 109.144 170.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 121.126 0.489 . . . . 0.92000000000000004 110.455 -179.097 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.702 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.193 0.521 . . . . 0.53000000000000003 111.327 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 tp -69.4 112.94 6.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.454 -0.794 . . . . 0.5 110.332 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.606 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 t70 -76.41 123.49 26.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.527 0.679 . . . . 2.5099999999999998 109.999 176.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.582 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 4.8 mt -64.18 -30.13 49.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.794 -1.094 . . . . 0.46000000000000002 110.667 -176.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.35 -8.43 19.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.71999999999999997 110.05 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.49 25.3 68.55 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.209 -0.905 . . . . 0.52000000000000002 111.654 -172.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.582 ' ND2' HD13 ' A' ' 44' ' ' LEU . 18.2 p-10 -105.07 -26.95 11.91 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.359 0.503 . . . . 0.94999999999999996 112.359 -177.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.56 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.66 7.51 25.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.308 -0.948 . . . . 0.71999999999999997 112.454 174.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.582 HD13 ' ND2' ' A' ' 42' ' ' ASN . 8.9 mp -110.2 -32.7 6.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.332 0.587 . . . . 1.5600000000000001 110.578 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.582 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 19.4 tp -122.55 104.04 9.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.11 -0.95 . . . . 0.32000000000000001 111.512 -170.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.572 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 77.9 mtm180 -134.63 144.91 48.14 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.942 -0.474 . . . . 1.1399999999999999 112.197 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HG3' HG22 ' A' ' 114' ' ' VAL . 14.8 ttpt -115.34 129.08 56.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.271 -0.27 . . . . 0.34999999999999998 110.271 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.702 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -111.08 120.02 40.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.891 0.377 . . . . 1.0700000000000001 111.109 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 p -72.91 101.03 3.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.747 -0.66 . . . . 0.33000000000000002 111.647 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 111' ' ' THR . 10.9 mt -68.08 -51.39 47.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.895 -1.521 . . . . 0.28000000000000003 106.895 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.849 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 69.0 t -136.58 130.46 17.94 Favored Pre-proline 0 CA--C 1.501 -0.927 0 CA-C-N 112.898 -1.956 . . . . 0.35999999999999999 106.097 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 44.4 Cg_endo -104.21 56.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.743 2.295 . . . . 0.54000000000000004 113.451 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.725 0 CA-C-N 115.564 -0.744 . . . . 0.55000000000000004 112.637 177.442 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 120.941 0.4 . . . . 0.98999999999999999 110.811 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.508 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 19.4 m -145.85 138.02 25.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.745 -0.465 . . . . 1.28 109.745 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 85.2 mtt180 -92.14 116.2 66.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 2.8100000000000001 109.626 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HG3' HD21 ' A' ' 144' ' ' LEU . 9.1 Cg_endo -52.19 155.35 9.28 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.552 2.834 . . . . 0.29999999999999999 113.042 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.604 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 3.9 p -106.82 154.38 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.88 109.935 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.88 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 58.6 mttp -63.49 123.83 19.78 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.568 0.699 . . . . 1.1699999999999999 109.54 178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.24 -9.73 13.48 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 114.799 -1.091 . . . . 0.41999999999999998 110.562 -170.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 2.1 mm-40 -94.45 136.32 34.88 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.948 -0.736 . . . . 0.58999999999999997 109.698 174.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 p -82.87 115.7 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 108.445 -0.946 . . . . 1.22 108.445 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.3 m -117.81 148.76 20.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.595 -0.729 . . . . 0.25 111.156 -170.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.64 HG22 HG12 ' A' ' 87' ' ' VAL . 77.1 p -98.12 113.75 25.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.984 -0.553 . . . . 0.28999999999999998 110.09 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.858 HG21 HD21 ' A' ' 99' ' ' LEU . 28.2 m -111.28 140.44 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 119.641 -0.824 . . . . 0.19 110.762 172.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.599 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.8 t-160 -102.29 115.27 30.21 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.891 -1.522 . . . . 0.19 106.891 168.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.93 HD23 ' HB3' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -124.44 129.46 50.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 118.921 -1.112 . . . . 0.39000000000000001 111.608 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 81' ' ' GLN . 1.5 mp0 -121.79 114.9 21.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.865 -1.902 . . . . 0.27000000000000002 105.865 169.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.592 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 58.9 m -103.31 128.66 50.3 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.676 -1.147 . . . . 0.19 111.562 -167.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.711 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.8 m -103.51 156.8 17.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.129 -0.942 . . . . 1.0600000000000001 108.869 176.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.69 165.34 19.02 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.199 -0.91 . . . . 0.83999999999999997 109.431 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.06 -21.65 23.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.338 0.59 . . . . 1.1399999999999999 110.482 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.94 -5.15 58.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.379 -0.828 . . . . 2.1400000000000001 110.997 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.59 -6.4 57.39 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.979 -0.629 . . . . 0.51000000000000001 112.878 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -81.04 112.95 18.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.786 0.327 . . . . 0.46000000000000002 111.791 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 16.0 mtt180 -75.0 122.62 23.79 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.499 0.666 . . . . 0.46999999999999997 110.747 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.644 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -108.0 -9.93 10.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.695 -1.139 . . . . 0.27000000000000002 112.1 -169.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.592 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.0 pt20 -158.88 133.3 7.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.449 -0.341 . . . . 0.58999999999999997 110.439 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.55 107.11 12.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.309 0.576 . . . . 1.3400000000000001 110.016 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.93 ' HB3' HD23 ' A' ' 70' ' ' LEU . 1.9 tp10 -111.29 105.68 57.0 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.237 -0.892 . . . . 2.5899999999999999 110.332 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.599 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 12.7 Cg_exo -67.91 -22.32 42.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.904 1.736 . . . . 0.5 112.223 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.9 123.09 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.776 0.798 . . . . 1.3700000000000001 111.09 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.622 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 40.8 tp -131.38 105.78 7.83 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.806 -1.543 . . . . 0.38 108.798 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 34.8 m -92.1 139.48 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-O 120.826 0.346 . . . . 1.0 110.492 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.569 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 33.8 p90 -158.36 159.63 36.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.098 -0.501 . . . . 0.23000000000000001 110.567 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 92' ' ' ASP . 7.4 m -77.63 115.99 17.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.607 -0.516 . . . . 0.41999999999999998 109.607 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.88 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.3 tp -56.76 131.41 49.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.558 -0.292 . . . . 0.59999999999999998 110.447 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.08 -3.66 86.85 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.908 -0.663 . . . . 0.37 112.55 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 12.6 t70 -86.34 -12.34 49.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.819 -0.438 . . . . 0.93000000000000005 109.819 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 m 60.38 33.73 20.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.902 -0.777 . . . . 0.62 108.902 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.8 t70 -72.67 -11.9 60.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.341 1.067 . . . . 1.3300000000000001 108.789 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.15 -158.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.502 -1.681 . . . . 0.23000000000000001 110.487 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -81.76 137.62 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.914 -1.143 . . . . 0.28999999999999998 107.914 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -60.48 -28.78 68.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.829 -0.348 . . . . 0.40000000000000002 111.095 -173.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.37 70.56 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.32 0.581 . . . . 0.20000000000000001 110.472 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 68' ' ' VAL . 56.1 tp -80.08 -40.78 26.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.406 -0.815 . . . . 0.22 110.941 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.58 -30.82 70.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.005 -0.998 . . . . 0.26000000000000001 110.018 -174.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.84 -33.24 15.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.25 112.208 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.0 t -64.72 -35.32 80.66 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.76 0.314 . . . . 1.01 111.348 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.569 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 65.7 t -60.72 -55.17 47.49 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.507 0.558 . . . . 0.20999999999999999 112.507 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.873 ' HD3' HD11 ' A' ' 90' ' ' LEU . 27.2 Cg_endo -64.51 -20.46 65.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.865 1.71 . . . . 0.27000000000000002 112.143 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.87 -12.72 59.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.64000000000000001 111.383 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 2.3 ptm -108.95 156.86 19.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 0.78000000000000003 110.625 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.96999999999999997 110.92 179.057 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.3 p -65.88 126.82 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.749 0.785 . . . . 0.80000000000000004 110.29 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.37 7.4 62.04 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 114.75 -1.113 . . . . 0.28000000000000003 112.723 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.849 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.9 pt-20 -95.44 167.75 11.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.483 0.659 . . . . 0.40999999999999998 111.839 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.431 HG22 HD12 ' A' ' 50' ' ' LEU . 5.3 m -126.06 116.96 22.22 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.838 -1.171 . . . . 0.22 107.838 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.9 134.97 55.07 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.123 0.487 . . . . 0.17999999999999999 110.813 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.1 ttm -97.54 117.88 32.79 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.381 -1.34 . . . . 1.3200000000000001 107.381 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.8 t -112.85 130.31 66.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.417 -0.586 . . . . 0.17999999999999999 109.417 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.569 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 78.9 m -110.29 112.75 24.9 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 119.146 -1.022 . . . . 0.20999999999999999 108.365 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.23 135.04 52.16 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.963 -1.471 . . . . 0.14999999999999999 109.91 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.625 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 9.6 t70 -52.36 147.94 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.819 -0.808 . . . . 0.57999999999999996 108.819 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.637 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.9 t -56.35 -26.29 52.18 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.013 0.435 . . . . 0.81999999999999995 110.218 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.625 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -57.86 -29.96 65.43 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.762 -0.586 . . . . 0.81000000000000005 111.394 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 81.9 m-85 -93.46 -2.11 54.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.543 0.687 . . . . 0.41999999999999998 110.221 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.648 ' HB3' HD22 ' A' ' 138' ' ' LEU . 64.7 m -119.53 -90.95 0.56 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.725 -1.125 . . . . 0.17999999999999999 110.416 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.645 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.1 m-85 -145.81 43.06 1.25 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.337 -0.545 . . . . 0.23999999999999999 112.266 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -54.42 -87.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.056 -0.593 . . . . 0.25 113.361 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.14 10.38 2.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.373 2.048 . . . . 0.57999999999999996 111.046 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.645 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -103.47 -45.85 4.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.65000000000000002 110.245 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.547 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 76.01 143.39 1.28 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.911 -1.041 . . . . 0.29999999999999999 112.546 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.666 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 13.0 t -91.89 164.05 13.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.987 0.422 . . . . 0.33000000000000002 111.639 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -58.14 -45.64 87.02 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.249 -0.887 . . . . 3.1699999999999999 112.02 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.904 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 58.4 m -87.46 -60.26 0.26 Allowed Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 120.805 -0.358 . . . . 1.23 110.269 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.1 Cg_endo -107.58 126.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.541 2.161 . . . . 0.37 111.899 171.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 20.6 t80 -58.14 97.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.862 -1.162 . . . . 1.1399999999999999 107.862 165.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.587 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.1 mm -64.3 127.88 92.59 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.756 -0.656 . . . . 0.39000000000000001 110.013 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.0 Cg_endo -50.05 136.79 37.21 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.21 2.607 . . . . 0.60999999999999999 111.87 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.567 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 31.2 Cg_exo -58.54 132.17 46.8 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.523 2.149 . . . . 0.52000000000000002 112.08 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 30.2 m170 77.0 0.21 3.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.912 -1.04 . . . . 2.3799999999999999 112.284 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.76 122.17 17.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.468 -0.493 . . . . 0.26000000000000001 109.686 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.5 112.81 9.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.336 0.589 . . . . 0.22 109.634 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -88.05 132.32 34.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.605 -0.725 . . . . 0.22 110.552 -176.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.6 t -115.08 99.54 7.52 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.755 -0.832 . . . . 1.2 108.755 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.8 OUTLIER -113.95 134.12 55.04 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.289 0.566 . . . . 0.32000000000000001 111.599 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 57.6 tt0 -99.56 112.71 24.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 1.05 109.459 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.686 HG11 HD13 ' A' ' 99' ' ' LEU . 6.8 m -109.44 123.15 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.53 0.681 . . . . 0.19 111.86 -177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -96.59 111.01 23.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.126 -0.943 . . . . 0.28000000000000003 110.167 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.65 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 58.1 tp -82.74 100.81 10.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.689 -0.856 . . . . 0.14999999999999999 108.689 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -99.33 -21.38 16.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.631 -0.713 . . . . 1.0800000000000001 110.653 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.8 m -158.12 147.02 19.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.848 -0.341 . . . . 0.37 111.408 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.74 127.68 33.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.25 109.225 169.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 109.307 -0.627 . . . . 0.92000000000000004 109.307 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.531 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.198 0.523 . . . . 0.53000000000000003 110.932 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.1 tp -70.47 111.83 6.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.506 -0.77 . . . . 0.5 110.621 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.592 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.7 t70 -73.06 131.88 42.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.586 0.708 . . . . 2.5099999999999998 110.678 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.5 mt -65.25 -34.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.612 -1.176 . . . . 0.46000000000000002 111.137 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.44 -2.35 20.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.503 0.668 . . . . 0.71999999999999997 109.71 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.88 24.26 68.21 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.879 -1.055 . . . . 0.52000000000000002 111.986 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.536 ' ND2' HD13 ' A' ' 44' ' ' LEU . 19.4 p-10 -100.11 -30.36 11.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.436 0.532 . . . . 0.94999999999999996 112.436 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 116.38 -0.98 20.62 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.717 -0.754 . . . . 0.71999999999999997 112.303 172.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD13 ' ND2' ' A' ' 42' ' ' ASN . 6.7 mp -100.98 -36.52 8.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.592 0.711 . . . . 1.5600000000000001 111.085 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 116' ' ' ALA . 12.0 tp -122.22 104.82 9.71 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.838 -1.074 . . . . 0.32000000000000001 111.112 -169.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -132.16 138.65 48.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 1.1399999999999999 111.856 -170.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -112.19 126.32 55.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.645 -0.252 . . . . 0.34999999999999998 110.54 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 39.0 ttpt -113.3 115.56 28.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 1.0700000000000001 110.885 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -74.17 103.11 4.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.33000000000000002 111.025 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD12 HG22 ' A' ' 111' ' ' THR . 7.6 mt -68.92 -56.08 8.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.656 -1.609 . . . . 0.28000000000000003 106.656 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 64.8 t -128.85 125.81 23.06 Favored Pre-proline 0 CA--C 1.499 -1.013 0 CA-C-N 113.125 -1.852 . . . . 0.35999999999999999 106.62 168.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 45.9 Cg_endo -105.02 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.949 2.433 . . . . 0.54000000000000004 113.413 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.55000000000000004 113.328 177.074 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 121.177 0.513 . . . . 0.98999999999999999 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.616 ' H ' HG12 ' A' ' 108' ' ' VAL . 23.7 m -135.62 127.17 28.8 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.004 -0.739 . . . . 1.28 109.004 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 4.0 ptt-85 -91.07 108.77 30.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 120.906 0.384 . . . . 2.8100000000000001 109.991 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.2 Cg_endo -51.07 159.3 2.69 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.155 3.237 . . . . 0.29999999999999999 114.571 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.7 t -98.17 156.22 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.097 -0.956 . . . . 0.88 109.703 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.992 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -73.72 121.43 20.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.603 0.716 . . . . 1.1699999999999999 109.632 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.71 -18.76 5.95 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.049 -1.221 . . . . 0.41999999999999998 110.049 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -92.44 141.05 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.445 -0.946 . . . . 0.58999999999999997 108.445 173.575 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 26.8 m -87.63 128.56 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.456 -0.898 . . . . 1.22 108.658 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -123.1 145.8 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.804 -1.089 . . . . 0.25 110.852 -173.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 66.9 p -89.84 115.81 27.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.013 0.435 . . . . 0.28999999999999998 110.117 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 99' ' ' LEU . 18.1 m -109.36 144.06 18.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.597 -0.841 . . . . 0.19 109.283 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.693 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.0 t-160 -103.96 118.98 37.95 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.463 -1.68 . . . . 0.19 106.463 169.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -122.08 133.73 54.77 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 118.847 -1.141 . . . . 0.39000000000000001 111.026 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' GLN . 1.7 mp0 -127.75 113.57 16.16 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.419 -2.067 . . . . 0.27000000000000002 105.419 167.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.594 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 84.8 m -104.81 126.48 51.92 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.477 -1.238 . . . . 0.19 111.43 -166.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -107.24 147.71 29.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.147 -0.933 . . . . 1.0600000000000001 109.511 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.71 165.79 24.09 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.732 -0.667 . . . . 0.83999999999999997 110.013 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.89 -22.79 27.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 1.1399999999999999 110.5 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -83.03 -8.33 59.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.242 -0.89 . . . . 2.1400000000000001 110.884 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.38 60.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.959 -0.639 . . . . 0.51000000000000001 112.089 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.5 m -81.33 110.14 16.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.72 0.295 . . . . 0.46000000000000002 111.397 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.6 mtt180 -74.37 121.46 21.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.834 0.826 . . . . 0.46999999999999997 110.82 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.752 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.7 m -105.22 -9.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.359 -1.291 . . . . 0.27000000000000002 111.984 -169.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.594 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.4 pt20 -159.94 132.41 6.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.184 -0.462 . . . . 0.58999999999999997 110.628 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 45.5 tt0 -127.78 109.52 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.484 . . . . 1.3400000000000001 109.828 171.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.45 109.1 26.39 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.576 -0.738 . . . . 2.5899999999999999 109.892 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.615 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 72.7 Cg_endo -68.19 -17.96 45.17 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.778 2.985 . . . . 0.5 113.454 -172.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.34 111.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.167 0.984 . . . . 1.3700000000000001 111.04 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.9 tp -128.56 97.88 4.84 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.347 -1.751 . . . . 0.38 109.043 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.6 p -89.73 130.96 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.115 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.0 p90 -151.83 158.15 42.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.23000000000000001 110.664 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.2 m -76.2 110.93 11.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.41999999999999998 110.283 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.992 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 14.1 tp -58.18 128.58 37.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.955 -0.566 . . . . 0.59999999999999998 110.382 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.638 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.68 7.92 83.61 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.716 -0.754 . . . . 0.37 112.419 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.6 6.0 23.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.577 -0.527 . . . . 0.93000000000000005 109.577 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.52 32.98 20.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.136 -0.938 . . . . 0.62 110.385 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 26.0 t0 -75.49 -4.21 38.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.341 1.067 . . . . 1.3300000000000001 109.335 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.2 m -135.24 -155.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.037 -1.438 . . . . 0.23000000000000001 110.602 -175.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 34.4 pt -83.56 135.75 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.296 -1.372 . . . . 0.28999999999999998 107.296 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp-100 -59.22 -31.19 68.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.472 -0.331 . . . . 0.40000000000000002 111.382 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.87 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.23 0.538 . . . . 0.20000000000000001 110.354 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 68' ' ' VAL . 58.6 tp -73.64 -41.41 62.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 0.22 110.496 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.95 -27.74 69.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.963 -1.017 . . . . 0.26000000000000001 110.098 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 64.8 mt -90.13 -36.41 14.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.194 -0.912 . . . . 0.25 111.91 176.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -37.58 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 1.01 111.107 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.549 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 64.0 t -60.51 -55.79 41.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.0 0.741 . . . . 0.20999999999999999 113.0 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.792 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.1 Cg_endo -61.69 -25.06 78.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.092 1.862 . . . . 0.27000000000000002 111.849 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.0 mt -80.06 -11.89 59.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.64000000000000001 111.593 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.664 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.2 153.81 23.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.307 -0.406 . . . . 0.78000000000000003 111.23 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.43 158.59 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 0.96999999999999997 110.593 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 58' ' ' SER . 1.5 p -66.16 128.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.84 0.829 . . . . 0.80000000000000004 110.378 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.4 4.62 59.49 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.909 -1.041 . . . . 0.28000000000000003 112.15 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.821 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -98.06 165.12 12.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.383 0.611 . . . . 0.40999999999999998 111.534 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.481 HG22 HD12 ' A' ' 50' ' ' LEU . 54.6 m -130.76 117.95 20.15 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.739 -1.119 . . . . 0.22 108.263 175.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.62 140.24 50.91 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.889 -0.596 . . . . 0.17999999999999999 110.618 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.9 ttm -98.91 117.46 33.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.181 -1.415 . . . . 1.3200000000000001 107.181 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.46 128.78 74.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.66 -0.496 . . . . 0.17999999999999999 109.66 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.53 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 52.9 m -109.29 113.85 27.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.77 -0.772 . . . . 0.20999999999999999 109.163 174.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -122.47 139.91 53.34 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.892 -1.504 . . . . 0.14999999999999999 110.05 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.8 t70 -52.29 146.48 9.25 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.711 -0.848 . . . . 0.57999999999999996 108.711 171.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.588 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.2 t -55.18 -26.98 42.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.81999999999999995 110.171 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.3 ptpt -55.3 -32.26 62.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.554 -0.294 . . . . 0.81000000000000005 111.426 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.554 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.7 m-85 -95.3 6.17 49.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.171 0.51 . . . . 0.41999999999999998 110.196 176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -124.74 -90.82 0.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.831 -1.077 . . . . 0.17999999999999999 110.489 -176.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.557 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.2 m-85 -143.75 37.72 1.33 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.978 0.353 . . . . 0.23999999999999999 111.831 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.11 -78.51 0.09 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.471 -0.395 . . . . 0.25 113.83 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.48 8.68 4.45 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.15 1.9 . . . . 0.57999999999999996 111.015 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -103.9 -50.12 3.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.435 -0.802 . . . . 0.65000000000000002 110.135 -172.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . 80.28 143.53 3.27 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.571 -1.195 . . . . 0.29999999999999999 111.753 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 12.1 t -89.82 158.4 17.5 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.505 -0.348 . . . . 0.33000000000000002 111.281 -177.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -58.81 -37.31 76.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.632 -0.713 . . . . 3.1699999999999999 111.738 -170.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.937 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 7.0 m -91.44 -60.71 0.21 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.598 -0.519 . . . . 1.23 109.598 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.937 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -107.41 126.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.808 2.339 . . . . 0.37 112.307 170.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CD1' ' HA3' ' A' ' 126' ' ' GLY . 64.6 t80 -57.61 97.5 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.361 -0.977 . . . . 1.1399999999999999 108.361 164.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.592 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.43 128.36 93.81 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.441 -0.8 . . . . 0.39000000000000001 109.522 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.7 Cg_exo -53.44 140.57 63.63 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.536 2.157 . . . . 0.60999999999999999 112.286 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.9 Cg_exo -57.97 134.81 64.74 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.254 1.969 . . . . 0.52000000000000002 112.079 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.435 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 18.6 m80 70.42 5.18 5.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.0 -1.0 . . . . 2.3799999999999999 112.661 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -68.88 122.34 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.307 -0.627 . . . . 0.26000000000000001 109.307 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.73 111.81 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.303 0.573 . . . . 0.22 109.583 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.66 131.32 36.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.834 -0.621 . . . . 0.22 111.063 -175.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.7 t -117.44 101.61 8.53 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.844 0.831 . . . . 1.2 109.55 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.9 OUTLIER -114.05 136.6 52.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.84 -1.073 . . . . 0.32000000000000001 111.702 -171.569 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 55.0 tt0 -101.28 117.11 34.32 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.082 -0.71 . . . . 1.05 109.082 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.777 HG11 HD13 ' A' ' 99' ' ' LEU . 5.5 m -116.15 121.95 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.367 0.603 . . . . 0.19 112.31 -175.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 5.9 m -96.71 114.47 26.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.28000000000000003 111.281 173.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.65 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 52.0 tp -84.5 102.18 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.626 -0.879 . . . . 0.14999999999999999 108.626 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HE3' ' O ' ' A' ' 84' ' ' PRO . 19.2 mtmm -105.06 -20.23 13.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.79 -0.641 . . . . 1.0800000000000001 111.019 -169.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.401 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.7 m -156.51 148.73 23.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.767 -0.651 . . . . 0.37 110.599 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.518 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -145.61 128.47 16.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.761 -0.829 . . . . 0.25 108.761 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 20.6 m . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 119.86 -0.736 . . . . 0.92000000000000004 111.715 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.695 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.594 0.711 . . . . 0.53000000000000003 112.422 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -69.09 111.93 5.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.5 111.037 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.725 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -64.51 101.53 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.084 -0.962 . . . . 2.5099999999999998 110.599 173.313 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.609 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.9 mt -54.07 -44.08 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.141 -0.936 . . . . 0.46000000000000002 112.009 -174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.484 HD21 HD13 ' A' ' 101' ' ' LEU . 86.5 mt -109.84 12.64 23.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.71999999999999997 110.525 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.725 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 70.66 0.12 30.49 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.52000000000000002 113.02 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.673 ' ND2' ' HB2' ' A' ' 44' ' ' LEU . 29.4 p-10 -81.06 -30.26 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.765 0.283 . . . . 0.94999999999999996 111.765 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.19 63.69 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.71999999999999997 112.311 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 2.3 mm? -79.04 -31.54 44.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.886 0.851 . . . . 1.5600000000000001 109.06 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 13.9 tp -119.31 114.01 21.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.087 -1.415 . . . . 0.32000000000000001 110.13 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 mtm180 -140.51 140.8 35.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.675 -0.239 . . . . 1.1399999999999999 111.37 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' HD11 ' A' ' 39' ' ' ILE . 11.1 ttpt -108.45 125.59 51.95 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.393 0.433 . . . . 0.34999999999999998 110.462 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.695 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.1 ttpt -107.63 113.67 27.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.164 -0.309 . . . . 1.0700000000000001 110.164 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -76.47 99.34 4.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.425 -0.352 . . . . 0.33000000000000002 110.931 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD21 ' HE3' ' A' ' 48' ' ' LYS . 15.5 mt -63.84 -50.67 67.96 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.926 -1.509 . . . . 0.28000000000000003 106.926 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.871 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 82.0 t -139.38 133.73 16.11 Favored Pre-proline 0 CA--C 1.502 -0.869 0 CA-C-N 113.303 -1.771 . . . . 0.35999999999999999 106.389 169.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 42.7 Cg_endo -107.63 64.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.749 2.299 . . . . 0.54000000000000004 113.446 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.07 0 CA-C-N 115.53 -0.759 . . . . 0.55000000000000004 112.504 178.746 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 108.872 -0.788 . . . . 0.98999999999999999 108.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 108' ' ' VAL . 17.9 t -128.22 -177.32 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.256 -1.016 . . . . 1.28 108.256 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 14.1 mtm180 -130.91 120.55 18.48 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.562 -0.533 . . . . 2.8100000000000001 109.562 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.4 Cg_endo -51.15 138.08 45.06 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.247 2.631 . . . . 0.29999999999999999 113.306 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.666 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.8 t -90.1 154.93 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.597 -0.729 . . . . 0.88 109.196 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.649 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 59.1 mttt -66.64 108.55 2.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.452 0.644 . . . . 1.1699999999999999 111.037 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.37 2.45 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.429 -1.259 . . . . 0.41999999999999998 110.287 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.1 mm-40 -76.27 138.71 40.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.855 -0.795 . . . . 0.58999999999999997 108.855 177.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -88.54 129.29 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.008 -1.108 . . . . 1.22 108.008 172.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.7 m -125.79 147.86 30.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.43 -0.804 . . . . 0.25 110.965 -171.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.509 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 26.6 p -96.32 113.37 24.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.979 -0.555 . . . . 0.28999999999999998 109.967 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.548 HG21 HD21 ' A' ' 99' ' ' LEU . 23.9 m -110.47 143.97 19.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.27 0.557 . . . . 0.19 110.336 174.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.58 112.1 24.7 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.106 -1.442 . . . . 0.19 107.106 169.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 83' ' ' GLU . 1.7 pt? -116.06 136.59 52.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.93 0.872 . . . . 0.39000000000000001 110.808 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.531 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.4 mp0 -135.21 116.58 14.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 105.702 -1.962 . . . . 0.27000000000000002 105.702 169.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.602 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 62.6 m -109.28 123.67 49.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.876 -1.056 . . . . 0.19 111.418 -165.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.773 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.62 149.49 25.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.429 -0.805 . . . . 1.0600000000000001 109.276 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.543 ' HG ' HG13 ' A' ' 80' ' ' VAL . 8.0 mt -77.53 166.83 22.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.749 -0.659 . . . . 0.83999999999999997 110.804 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.35 -23.89 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.493 0.663 . . . . 1.1399999999999999 110.4 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -82.55 -11.3 58.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.352 -0.84 . . . . 2.1400000000000001 110.76 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.43 59.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.142 -0.551 . . . . 0.51000000000000001 111.86 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 m -75.12 110.63 9.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.991 0.367 . . . . 0.46000000000000002 111.991 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.773 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.5 mtt180 -73.1 117.57 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.46999999999999997 110.804 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.686 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.7 m -98.96 -10.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.27000000000000002 112.081 -171.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.602 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.6 pt20 -159.99 141.25 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.677 -0.692 . . . . 0.58999999999999997 109.31 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 14.4 tt0 -145.56 103.89 3.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.367 0.603 . . . . 1.3400000000000001 109.657 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.623 ' HB2' HD23 ' A' ' 70' ' ' LEU . 4.1 mm-40 -118.56 115.16 35.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.203 -0.908 . . . . 2.5899999999999999 109.887 -173.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 47.1 Cg_endo -69.06 -14.51 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.377 2.051 . . . . 0.5 113.044 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -166.98 114.86 0.82 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.861 0.839 . . . . 1.3700000000000001 111.817 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.4 tp -123.97 112.18 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.604 -1.634 . . . . 0.38 108.802 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.4 p -103.23 128.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.785 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 47.2 p90 -148.75 159.83 43.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 0.23000000000000001 111.698 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 1.7 m -78.45 109.07 12.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.839 . . . . 0.41999999999999998 110.546 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.816 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.4 tp -61.56 127.9 33.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.474 -0.33 . . . . 0.59999999999999998 110.661 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.649 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 83.91 11.72 78.55 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.835 -0.698 . . . . 0.37 112.689 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 34.3 t70 -115.44 10.0 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.331 0.586 . . . . 0.93000000000000005 109.605 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.5 m 54.39 39.15 30.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.62 109.438 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.785 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -70.63 -12.78 61.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.092 -1.077 . . . . 1.3300000000000001 108.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 11.0 m -137.61 -159.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 113.758 -1.565 . . . . 0.23000000000000001 110.578 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.7 pt -79.23 140.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.709 -1.219 . . . . 0.28999999999999998 107.709 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.439 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.8 tp-100 -59.66 -31.2 69.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.407 -0.361 . . . . 0.40000000000000002 110.987 -173.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.96 -43.0 69.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.237 0.542 . . . . 0.20000000000000001 110.422 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 142' ' ' VAL . 50.4 tp -78.01 -41.38 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.459 -0.791 . . . . 0.22 110.897 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.28 -29.67 68.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.328 -0.851 . . . . 0.26000000000000001 110.123 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.484 HD13 HD21 ' A' ' 40' ' ' LEU . 73.3 mt -90.03 -33.3 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.414 -0.812 . . . . 0.25 111.92 176.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 106' ' ' MET . 40.0 t -66.28 -34.2 77.46 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.718 0.294 . . . . 1.01 110.888 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.609 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.3 t -64.0 -55.61 31.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.813 0.671 . . . . 0.20999999999999999 112.813 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.816 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.8 Cg_endo -62.5 -22.39 73.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.91 1.74 . . . . 0.27000000000000002 112.049 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.5 mt -79.56 -16.89 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.64000000000000001 111.275 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.574 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -104.43 157.24 17.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.095 -0.502 . . . . 0.78000000000000003 111.315 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.5 m-20 -94.54 155.1 17.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.982 0.42 . . . . 0.96999999999999997 111.17 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 58' ' ' SER . 40.0 t -60.89 125.16 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.581 0.705 . . . . 0.80000000000000004 110.394 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.47 14.74 56.65 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 115.172 -0.922 . . . . 0.28000000000000003 112.453 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.871 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -101.42 168.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.339 0.59 . . . . 0.40999999999999998 111.433 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.442 HG22 HD12 ' A' ' 50' ' ' LEU . 9.4 m -130.59 117.24 19.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.066 -1.087 . . . . 0.22 108.066 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -121.43 136.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.052 0.453 . . . . 0.17999999999999999 110.653 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 ttm -99.49 116.86 32.61 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.528 -1.286 . . . . 1.3200000000000001 107.528 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.416 HG22 ' HG3' ' A' ' 47' ' ' LYS . 3.4 t -113.81 127.67 71.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.945 -0.761 . . . . 0.17999999999999999 108.945 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.582 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 38.6 m -107.14 114.19 28.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.345 -0.942 . . . . 0.20999999999999999 108.94 175.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -122.14 136.43 54.91 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.749 -1.568 . . . . 0.14999999999999999 109.93 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.715 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.3 t70 -53.33 149.33 7.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.792 -0.818 . . . . 0.57999999999999996 108.792 172.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.63 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.8 t -55.0 -27.24 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.258 0.551 . . . . 0.81999999999999995 110.549 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.715 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.9 ptpt -54.15 -35.95 62.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.293 -0.412 . . . . 0.81000000000000005 111.515 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.553 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 99.2 m-85 -95.77 3.48 53.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.41999999999999998 110.304 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.761 ' HB3' HD22 ' A' ' 138' ' ' LEU . 68.2 m -119.45 -91.03 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.033 -0.985 . . . . 0.17999999999999999 110.572 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.685 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 7.6 m-85 -145.57 40.69 1.2 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.255 0.465 . . . . 0.23999999999999999 112.255 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.5 -84.41 0.03 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.341 0.518 . . . . 0.25 113.647 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -81.84 11.12 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.364 2.043 . . . . 0.57999999999999996 110.696 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.685 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.7 mt-30 -104.24 -50.19 3.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.203 -0.908 . . . . 0.65000000000000002 110.125 -174.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.627 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.03 141.6 3.09 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.731 -1.122 . . . . 0.29999999999999999 112.613 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.0 t -92.28 165.38 13.13 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.232 -0.484 . . . . 0.33000000000000002 111.373 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.709 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 2.6 mmp_? -54.79 -60.7 3.0 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.59 -0.732 . . . . 3.1699999999999999 112.197 -176.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.843 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 17.5 t -76.57 -58.06 1.19 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 116.142 -0.481 . . . . 1.23 109.871 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.4 Cg_endo -108.73 126.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.521 2.147 . . . . 0.37 112.25 171.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.627 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.9 t80 -57.0 99.37 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.59 -1.263 . . . . 1.1399999999999999 107.59 163.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.606 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.2 mm -65.61 128.54 93.88 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.39000000000000001 110.188 -177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.0 Cg_exo -54.29 141.63 70.58 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.724 2.283 . . . . 0.60999999999999999 112.051 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 Cg_exo -57.67 130.55 39.28 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.332 2.021 . . . . 0.52000000000000002 112.068 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.552 ' H ' ' HB3' ' A' ' 118' ' ' SER . 13.6 m-70 74.1 7.79 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.831 -1.077 . . . . 2.3799999999999999 113.105 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.48 ' N ' ' HB2' ' A' ' 118' ' ' SER . . . -68.9 120.59 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.503 -0.554 . . . . 0.26000000000000001 109.503 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.32 113.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.171 0.51 . . . . 0.22 109.809 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.761 HD22 ' HB3' ' A' ' 121' ' ' CYS . 2.2 mp -90.87 129.81 36.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.847 -0.615 . . . . 0.22 111.009 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.47 ' SG ' HG23 ' A' ' 115' ' ' THR . 35.2 m -112.55 98.91 7.56 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -108.46 134.96 50.52 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.793 -0.639 . . . . 0.32000000000000001 111.595 -174.338 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 43.2 tt0 -102.73 116.26 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.146 -0.687 . . . . 1.05 109.146 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.622 HG11 HD13 ' A' ' 99' ' ' LEU . 3.9 m -115.69 119.35 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.561 0.696 . . . . 0.19 112.758 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.7 m -90.32 110.48 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.28000000000000003 110.271 171.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.574 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 61.7 tp -82.82 97.85 8.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.651 -0.87 . . . . 0.14999999999999999 108.651 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.2 mtmt -94.57 -29.11 15.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 1.0800000000000001 110.597 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.509 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.9 m -153.53 149.31 27.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.466 -0.334 . . . . 0.37 111.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.496 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -140.12 127.99 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.27 -0.641 . . . . 0.25 109.27 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.44 0.638 . . . . 0.92000000000000004 111.357 -178.032 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.631 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.087 -0.709 . . . . 0.53000000000000003 109.087 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.44 109.99 7.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.894 0.378 . . . . 0.5 110.674 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.644 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -64.9 96.77 0.2 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.652 -0.704 . . . . 2.5099999999999998 111.499 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.732 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 15.1 mt -51.81 -53.08 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.46000000000000002 110.38 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.885 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -78.71 -16.98 56.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.15 -1.386 . . . . 0.71999999999999997 110.163 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.644 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 72.37 8.34 70.48 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.404 -0.816 . . . . 0.52000000000000002 111.674 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 44' ' ' LEU . 7.2 p-10 -106.41 -9.14 16.84 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.568 0.223 . . . . 0.94999999999999996 111.51 -178.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.85 -22.38 28.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.346 -0.931 . . . . 0.71999999999999997 113.238 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.581 ' HB2' HD22 ' A' ' 42' ' ' ASN . 4.2 mm? -80.09 -22.51 42.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.577 0.704 . . . . 1.5600000000000001 109.235 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.885 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 26.3 tp -120.51 110.39 16.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 0.32000000000000001 110.679 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.643 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 42.8 mtm105 -143.75 140.41 29.93 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.223 0.327 . . . . 1.1399999999999999 111.544 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.754 ' HG3' HG22 ' A' ' 114' ' ' VAL . 7.3 ttpp -116.95 127.8 54.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.16 0.184 . . . . 0.34999999999999998 110.553 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.631 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.9 ttpt -103.67 130.37 51.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.804 0.335 . . . . 1.0700000000000001 110.986 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 1.5 p -80.49 94.67 6.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.847 -0.615 . . . . 0.33000000000000002 110.381 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 111' ' ' THR . 12.5 mt -63.78 -52.77 58.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.014 -1.476 . . . . 0.28000000000000003 107.014 173.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.795 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 73.6 t -134.63 124.61 17.02 Favored Pre-proline 0 CA--C 1.494 -1.195 0 CA-C-N 113.362 -1.745 . . . . 0.35999999999999999 106.599 168.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 68.3 Cg_endo -105.6 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.623 2.215 . . . . 0.54000000000000004 113.593 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.533 ' HA3' ' OD2' ' A' ' 107' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.557 0 CA-C-N 115.201 -0.909 . . . . 0.55000000000000004 114.207 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 121.236 0.541 . . . . 0.98999999999999999 111.639 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.25 -0.886 . . . . 1.28 108.791 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -91.06 119.14 68.89 Favored Pre-proline 0 C--N 1.319 -0.732 0 C-N-CA 120.792 -0.363 . . . . 2.8100000000000001 110.59 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD3' HG23 ' A' ' 108' ' ' VAL . 11.3 Cg_endo -53.16 149.43 28.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.603 2.869 . . . . 0.29999999999999999 113.318 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.6 t -100.02 151.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.974 -0.557 . . . . 0.88 109.737 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 59.7 mttt -61.72 112.83 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.652 0.739 . . . . 1.1699999999999999 110.875 177.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.76 -30.0 2.91 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 114.165 -1.38 . . . . 0.41999999999999998 110.186 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 2.3 mm-40 -72.39 139.17 47.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.158 -0.617 . . . . 0.58999999999999997 110.202 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.512 ' O ' HG22 ' A' ' 148' ' ' VAL . 40.9 t -80.81 117.14 26.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.503 -0.925 . . . . 1.22 108.503 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -125.47 150.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.782 0.66 . . . . 0.25 112.782 -170.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 145' ' ' LYS . 0.8 OUTLIER -98.43 121.8 40.81 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.696 -1.138 . . . . 0.28999999999999998 110.41 174.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 99' ' ' LEU . 30.1 m -118.33 147.73 21.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.341 -0.543 . . . . 0.19 110.106 168.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.733 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.04 117.34 34.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.752 -1.573 . . . . 0.19 106.752 167.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -118.33 138.63 52.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.204 -0.999 . . . . 0.39000000000000001 111.004 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.548 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 1.3 mp0 -135.77 113.91 11.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.194 -2.15 . . . . 0.27000000000000002 105.194 165.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.618 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 72.0 m -102.73 127.3 49.93 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.738 -1.119 . . . . 0.19 111.076 -167.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.706 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 t -109.04 159.44 16.84 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.396 -0.82 . . . . 1.0600000000000001 109.358 -177.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.74 164.53 18.49 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.694 -0.684 . . . . 0.83999999999999997 109.303 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -52.19 -24.12 6.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.518 0.675 . . . . 1.1399999999999999 110.58 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -94.46 -7.33 41.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.062 -0.972 . . . . 2.1400000000000001 111.98 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.48 -8.72 37.86 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.83 -0.7 . . . . 0.51000000000000001 113.981 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.3 m -75.55 110.69 10.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.448 0.624 . . . . 0.46000000000000002 111.718 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.8 mtt180 -77.68 110.64 12.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.947 0.88 . . . . 0.46999999999999997 110.298 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.522 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.2 m -91.36 -12.61 9.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.069 -1.423 . . . . 0.27000000000000002 111.936 -169.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.618 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.1 pt20 -158.6 124.4 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.344 -0.389 . . . . 0.58999999999999997 110.746 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.53 124.53 48.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.315 -0.624 . . . . 1.3400000000000001 109.315 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 8.6 tt0 -144.61 107.28 4.7 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-O 121.879 0.847 . . . . 2.5899999999999999 110.506 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 53.1 Cg_endo -68.94 -19.2 40.43 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 123.35 2.7 . . . . 0.5 113.871 -171.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -158.74 99.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.0 0.905 . . . . 1.3700000000000001 111.016 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.4 tp -113.04 116.02 29.27 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.31 -1.768 . . . . 0.38 108.808 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.0 p -112.64 133.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 24.3 p90 -154.86 164.74 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.884 0.373 . . . . 0.23000000000000001 110.821 -172.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.402 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 2.7 m -83.38 112.46 19.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.634 -0.712 . . . . 0.41999999999999998 109.495 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.974 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.2 tp -59.53 126.26 26.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.405 -0.361 . . . . 0.59999999999999998 110.919 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' HG2' ' A' ' 62' ' ' LYS . . . 83.51 5.51 88.41 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.78 -0.724 . . . . 0.37 112.438 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 30.6 t70 -90.33 -7.34 53.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.565 -1.272 . . . . 0.93000000000000005 107.565 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 56.2 m 58.4 31.7 21.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.105 -1.407 . . . . 0.62 110.16 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.27 -18.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.256 1.026 . . . . 1.3300000000000001 109.168 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.38 -155.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.069 -1.423 . . . . 0.23000000000000001 110.454 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 28.8 pt -82.75 137.27 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.296 -1.372 . . . . 0.28999999999999998 107.296 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -56.77 -30.03 63.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.468 -0.333 . . . . 0.40000000000000002 110.96 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.77 78.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.163 0.506 . . . . 0.20000000000000001 110.746 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.661 HD21 HG21 ' A' ' 68' ' ' VAL . 62.6 tp -77.88 -37.76 47.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.671 -0.695 . . . . 0.22 110.678 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.414 ' OD2' ' HA2' ' A' ' 91' ' ' GLY . 22.9 t70 -61.9 -29.51 70.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 0.26000000000000001 109.59 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.3 -35.07 14.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.253 -0.885 . . . . 0.25 112.275 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 106' ' ' MET . 21.3 t -65.81 -32.83 74.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 1.01 111.479 -174.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.566 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 53.5 t -66.92 -54.91 18.43 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.519 0.563 . . . . 0.20999999999999999 112.519 -176.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.974 ' HD3' HD11 ' A' ' 90' ' ' LEU . 23.7 Cg_endo -63.76 -22.63 69.5 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.042 1.828 . . . . 0.27000000000000002 111.921 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.51 ' CD1' HG23 ' A' ' 39' ' ' ILE . 4.2 mt -77.38 -31.15 54.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.64000000000000001 111.336 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.703 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.3 ptm -88.52 157.23 18.69 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.936 -0.575 . . . . 0.78000000000000003 109.68 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.533 ' OD2' ' HA3' ' A' ' 53' ' ' GLY . 8.3 p-10 -103.49 158.39 16.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.337 0.589 . . . . 0.96999999999999997 111.713 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.647 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.8 t -61.37 125.82 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.524 -0.762 . . . . 0.80000000000000004 111.464 -174.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.65 59.2 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 114.815 -1.084 . . . . 0.28000000000000003 112.819 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.4 pt-20 -97.0 167.87 10.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.195 0.522 . . . . 0.40999999999999998 110.625 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.533 HG22 HD12 ' A' ' 50' ' ' LEU . 21.5 m -128.07 117.4 21.58 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.048 -1.093 . . . . 0.22 108.048 173.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -118.35 131.52 56.31 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.977 -0.556 . . . . 0.17999999999999999 110.963 -173.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.2 ttp -98.44 117.99 34.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.994 -1.113 . . . . 1.3200000000000001 107.994 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.754 HG22 ' HG3' ' A' ' 47' ' ' LYS . 12.7 t -109.1 137.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.878 -0.601 . . . . 0.17999999999999999 109.583 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.598 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 89.6 m -110.66 113.07 25.39 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.241 -1.022 . . . . 0.20999999999999999 108.241 170.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -122.7 132.14 54.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.564 -1.198 . . . . 0.14999999999999999 109.29 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.732 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.6 t70 -52.98 146.63 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.588 -0.893 . . . . 0.57999999999999996 108.588 171.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.586 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.5 t -52.32 -26.78 13.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.131 0.491 . . . . 0.81999999999999995 110.48 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.732 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.7 ptpt -54.33 -33.54 59.16 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 122.062 -0.399 . . . . 0.81000000000000005 112.01 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' OH ' ' HG ' ' A' ' 40' ' ' LEU . 98.5 m-85 -96.4 3.08 53.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.352 0.596 . . . . 0.41999999999999998 109.92 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.8 m -122.13 -90.46 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.034 . . . . 0.17999999999999999 110.389 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 13.0 m-85 -144.39 39.62 1.3 Allowed 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.262 0.467 . . . . 0.23999999999999999 112.262 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.71 -83.26 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.188 -0.529 . . . . 0.25 113.744 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.74 7.66 4.72 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.405 2.07 . . . . 0.57999999999999996 111.259 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.0 mt-30 -104.45 -51.17 3.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.716 -0.674 . . . . 0.65000000000000002 110.498 -173.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.559 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 85.85 142.68 6.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.074 -0.966 . . . . 0.29999999999999999 112.419 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.634 ' HB3' HG12 ' A' ' 132' ' ' ILE . 6.9 t -91.35 162.22 14.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.187 -0.506 . . . . 0.33000000000000002 112.162 -175.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 83' ' ' GLU . 14.5 ptp180 -52.89 -51.37 61.42 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 115.151 -0.931 . . . . 3.1699999999999999 112.238 -173.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.975 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 20.4 m -81.4 -64.7 0.27 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.438 . . . . 1.23 110.36 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.975 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 20.0 Cg_endo -105.24 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.401 2.067 . . . . 0.37 111.7 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.552 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 31.0 t80 -56.22 98.11 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.064 -1.087 . . . . 1.1399999999999999 108.064 163.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 127' ' ' SER . 33.5 mm -65.35 128.99 94.27 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.893 -0.594 . . . . 0.39000000000000001 109.639 -177.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.6 Cg_endo -52.38 139.14 55.72 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.659 2.239 . . . . 0.60999999999999999 112.282 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.554 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 40.7 Cg_exo -57.55 129.05 31.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.528 2.152 . . . . 0.52000000000000002 112.456 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.589 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 57.9 m80 75.36 12.16 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.936 -1.029 . . . . 2.3799999999999999 112.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.76 127.14 32.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.235 -0.654 . . . . 0.26000000000000001 109.235 173.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.48 113.08 11.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.521 -0.472 . . . . 0.22 110.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.14 132.87 35.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.072 -0.513 . . . . 0.22 110.97 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 5.2 t -118.11 100.07 7.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.605 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -109.5 136.71 48.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.651 -0.704 . . . . 0.32000000000000001 111.586 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.548 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 50.8 tt0 -101.85 118.44 36.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.175 -0.676 . . . . 1.05 109.175 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 4.2 m -119.67 123.3 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.435 0.636 . . . . 0.19 112.555 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 42.9 m -92.79 118.54 31.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.645 -0.707 . . . . 0.28000000000000003 109.362 170.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.703 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 37.4 tp -80.82 99.01 8.07 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.481 -0.933 . . . . 0.14999999999999999 108.481 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.625 ' HD3' ' HB ' ' A' ' 67' ' ' THR . 19.2 mtpt -79.91 -44.48 20.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.464 -1.244 . . . . 1.0800000000000001 110.328 -168.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 m -158.48 160.0 36.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.969 -0.56 . . . . 0.37 110.526 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.534 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.32 128.05 27.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.165 -0.68 . . . . 0.25 109.165 170.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 65' ' ' VAL . 20.4 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.92000000000000004 110.06 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.991 -0.374 . . . . 50.229999999999997 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.98 -95.09 1.68 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.714 -0.755 . . . . 47.990000000000002 112.71 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 76.4 mt-30 -105.46 150.03 38.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.345 0.117 . . . . 46.259999999999998 110.805 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 23.5 Cg_exo -63.92 131.06 29.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.718 2.279 . . . . 44.799999999999997 111.514 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 14.1 Cg_exo -68.62 123.16 10.17 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.826 2.351 . . . . 44.020000000000003 112.499 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.1 16.96 3.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 42.5 110.447 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.97 119.58 39.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 41.5 110.479 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.76 157.85 22.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.0 -0.545 . . . . 40.329999999999998 109.568 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 -174.81 0.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.076 0.86 . . . . 39.090000000000003 111.146 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.567 ' HG2' ' HG3' ' A' ' 11' ' ' GLN . 29.6 tt0 -127.26 -77.17 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 38.82 110.449 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.567 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 56.5 mt-30 -129.22 115.46 18.64 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 38.159999999999997 110.135 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 11' ' ' GLN . 2.7 Cg_endo -83.28 15.73 2.04 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.444 2.763 . . . . 36.700000000000003 112.031 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.02 -62.47 0.53 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.835 -0.698 . . . . 35.609999999999999 112.11 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.53 169.78 9.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.848 0.356 . . . . 35.030000000000001 110.803 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.01 -47.5 0.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 34.009999999999998 110.977 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 65.16 97.43 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.058 0.849 . . . . 32.890000000000001 111.409 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -81.86 179.2 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 31.940000000000001 111.193 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.45 61.06 0.66 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.72 -0.673 . . . . 31.239999999999998 110.789 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 31.2 t80 -80.79 -62.78 1.57 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.472 -0.786 . . . . 31.239999999999998 111.371 -174.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' HG ' ' CD2' ' A' ' 19' ' ' PHE . 96.2 mt -112.65 110.76 21.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.861 0.362 . . . . 29.850000000000001 111.242 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.61 113.9 14.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.732 -0.667 . . . . 28.199999999999999 110.787 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.0 34.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.769 . . . . 26.780000000000001 109.575 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.4 ttp -122.01 15.27 10.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.373 -0.83 . . . . 27.469999999999999 109.8 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 3.0 mp0 -64.43 112.83 8.59 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.132 -0.94 . . . . 24.41 110.678 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 4.0 Cg_endo -86.19 93.5 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.306 2.671 . . . . 21.629999999999999 112.338 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.72 146.3 31.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.285 -0.416 . . . . 20.670000000000002 110.308 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.1 119.94 7.51 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.003 2.469 . . . . 18.02 112.45 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.41 28.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.744 -0.662 . . . . 14.93 110.384 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.59 157.47 55.24 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.713 2.276 . . . . 13.81 112.277 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.83 80.55 0.26 Allowed Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 124.097 0.873 . . . . 10.76 112.023 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.63 96.02 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.602 2.201 . . . . 9.7699999999999996 112.181 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.03 130.96 22.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.788 -0.642 . . . . 5.8600000000000003 110.335 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.78 -19.67 46.82 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.578 2.186 . . . . 4.4699999999999998 112.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 71.2 -55.86 0.64 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.665 0.786 . . . . 4.1299999999999999 111.538 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.4 108.26 19.77 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.554 -0.536 . . . . 2.4500000000000002 109.554 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.609 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -95.71 -164.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 0.53000000000000003 110.856 -176.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.71 109.76 4.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.5 110.131 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.623 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.0 t70 -74.76 123.8 25.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 2.5099999999999998 110.818 174.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.506 HD12 HD11 ' A' ' 45' ' ' LEU . 8.8 mt -56.06 -36.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.711 -1.131 . . . . 0.46000000000000002 111.568 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -110.77 -2.39 16.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.208 0.528 . . . . 0.71999999999999997 110.473 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.17 24.75 67.51 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.33 -0.85 . . . . 0.52000000000000002 111.627 -173.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.525 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -94.5 -22.37 18.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.858 0.361 . . . . 0.94999999999999996 111.669 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.548 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.0 -17.67 41.09 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.922 -0.656 . . . . 0.71999999999999997 112.125 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.817 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 1.1 mt -96.07 -24.23 16.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.673 0.273 . . . . 1.5600000000000001 110.912 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 39' ' ' ILE . 19.5 tp -123.68 100.39 6.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.374 -0.376 . . . . 0.32000000000000001 111.854 -171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -130.11 139.88 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.097 -0.377 . . . . 1.1399999999999999 111.722 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 10.3 ttpt -112.13 125.82 54.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.477 0.311 . . . . 0.34999999999999998 110.637 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.2 ttpp -116.54 120.73 39.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 1.0700000000000001 110.969 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 p -74.93 110.44 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.464 . . . . 0.33000000000000002 111.646 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD11 ' HG3' ' A' ' 141' ' ' GLU . 9.0 mt -73.88 -52.0 14.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.827 -1.545 . . . . 0.28000000000000003 106.827 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.866 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.7 t -133.46 130.72 21.11 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 113.21 -1.814 . . . . 0.35999999999999999 106.752 170.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 22.7 Cg_endo -107.79 57.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.221 2.614 . . . . 0.54000000000000004 114.024 -176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 81.61 94.12 0.49 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.958 -0.639 . . . . 0.55000000000000004 112.848 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' CD ' ' HD3' ' A' ' 55' ' ' PRO . 36.5 Cg_exo -58.54 -48.13 16.39 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.198 2.599 . . . . 1.4199999999999999 114.671 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD3' ' CD ' ' A' ' 54' ' ' PRO . 28.6 Cg_endo -94.49 -159.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.236 1.957 . . . . 2.04 112.612 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 69.28 2.59 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 110.576 -1.01 . . . . 0.97999999999999998 110.576 173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 m -64.8 175.51 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.003 0.906 . . . . 0.98999999999999999 113.252 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 108' ' ' VAL . 16.5 m -146.71 140.0 25.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.582 -1.19 . . . . 1.28 108.229 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 96.4 mtt180 -89.36 116.22 65.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 120.567 -0.453 . . . . 2.8100000000000001 109.831 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 10.0 Cg_endo -52.38 148.59 25.53 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.493 2.795 . . . . 0.29999999999999999 112.67 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -94.65 152.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 0.88 109.28 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 61.3 mttt -63.71 120.69 12.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 1.1699999999999999 109.399 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 129.02 -41.92 1.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.06 -1.427 . . . . 0.41999999999999998 110.075 -170.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.5 mm-40 -69.42 132.67 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.069 -0.715 . . . . 0.58999999999999997 109.069 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 17.9 m -84.45 118.64 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 122.142 0.973 . . . . 1.22 108.727 175.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -115.65 144.84 22.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.93 -1.032 . . . . 0.25 111.486 -171.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.973 HG22 HG22 ' A' ' 87' ' ' VAL . 43.5 p -88.86 113.99 25.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.535 -0.757 . . . . 0.28999999999999998 110.221 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 99' ' ' LEU . 20.8 m -111.49 143.59 21.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.996 -0.682 . . . . 0.19 110.511 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -103.1 117.88 35.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.451 -1.314 . . . . 0.19 107.451 168.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -118.96 137.79 53.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 118.92 -1.112 . . . . 0.39000000000000001 111.035 176.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.501 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 2.0 mp0 -132.46 114.29 14.13 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.491 -2.041 . . . . 0.27000000000000002 105.491 166.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.662 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 60.3 m -105.45 132.61 51.41 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 114.976 -1.011 . . . . 0.19 111.831 -168.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 m -104.39 156.88 17.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.096 -0.956 . . . . 1.0600000000000001 108.874 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.419 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.8 mt -80.42 166.72 20.98 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 0.83999999999999997 108.908 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 11.1 pt-20 -59.88 -14.54 15.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.915 0.339 . . . . 1.1399999999999999 111.915 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.28 -15.63 25.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.897 0.38 . . . . 2.1400000000000001 110.711 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.44 -3.92 19.93 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.813 -0.708 . . . . 0.51000000000000001 113.644 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.1 m -75.67 110.88 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.369 0.584 . . . . 0.46000000000000002 111.573 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.6 mtt180 -75.99 112.42 12.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.854 0.835 . . . . 0.46999999999999997 110.857 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.573 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.2 m -99.02 -13.8 7.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 113.992 -1.458 . . . . 0.27000000000000002 112.377 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.611 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 19.1 pt20 -157.06 136.58 12.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.81 0.338 . . . . 0.58999999999999997 110.586 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.52 130.42 32.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.969 -0.559 . . . . 1.3400000000000001 109.687 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 4.8 tt0 -145.09 112.98 4.84 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.562 -0.745 . . . . 2.5899999999999999 109.815 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 15.2 Cg_exo -68.19 -15.77 43.27 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.501 2.801 . . . . 0.5 113.315 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.578 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 26.5 tt0 -166.34 113.28 0.86 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.021 0.915 . . . . 1.3700000000000001 111.572 -175.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.455 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 49.7 tp -126.72 110.76 13.49 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.55 -1.659 . . . . 0.38 108.737 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.973 HG22 HG22 ' A' ' 67' ' ' THR . 2.1 t -100.79 125.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 p90 -145.56 160.71 41.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.23000000000000001 111.44 -172.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 m -79.29 106.67 11.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.593 -0.73 . . . . 0.41999999999999998 110.4 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.856 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.02 134.54 57.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.213 -0.448 . . . . 0.59999999999999998 110.514 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 81.44 -5.63 67.63 Favored Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 120.824 -0.703 . . . . 0.37 113.293 173.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -107.17 15.54 25.04 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.534 -0.913 . . . . 0.93000000000000005 108.534 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 32.2 m 53.65 39.61 30.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.109 -1.405 . . . . 0.62 109.633 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.3 t0 -76.86 -2.79 35.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.563 1.173 . . . . 1.3300000000000001 108.383 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 6.2 m -140.04 -157.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 113.646 -1.616 . . . . 0.23000000000000001 110.757 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.5 pt -82.82 139.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.567 -1.272 . . . . 0.28999999999999998 107.567 173.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -58.85 -31.51 68.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.351 -0.386 . . . . 0.40000000000000002 111.261 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.91 79.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 0.20000000000000001 110.491 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 68' ' ' VAL . 53.7 tp -75.5 -38.01 59.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.314 -0.857 . . . . 0.22 110.551 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.41 -29.82 70.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.97 -1.014 . . . . 0.26000000000000001 109.868 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.55 -36.04 14.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.198 -0.91 . . . . 0.25 111.969 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.8 t -64.91 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.676 -0.238 . . . . 1.01 111.191 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 104' ' ' PRO . 76.1 t -65.55 -53.45 37.37 Favored Pre-proline 0 C--O 1.218 -0.578 0 CA-C-N 116.471 -0.332 . . . . 0.20999999999999999 111.888 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.802 ' HD3' HD11 ' A' ' 90' ' ' LEU . 64.5 Cg_exo -52.55 -28.83 38.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.992 1.795 . . . . 0.27000000000000002 112.706 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.56 -11.52 53.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.8 -0.636 . . . . 0.64000000000000001 111.279 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -100.43 142.07 32.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.27 -0.877 . . . . 0.78000000000000003 110.701 176.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.576 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -89.37 156.88 18.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.96999999999999997 108.781 172.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 58' ' ' SER . 1.3 p -66.04 126.47 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.935 0.874 . . . . 0.80000000000000004 110.459 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.8 -2.3 45.17 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.337 -0.847 . . . . 0.28000000000000003 112.254 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.866 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 6.8 pt-20 -96.95 168.13 10.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.529 0.68 . . . . 0.40999999999999998 110.913 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.438 HG22 HD12 ' A' ' 50' ' ' LEU . 10.2 m -130.18 116.96 19.18 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.369 -0.974 . . . . 0.22 108.369 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.595 ' HB3' ' SD ' ' A' ' 106' ' ' MET . . . -115.21 135.28 54.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.878 -0.601 . . . . 0.17999999999999999 110.314 -176.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttm -97.46 117.0 30.74 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.124 -1.436 . . . . 1.3200000000000001 107.124 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.62 130.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.584 -0.524 . . . . 0.17999999999999999 109.584 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.512 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 98.1 m -105.79 112.48 25.56 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.075 -1.083 . . . . 0.20999999999999999 108.075 170.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.31 133.69 52.52 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.988 -1.46 . . . . 0.14999999999999999 109.227 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.817 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 10.0 t70 -52.67 145.77 11.44 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.893 -0.78 . . . . 0.57999999999999996 108.893 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.8 t -52.74 -29.49 27.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.965 0.412 . . . . 0.81999999999999995 110.125 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.693 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 7.0 ptpp? -56.73 -27.14 58.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.206 0.447 . . . . 0.81000000000000005 112.206 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.564 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 88.9 m-85 -99.4 0.99 43.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.3 0.571 . . . . 0.41999999999999998 109.922 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -119.72 -92.03 0.54 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.816 -1.084 . . . . 0.17999999999999999 109.994 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.0 m-85 -142.02 43.62 1.68 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 111.761 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.29 -89.83 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 113.957 0.343 . . . . 0.25 113.957 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.65 15.27 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.639 2.226 . . . . 0.57999999999999996 110.707 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 33.0 mt-30 -104.3 -43.28 5.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.232 -0.895 . . . . 0.65000000000000002 109.672 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.595 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 75.85 144.99 1.44 Allowed Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.655 -1.157 . . . . 0.29999999999999999 112.673 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.678 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.3 t -92.08 159.91 15.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.417 -0.392 . . . . 0.33000000000000002 111.322 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.449 HH12 ' CD ' ' A' ' 83' ' ' GLU . 33.2 mtt180 -53.18 -57.0 11.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.329 -0.851 . . . . 3.1699999999999999 111.109 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.96 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.3 m -74.6 -64.31 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.833 -0.622 . . . . 1.23 110.553 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.96 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.6 Cg_endo -106.72 126.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.973 1.782 . . . . 0.37 112.132 174.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 34.3 t80 -58.85 98.02 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.153 -1.054 . . . . 1.1399999999999999 108.153 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.0 mm -65.97 132.33 94.66 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.39000000000000001 109.886 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 52.7 Cg_exo -54.53 140.5 75.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.675 2.25 . . . . 0.60999999999999999 112.436 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.477 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 48.2 Cg_exo -56.58 140.19 89.36 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.535 2.157 . . . . 0.52000000000000002 112.392 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.637 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 29.5 p80 47.59 28.76 1.27 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.398 1.079 . . . . 2.3799999999999999 113.145 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -86.19 134.2 33.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.374 -0.973 . . . . 0.26000000000000001 108.374 169.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -77.81 113.32 15.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.306 -0.558 . . . . 0.22 110.326 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.662 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 2.5 tp -90.41 132.01 35.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.774 -0.648 . . . . 0.22 110.015 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.8 t -115.56 100.38 8.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.308 -0.627 . . . . 1.2 109.308 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 pp -113.36 136.36 52.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.002 -0.545 . . . . 0.32000000000000001 111.686 -171.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 46.9 tt0 -104.21 111.26 23.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.72 . . . . 1.05 109.213 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.682 HG11 HD13 ' A' ' 99' ' ' LEU . 2.9 m -113.72 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.119 0.785 . . . . 0.19 113.119 -173.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.6 m -88.6 108.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.636 -1.165 . . . . 0.28000000000000003 110.369 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.407 HD21 ' HG3' ' A' ' 60' ' ' PRO . 61.7 tp -81.75 93.05 6.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.326 -0.99 . . . . 0.14999999999999999 108.326 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.472 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 24.7 mtmt -90.13 -31.21 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.679 -0.691 . . . . 1.0800000000000001 110.754 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 m -148.67 151.46 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.961 0.41 . . . . 0.37 111.293 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -139.78 128.11 22.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.25 109.289 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.54 145.14 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.479 -0.488 . . . . 0.92000000000000004 110.245 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -91.98 118.41 30.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.147 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 tp -141.5 10.02 2.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.371 0.605 . . . . 1.97 109.845 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 7.1 tp10 -115.05 105.08 12.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 2.1400000000000001 110.183 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -143.05 16.98 1.93 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.641 . . . . 5.79 110.082 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -112.49 145.1 40.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.812 0.339 . . . . 7.4800000000000004 111.098 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.8 m170 64.87 -172.27 0.18 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.701 -0.681 . . . . 8.4600000000000009 111.772 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -170.69 168.39 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.976 -1.12 . . . . 8.8300000000000001 107.976 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.51 143.85 29.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.513 -0.475 . . . . 12.17 111.056 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 117.953 -1.022 . . . . 13.460000000000001 109.11 179.575 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.825 0.345 . . . . 50.229999999999997 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.06 -23.25 5.89 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.039 -0.824 . . . . 47.990000000000002 111.039 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.407 ' OE1' ' HD2' ' A' ' 5' ' ' PRO . 6.7 tp-100 -118.95 82.15 20.71 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 109.654 -0.499 . . . . 46.259999999999998 109.654 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.551 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 39.5 Cg_exo -60.24 -55.92 1.33 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.265 2.643 . . . . 44.799999999999997 114.382 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 8.6 Cg_exo -72.0 123.04 8.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.328 1.352 . . . . 44.020000000000003 111.884 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 2.27 43.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.397 0.618 . . . . 42.5 110.299 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 -8.63 59.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.164 -0.925 . . . . 41.5 111.453 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -87.91 22.91 2.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.902 0.382 . . . . 40.329999999999998 110.687 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.54 130.17 7.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 39.090000000000003 110.492 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -151.4 113.59 4.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.24 0.543 . . . . 38.82 109.658 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.71 86.99 6.05 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.674 0.749 . . . . 38.159999999999997 110.613 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.54 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.807 2.338 . . . . 36.700000000000003 112.285 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.33 53.15 0.47 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.769 -0.729 . . . . 35.609999999999999 112.161 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.6 32.63 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.727 0.299 . . . . 35.030000000000001 111.5 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.36 103.62 15.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.526 -0.306 . . . . 34.009999999999998 110.477 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.81 102.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.693 -0.484 . . . . 32.890000000000001 109.693 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.18 -166.69 2.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.016 -0.538 . . . . 31.940000000000001 110.57 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.42 119.56 19.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.039 -0.528 . . . . 31.239999999999998 110.674 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -119.31 -3.82 10.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.024 -0.534 . . . . 31.239999999999998 110.625 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.1 pt? -124.21 161.89 24.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.175 -0.466 . . . . 29.850000000000001 110.145 -174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.52 -26.15 16.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.235 -0.439 . . . . 28.199999999999999 110.912 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.7 145.52 0.07 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.209 0.943 . . . . 26.780000000000001 111.711 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -95.85 -46.18 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.763 -0.653 . . . . 27.469999999999999 110.289 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -156.35 107.06 2.04 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.609 -0.723 . . . . 24.41 109.744 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.73 137.42 27.26 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.991 2.461 . . . . 21.629999999999999 112.008 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 44.6 mt-10 -79.29 133.32 60.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.054 -0.521 . . . . 20.670000000000002 110.364 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 34.5 Cg_exo -61.47 112.89 1.57 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.965 2.443 . . . . 18.02 113.356 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -119.96 126.68 26.75 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 14.93 109.952 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 23.6 Cg_exo -65.37 128.17 19.75 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.711 2.274 . . . . 13.81 112.533 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -171.03 -56.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 10.76 111.262 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 89.0 Cg_endo -81.39 168.9 16.16 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.0 1.8 . . . . 9.7699999999999996 112.568 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.93 145.69 37.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 5.8600000000000003 110.545 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.99 -16.51 50.3 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.232 2.621 . . . . 4.4699999999999998 113.203 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 5.8 mm-40 -96.94 1.19 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.5 . . . . 4.1299999999999999 110.984 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -99.58 78.47 2.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.144 -1.058 . . . . 2.4500000000000002 108.144 168.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.594 ' HZ3' ' H ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -72.38 -175.36 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.53000000000000003 110.528 -173.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.7 tp -69.39 110.81 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.551 -0.749 . . . . 0.5 109.618 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.621 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 11.6 t70 -75.71 128.56 35.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.202 -0.599 . . . . 2.5099999999999998 109.463 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.544 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 7.3 mt -65.13 -23.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.847 -1.069 . . . . 0.46000000000000002 110.839 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.3 mt -116.14 -5.5 11.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.71999999999999997 110.101 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 69.19 18.52 73.17 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.52000000000000002 112.361 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' ND2' HD13 ' A' ' 44' ' ' LEU . 19.1 p-10 -98.28 -31.17 12.19 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.636 0.606 . . . . 0.94999999999999996 112.636 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.516 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.85 -0.83 21.46 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.473 -0.87 . . . . 0.71999999999999997 112.242 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.522 HD13 ' ND2' ' A' ' 42' ' ' ASN . 7.8 mp -99.13 -35.59 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.173 0.511 . . . . 1.5600000000000001 110.801 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 18.2 tp -122.68 101.62 7.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.132 -0.94 . . . . 0.32000000000000001 111.253 -172.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 71.3 mtm180 -133.89 140.33 46.76 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.124 -0.36 . . . . 1.1399999999999999 111.472 -171.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HZ3' ' HA ' ' A' ' 106' ' ' MET . 14.2 ttpt -111.49 123.33 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.34999999999999998 110.696 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 11.2 ttmm -103.13 118.77 37.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.392 -0.225 . . . . 1.0700000000000001 110.392 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -76.71 96.09 4.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.486 -0.325 . . . . 0.33000000000000002 110.577 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 111' ' ' THR . 10.6 mt -63.1 -49.47 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.304 -1.369 . . . . 0.28000000000000003 107.304 174.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 72.2 t -140.1 126.32 11.97 Favored Pre-proline 0 CA--C 1.499 -0.987 0 CA-C-N 112.617 -2.083 . . . . 0.35999999999999999 106.588 170.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -104.28 64.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.546 2.164 . . . . 0.54000000000000004 113.845 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.8 178.13 21.09 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.4 -0.818 . . . . 0.55000000000000004 113.888 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 98.4 Cg_endo -89.95 165.06 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.259 2.64 . . . . 1.4199999999999999 111.071 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.58 105.7 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.226 1.951 . . . . 2.04 111.945 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.76 42.18 2.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.956 -0.64 . . . . 0.97999999999999998 112.015 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.625 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 2.3 p -83.65 -164.15 0.87 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.947 0.403 . . . . 0.98999999999999999 110.566 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.432 ' H ' HG12 ' A' ' 108' ' ' VAL . 10.6 t -152.48 136.05 16.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.787 -0.82 . . . . 1.28 108.787 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 84.6 mtt180 -92.48 108.57 32.29 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.73 -0.47 . . . . 2.8100000000000001 109.73 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 144' ' ' LEU . 5.3 Cg_endo -46.55 142.76 9.37 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.996 3.13 . . . . 0.29999999999999999 114.037 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -89.41 153.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.49 -0.777 . . . . 0.88 109.717 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.653 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -68.52 117.12 9.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.732 0.777 . . . . 1.1699999999999999 110.956 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.7 -27.24 3.23 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.354 -1.293 . . . . 0.41999999999999998 110.423 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -75.65 140.94 42.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.58999999999999997 109.147 176.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.3 m -86.71 126.54 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.42 -1.326 . . . . 1.22 107.42 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 33.3 m -120.6 146.41 25.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.174 -0.466 . . . . 0.25 110.195 -173.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.446 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 31.3 p -96.37 111.71 23.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.822 -0.626 . . . . 0.28999999999999998 110.047 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG21 HD21 ' A' ' 99' ' ' LEU . 3.9 m -111.42 143.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.746 -0.661 . . . . 0.19 110.362 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.3 114.04 27.65 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.018 -1.475 . . . . 0.19 107.018 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -114.67 135.47 54.12 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.301 -0.959 . . . . 0.39000000000000001 111.132 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' HB2' ' NH1' ' A' ' 79' ' ' ARG . 1.2 mp0 -134.17 113.45 12.05 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.742 -1.947 . . . . 0.27000000000000002 105.742 165.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 88.3 m -105.24 132.13 51.83 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.605 -1.18 . . . . 0.19 111.411 -168.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.791 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -110.46 156.61 20.61 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.297 -0.865 . . . . 1.0600000000000001 109.131 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.72 165.64 21.77 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.828 -0.624 . . . . 0.83999999999999997 109.807 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.7 -21.18 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 1.1399999999999999 111.266 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -91.3 -8.15 49.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.864 -0.607 . . . . 2.1400000000000001 110.61 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.44 -9.37 41.66 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.061 -0.59 . . . . 0.51000000000000001 112.702 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -74.23 109.41 7.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.72 0.267 . . . . 0.46000000000000002 111.72 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 23.3 mtt180 -75.71 124.37 27.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.254 0.55 . . . . 0.46999999999999997 110.532 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.0 m -112.76 -9.24 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.914 -1.039 . . . . 0.27000000000000002 112.777 -168.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.1 pt20 -159.4 132.5 7.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.475 -0.33 . . . . 0.58999999999999997 110.137 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.465 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 63.1 tt0 -140.85 118.58 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 1.3400000000000001 110.644 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 3.0 tt0 -137.48 121.15 11.77 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.622 -0.717 . . . . 2.5899999999999999 110.313 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 8.9 Cg_exo -71.23 -13.63 31.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.627 2.885 . . . . 0.5 113.274 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -161.5 105.58 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.048 0.928 . . . . 1.3700000000000001 111.784 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.558 ' HB3' HG23 ' A' ' 68' ' ' VAL . 25.7 tp -114.88 109.97 18.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.443 -1.708 . . . . 0.38 109.344 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.7 p -104.67 131.38 53.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.68 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 46.1 p90 -150.98 158.67 44.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.568 -0.287 . . . . 0.23000000000000001 111.111 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 m -77.07 109.48 10.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.41999999999999998 110.181 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.814 HD11 ' HD3' ' A' ' 104' ' ' PRO . 17.7 tp -62.05 133.96 55.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.59999999999999998 110.541 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 83.93 3.59 89.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.788 -0.72 . . . . 0.37 112.527 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -106.37 -2.68 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.42 . . . . 0.93000000000000005 110.021 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.3 m 59.46 35.91 22.98 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.775 -0.824 . . . . 0.62 108.775 -172.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -73.96 -2.86 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.26 1.028 . . . . 1.3300000000000001 108.48 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.465 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 5.8 m -139.87 -153.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 113.767 -1.56 . . . . 0.23000000000000001 109.726 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.2 pt -82.94 138.04 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.265 -1.383 . . . . 0.28999999999999998 107.265 172.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.428 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 3.0 tp-100 -57.65 -31.04 65.91 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.568 -0.287 . . . . 0.40000000000000002 111.071 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.63 -48.19 69.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.20000000000000001 110.863 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 68' ' ' VAL . 46.9 tp -72.92 -38.11 66.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.367 -0.833 . . . . 0.22 110.468 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.6 -30.04 70.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.824 -1.08 . . . . 0.26000000000000001 109.695 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 84.3 mt -89.92 -35.01 15.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.375 -0.83 . . . . 0.25 111.63 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.7 t -63.57 -36.2 83.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 1.01 111.321 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.532 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 46.6 t -62.61 -55.87 34.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 112.772 0.656 . . . . 0.20999999999999999 112.772 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.814 ' HD3' HD11 ' A' ' 90' ' ' LEU . 25.7 Cg_endo -64.42 -19.57 65.45 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 121.887 1.725 . . . . 0.27000000000000002 112.114 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 39' ' ' ILE . 12.8 mt -82.59 -13.62 56.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.016 -0.538 . . . . 0.64000000000000001 111.297 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.654 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.7 ptm -107.32 154.41 21.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.088 -0.505 . . . . 0.78000000000000003 110.72 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.71 152.75 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.96999999999999997 110.494 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 58' ' ' SER . 2.1 p -63.16 126.6 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.052 0.93 . . . . 0.80000000000000004 110.116 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.54 12.37 57.13 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.661 -1.154 . . . . 0.28000000000000003 112.952 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.823 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.1 pt-20 -101.7 168.48 9.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.40999999999999998 110.736 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.495 HG22 HD12 ' A' ' 50' ' ' LEU . 9.5 m -129.63 119.08 22.98 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.653 -1.24 . . . . 0.22 107.653 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.73 53.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.037 0.446 . . . . 0.17999999999999999 111.018 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.9 ttm -97.96 116.71 30.73 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.3200000000000001 107.216 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.2 t -113.91 128.75 70.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.985 -0.376 . . . . 0.17999999999999999 109.985 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.594 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 62.7 m -104.67 113.73 27.5 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 108.187 -1.042 . . . . 0.20999999999999999 108.187 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.63 141.92 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.01 -1.45 . . . . 0.14999999999999999 108.749 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 6.6 t70 -57.76 156.37 8.8 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.223 -0.591 . . . . 0.57999999999999996 109.578 174.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 135' ' ' HIS . 70.6 p -47.34 -43.4 22.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.996 -1.002 . . . . 0.81999999999999995 110.739 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 14.4 ptpt -59.76 -28.97 67.85 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.907 -1.042 . . . . 0.81000000000000005 112.042 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.592 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 91.6 m-85 -94.81 2.63 55.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.364 0.602 . . . . 0.41999999999999998 109.856 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.792 ' HB3' HD22 ' A' ' 138' ' ' LEU . 91.1 m -122.78 -92.34 0.54 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.623 -1.172 . . . . 0.17999999999999999 110.271 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.661 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 3.8 m-85 -147.37 37.66 0.93 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 119.019 -0.515 . . . . 0.23999999999999999 111.85 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 118' ' ' SER . . . -52.73 -83.5 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.597 -0.811 . . . . 0.25 112.998 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 7.36 4.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.551 2.167 . . . . 0.57999999999999996 111.692 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -104.22 -46.97 4.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.749 -0.66 . . . . 0.65000000000000002 110.66 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.608 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 80.73 142.06 3.07 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.954 -1.021 . . . . 0.29999999999999999 112.225 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.712 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.4 t -91.65 159.42 15.88 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.575 0.583 . . . . 0.33000000000000002 112.575 -174.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 129' ' ' SER . 9.6 ptp180 -48.97 -53.98 17.51 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.48 -1.236 . . . . 3.1699999999999999 112.259 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.957 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 3.5 m -82.4 -63.88 0.27 Allowed Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.895 -0.409 . . . . 1.23 109.895 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.957 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.1 Cg_endo -105.07 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.522 2.148 . . . . 0.37 112.262 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.608 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 26.1 t80 -55.57 97.45 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.674 -0.861 . . . . 1.1399999999999999 108.674 163.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.595 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.3 mm -66.77 122.57 82.86 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.75 -0.659 . . . . 0.39000000000000001 109.313 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 47.2 Cg_exo -56.02 137.74 80.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.261 1.974 . . . . 0.60999999999999999 111.965 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.501 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 38.4 Cg_exo -56.35 130.2 38.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.387 2.058 . . . . 0.52000000000000002 112.823 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.672 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 17.3 m80 74.39 23.82 1.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.577 -1.647 . . . . 2.3799999999999999 112.878 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.51 116.01 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.29 -1.004 . . . . 0.26000000000000001 108.29 166.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.61 132.5 43.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.99 0.424 . . . . 0.22 110.039 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -104.05 132.37 50.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.918 -0.583 . . . . 0.22 111.773 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.2 t -116.63 100.45 7.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.061 -0.718 . . . . 1.2 109.061 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.6 pp -112.57 137.13 51.25 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.771 -0.65 . . . . 0.32000000000000001 111.579 -171.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 41.2 tt0 -106.8 116.2 31.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.891 -0.781 . . . . 1.05 108.891 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 99' ' ' LEU . 4.6 m -117.12 120.91 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.724 0.638 . . . . 0.19 112.724 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 m -88.75 108.85 19.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.082 -0.963 . . . . 0.28000000000000003 110.737 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.654 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 55.7 tp -81.71 94.74 7.05 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.68 -0.859 . . . . 0.14999999999999999 108.68 172.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.9 mtmt -89.33 -25.1 21.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.141 -0.936 . . . . 1.0800000000000001 110.821 -171.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.446 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 22.0 m -160.84 148.12 15.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.664 0.269 . . . . 0.37 111.174 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -124.43 127.96 48.31 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.193 -0.669 . . . . 0.25 109.193 168.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.2 t -119.93 121.09 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.92000000000000004 109.619 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.409 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 5.1 t0 -74.75 116.31 15.31 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.815 -0.809 . . . . 2.27 108.815 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -152.95 22.94 0.57 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.445 -0.798 . . . . 1.97 109.482 -169.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.509 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -72.83 -96.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.039 -1.097 . . . . 2.1400000000000001 108.039 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.509 ' H ' ' HB3' ' A' ' 151' ' ' GLU . 82.0 m-70 37.53 68.32 0.3 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 124.184 0.928 . . . . 5.79 111.791 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -67.47 8.75 0.3 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.407 0.521 . . . . 7.4800000000000004 112.407 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -84.29 94.16 8.38 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.877 -0.416 . . . . 8.4600000000000009 109.877 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -140.28 138.72 35.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.568 -0.287 . . . . 8.8300000000000001 110.748 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -165.05 121.89 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 12.17 110.022 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 35.6 m170 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.42 -0.8 . . . . 13.460000000000001 110.051 175.937 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.968 -0.382 . . . . 50.229999999999997 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.22 -52.59 0.45 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.478 -0.867 . . . . 47.990000000000002 113.139 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 47.1 mt-30 -104.5 155.97 36.56 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.457 0.128 . . . . 46.259999999999998 110.72 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 61.1 Cg_exo -51.48 -50.11 15.01 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.09 2.526 . . . . 44.799999999999997 113.583 173.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 12.8 Cg_exo -71.45 122.63 8.8 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.501 1.467 . . . . 44.020000000000003 111.986 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 13.15 29.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.619 0.723 . . . . 42.5 109.704 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.77 -17.34 30.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.107 -0.951 . . . . 41.5 110.103 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.9 118.12 30.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.641 . . . . 40.329999999999998 110.941 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.22 127.99 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.93 -0.577 . . . . 39.090000000000003 110.831 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.6 25.76 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 38.82 109.707 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -98.67 120.91 57.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.554 0.692 . . . . 38.159999999999997 111.136 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.89 -60.56 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.45 2.767 . . . . 36.700000000000003 112.497 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.58 107.3 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.788 -0.525 . . . . 35.609999999999999 111.788 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 59.45 69.25 0.73 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.733 -0.469 . . . . 35.030000000000001 109.733 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 95.6 mt 69.13 -165.19 0.18 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.097 -0.956 . . . . 34.009999999999998 110.374 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.73 116.53 26.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.721 -0.844 . . . . 32.890000000000001 108.721 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 21.3 mmt180 -144.11 32.13 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.955 0.407 . . . . 31.940000000000001 111.496 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.89 92.53 0.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 31.239999999999998 109.751 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -66.54 -17.09 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.783 -0.644 . . . . 31.239999999999998 110.743 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.96 75.74 10.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 29.850000000000001 109.785 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.53 127.68 20.95 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.644 -0.707 . . . . 28.199999999999999 110.226 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.99 106.3 1.89 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 26.780000000000001 110.709 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.0 mtt -84.36 67.44 9.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.862 0.839 . . . . 27.469999999999999 110.417 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -133.07 93.53 22.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 114.693 -1.139 . . . . 24.41 108.813 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.15 137.82 58.64 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.674 2.249 . . . . 21.629999999999999 112.244 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 10.6 pt-20 -56.69 132.44 78.23 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 20.670000000000002 110.2 177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 53.1 Cg_exo -54.93 128.69 31.59 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.036 2.491 . . . . 18.02 112.655 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.32 147.5 36.91 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.623 -0.717 . . . . 14.93 110.981 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.73 128.16 22.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.52 2.147 . . . . 13.81 111.684 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.4 71.09 3.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.934 -0.575 . . . . 10.76 111.692 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.39 101.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.574 2.183 . . . . 9.7699999999999996 111.63 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.78 138.8 21.18 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.219 -0.446 . . . . 5.8600000000000003 110.674 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.24 -44.74 17.83 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.682 2.255 . . . . 4.4699999999999998 112.051 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 179.54 -55.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.964 -0.754 . . . . 4.1299999999999999 108.964 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 69.33 110.35 0.05 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.982 -1.008 . . . . 2.4500000000000002 112.371 173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.584 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 0.8 OUTLIER -109.84 -157.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.53000000000000003 110.625 -175.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.05 118.26 12.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.585 -0.734 . . . . 0.5 110.415 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.64 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.4 t70 -80.98 129.4 34.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.324 0.583 . . . . 2.5099999999999998 110.379 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.606 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.1 mt -65.51 -24.91 35.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.801 -1.091 . . . . 0.46000000000000002 111.088 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.66 0.7 10.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.55 . . . . 0.71999999999999997 110.47 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.25 22.37 65.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.436 -0.802 . . . . 0.52000000000000002 112.306 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.07 -28.24 15.83 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.137 0.421 . . . . 0.94999999999999996 112.137 -176.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 108.58 -1.01 32.41 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.818 -0.706 . . . . 0.71999999999999997 112.065 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.51 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 mp -105.42 -31.58 8.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.051 0.453 . . . . 1.5600000000000001 111.215 -176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 16.5 tp -122.31 101.33 7.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.4 -0.818 . . . . 0.32000000000000001 111.471 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HG2' ' CA ' ' A' ' 38' ' ' ASP . 67.5 mtm180 -133.42 141.01 47.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.356 0.502 . . . . 1.1399999999999999 112.356 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' HG3' HG22 ' A' ' 114' ' ' VAL . 11.4 ttpt -114.28 126.09 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.34999999999999998 110.654 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.6 ttpt -112.03 128.56 56.22 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 121.062 -0.255 . . . . 1.0700000000000001 110.894 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 p -83.94 103.89 13.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.223 -0.444 . . . . 0.33000000000000002 110.711 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 111' ' ' THR . 8.0 mt -65.26 -52.94 51.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.832 -1.544 . . . . 0.28000000000000003 106.832 170.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.815 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 86.6 t -131.93 131.99 22.92 Favored Pre-proline 0 CA--C 1.501 -0.912 0 CA-C-N 113.28 -1.782 . . . . 0.35999999999999999 106.242 167.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.7 Cg_endo -104.61 53.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.935 2.423 . . . . 0.54000000000000004 113.023 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.27 169.98 29.81 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.957 -1.02 . . . . 0.55000000000000004 112.807 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.55 150.45 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.6 2.2 . . . . 1.4199999999999999 110.264 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.91 115.06 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.329 2.019 . . . . 2.04 111.534 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.19 49.47 2.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.405 -0.902 . . . . 0.97999999999999998 111.724 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -81.89 170.93 15.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.543 0.687 . . . . 0.98999999999999999 111.901 -177.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.746 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 50.5 m -116.59 133.61 55.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.32 -0.855 . . . . 1.28 108.896 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 86.2 mtt180 -99.46 113.6 65.0 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-O 120.931 0.396 . . . . 2.8100000000000001 110.481 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.658 ' HG3' HD21 ' A' ' 144' ' ' LEU . 10.9 Cg_endo -53.77 145.78 48.34 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.43 2.754 . . . . 0.29999999999999999 113.382 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 17.6 t -97.19 152.68 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.88 109.396 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.976 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 89.1 mttt -71.34 120.84 17.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.454 0.645 . . . . 1.1699999999999999 109.762 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.48 -26.97 4.27 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.872 -1.291 . . . . 0.41999999999999998 109.872 -172.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.6 OUTLIER -86.06 139.73 30.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.455 -0.943 . . . . 0.58999999999999997 108.455 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.9 m -86.17 128.91 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 108.075 -1.083 . . . . 1.22 108.075 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -124.91 146.46 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.175 -0.92 . . . . 0.25 110.778 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.478 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 37.1 p -95.38 113.02 24.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.099 -0.501 . . . . 0.28999999999999998 110.572 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.682 HG21 HD21 ' A' ' 99' ' ' LEU . 30.3 m -110.65 143.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.037 -0.665 . . . . 0.19 109.846 173.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.52 116.29 32.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.701 -1.592 . . . . 0.19 106.701 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.71 137.94 52.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.079 -1.049 . . . . 0.39000000000000001 111.024 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.2 mp0 -132.74 114.56 14.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.788 -1.93 . . . . 0.27000000000000002 105.788 165.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.628 HG23 ' HB3' ' A' ' 140' ' ' LEU . 75.3 m -102.36 126.43 49.38 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.529 -1.214 . . . . 0.19 111.414 -166.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 13.1 t -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.464 -0.789 . . . . 1.0600000000000001 109.498 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.3 mt -82.32 164.89 20.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.368 -0.833 . . . . 0.83999999999999997 109.863 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.69 -24.82 36.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.391 0.615 . . . . 1.1399999999999999 110.443 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -80.42 -12.81 59.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.344 -0.844 . . . . 2.1400000000000001 111.204 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.58 17.69 30.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.714 -0.755 . . . . 0.51000000000000001 112.039 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 m -102.55 110.05 21.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.581 0.229 . . . . 0.46000000000000002 111.525 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.2 mtt180 -74.87 115.41 14.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.523 0.678 . . . . 0.46999999999999997 110.083 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.659 ' HB ' ' CG ' ' A' ' 130' ' ' PRO . 27.0 m -99.51 -11.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.017 -0.992 . . . . 0.27000000000000002 111.989 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.618 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.6 pt20 -159.48 136.1 9.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.05 -0.523 . . . . 0.58999999999999997 110.144 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 38.0 tt0 -133.43 123.94 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.999 0.428 . . . . 1.3400000000000001 109.849 173.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -136.96 116.85 10.62 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.344 -0.844 . . . . 2.5899999999999999 109.71 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.418 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 61.2 Cg_endo -72.09 -14.49 28.96 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.118 2.546 . . . . 0.5 113.105 -170.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 22.7 tt0 -164.94 110.83 0.95 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.181 0.991 . . . . 1.3700000000000001 111.029 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.09 103.25 8.88 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.179 -1.828 . . . . 0.38 108.877 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.0 p -97.52 125.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.834 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.817 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 43.3 p90 -147.19 159.58 43.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 0.23000000000000001 110.952 -172.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 2.8 m -80.62 110.0 15.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.864 -0.607 . . . . 0.41999999999999998 110.176 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.976 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 13.8 tp -58.06 134.49 56.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.59999999999999998 110.955 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 74.47 11.54 82.54 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 121.043 -0.598 . . . . 0.37 112.375 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 27.0 t70 -112.58 8.56 19.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.192 -0.67 . . . . 0.93000000000000005 109.192 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 55.0 m 55.83 33.69 22.03 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.938 -1.028 . . . . 0.62 109.877 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.817 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 2.4 t0 -68.63 -14.6 63.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.393 1.092 . . . . 1.3300000000000001 108.693 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -133.96 -156.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.799 -1.546 . . . . 0.23000000000000001 110.539 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.5 pt -82.87 139.68 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.722 -1.214 . . . . 0.28999999999999998 107.722 175.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.524 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.3 tp-100 -58.23 -30.53 66.58 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.244 -0.182 . . . . 0.40000000000000002 110.955 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -54.5 -45.31 73.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.385 0.612 . . . . 0.20000000000000001 110.495 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 68' ' ' VAL . 59.4 tp -77.88 -38.77 45.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.323 -0.853 . . . . 0.22 110.665 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.68 -28.52 69.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.108 -0.951 . . . . 0.26000000000000001 109.585 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 77.5 mt -90.47 -34.95 15.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.199 -0.91 . . . . 0.25 111.883 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.4 t -64.17 -35.43 80.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 1.01 111.287 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.565 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.6 t -63.32 -55.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.633 0.605 . . . . 0.20999999999999999 112.633 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.845 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.7 Cg_endo -63.16 -22.05 72.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.814 1.676 . . . . 0.27000000000000002 111.839 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 39' ' ' ILE . 9.5 mt -81.68 -13.1 58.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.64000000000000001 111.271 173.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.671 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -106.42 157.19 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.959 -0.564 . . . . 0.78000000000000003 110.828 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.0 m-20 -96.37 153.56 17.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.96999999999999997 110.187 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.746 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -64.05 129.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.667 0.746 . . . . 0.80000000000000004 110.728 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.66 7.47 61.57 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.536 -1.211 . . . . 0.28000000000000003 112.348 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.815 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.3 pt-20 -97.45 166.61 11.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.517 0.675 . . . . 0.40999999999999998 111.546 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.419 HG22 HD12 ' A' ' 50' ' ' LEU . 13.0 m -127.59 117.66 22.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.823 -1.177 . . . . 0.22 107.823 172.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.24 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.944 0.402 . . . . 0.17999999999999999 110.331 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.6 ttp -101.8 117.79 35.58 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.561 -1.274 . . . . 1.3200000000000001 107.561 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.517 HG22 ' HG3' ' A' ' 47' ' ' LYS . 10.5 t -112.67 135.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.296 -0.411 . . . . 0.17999999999999999 109.989 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 50.6 m -114.57 112.66 23.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.37 -0.974 . . . . 0.20999999999999999 108.37 171.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.16 136.56 53.72 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.399 -1.728 . . . . 0.14999999999999999 109.688 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.689 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 11.1 t70 -53.05 149.5 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.112 -0.699 . . . . 0.57999999999999996 109.112 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.6 t -56.13 -28.06 56.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.191 0.52 . . . . 0.81999999999999995 110.385 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.627 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.2 ptpt -55.33 -29.95 59.29 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 121.945 -0.472 . . . . 0.81000000000000005 111.498 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 72.6 m-85 -95.11 0.17 54.05 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.243 0.544 . . . . 0.41999999999999998 110.271 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.66 ' HB3' HD22 ' A' ' 138' ' ' LEU . 61.8 m -122.56 -89.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.988 -1.005 . . . . 0.17999999999999999 110.581 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.8 m-85 -143.88 40.67 1.4 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.004 0.372 . . . . 0.23999999999999999 112.004 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.04 -82.9 0.04 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 0.25 113.965 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.97 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.536 2.158 . . . . 0.57999999999999996 111.003 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -104.83 -51.5 3.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.376 -0.829 . . . . 0.65000000000000002 109.721 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.618 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.05 141.74 3.14 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.401 -1.272 . . . . 0.29999999999999999 112.151 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.2 t -91.67 152.32 20.27 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.229 0.538 . . . . 0.33000000000000002 111.961 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -46.65 -48.32 20.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.464 -1.244 . . . . 3.1699999999999999 113.428 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 1.044 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 47.2 m -81.54 -65.95 0.24 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.124 -0.63 . . . . 1.23 109.896 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.044 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -107.01 127.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.295 1.997 . . . . 0.37 112.043 172.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -55.95 97.97 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.916 -1.142 . . . . 1.1399999999999999 107.916 164.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.599 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -66.5 126.49 92.26 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.678 -0.692 . . . . 0.39000000000000001 109.532 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.78 145.29 31.8 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.734 2.289 . . . . 0.60999999999999999 112.189 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.608 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.7 Cg_endo -63.94 133.23 37.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.059 1.839 . . . . 0.52000000000000002 111.817 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.689 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 32.3 m170 71.77 8.3 6.07 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.018 -0.992 . . . . 2.3799999999999999 112.16 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -69.96 122.11 18.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.737 -0.838 . . . . 0.26000000000000001 108.737 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.58 112.78 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 0.22 110.24 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -89.63 131.84 35.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.192 -0.913 . . . . 0.22 110.285 -177.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 23.7 t -121.3 101.19 7.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.853 0.835 . . . . 1.2 109.155 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -113.08 137.4 51.49 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.611 -1.177 . . . . 0.32000000000000001 111.61 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -101.71 115.69 31.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.489 -0.778 . . . . 1.05 109.227 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -117.08 121.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.667 0.617 . . . . 0.19 112.667 -175.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.8 m -92.75 109.02 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.243 -0.889 . . . . 0.28000000000000003 110.249 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 60' ' ' PRO . 64.3 tp -81.85 98.63 8.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.493 -0.929 . . . . 0.14999999999999999 108.493 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -94.71 -27.86 15.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.33 -0.85 . . . . 1.0800000000000001 110.775 -170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.478 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 7.8 m -153.39 151.74 30.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.292 -0.413 . . . . 0.37 111.458 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.58 128.5 27.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.565 -0.743 . . . . 0.25 109.061 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.11 130.51 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.232 0.539 . . . . 0.92000000000000004 110.365 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.45 133.64 43.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.789 -0.641 . . . . 2.27 109.339 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -161.45 25.44 0.13 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.554 -0.535 . . . . 1.97 109.554 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -71.72 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 2.1400000000000001 110.048 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.7 m170 69.16 -7.03 0.84 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.48 0.919 . . . . 5.79 113.48 170.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -87.87 73.91 9.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.487 0.661 . . . . 7.4800000000000004 110.474 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -116.28 -24.13 8.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.562 -0.745 . . . . 8.4600000000000009 109.307 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.476 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 69.8 m-70 -147.13 159.3 43.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.276 -0.875 . . . . 8.8300000000000001 109.084 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 64.3 m-70 73.44 130.0 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.136 0.897 . . . . 12.17 109.517 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.059 -0.719 . . . . 13.460000000000001 109.059 -168.704 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.729 0.3 . . . . 50.229999999999997 110.586 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.46 -83.71 0.88 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.993 -0.623 . . . . 47.990000000000002 111.87 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -140.46 88.9 10.85 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 46.259999999999998 109.715 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.66 169.04 18.84 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.777 2.318 . . . . 44.799999999999997 112.104 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.18 124.42 16.23 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.667 2.244 . . . . 44.020000000000003 112.429 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.96 129.27 44.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.806 -0.634 . . . . 42.5 109.451 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -78.91 -37.32 40.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.937 -0.394 . . . . 41.5 109.937 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -157.47 -26.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 40.329999999999998 110.195 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.3 -88.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.807 -0.633 . . . . 39.090000000000003 111.23 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -163.04 -56.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.692 -0.231 . . . . 38.82 110.808 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -116.56 79.74 9.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.602 0.239 . . . . 38.159999999999997 111.571 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.15 2.36 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.581 2.187 . . . . 36.700000000000003 112.072 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.98 -142.09 4.26 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.751 . . . . 35.609999999999999 111.345 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.99 84.66 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.264 0.555 . . . . 35.030000000000001 110.907 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.17 -25.48 18.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.565 -0.743 . . . . 34.009999999999998 110.855 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 57.95 29.14 17.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.102 -0.499 . . . . 32.890000000000001 111.95 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 17' ' ' ARG . 14.9 tpt85 -90.83 25.83 2.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 31.940000000000001 110.787 -175.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.733 ' HG3' ' HD1' ' A' ' 19' ' ' PHE . 21.8 tp10 -59.48 -75.32 0.06 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.693 -0.685 . . . . 31.239999999999998 111.496 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.733 ' HD1' ' HG3' ' A' ' 18' ' ' GLU . 44.2 p90 -147.07 11.6 1.05 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.73 0.3 . . . . 31.239999999999998 111.648 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.495 HD12 ' H ' ' A' ' 19' ' ' PHE . 5.8 mp -80.87 -62.39 1.68 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 29.850000000000001 111.306 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.81 145.71 55.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.308 -0.405 . . . . 28.199999999999999 110.383 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 177.88 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.203 -0.453 . . . . 26.780000000000001 111.72 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.3 ttm 59.44 77.63 0.3 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.103 -0.953 . . . . 27.469999999999999 111.423 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 5.6 tp10 -166.66 109.96 0.68 Allowed Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.77 -0.826 . . . . 24.41 108.77 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 20.2 Cg_exo -66.13 143.3 71.04 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.2 2.6 . . . . 21.629999999999999 113.203 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -67.12 144.24 98.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.903 -0.59 . . . . 20.670000000000002 110.216 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.73 125.45 14.32 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.088 1.858 . . . . 18.02 111.418 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -114.7 120.49 37.49 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.87 0.367 . . . . 14.93 111.114 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.87 127.82 16.79 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.647 2.232 . . . . 13.81 111.57 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.09 80.99 70.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.129 -0.487 . . . . 10.76 111.241 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.16 105.39 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 9.7699999999999996 111.544 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -71.22 139.35 84.68 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.825 -0.435 . . . . 5.8600000000000003 109.825 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.26 -25.95 64.46 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.669 2.246 . . . . 4.4699999999999998 112.858 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.86 -65.94 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 4.1299999999999999 111.268 -173.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 12.5 mm-40 -107.63 120.11 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 2.4500000000000002 109.713 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.649 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -109.06 -165.6 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.564 0.697 . . . . 0.53000000000000003 112.138 -170.464 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.7 125.02 28.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.706 -1.134 . . . . 0.5 111.233 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.629 ' HB3' ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -77.17 123.55 26.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.131 -0.486 . . . . 2.5099999999999998 111.113 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.63 HD12 HD11 ' A' ' 45' ' ' LEU . 6.9 mt -62.54 -41.28 91.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.46000000000000002 110.959 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.555 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 89.1 mt -113.21 0.68 14.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.75 0.309 . . . . 0.71999999999999997 111.424 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 38' ' ' ASP . . . 68.65 24.15 75.38 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.4 -0.68 . . . . 0.52000000000000002 111.4 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 40' ' ' LEU . 7.2 p30 -97.46 -24.74 15.46 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.94999999999999996 113.243 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.32 -19.28 48.99 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 121.308 -0.472 . . . . 0.71999999999999997 112.372 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 2.8 mm? -90.12 -28.86 18.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.839 0.352 . . . . 1.5600000000000001 110.491 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 39' ' ' ILE . 20.9 tp -122.86 109.29 13.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.32000000000000001 111.865 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 71.2 mtm180 -139.38 140.46 37.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.987 0.366 . . . . 1.1399999999999999 111.987 -173.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -113.23 123.44 50.18 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.985 0.514 . . . . 0.34999999999999998 110.137 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.2 ttpt -109.77 113.64 26.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 1.0700000000000001 110.708 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 p -74.07 100.66 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.347 -0.388 . . . . 0.33000000000000002 111.328 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 111' ' ' THR . 7.8 mt -65.8 -49.55 67.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.427 -1.323 . . . . 0.28000000000000003 107.427 172.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.806 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.7 t -136.61 126.32 15.84 Favored Pre-proline 0 CA--C 1.505 -0.772 0 CA-C-N 113.007 -1.906 . . . . 0.35999999999999999 106.712 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 19.5 Cg_endo -104.35 61.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.108 2.539 . . . . 0.54000000000000004 113.846 -177.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 163.49 8.51 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.546 -0.752 . . . . 0.55000000000000004 113.634 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 97.5 Cg_endo -79.83 172.12 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.031 2.488 . . . . 1.4199999999999999 111.141 173.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.57 48.45 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.957 2.438 . . . . 2.04 112.936 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.67 43.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.593 -0.603 . . . . 0.97999999999999998 111.593 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.676 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -95.69 -174.44 3.15 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.98999999999999999 111.352 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.1 t -152.15 136.85 17.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.065 -1.087 . . . . 1.28 108.065 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 10.4 ptp180 -91.68 113.48 58.87 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.528 -0.469 . . . . 2.8100000000000001 110.39 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD3' HG23 ' A' ' 108' ' ' VAL . 4.9 Cg_endo -47.47 142.21 13.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.985 3.123 . . . . 0.29999999999999999 113.653 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.715 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 16.9 t -92.05 156.86 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.386 -0.824 . . . . 0.88 109.645 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -63.53 111.92 2.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.132 0.491 . . . . 1.1699999999999999 110.199 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 151' ' ' GLU . . . 137.05 -33.44 2.31 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 114.827 -1.079 . . . . 0.41999999999999998 110.491 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.6 OUTLIER -74.56 139.19 43.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.904 -0.776 . . . . 0.58999999999999997 108.904 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 2.7 m -89.25 131.33 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.696 -1.224 . . . . 1.22 107.696 174.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.0 m -129.18 149.42 33.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.609 -0.723 . . . . 0.25 110.718 -171.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 24.7 p -98.68 113.01 24.91 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.82 -0.627 . . . . 0.28999999999999998 110.041 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.676 HG21 HD21 ' A' ' 99' ' ' LEU . 19.2 m -110.63 144.28 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 119.988 -0.685 . . . . 0.19 110.214 173.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.572 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.45 117.14 34.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.203 -1.406 . . . . 0.19 107.203 170.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -121.17 134.83 55.23 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.384 -0.926 . . . . 0.39000000000000001 110.62 177.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 2.3 mp0 -126.95 114.07 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.241 -2.133 . . . . 0.27000000000000002 105.241 167.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 140' ' ' LEU . 59.0 m -106.13 123.59 48.25 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.317 -1.311 . . . . 0.19 111.057 -164.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.958 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.9 OUTLIER -104.81 170.99 7.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.821 -0.627 . . . . 1.0600000000000001 109.448 -178.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt -97.12 165.4 12.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.433 -0.803 . . . . 0.83999999999999997 109.249 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 12.7 pt-20 -59.26 -16.76 23.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.832 0.348 . . . . 1.1399999999999999 110.715 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -94.98 -14.7 24.15 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.364 -0.38 . . . . 2.1400000000000001 110.92 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.38 -24.44 6.91 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.544 -0.836 . . . . 0.51000000000000001 113.933 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.4 m -67.54 114.97 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.81 0.67 . . . . 0.46000000000000002 112.81 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.89 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.6 mtt180 -77.98 118.52 20.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.608 0.718 . . . . 0.46999999999999997 110.499 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.776 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.3 m -96.58 -9.08 9.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.613 -1.176 . . . . 0.27000000000000002 112.06 -170.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.595 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.7 pt20 -164.92 129.07 2.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.42 -0.355 . . . . 0.58999999999999997 110.891 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -122.38 109.61 14.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.382 -0.599 . . . . 1.3400000000000001 109.382 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.25 113.75 25.99 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.59 -0.732 . . . . 2.5899999999999999 110.363 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 56.6 Cg_endo -71.26 -16.05 31.52 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.307 2.671 . . . . 0.5 113.491 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -163.05 108.76 1.13 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.206 1.003 . . . . 1.3700000000000001 112.088 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 tp -118.49 105.98 12.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.086 -1.87 . . . . 0.38 108.728 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -100.11 130.78 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.214 -0.448 . . . . 1.0 109.842 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.667 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 31.4 p90 -151.74 157.78 42.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.691 0.281 . . . . 0.23000000000000001 110.582 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.8 m -76.98 114.29 15.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.752 -0.658 . . . . 0.41999999999999998 109.711 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.903 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.7 tp -58.96 127.63 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.59999999999999998 111.376 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.81 4.22 90.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.997 -0.62 . . . . 0.37 112.344 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -89.72 -4.71 57.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.176 -1.046 . . . . 0.93000000000000005 108.176 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 19.5 m 56.95 32.88 22.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.57 -1.196 . . . . 0.62 109.92 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.61 -21.37 64.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.167 0.984 . . . . 1.3300000000000001 108.955 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 m -113.67 -158.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.714 -1.585 . . . . 0.23000000000000001 110.859 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 99' ' ' LEU . 32.6 pt -78.44 137.25 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.317 -1.364 . . . . 0.28999999999999998 107.317 173.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -57.57 -30.35 65.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.471 -0.331 . . . . 0.40000000000000002 110.781 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.8 -46.83 81.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.20000000000000001 110.788 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 68' ' ' VAL . 48.5 tp -71.26 -40.3 71.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.22 110.728 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.07 -30.34 70.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.801 -1.09 . . . . 0.26000000000000001 109.977 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 40' ' ' LEU . 82.2 mt -91.44 -33.36 15.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.353 -0.839 . . . . 0.25 112.472 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.8 t -65.64 -32.11 73.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 1.01 111.119 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.667 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 57.9 t -66.38 -52.83 34.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.767 0.654 . . . . 0.20999999999999999 112.767 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -62.81 -19.98 70.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.634 1.556 . . . . 0.27000000000000002 112.113 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.518 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.9 mt -83.18 -16.14 47.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.476 0.655 . . . . 0.64000000000000001 111.109 170.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.797 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 28.3 ttm -96.16 141.5 29.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.744 -1.116 . . . . 0.78000000000000003 111.572 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.92 151.08 19.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.914 -0.402 . . . . 0.96999999999999997 109.914 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.654 HG23 ' HD3' ' A' ' 60' ' ' PRO . 3.7 t -59.73 124.3 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.80000000000000004 110.639 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.28 14.12 46.13 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.481 -0.782 . . . . 0.28000000000000003 112.787 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.806 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -104.31 168.23 9.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.615 0.708 . . . . 0.40999999999999998 110.574 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.443 HG22 HD12 ' A' ' 50' ' ' LEU . 17.9 m -133.65 117.97 17.62 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.923 -1.14 . . . . 0.22 107.923 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.08 140.98 52.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.181 0.515 . . . . 0.17999999999999999 110.805 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.423 ' HG2' ' CH2' ' A' ' 36' ' ' TRP . 16.9 ttt -98.12 117.88 33.49 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.297 -1.372 . . . . 1.3200000000000001 107.297 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.8 130.46 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.566 -0.531 . . . . 0.17999999999999999 109.566 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 99.3 m -108.3 114.45 28.33 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.652 -0.819 . . . . 0.20999999999999999 109.023 173.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -124.61 134.17 53.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.017 -1.447 . . . . 0.14999999999999999 110.063 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.749 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 9.6 t70 -52.31 147.5 7.81 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.57999999999999996 108.682 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.663 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.4 t -57.98 -25.68 61.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.232 0.539 . . . . 0.81999999999999995 110.138 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.624 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 4.2 ptpp? -55.32 -29.79 58.95 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.111 -0.368 . . . . 0.81000000000000005 111.29 173.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 97.3 m-85 -98.51 3.0 48.13 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.219 0.533 . . . . 0.41999999999999998 110.268 175.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.0 m -123.63 -91.59 0.54 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.148 -0.933 . . . . 0.17999999999999999 110.701 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 12.3 m-85 -141.91 42.83 1.7 Allowed 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 112.15 0.426 . . . . 0.23999999999999999 112.15 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.58 -86.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.163 -0.542 . . . . 0.25 113.572 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.26 11.92 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.536 2.158 . . . . 0.57999999999999996 111.09 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.4 mt-30 -103.2 -46.75 4.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.6 -0.727 . . . . 0.65000000000000002 109.968 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.559 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.95 144.28 2.22 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.693 -1.139 . . . . 0.29999999999999999 112.188 -175.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.649 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.9 t -91.16 158.74 16.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.229 -0.486 . . . . 0.33000000000000002 112.09 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -47.05 -55.49 8.17 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.811 -1.086 . . . . 3.1699999999999999 111.943 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.915 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 22.9 t -80.92 -62.95 0.34 Allowed Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.534 -0.466 . . . . 1.23 110.158 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.915 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.7 Cg_endo -106.08 127.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.348 2.032 . . . . 0.37 112.11 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 49.2 t80 -55.91 98.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.346 -0.983 . . . . 1.1399999999999999 108.346 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.612 HG12 ' CB ' ' A' ' 127' ' ' SER . 32.3 mm -66.49 128.24 93.75 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.668 -0.697 . . . . 0.39000000000000001 109.917 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.7 Cg_endo -54.59 139.29 75.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.572 2.181 . . . . 0.60999999999999999 112.144 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.527 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 72.2 Cg_exo -52.54 129.06 30.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.815 2.343 . . . . 0.52000000000000002 112.918 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.633 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 66.3 m170 70.11 15.54 7.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.992 -1.004 . . . . 2.3799999999999999 112.508 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.92 123.79 26.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.87 -0.789 . . . . 0.26000000000000001 108.87 170.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -74.11 115.96 14.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.328 0.585 . . . . 0.22 110.308 -173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.654 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.95 136.21 33.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.007 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.958 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 30.7 p -119.54 98.56 6.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.037 0.922 . . . . 1.2 110.026 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -110.41 134.69 52.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.004 -0.998 . . . . 0.32000000000000001 111.647 -173.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 46.4 tt0 -100.78 111.73 24.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.799 . . . . 1.05 109.084 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.621 HG11 HD13 ' A' ' 99' ' ' LEU . 1.3 m -112.17 117.05 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.516 0.674 . . . . 0.19 112.716 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.0 m -89.91 114.03 25.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.945 -1.025 . . . . 0.28000000000000003 110.573 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.741 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.8 tp -85.82 96.07 9.63 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.962 -0.755 . . . . 0.14999999999999999 108.962 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.5 mtmt -91.85 -30.49 16.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.55 -0.75 . . . . 1.0800000000000001 110.8 -171.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.508 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 19.1 m -151.93 148.07 27.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.484 -0.326 . . . . 0.37 111.167 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.92 128.79 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.244 -0.65 . . . . 0.25 109.244 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.462 HG23 HD22 ' A' ' 150' ' ' LEU . 36.0 m -128.93 135.89 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.568 -0.853 . . . . 0.92000000000000004 111.677 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -89.52 116.43 27.68 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.301 -0.863 . . . . 2.27 110.948 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.462 HD22 HG23 ' A' ' 148' ' ' VAL . 2.6 pt? -158.14 -37.46 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.105 -0.952 . . . . 1.97 109.11 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.862 ' HG2' ' H ' ' A' ' 152' ' ' HIS . 9.9 tt0 60.83 -169.16 0.16 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.499 -1.682 . . . . 2.1400000000000001 111.253 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.862 ' H ' ' HG2' ' A' ' 151' ' ' GLU . 8.6 t-160 -152.45 12.98 0.55 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.701 0.286 . . . . 5.79 110.858 -174.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -97.28 75.37 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 7.4800000000000004 110.578 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.3 m170 65.58 -99.36 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.149 -0.932 . . . . 8.4600000000000009 112.718 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -131.4 153.85 49.24 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.041 0.448 . . . . 8.8300000000000001 111.396 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.47 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 11.0 m170 -119.16 -45.67 2.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.923 -1.14 . . . . 12.17 107.923 169.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--O 1.247 0.96 0 CA-C-N 114.492 -1.231 . . . . 13.460000000000001 108.046 166.001 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.517 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.92 -0.4 . . . . 50.229999999999997 109.92 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.79 43.51 1.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.649 -0.786 . . . . 47.990000000000002 112.961 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.633 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.2 tm0? -164.59 -53.94 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.39 -0.338 . . . . 46.259999999999998 110.672 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 87.1 Cg_exo -48.33 -50.63 11.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.213 1.942 . . . . 44.799999999999997 113.994 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 10.8 Cg_exo -71.83 124.62 10.32 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.679 1.586 . . . . 44.020000000000003 111.345 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.95 146.51 45.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.782 0.325 . . . . 42.5 110.998 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.756 ' HG3' ' H ' ' A' ' 9' ' ' ALA . 9.9 tp10 -106.95 146.54 30.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 41.5 109.64 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.73 -7.58 49.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.28 -0.418 . . . . 40.329999999999998 110.868 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.756 ' H ' ' HG3' ' A' ' 7' ' ' GLU . . . -75.67 -28.96 58.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.167 -0.469 . . . . 39.090000000000003 110.818 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 63.11 93.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.517 -0.765 . . . . 38.82 111.745 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -169.84 79.01 0.65 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.417 -0.811 . . . . 38.159999999999997 110.296 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -88.01 -179.43 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.724 2.283 . . . . 36.700000000000003 112.13 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.87 129.38 10.77 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.64 -0.791 . . . . 35.609999999999999 111.975 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.7 116.59 29.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.696 0.284 . . . . 35.030000000000001 110.957 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.91 176.93 7.82 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.952 -0.388 . . . . 34.009999999999998 109.952 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 62.54 82.57 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.566 0.698 . . . . 32.890000000000001 110.457 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -131.25 156.53 45.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.492 -0.776 . . . . 31.940000000000001 109.82 -176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.03 78.45 8.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.755 0.788 . . . . 31.239999999999998 110.235 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -139.63 147.91 41.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.98 -1.009 . . . . 31.239999999999998 109.686 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.8 mt -71.65 103.69 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.292 -0.413 . . . . 29.850000000000001 110.143 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 24' ' ' GLU . . . -76.07 71.0 2.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.161 0.505 . . . . 28.199999999999999 111.049 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.75 -36.65 15.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.851 -0.613 . . . . 26.780000000000001 110.978 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.6 mtp -120.52 15.26 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.016 0.436 . . . . 27.469999999999999 110.768 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 34.8 mt-10 -138.78 117.11 9.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 24.41 110.663 175.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.12 159.21 26.85 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.503 2.135 . . . . 21.629999999999999 111.083 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.01 142.28 56.96 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.56 -0.291 . . . . 20.670000000000002 110.747 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.17 112.41 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.937 2.425 . . . . 18.02 112.232 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -79.34 147.18 68.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.853 -0.612 . . . . 14.93 110.561 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 15.7 Cg_exo -67.83 128.76 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.587 2.191 . . . . 13.81 112.137 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -94.42 -51.49 0.25 Allowed Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.231 -0.44 . . . . 10.76 111.565 177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 5.2 Cg_exo -75.03 104.27 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.841 1.694 . . . . 9.7699999999999996 111.665 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.5 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . . . -69.02 147.3 97.7 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.494 . . . . 5.8600000000000003 110.267 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.63 -2.36 12.57 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.537 2.158 . . . . 4.4699999999999998 112.864 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.29 150.9 51.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 4.1299999999999999 110.146 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.93 130.98 35.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.595 . . . . 2.4500000000000002 111.449 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.548 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.3 m0 -84.12 -168.93 2.35 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.392 0.615 . . . . 0.53000000000000003 110.634 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.6 tp -83.49 115.22 21.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.5 110.136 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -78.68 121.97 25.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.187 -0.671 . . . . 2.5099999999999998 109.187 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.643 HG23 HD11 ' A' ' 105' ' ' LEU . 13.5 mt -60.18 -35.91 64.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.188 -0.915 . . . . 0.46000000000000002 110.552 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 74.3 mt -102.54 -3.42 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.71999999999999997 110.565 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.05 27.9 65.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.52000000000000002 111.718 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.604 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -111.66 -23.22 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.012 0.745 . . . . 0.94999999999999996 113.012 -175.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 109.24 30.73 3.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.95 -1.119 . . . . 0.71999999999999997 114.377 168.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -151.77 -9.26 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.985 0.392 . . . . 1.5600000000000001 110.784 175.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.607 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 3.2 tp -119.5 99.47 6.69 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.32000000000000001 109.975 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 62.0 mtm180 -139.14 136.58 35.28 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.014 -0.675 . . . . 1.1399999999999999 112.065 -171.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 11.2 ttpt -112.52 124.52 52.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.217 -0.447 . . . . 0.34999999999999998 110.361 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 28.9 ttpp -112.88 117.46 32.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.87 0.367 . . . . 1.0700000000000001 110.524 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.9 p -73.62 106.45 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.275 -0.421 . . . . 0.33000000000000002 111.285 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 141' ' ' GLU . 12.0 mt -68.66 -52.13 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.798 -1.556 . . . . 0.28000000000000003 106.798 170.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.873 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 93.0 t -131.37 135.42 27.02 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 113.143 -1.844 . . . . 0.35999999999999999 106.071 168.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 40.3 Cg_endo -108.77 54.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.946 2.431 . . . . 0.54000000000000004 113.834 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.601 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 79.31 157.9 12.94 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.853 -0.612 . . . . 0.55000000000000004 113.319 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 18.8 Cg_exo -67.11 163.14 35.25 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.535 2.156 . . . . 1.4199999999999999 109.945 170.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.07 -11.46 10.19 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.561 2.174 . . . . 2.04 112.965 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -126.66 53.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.168 -0.539 . . . . 0.97999999999999998 112.016 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 9.3 p -84.81 -172.28 4.09 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.507 0.67 . . . . 0.98999999999999999 111.439 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.631 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 23.0 t -159.09 130.67 6.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.936 -1.135 . . . . 1.28 107.936 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 83.8 mtt180 -90.44 112.85 55.17 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 120.918 -0.313 . . . . 2.8100000000000001 110.313 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HG3' HD21 ' A' ' 144' ' ' LEU . 6.2 Cg_endo -47.3 152.99 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.831 3.021 . . . . 0.29999999999999999 114.142 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 11.4 t -102.67 151.56 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.211 -0.904 . . . . 0.88 109.774 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 62.7 mttt -64.24 108.78 1.67 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.02 0.914 . . . . 1.1699999999999999 110.792 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.3 -31.5 2.34 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.772 -1.558 . . . . 0.41999999999999998 110.125 -174.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.8 mm-40 -71.89 140.19 49.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.21 0.529 . . . . 0.58999999999999997 109.89 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 148' ' ' VAL . 65.4 t -84.68 119.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.598 -0.89 . . . . 1.22 108.598 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.2 m -124.54 147.97 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.11 0.411 . . . . 0.25 112.11 -170.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 30.0 p -102.26 116.52 32.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.923 -0.58 . . . . 0.28999999999999998 110.39 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.753 HG21 HD21 ' A' ' 99' ' ' LEU . 17.1 m -111.18 144.94 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.111 0.481 . . . . 0.19 110.06 172.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.9 t-160 -102.11 120.38 40.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.909 -1.515 . . . . 0.19 106.909 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.9 OUTLIER -125.36 135.11 52.1 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 119.426 -0.91 . . . . 0.39000000000000001 110.474 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.652 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 1.1 mp0 -127.52 114.97 18.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.902 -1.888 . . . . 0.27000000000000002 105.902 169.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.626 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 22.8 m -110.63 122.38 47.65 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.409 -1.268 . . . . 0.19 111.53 -165.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.967 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.7 OUTLIER -104.65 171.16 7.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.317 -0.856 . . . . 1.0600000000000001 108.851 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 80' ' ' VAL . 11.4 mt -97.53 167.46 10.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.537 -0.756 . . . . 0.83999999999999997 109.936 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.62 -17.64 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.313 0.383 . . . . 1.1399999999999999 111.236 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.32 -14.64 20.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.674 0.273 . . . . 2.1400000000000001 110.921 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.08 7.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.637 -0.792 . . . . 0.51000000000000001 113.651 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 m -63.26 112.06 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.228 0.455 . . . . 0.46000000000000002 112.228 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.9 mtt180 -74.28 118.23 17.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.847 0.832 . . . . 0.46999999999999997 110.571 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.928 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.1 m -96.68 -9.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.452 -1.249 . . . . 0.27000000000000002 110.928 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.626 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 18.1 pt20 -166.55 146.76 5.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.606 -0.724 . . . . 0.58999999999999997 109.753 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 71' ' ' GLN . 15.2 tt0 -150.96 103.29 3.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.173 -1.047 . . . . 1.3400000000000001 108.173 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 4.7 mm-40 -126.72 113.81 22.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.541 -0.754 . . . . 2.5899999999999999 110.308 -170.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 37.7 Cg_endo -65.7 -12.32 34.64 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.014 2.476 . . . . 0.5 112.982 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -151.94 112.02 4.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.366 0.603 . . . . 1.3700000000000001 110.724 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.428 ' HB3' HG23 ' A' ' 68' ' ' VAL . 50.8 tp -130.11 106.99 8.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.835 -1.075 . . . . 0.38 108.287 172.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.9 p -108.36 138.08 36.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.825 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 30.1 p90 -160.97 166.54 28.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.23000000000000001 110.868 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.1 m -86.0 115.07 23.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 0.41999999999999998 109.633 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.85 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.4 tp -60.54 126.64 28.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.59999999999999998 110.396 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 91.18 6.66 66.42 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.691 -0.766 . . . . 0.37 112.976 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.11 -8.62 21.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.93000000000000005 109.978 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.7 m 58.15 36.9 26.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.62 109.342 -172.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 22.1 t70 -70.75 -17.61 62.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.538 1.161 . . . . 1.3300000000000001 108.044 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.7 m -119.19 -154.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.323 -1.762 . . . . 0.23000000000000001 110.353 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.8 pt -83.0 138.81 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.647 -1.242 . . . . 0.28999999999999998 107.647 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.4 tp-100 -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.904 -0.318 . . . . 0.40000000000000002 110.898 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.14 -42.25 72.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.20000000000000001 110.627 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.753 HD21 HG21 ' A' ' 68' ' ' VAL . 56.5 tp -75.72 -40.78 55.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.729 -0.668 . . . . 0.22 110.551 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.14 -28.53 69.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.046 -0.979 . . . . 0.26000000000000001 109.883 -176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 76.1 mt -90.13 -36.59 14.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.006 -0.997 . . . . 0.25 111.893 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.1 t -67.96 -28.18 67.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.751 -0.204 . . . . 1.01 111.275 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.571 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 55.0 t -65.87 -55.8 20.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.401 0.519 . . . . 0.20999999999999999 112.401 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.85 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.1 Cg_endo -63.43 -18.77 66.07 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 121.998 1.799 . . . . 0.27000000000000002 111.906 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 39' ' ' ILE . 13.1 mt -84.32 -14.21 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.64000000000000001 111.239 173.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.811 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 1.1 ttp -105.84 141.15 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.239 -0.437 . . . . 0.78000000000000003 110.934 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 m-20 -79.01 152.48 30.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.867 0.365 . . . . 0.96999999999999997 110.067 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -65.58 126.29 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.653 0.74 . . . . 0.80000000000000004 109.789 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.81 10.71 56.23 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.117 -0.947 . . . . 0.28000000000000003 112.143 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.873 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.38 170.36 7.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.357 0.599 . . . . 0.40999999999999998 110.58 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.3 m -133.19 119.25 19.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.473 -0.936 . . . . 0.22 108.473 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.436 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -117.1 139.65 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.817 -0.629 . . . . 0.17999999999999999 110.663 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.5 ttt -97.8 117.09 31.34 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.654 -1.239 . . . . 1.3200000000000001 107.654 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.64 130.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.833 -0.622 . . . . 0.17999999999999999 109.359 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 91.8 m -107.16 114.09 27.93 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.38 -0.97 . . . . 0.20999999999999999 108.38 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -123.12 135.43 54.36 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.0 -1.455 . . . . 0.14999999999999999 109.651 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.1 t70 -55.71 148.86 15.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.767 -0.827 . . . . 0.57999999999999996 108.767 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -57.5 -27.21 62.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.376 0.608 . . . . 0.81999999999999995 110.132 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 18.6 ptpt -55.26 -31.78 61.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.242 -0.435 . . . . 0.81000000000000005 111.167 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.638 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 95.9 m-85 -100.84 10.77 40.72 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.41999999999999998 109.902 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.675 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 71.0 m -125.92 -93.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.17999999999999999 110.521 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.556 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 6.8 m-85 -141.45 41.82 1.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.369 -0.532 . . . . 0.23999999999999999 112.076 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.72 -84.81 0.03 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.143 -0.551 . . . . 0.25 113.67 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.67 8.49 4.22 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.551 2.167 . . . . 0.57999999999999996 111.088 175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.6 mt-30 -104.13 -47.15 4.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.65000000000000002 110.216 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.76 144.18 2.12 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.873 -1.058 . . . . 0.29999999999999999 112.094 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 10.9 t -91.61 157.63 16.88 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.294 -0.453 . . . . 0.33000000000000002 111.461 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.508 ' NH2' ' HG3' ' A' ' 83' ' ' GLU . 21.0 ptt180 -57.0 -43.1 81.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.613 -0.721 . . . . 3.1699999999999999 112.102 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.629 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -80.38 -68.87 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.333 -0.547 . . . . 1.23 110.354 175.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.928 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -106.3 129.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.857 2.371 . . . . 0.37 112.145 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 33.6 t80 -55.17 99.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.135 -1.061 . . . . 1.1399999999999999 108.135 163.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.1 mm -65.92 131.79 94.62 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 115.953 -0.567 . . . . 0.39000000000000001 110.285 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.61 138.46 40.12 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.845 2.363 . . . . 0.60999999999999999 111.908 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.743 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.9 Cg_endo -64.53 135.75 47.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.175 1.917 . . . . 0.52000000000000002 112.125 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.557 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 48.6 m-70 71.71 5.66 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.239 -0.891 . . . . 2.3799999999999999 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.02 125.63 28.08 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.595 -0.521 . . . . 0.26000000000000001 109.595 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.93 113.72 11.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.393 -0.523 . . . . 0.22 110.181 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.626 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.23 133.0 34.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.515 -0.766 . . . . 0.22 111.07 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.967 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 31.6 p -116.93 100.01 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.371 1.081 . . . . 1.2 110.05 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.59 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.4 OUTLIER -115.17 137.71 51.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.886 -1.052 . . . . 0.32000000000000001 111.632 -172.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.652 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 26.4 tt0 -103.36 114.58 28.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.05 108.305 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 99' ' ' LEU . 2.5 m -111.79 119.48 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.421 0.629 . . . . 0.19 112.2 -174.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 6.3 m -95.11 113.02 24.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.271 -0.877 . . . . 0.28000000000000003 110.156 174.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.589 HD21 ' HG3' ' A' ' 60' ' ' PRO . 60.4 tp -84.33 98.75 10.19 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.859 -0.793 . . . . 0.14999999999999999 108.859 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.7 mtmt -97.75 -26.12 14.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.159 -0.928 . . . . 1.0800000000000001 111.253 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.503 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 23.9 m -153.63 150.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.901 0.381 . . . . 0.37 111.773 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -143.78 128.3 18.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.659 -0.701 . . . . 0.25 109.406 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.1 m -126.22 138.23 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.92000000000000004 110.344 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 9.5 t70 -86.9 121.32 29.22 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.806 -0.357 . . . . 2.27 110.218 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.74 14.12 0.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.031 0.443 . . . . 1.97 110.23 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.16 146.44 52.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 2.1400000000000001 110.354 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -75.94 110.24 10.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 5.79 110.147 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -90.94 -61.97 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 7.4800000000000004 110.285 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -153.69 115.74 4.31 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.859 -0.336 . . . . 8.4600000000000009 110.743 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -90.61 107.08 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 8.8300000000000001 110.023 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -76.18 145.16 40.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.755 0.312 . . . . 12.17 110.695 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.384 -0.817 . . . . 13.460000000000001 109.597 175.109 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.889 0.376 . . . . 50.229999999999997 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.51 -156.58 10.45 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.918 -0.658 . . . . 47.990000000000002 112.913 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -121.52 93.97 48.63 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.576 -0.528 . . . . 46.259999999999998 109.576 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.622 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 31.5 Cg_exo -57.97 -56.98 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.587 2.191 . . . . 44.799999999999997 113.906 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 87.5 Cg_endo -85.96 132.72 4.03 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.648 1.565 . . . . 44.020000000000003 113.065 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.95 5.72 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.626 0.727 . . . . 42.5 109.921 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.8 54.27 3.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.282 -0.872 . . . . 41.5 109.731 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.73 -5.76 49.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.773 -0.649 . . . . 40.329999999999998 112.086 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.36 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.594 -0.276 . . . . 39.090000000000003 111.338 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 74.53 -55.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.648 0.779 . . . . 38.82 110.352 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -138.95 96.53 9.16 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.663 -0.699 . . . . 38.159999999999997 109.507 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.54 176.92 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.392 2.728 . . . . 36.700000000000003 113.029 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.94 -175.46 22.61 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.122 -0.791 . . . . 35.609999999999999 111.122 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.26 -3.41 19.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.821 0.31 . . . . 35.030000000000001 110.197 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.9 mt 59.13 72.69 0.52 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.439 -0.801 . . . . 34.009999999999998 110.639 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.41 -38.21 7.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.322 -0.853 . . . . 32.890000000000001 110.447 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 59.41 83.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.951 0.782 . . . . 31.940000000000001 111.487 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -79.9 54.48 1.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.26 -0.427 . . . . 31.239999999999998 110.28 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -64.84 -38.72 91.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 31.239999999999998 110.72 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.3 tp -170.76 46.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.338 0.589 . . . . 29.850000000000001 109.842 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.34 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 28.199999999999999 110.247 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 71.06 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.201 0.938 . . . . 26.780000000000001 112.505 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.5 mmt -102.78 15.36 29.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 27.469999999999999 110.148 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 53.0 tt0 -103.78 125.73 33.85 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-N 115.476 -0.783 . . . . 24.41 109.541 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 9.3 Cg_endo -51.96 154.32 10.4 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 124.38 3.387 . . . . 21.629999999999999 112.638 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 81.8 mm-40 -53.12 141.49 39.92 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 116.033 -0.531 . . . . 20.670000000000002 110.238 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 11.4 Cg_exo -69.21 85.72 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.61 2.207 . . . . 18.02 112.276 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.84 93.6 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.384 -0.825 . . . . 14.93 109.127 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.06 127.4 14.89 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.706 2.271 . . . . 13.81 113.11 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.95 77.88 55.41 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.502 -0.772 . . . . 10.76 109.622 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 103.86 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.864 2.376 . . . . 9.7699999999999996 111.684 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.68 61.53 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.579 -0.526 . . . . 5.8600000000000003 109.579 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.98 -10.3 21.19 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.658 2.239 . . . . 4.4699999999999998 112.874 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.518 ' HA ' ' HE1' ' A' ' 36' ' ' TRP . 35.8 mm-40 -95.69 5.82 50.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.435 . . . . 4.1299999999999999 111.742 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.539 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -98.29 84.41 3.23 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.081 -0.711 . . . . 2.4500000000000002 109.081 167.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.593 ' NE1' ' HE2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -83.71 -172.33 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.53000000000000003 110.76 -173.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.02 111.39 5.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.084 -0.962 . . . . 0.5 110.551 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.655 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.1 t70 -73.18 125.55 27.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.367 -0.533 . . . . 2.5099999999999998 110.083 173.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.652 HG23 HD11 ' A' ' 105' ' ' LEU . 7.7 mt -56.3 -32.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.808 -1.087 . . . . 0.46000000000000002 111.656 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.32 -1.73 13.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.101 -0.499 . . . . 0.71999999999999997 110.32 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.98 26.61 65.81 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.169 -0.772 . . . . 0.52000000000000002 111.169 -172.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' HD23 ' A' ' 44' ' ' LEU . 1.1 p30 -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.366 -0.417 . . . . 0.94999999999999996 110.583 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.478 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.8 -4.15 21.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.939 -0.648 . . . . 0.71999999999999997 112.988 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 4.2 mm? -112.19 -27.41 8.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.869 0.322 . . . . 1.5600000000000001 111.869 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.561 HD11 HD12 ' A' ' 39' ' ' ILE . 16.9 tp -120.62 100.66 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.3 -0.409 . . . . 0.32000000000000001 110.74 -170.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 89.7 mtm180 -133.18 141.44 48.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.6 0.222 . . . . 1.1399999999999999 111.6 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.0 ttpt -114.09 123.8 50.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.421 -0.354 . . . . 0.34999999999999998 110.244 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 18.2 ttmt -103.58 118.96 37.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.983 -0.377 . . . . 1.0700000000000001 109.983 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.441 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 1.3 p -76.02 96.74 3.86 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.989 -0.55 . . . . 0.33000000000000002 110.5 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD12 HG22 ' A' ' 111' ' ' THR . 12.5 mt -63.66 -52.93 58.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.893 -1.521 . . . . 0.28000000000000003 106.893 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.881 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 85.1 t -132.84 127.1 20.15 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-N 113.038 -1.892 . . . . 0.35999999999999999 106.157 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HB3' ' CG2' ' A' ' 49' ' ' THR . 30.4 Cg_endo -106.66 56.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.956 2.437 . . . . 0.54000000000000004 114.502 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 82.58 129.44 1.31 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.118 -0.563 . . . . 0.55000000000000004 113.201 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 127.85 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.041 1.828 . . . . 1.4199999999999999 110.306 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -37.58 118.41 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.631 2.887 . . . . 2.04 113.453 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.74 17.06 10.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.486 -0.779 . . . . 0.97999999999999998 111.919 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 p -80.96 -171.05 3.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.292 0.568 . . . . 0.98999999999999999 111.26 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -153.86 144.35 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.786 -0.82 . . . . 1.28 108.786 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.499 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 48.1 mtm180 -92.51 110.1 42.77 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.846 -0.428 . . . . 2.8100000000000001 109.846 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.755 ' HD3' HG23 ' A' ' 108' ' ' VAL . 5.8 Cg_endo -47.36 141.21 14.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.353 2.702 . . . . 0.29999999999999999 113.529 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.682 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.0 t -89.56 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.432 -0.804 . . . . 0.88 109.435 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.726 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 56.1 mttt -63.38 106.17 0.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.838 0.828 . . . . 1.1699999999999999 110.85 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.89 -28.85 2.12 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.145 -1.388 . . . . 0.41999999999999998 110.199 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.6 OUTLIER -79.28 128.0 32.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.859 -0.793 . . . . 0.58999999999999997 108.859 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.8 m -78.32 129.79 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.055 -1.091 . . . . 1.22 108.055 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.9 m -125.99 146.65 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.997 -0.547 . . . . 0.25 110.284 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.9 p -95.94 112.31 24.07 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.897 -0.592 . . . . 0.28999999999999998 109.825 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.713 HG21 HD21 ' A' ' 99' ' ' LEU . 7.4 m -110.5 142.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.849 -0.614 . . . . 0.19 110.074 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -100.76 116.42 32.61 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.721 -1.585 . . . . 0.19 106.721 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 136.94 53.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.285 1.041 . . . . 0.39000000000000001 111.336 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.429 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 1.0 OUTLIER -133.08 113.3 12.6 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.003 -1.851 . . . . 0.27000000000000002 106.003 165.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.617 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.1 m -101.37 127.18 48.12 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.743 -1.117 . . . . 0.19 111.29 -168.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 17.1 t -104.89 160.46 14.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.309 -0.86 . . . . 1.0600000000000001 109.626 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.444 HD21 HG11 ' A' ' 80' ' ' VAL . 13.7 mt -89.64 166.06 13.85 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.521 -0.763 . . . . 0.83999999999999997 109.795 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.26 -17.84 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.578 0.549 . . . . 1.1399999999999999 110.743 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -92.61 -8.68 43.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.641 -0.709 . . . . 2.1400000000000001 111.162 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.38 40.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.838 -0.696 . . . . 0.51000000000000001 111.855 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 m -98.17 109.91 22.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.878 0.371 . . . . 0.46000000000000002 111.469 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.7 mtt180 -76.04 116.42 16.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.46999999999999997 110.539 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.765 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -101.98 -8.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.561 -1.2 . . . . 0.27000000000000002 111.886 -168.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.617 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.2 pt20 -160.57 136.13 8.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.107 -0.497 . . . . 0.58999999999999997 109.983 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -136.41 112.65 9.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.008 0.433 . . . . 1.3400000000000001 110.283 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.0 115.51 15.41 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.436 0.636 . . . . 2.5899999999999999 110.221 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 55.9 Cg_endo -71.05 -13.26 31.31 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.201 2.601 . . . . 0.5 113.637 -172.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -160.16 110.41 1.84 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.292 1.044 . . . . 1.3700000000000001 111.571 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 68' ' ' VAL . 21.1 tp -119.62 100.59 7.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.126 -1.852 . . . . 0.38 108.756 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 10.7 p -95.73 132.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.0 p90 -153.47 158.43 41.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.612 -0.267 . . . . 0.23000000000000001 110.445 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.493 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 5.6 m -79.04 113.65 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 109.788 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.827 HD11 ' HD3' ' A' ' 104' ' ' PRO . 16.4 tp -61.76 130.27 44.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.455 . . . . 0.59999999999999998 109.921 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.726 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 83.51 6.35 87.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.37 111.947 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 32.3 t70 -100.12 -5.62 27.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.12 -0.696 . . . . 0.93000000000000005 109.12 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.8 m 54.9 34.09 21.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.125 -0.943 . . . . 0.62 109.839 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.74 -9.13 58.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.445 1.117 . . . . 1.3300000000000001 108.765 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.3 m -125.26 -159.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 113.531 -1.668 . . . . 0.23000000000000001 110.711 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.5 pt -81.62 138.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.088 -1.449 . . . . 0.28999999999999998 107.088 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.482 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.8 tp-100 -60.74 -28.68 68.87 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.835 -0.346 . . . . 0.40000000000000002 110.899 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.07 -37.32 69.14 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.079 0.466 . . . . 0.20000000000000001 110.679 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 68' ' ' VAL . 52.7 tp -81.84 -40.65 22.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.637 . . . . 0.22 110.719 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -61.93 -27.91 69.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.434 -0.803 . . . . 0.26000000000000001 109.886 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 66.3 mt -90.97 -36.54 14.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.335 -0.848 . . . . 0.25 112.355 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.542 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 p -72.03 -26.46 62.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.63 -0.428 . . . . 1.01 111.189 -173.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.513 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -64.6 -55.74 27.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.457 0.539 . . . . 0.20999999999999999 112.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.827 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -61.09 -24.44 79.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.071 1.847 . . . . 0.27000000000000002 112.007 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.652 HD11 HG23 ' A' ' 39' ' ' ILE . 17.0 mt -73.1 -30.84 63.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.152 -0.477 . . . . 0.64000000000000001 111.155 172.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.82 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -92.07 152.72 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.78000000000000003 111.425 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -90.52 151.89 21.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.002 0.43 . . . . 0.96999999999999997 110.642 178.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.755 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.5 t -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.33 0.586 . . . . 0.80000000000000004 110.337 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.63 43.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.362 -0.835 . . . . 0.28000000000000003 112.548 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.881 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.4 168.18 9.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.407 0.622 . . . . 0.40999999999999998 110.971 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 50' ' ' LEU . 20.9 m -130.63 117.44 19.51 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.175 -1.046 . . . . 0.22 108.175 174.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.35 138.27 53.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.032 0.444 . . . . 0.17999999999999999 110.684 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.2 ttp -98.42 116.82 31.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.3200000000000001 107.216 173.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.647 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.9 t -112.25 132.04 62.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.661 -0.496 . . . . 0.17999999999999999 109.661 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.544 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 91.4 m -109.39 112.87 25.25 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.175 -1.046 . . . . 0.20999999999999999 108.175 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.46 135.69 54.73 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.925 -1.489 . . . . 0.14999999999999999 108.946 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.734 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.9 t70 -52.94 146.54 10.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.397 -0.964 . . . . 0.57999999999999996 108.397 172.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.649 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.6 t -55.94 -26.07 46.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.071 0.463 . . . . 0.81999999999999995 110.439 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.684 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.5 ptpt -54.87 -29.75 56.28 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.103 -0.373 . . . . 0.81000000000000005 111.833 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.594 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.1 m-85 -97.15 2.31 50.95 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.41999999999999998 109.989 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 64.6 m -122.72 -89.91 0.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.141 -0.936 . . . . 0.17999999999999999 110.665 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.4 m-85 -141.29 41.08 1.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.103 -0.475 . . . . 0.23999999999999999 112.176 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.94 -81.82 0.04 OUTLIER Glycine 0 C--N 1.343 0.943 0 N-CA-C 113.995 0.358 . . . . 0.25 113.995 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.98 15.46 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.525 2.15 . . . . 0.57999999999999996 110.924 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.2 mt-30 -103.51 -48.63 3.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.65000000000000002 110.071 -174.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.471 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.12 142.81 3.5 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 114.668 -1.151 . . . . 0.29999999999999999 112.051 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 14.1 t -90.68 165.03 13.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.577 0.584 . . . . 0.33000000000000002 112.577 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -62.36 -23.28 66.71 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 115.114 -0.948 . . . . 3.1699999999999999 112.728 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . 1.048 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 18.3 t -105.51 -66.54 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.005 -0.739 . . . . 1.23 109.005 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.048 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 5.4 Cg_endo -99.07 129.63 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.937 2.425 . . . . 0.37 111.922 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.471 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -56.25 98.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.615 -1.254 . . . . 1.1399999999999999 107.615 158.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.668 HD13 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -65.22 130.44 94.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.317 -0.994 . . . . 0.39000000000000001 108.317 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.26 147.71 34.93 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.642 2.228 . . . . 0.60999999999999999 112.587 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.71 137.93 83.14 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.473 2.115 . . . . 0.52000000000000002 113.105 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.734 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 10.9 p80 53.04 21.45 2.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.665 -1.152 . . . . 2.3799999999999999 113.342 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.78 132.88 40.72 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.983 -0.747 . . . . 0.26000000000000001 108.983 172.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.9 113.82 12.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.141 0.496 . . . . 0.22 110.635 -171.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -92.07 133.5 35.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.902 -0.59 . . . . 0.22 110.516 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.4 t -118.53 100.69 7.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.334 -0.617 . . . . 1.2 109.334 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.598 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -112.53 136.55 51.92 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.868 -0.606 . . . . 0.32000000000000001 111.578 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.429 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 40.5 tt0 -105.0 114.49 28.72 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.481 -0.562 . . . . 1.05 109.481 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.665 HG11 HD13 ' A' ' 99' ' ' LEU . 3.6 m -115.76 119.87 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.013 0.745 . . . . 0.19 113.013 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 4.1 m -90.46 111.71 23.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.28000000000000003 110.754 170.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.1 tp -84.1 93.87 8.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.6 -0.889 . . . . 0.14999999999999999 108.6 172.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.1 mtmt -88.1 -33.94 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.095 -0.957 . . . . 1.0800000000000001 110.547 -171.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.454 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.1 m -149.68 154.41 38.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.37 111.729 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 128.26 26.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.299 -0.63 . . . . 0.25 109.299 172.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.85 111.56 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.58 -0.526 . . . . 0.92000000000000004 109.58 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.16 114.82 25.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.471 0.653 . . . . 2.27 109.658 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -140.42 -8.51 1.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.515 -0.766 . . . . 1.97 111.079 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.18 -57.79 2.18 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.978 -1.01 . . . . 2.1400000000000001 109.813 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 65.46 -93.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.241 -0.891 . . . . 5.79 110.539 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -177.06 115.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.093 -0.706 . . . . 7.4800000000000004 109.093 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -102.66 105.69 16.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.341 0.591 . . . . 8.4600000000000009 111.201 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -80.22 116.84 20.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 8.8300000000000001 111.35 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -136.74 140.99 42.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.911 -0.586 . . . . 12.17 110.001 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.245 0.83 0 CA-C-O 118.378 -0.82 . . . . 13.460000000000001 109.918 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.081 0.467 . . . . 50.229999999999997 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.67 -139.33 2.71 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.337 -0.935 . . . . 47.990000000000002 112.956 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 65.16 94.36 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.466 0.651 . . . . 46.259999999999998 110.417 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.928 2.419 . . . . 44.799999999999997 111.919 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.27 130.09 27.64 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.66 2.24 . . . . 44.020000000000003 112.364 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.8 166.13 11.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.195 -0.457 . . . . 42.5 110.609 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 67.95 120.44 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 O-C-N 124.024 0.828 . . . . 41.5 111.472 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.54 -17.59 64.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.062 -0.972 . . . . 40.329999999999998 111.615 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.83 42.87 15.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.151 0.5 . . . . 39.090000000000003 110.089 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.629 ' HG2' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -59.03 -39.23 81.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.194 -0.912 . . . . 38.82 110.732 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.629 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 78.7 mt-30 -110.89 94.15 19.39 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.473 . . . . 38.159999999999997 110.12 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 10' ' ' GLU . 13.7 Cg_exo -70.22 -28.85 22.51 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.676 2.25 . . . . 36.700000000000003 111.997 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.1 -82.47 0.76 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.8 -0.636 . . . . 35.609999999999999 112.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -178.81 -65.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.046 0.539 . . . . 35.030000000000001 109.642 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tt -163.79 -54.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 34.009999999999998 109.403 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.1 -94.6 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 32.890000000000001 110.543 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 58.23 20.82 7.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.752 0.421 . . . . 31.940000000000001 111.541 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -85.27 -20.16 30.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 31.239999999999998 110.036 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 22' ' ' ALA . 16.3 t80 71.55 169.9 0.32 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.871 -1.059 . . . . 31.239999999999998 110.09 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -82.93 96.76 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.114 -0.328 . . . . 29.850000000000001 110.114 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.68 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.539 -0.755 . . . . 28.199999999999999 110.536 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 24' ' ' GLU . . . 51.47 -143.16 0.67 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.329 0.393 . . . . 26.780000000000001 111.323 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.484 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 65.0 mtt 72.38 -21.47 0.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.563 0.745 . . . . 27.469999999999999 112.385 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 22' ' ' ALA . 67.8 mm-40 -90.34 108.07 24.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.929 -0.397 . . . . 24.41 109.929 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 23' ' ' MET . 45.5 Cg_endo -98.0 100.69 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.389 2.726 . . . . 21.629999999999999 112.462 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 12.9 pt-20 -81.37 127.27 74.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.882 0.372 . . . . 20.670000000000002 110.192 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 2.8 Cg_exo -75.72 97.13 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.735 2.29 . . . . 18.02 111.637 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.3 111.0 53.57 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.631 -0.507 . . . . 14.93 109.631 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.17 126.67 23.14 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.693 2.262 . . . . 13.81 112.515 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.32 75.92 19.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.271 -0.877 . . . . 10.76 109.448 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.29 130.05 24.4 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.802 2.335 . . . . 9.7699999999999996 111.933 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.8 124.25 75.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.41 -0.589 . . . . 5.8600000000000003 109.41 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.87 -36.77 59.18 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.541 2.161 . . . . 4.4699999999999998 112.73 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -103.09 -29.54 11.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.126 0.489 . . . . 4.1299999999999999 111.108 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.33 97.39 11.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 2.4500000000000002 110.51 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.685 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 -84.08 -164.72 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.274 -0.639 . . . . 0.53000000000000003 109.274 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.9 tp -73.31 110.61 7.73 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.5 109.672 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -75.24 124.59 27.33 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.003 -0.74 . . . . 2.5099999999999998 109.003 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 45' ' ' LEU . 14.4 mt -58.86 -31.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.872 -1.058 . . . . 0.46000000000000002 110.559 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.5 mt -116.13 -4.79 11.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.615 -0.72 . . . . 0.71999999999999997 110.64 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.85 23.31 72.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.057 -0.817 . . . . 0.52000000000000002 111.057 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -96.42 -15.57 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.482 0.549 . . . . 0.94999999999999996 112.482 -174.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.47 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 114.39 -13.79 20.92 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.575 -0.821 . . . . 0.71999999999999997 114.031 166.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -129.22 -2.21 5.06 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.057 0.762 . . . . 1.5600000000000001 113.057 -173.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 39' ' ' ILE . 21.3 tp -122.34 100.25 6.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.008 -0.368 . . . . 0.32000000000000001 110.008 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -136.09 139.32 42.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.308 0.484 . . . . 1.1399999999999999 112.308 -170.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.8 ttpt -110.97 123.56 50.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.36 -0.382 . . . . 0.34999999999999998 110.004 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.685 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -108.3 125.86 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.571 0.224 . . . . 1.0700000000000001 110.603 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 p -81.93 103.1 11.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.159 0.504 . . . . 0.33000000000000002 111.331 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 111' ' ' THR . 9.8 mt -69.47 -50.05 49.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.828 -1.545 . . . . 0.28000000000000003 106.828 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.845 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.0 t -140.04 126.14 11.93 Favored Pre-proline 0 CA--C 1.501 -0.907 0 CA-C-N 112.891 -1.959 . . . . 0.35999999999999999 106.688 170.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.4 Cg_endo -105.79 59.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.945 2.43 . . . . 0.54000000000000004 113.27 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.19 160.96 8.68 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.931 -0.577 . . . . 0.55000000000000004 112.762 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.09 175.07 8.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.612 2.208 . . . . 1.4199999999999999 110.779 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.82 75.19 1.26 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.089 1.86 . . . . 2.04 112.375 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.71 48.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.954 -0.641 . . . . 0.97999999999999998 113.015 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -96.14 -163.7 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.832 -0.433 . . . . 0.98999999999999999 109.832 178.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.4 m -150.05 142.58 24.44 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.979 -0.748 . . . . 1.28 108.979 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 36.7 mtm180 -90.14 116.45 66.4 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.402 -0.592 . . . . 2.8100000000000001 109.402 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.742 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.6 Cg_endo -50.86 146.86 20.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.569 2.846 . . . . 0.29999999999999999 112.902 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.2 t -96.24 151.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.88 109.582 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 90' ' ' LEU . 97.2 mttt -62.44 121.45 13.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.61 0.719 . . . . 1.1699999999999999 109.42 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.45 -25.55 5.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.675 -1.148 . . . . 0.41999999999999998 111.114 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.2 mm-40 -84.93 134.62 34.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.033 -0.728 . . . . 0.58999999999999997 109.033 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 m -82.12 131.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 108.184 -1.043 . . . . 1.22 108.184 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 28.1 m -128.04 148.03 32.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.362 -0.836 . . . . 0.25 110.412 -171.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.515 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 34.0 p -97.95 112.88 24.64 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.129 0.49 . . . . 0.28999999999999998 110.118 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 86' ' ' LEU . 4.7 m -110.2 144.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.098 0.475 . . . . 0.19 110.246 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.54 117.4 34.84 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.001 -1.481 . . . . 0.19 107.001 170.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 1.2 pt? -117.91 137.04 53.08 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.146 -1.022 . . . . 0.39000000000000001 111.018 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' GLN . 1.1 mp0 -135.42 114.22 11.94 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.308 -2.108 . . . . 0.27000000000000002 105.308 165.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.62 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.4 m -104.61 127.45 52.36 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.816 -1.083 . . . . 0.19 110.914 -166.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.783 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 4.2 t -105.52 159.94 15.55 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.442 -0.799 . . . . 1.0600000000000001 109.206 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.4 ' HG ' HG13 ' A' ' 80' ' ' VAL . 13.9 mt -86.67 165.22 16.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.83999999999999997 109.295 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.72 -23.92 54.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 1.1399999999999999 110.169 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -86.28 -4.18 59.12 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.695 -0.684 . . . . 2.1400000000000001 111.655 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.89 6.76 57.93 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.535 -0.84 . . . . 0.51000000000000001 113.392 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 89.2 m -91.52 112.88 24.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.514 0.657 . . . . 0.46000000000000002 111.947 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.783 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 32.9 mtt180 -74.76 117.11 16.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.793 0.806 . . . . 0.46999999999999997 110.634 176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.8 m -101.86 -9.1 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.438 -1.255 . . . . 0.27000000000000002 112.491 -168.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -156.34 126.57 6.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.422 -0.354 . . . . 0.58999999999999997 111.054 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -122.57 121.84 37.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 1.3400000000000001 109.953 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.532 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 7.3 tt0 -142.42 114.61 6.23 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.552 . . . . 2.5899999999999999 110.335 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -70.33 -18.68 34.18 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.538 2.826 . . . . 0.5 113.063 -172.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.29 108.25 2.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.175 0.988 . . . . 1.3700000000000001 111.662 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.559 ' HB3' HG23 ' A' ' 68' ' ' VAL . 24.0 tp -117.41 106.45 13.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.484 -1.689 . . . . 0.38 108.621 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -100.56 132.49 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.4 p90 -156.81 162.99 39.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.336 -0.393 . . . . 0.23000000000000001 110.534 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -88.92 117.45 27.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.185 -0.461 . . . . 0.41999999999999998 110.295 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.542 HD22 ' HD3' ' A' ' 104' ' ' PRO . 36.8 mt -60.83 136.59 58.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.59999999999999998 111.62 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 75.25 12.93 83.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.879 -0.677 . . . . 0.37 111.452 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.48 -3.37 14.44 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.082 -0.71 . . . . 0.93000000000000005 109.082 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.9 m 57.67 35.3 25.5 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.762 -1.108 . . . . 0.62 109.665 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.9 t70 -74.33 -9.0 58.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.126 0.965 . . . . 1.3300000000000001 108.484 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.7 -158.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.04 -1.436 . . . . 0.23000000000000001 110.747 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.9 pt -80.39 138.63 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 107.519 -1.289 . . . . 0.28999999999999998 107.519 174.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -59.71 -30.22 68.66 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.052 -0.259 . . . . 0.40000000000000002 111.038 -172.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.82 71.81 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.161 0.505 . . . . 0.20000000000000001 110.484 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 68' ' ' VAL . 45.3 tp -79.55 -42.14 25.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.683 -0.69 . . . . 0.22 110.567 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.64 -30.54 68.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.057 -0.974 . . . . 0.26000000000000001 110.068 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 86.5 mt -90.82 -36.07 14.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.197 -0.91 . . . . 0.25 112.929 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.8 p -70.93 -29.54 65.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.143 0.496 . . . . 1.01 111.034 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.584 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 80.5 t -64.74 -54.25 37.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.444 -0.798 . . . . 0.20999999999999999 112.957 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.542 ' HD3' HD22 ' A' ' 90' ' ' LEU . 21.2 Cg_endo -63.93 -20.41 68.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.737 1.625 . . . . 0.27000000000000002 111.661 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 39' ' ' ILE . 23.7 mt -78.47 -17.02 56.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.619 . . . . 0.64000000000000001 110.873 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.723 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -100.97 156.6 17.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.988 -0.551 . . . . 0.78000000000000003 110.59 -179.258 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -95.31 154.2 17.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.96999999999999997 110.817 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.742 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.4 t -62.43 123.89 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.454 0.645 . . . . 0.80000000000000004 110.277 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.64 45.48 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.903 -1.044 . . . . 0.28000000000000003 112.754 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.845 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.7 pt-20 -105.14 167.62 9.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.464 0.649 . . . . 0.40999999999999998 111.011 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.513 HG22 HD12 ' A' ' 50' ' ' LEU . 13.7 m -129.16 116.99 20.05 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.974 -1.121 . . . . 0.22 107.974 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -118.32 136.78 53.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.161 -0.472 . . . . 0.17999999999999999 110.81 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.9 ttm -98.34 117.14 32.07 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.22 -1.4 . . . . 1.3200000000000001 107.22 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.4 t -112.96 128.45 69.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.007 -0.368 . . . . 0.17999999999999999 110.007 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 73.8 m -107.45 112.6 25.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.401 -0.92 . . . . 0.20999999999999999 108.759 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.442 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.67 134.32 54.97 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.944 -1.48 . . . . 0.14999999999999999 109.229 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.2 t70 -52.61 145.44 11.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.647 -0.871 . . . . 0.57999999999999996 108.647 172.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -52.04 -26.65 11.38 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 123.416 0.448 . . . . 0.81999999999999995 110.54 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.725 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 13.8 ptpt -54.33 -35.02 62.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.95 0.352 . . . . 0.81000000000000005 111.95 176.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.554 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 87.5 m-85 -95.93 2.21 53.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.41999999999999998 110.373 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 80.2 m -118.47 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.116 -0.947 . . . . 0.17999999999999999 110.254 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.63 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.3 m-85 -144.41 40.71 1.33 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.34 -0.544 . . . . 0.23999999999999999 112.364 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.485 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.07 -83.08 0.04 OUTLIER Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.048 -0.596 . . . . 0.25 113.694 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.73 8.7 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.539 2.159 . . . . 0.57999999999999996 110.986 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.1 mt-30 -104.22 -51.4 3.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.624 0.726 . . . . 0.65000000000000002 110.216 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.66 143.71 4.19 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.478 -1.237 . . . . 0.29999999999999999 111.769 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t -91.77 156.75 17.32 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.62 0.6 . . . . 0.33000000000000002 112.62 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 129' ' ' SER . 7.4 ptm180 -43.1 -63.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.724 -1.125 . . . . 3.1699999999999999 112.159 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.984 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 17.2 m -72.56 -66.41 0.61 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 121.021 -0.271 . . . . 1.23 110.431 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.984 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -105.74 128.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.397 2.064 . . . . 0.37 112.31 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.597 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.0 t80 -57.31 98.24 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.41 -0.959 . . . . 1.1399999999999999 108.41 164.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.591 HG12 ' CB ' ' A' ' 127' ' ' SER . 26.9 mm -66.89 129.7 94.02 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.633 -0.506 . . . . 0.39000000000000001 109.633 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 11.6 Cg_endo -57.49 145.3 89.19 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.624 2.216 . . . . 0.60999999999999999 112.574 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.485 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 39.6 Cg_exo -57.9 134.27 61.4 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.802 2.335 . . . . 0.52000000000000002 112.888 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 31.6 m170 66.88 10.97 8.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.74 -1.118 . . . . 2.3799999999999999 112.471 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -71.81 124.54 25.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.337 -0.986 . . . . 0.26000000000000001 108.337 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.07 112.58 10.35 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.153 -0.619 . . . . 0.22 109.59 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 115' ' ' THR . 1.7 tp -90.14 131.64 35.88 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.546 -0.752 . . . . 0.22 110.065 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.5 t -116.84 99.94 7.44 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.821 -0.807 . . . . 1.2 108.821 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.3 pp -110.61 136.09 50.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.083 -0.508 . . . . 0.32000000000000001 111.106 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.473 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 34.5 tt0 -103.8 113.54 27.13 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.989 -0.745 . . . . 1.05 108.989 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.7 m -114.51 120.8 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.606 0.717 . . . . 0.19 112.486 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.7 m -91.41 113.09 25.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.938 -1.028 . . . . 0.28000000000000003 110.139 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.723 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.0 tp -84.65 98.13 10.02 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.885 -0.783 . . . . 0.14999999999999999 108.885 173.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 27.6 mtmt -94.42 -28.6 15.41 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.096 -0.957 . . . . 1.0800000000000001 110.664 -171.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.515 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 24.5 m -153.72 147.44 25.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 0.37 111.663 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.634 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 127.88 25.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.792 -0.448 . . . . 0.25 109.792 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.13 141.96 34.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 C-N-CA 120.643 -0.423 . . . . 0.92000000000000004 110.916 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.423 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 10.6 t70 -74.52 119.4 18.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.44 -0.346 . . . . 2.27 110.745 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.589 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -152.77 37.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.988 -0.745 . . . . 1.97 108.988 -176.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 156.99 36.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 2.1400000000000001 110.296 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.38 -42.84 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.721 0.637 . . . . 5.79 112.721 -169.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -150.55 105.96 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.72 0.295 . . . . 7.4800000000000004 110.637 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -66.97 100.18 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 8.4600000000000009 110.739 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -116.63 6.61 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.692 -0.231 . . . . 8.8300000000000001 111.538 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -150.89 151.74 32.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.514 0.197 . . . . 12.17 110.754 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.531 -0.747 . . . . 13.460000000000001 110.005 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 tpp . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.798 0.332 . . . . 50.229999999999997 110.958 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.6 41.33 0.57 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.961 -0.638 . . . . 47.990000000000002 111.515 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 81.6 mt-30 -79.97 152.63 74.52 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.174 . . . . 46.259999999999998 110.796 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' GLN . 16.2 Cg_exo -69.43 151.06 70.94 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.901 2.401 . . . . 44.799999999999997 111.729 176.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.35 153.41 66.24 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.581 2.187 . . . . 44.020000000000003 112.227 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 69.14 -170.03 0.18 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.011 -0.541 . . . . 42.5 112.171 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.641 ' HG3' ' H ' ' A' ' 9' ' ' ALA . 7.8 tp10 -134.7 140.59 46.09 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.178 -0.465 . . . . 41.5 109.747 -176.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -113.05 18.89 17.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.503 -0.317 . . . . 40.329999999999998 110.947 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.641 ' H ' ' HG3' ' A' ' 7' ' ' GLU . . . 80.1 162.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.03 -0.986 . . . . 39.090000000000003 112.003 173.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -130.44 -69.03 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.019 -0.991 . . . . 38.82 110.396 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.473 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 12.5 pt20 -98.6 121.69 55.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 38.159999999999997 111.169 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 11' ' ' GLN . 7.3 Cg_exo -73.08 125.4 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.782 2.321 . . . . 36.700000000000003 111.238 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.29 33.6 0.57 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.697 -0.763 . . . . 35.609999999999999 112.047 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.77 140.95 49.36 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.696 -0.296 . . . . 35.030000000000001 110.428 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -133.22 131.63 40.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.635 -0.505 . . . . 34.009999999999998 109.635 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.8 22.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.662 0.245 . . . . 32.890000000000001 111.662 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' HD2' ' C ' ' A' ' 17' ' ' ARG . 1.7 ppt_? -139.52 5.04 2.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.765 0.317 . . . . 31.940000000000001 111.206 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.31 -62.18 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.581 -0.736 . . . . 31.239999999999998 112.961 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.92 145.89 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.45 0.643 . . . . 31.239999999999998 111.937 -167.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.856 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.4 pt? -82.31 83.48 7.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 29.850000000000001 110.388 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.39 76.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.794 -0.639 . . . . 28.199999999999999 110.268 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.01 -53.59 2.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.764 -0.653 . . . . 26.780000000000001 110.375 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.6 ttm -158.15 66.71 0.46 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 27.469999999999999 109.838 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.82 107.91 61.1 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.505 -0.77 . . . . 24.41 109.29 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.77 -178.25 4.41 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.869 2.379 . . . . 21.629999999999999 113.336 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 91.2 mt-10 -94.7 137.02 22.57 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 115.632 -0.713 . . . . 20.670000000000002 110.012 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 22.0 Cg_exo -66.1 105.01 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.544 2.163 . . . . 18.02 111.404 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.72 141.35 92.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 14.93 110.306 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.16 127.77 27.01 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.495 2.13 . . . . 13.81 112.339 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.15 70.75 6.32 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.669 -0.696 . . . . 10.76 110.894 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.1 67.26 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.612 2.208 . . . . 9.7699999999999996 112.137 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.78 135.24 20.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 5.8600000000000003 109.962 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.87 -43.74 54.21 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.986 2.457 . . . . 4.4699999999999998 111.956 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -157.2 146.96 20.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.58 -0.736 . . . . 4.1299999999999999 109.244 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -114.17 106.28 14.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.063 0.459 . . . . 2.4500000000000002 110.801 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.675 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -92.4 -160.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.672 -0.694 . . . . 0.53000000000000003 110.193 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.93 110.69 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.5 110.903 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.752 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -71.03 99.94 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.637 -0.71 . . . . 2.5099999999999998 110.691 173.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.614 HG23 HD11 ' A' ' 105' ' ' LEU . 15.8 mt -48.71 -48.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.973 -1.012 . . . . 0.46000000000000002 112.189 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.567 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 88.4 mt -105.93 4.64 29.76 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.612 -0.435 . . . . 0.71999999999999997 111.103 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.71 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 67.86 18.73 70.84 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.52000000000000002 112.416 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 40' ' ' LEU . 13.1 p30 -98.03 -23.6 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.82 0.304 . . . . 0.94999999999999996 111.82 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.18 -27.21 19.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.189 -1.005 . . . . 0.71999999999999997 113.722 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -94.26 -11.18 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.395 0.597 . . . . 1.5600000000000001 111.732 -174.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.3 tp -121.52 107.94 13.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.021 -0.536 . . . . 0.32000000000000001 110.443 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 63.2 mtm180 -142.39 141.63 32.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.567 -0.288 . . . . 1.1399999999999999 111.435 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' HG22 ' A' ' 114' ' ' VAL . 18.7 ttpt -111.04 129.6 55.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.951 -0.388 . . . . 0.34999999999999998 109.951 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.675 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 12.4 ttmt -108.05 128.52 54.75 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.773 0.32 . . . . 1.0700000000000001 110.778 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -80.56 101.33 9.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.949 -0.569 . . . . 0.33000000000000002 110.91 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 111' ' ' THR . 10.0 mt -68.25 -51.85 40.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.042 -1.466 . . . . 0.28000000000000003 107.042 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 79.3 t -138.63 126.0 13.35 Favored Pre-proline 0 CA--C 1.497 -1.075 0 CA-C-N 113.091 -1.868 . . . . 0.35999999999999999 106.574 169.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -103.12 64.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.818 2.345 . . . . 0.54000000000000004 113.491 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.67 169.14 32.59 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.019 -0.991 . . . . 0.55000000000000004 113.085 175.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.687 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 73.4 Cg_endo -77.42 168.95 21.99 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.355 2.036 . . . . 1.4199999999999999 110.492 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.19 84.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.457 2.105 . . . . 2.04 111.941 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.19 48.07 0.33 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.992 -0.549 . . . . 0.97999999999999998 112.17 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.687 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 3.4 p -87.22 -172.39 3.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.299 0.571 . . . . 0.98999999999999999 110.977 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.72 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 9.8 m -153.08 127.07 8.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.646 -0.872 . . . . 1.28 108.646 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 22.1 ptt180 -90.41 123.46 65.44 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 119.66 -0.816 . . . . 2.8100000000000001 110.809 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.469 ' HB3' ' HB1' ' A' ' 147' ' ' ALA . 15.1 Cg_endo -56.39 155.22 26.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.909 3.073 . . . . 0.29999999999999999 113.741 -175.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.1 t -94.87 153.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.307 -0.861 . . . . 0.88 109.389 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.895 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 21.1 mtpt -67.59 119.35 12.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.496 0.665 . . . . 1.1699999999999999 109.401 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.36 -23.5 5.14 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.2 -1.16 . . . . 0.41999999999999998 110.2 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 2.7 mm-40 -80.79 142.69 33.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.58999999999999997 109.263 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.73 121.49 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.577 -0.897 . . . . 1.22 108.577 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.6 m -126.6 146.37 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.25 111.895 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.442 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 28.9 p -104.22 114.05 28.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.381 -0.827 . . . . 0.28999999999999998 110.337 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.652 HG21 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.59 145.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.083 -0.647 . . . . 0.19 110.038 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.624 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -102.37 115.08 29.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.804 -1.554 . . . . 0.19 106.804 169.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -116.19 136.36 53.08 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.149 -1.02 . . . . 0.39000000000000001 110.91 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HG2' ' OE2' ' A' ' 82' ' ' GLU . 1.9 mp0 -132.18 113.96 13.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.993 -1.854 . . . . 0.27000000000000002 105.993 166.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.636 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 61.0 m -104.24 125.71 50.74 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.683 -1.144 . . . . 0.19 111.186 -168.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.6 t -105.75 159.17 16.2 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.206 -0.906 . . . . 1.0600000000000001 109.034 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.436 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.3 mt -86.34 165.2 16.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.792 -0.64 . . . . 0.83999999999999997 110.017 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 9.5 pt-20 -54.93 -17.82 4.17 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.48 0.488 . . . . 1.1399999999999999 112.114 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.09 -15.2 20.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 2.1400000000000001 110.998 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.13 23.11 6.53 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.769 -0.729 . . . . 0.51000000000000001 113.357 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 m -101.42 109.58 21.43 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.302 -0.528 . . . . 0.46000000000000002 111.115 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 11.0 mtt180 -73.75 114.4 11.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.674 0.749 . . . . 0.46999999999999997 110.462 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.663 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.9 m -98.73 -9.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.529 -1.214 . . . . 0.27000000000000002 111.86 -171.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.636 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.5 pt20 -162.06 127.14 3.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.082 -0.508 . . . . 0.58999999999999997 110.168 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 71' ' ' GLN . 16.8 tt0 -130.52 106.85 8.79 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.641 -0.503 . . . . 1.3400000000000001 109.641 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 5.1 tt0 -126.91 117.98 22.27 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.444 -0.798 . . . . 2.5899999999999999 110.568 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 9.9 Cg_exo -71.39 -18.59 29.7 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.66 2.907 . . . . 0.5 113.932 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -161.99 99.28 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.573 1.178 . . . . 1.3700000000000001 112.416 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.2 107.87 19.03 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.171 -1.831 . . . . 0.38 108.7 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.6 p -104.6 137.12 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 17.5 p90 -158.73 167.92 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.71 0.29 . . . . 0.23000000000000001 111.332 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -88.63 112.09 22.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.263 -0.643 . . . . 0.41999999999999998 109.263 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.895 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 12.8 tp -53.44 121.55 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.116 -0.493 . . . . 0.59999999999999998 111.072 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.53 ' CA ' ' HE2' ' A' ' 62' ' ' LYS . . . 97.09 -3.21 61.95 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.444 -0.884 . . . . 0.37 113.383 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.7 10.4 41.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.97 -0.692 . . . . 0.93000000000000005 109.454 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.3 m 58.98 30.54 20.37 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 114.671 -1.15 . . . . 0.62 110.308 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 88' ' ' PHE . 18.1 m-20 -67.28 -11.29 57.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.816 0.817 . . . . 1.3300000000000001 109.835 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 m -131.66 -162.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.245 -1.343 . . . . 0.23000000000000001 110.026 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.61 HG13 ' H ' ' A' ' 99' ' ' LEU . 28.0 pt -76.11 141.27 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.668 -1.234 . . . . 0.28999999999999998 107.668 173.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.85 -28.61 69.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.555 -0.293 . . . . 0.40000000000000002 110.863 -173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.9 80.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.988 0.423 . . . . 0.20000000000000001 110.226 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.652 HD21 HG21 ' A' ' 68' ' ' VAL . 57.2 tp -73.17 -40.98 64.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.479 -0.782 . . . . 0.22 110.955 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.9 -31.36 69.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.08 -0.963 . . . . 0.26000000000000001 109.906 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.57 -34.49 15.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.127 -0.942 . . . . 0.25 112.167 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 78.3 p -70.68 -28.64 64.92 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.918 -0.313 . . . . 1.01 110.911 -173.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.429 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 55.6 t -64.47 -55.0 33.15 Favored Pre-proline 0 C--O 1.217 -0.648 0 CA-C-N 115.991 -0.549 . . . . 0.20999999999999999 112.227 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.888 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.0 Cg_endo -63.78 -17.79 61.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.95 1.766 . . . . 0.27000000000000002 111.873 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.614 HD11 HG23 ' A' ' 39' ' ' ILE . 14.0 mt -82.75 -15.69 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.933 -0.576 . . . . 0.64000000000000001 111.136 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -103.77 148.57 25.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.144 -0.48 . . . . 0.78000000000000003 111.026 178.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -90.38 160.67 15.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.96999999999999997 110.786 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -66.97 129.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.544 0.687 . . . . 0.80000000000000004 110.311 -176.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.94 66.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.239 -0.892 . . . . 0.28000000000000003 112.153 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -98.05 166.97 11.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.5 0.667 . . . . 0.40999999999999998 110.939 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.516 HG22 HD12 ' A' ' 50' ' ' LEU . 8.1 m -128.74 118.18 22.39 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.972 -1.121 . . . . 0.22 107.972 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.501 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.32 136.61 54.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.277 -0.419 . . . . 0.17999999999999999 110.602 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.1 ttp -101.89 117.04 34.01 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.667 -1.234 . . . . 1.3200000000000001 107.667 171.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.749 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.8 t -110.84 134.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.563 -0.532 . . . . 0.17999999999999999 109.563 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.552 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 89.5 m -107.66 114.06 27.78 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 119.202 -0.999 . . . . 0.20999999999999999 108.491 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.16 130.7 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.958 -1.474 . . . . 0.14999999999999999 109.022 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.777 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 5.8 t70 -53.06 147.31 9.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.437 -0.579 . . . . 0.57999999999999996 109.437 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.9 t -53.0 -29.27 28.25 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.81999999999999995 110.197 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.777 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.3 ptpt -55.26 -31.48 61.59 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.079 0.4 . . . . 0.81000000000000005 112.079 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.592 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.0 m-85 -95.44 -0.66 52.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.196 0.522 . . . . 0.41999999999999998 110.148 175.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 77.3 m -118.24 -87.82 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.119 -0.946 . . . . 0.17999999999999999 110.648 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.54 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.8 m-85 -144.94 36.2 1.14 Allowed 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.376 -0.53 . . . . 0.23999999999999999 112.063 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.89 -76.77 0.18 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.825 -0.702 . . . . 0.25 113.052 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.9 3.66 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.471 2.114 . . . . 0.57999999999999996 111.507 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -104.74 -51.92 2.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.506 0.67 . . . . 0.65000000000000002 109.91 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.54 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 83.92 141.83 4.94 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.592 -1.186 . . . . 0.29999999999999999 111.31 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.69 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.4 t -90.54 153.03 20.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.817 0.341 . . . . 0.33000000000000002 111.134 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -52.82 -42.48 65.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.386 -0.824 . . . . 3.1699999999999999 111.971 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 1.001 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 10.1 m -84.97 -66.06 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.266 -0.642 . . . . 1.23 109.266 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.001 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.0 Cg_endo -105.38 126.28 0.06 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.37 111.497 171.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.411 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 12.9 t80 -59.65 97.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.776 -1.194 . . . . 1.1399999999999999 107.776 167.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.569 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.9 mm -65.52 126.92 92.48 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.966 -0.561 . . . . 0.39000000000000001 109.633 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 53.2 Cg_exo -51.89 142.45 42.73 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.639 2.226 . . . . 0.60999999999999999 112.008 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 41.1 Cg_exo -57.03 134.42 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.352 2.035 . . . . 0.52000000000000002 112.0 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.448 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.8 OUTLIER 74.28 0.67 3.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.363 -0.835 . . . . 2.3799999999999999 111.422 174.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.6 119.41 12.32 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.193 -0.669 . . . . 0.26000000000000001 109.193 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -73.24 113.81 10.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.195 -0.602 . . . . 0.22 110.54 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.597 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 mp -89.6 134.21 34.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.861 -0.609 . . . . 0.22 111.708 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 t -118.0 100.47 7.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.025 -0.731 . . . . 1.2 109.025 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.594 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.4 pp -111.02 137.05 49.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.609 -0.723 . . . . 0.32000000000000001 111.592 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 81.0 tt0 -103.53 124.79 49.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.703 -0.851 . . . . 1.05 108.703 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' HE3' ' A' ' 106' ' ' MET . 3.3 m -122.74 126.15 73.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.257 0.551 . . . . 0.19 112.252 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 7.3 m -96.11 115.97 28.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.28000000000000003 110.219 170.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.752 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.8 tp -85.39 98.13 10.39 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.727 -0.842 . . . . 0.14999999999999999 108.727 172.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.5 mtmt -94.14 -30.3 14.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.336 -0.847 . . . . 1.0800000000000001 110.661 -169.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.5 m -150.92 146.14 26.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.128 0.49 . . . . 0.37 111.814 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.508 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -136.1 127.68 28.81 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.485 -0.932 . . . . 0.25 108.485 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.31 125.29 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.18 0.514 . . . . 0.92000000000000004 111.13 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.431 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 6.7 t70 -67.73 121.45 15.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 2.27 110.163 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.85 12.53 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 1.97 111.299 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.27 169.99 13.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.208 -0.597 . . . . 2.1400000000000001 109.993 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -108.02 -179.58 3.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.725 -0.67 . . . . 5.79 111.593 -167.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -95.9 9.92 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.759 -0.655 . . . . 7.4800000000000004 110.084 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -135.63 96.61 3.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.318 -0.855 . . . . 8.4600000000000009 108.698 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.09 148.97 42.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.765 -0.652 . . . . 8.8300000000000001 111.853 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -92.71 -32.45 14.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 12.17 109.998 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 37.8 m80 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.085 -0.959 . . . . 13.460000000000001 109.419 -179.494 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 121.01 0.433 . . . . 50.229999999999997 110.283 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.89 54.48 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.707 -0.957 . . . . 47.990000000000002 110.707 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -75.84 145.42 77.96 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 110.374 -0.232 . . . . 46.259999999999998 110.374 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 52.8 Cg_exo -55.27 121.36 9.79 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.781 2.321 . . . . 44.799999999999997 112.148 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 54.0 Cg_exo -53.28 135.86 61.15 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.27 2.647 . . . . 44.020000000000003 113.136 -175.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.84 136.07 53.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.743 -0.662 . . . . 42.5 109.641 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 58.1 72.94 0.49 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.582 0.551 . . . . 41.5 110.23 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.31 127.25 32.14 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.426 -0.583 . . . . 40.329999999999998 109.426 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.45 -57.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.81 -0.177 . . . . 39.090000000000003 111.432 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 64.7 103.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.756 0.66 . . . . 38.82 112.081 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 61.99 70.41 0.85 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 114.907 -1.042 . . . . 38.159999999999997 111.538 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.62 174.93 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.392 2.728 . . . . 36.700000000000003 112.562 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.25 -122.8 5.94 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 35.609999999999999 111.973 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.94 166.57 23.13 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.135 -0.32 . . . . 35.030000000000001 110.135 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.46 83.25 2.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.023 0.44 . . . . 34.009999999999998 110.994 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.39 97.78 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.705 -0.85 . . . . 32.890000000000001 108.705 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -117.45 166.98 11.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.96 -0.563 . . . . 31.940000000000001 111.23 -172.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -96.18 142.16 28.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.268 -0.878 . . . . 31.239999999999998 110.437 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -86.13 11.4 11.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.599 -0.728 . . . . 31.239999999999998 110.65 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -88.58 8.8 26.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.661 -0.7 . . . . 29.850000000000001 111.12 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.59 -168.63 0.21 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.743 -0.662 . . . . 28.199999999999999 111.371 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.29 49.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 26.780000000000001 110.535 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 58.8 mtt -90.88 35.39 0.9 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 27.469999999999999 110.423 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 34.7 tt0 67.29 112.09 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.39 -0.823 . . . . 24.41 110.808 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 12.0 Cg_exo -71.13 173.74 11.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.231 2.62 . . . . 21.629999999999999 113.197 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -73.14 144.04 84.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 20.670000000000002 110.595 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.64 137.08 37.92 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.543 2.162 . . . . 18.02 112.205 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -80.62 148.22 65.16 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 14.93 110.323 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 21.7 Cg_exo -64.85 128.02 19.93 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 122.688 2.258 . . . . 13.81 111.723 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' ALA . . . -141.66 77.16 19.49 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.863 -0.608 . . . . 10.76 111.169 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.34 35.55 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.059 2.506 . . . . 9.7699999999999996 112.564 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -112.33 117.02 48.12 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.773 -0.649 . . . . 5.8600000000000003 110.468 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 25.5 Cg_exo -63.75 -28.05 68.28 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.792 2.328 . . . . 4.4699999999999998 112.783 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.98 -54.04 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.464 -0.334 . . . . 4.1299999999999999 111.216 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' HH11 ' A' ' 46' ' ' ARG . 9.6 pt-20 -54.99 125.11 19.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 2.4500000000000002 112.42 -174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.583 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -86.94 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.556 -0.747 . . . . 0.53000000000000003 109.729 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.3 tp -73.01 110.33 7.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.5 110.037 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.664 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -74.75 123.53 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.38 -0.528 . . . . 2.5099999999999998 109.831 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.639 HG23 HD11 ' A' ' 105' ' ' LEU . 8.4 mt -55.22 -33.21 29.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.985 -1.007 . . . . 0.46000000000000002 111.462 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -115.9 -1.39 12.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.014 -0.539 . . . . 0.71999999999999997 110.313 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.66 23.05 66.71 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.093 -0.803 . . . . 0.52000000000000002 111.093 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.497 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -97.32 -17.67 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.622 0.601 . . . . 0.94999999999999996 112.622 -172.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.17 -15.43 18.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.446 -0.883 . . . . 0.71999999999999997 114.72 166.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -120.29 -7.79 9.74 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.972 0.73 . . . . 1.5600000000000001 112.972 -175.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 39' ' ' ILE . 25.2 tp -121.75 100.07 6.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.578 0.228 . . . . 0.32000000000000001 110.624 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.541 HH11 ' HA ' ' A' ' 35' ' ' GLU . 81.2 mtm180 -134.86 139.23 44.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.697 0.258 . . . . 1.1399999999999999 111.697 -171.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.7 ttpt -113.05 123.31 50.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.244 0.217 . . . . 0.34999999999999998 110.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.3 ttpp -111.07 117.69 33.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.832 0.349 . . . . 1.0700000000000001 111.253 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.547 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 2.2 p -74.1 98.89 3.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.33000000000000002 111.656 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 111' ' ' THR . 7.7 mt -67.01 -53.38 31.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.413 -1.329 . . . . 0.28000000000000003 107.413 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.801 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t -134.39 123.01 16.24 Favored Pre-proline 0 CA--C 1.498 -1.032 0 CA-C-N 112.908 -1.951 . . . . 0.35999999999999999 106.478 168.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 57.7 Cg_endo -108.37 72.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.521 2.148 . . . . 0.54000000000000004 114.578 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 54' ' ' PRO . . . 81.23 140.65 2.94 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.55000000000000004 113.756 169.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 11.6 Cg_exo -70.71 148.71 59.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.411 2.074 . . . . 1.4199999999999999 110.134 169.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.33 110.38 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.756 2.304 . . . . 2.04 112.711 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.72 44.65 2.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.818 -0.706 . . . . 0.97999999999999998 112.053 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -89.93 -165.34 1.32 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.935 0.398 . . . . 0.98999999999999999 110.629 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -158.75 144.57 16.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.616 -0.883 . . . . 1.28 108.616 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 49.5 mtm180 -94.13 111.38 53.06 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.659 -0.497 . . . . 2.8100000000000001 109.659 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.65 ' HG3' HD21 ' A' ' 144' ' ' LEU . 9.9 Cg_endo -49.96 149.55 11.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.693 2.928 . . . . 0.29999999999999999 113.657 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.676 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 20.2 t -96.22 153.05 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.88 109.531 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.853 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 98.5 mttt -68.78 119.61 13.42 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.523 0.678 . . . . 1.1699999999999999 109.231 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 -28.5 3.82 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.836 -1.306 . . . . 0.41999999999999998 109.836 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.1 mm-40 -82.34 139.28 34.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.637 -0.875 . . . . 0.58999999999999997 108.637 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.3 m -88.69 125.74 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 108.024 -1.102 . . . . 1.22 108.024 173.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.3 m -124.7 143.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.57 -0.741 . . . . 0.25 111.468 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.867 HG22 HG22 ' A' ' 87' ' ' VAL . 69.4 p -90.11 113.03 24.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.423 -0.808 . . . . 0.28999999999999998 110.243 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.823 HG21 HD21 ' A' ' 99' ' ' LEU . 19.0 m -111.71 141.11 28.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 120.095 -0.642 . . . . 0.19 110.366 172.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.8 t-160 -101.67 119.13 38.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.848 -1.538 . . . . 0.19 106.848 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -124.92 133.59 52.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 118.789 -1.164 . . . . 0.39000000000000001 111.297 177.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 2.4 mp0 -125.45 115.13 19.77 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.082 -1.821 . . . . 0.27000000000000002 106.082 168.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.627 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 54.1 m -106.8 129.26 54.69 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.875 -1.057 . . . . 0.19 111.591 -168.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.705 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.56 155.46 18.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.192 -0.913 . . . . 1.0600000000000001 109.159 177.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.484 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.0 mt -83.31 166.24 18.65 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.472 -0.785 . . . . 0.83999999999999997 110.243 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -54.52 -19.18 5.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.01 -0.541 . . . . 1.1399999999999999 110.946 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -91.39 -3.59 56.54 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.573 -0.74 . . . . 2.1400000000000001 110.947 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.4 10.23 62.33 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.319 -0.467 . . . . 0.51000000000000001 112.24 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.4 m -95.5 112.05 23.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.46000000000000002 111.441 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 14.5 mtt180 -74.38 120.02 19.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.518 0.675 . . . . 0.46999999999999997 110.609 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.614 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.5 m -108.48 -10.79 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.617 -1.174 . . . . 0.27000000000000002 112.272 -169.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.627 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 18.1 pt20 -159.72 125.63 4.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.288 -0.414 . . . . 0.58999999999999997 109.961 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.541 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 73.4 tt0 -128.41 108.09 10.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 1.3400000000000001 109.972 174.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.544 ' HB3' HD23 ' A' ' 70' ' ' LEU . 4.7 tp10 -119.18 111.56 36.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.922 -1.036 . . . . 2.5899999999999999 109.941 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 37.3 Cg_endo -66.48 -19.61 54.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.209 2.606 . . . . 0.5 113.918 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.582 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 25.5 tt0 -165.18 101.47 0.74 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 122.364 1.078 . . . . 1.3700000000000001 112.479 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.1 tp -109.69 107.55 17.62 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.657 -1.61 . . . . 0.38 108.786 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.867 HG22 HG22 ' A' ' 67' ' ' THR . 1.7 t -101.55 125.02 55.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -144.95 161.63 38.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.586 -0.279 . . . . 0.23000000000000001 110.381 -172.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -81.17 111.72 17.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.174 -0.467 . . . . 0.41999999999999998 109.774 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.853 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.1 tp -58.91 132.21 53.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.59999999999999998 110.161 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 84.2 2.65 89.24 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.128 -0.558 . . . . 0.37 112.415 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -99.38 -3.91 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.059 0.457 . . . . 0.93000000000000005 110.372 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.5 m 58.6 33.31 23.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.497 -0.774 . . . . 0.62 109.351 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.3 t70 -72.4 -10.68 60.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 122.534 1.159 . . . . 1.3300000000000001 108.891 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.24 -158.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.542 -1.663 . . . . 0.23000000000000001 109.665 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.711 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.2 pt -80.3 137.73 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.954 -1.128 . . . . 0.28999999999999998 107.954 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.5 tp-100 -59.53 -28.32 66.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.374 -0.376 . . . . 0.40000000000000002 110.408 -174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.62 93.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.133 0.492 . . . . 0.20000000000000001 110.655 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.823 HD21 HG21 ' A' ' 68' ' ' VAL . 58.2 tp -76.4 -38.69 55.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.706 -0.679 . . . . 0.22 110.141 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.47 -29.09 69.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.965 -1.016 . . . . 0.26000000000000001 109.825 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 78.4 mt -91.12 -35.2 14.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.518 -0.764 . . . . 0.25 112.533 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 23.3 p -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.088 -0.383 . . . . 1.01 111.312 -172.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.558 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -62.23 -55.61 38.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.297 0.48 . . . . 0.20999999999999999 112.297 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.846 ' HD3' HD11 ' A' ' 90' ' ' LEU . 19.0 Cg_endo -62.6 -23.21 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.898 1.732 . . . . 0.27000000000000002 111.305 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.639 HD11 HG23 ' A' ' 39' ' ' ILE . 16.8 mt -78.14 -15.62 58.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.55 . . . . 0.64000000000000001 111.707 173.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.54 ' HE3' HG23 ' A' ' 142' ' ' VAL . 2.9 ptm -106.93 154.9 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.497 -0.32 . . . . 0.78000000000000003 111.261 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.16 153.56 20.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.912 0.387 . . . . 0.96999999999999997 110.532 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -64.19 127.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.618 0.723 . . . . 0.80000000000000004 109.972 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.58 58.4 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.128 -0.942 . . . . 0.28000000000000003 112.865 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.801 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.4 pt-20 -99.07 167.71 10.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.629 0.728 . . . . 0.40999999999999998 111.455 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 50' ' ' LEU . 7.4 m -128.69 117.83 21.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.83 -1.174 . . . . 0.22 107.83 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.72 139.01 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.995 0.426 . . . . 0.17999999999999999 110.652 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.7 ttm -98.21 118.27 34.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.307 -1.368 . . . . 1.3200000000000001 107.307 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.4 t -115.35 128.2 72.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.781 -0.452 . . . . 0.17999999999999999 109.781 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.511 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 85.2 m -106.14 113.98 27.83 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.206 -1.035 . . . . 0.20999999999999999 108.206 172.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.72 136.88 53.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.31 -1.314 . . . . 0.14999999999999999 109.617 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.0 t70 -55.49 148.92 14.47 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.101 -0.703 . . . . 0.57999999999999996 109.101 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.643 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -56.32 -27.29 55.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.136 0.493 . . . . 0.81999999999999995 110.453 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 15.1 ptpt -54.94 -32.63 61.54 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.215 -0.303 . . . . 0.81000000000000005 111.717 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 80.0 m-85 -96.44 0.44 50.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 120.998 0.428 . . . . 0.41999999999999998 110.165 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.6 m -117.02 -92.01 0.53 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.076 -0.965 . . . . 0.17999999999999999 110.382 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.2 m-85 -142.42 39.78 1.57 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.429 -0.508 . . . . 0.23999999999999999 112.233 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.2 -80.58 0.07 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 121.208 -0.52 . . . . 0.25 114.031 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.32 9.08 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 111.017 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.25 -50.43 3.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.065 -0.971 . . . . 0.65000000000000002 110.173 -173.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.574 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.91 143.94 4.46 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.912 -1.04 . . . . 0.29999999999999999 112.243 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.8 t -90.42 157.03 17.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.532 . . . . 0.33000000000000002 111.489 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -59.18 -34.83 72.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.287 -0.869 . . . . 3.1699999999999999 112.259 -172.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 1.033 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 48.2 m -89.45 -67.22 0.13 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.174 -0.61 . . . . 1.23 109.718 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.033 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -104.62 127.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.275 1.983 . . . . 0.37 111.95 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.574 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 36.5 t80 -56.91 97.87 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.194 -1.039 . . . . 1.1399999999999999 108.194 165.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -65.95 128.97 94.19 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.734 -0.666 . . . . 0.39000000000000001 109.577 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.6 Cg_exo -53.78 144.29 55.22 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.61 2.206 . . . . 0.60999999999999999 112.033 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.2 Cg_exo -58.92 133.86 56.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.315 2.01 . . . . 0.52000000000000002 112.091 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.565 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER 73.61 0.12 3.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.232 -0.895 . . . . 2.3799999999999999 112.775 177.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -66.4 123.52 20.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.728 -0.471 . . . . 0.26000000000000001 109.728 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.89 113.52 11.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.425 0.631 . . . . 0.22 110.41 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.621 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.0 OUTLIER -92.06 132.4 36.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.455 -0.793 . . . . 0.22 111.214 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.0 t -116.6 100.65 7.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.182 -0.673 . . . . 1.2 109.182 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -117.01 135.21 53.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.081 -0.509 . . . . 0.32000000000000001 111.664 -172.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 35.8 tt0 -99.63 117.47 34.06 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.451 -0.574 . . . . 1.05 109.451 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.818 HG11 HD13 ' A' ' 99' ' ' LEU . 5.3 m -110.51 124.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.608 . . . . 0.19 111.95 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -99.91 108.88 21.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.36 -0.836 . . . . 0.28000000000000003 109.777 172.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 60' ' ' PRO . 49.4 tp -82.59 96.91 8.23 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.384 -0.969 . . . . 0.14999999999999999 108.384 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -94.46 -25.13 17.02 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.583 -0.735 . . . . 1.0800000000000001 110.601 -170.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -154.66 146.25 23.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.876 -0.602 . . . . 0.37 110.841 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.14 127.65 21.5 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.975 -0.75 . . . . 0.25 108.975 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.83 139.34 44.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.288 -0.565 . . . . 0.92000000000000004 110.86 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.62 122.0 25.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.691 -0.485 . . . . 2.27 109.691 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.4 tp -152.76 22.33 0.6 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.141 -0.481 . . . . 1.97 110.675 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.81 151.71 31.78 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.543 -0.91 . . . . 2.1400000000000001 108.543 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 153' ' ' HIS . 3.7 t60 -61.84 -55.56 28.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.661 -0.496 . . . . 5.79 109.661 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 152' ' ' HIS . 0.9 OUTLIER 157.73 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.52 1.138 . . . . 7.4800000000000004 109.72 176.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -146.07 54.34 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 8.4600000000000009 110.543 -170.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -70.87 86.44 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 8.8300000000000001 110.093 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 27.2 t60 -178.38 -27.2 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.807 -0.633 . . . . 12.17 110.619 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 31.8 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 117.847 -1.073 . . . . 13.460000000000001 109.811 -172.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.85 0.357 . . . . 50.229999999999997 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.43 157.19 29.56 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.315 -0.714 . . . . 47.990000000000002 111.315 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 26.9 pt20 -113.61 144.63 31.75 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 110.238 -0.282 . . . . 46.259999999999998 110.238 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 3' ' ' GLN . 25.0 Cg_exo -63.01 118.92 5.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.032 2.488 . . . . 44.799999999999997 112.686 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.78 165.22 24.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.714 2.276 . . . . 44.020000000000003 111.804 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.59 113.4 25.5 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.46 -0.336 . . . . 42.5 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 72.98 130.17 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.149 0.906 . . . . 41.5 113.004 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.2 127.23 33.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.656 -0.702 . . . . 40.329999999999998 109.133 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.52 11.48 2.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.571 -0.286 . . . . 39.090000000000003 111.345 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.75 -46.76 68.01 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.316 0.579 . . . . 38.82 109.663 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -125.83 97.13 36.32 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.7 -0.682 . . . . 38.159999999999997 109.85 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.84 98.37 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.718 2.279 . . . . 36.700000000000003 111.87 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.25 -166.76 11.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.044 -0.598 . . . . 35.609999999999999 112.223 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.61 176.32 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 35.030000000000001 109.583 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -74.79 -68.21 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.649 -0.5 . . . . 34.009999999999998 109.649 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 52.47 26.7 4.39 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.259 0.837 . . . . 32.890000000000001 113.259 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -105.9 -9.39 17.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 31.940000000000001 110.586 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 45.8 tt0 -77.09 106.11 8.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.407 -0.59 . . . . 31.239999999999998 109.407 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 6.2 t80 74.13 -36.45 0.33 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.079 0.862 . . . . 31.239999999999998 112.454 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.06 92.83 0.55 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.407 0.623 . . . . 29.850000000000001 111.473 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.88 167.09 10.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.362 -0.835 . . . . 28.199999999999999 110.412 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB1' ' OE1' ' A' ' 24' ' ' GLU . . . -121.21 176.96 5.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.409 -0.359 . . . . 26.780000000000001 111.307 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 47.0 ttm -133.63 -72.09 0.5 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.569 -0.9 . . . . 27.469999999999999 108.569 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 1.7 mp0 44.97 88.05 0.11 Allowed Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 124.514 1.134 . . . . 24.41 112.874 171.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 14.0 Cg_endo -55.78 112.75 1.15 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.974 2.449 . . . . 21.629999999999999 112.236 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 45.5 mt-10 -68.84 127.5 93.12 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.839 -0.619 . . . . 20.670000000000002 110.657 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 11.4 Cg_exo -71.02 154.72 62.61 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.395 2.73 . . . . 18.02 112.117 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -120.05 134.26 24.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.518 . . . . 14.93 111.038 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.98 146.26 94.62 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.718 2.278 . . . . 13.81 111.52 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.61 79.78 16.4 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 120.87 -0.332 . . . . 10.76 111.694 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.63 122.46 11.07 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.68 2.253 . . . . 9.7699999999999996 111.116 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.51 121.95 70.84 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.194 -0.457 . . . . 5.8600000000000003 111.133 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.72 -5.33 8.04 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.742 2.295 . . . . 4.4699999999999998 112.298 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.48 118.5 21.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 4.1299999999999999 111.347 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 9.6 tp10 -82.33 103.72 12.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.518 -0.764 . . . . 2.4500000000000002 109.408 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.56 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 7.6 m0 -79.38 -161.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.53000000000000003 111.049 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.9 tp -81.24 111.71 17.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.333 -0.848 . . . . 0.5 110.765 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.65 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -63.61 115.19 4.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.686 0.755 . . . . 2.5099999999999998 110.543 173.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.628 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 21.0 mt -66.86 -44.69 88.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.192 -0.913 . . . . 0.46000000000000002 111.152 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 101' ' ' LEU . 93.0 mt -111.05 10.41 22.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 0.71999999999999997 110.14 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.65 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 77.22 -2.34 61.81 Favored Glycine 0 C--O 1.225 -0.46 0 CA-C-N 115.539 -0.755 . . . . 0.52000000000000002 112.137 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 40' ' ' LEU . 25.5 p30 -83.74 -21.21 32.33 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.678 0.621 . . . . 0.94999999999999996 112.678 -174.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.52 -22.67 7.23 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.413 -0.899 . . . . 0.71999999999999997 112.437 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.8 -32.84 72.85 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 122.109 0.957 . . . . 1.5600000000000001 108.948 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 21.3 tp -121.21 114.09 20.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.685 -1.598 . . . . 0.32000000000000001 110.292 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.509 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 49.8 mtm180 -142.32 143.43 32.77 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.296 0.372 . . . . 1.1399999999999999 110.615 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 114' ' ' VAL . 23.0 ttpt -111.36 134.82 52.67 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.19 -0.3 . . . . 0.34999999999999998 110.19 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.1 ttpp -124.02 126.99 47.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.194 -0.299 . . . . 1.0700000000000001 110.194 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -79.89 116.53 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.33000000000000002 111.223 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 141' ' ' GLU . 7.5 mt -75.05 -49.28 20.28 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.507 -1.664 . . . . 0.28000000000000003 106.507 169.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.863 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 89.6 t -134.09 130.7 20.47 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 113.105 -1.861 . . . . 0.35999999999999999 106.287 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 20.6 Cg_endo -108.66 63.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.119 2.546 . . . . 0.54000000000000004 113.873 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.646 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 68.03 170.49 5.5 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.396 -0.82 . . . . 0.55000000000000004 113.685 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.708 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 93.8 Cg_endo -87.27 175.32 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.235 2.624 . . . . 1.4199999999999999 111.451 172.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.82 65.98 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.404 2.069 . . . . 2.04 112.801 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.74 56.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.028 -0.606 . . . . 0.97999999999999998 112.796 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.708 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.9 p -99.84 -171.92 2.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.038 0.447 . . . . 0.98999999999999999 111.13 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.13 153.19 41.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.224 -1.028 . . . . 1.28 108.224 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -103.71 115.02 64.2 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 2.8100000000000001 110.098 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.786 ' HD3' HG23 ' A' ' 108' ' ' VAL . 61.4 Cg_exo -37.26 135.66 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.827 3.018 . . . . 0.29999999999999999 113.982 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.542 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 18.9 t -90.73 150.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.092 -0.707 . . . . 0.88 109.092 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.588 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 64.6 mttt -65.56 104.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.899 0.857 . . . . 1.1699999999999999 111.117 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 151' ' ' GLU . . . 142.18 -24.41 2.38 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 113.888 -1.505 . . . . 0.41999999999999998 110.113 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.7 mm-40 -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.044 0.449 . . . . 0.58999999999999997 109.948 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 76.1 t -83.51 117.03 28.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.313 -0.858 . . . . 1.22 108.768 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.7 m -123.1 150.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.591 . . . . 0.25 111.255 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.649 ' HB ' ' HG3' ' A' ' 85' ' ' GLU . 62.0 p -104.49 113.4 26.94 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.28999999999999998 110.085 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.623 HG21 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.3 145.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.331 -0.547 . . . . 0.19 109.977 175.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.675 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.34 114.46 28.76 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.188 -1.412 . . . . 0.19 107.188 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.39 134.15 55.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.012 -1.075 . . . . 0.39000000000000001 111.075 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.524 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.3 mp0 -129.94 114.72 16.19 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.902 -1.888 . . . . 0.27000000000000002 105.902 166.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 62.5 m -103.94 128.19 51.47 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.66 -1.155 . . . . 0.19 111.619 -168.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -105.01 151.21 24.22 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.914 -1.039 . . . . 1.0600000000000001 108.653 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.27 165.46 25.0 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.97 -0.559 . . . . 0.83999999999999997 109.604 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 6.4 pt-20 -55.77 -15.37 3.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.077 0.465 . . . . 1.1399999999999999 110.807 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.422 ' OD1' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -88.68 -16.71 31.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.699 -0.682 . . . . 2.1400000000000001 109.808 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.5 -4.71 37.44 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.656 -0.702 . . . . 0.51000000000000001 111.844 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -81.45 110.21 16.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.815 0.341 . . . . 0.46000000000000002 111.859 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 29.9 mtt180 -72.54 123.7 23.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.552 0.691 . . . . 0.46999999999999997 111.187 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.0 m -109.11 -15.73 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.832 -1.076 . . . . 0.27000000000000002 112.295 -170.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.636 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.4 pt20 -154.74 137.44 15.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.437 -0.579 . . . . 0.58999999999999997 109.437 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 26.1 tt0 -144.41 105.69 4.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.171 0.51 . . . . 1.3400000000000001 110.152 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -119.73 121.41 29.85 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.539 -0.755 . . . . 2.5899999999999999 109.499 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 11.8 Cg_exo -69.0 -18.73 40.43 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.894 2.396 . . . . 0.5 113.059 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.649 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 14.1 tt0 -166.56 96.3 0.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.089 0.947 . . . . 1.3700000000000001 111.53 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -98.38 102.94 14.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.485 -1.689 . . . . 0.38 108.514 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.9 p -97.33 135.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.636 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 31.2 p90 -157.42 169.06 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.23000000000000001 111.417 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m -89.66 114.76 26.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.41999999999999998 109.648 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.903 HD11 ' HD3' ' A' ' 104' ' ' PRO . 16.3 tp -63.02 129.93 42.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.015 -0.538 . . . . 0.59999999999999998 110.65 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.49 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.06 6.18 86.83 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.885 -0.674 . . . . 0.37 112.083 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.65 -1.51 30.05 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.73 -0.47 . . . . 0.93000000000000005 109.73 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 40.0 m 56.16 33.99 23.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.62 109.727 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 17.7 t70 -71.47 -9.45 58.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 122.54 1.162 . . . . 1.3300000000000001 108.549 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.61 -162.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.497 -1.683 . . . . 0.23000000000000001 110.409 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.1 pt -77.6 139.64 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 107.67 -1.233 . . . . 0.28999999999999998 107.67 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.583 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.8 tp-100 -60.05 -28.6 67.91 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.931 -0.308 . . . . 0.40000000000000002 110.941 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -57.13 -43.05 82.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.179 0.514 . . . . 0.20000000000000001 110.262 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.623 HD21 HG21 ' A' ' 68' ' ' VAL . 47.4 tp -74.67 -40.48 61.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.22 110.247 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.74 -28.06 69.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.906 -1.043 . . . . 0.26000000000000001 109.919 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.8 mt -91.28 -36.75 13.7 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.282 -0.872 . . . . 0.25 112.587 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.476 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 17.4 p -74.13 -23.6 59.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 1.01 110.972 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.592 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 38.9 t -67.8 -55.27 14.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.20999999999999999 112.1 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' HD11 ' A' ' 90' ' ' LEU . 28.2 Cg_endo -62.69 -18.76 65.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.138 1.892 . . . . 0.27000000000000002 111.999 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.481 ' CD1' HG23 ' A' ' 39' ' ' ILE . 13.7 mt -83.43 -17.39 42.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.999 -0.546 . . . . 0.64000000000000001 111.713 172.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.732 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 10.4 ttp -97.37 142.71 28.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.354 -0.385 . . . . 0.78000000000000003 111.344 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -85.51 151.3 24.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.176 0.512 . . . . 0.96999999999999997 110.855 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.786 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -59.78 123.47 12.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.903 -0.589 . . . . 0.80000000000000004 110.053 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.3 12.72 47.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.066 -0.97 . . . . 0.28000000000000003 112.871 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.863 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 8.4 pt-20 -114.24 169.19 9.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.2 0.524 . . . . 0.40999999999999998 110.64 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.402 HG22 HD12 ' A' ' 50' ' ' LEU . 10.6 m -129.32 120.9 26.42 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.651 -0.87 . . . . 0.22 108.651 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.57 135.57 53.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.693 -0.685 . . . . 0.17999999999999999 110.88 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.6 ttm -97.78 117.81 32.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.544 -1.28 . . . . 1.3200000000000001 107.544 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.706 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.4 t -115.1 133.06 62.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.531 -0.544 . . . . 0.17999999999999999 109.531 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 87.5 m -110.38 114.66 28.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.602 0.715 . . . . 0.20999999999999999 109.077 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.521 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -125.17 137.02 54.15 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 0.14999999999999999 110.41 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.595 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.81 147.35 9.07 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.737 -0.838 . . . . 0.57999999999999996 108.737 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 2.5 t -54.77 -27.16 39.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.04 0.447 . . . . 0.81999999999999995 110.288 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.595 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 12.7 ptpt -55.19 -33.13 62.75 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.165 -0.334 . . . . 0.81000000000000005 111.511 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.574 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 83.9 m-85 -94.86 3.22 55.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.073 0.463 . . . . 0.41999999999999998 110.1 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 72.3 m -123.16 -91.77 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.193 -0.912 . . . . 0.17999999999999999 110.528 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 8.1 m-85 -142.59 41.08 1.58 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.153 -0.619 . . . . 0.23999999999999999 112.123 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.77 -88.57 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.486 -0.387 . . . . 0.25 113.909 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.49 11.69 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.396 2.064 . . . . 0.57999999999999996 111.168 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.04 -48.87 3.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.396 -0.82 . . . . 0.65000000000000002 109.884 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.637 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 79.13 143.63 2.64 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 114.616 -1.174 . . . . 0.29999999999999999 112.216 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.695 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.0 t -90.48 147.54 23.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.103 0.478 . . . . 0.33000000000000002 111.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.593 ' HD2' ' H ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -54.87 -28.18 48.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.12 -0.945 . . . . 3.1699999999999999 112.485 -175.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 1.089 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 27.5 t -91.59 -70.03 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.891 -0.781 . . . . 1.23 108.891 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.089 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.4 Cg_endo -105.19 128.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.5 2.134 . . . . 0.37 111.998 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.637 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 22.3 t80 -55.72 97.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.32 -0.993 . . . . 1.1399999999999999 108.32 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 127' ' ' SER . 28.6 mm -67.16 125.97 91.8 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.556 -0.747 . . . . 0.39000000000000001 109.31 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' A' ' 136' ' ' ALA . 9.7 Cg_endo -53.47 135.99 62.52 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.321 2.014 . . . . 0.60999999999999999 111.688 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.633 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 54.2 Cg_exo -53.33 129.01 31.53 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.491 2.127 . . . . 0.52000000000000002 112.304 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.621 ' H ' ' HB3' ' A' ' 118' ' ' SER . 70.3 m-70 74.69 11.09 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.69 -1.141 . . . . 2.3799999999999999 112.931 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 133' ' ' PRO . . . -71.07 118.87 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.254 -1.017 . . . . 0.26000000000000001 108.254 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.19 113.68 10.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.463 0.649 . . . . 0.22 109.902 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.637 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.37 131.98 34.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.153 -0.931 . . . . 0.22 110.966 -174.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.1 t -115.18 99.74 7.64 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.891 -0.781 . . . . 1.2 108.891 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -112.85 134.53 54.32 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.467 0.651 . . . . 0.32000000000000001 111.781 -173.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.484 ' HG3' HD11 ' A' ' 50' ' ' LEU . 39.9 tt0 -99.8 113.59 26.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.186 -0.916 . . . . 1.05 108.916 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 2.2 m -115.7 121.3 67.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.46 0.648 . . . . 0.19 112.674 -175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.1 m -88.05 121.67 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.18 -0.918 . . . . 0.28000000000000003 109.756 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 60' ' ' PRO . 39.0 tp -93.89 93.33 7.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.401 -0.962 . . . . 0.14999999999999999 108.401 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.535 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -85.81 -30.83 22.69 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.898 -1.047 . . . . 1.0800000000000001 110.629 -172.246 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.625 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 85.2 m -157.14 145.09 19.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.813 -0.631 . . . . 0.37 111.562 -168.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.619 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . . . -137.55 128.32 27.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.74 -0.664 . . . . 0.25 109.369 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 65' ' ' VAL . 11.2 m -132.12 145.66 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.563 -0.532 . . . . 0.92000000000000004 109.563 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.33 118.29 24.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.366 -0.533 . . . . 2.27 110.105 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.441 ' HB3' HG23 ' A' ' 65' ' ' VAL . 13.1 tp -137.55 16.33 2.93 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.667 -0.864 . . . . 1.97 108.667 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.484 ' CG ' ' HA3' ' A' ' 63' ' ' GLY . 2.0 tm-20 -72.82 -41.85 64.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.64 -1.164 . . . . 2.1400000000000001 108.632 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -77.24 61.74 2.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.913 -1.039 . . . . 5.79 110.518 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -71.52 129.45 38.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.953 -1.021 . . . . 7.4800000000000004 110.703 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -135.2 149.29 49.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.003 -0.544 . . . . 8.4600000000000009 110.237 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -75.06 131.2 40.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.772 -0.649 . . . . 8.8300000000000001 110.827 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -127.82 162.53 26.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.973 -0.751 . . . . 12.17 108.973 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.408 -0.806 . . . . 13.460000000000001 110.445 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 ttm . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.936 0.398 . . . . 50.229999999999997 110.182 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.97 163.97 12.21 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.065 -0.814 . . . . 47.990000000000002 111.065 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 65.08 87.24 0.12 Allowed Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 121.18 0.514 . . . . 46.259999999999998 111.212 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 74.3 Cg_endo -73.7 152.29 47.56 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 123.008 2.472 . . . . 44.799999999999997 112.431 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 12.5 Cg_exo -70.57 145.26 51.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.488 2.125 . . . . 44.020000000000003 111.482 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 71.81 102.17 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.925 0.766 . . . . 42.5 111.941 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.11 170.14 8.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 41.5 109.798 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.91 175.4 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 40.329999999999998 110.906 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.06 42.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.648 . . . . 39.090000000000003 109.554 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -88.82 -78.85 0.33 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.212 0.53 . . . . 38.82 109.92 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -114.69 124.0 31.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 38.159999999999997 110.727 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 -27.36 84.72 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.3 2.0 . . . . 36.700000000000003 111.277 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.59 31.79 7.66 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.847 -0.615 . . . . 35.609999999999999 112.079 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 56.08 -96.02 0.06 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.092 0.525 . . . . 35.030000000000001 110.335 -174.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 35.4 tp 174.08 -88.68 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 123.95 0.781 . . . . 34.009999999999998 109.379 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 171.56 -40.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.396 -0.82 . . . . 32.890000000000001 109.085 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -124.62 117.04 23.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.97 -1.014 . . . . 31.940000000000001 110.182 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 19' ' ' PHE . 4.4 pt-20 -103.14 -49.13 3.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 31.239999999999998 110.981 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.59 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 62.6 t80 -152.32 -60.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.435 . . . . 31.239999999999998 110.455 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' A' ' 19' ' ' PHE . 89.1 mt -121.81 -174.25 2.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.635 0.255 . . . . 29.850000000000001 110.318 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.94 -164.84 1.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.978 -0.556 . . . . 28.199999999999999 110.059 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.65 160.84 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.483 0.182 . . . . 26.780000000000001 110.829 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.2 mmt 72.28 5.55 5.31 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.841 0.713 . . . . 27.469999999999999 112.357 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -133.41 91.64 26.34 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.19 -0.671 . . . . 24.41 109.19 173.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -83.63 154.64 13.7 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.759 2.306 . . . . 21.629999999999999 112.671 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 16.1 pt-20 -96.79 145.17 29.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 20.670000000000002 109.797 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 18.4 Cg_exo -66.54 137.18 45.52 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.832 2.355 . . . . 18.02 112.747 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -86.17 137.03 35.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 14.93 110.172 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 26.2 Cg_exo -62.26 127.7 21.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.239 1.959 . . . . 13.81 112.04 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.29 65.22 10.37 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.999 -0.546 . . . . 10.76 110.869 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.57 118.92 5.87 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.432 2.088 . . . . 9.7699999999999996 111.463 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -99.62 116.73 64.64 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.415 -0.357 . . . . 5.8600000000000003 110.875 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 3.3 Cg_exo -78.1 -0.53 10.77 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.2 2.6 . . . . 4.4699999999999998 111.58 177.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -98.63 146.72 25.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 4.1299999999999999 109.434 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -85.07 121.5 27.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.705 0.288 . . . . 2.4500000000000002 110.236 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.534 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -80.44 -166.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.17 -0.468 . . . . 0.53000000000000003 110.378 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.46 110.83 7.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.5 110.409 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.633 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -75.0 127.15 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.332 0.587 . . . . 2.5099999999999998 110.612 174.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 45' ' ' LEU . 8.4 mt -57.78 -35.55 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.586 -1.188 . . . . 0.46000000000000002 111.549 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.6 mt -111.12 -1.16 16.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.286 0.565 . . . . 0.71999999999999997 110.278 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.22 26.63 66.26 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.318 -0.855 . . . . 0.52000000000000002 111.746 -172.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.39 -29.09 14.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.65 0.241 . . . . 0.94999999999999996 111.65 -178.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.541 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.41 -9.14 30.72 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 121.114 -0.565 . . . . 0.71999999999999997 111.751 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 7.3 mp -97.4 -33.18 11.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.253 -0.474 . . . . 1.5600000000000001 110.971 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.573 HD11 HD12 ' A' ' 39' ' ' ILE . 19.8 tp -122.91 100.7 7.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.32000000000000001 111.352 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 66.7 mtm180 -132.23 140.73 48.78 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.178 -0.326 . . . . 1.1399999999999999 111.163 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 13.4 ttpt -111.51 123.66 50.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.265 -0.272 . . . . 0.34999999999999998 110.265 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 20.1 ttmt -101.17 122.08 42.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.157 -0.312 . . . . 1.0700000000000001 110.157 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' PRO . 5.3 p -76.67 100.82 5.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.497 -0.319 . . . . 0.33000000000000002 110.977 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD12 HG22 ' A' ' 111' ' ' THR . 11.5 mt -68.71 -55.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.065 -1.457 . . . . 0.28000000000000003 107.065 171.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.784 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.5 t -129.82 126.35 22.52 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 113.024 -1.898 . . . . 0.35999999999999999 106.299 167.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 16.5 Cg_endo -104.48 60.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.832 2.355 . . . . 0.54000000000000004 113.477 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.81 151.89 4.35 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.959 -0.564 . . . . 0.55000000000000004 113.213 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 38.0 Cg_endo -68.39 163.28 37.12 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.176 1.918 . . . . 1.4199999999999999 110.466 172.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.24 98.65 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.375 2.05 . . . . 2.04 112.009 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.04 51.37 2.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.134 -0.555 . . . . 0.97999999999999998 112.674 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -83.09 -162.97 0.66 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 110.185 -0.302 . . . . 0.98999999999999999 110.185 174.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 t -152.81 127.93 9.75 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.04 -0.726 . . . . 1.28 109.04 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.81 122.14 67.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.583 -0.447 . . . . 2.8100000000000001 110.946 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.6 153.24 11.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.789 2.992 . . . . 0.29999999999999999 114.13 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.7 t -100.08 155.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.004 -0.998 . . . . 0.88 109.449 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 95.4 mttt -64.34 106.86 1.19 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.386 0.613 . . . . 1.1699999999999999 110.364 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 141.75 -24.73 2.44 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.28 -1.128 . . . . 0.41999999999999998 110.28 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.1 mm-40 -83.01 137.72 34.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.282 -0.636 . . . . 0.58999999999999997 109.282 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.5 m -81.05 133.54 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.064 -1.087 . . . . 1.22 108.064 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.2 m -127.8 143.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.022 -0.535 . . . . 0.25 110.92 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 45.9 p -94.11 112.61 24.44 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.309 -0.626 . . . . 0.28999999999999998 109.309 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.59 HG21 HD21 ' A' ' 99' ' ' LEU . 19.6 m -110.15 143.41 20.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.901 -0.72 . . . . 0.19 109.849 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.596 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.7 t-160 -102.33 116.11 31.95 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.824 -1.547 . . . . 0.19 106.824 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 83' ' ' GLU . 1.2 pt? -122.5 137.95 54.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.462 -0.895 . . . . 0.39000000000000001 110.83 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HB2' ' NH1' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -133.11 114.31 13.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.277 -2.12 . . . . 0.27000000000000002 105.277 166.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.654 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 71.0 m -105.04 129.69 53.42 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.6 -1.182 . . . . 0.19 111.016 -166.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.993 ' HB3' ' SG ' ' A' ' 139' ' ' CYS . 4.7 t -104.38 172.51 6.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.268 -0.878 . . . . 1.0600000000000001 108.884 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 80' ' ' VAL . 12.3 mt -101.48 165.54 11.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.517 -0.765 . . . . 0.83999999999999997 109.178 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.18 -23.35 34.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.1 0.476 . . . . 1.1399999999999999 110.492 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.28 -8.49 53.28 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.776 -0.647 . . . . 2.1400000000000001 111.492 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.39 10.56 44.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.259 -0.972 . . . . 0.51000000000000001 113.568 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 92.1 m -98.64 113.0 24.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.311 0.555 . . . . 0.46000000000000002 112.332 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.894 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.4 mtt180 -69.91 125.56 27.12 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.46999999999999997 110.363 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.012 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.2 m -108.89 -20.17 6.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.004 -0.998 . . . . 0.27000000000000002 112.295 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.654 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.4 pt20 -146.99 124.3 11.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.421 -0.354 . . . . 0.58999999999999997 110.242 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -118.41 118.0 30.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.31 0.576 . . . . 1.3400000000000001 109.964 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.563 ' HB3' HD23 ' A' ' 70' ' ' LEU . 6.4 tp10 -135.8 107.58 9.85 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.589 -0.732 . . . . 2.5899999999999999 110.814 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.596 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 14.3 Cg_exo -68.12 -19.83 44.6 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.056 2.504 . . . . 0.5 112.952 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -164.22 113.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.025 0.917 . . . . 1.3700000000000001 112.567 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.08 110.31 16.08 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.772 -1.558 . . . . 0.38 108.763 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.8 p -100.17 137.03 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -159.45 157.64 30.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 0.23000000000000001 110.426 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 24.4 m -76.87 119.13 20.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.527 -0.546 . . . . 0.41999999999999998 109.527 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.915 HD11 ' HD3' ' A' ' 104' ' ' PRO . 17.4 tp -62.19 133.22 54.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 0.59999999999999998 110.544 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.71 -4.91 80.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 0.37 111.844 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 12.8 t70 -83.77 -15.06 49.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.165 -0.68 . . . . 0.93000000000000005 109.165 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.0 m 62.65 30.1 16.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.863 -1.062 . . . . 0.62 109.414 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 13.7 t70 -62.55 -26.36 68.53 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 122.367 1.079 . . . . 1.3300000000000001 108.45 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 15.1 m -114.46 -158.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 113.341 -1.754 . . . . 0.23000000000000001 110.834 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.7 pt -84.34 139.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.81 -1.182 . . . . 0.28999999999999998 107.81 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.512 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -60.17 -27.34 67.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.449 -0.341 . . . . 0.40000000000000002 110.966 -173.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -56.39 -42.95 78.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.324 0.583 . . . . 0.20000000000000001 110.286 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 68' ' ' VAL . 53.0 tp -78.53 -40.49 34.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.131 -0.941 . . . . 0.22 110.377 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.97 -29.72 70.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.794 -1.094 . . . . 0.26000000000000001 109.973 -174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 57.6 mt -90.66 -33.64 15.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.44 -0.8 . . . . 0.25 111.959 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.5 t -65.63 -34.54 78.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 1.01 110.769 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.7 t -63.56 -53.29 52.78 Favored Pre-proline 0 C--O 1.22 -0.492 0 N-CA-C 113.129 0.789 . . . . 0.20999999999999999 113.129 -177.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.915 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.7 Cg_endo -62.03 -22.15 73.71 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.988 1.792 . . . . 0.27000000000000002 111.945 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' A' ' 39' ' ' ILE . 9.5 mt -83.82 -11.98 56.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.416 0.627 . . . . 0.64000000000000001 110.991 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.771 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 34.8 ttm -98.28 140.36 32.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.969 -1.014 . . . . 0.78000000000000003 111.635 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.13 153.11 19.56 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.485 -0.561 . . . . 0.96999999999999997 109.485 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.588 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.0 t -62.0 124.98 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 0.80000000000000004 110.65 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 12.95 52.98 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.28000000000000003 112.723 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.784 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.6 pt-20 -105.43 168.63 8.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.478 0.639 . . . . 0.40999999999999998 110.432 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.49 HG22 HD12 ' A' ' 50' ' ' LEU . 24.4 m -132.83 119.8 20.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.402 -0.962 . . . . 0.22 108.402 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.68 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -117.54 137.45 52.57 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.483 -0.781 . . . . 0.17999999999999999 110.718 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 ttt -96.85 116.03 28.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.872 -1.529 . . . . 1.3200000000000001 106.872 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.506 HG22 ' HG3' ' A' ' 47' ' ' LYS . 3.4 t -113.34 132.96 60.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.53 -0.545 . . . . 0.17999999999999999 109.53 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.525 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 63.0 m -110.7 114.43 27.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.629 -0.828 . . . . 0.20999999999999999 109.36 171.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.99 53.83 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.896 -1.502 . . . . 0.14999999999999999 109.813 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.576 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.3 t70 -52.47 147.24 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.981 -0.748 . . . . 0.57999999999999996 108.981 173.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.627 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.1 t -55.78 -28.32 55.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 0.81999999999999995 110.086 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.58 ' HG3' ' CD1' ' A' ' 120' ' ' TYR . 15.6 ptpt -55.48 -31.44 62.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.629 -0.259 . . . . 0.81000000000000005 111.634 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.58 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 78.5 m-85 -95.2 -1.55 51.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.147 0.499 . . . . 0.41999999999999998 109.839 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 65.6 m -117.14 -93.47 0.51 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.061 -0.972 . . . . 0.17999999999999999 110.371 -177.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.609 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.8 m-85 -140.78 39.71 1.83 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.207 -0.597 . . . . 0.23999999999999999 112.091 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -45.59 -83.03 0.02 OUTLIER Glycine 0 C--N 1.344 0.99 0 N-CA-C 114.242 0.457 . . . . 0.25 114.242 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.4 13.93 2.53 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.393 2.062 . . . . 0.57999999999999996 110.77 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.4 mt-30 -104.65 -49.28 3.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.978 -1.01 . . . . 0.65000000000000002 110.498 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 131' ' ' TYR . . . 81.83 142.2 3.76 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 114.544 -1.207 . . . . 0.29999999999999999 112.622 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.609 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 30.4 t -91.93 165.99 12.94 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.091 0.404 . . . . 0.33000000000000002 112.091 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.579 ' HG3' ' N ' ' A' ' 129' ' ' SER . 6.9 ptp180 -52.87 -49.88 64.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.728 -0.669 . . . . 3.1699999999999999 112.219 -171.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.986 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 13.0 m -87.78 -62.72 0.22 Allowed Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.704 -0.48 . . . . 1.23 109.704 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.012 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 8.9 Cg_endo -101.08 127.7 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.592 2.195 . . . . 0.37 111.707 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.44 ' HA ' ' CA ' ' A' ' 126' ' ' GLY . 9.6 t80 -57.43 97.35 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.938 -1.504 . . . . 1.1399999999999999 106.938 159.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -64.87 124.66 87.13 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 107.965 -1.124 . . . . 0.39000000000000001 107.965 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.22 141.19 31.91 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.499 2.133 . . . . 0.60999999999999999 112.301 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 55.0 Cg_exo -52.37 132.32 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.582 2.188 . . . . 0.52000000000000002 112.156 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.515 ' H ' ' HB3' ' A' ' 118' ' ' SER . 1.4 m-70 72.35 9.22 5.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.069 -0.969 . . . . 2.3799999999999999 113.015 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -74.09 123.84 25.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.162 -0.681 . . . . 0.26000000000000001 109.162 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.82 112.28 9.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.351 0.596 . . . . 0.22 109.643 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 121' ' ' CYS . 2.0 tp -88.76 131.87 34.86 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.549 -0.751 . . . . 0.22 110.586 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.993 ' SG ' ' HB3' ' A' ' 73' ' ' SER . 24.7 p -116.73 100.29 7.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.795 0.807 . . . . 1.2 110.501 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -109.66 133.64 52.89 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.323 -0.853 . . . . 0.32000000000000001 111.491 -172.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 40.1 tt0 -98.33 109.09 21.9 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.508 -0.769 . . . . 1.05 109.212 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.654 HG23 ' HE1' ' A' ' 106' ' ' MET . 0.8 OUTLIER -113.35 116.46 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.463 0.649 . . . . 0.19 112.39 -174.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 9.5 m -89.2 113.72 24.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 0.28000000000000003 111.034 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.771 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -84.8 93.55 8.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.773 -0.825 . . . . 0.14999999999999999 108.773 172.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -86.45 -32.61 20.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.111 -0.95 . . . . 1.0800000000000001 110.799 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.3 m -150.71 147.31 27.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.309 -0.405 . . . . 0.37 111.197 -173.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -134.22 128.31 33.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.156 -0.683 . . . . 0.25 109.156 171.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.83 125.39 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 110.063 -0.347 . . . . 0.92000000000000004 110.063 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -70.67 117.15 11.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 120.335 -0.546 . . . . 2.27 109.961 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.59 25.07 1.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.777 . . . . 1.97 109.168 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -92.06 116.26 28.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.07 -0.715 . . . . 2.1400000000000001 109.07 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -134.92 74.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.108 -0.701 . . . . 5.79 109.108 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -51.97 110.57 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.699 -1.137 . . . . 7.4800000000000004 111.57 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -136.43 -65.99 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.952 -0.759 . . . . 8.4600000000000009 108.952 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -157.4 25.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.752 0.787 . . . . 8.8300000000000001 109.472 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 61.0 t-80 -130.09 53.36 1.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.932 -1.507 . . . . 12.17 106.932 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 33.6 m170 . . . . . 0 C--O 1.24 0.595 0 CA-C-N 114.483 -1.235 . . . . 13.460000000000001 109.082 -163.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.167 -0.309 . . . . 50.229999999999997 110.167 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.0 36.4 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.481 -0.648 . . . . 47.990000000000002 111.481 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -145.04 98.83 4.69 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 109.791 -0.448 . . . . 46.259999999999998 109.791 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.07 134.45 42.87 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.711 2.274 . . . . 44.799999999999997 111.443 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.79 123.82 14.68 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.126 2.551 . . . . 44.020000000000003 113.19 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.87 82.39 2.0 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.435 -0.802 . . . . 42.5 109.001 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.693 ' HG3' ' H ' ' A' ' 8' ' ' GLU . 5.3 pt-20 -153.35 -69.79 0.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.714 -0.675 . . . . 41.5 111.496 -170.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.693 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 41.4 tt0 64.11 89.82 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.701 0.625 . . . . 40.329999999999998 110.164 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.91 -168.82 0.14 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.574 -0.739 . . . . 39.090000000000003 110.893 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -44.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.192 -0.458 . . . . 38.82 110.774 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -151.06 106.14 3.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 38.159999999999997 111.186 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.27 154.19 61.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.239 2.626 . . . . 36.700000000000003 111.85 175.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.81 -138.92 2.52 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.843 -0.694 . . . . 35.609999999999999 112.682 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 73.02 -64.55 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.024 0.93 . . . . 35.030000000000001 111.967 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 tt -94.09 133.24 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.418 -0.355 . . . . 34.009999999999998 110.344 -174.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 135.59 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 32.890000000000001 110.377 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -144.04 163.01 34.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.358 -0.383 . . . . 31.940000000000001 110.477 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HB3' ' H ' ' A' ' 21' ' ' ALA . 42.2 mt-10 -92.61 115.49 28.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.979 0.419 . . . . 31.239999999999998 110.754 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -85.82 0.94 51.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.151 -0.477 . . . . 31.239999999999998 110.429 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 21' ' ' ALA . 1.4 pp -129.09 -20.65 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 29.850000000000001 111.659 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 57.36 90.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.995 0.518 . . . . 28.199999999999999 111.858 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.5 10.62 3.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.981 0.419 . . . . 26.780000000000001 111.734 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.52 2.71 56.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.154 -0.476 . . . . 27.469999999999999 110.621 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.604 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 9.8 tp10 -81.56 -47.55 1.04 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.816 -0.629 . . . . 24.41 111.465 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 36.5 Cg_exo -62.72 -169.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.353 2.035 . . . . 21.629999999999999 112.777 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.466 ' OE2' ' HD2' ' A' ' 27' ' ' PRO . 10.0 tp10 -58.54 119.7 38.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 20.670000000000002 110.596 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HD2' ' OE2' ' A' ' 26' ' ' GLU . 28.5 Cg_endo -63.41 131.64 32.73 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 18.02 112.957 -176.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.85 153.78 37.59 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.689 -0.687 . . . . 14.93 109.564 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.11 128.22 27.94 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.416 2.077 . . . . 13.81 112.525 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -144.68 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.701 -0.681 . . . . 10.76 110.311 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 17.1 Cg_exo -68.19 132.15 25.31 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.924 1.749 . . . . 9.7699999999999996 110.502 170.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.22 148.06 35.87 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 121.023 -0.271 . . . . 5.8600000000000003 110.863 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.33 -19.57 65.72 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.384 2.056 . . . . 4.4699999999999998 111.251 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.39 -54.21 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.351 -0.84 . . . . 4.1299999999999999 109.848 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 34.9 mm-40 -97.44 99.2 10.62 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.399 -0.364 . . . . 2.4500000000000002 110.113 176.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.686 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -83.18 -158.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.81 -0.632 . . . . 0.53000000000000003 110.995 -175.47 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.75 110.99 5.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.5 110.398 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.676 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -66.59 103.2 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 2.5099999999999998 110.963 175.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.742 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.2 mt -53.88 -48.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.66 -1.155 . . . . 0.46000000000000002 111.522 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 45' ' ' LEU . 52.0 mt -105.68 12.79 30.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 0.71999999999999997 110.712 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.676 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 69.08 6.83 55.07 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.331 -0.849 . . . . 0.52000000000000002 113.332 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.541 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -99.27 -12.76 20.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.676 0.275 . . . . 0.94999999999999996 111.468 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.32 -19.11 37.35 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.382 -0.913 . . . . 0.71999999999999997 112.832 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.5 mp -75.33 -24.47 57.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.039 0.923 . . . . 1.5600000000000001 109.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 tp -119.13 113.84 21.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.911 -1.495 . . . . 0.32000000000000001 110.145 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 43.4 mtm180 -142.86 133.44 25.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.35 0.5 . . . . 1.1399999999999999 112.35 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB2' HD11 ' A' ' 39' ' ' ILE . 12.8 ttpt -109.97 125.04 52.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.34999999999999998 109.976 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.686 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 26.5 ttpp -114.4 121.6 44.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.146 0.498 . . . . 1.0700000000000001 111.046 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.612 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.3 p -74.68 103.45 4.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.198 -0.91 . . . . 0.33000000000000002 111.713 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.09 -56.41 7.8 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.67 -1.604 . . . . 0.28000000000000003 106.67 171.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 56.0 t -131.97 123.89 19.28 Favored Pre-proline 0 CA--C 1.502 -0.9 0 CA-C-N 112.726 -2.034 . . . . 0.35999999999999999 106.719 168.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.708 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 73.5 Cg_endo -107.92 66.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 122.563 2.175 . . . . 0.54000000000000004 114.055 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.48 157.68 5.58 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.435 -0.802 . . . . 0.55000000000000004 113.394 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 97.0 Cg_endo -78.75 161.0 27.71 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.536 2.157 . . . . 1.4199999999999999 110.927 172.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.38 98.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.176 1.917 . . . . 2.04 111.865 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.0 47.15 0.97 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.599 -0.81 . . . . 0.97999999999999998 112.153 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.1 p -90.34 -165.81 1.44 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.108 0.48 . . . . 0.98999999999999999 110.601 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -149.82 147.21 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.912 -0.773 . . . . 1.28 108.912 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 85.2 mtt180 -96.24 116.37 66.13 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.578 -0.449 . . . . 2.8100000000000001 110.116 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.801 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -49.47 144.48 18.42 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.756 2.971 . . . . 0.29999999999999999 112.975 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 9.0 t -89.25 145.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.18 -0.463 . . . . 0.88 110.031 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.902 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 97.9 mttt -65.72 104.42 1.05 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.639 0.733 . . . . 1.1699999999999999 109.788 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 142.12 -29.92 2.16 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 114.394 -1.276 . . . . 0.41999999999999998 109.948 -174.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.9 mm-40 -74.83 136.16 41.6 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.363 -0.977 . . . . 0.58999999999999997 108.363 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.3 m -84.16 115.23 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.951 -1.129 . . . . 1.22 107.951 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -109.65 146.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.95 -1.023 . . . . 0.25 110.853 -171.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.797 ' HB ' ' OE1' ' A' ' 85' ' ' GLU . 78.9 p -91.12 112.46 24.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.289 0.566 . . . . 0.28999999999999998 109.725 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.739 HG21 HD21 ' A' ' 99' ' ' LEU . 26.8 m -111.04 142.39 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 119.907 -0.717 . . . . 0.19 109.319 170.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -102.41 116.7 33.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.529 -1.656 . . . . 0.19 106.529 169.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -116.86 135.15 53.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.98 -1.088 . . . . 0.39000000000000001 110.781 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.572 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 2.9 mp0 -130.49 114.23 15.25 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.427 -2.064 . . . . 0.27000000000000002 105.427 167.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.563 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 86.8 m -106.43 127.27 53.16 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.229 -1.35 . . . . 0.19 111.145 -166.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.789 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -107.1 153.22 22.95 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.21 -0.905 . . . . 1.0600000000000001 109.335 -178.246 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.7 mt -78.6 164.79 24.36 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.488 -0.778 . . . . 0.83999999999999997 109.293 174.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 6.4 pt-20 -58.37 -14.21 7.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.436 0.636 . . . . 1.1399999999999999 110.507 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.442 ' OD1' ' HG3' ' A' ' 75' ' ' GLU . 2.0 m-20 -87.25 -14.77 40.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.242 -0.89 . . . . 2.1400000000000001 109.895 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.33 -6.68 46.34 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.851 -0.613 . . . . 0.51000000000000001 111.763 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -81.42 110.05 16.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.926 0.343 . . . . 0.46000000000000002 111.926 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 37.5 mtt180 -74.11 116.75 15.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.511 0.672 . . . . 0.46999999999999997 110.394 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.1 m -99.33 -12.91 8.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.27000000000000002 112.314 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.536 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 28.9 pt20 -156.61 136.07 12.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.224 -0.444 . . . . 0.58999999999999997 110.385 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 33.1 tt0 -135.13 116.54 14.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.962 -0.563 . . . . 1.3400000000000001 109.652 174.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 86' ' ' LEU . 5.2 tt0 -129.5 109.59 17.55 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.29 -0.868 . . . . 2.5899999999999999 109.795 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 16.5 Cg_exo -68.34 -13.57 38.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.736 2.957 . . . . 0.5 113.256 -172.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OE1' ' HB ' ' A' ' 67' ' ' THR . 2.9 tp10 -157.96 101.94 1.8 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.037 0.923 . . . . 1.3700000000000001 110.711 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.478 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 28.1 tp -116.92 106.46 13.46 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.986 -1.461 . . . . 0.38 108.65 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.5 p -101.97 132.08 48.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.7 p90 -153.8 156.16 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.23000000000000001 110.824 -174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 5.3 m -75.32 112.03 11.2 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.674 -0.693 . . . . 0.41999999999999998 109.66 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.902 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.8 tp -60.18 137.7 58.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.037 -0.528 . . . . 0.59999999999999998 110.21 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 77.61 5.98 86.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.37 112.264 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 29.5 t70 -103.3 -5.6 22.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.952 0.406 . . . . 0.93000000000000005 110.044 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 47.5 m 59.99 32.91 21.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.48 -0.782 . . . . 0.62 109.095 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 18.6 t70 -70.16 -16.52 63.1 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.424 1.107 . . . . 1.3300000000000001 108.758 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.76 -150.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 113.537 -1.665 . . . . 0.23000000000000001 110.253 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.6 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.1 pt -87.5 139.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.649 -1.241 . . . . 0.28999999999999998 107.649 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -58.68 -29.18 66.41 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 123.264 0.352 . . . . 0.40000000000000002 110.916 -173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -55.36 -48.34 74.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.362 0.601 . . . . 0.20000000000000001 110.664 174.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 68' ' ' VAL . 56.5 tp -75.6 -36.22 60.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.443 -0.799 . . . . 0.22 110.604 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.29 -30.63 71.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 0.26000000000000001 109.594 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 0.25 112.296 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 t -63.75 -36.65 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 1.01 110.959 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.554 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 77.2 t -62.97 -54.88 42.76 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.059 0.763 . . . . 0.20999999999999999 113.059 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.838 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.6 Cg_endo -62.54 -20.83 71.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.282 1.988 . . . . 0.27000000000000002 111.721 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.584 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.8 mt -83.96 -12.69 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.64000000000000001 111.29 173.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -106.98 155.94 19.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.268 -0.424 . . . . 0.78000000000000003 110.887 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.98 153.17 17.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.995 0.426 . . . . 0.96999999999999997 110.825 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.801 HG23 ' HD3' ' A' ' 60' ' ' PRO . 1.7 t -60.4 125.4 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.118 0.485 . . . . 0.80000000000000004 110.403 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 18.58 41.98 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.103 -0.953 . . . . 0.28000000000000003 112.499 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.774 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.0 pt-20 -107.57 167.3 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.418 0.628 . . . . 0.40999999999999998 110.992 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 m -130.54 117.46 19.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.957 -1.127 . . . . 0.22 107.957 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.28 138.89 52.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.115 0.483 . . . . 0.17999999999999999 110.736 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.0 ttp -100.03 117.45 34.32 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.079 -1.452 . . . . 1.3200000000000001 107.079 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 47' ' ' LYS . 9.8 t -114.74 131.0 68.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.764 -0.458 . . . . 0.17999999999999999 109.764 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.516 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 86.0 m -107.49 113.5 26.88 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.658 -0.867 . . . . 0.20999999999999999 108.658 173.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.55 135.8 53.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.263 -1.335 . . . . 0.14999999999999999 109.354 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.614 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.4 t70 -53.82 149.86 8.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.818 -0.808 . . . . 0.57999999999999996 108.818 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -56.66 -28.01 59.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.202 0.525 . . . . 0.81999999999999995 110.059 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.9 ptpt -56.43 -31.94 64.41 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.902 -0.499 . . . . 0.81000000000000005 111.779 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.593 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.3 m-85 -94.87 4.22 54.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.41999999999999998 109.632 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 66.8 m -123.16 -92.76 0.53 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.067 -0.97 . . . . 0.17999999999999999 110.489 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 6.5 m-85 -142.0 39.77 1.64 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 119.041 -0.504 . . . . 0.23999999999999999 112.135 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.16 -88.7 0.01 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 114.09 0.396 . . . . 0.25 114.09 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.96 10.63 3.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.015 1.81 . . . . 0.57999999999999996 111.434 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -103.49 -49.4 3.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.567 -0.742 . . . . 0.65000000000000002 109.924 -173.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.515 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 81.72 145.42 4.96 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.758 -1.11 . . . . 0.29999999999999999 111.698 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.687 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.5 t -90.49 162.54 15.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.405 -0.398 . . . . 0.33000000000000002 110.925 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -51.63 -58.74 5.49 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.892 0.745 . . . . 3.1699999999999999 110.733 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.849 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 59.6 m -77.48 -61.34 0.65 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.897 -0.592 . . . . 1.23 110.411 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.849 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.8 Cg_endo -106.04 125.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.09 1.86 . . . . 0.37 112.619 174.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.14 96.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.514 -0.921 . . . . 1.1399999999999999 108.514 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.573 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.9 123.87 87.2 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.536 -0.757 . . . . 0.39000000000000001 109.717 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.88 136.93 43.76 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.841 2.361 . . . . 0.60999999999999999 112.459 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.672 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 Cg_endo -55.44 128.71 31.55 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.159 1.906 . . . . 0.52000000000000002 111.998 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.593 ' H ' ' HB3' ' A' ' 118' ' ' SER . 62.7 m170 74.13 12.97 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.98 -1.009 . . . . 2.3799999999999999 112.397 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -76.33 121.1 22.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.554 -0.906 . . . . 0.26000000000000001 108.554 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -72.95 113.11 9.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.22 109.754 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.563 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.2 tp -88.45 131.45 34.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.572 -0.74 . . . . 0.22 110.566 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.4 100.68 8.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.301 -1.0 . . . . 1.2 108.301 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.536 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.1 pp -115.22 136.54 53.0 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.058 -0.519 . . . . 0.32000000000000001 111.734 -171.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.572 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 40.0 tt0 -102.71 117.14 34.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.479 -0.934 . . . . 1.05 108.479 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 99' ' ' LEU . 3.5 m -117.93 116.7 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.535 0.683 . . . . 0.19 112.785 -174.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -89.73 108.77 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 0.28000000000000003 110.576 173.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.652 HD21 ' HG3' ' A' ' 60' ' ' PRO . 57.6 tp -85.44 97.78 10.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.379 -0.971 . . . . 0.14999999999999999 108.379 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 143' ' ' THR . 19.7 mtmm -103.39 -18.17 14.94 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.0800000000000001 110.702 -168.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m -156.16 145.36 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.913 -0.585 . . . . 0.37 110.913 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.531 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.62 127.26 32.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.641 -0.874 . . . . 0.25 108.641 169.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 65' ' ' VAL . 20.4 m -131.29 137.87 54.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.203 -0.599 . . . . 0.92000000000000004 110.436 -178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.61 117.96 21.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.918 -0.583 . . . . 2.27 110.04 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.9 5.3 3.08 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.808 -0.633 . . . . 1.97 109.764 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -85.68 85.78 7.39 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.522 0.677 . . . . 2.1400000000000001 110.194 -175.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.07 79.02 1.45 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.538 -1.21 . . . . 5.79 108.407 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -52.02 143.52 13.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.611 -1.177 . . . . 7.4800000000000004 110.539 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -45.27 7.88 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.476 0.917 . . . . 8.4600000000000009 113.476 -166.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -116.08 32.65 5.97 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.533 -0.467 . . . . 8.8300000000000001 111.826 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 42.1 m80 63.35 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.537 0.523 . . . . 12.17 110.978 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.136 -0.935 . . . . 13.460000000000001 109.38 179.833 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.633 0.254 . . . . 50.229999999999997 110.515 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.53 -43.69 2.62 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.717 -0.754 . . . . 47.990000000000002 111.363 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -89.91 122.52 67.79 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.24 -0.652 . . . . 46.259999999999998 109.24 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.598 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 72.3 Cg_exo -47.49 -51.72 9.17 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.284 2.656 . . . . 44.799999999999997 114.5 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 1.8 Cg_endo -83.65 120.61 2.79 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.346 1.364 . . . . 44.020000000000003 112.025 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 -0.96 2.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.605 -0.725 . . . . 42.5 110.217 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -132.83 148.03 52.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.343 -0.844 . . . . 41.5 109.938 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -122.18 107.97 12.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.116 -0.493 . . . . 40.329999999999998 109.689 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.29 -65.41 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.093 0.87 . . . . 39.090000000000003 111.27 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 179.07 -59.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.222 0.534 . . . . 38.82 110.022 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.14 76.74 0.44 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.805 -1.089 . . . . 38.159999999999997 109.978 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -95.8 -172.17 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.232 2.621 . . . . 36.700000000000003 112.1 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.52 -25.92 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.628 -0.796 . . . . 35.609999999999999 112.591 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.23 9.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.728 0.299 . . . . 35.030000000000001 110.562 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp 67.04 167.06 0.23 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.243 -0.89 . . . . 34.009999999999998 110.197 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 54.59 68.43 0.86 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.431 0.634 . . . . 32.890000000000001 110.601 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -76.49 24.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.584 -0.735 . . . . 31.940000000000001 112.523 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 54.86 74.63 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.061 0.458 . . . . 31.239999999999998 109.824 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.551 ' HD2' ' HG ' ' A' ' 20' ' ' LEU . 39.0 t80 -163.44 -60.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.097 0.475 . . . . 31.239999999999998 110.128 -177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 19' ' ' PHE . 96.1 mt -121.29 163.21 18.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 29.850000000000001 110.479 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.02 170.25 8.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.09 -0.505 . . . . 28.199999999999999 110.302 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.11 99.45 9.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 26.780000000000001 111.063 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 52.5 tpp -105.14 79.56 1.51 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.072 -0.714 . . . . 27.469999999999999 109.072 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 18.6 mm-40 -105.64 121.11 47.08 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.673 -0.694 . . . . 24.41 110.933 -174.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 3.9 Cg_exo -78.05 111.4 3.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.717 2.278 . . . . 21.629999999999999 111.485 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 40.8 mt-10 -70.99 145.34 91.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 20.670000000000002 110.438 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 37.0 Cg_exo -57.82 96.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.479 2.786 . . . . 18.02 113.925 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -120.61 142.16 33.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.61 . . . . 14.93 110.114 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 3.7 Cg_exo -80.84 163.29 20.88 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.994 2.463 . . . . 13.81 111.542 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.15 67.98 1.76 Allowed Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 123.961 0.788 . . . . 10.76 110.9 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.37 67.58 6.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.184 2.589 . . . . 9.7699999999999996 110.963 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 145.38 73.29 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.526 -0.761 . . . . 5.8600000000000003 110.402 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.89 -25.11 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.325 2.017 . . . . 4.4699999999999998 112.374 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.15 122.51 19.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 4.1299999999999999 111.186 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -93.08 103.63 15.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.886 -0.597 . . . . 2.4500000000000002 109.575 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.565 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 1.0 OUTLIER -87.99 -170.41 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.53000000000000003 109.864 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.76 111.47 8.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.851 -0.613 . . . . 0.5 110.3 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.797 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 11.0 t70 -75.14 126.65 31.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.779 -0.768 . . . . 2.5099999999999998 109.795 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 105' ' ' LEU . 5.0 mt -59.47 -30.22 43.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.46000000000000002 110.771 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.6 mt -113.21 -5.58 13.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.577 -0.738 . . . . 0.71999999999999997 110.572 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.676 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.71 21.8 71.32 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.428 -0.806 . . . . 0.52000000000000002 111.675 -174.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.509 HD22 ' H ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -103.18 -20.27 14.21 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.078 0.769 . . . . 0.94999999999999996 113.078 -175.137 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.491 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 125.79 -26.43 5.38 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.036 -1.078 . . . . 0.71999999999999997 114.827 166.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -106.17 -11.47 16.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.124 0.787 . . . . 1.5600000000000001 113.124 -171.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.7 tp -123.11 100.99 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.505 -0.122 . . . . 0.32000000000000001 111.108 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.797 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 83.7 mtm180 -140.88 145.46 36.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.551 0.574 . . . . 1.1399999999999999 112.551 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.652 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.7 ttpt -116.29 131.39 56.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.218 -0.447 . . . . 0.34999999999999998 110.259 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 4.2 ttmm -111.85 125.75 54.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.626 0.251 . . . . 1.0700000000000001 110.511 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 p -80.18 100.22 8.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.376 -0.375 . . . . 0.33000000000000002 111.434 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.464 HD12 HG22 ' A' ' 111' ' ' THR . 11.8 mt -63.94 -53.15 54.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.943 -1.503 . . . . 0.28000000000000003 106.943 170.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.8 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.9 t -136.35 129.36 17.72 Favored Pre-proline 0 CA--C 1.503 -0.844 0 CA-C-N 112.753 -2.021 . . . . 0.35999999999999999 106.638 170.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 38.7 Cg_endo -103.91 56.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 122.812 2.342 . . . . 0.54000000000000004 113.671 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.42 170.71 44.25 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.303 -0.862 . . . . 0.55000000000000004 113.062 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.4 172.41 14.58 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.655 2.237 . . . . 1.4199999999999999 110.93 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.56 103.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.362 2.041 . . . . 2.04 112.254 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.89 56.68 1.59 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.023 -0.608 . . . . 0.97999999999999998 112.51 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.61 -173.85 4.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.5 0.667 . . . . 0.98999999999999999 111.566 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -136.42 140.93 43.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.527 -0.916 . . . . 1.28 108.527 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 97.7 mtt180 -101.13 114.1 65.79 Favored Pre-proline 0 C--N 1.311 -1.097 0 C-N-CA 120.786 -0.366 . . . . 2.8100000000000001 110.539 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.685 ' HD3' HG23 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -47.29 142.1 12.77 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.875 3.05 . . . . 0.29999999999999999 113.735 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.69 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.1 t -95.67 152.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.486 -0.779 . . . . 0.88 109.564 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 40.4 mttp -66.51 106.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.569 0.699 . . . . 1.1699999999999999 110.488 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.2 -23.14 2.57 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.96 -1.018 . . . . 0.41999999999999998 110.756 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.2 OUTLIER -85.25 139.13 31.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.803 -0.814 . . . . 0.58999999999999997 108.803 177.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 HD11 ' A' ' 150' ' ' LEU . 10.7 m -87.28 129.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.677 -0.861 . . . . 1.22 108.677 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 24.9 m -123.15 149.64 26.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.928 -1.033 . . . . 0.25 110.502 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 20.2 p -97.82 112.85 24.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.748 -0.66 . . . . 0.28999999999999998 110.218 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 99' ' ' LEU . 24.4 m -110.93 147.01 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 120.376 -0.53 . . . . 0.19 110.375 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.611 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.78 114.84 29.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.988 -1.486 . . . . 0.19 106.988 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.9 OUTLIER -120.33 138.16 53.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.387 -0.925 . . . . 0.39000000000000001 111.194 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.477 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 mp0 -133.27 114.83 14.22 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.127 -1.805 . . . . 0.27000000000000002 106.127 167.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.675 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 32.6 m -103.14 118.99 38.02 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.867 -1.06 . . . . 0.19 111.848 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -105.65 135.05 47.75 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.477 -0.783 . . . . 1.0600000000000001 109.248 176.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.531 HD13 ' CG1' ' A' ' 80' ' ' VAL . 4.2 mp -58.46 165.29 2.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.562 0.22 . . . . 0.83999999999999997 111.26 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 8.1 pt-20 -52.45 -20.48 2.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.374 0.607 . . . . 1.1399999999999999 111.267 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -87.46 -14.73 39.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.706 -0.679 . . . . 2.1400000000000001 111.15 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.66 -10.57 38.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.35 -0.452 . . . . 0.51000000000000001 112.249 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -72.27 108.97 5.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.995 0.426 . . . . 0.46000000000000002 111.552 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 18.1 mtt180 -73.33 128.47 35.57 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.472 0.653 . . . . 0.46999999999999997 110.367 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.851 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.2 m -115.6 -8.17 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.683 -1.144 . . . . 0.27000000000000002 111.501 -171.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.675 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.8 pt20 -162.69 130.74 3.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.697 -0.683 . . . . 0.58999999999999997 109.334 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 25.9 tt0 -141.84 105.92 4.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 1.3400000000000001 110.258 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 6.4 mm-40 -125.84 126.82 24.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.743 -0.662 . . . . 2.5899999999999999 109.754 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.492 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 10.9 Cg_exo -70.94 -17.06 32.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.424 2.083 . . . . 0.5 112.639 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -159.66 122.9 3.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.99 0.9 . . . . 1.3700000000000001 111.923 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.6 tp -132.82 113.15 12.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.519 -1.673 . . . . 0.38 108.774 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.9 p -104.94 132.58 51.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.6 p90 -153.16 156.29 38.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.651 0.262 . . . . 0.23000000000000001 110.638 -176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -75.86 112.06 11.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.41999999999999998 110.172 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.84 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.5 tp -60.26 135.38 57.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.59999999999999998 110.427 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.573 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 81.01 5.43 90.16 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.708 -0.758 . . . . 0.37 112.069 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.82 -13.13 19.35 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.852 -0.425 . . . . 0.93000000000000005 109.852 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.7 m 62.32 35.04 15.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.556 -0.905 . . . . 0.62 108.556 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.27 -6.34 49.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.55 1.167 . . . . 1.3300000000000001 108.431 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 7.8 m -131.13 -156.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.375 -1.739 . . . . 0.23000000000000001 110.021 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -80.08 137.36 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 107.482 -1.303 . . . . 0.28999999999999998 107.482 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -58.04 -29.16 65.13 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.583 -0.28 . . . . 0.40000000000000002 110.891 -173.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.91 78.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.20000000000000001 110.802 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.565 ' H ' HG13 ' A' ' 96' ' ' ILE . 51.4 tp -72.51 -41.34 66.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.22 110.503 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.11 -30.22 70.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.26000000000000001 109.911 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.14 -33.77 16.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.25 112.196 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.7 t -68.91 -29.11 67.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.593 -0.276 . . . . 1.01 111.111 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.602 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -66.31 -55.11 21.34 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.659 0.615 . . . . 0.20999999999999999 112.659 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.84 ' HD3' HD11 ' A' ' 90' ' ' LEU . 20.7 Cg_endo -62.45 -23.62 75.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.921 1.747 . . . . 0.27000000000000002 111.818 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 39' ' ' ILE . 20.2 mt -73.75 -26.12 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.738 -0.664 . . . . 0.64000000000000001 111.015 172.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.767 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -95.72 156.52 16.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.09 -0.505 . . . . 0.78000000000000003 111.082 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.03 151.54 21.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.055 0.455 . . . . 0.96999999999999997 110.923 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.685 HG23 ' HD3' ' A' ' 60' ' ' PRO . 1.3 t -60.07 125.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.461 0.648 . . . . 0.80000000000000004 110.22 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.39 56.74 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.865 -1.061 . . . . 0.28000000000000003 112.803 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.8 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.0 pt-20 -103.14 167.93 9.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.40999999999999998 111.096 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.464 HG22 HD12 ' A' ' 50' ' ' LEU . 7.2 m -129.41 117.19 20.16 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.716 -1.216 . . . . 0.22 107.716 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.74 134.35 55.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.049 -0.523 . . . . 0.17999999999999999 110.717 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.4 ttp -98.39 117.93 33.9 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.759 -1.2 . . . . 1.3200000000000001 107.759 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.652 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.1 t -111.92 135.21 51.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.689 -0.687 . . . . 0.17999999999999999 109.431 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.565 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 87.8 m -114.32 113.68 24.89 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.616 -0.834 . . . . 0.20999999999999999 108.795 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.64 54.94 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.18 -1.373 . . . . 0.14999999999999999 109.796 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.706 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.79 148.79 6.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.004 -0.739 . . . . 0.57999999999999996 109.004 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.3 t -55.23 -28.5 53.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.116 0.484 . . . . 0.81999999999999995 110.489 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.706 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.5 ptpt -54.77 -32.88 60.63 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.448 -0.342 . . . . 0.81000000000000005 111.535 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.636 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 98.3 m-85 -97.25 7.8 45.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.41999999999999998 110.04 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.667 ' HB3' HD22 ' A' ' 138' ' ' LEU . 61.4 m -123.7 -91.74 0.54 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.118 -0.946 . . . . 0.17999999999999999 110.115 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 4.1 m-85 -144.56 41.57 1.34 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 119.272 -0.394 . . . . 0.23999999999999999 111.985 175.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.692 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.49 -84.01 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 121.449 -0.405 . . . . 0.25 113.836 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.76 12.07 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.32 2.013 . . . . 0.57999999999999996 111.088 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -104.45 -51.52 3.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.499 -0.773 . . . . 0.65000000000000002 110.176 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.558 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 83.27 142.46 4.77 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.606 -1.179 . . . . 0.29999999999999999 111.982 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.618 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.7 t -92.65 164.23 13.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.176 -0.512 . . . . 0.33000000000000002 112.074 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 128' ' ' ARG . 44.6 mtm180 -50.59 -62.64 1.47 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.905 -1.043 . . . . 3.1699999999999999 111.905 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.939 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 30.9 t -72.09 -63.68 1.21 Allowed Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 1.23 110.067 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.9 Cg_endo -107.22 127.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 122.653 2.235 . . . . 0.37 112.315 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.558 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 42.1 t80 -55.97 98.6 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.861 -1.163 . . . . 1.1399999999999999 107.861 162.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.612 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.2 mm -66.44 128.82 94.05 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 115.713 -0.676 . . . . 0.39000000000000001 109.484 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.25 145.52 65.69 Favored 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.656 2.237 . . . . 0.60999999999999999 111.839 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.692 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 34.8 Cg_endo -63.85 139.39 68.14 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.922 1.748 . . . . 0.52000000000000002 111.783 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.565 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 4.9 m-70 68.75 6.97 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.129 -0.941 . . . . 2.3799999999999999 112.558 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -72.4 120.65 18.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.283 -0.636 . . . . 0.26000000000000001 109.283 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -73.45 113.2 10.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.355 0.598 . . . . 0.22 109.904 -172.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 121' ' ' CYS . 0.9 OUTLIER -87.95 131.32 34.65 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.567 -0.742 . . . . 0.22 110.663 -177.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.8 t -115.73 99.94 7.67 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.901 -0.778 . . . . 1.2 108.901 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.2 pp -115.23 134.32 55.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.116 -0.493 . . . . 0.32000000000000001 111.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 34.0 tt0 -98.86 122.04 41.59 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.223 -0.658 . . . . 1.05 109.223 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.8 m -117.69 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.476 0.655 . . . . 0.19 112.342 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 6.8 m -95.08 111.01 22.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.102 -0.954 . . . . 0.28000000000000003 110.06 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.619 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -83.6 99.19 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.66 -0.867 . . . . 0.14999999999999999 108.66 173.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.424 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 21.4 mtmt -94.69 -32.28 13.44 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.052 -0.976 . . . . 1.0800000000000001 110.598 -170.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.463 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.9 m -152.44 151.69 31.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.37 111.019 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -139.25 129.35 25.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.249 -0.648 . . . . 0.25 109.249 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.55 128.73 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.385 0.612 . . . . 0.92000000000000004 110.534 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.47 125.57 34.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.644 -0.707 . . . . 2.27 110.615 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.63 HD11 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.2 -1.24 1.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.674 -0.694 . . . . 1.97 110.514 178.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.82 98.15 7.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.661 . . . . 2.1400000000000001 109.796 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 70.24 -1.53 2.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.56 -0.745 . . . . 5.79 111.022 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 69.72 137.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.71 0.804 . . . . 7.4800000000000004 112.421 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -46.6 115.14 0.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.967 -1.015 . . . . 8.4600000000000009 111.597 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -91.98 -12.03 34.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.486 -0.561 . . . . 8.8300000000000001 109.486 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -76.74 87.64 3.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.593 -0.891 . . . . 12.17 108.593 167.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.6 m170 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 114.995 -1.002 . . . . 13.460000000000001 110.203 -174.472 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.134 -0.321 . . . . 50.229999999999997 110.134 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.65 -159.82 9.25 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.153 -0.779 . . . . 47.990000000000002 111.153 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -117.2 137.76 24.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.996 0.398 . . . . 46.259999999999998 110.092 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 31.9 Cg_exo -60.11 144.34 99.49 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.276 1.984 . . . . 44.799999999999997 111.441 172.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 23.6 Cg_exo -64.02 127.37 19.24 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.577 2.185 . . . . 44.020000000000003 112.214 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.86 -168.44 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 42.5 110.517 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 59.83 88.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.844 -0.798 . . . . 41.5 108.844 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.3 pm0 -68.81 135.29 50.95 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.275 0.843 . . . . 40.329999999999998 113.275 -166.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.25 5.55 12.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.917 -1.038 . . . . 39.090000000000003 109.746 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -90.01 -63.89 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 38.82 109.519 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.83 86.35 43.93 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.031 -0.531 . . . . 38.159999999999997 109.909 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -86.19 -177.27 2.39 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.779 2.32 . . . . 36.700000000000003 111.407 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.79 70.45 0.68 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.174 -1.012 . . . . 35.609999999999999 112.319 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.05 95.4 2.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.024 0.44 . . . . 35.030000000000001 110.468 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.9 -53.64 3.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.941 -0.572 . . . . 34.009999999999998 110.241 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.79 77.83 6.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.046 -0.524 . . . . 32.890000000000001 110.622 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -87.88 -7.12 57.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 31.940000000000001 111.351 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 70.74 114.79 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.789 0.68 . . . . 31.239999999999998 111.117 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.673 ' HD2' ' HG ' ' A' ' 20' ' ' LEU . 26.5 p90 -164.09 164.59 22.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 31.239999999999998 110.712 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HG ' ' HD2' ' A' ' 19' ' ' PHE . 67.1 mt 66.44 71.61 0.39 Allowed 'General case' 0 C--O 1.239 0.512 0 O-C-N 124.143 0.902 . . . . 29.850000000000001 111.311 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.01 -110.82 0.56 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.864 -1.062 . . . . 28.199999999999999 110.987 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.81 -48.44 2.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.803 0.335 . . . . 26.780000000000001 110.403 175.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.4 mtm -138.34 16.42 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.35 . . . . 27.469999999999999 111.673 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 57.45 98.85 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.685 0.616 . . . . 24.41 110.895 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.78 101.09 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.58 2.186 . . . . 21.629999999999999 112.797 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.92 149.56 42.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.021 -0.536 . . . . 20.670000000000002 109.77 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.59 122.66 11.61 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.734 2.29 . . . . 18.02 111.984 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.19 155.98 92.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 14.93 110.515 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.06 134.96 51.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.845 2.363 . . . . 13.81 112.576 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -73.81 -52.85 4.45 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.102 -0.499 . . . . 10.76 111.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 5.5 Cg_exo -78.8 115.52 3.6 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.063 1.842 . . . . 9.7699999999999996 111.343 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.5 112.63 6.88 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.452 -0.34 . . . . 5.8600000000000003 111.242 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -93.04 29.69 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.116 2.544 . . . . 4.4699999999999998 111.965 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 65.68 41.87 3.81 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.438 -0.801 . . . . 4.1299999999999999 110.617 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -84.79 92.97 8.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.523 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 2.0 m0 -72.56 -161.21 0.08 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.53000000000000003 110.334 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 49.0 tp -80.04 109.99 15.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.5 110.661 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.713 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 2.8 p-10 -63.06 97.71 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.089 -0.959 . . . . 2.5099999999999998 110.696 171.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.817 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 12.0 mt -51.14 -49.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.021 -0.99 . . . . 0.46000000000000002 111.986 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 45' ' ' LEU . 55.2 mt -102.33 3.84 38.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.71999999999999997 110.99 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.713 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 75.61 8.5 84.23 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.52000000000000002 112.314 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -98.12 -15.85 19.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.224 0.453 . . . . 0.94999999999999996 112.224 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.14 -26.87 5.86 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.71999999999999997 112.623 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.6 mp -69.15 -23.74 63.99 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 122.018 0.913 . . . . 1.5600000000000001 109.033 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.817 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.9 tp -120.24 112.39 19.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.133 -1.394 . . . . 0.32000000000000001 110.486 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 57.2 mtm180 -142.45 140.76 32.04 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 122.962 0.164 . . . . 1.1399999999999999 111.229 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HG3' HG22 ' A' ' 114' ' ' VAL . 15.9 ttpt -115.53 127.04 54.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.801 -0.444 . . . . 0.34999999999999998 109.801 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 15.0 ttmt -107.16 122.42 46.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 110.216 -0.29 . . . . 1.0700000000000001 110.216 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.0 p -79.05 99.6 6.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.896 0.379 . . . . 0.33000000000000002 111.063 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 111' ' ' THR . 9.3 mt -67.8 -52.5 36.32 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.724 -1.584 . . . . 0.28000000000000003 106.724 173.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.819 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.3 t -134.68 126.66 18.15 Favored Pre-proline 0 CA--C 1.502 -0.88 0 CA-C-N 113.039 -1.891 . . . . 0.35999999999999999 106.196 168.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 65.7 Cg_endo -107.01 54.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.013 2.476 . . . . 0.54000000000000004 114.474 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 54' ' ' PRO . . . 87.43 140.73 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.849 -0.691 . . . . 0.55000000000000004 113.206 173.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 14.3 Cg_exo -69.0 153.73 71.93 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.76 2.307 . . . . 1.4199999999999999 110.695 173.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -50.31 108.69 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.593 2.195 . . . . 2.04 112.469 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.81 43.47 2.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.827 -0.701 . . . . 0.97999999999999998 112.205 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -87.11 -172.23 3.87 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.163 0.506 . . . . 0.98999999999999999 111.095 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 t -146.21 143.58 29.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.929 -0.767 . . . . 1.28 108.929 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 69.1 mtm180 -94.16 116.84 66.92 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 120.449 -0.5 . . . . 2.8100000000000001 109.756 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.778 ' HD3' HG23 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -49.05 148.02 10.07 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.51 2.807 . . . . 0.29999999999999999 113.077 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 10.6 t -92.73 150.24 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.669 . . . . 0.88 109.195 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 66.1 mttt -71.33 120.26 16.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.709 0.766 . . . . 1.1699999999999999 109.862 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.85 -26.8 4.74 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.175 -1.375 . . . . 0.41999999999999998 110.103 -172.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.3 mm-40 -82.1 135.88 35.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.86 -0.793 . . . . 0.58999999999999997 108.86 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 11.4 m -82.63 118.47 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.524 -0.917 . . . . 1.22 108.524 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -112.96 146.06 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.249 -0.887 . . . . 0.25 110.513 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.0 p -97.05 113.1 24.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.946 -0.57 . . . . 0.28999999999999998 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.446 HG21 HD21 ' A' ' 99' ' ' LEU . 27.1 m -111.05 150.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.767 -0.651 . . . . 0.19 110.187 174.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.734 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.52 -1.659 . . . . 0.19 106.52 167.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pt? -125.0 141.62 52.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.901 0.858 . . . . 0.39000000000000001 110.88 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 mp0 -139.28 120.03 14.26 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.464 -2.05 . . . . 0.27000000000000002 105.464 167.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 43.3 m -112.26 121.66 45.55 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.382 -0.826 . . . . 0.19 111.808 -165.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -103.59 148.7 25.68 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.885 -0.598 . . . . 1.0600000000000001 109.515 175.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD23 HD21 ' A' ' 76' ' ' ASN . 3.4 mp -71.56 165.6 23.56 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.955 -0.566 . . . . 0.83999999999999997 111.067 170.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.34 -18.95 12.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.416 0.627 . . . . 1.1399999999999999 110.08 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.496 HD21 HD23 ' A' ' 74' ' ' LEU . 29.5 p30 -92.44 -5.07 52.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.366 -0.833 . . . . 2.1400000000000001 111.133 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.49 -10.74 53.89 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.248 -0.501 . . . . 0.51000000000000001 113.577 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.6 m -78.49 110.45 13.58 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.74 -0.27 . . . . 0.46000000000000002 111.697 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 33.9 mtt180 -71.19 122.25 19.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.476 0.655 . . . . 0.46999999999999997 110.253 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.735 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 32.8 m -108.18 -10.13 10.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.976 -1.011 . . . . 0.27000000000000002 111.625 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 4.5 pt20 -159.96 145.58 15.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.889 -0.596 . . . . 0.58999999999999997 109.501 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 43.8 tt0 -148.96 105.57 3.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.195 0.521 . . . . 1.3400000000000001 109.902 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HB2' HD23 ' A' ' 70' ' ' LEU . 7.1 mm-40 -122.27 117.57 29.28 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.693 -0.685 . . . . 2.5899999999999999 109.435 -175.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -66.5 -19.18 55.02 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.705 2.27 . . . . 0.5 112.182 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -159.54 118.67 2.89 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.269 1.033 . . . . 1.3700000000000001 111.685 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.3 tp -126.07 99.65 6.0 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.174 -1.83 . . . . 0.38 108.423 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.0 p -89.57 134.42 28.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.5 p90 -153.56 162.7 41.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.11 0.481 . . . . 0.23000000000000001 111.168 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 5.1 m -84.09 108.27 16.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.249 -0.887 . . . . 0.41999999999999998 110.063 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.859 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.24 132.52 54.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.59999999999999998 110.152 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.692 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 86.93 4.9 81.67 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.498 -0.858 . . . . 0.37 112.376 175.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 31.4 t70 -117.8 9.3 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.692 -0.485 . . . . 0.93000000000000005 109.692 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p 43.9 42.45 4.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.145 -0.934 . . . . 0.62 110.296 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 48.9 t0 -71.41 -12.29 61.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.766 1.27 . . . . 1.3300000000000001 108.166 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.471 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 4.1 m -123.48 -153.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 113.168 -1.833 . . . . 0.23000000000000001 109.558 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.682 HG13 ' H ' ' A' ' 99' ' ' LEU . 38.9 pt -81.67 142.85 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 107.541 -1.281 . . . . 0.28999999999999998 107.541 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.494 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 3.1 tp-100 -59.96 -34.85 73.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.619 -0.264 . . . . 0.40000000000000002 111.08 -173.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -53.18 -48.79 67.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.204 0.526 . . . . 0.20000000000000001 110.759 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.682 ' H ' HG13 ' A' ' 96' ' ' ILE . 57.8 tp -67.68 -41.91 82.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.184 -0.916 . . . . 0.22 110.534 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.54 -28.01 68.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.923 -1.035 . . . . 0.26000000000000001 109.913 -176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 87.0 mt -89.66 -34.86 16.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.246 -0.888 . . . . 0.25 111.893 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.477 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 60.3 p -70.82 -27.11 63.63 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.635 0.255 . . . . 1.01 110.768 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.613 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.1 t -66.05 -55.33 21.92 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 112.48 0.548 . . . . 0.20999999999999999 112.48 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.676 ' HD3' HD11 ' A' ' 90' ' ' LEU . 21.9 Cg_endo -61.39 -24.64 78.84 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.806 1.67 . . . . 0.27000000000000002 112.112 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.9 mt -77.98 -13.25 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.64000000000000001 111.213 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.799 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -106.9 155.03 20.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.849 -0.614 . . . . 0.78000000000000003 111.077 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.74 155.61 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.711 0.291 . . . . 0.96999999999999997 110.619 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.778 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.1 t -60.5 125.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.80000000000000004 110.659 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.01 5.86 56.19 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.201 -0.909 . . . . 0.28000000000000003 112.499 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -98.45 168.29 10.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.466 0.65 . . . . 0.40999999999999998 111.139 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.524 HG22 HD12 ' A' ' 50' ' ' LEU . 31.6 m -132.69 117.42 17.85 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.995 -1.002 . . . . 0.22 108.479 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -118.54 140.15 50.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.917 -0.583 . . . . 0.17999999999999999 110.564 -176.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 ttm -97.92 117.16 31.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.263 -1.384 . . . . 1.3200000000000001 107.263 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.476 HG22 ' HG3' ' A' ' 47' ' ' LYS . 4.2 t -113.29 132.81 61.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.424 -0.584 . . . . 0.17999999999999999 109.424 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 79.4 m -112.71 113.75 26.01 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.133 0.968 . . . . 0.20999999999999999 109.072 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.46 135.36 53.17 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.434 -1.712 . . . . 0.14999999999999999 109.693 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.75 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.6 t70 -52.33 147.28 8.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.789 -0.819 . . . . 0.57999999999999996 108.789 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.639 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -55.8 -27.92 53.6 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 120.993 0.425 . . . . 0.81999999999999995 110.234 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.599 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.6 ptpt -56.29 -29.28 60.99 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.894 -0.504 . . . . 0.81000000000000005 111.455 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.593 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 85.0 m-85 -97.35 1.72 49.74 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.196 0.522 . . . . 0.41999999999999998 109.9 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.639 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.1 m -122.02 -90.71 0.57 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.954 -1.021 . . . . 0.17999999999999999 110.66 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.659 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 8.1 m-85 -142.9 41.62 1.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.587 -0.445 . . . . 0.23999999999999999 111.921 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.44 -80.82 0.06 OUTLIER Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.09 -0.576 . . . . 0.25 113.4 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.26 10.36 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.478 2.119 . . . . 0.57999999999999996 111.003 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.659 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.2 mt-30 -102.83 -46.45 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.756 -1.111 . . . . 0.65000000000000002 109.876 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.571 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 79.21 142.58 2.42 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.181 -0.918 . . . . 0.29999999999999999 112.634 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.607 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.7 t -90.53 164.57 14.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.218 -0.491 . . . . 0.33000000000000002 111.558 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -56.16 -50.22 71.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.651 -0.704 . . . . 3.1699999999999999 112.065 -173.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.895 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 51.1 m -80.91 -62.4 0.36 Allowed Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.214 -0.594 . . . . 1.23 109.998 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.895 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 22.1 Cg_endo -107.19 127.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.892 2.395 . . . . 0.37 112.541 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.543 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 41.2 t80 -55.97 98.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.863 -1.162 . . . . 1.1399999999999999 107.863 162.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.589 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.2 mm -64.74 133.0 95.59 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.767 . . . . 0.39000000000000001 110.196 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 146.05 37.55 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.622 2.215 . . . . 0.60999999999999999 112.14 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.3 Cg_endo -63.74 135.57 49.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.296 1.998 . . . . 0.52000000000000002 112.387 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.75 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER 70.75 -0.42 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.915 -1.038 . . . . 2.3799999999999999 112.744 178.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -61.12 118.97 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.129 -0.693 . . . . 0.26000000000000001 109.129 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.92 113.09 10.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.422 0.63 . . . . 0.22 109.685 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 115' ' ' THR . 0.9 OUTLIER -88.83 131.07 35.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.86 . . . . 0.22 110.982 -173.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.2 t -114.64 100.38 8.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.57 -0.9 . . . . 1.2 108.57 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.571 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.0 OUTLIER -121.32 135.46 55.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.008 -0.542 . . . . 0.32000000000000001 111.816 -174.358 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 4.8 tt0 -98.0 125.97 43.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.511 -0.768 . . . . 1.05 109.482 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.4 m -124.42 117.14 49.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.31 0.576 . . . . 0.19 112.053 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 24.4 m -89.25 114.8 26.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.365 -0.834 . . . . 0.28000000000000003 110.391 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.697 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 62.0 tp -84.57 100.35 11.35 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.238 -0.653 . . . . 0.14999999999999999 109.238 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 25.8 mtmt -95.08 -25.8 16.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.528 -0.76 . . . . 1.0800000000000001 110.88 -170.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.536 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 14.2 m -157.37 155.25 30.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.115 0.413 . . . . 0.37 112.115 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.564 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.49 127.9 21.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.28 -0.637 . . . . 0.25 109.28 171.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 17.8 m -136.32 142.44 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.423 . . . . 0.92000000000000004 110.412 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -79.85 118.66 21.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.242 0.544 . . . . 2.27 110.335 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.446 ' HB3' HG13 ' A' ' 65' ' ' VAL . 12.6 tp -137.07 16.36 3.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.532 -0.914 . . . . 1.97 108.532 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.83 -47.04 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.535 -1.212 . . . . 2.1400000000000001 108.198 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -90.11 62.07 5.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.904 -1.044 . . . . 5.79 110.122 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -61.54 159.73 12.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.669 -1.15 . . . . 7.4800000000000004 110.932 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -72.03 145.79 48.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.423 -0.353 . . . . 8.4600000000000009 110.267 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.3 t60 66.29 107.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.0 0.812 . . . . 8.8300000000000001 111.679 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -107.99 175.88 5.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.062 -0.517 . . . . 12.17 110.616 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 C--O 1.244 0.804 0 N-CA-C 108.196 -1.039 . . . . 13.460000000000001 108.196 172.134 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.425 -0.213 . . . . 50.229999999999997 110.425 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.38 6.76 55.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 47.990000000000002 112.743 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -132.64 121.98 17.54 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 122.531 -0.394 . . . . 46.259999999999998 110.681 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 13.8 Cg_exo -70.52 146.7 56.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.721 2.28 . . . . 44.799999999999997 111.394 173.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 27.9 Cg_exo -62.27 150.24 87.71 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.019 2.479 . . . . 44.020000000000003 112.488 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.1 98.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 42.5 110.927 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.5 129.65 47.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.003 0.43 . . . . 41.5 110.307 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.27 164.71 12.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 40.329999999999998 111.091 -171.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.72 143.33 26.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.186 -0.461 . . . . 39.090000000000003 110.713 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.13 -11.05 60.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 38.82 110.617 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.99 97.58 26.16 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.361 0.6 . . . . 38.159999999999997 110.084 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.46 -33.1 30.32 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.956 2.437 . . . . 36.700000000000003 113.164 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.12 3.65 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.614 -0.803 . . . . 35.609999999999999 112.847 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.88 -152.03 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.44 -0.207 . . . . 35.030000000000001 110.44 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.11 94.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.985 0.421 . . . . 34.009999999999998 110.353 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.13 94.83 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 32.890000000000001 111.03 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -100.74 150.09 23.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.593 -0.73 . . . . 31.940000000000001 109.041 172.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -104.83 160.42 15.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.794 0.807 . . . . 31.239999999999998 111.417 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -144.81 20.51 1.64 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.46 -1.245 . . . . 31.239999999999998 108.374 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.01 -51.95 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.565 -1.198 . . . . 29.850000000000001 110.592 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.8 -64.16 1.33 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.851 -0.613 . . . . 28.199999999999999 109.802 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . . . 56.53 11.6 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.571 -0.74 . . . . 26.780000000000001 112.4 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt 58.26 24.77 11.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.148 0.579 . . . . 27.469999999999999 111.296 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 46.7 mt-10 -77.86 -53.26 1.49 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.334 -0.393 . . . . 24.41 111.611 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 24' ' ' GLU . 11.4 Cg_endo -54.93 129.06 33.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.474 2.116 . . . . 21.629999999999999 112.332 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.73 145.94 90.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.036 -0.529 . . . . 20.670000000000002 111.322 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.72 165.88 30.62 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.962 2.441 . . . . 18.02 112.9 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.16 139.34 20.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 14.93 110.311 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.788 ' HG2' ' HB2' ' A' ' 32' ' ' ALA . 13.2 Cg_endo -60.38 157.27 36.68 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.513 2.142 . . . . 13.81 112.738 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -72.44 -48.46 9.49 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.151 -0.477 . . . . 10.76 112.219 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 6.3 Cg_exo -80.27 42.63 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.212 1.941 . . . . 9.7699999999999996 112.179 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.788 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . . . -101.75 148.94 35.99 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 5.8600000000000003 110.55 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 22.0 Cg_exo -65.34 -31.17 53.09 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.568 2.178 . . . . 4.4699999999999998 112.053 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 73.07 168.19 0.31 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.079 0.862 . . . . 4.1299999999999999 111.089 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.489 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 2.0 mp0 -83.74 104.41 13.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.853 -0.612 . . . . 2.4500000000000002 110.011 176.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 46' ' ' ARG . 3.8 m0 -74.65 -170.0 0.96 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.124 -0.489 . . . . 0.53000000000000003 109.765 174.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.07 109.58 4.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.304 -0.628 . . . . 0.5 109.304 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.645 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.2 t70 -78.53 127.19 31.8 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.166 -0.614 . . . . 2.5099999999999998 109.852 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 45' ' ' LEU . 3.3 mt -61.68 -31.1 49.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.702 -1.136 . . . . 0.46000000000000002 110.531 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -115.45 0.54 13.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.9 -0.591 . . . . 0.71999999999999997 110.546 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.645 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.2 25.27 64.36 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.522 -0.763 . . . . 0.52000000000000002 111.552 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -96.03 -26.56 15.49 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.936 0.347 . . . . 0.94999999999999996 111.936 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 105.45 0.86 40.54 Favored Glycine 0 CA--C 1.512 -0.122 0 C-N-CA 120.847 -0.692 . . . . 0.71999999999999997 111.871 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.1 mp -105.49 -32.73 8.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.037 0.446 . . . . 1.5600000000000001 110.873 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 39' ' ' ILE . 19.0 tp -123.12 101.55 7.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 0.32000000000000001 111.572 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 66.4 mtm180 -137.35 148.31 46.18 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.152 -0.342 . . . . 1.1399999999999999 111.449 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HG3' HG22 ' A' ' 114' ' ' VAL . 25.3 ttpt -113.75 132.16 55.93 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.435 -0.209 . . . . 0.34999999999999998 110.435 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.6 ttpt -115.92 129.9 56.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.0700000000000001 110.219 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.466 HG22 ' OE1' ' A' ' 110' ' ' GLU . 5.9 p -82.43 107.67 15.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.163 -0.471 . . . . 0.33000000000000002 111.549 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.486 HD12 HG22 ' A' ' 111' ' ' THR . 6.7 mt -76.04 -54.76 6.37 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.344 -1.354 . . . . 0.28000000000000003 107.344 172.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.814 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 97.7 t -127.24 124.57 23.79 Favored Pre-proline 0 CA--C 1.501 -0.923 0 CA-C-N 113.06 -1.882 . . . . 0.35999999999999999 106.879 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.0 Cg_endo -111.56 88.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.932 2.421 . . . . 0.54000000000000004 114.252 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' A' ' 110' ' ' GLU . . . 50.48 76.95 0.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.387 -0.37 . . . . 0.55000000000000004 113.446 174.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 51.6 Cg_exo -50.93 -59.33 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.455 2.77 . . . . 1.4199999999999999 115.439 -170.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 12.5 Cg_endo -91.65 -4.2 4.11 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.48 2.12 . . . . 2.04 114.248 -170.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.82 90.35 0.91 Allowed Glycine 0 CA--C 1.509 -0.336 0 C-N-CA 120.479 -0.867 . . . . 0.97999999999999998 111.107 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 2.1 p -96.58 -171.87 2.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.055 0.761 . . . . 0.98999999999999999 113.055 -170.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -150.0 143.94 25.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.48 -1.304 . . . . 1.28 107.48 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 6.8 mtm-85 -91.15 115.38 64.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.484 -0.486 . . . . 2.8100000000000001 110.638 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.79 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.23 140.26 42.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.98 2.453 . . . . 0.29999999999999999 113.598 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.711 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.3 t -90.91 156.99 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.531 -0.759 . . . . 0.88 109.845 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -66.26 107.89 2.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.408 0.623 . . . . 1.1699999999999999 110.399 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.04 -27.12 2.56 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 110.534 -1.027 . . . . 0.41999999999999998 110.534 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.711 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.1 mm-40 -74.45 140.14 44.43 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.465 -0.569 . . . . 0.58999999999999997 109.465 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.531 HG23 HD11 ' A' ' 150' ' ' LEU . 69.8 t -86.03 124.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.896 -0.779 . . . . 1.22 108.896 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.6 m -127.79 146.82 32.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 112.296 0.48 . . . . 0.25 112.296 -170.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.0 p -96.46 113.83 25.44 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.767 -0.651 . . . . 0.28999999999999998 110.008 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 99' ' ' LEU . 24.5 m -110.68 142.05 24.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 120.071 -0.652 . . . . 0.19 109.803 172.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.34 112.43 24.94 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.981 -1.859 . . . . 0.19 105.981 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -119.21 133.69 55.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.318 1.056 . . . . 0.39000000000000001 111.097 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.522 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 1.2 mp0 -129.09 114.12 15.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.109 -2.182 . . . . 0.27000000000000002 105.109 167.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.61 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 80.4 m -106.04 126.41 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.745 -1.116 . . . . 0.19 111.279 -166.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.8 t -106.89 157.21 17.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.341 -0.845 . . . . 1.0600000000000001 109.504 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.38 167.12 15.02 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.613 -0.722 . . . . 0.83999999999999997 110.65 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE1' ' HB1' ' A' ' 136' ' ' ALA . 4.6 pm0 -50.81 -24.97 3.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.106 -0.952 . . . . 1.1399999999999999 111.371 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -93.55 -10.25 35.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.036 -0.529 . . . . 2.1400000000000001 111.371 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.48 20.08 20.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.327 -0.94 . . . . 0.51000000000000001 112.492 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.1 m -96.29 109.6 22.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.628 0.251 . . . . 0.46000000000000002 110.72 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.9 mtt180 -76.03 109.94 10.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.736 0.779 . . . . 0.46999999999999997 110.004 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.744 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -95.1 -9.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.36 -1.291 . . . . 0.27000000000000002 111.833 -169.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.61 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 11.7 pt20 -159.69 148.65 17.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.58999999999999997 109.597 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 71' ' ' GLN . 28.7 tt0 -152.65 105.78 3.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.087 0.47 . . . . 1.3400000000000001 110.172 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -124.77 117.15 26.17 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.697 -0.683 . . . . 2.5899999999999999 110.072 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 30.0 Cg_endo -63.97 -17.96 61.85 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.592 2.194 . . . . 0.5 112.103 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.74 106.72 2.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.161 0.982 . . . . 1.3700000000000001 111.699 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.4 tp -115.72 111.84 21.17 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.473 -1.694 . . . . 0.38 107.635 170.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.3 p -109.17 131.05 61.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 110.041 -0.355 . . . . 1.0 110.041 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 31.0 p90 -154.17 163.26 40.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.601 -0.272 . . . . 0.23000000000000001 110.917 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.6 m -82.91 117.75 22.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.915 -0.584 . . . . 0.41999999999999998 109.628 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.945 HD11 ' HD3' ' A' ' 104' ' ' PRO . 13.8 tp -61.45 138.08 58.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.59999999999999998 110.843 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.29 -7.2 61.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.015 -0.612 . . . . 0.37 112.162 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.18 -9.14 55.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.93000000000000005 109.761 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.2 m 60.2 30.31 19.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.178 -0.919 . . . . 0.62 109.54 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.19 -20.63 63.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.542 1.163 . . . . 1.3300000000000001 108.302 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 m -112.88 -158.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 113.279 -1.782 . . . . 0.23000000000000001 110.38 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.654 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.8 pt -79.51 140.29 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.689 -1.226 . . . . 0.28999999999999998 107.689 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.521 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.1 tp-100 -59.88 -30.97 69.36 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.267 0.355 . . . . 0.40000000000000002 110.821 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -54.16 -49.88 68.28 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.373 0.606 . . . . 0.20000000000000001 110.544 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.654 ' H ' HG13 ' A' ' 96' ' ' ILE . 58.4 tp -69.87 -41.68 74.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.832 -1.076 . . . . 0.22 110.294 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.72 -28.42 68.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.831 -1.077 . . . . 0.26000000000000001 109.963 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 80.9 mt -90.84 -34.81 15.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.394 -0.821 . . . . 0.25 112.256 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 79.4 p -70.86 -24.63 62.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.538 -0.301 . . . . 1.01 111.143 -173.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.581 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 53.3 t -72.42 -50.27 8.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 112.793 0.664 . . . . 0.20999999999999999 112.793 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.945 ' HD3' HD11 ' A' ' 90' ' ' LEU . 30.8 Cg_endo -65.01 -20.96 64.08 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 121.553 1.502 . . . . 0.27000000000000002 111.61 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.454 HD11 HG23 ' A' ' 39' ' ' ILE . 15.9 mt -80.94 -18.62 46.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.64000000000000001 110.541 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.724 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 31.8 ttm -90.09 149.84 22.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.78000000000000003 111.104 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.37 147.45 23.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.96999999999999997 110.39 176.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.79 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -60.44 123.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.328 0.585 . . . . 0.80000000000000004 110.68 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.27 56.89 Favored Glycine 0 C--N 1.314 -0.679 0 C-N-CA 120.784 -0.722 . . . . 0.28000000000000003 113.017 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.814 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -99.68 168.78 9.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.253 0.549 . . . . 0.40999999999999998 110.674 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.486 HG22 HD12 ' A' ' 50' ' ' LEU . 11.5 m -127.68 116.87 20.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.461 -1.311 . . . . 0.22 107.461 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.53 139.56 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.076 -0.511 . . . . 0.17999999999999999 110.494 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 ttm -98.44 117.02 31.91 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.328 -1.36 . . . . 1.3200000000000001 107.328 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.683 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.3 t -113.19 131.34 65.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 109.078 -0.712 . . . . 0.17999999999999999 109.078 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.542 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 41.6 m -115.81 113.93 24.06 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 119.278 -0.969 . . . . 0.20999999999999999 109.068 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.42 139.03 53.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.038 -1.892 . . . . 0.14999999999999999 109.739 -176.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 10.1 t70 -53.93 150.8 7.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.407 -0.59 . . . . 0.57999999999999996 109.407 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.595 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 1.9 t -54.81 -30.02 56.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.81999999999999995 110.341 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.639 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -55.53 -30.13 60.15 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 122.229 -0.294 . . . . 0.81000000000000005 111.56 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.532 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 76.6 m-85 -95.87 2.03 53.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.231 0.538 . . . . 0.41999999999999998 110.171 176.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.827 ' HB3' HD22 ' A' ' 138' ' ' LEU . 60.5 m -123.69 -91.05 0.56 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.156 -0.929 . . . . 0.17999999999999999 110.654 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.803 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.9 m-85 -140.15 38.36 1.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.574 0.583 . . . . 0.23999999999999999 112.574 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.48 -78.82 0.08 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.474 0.579 . . . . 0.25 113.628 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -89.64 13.79 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.367 2.044 . . . . 0.57999999999999996 110.559 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.803 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 42.0 mt-30 -104.28 -49.02 3.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.97 -1.014 . . . . 0.65000000000000002 110.464 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.586 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 76.93 142.75 1.48 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.996 -1.002 . . . . 0.29999999999999999 112.905 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.608 ' CB ' HG12 ' A' ' 132' ' ' ILE . 10.3 t -90.68 159.62 16.28 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.042 -0.579 . . . . 0.33000000000000002 112.376 -175.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -52.45 -48.83 65.57 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.016 -0.993 . . . . 3.1699999999999999 111.968 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.966 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 34.6 m -80.59 -67.76 0.22 Allowed Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.453 -0.499 . . . . 1.23 109.946 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.966 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.4 Cg_endo -104.91 127.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.611 2.208 . . . . 0.37 112.091 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.586 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 39.4 t80 -55.67 99.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.194 -1.039 . . . . 1.1399999999999999 108.194 163.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.608 HG12 ' CB ' ' A' ' 127' ' ' SER . 35.1 mm -65.63 129.58 94.37 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.282 -0.872 . . . . 0.39000000000000001 109.726 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.4 Cg_endo -53.52 141.78 61.51 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.828 2.352 . . . . 0.60999999999999999 112.499 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.645 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 35.3 Cg_exo -58.28 131.35 42.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.467 2.111 . . . . 0.52000000000000002 112.52 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.595 ' H ' ' HB3' ' A' ' 118' ' ' SER . 32.2 m170 73.37 9.82 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.916 -1.038 . . . . 2.3799999999999999 112.35 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.68 127.75 33.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.215 -0.661 . . . . 0.26000000000000001 109.215 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.69 111.58 10.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.074 0.464 . . . . 0.22 110.533 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.8 tp -88.4 130.97 35.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.684 -0.689 . . . . 0.22 110.213 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.55 100.85 7.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.707 0.765 . . . . 1.2 110.085 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -109.58 136.7 48.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.96 -1.018 . . . . 0.32000000000000001 112.067 -173.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 38.2 tt0 -101.14 118.19 36.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.74 -0.837 . . . . 1.05 108.74 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -121.43 118.15 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.092 0.775 . . . . 0.19 113.092 -173.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 2.9 m -90.75 109.31 20.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.709 -0.678 . . . . 0.28000000000000003 110.539 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.724 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 38.3 tp -82.86 102.72 11.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.428 -0.952 . . . . 0.14999999999999999 108.428 172.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -103.53 -19.93 14.21 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.452 -0.795 . . . . 1.0800000000000001 110.901 -170.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 m -156.41 144.94 19.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.37 111.152 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -141.0 128.7 21.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.212 -0.662 . . . . 0.25 109.212 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 65' ' ' VAL . 18.3 m -124.37 127.31 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.478 -0.489 . . . . 0.92000000000000004 110.7 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -87.43 121.67 30.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.416 -0.356 . . . . 2.27 110.751 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -144.37 -1.21 0.93 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.812 0.339 . . . . 1.97 111.428 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.99 -71.1 0.72 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 2.1400000000000001 111.767 -172.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.33 122.07 11.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 5.79 111.299 -173.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -72.39 107.55 5.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 7.4800000000000004 109.524 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -51.85 127.2 20.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.682 -0.69 . . . . 8.4600000000000009 111.808 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -151.03 176.9 10.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 8.8300000000000001 110.149 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 59.7 m-70 -110.9 118.21 35.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.09 0.404 . . . . 12.17 112.09 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 36.1 t60 . . . . . 0 C--O 1.243 0.715 0 CA-C-O 118.292 -0.861 . . . . 13.460000000000001 109.222 170.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.67 0.271 . . . . 50.229999999999997 110.362 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.66 128.71 1.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.003 -0.618 . . . . 47.990000000000002 111.865 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 36.8 mt-30 -82.9 129.23 62.52 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.484 0.183 . . . . 46.259999999999998 110.55 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 8' ' ' GLU . 3.8 Cg_exo -78.32 130.17 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.879 2.386 . . . . 44.799999999999997 111.569 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.73 141.74 43.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.923 2.416 . . . . 44.020000000000003 111.933 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.97 -82.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.956 0.785 . . . . 42.5 110.471 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.06 161.96 34.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.755 0.312 . . . . 41.5 110.315 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.536 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 35.0 tt0 -81.18 96.76 7.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.498 -0.927 . . . . 40.329999999999998 108.498 173.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.03 -166.99 1.31 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.811 -0.631 . . . . 39.090000000000003 111.765 -171.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 11' ' ' GLN . 12.8 pt-20 -129.73 -58.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.6 . . . . 38.82 112.322 -171.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 31.3 mm-40 65.76 74.91 0.36 Allowed Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 123.141 0.576 . . . . 38.159999999999997 110.235 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.05 128.54 18.83 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.112 2.541 . . . . 36.700000000000003 112.253 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.17 -170.28 35.5 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.677 -0.569 . . . . 35.609999999999999 111.677 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.36 95.11 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 35.030000000000001 110.347 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -117.93 -10.49 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.866 -0.606 . . . . 34.009999999999998 110.286 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 72.34 -41.61 0.51 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.479 0.712 . . . . 32.890000000000001 110.901 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -85.68 96.6 9.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.423 -0.353 . . . . 31.940000000000001 110.394 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -76.46 -27.62 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.442 -0.577 . . . . 31.239999999999998 109.442 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.1 t80 71.37 120.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.801 -1.09 . . . . 31.239999999999998 112.337 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.93 68.99 0.76 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.967 -1.015 . . . . 29.850000000000001 110.929 172.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.57 98.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.279 -0.873 . . . . 28.199999999999999 111.643 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.15 129.55 12.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.918 -0.313 . . . . 26.780000000000001 111.06 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 tpt -174.58 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.445 -0.946 . . . . 27.469999999999999 108.445 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 39.3 tt0 -103.74 120.06 52.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.579 -1.192 . . . . 24.41 108.816 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 19.8 Cg_exo -66.39 136.98 45.39 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.047 2.498 . . . . 21.629999999999999 112.947 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 12.4 pt-20 -91.92 136.68 25.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 20.670000000000002 110.199 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 8.3 Cg_exo -73.14 131.85 17.24 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.846 2.364 . . . . 18.02 111.843 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.84 147.42 70.54 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 14.93 110.39 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 162.99 40.39 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.499 2.132 . . . . 13.81 112.121 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.96 68.89 1.7 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.365 -0.834 . . . . 10.76 111.107 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.35 126.51 8.46 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.381 2.054 . . . . 9.7699999999999996 112.724 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.4 134.96 94.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 5.8600000000000003 110.764 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 57.6 Cg_endo -72.13 -13.14 28.47 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.859 2.372 . . . . 4.4699999999999998 113.039 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mm-40 76.78 -7.18 1.89 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.628 0.771 . . . . 4.1299999999999999 111.64 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 52.54 89.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.958 0.787 . . . . 2.4500000000000002 111.74 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.676 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 -85.89 -164.44 1.03 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.405 0.622 . . . . 0.53000000000000003 110.663 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.75 110.91 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.684 -0.689 . . . . 0.5 110.012 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.665 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.3 t70 -73.83 123.73 24.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.264 -0.574 . . . . 2.5099999999999998 110.086 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 105' ' ' LEU . 9.4 mt -54.51 -37.82 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.053 -0.976 . . . . 0.46000000000000002 111.309 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -111.8 2.89 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.203 -0.453 . . . . 0.71999999999999997 110.617 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.11 22.7 60.91 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.57 -0.741 . . . . 0.52000000000000002 112.066 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -92.16 -27.8 17.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.146 0.424 . . . . 0.94999999999999996 112.146 -176.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.52 2.69 37.76 Favored Glycine 0 N--CA 1.454 -0.136 0 C-N-CA 120.926 -0.655 . . . . 0.71999999999999997 112.271 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 3.8 mm? -112.72 -28.38 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.682 0.277 . . . . 1.5600000000000001 110.969 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 39' ' ' ILE . 23.3 tp -122.06 100.33 6.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.32000000000000001 110.989 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -131.98 136.85 47.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.905 0.335 . . . . 1.1399999999999999 111.905 -171.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.8 ttpt -109.01 123.09 48.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.629 -0.508 . . . . 0.34999999999999998 109.629 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.676 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 24.4 ttpp -105.46 110.79 23.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.666 0.269 . . . . 1.0700000000000001 110.538 176.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -70.65 98.99 1.59 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.33000000000000002 110.898 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 111' ' ' THR . 10.7 mt -66.06 -52.54 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.724 -1.584 . . . . 0.28000000000000003 106.724 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.855 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 90.1 t -137.29 131.55 17.6 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 112.982 -1.917 . . . . 0.35999999999999999 106.483 169.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 33.6 Cg_endo -105.65 52.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.704 2.269 . . . . 0.54000000000000004 113.798 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.92 148.99 12.01 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.924 -0.655 . . . . 0.55000000000000004 112.982 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.08 147.9 68.25 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.379 2.053 . . . . 1.4199999999999999 110.484 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.77 107.35 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.869 2.379 . . . . 2.04 112.455 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.67 30.98 4.1 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.657 -0.701 . . . . 0.97999999999999998 112.168 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -167.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.474 0.654 . . . . 0.98999999999999999 111.173 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -153.22 137.52 16.6 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.944 -1.132 . . . . 1.28 107.944 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 106' ' ' MET . 40.3 mtm180 -91.67 110.61 44.57 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.696 -0.229 . . . . 2.8100000000000001 110.451 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.842 ' HD3' HG23 ' A' ' 108' ' ' VAL . 12.1 Cg_endo -53.82 149.11 34.62 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.412 2.741 . . . . 0.29999999999999999 112.8 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 2.2 m -102.99 157.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.204 -0.665 . . . . 0.88 109.204 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 56.6 mttp -62.97 119.85 10.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.246 0.546 . . . . 1.1699999999999999 109.749 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.417 ' CA ' ' HG2' ' A' ' 151' ' ' GLU . . . 128.72 -26.75 4.5 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.49 -1.044 . . . . 0.41999999999999998 110.49 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.656 ' OE1' ' HB2' ' A' ' 149' ' ' ASP . 3.1 mm-40 -83.88 127.14 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.884 -1.154 . . . . 0.58999999999999997 107.884 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -80.37 126.75 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.18 -1.044 . . . . 1.22 108.18 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 147' ' ' ALA . 18.2 m -121.89 145.9 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.066 -0.97 . . . . 0.25 110.533 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.675 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 54.4 p -96.92 112.99 24.5 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.28999999999999998 109.778 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.754 HG21 HD21 ' A' ' 99' ' ' LEU . 17.1 m -110.91 145.6 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 C-N-CA 120.228 -0.589 . . . . 0.19 110.697 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.654 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.1 t-160 -102.03 114.87 29.37 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.014 -1.476 . . . . 0.19 107.014 169.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -121.21 133.5 55.17 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.218 1.008 . . . . 0.39000000000000001 110.905 176.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' CG ' ' HG2' ' A' ' 82' ' ' GLU . 2.1 mp0 -128.79 113.59 15.5 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.372 -2.084 . . . . 0.27000000000000002 105.372 168.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.635 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 40.1 m -104.4 127.69 52.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.953 -1.021 . . . . 0.19 111.724 -168.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.9 m -103.16 162.17 13.19 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.291 -0.868 . . . . 1.0600000000000001 109.308 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.22 166.14 15.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.739 -1.119 . . . . 0.83999999999999997 109.904 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 9.8 pt-20 -56.97 -21.88 33.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.187 0.518 . . . . 1.1399999999999999 110.296 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.43 -4.47 55.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.909 -0.587 . . . . 2.1400000000000001 111.29 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.98 -23.07 28.46 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.658 -0.782 . . . . 0.51000000000000001 113.567 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 118.02 10.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.391 0.515 . . . . 0.46000000000000002 112.391 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.0 mtt180 -76.38 125.25 28.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.74 0.781 . . . . 0.46999999999999997 111.121 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.702 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -106.76 -9.09 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 0.27000000000000002 111.886 -170.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.635 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 15.7 pt20 -160.91 145.95 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.828 -0.624 . . . . 0.58999999999999997 109.399 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 71' ' ' GLN . 1.2 tm-20 -150.56 105.53 3.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.347 -0.612 . . . . 1.3400000000000001 109.347 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -125.59 111.15 25.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 2.5899999999999999 110.069 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 24.6 Cg_exo -63.12 -16.63 55.62 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.137 2.558 . . . . 0.5 113.192 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 11.6 tt0 -164.49 100.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.3 1.048 . . . . 1.3700000000000001 111.682 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.0 tp -109.11 110.35 21.57 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 0.38 108.878 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.2 p -102.36 133.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.2 p90 -153.31 157.29 39.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.695 0.283 . . . . 0.23000000000000001 110.622 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -76.67 110.85 11.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.711 -0.677 . . . . 0.41999999999999998 109.646 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.874 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.3 tp -55.03 129.74 39.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.348 -0.387 . . . . 0.59999999999999998 110.862 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.12 2.02 90.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.918 -0.658 . . . . 0.37 112.368 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.16 -7.16 52.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.387 -0.598 . . . . 0.93000000000000005 109.387 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.8 m 60.65 28.77 18.48 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.207 -0.906 . . . . 0.62 110.019 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -63.87 -28.34 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.685 1.231 . . . . 1.3300000000000001 108.633 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 16.0 m -110.15 -153.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 113.329 -1.76 . . . . 0.23000000000000001 111.057 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.3 pt -89.04 139.47 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.548 -1.279 . . . . 0.28999999999999998 107.548 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -59.23 -29.35 67.46 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.458 -0.337 . . . . 0.40000000000000002 110.663 -174.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -55.02 -47.48 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.212 0.53 . . . . 0.20000000000000001 110.477 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.754 HD21 HG21 ' A' ' 68' ' ' VAL . 58.0 tp -78.04 -36.89 47.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.2 -0.909 . . . . 0.22 110.259 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.49 -30.45 71.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.223 -0.899 . . . . 0.26000000000000001 109.588 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.2 mt -91.02 -33.32 15.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.418 -0.81 . . . . 0.25 112.214 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 106' ' ' MET . 34.1 t -67.2 -31.92 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.58 -0.282 . . . . 1.01 111.1 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.534 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.1 t -62.11 -55.45 40.57 Favored Pre-proline 0 C--O 1.219 -0.55 0 N-CA-C 112.309 0.485 . . . . 0.20999999999999999 112.309 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.874 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.9 Cg_endo -62.57 -20.64 71.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 121.747 1.632 . . . . 0.27000000000000002 111.75 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 39' ' ' ILE . 12.1 mt -82.14 -15.15 54.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.584 . . . . 0.64000000000000001 111.299 173.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.759 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -107.41 146.41 31.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.925 -0.58 . . . . 0.78000000000000003 111.095 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.96 157.5 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.18 0.514 . . . . 0.96999999999999997 111.022 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.842 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.3 t -63.97 124.52 18.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.403 0.621 . . . . 0.80000000000000004 110.169 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.68 16.39 45.81 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.067 -0.969 . . . . 0.28000000000000003 112.342 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.855 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.5 pt-20 -105.28 167.98 9.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.334 0.588 . . . . 0.40999999999999998 111.25 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 50' ' ' LEU . 17.8 m -132.98 118.46 18.88 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 173.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.13 140.19 52.84 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.885 -0.598 . . . . 0.17999999999999999 110.327 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.6 ttp -100.61 118.26 36.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.506 -1.294 . . . . 1.3200000000000001 107.506 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.7 t -111.95 131.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.209 -0.45 . . . . 0.17999999999999999 110.086 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 96.1 m -108.16 112.98 25.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.364 -0.976 . . . . 0.20999999999999999 108.364 172.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.62 135.17 52.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.378 -1.283 . . . . 0.14999999999999999 109.399 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.647 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.8 t70 -54.25 149.35 9.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.1 -0.704 . . . . 0.57999999999999996 109.1 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -54.49 -28.49 45.25 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.407 0.442 . . . . 0.81999999999999995 110.351 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.647 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.0 ptpt -54.68 -32.91 60.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.633 -0.258 . . . . 0.81000000000000005 111.463 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.582 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 82.8 m-85 -95.39 1.68 54.31 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.01 0.434 . . . . 0.41999999999999998 110.279 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 70.8 m -120.74 -89.8 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.215 -0.902 . . . . 0.17999999999999999 110.6 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.0 m-85 -144.04 38.78 1.32 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.066 -0.396 . . . . 0.23999999999999999 111.777 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.03 -79.39 0.08 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.215 -0.517 . . . . 0.25 113.636 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -85.02 9.51 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.197 1.931 . . . . 0.57999999999999996 111.044 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -104.0 -50.57 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.994 -1.003 . . . . 0.65000000000000002 109.81 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 79.87 141.53 2.51 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.602 -1.181 . . . . 0.29999999999999999 111.985 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.607 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.1 t -91.29 163.85 14.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.36 -0.42 . . . . 0.33000000000000002 111.374 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -48.82 -69.05 0.13 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.899 0.749 . . . . 3.1699999999999999 111.66 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.987 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.9 m -64.2 -66.37 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 115.675 -0.693 . . . . 1.23 110.608 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.987 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 28.5 Cg_endo -106.94 127.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.5 2.133 . . . . 0.37 112.259 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.572 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 23.5 t80 -57.15 97.34 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.978 -1.119 . . . . 1.1399999999999999 107.978 164.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.593 HG12 ' CB ' ' A' ' 127' ' ' SER . 31.8 mm -65.72 129.84 94.4 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 109.591 -0.522 . . . . 0.39000000000000001 109.591 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.5 Cg_exo -53.76 140.88 66.61 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.59 2.194 . . . . 0.60999999999999999 112.199 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.602 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 44.2 Cg_exo -57.8 131.28 43.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.234 1.956 . . . . 0.52000000000000002 112.292 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.523 ' H ' ' HB3' ' A' ' 118' ' ' SER . 0.2 OUTLIER 75.15 4.68 4.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.14 -0.936 . . . . 2.3799999999999999 112.356 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -70.05 123.3 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.281 -0.637 . . . . 0.26000000000000001 109.281 176.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -75.06 113.58 12.55 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.229 -0.588 . . . . 0.22 110.306 -172.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.614 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.3 tp -90.87 132.81 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.779 -0.646 . . . . 0.22 110.918 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.78 100.75 7.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.183 0.516 . . . . 1.2 109.696 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.583 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -116.19 136.16 53.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.138 -0.483 . . . . 0.32000000000000001 111.836 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 6.4 tt0 -102.05 121.8 42.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.224 -0.658 . . . . 1.05 109.224 178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -118.14 117.56 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.682 0.753 . . . . 0.19 112.52 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.3 m -87.8 115.36 25.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.971 -1.013 . . . . 0.28000000000000003 110.387 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.701 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 42.8 tp -88.87 100.73 13.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.223 -1.028 . . . . 0.14999999999999999 108.223 170.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.622 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -93.75 -23.27 18.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.191 -0.913 . . . . 1.0800000000000001 110.781 -173.103 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.675 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 94.7 m -159.84 144.91 15.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.763 -0.653 . . . . 0.37 111.494 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -136.44 126.92 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.144 -0.688 . . . . 0.25 109.144 170.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.0 m -135.41 131.07 51.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.126 0.489 . . . . 0.92000000000000004 110.455 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.656 ' HB2' ' OE1' ' A' ' 64' ' ' GLN . 8.5 t70 -69.69 119.11 13.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.317 -0.401 . . . . 2.27 110.783 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.35 31.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.033 -0.728 . . . . 1.97 109.033 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.417 ' HG2' ' CA ' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -69.45 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.578 -0.737 . . . . 2.1400000000000001 109.756 -176.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -113.43 112.45 23.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.478 . . . . 5.79 110.677 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -91.09 51.27 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.998 -0.742 . . . . 7.4800000000000004 108.998 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -83.66 -15.75 47.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 8.4600000000000009 110.541 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -66.59 153.17 43.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 8.8300000000000001 110.876 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 67.47 27.61 7.93 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.972 0.795 . . . . 12.17 110.619 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.486 -0.769 . . . . 13.460000000000001 109.139 176.685 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.699 -0.482 . . . . 50.229999999999997 109.699 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.553 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . 62.91 54.36 33.93 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.13 -0.788 . . . . 47.990000000000002 111.13 -172.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -102.36 103.31 30.36 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.825 0.345 . . . . 46.259999999999998 111.618 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 2' ' ' GLY . 55.3 Cg_endo -95.2 117.86 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.006 2.471 . . . . 44.799999999999997 111.455 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 4' ' ' PRO . 19.1 Cg_endo -60.72 121.31 9.51 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.858 1.705 . . . . 44.020000000000003 111.269 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.88 -55.34 3.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 42.5 110.432 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -125.6 82.23 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 41.5 110.498 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.37 121.01 25.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.362 -0.607 . . . . 40.329999999999998 109.362 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.73 158.47 33.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 39.090000000000003 111.393 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -78.23 -32.79 49.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.494 -0.775 . . . . 38.82 109.623 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -124.56 92.29 48.17 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.225 -0.898 . . . . 38.159999999999997 111.3 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.01 114.83 3.89 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.446 2.097 . . . . 36.700000000000003 111.616 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.57 -21.08 4.3 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.528 -0.844 . . . . 35.609999999999999 112.389 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.56 -67.97 0.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.651 0.262 . . . . 35.030000000000001 110.34 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 tp 62.88 98.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.585 -0.734 . . . . 34.009999999999998 112.296 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.63 101.73 11.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.156 -0.683 . . . . 32.890000000000001 109.156 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HE ' ' C ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -98.19 162.92 12.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.324 0.49 . . . . 31.940000000000001 112.324 -174.13 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.41 173.25 7.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 31.239999999999998 109.179 171.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 26.0 p90 -155.12 159.15 39.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.028 -0.269 . . . . 31.239999999999998 110.719 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 7.5 mt -173.41 -55.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.042 0.839 . . . . 29.850000000000001 109.516 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.41 102.49 4.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.016 -0.538 . . . . 28.199999999999999 109.831 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.68 -80.53 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.331 -0.395 . . . . 26.780000000000001 110.684 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ptm -120.04 -9.93 9.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.905 0.383 . . . . 27.469999999999999 111.108 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 6.5 tp10 -150.09 121.31 4.0 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.401 -0.363 . . . . 24.41 110.526 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 4.7 Cg_exo -76.49 -173.39 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.71 2.274 . . . . 21.629999999999999 110.834 173.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.59 131.09 22.1 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.797 -0.445 . . . . 20.670000000000002 109.797 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.05 115.1 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.033 2.489 . . . . 18.02 112.135 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -92.01 126.75 52.2 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 14.93 110.989 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 15.0 Cg_exo -70.71 129.29 16.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.953 2.436 . . . . 13.81 111.896 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -90.33 -52.59 0.32 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.395 -0.366 . . . . 10.76 111.888 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 4.3 Cg_exo -77.39 48.03 2.44 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.753 2.302 . . . . 9.7699999999999996 112.156 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -100.26 140.89 21.81 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 5.8600000000000003 110.41 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 19.2 Cg_exo -66.79 -24.94 46.41 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.873 2.382 . . . . 4.4699999999999998 112.096 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 45.1 tt0 80.17 144.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.308 1.005 . . . . 4.1299999999999999 110.681 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 35' ' ' GLU . 1.0 OUTLIER -96.59 90.89 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.438 0.637 . . . . 2.4500000000000002 110.162 178.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.702 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -73.73 -169.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.884 -1.053 . . . . 0.53000000000000003 111.327 -176.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 tp -69.4 112.94 6.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.454 -0.794 . . . . 0.5 110.332 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.606 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 t70 -76.41 123.49 26.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.527 0.679 . . . . 2.5099999999999998 109.999 176.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.582 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 4.8 mt -64.18 -30.13 49.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.794 -1.094 . . . . 0.46000000000000002 110.667 -176.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.35 -8.43 19.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.71999999999999997 110.05 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.49 25.3 68.55 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.209 -0.905 . . . . 0.52000000000000002 111.654 -172.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.582 ' ND2' HD13 ' A' ' 44' ' ' LEU . 18.2 p-10 -105.07 -26.95 11.91 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.359 0.503 . . . . 0.94999999999999996 112.359 -177.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.56 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.66 7.51 25.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.308 -0.948 . . . . 0.71999999999999997 112.454 174.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.582 HD13 ' ND2' ' A' ' 42' ' ' ASN . 8.9 mp -110.2 -32.7 6.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.332 0.587 . . . . 1.5600000000000001 110.578 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.582 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 19.4 tp -122.55 104.04 9.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.11 -0.95 . . . . 0.32000000000000001 111.512 -170.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.572 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 77.9 mtm180 -134.63 144.91 48.14 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.942 -0.474 . . . . 1.1399999999999999 112.197 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HG3' HG22 ' A' ' 114' ' ' VAL . 14.8 ttpt -115.34 129.08 56.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.271 -0.27 . . . . 0.34999999999999998 110.271 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.702 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -111.08 120.02 40.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.891 0.377 . . . . 1.0700000000000001 111.109 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 p -72.91 101.03 3.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.747 -0.66 . . . . 0.33000000000000002 111.647 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 111' ' ' THR . 10.9 mt -68.08 -51.39 47.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.895 -1.521 . . . . 0.28000000000000003 106.895 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.849 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 69.0 t -136.58 130.46 17.94 Favored Pre-proline 0 CA--C 1.501 -0.927 0 CA-C-N 112.898 -1.956 . . . . 0.35999999999999999 106.097 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 44.4 Cg_endo -104.21 56.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.743 2.295 . . . . 0.54000000000000004 113.451 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.99 174.34 33.75 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.564 -0.744 . . . . 0.55000000000000004 112.637 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.02 151.72 45.08 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.205 1.936 . . . . 1.4199999999999999 110.685 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.21 97.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.448 2.098 . . . . 2.04 111.978 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.35 39.12 1.05 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.864 -0.607 . . . . 0.97999999999999998 111.93 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -86.73 -168.78 2.36 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.941 0.4 . . . . 0.98999999999999999 110.811 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.508 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 19.4 m -145.85 138.02 25.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.745 -0.465 . . . . 1.28 109.745 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 85.2 mtt180 -92.14 116.2 66.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 2.8100000000000001 109.626 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HG3' HD21 ' A' ' 144' ' ' LEU . 9.1 Cg_endo -52.19 155.35 9.28 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.552 2.834 . . . . 0.29999999999999999 113.042 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.604 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 3.9 p -106.82 154.38 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.88 109.935 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.88 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 58.6 mttp -63.49 123.83 19.78 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.568 0.699 . . . . 1.1699999999999999 109.54 178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 151' ' ' GLU . . . 118.24 -9.73 13.48 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 114.799 -1.091 . . . . 0.41999999999999998 110.562 -170.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 2.1 mm-40 -94.45 136.32 34.88 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.948 -0.736 . . . . 0.58999999999999997 109.698 174.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 p -82.87 115.7 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 108.445 -0.946 . . . . 1.22 108.445 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.3 m -117.81 148.76 20.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.595 -0.729 . . . . 0.25 111.156 -170.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.64 HG22 HG12 ' A' ' 87' ' ' VAL . 77.1 p -98.12 113.75 25.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.984 -0.553 . . . . 0.28999999999999998 110.09 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.858 HG21 HD21 ' A' ' 99' ' ' LEU . 28.2 m -111.28 140.44 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 119.641 -0.824 . . . . 0.19 110.762 172.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.599 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.8 t-160 -102.29 115.27 30.21 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.891 -1.522 . . . . 0.19 106.891 168.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.93 HD23 ' HB3' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -124.44 129.46 50.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 118.921 -1.112 . . . . 0.39000000000000001 111.608 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 81' ' ' GLN . 1.5 mp0 -121.79 114.9 21.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.865 -1.902 . . . . 0.27000000000000002 105.865 169.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.592 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 58.9 m -103.31 128.66 50.3 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.676 -1.147 . . . . 0.19 111.562 -167.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.711 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.8 m -103.51 156.8 17.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.129 -0.942 . . . . 1.0600000000000001 108.869 176.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.69 165.34 19.02 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.199 -0.91 . . . . 0.83999999999999997 109.431 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.06 -21.65 23.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.338 0.59 . . . . 1.1399999999999999 110.482 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.94 -5.15 58.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.379 -0.828 . . . . 2.1400000000000001 110.997 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.59 -6.4 57.39 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.979 -0.629 . . . . 0.51000000000000001 112.878 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -81.04 112.95 18.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.786 0.327 . . . . 0.46000000000000002 111.791 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 16.0 mtt180 -75.0 122.62 23.79 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.499 0.666 . . . . 0.46999999999999997 110.747 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.644 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -108.0 -9.93 10.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.695 -1.139 . . . . 0.27000000000000002 112.1 -169.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.592 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.0 pt20 -158.88 133.3 7.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.449 -0.341 . . . . 0.58999999999999997 110.439 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.55 107.11 12.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.309 0.576 . . . . 1.3400000000000001 110.016 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.93 ' HB3' HD23 ' A' ' 70' ' ' LEU . 1.9 tp10 -111.29 105.68 57.0 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.237 -0.892 . . . . 2.5899999999999999 110.332 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.599 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 12.7 Cg_exo -67.91 -22.32 42.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.904 1.736 . . . . 0.5 112.223 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.9 123.09 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.776 0.798 . . . . 1.3700000000000001 111.09 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.622 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 40.8 tp -131.38 105.78 7.83 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.806 -1.543 . . . . 0.38 108.798 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 34.8 m -92.1 139.48 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-O 120.826 0.346 . . . . 1.0 110.492 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 33.8 p90 -158.36 159.63 36.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.098 -0.501 . . . . 0.23000000000000001 110.567 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 92' ' ' ASP . 7.4 m -77.63 115.99 17.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.607 -0.516 . . . . 0.41999999999999998 109.607 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.88 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.3 tp -56.76 131.41 49.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.558 -0.292 . . . . 0.59999999999999998 110.447 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.08 -3.66 86.85 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.908 -0.663 . . . . 0.37 112.55 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 12.6 t70 -86.34 -12.34 49.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.819 -0.438 . . . . 0.93000000000000005 109.819 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 m 60.38 33.73 20.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.902 -0.777 . . . . 0.62 108.902 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.8 t70 -72.67 -11.9 60.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.341 1.067 . . . . 1.3300000000000001 108.789 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.15 -158.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.502 -1.681 . . . . 0.23000000000000001 110.487 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -81.76 137.62 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.914 -1.143 . . . . 0.28999999999999998 107.914 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -60.48 -28.78 68.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.829 -0.348 . . . . 0.40000000000000002 111.095 -173.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.37 70.56 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.32 0.581 . . . . 0.20000000000000001 110.472 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 68' ' ' VAL . 56.1 tp -80.08 -40.78 26.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.406 -0.815 . . . . 0.22 110.941 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.58 -30.82 70.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.005 -0.998 . . . . 0.26000000000000001 110.018 -174.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.84 -33.24 15.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.25 112.208 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.0 t -64.72 -35.32 80.66 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.76 0.314 . . . . 1.01 111.348 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.569 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 65.7 t -60.72 -55.17 47.49 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.507 0.558 . . . . 0.20999999999999999 112.507 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.873 ' HD3' HD11 ' A' ' 90' ' ' LEU . 27.2 Cg_endo -64.51 -20.46 65.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.865 1.71 . . . . 0.27000000000000002 112.143 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.87 -12.72 59.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.64000000000000001 111.383 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 2.3 ptm -108.95 156.86 19.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 0.78000000000000003 110.625 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.96999999999999997 110.92 179.057 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.3 p -65.88 126.82 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.749 0.785 . . . . 0.80000000000000004 110.29 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.37 7.4 62.04 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 114.75 -1.113 . . . . 0.28000000000000003 112.723 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.849 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.9 pt-20 -95.44 167.75 11.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.483 0.659 . . . . 0.40999999999999998 111.839 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.431 HG22 HD12 ' A' ' 50' ' ' LEU . 5.3 m -126.06 116.96 22.22 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.838 -1.171 . . . . 0.22 107.838 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.9 134.97 55.07 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.123 0.487 . . . . 0.17999999999999999 110.813 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.1 ttm -97.54 117.88 32.79 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.381 -1.34 . . . . 1.3200000000000001 107.381 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.8 t -112.85 130.31 66.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.417 -0.586 . . . . 0.17999999999999999 109.417 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.569 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 78.9 m -110.29 112.75 24.9 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 119.146 -1.022 . . . . 0.20999999999999999 108.365 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.23 135.04 52.16 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.963 -1.471 . . . . 0.14999999999999999 109.91 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.625 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 9.6 t70 -52.36 147.94 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.819 -0.808 . . . . 0.57999999999999996 108.819 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.637 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.9 t -56.35 -26.29 52.18 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.013 0.435 . . . . 0.81999999999999995 110.218 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.625 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -57.86 -29.96 65.43 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.762 -0.586 . . . . 0.81000000000000005 111.394 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 81.9 m-85 -93.46 -2.11 54.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.543 0.687 . . . . 0.41999999999999998 110.221 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.648 ' HB3' HD22 ' A' ' 138' ' ' LEU . 64.7 m -119.53 -90.95 0.56 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.725 -1.125 . . . . 0.17999999999999999 110.416 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.645 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.1 m-85 -145.81 43.06 1.25 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.337 -0.545 . . . . 0.23999999999999999 112.266 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -54.42 -87.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.056 -0.593 . . . . 0.25 113.361 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.14 10.38 2.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.373 2.048 . . . . 0.57999999999999996 111.046 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.645 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -103.47 -45.85 4.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.65000000000000002 110.245 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.547 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 76.01 143.39 1.28 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.911 -1.041 . . . . 0.29999999999999999 112.546 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.666 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 13.0 t -91.89 164.05 13.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.987 0.422 . . . . 0.33000000000000002 111.639 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -58.14 -45.64 87.02 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.249 -0.887 . . . . 3.1699999999999999 112.02 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.904 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 58.4 m -87.46 -60.26 0.26 Allowed Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 120.805 -0.358 . . . . 1.23 110.269 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.1 Cg_endo -107.58 126.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.541 2.161 . . . . 0.37 111.899 171.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 20.6 t80 -58.14 97.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.862 -1.162 . . . . 1.1399999999999999 107.862 165.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.587 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.1 mm -64.3 127.88 92.59 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.756 -0.656 . . . . 0.39000000000000001 110.013 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.0 Cg_endo -50.05 136.79 37.21 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.21 2.607 . . . . 0.60999999999999999 111.87 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.567 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 31.2 Cg_exo -58.54 132.17 46.8 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.523 2.149 . . . . 0.52000000000000002 112.08 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 30.2 m170 77.0 0.21 3.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.912 -1.04 . . . . 2.3799999999999999 112.284 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.76 122.17 17.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.468 -0.493 . . . . 0.26000000000000001 109.686 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.5 112.81 9.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.336 0.589 . . . . 0.22 109.634 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -88.05 132.32 34.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.605 -0.725 . . . . 0.22 110.552 -176.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.6 t -115.08 99.54 7.52 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.755 -0.832 . . . . 1.2 108.755 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.8 OUTLIER -113.95 134.12 55.04 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.289 0.566 . . . . 0.32000000000000001 111.599 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 57.6 tt0 -99.56 112.71 24.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 1.05 109.459 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.686 HG11 HD13 ' A' ' 99' ' ' LEU . 6.8 m -109.44 123.15 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.53 0.681 . . . . 0.19 111.86 -177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -96.59 111.01 23.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.126 -0.943 . . . . 0.28000000000000003 110.167 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.65 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 58.1 tp -82.74 100.81 10.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.689 -0.856 . . . . 0.14999999999999999 108.689 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -99.33 -21.38 16.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.631 -0.713 . . . . 1.0800000000000001 110.653 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.8 m -158.12 147.02 19.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.848 -0.341 . . . . 0.37 111.408 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.74 127.68 33.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.25 109.225 169.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -124.12 147.57 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.307 -0.627 . . . . 0.92000000000000004 109.307 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.61 ' HB2' ' CD2' ' A' ' 152' ' ' HIS . 6.8 p-10 -97.24 128.15 43.85 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 110.21 -0.293 . . . . 2.27 110.21 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 150' ' ' LEU . 1.3 tm? -135.13 -38.11 0.78 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.741 0.781 . . . . 1.97 110.21 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.614 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 4.8 tp10 -82.66 -34.89 27.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.468 -1.242 . . . . 2.1400000000000001 111.593 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 149' ' ' ASP . 0.1 OUTLIER -71.59 154.75 41.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 5.79 111.106 -173.105 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.7 t60 62.88 20.12 11.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.9 -0.591 . . . . 7.4800000000000004 112.048 170.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -105.37 142.05 35.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.111 -0.329 . . . . 8.4600000000000009 110.111 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 60.18 77.3 0.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.79 0.681 . . . . 8.8300000000000001 111.277 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -112.5 128.92 56.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.119 -0.492 . . . . 12.17 110.683 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.167 -0.921 . . . . 13.460000000000001 109.267 175.434 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.449 0.166 . . . . 50.229999999999997 110.649 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.02 -17.65 5.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.207 -0.997 . . . . 47.990000000000002 113.365 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -137.91 121.93 11.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.091 0.445 . . . . 46.259999999999998 110.787 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.487 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.6 Cg_endo -76.96 150.45 30.02 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.682 2.255 . . . . 44.799999999999997 112.254 177.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 17.0 Cg_exo -68.67 123.41 10.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.543 2.162 . . . . 44.020000000000003 111.982 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.29 152.76 47.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 42.5 111.32 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.41 144.25 51.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.303 -0.629 . . . . 41.5 109.303 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -86.75 149.74 24.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 40.329999999999998 110.8 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.33 137.36 53.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.106 -0.497 . . . . 39.090000000000003 111.305 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -126.6 -60.85 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 38.82 109.034 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -127.44 90.28 49.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.593 -0.731 . . . . 38.159999999999997 109.59 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.61 -64.88 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.753 2.302 . . . . 36.700000000000003 112.675 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.58 159.5 13.89 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.806 -0.712 . . . . 35.609999999999999 112.114 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.8 -53.54 7.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 35.030000000000001 110.568 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tt -125.35 103.71 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 34.009999999999998 109.577 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.02 124.91 50.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.572 . . . . 32.890000000000001 110.093 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -127.79 142.51 51.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.974 0.416 . . . . 31.940000000000001 111.313 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -77.76 -33.72 52.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.657 -0.701 . . . . 31.239999999999998 110.82 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -93.81 158.9 15.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 31.239999999999998 110.349 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.94 173.54 12.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 29.850000000000001 111.352 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.8 94.02 9.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 28.199999999999999 110.455 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.62 152.63 33.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.619 . . . . 26.780000000000001 109.33 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -104.27 -64.66 1.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.579 0.228 . . . . 27.469999999999999 110.848 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 37.4 tt0 -173.11 -49.76 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.43 0.529 . . . . 24.41 112.43 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 11.2 Cg_exo -72.18 52.68 1.92 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.45 2.1 . . . . 21.629999999999999 112.989 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 45.9 mt-10 -71.45 126.75 91.71 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.781 -0.645 . . . . 20.670000000000002 110.603 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 14.2 Cg_exo -69.2 146.66 64.41 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.595 2.196 . . . . 18.02 111.831 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.37 131.87 74.02 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 14.93 110.726 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.78 129.34 32.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.98 2.453 . . . . 13.81 112.039 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.581 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -149.91 -51.96 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.614 0.598 . . . . 10.76 112.614 -175.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 3.3 Cg_exo -81.83 173.03 11.57 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.659 2.239 . . . . 9.7699999999999996 112.456 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -101.09 113.95 65.8 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.664 . . . . 5.8600000000000003 109.822 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.664 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 32.2 Cg_endo -93.56 -0.89 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.299 2.666 . . . . 4.4699999999999998 114.4 -173.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.0 28.34 12.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.894 0.378 . . . . 4.1299999999999999 110.633 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 33.0 mt-10 -101.24 95.47 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.319 0.581 . . . . 2.4500000000000002 110.03 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.531 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -81.16 -156.4 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.827 -1.079 . . . . 0.53000000000000003 110.932 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.1 tp -70.47 111.83 6.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.506 -0.77 . . . . 0.5 110.621 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.592 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.7 t70 -73.06 131.88 42.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.586 0.708 . . . . 2.5099999999999998 110.678 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.5 mt -65.25 -34.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.612 -1.176 . . . . 0.46000000000000002 111.137 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.44 -2.35 20.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.503 0.668 . . . . 0.71999999999999997 109.71 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.88 24.26 68.21 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.879 -1.055 . . . . 0.52000000000000002 111.986 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.536 ' ND2' HD13 ' A' ' 44' ' ' LEU . 19.4 p-10 -100.11 -30.36 11.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.436 0.532 . . . . 0.94999999999999996 112.436 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 116.38 -0.98 20.62 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.717 -0.754 . . . . 0.71999999999999997 112.303 172.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD13 ' ND2' ' A' ' 42' ' ' ASN . 6.7 mp -100.98 -36.52 8.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.592 0.711 . . . . 1.5600000000000001 111.085 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 116' ' ' ALA . 12.0 tp -122.22 104.82 9.71 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.838 -1.074 . . . . 0.32000000000000001 111.112 -169.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 35' ' ' GLU . 15.1 mtm180 -132.16 138.65 48.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 1.1399999999999999 111.856 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -112.19 126.32 55.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.645 -0.252 . . . . 0.34999999999999998 110.54 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 39.0 ttpt -113.3 115.56 28.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 1.0700000000000001 110.885 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -74.17 103.11 4.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.33000000000000002 111.025 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD12 HG22 ' A' ' 111' ' ' THR . 7.6 mt -68.92 -56.08 8.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.656 -1.609 . . . . 0.28000000000000003 106.656 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 64.8 t -128.85 125.81 23.06 Favored Pre-proline 0 CA--C 1.499 -1.013 0 CA-C-N 113.125 -1.852 . . . . 0.35999999999999999 106.62 168.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 45.9 Cg_endo -105.02 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.949 2.433 . . . . 0.54000000000000004 113.413 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 54' ' ' PRO . . . 71.32 149.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.55000000000000004 113.328 177.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 27.2 Cg_exo -65.19 151.71 84.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.572 2.181 . . . . 1.4199999999999999 110.591 169.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.97 109.58 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.352 2.035 . . . . 2.04 111.967 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 33.42 2.98 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.664 -0.698 . . . . 0.97999999999999998 112.765 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m -85.18 178.74 7.41 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.177 0.513 . . . . 0.98999999999999999 110.84 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.616 ' H ' HG12 ' A' ' 108' ' ' VAL . 23.7 m -135.62 127.17 28.8 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.004 -0.739 . . . . 1.28 109.004 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 4.0 ptt-85 -91.07 108.77 30.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 120.906 0.384 . . . . 2.8100000000000001 109.991 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.2 Cg_endo -51.07 159.3 2.69 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.155 3.237 . . . . 0.29999999999999999 114.571 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.7 t -98.17 156.22 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.097 -0.956 . . . . 0.88 109.703 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.992 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -73.72 121.43 20.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.603 0.716 . . . . 1.1699999999999999 109.632 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' CA ' ' HG2' ' A' ' 151' ' ' GLU . . . 127.71 -18.76 5.95 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.049 -1.221 . . . . 0.41999999999999998 110.049 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -92.44 141.05 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.445 -0.946 . . . . 0.58999999999999997 108.445 173.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG13 HD21 ' A' ' 150' ' ' LEU . 26.8 m -87.63 128.56 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.456 -0.898 . . . . 1.22 108.658 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -123.1 145.8 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.804 -1.089 . . . . 0.25 110.852 -173.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 66.9 p -89.84 115.81 27.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.013 0.435 . . . . 0.28999999999999998 110.117 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 99' ' ' LEU . 18.1 m -109.36 144.06 18.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.597 -0.841 . . . . 0.19 109.283 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.693 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.0 t-160 -103.96 118.98 37.95 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.463 -1.68 . . . . 0.19 106.463 169.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -122.08 133.73 54.77 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 118.847 -1.141 . . . . 0.39000000000000001 111.026 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' GLN . 1.7 mp0 -127.75 113.57 16.16 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.419 -2.067 . . . . 0.27000000000000002 105.419 167.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.594 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 84.8 m -104.81 126.48 51.92 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.477 -1.238 . . . . 0.19 111.43 -166.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -107.24 147.71 29.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.147 -0.933 . . . . 1.0600000000000001 109.511 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.71 165.79 24.09 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.732 -0.667 . . . . 0.83999999999999997 110.013 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.89 -22.79 27.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 1.1399999999999999 110.5 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -83.03 -8.33 59.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.242 -0.89 . . . . 2.1400000000000001 110.884 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.38 60.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.959 -0.639 . . . . 0.51000000000000001 112.089 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.5 m -81.33 110.14 16.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.72 0.295 . . . . 0.46000000000000002 111.397 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.6 mtt180 -74.37 121.46 21.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.834 0.826 . . . . 0.46999999999999997 110.82 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.752 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.7 m -105.22 -9.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.359 -1.291 . . . . 0.27000000000000002 111.984 -169.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.594 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.4 pt20 -159.94 132.41 6.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.184 -0.462 . . . . 0.58999999999999997 110.628 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 45.5 tt0 -127.78 109.52 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.484 . . . . 1.3400000000000001 109.828 171.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.45 109.1 26.39 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.576 -0.738 . . . . 2.5899999999999999 109.892 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.615 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 72.7 Cg_endo -68.19 -17.96 45.17 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.778 2.985 . . . . 0.5 113.454 -172.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.34 111.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.167 0.984 . . . . 1.3700000000000001 111.04 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.9 tp -128.56 97.88 4.84 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.347 -1.751 . . . . 0.38 109.043 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.6 p -89.73 130.96 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.115 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.0 p90 -151.83 158.15 42.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.23000000000000001 110.664 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.2 m -76.2 110.93 11.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.41999999999999998 110.283 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.992 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 14.1 tp -58.18 128.58 37.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.955 -0.566 . . . . 0.59999999999999998 110.382 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.638 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.68 7.92 83.61 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.716 -0.754 . . . . 0.37 112.419 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.6 6.0 23.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.577 -0.527 . . . . 0.93000000000000005 109.577 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.52 32.98 20.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.136 -0.938 . . . . 0.62 110.385 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 26.0 t0 -75.49 -4.21 38.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.341 1.067 . . . . 1.3300000000000001 109.335 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.2 m -135.24 -155.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.037 -1.438 . . . . 0.23000000000000001 110.602 -175.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 34.4 pt -83.56 135.75 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.296 -1.372 . . . . 0.28999999999999998 107.296 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp-100 -59.22 -31.19 68.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.472 -0.331 . . . . 0.40000000000000002 111.382 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.87 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.23 0.538 . . . . 0.20000000000000001 110.354 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 68' ' ' VAL . 58.6 tp -73.64 -41.41 62.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 0.22 110.496 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.95 -27.74 69.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.963 -1.017 . . . . 0.26000000000000001 110.098 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 64.8 mt -90.13 -36.41 14.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.194 -0.912 . . . . 0.25 111.91 176.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -37.58 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 1.01 111.107 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.549 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 64.0 t -60.51 -55.79 41.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.0 0.741 . . . . 0.20999999999999999 113.0 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.792 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.1 Cg_endo -61.69 -25.06 78.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.092 1.862 . . . . 0.27000000000000002 111.849 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.0 mt -80.06 -11.89 59.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.64000000000000001 111.593 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.664 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.2 153.81 23.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.307 -0.406 . . . . 0.78000000000000003 111.23 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.43 158.59 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 0.96999999999999997 110.593 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 58' ' ' SER . 1.5 p -66.16 128.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.84 0.829 . . . . 0.80000000000000004 110.378 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.4 4.62 59.49 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.909 -1.041 . . . . 0.28000000000000003 112.15 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.821 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -98.06 165.12 12.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.383 0.611 . . . . 0.40999999999999998 111.534 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.481 HG22 HD12 ' A' ' 50' ' ' LEU . 54.6 m -130.76 117.95 20.15 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.739 -1.119 . . . . 0.22 108.263 175.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.62 140.24 50.91 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.889 -0.596 . . . . 0.17999999999999999 110.618 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.9 ttm -98.91 117.46 33.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.181 -1.415 . . . . 1.3200000000000001 107.181 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.46 128.78 74.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.66 -0.496 . . . . 0.17999999999999999 109.66 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.53 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 52.9 m -109.29 113.85 27.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.77 -0.772 . . . . 0.20999999999999999 109.163 174.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -122.47 139.91 53.34 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.892 -1.504 . . . . 0.14999999999999999 110.05 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.8 t70 -52.29 146.48 9.25 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.711 -0.848 . . . . 0.57999999999999996 108.711 171.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.588 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.2 t -55.18 -26.98 42.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.81999999999999995 110.171 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.3 ptpt -55.3 -32.26 62.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.554 -0.294 . . . . 0.81000000000000005 111.426 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.554 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.7 m-85 -95.3 6.17 49.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.171 0.51 . . . . 0.41999999999999998 110.196 176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -124.74 -90.82 0.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.831 -1.077 . . . . 0.17999999999999999 110.489 -176.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.557 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.2 m-85 -143.75 37.72 1.33 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.978 0.353 . . . . 0.23999999999999999 111.831 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.11 -78.51 0.09 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.471 -0.395 . . . . 0.25 113.83 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.48 8.68 4.45 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.15 1.9 . . . . 0.57999999999999996 111.015 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -103.9 -50.12 3.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.435 -0.802 . . . . 0.65000000000000002 110.135 -172.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . 80.28 143.53 3.27 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.571 -1.195 . . . . 0.29999999999999999 111.753 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 12.1 t -89.82 158.4 17.5 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.505 -0.348 . . . . 0.33000000000000002 111.281 -177.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -58.81 -37.31 76.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.632 -0.713 . . . . 3.1699999999999999 111.738 -170.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.937 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 7.0 m -91.44 -60.71 0.21 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.598 -0.519 . . . . 1.23 109.598 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.937 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -107.41 126.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.808 2.339 . . . . 0.37 112.307 170.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CD1' ' HA3' ' A' ' 126' ' ' GLY . 64.6 t80 -57.61 97.5 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.361 -0.977 . . . . 1.1399999999999999 108.361 164.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.592 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.43 128.36 93.81 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.441 -0.8 . . . . 0.39000000000000001 109.522 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.7 Cg_exo -53.44 140.57 63.63 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.536 2.157 . . . . 0.60999999999999999 112.286 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.9 Cg_exo -57.97 134.81 64.74 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.254 1.969 . . . . 0.52000000000000002 112.079 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.435 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 18.6 m80 70.42 5.18 5.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.0 -1.0 . . . . 2.3799999999999999 112.661 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -68.88 122.34 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.307 -0.627 . . . . 0.26000000000000001 109.307 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.73 111.81 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.303 0.573 . . . . 0.22 109.583 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.66 131.32 36.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.834 -0.621 . . . . 0.22 111.063 -175.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.7 t -117.44 101.61 8.53 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.844 0.831 . . . . 1.2 109.55 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.9 OUTLIER -114.05 136.6 52.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.84 -1.073 . . . . 0.32000000000000001 111.702 -171.569 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 55.0 tt0 -101.28 117.11 34.32 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.082 -0.71 . . . . 1.05 109.082 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.777 HG11 HD13 ' A' ' 99' ' ' LEU . 5.5 m -116.15 121.95 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.367 0.603 . . . . 0.19 112.31 -175.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 5.9 m -96.71 114.47 26.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.28000000000000003 111.281 173.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.65 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 52.0 tp -84.5 102.18 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.626 -0.879 . . . . 0.14999999999999999 108.626 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HE3' ' O ' ' A' ' 84' ' ' PRO . 19.2 mtmm -105.06 -20.23 13.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.79 -0.641 . . . . 1.0800000000000001 111.019 -169.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.401 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.7 m -156.51 148.73 23.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.767 -0.651 . . . . 0.37 110.599 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.518 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -145.61 128.47 16.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.761 -0.829 . . . . 0.25 108.761 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 20.6 m -134.35 133.77 55.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.86 -0.736 . . . . 0.92000000000000004 111.715 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.4 123.4 28.0 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.022 -0.99 . . . . 2.27 110.807 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 65' ' ' VAL . 1.5 pt? -153.11 13.14 0.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.319 -0.4 . . . . 1.97 110.986 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.459 ' HG2' ' CA ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -54.05 -72.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.624 0.577 . . . . 2.1400000000000001 110.918 -172.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -122.06 101.23 7.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 5.79 112.188 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -54.81 121.15 7.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.022 -0.99 . . . . 7.4800000000000004 110.173 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -76.78 55.72 1.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.591 0.589 . . . . 8.4600000000000009 112.591 -172.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 56.72 30.13 17.07 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.691 0.396 . . . . 8.8300000000000001 111.508 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -134.73 156.33 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.975 0.417 . . . . 12.17 110.789 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m80 . . . . . 0 C--O 1.245 0.827 0 CA-C-N 115.508 -0.769 . . . . 13.460000000000001 109.466 173.576 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 mmt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.155 -0.683 . . . . 50.229999999999997 109.155 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.72 28.11 1.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.392 -0.908 . . . . 47.990000000000002 112.777 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 18.7 mm-40 -97.94 142.99 25.45 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 122.748 -0.266 . . . . 46.259999999999998 110.336 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.631 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 64.4 Cg_exo -50.93 -48.09 22.51 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.726 2.284 . . . . 44.799999999999997 112.682 174.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 2.9 Cg_endo -82.94 122.33 3.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.825 1.683 . . . . 44.020000000000003 110.928 169.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.27 -21.66 15.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.873 0.368 . . . . 42.5 110.928 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 9' ' ' ALA . 10.6 tp10 -157.48 139.17 14.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 41.5 109.628 -177.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.44 -40.77 18.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.677 -0.49 . . . . 40.329999999999998 109.677 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HB2' ' HG3' ' A' ' 7' ' ' GLU . . . 51.66 39.85 26.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.37 -0.832 . . . . 39.090000000000003 112.156 174.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -88.84 -76.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.427 -0.352 . . . . 38.82 110.904 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 55.18 81.86 0.25 Allowed Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.658 -0.701 . . . . 38.159999999999997 110.08 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.06 -176.51 3.28 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.08 2.52 . . . . 36.700000000000003 113.643 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.08 -12.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.877 -0.677 . . . . 35.609999999999999 112.464 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.98 -84.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.361 0.664 . . . . 35.030000000000001 111.57 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -170.65 -70.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.307 . . . . 34.009999999999998 110.611 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 177.59 -60.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.618 0.723 . . . . 32.890000000000001 109.528 -174.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -120.96 -11.68 8.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 31.940000000000001 110.379 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 62.41 -84.68 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.865 0.728 . . . . 31.239999999999998 111.167 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -146.02 144.88 30.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.863 -0.421 . . . . 31.239999999999998 109.863 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.827 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.4 pt? -99.25 10.13 42.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 29.850000000000001 111.992 -172.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.79 87.3 6.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 28.199999999999999 110.39 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 -12.59 21.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.797 -0.638 . . . . 26.780000000000001 110.452 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 52.3 mtt -90.44 0.32 57.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 27.469999999999999 110.717 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -114.23 96.96 44.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.484 -0.561 . . . . 24.41 109.484 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -91.34 112.62 0.36 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.958 2.439 . . . . 21.629999999999999 113.018 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -100.26 150.02 36.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.723 -0.473 . . . . 20.670000000000002 109.723 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.53 126.82 22.48 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.595 2.196 . . . . 18.02 111.715 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.17 132.65 93.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 14.93 110.994 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.67 143.18 70.52 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.215 2.61 . . . . 13.81 113.319 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.08 65.16 18.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 10.76 110.355 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.8 166.26 19.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.775 2.317 . . . . 9.7699999999999996 112.582 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.702 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . . . -111.13 142.71 26.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.293 -0.412 . . . . 5.8600000000000003 110.552 176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 22.4 Cg_exo -66.78 -24.0 47.6 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.215 2.61 . . . . 4.4699999999999998 113.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -144.7 105.96 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.084 -0.71 . . . . 4.1299999999999999 109.084 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.702 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 24.2 mt-10 -105.89 113.99 27.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.745 -0.661 . . . . 2.4500000000000002 109.738 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.695 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -68.13 -166.85 0.07 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.066 -0.97 . . . . 0.53000000000000003 112.422 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -69.09 111.93 5.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.5 111.037 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.725 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -64.51 101.53 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.084 -0.962 . . . . 2.5099999999999998 110.599 173.313 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.609 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.9 mt -54.07 -44.08 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.141 -0.936 . . . . 0.46000000000000002 112.009 -174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.484 HD21 HD13 ' A' ' 101' ' ' LEU . 86.5 mt -109.84 12.64 23.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.71999999999999997 110.525 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.725 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 70.66 0.12 30.49 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.52000000000000002 113.02 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.673 ' ND2' ' HB2' ' A' ' 44' ' ' LEU . 29.4 p-10 -81.06 -30.26 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.765 0.283 . . . . 0.94999999999999996 111.765 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.19 63.69 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.71999999999999997 112.311 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 2.3 mm? -79.04 -31.54 44.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.886 0.851 . . . . 1.5600000000000001 109.06 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 13.9 tp -119.31 114.01 21.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.087 -1.415 . . . . 0.32000000000000001 110.13 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 mtm180 -140.51 140.8 35.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.675 -0.239 . . . . 1.1399999999999999 111.37 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' HD11 ' A' ' 39' ' ' ILE . 11.1 ttpt -108.45 125.59 51.95 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.393 0.433 . . . . 0.34999999999999998 110.462 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.695 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.1 ttpt -107.63 113.67 27.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.164 -0.309 . . . . 1.0700000000000001 110.164 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -76.47 99.34 4.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.425 -0.352 . . . . 0.33000000000000002 110.931 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD21 ' HE3' ' A' ' 48' ' ' LYS . 15.5 mt -63.84 -50.67 67.96 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.926 -1.509 . . . . 0.28000000000000003 106.926 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.871 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 82.0 t -139.38 133.73 16.11 Favored Pre-proline 0 CA--C 1.502 -0.869 0 CA-C-N 113.303 -1.771 . . . . 0.35999999999999999 106.389 169.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 42.7 Cg_endo -107.63 64.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.749 2.299 . . . . 0.54000000000000004 113.446 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.89 142.13 1.77 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.53 -0.759 . . . . 0.55000000000000004 112.504 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.48 145.94 96.52 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.943 1.762 . . . . 1.4199999999999999 109.63 168.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -46.88 99.09 0.03 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.686 2.257 . . . . 2.04 112.351 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.4 60.64 0.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.669 -0.696 . . . . 0.97999999999999998 112.491 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -116.57 -172.35 2.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.872 -0.788 . . . . 0.98999999999999999 108.872 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 108' ' ' VAL . 17.9 t -128.22 -177.32 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.256 -1.016 . . . . 1.28 108.256 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 14.1 mtm180 -130.91 120.55 18.48 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.562 -0.533 . . . . 2.8100000000000001 109.562 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.4 Cg_endo -51.15 138.08 45.06 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.247 2.631 . . . . 0.29999999999999999 113.306 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.666 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.8 t -90.1 154.93 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.597 -0.729 . . . . 0.88 109.196 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.649 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 59.1 mttt -66.64 108.55 2.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.452 0.644 . . . . 1.1699999999999999 111.037 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 140.44 -28.37 2.45 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.429 -1.259 . . . . 0.41999999999999998 110.287 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 1.1 mm-40 -76.27 138.71 40.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.855 -0.795 . . . . 0.58999999999999997 108.855 177.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -88.54 129.29 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.008 -1.108 . . . . 1.22 108.008 172.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.7 m -125.79 147.86 30.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.43 -0.804 . . . . 0.25 110.965 -171.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.509 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 26.6 p -96.32 113.37 24.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.979 -0.555 . . . . 0.28999999999999998 109.967 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.548 HG21 HD21 ' A' ' 99' ' ' LEU . 23.9 m -110.47 143.97 19.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.27 0.557 . . . . 0.19 110.336 174.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.58 112.1 24.7 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.106 -1.442 . . . . 0.19 107.106 169.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 83' ' ' GLU . 1.7 pt? -116.06 136.59 52.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.93 0.872 . . . . 0.39000000000000001 110.808 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.531 ' CG ' ' HG3' ' A' ' 82' ' ' GLU . 1.4 mp0 -135.21 116.58 14.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 105.702 -1.962 . . . . 0.27000000000000002 105.702 169.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.602 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 62.6 m -109.28 123.67 49.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.876 -1.056 . . . . 0.19 111.418 -165.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.773 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.62 149.49 25.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.429 -0.805 . . . . 1.0600000000000001 109.276 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.543 ' HG ' HG13 ' A' ' 80' ' ' VAL . 8.0 mt -77.53 166.83 22.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.749 -0.659 . . . . 0.83999999999999997 110.804 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.35 -23.89 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.493 0.663 . . . . 1.1399999999999999 110.4 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -82.55 -11.3 58.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.352 -0.84 . . . . 2.1400000000000001 110.76 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.43 59.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.142 -0.551 . . . . 0.51000000000000001 111.86 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 m -75.12 110.63 9.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.991 0.367 . . . . 0.46000000000000002 111.991 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.773 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.5 mtt180 -73.1 117.57 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.46999999999999997 110.804 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.686 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.7 m -98.96 -10.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.27000000000000002 112.081 -171.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.602 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.6 pt20 -159.99 141.25 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.677 -0.692 . . . . 0.58999999999999997 109.31 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 14.4 tt0 -145.56 103.89 3.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.367 0.603 . . . . 1.3400000000000001 109.657 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.623 ' HB2' HD23 ' A' ' 70' ' ' LEU . 4.1 mm-40 -118.56 115.16 35.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.203 -0.908 . . . . 2.5899999999999999 109.887 -173.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 47.1 Cg_endo -69.06 -14.51 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.377 2.051 . . . . 0.5 113.044 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -166.98 114.86 0.82 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.861 0.839 . . . . 1.3700000000000001 111.817 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.4 tp -123.97 112.18 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.604 -1.634 . . . . 0.38 108.802 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.4 p -103.23 128.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.785 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 47.2 p90 -148.75 159.83 43.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 0.23000000000000001 111.698 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 1.7 m -78.45 109.07 12.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.839 . . . . 0.41999999999999998 110.546 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.816 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.4 tp -61.56 127.9 33.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.474 -0.33 . . . . 0.59999999999999998 110.661 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.649 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 83.91 11.72 78.55 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.835 -0.698 . . . . 0.37 112.689 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 34.3 t70 -115.44 10.0 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.331 0.586 . . . . 0.93000000000000005 109.605 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.5 m 54.39 39.15 30.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.62 109.438 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.785 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -70.63 -12.78 61.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.092 -1.077 . . . . 1.3300000000000001 108.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 11.0 m -137.61 -159.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 113.758 -1.565 . . . . 0.23000000000000001 110.578 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.7 pt -79.23 140.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.709 -1.219 . . . . 0.28999999999999998 107.709 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.439 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 1.8 tp-100 -59.66 -31.2 69.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.407 -0.361 . . . . 0.40000000000000002 110.987 -173.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.96 -43.0 69.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.237 0.542 . . . . 0.20000000000000001 110.422 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 142' ' ' VAL . 50.4 tp -78.01 -41.38 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.459 -0.791 . . . . 0.22 110.897 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.28 -29.67 68.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.328 -0.851 . . . . 0.26000000000000001 110.123 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.484 HD13 HD21 ' A' ' 40' ' ' LEU . 73.3 mt -90.03 -33.3 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.414 -0.812 . . . . 0.25 111.92 176.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 106' ' ' MET . 40.0 t -66.28 -34.2 77.46 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.718 0.294 . . . . 1.01 110.888 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.609 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.3 t -64.0 -55.61 31.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.813 0.671 . . . . 0.20999999999999999 112.813 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.816 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.8 Cg_endo -62.5 -22.39 73.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.91 1.74 . . . . 0.27000000000000002 112.049 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.5 mt -79.56 -16.89 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.64000000000000001 111.275 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.574 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -104.43 157.24 17.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.095 -0.502 . . . . 0.78000000000000003 111.315 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.5 m-20 -94.54 155.1 17.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.982 0.42 . . . . 0.96999999999999997 111.17 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 58' ' ' SER . 40.0 t -60.89 125.16 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.581 0.705 . . . . 0.80000000000000004 110.394 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.47 14.74 56.65 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 115.172 -0.922 . . . . 0.28000000000000003 112.453 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.871 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -101.42 168.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.339 0.59 . . . . 0.40999999999999998 111.433 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.442 HG22 HD12 ' A' ' 50' ' ' LEU . 9.4 m -130.59 117.24 19.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.066 -1.087 . . . . 0.22 108.066 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -121.43 136.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.052 0.453 . . . . 0.17999999999999999 110.653 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 ttm -99.49 116.86 32.61 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.528 -1.286 . . . . 1.3200000000000001 107.528 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.416 HG22 ' HG3' ' A' ' 47' ' ' LYS . 3.4 t -113.81 127.67 71.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.945 -0.761 . . . . 0.17999999999999999 108.945 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.582 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 38.6 m -107.14 114.19 28.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.345 -0.942 . . . . 0.20999999999999999 108.94 175.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -122.14 136.43 54.91 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.749 -1.568 . . . . 0.14999999999999999 109.93 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.715 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.3 t70 -53.33 149.33 7.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.792 -0.818 . . . . 0.57999999999999996 108.792 172.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.63 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.8 t -55.0 -27.24 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.258 0.551 . . . . 0.81999999999999995 110.549 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.715 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.9 ptpt -54.15 -35.95 62.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.293 -0.412 . . . . 0.81000000000000005 111.515 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.553 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 99.2 m-85 -95.77 3.48 53.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.41999999999999998 110.304 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.761 ' HB3' HD22 ' A' ' 138' ' ' LEU . 68.2 m -119.45 -91.03 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.033 -0.985 . . . . 0.17999999999999999 110.572 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.685 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 7.6 m-85 -145.57 40.69 1.2 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.255 0.465 . . . . 0.23999999999999999 112.255 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.5 -84.41 0.03 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.341 0.518 . . . . 0.25 113.647 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -81.84 11.12 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.364 2.043 . . . . 0.57999999999999996 110.696 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.685 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.7 mt-30 -104.24 -50.19 3.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.203 -0.908 . . . . 0.65000000000000002 110.125 -174.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.627 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.03 141.6 3.09 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.731 -1.122 . . . . 0.29999999999999999 112.613 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.0 t -92.28 165.38 13.13 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.232 -0.484 . . . . 0.33000000000000002 111.373 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.709 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 2.6 mmp_? -54.79 -60.7 3.0 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.59 -0.732 . . . . 3.1699999999999999 112.197 -176.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.843 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 17.5 t -76.57 -58.06 1.19 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 116.142 -0.481 . . . . 1.23 109.871 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.4 Cg_endo -108.73 126.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.521 2.147 . . . . 0.37 112.25 171.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.627 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.9 t80 -57.0 99.37 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.59 -1.263 . . . . 1.1399999999999999 107.59 163.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.606 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.2 mm -65.61 128.54 93.88 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.39000000000000001 110.188 -177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.0 Cg_exo -54.29 141.63 70.58 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.724 2.283 . . . . 0.60999999999999999 112.051 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 Cg_exo -57.67 130.55 39.28 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.332 2.021 . . . . 0.52000000000000002 112.068 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.552 ' H ' ' HB3' ' A' ' 118' ' ' SER . 13.6 m-70 74.1 7.79 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.831 -1.077 . . . . 2.3799999999999999 113.105 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.48 ' N ' ' HB2' ' A' ' 118' ' ' SER . . . -68.9 120.59 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.503 -0.554 . . . . 0.26000000000000001 109.503 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.32 113.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.171 0.51 . . . . 0.22 109.809 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.761 HD22 ' HB3' ' A' ' 121' ' ' CYS . 2.2 mp -90.87 129.81 36.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.847 -0.615 . . . . 0.22 111.009 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.47 ' SG ' HG23 ' A' ' 115' ' ' THR . 35.2 m -112.55 98.91 7.56 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -108.46 134.96 50.52 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.793 -0.639 . . . . 0.32000000000000001 111.595 -174.338 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' LEU . 43.2 tt0 -102.73 116.26 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.146 -0.687 . . . . 1.05 109.146 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.622 HG11 HD13 ' A' ' 99' ' ' LEU . 3.9 m -115.69 119.35 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.561 0.696 . . . . 0.19 112.758 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.7 m -90.32 110.48 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.28000000000000003 110.271 171.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.574 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 61.7 tp -82.82 97.85 8.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.651 -0.87 . . . . 0.14999999999999999 108.651 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.2 mtmt -94.57 -29.11 15.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 1.0800000000000001 110.597 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.509 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.9 m -153.53 149.31 27.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.466 -0.334 . . . . 0.37 111.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.496 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -140.12 127.99 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.27 -0.641 . . . . 0.25 109.27 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.12 140.35 49.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.44 0.638 . . . . 0.92000000000000004 111.357 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.401 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . 6.5 t70 -90.43 121.12 32.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 2.27 110.076 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.7 mt -153.65 15.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 1.97 110.765 -171.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 6.5 tp10 -97.13 -84.02 0.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 2.1400000000000001 110.43 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -150.28 139.95 21.67 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.236 -0.586 . . . . 5.79 111.615 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -118.77 12.23 12.92 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.491 0.663 . . . . 7.4800000000000004 109.243 169.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.87 127.15 33.63 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.864 -1.062 . . . . 8.4600000000000009 109.061 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 64.23 -176.9 0.16 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.851 0.719 . . . . 8.8300000000000001 111.682 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -115.22 11.73 16.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.44 -0.578 . . . . 12.17 109.44 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.402 -0.809 . . . . 13.460000000000001 109.53 -174.648 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.758 0.314 . . . . 50.229999999999997 110.821 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.93 134.59 6.86 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.733 -0.746 . . . . 47.990000000000002 112.123 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -111.22 158.78 35.08 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.405 -0.22 . . . . 46.259999999999998 110.405 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 29.4 Cg_endo -65.57 134.18 37.26 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.182 1.921 . . . . 44.799999999999997 110.809 169.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 33.5 Cg_exo -61.35 142.77 96.91 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.82 2.347 . . . . 44.020000000000003 112.771 -176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 73.14 -77.29 0.06 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.08 -0.963 . . . . 42.5 112.554 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.58 162.4 41.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 41.5 111.426 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 9' ' ' ALA . 3.7 pt-20 -127.16 -31.57 2.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 40.329999999999998 110.711 173.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' A' ' 8' ' ' GLU . . . -166.21 105.35 0.66 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.889 0.376 . . . . 39.090000000000003 111.958 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -175.03 146.57 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.62 -0.882 . . . . 38.82 108.62 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 61.06 75.1 0.47 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.329 -0.619 . . . . 38.159999999999997 109.329 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.61 -18.98 58.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.19 2.593 . . . . 36.700000000000003 112.826 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.43 73.22 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.445 -0.883 . . . . 35.609999999999999 111.961 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.65 -21.53 66.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.259 . . . . 35.030000000000001 111.03 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt 66.82 -172.62 0.19 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.629 -0.714 . . . . 34.009999999999998 111.418 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.81 -81.04 0.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 32.890000000000001 109.748 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -103.08 -2.29 27.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.089 -0.505 . . . . 31.940000000000001 110.595 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 55.58 89.8 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.385 0.612 . . . . 31.239999999999998 110.84 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 10.13 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.285 -0.416 . . . . 31.239999999999998 111.971 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp -144.8 17.2 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.719 0.295 . . . . 29.850000000000001 111.772 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.02 113.84 20.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.735 -0.211 . . . . 28.199999999999999 110.811 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.69 -179.78 0.23 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.041 0.838 . . . . 26.780000000000001 111.54 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.2 13.88 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 27.469999999999999 110.338 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 56.64 91.54 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 124.067 0.854 . . . . 24.41 110.95 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.83 149.93 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.889 2.392 . . . . 21.629999999999999 112.456 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 24.1 mm-40 -62.91 132.94 95.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.856 -0.611 . . . . 20.670000000000002 110.066 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 16.5 Cg_exo -68.08 131.89 24.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.571 2.181 . . . . 18.02 111.361 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 144.85 84.88 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.294 -0.262 . . . . 14.93 110.294 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 140.82 22.37 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 13.81 113.908 -174.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -97.67 -44.53 0.24 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.45 -0.795 . . . . 10.76 111.876 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 45.1 Cg_exo -57.96 128.22 28.07 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.821 1.681 . . . . 9.7699999999999996 112.19 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . . . -111.01 112.48 55.52 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.272 -0.422 . . . . 5.8600000000000003 110.481 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 32' ' ' ALA . 18.8 Cg_endo -61.22 -36.95 77.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.606 2.204 . . . . 4.4699999999999998 112.035 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -168.83 110.4 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.392 -0.822 . . . . 4.1299999999999999 109.093 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 2.3 pm0 -87.27 114.01 23.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.827 0.823 . . . . 2.4500000000000002 111.592 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.631 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -96.87 -163.52 1.06 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 0.53000000000000003 109.087 173.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.44 109.99 7.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.894 0.378 . . . . 0.5 110.674 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.644 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -64.9 96.77 0.2 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.652 -0.704 . . . . 2.5099999999999998 111.499 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.732 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 15.1 mt -51.81 -53.08 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.46000000000000002 110.38 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.885 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -78.71 -16.98 56.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.15 -1.386 . . . . 0.71999999999999997 110.163 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.644 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 72.37 8.34 70.48 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.404 -0.816 . . . . 0.52000000000000002 111.674 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 44' ' ' LEU . 7.2 p-10 -106.41 -9.14 16.84 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.568 0.223 . . . . 0.94999999999999996 111.51 -178.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.85 -22.38 28.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.346 -0.931 . . . . 0.71999999999999997 113.238 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.581 ' HB2' HD22 ' A' ' 42' ' ' ASN . 4.2 mm? -80.09 -22.51 42.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.577 0.704 . . . . 1.5600000000000001 109.235 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.885 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 26.3 tp -120.51 110.39 16.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 0.32000000000000001 110.679 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.643 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 42.8 mtm105 -143.75 140.41 29.93 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.223 0.327 . . . . 1.1399999999999999 111.544 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.754 ' HG3' HG22 ' A' ' 114' ' ' VAL . 7.3 ttpp -116.95 127.8 54.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.16 0.184 . . . . 0.34999999999999998 110.553 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.631 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.9 ttpt -103.67 130.37 51.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.804 0.335 . . . . 1.0700000000000001 110.986 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 1.5 p -80.49 94.67 6.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.847 -0.615 . . . . 0.33000000000000002 110.381 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 111' ' ' THR . 12.5 mt -63.78 -52.77 58.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.014 -1.476 . . . . 0.28000000000000003 107.014 173.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.795 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 73.6 t -134.63 124.61 17.02 Favored Pre-proline 0 CA--C 1.494 -1.195 0 CA-C-N 113.362 -1.745 . . . . 0.35999999999999999 106.599 168.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 68.3 Cg_endo -105.6 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.623 2.215 . . . . 0.54000000000000004 113.593 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.533 ' HA3' ' OD2' ' A' ' 107' ' ' ASP . . . 60.71 173.93 1.05 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.201 -0.909 . . . . 0.55000000000000004 114.207 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 71.9 Cg_endo -77.82 178.98 6.95 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.52 2.147 . . . . 1.4199999999999999 109.475 164.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 50.9 Cg_endo -71.22 36.52 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.922 1.748 . . . . 2.04 112.656 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 54' ' ' PRO . . . 177.4 53.35 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.275 -0.421 . . . . 0.97999999999999998 112.073 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.83 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -95.66 -174.78 3.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.236 0.541 . . . . 0.98999999999999999 111.639 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.25 -0.886 . . . . 1.28 108.791 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -91.06 119.14 68.89 Favored Pre-proline 0 C--N 1.319 -0.732 0 C-N-CA 120.792 -0.363 . . . . 2.8100000000000001 110.59 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD3' HG23 ' A' ' 108' ' ' VAL . 11.3 Cg_endo -53.16 149.43 28.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.603 2.869 . . . . 0.29999999999999999 113.318 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.6 t -100.02 151.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.974 -0.557 . . . . 0.88 109.737 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 59.7 mttt -61.72 112.83 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.652 0.739 . . . . 1.1699999999999999 110.875 177.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 134.76 -30.0 2.91 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 114.165 -1.38 . . . . 0.41999999999999998 110.186 -174.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 2.3 mm-40 -72.39 139.17 47.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.158 -0.617 . . . . 0.58999999999999997 110.202 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.512 ' O ' HG22 ' A' ' 148' ' ' VAL . 40.9 t -80.81 117.14 26.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.503 -0.925 . . . . 1.22 108.503 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -125.47 150.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.782 0.66 . . . . 0.25 112.782 -170.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 145' ' ' LYS . 0.8 OUTLIER -98.43 121.8 40.81 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.696 -1.138 . . . . 0.28999999999999998 110.41 174.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 99' ' ' LEU . 30.1 m -118.33 147.73 21.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.341 -0.543 . . . . 0.19 110.106 168.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.733 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.04 117.34 34.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.752 -1.573 . . . . 0.19 106.752 167.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -118.33 138.63 52.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.204 -0.999 . . . . 0.39000000000000001 111.004 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.548 ' OE1' ' HB3' ' A' ' 141' ' ' GLU . 1.3 mp0 -135.77 113.91 11.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.194 -2.15 . . . . 0.27000000000000002 105.194 165.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.618 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 72.0 m -102.73 127.3 49.93 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.738 -1.119 . . . . 0.19 111.076 -167.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.706 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 t -109.04 159.44 16.84 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.396 -0.82 . . . . 1.0600000000000001 109.358 -177.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.74 164.53 18.49 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.694 -0.684 . . . . 0.83999999999999997 109.303 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -52.19 -24.12 6.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.518 0.675 . . . . 1.1399999999999999 110.58 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -94.46 -7.33 41.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.062 -0.972 . . . . 2.1400000000000001 111.98 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.48 -8.72 37.86 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.83 -0.7 . . . . 0.51000000000000001 113.981 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.3 m -75.55 110.69 10.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.448 0.624 . . . . 0.46000000000000002 111.718 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.8 mtt180 -77.68 110.64 12.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.947 0.88 . . . . 0.46999999999999997 110.298 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.522 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.2 m -91.36 -12.61 9.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.069 -1.423 . . . . 0.27000000000000002 111.936 -169.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.618 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.1 pt20 -158.6 124.4 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.344 -0.389 . . . . 0.58999999999999997 110.746 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.53 124.53 48.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.315 -0.624 . . . . 1.3400000000000001 109.315 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 8.6 tt0 -144.61 107.28 4.7 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-O 121.879 0.847 . . . . 2.5899999999999999 110.506 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 53.1 Cg_endo -68.94 -19.2 40.43 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 123.35 2.7 . . . . 0.5 113.871 -171.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -158.74 99.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.0 0.905 . . . . 1.3700000000000001 111.016 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.4 tp -113.04 116.02 29.27 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.31 -1.768 . . . . 0.38 108.808 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.0 p -112.64 133.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 24.3 p90 -154.86 164.74 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.884 0.373 . . . . 0.23000000000000001 110.821 -172.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.402 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 2.7 m -83.38 112.46 19.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.634 -0.712 . . . . 0.41999999999999998 109.495 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.974 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.2 tp -59.53 126.26 26.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.405 -0.361 . . . . 0.59999999999999998 110.919 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' HG2' ' A' ' 62' ' ' LYS . . . 83.51 5.51 88.41 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.78 -0.724 . . . . 0.37 112.438 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 30.6 t70 -90.33 -7.34 53.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.565 -1.272 . . . . 0.93000000000000005 107.565 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 56.2 m 58.4 31.7 21.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.105 -1.407 . . . . 0.62 110.16 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.27 -18.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.256 1.026 . . . . 1.3300000000000001 109.168 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.38 -155.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.069 -1.423 . . . . 0.23000000000000001 110.454 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 28.8 pt -82.75 137.27 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.296 -1.372 . . . . 0.28999999999999998 107.296 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -56.77 -30.03 63.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.468 -0.333 . . . . 0.40000000000000002 110.96 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.77 78.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.163 0.506 . . . . 0.20000000000000001 110.746 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.661 HD21 HG21 ' A' ' 68' ' ' VAL . 62.6 tp -77.88 -37.76 47.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.671 -0.695 . . . . 0.22 110.678 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.414 ' OD2' ' HA2' ' A' ' 91' ' ' GLY . 22.9 t70 -61.9 -29.51 70.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 0.26000000000000001 109.59 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.3 -35.07 14.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.253 -0.885 . . . . 0.25 112.275 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 106' ' ' MET . 21.3 t -65.81 -32.83 74.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 1.01 111.479 -174.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.566 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 53.5 t -66.92 -54.91 18.43 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.519 0.563 . . . . 0.20999999999999999 112.519 -176.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.974 ' HD3' HD11 ' A' ' 90' ' ' LEU . 23.7 Cg_endo -63.76 -22.63 69.5 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.042 1.828 . . . . 0.27000000000000002 111.921 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.51 ' CD1' HG23 ' A' ' 39' ' ' ILE . 4.2 mt -77.38 -31.15 54.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.64000000000000001 111.336 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.703 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.3 ptm -88.52 157.23 18.69 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.936 -0.575 . . . . 0.78000000000000003 109.68 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.533 ' OD2' ' HA3' ' A' ' 53' ' ' GLY . 8.3 p-10 -103.49 158.39 16.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.337 0.589 . . . . 0.96999999999999997 111.713 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.647 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.8 t -61.37 125.82 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.524 -0.762 . . . . 0.80000000000000004 111.464 -174.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.65 59.2 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 114.815 -1.084 . . . . 0.28000000000000003 112.819 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.4 pt-20 -97.0 167.87 10.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.195 0.522 . . . . 0.40999999999999998 110.625 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.533 HG22 HD12 ' A' ' 50' ' ' LEU . 21.5 m -128.07 117.4 21.58 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.048 -1.093 . . . . 0.22 108.048 173.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -118.35 131.52 56.31 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.977 -0.556 . . . . 0.17999999999999999 110.963 -173.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.2 ttp -98.44 117.99 34.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.994 -1.113 . . . . 1.3200000000000001 107.994 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.754 HG22 ' HG3' ' A' ' 47' ' ' LYS . 12.7 t -109.1 137.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.878 -0.601 . . . . 0.17999999999999999 109.583 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.598 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 89.6 m -110.66 113.07 25.39 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.241 -1.022 . . . . 0.20999999999999999 108.241 170.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -122.7 132.14 54.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.564 -1.198 . . . . 0.14999999999999999 109.29 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.732 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.6 t70 -52.98 146.63 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.588 -0.893 . . . . 0.57999999999999996 108.588 171.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.586 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.5 t -52.32 -26.78 13.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.131 0.491 . . . . 0.81999999999999995 110.48 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.732 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.7 ptpt -54.33 -33.54 59.16 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 122.062 -0.399 . . . . 0.81000000000000005 112.01 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' OH ' ' HG ' ' A' ' 40' ' ' LEU . 98.5 m-85 -96.4 3.08 53.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.352 0.596 . . . . 0.41999999999999998 109.92 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.8 m -122.13 -90.46 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.034 . . . . 0.17999999999999999 110.389 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 13.0 m-85 -144.39 39.62 1.3 Allowed 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.262 0.467 . . . . 0.23999999999999999 112.262 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.71 -83.26 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.188 -0.529 . . . . 0.25 113.744 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.74 7.66 4.72 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.405 2.07 . . . . 0.57999999999999996 111.259 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.0 mt-30 -104.45 -51.17 3.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.716 -0.674 . . . . 0.65000000000000002 110.498 -173.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.559 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 85.85 142.68 6.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.074 -0.966 . . . . 0.29999999999999999 112.419 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.634 ' HB3' HG12 ' A' ' 132' ' ' ILE . 6.9 t -91.35 162.22 14.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.187 -0.506 . . . . 0.33000000000000002 112.162 -175.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 83' ' ' GLU . 14.5 ptp180 -52.89 -51.37 61.42 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 115.151 -0.931 . . . . 3.1699999999999999 112.238 -173.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.975 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 20.4 m -81.4 -64.7 0.27 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.438 . . . . 1.23 110.36 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.975 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 20.0 Cg_endo -105.24 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.401 2.067 . . . . 0.37 111.7 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.552 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 31.0 t80 -56.22 98.11 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.064 -1.087 . . . . 1.1399999999999999 108.064 163.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 127' ' ' SER . 33.5 mm -65.35 128.99 94.27 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.893 -0.594 . . . . 0.39000000000000001 109.639 -177.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.6 Cg_endo -52.38 139.14 55.72 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.659 2.239 . . . . 0.60999999999999999 112.282 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.554 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 40.7 Cg_exo -57.55 129.05 31.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.528 2.152 . . . . 0.52000000000000002 112.456 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.589 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 57.9 m80 75.36 12.16 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.936 -1.029 . . . . 2.3799999999999999 112.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.76 127.14 32.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.235 -0.654 . . . . 0.26000000000000001 109.235 173.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.48 113.08 11.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.521 -0.472 . . . . 0.22 110.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.14 132.87 35.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.072 -0.513 . . . . 0.22 110.97 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 5.2 t -118.11 100.07 7.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.605 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -109.5 136.71 48.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.651 -0.704 . . . . 0.32000000000000001 111.586 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.548 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 50.8 tt0 -101.85 118.44 36.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.175 -0.676 . . . . 1.05 109.175 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 4.2 m -119.67 123.3 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.435 0.636 . . . . 0.19 112.555 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 42.9 m -92.79 118.54 31.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.645 -0.707 . . . . 0.28000000000000003 109.362 170.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.703 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 37.4 tp -80.82 99.01 8.07 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.481 -0.933 . . . . 0.14999999999999999 108.481 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.625 ' HD3' ' HB ' ' A' ' 67' ' ' THR . 19.2 mtpt -79.91 -44.48 20.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.464 -1.244 . . . . 1.0800000000000001 110.328 -168.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 m -158.48 160.0 36.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.969 -0.56 . . . . 0.37 110.526 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.534 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.32 128.05 27.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.165 -0.68 . . . . 0.25 109.165 170.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 65' ' ' VAL . 20.4 m -126.19 140.23 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.92000000000000004 110.06 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -86.36 117.76 25.36 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.509 -0.476 . . . . 2.27 110.55 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.5 tp -136.25 6.9 3.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.878 -0.601 . . . . 1.97 109.793 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -109.07 117.87 35.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.496 -0.775 . . . . 2.1400000000000001 109.198 -178.097 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -128.97 73.95 1.55 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.363 0.602 . . . . 5.79 109.745 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -71.29 120.57 17.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 7.4800000000000004 110.897 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -84.34 -29.21 26.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 8.4600000000000009 111.104 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -125.95 82.13 2.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.693 0.282 . . . . 8.8300000000000001 110.999 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.0 m80 61.5 -89.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.695 -0.684 . . . . 12.17 111.385 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 . . . . . 0 C--O 1.244 0.798 0 N-CA-C 109.132 -0.692 . . . . 13.460000000000001 109.132 176.037 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.609 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.388 0.613 . . . . 0.53 110.856 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.71 109.76 4.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.5 110.131 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.623 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.0 t70 -74.76 123.8 25.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 2.51 110.818 174.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.506 HD12 HD11 ' A' ' 45' ' ' LEU . 8.8 mt -56.06 -36.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.711 -1.131 . . . . 0.46 111.568 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -110.77 -2.39 16.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.208 0.528 . . . . 0.72 110.473 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.17 24.75 67.51 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.33 -0.85 . . . . 0.52 111.627 -173.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.525 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -94.5 -22.37 18.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.858 0.361 . . . . 0.95 111.669 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.548 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.0 -17.67 41.09 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.922 -0.656 . . . . 0.72 112.125 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.817 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 1.1 mt -96.07 -24.23 16.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.673 0.273 . . . . 1.56 110.912 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 39' ' ' ILE . 19.5 tp -123.68 100.39 6.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.374 -0.376 . . . . 0.32 111.854 -171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -130.11 139.88 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.097 -0.377 . . . . 1.14 111.722 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 10.3 ttpt -112.13 125.82 54.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.477 0.311 . . . . 0.35 110.637 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.2 ttpp -116.54 120.73 39.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 1.07 110.969 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 p -74.93 110.44 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.464 . . . . 0.33 111.646 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD11 ' HG3' ' A' ' 141' ' ' GLU . 9.0 mt -73.88 -52.0 14.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.827 -1.545 . . . . 0.28 106.827 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.866 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.7 t -133.46 130.72 21.11 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 113.21 -1.814 . . . . 0.36 106.752 170.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 22.7 Cg_endo -107.79 57.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.221 2.614 . . . . 0.54 114.024 -176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.449 -0.49 0 C-N-CA 120.958 -0.639 . . . . 0.55 112.848 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 122.003 0.906 . . . . 0.99 113.252 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 108' ' ' VAL . 16.5 m -146.71 140.0 25.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.582 -1.19 . . . . 1.28 108.229 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 96.4 mtt180 -89.36 116.22 65.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 120.567 -0.453 . . . . 2.81 109.831 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 10.0 Cg_endo -52.38 148.59 25.53 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.493 2.795 . . . . 0.3 112.67 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -94.65 152.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 0.88 109.28 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 61.3 mttt -63.71 120.69 12.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 1.17 109.399 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.02 -41.92 1.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.06 -1.427 . . . . 0.42 110.075 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.687 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -69.42 132.67 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.069 -0.715 . . . . 0.59 109.069 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 17.9 m -84.45 118.64 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 122.142 0.973 . . . . 1.22 108.727 175.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -115.65 144.84 22.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.93 -1.032 . . . . 0.25 111.486 -171.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.973 HG22 HG22 ' A' ' 87' ' ' VAL . 43.5 p -88.86 113.99 25.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.535 -0.757 . . . . 0.29 110.221 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 99' ' ' LEU . 20.8 m -111.49 143.59 21.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.996 -0.682 . . . . 0.19 110.511 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -103.1 117.88 35.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.451 -1.314 . . . . 0.19 107.451 168.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -118.96 137.79 53.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 118.92 -1.112 . . . . 0.39 111.035 176.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.653 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.46 114.29 14.13 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.491 -2.041 . . . . 0.27 105.491 166.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.662 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 60.3 m -105.45 132.61 51.41 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 114.976 -1.011 . . . . 0.19 111.831 -168.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 m -104.39 156.88 17.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.096 -0.956 . . . . 1.06 108.874 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.419 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.8 mt -80.42 166.72 20.98 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 0.84 108.908 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 11.1 pt-20 -59.88 -14.54 15.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.915 0.339 . . . . 1.14 111.915 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -93.28 -15.63 25.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.897 0.38 . . . . 2.14 110.711 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.44 -3.92 19.93 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.813 -0.708 . . . . 0.51 113.644 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.1 m -75.67 110.88 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.369 0.584 . . . . 0.46 111.573 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.6 mtt180 -75.99 112.42 12.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.854 0.835 . . . . 0.47 110.857 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.573 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.2 m -99.02 -13.8 7.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 113.992 -1.458 . . . . 0.27 112.377 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.611 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.8 pt20 -157.06 136.58 12.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.81 0.338 . . . . 0.59 110.586 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.52 130.42 32.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.969 -0.559 . . . . 1.34 109.687 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 4.8 tt0 -145.09 112.98 4.84 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.562 -0.745 . . . . 2.59 109.815 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 15.2 Cg_exo -68.19 -15.77 43.27 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.501 2.801 . . . . 0.5 113.315 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.578 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 26.5 tt0 -166.34 113.28 0.86 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.021 0.915 . . . . 1.37 111.572 -175.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.455 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 49.7 tp -126.72 110.76 13.49 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.55 -1.659 . . . . 0.38 108.737 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.973 HG22 HG22 ' A' ' 67' ' ' THR . 2.1 t -100.79 125.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 p90 -145.56 160.71 41.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.23 111.44 -172.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 m -79.29 106.67 11.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.593 -0.73 . . . . 0.42 110.4 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.856 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.02 134.54 57.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.213 -0.448 . . . . 0.6 110.514 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 81.44 -5.63 67.63 Favored Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 120.824 -0.703 . . . . 0.37 113.293 173.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -107.17 15.54 25.04 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.534 -0.913 . . . . 0.93 108.534 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 32.2 m 53.65 39.61 30.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.109 -1.405 . . . . 0.62 109.633 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.3 t0 -76.86 -2.79 35.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.563 1.173 . . . . 1.33 108.383 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 6.2 m -140.04 -157.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 113.646 -1.616 . . . . 0.23 110.757 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.5 pt -82.82 139.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.567 -1.272 . . . . 0.29 107.567 173.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.523 HE21 ' HB3' ' A' ' 100' ' ' ASP . 6.3 tp60 -58.85 -31.51 68.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.351 -0.386 . . . . 0.4 111.261 -171.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.91 79.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 0.2 110.491 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 68' ' ' VAL . 53.7 tp -75.5 -38.01 59.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.314 -0.857 . . . . 0.22 110.551 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' HB3' HE21 ' A' ' 97' ' ' GLN . 13.2 t70 -61.41 -29.82 70.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.97 -1.014 . . . . 0.26 109.868 -175.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.55 -36.04 14.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.198 -0.91 . . . . 0.25 111.969 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.8 t -64.91 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.676 -0.238 . . . . 1.01 111.191 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 104' ' ' PRO . 76.1 t -65.55 -53.45 37.37 Favored Pre-proline 0 C--O 1.218 -0.578 0 CA-C-N 116.471 -0.332 . . . . 0.21 111.888 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.802 ' HD3' HD11 ' A' ' 90' ' ' LEU . 64.5 Cg_exo -52.55 -28.83 38.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.992 1.795 . . . . 0.27 112.706 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.56 -11.52 53.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.8 -0.636 . . . . 0.64 111.279 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -100.43 142.07 32.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.27 -0.877 . . . . 0.78 110.701 176.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.576 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -89.37 156.88 18.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.97 108.781 172.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 58' ' ' SER . 1.3 p -66.04 126.47 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.935 0.874 . . . . 0.8 110.459 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.8 -2.3 45.17 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.337 -0.847 . . . . 0.28 112.254 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.866 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 6.8 pt-20 -96.95 168.13 10.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.529 0.68 . . . . 0.41 110.913 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.438 HG22 HD12 ' A' ' 50' ' ' LEU . 10.2 m -130.18 116.96 19.18 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.369 -0.974 . . . . 0.22 108.369 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.595 ' HB3' ' SD ' ' A' ' 106' ' ' MET . . . -115.21 135.28 54.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.878 -0.601 . . . . 0.18 110.314 -176.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttm -97.46 117.0 30.74 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.124 -1.436 . . . . 1.32 107.124 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.62 130.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.584 -0.524 . . . . 0.18 109.584 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.512 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 98.1 m -105.79 112.48 25.56 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.075 -1.083 . . . . 0.21 108.075 170.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.31 133.69 52.52 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.988 -1.46 . . . . 0.15 109.227 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.817 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 10.0 t70 -52.67 145.77 11.44 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.893 -0.78 . . . . 0.58 108.893 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.8 t -52.74 -29.49 27.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.965 0.412 . . . . 0.82 110.125 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.693 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 7.0 ptpp? -56.73 -27.14 58.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.206 0.447 . . . . 0.81 112.206 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.564 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 88.9 m-85 -99.4 0.99 43.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.3 0.571 . . . . 0.42 109.922 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -119.72 -92.03 0.54 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.816 -1.084 . . . . 0.18 109.994 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.0 m-85 -142.02 43.62 1.68 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 120.71 -0.396 . . . . 0.24 111.761 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.29 -89.83 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 113.957 0.343 . . . . 0.25 113.957 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.65 15.27 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.639 2.226 . . . . 0.58 110.707 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 33.0 mt-30 -104.3 -43.28 5.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.232 -0.895 . . . . 0.65 109.672 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.595 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 75.85 144.99 1.44 Allowed Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.655 -1.157 . . . . 0.3 112.673 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.678 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.3 t -92.08 159.91 15.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.417 -0.392 . . . . 0.33 111.322 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.449 HH12 ' CD ' ' A' ' 83' ' ' GLU . 33.2 mtt180 -53.18 -57.0 11.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.329 -0.851 . . . . 3.17 111.109 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.96 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.3 m -74.6 -64.31 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.833 -0.622 . . . . 1.23 110.553 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.96 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.6 Cg_endo -106.72 126.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.973 1.782 . . . . 0.37 112.132 174.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 34.3 t80 -58.85 98.02 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.153 -1.054 . . . . 1.14 108.153 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.0 mm -65.97 132.33 94.66 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.39 109.886 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 52.7 Cg_exo -54.53 140.5 75.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.675 2.25 . . . . 0.61 112.436 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.477 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 48.2 Cg_exo -56.58 140.19 89.36 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.535 2.157 . . . . 0.52 112.392 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.637 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 29.5 p80 47.59 28.76 1.27 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.398 1.079 . . . . 2.38 113.145 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -86.19 134.2 33.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.374 -0.973 . . . . 0.26 108.374 169.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -77.81 113.32 15.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.306 -0.558 . . . . 0.22 110.326 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.662 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 2.5 tp -90.41 132.01 35.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.774 -0.648 . . . . 0.22 110.015 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.8 t -115.56 100.38 8.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.308 -0.627 . . . . 1.2 109.308 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 pp -113.36 136.36 52.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.002 -0.545 . . . . 0.32 111.686 -171.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.653 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 46.9 tt0 -104.21 111.26 23.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.72 . . . . 1.05 109.213 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.682 HG11 HD13 ' A' ' 99' ' ' LEU . 2.9 m -113.72 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.119 0.785 . . . . 0.19 113.119 -173.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.6 m -88.6 108.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.636 -1.165 . . . . 0.28 110.369 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.407 HD21 ' HG3' ' A' ' 60' ' ' PRO . 61.7 tp -81.75 93.05 6.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.326 -0.99 . . . . 0.15 108.326 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.472 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 24.7 mtmt -90.13 -31.21 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.679 -0.691 . . . . 1.08 110.754 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 m -148.67 151.46 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.961 0.41 . . . . 0.37 111.293 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -139.78 128.11 22.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.25 109.289 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.327 -0.384 0 C-N-CA 120.479 -0.488 . . . . 0.92 110.245 -179.456 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.594 ' HZ3' ' H ' ' A' ' 115' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.53 110.528 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.7 tp -69.39 110.81 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.551 -0.749 . . . . 0.5 109.618 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.621 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 11.6 t70 -75.71 128.56 35.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.202 -0.599 . . . . 2.51 109.463 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.544 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 7.3 mt -65.13 -23.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.847 -1.069 . . . . 0.46 110.839 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.3 mt -116.14 -5.5 11.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.72 110.101 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 69.19 18.52 73.17 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.52 112.361 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.464 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -98.28 -31.17 12.19 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.636 0.606 . . . . 0.95 112.636 -176.035 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.516 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.85 -0.83 21.46 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.473 -0.87 . . . . 0.72 112.242 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.13 -35.59 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.173 0.511 . . . . 1.56 110.801 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 18.2 tp -122.68 101.62 7.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.132 -0.94 . . . . 0.32 111.253 -172.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -133.89 140.33 46.76 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.124 -0.36 . . . . 1.14 111.472 -171.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HZ3' ' HA ' ' A' ' 106' ' ' MET . 14.2 ttpt -111.49 123.33 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.35 110.696 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 11.2 ttmm -103.13 118.77 37.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.392 -0.225 . . . . 1.07 110.392 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -76.71 96.09 4.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.486 -0.325 . . . . 0.33 110.577 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 111' ' ' THR . 10.6 mt -63.1 -49.47 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.304 -1.369 . . . . 0.28 107.304 174.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 72.2 t -140.1 126.32 11.97 Favored Pre-proline 0 CA--C 1.499 -0.987 0 CA-C-N 112.617 -2.083 . . . . 0.36 106.588 170.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -104.28 64.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.546 2.164 . . . . 0.54 113.845 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.4 -0.818 . . . . 0.55 113.888 173.608 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.444 -0.773 0 CA-C-O 120.947 0.403 . . . . 0.99 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.432 ' H ' HG12 ' A' ' 108' ' ' VAL . 10.6 t -152.48 136.05 16.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.787 -0.82 . . . . 1.28 108.787 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 84.6 mtt180 -92.48 108.57 32.29 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.73 -0.47 . . . . 2.81 109.73 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 144' ' ' LEU . 5.3 Cg_endo -46.55 142.76 9.37 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.996 3.13 . . . . 0.3 114.037 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -89.41 153.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.49 -0.777 . . . . 0.88 109.717 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.653 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -68.52 117.12 9.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.732 0.777 . . . . 1.17 110.956 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.7 -27.24 3.23 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.354 -1.293 . . . . 0.42 110.423 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -75.65 140.94 42.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.59 109.147 176.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.3 m -86.71 126.54 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.42 -1.326 . . . . 1.22 107.42 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 33.3 m -120.6 146.41 25.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.174 -0.466 . . . . 0.25 110.195 -173.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.446 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 31.3 p -96.37 111.71 23.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.822 -0.626 . . . . 0.29 110.047 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG21 HD21 ' A' ' 99' ' ' LEU . 3.9 m -111.42 143.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.746 -0.661 . . . . 0.19 110.362 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.3 114.04 27.65 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.018 -1.475 . . . . 0.19 107.018 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -114.67 135.47 54.12 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.301 -0.959 . . . . 0.39 111.132 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -134.17 113.45 12.05 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.742 -1.947 . . . . 0.27 105.742 165.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 88.3 m -105.24 132.13 51.83 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.605 -1.18 . . . . 0.19 111.411 -168.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.791 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -110.46 156.61 20.61 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.297 -0.865 . . . . 1.06 109.131 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.72 165.64 21.77 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.828 -0.624 . . . . 0.84 109.807 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.7 -21.18 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 1.14 111.266 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -91.3 -8.15 49.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.864 -0.607 . . . . 2.14 110.61 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.44 -9.37 41.66 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.061 -0.59 . . . . 0.51 112.702 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -74.23 109.41 7.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.72 0.267 . . . . 0.46 111.72 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 23.3 mtt180 -75.71 124.37 27.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.254 0.55 . . . . 0.47 110.532 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.0 m -112.76 -9.24 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.914 -1.039 . . . . 0.27 112.777 -168.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.8 pt20 -159.4 132.5 7.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.475 -0.33 . . . . 0.59 110.137 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.465 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 63.1 tt0 -140.85 118.58 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 1.34 110.644 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 3.0 tt0 -137.48 121.15 11.77 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.622 -0.717 . . . . 2.59 110.313 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 8.9 Cg_exo -71.23 -13.63 31.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.627 2.885 . . . . 0.5 113.274 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -161.5 105.58 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.048 0.928 . . . . 1.37 111.784 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.558 ' HB3' HG23 ' A' ' 68' ' ' VAL . 25.7 tp -114.88 109.97 18.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.443 -1.708 . . . . 0.38 109.344 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.7 p -104.67 131.38 53.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.68 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 46.1 p90 -150.98 158.67 44.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.568 -0.287 . . . . 0.23 111.111 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 m -77.07 109.48 10.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.42 110.181 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.814 HD11 ' HD3' ' A' ' 104' ' ' PRO . 17.7 tp -62.05 133.96 55.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.6 110.541 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 83.93 3.59 89.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.788 -0.72 . . . . 0.37 112.527 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -106.37 -2.68 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.42 . . . . 0.93 110.021 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.3 m 59.46 35.91 22.98 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.775 -0.824 . . . . 0.62 108.775 -172.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -73.96 -2.86 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.26 1.028 . . . . 1.33 108.48 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.465 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 5.8 m -139.87 -153.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 113.767 -1.56 . . . . 0.23 109.726 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.2 pt -82.94 138.04 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.265 -1.383 . . . . 0.29 107.265 172.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.52 HE21 ' HB3' ' A' ' 100' ' ' ASP . 9.3 tp60 -57.65 -31.04 65.91 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.568 -0.287 . . . . 0.4 111.071 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.63 -48.19 69.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.2 110.863 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 68' ' ' VAL . 46.9 tp -72.92 -38.11 66.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.367 -0.833 . . . . 0.22 110.468 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.52 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.2 t70 -61.6 -30.04 70.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.824 -1.08 . . . . 0.26 109.695 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 84.3 mt -89.92 -35.01 15.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.375 -0.83 . . . . 0.25 111.63 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.7 t -63.57 -36.2 83.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 1.01 111.321 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.532 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 46.6 t -62.61 -55.87 34.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 112.772 0.656 . . . . 0.21 112.772 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.814 ' HD3' HD11 ' A' ' 90' ' ' LEU . 25.7 Cg_endo -64.42 -19.57 65.45 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 121.887 1.725 . . . . 0.27 112.114 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 39' ' ' ILE . 12.8 mt -82.59 -13.62 56.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.016 -0.538 . . . . 0.64 111.297 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.654 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.7 ptm -107.32 154.41 21.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.088 -0.505 . . . . 0.78 110.72 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.71 152.75 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.97 110.494 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 58' ' ' SER . 2.1 p -63.16 126.6 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.052 0.93 . . . . 0.8 110.116 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.54 12.37 57.13 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.661 -1.154 . . . . 0.28 112.952 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.823 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.1 pt-20 -101.7 168.48 9.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.41 110.736 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.495 HG22 HD12 ' A' ' 50' ' ' LEU . 9.5 m -129.63 119.08 22.98 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.653 -1.24 . . . . 0.22 107.653 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.73 53.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.037 0.446 . . . . 0.18 111.018 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.9 ttm -97.96 116.71 30.73 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.32 107.216 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.2 t -113.91 128.75 70.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.985 -0.376 . . . . 0.18 109.985 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.594 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 62.7 m -104.67 113.73 27.5 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 108.187 -1.042 . . . . 0.21 108.187 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.63 141.92 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.01 -1.45 . . . . 0.15 108.749 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 6.6 t70 -57.76 156.37 8.8 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.223 -0.591 . . . . 0.58 109.578 174.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 135' ' ' HIS . 70.6 p -47.34 -43.4 22.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.996 -1.002 . . . . 0.82 110.739 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 14.4 ptpt -59.76 -28.97 67.85 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.907 -1.042 . . . . 0.81 112.042 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.592 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 91.6 m-85 -94.81 2.63 55.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.364 0.602 . . . . 0.42 109.856 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.792 ' HB3' HD22 ' A' ' 138' ' ' LEU . 91.1 m -122.78 -92.34 0.54 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.623 -1.172 . . . . 0.18 110.271 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.661 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 3.8 m-85 -147.37 37.66 0.93 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 119.019 -0.515 . . . . 0.24 111.85 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 118' ' ' SER . . . -52.73 -83.5 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.597 -0.811 . . . . 0.25 112.998 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 7.36 4.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.551 2.167 . . . . 0.58 111.692 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -104.22 -46.97 4.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.749 -0.66 . . . . 0.65 110.66 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.608 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 80.73 142.06 3.07 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.954 -1.021 . . . . 0.3 112.225 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.712 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.4 t -91.65 159.42 15.88 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.575 0.583 . . . . 0.33 112.575 -174.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 129' ' ' SER . 9.6 ptp180 -48.97 -53.98 17.51 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.48 -1.236 . . . . 3.17 112.259 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.957 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 3.5 m -82.4 -63.88 0.27 Allowed Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.895 -0.409 . . . . 1.23 109.895 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.957 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.1 Cg_endo -105.07 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.522 2.148 . . . . 0.37 112.262 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.608 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 26.1 t80 -55.57 97.45 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.674 -0.861 . . . . 1.14 108.674 163.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.595 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.3 mm -66.77 122.57 82.86 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.75 -0.659 . . . . 0.39 109.313 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 47.2 Cg_exo -56.02 137.74 80.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.261 1.974 . . . . 0.61 111.965 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.501 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 38.4 Cg_exo -56.35 130.2 38.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.387 2.058 . . . . 0.52 112.823 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.672 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 17.3 m80 74.39 23.82 1.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.577 -1.647 . . . . 2.38 112.878 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.51 116.01 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.29 -1.004 . . . . 0.26 108.29 166.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.61 132.5 43.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.99 0.424 . . . . 0.22 110.039 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -104.05 132.37 50.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.918 -0.583 . . . . 0.22 111.773 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.2 t -116.63 100.45 7.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.061 -0.718 . . . . 1.2 109.061 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.6 pp -112.57 137.13 51.25 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.771 -0.65 . . . . 0.32 111.579 -171.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.547 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 41.2 tt0 -106.8 116.2 31.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.891 -0.781 . . . . 1.05 108.891 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 99' ' ' LEU . 4.6 m -117.12 120.91 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.724 0.638 . . . . 0.19 112.724 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 m -88.75 108.85 19.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.082 -0.963 . . . . 0.28 110.737 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.654 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 55.7 tp -81.71 94.74 7.05 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.68 -0.859 . . . . 0.15 108.68 172.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.9 mtmt -89.33 -25.1 21.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.141 -0.936 . . . . 1.08 110.821 -171.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.446 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 22.0 m -160.84 148.12 15.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.664 0.269 . . . . 0.37 111.174 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -124.43 127.96 48.31 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.193 -0.669 . . . . 0.25 109.193 168.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.92 109.619 -178.032 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.584 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.805 0.336 . . . . 0.53 110.625 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.05 118.26 12.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.585 -0.734 . . . . 0.5 110.415 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.64 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.4 t70 -80.98 129.4 34.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.324 0.583 . . . . 2.51 110.379 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.606 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.1 mt -65.51 -24.91 35.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.801 -1.091 . . . . 0.46 111.088 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.66 0.7 10.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.55 . . . . 0.72 110.47 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.25 22.37 65.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.436 -0.802 . . . . 0.52 112.306 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.07 -28.24 15.83 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.137 0.421 . . . . 0.95 112.137 -176.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 108.58 -1.01 32.41 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.818 -0.706 . . . . 0.72 112.065 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.51 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 mp -105.42 -31.58 8.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.051 0.453 . . . . 1.56 111.215 -176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 16.5 tp -122.31 101.33 7.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.4 -0.818 . . . . 0.32 111.471 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HG2' ' CA ' ' A' ' 38' ' ' ASP . 67.5 mtm180 -133.42 141.01 47.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.356 0.502 . . . . 1.14 112.356 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' HG3' HG22 ' A' ' 114' ' ' VAL . 11.4 ttpt -114.28 126.09 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.35 110.654 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.6 ttpt -112.03 128.56 56.22 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 121.062 -0.255 . . . . 1.07 110.894 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 p -83.94 103.89 13.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.223 -0.444 . . . . 0.33 110.711 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 111' ' ' THR . 8.0 mt -65.26 -52.94 51.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.832 -1.544 . . . . 0.28 106.832 170.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.815 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 86.6 t -131.93 131.99 22.92 Favored Pre-proline 0 CA--C 1.501 -0.912 0 CA-C-N 113.28 -1.782 . . . . 0.36 106.242 167.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.7 Cg_endo -104.61 53.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.935 2.423 . . . . 0.54 113.023 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 CA-C-N 114.957 -1.02 . . . . 0.55 112.807 178.269 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 121.543 0.687 . . . . 0.99 111.901 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.746 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 50.5 m -116.59 133.61 55.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.32 -0.855 . . . . 1.28 108.896 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 86.2 mtt180 -99.46 113.6 65.0 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-O 120.931 0.396 . . . . 2.81 110.481 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.658 ' HG3' HD21 ' A' ' 144' ' ' LEU . 10.9 Cg_endo -53.77 145.78 48.34 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.43 2.754 . . . . 0.3 113.382 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 17.6 t -97.19 152.68 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.88 109.396 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.976 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 89.1 mttt -71.34 120.84 17.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.454 0.645 . . . . 1.17 109.762 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.48 -26.97 4.27 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.872 -1.291 . . . . 0.42 109.872 -172.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.657 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.06 139.73 30.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.455 -0.943 . . . . 0.59 108.455 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.9 m -86.17 128.91 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 108.075 -1.083 . . . . 1.22 108.075 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -124.91 146.46 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.175 -0.92 . . . . 0.25 110.778 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.478 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 37.1 p -95.38 113.02 24.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.099 -0.501 . . . . 0.29 110.572 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.682 HG21 HD21 ' A' ' 99' ' ' LEU . 30.3 m -110.65 143.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.037 -0.665 . . . . 0.19 109.846 173.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.52 116.29 32.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.701 -1.592 . . . . 0.19 106.701 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.71 137.94 52.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.079 -1.049 . . . . 0.39 111.024 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.74 114.56 14.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.788 -1.93 . . . . 0.27 105.788 165.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.628 HG23 ' HB3' ' A' ' 140' ' ' LEU . 75.3 m -102.36 126.43 49.38 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.529 -1.214 . . . . 0.19 111.414 -166.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 13.1 t -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.464 -0.789 . . . . 1.06 109.498 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.3 mt -82.32 164.89 20.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.368 -0.833 . . . . 0.84 109.863 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.69 -24.82 36.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.391 0.615 . . . . 1.14 110.443 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -80.42 -12.81 59.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.344 -0.844 . . . . 2.14 111.204 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.58 17.69 30.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.714 -0.755 . . . . 0.51 112.039 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 m -102.55 110.05 21.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.581 0.229 . . . . 0.46 111.525 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.2 mtt180 -74.87 115.41 14.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.523 0.678 . . . . 0.47 110.083 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.659 ' HB ' ' CG ' ' A' ' 130' ' ' PRO . 27.0 m -99.51 -11.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.017 -0.992 . . . . 0.27 111.989 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.618 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.6 pt20 -159.48 136.1 9.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.05 -0.523 . . . . 0.59 110.144 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 38.0 tt0 -133.43 123.94 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.999 0.428 . . . . 1.34 109.849 173.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -136.96 116.85 10.62 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.344 -0.844 . . . . 2.59 109.71 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.418 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 61.2 Cg_endo -72.09 -14.49 28.96 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.118 2.546 . . . . 0.5 113.105 -170.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 22.7 tt0 -164.94 110.83 0.95 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.181 0.991 . . . . 1.37 111.029 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.09 103.25 8.88 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.179 -1.828 . . . . 0.38 108.877 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.0 p -97.52 125.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.834 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.817 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 43.3 p90 -147.19 159.58 43.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 0.23 110.952 -172.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 2.8 m -80.62 110.0 15.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.864 -0.607 . . . . 0.42 110.176 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.976 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 13.8 tp -58.06 134.49 56.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.6 110.955 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 74.47 11.54 82.54 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 121.043 -0.598 . . . . 0.37 112.375 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 27.0 t70 -112.58 8.56 19.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.192 -0.67 . . . . 0.93 109.192 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 55.0 m 55.83 33.69 22.03 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.938 -1.028 . . . . 0.62 109.877 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.817 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 2.4 t0 -68.63 -14.6 63.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.393 1.092 . . . . 1.33 108.693 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -133.96 -156.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.799 -1.546 . . . . 0.23 110.539 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.5 pt -82.87 139.68 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.722 -1.214 . . . . 0.29 107.722 175.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.524 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.4 tp60 -58.23 -30.53 66.58 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.244 -0.182 . . . . 0.4 110.955 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -54.5 -45.31 73.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.385 0.612 . . . . 0.2 110.495 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 68' ' ' VAL . 59.4 tp -77.88 -38.77 45.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.323 -0.853 . . . . 0.22 110.665 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.68 -28.52 69.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.108 -0.951 . . . . 0.26 109.585 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 77.5 mt -90.47 -34.95 15.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.199 -0.91 . . . . 0.25 111.883 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.4 t -64.17 -35.43 80.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 1.01 111.287 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.565 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.6 t -63.32 -55.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.633 0.605 . . . . 0.21 112.633 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.845 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.7 Cg_endo -63.16 -22.05 72.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.814 1.676 . . . . 0.27 111.839 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 39' ' ' ILE . 9.5 mt -81.68 -13.1 58.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.64 111.271 173.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.671 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -106.42 157.19 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.959 -0.564 . . . . 0.78 110.828 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.0 m-20 -96.37 153.56 17.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.97 110.187 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.746 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -64.05 129.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.667 0.746 . . . . 0.8 110.728 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.66 7.47 61.57 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.536 -1.211 . . . . 0.28 112.348 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.815 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.3 pt-20 -97.45 166.61 11.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.517 0.675 . . . . 0.41 111.546 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.419 HG22 HD12 ' A' ' 50' ' ' LEU . 13.0 m -127.59 117.66 22.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.823 -1.177 . . . . 0.22 107.823 172.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.24 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.944 0.402 . . . . 0.18 110.331 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.6 ttp -101.8 117.79 35.58 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.561 -1.274 . . . . 1.32 107.561 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.517 HG22 ' HG3' ' A' ' 47' ' ' LYS . 10.5 t -112.67 135.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.296 -0.411 . . . . 0.18 109.989 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 50.6 m -114.57 112.66 23.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.37 -0.974 . . . . 0.21 108.37 171.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.16 136.56 53.72 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.399 -1.728 . . . . 0.15 109.688 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.689 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 11.1 t70 -53.05 149.5 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.112 -0.699 . . . . 0.58 109.112 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.6 t -56.13 -28.06 56.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.191 0.52 . . . . 0.82 110.385 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.627 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.2 ptpt -55.33 -29.95 59.29 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 121.945 -0.472 . . . . 0.81 111.498 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 72.6 m-85 -95.11 0.17 54.05 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.243 0.544 . . . . 0.42 110.271 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.66 ' HB3' HD22 ' A' ' 138' ' ' LEU . 61.8 m -122.56 -89.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.988 -1.005 . . . . 0.18 110.581 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.8 m-85 -143.88 40.67 1.4 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.004 0.372 . . . . 0.24 112.004 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.04 -82.9 0.04 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 0.25 113.965 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.97 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.536 2.158 . . . . 0.58 111.003 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -104.83 -51.5 3.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.376 -0.829 . . . . 0.65 109.721 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.618 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.05 141.74 3.14 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.401 -1.272 . . . . 0.3 112.151 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.2 t -91.67 152.32 20.27 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.229 0.538 . . . . 0.33 111.961 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -46.65 -48.32 20.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.464 -1.244 . . . . 3.17 113.428 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 1.044 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 47.2 m -81.54 -65.95 0.24 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.124 -0.63 . . . . 1.23 109.896 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.044 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -107.01 127.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.295 1.997 . . . . 0.37 112.043 172.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -55.95 97.97 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.916 -1.142 . . . . 1.14 107.916 164.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.599 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -66.5 126.49 92.26 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.678 -0.692 . . . . 0.39 109.532 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.78 145.29 31.8 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.734 2.289 . . . . 0.61 112.189 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.608 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.7 Cg_endo -63.94 133.23 37.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.059 1.839 . . . . 0.52 111.817 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.689 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 32.3 m170 71.77 8.3 6.07 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.018 -0.992 . . . . 2.38 112.16 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -69.96 122.11 18.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.737 -0.838 . . . . 0.26 108.737 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.58 112.78 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 0.22 110.24 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -89.63 131.84 35.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.192 -0.913 . . . . 0.22 110.285 -177.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 23.7 t -121.3 101.19 7.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.853 0.835 . . . . 1.2 109.155 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -113.08 137.4 51.49 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.611 -1.177 . . . . 0.32 111.61 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.521 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 42.4 tt0 -101.71 115.69 31.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.489 -0.778 . . . . 1.05 109.227 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -117.08 121.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.667 0.617 . . . . 0.19 112.667 -175.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.8 m -92.75 109.02 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.243 -0.889 . . . . 0.28 110.249 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 60' ' ' PRO . 64.3 tp -81.85 98.63 8.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.493 -0.929 . . . . 0.15 108.493 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -94.71 -27.86 15.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.33 -0.85 . . . . 1.08 110.775 -170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.478 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 7.8 m -153.39 151.74 30.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.292 -0.413 . . . . 0.37 111.458 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.58 128.5 27.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.565 -0.743 . . . . 0.25 109.061 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.515 -0.39 0 CA-C-O 121.232 0.539 . . . . 0.92 110.365 -178.588 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.649 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.564 0.697 . . . . 0.53 112.138 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.7 125.02 28.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.706 -1.134 . . . . 0.5 111.233 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.629 ' HB3' ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -77.17 123.55 26.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.131 -0.486 . . . . 2.51 111.113 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.63 HD12 HD11 ' A' ' 45' ' ' LEU . 6.9 mt -62.54 -41.28 91.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.46 110.959 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD21 HD13 ' A' ' 101' ' ' LEU . 89.1 mt -113.21 0.68 14.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.75 0.309 . . . . 0.72 111.424 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 38' ' ' ASP . . . 68.65 24.15 75.38 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.4 -0.68 . . . . 0.52 111.4 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.549 HD22 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -97.46 -24.74 15.46 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.95 113.243 -177.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.549 ' N ' HD22 ' A' ' 42' ' ' ASN . . . 102.32 -19.28 48.99 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 121.308 -0.472 . . . . 0.72 112.372 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 2.8 mm? -90.12 -28.86 18.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.839 0.352 . . . . 1.56 110.491 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 39' ' ' ILE . 20.9 tp -122.86 109.29 13.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.32 111.865 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 71.2 mtm180 -139.38 140.46 37.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.987 0.366 . . . . 1.14 111.987 -173.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -113.23 123.44 50.18 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.985 0.514 . . . . 0.35 110.137 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.2 ttpt -109.77 113.64 26.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 1.07 110.708 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 p -74.07 100.66 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.347 -0.388 . . . . 0.33 111.328 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 111' ' ' THR . 7.8 mt -65.8 -49.55 67.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.427 -1.323 . . . . 0.28 107.427 172.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.806 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.7 t -136.61 126.32 15.84 Favored Pre-proline 0 CA--C 1.505 -0.772 0 CA-C-N 113.007 -1.906 . . . . 0.36 106.712 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 19.5 Cg_endo -104.35 61.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.108 2.539 . . . . 0.54 113.846 -177.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-N 115.546 -0.752 . . . . 0.55 113.634 177.001 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.99 111.352 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.1 t -152.15 136.85 17.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.065 -1.087 . . . . 1.28 108.065 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 10.4 ptp180 -91.68 113.48 58.87 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.528 -0.469 . . . . 2.81 110.39 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD3' HG23 ' A' ' 108' ' ' VAL . 4.9 Cg_endo -47.47 142.21 13.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.985 3.123 . . . . 0.3 113.653 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.715 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 16.9 t -92.05 156.86 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.386 -0.824 . . . . 0.88 109.645 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -63.53 111.92 2.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.132 0.491 . . . . 1.17 110.199 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.05 -33.44 2.31 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 114.827 -1.079 . . . . 0.42 110.491 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -74.56 139.19 43.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.904 -0.776 . . . . 0.59 108.904 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 2.7 m -89.25 131.33 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.696 -1.224 . . . . 1.22 107.696 174.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.0 m -129.18 149.42 33.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.609 -0.723 . . . . 0.25 110.718 -171.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 24.7 p -98.68 113.01 24.91 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.82 -0.627 . . . . 0.29 110.041 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.676 HG21 HD21 ' A' ' 99' ' ' LEU . 19.2 m -110.63 144.28 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 119.988 -0.685 . . . . 0.19 110.214 173.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.572 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.45 117.14 34.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.203 -1.406 . . . . 0.19 107.203 170.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -121.17 134.83 55.23 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.384 -0.926 . . . . 0.39 110.62 177.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.587 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -126.95 114.07 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.241 -2.133 . . . . 0.27 105.241 167.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 140' ' ' LEU . 59.0 m -106.13 123.59 48.25 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.317 -1.311 . . . . 0.19 111.057 -164.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.958 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.9 OUTLIER -104.81 170.99 7.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.821 -0.627 . . . . 1.06 109.448 -178.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt -97.12 165.4 12.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.433 -0.803 . . . . 0.84 109.249 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 12.7 pt-20 -59.26 -16.76 23.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.832 0.348 . . . . 1.14 110.715 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -94.98 -14.7 24.15 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.364 -0.38 . . . . 2.14 110.92 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.38 -24.44 6.91 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.544 -0.836 . . . . 0.51 113.933 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.4 m -67.54 114.97 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.81 0.67 . . . . 0.46 112.81 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.89 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.6 mtt180 -77.98 118.52 20.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.608 0.718 . . . . 0.47 110.499 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.776 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.3 m -96.58 -9.08 9.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.613 -1.176 . . . . 0.27 112.06 -170.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.595 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.7 pt20 -164.92 129.07 2.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.42 -0.355 . . . . 0.59 110.891 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -122.38 109.61 14.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.382 -0.599 . . . . 1.34 109.382 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.25 113.75 25.99 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.59 -0.732 . . . . 2.59 110.363 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 56.6 Cg_endo -71.26 -16.05 31.52 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.307 2.671 . . . . 0.5 113.491 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -163.05 108.76 1.13 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.206 1.003 . . . . 1.37 112.088 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 tp -118.49 105.98 12.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.086 -1.87 . . . . 0.38 108.728 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -100.11 130.78 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.214 -0.448 . . . . 1.0 109.842 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.667 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 31.4 p90 -151.74 157.78 42.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.691 0.281 . . . . 0.23 110.582 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.8 m -76.98 114.29 15.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.752 -0.658 . . . . 0.42 109.711 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.903 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.7 tp -58.96 127.63 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.6 111.376 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.81 4.22 90.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.997 -0.62 . . . . 0.37 112.344 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -89.72 -4.71 57.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.176 -1.046 . . . . 0.93 108.176 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 19.5 m 56.95 32.88 22.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.57 -1.196 . . . . 0.62 109.92 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.61 -21.37 64.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.167 0.984 . . . . 1.33 108.955 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 m -113.67 -158.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.714 -1.585 . . . . 0.23 110.859 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 99' ' ' LEU . 32.6 pt -78.44 137.25 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.317 -1.364 . . . . 0.29 107.317 173.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -57.57 -30.35 65.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.471 -0.331 . . . . 0.4 110.781 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.8 -46.83 81.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.2 110.788 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 68' ' ' VAL . 48.5 tp -71.26 -40.3 71.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.22 110.728 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.07 -30.34 70.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.801 -1.09 . . . . 0.26 109.977 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 40' ' ' LEU . 82.2 mt -91.44 -33.36 15.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.353 -0.839 . . . . 0.25 112.472 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.8 t -65.64 -32.11 73.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 1.01 111.119 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.667 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 57.9 t -66.38 -52.83 34.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.767 0.654 . . . . 0.21 112.767 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -62.81 -19.98 70.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.634 1.556 . . . . 0.27 112.113 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.518 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.9 mt -83.18 -16.14 47.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.476 0.655 . . . . 0.64 111.109 170.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.797 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 28.3 ttm -96.16 141.5 29.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.744 -1.116 . . . . 0.78 111.572 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.92 151.08 19.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.914 -0.402 . . . . 0.97 109.914 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.654 HG23 ' HD3' ' A' ' 60' ' ' PRO . 3.7 t -59.73 124.3 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.8 110.639 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.28 14.12 46.13 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.481 -0.782 . . . . 0.28 112.787 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.806 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -104.31 168.23 9.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.615 0.708 . . . . 0.41 110.574 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.443 HG22 HD12 ' A' ' 50' ' ' LEU . 17.9 m -133.65 117.97 17.62 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.923 -1.14 . . . . 0.22 107.923 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.08 140.98 52.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.181 0.515 . . . . 0.18 110.805 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.423 ' HG2' ' CH2' ' A' ' 36' ' ' TRP . 16.9 ttt -98.12 117.88 33.49 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.297 -1.372 . . . . 1.32 107.297 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.8 130.46 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.566 -0.531 . . . . 0.18 109.566 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 99.3 m -108.3 114.45 28.33 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.652 -0.819 . . . . 0.21 109.023 173.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -124.61 134.17 53.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.017 -1.447 . . . . 0.15 110.063 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.749 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 9.6 t70 -52.31 147.5 7.81 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.58 108.682 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.663 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.4 t -57.98 -25.68 61.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.232 0.539 . . . . 0.82 110.138 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.624 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 4.2 ptpp? -55.32 -29.79 58.95 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.111 -0.368 . . . . 0.81 111.29 173.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.56 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 97.3 m-85 -98.51 3.0 48.13 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.219 0.533 . . . . 0.42 110.268 175.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.0 m -123.63 -91.59 0.54 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.148 -0.933 . . . . 0.18 110.701 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 12.3 m-85 -141.91 42.83 1.7 Allowed 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 112.15 0.426 . . . . 0.24 112.15 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.58 -86.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.163 -0.542 . . . . 0.25 113.572 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.26 11.92 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.536 2.158 . . . . 0.58 111.09 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.4 mt-30 -103.2 -46.75 4.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.6 -0.727 . . . . 0.65 109.968 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.559 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.95 144.28 2.22 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.693 -1.139 . . . . 0.3 112.188 -175.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.649 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.9 t -91.16 158.74 16.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.229 -0.486 . . . . 0.33 112.09 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -47.05 -55.49 8.17 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.811 -1.086 . . . . 3.17 111.943 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.915 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 22.9 t -80.92 -62.95 0.34 Allowed Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.534 -0.466 . . . . 1.23 110.158 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.915 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.7 Cg_endo -106.08 127.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.348 2.032 . . . . 0.37 112.11 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.559 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 49.2 t80 -55.91 98.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.346 -0.983 . . . . 1.14 108.346 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.612 HG12 ' CB ' ' A' ' 127' ' ' SER . 32.3 mm -66.49 128.24 93.75 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.668 -0.697 . . . . 0.39 109.917 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.7 Cg_endo -54.59 139.29 75.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.572 2.181 . . . . 0.61 112.144 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.527 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 72.2 Cg_exo -52.54 129.06 30.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.815 2.343 . . . . 0.52 112.918 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.633 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 66.3 m170 70.11 15.54 7.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.992 -1.004 . . . . 2.38 112.508 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.92 123.79 26.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.87 -0.789 . . . . 0.26 108.87 170.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -74.11 115.96 14.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.328 0.585 . . . . 0.22 110.308 -173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.654 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.95 136.21 33.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.007 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.958 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 30.7 p -119.54 98.56 6.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.037 0.922 . . . . 1.2 110.026 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -110.41 134.69 52.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.004 -0.998 . . . . 0.32 111.647 -173.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.587 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 46.4 tt0 -100.78 111.73 24.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.799 . . . . 1.05 109.084 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.621 HG11 HD13 ' A' ' 99' ' ' LEU . 1.3 m -112.17 117.05 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.516 0.674 . . . . 0.19 112.716 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.0 m -89.91 114.03 25.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.945 -1.025 . . . . 0.28 110.573 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.741 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.8 tp -85.82 96.07 9.63 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.962 -0.755 . . . . 0.15 108.962 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.5 mtmt -91.85 -30.49 16.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.55 -0.75 . . . . 1.08 110.8 -171.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.508 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 19.1 m -151.93 148.07 27.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.484 -0.326 . . . . 0.37 111.167 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.92 128.79 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.244 -0.65 . . . . 0.25 109.244 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 CA--C 1.514 -0.435 0 C-N-CA 119.568 -0.853 . . . . 0.92 111.677 -178.0 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.548 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.3 m0 . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.392 0.615 . . . . 0.53 110.634 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.6 tp -83.49 115.22 21.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.5 110.136 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.617 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -78.68 121.97 25.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.187 -0.671 . . . . 2.51 109.187 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.643 HG23 HD11 ' A' ' 105' ' ' LEU . 13.5 mt -60.18 -35.91 64.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.188 -0.915 . . . . 0.46 110.552 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 74.3 mt -102.54 -3.42 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.72 110.565 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.05 27.9 65.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.52 111.718 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.604 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -111.66 -23.22 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.012 0.745 . . . . 0.95 113.012 -175.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 109.24 30.73 3.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.95 -1.119 . . . . 0.72 114.377 168.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -151.77 -9.26 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.985 0.392 . . . . 1.56 110.784 175.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.607 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 3.2 tp -119.5 99.47 6.69 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.32 109.975 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 62.0 mtm180 -139.14 136.58 35.28 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.014 -0.675 . . . . 1.14 112.065 -171.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 11.2 ttpt -112.52 124.52 52.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.217 -0.447 . . . . 0.35 110.361 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 28.9 ttpp -112.88 117.46 32.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.87 0.367 . . . . 1.07 110.524 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.9 p -73.62 106.45 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.275 -0.421 . . . . 0.33 111.285 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 141' ' ' GLU . 12.0 mt -68.66 -52.13 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.798 -1.556 . . . . 0.28 106.798 170.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.873 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 93.0 t -131.37 135.42 27.02 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 113.143 -1.844 . . . . 0.36 106.071 168.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 40.3 Cg_endo -108.77 54.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.946 2.431 . . . . 0.54 113.834 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.601 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 115.853 -0.612 . . . . 0.55 113.319 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 9.3 p . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 121.507 0.67 . . . . 0.99 111.439 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.631 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 23.0 t -159.09 130.67 6.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.936 -1.135 . . . . 1.28 107.936 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 83.8 mtt180 -90.44 112.85 55.17 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 120.918 -0.313 . . . . 2.81 110.313 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HG3' HD21 ' A' ' 144' ' ' LEU . 6.2 Cg_endo -47.3 152.99 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.831 3.021 . . . . 0.3 114.142 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 11.4 t -102.67 151.56 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.211 -0.904 . . . . 0.88 109.774 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 62.7 mttt -64.24 108.78 1.67 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.02 0.914 . . . . 1.17 110.792 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.3 -31.5 2.34 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.772 -1.558 . . . . 0.42 110.125 -174.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.672 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -71.89 140.19 49.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.21 0.529 . . . . 0.59 109.89 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 148' ' ' VAL . 65.4 t -84.68 119.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.598 -0.89 . . . . 1.22 108.598 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.2 m -124.54 147.97 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.11 0.411 . . . . 0.25 112.11 -170.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 30.0 p -102.26 116.52 32.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.923 -0.58 . . . . 0.29 110.39 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.753 HG21 HD21 ' A' ' 99' ' ' LEU . 17.1 m -111.18 144.94 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.111 0.481 . . . . 0.19 110.06 172.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.9 t-160 -102.11 120.38 40.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.909 -1.515 . . . . 0.19 106.909 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.548 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.9 OUTLIER -125.36 135.11 52.1 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 119.426 -0.91 . . . . 0.39 110.474 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.928 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -127.52 114.97 18.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.902 -1.888 . . . . 0.27 105.902 169.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.626 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 22.8 m -110.63 122.38 47.65 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.409 -1.268 . . . . 0.19 111.53 -165.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.967 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.7 OUTLIER -104.65 171.16 7.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.317 -0.856 . . . . 1.06 108.851 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 80' ' ' VAL . 11.4 mt -97.53 167.46 10.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.537 -0.756 . . . . 0.84 109.936 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.62 -17.64 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.313 0.383 . . . . 1.14 111.236 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.32 -14.64 20.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.674 0.273 . . . . 2.14 110.921 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.08 7.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.637 -0.792 . . . . 0.51 113.651 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 m -63.26 112.06 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.228 0.455 . . . . 0.46 112.228 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.9 mtt180 -74.28 118.23 17.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.847 0.832 . . . . 0.47 110.571 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.928 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.1 m -96.68 -9.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.452 -1.249 . . . . 0.27 110.928 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.626 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.1 pt20 -166.55 146.76 5.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.606 -0.724 . . . . 0.59 109.753 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 71' ' ' GLN . 15.2 tt0 -150.96 103.29 3.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.173 -1.047 . . . . 1.34 108.173 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 4.7 mm-40 -126.72 113.81 22.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.541 -0.754 . . . . 2.59 110.308 -170.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 37.7 Cg_endo -65.7 -12.32 34.64 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.014 2.476 . . . . 0.5 112.982 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -151.94 112.02 4.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.366 0.603 . . . . 1.37 110.724 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.428 ' HB3' HG23 ' A' ' 68' ' ' VAL . 50.8 tp -130.11 106.99 8.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.835 -1.075 . . . . 0.38 108.287 172.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.9 p -108.36 138.08 36.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.825 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 30.1 p90 -160.97 166.54 28.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.23 110.868 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.1 m -86.0 115.07 23.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 0.42 109.633 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.85 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.4 tp -60.54 126.64 28.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.6 110.396 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 91.18 6.66 66.42 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.691 -0.766 . . . . 0.37 112.976 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.11 -8.62 21.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.93 109.978 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.7 m 58.15 36.9 26.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.62 109.342 -172.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 22.1 t70 -70.75 -17.61 62.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.538 1.161 . . . . 1.33 108.044 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.7 m -119.19 -154.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.323 -1.762 . . . . 0.23 110.353 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.8 pt -83.0 138.81 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.647 -1.242 . . . . 0.29 107.647 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 6.5 tp60 -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.904 -0.318 . . . . 0.4 110.898 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.14 -42.25 72.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.2 110.627 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.753 HD21 HG21 ' A' ' 68' ' ' VAL . 56.5 tp -75.72 -40.78 55.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.729 -0.668 . . . . 0.22 110.551 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.9 t70 -61.14 -28.53 69.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.046 -0.979 . . . . 0.26 109.883 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 76.1 mt -90.13 -36.59 14.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.006 -0.997 . . . . 0.25 111.893 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.1 t -67.96 -28.18 67.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.751 -0.204 . . . . 1.01 111.275 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.571 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 55.0 t -65.87 -55.8 20.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.401 0.519 . . . . 0.21 112.401 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.85 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.1 Cg_endo -63.43 -18.77 66.07 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 121.998 1.799 . . . . 0.27 111.906 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 39' ' ' ILE . 13.1 mt -84.32 -14.21 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.64 111.239 173.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.811 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 1.1 ttp -105.84 141.15 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.239 -0.437 . . . . 0.78 110.934 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 m-20 -79.01 152.48 30.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.867 0.365 . . . . 0.97 110.067 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -65.58 126.29 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.653 0.74 . . . . 0.8 109.789 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.81 10.71 56.23 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.117 -0.947 . . . . 0.28 112.143 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.873 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.38 170.36 7.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.357 0.599 . . . . 0.41 110.58 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.3 m -133.19 119.25 19.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.473 -0.936 . . . . 0.22 108.473 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.436 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -117.1 139.65 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.817 -0.629 . . . . 0.18 110.663 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.5 ttt -97.8 117.09 31.34 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.654 -1.239 . . . . 1.32 107.654 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.64 130.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.833 -0.622 . . . . 0.18 109.359 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 91.8 m -107.16 114.09 27.93 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.38 -0.97 . . . . 0.21 108.38 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -123.12 135.43 54.36 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.0 -1.455 . . . . 0.15 109.651 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.1 t70 -55.71 148.86 15.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.767 -0.827 . . . . 0.58 108.767 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -57.5 -27.21 62.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.376 0.608 . . . . 0.82 110.132 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 18.6 ptpt -55.26 -31.78 61.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.242 -0.435 . . . . 0.81 111.167 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.638 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 95.9 m-85 -100.84 10.77 40.72 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.42 109.902 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.675 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 71.0 m -125.92 -93.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.18 110.521 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.556 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 6.8 m-85 -141.45 41.82 1.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.369 -0.532 . . . . 0.24 112.076 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.72 -84.81 0.03 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.143 -0.551 . . . . 0.25 113.67 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.67 8.49 4.22 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.551 2.167 . . . . 0.58 111.088 175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.6 mt-30 -104.13 -47.15 4.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.65 110.216 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.76 144.18 2.12 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.873 -1.058 . . . . 0.3 112.094 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 10.9 t -91.61 157.63 16.88 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.294 -0.453 . . . . 0.33 111.461 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.508 ' NH2' ' HG3' ' A' ' 83' ' ' GLU . 21.0 ptt180 -57.0 -43.1 81.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.613 -0.721 . . . . 3.17 112.102 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.629 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -80.38 -68.87 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.333 -0.547 . . . . 1.23 110.354 175.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.928 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -106.3 129.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.857 2.371 . . . . 0.37 112.145 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 33.6 t80 -55.17 99.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.135 -1.061 . . . . 1.14 108.135 163.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.1 mm -65.92 131.79 94.62 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 115.953 -0.567 . . . . 0.39 110.285 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.61 138.46 40.12 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.845 2.363 . . . . 0.61 111.908 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.743 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.9 Cg_endo -64.53 135.75 47.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.175 1.917 . . . . 0.52 112.125 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.557 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 48.6 m-70 71.71 5.66 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.239 -0.891 . . . . 2.38 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.02 125.63 28.08 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.595 -0.521 . . . . 0.26 109.595 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.93 113.72 11.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.393 -0.523 . . . . 0.22 110.181 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.626 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.23 133.0 34.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.515 -0.766 . . . . 0.22 111.07 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.967 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 31.6 p -116.93 100.01 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.371 1.081 . . . . 1.2 110.05 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.59 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.4 OUTLIER -115.17 137.71 51.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.886 -1.052 . . . . 0.32 111.632 -172.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.928 ' HB3' HE22 ' A' ' 71' ' ' GLN . 26.4 tt0 -103.36 114.58 28.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.05 108.305 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 99' ' ' LEU . 2.5 m -111.79 119.48 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.421 0.629 . . . . 0.19 112.2 -174.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 6.3 m -95.11 113.02 24.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.271 -0.877 . . . . 0.28 110.156 174.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.589 HD21 ' HG3' ' A' ' 60' ' ' PRO . 60.4 tp -84.33 98.75 10.19 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.859 -0.793 . . . . 0.15 108.859 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.7 mtmt -97.75 -26.12 14.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.159 -0.928 . . . . 1.08 111.253 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.503 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 23.9 m -153.63 150.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.901 0.381 . . . . 0.37 111.773 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -143.78 128.3 18.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.659 -0.701 . . . . 0.25 109.406 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.1 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.92 110.344 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.593 ' NE1' ' HE2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.147 0.498 . . . . 0.53 110.76 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.02 111.39 5.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.084 -0.962 . . . . 0.5 110.551 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.655 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.1 t70 -73.18 125.55 27.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.367 -0.533 . . . . 2.51 110.083 173.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.652 HG23 HD11 ' A' ' 105' ' ' LEU . 7.7 mt -56.3 -32.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.808 -1.087 . . . . 0.46 111.656 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.32 -1.73 13.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.101 -0.499 . . . . 0.72 110.32 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.98 26.61 65.81 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.169 -0.772 . . . . 0.52 111.169 -172.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' HD23 ' A' ' 44' ' ' LEU . 1.1 p30 -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.366 -0.417 . . . . 0.95 110.583 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.478 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.8 -4.15 21.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.939 -0.648 . . . . 0.72 112.988 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 4.2 mm? -112.19 -27.41 8.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.869 0.322 . . . . 1.56 111.869 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.561 HD11 HD12 ' A' ' 39' ' ' ILE . 16.9 tp -120.62 100.66 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.3 -0.409 . . . . 0.32 110.74 -170.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 89.7 mtm180 -133.18 141.44 48.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.6 0.222 . . . . 1.14 111.6 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.0 ttpt -114.09 123.8 50.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.421 -0.354 . . . . 0.35 110.244 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 18.2 ttmt -103.58 118.96 37.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.983 -0.377 . . . . 1.07 109.983 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.441 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 1.3 p -76.02 96.74 3.86 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.989 -0.55 . . . . 0.33 110.5 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD12 HG22 ' A' ' 111' ' ' THR . 12.5 mt -63.66 -52.93 58.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.893 -1.521 . . . . 0.28 106.893 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.881 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 85.1 t -132.84 127.1 20.15 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-N 113.038 -1.892 . . . . 0.36 106.157 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HB3' ' CG2' ' A' ' 49' ' ' THR . 30.4 Cg_endo -106.66 56.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.956 2.437 . . . . 0.54 114.502 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.718 0 C-N-CA 121.118 -0.563 . . . . 0.55 113.201 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.435 -1.206 0 CA-C-O 121.292 0.568 . . . . 0.99 111.26 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -153.86 144.35 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.786 -0.82 . . . . 1.28 108.786 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.499 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 48.1 mtm180 -92.51 110.1 42.77 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.846 -0.428 . . . . 2.81 109.846 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.755 ' HD3' HG23 ' A' ' 108' ' ' VAL . 5.8 Cg_endo -47.36 141.21 14.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.353 2.702 . . . . 0.3 113.529 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.682 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.0 t -89.56 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.432 -0.804 . . . . 0.88 109.435 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.726 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 56.1 mttt -63.38 106.17 0.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.838 0.828 . . . . 1.17 110.85 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.89 -28.85 2.12 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.145 -1.388 . . . . 0.42 110.199 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -79.28 128.0 32.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.859 -0.793 . . . . 0.59 108.859 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.8 m -78.32 129.79 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.055 -1.091 . . . . 1.22 108.055 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.9 m -125.99 146.65 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.997 -0.547 . . . . 0.25 110.284 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.9 p -95.94 112.31 24.07 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.897 -0.592 . . . . 0.29 109.825 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.713 HG21 HD21 ' A' ' 99' ' ' LEU . 7.4 m -110.5 142.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.849 -0.614 . . . . 0.19 110.074 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -100.76 116.42 32.61 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.721 -1.585 . . . . 0.19 106.721 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 136.94 53.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.285 1.041 . . . . 0.39 111.336 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.08 113.3 12.6 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.003 -1.851 . . . . 0.27 106.003 165.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.617 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.1 m -101.37 127.18 48.12 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.743 -1.117 . . . . 0.19 111.29 -168.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 17.1 t -104.89 160.46 14.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.309 -0.86 . . . . 1.06 109.626 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.444 HD21 HG11 ' A' ' 80' ' ' VAL . 13.7 mt -89.64 166.06 13.85 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.521 -0.763 . . . . 0.84 109.795 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.26 -17.84 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.578 0.549 . . . . 1.14 110.743 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -92.61 -8.68 43.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.641 -0.709 . . . . 2.14 111.162 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.38 40.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.838 -0.696 . . . . 0.51 111.855 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 m -98.17 109.91 22.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.878 0.371 . . . . 0.46 111.469 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.7 mtt180 -76.04 116.42 16.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.47 110.539 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.765 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -101.98 -8.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.561 -1.2 . . . . 0.27 111.886 -168.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.617 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.2 pt20 -160.57 136.13 8.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.107 -0.497 . . . . 0.59 109.983 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -136.41 112.65 9.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.008 0.433 . . . . 1.34 110.283 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.0 115.51 15.41 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.436 0.636 . . . . 2.59 110.221 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 55.9 Cg_endo -71.05 -13.26 31.31 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.201 2.601 . . . . 0.5 113.637 -172.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -160.16 110.41 1.84 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.292 1.044 . . . . 1.37 111.571 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 68' ' ' VAL . 21.1 tp -119.62 100.59 7.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.126 -1.852 . . . . 0.38 108.756 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 10.7 p -95.73 132.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.0 p90 -153.47 158.43 41.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.612 -0.267 . . . . 0.23 110.445 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.493 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 5.6 m -79.04 113.65 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.05 -0.523 . . . . 0.42 109.788 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.827 HD11 ' HD3' ' A' ' 104' ' ' PRO . 16.4 tp -61.76 130.27 44.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.455 . . . . 0.6 109.921 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.726 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 83.51 6.35 87.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.37 111.947 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 32.3 t70 -100.12 -5.62 27.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.12 -0.696 . . . . 0.93 109.12 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.8 m 54.9 34.09 21.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.125 -0.943 . . . . 0.62 109.839 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.74 -9.13 58.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.445 1.117 . . . . 1.33 108.765 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.3 m -125.26 -159.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 113.531 -1.668 . . . . 0.23 110.711 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.5 pt -81.62 138.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.088 -1.449 . . . . 0.29 107.088 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.6 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.6 tp60 -60.74 -28.68 68.87 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.835 -0.346 . . . . 0.4 110.899 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.07 -37.32 69.14 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.079 0.466 . . . . 0.2 110.679 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 68' ' ' VAL . 52.7 tp -81.84 -40.65 22.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.637 . . . . 0.22 110.719 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.6 ' HB3' HE21 ' A' ' 97' ' ' GLN . 14.3 t70 -61.93 -27.91 69.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.434 -0.803 . . . . 0.26 109.886 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 66.3 mt -90.97 -36.54 14.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.335 -0.848 . . . . 0.25 112.355 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.542 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 p -72.03 -26.46 62.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.63 -0.428 . . . . 1.01 111.189 -173.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.513 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -64.6 -55.74 27.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.457 0.539 . . . . 0.21 112.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.827 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -61.09 -24.44 79.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.071 1.847 . . . . 0.27 112.007 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.652 HD11 HG23 ' A' ' 39' ' ' ILE . 17.0 mt -73.1 -30.84 63.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.152 -0.477 . . . . 0.64 111.155 172.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.82 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -92.07 152.72 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.78 111.425 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -90.52 151.89 21.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.002 0.43 . . . . 0.97 110.642 178.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.755 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.5 t -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.33 0.586 . . . . 0.8 110.337 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.63 43.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.362 -0.835 . . . . 0.28 112.548 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.881 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.4 168.18 9.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.407 0.622 . . . . 0.41 110.971 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 50' ' ' LEU . 20.9 m -130.63 117.44 19.51 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.175 -1.046 . . . . 0.22 108.175 174.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.35 138.27 53.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.032 0.444 . . . . 0.18 110.684 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.2 ttp -98.42 116.82 31.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.32 107.216 173.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.647 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.9 t -112.25 132.04 62.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.661 -0.496 . . . . 0.18 109.661 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.544 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 91.4 m -109.39 112.87 25.25 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.175 -1.046 . . . . 0.21 108.175 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.46 135.69 54.73 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.925 -1.489 . . . . 0.15 108.946 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.734 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.9 t70 -52.94 146.54 10.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.397 -0.964 . . . . 0.58 108.397 172.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.649 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.6 t -55.94 -26.07 46.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.071 0.463 . . . . 0.82 110.439 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.684 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.5 ptpt -54.87 -29.75 56.28 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.103 -0.373 . . . . 0.81 111.833 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.594 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.1 m-85 -97.15 2.31 50.95 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.42 109.989 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 64.6 m -122.72 -89.91 0.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.141 -0.936 . . . . 0.18 110.665 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.4 m-85 -141.29 41.08 1.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.103 -0.475 . . . . 0.24 112.176 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.94 -81.82 0.04 OUTLIER Glycine 0 C--N 1.343 0.943 0 N-CA-C 113.995 0.358 . . . . 0.25 113.995 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.98 15.46 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.525 2.15 . . . . 0.58 110.924 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.7 mt-30 -103.51 -48.63 3.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.65 110.071 -174.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.471 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.12 142.81 3.5 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 114.668 -1.151 . . . . 0.3 112.051 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 14.1 t -90.68 165.03 13.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.577 0.584 . . . . 0.33 112.577 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -62.36 -23.28 66.71 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 115.114 -0.948 . . . . 3.17 112.728 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 1.048 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 18.3 t -105.51 -66.54 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.005 -0.739 . . . . 1.23 109.005 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.048 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 5.4 Cg_endo -99.07 129.63 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.937 2.425 . . . . 0.37 111.922 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.471 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -56.25 98.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.615 -1.254 . . . . 1.14 107.615 158.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.668 HD13 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -65.22 130.44 94.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.317 -0.994 . . . . 0.39 108.317 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.26 147.71 34.93 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.642 2.228 . . . . 0.61 112.587 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.71 137.93 83.14 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.473 2.115 . . . . 0.52 113.105 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.734 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 10.9 p80 53.04 21.45 2.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.665 -1.152 . . . . 2.38 113.342 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.78 132.88 40.72 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.983 -0.747 . . . . 0.26 108.983 172.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.9 113.82 12.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.141 0.496 . . . . 0.22 110.635 -171.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -92.07 133.5 35.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.902 -0.59 . . . . 0.22 110.516 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.4 t -118.53 100.69 7.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.334 -0.617 . . . . 1.2 109.334 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.598 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -112.53 136.55 51.92 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.868 -0.606 . . . . 0.32 111.578 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.5 tt0 -105.0 114.49 28.72 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.481 -0.562 . . . . 1.05 109.481 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.665 HG11 HD13 ' A' ' 99' ' ' LEU . 3.6 m -115.76 119.87 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.013 0.745 . . . . 0.19 113.013 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 4.1 m -90.46 111.71 23.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.28 110.754 170.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.1 tp -84.1 93.87 8.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.6 -0.889 . . . . 0.15 108.6 172.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.1 mtmt -88.1 -33.94 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.095 -0.957 . . . . 1.08 110.547 -171.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.454 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.1 m -149.68 154.41 38.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.37 111.729 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 128.26 26.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.299 -0.63 . . . . 0.25 109.299 172.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 109.58 -0.526 . . . . 0.92 109.58 179.02 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.685 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.274 -0.639 . . . . 0.53 109.274 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.9 tp -73.31 110.61 7.73 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.5 109.672 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -75.24 124.59 27.33 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.003 -0.74 . . . . 2.51 109.003 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 45' ' ' LEU . 14.4 mt -58.86 -31.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.872 -1.058 . . . . 0.46 110.559 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.5 mt -116.13 -4.79 11.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.615 -0.72 . . . . 0.72 110.64 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.85 23.31 72.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.057 -0.817 . . . . 0.52 111.057 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.402 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -96.42 -15.57 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.482 0.549 . . . . 0.95 112.482 -174.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.47 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 114.39 -13.79 20.92 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.575 -0.821 . . . . 0.72 114.031 166.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -129.22 -2.21 5.06 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.057 0.762 . . . . 1.56 113.057 -173.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 39' ' ' ILE . 21.3 tp -122.34 100.25 6.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.008 -0.368 . . . . 0.32 110.008 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -136.09 139.32 42.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.308 0.484 . . . . 1.14 112.308 -170.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.8 ttpt -110.97 123.56 50.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.36 -0.382 . . . . 0.35 110.004 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.685 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -108.3 125.86 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.571 0.224 . . . . 1.07 110.603 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 p -81.93 103.1 11.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.159 0.504 . . . . 0.33 111.331 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 111' ' ' THR . 9.8 mt -69.47 -50.05 49.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.828 -1.545 . . . . 0.28 106.828 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.845 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.0 t -140.04 126.14 11.93 Favored Pre-proline 0 CA--C 1.501 -0.907 0 CA-C-N 112.891 -1.959 . . . . 0.36 106.688 170.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.4 Cg_endo -105.79 59.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.945 2.43 . . . . 0.54 113.27 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.931 -0.577 . . . . 0.55 112.762 178.147 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.832 -0.433 . . . . 0.99 109.832 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.4 m -150.05 142.58 24.44 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.979 -0.748 . . . . 1.28 108.979 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 36.7 mtm180 -90.14 116.45 66.4 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.402 -0.592 . . . . 2.81 109.402 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.742 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.6 Cg_endo -50.86 146.86 20.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.569 2.846 . . . . 0.3 112.902 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.2 t -96.24 151.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.88 109.582 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 90' ' ' LEU . 97.2 mttt -62.44 121.45 13.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.61 0.719 . . . . 1.17 109.42 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.45 -25.55 5.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.675 -1.148 . . . . 0.42 111.114 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.686 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 134.62 34.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.033 -0.728 . . . . 0.59 109.033 178.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 m -82.12 131.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 108.184 -1.043 . . . . 1.22 108.184 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 28.1 m -128.04 148.03 32.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.362 -0.836 . . . . 0.25 110.412 -171.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.515 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 34.0 p -97.95 112.88 24.64 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.129 0.49 . . . . 0.29 110.118 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 86' ' ' LEU . 4.7 m -110.2 144.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.098 0.475 . . . . 0.19 110.246 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.54 117.4 34.84 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.001 -1.481 . . . . 0.19 107.001 170.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 1.2 pt? -117.91 137.04 53.08 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.146 -1.022 . . . . 0.39 111.018 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.42 114.22 11.94 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.308 -2.108 . . . . 0.27 105.308 165.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.62 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.4 m -104.61 127.45 52.36 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.816 -1.083 . . . . 0.19 110.914 -166.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.783 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 4.2 t -105.52 159.94 15.55 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.442 -0.799 . . . . 1.06 109.206 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.4 ' HG ' HG13 ' A' ' 80' ' ' VAL . 13.9 mt -86.67 165.22 16.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.84 109.295 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.72 -23.92 54.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 1.14 110.169 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -86.28 -4.18 59.12 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.695 -0.684 . . . . 2.14 111.655 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.89 6.76 57.93 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.535 -0.84 . . . . 0.51 113.392 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 89.2 m -91.52 112.88 24.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.514 0.657 . . . . 0.46 111.947 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.783 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 32.9 mtt180 -74.76 117.11 16.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.793 0.806 . . . . 0.47 110.634 176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.8 m -101.86 -9.1 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.438 -1.255 . . . . 0.27 112.491 -168.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -156.34 126.57 6.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.422 -0.354 . . . . 0.59 111.054 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -122.57 121.84 37.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 1.34 109.953 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.532 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 7.3 tt0 -142.42 114.61 6.23 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.552 . . . . 2.59 110.335 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -70.33 -18.68 34.18 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.538 2.826 . . . . 0.5 113.063 -172.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.29 108.25 2.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.175 0.988 . . . . 1.37 111.662 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.559 ' HB3' HG23 ' A' ' 68' ' ' VAL . 24.0 tp -117.41 106.45 13.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.484 -1.689 . . . . 0.38 108.621 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -100.56 132.49 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.4 p90 -156.81 162.99 39.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.336 -0.393 . . . . 0.23 110.534 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -88.92 117.45 27.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.185 -0.461 . . . . 0.42 110.295 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.542 HD22 ' HD3' ' A' ' 104' ' ' PRO . 36.8 mt -60.83 136.59 58.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.6 111.62 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 75.25 12.93 83.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.879 -0.677 . . . . 0.37 111.452 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.48 -3.37 14.44 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.082 -0.71 . . . . 0.93 109.082 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.9 m 57.67 35.3 25.5 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.762 -1.108 . . . . 0.62 109.665 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.9 t70 -74.33 -9.0 58.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.126 0.965 . . . . 1.33 108.484 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.7 -158.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.04 -1.436 . . . . 0.23 110.747 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.9 pt -80.39 138.63 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 107.519 -1.289 . . . . 0.29 107.519 174.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.3 tp60 -59.71 -30.22 68.66 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.052 -0.259 . . . . 0.4 111.038 -172.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.82 71.81 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.161 0.505 . . . . 0.2 110.484 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 68' ' ' VAL . 45.3 tp -79.55 -42.14 25.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.683 -0.69 . . . . 0.22 110.567 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.467 ' HB3' HE21 ' A' ' 97' ' ' GLN . 22.0 t70 -59.64 -30.54 68.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.057 -0.974 . . . . 0.26 110.068 -174.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 86.5 mt -90.82 -36.07 14.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.197 -0.91 . . . . 0.25 112.929 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.8 p -70.93 -29.54 65.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.143 0.496 . . . . 1.01 111.034 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.584 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 80.5 t -64.74 -54.25 37.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.444 -0.798 . . . . 0.21 112.957 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.542 ' HD3' HD22 ' A' ' 90' ' ' LEU . 21.2 Cg_endo -63.93 -20.41 68.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.737 1.625 . . . . 0.27 111.661 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 39' ' ' ILE . 23.7 mt -78.47 -17.02 56.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.619 . . . . 0.64 110.873 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.723 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -100.97 156.6 17.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.988 -0.551 . . . . 0.78 110.59 -179.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -95.31 154.2 17.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.97 110.817 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.742 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.4 t -62.43 123.89 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.454 0.645 . . . . 0.8 110.277 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.64 45.48 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.903 -1.044 . . . . 0.28 112.754 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.845 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.7 pt-20 -105.14 167.62 9.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.464 0.649 . . . . 0.41 111.011 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.513 HG22 HD12 ' A' ' 50' ' ' LEU . 13.7 m -129.16 116.99 20.05 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.974 -1.121 . . . . 0.22 107.974 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -118.32 136.78 53.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.161 -0.472 . . . . 0.18 110.81 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.9 ttm -98.34 117.14 32.07 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.22 -1.4 . . . . 1.32 107.22 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.4 t -112.96 128.45 69.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.007 -0.368 . . . . 0.18 110.007 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 73.8 m -107.45 112.6 25.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.401 -0.92 . . . . 0.21 108.759 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.442 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.67 134.32 54.97 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.944 -1.48 . . . . 0.15 109.229 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.2 t70 -52.61 145.44 11.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.647 -0.871 . . . . 0.58 108.647 172.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -52.04 -26.65 11.38 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 123.416 0.448 . . . . 0.82 110.54 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.725 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 13.8 ptpt -54.33 -35.02 62.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.95 0.352 . . . . 0.81 111.95 176.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.554 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 87.5 m-85 -95.93 2.21 53.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.42 110.373 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 80.2 m -118.47 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.116 -0.947 . . . . 0.18 110.254 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.63 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.3 m-85 -144.41 40.71 1.33 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.34 -0.544 . . . . 0.24 112.364 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.485 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.07 -83.08 0.04 OUTLIER Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.048 -0.596 . . . . 0.25 113.694 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.73 8.7 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.539 2.159 . . . . 0.58 110.986 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.1 mt-30 -104.22 -51.4 3.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.624 0.726 . . . . 0.65 110.216 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.66 143.71 4.19 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.478 -1.237 . . . . 0.3 111.769 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t -91.77 156.75 17.32 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.62 0.6 . . . . 0.33 112.62 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 129' ' ' SER . 7.4 ptm180 -43.1 -63.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.724 -1.125 . . . . 3.17 112.159 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.984 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 17.2 m -72.56 -66.41 0.61 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 121.021 -0.271 . . . . 1.23 110.431 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.984 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -105.74 128.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.397 2.064 . . . . 0.37 112.31 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.597 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.0 t80 -57.31 98.24 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.41 -0.959 . . . . 1.14 108.41 164.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.591 HG12 ' CB ' ' A' ' 127' ' ' SER . 26.9 mm -66.89 129.7 94.02 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.633 -0.506 . . . . 0.39 109.633 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 11.6 Cg_endo -57.49 145.3 89.19 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.624 2.216 . . . . 0.61 112.574 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.485 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 39.6 Cg_exo -57.9 134.27 61.4 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.802 2.335 . . . . 0.52 112.888 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 31.6 m170 66.88 10.97 8.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.74 -1.118 . . . . 2.38 112.471 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -71.81 124.54 25.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.337 -0.986 . . . . 0.26 108.337 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.07 112.58 10.35 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.153 -0.619 . . . . 0.22 109.59 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 115' ' ' THR . 1.7 tp -90.14 131.64 35.88 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.546 -0.752 . . . . 0.22 110.065 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.5 t -116.84 99.94 7.44 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.821 -0.807 . . . . 1.2 108.821 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.3 pp -110.61 136.09 50.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.083 -0.508 . . . . 0.32 111.106 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.623 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 34.5 tt0 -103.8 113.54 27.13 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.989 -0.745 . . . . 1.05 108.989 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.7 m -114.51 120.8 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.606 0.717 . . . . 0.19 112.486 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.7 m -91.41 113.09 25.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.938 -1.028 . . . . 0.28 110.139 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.723 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.0 tp -84.65 98.13 10.02 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.885 -0.783 . . . . 0.15 108.885 173.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 27.6 mtmt -94.42 -28.6 15.41 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.096 -0.957 . . . . 1.08 110.664 -171.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.515 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 24.5 m -153.72 147.44 25.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 0.37 111.663 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.634 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 127.88 25.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.792 -0.448 . . . . 0.25 109.792 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.225 -0.187 0 C-N-CA 120.643 -0.423 . . . . 0.92 110.916 -177.596 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.675 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 110.193 -0.299 . . . . 0.53 110.193 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.93 110.69 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.5 110.903 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.752 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -71.03 99.94 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.637 -0.71 . . . . 2.51 110.691 173.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.614 HG23 HD11 ' A' ' 105' ' ' LEU . 15.8 mt -48.71 -48.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.973 -1.012 . . . . 0.46 112.189 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 88.4 mt -105.93 4.64 29.76 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.612 -0.435 . . . . 0.72 111.103 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.71 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 67.86 18.73 70.84 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.52 112.416 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.731 HD22 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -98.03 -23.6 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.82 0.304 . . . . 0.95 111.82 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.731 ' N ' HD22 ' A' ' 42' ' ' ASN . . . 105.18 -27.21 19.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.189 -1.005 . . . . 0.72 113.722 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -94.26 -11.18 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.395 0.597 . . . . 1.56 111.732 -174.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.3 tp -121.52 107.94 13.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.021 -0.536 . . . . 0.32 110.443 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 63.2 mtm180 -142.39 141.63 32.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.567 -0.288 . . . . 1.14 111.435 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' HG22 ' A' ' 114' ' ' VAL . 18.7 ttpt -111.04 129.6 55.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.951 -0.388 . . . . 0.35 109.951 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.675 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 12.4 ttmt -108.05 128.52 54.75 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.773 0.32 . . . . 1.07 110.778 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -80.56 101.33 9.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.949 -0.569 . . . . 0.33 110.91 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 111' ' ' THR . 10.0 mt -68.25 -51.85 40.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.042 -1.466 . . . . 0.28 107.042 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 79.3 t -138.63 126.0 13.35 Favored Pre-proline 0 CA--C 1.497 -1.075 0 CA-C-N 113.091 -1.868 . . . . 0.36 106.574 169.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -103.12 64.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.818 2.345 . . . . 0.54 113.491 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.872 0 CA-C-N 115.019 -0.991 . . . . 0.55 113.085 175.558 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.44 -0.939 0 CA-C-O 121.299 0.571 . . . . 0.99 110.977 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.72 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 9.8 m -153.08 127.07 8.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.646 -0.872 . . . . 1.28 108.646 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 22.1 ptt180 -90.41 123.46 65.44 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 119.66 -0.816 . . . . 2.81 110.809 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.469 ' HB3' ' HB1' ' A' ' 147' ' ' ALA . 15.1 Cg_endo -56.39 155.22 26.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.909 3.073 . . . . 0.3 113.741 -175.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.1 t -94.87 153.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.307 -0.861 . . . . 0.88 109.389 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.895 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 21.1 mtpt -67.59 119.35 12.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.496 0.665 . . . . 1.17 109.401 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.36 -23.5 5.14 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.2 -1.16 . . . . 0.42 110.2 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.703 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.79 142.69 33.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.59 109.263 176.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.73 121.49 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.577 -0.897 . . . . 1.22 108.577 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.6 m -126.6 146.37 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.25 111.895 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.442 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 28.9 p -104.22 114.05 28.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.381 -0.827 . . . . 0.29 110.337 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.652 HG21 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.59 145.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.083 -0.647 . . . . 0.19 110.038 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.624 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -102.37 115.08 29.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.804 -1.554 . . . . 0.19 106.804 169.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -116.19 136.36 53.08 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.149 -1.02 . . . . 0.39 110.91 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.585 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.18 113.96 13.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.993 -1.854 . . . . 0.27 105.993 166.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.636 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 61.0 m -104.24 125.71 50.74 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.683 -1.144 . . . . 0.19 111.186 -168.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.6 t -105.75 159.17 16.2 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.206 -0.906 . . . . 1.06 109.034 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.436 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.3 mt -86.34 165.2 16.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.792 -0.64 . . . . 0.84 110.017 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 9.5 pt-20 -54.93 -17.82 4.17 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.48 0.488 . . . . 1.14 112.114 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -98.09 -15.2 20.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 2.14 110.998 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.13 23.11 6.53 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.769 -0.729 . . . . 0.51 113.357 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 m -101.42 109.58 21.43 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.302 -0.528 . . . . 0.46 111.115 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 11.0 mtt180 -73.75 114.4 11.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.674 0.749 . . . . 0.47 110.462 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.663 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.9 m -98.73 -9.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.529 -1.214 . . . . 0.27 111.86 -171.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.636 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 8.4 pt20 -162.06 127.14 3.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.082 -0.508 . . . . 0.59 110.168 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 71' ' ' GLN . 16.8 tt0 -130.52 106.85 8.79 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.641 -0.503 . . . . 1.34 109.641 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 5.1 tt0 -126.91 117.98 22.27 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.444 -0.798 . . . . 2.59 110.568 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 9.9 Cg_exo -71.39 -18.59 29.7 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.66 2.907 . . . . 0.5 113.932 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -161.99 99.28 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.573 1.178 . . . . 1.37 112.416 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.2 107.87 19.03 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.171 -1.831 . . . . 0.38 108.7 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.6 p -104.6 137.12 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 17.5 p90 -158.73 167.92 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.71 0.29 . . . . 0.23 111.332 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -88.63 112.09 22.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.263 -0.643 . . . . 0.42 109.263 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.895 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 12.8 tp -53.44 121.55 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.116 -0.493 . . . . 0.6 111.072 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.53 ' CA ' ' HE2' ' A' ' 62' ' ' LYS . . . 97.09 -3.21 61.95 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.444 -0.884 . . . . 0.37 113.383 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.7 10.4 41.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.97 -0.692 . . . . 0.93 109.454 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.3 m 58.98 30.54 20.37 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 114.671 -1.15 . . . . 0.62 110.308 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 88' ' ' PHE . 18.1 m-20 -67.28 -11.29 57.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.816 0.817 . . . . 1.33 109.835 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 m -131.66 -162.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.245 -1.343 . . . . 0.23 110.026 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.61 HG13 ' H ' ' A' ' 99' ' ' LEU . 28.0 pt -76.11 141.27 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.668 -1.234 . . . . 0.29 107.668 173.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 100' ' ' ASP . 4.2 tp60 -61.85 -28.61 69.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.555 -0.293 . . . . 0.4 110.863 -173.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.9 80.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.988 0.423 . . . . 0.2 110.226 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.652 HD21 HG21 ' A' ' 68' ' ' VAL . 57.2 tp -73.17 -40.98 64.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.479 -0.782 . . . . 0.22 110.955 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.427 ' HB3' HE21 ' A' ' 97' ' ' GLN . 18.3 t70 -59.9 -31.36 69.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.08 -0.963 . . . . 0.26 109.906 -175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.57 -34.49 15.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.127 -0.942 . . . . 0.25 112.167 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 78.3 p -70.68 -28.64 64.92 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.918 -0.313 . . . . 1.01 110.911 -173.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.429 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 55.6 t -64.47 -55.0 33.15 Favored Pre-proline 0 C--O 1.217 -0.648 0 CA-C-N 115.991 -0.549 . . . . 0.21 112.227 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.888 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.0 Cg_endo -63.78 -17.79 61.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.95 1.766 . . . . 0.27 111.873 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.614 HD11 HG23 ' A' ' 39' ' ' ILE . 14.0 mt -82.75 -15.69 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.933 -0.576 . . . . 0.64 111.136 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -103.77 148.57 25.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.144 -0.48 . . . . 0.78 111.026 178.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -90.38 160.67 15.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.97 110.786 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -66.97 129.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.544 0.687 . . . . 0.8 110.311 -176.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.94 66.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.239 -0.892 . . . . 0.28 112.153 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -98.05 166.97 11.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.5 0.667 . . . . 0.41 110.939 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.516 HG22 HD12 ' A' ' 50' ' ' LEU . 8.1 m -128.74 118.18 22.39 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.972 -1.121 . . . . 0.22 107.972 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.501 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.32 136.61 54.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.277 -0.419 . . . . 0.18 110.602 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.1 ttp -101.89 117.04 34.01 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.667 -1.234 . . . . 1.32 107.667 171.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.749 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.8 t -110.84 134.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.563 -0.532 . . . . 0.18 109.563 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.552 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 89.5 m -107.66 114.06 27.78 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 119.202 -0.999 . . . . 0.21 108.491 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.16 130.7 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.958 -1.474 . . . . 0.15 109.022 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.777 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 5.8 t70 -53.06 147.31 9.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.437 -0.579 . . . . 0.58 109.437 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.9 t -53.0 -29.27 28.25 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.82 110.197 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.777 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.3 ptpt -55.26 -31.48 61.59 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.079 0.4 . . . . 0.81 112.079 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.592 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.0 m-85 -95.44 -0.66 52.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.196 0.522 . . . . 0.42 110.148 175.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 77.3 m -118.24 -87.82 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.119 -0.946 . . . . 0.18 110.648 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.54 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.8 m-85 -144.94 36.2 1.14 Allowed 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.376 -0.53 . . . . 0.24 112.063 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.89 -76.77 0.18 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.825 -0.702 . . . . 0.25 113.052 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.9 3.66 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.471 2.114 . . . . 0.58 111.507 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -104.74 -51.92 2.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.506 0.67 . . . . 0.65 109.91 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.54 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 83.92 141.83 4.94 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.592 -1.186 . . . . 0.3 111.31 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.69 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.4 t -90.54 153.03 20.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.817 0.341 . . . . 0.33 111.134 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -52.82 -42.48 65.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.386 -0.824 . . . . 3.17 111.971 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 1.001 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 10.1 m -84.97 -66.06 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.266 -0.642 . . . . 1.23 109.266 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.001 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.0 Cg_endo -105.38 126.28 0.06 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.37 111.497 171.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.411 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 12.9 t80 -59.65 97.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.776 -1.194 . . . . 1.14 107.776 167.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.569 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.9 mm -65.52 126.92 92.48 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.966 -0.561 . . . . 0.39 109.633 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 53.2 Cg_exo -51.89 142.45 42.73 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.639 2.226 . . . . 0.61 112.008 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 41.1 Cg_exo -57.03 134.42 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.352 2.035 . . . . 0.52 112.0 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.448 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.8 OUTLIER 74.28 0.67 3.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.363 -0.835 . . . . 2.38 111.422 174.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.6 119.41 12.32 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.193 -0.669 . . . . 0.26 109.193 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -73.24 113.81 10.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.195 -0.602 . . . . 0.22 110.54 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.597 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 mp -89.6 134.21 34.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.861 -0.609 . . . . 0.22 111.708 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 t -118.0 100.47 7.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.025 -0.731 . . . . 1.2 109.025 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.594 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.4 pp -111.02 137.05 49.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.609 -0.723 . . . . 0.32 111.592 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.585 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 81.0 tt0 -103.53 124.79 49.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.703 -0.851 . . . . 1.05 108.703 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' HE3' ' A' ' 106' ' ' MET . 3.3 m -122.74 126.15 73.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.257 0.551 . . . . 0.19 112.252 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 7.3 m -96.11 115.97 28.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.28 110.219 170.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.752 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.8 tp -85.39 98.13 10.39 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.727 -0.842 . . . . 0.15 108.727 172.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.443 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.5 mtmt -94.14 -30.3 14.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.336 -0.847 . . . . 1.08 110.661 -169.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.5 m -150.92 146.14 26.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.128 0.49 . . . . 0.37 111.814 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.508 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -136.1 127.68 28.81 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.485 -0.932 . . . . 0.25 108.485 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 121.18 0.514 . . . . 0.92 111.13 -179.295 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.583 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.096 0.475 . . . . 0.53 109.729 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.3 tp -73.01 110.33 7.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.5 110.037 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.664 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -74.75 123.53 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.38 -0.528 . . . . 2.51 109.831 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.639 HG23 HD11 ' A' ' 105' ' ' LEU . 8.4 mt -55.22 -33.21 29.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.985 -1.007 . . . . 0.46 111.462 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -115.9 -1.39 12.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.014 -0.539 . . . . 0.72 110.313 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.66 23.05 66.71 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.093 -0.803 . . . . 0.52 111.093 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.497 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -97.32 -17.67 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.622 0.601 . . . . 0.95 112.622 -172.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.17 -15.43 18.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.446 -0.883 . . . . 0.72 114.72 166.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -120.29 -7.79 9.74 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.972 0.73 . . . . 1.56 112.972 -175.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 39' ' ' ILE . 25.2 tp -121.75 100.07 6.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.578 0.228 . . . . 0.32 110.624 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -134.86 139.23 44.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.697 0.258 . . . . 1.14 111.697 -171.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.7 ttpt -113.05 123.31 50.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.244 0.217 . . . . 0.35 110.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.3 ttpp -111.07 117.69 33.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.832 0.349 . . . . 1.07 111.253 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.547 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 2.2 p -74.1 98.89 3.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.33 111.656 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 111' ' ' THR . 7.7 mt -67.01 -53.38 31.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.413 -1.329 . . . . 0.28 107.413 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.801 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t -134.39 123.01 16.24 Favored Pre-proline 0 CA--C 1.498 -1.032 0 CA-C-N 112.908 -1.951 . . . . 0.36 106.478 168.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 57.7 Cg_endo -108.37 72.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.521 2.148 . . . . 0.54 114.578 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.55 113.756 169.821 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.439 -0.978 0 CA-C-O 120.935 0.398 . . . . 0.99 110.629 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -158.75 144.57 16.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.616 -0.883 . . . . 1.28 108.616 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 49.5 mtm180 -94.13 111.38 53.06 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.659 -0.497 . . . . 2.81 109.659 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.65 ' HG3' HD21 ' A' ' 144' ' ' LEU . 9.9 Cg_endo -49.96 149.55 11.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.693 2.928 . . . . 0.3 113.657 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.676 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 20.2 t -96.22 153.05 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.88 109.531 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.853 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 98.5 mttt -68.78 119.61 13.42 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.523 0.678 . . . . 1.17 109.231 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 -28.5 3.82 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.836 -1.306 . . . . 0.42 109.836 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.683 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.34 139.28 34.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.637 -0.875 . . . . 0.59 108.637 177.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.3 m -88.69 125.74 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 108.024 -1.102 . . . . 1.22 108.024 173.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.3 m -124.7 143.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.57 -0.741 . . . . 0.25 111.468 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.867 HG22 HG22 ' A' ' 87' ' ' VAL . 69.4 p -90.11 113.03 24.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.423 -0.808 . . . . 0.29 110.243 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.823 HG21 HD21 ' A' ' 99' ' ' LEU . 19.0 m -111.71 141.11 28.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 120.095 -0.642 . . . . 0.19 110.366 172.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.8 t-160 -101.67 119.13 38.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.848 -1.538 . . . . 0.19 106.848 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -124.92 133.59 52.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 118.789 -1.164 . . . . 0.39 111.297 177.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.568 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -125.45 115.13 19.77 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.082 -1.821 . . . . 0.27 106.082 168.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.627 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 54.1 m -106.8 129.26 54.69 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.875 -1.057 . . . . 0.19 111.591 -168.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.705 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.56 155.46 18.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.192 -0.913 . . . . 1.06 109.159 177.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.484 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.0 mt -83.31 166.24 18.65 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.472 -0.785 . . . . 0.84 110.243 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -54.52 -19.18 5.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.01 -0.541 . . . . 1.14 110.946 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -91.39 -3.59 56.54 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.573 -0.74 . . . . 2.14 110.947 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.4 10.23 62.33 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.319 -0.467 . . . . 0.51 112.24 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.4 m -95.5 112.05 23.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.46 111.441 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 14.5 mtt180 -74.38 120.02 19.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.518 0.675 . . . . 0.47 110.609 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.614 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.5 m -108.48 -10.79 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.617 -1.174 . . . . 0.27 112.272 -169.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.627 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.2 pt20 -159.72 125.63 4.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.288 -0.414 . . . . 0.59 109.961 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.541 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 73.4 tt0 -128.41 108.09 10.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 1.34 109.972 174.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.544 ' HB3' HD23 ' A' ' 70' ' ' LEU . 4.7 tp10 -119.18 111.56 36.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.922 -1.036 . . . . 2.59 109.941 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 37.3 Cg_endo -66.48 -19.61 54.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.209 2.606 . . . . 0.5 113.918 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.582 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 25.5 tt0 -165.18 101.47 0.74 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 122.364 1.078 . . . . 1.37 112.479 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.1 tp -109.69 107.55 17.62 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.657 -1.61 . . . . 0.38 108.786 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.867 HG22 HG22 ' A' ' 67' ' ' THR . 1.7 t -101.55 125.02 55.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -144.95 161.63 38.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.586 -0.279 . . . . 0.23 110.381 -172.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -81.17 111.72 17.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.174 -0.467 . . . . 0.42 109.774 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.853 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.1 tp -58.91 132.21 53.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.6 110.161 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 84.2 2.65 89.24 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.128 -0.558 . . . . 0.37 112.415 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -99.38 -3.91 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.059 0.457 . . . . 0.93 110.372 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.5 m 58.6 33.31 23.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.497 -0.774 . . . . 0.62 109.351 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.3 t70 -72.4 -10.68 60.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 122.534 1.159 . . . . 1.33 108.891 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.24 -158.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.542 -1.663 . . . . 0.23 109.665 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.711 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.2 pt -80.3 137.73 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.954 -1.128 . . . . 0.29 107.954 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.5 tp60 -59.53 -28.32 66.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.374 -0.376 . . . . 0.4 110.408 -174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.62 93.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.133 0.492 . . . . 0.2 110.655 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.823 HD21 HG21 ' A' ' 68' ' ' VAL . 58.2 tp -76.4 -38.69 55.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.706 -0.679 . . . . 0.22 110.141 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.47 -29.09 69.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.965 -1.016 . . . . 0.26 109.825 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 78.4 mt -91.12 -35.2 14.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.518 -0.764 . . . . 0.25 112.533 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 23.3 p -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.088 -0.383 . . . . 1.01 111.312 -172.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.558 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -62.23 -55.61 38.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.297 0.48 . . . . 0.21 112.297 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.846 ' HD3' HD11 ' A' ' 90' ' ' LEU . 19.0 Cg_endo -62.6 -23.21 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.898 1.732 . . . . 0.27 111.305 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.639 HD11 HG23 ' A' ' 39' ' ' ILE . 16.8 mt -78.14 -15.62 58.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.55 . . . . 0.64 111.707 173.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.54 ' HE3' HG23 ' A' ' 142' ' ' VAL . 2.9 ptm -106.93 154.9 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.497 -0.32 . . . . 0.78 111.261 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.16 153.56 20.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.912 0.387 . . . . 0.97 110.532 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -64.19 127.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.618 0.723 . . . . 0.8 109.972 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.58 58.4 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.128 -0.942 . . . . 0.28 112.865 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.801 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.4 pt-20 -99.07 167.71 10.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.629 0.728 . . . . 0.41 111.455 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 50' ' ' LEU . 7.4 m -128.69 117.83 21.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.83 -1.174 . . . . 0.22 107.83 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.72 139.01 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.995 0.426 . . . . 0.18 110.652 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.7 ttm -98.21 118.27 34.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.307 -1.368 . . . . 1.32 107.307 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.4 t -115.35 128.2 72.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.781 -0.452 . . . . 0.18 109.781 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.511 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 85.2 m -106.14 113.98 27.83 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.206 -1.035 . . . . 0.21 108.206 172.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.72 136.88 53.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.31 -1.314 . . . . 0.15 109.617 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.0 t70 -55.49 148.92 14.47 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.101 -0.703 . . . . 0.58 109.101 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.643 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -56.32 -27.29 55.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.136 0.493 . . . . 0.82 110.453 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 15.1 ptpt -54.94 -32.63 61.54 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.215 -0.303 . . . . 0.81 111.717 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.604 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 80.0 m-85 -96.44 0.44 50.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 120.998 0.428 . . . . 0.42 110.165 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.6 m -117.02 -92.01 0.53 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.076 -0.965 . . . . 0.18 110.382 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.2 m-85 -142.42 39.78 1.57 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.429 -0.508 . . . . 0.24 112.233 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.2 -80.58 0.07 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 121.208 -0.52 . . . . 0.25 114.031 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.32 9.08 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.191 1.927 . . . . 0.58 111.017 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.25 -50.43 3.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.065 -0.971 . . . . 0.65 110.173 -173.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.574 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.91 143.94 4.46 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.912 -1.04 . . . . 0.3 112.243 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.8 t -90.42 157.03 17.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.532 . . . . 0.33 111.489 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -59.18 -34.83 72.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.287 -0.869 . . . . 3.17 112.259 -172.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 1.033 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 48.2 m -89.45 -67.22 0.13 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.174 -0.61 . . . . 1.23 109.718 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.033 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -104.62 127.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.275 1.983 . . . . 0.37 111.95 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.574 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 36.5 t80 -56.91 97.87 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.194 -1.039 . . . . 1.14 108.194 165.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -65.95 128.97 94.19 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.734 -0.666 . . . . 0.39 109.577 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.6 Cg_exo -53.78 144.29 55.22 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.61 2.206 . . . . 0.61 112.033 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.2 Cg_exo -58.92 133.86 56.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.315 2.01 . . . . 0.52 112.091 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.565 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER 73.61 0.12 3.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.232 -0.895 . . . . 2.38 112.775 177.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -66.4 123.52 20.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.728 -0.471 . . . . 0.26 109.728 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.89 113.52 11.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.425 0.631 . . . . 0.22 110.41 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.621 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.0 OUTLIER -92.06 132.4 36.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.455 -0.793 . . . . 0.22 111.214 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.0 t -116.6 100.65 7.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.182 -0.673 . . . . 1.2 109.182 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -117.01 135.21 53.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.081 -0.509 . . . . 0.32 111.664 -172.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.568 ' HB3' HE22 ' A' ' 71' ' ' GLN . 35.8 tt0 -99.63 117.47 34.06 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.451 -0.574 . . . . 1.05 109.451 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.818 HG11 HD13 ' A' ' 99' ' ' LEU . 5.3 m -110.51 124.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.608 . . . . 0.19 111.95 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -99.91 108.88 21.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.36 -0.836 . . . . 0.28 109.777 172.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 60' ' ' PRO . 49.4 tp -82.59 96.91 8.23 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.384 -0.969 . . . . 0.15 108.384 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -94.46 -25.13 17.02 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.583 -0.735 . . . . 1.08 110.601 -170.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -154.66 146.25 23.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.876 -0.602 . . . . 0.37 110.841 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.14 127.65 21.5 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.975 -0.75 . . . . 0.25 108.975 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.288 -0.565 . . . . 0.92 110.86 -177.506 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.56 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 7.6 m0 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.293 0.568 . . . . 0.53 111.049 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.9 tp -81.24 111.71 17.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.333 -0.848 . . . . 0.5 110.765 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.65 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -63.61 115.19 4.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.686 0.755 . . . . 2.51 110.543 173.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.628 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 21.0 mt -66.86 -44.69 88.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.192 -0.913 . . . . 0.46 111.152 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 101' ' ' LEU . 93.0 mt -111.05 10.41 22.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 0.72 110.14 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.65 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 77.22 -2.34 61.81 Favored Glycine 0 C--O 1.225 -0.46 0 CA-C-N 115.539 -0.755 . . . . 0.52 112.137 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.752 HD22 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -83.74 -21.21 32.33 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.678 0.621 . . . . 0.95 112.678 -174.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.752 ' N ' HD22 ' A' ' 42' ' ' ASN . . . 83.52 -22.67 7.23 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.413 -0.899 . . . . 0.72 112.437 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.8 -32.84 72.85 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 122.109 0.957 . . . . 1.56 108.948 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 21.3 tp -121.21 114.09 20.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.685 -1.598 . . . . 0.32 110.292 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 49.8 mtm180 -142.32 143.43 32.77 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.296 0.372 . . . . 1.14 110.615 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 114' ' ' VAL . 23.0 ttpt -111.36 134.82 52.67 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.19 -0.3 . . . . 0.35 110.19 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.1 ttpp -124.02 126.99 47.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.194 -0.299 . . . . 1.07 110.194 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -79.89 116.53 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.33 111.223 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 141' ' ' GLU . 7.5 mt -75.05 -49.28 20.28 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.507 -1.664 . . . . 0.28 106.507 169.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.863 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 89.6 t -134.09 130.7 20.47 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 113.105 -1.861 . . . . 0.36 106.287 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 20.6 Cg_endo -108.66 63.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.119 2.546 . . . . 0.54 113.873 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.646 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-N 115.396 -0.82 . . . . 0.55 113.685 175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.445 -0.7 0 CA-C-O 121.038 0.447 . . . . 0.99 111.13 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.13 153.19 41.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.224 -1.028 . . . . 1.28 108.224 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -103.71 115.02 64.2 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 2.81 110.098 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.786 ' HD3' HG23 ' A' ' 108' ' ' VAL . 61.4 Cg_exo -37.26 135.66 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.827 3.018 . . . . 0.3 113.982 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.542 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 18.9 t -90.73 150.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.092 -0.707 . . . . 0.88 109.092 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.588 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 64.6 mttt -65.56 104.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.899 0.857 . . . . 1.17 111.117 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.18 -24.41 2.38 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 113.888 -1.505 . . . . 0.42 110.113 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.719 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.044 0.449 . . . . 0.59 109.948 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 76.1 t -83.51 117.03 28.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.313 -0.858 . . . . 1.22 108.768 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.7 m -123.1 150.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.591 . . . . 0.25 111.255 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.649 ' HB ' ' HG3' ' A' ' 85' ' ' GLU . 62.0 p -104.49 113.4 26.94 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.29 110.085 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.623 HG21 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.3 145.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.331 -0.547 . . . . 0.19 109.977 175.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.675 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.34 114.46 28.76 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.188 -1.412 . . . . 0.19 107.188 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.39 134.15 55.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.012 -1.075 . . . . 0.39 111.075 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -129.94 114.72 16.19 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.902 -1.888 . . . . 0.27 105.902 166.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 62.5 m -103.94 128.19 51.47 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.66 -1.155 . . . . 0.19 111.619 -168.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -105.01 151.21 24.22 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.914 -1.039 . . . . 1.06 108.653 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.27 165.46 25.0 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.97 -0.559 . . . . 0.84 109.604 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.572 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 6.4 pt-20 -55.77 -15.37 3.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.077 0.465 . . . . 1.14 110.807 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.572 ' ND2' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -88.68 -16.71 31.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.699 -0.682 . . . . 2.14 109.808 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.5 -4.71 37.44 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.656 -0.702 . . . . 0.51 111.844 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -81.45 110.21 16.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.815 0.341 . . . . 0.46 111.859 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 29.9 mtt180 -72.54 123.7 23.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.552 0.691 . . . . 0.47 111.187 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.0 m -109.11 -15.73 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.832 -1.076 . . . . 0.27 112.295 -170.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.636 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.9 pt20 -154.74 137.44 15.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.437 -0.579 . . . . 0.59 109.437 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 26.1 tt0 -144.41 105.69 4.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.171 0.51 . . . . 1.34 110.152 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -119.73 121.41 29.85 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.539 -0.755 . . . . 2.59 109.499 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 11.8 Cg_exo -69.0 -18.73 40.43 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.894 2.396 . . . . 0.5 113.059 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.649 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 14.1 tt0 -166.56 96.3 0.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.089 0.947 . . . . 1.37 111.53 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -98.38 102.94 14.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.485 -1.689 . . . . 0.38 108.514 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.9 p -97.33 135.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.636 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 31.2 p90 -157.42 169.06 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.23 111.417 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m -89.66 114.76 26.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.42 109.648 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.903 HD11 ' HD3' ' A' ' 104' ' ' PRO . 16.3 tp -63.02 129.93 42.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.015 -0.538 . . . . 0.6 110.65 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.49 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.06 6.18 86.83 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.885 -0.674 . . . . 0.37 112.083 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.65 -1.51 30.05 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.73 -0.47 . . . . 0.93 109.73 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 40.0 m 56.16 33.99 23.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.62 109.727 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 17.7 t70 -71.47 -9.45 58.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 122.54 1.162 . . . . 1.33 108.549 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.61 -162.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.497 -1.683 . . . . 0.23 110.409 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.1 pt -77.6 139.64 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 107.67 -1.233 . . . . 0.29 107.67 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.583 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 5.2 tp60 -60.05 -28.6 67.91 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.931 -0.308 . . . . 0.4 110.941 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -57.13 -43.05 82.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.179 0.514 . . . . 0.2 110.262 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.623 HD21 HG21 ' A' ' 68' ' ' VAL . 47.4 tp -74.67 -40.48 61.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.22 110.247 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' HB3' HE21 ' A' ' 97' ' ' GLN . 13.9 t70 -61.74 -28.06 69.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.906 -1.043 . . . . 0.26 109.919 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.8 mt -91.28 -36.75 13.7 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.282 -0.872 . . . . 0.25 112.587 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.476 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 17.4 p -74.13 -23.6 59.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 1.01 110.972 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.592 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 38.9 t -67.8 -55.27 14.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.21 112.1 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' HD11 ' A' ' 90' ' ' LEU . 28.2 Cg_endo -62.69 -18.76 65.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.138 1.892 . . . . 0.27 111.999 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.481 ' CD1' HG23 ' A' ' 39' ' ' ILE . 13.7 mt -83.43 -17.39 42.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.999 -0.546 . . . . 0.64 111.713 172.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.732 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 10.4 ttp -97.37 142.71 28.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.354 -0.385 . . . . 0.78 111.344 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -85.51 151.3 24.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.176 0.512 . . . . 0.97 110.855 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.786 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -59.78 123.47 12.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.903 -0.589 . . . . 0.8 110.053 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.3 12.72 47.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.066 -0.97 . . . . 0.28 112.871 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.863 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 8.4 pt-20 -114.24 169.19 9.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.2 0.524 . . . . 0.41 110.64 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.402 HG22 HD12 ' A' ' 50' ' ' LEU . 10.6 m -129.32 120.9 26.42 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.651 -0.87 . . . . 0.22 108.651 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.57 135.57 53.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.693 -0.685 . . . . 0.18 110.88 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.6 ttm -97.78 117.81 32.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.544 -1.28 . . . . 1.32 107.544 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.706 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.4 t -115.1 133.06 62.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.531 -0.544 . . . . 0.18 109.531 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 87.5 m -110.38 114.66 28.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.602 0.715 . . . . 0.21 109.077 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.521 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -125.17 137.02 54.15 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 0.15 110.41 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.595 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.81 147.35 9.07 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.737 -0.838 . . . . 0.58 108.737 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 2.5 t -54.77 -27.16 39.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.04 0.447 . . . . 0.82 110.288 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.595 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 12.7 ptpt -55.19 -33.13 62.75 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.165 -0.334 . . . . 0.81 111.511 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.574 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 83.9 m-85 -94.86 3.22 55.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.073 0.463 . . . . 0.42 110.1 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 72.3 m -123.16 -91.77 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.193 -0.912 . . . . 0.18 110.528 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 8.1 m-85 -142.59 41.08 1.58 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.153 -0.619 . . . . 0.24 112.123 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.77 -88.57 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.486 -0.387 . . . . 0.25 113.909 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.49 11.69 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.396 2.064 . . . . 0.58 111.168 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.04 -48.87 3.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.396 -0.82 . . . . 0.65 109.884 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.637 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 79.13 143.63 2.64 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 114.616 -1.174 . . . . 0.3 112.216 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.695 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.0 t -90.48 147.54 23.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.103 0.478 . . . . 0.33 111.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.593 ' H ' ' HD2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -54.87 -28.18 48.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.12 -0.945 . . . . 3.17 112.485 -175.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 1.089 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 27.5 t -91.59 -70.03 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.891 -0.781 . . . . 1.23 108.891 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.089 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.4 Cg_endo -105.19 128.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.5 2.134 . . . . 0.37 111.998 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.637 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 22.3 t80 -55.72 97.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.32 -0.993 . . . . 1.14 108.32 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 127' ' ' SER . 28.6 mm -67.16 125.97 91.8 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.556 -0.747 . . . . 0.39 109.31 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' A' ' 136' ' ' ALA . 9.7 Cg_endo -53.47 135.99 62.52 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.321 2.014 . . . . 0.61 111.688 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.633 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 54.2 Cg_exo -53.33 129.01 31.53 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.491 2.127 . . . . 0.52 112.304 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.621 ' H ' ' HB3' ' A' ' 118' ' ' SER . 70.3 m-70 74.69 11.09 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.69 -1.141 . . . . 2.38 112.931 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 133' ' ' PRO . . . -71.07 118.87 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.254 -1.017 . . . . 0.26 108.254 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.19 113.68 10.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.463 0.649 . . . . 0.22 109.902 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.637 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.37 131.98 34.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.153 -0.931 . . . . 0.22 110.966 -174.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.1 t -115.18 99.74 7.64 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.891 -0.781 . . . . 1.2 108.891 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -112.85 134.53 54.32 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.467 0.651 . . . . 0.32 111.781 -173.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.551 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 39.9 tt0 -99.8 113.59 26.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.186 -0.916 . . . . 1.05 108.916 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 2.2 m -115.7 121.3 67.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.46 0.648 . . . . 0.19 112.674 -175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.1 m -88.05 121.67 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.18 -0.918 . . . . 0.28 109.756 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 60' ' ' PRO . 39.0 tp -93.89 93.33 7.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.401 -0.962 . . . . 0.15 108.401 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.535 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -85.81 -30.83 22.69 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.898 -1.047 . . . . 1.08 110.629 -172.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.625 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 85.2 m -157.14 145.09 19.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.813 -0.631 . . . . 0.37 111.562 -168.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.619 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . . . -137.55 128.32 27.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.74 -0.664 . . . . 0.25 109.369 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 65' ' ' VAL . 11.2 m . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 109.563 -0.532 . . . . 0.92 109.563 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.534 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.05 0.452 . . . . 0.53 110.378 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.46 110.83 7.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.5 110.409 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.633 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -75.0 127.15 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.332 0.587 . . . . 2.51 110.612 174.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 45' ' ' LEU . 8.4 mt -57.78 -35.55 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.586 -1.188 . . . . 0.46 111.549 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.6 mt -111.12 -1.16 16.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.286 0.565 . . . . 0.72 110.278 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.22 26.63 66.26 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.318 -0.855 . . . . 0.52 111.746 -172.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.39 -29.09 14.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.65 0.241 . . . . 0.95 111.65 -178.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.541 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.41 -9.14 30.72 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 121.114 -0.565 . . . . 0.72 111.751 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 7.3 mp -97.4 -33.18 11.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.253 -0.474 . . . . 1.56 110.971 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.573 HD11 HD12 ' A' ' 39' ' ' ILE . 19.8 tp -122.91 100.7 7.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.32 111.352 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 66.7 mtm180 -132.23 140.73 48.78 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.178 -0.326 . . . . 1.14 111.163 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 13.4 ttpt -111.51 123.66 50.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.265 -0.272 . . . . 0.35 110.265 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 20.1 ttmt -101.17 122.08 42.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.157 -0.312 . . . . 1.07 110.157 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' PRO . 5.3 p -76.67 100.82 5.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.497 -0.319 . . . . 0.33 110.977 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD12 HG22 ' A' ' 111' ' ' THR . 11.5 mt -68.71 -55.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.065 -1.457 . . . . 0.28 107.065 171.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.784 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.5 t -129.82 126.35 22.52 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 113.024 -1.898 . . . . 0.36 106.299 167.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 16.5 Cg_endo -104.48 60.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.832 2.355 . . . . 0.54 113.477 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.959 -0.564 . . . . 0.55 113.213 177.088 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 110.185 -0.302 . . . . 0.99 110.185 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 t -152.81 127.93 9.75 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.04 -0.726 . . . . 1.28 109.04 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.81 122.14 67.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.583 -0.447 . . . . 2.81 110.946 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.6 153.24 11.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.789 2.992 . . . . 0.3 114.13 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.7 t -100.08 155.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.004 -0.998 . . . . 0.88 109.449 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 95.4 mttt -64.34 106.86 1.19 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.386 0.613 . . . . 1.17 110.364 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.75 -24.73 2.44 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.28 -1.128 . . . . 0.42 110.28 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.652 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.01 137.72 34.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.282 -0.636 . . . . 0.59 109.282 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.5 m -81.05 133.54 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.064 -1.087 . . . . 1.22 108.064 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.2 m -127.8 143.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.022 -0.535 . . . . 0.25 110.92 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 45.9 p -94.11 112.61 24.44 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.309 -0.626 . . . . 0.29 109.309 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.59 HG21 HD21 ' A' ' 99' ' ' LEU . 19.6 m -110.15 143.41 20.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.901 -0.72 . . . . 0.19 109.849 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.596 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.7 t-160 -102.33 116.11 31.95 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.824 -1.547 . . . . 0.19 106.824 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 83' ' ' GLU . 1.2 pt? -122.5 137.95 54.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.462 -0.895 . . . . 0.39 110.83 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.11 114.31 13.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.277 -2.12 . . . . 0.27 105.277 166.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.654 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 71.0 m -105.04 129.69 53.42 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.6 -1.182 . . . . 0.19 111.016 -166.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.993 ' HB3' ' SG ' ' A' ' 139' ' ' CYS . 4.7 t -104.38 172.51 6.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.268 -0.878 . . . . 1.06 108.884 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 80' ' ' VAL . 12.3 mt -101.48 165.54 11.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.517 -0.765 . . . . 0.84 109.178 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.18 -23.35 34.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.1 0.476 . . . . 1.14 110.492 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.28 -8.49 53.28 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.776 -0.647 . . . . 2.14 111.492 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.39 10.56 44.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.259 -0.972 . . . . 0.51 113.568 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 92.1 m -98.64 113.0 24.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.311 0.555 . . . . 0.46 112.332 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.894 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.4 mtt180 -69.91 125.56 27.12 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.47 110.363 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.012 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.2 m -108.89 -20.17 6.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.004 -0.998 . . . . 0.27 112.295 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.654 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -146.99 124.3 11.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.421 -0.354 . . . . 0.59 110.242 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -118.41 118.0 30.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.31 0.576 . . . . 1.34 109.964 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.563 ' HB3' HD23 ' A' ' 70' ' ' LEU . 6.4 tp10 -135.8 107.58 9.85 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.589 -0.732 . . . . 2.59 110.814 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.596 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 14.3 Cg_exo -68.12 -19.83 44.6 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.056 2.504 . . . . 0.5 112.952 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -164.22 113.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.025 0.917 . . . . 1.37 112.567 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.08 110.31 16.08 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.772 -1.558 . . . . 0.38 108.763 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.8 p -100.17 137.03 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -159.45 157.64 30.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 0.23 110.426 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 24.4 m -76.87 119.13 20.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.527 -0.546 . . . . 0.42 109.527 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.915 HD11 ' HD3' ' A' ' 104' ' ' PRO . 17.4 tp -62.19 133.22 54.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 0.6 110.544 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.71 -4.91 80.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 0.37 111.844 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 12.8 t70 -83.77 -15.06 49.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.165 -0.68 . . . . 0.93 109.165 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.0 m 62.65 30.1 16.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.863 -1.062 . . . . 0.62 109.414 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 13.7 t70 -62.55 -26.36 68.53 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 122.367 1.079 . . . . 1.33 108.45 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 15.1 m -114.46 -158.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 113.341 -1.754 . . . . 0.23 110.834 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.7 pt -84.34 139.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.81 -1.182 . . . . 0.29 107.81 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.512 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -60.17 -27.34 67.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.449 -0.341 . . . . 0.4 110.966 -173.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -56.39 -42.95 78.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.324 0.583 . . . . 0.2 110.286 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 68' ' ' VAL . 53.0 tp -78.53 -40.49 34.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.131 -0.941 . . . . 0.22 110.377 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HB3' HE21 ' A' ' 97' ' ' GLN . 20.1 t70 -61.97 -29.72 70.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.794 -1.094 . . . . 0.26 109.973 -174.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 57.6 mt -90.66 -33.64 15.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.44 -0.8 . . . . 0.25 111.959 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.5 t -65.63 -34.54 78.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 1.01 110.769 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.7 t -63.56 -53.29 52.78 Favored Pre-proline 0 C--O 1.22 -0.492 0 N-CA-C 113.129 0.789 . . . . 0.21 113.129 -177.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.915 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.7 Cg_endo -62.03 -22.15 73.71 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.988 1.792 . . . . 0.27 111.945 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' A' ' 39' ' ' ILE . 9.5 mt -83.82 -11.98 56.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.416 0.627 . . . . 0.64 110.991 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.771 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 34.8 ttm -98.28 140.36 32.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.969 -1.014 . . . . 0.78 111.635 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.13 153.11 19.56 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.485 -0.561 . . . . 0.97 109.485 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.588 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.0 t -62.0 124.98 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 0.8 110.65 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 12.95 52.98 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.28 112.723 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.784 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.6 pt-20 -105.43 168.63 8.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.478 0.639 . . . . 0.41 110.432 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.49 HG22 HD12 ' A' ' 50' ' ' LEU . 24.4 m -132.83 119.8 20.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.402 -0.962 . . . . 0.22 108.402 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.68 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -117.54 137.45 52.57 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.483 -0.781 . . . . 0.18 110.718 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 ttt -96.85 116.03 28.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.872 -1.529 . . . . 1.32 106.872 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.506 HG22 ' HG3' ' A' ' 47' ' ' LYS . 3.4 t -113.34 132.96 60.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.53 -0.545 . . . . 0.18 109.53 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.525 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 63.0 m -110.7 114.43 27.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.629 -0.828 . . . . 0.21 109.36 171.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.99 53.83 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.896 -1.502 . . . . 0.15 109.813 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.576 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.3 t70 -52.47 147.24 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.981 -0.748 . . . . 0.58 108.981 173.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.627 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.1 t -55.78 -28.32 55.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 0.82 110.086 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.58 ' HG3' ' CD1' ' A' ' 120' ' ' TYR . 15.6 ptpt -55.48 -31.44 62.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.629 -0.259 . . . . 0.81 111.634 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.58 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 78.5 m-85 -95.2 -1.55 51.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.147 0.499 . . . . 0.42 109.839 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 65.6 m -117.14 -93.47 0.51 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.061 -0.972 . . . . 0.18 110.371 -177.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.609 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.8 m-85 -140.78 39.71 1.83 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.207 -0.597 . . . . 0.24 112.091 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -45.59 -83.03 0.02 OUTLIER Glycine 0 C--N 1.344 0.99 0 N-CA-C 114.242 0.457 . . . . 0.25 114.242 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.4 13.93 2.53 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.393 2.062 . . . . 0.58 110.77 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.9 mt-30 -104.65 -49.28 3.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.978 -1.01 . . . . 0.65 110.498 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 131' ' ' TYR . . . 81.83 142.2 3.76 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 114.544 -1.207 . . . . 0.3 112.622 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.609 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 30.4 t -91.93 165.99 12.94 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.091 0.404 . . . . 0.33 112.091 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.579 ' HG3' ' N ' ' A' ' 129' ' ' SER . 6.9 ptp180 -52.87 -49.88 64.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.728 -0.669 . . . . 3.17 112.219 -171.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.986 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 13.0 m -87.78 -62.72 0.22 Allowed Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.704 -0.48 . . . . 1.23 109.704 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.012 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 8.9 Cg_endo -101.08 127.7 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.592 2.195 . . . . 0.37 111.707 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.44 ' HA ' ' CA ' ' A' ' 126' ' ' GLY . 9.6 t80 -57.43 97.35 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.938 -1.504 . . . . 1.14 106.938 159.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -64.87 124.66 87.13 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 107.965 -1.124 . . . . 0.39 107.965 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.22 141.19 31.91 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.499 2.133 . . . . 0.61 112.301 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 55.0 Cg_exo -52.37 132.32 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.582 2.188 . . . . 0.52 112.156 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.515 ' H ' ' HB3' ' A' ' 118' ' ' SER . 1.4 m-70 72.35 9.22 5.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.069 -0.969 . . . . 2.38 113.015 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -74.09 123.84 25.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.162 -0.681 . . . . 0.26 109.162 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.82 112.28 9.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.351 0.596 . . . . 0.22 109.643 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 121' ' ' CYS . 2.0 tp -88.76 131.87 34.86 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.549 -0.751 . . . . 0.22 110.586 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.993 ' SG ' ' HB3' ' A' ' 73' ' ' SER . 24.7 p -116.73 100.29 7.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.795 0.807 . . . . 1.2 110.501 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -109.66 133.64 52.89 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.323 -0.853 . . . . 0.32 111.491 -172.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.537 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.1 tt0 -98.33 109.09 21.9 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.508 -0.769 . . . . 1.05 109.212 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.654 HG23 ' HE1' ' A' ' 106' ' ' MET . 0.8 OUTLIER -113.35 116.46 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.463 0.649 . . . . 0.19 112.39 -174.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 9.5 m -89.2 113.72 24.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 0.28 111.034 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.771 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -84.8 93.55 8.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.773 -0.825 . . . . 0.15 108.773 172.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -86.45 -32.61 20.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.111 -0.95 . . . . 1.08 110.799 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.3 m -150.71 147.31 27.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.309 -0.405 . . . . 0.37 111.197 -173.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -134.22 128.31 33.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.156 -0.683 . . . . 0.25 109.156 171.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 110.063 -0.347 . . . . 0.92 110.063 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.686 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.53 110.995 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.75 110.99 5.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.5 110.398 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.676 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -66.59 103.2 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 2.51 110.963 175.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.742 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.2 mt -53.88 -48.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.66 -1.155 . . . . 0.46 111.522 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 45' ' ' LEU . 52.0 mt -105.68 12.79 30.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 0.72 110.712 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.676 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 69.08 6.83 55.07 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.331 -0.849 . . . . 0.52 113.332 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.541 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -99.27 -12.76 20.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.676 0.275 . . . . 0.95 111.468 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.32 -19.11 37.35 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.382 -0.913 . . . . 0.72 112.832 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.5 mp -75.33 -24.47 57.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.039 0.923 . . . . 1.56 109.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 tp -119.13 113.84 21.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.911 -1.495 . . . . 0.32 110.145 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 46' ' ' ARG . 43.4 mtm180 -142.86 133.44 25.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.35 0.5 . . . . 1.14 112.35 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB2' HD11 ' A' ' 39' ' ' ILE . 12.8 ttpt -109.97 125.04 52.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.35 109.976 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.686 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 26.5 ttpp -114.4 121.6 44.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.146 0.498 . . . . 1.07 111.046 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.612 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.3 p -74.68 103.45 4.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.198 -0.91 . . . . 0.33 111.713 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.09 -56.41 7.8 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.67 -1.604 . . . . 0.28 106.67 171.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 56.0 t -131.97 123.89 19.28 Favored Pre-proline 0 CA--C 1.502 -0.9 0 CA-C-N 112.726 -2.034 . . . . 0.36 106.719 168.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.708 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 73.5 Cg_endo -107.92 66.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 122.563 2.175 . . . . 0.54 114.055 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.435 -0.802 . . . . 0.55 113.394 173.34 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 121.108 0.48 . . . . 0.99 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -149.82 147.21 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.912 -0.773 . . . . 1.28 108.912 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 85.2 mtt180 -96.24 116.37 66.13 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.578 -0.449 . . . . 2.81 110.116 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.801 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -49.47 144.48 18.42 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.756 2.971 . . . . 0.3 112.975 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 9.0 t -89.25 145.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.18 -0.463 . . . . 0.88 110.031 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.902 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 97.9 mttt -65.72 104.42 1.05 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.639 0.733 . . . . 1.17 109.788 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.12 -29.92 2.16 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 114.394 -1.276 . . . . 0.42 109.948 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.663 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -74.83 136.16 41.6 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.363 -0.977 . . . . 0.59 108.363 175.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.3 m -84.16 115.23 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.951 -1.129 . . . . 1.22 107.951 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -109.65 146.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.95 -1.023 . . . . 0.25 110.853 -171.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.797 ' HB ' ' OE1' ' A' ' 85' ' ' GLU . 78.9 p -91.12 112.46 24.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.289 0.566 . . . . 0.29 109.725 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.739 HG21 HD21 ' A' ' 99' ' ' LEU . 26.8 m -111.04 142.39 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 119.907 -0.717 . . . . 0.19 109.319 170.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -102.41 116.7 33.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.529 -1.656 . . . . 0.19 106.529 169.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -116.86 135.15 53.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.98 -1.088 . . . . 0.39 110.781 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.715 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -130.49 114.23 15.25 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.427 -2.064 . . . . 0.27 105.427 167.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.563 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 86.8 m -106.43 127.27 53.16 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.229 -1.35 . . . . 0.19 111.145 -166.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.789 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -107.1 153.22 22.95 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.21 -0.905 . . . . 1.06 109.335 -178.246 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.7 mt -78.6 164.79 24.36 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.488 -0.778 . . . . 0.84 109.293 174.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HG3' HD22 ' A' ' 76' ' ' ASN . 6.4 pt-20 -58.37 -14.21 7.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.436 0.636 . . . . 1.14 110.507 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -87.25 -14.77 40.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.242 -0.89 . . . . 2.14 109.895 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.33 -6.68 46.34 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.851 -0.613 . . . . 0.51 111.763 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -81.42 110.05 16.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.926 0.343 . . . . 0.46 111.926 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 37.5 mtt180 -74.11 116.75 15.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.511 0.672 . . . . 0.47 110.394 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.1 m -99.33 -12.91 8.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.27 112.314 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.536 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 28.9 pt20 -156.61 136.07 12.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.224 -0.444 . . . . 0.59 110.385 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 33.1 tt0 -135.13 116.54 14.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.962 -0.563 . . . . 1.34 109.652 174.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 86' ' ' LEU . 5.2 tt0 -129.5 109.59 17.55 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.29 -0.868 . . . . 2.59 109.795 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 16.5 Cg_exo -68.34 -13.57 38.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.736 2.957 . . . . 0.5 113.256 -172.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OE1' ' HB ' ' A' ' 67' ' ' THR . 2.9 tp10 -157.96 101.94 1.8 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.037 0.923 . . . . 1.37 110.711 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.478 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 28.1 tp -116.92 106.46 13.46 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.986 -1.461 . . . . 0.38 108.65 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.5 p -101.97 132.08 48.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.7 p90 -153.8 156.16 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.23 110.824 -174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 5.3 m -75.32 112.03 11.2 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.674 -0.693 . . . . 0.42 109.66 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.902 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.8 tp -60.18 137.7 58.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.037 -0.528 . . . . 0.6 110.21 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 77.61 5.98 86.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.37 112.264 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.421 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 29.5 t70 -103.3 -5.6 22.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.952 0.406 . . . . 0.93 110.044 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 47.5 m 59.99 32.91 21.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.48 -0.782 . . . . 0.62 109.095 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 18.6 t70 -70.16 -16.52 63.1 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.424 1.107 . . . . 1.33 108.758 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.76 -150.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 113.537 -1.665 . . . . 0.23 110.253 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.6 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.1 pt -87.5 139.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.649 -1.241 . . . . 0.29 107.649 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -58.68 -29.18 66.41 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 123.264 0.352 . . . . 0.4 110.916 -173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -55.36 -48.34 74.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.362 0.601 . . . . 0.2 110.664 174.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 68' ' ' VAL . 56.5 tp -75.6 -36.22 60.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.443 -0.799 . . . . 0.22 110.604 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.29 -30.63 71.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 0.26 109.594 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 0.25 112.296 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 t -63.75 -36.65 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 1.01 110.959 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.554 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 77.2 t -62.97 -54.88 42.76 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.059 0.763 . . . . 0.21 113.059 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.838 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.6 Cg_endo -62.54 -20.83 71.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.282 1.988 . . . . 0.27 111.721 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.584 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.8 mt -83.96 -12.69 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.64 111.29 173.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -106.98 155.94 19.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.268 -0.424 . . . . 0.78 110.887 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.98 153.17 17.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.995 0.426 . . . . 0.97 110.825 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.801 HG23 ' HD3' ' A' ' 60' ' ' PRO . 1.7 t -60.4 125.4 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.118 0.485 . . . . 0.8 110.403 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 18.58 41.98 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.103 -0.953 . . . . 0.28 112.499 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.774 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.0 pt-20 -107.57 167.3 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.418 0.628 . . . . 0.41 110.992 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 m -130.54 117.46 19.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.957 -1.127 . . . . 0.22 107.957 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.28 138.89 52.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.115 0.483 . . . . 0.18 110.736 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.0 ttp -100.03 117.45 34.32 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.079 -1.452 . . . . 1.32 107.079 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 47' ' ' LYS . 9.8 t -114.74 131.0 68.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.764 -0.458 . . . . 0.18 109.764 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.516 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 86.0 m -107.49 113.5 26.88 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.658 -0.867 . . . . 0.21 108.658 173.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.55 135.8 53.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.263 -1.335 . . . . 0.15 109.354 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.614 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.4 t70 -53.82 149.86 8.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.818 -0.808 . . . . 0.58 108.818 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -56.66 -28.01 59.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.202 0.525 . . . . 0.82 110.059 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.9 ptpt -56.43 -31.94 64.41 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.902 -0.499 . . . . 0.81 111.779 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.593 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.3 m-85 -94.87 4.22 54.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.42 109.632 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 66.8 m -123.16 -92.76 0.53 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.067 -0.97 . . . . 0.18 110.489 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 6.5 m-85 -142.0 39.77 1.64 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 119.041 -0.504 . . . . 0.24 112.135 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.16 -88.7 0.01 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 114.09 0.396 . . . . 0.25 114.09 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.96 10.63 3.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.015 1.81 . . . . 0.58 111.434 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -103.49 -49.4 3.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.567 -0.742 . . . . 0.65 109.924 -173.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.515 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 81.72 145.42 4.96 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.758 -1.11 . . . . 0.3 111.698 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.687 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.5 t -90.49 162.54 15.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.405 -0.398 . . . . 0.33 110.925 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -51.63 -58.74 5.49 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.892 0.745 . . . . 3.17 110.733 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.849 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 59.6 m -77.48 -61.34 0.65 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.897 -0.592 . . . . 1.23 110.411 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.849 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.8 Cg_endo -106.04 125.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.09 1.86 . . . . 0.37 112.619 174.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.14 96.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.514 -0.921 . . . . 1.14 108.514 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.573 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.9 123.87 87.2 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.536 -0.757 . . . . 0.39 109.717 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.88 136.93 43.76 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.841 2.361 . . . . 0.61 112.459 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.672 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 Cg_endo -55.44 128.71 31.55 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.159 1.906 . . . . 0.52 111.998 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.593 ' H ' ' HB3' ' A' ' 118' ' ' SER . 62.7 m170 74.13 12.97 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.98 -1.009 . . . . 2.38 112.397 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -76.33 121.1 22.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.554 -0.906 . . . . 0.26 108.554 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -72.95 113.11 9.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.22 109.754 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.563 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.2 tp -88.45 131.45 34.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.572 -0.74 . . . . 0.22 110.566 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.4 100.68 8.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.301 -1.0 . . . . 1.2 108.301 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.536 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.1 pp -115.22 136.54 53.0 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.058 -0.519 . . . . 0.32 111.734 -171.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.715 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.0 tt0 -102.71 117.14 34.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.479 -0.934 . . . . 1.05 108.479 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 99' ' ' LEU . 3.5 m -117.93 116.7 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.535 0.683 . . . . 0.19 112.785 -174.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -89.73 108.77 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 0.28 110.576 173.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.652 HD21 ' HG3' ' A' ' 60' ' ' PRO . 57.6 tp -85.44 97.78 10.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.379 -0.971 . . . . 0.15 108.379 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 143' ' ' THR . 19.7 mtmm -103.39 -18.17 14.94 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.08 110.702 -168.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m -156.16 145.36 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.913 -0.585 . . . . 0.37 110.913 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.531 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.62 127.26 32.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.641 -0.874 . . . . 0.25 108.641 169.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 65' ' ' VAL . 20.4 m . . . . . 0 C--N 1.323 -0.563 0 C-N-CA 120.203 -0.599 . . . . 0.92 110.436 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.565 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 N-CA-C 109.864 -0.421 . . . . 0.53 109.864 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.76 111.47 8.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.851 -0.613 . . . . 0.5 110.3 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.797 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 11.0 t70 -75.14 126.65 31.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.779 -0.768 . . . . 2.51 109.795 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 105' ' ' LEU . 5.0 mt -59.47 -30.22 43.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.46 110.771 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.6 mt -113.21 -5.58 13.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.577 -0.738 . . . . 0.72 110.572 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.676 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.71 21.8 71.32 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.428 -0.806 . . . . 0.52 111.675 -174.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.509 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -103.18 -20.27 14.21 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.078 0.769 . . . . 0.95 113.078 -175.137 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.491 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 125.79 -26.43 5.38 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.036 -1.078 . . . . 0.72 114.827 166.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -106.17 -11.47 16.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.124 0.787 . . . . 1.56 113.124 -171.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.7 tp -123.11 100.99 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.505 -0.122 . . . . 0.32 111.108 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.797 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 83.7 mtm180 -140.88 145.46 36.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.551 0.574 . . . . 1.14 112.551 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.652 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.7 ttpt -116.29 131.39 56.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.218 -0.447 . . . . 0.35 110.259 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 4.2 ttmm -111.85 125.75 54.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.626 0.251 . . . . 1.07 110.511 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 p -80.18 100.22 8.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.376 -0.375 . . . . 0.33 111.434 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.464 HD12 HG22 ' A' ' 111' ' ' THR . 11.8 mt -63.94 -53.15 54.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.943 -1.503 . . . . 0.28 106.943 170.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.8 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.9 t -136.35 129.36 17.72 Favored Pre-proline 0 CA--C 1.503 -0.844 0 CA-C-N 112.753 -2.021 . . . . 0.36 106.638 170.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 38.7 Cg_endo -103.91 56.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 122.812 2.342 . . . . 0.54 113.671 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.773 0 CA-C-N 115.303 -0.862 . . . . 0.55 113.062 176.156 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 121.5 0.667 . . . . 0.99 111.566 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -136.42 140.93 43.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.527 -0.916 . . . . 1.28 108.527 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 97.7 mtt180 -101.13 114.1 65.79 Favored Pre-proline 0 C--N 1.311 -1.097 0 C-N-CA 120.786 -0.366 . . . . 2.81 110.539 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.685 ' HD3' HG23 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -47.29 142.1 12.77 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.875 3.05 . . . . 0.3 113.735 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.69 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.1 t -95.67 152.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.486 -0.779 . . . . 0.88 109.564 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 40.4 mttp -66.51 106.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.569 0.699 . . . . 1.17 110.488 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.2 -23.14 2.57 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.96 -1.018 . . . . 0.42 110.756 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -85.25 139.13 31.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.803 -0.814 . . . . 0.59 108.803 177.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 10.7 m -87.28 129.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.677 -0.861 . . . . 1.22 108.677 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 24.9 m -123.15 149.64 26.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.928 -1.033 . . . . 0.25 110.502 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 20.2 p -97.82 112.85 24.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.748 -0.66 . . . . 0.29 110.218 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 99' ' ' LEU . 24.4 m -110.93 147.01 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 120.376 -0.53 . . . . 0.19 110.375 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.611 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.78 114.84 29.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.988 -1.486 . . . . 0.19 106.988 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.9 OUTLIER -120.33 138.16 53.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.387 -0.925 . . . . 0.39 111.194 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.732 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.27 114.83 14.22 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.127 -1.805 . . . . 0.27 106.127 167.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.675 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 32.6 m -103.14 118.99 38.02 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.867 -1.06 . . . . 0.19 111.848 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -105.65 135.05 47.75 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.477 -0.783 . . . . 1.06 109.248 176.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.531 HD13 ' CG1' ' A' ' 80' ' ' VAL . 4.2 mp -58.46 165.29 2.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.562 0.22 . . . . 0.84 111.26 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 8.1 pt-20 -52.45 -20.48 2.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.374 0.607 . . . . 1.14 111.267 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -87.46 -14.73 39.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.706 -0.679 . . . . 2.14 111.15 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.66 -10.57 38.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.35 -0.452 . . . . 0.51 112.249 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -72.27 108.97 5.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.995 0.426 . . . . 0.46 111.552 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 18.1 mtt180 -73.33 128.47 35.57 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.472 0.653 . . . . 0.47 110.367 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.851 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.2 m -115.6 -8.17 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.683 -1.144 . . . . 0.27 111.501 -171.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.675 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.7 pt20 -162.69 130.74 3.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.697 -0.683 . . . . 0.59 109.334 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 25.9 tt0 -141.84 105.92 4.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 1.34 110.258 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 6.4 mm-40 -125.84 126.82 24.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.743 -0.662 . . . . 2.59 109.754 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.492 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 10.9 Cg_exo -70.94 -17.06 32.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.424 2.083 . . . . 0.5 112.639 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -159.66 122.9 3.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.99 0.9 . . . . 1.37 111.923 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.6 tp -132.82 113.15 12.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.519 -1.673 . . . . 0.38 108.774 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.9 p -104.94 132.58 51.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.6 p90 -153.16 156.29 38.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.651 0.262 . . . . 0.23 110.638 -176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -75.86 112.06 11.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.42 110.172 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.84 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.5 tp -60.26 135.38 57.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.6 110.427 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.573 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 81.01 5.43 90.16 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.708 -0.758 . . . . 0.37 112.069 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.82 -13.13 19.35 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.852 -0.425 . . . . 0.93 109.852 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.7 m 62.32 35.04 15.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.556 -0.905 . . . . 0.62 108.556 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.27 -6.34 49.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.55 1.167 . . . . 1.33 108.431 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 7.8 m -131.13 -156.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.375 -1.739 . . . . 0.23 110.021 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -80.08 137.36 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 107.482 -1.303 . . . . 0.29 107.482 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.507 HE21 ' HB3' ' A' ' 100' ' ' ASP . 8.0 tp60 -58.04 -29.16 65.13 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.583 -0.28 . . . . 0.4 110.891 -173.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.91 78.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.2 110.802 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.565 ' H ' HG13 ' A' ' 96' ' ' ILE . 51.4 tp -72.51 -41.34 66.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.22 110.503 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.507 ' HB3' HE21 ' A' ' 97' ' ' GLN . 15.7 t70 -61.11 -30.22 70.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.26 109.911 -174.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.14 -33.77 16.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.25 112.196 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.7 t -68.91 -29.11 67.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.593 -0.276 . . . . 1.01 111.111 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.602 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -66.31 -55.11 21.34 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.659 0.615 . . . . 0.21 112.659 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.84 ' HD3' HD11 ' A' ' 90' ' ' LEU . 20.7 Cg_endo -62.45 -23.62 75.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.921 1.747 . . . . 0.27 111.818 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 39' ' ' ILE . 20.2 mt -73.75 -26.12 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.738 -0.664 . . . . 0.64 111.015 172.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.767 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -95.72 156.52 16.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.09 -0.505 . . . . 0.78 111.082 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.03 151.54 21.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.055 0.455 . . . . 0.97 110.923 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.685 HG23 ' HD3' ' A' ' 60' ' ' PRO . 1.3 t -60.07 125.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.461 0.648 . . . . 0.8 110.22 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.39 56.74 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.865 -1.061 . . . . 0.28 112.803 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.8 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.0 pt-20 -103.14 167.93 9.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.41 111.096 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.464 HG22 HD12 ' A' ' 50' ' ' LEU . 7.2 m -129.41 117.19 20.16 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.716 -1.216 . . . . 0.22 107.716 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.74 134.35 55.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.049 -0.523 . . . . 0.18 110.717 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.4 ttp -98.39 117.93 33.9 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.759 -1.2 . . . . 1.32 107.759 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.652 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.1 t -111.92 135.21 51.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.689 -0.687 . . . . 0.18 109.431 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.565 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 87.8 m -114.32 113.68 24.89 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.616 -0.834 . . . . 0.21 108.795 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.64 54.94 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.18 -1.373 . . . . 0.15 109.796 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.706 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.79 148.79 6.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.004 -0.739 . . . . 0.58 109.004 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.3 t -55.23 -28.5 53.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.116 0.484 . . . . 0.82 110.489 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.706 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.5 ptpt -54.77 -32.88 60.63 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.448 -0.342 . . . . 0.81 111.535 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.636 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 98.3 m-85 -97.25 7.8 45.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.42 110.04 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.667 ' HB3' HD22 ' A' ' 138' ' ' LEU . 61.4 m -123.7 -91.74 0.54 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.118 -0.946 . . . . 0.18 110.115 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 4.1 m-85 -144.56 41.57 1.34 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 119.272 -0.394 . . . . 0.24 111.985 175.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.692 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.49 -84.01 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 121.449 -0.405 . . . . 0.25 113.836 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.76 12.07 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.32 2.013 . . . . 0.58 111.088 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -104.45 -51.52 3.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.499 -0.773 . . . . 0.65 110.176 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.558 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 83.27 142.46 4.77 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.606 -1.179 . . . . 0.3 111.982 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.618 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.7 t -92.65 164.23 13.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.176 -0.512 . . . . 0.33 112.074 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 128' ' ' ARG . 44.6 mtm180 -50.59 -62.64 1.47 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.905 -1.043 . . . . 3.17 111.905 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.939 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 30.9 t -72.09 -63.68 1.21 Allowed Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 1.23 110.067 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.9 Cg_endo -107.22 127.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 122.653 2.235 . . . . 0.37 112.315 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.558 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 42.1 t80 -55.97 98.6 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.861 -1.163 . . . . 1.14 107.861 162.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.612 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.2 mm -66.44 128.82 94.05 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 115.713 -0.676 . . . . 0.39 109.484 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.25 145.52 65.69 Favored 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.656 2.237 . . . . 0.61 111.839 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.692 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 34.8 Cg_endo -63.85 139.39 68.14 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.922 1.748 . . . . 0.52 111.783 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.565 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 1.4 m80 68.75 6.97 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.129 -0.941 . . . . 2.38 112.558 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -72.4 120.65 18.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.283 -0.636 . . . . 0.26 109.283 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -73.45 113.2 10.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.355 0.598 . . . . 0.22 109.904 -172.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 121' ' ' CYS . 0.9 OUTLIER -87.95 131.32 34.65 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.567 -0.742 . . . . 0.22 110.663 -177.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.8 t -115.73 99.94 7.67 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.901 -0.778 . . . . 1.2 108.901 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.2 pp -115.23 134.32 55.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.116 -0.493 . . . . 0.32 111.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.732 ' HB3' HE22 ' A' ' 71' ' ' GLN . 34.0 tt0 -98.86 122.04 41.59 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.223 -0.658 . . . . 1.05 109.223 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.8 m -117.69 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.476 0.655 . . . . 0.19 112.342 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 6.8 m -95.08 111.01 22.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.102 -0.954 . . . . 0.28 110.06 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.619 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -83.6 99.19 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.66 -0.867 . . . . 0.15 108.66 173.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.424 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 21.4 mtmt -94.69 -32.28 13.44 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.052 -0.976 . . . . 1.08 110.598 -170.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.463 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.9 m -152.44 151.69 31.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.37 111.019 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -139.25 129.35 25.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.249 -0.648 . . . . 0.25 109.249 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.385 0.612 . . . . 0.92 110.534 -178.609 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.523 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 2.0 m0 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 121.238 0.542 . . . . 0.53 110.334 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 49.0 tp -80.04 109.99 15.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.5 110.661 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.713 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 2.8 p-10 -63.06 97.71 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.089 -0.959 . . . . 2.51 110.696 171.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.817 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 12.0 mt -51.14 -49.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.021 -0.99 . . . . 0.46 111.986 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 45' ' ' LEU . 55.2 mt -102.33 3.84 38.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.72 110.99 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.713 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 75.61 8.5 84.23 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.52 112.314 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.687 HD22 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -98.12 -15.85 19.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.224 0.453 . . . . 0.95 112.224 -177.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.687 ' N ' HD22 ' A' ' 42' ' ' ASN . . . 86.14 -26.87 5.86 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.72 112.623 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.6 mp -69.15 -23.74 63.99 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 122.018 0.913 . . . . 1.56 109.033 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.817 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.9 tp -120.24 112.39 19.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.133 -1.394 . . . . 0.32 110.486 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 57.2 mtm180 -142.45 140.76 32.04 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 122.962 0.164 . . . . 1.14 111.229 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HG3' HG22 ' A' ' 114' ' ' VAL . 15.9 ttpt -115.53 127.04 54.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.801 -0.444 . . . . 0.35 109.801 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 15.0 ttmt -107.16 122.42 46.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 110.216 -0.29 . . . . 1.07 110.216 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.0 p -79.05 99.6 6.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.896 0.379 . . . . 0.33 111.063 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 111' ' ' THR . 9.3 mt -67.8 -52.5 36.32 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.724 -1.584 . . . . 0.28 106.724 173.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.819 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.3 t -134.68 126.66 18.15 Favored Pre-proline 0 CA--C 1.502 -0.88 0 CA-C-N 113.039 -1.891 . . . . 0.36 106.196 168.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 65.7 Cg_endo -107.01 54.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.013 2.476 . . . . 0.54 114.474 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.452 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.714 0 C-N-CA 120.849 -0.691 . . . . 0.55 113.206 173.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 121.163 0.506 . . . . 0.99 111.095 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 t -146.21 143.58 29.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.929 -0.767 . . . . 1.28 108.929 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 69.1 mtm180 -94.16 116.84 66.92 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 120.449 -0.5 . . . . 2.81 109.756 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.778 ' HD3' HG23 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -49.05 148.02 10.07 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.51 2.807 . . . . 0.3 113.077 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 10.6 t -92.73 150.24 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.669 . . . . 0.88 109.195 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 66.1 mttt -71.33 120.26 16.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.709 0.766 . . . . 1.17 109.862 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.85 -26.8 4.74 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.175 -1.375 . . . . 0.42 110.103 -172.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.686 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.1 135.88 35.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.86 -0.793 . . . . 0.59 108.86 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 11.4 m -82.63 118.47 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.524 -0.917 . . . . 1.22 108.524 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -112.96 146.06 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.249 -0.887 . . . . 0.25 110.513 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.0 p -97.05 113.1 24.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.946 -0.57 . . . . 0.29 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.446 HG21 HD21 ' A' ' 99' ' ' LEU . 27.1 m -111.05 150.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.767 -0.651 . . . . 0.19 110.187 174.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.734 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.52 -1.659 . . . . 0.19 106.52 167.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pt? -125.0 141.62 52.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.901 0.858 . . . . 0.39 110.88 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.639 HE22 ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -139.28 120.03 14.26 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.464 -2.05 . . . . 0.27 105.464 167.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 43.3 m -112.26 121.66 45.55 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.382 -0.826 . . . . 0.19 111.808 -165.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -103.59 148.7 25.68 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.885 -0.598 . . . . 1.06 109.515 175.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD23 HD21 ' A' ' 76' ' ' ASN . 3.4 mp -71.56 165.6 23.56 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.955 -0.566 . . . . 0.84 111.067 170.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.34 -18.95 12.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.416 0.627 . . . . 1.14 110.08 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.496 HD21 HD23 ' A' ' 74' ' ' LEU . 29.5 p30 -92.44 -5.07 52.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.366 -0.833 . . . . 2.14 111.133 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.49 -10.74 53.89 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.248 -0.501 . . . . 0.51 113.577 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.6 m -78.49 110.45 13.58 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.74 -0.27 . . . . 0.46 111.697 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 33.9 mtt180 -71.19 122.25 19.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.476 0.655 . . . . 0.47 110.253 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.735 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 32.8 m -108.18 -10.13 10.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.976 -1.011 . . . . 0.27 111.625 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 29.4 pt20 -159.96 145.58 15.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.889 -0.596 . . . . 0.59 109.501 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 43.8 tt0 -148.96 105.57 3.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.195 0.521 . . . . 1.34 109.902 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HB2' HD23 ' A' ' 70' ' ' LEU . 7.1 mm-40 -122.27 117.57 29.28 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.693 -0.685 . . . . 2.59 109.435 -175.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -66.5 -19.18 55.02 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.705 2.27 . . . . 0.5 112.182 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -159.54 118.67 2.89 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.269 1.033 . . . . 1.37 111.685 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.3 tp -126.07 99.65 6.0 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.174 -1.83 . . . . 0.38 108.423 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.0 p -89.57 134.42 28.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.5 p90 -153.56 162.7 41.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.11 0.481 . . . . 0.23 111.168 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 5.1 m -84.09 108.27 16.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.249 -0.887 . . . . 0.42 110.063 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.859 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.24 132.52 54.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.6 110.152 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.692 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 86.93 4.9 81.67 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.498 -0.858 . . . . 0.37 112.376 175.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 31.4 t70 -117.8 9.3 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.692 -0.485 . . . . 0.93 109.692 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p 43.9 42.45 4.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.145 -0.934 . . . . 0.62 110.296 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 48.9 t0 -71.41 -12.29 61.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.766 1.27 . . . . 1.33 108.166 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.471 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 4.1 m -123.48 -153.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 113.168 -1.833 . . . . 0.23 109.558 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.682 HG13 ' H ' ' A' ' 99' ' ' LEU . 38.9 pt -81.67 142.85 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 107.541 -1.281 . . . . 0.29 107.541 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.494 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 9.0 tp60 -59.96 -34.85 73.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.619 -0.264 . . . . 0.4 111.08 -173.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -53.18 -48.79 67.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.204 0.526 . . . . 0.2 110.759 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.682 ' H ' HG13 ' A' ' 96' ' ' ILE . 57.8 tp -67.68 -41.91 82.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.184 -0.916 . . . . 0.22 110.534 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.8 t70 -60.54 -28.01 68.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.923 -1.035 . . . . 0.26 109.913 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 87.0 mt -89.66 -34.86 16.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.246 -0.888 . . . . 0.25 111.893 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.477 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 60.3 p -70.82 -27.11 63.63 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.635 0.255 . . . . 1.01 110.768 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.613 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.1 t -66.05 -55.33 21.92 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 112.48 0.548 . . . . 0.21 112.48 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.676 ' HD3' HD11 ' A' ' 90' ' ' LEU . 21.9 Cg_endo -61.39 -24.64 78.84 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.806 1.67 . . . . 0.27 112.112 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.9 mt -77.98 -13.25 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.64 111.213 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.799 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -106.9 155.03 20.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.849 -0.614 . . . . 0.78 111.077 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.74 155.61 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.711 0.291 . . . . 0.97 110.619 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.778 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.1 t -60.5 125.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.8 110.659 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.01 5.86 56.19 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.201 -0.909 . . . . 0.28 112.499 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -98.45 168.29 10.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.466 0.65 . . . . 0.41 111.139 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.524 HG22 HD12 ' A' ' 50' ' ' LEU . 31.6 m -132.69 117.42 17.85 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.995 -1.002 . . . . 0.22 108.479 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -118.54 140.15 50.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.917 -0.583 . . . . 0.18 110.564 -176.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 ttm -97.92 117.16 31.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.263 -1.384 . . . . 1.32 107.263 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.476 HG22 ' HG3' ' A' ' 47' ' ' LYS . 4.2 t -113.29 132.81 61.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.424 -0.584 . . . . 0.18 109.424 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 79.4 m -112.71 113.75 26.01 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.133 0.968 . . . . 0.21 109.072 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.46 135.36 53.17 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.434 -1.712 . . . . 0.15 109.693 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.75 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.6 t70 -52.33 147.28 8.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.789 -0.819 . . . . 0.58 108.789 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.639 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -55.8 -27.92 53.6 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 120.993 0.425 . . . . 0.82 110.234 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.599 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.6 ptpt -56.29 -29.28 60.99 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.894 -0.504 . . . . 0.81 111.455 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.593 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 85.0 m-85 -97.35 1.72 49.74 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.196 0.522 . . . . 0.42 109.9 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.639 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.1 m -122.02 -90.71 0.57 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.954 -1.021 . . . . 0.18 110.66 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.659 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 8.1 m-85 -142.9 41.62 1.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.587 -0.445 . . . . 0.24 111.921 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.44 -80.82 0.06 OUTLIER Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.09 -0.576 . . . . 0.25 113.4 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.26 10.36 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.478 2.119 . . . . 0.58 111.003 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.659 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.2 mt-30 -102.83 -46.45 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.756 -1.111 . . . . 0.65 109.876 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.571 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 79.21 142.58 2.42 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.181 -0.918 . . . . 0.3 112.634 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.607 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.7 t -90.53 164.57 14.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.218 -0.491 . . . . 0.33 111.558 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -56.16 -50.22 71.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.651 -0.704 . . . . 3.17 112.065 -173.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.895 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 51.1 m -80.91 -62.4 0.36 Allowed Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.214 -0.594 . . . . 1.23 109.998 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.895 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 22.1 Cg_endo -107.19 127.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.892 2.395 . . . . 0.37 112.541 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.543 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 41.2 t80 -55.97 98.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.863 -1.162 . . . . 1.14 107.863 162.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.589 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.2 mm -64.74 133.0 95.59 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.767 . . . . 0.39 110.196 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 146.05 37.55 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.622 2.215 . . . . 0.61 112.14 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.3 Cg_endo -63.74 135.57 49.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.296 1.998 . . . . 0.52 112.387 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.75 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER 70.75 -0.42 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.915 -1.038 . . . . 2.38 112.744 178.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -61.12 118.97 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.129 -0.693 . . . . 0.26 109.129 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.92 113.09 10.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.422 0.63 . . . . 0.22 109.685 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 115' ' ' THR . 0.9 OUTLIER -88.83 131.07 35.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.86 . . . . 0.22 110.982 -173.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.2 t -114.64 100.38 8.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.57 -0.9 . . . . 1.2 108.57 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.571 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.0 OUTLIER -121.32 135.46 55.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.008 -0.542 . . . . 0.32 111.816 -174.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.639 ' HG2' HE22 ' A' ' 71' ' ' GLN . 4.8 tt0 -98.0 125.97 43.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.511 -0.768 . . . . 1.05 109.482 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.4 m -124.42 117.14 49.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.31 0.576 . . . . 0.19 112.053 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 24.4 m -89.25 114.8 26.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.365 -0.834 . . . . 0.28 110.391 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.697 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 62.0 tp -84.57 100.35 11.35 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.238 -0.653 . . . . 0.15 109.238 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 25.8 mtmt -95.08 -25.8 16.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.528 -0.76 . . . . 1.08 110.88 -170.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.536 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 14.2 m -157.37 155.25 30.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.115 0.413 . . . . 0.37 112.115 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.564 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.49 127.9 21.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.28 -0.637 . . . . 0.25 109.28 171.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 17.8 m . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.423 . . . . 0.92 110.412 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 46' ' ' ARG . 3.8 m0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.765 -0.457 . . . . 0.53 109.765 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.07 109.58 4.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.304 -0.628 . . . . 0.5 109.304 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.645 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.2 t70 -78.53 127.19 31.8 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.166 -0.614 . . . . 2.51 109.852 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 45' ' ' LEU . 3.3 mt -61.68 -31.1 49.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.702 -1.136 . . . . 0.46 110.531 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -115.45 0.54 13.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.9 -0.591 . . . . 0.72 110.546 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.645 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.2 25.27 64.36 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.522 -0.763 . . . . 0.52 111.552 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -96.03 -26.56 15.49 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.936 0.347 . . . . 0.95 111.936 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 105.45 0.86 40.54 Favored Glycine 0 CA--C 1.512 -0.122 0 C-N-CA 120.847 -0.692 . . . . 0.72 111.871 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.1 mp -105.49 -32.73 8.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.037 0.446 . . . . 1.56 110.873 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 39' ' ' ILE . 19.0 tp -123.12 101.55 7.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 0.32 111.572 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 66.4 mtm180 -137.35 148.31 46.18 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.152 -0.342 . . . . 1.14 111.449 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HG3' HG22 ' A' ' 114' ' ' VAL . 25.3 ttpt -113.75 132.16 55.93 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.435 -0.209 . . . . 0.35 110.435 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.6 ttpt -115.92 129.9 56.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.07 110.219 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.466 HG22 ' OE1' ' A' ' 110' ' ' GLU . 5.9 p -82.43 107.67 15.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.163 -0.471 . . . . 0.33 111.549 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.486 HD12 HG22 ' A' ' 111' ' ' THR . 6.7 mt -76.04 -54.76 6.37 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.344 -1.354 . . . . 0.28 107.344 172.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.814 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 97.7 t -127.24 124.57 23.79 Favored Pre-proline 0 CA--C 1.501 -0.923 0 CA-C-N 113.06 -1.882 . . . . 0.36 106.879 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.0 Cg_endo -111.56 88.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.932 2.421 . . . . 0.54 114.252 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' A' ' 110' ' ' GLU . . . . . . . . 0 CA--C 1.527 0.811 0 CA-C-N 116.387 -0.37 . . . . 0.55 113.446 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 113.055 0.761 . . . . 0.99 113.055 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -150.0 143.94 25.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.48 -1.304 . . . . 1.28 107.48 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 6.8 mtm-85 -91.15 115.38 64.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.484 -0.486 . . . . 2.81 110.638 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.79 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.23 140.26 42.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.98 2.453 . . . . 0.3 113.598 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.711 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.3 t -90.91 156.99 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.531 -0.759 . . . . 0.88 109.845 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -66.26 107.89 2.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.408 0.623 . . . . 1.17 110.399 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.04 -27.12 2.56 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 110.534 -1.027 . . . . 0.42 110.534 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.711 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -74.45 140.14 44.43 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.465 -0.569 . . . . 0.59 109.465 178.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.517 ' O ' HG22 ' A' ' 148' ' ' VAL . 69.8 t -86.03 124.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.896 -0.779 . . . . 1.22 108.896 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.6 m -127.79 146.82 32.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 112.296 0.48 . . . . 0.25 112.296 -170.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.0 p -96.46 113.83 25.44 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.767 -0.651 . . . . 0.29 110.008 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 99' ' ' LEU . 24.5 m -110.68 142.05 24.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 120.071 -0.652 . . . . 0.19 109.803 172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.34 112.43 24.94 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.981 -1.859 . . . . 0.19 105.981 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -119.21 133.69 55.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.318 1.056 . . . . 0.39 111.097 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.667 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -129.09 114.12 15.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.109 -2.182 . . . . 0.27 105.109 167.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.61 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 80.4 m -106.04 126.41 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.745 -1.116 . . . . 0.19 111.279 -166.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.8 t -106.89 157.21 17.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.341 -0.845 . . . . 1.06 109.504 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.38 167.12 15.02 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.613 -0.722 . . . . 0.84 110.65 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE1' ' HB1' ' A' ' 136' ' ' ALA . 4.6 pm0 -50.81 -24.97 3.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.106 -0.952 . . . . 1.14 111.371 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -93.55 -10.25 35.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.036 -0.529 . . . . 2.14 111.371 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.48 20.08 20.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.327 -0.94 . . . . 0.51 112.492 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.1 m -96.29 109.6 22.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.628 0.251 . . . . 0.46 110.72 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.9 mtt180 -76.03 109.94 10.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.736 0.779 . . . . 0.47 110.004 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.744 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -95.1 -9.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.36 -1.291 . . . . 0.27 111.833 -169.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.61 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 11.7 pt20 -159.69 148.65 17.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.59 109.597 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 71' ' ' GLN . 28.7 tt0 -152.65 105.78 3.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.087 0.47 . . . . 1.34 110.172 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -124.77 117.15 26.17 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.697 -0.683 . . . . 2.59 110.072 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 30.0 Cg_endo -63.97 -17.96 61.85 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.592 2.194 . . . . 0.5 112.103 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.74 106.72 2.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.161 0.982 . . . . 1.37 111.699 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.4 tp -115.72 111.84 21.17 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.473 -1.694 . . . . 0.38 107.635 170.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.3 p -109.17 131.05 61.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 110.041 -0.355 . . . . 1.0 110.041 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 31.0 p90 -154.17 163.26 40.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.601 -0.272 . . . . 0.23 110.917 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.6 m -82.91 117.75 22.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.915 -0.584 . . . . 0.42 109.628 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.945 HD11 ' HD3' ' A' ' 104' ' ' PRO . 13.8 tp -61.45 138.08 58.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.6 110.843 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.29 -7.2 61.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.015 -0.612 . . . . 0.37 112.162 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.18 -9.14 55.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.93 109.761 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.2 m 60.2 30.31 19.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.178 -0.919 . . . . 0.62 109.54 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.19 -20.63 63.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.542 1.163 . . . . 1.33 108.302 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 m -112.88 -158.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 113.279 -1.782 . . . . 0.23 110.38 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.654 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.8 pt -79.51 140.29 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.689 -1.226 . . . . 0.29 107.689 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.521 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 5.9 tp60 -59.88 -30.97 69.36 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.267 0.355 . . . . 0.4 110.821 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -54.16 -49.88 68.28 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.373 0.606 . . . . 0.2 110.544 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.654 ' H ' HG13 ' A' ' 96' ' ' ILE . 58.4 tp -69.87 -41.68 74.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.832 -1.076 . . . . 0.22 110.294 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.443 ' HB3' HE21 ' A' ' 97' ' ' GLN . 19.9 t70 -60.72 -28.42 68.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.831 -1.077 . . . . 0.26 109.963 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 80.9 mt -90.84 -34.81 15.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.394 -0.821 . . . . 0.25 112.256 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 79.4 p -70.86 -24.63 62.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.538 -0.301 . . . . 1.01 111.143 -173.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.581 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 53.3 t -72.42 -50.27 8.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 112.793 0.664 . . . . 0.21 112.793 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.945 ' HD3' HD11 ' A' ' 90' ' ' LEU . 30.8 Cg_endo -65.01 -20.96 64.08 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 121.553 1.502 . . . . 0.27 111.61 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.454 HD11 HG23 ' A' ' 39' ' ' ILE . 15.9 mt -80.94 -18.62 46.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.64 110.541 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.724 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 31.8 ttm -90.09 149.84 22.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.78 111.104 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.37 147.45 23.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.97 110.39 176.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.79 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -60.44 123.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.328 0.585 . . . . 0.8 110.68 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.27 56.89 Favored Glycine 0 C--N 1.314 -0.679 0 C-N-CA 120.784 -0.722 . . . . 0.28 113.017 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.814 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -99.68 168.78 9.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.253 0.549 . . . . 0.41 110.674 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.486 HG22 HD12 ' A' ' 50' ' ' LEU . 11.5 m -127.68 116.87 20.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.461 -1.311 . . . . 0.22 107.461 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.53 139.56 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.076 -0.511 . . . . 0.18 110.494 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 ttm -98.44 117.02 31.91 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.328 -1.36 . . . . 1.32 107.328 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.683 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.3 t -113.19 131.34 65.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 109.078 -0.712 . . . . 0.18 109.078 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.542 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 41.6 m -115.81 113.93 24.06 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 119.278 -0.969 . . . . 0.21 109.068 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.42 139.03 53.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.038 -1.892 . . . . 0.15 109.739 -176.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 10.1 t70 -53.93 150.8 7.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.407 -0.59 . . . . 0.58 109.407 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.595 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 1.9 t -54.81 -30.02 56.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.82 110.341 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.639 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -55.53 -30.13 60.15 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 122.229 -0.294 . . . . 0.81 111.56 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.532 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 76.6 m-85 -95.87 2.03 53.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.231 0.538 . . . . 0.42 110.171 176.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.827 ' HB3' HD22 ' A' ' 138' ' ' LEU . 60.5 m -123.69 -91.05 0.56 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.156 -0.929 . . . . 0.18 110.654 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.803 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.9 m-85 -140.15 38.36 1.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.574 0.583 . . . . 0.24 112.574 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.48 -78.82 0.08 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.474 0.579 . . . . 0.25 113.628 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -89.64 13.79 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.367 2.044 . . . . 0.58 110.559 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.803 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 42.0 mt-30 -104.28 -49.02 3.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.97 -1.014 . . . . 0.65 110.464 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.586 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 76.93 142.75 1.48 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.996 -1.002 . . . . 0.3 112.905 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.608 ' CB ' HG12 ' A' ' 132' ' ' ILE . 10.3 t -90.68 159.62 16.28 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.042 -0.579 . . . . 0.33 112.376 -175.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -52.45 -48.83 65.57 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.016 -0.993 . . . . 3.17 111.968 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.966 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 34.6 m -80.59 -67.76 0.22 Allowed Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.453 -0.499 . . . . 1.23 109.946 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.966 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.4 Cg_endo -104.91 127.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.611 2.208 . . . . 0.37 112.091 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.586 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 39.4 t80 -55.67 99.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.194 -1.039 . . . . 1.14 108.194 163.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.608 HG12 ' CB ' ' A' ' 127' ' ' SER . 35.1 mm -65.63 129.58 94.37 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.282 -0.872 . . . . 0.39 109.726 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.4 Cg_endo -53.52 141.78 61.51 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.828 2.352 . . . . 0.61 112.499 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.645 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 35.3 Cg_exo -58.28 131.35 42.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.467 2.111 . . . . 0.52 112.52 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.595 ' H ' ' HB3' ' A' ' 118' ' ' SER . 32.2 m170 73.37 9.82 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.916 -1.038 . . . . 2.38 112.35 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.68 127.75 33.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.215 -0.661 . . . . 0.26 109.215 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.69 111.58 10.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.074 0.464 . . . . 0.22 110.533 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.8 tp -88.4 130.97 35.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.684 -0.689 . . . . 0.22 110.213 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.55 100.85 7.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.707 0.765 . . . . 1.2 110.085 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -109.58 136.7 48.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.96 -1.018 . . . . 0.32 112.067 -173.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.667 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 38.2 tt0 -101.14 118.19 36.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.74 -0.837 . . . . 1.05 108.74 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -121.43 118.15 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.092 0.775 . . . . 0.19 113.092 -173.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 2.9 m -90.75 109.31 20.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.709 -0.678 . . . . 0.28 110.539 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.724 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 38.3 tp -82.86 102.72 11.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.428 -0.952 . . . . 0.15 108.428 172.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -103.53 -19.93 14.21 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.452 -0.795 . . . . 1.08 110.901 -170.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 m -156.41 144.94 19.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.37 111.152 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -141.0 128.7 21.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.212 -0.662 . . . . 0.25 109.212 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 65' ' ' VAL . 18.3 m . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.478 -0.489 . . . . 0.92 110.7 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.676 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.622 . . . . 0.53 110.663 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.75 110.91 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.684 -0.689 . . . . 0.5 110.012 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.665 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.3 t70 -73.83 123.73 24.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.264 -0.574 . . . . 2.51 110.086 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 105' ' ' LEU . 9.4 mt -54.51 -37.82 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.053 -0.976 . . . . 0.46 111.309 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -111.8 2.89 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.203 -0.453 . . . . 0.72 110.617 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.11 22.7 60.91 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.57 -0.741 . . . . 0.52 112.066 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -92.16 -27.8 17.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.146 0.424 . . . . 0.95 112.146 -176.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.52 2.69 37.76 Favored Glycine 0 N--CA 1.454 -0.136 0 C-N-CA 120.926 -0.655 . . . . 0.72 112.271 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 3.8 mm? -112.72 -28.38 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.682 0.277 . . . . 1.56 110.969 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 39' ' ' ILE . 23.3 tp -122.06 100.33 6.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.32 110.989 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -131.98 136.85 47.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.905 0.335 . . . . 1.14 111.905 -171.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.8 ttpt -109.01 123.09 48.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.629 -0.508 . . . . 0.35 109.629 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.676 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 24.4 ttpp -105.46 110.79 23.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.666 0.269 . . . . 1.07 110.538 176.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -70.65 98.99 1.59 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.33 110.898 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 111' ' ' THR . 10.7 mt -66.06 -52.54 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.724 -1.584 . . . . 0.28 106.724 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.855 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 90.1 t -137.29 131.55 17.6 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 112.982 -1.917 . . . . 0.36 106.483 169.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 33.6 Cg_endo -105.65 52.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.704 2.269 . . . . 0.54 113.798 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 120.924 -0.655 . . . . 0.55 112.982 175.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.474 0.654 . . . . 0.99 111.173 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -153.22 137.52 16.6 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.944 -1.132 . . . . 1.28 107.944 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 106' ' ' MET . 40.3 mtm180 -91.67 110.61 44.57 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.696 -0.229 . . . . 2.81 110.451 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.842 ' HD3' HG23 ' A' ' 108' ' ' VAL . 12.1 Cg_endo -53.82 149.11 34.62 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.412 2.741 . . . . 0.3 112.8 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 2.2 m -102.99 157.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.204 -0.665 . . . . 0.88 109.204 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 56.6 mttp -62.97 119.85 10.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.246 0.546 . . . . 1.17 109.749 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.72 -26.75 4.5 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.49 -1.044 . . . . 0.42 110.49 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 3.1 mm-40 -83.88 127.14 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.884 -1.154 . . . . 0.59 107.884 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -80.37 126.75 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.18 -1.044 . . . . 1.22 108.18 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 147' ' ' ALA . 18.2 m -121.89 145.9 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.066 -0.97 . . . . 0.25 110.533 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.675 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 54.4 p -96.92 112.99 24.5 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.29 109.778 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.754 HG21 HD21 ' A' ' 99' ' ' LEU . 17.1 m -110.91 145.6 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 C-N-CA 120.228 -0.589 . . . . 0.19 110.697 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.654 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.1 t-160 -102.03 114.87 29.37 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.014 -1.476 . . . . 0.19 107.014 169.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -121.21 133.5 55.17 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.218 1.008 . . . . 0.39 110.905 176.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.689 HE22 ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -128.79 113.59 15.5 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.372 -2.084 . . . . 0.27 105.372 168.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.635 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 40.1 m -104.4 127.69 52.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.953 -1.021 . . . . 0.19 111.724 -168.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.9 m -103.16 162.17 13.19 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.291 -0.868 . . . . 1.06 109.308 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.22 166.14 15.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.739 -1.119 . . . . 0.84 109.904 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 9.8 pt-20 -56.97 -21.88 33.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.187 0.518 . . . . 1.14 110.296 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.43 -4.47 55.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.909 -0.587 . . . . 2.14 111.29 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.98 -23.07 28.46 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.658 -0.782 . . . . 0.51 113.567 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 118.02 10.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.391 0.515 . . . . 0.46 112.391 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.0 mtt180 -76.38 125.25 28.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.74 0.781 . . . . 0.47 111.121 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.702 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -106.76 -9.09 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 0.27 111.886 -170.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.635 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 8.6 pt20 -160.91 145.95 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.828 -0.624 . . . . 0.59 109.399 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 71' ' ' GLN . 1.2 tm-20 -150.56 105.53 3.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.347 -0.612 . . . . 1.34 109.347 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -125.59 111.15 25.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 2.59 110.069 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 24.6 Cg_exo -63.12 -16.63 55.62 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.137 2.558 . . . . 0.5 113.192 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 11.6 tt0 -164.49 100.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.3 1.048 . . . . 1.37 111.682 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.0 tp -109.11 110.35 21.57 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 0.38 108.878 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.2 p -102.36 133.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.2 p90 -153.31 157.29 39.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.695 0.283 . . . . 0.23 110.622 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -76.67 110.85 11.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.711 -0.677 . . . . 0.42 109.646 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.874 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.3 tp -55.03 129.74 39.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.348 -0.387 . . . . 0.6 110.862 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.12 2.02 90.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.918 -0.658 . . . . 0.37 112.368 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.16 -7.16 52.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.387 -0.598 . . . . 0.93 109.387 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.8 m 60.65 28.77 18.48 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.207 -0.906 . . . . 0.62 110.019 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -63.87 -28.34 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.685 1.231 . . . . 1.33 108.633 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 16.0 m -110.15 -153.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 113.329 -1.76 . . . . 0.23 111.057 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.3 pt -89.04 139.47 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.548 -1.279 . . . . 0.29 107.548 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -59.23 -29.35 67.46 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.458 -0.337 . . . . 0.4 110.663 -174.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -55.02 -47.48 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.212 0.53 . . . . 0.2 110.477 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.754 HD21 HG21 ' A' ' 68' ' ' VAL . 58.0 tp -78.04 -36.89 47.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.2 -0.909 . . . . 0.22 110.259 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.49 -30.45 71.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.223 -0.899 . . . . 0.26 109.588 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.2 mt -91.02 -33.32 15.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.418 -0.81 . . . . 0.25 112.214 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 106' ' ' MET . 34.1 t -67.2 -31.92 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.58 -0.282 . . . . 1.01 111.1 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.534 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.1 t -62.11 -55.45 40.57 Favored Pre-proline 0 C--O 1.219 -0.55 0 N-CA-C 112.309 0.485 . . . . 0.21 112.309 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.874 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.9 Cg_endo -62.57 -20.64 71.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 121.747 1.632 . . . . 0.27 111.75 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 39' ' ' ILE . 12.1 mt -82.14 -15.15 54.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.584 . . . . 0.64 111.299 173.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.759 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -107.41 146.41 31.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.925 -0.58 . . . . 0.78 111.095 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.96 157.5 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.18 0.514 . . . . 0.97 111.022 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.842 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.3 t -63.97 124.52 18.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.403 0.621 . . . . 0.8 110.169 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.68 16.39 45.81 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.067 -0.969 . . . . 0.28 112.342 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.855 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.5 pt-20 -105.28 167.98 9.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.334 0.588 . . . . 0.41 111.25 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 50' ' ' LEU . 17.8 m -132.98 118.46 18.88 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 173.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.13 140.19 52.84 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.885 -0.598 . . . . 0.18 110.327 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.6 ttp -100.61 118.26 36.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.506 -1.294 . . . . 1.32 107.506 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.7 t -111.95 131.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.209 -0.45 . . . . 0.18 110.086 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 96.1 m -108.16 112.98 25.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.364 -0.976 . . . . 0.21 108.364 172.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.62 135.17 52.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.378 -1.283 . . . . 0.15 109.399 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.647 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.8 t70 -54.25 149.35 9.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.1 -0.704 . . . . 0.58 109.1 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -54.49 -28.49 45.25 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.407 0.442 . . . . 0.82 110.351 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.647 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.0 ptpt -54.68 -32.91 60.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.633 -0.258 . . . . 0.81 111.463 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.582 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 82.8 m-85 -95.39 1.68 54.31 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.01 0.434 . . . . 0.42 110.279 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 70.8 m -120.74 -89.8 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.215 -0.902 . . . . 0.18 110.6 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.0 m-85 -144.04 38.78 1.32 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.066 -0.396 . . . . 0.24 111.777 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.03 -79.39 0.08 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.215 -0.517 . . . . 0.25 113.636 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -85.02 9.51 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.197 1.931 . . . . 0.58 111.044 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -104.0 -50.57 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.994 -1.003 . . . . 0.65 109.81 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 79.87 141.53 2.51 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.602 -1.181 . . . . 0.3 111.985 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.607 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.1 t -91.29 163.85 14.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.36 -0.42 . . . . 0.33 111.374 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -48.82 -69.05 0.13 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.899 0.749 . . . . 3.17 111.66 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.987 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.9 m -64.2 -66.37 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 115.675 -0.693 . . . . 1.23 110.608 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.987 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 28.5 Cg_endo -106.94 127.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.5 2.133 . . . . 0.37 112.259 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.572 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 23.5 t80 -57.15 97.34 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.978 -1.119 . . . . 1.14 107.978 164.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.593 HG12 ' CB ' ' A' ' 127' ' ' SER . 31.8 mm -65.72 129.84 94.4 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 109.591 -0.522 . . . . 0.39 109.591 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.5 Cg_exo -53.76 140.88 66.61 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.59 2.194 . . . . 0.61 112.199 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.602 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 44.2 Cg_exo -57.8 131.28 43.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.234 1.956 . . . . 0.52 112.292 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.523 ' H ' ' HB3' ' A' ' 118' ' ' SER . 0.2 OUTLIER 75.15 4.68 4.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.14 -0.936 . . . . 2.38 112.356 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -70.05 123.3 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.281 -0.637 . . . . 0.26 109.281 176.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -75.06 113.58 12.55 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.229 -0.588 . . . . 0.22 110.306 -172.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.614 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.3 tp -90.87 132.81 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.779 -0.646 . . . . 0.22 110.918 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.78 100.75 7.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.183 0.516 . . . . 1.2 109.696 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.583 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -116.19 136.16 53.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.138 -0.483 . . . . 0.32 111.836 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.689 ' HG2' HE22 ' A' ' 71' ' ' GLN . 6.4 tt0 -102.05 121.8 42.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.224 -0.658 . . . . 1.05 109.224 178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -118.14 117.56 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.682 0.753 . . . . 0.19 112.52 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.3 m -87.8 115.36 25.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.971 -1.013 . . . . 0.28 110.387 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.701 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 42.8 tp -88.87 100.73 13.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.223 -1.028 . . . . 0.15 108.223 170.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.622 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -93.75 -23.27 18.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.191 -0.913 . . . . 1.08 110.781 -173.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.675 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 94.7 m -159.84 144.91 15.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.763 -0.653 . . . . 0.37 111.494 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -136.44 126.92 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.144 -0.688 . . . . 0.25 109.144 170.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 121.126 0.489 . . . . 0.92 110.455 -179.097 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.702 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.193 0.521 . . . . 0.53 111.327 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 tp -69.4 112.94 6.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.454 -0.794 . . . . 0.5 110.332 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.606 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 t70 -76.41 123.49 26.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.527 0.679 . . . . 2.51 109.999 176.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.582 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 4.8 mt -64.18 -30.13 49.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.794 -1.094 . . . . 0.46 110.667 -176.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.35 -8.43 19.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.72 110.05 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.49 25.3 68.55 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.209 -0.905 . . . . 0.52 111.654 -172.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.504 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -105.07 -26.95 11.91 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.359 0.503 . . . . 0.95 112.359 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.56 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.66 7.51 25.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.308 -0.948 . . . . 0.72 112.454 174.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.433 HD13 ' OD1' ' A' ' 42' ' ' ASN . 8.9 mp -110.2 -32.7 6.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.332 0.587 . . . . 1.56 110.578 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.582 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 19.4 tp -122.55 104.04 9.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.11 -0.95 . . . . 0.32 111.512 -170.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.572 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 77.9 mtm180 -134.63 144.91 48.14 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.942 -0.474 . . . . 1.14 112.197 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HG3' HG22 ' A' ' 114' ' ' VAL . 14.8 ttpt -115.34 129.08 56.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.271 -0.27 . . . . 0.35 110.271 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.702 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -111.08 120.02 40.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.891 0.377 . . . . 1.07 111.109 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 p -72.91 101.03 3.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.747 -0.66 . . . . 0.33 111.647 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 111' ' ' THR . 10.9 mt -68.08 -51.39 47.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.895 -1.521 . . . . 0.28 106.895 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.849 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 69.0 t -136.58 130.46 17.94 Favored Pre-proline 0 CA--C 1.501 -0.927 0 CA-C-N 112.898 -1.956 . . . . 0.36 106.097 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 44.4 Cg_endo -104.21 56.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.743 2.295 . . . . 0.54 113.451 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.725 0 CA-C-N 115.564 -0.744 . . . . 0.55 112.637 177.442 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 120.941 0.4 . . . . 0.99 110.811 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.508 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 19.4 m -145.85 138.02 25.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.745 -0.465 . . . . 1.28 109.745 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 85.2 mtt180 -92.14 116.2 66.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 2.81 109.626 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HG3' HD21 ' A' ' 144' ' ' LEU . 9.1 Cg_endo -52.19 155.35 9.28 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.552 2.834 . . . . 0.3 113.042 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.604 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 3.9 p -106.82 154.38 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.88 109.935 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.88 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 58.6 mttp -63.49 123.83 19.78 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.568 0.699 . . . . 1.17 109.54 178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' HE21 ' A' ' 64' ' ' GLN . . . 118.24 -9.73 13.48 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 114.799 -1.091 . . . . 0.42 110.562 -170.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.705 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.45 136.32 34.88 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.948 -0.736 . . . . 0.59 109.698 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 p -82.87 115.7 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 108.445 -0.946 . . . . 1.22 108.445 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.3 m -117.81 148.76 20.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.595 -0.729 . . . . 0.25 111.156 -170.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.64 HG22 HG12 ' A' ' 87' ' ' VAL . 77.1 p -98.12 113.75 25.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.984 -0.553 . . . . 0.29 110.09 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.858 HG21 HD21 ' A' ' 99' ' ' LEU . 28.2 m -111.28 140.44 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 119.641 -0.824 . . . . 0.19 110.762 172.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.599 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.8 t-160 -102.29 115.27 30.21 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.891 -1.522 . . . . 0.19 106.891 168.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.93 HD23 ' HB3' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -124.44 129.46 50.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 118.921 -1.112 . . . . 0.39 111.608 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -121.79 114.9 21.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.865 -1.902 . . . . 0.27 105.865 169.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.592 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 58.9 m -103.31 128.66 50.3 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.676 -1.147 . . . . 0.19 111.562 -167.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.711 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.8 m -103.51 156.8 17.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.129 -0.942 . . . . 1.06 108.869 176.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.69 165.34 19.02 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.199 -0.91 . . . . 0.84 109.431 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.06 -21.65 23.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.338 0.59 . . . . 1.14 110.482 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.94 -5.15 58.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.379 -0.828 . . . . 2.14 110.997 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.59 -6.4 57.39 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.979 -0.629 . . . . 0.51 112.878 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -81.04 112.95 18.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.786 0.327 . . . . 0.46 111.791 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 16.0 mtt180 -75.0 122.62 23.79 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.499 0.666 . . . . 0.47 110.747 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.644 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -108.0 -9.93 10.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.695 -1.139 . . . . 0.27 112.1 -169.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.592 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.0 pt20 -158.88 133.3 7.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.449 -0.341 . . . . 0.59 110.439 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.55 107.11 12.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.309 0.576 . . . . 1.34 110.016 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.93 ' HB3' HD23 ' A' ' 70' ' ' LEU . 1.9 tp10 -111.29 105.68 57.0 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.237 -0.892 . . . . 2.59 110.332 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.599 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 12.7 Cg_exo -67.91 -22.32 42.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.904 1.736 . . . . 0.5 112.223 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.9 123.09 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.776 0.798 . . . . 1.37 111.09 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.622 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 40.8 tp -131.38 105.78 7.83 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.806 -1.543 . . . . 0.38 108.798 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 34.8 m -92.1 139.48 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-O 120.826 0.346 . . . . 1.0 110.492 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.569 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 33.8 p90 -158.36 159.63 36.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.098 -0.501 . . . . 0.23 110.567 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 92' ' ' ASP . 7.4 m -77.63 115.99 17.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.607 -0.516 . . . . 0.42 109.607 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.88 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.3 tp -56.76 131.41 49.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.558 -0.292 . . . . 0.6 110.447 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.08 -3.66 86.85 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.908 -0.663 . . . . 0.37 112.55 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 12.6 t70 -86.34 -12.34 49.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.819 -0.438 . . . . 0.93 109.819 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 m 60.38 33.73 20.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.902 -0.777 . . . . 0.62 108.902 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.8 t70 -72.67 -11.9 60.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.341 1.067 . . . . 1.33 108.789 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.15 -158.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.502 -1.681 . . . . 0.23 110.487 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -81.76 137.62 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.914 -1.143 . . . . 0.29 107.914 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.527 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.0 tp60 -60.48 -28.78 68.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.829 -0.348 . . . . 0.4 111.095 -173.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.37 70.56 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.32 0.581 . . . . 0.2 110.472 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 68' ' ' VAL . 56.1 tp -80.08 -40.78 26.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.406 -0.815 . . . . 0.22 110.941 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.527 ' HB3' HE21 ' A' ' 97' ' ' GLN . 16.3 t70 -60.58 -30.82 70.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.005 -0.998 . . . . 0.26 110.018 -174.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.84 -33.24 15.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.25 112.208 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.0 t -64.72 -35.32 80.66 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.76 0.314 . . . . 1.01 111.348 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.569 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 65.7 t -60.72 -55.17 47.49 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.507 0.558 . . . . 0.21 112.507 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.873 ' HD3' HD11 ' A' ' 90' ' ' LEU . 27.2 Cg_endo -64.51 -20.46 65.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.865 1.71 . . . . 0.27 112.143 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.87 -12.72 59.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.64 111.383 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 2.3 ptm -108.95 156.86 19.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 0.78 110.625 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.97 110.92 179.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.3 p -65.88 126.82 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.749 0.785 . . . . 0.8 110.29 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.37 7.4 62.04 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 114.75 -1.113 . . . . 0.28 112.723 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.849 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.9 pt-20 -95.44 167.75 11.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.483 0.659 . . . . 0.41 111.839 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.431 HG22 HD12 ' A' ' 50' ' ' LEU . 5.3 m -126.06 116.96 22.22 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.838 -1.171 . . . . 0.22 107.838 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.9 134.97 55.07 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.123 0.487 . . . . 0.18 110.813 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.1 ttm -97.54 117.88 32.79 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.381 -1.34 . . . . 1.32 107.381 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.8 t -112.85 130.31 66.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.417 -0.586 . . . . 0.18 109.417 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.569 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 78.9 m -110.29 112.75 24.9 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 119.146 -1.022 . . . . 0.21 108.365 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.23 135.04 52.16 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.963 -1.471 . . . . 0.15 109.91 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.625 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 9.6 t70 -52.36 147.94 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.819 -0.808 . . . . 0.58 108.819 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.637 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.9 t -56.35 -26.29 52.18 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.013 0.435 . . . . 0.82 110.218 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.625 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -57.86 -29.96 65.43 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.762 -0.586 . . . . 0.81 111.394 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 81.9 m-85 -93.46 -2.11 54.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.543 0.687 . . . . 0.42 110.221 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.648 ' HB3' HD22 ' A' ' 138' ' ' LEU . 64.7 m -119.53 -90.95 0.56 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.725 -1.125 . . . . 0.18 110.416 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.645 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.1 m-85 -145.81 43.06 1.25 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.337 -0.545 . . . . 0.24 112.266 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -54.42 -87.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.056 -0.593 . . . . 0.25 113.361 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.14 10.38 2.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.373 2.048 . . . . 0.58 111.046 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.645 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -103.47 -45.85 4.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.65 110.245 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.547 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 76.01 143.39 1.28 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.911 -1.041 . . . . 0.3 112.546 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.666 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 13.0 t -91.89 164.05 13.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.987 0.422 . . . . 0.33 111.639 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -58.14 -45.64 87.02 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.249 -0.887 . . . . 3.17 112.02 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.904 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 58.4 m -87.46 -60.26 0.26 Allowed Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 120.805 -0.358 . . . . 1.23 110.269 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.1 Cg_endo -107.58 126.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.541 2.161 . . . . 0.37 111.899 171.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 20.6 t80 -58.14 97.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.862 -1.162 . . . . 1.14 107.862 165.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.587 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.1 mm -64.3 127.88 92.59 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.756 -0.656 . . . . 0.39 110.013 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.0 Cg_endo -50.05 136.79 37.21 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.21 2.607 . . . . 0.61 111.87 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.567 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 31.2 Cg_exo -58.54 132.17 46.8 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.523 2.149 . . . . 0.52 112.08 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 30.2 m170 77.0 0.21 3.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.912 -1.04 . . . . 2.38 112.284 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.76 122.17 17.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.468 -0.493 . . . . 0.26 109.686 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.5 112.81 9.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.336 0.589 . . . . 0.22 109.634 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -88.05 132.32 34.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.605 -0.725 . . . . 0.22 110.552 -176.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.6 t -115.08 99.54 7.52 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.755 -0.832 . . . . 1.2 108.755 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.8 OUTLIER -113.95 134.12 55.04 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.289 0.566 . . . . 0.32 111.599 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.516 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 57.6 tt0 -99.56 112.71 24.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 1.05 109.459 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.686 HG11 HD13 ' A' ' 99' ' ' LEU . 6.8 m -109.44 123.15 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.53 0.681 . . . . 0.19 111.86 -177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -96.59 111.01 23.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.126 -0.943 . . . . 0.28 110.167 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.65 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 58.1 tp -82.74 100.81 10.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.689 -0.856 . . . . 0.15 108.689 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -99.33 -21.38 16.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.631 -0.713 . . . . 1.08 110.653 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.8 m -158.12 147.02 19.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.848 -0.341 . . . . 0.37 111.408 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.74 127.68 33.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.25 109.225 169.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 109.307 -0.627 . . . . 0.92 109.307 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.531 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.198 0.523 . . . . 0.53 110.932 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.1 tp -70.47 111.83 6.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.506 -0.77 . . . . 0.5 110.621 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.592 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.7 t70 -73.06 131.88 42.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.586 0.708 . . . . 2.51 110.678 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.5 mt -65.25 -34.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.612 -1.176 . . . . 0.46 111.137 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.44 -2.35 20.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.503 0.668 . . . . 0.72 109.71 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.88 24.26 68.21 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.879 -1.055 . . . . 0.52 111.986 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -100.11 -30.36 11.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.436 0.532 . . . . 0.95 112.436 -177.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 116.38 -0.98 20.62 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.717 -0.754 . . . . 0.72 112.303 172.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.433 HD23 ' HD2' ' A' ' 119' ' ' LYS . 6.7 mp -100.98 -36.52 8.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.592 0.711 . . . . 1.56 111.085 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 116' ' ' ALA . 12.0 tp -122.22 104.82 9.71 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.838 -1.074 . . . . 0.32 111.112 -169.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -132.16 138.65 48.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 1.14 111.856 -170.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -112.19 126.32 55.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.645 -0.252 . . . . 0.35 110.54 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 39.0 ttpt -113.3 115.56 28.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 1.07 110.885 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -74.17 103.11 4.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.33 111.025 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD12 HG22 ' A' ' 111' ' ' THR . 7.6 mt -68.92 -56.08 8.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.656 -1.609 . . . . 0.28 106.656 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 64.8 t -128.85 125.81 23.06 Favored Pre-proline 0 CA--C 1.499 -1.013 0 CA-C-N 113.125 -1.852 . . . . 0.36 106.62 168.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 45.9 Cg_endo -105.02 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.949 2.433 . . . . 0.54 113.413 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.55 113.328 177.074 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 121.177 0.513 . . . . 0.99 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.616 ' H ' HG12 ' A' ' 108' ' ' VAL . 23.7 m -135.62 127.17 28.8 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.004 -0.739 . . . . 1.28 109.004 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 4.0 ptt-85 -91.07 108.77 30.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 120.906 0.384 . . . . 2.81 109.991 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.2 Cg_endo -51.07 159.3 2.69 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.155 3.237 . . . . 0.3 114.571 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.7 t -98.17 156.22 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.097 -0.956 . . . . 0.88 109.703 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.992 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -73.72 121.43 20.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.603 0.716 . . . . 1.17 109.632 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.71 -18.76 5.95 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.049 -1.221 . . . . 0.42 110.049 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.44 141.05 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.445 -0.946 . . . . 0.59 108.445 173.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 26.8 m -87.63 128.56 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.456 -0.898 . . . . 1.22 108.658 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -123.1 145.8 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.804 -1.089 . . . . 0.25 110.852 -173.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 66.9 p -89.84 115.81 27.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.013 0.435 . . . . 0.29 110.117 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 99' ' ' LEU . 18.1 m -109.36 144.06 18.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.597 -0.841 . . . . 0.19 109.283 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.693 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.0 t-160 -103.96 118.98 37.95 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.463 -1.68 . . . . 0.19 106.463 169.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -122.08 133.73 54.77 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 118.847 -1.141 . . . . 0.39 111.026 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.573 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -127.75 113.57 16.16 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.419 -2.067 . . . . 0.27 105.419 167.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.594 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 84.8 m -104.81 126.48 51.92 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.477 -1.238 . . . . 0.19 111.43 -166.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -107.24 147.71 29.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.147 -0.933 . . . . 1.06 109.511 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.71 165.79 24.09 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.732 -0.667 . . . . 0.84 110.013 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.89 -22.79 27.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 1.14 110.5 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -83.03 -8.33 59.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.242 -0.89 . . . . 2.14 110.884 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.38 60.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.959 -0.639 . . . . 0.51 112.089 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.5 m -81.33 110.14 16.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.72 0.295 . . . . 0.46 111.397 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.6 mtt180 -74.37 121.46 21.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.834 0.826 . . . . 0.47 110.82 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.752 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.7 m -105.22 -9.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.359 -1.291 . . . . 0.27 111.984 -169.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.594 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.4 pt20 -159.94 132.41 6.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.184 -0.462 . . . . 0.59 110.628 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 45.5 tt0 -127.78 109.52 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.484 . . . . 1.34 109.828 171.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.45 109.1 26.39 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.576 -0.738 . . . . 2.59 109.892 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.615 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 72.7 Cg_endo -68.19 -17.96 45.17 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.778 2.985 . . . . 0.5 113.454 -172.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.34 111.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.167 0.984 . . . . 1.37 111.04 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.9 tp -128.56 97.88 4.84 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.347 -1.751 . . . . 0.38 109.043 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.6 p -89.73 130.96 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.115 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.0 p90 -151.83 158.15 42.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.23 110.664 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.2 m -76.2 110.93 11.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.42 110.283 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.992 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 14.1 tp -58.18 128.58 37.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.955 -0.566 . . . . 0.6 110.382 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.638 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.68 7.92 83.61 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.716 -0.754 . . . . 0.37 112.419 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.6 6.0 23.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.577 -0.527 . . . . 0.93 109.577 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.52 32.98 20.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.136 -0.938 . . . . 0.62 110.385 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 26.0 t0 -75.49 -4.21 38.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.341 1.067 . . . . 1.33 109.335 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.2 m -135.24 -155.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.037 -1.438 . . . . 0.23 110.602 -175.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 34.4 pt -83.56 135.75 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.296 -1.372 . . . . 0.29 107.296 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 6.6 tp60 -59.22 -31.19 68.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.472 -0.331 . . . . 0.4 111.382 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.87 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.23 0.538 . . . . 0.2 110.354 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 68' ' ' VAL . 58.6 tp -73.64 -41.41 62.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 0.22 110.496 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.528 ' HB3' HE21 ' A' ' 97' ' ' GLN . 12.7 t70 -61.95 -27.74 69.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.963 -1.017 . . . . 0.26 110.098 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 64.8 mt -90.13 -36.41 14.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.194 -0.912 . . . . 0.25 111.91 176.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -37.58 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 1.01 111.107 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.549 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 64.0 t -60.51 -55.79 41.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.0 0.741 . . . . 0.21 113.0 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.792 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.1 Cg_endo -61.69 -25.06 78.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.092 1.862 . . . . 0.27 111.849 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.0 mt -80.06 -11.89 59.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.64 111.593 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.664 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.2 153.81 23.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.307 -0.406 . . . . 0.78 111.23 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.43 158.59 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 0.97 110.593 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 58' ' ' SER . 1.5 p -66.16 128.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.84 0.829 . . . . 0.8 110.378 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.4 4.62 59.49 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.909 -1.041 . . . . 0.28 112.15 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.821 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -98.06 165.12 12.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.383 0.611 . . . . 0.41 111.534 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.481 HG22 HD12 ' A' ' 50' ' ' LEU . 54.6 m -130.76 117.95 20.15 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.739 -1.119 . . . . 0.22 108.263 175.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.62 140.24 50.91 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.889 -0.596 . . . . 0.18 110.618 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.9 ttm -98.91 117.46 33.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.181 -1.415 . . . . 1.32 107.181 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.46 128.78 74.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.66 -0.496 . . . . 0.18 109.66 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.53 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 52.9 m -109.29 113.85 27.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.77 -0.772 . . . . 0.21 109.163 174.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -122.47 139.91 53.34 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.892 -1.504 . . . . 0.15 110.05 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.8 t70 -52.29 146.48 9.25 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.711 -0.848 . . . . 0.58 108.711 171.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.588 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.2 t -55.18 -26.98 42.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.82 110.171 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.3 ptpt -55.3 -32.26 62.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.554 -0.294 . . . . 0.81 111.426 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.554 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.7 m-85 -95.3 6.17 49.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.171 0.51 . . . . 0.42 110.196 176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -124.74 -90.82 0.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.831 -1.077 . . . . 0.18 110.489 -176.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.557 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.2 m-85 -143.75 37.72 1.33 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.978 0.353 . . . . 0.24 111.831 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.11 -78.51 0.09 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.471 -0.395 . . . . 0.25 113.83 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.48 8.68 4.45 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.15 1.9 . . . . 0.58 111.015 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -103.9 -50.12 3.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.435 -0.802 . . . . 0.65 110.135 -172.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . 80.28 143.53 3.27 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.571 -1.195 . . . . 0.3 111.753 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 12.1 t -89.82 158.4 17.5 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.505 -0.348 . . . . 0.33 111.281 -177.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -58.81 -37.31 76.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.632 -0.713 . . . . 3.17 111.738 -170.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.937 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 7.0 m -91.44 -60.71 0.21 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.598 -0.519 . . . . 1.23 109.598 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.937 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -107.41 126.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.808 2.339 . . . . 0.37 112.307 170.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CD1' ' HA3' ' A' ' 126' ' ' GLY . 64.6 t80 -57.61 97.5 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.361 -0.977 . . . . 1.14 108.361 164.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.592 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.43 128.36 93.81 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.441 -0.8 . . . . 0.39 109.522 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.7 Cg_exo -53.44 140.57 63.63 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.536 2.157 . . . . 0.61 112.286 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.9 Cg_exo -57.97 134.81 64.74 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.254 1.969 . . . . 0.52 112.079 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.435 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 18.6 m80 70.42 5.18 5.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.0 -1.0 . . . . 2.38 112.661 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -68.88 122.34 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.307 -0.627 . . . . 0.26 109.307 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.73 111.81 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.303 0.573 . . . . 0.22 109.583 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.66 131.32 36.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.834 -0.621 . . . . 0.22 111.063 -175.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.7 t -117.44 101.61 8.53 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.844 0.831 . . . . 1.2 109.55 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.9 OUTLIER -114.05 136.6 52.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.84 -1.073 . . . . 0.32 111.702 -171.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.573 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 55.0 tt0 -101.28 117.11 34.32 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.082 -0.71 . . . . 1.05 109.082 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.777 HG11 HD13 ' A' ' 99' ' ' LEU . 5.5 m -116.15 121.95 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.367 0.603 . . . . 0.19 112.31 -175.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 5.9 m -96.71 114.47 26.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.28 111.281 173.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.65 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 52.0 tp -84.5 102.18 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.626 -0.879 . . . . 0.15 108.626 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HE3' ' O ' ' A' ' 84' ' ' PRO . 19.2 mtmm -105.06 -20.23 13.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.79 -0.641 . . . . 1.08 111.019 -169.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.401 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.7 m -156.51 148.73 23.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.767 -0.651 . . . . 0.37 110.599 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.518 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -145.61 128.47 16.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.761 -0.829 . . . . 0.25 108.761 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 20.6 m . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 119.86 -0.736 . . . . 0.92 111.715 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.695 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.594 0.711 . . . . 0.53 112.422 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -69.09 111.93 5.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.5 111.037 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.725 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -64.51 101.53 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.084 -0.962 . . . . 2.51 110.599 173.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.609 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.9 mt -54.07 -44.08 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.141 -0.936 . . . . 0.46 112.009 -174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.484 HD21 HD13 ' A' ' 101' ' ' LEU . 86.5 mt -109.84 12.64 23.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.72 110.525 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.725 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 70.66 0.12 30.49 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.52 113.02 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.597 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -81.06 -30.26 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.765 0.283 . . . . 0.95 111.765 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.19 63.69 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.72 112.311 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 2.3 mm? -79.04 -31.54 44.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.886 0.851 . . . . 1.56 109.06 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 13.9 tp -119.31 114.01 21.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.087 -1.415 . . . . 0.32 110.13 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 mtm180 -140.51 140.8 35.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.675 -0.239 . . . . 1.14 111.37 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' HD11 ' A' ' 39' ' ' ILE . 11.1 ttpt -108.45 125.59 51.95 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.393 0.433 . . . . 0.35 110.462 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.695 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.1 ttpt -107.63 113.67 27.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.164 -0.309 . . . . 1.07 110.164 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -76.47 99.34 4.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.425 -0.352 . . . . 0.33 110.931 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD21 ' HE3' ' A' ' 48' ' ' LYS . 15.5 mt -63.84 -50.67 67.96 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.926 -1.509 . . . . 0.28 106.926 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.871 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 82.0 t -139.38 133.73 16.11 Favored Pre-proline 0 CA--C 1.502 -0.869 0 CA-C-N 113.303 -1.771 . . . . 0.36 106.389 169.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 42.7 Cg_endo -107.63 64.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.749 2.299 . . . . 0.54 113.446 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.07 0 CA-C-N 115.53 -0.759 . . . . 0.55 112.504 178.746 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 108.872 -0.788 . . . . 0.99 108.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 108' ' ' VAL . 17.9 t -128.22 -177.32 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.256 -1.016 . . . . 1.28 108.256 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 14.1 mtm180 -130.91 120.55 18.48 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.562 -0.533 . . . . 2.81 109.562 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.4 Cg_endo -51.15 138.08 45.06 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.247 2.631 . . . . 0.3 113.306 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.666 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.8 t -90.1 154.93 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.597 -0.729 . . . . 0.88 109.196 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.649 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 59.1 mttt -66.64 108.55 2.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.452 0.644 . . . . 1.17 111.037 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.44 -28.37 2.45 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.429 -1.259 . . . . 0.42 110.287 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -76.27 138.71 40.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.855 -0.795 . . . . 0.59 108.855 177.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -88.54 129.29 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.008 -1.108 . . . . 1.22 108.008 172.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.7 m -125.79 147.86 30.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.43 -0.804 . . . . 0.25 110.965 -171.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.509 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 26.6 p -96.32 113.37 24.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.979 -0.555 . . . . 0.29 109.967 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.548 HG21 HD21 ' A' ' 99' ' ' LEU . 23.9 m -110.47 143.97 19.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.27 0.557 . . . . 0.19 110.336 174.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.58 112.1 24.7 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.106 -1.442 . . . . 0.19 107.106 169.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 83' ' ' GLU . 1.7 pt? -116.06 136.59 52.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.93 0.872 . . . . 0.39 110.808 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.21 116.58 14.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 105.702 -1.962 . . . . 0.27 105.702 169.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.602 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 62.6 m -109.28 123.67 49.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.876 -1.056 . . . . 0.19 111.418 -165.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.773 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.62 149.49 25.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.429 -0.805 . . . . 1.06 109.276 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.543 ' HG ' HG13 ' A' ' 80' ' ' VAL . 8.0 mt -77.53 166.83 22.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.749 -0.659 . . . . 0.84 110.804 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.35 -23.89 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.493 0.663 . . . . 1.14 110.4 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -82.55 -11.3 58.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.352 -0.84 . . . . 2.14 110.76 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.43 59.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.142 -0.551 . . . . 0.51 111.86 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 m -75.12 110.63 9.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.991 0.367 . . . . 0.46 111.991 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.773 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.5 mtt180 -73.1 117.57 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.47 110.804 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.686 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.7 m -98.96 -10.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.27 112.081 -171.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.602 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.6 pt20 -159.99 141.25 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.677 -0.692 . . . . 0.59 109.31 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 14.4 tt0 -145.56 103.89 3.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.367 0.603 . . . . 1.34 109.657 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.623 ' HB2' HD23 ' A' ' 70' ' ' LEU . 4.1 mm-40 -118.56 115.16 35.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.203 -0.908 . . . . 2.59 109.887 -173.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 47.1 Cg_endo -69.06 -14.51 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.377 2.051 . . . . 0.5 113.044 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -166.98 114.86 0.82 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.861 0.839 . . . . 1.37 111.817 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.4 tp -123.97 112.18 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.604 -1.634 . . . . 0.38 108.802 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.4 p -103.23 128.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.785 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 47.2 p90 -148.75 159.83 43.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 0.23 111.698 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 1.7 m -78.45 109.07 12.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.839 . . . . 0.42 110.546 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.816 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.4 tp -61.56 127.9 33.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.474 -0.33 . . . . 0.6 110.661 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.649 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 83.91 11.72 78.55 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.835 -0.698 . . . . 0.37 112.689 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 34.3 t70 -115.44 10.0 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.331 0.586 . . . . 0.93 109.605 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.5 m 54.39 39.15 30.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.62 109.438 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.785 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -70.63 -12.78 61.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.092 -1.077 . . . . 1.33 108.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 11.0 m -137.61 -159.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 113.758 -1.565 . . . . 0.23 110.578 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.7 pt -79.23 140.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.709 -1.219 . . . . 0.29 107.709 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.502 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.2 tp60 -59.66 -31.2 69.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.407 -0.361 . . . . 0.4 110.987 -173.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.96 -43.0 69.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.237 0.542 . . . . 0.2 110.422 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 142' ' ' VAL . 50.4 tp -78.01 -41.38 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.459 -0.791 . . . . 0.22 110.897 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' HB3' HE21 ' A' ' 97' ' ' GLN . 11.1 t70 -60.28 -29.67 68.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.328 -0.851 . . . . 0.26 110.123 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.484 HD13 HD21 ' A' ' 40' ' ' LEU . 73.3 mt -90.03 -33.3 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.414 -0.812 . . . . 0.25 111.92 176.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 106' ' ' MET . 40.0 t -66.28 -34.2 77.46 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.718 0.294 . . . . 1.01 110.888 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.609 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.3 t -64.0 -55.61 31.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.813 0.671 . . . . 0.21 112.813 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.816 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.8 Cg_endo -62.5 -22.39 73.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.91 1.74 . . . . 0.27 112.049 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.5 mt -79.56 -16.89 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.64 111.275 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.574 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -104.43 157.24 17.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.095 -0.502 . . . . 0.78 111.315 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.5 m-20 -94.54 155.1 17.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.982 0.42 . . . . 0.97 111.17 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 58' ' ' SER . 40.0 t -60.89 125.16 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.581 0.705 . . . . 0.8 110.394 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.47 14.74 56.65 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 115.172 -0.922 . . . . 0.28 112.453 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.871 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -101.42 168.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.339 0.59 . . . . 0.41 111.433 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.442 HG22 HD12 ' A' ' 50' ' ' LEU . 9.4 m -130.59 117.24 19.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.066 -1.087 . . . . 0.22 108.066 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -121.43 136.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.052 0.453 . . . . 0.18 110.653 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 ttm -99.49 116.86 32.61 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.528 -1.286 . . . . 1.32 107.528 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.416 HG22 ' HG3' ' A' ' 47' ' ' LYS . 3.4 t -113.81 127.67 71.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.945 -0.761 . . . . 0.18 108.945 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.582 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 38.6 m -107.14 114.19 28.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.345 -0.942 . . . . 0.21 108.94 175.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -122.14 136.43 54.91 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.749 -1.568 . . . . 0.15 109.93 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.715 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.3 t70 -53.33 149.33 7.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.792 -0.818 . . . . 0.58 108.792 172.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.63 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.8 t -55.0 -27.24 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.258 0.551 . . . . 0.82 110.549 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.715 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.9 ptpt -54.15 -35.95 62.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.293 -0.412 . . . . 0.81 111.515 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.553 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 99.2 m-85 -95.77 3.48 53.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.42 110.304 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.761 ' HB3' HD22 ' A' ' 138' ' ' LEU . 68.2 m -119.45 -91.03 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.033 -0.985 . . . . 0.18 110.572 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.685 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 7.6 m-85 -145.57 40.69 1.2 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.255 0.465 . . . . 0.24 112.255 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.5 -84.41 0.03 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.341 0.518 . . . . 0.25 113.647 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -81.84 11.12 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.364 2.043 . . . . 0.58 110.696 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.685 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.7 mt-30 -104.24 -50.19 3.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.203 -0.908 . . . . 0.65 110.125 -174.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.627 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.03 141.6 3.09 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.731 -1.122 . . . . 0.3 112.613 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.0 t -92.28 165.38 13.13 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.232 -0.484 . . . . 0.33 111.373 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.709 ' HE ' ' HA ' ' A' ' 128' ' ' ARG . 2.6 mmp_? -54.79 -60.7 3.0 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.59 -0.732 . . . . 3.17 112.197 -176.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.843 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 17.5 t -76.57 -58.06 1.19 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 116.142 -0.481 . . . . 1.23 109.871 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.4 Cg_endo -108.73 126.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.521 2.147 . . . . 0.37 112.25 171.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.627 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.9 t80 -57.0 99.37 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.59 -1.263 . . . . 1.14 107.59 163.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.606 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.2 mm -65.61 128.54 93.88 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.39 110.188 -177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.0 Cg_exo -54.29 141.63 70.58 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.724 2.283 . . . . 0.61 112.051 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 Cg_exo -57.67 130.55 39.28 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.332 2.021 . . . . 0.52 112.068 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.552 ' H ' ' HB3' ' A' ' 118' ' ' SER . 13.6 m-70 74.1 7.79 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.831 -1.077 . . . . 2.38 113.105 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.48 ' N ' ' HB2' ' A' ' 118' ' ' SER . . . -68.9 120.59 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.503 -0.554 . . . . 0.26 109.503 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.32 113.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.171 0.51 . . . . 0.22 109.809 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.761 HD22 ' HB3' ' A' ' 121' ' ' CYS . 2.2 mp -90.87 129.81 36.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.847 -0.615 . . . . 0.22 111.009 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.47 ' SG ' HG23 ' A' ' 115' ' ' THR . 35.2 m -112.55 98.91 7.56 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -108.46 134.96 50.52 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.793 -0.639 . . . . 0.32 111.595 -174.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.575 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 43.2 tt0 -102.73 116.26 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.146 -0.687 . . . . 1.05 109.146 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.622 HG11 HD13 ' A' ' 99' ' ' LEU . 3.9 m -115.69 119.35 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.561 0.696 . . . . 0.19 112.758 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.7 m -90.32 110.48 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.28 110.271 171.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.574 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 61.7 tp -82.82 97.85 8.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.651 -0.87 . . . . 0.15 108.651 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.2 mtmt -94.57 -29.11 15.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 1.08 110.597 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.509 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.9 m -153.53 149.31 27.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.466 -0.334 . . . . 0.37 111.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.496 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -140.12 127.99 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.27 -0.641 . . . . 0.25 109.27 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.44 0.638 . . . . 0.92 111.357 -178.032 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.631 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.087 -0.709 . . . . 0.53 109.087 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.44 109.99 7.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.894 0.378 . . . . 0.5 110.674 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.644 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -64.9 96.77 0.2 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.652 -0.704 . . . . 2.51 111.499 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.732 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 15.1 mt -51.81 -53.08 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.46 110.38 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.885 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -78.71 -16.98 56.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.15 -1.386 . . . . 0.72 110.163 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.644 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 72.37 8.34 70.48 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.404 -0.816 . . . . 0.52 111.674 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.515 ' ND2' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.41 -9.14 16.84 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.568 0.223 . . . . 0.95 111.51 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.85 -22.38 28.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.346 -0.931 . . . . 0.72 113.238 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 4.2 mm? -80.09 -22.51 42.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.577 0.704 . . . . 1.56 109.235 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.885 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 26.3 tp -120.51 110.39 16.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 0.32 110.679 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.643 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 42.8 mtm105 -143.75 140.41 29.93 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.223 0.327 . . . . 1.14 111.544 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.754 ' HG3' HG22 ' A' ' 114' ' ' VAL . 7.3 ttpp -116.95 127.8 54.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.16 0.184 . . . . 0.35 110.553 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.631 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.9 ttpt -103.67 130.37 51.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.804 0.335 . . . . 1.07 110.986 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 1.5 p -80.49 94.67 6.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.847 -0.615 . . . . 0.33 110.381 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 111' ' ' THR . 12.5 mt -63.78 -52.77 58.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.014 -1.476 . . . . 0.28 107.014 173.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.795 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 73.6 t -134.63 124.61 17.02 Favored Pre-proline 0 CA--C 1.494 -1.195 0 CA-C-N 113.362 -1.745 . . . . 0.36 106.599 168.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 68.3 Cg_endo -105.6 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.623 2.215 . . . . 0.54 113.593 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.533 ' HA3' ' OD2' ' A' ' 107' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.557 0 CA-C-N 115.201 -0.909 . . . . 0.55 114.207 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 121.236 0.541 . . . . 0.99 111.639 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.25 -0.886 . . . . 1.28 108.791 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -91.06 119.14 68.89 Favored Pre-proline 0 C--N 1.319 -0.732 0 C-N-CA 120.792 -0.363 . . . . 2.81 110.59 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD3' HG23 ' A' ' 108' ' ' VAL . 11.3 Cg_endo -53.16 149.43 28.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.603 2.869 . . . . 0.3 113.318 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.6 t -100.02 151.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.974 -0.557 . . . . 0.88 109.737 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 59.7 mttt -61.72 112.83 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.652 0.739 . . . . 1.17 110.875 177.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.76 -30.0 2.91 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 114.165 -1.38 . . . . 0.42 110.186 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.698 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -72.39 139.17 47.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.158 -0.617 . . . . 0.59 110.202 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.512 ' O ' HG22 ' A' ' 148' ' ' VAL . 40.9 t -80.81 117.14 26.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.503 -0.925 . . . . 1.22 108.503 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -125.47 150.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.782 0.66 . . . . 0.25 112.782 -170.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 145' ' ' LYS . 0.8 OUTLIER -98.43 121.8 40.81 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.696 -1.138 . . . . 0.29 110.41 174.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 99' ' ' LEU . 30.1 m -118.33 147.73 21.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.341 -0.543 . . . . 0.19 110.106 168.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.733 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.04 117.34 34.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.752 -1.573 . . . . 0.19 106.752 167.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -118.33 138.63 52.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.204 -0.999 . . . . 0.39 111.004 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.694 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.77 113.91 11.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.194 -2.15 . . . . 0.27 105.194 165.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.618 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 72.0 m -102.73 127.3 49.93 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.738 -1.119 . . . . 0.19 111.076 -167.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.706 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 t -109.04 159.44 16.84 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.396 -0.82 . . . . 1.06 109.358 -177.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.74 164.53 18.49 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.694 -0.684 . . . . 0.84 109.303 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -52.19 -24.12 6.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.518 0.675 . . . . 1.14 110.58 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -94.46 -7.33 41.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.062 -0.972 . . . . 2.14 111.98 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.48 -8.72 37.86 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.83 -0.7 . . . . 0.51 113.981 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.3 m -75.55 110.69 10.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.448 0.624 . . . . 0.46 111.718 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.8 mtt180 -77.68 110.64 12.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.947 0.88 . . . . 0.47 110.298 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.522 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.2 m -91.36 -12.61 9.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.069 -1.423 . . . . 0.27 111.936 -169.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.618 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -158.6 124.4 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.344 -0.389 . . . . 0.59 110.746 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.53 124.53 48.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.315 -0.624 . . . . 1.34 109.315 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 8.6 tt0 -144.61 107.28 4.7 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-O 121.879 0.847 . . . . 2.59 110.506 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 53.1 Cg_endo -68.94 -19.2 40.43 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 123.35 2.7 . . . . 0.5 113.871 -171.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -158.74 99.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.0 0.905 . . . . 1.37 111.016 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.4 tp -113.04 116.02 29.27 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.31 -1.768 . . . . 0.38 108.808 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.0 p -112.64 133.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 24.3 p90 -154.86 164.74 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.884 0.373 . . . . 0.23 110.821 -172.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.402 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 2.7 m -83.38 112.46 19.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.634 -0.712 . . . . 0.42 109.495 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.974 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.2 tp -59.53 126.26 26.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.405 -0.361 . . . . 0.6 110.919 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' HG2' ' A' ' 62' ' ' LYS . . . 83.51 5.51 88.41 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.78 -0.724 . . . . 0.37 112.438 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 30.6 t70 -90.33 -7.34 53.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.565 -1.272 . . . . 0.93 107.565 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 56.2 m 58.4 31.7 21.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.105 -1.407 . . . . 0.62 110.16 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.27 -18.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.256 1.026 . . . . 1.33 109.168 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.38 -155.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.069 -1.423 . . . . 0.23 110.454 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 28.8 pt -82.75 137.27 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.296 -1.372 . . . . 0.29 107.296 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.601 HE21 ' HB3' ' A' ' 100' ' ' ASP . 12.4 tp60 -56.77 -30.03 63.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.468 -0.333 . . . . 0.4 110.96 -173.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.77 78.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.163 0.506 . . . . 0.2 110.746 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.661 HD21 HG21 ' A' ' 68' ' ' VAL . 62.6 tp -77.88 -37.76 47.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.671 -0.695 . . . . 0.22 110.678 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.601 ' HB3' HE21 ' A' ' 97' ' ' GLN . 22.9 t70 -61.9 -29.51 70.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 0.26 109.59 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.3 -35.07 14.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.253 -0.885 . . . . 0.25 112.275 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 106' ' ' MET . 21.3 t -65.81 -32.83 74.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 1.01 111.479 -174.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.566 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 53.5 t -66.92 -54.91 18.43 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.519 0.563 . . . . 0.21 112.519 -176.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.974 ' HD3' HD11 ' A' ' 90' ' ' LEU . 23.7 Cg_endo -63.76 -22.63 69.5 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.042 1.828 . . . . 0.27 111.921 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.51 ' CD1' HG23 ' A' ' 39' ' ' ILE . 4.2 mt -77.38 -31.15 54.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.64 111.336 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.703 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.3 ptm -88.52 157.23 18.69 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.936 -0.575 . . . . 0.78 109.68 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.533 ' OD2' ' HA3' ' A' ' 53' ' ' GLY . 8.3 p-10 -103.49 158.39 16.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.337 0.589 . . . . 0.97 111.713 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.647 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.8 t -61.37 125.82 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.524 -0.762 . . . . 0.8 111.464 -174.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.65 59.2 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 114.815 -1.084 . . . . 0.28 112.819 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.4 pt-20 -97.0 167.87 10.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.195 0.522 . . . . 0.41 110.625 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.533 HG22 HD12 ' A' ' 50' ' ' LEU . 21.5 m -128.07 117.4 21.58 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.048 -1.093 . . . . 0.22 108.048 173.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -118.35 131.52 56.31 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.977 -0.556 . . . . 0.18 110.963 -173.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.2 ttp -98.44 117.99 34.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.994 -1.113 . . . . 1.32 107.994 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.754 HG22 ' HG3' ' A' ' 47' ' ' LYS . 12.7 t -109.1 137.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.878 -0.601 . . . . 0.18 109.583 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.598 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 89.6 m -110.66 113.07 25.39 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.241 -1.022 . . . . 0.21 108.241 170.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -122.7 132.14 54.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.564 -1.198 . . . . 0.15 109.29 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.732 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.6 t70 -52.98 146.63 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.588 -0.893 . . . . 0.58 108.588 171.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.586 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.5 t -52.32 -26.78 13.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.131 0.491 . . . . 0.82 110.48 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.732 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.7 ptpt -54.33 -33.54 59.16 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 122.062 -0.399 . . . . 0.81 112.01 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' OH ' ' HG ' ' A' ' 40' ' ' LEU . 98.5 m-85 -96.4 3.08 53.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.352 0.596 . . . . 0.42 109.92 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.8 m -122.13 -90.46 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.034 . . . . 0.18 110.389 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 13.0 m-85 -144.39 39.62 1.3 Allowed 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.262 0.467 . . . . 0.24 112.262 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.71 -83.26 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.188 -0.529 . . . . 0.25 113.744 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.74 7.66 4.72 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.405 2.07 . . . . 0.58 111.259 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.0 mt-30 -104.45 -51.17 3.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.716 -0.674 . . . . 0.65 110.498 -173.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.559 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 85.85 142.68 6.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.074 -0.966 . . . . 0.3 112.419 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.634 ' HB3' HG12 ' A' ' 132' ' ' ILE . 6.9 t -91.35 162.22 14.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.187 -0.506 . . . . 0.33 112.162 -175.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 83' ' ' GLU . 14.5 ptp180 -52.89 -51.37 61.42 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 115.151 -0.931 . . . . 3.17 112.238 -173.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.975 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 20.4 m -81.4 -64.7 0.27 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.438 . . . . 1.23 110.36 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.975 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 20.0 Cg_endo -105.24 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.401 2.067 . . . . 0.37 111.7 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.552 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 31.0 t80 -56.22 98.11 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.064 -1.087 . . . . 1.14 108.064 163.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 127' ' ' SER . 33.5 mm -65.35 128.99 94.27 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.893 -0.594 . . . . 0.39 109.639 -177.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.6 Cg_endo -52.38 139.14 55.72 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.659 2.239 . . . . 0.61 112.282 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.554 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 40.7 Cg_exo -57.55 129.05 31.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.528 2.152 . . . . 0.52 112.456 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.589 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 57.9 m80 75.36 12.16 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.936 -1.029 . . . . 2.38 112.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.76 127.14 32.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.235 -0.654 . . . . 0.26 109.235 173.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.48 113.08 11.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.521 -0.472 . . . . 0.22 110.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.14 132.87 35.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.072 -0.513 . . . . 0.22 110.97 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 5.2 t -118.11 100.07 7.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.605 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -109.5 136.71 48.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.651 -0.704 . . . . 0.32 111.586 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.694 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 50.8 tt0 -101.85 118.44 36.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.175 -0.676 . . . . 1.05 109.175 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 4.2 m -119.67 123.3 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.435 0.636 . . . . 0.19 112.555 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 42.9 m -92.79 118.54 31.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.645 -0.707 . . . . 0.28 109.362 170.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.703 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 37.4 tp -80.82 99.01 8.07 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.481 -0.933 . . . . 0.15 108.481 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.625 ' HD3' ' HB ' ' A' ' 67' ' ' THR . 19.2 mtpt -79.91 -44.48 20.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.464 -1.244 . . . . 1.08 110.328 -168.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 m -158.48 160.0 36.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.969 -0.56 . . . . 0.37 110.526 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.534 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.32 128.05 27.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.165 -0.68 . . . . 0.25 109.165 170.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 65' ' ' VAL . 20.4 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.92 110.06 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.991 -0.374 . . . . 50.23 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.98 -95.09 1.68 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.714 -0.755 . . . . 47.99 112.71 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 26.8 mt-30 -105.46 150.03 38.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.345 0.117 . . . . 46.26 110.805 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 23.5 Cg_exo -63.92 131.06 29.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.718 2.279 . . . . 44.8 111.514 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 14.1 Cg_exo -68.62 123.16 10.17 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.826 2.351 . . . . 44.02 112.499 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.1 16.96 3.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 42.5 110.447 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -109.97 119.58 39.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.948 -0.569 . . . . 41.5 110.479 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.76 157.85 22.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.0 -0.545 . . . . 40.33 109.568 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 -174.81 0.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.076 0.86 . . . . 39.09 111.146 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.567 ' HG2' ' HG3' ' A' ' 11' ' ' GLN . 29.6 tt0 -127.26 -77.17 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.045 0.45 . . . . 38.82 110.449 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.567 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 56.5 mt-30 -129.22 115.46 18.64 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 38.16 110.135 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 11' ' ' GLN . 2.7 Cg_endo -83.28 15.73 2.04 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.444 2.763 . . . . 36.7 112.031 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.02 -62.47 0.53 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.835 -0.698 . . . . 35.61 112.11 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.53 169.78 9.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.848 0.356 . . . . 35.03 110.803 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.01 -47.5 0.85 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.959 -0.564 . . . . 34.01 110.977 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 65.16 97.43 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.058 0.849 . . . . 32.89 111.409 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -81.86 179.2 7.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 31.94 111.193 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.45 61.06 0.66 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.72 -0.673 . . . . 31.24 110.789 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 31.2 t80 -80.79 -62.78 1.57 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.472 -0.786 . . . . 31.24 111.371 -174.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' HG ' ' CD2' ' A' ' 19' ' ' PHE . 96.2 mt -112.65 110.76 21.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.861 0.362 . . . . 29.85 111.242 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.61 113.9 14.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.732 -0.667 . . . . 28.2 110.787 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.0 34.12 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.507 -0.769 . . . . 26.78 109.575 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.4 ttp -122.01 15.27 10.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.373 -0.83 . . . . 27.47 109.8 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 3.0 mp0 -64.43 112.83 8.59 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.132 -0.94 . . . . 24.41 110.678 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 4.0 Cg_endo -86.19 93.5 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.306 2.671 . . . . 21.63 112.338 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.72 146.3 31.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.285 -0.416 . . . . 20.67 110.308 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.1 119.94 7.51 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.003 2.469 . . . . 18.02 112.45 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.41 28.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.744 -0.662 . . . . 14.93 110.384 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -64.59 157.47 55.24 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.713 2.276 . . . . 13.81 112.277 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.83 80.55 0.26 Allowed Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 124.097 0.873 . . . . 10.76 112.023 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.63 96.02 0.35 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.602 2.201 . . . . 9.77 112.181 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.03 130.96 22.41 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.788 -0.642 . . . . 5.86 110.335 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.78 -19.67 46.82 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.578 2.186 . . . . 4.47 112.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 71.2 -55.86 0.64 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.665 0.786 . . . . 4.13 111.538 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -91.4 108.26 19.77 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.554 -0.536 . . . . 2.45 109.554 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.609 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -95.71 -164.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 0.53 110.856 -176.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.71 109.76 4.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.2 -0.909 . . . . 0.5 110.131 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.623 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.0 t70 -74.76 123.8 25.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 2.51 110.818 174.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.506 HD12 HD11 ' A' ' 45' ' ' LEU . 8.8 mt -56.06 -36.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.711 -1.131 . . . . 0.46 111.568 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -110.77 -2.39 16.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.208 0.528 . . . . 0.72 110.473 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.17 24.75 67.51 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.33 -0.85 . . . . 0.52 111.627 -173.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.525 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -94.5 -22.37 18.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.858 0.361 . . . . 0.95 111.669 -177.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.548 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.0 -17.67 41.09 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.922 -0.656 . . . . 0.72 112.125 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.817 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 1.1 mt -96.07 -24.23 16.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.673 0.273 . . . . 1.56 110.912 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 39' ' ' ILE . 19.5 tp -123.68 100.39 6.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.374 -0.376 . . . . 0.32 111.854 -171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -130.11 139.88 50.87 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.097 -0.377 . . . . 1.14 111.722 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 10.3 ttpt -112.13 125.82 54.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.477 0.311 . . . . 0.35 110.637 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.2 ttpp -116.54 120.73 39.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 1.07 110.969 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 p -74.93 110.44 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.464 . . . . 0.33 111.646 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD11 ' HG3' ' A' ' 141' ' ' GLU . 9.0 mt -73.88 -52.0 14.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.827 -1.545 . . . . 0.28 106.827 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.866 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.7 t -133.46 130.72 21.11 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 113.21 -1.814 . . . . 0.36 106.752 170.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 22.7 Cg_endo -107.79 57.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.221 2.614 . . . . 0.54 114.024 -176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 81.61 94.12 0.49 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.958 -0.639 . . . . 0.55 112.848 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' CD ' ' HD3' ' A' ' 55' ' ' PRO . 36.5 Cg_exo -58.54 -48.13 16.39 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.198 2.599 . . . . 1.42 114.671 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD3' ' CD ' ' A' ' 54' ' ' PRO . 28.6 Cg_endo -94.49 -159.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.236 1.957 . . . . 2.04 112.612 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 69.28 2.59 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 110.576 -1.01 . . . . 0.98 110.576 173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 m -64.8 175.51 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 122.003 0.906 . . . . 0.99 113.252 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 108' ' ' VAL . 16.5 m -146.71 140.0 25.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.582 -1.19 . . . . 1.28 108.229 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 96.4 mtt180 -89.36 116.22 65.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 120.567 -0.453 . . . . 2.81 109.831 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 10.0 Cg_endo -52.38 148.59 25.53 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.493 2.795 . . . . 0.3 112.67 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -94.65 152.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 0.88 109.28 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.856 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 61.3 mttt -63.71 120.69 12.31 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 1.17 109.399 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 129.02 -41.92 1.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.06 -1.427 . . . . 0.42 110.075 -170.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.687 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -69.42 132.67 46.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.069 -0.715 . . . . 0.59 109.069 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 17.9 m -84.45 118.64 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-O 122.142 0.973 . . . . 1.22 108.727 175.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -115.65 144.84 22.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.93 -1.032 . . . . 0.25 111.486 -171.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.973 HG22 HG22 ' A' ' 87' ' ' VAL . 43.5 p -88.86 113.99 25.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.535 -0.757 . . . . 0.29 110.221 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.727 HG21 HD21 ' A' ' 99' ' ' LEU . 20.8 m -111.49 143.59 21.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 119.996 -0.682 . . . . 0.19 110.511 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.612 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -103.1 117.88 35.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.451 -1.314 . . . . 0.19 107.451 168.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -118.96 137.79 53.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 118.92 -1.112 . . . . 0.39 111.035 176.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.653 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.46 114.29 14.13 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.491 -2.041 . . . . 0.27 105.491 166.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.662 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 60.3 m -105.45 132.61 51.41 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 114.976 -1.011 . . . . 0.19 111.831 -168.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 m -104.39 156.88 17.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.096 -0.956 . . . . 1.06 108.874 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.419 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.8 mt -80.42 166.72 20.98 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.908 -0.775 . . . . 0.84 108.908 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 11.1 pt-20 -59.88 -14.54 15.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.915 0.339 . . . . 1.14 111.915 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -93.28 -15.63 25.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.897 0.38 . . . . 2.14 110.711 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.44 -3.92 19.93 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.813 -0.708 . . . . 0.51 113.644 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.1 m -75.67 110.88 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.369 0.584 . . . . 0.46 111.573 -177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.6 mtt180 -75.99 112.42 12.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.854 0.835 . . . . 0.47 110.857 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.573 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.2 m -99.02 -13.8 7.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 113.992 -1.458 . . . . 0.27 112.377 -169.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.611 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.8 pt20 -157.06 136.58 12.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.81 0.338 . . . . 0.59 110.586 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.52 130.42 32.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.969 -0.559 . . . . 1.34 109.687 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 4.8 tt0 -145.09 112.98 4.84 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.562 -0.745 . . . . 2.59 109.815 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 15.2 Cg_exo -68.19 -15.77 43.27 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.501 2.801 . . . . 0.5 113.315 -171.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.578 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 26.5 tt0 -166.34 113.28 0.86 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.021 0.915 . . . . 1.37 111.572 -175.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.455 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 49.7 tp -126.72 110.76 13.49 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.55 -1.659 . . . . 0.38 108.737 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.973 HG22 HG22 ' A' ' 67' ' ' THR . 2.1 t -100.79 125.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 p90 -145.56 160.71 41.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.23 111.44 -172.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 m -79.29 106.67 11.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.593 -0.73 . . . . 0.42 110.4 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.856 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.02 134.54 57.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.213 -0.448 . . . . 0.6 110.514 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.681 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 81.44 -5.63 67.63 Favored Glycine 0 CA--C 1.503 -0.71 0 C-N-CA 120.824 -0.703 . . . . 0.37 113.293 173.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -107.17 15.54 25.04 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.534 -0.913 . . . . 0.93 108.534 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 32.2 m 53.65 39.61 30.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.109 -1.405 . . . . 0.62 109.633 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.3 t0 -76.86 -2.79 35.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.563 1.173 . . . . 1.33 108.383 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 6.2 m -140.04 -157.07 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 113.646 -1.616 . . . . 0.23 110.757 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.5 pt -82.82 139.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.567 -1.272 . . . . 0.29 107.567 173.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.523 HE21 ' HB3' ' A' ' 100' ' ' ASP . 6.3 tp60 -58.85 -31.51 68.6 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.351 -0.386 . . . . 0.4 111.261 -171.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.91 79.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 0.2 110.491 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 68' ' ' VAL . 53.7 tp -75.5 -38.01 59.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.314 -0.857 . . . . 0.22 110.551 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' HB3' HE21 ' A' ' 97' ' ' GLN . 13.2 t70 -61.41 -29.82 70.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.97 -1.014 . . . . 0.26 109.868 -175.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.55 -36.04 14.7 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.198 -0.91 . . . . 0.25 111.969 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.8 t -64.91 -30.87 71.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.676 -0.238 . . . . 1.01 111.191 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 104' ' ' PRO . 76.1 t -65.55 -53.45 37.37 Favored Pre-proline 0 C--O 1.218 -0.578 0 CA-C-N 116.471 -0.332 . . . . 0.21 111.888 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.802 ' HD3' HD11 ' A' ' 90' ' ' LEU . 64.5 Cg_exo -52.55 -28.83 38.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.992 1.795 . . . . 0.27 112.706 171.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.56 -11.52 53.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.8 -0.636 . . . . 0.64 111.279 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -100.43 142.07 32.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.27 -0.877 . . . . 0.78 110.701 176.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.576 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -89.37 156.88 18.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.97 108.781 172.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 58' ' ' SER . 1.3 p -66.04 126.47 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.935 0.874 . . . . 0.8 110.459 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.8 -2.3 45.17 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.337 -0.847 . . . . 0.28 112.254 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.866 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 6.8 pt-20 -96.95 168.13 10.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.529 0.68 . . . . 0.41 110.913 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.438 HG22 HD12 ' A' ' 50' ' ' LEU . 10.2 m -130.18 116.96 19.18 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.369 -0.974 . . . . 0.22 108.369 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.595 ' HB3' ' SD ' ' A' ' 106' ' ' MET . . . -115.21 135.28 54.34 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.878 -0.601 . . . . 0.18 110.314 -176.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttm -97.46 117.0 30.74 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.124 -1.436 . . . . 1.32 107.124 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.62 130.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.584 -0.524 . . . . 0.18 109.584 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.512 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 98.1 m -105.79 112.48 25.56 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.075 -1.083 . . . . 0.21 108.075 170.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.31 133.69 52.52 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.988 -1.46 . . . . 0.15 109.227 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.817 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 10.0 t70 -52.67 145.77 11.44 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.893 -0.78 . . . . 0.58 108.893 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.8 t -52.74 -29.49 27.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.965 0.412 . . . . 0.82 110.125 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.693 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 7.0 ptpp? -56.73 -27.14 58.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.206 0.447 . . . . 0.81 112.206 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.564 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 88.9 m-85 -99.4 0.99 43.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.3 0.571 . . . . 0.42 109.922 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -119.72 -92.03 0.54 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.816 -1.084 . . . . 0.18 109.994 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.0 m-85 -142.02 43.62 1.68 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 120.71 -0.396 . . . . 0.24 111.761 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.29 -89.83 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 113.957 0.343 . . . . 0.25 113.957 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.65 15.27 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.639 2.226 . . . . 0.58 110.707 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 33.0 mt-30 -104.3 -43.28 5.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.232 -0.895 . . . . 0.65 109.672 -176.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.595 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 75.85 144.99 1.44 Allowed Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 114.655 -1.157 . . . . 0.3 112.673 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.678 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.3 t -92.08 159.91 15.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.417 -0.392 . . . . 0.33 111.322 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.449 HH12 ' CD ' ' A' ' 83' ' ' GLU . 33.2 mtt180 -53.18 -57.0 11.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.329 -0.851 . . . . 3.17 111.109 -173.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.96 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.3 m -74.6 -64.31 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 115.833 -0.622 . . . . 1.23 110.553 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.96 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.6 Cg_endo -106.72 126.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.973 1.782 . . . . 0.37 112.132 174.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.595 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 34.3 t80 -58.85 98.02 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.153 -1.054 . . . . 1.14 108.153 165.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.0 mm -65.97 132.33 94.66 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.39 109.886 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 52.7 Cg_exo -54.53 140.5 75.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.675 2.25 . . . . 0.61 112.436 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.477 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 48.2 Cg_exo -56.58 140.19 89.36 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.535 2.157 . . . . 0.52 112.392 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.637 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 29.5 p80 47.59 28.76 1.27 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.398 1.079 . . . . 2.38 113.145 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -86.19 134.2 33.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.374 -0.973 . . . . 0.26 108.374 169.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -77.81 113.32 15.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.306 -0.558 . . . . 0.22 110.326 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.662 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 2.5 tp -90.41 132.01 35.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.774 -0.648 . . . . 0.22 110.015 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.8 t -115.56 100.38 8.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.308 -0.627 . . . . 1.2 109.308 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.4 pp -113.36 136.36 52.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.002 -0.545 . . . . 0.32 111.686 -171.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.653 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 46.9 tt0 -104.21 111.26 23.8 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.72 . . . . 1.05 109.213 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.682 HG11 HD13 ' A' ' 99' ' ' LEU . 2.9 m -113.72 117.18 54.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.119 0.785 . . . . 0.19 113.119 -173.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.6 m -88.6 108.96 19.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.636 -1.165 . . . . 0.28 110.369 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.407 HD21 ' HG3' ' A' ' 60' ' ' PRO . 61.7 tp -81.75 93.05 6.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.326 -0.99 . . . . 0.15 108.326 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.472 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 24.7 mtmt -90.13 -31.21 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.679 -0.691 . . . . 1.08 110.754 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.4 m -148.67 151.46 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.961 0.41 . . . . 0.37 111.293 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.551 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -139.78 128.11 22.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.25 109.289 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.54 145.14 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.479 -0.488 . . . . 0.92 110.245 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.45 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 10.0 t0 -91.98 118.41 30.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.171 -0.468 . . . . 2.27 110.147 -174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 tp -141.5 10.02 2.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.371 0.605 . . . . 1.97 109.845 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 7.1 tp10 -115.05 105.08 12.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 2.14 110.183 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -143.05 16.98 1.93 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.789 -0.641 . . . . 5.79 110.082 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -112.49 145.1 40.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.812 0.339 . . . . 7.48 111.098 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 26.8 m170 64.87 -172.27 0.18 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.701 -0.681 . . . . 8.46 111.772 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -170.69 168.39 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.976 -1.12 . . . . 8.83 107.976 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.51 143.85 29.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.513 -0.475 . . . . 12.17 111.056 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 117.953 -1.022 . . . . 13.46 109.11 179.575 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.825 0.345 . . . . 50.23 110.343 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.06 -23.25 5.89 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.039 -0.824 . . . . 47.99 111.039 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.717 HE21 ' HD2' ' A' ' 5' ' ' PRO . 24.2 tp60 -118.95 82.15 20.71 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 109.654 -0.499 . . . . 46.26 109.654 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.551 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 39.5 Cg_exo -60.24 -55.92 1.33 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.265 2.643 . . . . 44.8 114.382 -176.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.717 ' HD2' HE21 ' A' ' 3' ' ' GLN . 8.6 Cg_exo -72.0 123.04 8.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.328 1.352 . . . . 44.02 111.884 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 2.27 43.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.397 0.618 . . . . 42.5 110.299 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 -8.63 59.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.164 -0.925 . . . . 41.5 111.453 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -87.91 22.91 2.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.902 0.382 . . . . 40.33 110.687 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.54 130.17 7.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 39.09 110.492 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -151.4 113.59 4.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.24 0.543 . . . . 38.82 109.658 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.71 86.99 6.05 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 121.674 0.749 . . . . 38.16 110.613 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.54 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.807 2.338 . . . . 36.7 112.285 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.33 53.15 0.47 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.769 -0.729 . . . . 35.61 112.161 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.6 32.63 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.727 0.299 . . . . 35.03 111.5 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.36 103.62 15.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.526 -0.306 . . . . 34.01 110.477 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.81 102.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.693 -0.484 . . . . 32.89 109.693 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -139.18 -166.69 2.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.016 -0.538 . . . . 31.94 110.57 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.42 119.56 19.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.039 -0.528 . . . . 31.24 110.674 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -119.31 -3.82 10.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.024 -0.534 . . . . 31.24 110.625 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.1 pt? -124.21 161.89 24.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.175 -0.466 . . . . 29.85 110.145 -174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.52 -26.15 16.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.235 -0.439 . . . . 28.2 110.912 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 72.7 145.52 0.07 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.209 0.943 . . . . 26.78 111.711 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -95.85 -46.18 6.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.763 -0.653 . . . . 27.47 110.289 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -156.35 107.06 2.04 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.609 -0.723 . . . . 24.41 109.744 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.73 137.42 27.26 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.991 2.461 . . . . 21.63 112.008 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 44.6 mt-10 -79.29 133.32 60.56 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.054 -0.521 . . . . 20.67 110.364 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 34.5 Cg_exo -61.47 112.89 1.57 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.965 2.443 . . . . 18.02 113.356 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -119.96 126.68 26.75 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 14.93 109.952 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 23.6 Cg_exo -65.37 128.17 19.75 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.711 2.274 . . . . 13.81 112.533 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -171.03 -56.63 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 10.76 111.262 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 89.0 Cg_endo -81.39 168.9 16.16 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.0 1.8 . . . . 9.77 112.568 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.93 145.69 37.1 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 5.86 110.545 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.99 -16.51 50.3 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.232 2.621 . . . . 4.47 113.203 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 5.8 mm-40 -96.94 1.19 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.5 . . . . 4.13 110.984 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -99.58 78.47 2.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.144 -1.058 . . . . 2.45 108.144 168.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.594 ' HZ3' ' H ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -72.38 -175.36 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.53 110.528 -173.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.7 tp -69.39 110.81 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.551 -0.749 . . . . 0.5 109.618 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.621 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 11.6 t70 -75.71 128.56 35.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.202 -0.599 . . . . 2.51 109.463 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.544 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 7.3 mt -65.13 -23.62 33.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.847 -1.069 . . . . 0.46 110.839 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.3 mt -116.14 -5.5 11.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.72 110.101 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 69.19 18.52 73.17 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.361 -0.836 . . . . 0.52 112.361 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.464 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -98.28 -31.17 12.19 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.636 0.606 . . . . 0.95 112.636 -176.035 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.516 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.85 -0.83 21.46 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.473 -0.87 . . . . 0.72 112.242 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.13 -35.59 9.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.173 0.511 . . . . 1.56 110.801 -176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 18.2 tp -122.68 101.62 7.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.132 -0.94 . . . . 0.32 111.253 -172.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 71.3 mtm180 -133.89 140.33 46.76 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.124 -0.36 . . . . 1.14 111.472 -171.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HZ3' ' HA ' ' A' ' 106' ' ' MET . 14.2 ttpt -111.49 123.33 50.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.35 110.696 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 11.2 ttmm -103.13 118.77 37.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.392 -0.225 . . . . 1.07 110.392 175.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -76.71 96.09 4.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.486 -0.325 . . . . 0.33 110.577 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 111' ' ' THR . 10.6 mt -63.1 -49.47 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.304 -1.369 . . . . 0.28 107.304 174.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 72.2 t -140.1 126.32 11.97 Favored Pre-proline 0 CA--C 1.499 -0.987 0 CA-C-N 112.617 -2.083 . . . . 0.36 106.588 170.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -104.28 64.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.546 2.164 . . . . 0.54 113.845 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.8 178.13 21.09 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.4 -0.818 . . . . 0.55 113.888 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 98.4 Cg_endo -89.95 165.06 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.259 2.64 . . . . 1.42 111.071 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.58 105.7 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.226 1.951 . . . . 2.04 111.945 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.76 42.18 2.02 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.956 -0.64 . . . . 0.98 112.015 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.625 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 2.3 p -83.65 -164.15 0.87 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.947 0.403 . . . . 0.99 110.566 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.432 ' H ' HG12 ' A' ' 108' ' ' VAL . 10.6 t -152.48 136.05 16.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.787 -0.82 . . . . 1.28 108.787 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 84.6 mtt180 -92.48 108.57 32.29 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.73 -0.47 . . . . 2.81 109.73 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 144' ' ' LEU . 5.3 Cg_endo -46.55 142.76 9.37 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.996 3.13 . . . . 0.3 114.037 -175.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 15.7 t -89.41 153.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.49 -0.777 . . . . 0.88 109.717 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.653 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -68.52 117.12 9.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.732 0.777 . . . . 1.17 110.956 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.7 -27.24 3.23 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.354 -1.293 . . . . 0.42 110.423 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -75.65 140.94 42.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.59 109.147 176.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.3 m -86.71 126.54 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.42 -1.326 . . . . 1.22 107.42 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 33.3 m -120.6 146.41 25.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.174 -0.466 . . . . 0.25 110.195 -173.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.446 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 31.3 p -96.37 111.71 23.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.822 -0.626 . . . . 0.29 110.047 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG21 HD21 ' A' ' 99' ' ' LEU . 3.9 m -111.42 143.57 20.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.746 -0.661 . . . . 0.19 110.362 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.3 114.04 27.65 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.018 -1.475 . . . . 0.19 107.018 171.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -114.67 135.47 54.12 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.301 -0.959 . . . . 0.39 111.132 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -134.17 113.45 12.05 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.742 -1.947 . . . . 0.27 105.742 165.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.608 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 88.3 m -105.24 132.13 51.83 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.605 -1.18 . . . . 0.19 111.411 -168.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.791 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -110.46 156.61 20.61 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.297 -0.865 . . . . 1.06 109.131 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.72 165.64 21.77 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.828 -0.624 . . . . 0.84 109.807 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.7 -21.18 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 1.14 111.266 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -91.3 -8.15 49.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.864 -0.607 . . . . 2.14 110.61 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.44 -9.37 41.66 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.061 -0.59 . . . . 0.51 112.702 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -74.23 109.41 7.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.72 0.267 . . . . 0.46 111.72 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 23.3 mtt180 -75.71 124.37 27.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.254 0.55 . . . . 0.47 110.532 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.0 m -112.76 -9.24 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.914 -1.039 . . . . 0.27 112.777 -168.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.608 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.8 pt20 -159.4 132.5 7.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.475 -0.33 . . . . 0.59 110.137 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.465 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 63.1 tt0 -140.85 118.58 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 1.34 110.644 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 3.0 tt0 -137.48 121.15 11.77 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.622 -0.717 . . . . 2.59 110.313 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 8.9 Cg_exo -71.23 -13.63 31.06 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.627 2.885 . . . . 0.5 113.274 -174.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -161.5 105.58 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.048 0.928 . . . . 1.37 111.784 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.558 ' HB3' HG23 ' A' ' 68' ' ' VAL . 25.7 tp -114.88 109.97 18.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.443 -1.708 . . . . 0.38 109.344 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.7 p -104.67 131.38 53.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.68 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 46.1 p90 -150.98 158.67 44.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.568 -0.287 . . . . 0.23 111.111 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 m -77.07 109.48 10.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.42 110.181 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.814 HD11 ' HD3' ' A' ' 104' ' ' PRO . 17.7 tp -62.05 133.96 55.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.6 110.541 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 83.93 3.59 89.13 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.788 -0.72 . . . . 0.37 112.527 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -106.37 -2.68 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.42 . . . . 0.93 110.021 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.3 m 59.46 35.91 22.98 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.775 -0.824 . . . . 0.62 108.775 -172.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -73.96 -2.86 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.26 1.028 . . . . 1.33 108.48 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.465 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 5.8 m -139.87 -153.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 113.767 -1.56 . . . . 0.23 109.726 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.2 pt -82.94 138.04 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.265 -1.383 . . . . 0.29 107.265 172.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.52 HE21 ' HB3' ' A' ' 100' ' ' ASP . 9.3 tp60 -57.65 -31.04 65.91 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.568 -0.287 . . . . 0.4 111.071 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.63 -48.19 69.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.2 110.863 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 68' ' ' VAL . 46.9 tp -72.92 -38.11 66.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.367 -0.833 . . . . 0.22 110.468 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.52 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.2 t70 -61.6 -30.04 70.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.824 -1.08 . . . . 0.26 109.695 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 84.3 mt -89.92 -35.01 15.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.375 -0.83 . . . . 0.25 111.63 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.7 t -63.57 -36.2 83.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 1.01 111.321 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.532 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 46.6 t -62.61 -55.87 34.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 112.772 0.656 . . . . 0.21 112.772 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.814 ' HD3' HD11 ' A' ' 90' ' ' LEU . 25.7 Cg_endo -64.42 -19.57 65.45 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 121.887 1.725 . . . . 0.27 112.114 176.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 39' ' ' ILE . 12.8 mt -82.59 -13.62 56.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.016 -0.538 . . . . 0.64 111.297 173.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.654 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.7 ptm -107.32 154.41 21.32 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.088 -0.505 . . . . 0.78 110.72 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.71 152.75 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.97 110.494 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 58' ' ' SER . 2.1 p -63.16 126.6 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 122.052 0.93 . . . . 0.8 110.116 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.54 12.37 57.13 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.661 -1.154 . . . . 0.28 112.952 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.823 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.1 pt-20 -101.7 168.48 9.43 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.41 110.736 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.495 HG22 HD12 ' A' ' 50' ' ' LEU . 9.5 m -129.63 119.08 22.98 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.653 -1.24 . . . . 0.22 107.653 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.73 53.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.037 0.446 . . . . 0.18 111.018 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.9 ttm -97.96 116.71 30.73 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.32 107.216 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.2 t -113.91 128.75 70.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.985 -0.376 . . . . 0.18 109.985 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.594 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 62.7 m -104.67 113.73 27.5 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 108.187 -1.042 . . . . 0.21 108.187 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.63 141.92 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.01 -1.45 . . . . 0.15 108.749 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 6.6 t70 -57.76 156.37 8.8 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.223 -0.591 . . . . 0.58 109.578 174.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.672 ' OG ' ' HA ' ' A' ' 135' ' ' HIS . 70.6 p -47.34 -43.4 22.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.996 -1.002 . . . . 0.82 110.739 175.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 14.4 ptpt -59.76 -28.97 67.85 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.907 -1.042 . . . . 0.81 112.042 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.592 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 91.6 m-85 -94.81 2.63 55.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.364 0.602 . . . . 0.42 109.856 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.792 ' HB3' HD22 ' A' ' 138' ' ' LEU . 91.1 m -122.78 -92.34 0.54 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.623 -1.172 . . . . 0.18 110.271 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.661 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 3.8 m-85 -147.37 37.66 0.93 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 119.019 -0.515 . . . . 0.24 111.85 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 118' ' ' SER . . . -52.73 -83.5 0.03 OUTLIER Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.597 -0.811 . . . . 0.25 112.998 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.53 7.36 4.54 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.551 2.167 . . . . 0.58 111.692 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -104.22 -46.97 4.28 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.749 -0.66 . . . . 0.65 110.66 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.608 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 80.73 142.06 3.07 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.954 -1.021 . . . . 0.3 112.225 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.712 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.4 t -91.65 159.42 15.88 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.575 0.583 . . . . 0.33 112.575 -174.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 129' ' ' SER . 9.6 ptp180 -48.97 -53.98 17.51 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.48 -1.236 . . . . 3.17 112.259 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.957 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 3.5 m -82.4 -63.88 0.27 Allowed Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.895 -0.409 . . . . 1.23 109.895 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.957 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.1 Cg_endo -105.07 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.522 2.148 . . . . 0.37 112.262 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.608 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 26.1 t80 -55.57 97.45 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.674 -0.861 . . . . 1.14 108.674 163.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.595 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.3 mm -66.77 122.57 82.86 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.75 -0.659 . . . . 0.39 109.313 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 47.2 Cg_exo -56.02 137.74 80.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.261 1.974 . . . . 0.61 111.965 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.501 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 38.4 Cg_exo -56.35 130.2 38.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.387 2.058 . . . . 0.52 112.823 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.672 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 17.3 m80 74.39 23.82 1.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.577 -1.647 . . . . 2.38 112.878 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.51 116.01 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.29 -1.004 . . . . 0.26 108.29 166.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.61 132.5 43.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.99 0.424 . . . . 0.22 110.039 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -104.05 132.37 50.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.918 -0.583 . . . . 0.22 111.773 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.2 t -116.63 100.45 7.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.061 -0.718 . . . . 1.2 109.061 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.6 pp -112.57 137.13 51.25 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.771 -0.65 . . . . 0.32 111.579 -171.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.547 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 41.2 tt0 -106.8 116.2 31.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.891 -0.781 . . . . 1.05 108.891 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 99' ' ' LEU . 4.6 m -117.12 120.91 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.724 0.638 . . . . 0.19 112.724 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.9 m -88.75 108.85 19.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.082 -0.963 . . . . 0.28 110.737 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.654 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 55.7 tp -81.71 94.74 7.05 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.68 -0.859 . . . . 0.15 108.68 172.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.9 mtmt -89.33 -25.1 21.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.141 -0.936 . . . . 1.08 110.821 -171.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.446 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 22.0 m -160.84 148.12 15.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.664 0.269 . . . . 0.37 111.174 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -124.43 127.96 48.31 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.193 -0.669 . . . . 0.25 109.193 168.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.2 t -119.93 121.09 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.92 109.619 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.559 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 5.1 t0 -74.75 116.31 15.31 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.815 -0.809 . . . . 2.27 108.815 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -152.95 22.94 0.57 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.445 -0.798 . . . . 1.97 109.482 -169.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.509 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -72.83 -96.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.039 -1.097 . . . . 2.14 108.039 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.509 ' H ' ' HB3' ' A' ' 151' ' ' GLU . 82.0 m-70 37.53 68.32 0.3 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 124.184 0.928 . . . . 5.79 111.791 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -67.47 8.75 0.3 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.407 0.521 . . . . 7.48 112.407 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -84.29 94.16 8.38 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.877 -0.416 . . . . 8.46 109.877 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -140.28 138.72 35.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.568 -0.287 . . . . 8.83 110.748 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -165.05 121.89 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 12.17 110.022 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 35.6 m170 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.42 -0.8 . . . . 13.46 110.051 175.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.968 -0.382 . . . . 50.23 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.22 -52.59 0.45 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.478 -0.867 . . . . 47.99 113.139 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 47.1 mt-30 -104.5 155.97 36.56 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.457 0.128 . . . . 46.26 110.72 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 61.1 Cg_exo -51.48 -50.11 15.01 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.09 2.526 . . . . 44.8 113.583 173.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 12.8 Cg_exo -71.45 122.63 8.8 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.501 1.467 . . . . 44.02 111.986 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 13.15 29.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.619 0.723 . . . . 42.5 109.704 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.77 -17.34 30.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.107 -0.951 . . . . 41.5 110.103 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.9 118.12 30.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.789 -0.641 . . . . 40.33 110.941 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.22 127.99 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.93 -0.577 . . . . 39.09 110.831 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.6 25.76 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 38.82 109.707 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -98.67 120.91 57.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.554 0.692 . . . . 38.16 111.136 -171.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.89 -60.56 0.17 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.45 2.767 . . . . 36.7 112.497 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.58 107.3 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.788 -0.525 . . . . 35.61 111.788 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 59.45 69.25 0.73 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.733 -0.469 . . . . 35.03 109.733 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 95.6 mt 69.13 -165.19 0.18 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.097 -0.956 . . . . 34.01 110.374 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.73 116.53 26.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.721 -0.844 . . . . 32.89 108.721 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 17' ' ' ARG . 21.3 mmt180 -144.11 32.13 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.955 0.407 . . . . 31.94 111.496 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.89 92.53 0.51 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 31.24 109.751 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -66.54 -17.09 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.783 -0.644 . . . . 31.24 110.743 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.96 75.74 10.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 29.85 109.785 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.53 127.68 20.95 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.644 -0.707 . . . . 28.2 110.226 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.99 106.3 1.89 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 26.78 110.709 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.0 mtt -84.36 67.44 9.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.862 0.839 . . . . 27.47 110.417 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -133.07 93.53 22.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 114.693 -1.139 . . . . 24.41 108.813 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.15 137.82 58.64 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.674 2.249 . . . . 21.63 112.244 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 10.6 pt-20 -56.69 132.44 78.23 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 20.67 110.2 177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 53.1 Cg_exo -54.93 128.69 31.59 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.036 2.491 . . . . 18.02 112.655 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.32 147.5 36.91 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.623 -0.717 . . . . 14.93 110.981 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.73 128.16 22.55 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.52 2.147 . . . . 13.81 111.684 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.4 71.09 3.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.934 -0.575 . . . . 10.76 111.692 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.39 101.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.574 2.183 . . . . 9.77 111.63 169.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.78 138.8 21.18 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.219 -0.446 . . . . 5.86 110.674 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.24 -44.74 17.83 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.682 2.255 . . . . 4.47 112.051 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 179.54 -55.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.964 -0.754 . . . . 4.13 108.964 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 69.33 110.35 0.05 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.982 -1.008 . . . . 2.45 112.371 173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.584 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 0.8 OUTLIER -109.84 -157.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.53 110.625 -175.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.05 118.26 12.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.585 -0.734 . . . . 0.5 110.415 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.64 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.4 t70 -80.98 129.4 34.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.324 0.583 . . . . 2.51 110.379 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.606 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.1 mt -65.51 -24.91 35.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.801 -1.091 . . . . 0.46 111.088 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.66 0.7 10.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.55 . . . . 0.72 110.47 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.25 22.37 65.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.436 -0.802 . . . . 0.52 112.306 -174.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.07 -28.24 15.83 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.137 0.421 . . . . 0.95 112.137 -176.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 108.58 -1.01 32.41 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.818 -0.706 . . . . 0.72 112.065 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.51 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 8.6 mp -105.42 -31.58 8.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.051 0.453 . . . . 1.56 111.215 -176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 16.5 tp -122.31 101.33 7.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.4 -0.818 . . . . 0.32 111.471 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HG2' ' CA ' ' A' ' 38' ' ' ASP . 67.5 mtm180 -133.42 141.01 47.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.356 0.502 . . . . 1.14 112.356 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' HG3' HG22 ' A' ' 114' ' ' VAL . 11.4 ttpt -114.28 126.09 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.35 110.654 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.6 ttpt -112.03 128.56 56.22 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 121.062 -0.255 . . . . 1.07 110.894 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 p -83.94 103.89 13.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.223 -0.444 . . . . 0.33 110.711 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 111' ' ' THR . 8.0 mt -65.26 -52.94 51.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.832 -1.544 . . . . 0.28 106.832 170.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.815 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 86.6 t -131.93 131.99 22.92 Favored Pre-proline 0 CA--C 1.501 -0.912 0 CA-C-N 113.28 -1.782 . . . . 0.36 106.242 167.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.7 Cg_endo -104.61 53.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.935 2.423 . . . . 0.54 113.023 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.27 169.98 29.81 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.957 -1.02 . . . . 0.55 112.807 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.55 150.45 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.6 2.2 . . . . 1.42 110.264 172.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.91 115.06 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.329 2.019 . . . . 2.04 111.534 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.19 49.47 2.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.405 -0.902 . . . . 0.98 111.724 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -81.89 170.93 15.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.543 0.687 . . . . 0.99 111.901 -177.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.746 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 50.5 m -116.59 133.61 55.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.32 -0.855 . . . . 1.28 108.896 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 86.2 mtt180 -99.46 113.6 65.0 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-O 120.931 0.396 . . . . 2.81 110.481 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.658 ' HG3' HD21 ' A' ' 144' ' ' LEU . 10.9 Cg_endo -53.77 145.78 48.34 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.43 2.754 . . . . 0.3 113.382 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 17.6 t -97.19 152.68 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.88 109.396 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.976 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 89.1 mttt -71.34 120.84 17.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.454 0.645 . . . . 1.17 109.762 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.48 -26.97 4.27 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 109.872 -1.291 . . . . 0.42 109.872 -172.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.657 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.06 139.73 30.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.455 -0.943 . . . . 0.59 108.455 176.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 6.9 m -86.17 128.91 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 108.075 -1.083 . . . . 1.22 108.075 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -124.91 146.46 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.175 -0.92 . . . . 0.25 110.778 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.478 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 37.1 p -95.38 113.02 24.64 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.099 -0.501 . . . . 0.29 110.572 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.682 HG21 HD21 ' A' ' 99' ' ' LEU . 30.3 m -110.65 143.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.037 -0.665 . . . . 0.19 109.846 173.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.52 116.29 32.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.701 -1.592 . . . . 0.19 106.701 168.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.71 137.94 52.98 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.079 -1.049 . . . . 0.39 111.024 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.74 114.56 14.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.788 -1.93 . . . . 0.27 105.788 165.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.628 HG23 ' HB3' ' A' ' 140' ' ' LEU . 75.3 m -102.36 126.43 49.38 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.529 -1.214 . . . . 0.19 111.414 -166.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 13.1 t -105.23 152.44 22.86 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.464 -0.789 . . . . 1.06 109.498 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.3 mt -82.32 164.89 20.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.368 -0.833 . . . . 0.84 109.863 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.69 -24.82 36.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.391 0.615 . . . . 1.14 110.443 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -80.42 -12.81 59.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.344 -0.844 . . . . 2.14 111.204 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.58 17.69 30.25 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.714 -0.755 . . . . 0.51 112.039 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 m -102.55 110.05 21.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.581 0.229 . . . . 0.46 111.525 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.687 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.2 mtt180 -74.87 115.41 14.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.523 0.678 . . . . 0.47 110.083 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.659 ' HB ' ' CG ' ' A' ' 130' ' ' PRO . 27.0 m -99.51 -11.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.017 -0.992 . . . . 0.27 111.989 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.618 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.6 pt20 -159.48 136.1 9.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.05 -0.523 . . . . 0.59 110.144 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 38.0 tt0 -133.43 123.94 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.999 0.428 . . . . 1.34 109.849 173.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -136.96 116.85 10.62 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.344 -0.844 . . . . 2.59 109.71 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.418 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 61.2 Cg_endo -72.09 -14.49 28.96 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.118 2.546 . . . . 0.5 113.105 -170.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 22.7 tt0 -164.94 110.83 0.95 Allowed 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 122.181 0.991 . . . . 1.37 111.029 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.09 103.25 8.88 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.179 -1.828 . . . . 0.38 108.877 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.0 p -97.52 125.42 50.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.834 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.817 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 43.3 p90 -147.19 159.58 43.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 0.23 110.952 -172.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 2.8 m -80.62 110.0 15.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.864 -0.607 . . . . 0.42 110.176 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.976 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 13.8 tp -58.06 134.49 56.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.6 110.955 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 74.47 11.54 82.54 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 121.043 -0.598 . . . . 0.37 112.375 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 27.0 t70 -112.58 8.56 19.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.192 -0.67 . . . . 0.93 109.192 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 55.0 m 55.83 33.69 22.03 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.938 -1.028 . . . . 0.62 109.877 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.817 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 2.4 t0 -68.63 -14.6 63.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.393 1.092 . . . . 1.33 108.693 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -133.96 -156.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 113.799 -1.546 . . . . 0.23 110.539 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.5 pt -82.87 139.68 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.722 -1.214 . . . . 0.29 107.722 175.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.524 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.4 tp60 -58.23 -30.53 66.58 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.244 -0.182 . . . . 0.4 110.955 -172.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -54.5 -45.31 73.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.385 0.612 . . . . 0.2 110.495 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 68' ' ' VAL . 59.4 tp -77.88 -38.77 45.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.323 -0.853 . . . . 0.22 110.665 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.68 -28.52 69.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.108 -0.951 . . . . 0.26 109.585 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 77.5 mt -90.47 -34.95 15.39 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.199 -0.91 . . . . 0.25 111.883 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' MET . 32.4 t -64.17 -35.43 80.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.343 . . . . 1.01 111.287 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.565 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.6 t -63.32 -55.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.633 0.605 . . . . 0.21 112.633 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.845 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.7 Cg_endo -63.16 -22.05 72.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.814 1.676 . . . . 0.27 111.839 176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 39' ' ' ILE . 9.5 mt -81.68 -13.1 58.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.64 111.271 173.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.671 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -106.42 157.19 17.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.959 -0.564 . . . . 0.78 110.828 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.0 m-20 -96.37 153.56 17.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.91 0.386 . . . . 0.97 110.187 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.746 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -64.05 129.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.667 0.746 . . . . 0.8 110.728 -178.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.66 7.47 61.57 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.536 -1.211 . . . . 0.28 112.348 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.815 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.3 pt-20 -97.45 166.61 11.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.517 0.675 . . . . 0.41 111.546 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.419 HG22 HD12 ' A' ' 50' ' ' LEU . 13.0 m -127.59 117.66 22.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.823 -1.177 . . . . 0.22 107.823 172.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -119.98 137.24 54.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.944 0.402 . . . . 0.18 110.331 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.6 ttp -101.8 117.79 35.58 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.561 -1.274 . . . . 1.32 107.561 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.517 HG22 ' HG3' ' A' ' 47' ' ' LYS . 10.5 t -112.67 135.83 50.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.296 -0.411 . . . . 0.18 109.989 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 50.6 m -114.57 112.66 23.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.37 -0.974 . . . . 0.21 108.37 171.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -125.16 136.56 53.72 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.399 -1.728 . . . . 0.15 109.688 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.689 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 11.1 t70 -53.05 149.5 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.112 -0.699 . . . . 0.58 109.112 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.6 t -56.13 -28.06 56.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.191 0.52 . . . . 0.82 110.385 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.627 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.2 ptpt -55.33 -29.95 59.29 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 121.945 -0.472 . . . . 0.81 111.498 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 72.6 m-85 -95.11 0.17 54.05 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.243 0.544 . . . . 0.42 110.271 176.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.66 ' HB3' HD22 ' A' ' 138' ' ' LEU . 61.8 m -122.56 -89.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.988 -1.005 . . . . 0.18 110.581 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.8 m-85 -143.88 40.67 1.4 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.004 0.372 . . . . 0.24 112.004 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.04 -82.9 0.04 OUTLIER Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 0.25 113.965 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.97 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.536 2.158 . . . . 0.58 111.003 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -104.83 -51.5 3.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.376 -0.829 . . . . 0.65 109.721 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.618 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.05 141.74 3.14 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 114.401 -1.272 . . . . 0.3 112.151 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.2 t -91.67 152.32 20.27 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.229 0.538 . . . . 0.33 111.961 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -46.65 -48.32 20.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.464 -1.244 . . . . 3.17 113.428 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 1.044 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 47.2 m -81.54 -65.95 0.24 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.124 -0.63 . . . . 1.23 109.896 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.044 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -107.01 127.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 122.295 1.997 . . . . 0.37 112.043 172.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -55.95 97.97 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.916 -1.142 . . . . 1.14 107.916 164.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.599 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -66.5 126.49 92.26 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.678 -0.692 . . . . 0.39 109.532 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.78 145.29 31.8 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.734 2.289 . . . . 0.61 112.189 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.608 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.7 Cg_endo -63.94 133.23 37.77 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.059 1.839 . . . . 0.52 111.817 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.689 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 32.3 m170 71.77 8.3 6.07 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.018 -0.992 . . . . 2.38 112.16 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -69.96 122.11 18.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.737 -0.838 . . . . 0.26 108.737 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.58 112.78 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 0.22 110.24 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -89.63 131.84 35.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.192 -0.913 . . . . 0.22 110.285 -177.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 23.7 t -121.3 101.19 7.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.853 0.835 . . . . 1.2 109.155 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -113.08 137.4 51.49 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.611 -1.177 . . . . 0.32 111.61 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.521 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 42.4 tt0 -101.71 115.69 31.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.489 -0.778 . . . . 1.05 109.227 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -117.08 121.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.667 0.617 . . . . 0.19 112.667 -175.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.8 m -92.75 109.02 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.243 -0.889 . . . . 0.28 110.249 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 60' ' ' PRO . 64.3 tp -81.85 98.63 8.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.493 -0.929 . . . . 0.15 108.493 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -94.71 -27.86 15.62 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.33 -0.85 . . . . 1.08 110.775 -170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.478 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 7.8 m -153.39 151.74 30.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.292 -0.413 . . . . 0.37 111.458 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.58 128.5 27.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.565 -0.743 . . . . 0.25 109.061 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.11 130.51 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.232 0.539 . . . . 0.92 110.365 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.45 133.64 43.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.789 -0.641 . . . . 2.27 109.339 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -161.45 25.44 0.13 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.554 -0.535 . . . . 1.97 109.554 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.68 -71.72 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 2.14 110.048 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.7 m170 69.16 -7.03 0.84 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.48 0.919 . . . . 5.79 113.48 170.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -87.87 73.91 9.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.487 0.661 . . . . 7.48 110.474 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -116.28 -24.13 8.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.562 -0.745 . . . . 8.46 109.307 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.476 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 69.8 m-70 -147.13 159.3 43.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.276 -0.875 . . . . 8.83 109.084 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 64.3 m-70 73.44 130.0 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.136 0.897 . . . . 12.17 109.517 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.059 -0.719 . . . . 13.46 109.059 -168.704 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.729 0.3 . . . . 50.23 110.586 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.46 -83.71 0.88 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.993 -0.623 . . . . 47.99 111.87 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -140.46 88.9 10.85 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.206 0.527 . . . . 46.26 109.715 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.66 169.04 18.84 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.777 2.318 . . . . 44.8 112.104 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.18 124.42 16.23 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.667 2.244 . . . . 44.02 112.429 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.96 129.27 44.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.806 -0.634 . . . . 42.5 109.451 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -78.91 -37.32 40.24 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.937 -0.394 . . . . 41.5 109.937 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -157.47 -26.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 40.33 110.195 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.3 -88.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.807 -0.633 . . . . 39.09 111.23 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -163.04 -56.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.692 -0.231 . . . . 38.82 110.808 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -116.56 79.74 9.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.602 0.239 . . . . 38.16 111.571 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.15 2.36 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.581 2.187 . . . . 36.7 112.072 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.98 -142.09 4.26 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.751 . . . . 35.61 111.345 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.99 84.66 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.264 0.555 . . . . 35.03 110.907 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.17 -25.48 18.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.565 -0.743 . . . . 34.01 110.855 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 57.95 29.14 17.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.102 -0.499 . . . . 32.89 111.95 175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 17' ' ' ARG . 14.9 tpt85 -90.83 25.83 2.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.088 0.47 . . . . 31.94 110.787 -175.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.733 ' HG3' ' HD1' ' A' ' 19' ' ' PHE . 21.8 tp10 -59.48 -75.32 0.06 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.693 -0.685 . . . . 31.24 111.496 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.733 ' HD1' ' HG3' ' A' ' 18' ' ' GLU . 44.2 p90 -147.07 11.6 1.05 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.73 0.3 . . . . 31.24 111.648 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.495 HD12 ' H ' ' A' ' 19' ' ' PHE . 5.8 mp -80.87 -62.39 1.68 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.311 -0.404 . . . . 29.85 111.306 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.81 145.71 55.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.308 -0.405 . . . . 28.2 110.383 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 177.88 8.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.203 -0.453 . . . . 26.78 111.72 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.3 ttm 59.44 77.63 0.3 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.103 -0.953 . . . . 27.47 111.423 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 5.6 tp10 -166.66 109.96 0.68 Allowed Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.77 -0.826 . . . . 24.41 108.77 175.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 20.2 Cg_exo -66.13 143.3 71.04 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.2 2.6 . . . . 21.63 113.203 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -67.12 144.24 98.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.903 -0.59 . . . . 20.67 110.216 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.73 125.45 14.32 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.088 1.858 . . . . 18.02 111.418 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -114.7 120.49 37.49 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.87 0.367 . . . . 14.93 111.114 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.87 127.82 16.79 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.647 2.232 . . . . 13.81 111.57 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.09 80.99 70.73 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.129 -0.487 . . . . 10.76 111.241 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.16 105.39 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 9.77 111.544 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -71.22 139.35 84.68 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.825 -0.435 . . . . 5.86 109.825 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.26 -25.95 64.46 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.669 2.246 . . . . 4.47 112.858 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -96.86 -65.94 0.93 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 4.13 111.268 -173.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 12.5 mm-40 -107.63 120.11 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 2.45 109.713 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.649 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -109.06 -165.6 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.564 0.697 . . . . 0.53 112.138 -170.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.8 tp -77.7 125.02 28.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.706 -1.134 . . . . 0.5 111.233 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.629 ' HB3' ' H ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -77.17 123.55 26.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.131 -0.486 . . . . 2.51 111.113 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.63 HD12 HD11 ' A' ' 45' ' ' LEU . 6.9 mt -62.54 -41.28 91.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.46 110.959 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD21 HD13 ' A' ' 101' ' ' LEU . 89.1 mt -113.21 0.68 14.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.75 0.309 . . . . 0.72 111.424 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 38' ' ' ASP . . . 68.65 24.15 75.38 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.4 -0.68 . . . . 0.52 111.4 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.549 HD22 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -97.46 -24.74 15.46 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.95 113.243 -177.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.549 ' N ' HD22 ' A' ' 42' ' ' ASN . . . 102.32 -19.28 48.99 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 121.308 -0.472 . . . . 0.72 112.372 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 2.8 mm? -90.12 -28.86 18.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.839 0.352 . . . . 1.56 110.491 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 39' ' ' ILE . 20.9 tp -122.86 109.29 13.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.32 111.865 -171.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 71.2 mtm180 -139.38 140.46 37.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.987 0.366 . . . . 1.14 111.987 -173.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -113.23 123.44 50.18 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.985 0.514 . . . . 0.35 110.137 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.2 ttpt -109.77 113.64 26.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 1.07 110.708 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 p -74.07 100.66 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.347 -0.388 . . . . 0.33 111.328 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 111' ' ' THR . 7.8 mt -65.8 -49.55 67.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.427 -1.323 . . . . 0.28 107.427 172.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.806 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.7 t -136.61 126.32 15.84 Favored Pre-proline 0 CA--C 1.505 -0.772 0 CA-C-N 113.007 -1.906 . . . . 0.36 106.712 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 19.5 Cg_endo -104.35 61.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.108 2.539 . . . . 0.54 113.846 -177.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.55 163.49 8.51 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.546 -0.752 . . . . 0.55 113.634 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 97.5 Cg_endo -79.83 172.12 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.031 2.488 . . . . 1.42 111.141 173.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.57 48.45 0.6 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.957 2.438 . . . . 2.04 112.936 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.67 43.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.593 -0.603 . . . . 0.98 111.593 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.676 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -95.69 -174.44 3.15 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.99 111.352 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.1 t -152.15 136.85 17.01 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.065 -1.087 . . . . 1.28 108.065 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 10.4 ptp180 -91.68 113.48 58.87 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.528 -0.469 . . . . 2.81 110.39 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD3' HG23 ' A' ' 108' ' ' VAL . 4.9 Cg_endo -47.47 142.21 13.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.985 3.123 . . . . 0.3 113.653 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.715 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 16.9 t -92.05 156.86 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.386 -0.824 . . . . 0.88 109.645 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -63.53 111.92 2.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.132 0.491 . . . . 1.17 110.199 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 151' ' ' GLU . . . 137.05 -33.44 2.31 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 114.827 -1.079 . . . . 0.42 110.491 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -74.56 139.19 43.56 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.904 -0.776 . . . . 0.59 108.904 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 2.7 m -89.25 131.33 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.696 -1.224 . . . . 1.22 107.696 174.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.0 m -129.18 149.42 33.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.609 -0.723 . . . . 0.25 110.718 -171.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 24.7 p -98.68 113.01 24.91 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.82 -0.627 . . . . 0.29 110.041 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.676 HG21 HD21 ' A' ' 99' ' ' LEU . 19.2 m -110.63 144.28 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 119.988 -0.685 . . . . 0.19 110.214 173.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.572 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.45 117.14 34.07 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.203 -1.406 . . . . 0.19 107.203 170.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -121.17 134.83 55.23 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.384 -0.926 . . . . 0.39 110.62 177.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.587 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -126.95 114.07 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.241 -2.133 . . . . 0.27 105.241 167.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 140' ' ' LEU . 59.0 m -106.13 123.59 48.25 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.317 -1.311 . . . . 0.19 111.057 -164.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.958 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.9 OUTLIER -104.81 170.99 7.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.821 -0.627 . . . . 1.06 109.448 -178.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt -97.12 165.4 12.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.433 -0.803 . . . . 0.84 109.249 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 12.7 pt-20 -59.26 -16.76 23.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.832 0.348 . . . . 1.14 110.715 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -94.98 -14.7 24.15 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.364 -0.38 . . . . 2.14 110.92 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.38 -24.44 6.91 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.544 -0.836 . . . . 0.51 113.933 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.4 m -67.54 114.97 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.81 0.67 . . . . 0.46 112.81 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.89 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.6 mtt180 -77.98 118.52 20.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.608 0.718 . . . . 0.47 110.499 176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.776 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.3 m -96.58 -9.08 9.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.613 -1.176 . . . . 0.27 112.06 -170.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.595 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.7 pt20 -164.92 129.07 2.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.42 -0.355 . . . . 0.59 110.891 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -122.38 109.61 14.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.382 -0.599 . . . . 1.34 109.382 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.25 113.75 25.99 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.59 -0.732 . . . . 2.59 110.363 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 56.6 Cg_endo -71.26 -16.05 31.52 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.307 2.671 . . . . 0.5 113.491 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -163.05 108.76 1.13 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.206 1.003 . . . . 1.37 112.088 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 tp -118.49 105.98 12.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.086 -1.87 . . . . 0.38 108.728 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.8 p -100.11 130.78 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.214 -0.448 . . . . 1.0 109.842 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.667 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 31.4 p90 -151.74 157.78 42.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.691 0.281 . . . . 0.23 110.582 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.8 m -76.98 114.29 15.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.752 -0.658 . . . . 0.42 109.711 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.903 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.7 tp -58.96 127.63 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.6 111.376 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.81 4.22 90.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.997 -0.62 . . . . 0.37 112.344 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -89.72 -4.71 57.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.176 -1.046 . . . . 0.93 108.176 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 19.5 m 56.95 32.88 22.36 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.57 -1.196 . . . . 0.62 109.92 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.61 -21.37 64.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.167 0.984 . . . . 1.33 108.955 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 m -113.67 -158.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.714 -1.585 . . . . 0.23 110.859 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.614 HG13 ' H ' ' A' ' 99' ' ' LEU . 32.6 pt -78.44 137.25 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 107.317 -1.364 . . . . 0.29 107.317 173.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -57.57 -30.35 65.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.471 -0.331 . . . . 0.4 110.781 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.8 -46.83 81.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.806 -0.634 . . . . 0.2 110.788 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 68' ' ' VAL . 48.5 tp -71.26 -40.3 71.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.22 110.728 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -61.07 -30.34 70.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.801 -1.09 . . . . 0.26 109.977 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 40' ' ' LEU . 82.2 mt -91.44 -33.36 15.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.353 -0.839 . . . . 0.25 112.472 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.8 t -65.64 -32.11 73.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 1.01 111.119 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.667 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 57.9 t -66.38 -52.83 34.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.767 0.654 . . . . 0.21 112.767 -177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -62.81 -19.98 70.0 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.634 1.556 . . . . 0.27 112.113 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.518 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.9 mt -83.18 -16.14 47.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.476 0.655 . . . . 0.64 111.109 170.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.797 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 28.3 ttm -96.16 141.5 29.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.744 -1.116 . . . . 0.78 111.572 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.92 151.08 19.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.914 -0.402 . . . . 0.97 109.914 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.654 HG23 ' HD3' ' A' ' 60' ' ' PRO . 3.7 t -59.73 124.3 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.164 0.507 . . . . 0.8 110.639 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.28 14.12 46.13 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.481 -0.782 . . . . 0.28 112.787 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.806 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -104.31 168.23 9.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.615 0.708 . . . . 0.41 110.574 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.443 HG22 HD12 ' A' ' 50' ' ' LEU . 17.9 m -133.65 117.97 17.62 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.923 -1.14 . . . . 0.22 107.923 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.08 140.98 52.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.181 0.515 . . . . 0.18 110.805 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.423 ' HG2' ' CH2' ' A' ' 36' ' ' TRP . 16.9 ttt -98.12 117.88 33.49 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.297 -1.372 . . . . 1.32 107.297 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.8 130.46 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.566 -0.531 . . . . 0.18 109.566 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 99.3 m -108.3 114.45 28.33 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 119.652 -0.819 . . . . 0.21 109.023 173.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -124.61 134.17 53.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.017 -1.447 . . . . 0.15 110.063 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.749 ' HB2' ' HB3' ' A' ' 44' ' ' LEU . 9.6 t70 -52.31 147.5 7.81 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.682 -0.859 . . . . 0.58 108.682 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.663 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.4 t -57.98 -25.68 61.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.232 0.539 . . . . 0.82 110.138 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.624 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 4.2 ptpp? -55.32 -29.79 58.95 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.111 -0.368 . . . . 0.81 111.29 173.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 97.3 m-85 -98.51 3.0 48.13 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.219 0.533 . . . . 0.42 110.268 175.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.0 m -123.63 -91.59 0.54 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.148 -0.933 . . . . 0.18 110.701 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 12.3 m-85 -141.91 42.83 1.7 Allowed 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 112.15 0.426 . . . . 0.24 112.15 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.58 -86.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.163 -0.542 . . . . 0.25 113.572 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.26 11.92 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.536 2.158 . . . . 0.58 111.09 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.4 mt-30 -103.2 -46.75 4.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.6 -0.727 . . . . 0.65 109.968 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.559 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.95 144.28 2.22 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.693 -1.139 . . . . 0.3 112.188 -175.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.649 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.9 t -91.16 158.74 16.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.229 -0.486 . . . . 0.33 112.09 -175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -47.05 -55.49 8.17 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.811 -1.086 . . . . 3.17 111.943 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.915 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 22.9 t -80.92 -62.95 0.34 Allowed Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.534 -0.466 . . . . 1.23 110.158 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.915 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.7 Cg_endo -106.08 127.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.348 2.032 . . . . 0.37 112.11 173.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 49.2 t80 -55.91 98.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.346 -0.983 . . . . 1.14 108.346 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.612 HG12 ' CB ' ' A' ' 127' ' ' SER . 32.3 mm -66.49 128.24 93.75 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.668 -0.697 . . . . 0.39 109.917 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.7 Cg_endo -54.59 139.29 75.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.572 2.181 . . . . 0.61 112.144 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.527 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 72.2 Cg_exo -52.54 129.06 30.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.815 2.343 . . . . 0.52 112.918 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.633 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 66.3 m170 70.11 15.54 7.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.992 -1.004 . . . . 2.38 112.508 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.92 123.79 26.28 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.87 -0.789 . . . . 0.26 108.87 170.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -74.11 115.96 14.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.328 0.585 . . . . 0.22 110.308 -173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.654 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.95 136.21 33.13 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.007 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.958 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 30.7 p -119.54 98.56 6.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.037 0.922 . . . . 1.2 110.026 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -110.41 134.69 52.08 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.004 -0.998 . . . . 0.32 111.647 -173.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.587 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 46.4 tt0 -100.78 111.73 24.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.799 . . . . 1.05 109.084 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.621 HG11 HD13 ' A' ' 99' ' ' LEU . 1.3 m -112.17 117.05 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.516 0.674 . . . . 0.19 112.716 -173.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.0 m -89.91 114.03 25.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.945 -1.025 . . . . 0.28 110.573 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.741 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.8 tp -85.82 96.07 9.63 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.962 -0.755 . . . . 0.15 108.962 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 23.5 mtmt -91.85 -30.49 16.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.55 -0.75 . . . . 1.08 110.8 -171.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.508 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 19.1 m -151.93 148.07 27.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.484 -0.326 . . . . 0.37 111.167 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.92 128.79 21.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.244 -0.65 . . . . 0.25 109.244 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.462 HG23 HD22 ' A' ' 150' ' ' LEU . 36.0 m -128.93 135.89 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.568 -0.853 . . . . 0.92 111.677 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -89.52 116.43 27.68 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.301 -0.863 . . . . 2.27 110.948 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.462 HD22 HG23 ' A' ' 148' ' ' VAL . 2.6 pt? -158.14 -37.46 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.105 -0.952 . . . . 1.97 109.11 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.862 ' HG2' ' H ' ' A' ' 152' ' ' HIS . 9.9 tt0 60.83 -169.16 0.16 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.499 -1.682 . . . . 2.14 111.253 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.862 ' H ' ' HG2' ' A' ' 151' ' ' GLU . 8.6 t-160 -152.45 12.98 0.55 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.701 0.286 . . . . 5.79 110.858 -174.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -97.28 75.37 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.205 0.526 . . . . 7.48 110.578 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.3 m170 65.58 -99.36 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.149 -0.932 . . . . 8.46 112.718 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -131.4 153.85 49.24 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.041 0.448 . . . . 8.83 111.396 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.47 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 11.0 m170 -119.16 -45.67 2.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.923 -1.14 . . . . 12.17 107.923 169.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--O 1.247 0.96 0 CA-C-N 114.492 -1.231 . . . . 13.46 108.046 166.001 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.517 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.92 -0.4 . . . . 50.23 109.92 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.79 43.51 1.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.649 -0.786 . . . . 47.99 112.961 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.633 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.2 tm0? -164.59 -53.94 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.39 -0.338 . . . . 46.26 110.672 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 87.1 Cg_exo -48.33 -50.63 11.72 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.213 1.942 . . . . 44.8 113.994 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 10.8 Cg_exo -71.83 124.62 10.32 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.679 1.586 . . . . 44.02 111.345 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.95 146.51 45.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.782 0.325 . . . . 42.5 110.998 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.756 ' HG3' ' H ' ' A' ' 9' ' ' ALA . 9.9 tp10 -106.95 146.54 30.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.754 -0.657 . . . . 41.5 109.64 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.73 -7.58 49.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.28 -0.418 . . . . 40.33 110.868 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.756 ' H ' ' HG3' ' A' ' 7' ' ' GLU . . . -75.67 -28.96 58.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.167 -0.469 . . . . 39.09 110.818 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 63.11 93.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.517 -0.765 . . . . 38.82 111.745 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -169.84 79.01 0.65 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.417 -0.811 . . . . 38.16 110.296 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -88.01 -179.43 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.724 2.283 . . . . 36.7 112.13 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.87 129.38 10.77 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.64 -0.791 . . . . 35.61 111.975 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.7 116.59 29.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.696 0.284 . . . . 35.03 110.957 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.91 176.93 7.82 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.952 -0.388 . . . . 34.01 109.952 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 62.54 82.57 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.566 0.698 . . . . 32.89 110.457 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -131.25 156.53 45.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.492 -0.776 . . . . 31.94 109.82 -176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -87.03 78.45 8.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.755 0.788 . . . . 31.24 110.235 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -139.63 147.91 41.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.98 -1.009 . . . . 31.24 109.686 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.8 mt -71.65 103.69 3.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.292 -0.413 . . . . 29.85 110.143 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 24' ' ' GLU . . . -76.07 71.0 2.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.161 0.505 . . . . 28.2 111.049 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.75 -36.65 15.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.851 -0.613 . . . . 26.78 110.978 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 84.6 mtp -120.52 15.26 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.016 0.436 . . . . 27.47 110.768 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 34.8 mt-10 -138.78 117.11 9.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 24.41 110.663 175.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.12 159.21 26.85 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.503 2.135 . . . . 21.63 111.083 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -55.01 142.28 56.96 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.56 -0.291 . . . . 20.67 110.747 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.17 112.41 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.937 2.425 . . . . 18.02 112.232 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -79.34 147.18 68.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.853 -0.612 . . . . 14.93 110.561 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 15.7 Cg_exo -67.83 128.76 18.43 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.587 2.191 . . . . 13.81 112.137 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -94.42 -51.49 0.25 Allowed Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.231 -0.44 . . . . 10.76 111.565 177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 5.2 Cg_exo -75.03 104.27 1.87 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 121.841 1.694 . . . . 9.77 111.665 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.5 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . . . -69.02 147.3 97.7 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.494 . . . . 5.86 110.267 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.63 -2.36 12.57 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.537 2.158 . . . . 4.47 112.864 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.29 150.9 51.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.418 -0.355 . . . . 4.13 110.146 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.93 130.98 35.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.595 . . . . 2.45 111.449 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.548 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.3 m0 -84.12 -168.93 2.35 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.392 0.615 . . . . 0.53 110.634 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.6 tp -83.49 115.22 21.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.559 -0.746 . . . . 0.5 110.136 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -78.68 121.97 25.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.187 -0.671 . . . . 2.51 109.187 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.643 HG23 HD11 ' A' ' 105' ' ' LEU . 13.5 mt -60.18 -35.91 64.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.188 -0.915 . . . . 0.46 110.552 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 74.3 mt -102.54 -3.42 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.722 -0.672 . . . . 0.72 110.565 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.05 27.9 65.53 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.52 111.718 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.604 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -111.66 -23.22 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.012 0.745 . . . . 0.95 113.012 -175.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 109.24 30.73 3.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.95 -1.119 . . . . 0.72 114.377 168.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -151.77 -9.26 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.985 0.392 . . . . 1.56 110.784 175.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.607 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 3.2 tp -119.5 99.47 6.69 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.918 -0.583 . . . . 0.32 109.975 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 62.0 mtm180 -139.14 136.58 35.28 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.014 -0.675 . . . . 1.14 112.065 -171.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 11.2 ttpt -112.52 124.52 52.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.217 -0.447 . . . . 0.35 110.361 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 28.9 ttpp -112.88 117.46 32.19 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.87 0.367 . . . . 1.07 110.524 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.9 p -73.62 106.45 5.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.275 -0.421 . . . . 0.33 111.285 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 141' ' ' GLU . 12.0 mt -68.66 -52.13 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.798 -1.556 . . . . 0.28 106.798 170.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.873 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 93.0 t -131.37 135.42 27.02 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 113.143 -1.844 . . . . 0.36 106.071 168.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 40.3 Cg_endo -108.77 54.25 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.946 2.431 . . . . 0.54 113.834 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.601 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 79.31 157.9 12.94 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.853 -0.612 . . . . 0.55 113.319 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 18.8 Cg_exo -67.11 163.14 35.25 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.535 2.156 . . . . 1.42 109.945 170.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.07 -11.46 10.19 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 122.561 2.174 . . . . 2.04 112.965 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -126.66 53.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.168 -0.539 . . . . 0.98 112.016 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 9.3 p -84.81 -172.28 4.09 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.507 0.67 . . . . 0.99 111.439 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.631 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 23.0 t -159.09 130.67 6.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.936 -1.135 . . . . 1.28 107.936 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 83.8 mtt180 -90.44 112.85 55.17 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 120.918 -0.313 . . . . 2.81 110.313 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HG3' HD21 ' A' ' 144' ' ' LEU . 6.2 Cg_endo -47.3 152.99 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.831 3.021 . . . . 0.3 114.142 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 11.4 t -102.67 151.56 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.211 -0.904 . . . . 0.88 109.774 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 62.7 mttt -64.24 108.78 1.67 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 122.02 0.914 . . . . 1.17 110.792 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.3 -31.5 2.34 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.772 -1.558 . . . . 0.42 110.125 -174.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.672 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -71.89 140.19 49.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.21 0.529 . . . . 0.59 109.89 -178.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 148' ' ' VAL . 65.4 t -84.68 119.65 33.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.598 -0.89 . . . . 1.22 108.598 174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.2 m -124.54 147.97 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 112.11 0.411 . . . . 0.25 112.11 -170.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 30.0 p -102.26 116.52 32.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.923 -0.58 . . . . 0.29 110.39 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.753 HG21 HD21 ' A' ' 99' ' ' LEU . 17.1 m -111.18 144.94 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.111 0.481 . . . . 0.19 110.06 172.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.9 t-160 -102.11 120.38 40.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.909 -1.515 . . . . 0.19 106.909 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 0.9 OUTLIER -125.36 135.11 52.1 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 119.426 -0.91 . . . . 0.39 110.474 178.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.928 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -127.52 114.97 18.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 105.902 -1.888 . . . . 0.27 105.902 169.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.626 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 22.8 m -110.63 122.38 47.65 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.409 -1.268 . . . . 0.19 111.53 -165.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.967 ' HB2' ' SG ' ' A' ' 139' ' ' CYS . 0.7 OUTLIER -104.65 171.16 7.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.317 -0.856 . . . . 1.06 108.851 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 80' ' ' VAL . 11.4 mt -97.53 167.46 10.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.537 -0.756 . . . . 0.84 109.936 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.62 -17.64 9.38 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.313 0.383 . . . . 1.14 111.236 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.32 -14.64 20.11 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.674 0.273 . . . . 2.14 110.921 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.08 7.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.637 -0.792 . . . . 0.51 113.651 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.4 m -63.26 112.06 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.228 0.455 . . . . 0.46 112.228 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.9 mtt180 -74.28 118.23 17.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.847 0.832 . . . . 0.47 110.571 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.928 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.1 m -96.68 -9.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.452 -1.249 . . . . 0.27 110.928 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.626 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.1 pt20 -166.55 146.76 5.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.606 -0.724 . . . . 0.59 109.753 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 71' ' ' GLN . 15.2 tt0 -150.96 103.29 3.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.173 -1.047 . . . . 1.34 108.173 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 4.7 mm-40 -126.72 113.81 22.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.541 -0.754 . . . . 2.59 110.308 -170.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 37.7 Cg_endo -65.7 -12.32 34.64 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 123.014 2.476 . . . . 0.5 112.982 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -151.94 112.02 4.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.366 0.603 . . . . 1.37 110.724 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.428 ' HB3' HG23 ' A' ' 68' ' ' VAL . 50.8 tp -130.11 106.99 8.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.835 -1.075 . . . . 0.38 108.287 172.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.9 p -108.36 138.08 36.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.825 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 30.1 p90 -160.97 166.54 28.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.388 . . . . 0.23 110.868 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.1 m -86.0 115.07 23.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 0.42 109.633 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.85 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.4 tp -60.54 126.64 28.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.898 -0.592 . . . . 0.6 110.396 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 91.18 6.66 66.42 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.691 -0.766 . . . . 0.37 112.976 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.11 -8.62 21.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.93 109.978 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.7 m 58.15 36.9 26.2 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.605 -0.725 . . . . 0.62 109.342 -172.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 22.1 t70 -70.75 -17.61 62.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.538 1.161 . . . . 1.33 108.044 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.7 m -119.19 -154.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.323 -1.762 . . . . 0.23 110.353 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.638 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 35.8 pt -83.0 138.81 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.647 -1.242 . . . . 0.29 107.647 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 6.5 tp60 -59.1 -32.46 69.84 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.904 -0.318 . . . . 0.4 110.898 -173.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.14 -42.25 72.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.2 110.627 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.753 HD21 HG21 ' A' ' 68' ' ' VAL . 56.5 tp -75.72 -40.78 55.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.729 -0.668 . . . . 0.22 110.551 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.9 t70 -61.14 -28.53 69.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.046 -0.979 . . . . 0.26 109.883 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 76.1 mt -90.13 -36.59 14.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.006 -0.997 . . . . 0.25 111.893 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.1 t -67.96 -28.18 67.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.751 -0.204 . . . . 1.01 111.275 -174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.571 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 55.0 t -65.87 -55.8 20.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.401 0.519 . . . . 0.21 112.401 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.85 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.1 Cg_endo -63.43 -18.77 66.07 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 121.998 1.799 . . . . 0.27 111.906 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 39' ' ' ILE . 13.1 mt -84.32 -14.21 50.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.64 111.239 173.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.811 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 1.1 ttp -105.84 141.15 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.239 -0.437 . . . . 0.78 110.934 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 m-20 -79.01 152.48 30.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.867 0.365 . . . . 0.97 110.067 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -65.58 126.29 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.653 0.74 . . . . 0.8 109.789 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.81 10.71 56.23 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.117 -0.947 . . . . 0.28 112.143 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.873 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.38 170.36 7.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.357 0.599 . . . . 0.41 110.58 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.3 m -133.19 119.25 19.63 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.473 -0.936 . . . . 0.22 108.473 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.436 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -117.1 139.65 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.817 -0.629 . . . . 0.18 110.663 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.5 ttt -97.8 117.09 31.34 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.654 -1.239 . . . . 1.32 107.654 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.64 130.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.833 -0.622 . . . . 0.18 109.359 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 91.8 m -107.16 114.09 27.93 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.38 -0.97 . . . . 0.21 108.38 171.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -123.12 135.43 54.36 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.0 -1.455 . . . . 0.15 109.651 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.707 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.1 t70 -55.71 148.86 15.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.767 -0.827 . . . . 0.58 108.767 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -57.5 -27.21 62.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.376 0.608 . . . . 0.82 110.132 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 18.6 ptpt -55.26 -31.78 61.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.242 -0.435 . . . . 0.81 111.167 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.638 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 95.9 m-85 -100.84 10.77 40.72 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.297 0.57 . . . . 0.42 109.902 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.675 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 71.0 m -125.92 -93.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.986 . . . . 0.18 110.521 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.556 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 6.8 m-85 -141.45 41.82 1.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.369 -0.532 . . . . 0.24 112.076 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.72 -84.81 0.03 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.143 -0.551 . . . . 0.25 113.67 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.67 8.49 4.22 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.551 2.167 . . . . 0.58 111.088 175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.6 mt-30 -104.13 -47.15 4.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.65 110.216 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 77.76 144.18 2.12 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 114.873 -1.058 . . . . 0.3 112.094 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.66 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 10.9 t -91.61 157.63 16.88 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.294 -0.453 . . . . 0.33 111.461 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.508 ' NH2' ' HG3' ' A' ' 83' ' ' GLU . 21.0 ptt180 -57.0 -43.1 81.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.613 -0.721 . . . . 3.17 112.102 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.629 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -80.38 -68.87 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 120.333 -0.547 . . . . 1.23 110.354 175.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.928 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -106.3 129.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.857 2.371 . . . . 0.37 112.145 171.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 33.6 t80 -55.17 99.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.135 -1.061 . . . . 1.14 108.135 163.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.1 mm -65.92 131.79 94.62 Favored Pre-proline 0 N--CA 1.446 -0.647 0 CA-C-N 115.953 -0.567 . . . . 0.39 110.285 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -50.61 138.46 40.12 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.845 2.363 . . . . 0.61 111.908 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.743 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.9 Cg_endo -64.53 135.75 47.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.175 1.917 . . . . 0.52 112.125 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.557 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 48.6 m-70 71.71 5.66 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.239 -0.891 . . . . 2.38 112.521 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.02 125.63 28.08 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.595 -0.521 . . . . 0.26 109.595 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.93 113.72 11.41 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.393 -0.523 . . . . 0.22 110.181 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.626 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.1 mp -88.23 133.0 34.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.515 -0.766 . . . . 0.22 111.07 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.967 ' SG ' ' HB2' ' A' ' 73' ' ' SER . 31.6 p -116.93 100.01 7.47 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.371 1.081 . . . . 1.2 110.05 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.59 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.4 OUTLIER -115.17 137.71 51.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.886 -1.052 . . . . 0.32 111.632 -172.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.928 ' HB3' HE22 ' A' ' 71' ' ' GLN . 26.4 tt0 -103.36 114.58 28.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.305 -0.998 . . . . 1.05 108.305 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 99' ' ' LEU . 2.5 m -111.79 119.48 60.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.421 0.629 . . . . 0.19 112.2 -174.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 6.3 m -95.11 113.02 24.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.271 -0.877 . . . . 0.28 110.156 174.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.589 HD21 ' HG3' ' A' ' 60' ' ' PRO . 60.4 tp -84.33 98.75 10.19 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.859 -0.793 . . . . 0.15 108.859 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.7 mtmt -97.75 -26.12 14.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.159 -0.928 . . . . 1.08 111.253 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.503 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 23.9 m -153.63 150.12 28.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.901 0.381 . . . . 0.37 111.773 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -143.78 128.3 18.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.659 -0.701 . . . . 0.25 109.406 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.1 m -126.22 138.23 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.92 110.344 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.582 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 9.5 t70 -86.9 121.32 29.22 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.806 -0.357 . . . . 2.27 110.218 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.1 tp -148.74 14.12 0.93 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.031 0.443 . . . . 1.97 110.23 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.16 146.44 52.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 2.14 110.354 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -75.94 110.24 10.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 5.79 110.147 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -90.94 -61.97 1.55 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 7.48 110.285 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -153.69 115.74 4.31 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.859 -0.336 . . . . 8.46 110.743 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -90.61 107.08 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 8.83 110.023 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -76.18 145.16 40.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.755 0.312 . . . . 12.17 110.695 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.384 -0.817 . . . . 13.46 109.597 175.109 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.889 0.376 . . . . 50.23 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.51 -156.58 10.45 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.918 -0.658 . . . . 47.99 112.913 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -121.52 93.97 48.63 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.576 -0.528 . . . . 46.26 109.576 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.622 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 31.5 Cg_exo -57.97 -56.98 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.587 2.191 . . . . 44.8 113.906 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 87.5 Cg_endo -85.96 132.72 4.03 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.648 1.565 . . . . 44.02 113.065 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.95 5.72 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.626 0.727 . . . . 42.5 109.921 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.8 54.27 3.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.282 -0.872 . . . . 41.5 109.731 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.73 -5.76 49.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.773 -0.649 . . . . 40.33 112.086 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.36 -49.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.594 -0.276 . . . . 39.09 111.338 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 74.53 -55.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.648 0.779 . . . . 38.82 110.352 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -138.95 96.53 9.16 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.663 -0.699 . . . . 38.16 109.507 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.54 176.92 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.392 2.728 . . . . 36.7 113.029 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.94 -175.46 22.61 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.122 -0.791 . . . . 35.61 111.122 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.26 -3.41 19.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.821 0.31 . . . . 35.03 110.197 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.9 mt 59.13 72.69 0.52 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.439 -0.801 . . . . 34.01 110.639 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.41 -38.21 7.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.322 -0.853 . . . . 32.89 110.447 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 59.41 83.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.951 0.782 . . . . 31.94 111.487 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -79.9 54.48 1.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.26 -0.427 . . . . 31.24 110.28 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -64.84 -38.72 91.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 31.24 110.72 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.3 tp -170.76 46.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.338 0.589 . . . . 29.85 109.842 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.34 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.811 -0.631 . . . . 28.2 110.247 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 71.06 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.201 0.938 . . . . 26.78 112.505 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.5 mmt -102.78 15.36 29.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 27.47 110.148 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 53.0 tt0 -103.78 125.73 33.85 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-N 115.476 -0.783 . . . . 24.41 109.541 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 9.3 Cg_endo -51.96 154.32 10.4 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 124.38 3.387 . . . . 21.63 112.638 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 81.8 mm-40 -53.12 141.49 39.92 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 116.033 -0.531 . . . . 20.67 110.238 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 11.4 Cg_exo -69.21 85.72 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.61 2.207 . . . . 18.02 112.276 -177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.84 93.6 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.384 -0.825 . . . . 14.93 109.127 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.06 127.4 14.89 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.706 2.271 . . . . 13.81 113.11 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.95 77.88 55.41 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.502 -0.772 . . . . 10.76 109.622 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 103.86 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.864 2.376 . . . . 9.77 111.684 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.19 111.68 61.53 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.579 -0.526 . . . . 5.86 109.579 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.98 -10.3 21.19 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.658 2.239 . . . . 4.47 112.874 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.518 ' HA ' ' HE1' ' A' ' 36' ' ' TRP . 35.8 mm-40 -95.69 5.82 50.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.614 -0.435 . . . . 4.13 111.742 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.539 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -98.29 84.41 3.23 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.081 -0.711 . . . . 2.45 109.081 167.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.593 ' NE1' ' HE2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -83.71 -172.33 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.53 110.76 -173.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.02 111.39 5.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.084 -0.962 . . . . 0.5 110.551 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.655 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.1 t70 -73.18 125.55 27.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.367 -0.533 . . . . 2.51 110.083 173.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.652 HG23 HD11 ' A' ' 105' ' ' LEU . 7.7 mt -56.3 -32.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.808 -1.087 . . . . 0.46 111.656 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.32 -1.73 13.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.101 -0.499 . . . . 0.72 110.32 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 60.98 26.61 65.81 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.169 -0.772 . . . . 0.52 111.169 -172.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' HD23 ' A' ' 44' ' ' LEU . 1.1 p30 -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.366 -0.417 . . . . 0.95 110.583 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.478 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.8 -4.15 21.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.939 -0.648 . . . . 0.72 112.988 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 4.2 mm? -112.19 -27.41 8.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.869 0.322 . . . . 1.56 111.869 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.561 HD11 HD12 ' A' ' 39' ' ' ILE . 16.9 tp -120.62 100.66 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.3 -0.409 . . . . 0.32 110.74 -170.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 89.7 mtm180 -133.18 141.44 48.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.6 0.222 . . . . 1.14 111.6 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.0 ttpt -114.09 123.8 50.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.421 -0.354 . . . . 0.35 110.244 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 18.2 ttmt -103.58 118.96 37.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.983 -0.377 . . . . 1.07 109.983 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.441 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 1.3 p -76.02 96.74 3.86 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.989 -0.55 . . . . 0.33 110.5 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD12 HG22 ' A' ' 111' ' ' THR . 12.5 mt -63.66 -52.93 58.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.893 -1.521 . . . . 0.28 106.893 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.881 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 85.1 t -132.84 127.1 20.15 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-N 113.038 -1.892 . . . . 0.36 106.157 167.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HB3' ' CG2' ' A' ' 49' ' ' THR . 30.4 Cg_endo -106.66 56.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.956 2.437 . . . . 0.54 114.502 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 82.58 129.44 1.31 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 121.118 -0.563 . . . . 0.55 113.201 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.46 127.85 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.041 1.828 . . . . 1.42 110.306 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -37.58 118.41 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.631 2.887 . . . . 2.04 113.453 -176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.74 17.06 10.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.486 -0.779 . . . . 0.98 111.919 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 p -80.96 -171.05 3.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.292 0.568 . . . . 0.99 111.26 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -153.86 144.35 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.786 -0.82 . . . . 1.28 108.786 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.499 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 48.1 mtm180 -92.51 110.1 42.77 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.846 -0.428 . . . . 2.81 109.846 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.755 ' HD3' HG23 ' A' ' 108' ' ' VAL . 5.8 Cg_endo -47.36 141.21 14.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.353 2.702 . . . . 0.3 113.529 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.682 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.0 t -89.56 154.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.432 -0.804 . . . . 0.88 109.435 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.726 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 56.1 mttt -63.38 106.17 0.87 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.838 0.828 . . . . 1.17 110.85 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.89 -28.85 2.12 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.145 -1.388 . . . . 0.42 110.199 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -79.28 128.0 32.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.859 -0.793 . . . . 0.59 108.859 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.8 m -78.32 129.79 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.055 -1.091 . . . . 1.22 108.055 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.9 m -125.99 146.65 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.997 -0.547 . . . . 0.25 110.284 -173.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.9 p -95.94 112.31 24.07 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.897 -0.592 . . . . 0.29 109.825 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.713 HG21 HD21 ' A' ' 99' ' ' LEU . 7.4 m -110.5 142.02 24.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.849 -0.614 . . . . 0.19 110.074 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -100.76 116.42 32.61 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.721 -1.585 . . . . 0.19 106.721 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 136.94 53.07 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.285 1.041 . . . . 0.39 111.336 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.08 113.3 12.6 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.003 -1.851 . . . . 0.27 106.003 165.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.617 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.1 m -101.37 127.18 48.12 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.743 -1.117 . . . . 0.19 111.29 -168.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 17.1 t -104.89 160.46 14.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.309 -0.86 . . . . 1.06 109.626 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.444 HD21 HG11 ' A' ' 80' ' ' VAL . 13.7 mt -89.64 166.06 13.85 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.521 -0.763 . . . . 0.84 109.795 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.26 -17.84 8.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.578 0.549 . . . . 1.14 110.743 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -92.61 -8.68 43.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.641 -0.709 . . . . 2.14 111.162 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.38 40.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.838 -0.696 . . . . 0.51 111.855 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 m -98.17 109.91 22.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.878 0.371 . . . . 0.46 111.469 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 7.7 mtt180 -76.04 116.42 16.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.561 0.696 . . . . 0.47 110.539 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.765 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -101.98 -8.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.561 -1.2 . . . . 0.27 111.886 -168.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.617 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.2 pt20 -160.57 136.13 8.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.107 -0.497 . . . . 0.59 109.983 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -136.41 112.65 9.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.008 0.433 . . . . 1.34 110.283 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.0 115.51 15.41 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.436 0.636 . . . . 2.59 110.221 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 55.9 Cg_endo -71.05 -13.26 31.31 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.201 2.601 . . . . 0.5 113.637 -172.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -160.16 110.41 1.84 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.292 1.044 . . . . 1.37 111.571 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 68' ' ' VAL . 21.1 tp -119.62 100.59 7.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.126 -1.852 . . . . 0.38 108.756 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 10.7 p -95.73 132.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.0 p90 -153.47 158.43 41.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.612 -0.267 . . . . 0.23 110.445 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.493 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 5.6 m -79.04 113.65 17.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.05 -0.523 . . . . 0.42 109.788 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.827 HD11 ' HD3' ' A' ' 104' ' ' PRO . 16.4 tp -61.76 130.27 44.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.455 . . . . 0.6 109.921 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.726 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 83.51 6.35 87.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.37 111.947 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 32.3 t70 -100.12 -5.62 27.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.12 -0.696 . . . . 0.93 109.12 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.8 m 54.9 34.09 21.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.125 -0.943 . . . . 0.62 109.839 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.74 -9.13 58.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.445 1.117 . . . . 1.33 108.765 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.3 m -125.26 -159.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 113.531 -1.668 . . . . 0.23 110.711 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 36.5 pt -81.62 138.34 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.088 -1.449 . . . . 0.29 107.088 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.6 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.6 tp60 -60.74 -28.68 68.87 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.835 -0.346 . . . . 0.4 110.899 -172.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.07 -37.32 69.14 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.079 0.466 . . . . 0.2 110.679 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 68' ' ' VAL . 52.7 tp -81.84 -40.65 22.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.637 . . . . 0.22 110.719 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.6 ' HB3' HE21 ' A' ' 97' ' ' GLN . 14.3 t70 -61.93 -27.91 69.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.434 -0.803 . . . . 0.26 109.886 -175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 66.3 mt -90.97 -36.54 14.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.335 -0.848 . . . . 0.25 112.355 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.542 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 21.0 p -72.03 -26.46 62.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.63 -0.428 . . . . 1.01 111.189 -173.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.513 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -64.6 -55.74 27.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.457 0.539 . . . . 0.21 112.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.827 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.7 Cg_endo -61.09 -24.44 79.36 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.071 1.847 . . . . 0.27 112.007 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.652 HD11 HG23 ' A' ' 39' ' ' ILE . 17.0 mt -73.1 -30.84 63.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.152 -0.477 . . . . 0.64 111.155 172.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.82 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -92.07 152.72 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.78 111.425 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -90.52 151.89 21.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.002 0.43 . . . . 0.97 110.642 178.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.755 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.5 t -59.96 123.75 13.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.33 0.586 . . . . 0.8 110.337 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.63 43.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.362 -0.835 . . . . 0.28 112.548 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.881 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.6 pt-20 -105.4 168.18 9.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.407 0.622 . . . . 0.41 110.971 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 50' ' ' LEU . 20.9 m -130.63 117.44 19.51 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.175 -1.046 . . . . 0.22 108.175 174.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.35 138.27 53.17 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.032 0.444 . . . . 0.18 110.684 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.2 ttp -98.42 116.82 31.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.216 -1.401 . . . . 1.32 107.216 173.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.647 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.9 t -112.25 132.04 62.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.661 -0.496 . . . . 0.18 109.661 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.544 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 91.4 m -109.39 112.87 25.25 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.175 -1.046 . . . . 0.21 108.175 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.46 135.69 54.73 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.925 -1.489 . . . . 0.15 108.946 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.734 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.9 t70 -52.94 146.54 10.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.397 -0.964 . . . . 0.58 108.397 172.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.649 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.6 t -55.94 -26.07 46.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.071 0.463 . . . . 0.82 110.439 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.684 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.5 ptpt -54.87 -29.75 56.28 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.103 -0.373 . . . . 0.81 111.833 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.594 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.1 m-85 -97.15 2.31 50.95 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.042 0.448 . . . . 0.42 109.989 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 64.6 m -122.72 -89.91 0.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.141 -0.936 . . . . 0.18 110.665 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.657 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.4 m-85 -141.29 41.08 1.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.103 -0.475 . . . . 0.24 112.176 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -45.94 -81.82 0.04 OUTLIER Glycine 0 C--N 1.343 0.943 0 N-CA-C 113.995 0.358 . . . . 0.25 113.995 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.98 15.46 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.525 2.15 . . . . 0.58 110.924 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.7 mt-30 -103.51 -48.63 3.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.65 110.071 -174.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.471 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.12 142.81 3.5 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 114.668 -1.151 . . . . 0.3 112.051 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.657 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 14.1 t -90.68 165.03 13.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.577 0.584 . . . . 0.33 112.577 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -62.36 -23.28 66.71 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 115.114 -0.948 . . . . 3.17 112.728 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 1.048 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 18.3 t -105.51 -66.54 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.005 -0.739 . . . . 1.23 109.005 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.048 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 5.4 Cg_endo -99.07 129.63 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.937 2.425 . . . . 0.37 111.922 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.471 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 40.1 t80 -56.25 98.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.615 -1.254 . . . . 1.14 107.615 158.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.668 HD13 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -65.22 130.44 94.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.317 -0.994 . . . . 0.39 108.317 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.26 147.71 34.93 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.642 2.228 . . . . 0.61 112.587 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.71 137.93 83.14 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.473 2.115 . . . . 0.52 113.105 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.734 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 10.9 p80 53.04 21.45 2.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.665 -1.152 . . . . 2.38 113.342 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.78 132.88 40.72 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.983 -0.747 . . . . 0.26 108.983 172.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.9 113.82 12.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.141 0.496 . . . . 0.22 110.635 -171.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 tp -92.07 133.5 35.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.902 -0.59 . . . . 0.22 110.516 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.4 t -118.53 100.69 7.61 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.334 -0.617 . . . . 1.2 109.334 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.598 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.5 pp -112.53 136.55 51.92 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.868 -0.606 . . . . 0.32 111.578 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.5 tt0 -105.0 114.49 28.72 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.481 -0.562 . . . . 1.05 109.481 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.665 HG11 HD13 ' A' ' 99' ' ' LEU . 3.6 m -115.76 119.87 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.013 0.745 . . . . 0.19 113.013 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 4.1 m -90.46 111.71 23.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.28 110.754 170.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.1 tp -84.1 93.87 8.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.6 -0.889 . . . . 0.15 108.6 172.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 26.1 mtmt -88.1 -33.94 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.095 -0.957 . . . . 1.08 110.547 -171.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.454 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.1 m -149.68 154.41 38.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.37 111.729 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 128.26 26.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.299 -0.63 . . . . 0.25 109.299 172.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.85 111.56 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.58 -0.526 . . . . 0.92 109.58 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.16 114.82 25.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.471 0.653 . . . . 2.27 109.658 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -140.42 -8.51 1.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.515 -0.766 . . . . 1.97 111.079 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -97.18 -57.79 2.18 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.978 -1.01 . . . . 2.14 109.813 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 65.46 -93.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.241 -0.891 . . . . 5.79 110.539 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -177.06 115.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.093 -0.706 . . . . 7.48 109.093 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -102.66 105.69 16.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.341 0.591 . . . . 8.46 111.201 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -80.22 116.84 20.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.462 -0.79 . . . . 8.83 111.35 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -136.74 140.99 42.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.911 -0.586 . . . . 12.17 110.001 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.245 0.83 0 CA-C-O 118.378 -0.82 . . . . 13.46 109.918 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 121.081 0.467 . . . . 50.23 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.67 -139.33 2.71 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.337 -0.935 . . . . 47.99 112.956 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 65.16 94.36 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.466 0.651 . . . . 46.26 110.417 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.928 2.419 . . . . 44.8 111.919 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.27 130.09 27.64 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.66 2.24 . . . . 44.02 112.364 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.8 166.13 11.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.195 -0.457 . . . . 42.5 110.609 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 67.95 120.44 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 O-C-N 124.024 0.828 . . . . 41.5 111.472 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.54 -17.59 64.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.062 -0.972 . . . . 40.33 111.615 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.83 42.87 15.88 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.151 0.5 . . . . 39.09 110.089 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.629 ' HG2' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -59.03 -39.23 81.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.194 -0.912 . . . . 38.82 110.732 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.629 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 78.7 mt-30 -110.89 94.15 19.39 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.473 . . . . 38.16 110.12 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 10' ' ' GLU . 13.7 Cg_exo -70.22 -28.85 22.51 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.676 2.25 . . . . 36.7 111.997 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.1 -82.47 0.76 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.8 -0.636 . . . . 35.61 112.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -178.81 -65.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.046 0.539 . . . . 35.03 109.642 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 tt -163.79 -54.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 34.01 109.403 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.1 -94.6 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 32.89 110.543 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 58.23 20.82 7.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.752 0.421 . . . . 31.94 111.541 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -85.27 -20.16 30.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.07 -0.514 . . . . 31.24 110.036 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 22' ' ' ALA . 16.3 t80 71.55 169.9 0.32 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.871 -1.059 . . . . 31.24 110.09 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -82.93 96.76 8.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.114 -0.328 . . . . 29.85 110.114 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 67.68 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.539 -0.755 . . . . 28.2 110.536 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 24' ' ' GLU . . . 51.47 -143.16 0.67 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.329 0.393 . . . . 26.78 111.323 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.484 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 65.0 mtt 72.38 -21.47 0.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.563 0.745 . . . . 27.47 112.385 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 22' ' ' ALA . 67.8 mm-40 -90.34 108.07 24.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.929 -0.397 . . . . 24.41 109.929 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 23' ' ' MET . 45.5 Cg_endo -98.0 100.69 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.389 2.726 . . . . 21.63 112.462 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 12.9 pt-20 -81.37 127.27 74.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.882 0.372 . . . . 20.67 110.192 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 2.8 Cg_exo -75.72 97.13 1.08 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.735 2.29 . . . . 18.02 111.637 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.3 111.0 53.57 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.631 -0.507 . . . . 14.93 109.631 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.17 126.67 23.14 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.693 2.262 . . . . 13.81 112.515 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.32 75.92 19.17 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.271 -0.877 . . . . 10.76 109.448 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.29 130.05 24.4 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.802 2.335 . . . . 9.77 111.933 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.8 124.25 75.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.41 -0.589 . . . . 5.86 109.41 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.87 -36.77 59.18 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.541 2.161 . . . . 4.47 112.73 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -103.09 -29.54 11.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.126 0.489 . . . . 4.13 111.108 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.33 97.39 11.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 2.45 110.51 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.685 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 -84.08 -164.72 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.274 -0.639 . . . . 0.53 109.274 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.9 tp -73.31 110.61 7.73 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.672 -0.492 . . . . 0.5 109.672 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 8.9 t70 -75.24 124.59 27.33 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.003 -0.74 . . . . 2.51 109.003 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 45' ' ' LEU . 14.4 mt -58.86 -31.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.872 -1.058 . . . . 0.46 110.559 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.5 mt -116.13 -4.79 11.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.615 -0.72 . . . . 0.72 110.64 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.85 23.31 72.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.057 -0.817 . . . . 0.52 111.057 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -96.42 -15.57 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.482 0.549 . . . . 0.95 112.482 -174.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.47 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 114.39 -13.79 20.92 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.575 -0.821 . . . . 0.72 114.031 166.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -129.22 -2.21 5.06 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.057 0.762 . . . . 1.56 113.057 -173.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 39' ' ' ILE . 21.3 tp -122.34 100.25 6.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.008 -0.368 . . . . 0.32 110.008 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -136.09 139.32 42.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.308 0.484 . . . . 1.14 112.308 -170.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.8 ttpt -110.97 123.56 50.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.36 -0.382 . . . . 0.35 110.004 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.685 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -108.3 125.86 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.571 0.224 . . . . 1.07 110.603 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 p -81.93 103.1 11.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.159 0.504 . . . . 0.33 111.331 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 111' ' ' THR . 9.8 mt -69.47 -50.05 49.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.828 -1.545 . . . . 0.28 106.828 172.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.845 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.0 t -140.04 126.14 11.93 Favored Pre-proline 0 CA--C 1.501 -0.907 0 CA-C-N 112.891 -1.959 . . . . 0.36 106.688 170.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.4 Cg_endo -105.79 59.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.945 2.43 . . . . 0.54 113.27 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.19 160.96 8.68 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.931 -0.577 . . . . 0.55 112.762 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.09 175.07 8.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.612 2.208 . . . . 1.42 110.779 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.82 75.19 1.26 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.089 1.86 . . . . 2.04 112.375 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.71 48.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.954 -0.641 . . . . 0.98 113.015 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -96.14 -163.7 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.832 -0.433 . . . . 0.99 109.832 178.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.4 m -150.05 142.58 24.44 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.979 -0.748 . . . . 1.28 108.979 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.488 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 36.7 mtm180 -90.14 116.45 66.4 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.402 -0.592 . . . . 2.81 109.402 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.742 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.6 Cg_endo -50.86 146.86 20.06 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.569 2.846 . . . . 0.3 112.902 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.2 t -96.24 151.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.012 -0.54 . . . . 0.88 109.582 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 90' ' ' LEU . 97.2 mttt -62.44 121.45 13.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.61 0.719 . . . . 1.17 109.42 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 124.45 -25.55 5.94 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 114.675 -1.148 . . . . 0.42 111.114 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.686 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -84.93 134.62 34.25 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.033 -0.728 . . . . 0.59 109.033 178.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 m -82.12 131.05 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 108.184 -1.043 . . . . 1.22 108.184 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 28.1 m -128.04 148.03 32.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.362 -0.836 . . . . 0.25 110.412 -171.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.515 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 34.0 p -97.95 112.88 24.64 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.129 0.49 . . . . 0.29 110.118 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 86' ' ' LEU . 4.7 m -110.2 144.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.098 0.475 . . . . 0.19 110.246 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.1 t-160 -101.54 117.4 34.84 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.001 -1.481 . . . . 0.19 107.001 170.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' N ' ' HD2' ' A' ' 69' ' ' HIS . 1.2 pt? -117.91 137.04 53.08 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.146 -1.022 . . . . 0.39 111.018 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.42 114.22 11.94 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.308 -2.108 . . . . 0.27 105.308 165.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.62 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 86.4 m -104.61 127.45 52.36 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.816 -1.083 . . . . 0.19 110.914 -166.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.783 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 4.2 t -105.52 159.94 15.55 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.442 -0.799 . . . . 1.06 109.206 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.4 ' HG ' HG13 ' A' ' 80' ' ' VAL . 13.9 mt -86.67 165.22 16.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.84 109.295 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.72 -23.92 54.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 1.14 110.169 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -86.28 -4.18 59.12 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.695 -0.684 . . . . 2.14 111.655 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.89 6.76 57.93 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.535 -0.84 . . . . 0.51 113.392 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 89.2 m -91.52 112.88 24.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.514 0.657 . . . . 0.46 111.947 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.783 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 32.9 mtt180 -74.76 117.11 16.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.793 0.806 . . . . 0.47 110.634 176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.8 m -101.86 -9.1 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.438 -1.255 . . . . 0.27 112.491 -168.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.62 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -156.34 126.57 6.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.422 -0.354 . . . . 0.59 111.054 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -122.57 121.84 37.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 1.34 109.953 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.532 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 7.3 tt0 -142.42 114.61 6.23 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.552 . . . . 2.59 110.335 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -70.33 -18.68 34.18 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.538 2.826 . . . . 0.5 113.063 -172.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.29 108.25 2.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.175 0.988 . . . . 1.37 111.662 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.559 ' HB3' HG23 ' A' ' 68' ' ' VAL . 24.0 tp -117.41 106.45 13.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.484 -1.689 . . . . 0.38 108.621 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 13.6 p -100.56 132.49 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.4 p90 -156.81 162.99 39.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.336 -0.393 . . . . 0.23 110.534 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -88.92 117.45 27.93 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.185 -0.461 . . . . 0.42 110.295 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.542 HD22 ' HD3' ' A' ' 104' ' ' PRO . 36.8 mt -60.83 136.59 58.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.6 111.62 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 75.25 12.93 83.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.879 -0.677 . . . . 0.37 111.452 175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.48 -3.37 14.44 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.082 -0.71 . . . . 0.93 109.082 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.9 m 57.67 35.3 25.5 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.762 -1.108 . . . . 0.62 109.665 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.9 t70 -74.33 -9.0 58.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.126 0.965 . . . . 1.33 108.484 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.7 -158.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.04 -1.436 . . . . 0.23 110.747 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.9 pt -80.39 138.63 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 107.519 -1.289 . . . . 0.29 107.519 174.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.3 tp60 -59.71 -30.22 68.66 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.052 -0.259 . . . . 0.4 111.038 -172.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.79 -39.82 71.81 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.161 0.505 . . . . 0.2 110.484 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 68' ' ' VAL . 45.3 tp -79.55 -42.14 25.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.683 -0.69 . . . . 0.22 110.567 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.467 ' HB3' HE21 ' A' ' 97' ' ' GLN . 22.0 t70 -59.64 -30.54 68.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.057 -0.974 . . . . 0.26 110.068 -174.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 86.5 mt -90.82 -36.07 14.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.197 -0.91 . . . . 0.25 112.929 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.8 p -70.93 -29.54 65.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.143 0.496 . . . . 1.01 111.034 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.584 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 80.5 t -64.74 -54.25 37.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.444 -0.798 . . . . 0.21 112.957 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.542 ' HD3' HD22 ' A' ' 90' ' ' LEU . 21.2 Cg_endo -63.93 -20.41 68.04 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.737 1.625 . . . . 0.27 111.661 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 39' ' ' ILE . 23.7 mt -78.47 -17.02 56.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.619 . . . . 0.64 110.873 171.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.723 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -100.97 156.6 17.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.988 -0.551 . . . . 0.78 110.59 -179.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 0.2 OUTLIER -95.31 154.2 17.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.97 110.817 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.742 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.4 t -62.43 123.89 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.454 0.645 . . . . 0.8 110.277 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.46 16.64 45.48 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.903 -1.044 . . . . 0.28 112.754 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.845 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.7 pt-20 -105.14 167.62 9.6 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.464 0.649 . . . . 0.41 111.011 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.513 HG22 HD12 ' A' ' 50' ' ' LEU . 13.7 m -129.16 116.99 20.05 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.974 -1.121 . . . . 0.22 107.974 174.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -118.32 136.78 53.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.161 -0.472 . . . . 0.18 110.81 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.9 ttm -98.34 117.14 32.07 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.22 -1.4 . . . . 1.32 107.22 172.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.4 t -112.96 128.45 69.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.007 -0.368 . . . . 0.18 110.007 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.535 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 73.8 m -107.45 112.6 25.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.401 -0.92 . . . . 0.21 108.759 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.442 ' HB3' ' SG ' ' A' ' 121' ' ' CYS . . . -121.67 134.32 54.97 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.944 -1.48 . . . . 0.15 109.229 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.2 t70 -52.61 145.44 11.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.647 -0.871 . . . . 0.58 108.647 172.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -52.04 -26.65 11.38 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 123.416 0.448 . . . . 0.82 110.54 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.725 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 13.8 ptpt -54.33 -35.02 62.24 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.95 0.352 . . . . 0.81 111.95 176.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.554 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 87.5 m-85 -95.93 2.21 53.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.42 110.373 176.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 80.2 m -118.47 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.116 -0.947 . . . . 0.18 110.254 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.63 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 9.3 m-85 -144.41 40.71 1.33 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.34 -0.544 . . . . 0.24 112.364 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.485 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.07 -83.08 0.04 OUTLIER Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.048 -0.596 . . . . 0.25 113.694 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.73 8.7 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.539 2.159 . . . . 0.58 110.986 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 39.1 mt-30 -104.22 -51.4 3.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.624 0.726 . . . . 0.65 110.216 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.66 143.71 4.19 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.478 -1.237 . . . . 0.3 111.769 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.9 t -91.77 156.75 17.32 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 112.62 0.6 . . . . 0.33 112.62 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 129' ' ' SER . 7.4 ptm180 -43.1 -63.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.724 -1.125 . . . . 3.17 112.159 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.984 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 17.2 m -72.56 -66.41 0.61 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 121.021 -0.271 . . . . 1.23 110.431 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.984 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -105.74 128.05 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.397 2.064 . . . . 0.37 112.31 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.597 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.0 t80 -57.31 98.24 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.41 -0.959 . . . . 1.14 108.41 164.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.591 HG12 ' CB ' ' A' ' 127' ' ' SER . 26.9 mm -66.89 129.7 94.02 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.633 -0.506 . . . . 0.39 109.633 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 11.6 Cg_endo -57.49 145.3 89.19 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.624 2.216 . . . . 0.61 112.574 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.485 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 39.6 Cg_exo -57.9 134.27 61.4 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.802 2.335 . . . . 0.52 112.888 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.626 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 31.6 m170 66.88 10.97 8.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.74 -1.118 . . . . 2.38 112.471 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -71.81 124.54 25.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.337 -0.986 . . . . 0.26 108.337 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.07 112.58 10.35 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.153 -0.619 . . . . 0.22 109.59 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 115' ' ' THR . 1.7 tp -90.14 131.64 35.88 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.546 -0.752 . . . . 0.22 110.065 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.5 t -116.84 99.94 7.44 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.821 -0.807 . . . . 1.2 108.821 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.3 pp -110.61 136.09 50.24 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.083 -0.508 . . . . 0.32 111.106 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.623 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 34.5 tt0 -103.8 113.54 27.13 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.989 -0.745 . . . . 1.05 108.989 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.7 m -114.51 120.8 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.606 0.717 . . . . 0.19 112.486 -175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.7 m -91.41 113.09 25.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.938 -1.028 . . . . 0.28 110.139 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.723 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 47.0 tp -84.65 98.13 10.02 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.885 -0.783 . . . . 0.15 108.885 173.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 27.6 mtmt -94.42 -28.6 15.41 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.096 -0.957 . . . . 1.08 110.664 -171.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.515 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 24.5 m -153.72 147.44 25.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 0.37 111.663 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.634 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.95 127.88 25.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.792 -0.448 . . . . 0.25 109.792 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.13 141.96 34.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 C-N-CA 120.643 -0.423 . . . . 0.92 110.916 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.561 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 10.6 t70 -74.52 119.4 18.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.44 -0.346 . . . . 2.27 110.745 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.589 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -152.77 37.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.988 -0.745 . . . . 1.97 108.988 -176.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 156.99 36.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 2.14 110.296 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.38 -42.84 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.721 0.637 . . . . 5.79 112.721 -169.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -150.55 105.96 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.72 0.295 . . . . 7.48 110.637 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -66.97 100.18 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 8.46 110.739 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -116.63 6.61 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.692 -0.231 . . . . 8.83 111.538 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -150.89 151.74 32.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.514 0.197 . . . . 12.17 110.754 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.531 -0.747 . . . . 13.46 110.005 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 tpp . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.798 0.332 . . . . 50.23 110.958 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.6 41.33 0.57 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.961 -0.638 . . . . 47.99 111.515 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 20.5 mt-30 -79.97 152.63 74.52 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.851 -0.174 . . . . 46.26 110.796 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' GLN . 16.2 Cg_exo -69.43 151.06 70.94 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.901 2.401 . . . . 44.8 111.729 176.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.35 153.41 66.24 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.581 2.187 . . . . 44.02 112.227 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 69.14 -170.03 0.18 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.011 -0.541 . . . . 42.5 112.171 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.641 ' HG3' ' H ' ' A' ' 9' ' ' ALA . 7.8 tp10 -134.7 140.59 46.09 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.178 -0.465 . . . . 41.5 109.747 -176.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -113.05 18.89 17.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.503 -0.317 . . . . 40.33 110.947 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.641 ' H ' ' HG3' ' A' ' 7' ' ' GLU . . . 80.1 162.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.03 -0.986 . . . . 39.09 112.003 173.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -130.44 -69.03 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.019 -0.991 . . . . 38.82 110.396 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.473 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 3.6 pt20 -98.6 121.69 55.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 38.16 111.169 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 11' ' ' GLN . 7.3 Cg_exo -73.08 125.4 10.31 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.782 2.321 . . . . 36.7 111.238 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.29 33.6 0.57 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.697 -0.763 . . . . 35.61 112.047 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.77 140.95 49.36 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.696 -0.296 . . . . 35.03 110.428 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt -133.22 131.63 40.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.635 -0.505 . . . . 34.01 109.635 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.8 22.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.662 0.245 . . . . 32.89 111.662 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' HD2' ' C ' ' A' ' 17' ' ' ARG . 1.7 ppt_? -139.52 5.04 2.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.765 0.317 . . . . 31.94 111.206 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.31 -62.18 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.581 -0.736 . . . . 31.24 112.961 -169.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.92 145.89 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.45 0.643 . . . . 31.24 111.937 -167.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.856 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.4 pt? -82.31 83.48 7.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.267 -0.878 . . . . 29.85 110.388 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.39 76.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.794 -0.639 . . . . 28.2 110.268 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.01 -53.59 2.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.764 -0.653 . . . . 26.78 110.375 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.6 ttm -158.15 66.71 0.46 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.381 0.61 . . . . 27.47 109.838 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -106.82 107.91 61.1 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.505 -0.77 . . . . 24.41 109.29 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.77 -178.25 4.41 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.869 2.379 . . . . 21.63 113.336 -174.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 91.2 mt-10 -94.7 137.02 22.57 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-N 115.632 -0.713 . . . . 20.67 110.012 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 22.0 Cg_exo -66.1 105.01 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.544 2.163 . . . . 18.02 111.404 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.72 141.35 92.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.276 -0.42 . . . . 14.93 110.306 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.16 127.77 27.01 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.495 2.13 . . . . 13.81 112.339 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.15 70.75 6.32 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.669 -0.696 . . . . 10.76 110.894 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.1 67.26 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.612 2.208 . . . . 9.77 112.137 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.78 135.24 20.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 5.86 109.962 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.87 -43.74 54.21 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.986 2.457 . . . . 4.47 111.956 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -157.2 146.96 20.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.58 -0.736 . . . . 4.13 109.244 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -114.17 106.28 14.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.063 0.459 . . . . 2.45 110.801 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.675 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -92.4 -160.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.672 -0.694 . . . . 0.53 110.193 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.93 110.69 5.17 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.155 -0.475 . . . . 0.5 110.903 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.752 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -71.03 99.94 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.637 -0.71 . . . . 2.51 110.691 173.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.614 HG23 HD11 ' A' ' 105' ' ' LEU . 15.8 mt -48.71 -48.5 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.973 -1.012 . . . . 0.46 112.189 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 88.4 mt -105.93 4.64 29.76 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.612 -0.435 . . . . 0.72 111.103 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.71 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 67.86 18.73 70.84 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.52 112.416 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.731 HD22 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -98.03 -23.6 15.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.82 0.304 . . . . 0.95 111.82 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.731 ' N ' HD22 ' A' ' 42' ' ' ASN . . . 105.18 -27.21 19.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.189 -1.005 . . . . 0.72 113.722 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -94.26 -11.18 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.395 0.597 . . . . 1.56 111.732 -174.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.3 tp -121.52 107.94 13.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.021 -0.536 . . . . 0.32 110.443 175.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.752 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 63.2 mtm180 -142.39 141.63 32.31 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.567 -0.288 . . . . 1.14 111.435 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' HG22 ' A' ' 114' ' ' VAL . 18.7 ttpt -111.04 129.6 55.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.951 -0.388 . . . . 0.35 109.951 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.675 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 12.4 ttmt -108.05 128.52 54.75 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.773 0.32 . . . . 1.07 110.778 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -80.56 101.33 9.09 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.949 -0.569 . . . . 0.33 110.91 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 111' ' ' THR . 10.0 mt -68.25 -51.85 40.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.042 -1.466 . . . . 0.28 107.042 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 79.3 t -138.63 126.0 13.35 Favored Pre-proline 0 CA--C 1.497 -1.075 0 CA-C-N 113.091 -1.868 . . . . 0.36 106.574 169.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 41.8 Cg_endo -103.12 64.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.818 2.345 . . . . 0.54 113.491 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.67 169.14 32.59 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.019 -0.991 . . . . 0.55 113.085 175.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.687 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 73.4 Cg_endo -77.42 168.95 21.99 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.355 2.036 . . . . 1.42 110.492 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.19 84.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.457 2.105 . . . . 2.04 111.941 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.19 48.07 0.33 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.992 -0.549 . . . . 0.98 112.17 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.687 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 3.4 p -87.22 -172.39 3.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.299 0.571 . . . . 0.99 110.977 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.72 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 9.8 m -153.08 127.07 8.99 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.646 -0.872 . . . . 1.28 108.646 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 22.1 ptt180 -90.41 123.46 65.44 Favored Pre-proline 0 C--N 1.317 -0.814 0 C-N-CA 119.66 -0.816 . . . . 2.81 110.809 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.469 ' HB3' ' HB1' ' A' ' 147' ' ' ALA . 15.1 Cg_endo -56.39 155.22 26.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.909 3.073 . . . . 0.3 113.741 -175.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 12.1 t -94.87 153.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.307 -0.861 . . . . 0.88 109.389 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.895 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 21.1 mtpt -67.59 119.35 12.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.496 0.665 . . . . 1.17 109.401 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.36 -23.5 5.14 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.2 -1.16 . . . . 0.42 110.2 -170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.703 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -80.79 142.69 33.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.59 109.263 176.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.73 121.49 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.577 -0.897 . . . . 1.22 108.577 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.6 m -126.6 146.37 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.25 111.895 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.442 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 28.9 p -104.22 114.05 28.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.381 -0.827 . . . . 0.29 110.337 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.652 HG21 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.59 145.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.083 -0.647 . . . . 0.19 110.038 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.624 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -102.37 115.08 29.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.804 -1.554 . . . . 0.19 106.804 169.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -116.19 136.36 53.08 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.149 -1.02 . . . . 0.39 110.91 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.585 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -132.18 113.96 13.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.993 -1.854 . . . . 0.27 105.993 166.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.636 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 61.0 m -104.24 125.71 50.74 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.683 -1.144 . . . . 0.19 111.186 -168.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.6 t -105.75 159.17 16.2 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.206 -0.906 . . . . 1.06 109.034 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.436 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.3 mt -86.34 165.2 16.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.792 -0.64 . . . . 0.84 110.017 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 9.5 pt-20 -54.93 -17.82 4.17 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.48 0.488 . . . . 1.14 112.114 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -98.09 -15.2 20.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 2.14 110.998 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.13 23.11 6.53 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.769 -0.729 . . . . 0.51 113.357 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 m -101.42 109.58 21.43 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.302 -0.528 . . . . 0.46 111.115 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 11.0 mtt180 -73.75 114.4 11.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.674 0.749 . . . . 0.47 110.462 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.663 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.9 m -98.73 -9.02 9.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.529 -1.214 . . . . 0.27 111.86 -171.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.636 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 8.4 pt20 -162.06 127.14 3.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.082 -0.508 . . . . 0.59 110.168 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 71' ' ' GLN . 16.8 tt0 -130.52 106.85 8.79 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.641 -0.503 . . . . 1.34 109.641 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 5.1 tt0 -126.91 117.98 22.27 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.444 -0.798 . . . . 2.59 110.568 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 9.9 Cg_exo -71.39 -18.59 29.7 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.66 2.907 . . . . 0.5 113.932 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -161.99 99.28 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.573 1.178 . . . . 1.37 112.416 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.2 107.87 19.03 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.171 -1.831 . . . . 0.38 108.7 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.6 p -104.6 137.12 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 17.5 p90 -158.73 167.92 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.71 0.29 . . . . 0.23 111.332 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -88.63 112.09 22.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.263 -0.643 . . . . 0.42 109.263 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.895 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 12.8 tp -53.44 121.55 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.116 -0.493 . . . . 0.6 111.072 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.53 ' CA ' ' HE2' ' A' ' 62' ' ' LYS . . . 97.09 -3.21 61.95 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.444 -0.884 . . . . 0.37 113.383 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.7 10.4 41.41 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.97 -0.692 . . . . 0.93 109.454 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 33.3 m 58.98 30.54 20.37 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 114.671 -1.15 . . . . 0.62 110.308 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 88' ' ' PHE . 18.1 m-20 -67.28 -11.29 57.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.816 0.817 . . . . 1.33 109.835 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 m -131.66 -162.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.245 -1.343 . . . . 0.23 110.026 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.61 HG13 ' H ' ' A' ' 99' ' ' LEU . 28.0 pt -76.11 141.27 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.668 -1.234 . . . . 0.29 107.668 173.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 100' ' ' ASP . 4.2 tp60 -61.85 -28.61 69.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.555 -0.293 . . . . 0.4 110.863 -173.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.9 80.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.988 0.423 . . . . 0.2 110.226 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.652 HD21 HG21 ' A' ' 68' ' ' VAL . 57.2 tp -73.17 -40.98 64.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.479 -0.782 . . . . 0.22 110.955 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.427 ' HB3' HE21 ' A' ' 97' ' ' GLN . 18.3 t70 -59.9 -31.36 69.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.08 -0.963 . . . . 0.26 109.906 -175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.57 -34.49 15.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.127 -0.942 . . . . 0.25 112.167 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 78.3 p -70.68 -28.64 64.92 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.918 -0.313 . . . . 1.01 110.911 -173.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.429 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 55.6 t -64.47 -55.0 33.15 Favored Pre-proline 0 C--O 1.217 -0.648 0 CA-C-N 115.991 -0.549 . . . . 0.21 112.227 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.888 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.0 Cg_endo -63.78 -17.79 61.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.95 1.766 . . . . 0.27 111.873 175.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.614 HD11 HG23 ' A' ' 39' ' ' ILE . 14.0 mt -82.75 -15.69 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.933 -0.576 . . . . 0.64 111.136 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -103.77 148.57 25.93 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.144 -0.48 . . . . 0.78 111.026 178.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -90.38 160.67 15.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.97 110.786 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -66.97 129.67 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.544 0.687 . . . . 0.8 110.311 -176.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.94 66.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.239 -0.892 . . . . 0.28 112.153 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.807 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -98.05 166.97 11.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.5 0.667 . . . . 0.41 110.939 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.516 HG22 HD12 ' A' ' 50' ' ' LEU . 8.1 m -128.74 118.18 22.39 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.972 -1.121 . . . . 0.22 107.972 175.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.501 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.32 136.61 54.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.277 -0.419 . . . . 0.18 110.602 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.1 ttp -101.89 117.04 34.01 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.667 -1.234 . . . . 1.32 107.667 171.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.749 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.8 t -110.84 134.55 52.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.563 -0.532 . . . . 0.18 109.563 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.552 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 89.5 m -107.66 114.06 27.78 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 119.202 -0.999 . . . . 0.21 108.491 170.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.16 130.7 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.958 -1.474 . . . . 0.15 109.022 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.777 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 5.8 t70 -53.06 147.31 9.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.437 -0.579 . . . . 0.58 109.437 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 1.9 t -53.0 -29.27 28.25 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 121.027 0.441 . . . . 0.82 110.197 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.777 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.3 ptpt -55.26 -31.48 61.59 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.079 0.4 . . . . 0.81 112.079 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.592 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 91.0 m-85 -95.44 -0.66 52.15 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.196 0.522 . . . . 0.42 110.148 175.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 77.3 m -118.24 -87.82 0.62 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.119 -0.946 . . . . 0.18 110.648 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.54 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.8 m-85 -144.94 36.2 1.14 Allowed 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.376 -0.53 . . . . 0.24 112.063 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 134' ' ' PRO . . . -55.89 -76.77 0.18 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.825 -0.702 . . . . 0.25 113.052 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.9 3.66 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.471 2.114 . . . . 0.58 111.507 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -104.74 -51.92 2.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.506 0.67 . . . . 0.65 109.91 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.54 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 83.92 141.83 4.94 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.592 -1.186 . . . . 0.3 111.31 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.69 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.4 t -90.54 153.03 20.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.817 0.341 . . . . 0.33 111.134 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -52.82 -42.48 65.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.386 -0.824 . . . . 3.17 111.971 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 1.001 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 10.1 m -84.97 -66.06 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.266 -0.642 . . . . 1.23 109.266 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.001 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.0 Cg_endo -105.38 126.28 0.06 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.37 111.497 171.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.411 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 12.9 t80 -59.65 97.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.776 -1.194 . . . . 1.14 107.776 167.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.569 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.9 mm -65.52 126.92 92.48 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.966 -0.561 . . . . 0.39 109.633 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 53.2 Cg_exo -51.89 142.45 42.73 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.639 2.226 . . . . 0.61 112.008 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 41.1 Cg_exo -57.03 134.42 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.352 2.035 . . . . 0.52 112.0 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.448 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.8 OUTLIER 74.28 0.67 3.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.363 -0.835 . . . . 2.38 111.422 174.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.6 119.41 12.32 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.193 -0.669 . . . . 0.26 109.193 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -73.24 113.81 10.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.195 -0.602 . . . . 0.22 110.54 -171.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.597 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.3 mp -89.6 134.21 34.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.861 -0.609 . . . . 0.22 111.708 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 t -118.0 100.47 7.57 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.025 -0.731 . . . . 1.2 109.025 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.594 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.4 pp -111.02 137.05 49.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.609 -0.723 . . . . 0.32 111.592 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.585 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 81.0 tt0 -103.53 124.79 49.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.703 -0.851 . . . . 1.05 108.703 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' HE3' ' A' ' 106' ' ' MET . 3.3 m -122.74 126.15 73.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.257 0.551 . . . . 0.19 112.252 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 7.3 m -96.11 115.97 28.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.28 110.219 170.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.752 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 46.8 tp -85.39 98.13 10.39 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.727 -0.842 . . . . 0.15 108.727 172.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.5 mtmt -94.14 -30.3 14.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.336 -0.847 . . . . 1.08 110.661 -169.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.5 m -150.92 146.14 26.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.128 0.49 . . . . 0.37 111.814 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.508 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -136.1 127.68 28.81 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.485 -0.932 . . . . 0.25 108.485 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.31 125.29 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.18 0.514 . . . . 0.92 111.13 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.581 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.7 t70 -67.73 121.45 15.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.757 -0.656 . . . . 2.27 110.163 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.85 12.53 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.142 -0.481 . . . . 1.97 111.299 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.27 169.99 13.24 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.208 -0.597 . . . . 2.14 109.993 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -108.02 -179.58 3.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.725 -0.67 . . . . 5.79 111.593 -167.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -95.9 9.92 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.759 -0.655 . . . . 7.48 110.084 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -135.63 96.61 3.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.318 -0.855 . . . . 8.46 108.698 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.09 148.97 42.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.765 -0.652 . . . . 8.83 111.853 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -92.71 -32.45 14.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 12.17 109.998 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 37.8 m80 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.085 -0.959 . . . . 13.46 109.419 -179.494 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 121.01 0.433 . . . . 50.23 110.283 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.89 54.48 0.92 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.707 -0.957 . . . . 47.99 110.707 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -75.84 145.42 77.96 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 110.374 -0.232 . . . . 46.26 110.374 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 52.8 Cg_exo -55.27 121.36 9.79 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.781 2.321 . . . . 44.8 112.148 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 54.0 Cg_exo -53.28 135.86 61.15 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.27 2.647 . . . . 44.02 113.136 -175.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.84 136.07 53.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.743 -0.662 . . . . 42.5 109.641 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 58.1 72.94 0.49 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.582 0.551 . . . . 41.5 110.23 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.31 127.25 32.14 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.426 -0.583 . . . . 40.33 109.426 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.45 -57.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.81 -0.177 . . . . 39.09 111.432 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 64.7 103.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.756 0.66 . . . . 38.82 112.081 -176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 61.99 70.41 0.85 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 114.907 -1.042 . . . . 38.16 111.538 174.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.62 174.93 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.392 2.728 . . . . 36.7 112.562 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.25 -122.8 5.94 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 35.61 111.973 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.94 166.57 23.13 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.135 -0.32 . . . . 35.03 110.135 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 tp -75.46 83.25 2.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.023 0.44 . . . . 34.01 110.994 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.39 97.78 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.705 -0.85 . . . . 32.89 108.705 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -117.45 166.98 11.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.96 -0.563 . . . . 31.94 111.23 -172.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -96.18 142.16 28.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.268 -0.878 . . . . 31.24 110.437 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -86.13 11.4 11.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.599 -0.728 . . . . 31.24 110.65 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.3 mt -88.58 8.8 26.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.661 -0.7 . . . . 29.85 111.12 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 65.59 -168.63 0.21 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.743 -0.662 . . . . 28.2 111.371 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.29 49.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 26.78 110.535 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 58.8 mtt -90.88 35.39 0.9 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.597 . . . . 27.47 110.423 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 34.7 tt0 67.29 112.09 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.39 -0.823 . . . . 24.41 110.808 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 12.0 Cg_exo -71.13 173.74 11.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.231 2.62 . . . . 21.63 113.197 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -73.14 144.04 84.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 20.67 110.595 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.64 137.08 37.92 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.543 2.162 . . . . 18.02 112.205 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -80.62 148.22 65.16 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.125 -0.489 . . . . 14.93 110.323 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 21.7 Cg_exo -64.85 128.02 19.93 Favored 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 122.688 2.258 . . . . 13.81 111.723 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' ALA . . . -141.66 77.16 19.49 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.863 -0.608 . . . . 10.76 111.169 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.34 35.55 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.059 2.506 . . . . 9.77 112.564 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -112.33 117.02 48.12 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.773 -0.649 . . . . 5.86 110.468 -178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 25.5 Cg_exo -63.75 -28.05 68.28 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.792 2.328 . . . . 4.47 112.783 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.98 -54.04 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.464 -0.334 . . . . 4.13 111.216 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' HA ' HH11 ' A' ' 46' ' ' ARG . 9.6 pt-20 -54.99 125.11 19.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 2.45 112.42 -174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.583 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -86.94 -168.64 2.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.556 -0.747 . . . . 0.53 109.729 177.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.3 tp -73.01 110.33 7.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.5 110.037 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.664 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -74.75 123.53 25.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.38 -0.528 . . . . 2.51 109.831 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.639 HG23 HD11 ' A' ' 105' ' ' LEU . 8.4 mt -55.22 -33.21 29.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.985 -1.007 . . . . 0.46 111.462 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.9 mt -115.9 -1.39 12.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.014 -0.539 . . . . 0.72 110.313 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.66 23.05 66.71 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.093 -0.803 . . . . 0.52 111.093 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.497 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -97.32 -17.67 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.622 0.601 . . . . 0.95 112.622 -172.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 115.17 -15.43 18.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.446 -0.883 . . . . 0.72 114.72 166.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -120.29 -7.79 9.74 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.972 0.73 . . . . 1.56 112.972 -175.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 39' ' ' ILE . 25.2 tp -121.75 100.07 6.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.578 0.228 . . . . 0.32 110.624 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.541 HH11 ' HA ' ' A' ' 35' ' ' GLU . 81.2 mtm180 -134.86 139.23 44.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 111.697 0.258 . . . . 1.14 111.697 -171.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.7 ttpt -113.05 123.31 50.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.244 0.217 . . . . 0.35 110.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.3 ttpp -111.07 117.69 33.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.832 0.349 . . . . 1.07 111.253 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.547 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 2.2 p -74.1 98.89 3.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.33 111.656 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 111' ' ' THR . 7.7 mt -67.01 -53.38 31.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.413 -1.329 . . . . 0.28 107.413 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.801 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t -134.39 123.01 16.24 Favored Pre-proline 0 CA--C 1.498 -1.032 0 CA-C-N 112.908 -1.951 . . . . 0.36 106.478 168.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.721 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 57.7 Cg_endo -108.37 72.09 0.01 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 122.521 2.148 . . . . 0.54 114.578 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 54' ' ' PRO . . . 81.23 140.65 2.94 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.55 113.756 169.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 11.6 Cg_exo -70.71 148.71 59.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.411 2.074 . . . . 1.42 110.134 169.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.33 110.38 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.756 2.304 . . . . 2.04 112.711 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.72 44.65 2.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.818 -0.706 . . . . 0.98 112.053 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 p -89.93 -165.34 1.32 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.935 0.398 . . . . 0.99 110.629 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -158.75 144.57 16.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.616 -0.883 . . . . 1.28 108.616 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 49.5 mtm180 -94.13 111.38 53.06 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.659 -0.497 . . . . 2.81 109.659 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.65 ' HG3' HD21 ' A' ' 144' ' ' LEU . 9.9 Cg_endo -49.96 149.55 11.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.693 2.928 . . . . 0.3 113.657 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.676 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 20.2 t -96.22 153.05 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.88 109.531 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.853 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 98.5 mttt -68.78 119.61 13.42 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.523 0.678 . . . . 1.17 109.231 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 -28.5 3.82 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.836 -1.306 . . . . 0.42 109.836 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.683 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.34 139.28 34.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.637 -0.875 . . . . 0.59 108.637 177.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.3 m -88.69 125.74 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 108.024 -1.102 . . . . 1.22 108.024 173.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.3 m -124.7 143.32 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.57 -0.741 . . . . 0.25 111.468 -171.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.867 HG22 HG22 ' A' ' 87' ' ' VAL . 69.4 p -90.11 113.03 24.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.423 -0.808 . . . . 0.29 110.243 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.823 HG21 HD21 ' A' ' 99' ' ' LEU . 19.0 m -111.71 141.11 28.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 120.095 -0.642 . . . . 0.19 110.366 172.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.8 t-160 -101.67 119.13 38.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.848 -1.538 . . . . 0.19 106.848 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -124.92 133.59 52.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 118.789 -1.164 . . . . 0.39 111.297 177.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.568 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -125.45 115.13 19.77 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.082 -1.821 . . . . 0.27 106.082 168.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.627 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 54.1 m -106.8 129.26 54.69 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.875 -1.057 . . . . 0.19 111.591 -168.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.705 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.56 155.46 18.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.192 -0.913 . . . . 1.06 109.159 177.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.484 ' HG ' HG13 ' A' ' 80' ' ' VAL . 10.0 mt -83.31 166.24 18.65 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.472 -0.785 . . . . 0.84 110.243 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -54.52 -19.18 5.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.01 -0.541 . . . . 1.14 110.946 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -91.39 -3.59 56.54 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.573 -0.74 . . . . 2.14 110.947 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.4 10.23 62.33 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.319 -0.467 . . . . 0.51 112.24 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.4 m -95.5 112.05 23.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.46 111.441 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 14.5 mtt180 -74.38 120.02 19.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.518 0.675 . . . . 0.47 110.609 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.614 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.5 m -108.48 -10.79 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.617 -1.174 . . . . 0.27 112.272 -169.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.627 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.2 pt20 -159.72 125.63 4.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.288 -0.414 . . . . 0.59 109.961 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.541 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 73.4 tt0 -128.41 108.09 10.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 1.34 109.972 174.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.544 ' HB3' HD23 ' A' ' 70' ' ' LEU . 4.7 tp10 -119.18 111.56 36.79 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.922 -1.036 . . . . 2.59 109.941 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 37.3 Cg_endo -66.48 -19.61 54.78 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.209 2.606 . . . . 0.5 113.918 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.582 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 25.5 tt0 -165.18 101.47 0.74 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 122.364 1.078 . . . . 1.37 112.479 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.1 tp -109.69 107.55 17.62 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.657 -1.61 . . . . 0.38 108.786 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.867 HG22 HG22 ' A' ' 67' ' ' THR . 1.7 t -101.55 125.02 55.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -144.95 161.63 38.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.586 -0.279 . . . . 0.23 110.381 -172.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -81.17 111.72 17.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.174 -0.467 . . . . 0.42 109.774 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.853 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.1 tp -58.91 132.21 53.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.6 110.161 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 84.2 2.65 89.24 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.128 -0.558 . . . . 0.37 112.415 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -99.38 -3.91 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.059 0.457 . . . . 0.93 110.372 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.5 m 58.6 33.31 23.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.497 -0.774 . . . . 0.62 109.351 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 33.3 t70 -72.4 -10.68 60.09 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 122.534 1.159 . . . . 1.33 108.891 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.24 -158.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 113.542 -1.663 . . . . 0.23 109.665 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.711 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.2 pt -80.3 137.73 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.954 -1.128 . . . . 0.29 107.954 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.5 tp60 -59.53 -28.32 66.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.374 -0.376 . . . . 0.4 110.408 -174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.62 93.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.133 0.492 . . . . 0.2 110.655 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.823 HD21 HG21 ' A' ' 68' ' ' VAL . 58.2 tp -76.4 -38.69 55.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.706 -0.679 . . . . 0.22 110.141 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.47 -29.09 69.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.965 -1.016 . . . . 0.26 109.825 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 78.4 mt -91.12 -35.2 14.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.518 -0.764 . . . . 0.25 112.533 177.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 23.3 p -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.088 -0.383 . . . . 1.01 111.312 -172.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.558 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -62.23 -55.61 38.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 112.297 0.48 . . . . 0.21 112.297 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.846 ' HD3' HD11 ' A' ' 90' ' ' LEU . 19.0 Cg_endo -62.6 -23.21 74.66 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.898 1.732 . . . . 0.27 111.305 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.639 HD11 HG23 ' A' ' 39' ' ' ILE . 16.8 mt -78.14 -15.62 58.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.55 . . . . 0.64 111.707 173.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.54 ' HE3' HG23 ' A' ' 142' ' ' VAL . 2.9 ptm -106.93 154.9 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.497 -0.32 . . . . 0.78 111.261 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -89.16 153.56 20.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.912 0.387 . . . . 0.97 110.532 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 p -64.19 127.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.618 0.723 . . . . 0.8 109.972 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.58 58.4 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.128 -0.942 . . . . 0.28 112.865 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.801 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.4 pt-20 -99.07 167.71 10.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.629 0.728 . . . . 0.41 111.455 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 50' ' ' LEU . 7.4 m -128.69 117.83 21.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.83 -1.174 . . . . 0.22 107.83 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.72 139.01 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.995 0.426 . . . . 0.18 110.652 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.7 ttm -98.21 118.27 34.48 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.307 -1.368 . . . . 1.32 107.307 173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.4 t -115.35 128.2 72.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.781 -0.452 . . . . 0.18 109.781 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.511 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 85.2 m -106.14 113.98 27.83 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.206 -1.035 . . . . 0.21 108.206 172.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.72 136.88 53.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.31 -1.314 . . . . 0.15 109.617 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.0 t70 -55.49 148.92 14.47 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.101 -0.703 . . . . 0.58 109.101 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.643 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.7 t -56.32 -27.29 55.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.136 0.493 . . . . 0.82 110.453 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 15.1 ptpt -54.94 -32.63 61.54 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.215 -0.303 . . . . 0.81 111.717 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 80.0 m-85 -96.44 0.44 50.41 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 120.998 0.428 . . . . 0.42 110.165 175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.6 m -117.02 -92.01 0.53 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.076 -0.965 . . . . 0.18 110.382 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' HB3' ' C ' ' A' ' 126' ' ' GLY . 9.2 m-85 -142.42 39.78 1.57 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 120.429 -0.508 . . . . 0.24 112.233 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -53.2 -80.58 0.07 OUTLIER Glycine 0 C--N 1.338 0.686 0 C-N-CA 121.208 -0.52 . . . . 0.25 114.031 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.32 9.08 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.191 1.927 . . . . 0.58 111.017 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.25 -50.43 3.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.065 -0.971 . . . . 0.65 110.173 -173.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.574 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.91 143.94 4.46 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 114.912 -1.04 . . . . 0.3 112.243 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 8.8 t -90.42 157.03 17.8 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.135 -0.532 . . . . 0.33 111.489 -176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -59.18 -34.83 72.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.287 -0.869 . . . . 3.17 112.259 -172.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 1.033 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 48.2 m -89.45 -67.22 0.13 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.174 -0.61 . . . . 1.23 109.718 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.033 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.7 Cg_endo -104.62 127.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.275 1.983 . . . . 0.37 111.95 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.574 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 36.5 t80 -56.91 97.87 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.194 -1.039 . . . . 1.14 108.194 165.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.568 HG12 ' CB ' ' A' ' 127' ' ' SER . 30.8 mm -65.95 128.97 94.19 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 115.734 -0.666 . . . . 0.39 109.577 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.6 Cg_exo -53.78 144.29 55.22 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.61 2.206 . . . . 0.61 112.033 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.2 Cg_exo -58.92 133.86 56.36 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.315 2.01 . . . . 0.52 112.091 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.565 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER 73.61 0.12 3.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.232 -0.895 . . . . 2.38 112.775 177.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -66.4 123.52 20.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.728 -0.471 . . . . 0.26 109.728 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.89 113.52 11.14 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.425 0.631 . . . . 0.22 110.41 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.621 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.0 OUTLIER -92.06 132.4 36.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.455 -0.793 . . . . 0.22 111.214 -176.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.0 t -116.6 100.65 7.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.182 -0.673 . . . . 1.2 109.182 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -117.01 135.21 53.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.081 -0.509 . . . . 0.32 111.664 -172.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.568 ' HB3' HE22 ' A' ' 71' ' ' GLN . 35.8 tt0 -99.63 117.47 34.06 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.451 -0.574 . . . . 1.05 109.451 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.818 HG11 HD13 ' A' ' 99' ' ' LEU . 5.3 m -110.51 124.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.608 . . . . 0.19 111.95 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -99.91 108.88 21.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.36 -0.836 . . . . 0.28 109.777 172.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 60' ' ' PRO . 49.4 tp -82.59 96.91 8.23 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.384 -0.969 . . . . 0.15 108.384 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -94.46 -25.13 17.02 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.583 -0.735 . . . . 1.08 110.601 -170.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.1 m -154.66 146.25 23.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.876 -0.602 . . . . 0.37 110.841 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.14 127.65 21.5 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.975 -0.75 . . . . 0.25 108.975 173.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.83 139.34 44.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.288 -0.565 . . . . 0.92 110.86 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.529 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 8.8 t70 -78.62 122.0 25.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.691 -0.485 . . . . 2.27 109.691 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.4 tp -152.76 22.33 0.6 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.141 -0.481 . . . . 1.97 110.675 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.81 151.71 31.78 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.543 -0.91 . . . . 2.14 108.543 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 153' ' ' HIS . 3.7 t60 -61.84 -55.56 28.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.661 -0.496 . . . . 5.79 109.661 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 152' ' ' HIS . 0.9 OUTLIER 157.73 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 124.52 1.138 . . . . 7.48 109.72 176.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -146.07 54.34 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 8.46 110.543 -170.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -70.87 86.44 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 8.83 110.093 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 27.2 t60 -178.38 -27.2 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.807 -0.633 . . . . 12.17 110.619 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 31.8 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 117.847 -1.073 . . . . 13.46 109.811 -172.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.85 0.357 . . . . 50.23 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.43 157.19 29.56 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.315 -0.714 . . . . 47.99 111.315 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 26.9 pt20 -113.61 144.63 31.75 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 110.238 -0.282 . . . . 46.26 110.238 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 3' ' ' GLN . 25.0 Cg_exo -63.01 118.92 5.82 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.032 2.488 . . . . 44.8 112.686 -176.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -78.78 165.22 24.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.714 2.276 . . . . 44.02 111.804 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.59 113.4 25.5 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.46 -0.336 . . . . 42.5 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 72.98 130.17 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.149 0.906 . . . . 41.5 113.004 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.2 127.23 33.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.656 -0.702 . . . . 40.33 109.133 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.52 11.48 2.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.571 -0.286 . . . . 39.09 111.345 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.75 -46.76 68.01 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.316 0.579 . . . . 38.82 109.663 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -125.83 97.13 36.32 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.7 -0.682 . . . . 38.16 109.85 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.84 98.37 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.718 2.279 . . . . 36.7 111.87 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.25 -166.76 11.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.044 -0.598 . . . . 35.61 112.223 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -172.61 176.32 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 35.03 109.583 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.3 tp -74.79 -68.21 0.56 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.649 -0.5 . . . . 34.01 109.649 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 52.47 26.7 4.39 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.259 0.837 . . . . 32.89 113.259 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -105.9 -9.39 17.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 31.94 110.586 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 45.8 tt0 -77.09 106.11 8.59 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.407 -0.59 . . . . 31.24 109.407 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 6.2 t80 74.13 -36.45 0.33 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.079 0.862 . . . . 31.24 112.454 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.06 92.83 0.55 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.407 0.623 . . . . 29.85 111.473 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.88 167.09 10.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.362 -0.835 . . . . 28.2 110.412 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB1' ' OE1' ' A' ' 24' ' ' GLU . . . -121.21 176.96 5.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.409 -0.359 . . . . 26.78 111.307 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 47.0 ttm -133.63 -72.09 0.5 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.569 -0.9 . . . . 27.47 108.569 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 1.7 mp0 44.97 88.05 0.11 Allowed Pre-proline 0 N--CA 1.467 0.376 0 O-C-N 124.514 1.134 . . . . 24.41 112.874 171.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 14.0 Cg_endo -55.78 112.75 1.15 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.974 2.449 . . . . 21.63 112.236 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 45.5 mt-10 -68.84 127.5 93.12 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.839 -0.619 . . . . 20.67 110.657 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 11.4 Cg_exo -71.02 154.72 62.61 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.395 2.73 . . . . 18.02 112.117 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -120.05 134.26 24.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.059 -0.518 . . . . 14.93 111.038 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.98 146.26 94.62 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.718 2.278 . . . . 13.81 111.52 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.61 79.78 16.4 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 120.87 -0.332 . . . . 10.76 111.694 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.63 122.46 11.07 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.68 2.253 . . . . 9.77 111.116 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.51 121.95 70.84 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.194 -0.457 . . . . 5.86 111.133 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.72 -5.33 8.04 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.742 2.295 . . . . 4.47 112.298 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -79.48 118.5 21.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 4.13 111.347 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 9.6 tp10 -82.33 103.72 12.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.518 -0.764 . . . . 2.45 109.408 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.56 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 7.6 m0 -79.38 -161.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.53 111.049 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.9 tp -81.24 111.71 17.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.333 -0.848 . . . . 0.5 110.765 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.65 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -63.61 115.19 4.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.686 0.755 . . . . 2.51 110.543 173.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.628 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 21.0 mt -66.86 -44.69 88.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.192 -0.913 . . . . 0.46 111.152 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 HD13 ' A' ' 101' ' ' LEU . 93.0 mt -111.05 10.41 22.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 0.72 110.14 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.65 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 77.22 -2.34 61.81 Favored Glycine 0 C--O 1.225 -0.46 0 CA-C-N 115.539 -0.755 . . . . 0.52 112.137 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.752 HD22 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -83.74 -21.21 32.33 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.678 0.621 . . . . 0.95 112.678 -174.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.752 ' N ' HD22 ' A' ' 42' ' ' ASN . . . 83.52 -22.67 7.23 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.413 -0.899 . . . . 0.72 112.437 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.8 -32.84 72.85 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 122.109 0.957 . . . . 1.56 108.948 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.628 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 21.3 tp -121.21 114.09 20.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.685 -1.598 . . . . 0.32 110.292 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.509 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 49.8 mtm180 -142.32 143.43 32.77 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.296 0.372 . . . . 1.14 110.615 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 114' ' ' VAL . 23.0 ttpt -111.36 134.82 52.67 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.19 -0.3 . . . . 0.35 110.19 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 29.1 ttpp -124.02 126.99 47.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.194 -0.299 . . . . 1.07 110.194 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -79.89 116.53 20.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.33 111.223 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD11 ' HG3' ' A' ' 141' ' ' GLU . 7.5 mt -75.05 -49.28 20.28 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.507 -1.664 . . . . 0.28 106.507 169.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.863 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 89.6 t -134.09 130.7 20.47 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 113.105 -1.861 . . . . 0.36 106.287 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 51' ' ' VAL . 20.6 Cg_endo -108.66 63.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.119 2.546 . . . . 0.54 113.873 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.646 ' N ' ' HB3' ' A' ' 110' ' ' GLU . . . 68.03 170.49 5.5 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.396 -0.82 . . . . 0.55 113.685 175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.708 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 93.8 Cg_endo -87.27 175.32 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.235 2.624 . . . . 1.42 111.451 172.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.82 65.98 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.404 2.069 . . . . 2.04 112.801 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.74 56.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.028 -0.606 . . . . 0.98 112.796 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.708 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.9 p -99.84 -171.92 2.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.038 0.447 . . . . 0.99 111.13 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.13 153.19 41.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.224 -1.028 . . . . 1.28 108.224 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -103.71 115.02 64.2 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 2.81 110.098 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.786 ' HD3' HG23 ' A' ' 108' ' ' VAL . 61.4 Cg_exo -37.26 135.66 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.827 3.018 . . . . 0.3 113.982 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.542 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 18.9 t -90.73 150.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.092 -0.707 . . . . 0.88 109.092 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.588 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 64.6 mttt -65.56 104.21 0.98 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.899 0.857 . . . . 1.17 111.117 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 151' ' ' GLU . . . 142.18 -24.41 2.38 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 113.888 -1.505 . . . . 0.42 110.113 -176.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.719 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.044 0.449 . . . . 0.59 109.948 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 76.1 t -83.51 117.03 28.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.313 -0.858 . . . . 1.22 108.768 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.7 m -123.1 150.52 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.899 -0.591 . . . . 0.25 111.255 -170.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.649 ' HB ' ' HG3' ' A' ' 85' ' ' GLU . 62.0 p -104.49 113.4 26.94 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.629 -0.714 . . . . 0.29 110.085 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.623 HG21 HD21 ' A' ' 99' ' ' LEU . 30.0 m -110.3 145.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.331 -0.547 . . . . 0.19 109.977 175.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.675 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.34 114.46 28.76 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.188 -1.412 . . . . 0.19 107.188 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.39 134.15 55.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.012 -1.075 . . . . 0.39 111.075 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.551 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -129.94 114.72 16.19 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.902 -1.888 . . . . 0.27 105.902 166.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 62.5 m -103.94 128.19 51.47 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.66 -1.155 . . . . 0.19 111.619 -168.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -105.01 151.21 24.22 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.914 -1.039 . . . . 1.06 108.653 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 mt -73.27 165.46 25.0 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.97 -0.559 . . . . 0.84 109.604 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.572 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 6.4 pt-20 -55.77 -15.37 3.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.077 0.465 . . . . 1.14 110.807 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.572 ' ND2' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -88.68 -16.71 31.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.699 -0.682 . . . . 2.14 109.808 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.5 -4.71 37.44 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.656 -0.702 . . . . 0.51 111.844 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.8 m -81.45 110.21 16.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.815 0.341 . . . . 0.46 111.859 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 29.9 mtt180 -72.54 123.7 23.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.552 0.691 . . . . 0.47 111.187 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 31.0 m -109.11 -15.73 9.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.832 -1.076 . . . . 0.27 112.295 -170.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.636 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.9 pt20 -154.74 137.44 15.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.437 -0.579 . . . . 0.59 109.437 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 26.1 tt0 -144.41 105.69 4.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.171 0.51 . . . . 1.34 110.152 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -119.73 121.41 29.85 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.539 -0.755 . . . . 2.59 109.499 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 11.8 Cg_exo -69.0 -18.73 40.43 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.894 2.396 . . . . 0.5 113.059 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.649 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 14.1 tt0 -166.56 96.3 0.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.089 0.947 . . . . 1.37 111.53 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -98.38 102.94 14.83 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.485 -1.689 . . . . 0.38 108.514 172.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 6.9 p -97.33 135.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.636 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 31.2 p90 -157.42 169.06 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.23 111.417 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m -89.66 114.76 26.43 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.42 109.648 176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.903 HD11 ' HD3' ' A' ' 104' ' ' PRO . 16.3 tp -63.02 129.93 42.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.015 -0.538 . . . . 0.6 110.65 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.49 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.06 6.18 86.83 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.885 -0.674 . . . . 0.37 112.083 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.65 -1.51 30.05 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.73 -0.47 . . . . 0.93 109.73 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 40.0 m 56.16 33.99 23.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.62 109.727 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 17.7 t70 -71.47 -9.45 58.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 122.54 1.162 . . . . 1.33 108.549 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.61 -162.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.497 -1.683 . . . . 0.23 110.409 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.1 pt -77.6 139.64 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 107.67 -1.233 . . . . 0.29 107.67 173.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.583 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 5.2 tp60 -60.05 -28.6 67.91 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.931 -0.308 . . . . 0.4 110.941 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -57.13 -43.05 82.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.179 0.514 . . . . 0.2 110.262 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.623 HD21 HG21 ' A' ' 68' ' ' VAL . 47.4 tp -74.67 -40.48 61.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.793 -0.64 . . . . 0.22 110.247 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' HB3' HE21 ' A' ' 97' ' ' GLN . 13.9 t70 -61.74 -28.06 69.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.906 -1.043 . . . . 0.26 109.919 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.8 mt -91.28 -36.75 13.7 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.282 -0.872 . . . . 0.25 112.587 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.476 ' HG ' ' HA ' ' A' ' 99' ' ' LEU . 17.4 p -74.13 -23.6 59.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.864 0.364 . . . . 1.01 110.972 -171.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.592 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 38.9 t -67.8 -55.27 14.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.21 112.1 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.903 ' HD3' HD11 ' A' ' 90' ' ' LEU . 28.2 Cg_endo -62.69 -18.76 65.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.138 1.892 . . . . 0.27 111.999 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.481 ' CD1' HG23 ' A' ' 39' ' ' ILE . 13.7 mt -83.43 -17.39 42.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.999 -0.546 . . . . 0.64 111.713 172.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.732 ' HG3' ' CG ' ' A' ' 110' ' ' GLU . 10.4 ttp -97.37 142.71 28.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.354 -0.385 . . . . 0.78 111.344 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -85.51 151.3 24.06 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.176 0.512 . . . . 0.97 110.855 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.786 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -59.78 123.47 12.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.903 -0.589 . . . . 0.8 110.053 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.3 12.72 47.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.066 -0.97 . . . . 0.28 112.871 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.863 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 8.4 pt-20 -114.24 169.19 9.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.2 0.524 . . . . 0.41 110.64 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.402 HG22 HD12 ' A' ' 50' ' ' LEU . 10.6 m -129.32 120.9 26.42 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.651 -0.87 . . . . 0.22 108.651 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.57 135.57 53.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.693 -0.685 . . . . 0.18 110.88 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.6 ttm -97.78 117.81 32.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.544 -1.28 . . . . 1.32 107.544 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.706 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.4 t -115.1 133.06 62.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.531 -0.544 . . . . 0.18 109.531 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 87.5 m -110.38 114.66 28.28 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.602 0.715 . . . . 0.21 109.077 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.521 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -125.17 137.02 54.15 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 0.15 110.41 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.595 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.81 147.35 9.07 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.737 -0.838 . . . . 0.58 108.737 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 2.5 t -54.77 -27.16 39.29 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.04 0.447 . . . . 0.82 110.288 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.595 ' HG2' ' CG ' ' A' ' 117' ' ' ASP . 12.7 ptpt -55.19 -33.13 62.75 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.165 -0.334 . . . . 0.81 111.511 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.574 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 83.9 m-85 -94.86 3.22 55.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.073 0.463 . . . . 0.42 110.1 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 72.3 m -123.16 -91.77 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.193 -0.912 . . . . 0.18 110.528 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 8.1 m-85 -142.59 41.08 1.58 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 120.153 -0.619 . . . . 0.24 112.123 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.77 -88.57 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.486 -0.387 . . . . 0.25 113.909 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.49 11.69 2.81 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.396 2.064 . . . . 0.58 111.168 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.5 mt-30 -104.04 -48.87 3.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.396 -0.82 . . . . 0.65 109.884 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.637 ' HA3' ' HD1' ' A' ' 131' ' ' TYR . . . 79.13 143.63 2.64 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 114.616 -1.174 . . . . 0.3 112.216 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.695 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.0 t -90.48 147.54 23.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.103 0.478 . . . . 0.33 111.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.593 ' H ' ' HD2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -54.87 -28.18 48.18 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.12 -0.945 . . . . 3.17 112.485 -175.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 1.089 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 27.5 t -91.59 -70.03 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.891 -0.781 . . . . 1.23 108.891 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.089 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 19.4 Cg_endo -105.19 128.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.5 2.134 . . . . 0.37 111.998 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.637 ' HD1' ' HA3' ' A' ' 126' ' ' GLY . 22.3 t80 -55.72 97.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.32 -0.993 . . . . 1.14 108.32 164.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 127' ' ' SER . 28.6 mm -67.16 125.97 91.8 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.556 -0.747 . . . . 0.39 109.31 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' A' ' 136' ' ' ALA . 9.7 Cg_endo -53.47 135.99 62.52 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.321 2.014 . . . . 0.61 111.688 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.633 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 54.2 Cg_exo -53.33 129.01 31.53 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.491 2.127 . . . . 0.52 112.304 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.621 ' H ' ' HB3' ' A' ' 118' ' ' SER . 70.3 m-70 74.69 11.09 3.91 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.69 -1.141 . . . . 2.38 112.931 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 133' ' ' PRO . . . -71.07 118.87 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.254 -1.017 . . . . 0.26 108.254 171.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.19 113.68 10.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.463 0.649 . . . . 0.22 109.902 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.637 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.37 131.98 34.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.153 -0.931 . . . . 0.22 110.966 -174.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.1 t -115.18 99.74 7.64 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.891 -0.781 . . . . 1.2 108.891 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -112.85 134.53 54.32 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.467 0.651 . . . . 0.32 111.781 -173.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.551 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 39.9 tt0 -99.8 113.59 26.2 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.186 -0.916 . . . . 1.05 108.916 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 2.2 m -115.7 121.3 67.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.46 0.648 . . . . 0.19 112.674 -175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.1 m -88.05 121.67 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.18 -0.918 . . . . 0.28 109.756 171.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 60' ' ' PRO . 39.0 tp -93.89 93.33 7.86 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.401 -0.962 . . . . 0.15 108.401 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.535 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -85.81 -30.83 22.69 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.898 -1.047 . . . . 1.08 110.629 -172.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.625 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 85.2 m -157.14 145.09 19.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.813 -0.631 . . . . 0.37 111.562 -168.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.619 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . . . -137.55 128.32 27.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.74 -0.664 . . . . 0.25 109.369 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 65' ' ' VAL . 11.2 m -132.12 145.66 34.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.563 -0.532 . . . . 0.92 109.563 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.45 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 4.4 t70 -84.33 118.29 24.12 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.366 -0.533 . . . . 2.27 110.105 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.441 ' HB3' HG23 ' A' ' 65' ' ' VAL . 13.1 tp -137.55 16.33 2.93 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.667 -0.864 . . . . 1.97 108.667 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.484 ' CG ' ' HA3' ' A' ' 63' ' ' GLY . 2.0 tm-20 -72.82 -41.85 64.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.64 -1.164 . . . . 2.14 108.632 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -77.24 61.74 2.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.913 -1.039 . . . . 5.79 110.518 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -71.52 129.45 38.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.953 -1.021 . . . . 7.48 110.703 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -135.2 149.29 49.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.003 -0.544 . . . . 8.46 110.237 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -75.06 131.2 40.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.772 -0.649 . . . . 8.83 110.827 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -127.82 162.53 26.45 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.973 -0.751 . . . . 12.17 108.973 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.408 -0.806 . . . . 13.46 110.445 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 ttm . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.936 0.398 . . . . 50.23 110.182 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.97 163.97 12.21 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.065 -0.814 . . . . 47.99 111.065 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 65.08 87.24 0.12 Allowed Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 121.18 0.514 . . . . 46.26 111.212 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 74.3 Cg_endo -73.7 152.29 47.56 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 123.008 2.472 . . . . 44.8 112.431 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 12.5 Cg_exo -70.57 145.26 51.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.488 2.125 . . . . 44.02 111.482 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 71.81 102.17 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.925 0.766 . . . . 42.5 111.941 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -102.11 170.14 8.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 41.5 109.798 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.91 175.4 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 40.33 110.906 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.97 161.06 42.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.648 . . . . 39.09 109.554 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -88.82 -78.85 0.33 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.212 0.53 . . . . 38.82 109.92 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -114.69 124.0 31.23 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 38.16 110.727 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 -27.36 84.72 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.3 2.0 . . . . 36.7 111.277 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.59 31.79 7.66 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.847 -0.615 . . . . 35.61 112.079 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 56.08 -96.02 0.06 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.092 0.525 . . . . 35.03 110.335 -174.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 35.4 tp 174.08 -88.68 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 123.95 0.781 . . . . 34.01 109.379 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 171.56 -40.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.396 -0.82 . . . . 32.89 109.085 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -124.62 117.04 23.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.97 -1.014 . . . . 31.94 110.182 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 19' ' ' PHE . 4.4 pt-20 -103.14 -49.13 3.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.972 0.415 . . . . 31.24 110.981 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.59 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 62.6 t80 -152.32 -60.58 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.435 . . . . 31.24 110.455 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' A' ' 19' ' ' PHE . 89.1 mt -121.81 -174.25 2.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.635 0.255 . . . . 29.85 110.318 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -96.94 -164.84 1.19 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.978 -0.556 . . . . 28.2 110.059 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.65 160.84 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.483 0.182 . . . . 26.78 110.829 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.2 mmt 72.28 5.55 5.31 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.841 0.713 . . . . 27.47 112.357 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -133.41 91.64 26.34 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.19 -0.671 . . . . 24.41 109.19 173.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -83.63 154.64 13.7 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.759 2.306 . . . . 21.63 112.671 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 16.1 pt-20 -96.79 145.17 29.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 20.67 109.797 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 18.4 Cg_exo -66.54 137.18 45.52 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.832 2.355 . . . . 18.02 112.747 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -86.17 137.03 35.22 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 14.93 110.172 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 26.2 Cg_exo -62.26 127.7 21.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.239 1.959 . . . . 13.81 112.04 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.29 65.22 10.37 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.999 -0.546 . . . . 10.76 110.869 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.57 118.92 5.87 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.432 2.088 . . . . 9.77 111.463 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -99.62 116.73 64.64 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.415 -0.357 . . . . 5.86 110.875 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 3.3 Cg_exo -78.1 -0.53 10.77 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.2 2.6 . . . . 4.47 111.58 177.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -98.63 146.72 25.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 4.13 109.434 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -85.07 121.5 27.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.705 0.288 . . . . 2.45 110.236 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.534 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -80.44 -166.56 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.17 -0.468 . . . . 0.53 110.378 178.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.46 110.83 7.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.5 110.409 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.633 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.4 t70 -75.0 127.15 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.332 0.587 . . . . 2.51 110.612 174.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 45' ' ' LEU . 8.4 mt -57.78 -35.55 51.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.586 -1.188 . . . . 0.46 111.549 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.6 mt -111.12 -1.16 16.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.286 0.565 . . . . 0.72 110.278 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.22 26.63 66.26 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.318 -0.855 . . . . 0.52 111.746 -172.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -95.39 -29.09 14.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.65 0.241 . . . . 0.95 111.65 -178.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.541 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.41 -9.14 30.72 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 121.114 -0.565 . . . . 0.72 111.751 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 7.3 mp -97.4 -33.18 11.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.253 -0.474 . . . . 1.56 110.971 -175.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.573 HD11 HD12 ' A' ' 39' ' ' ILE . 19.8 tp -122.91 100.7 7.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.786 -0.643 . . . . 0.32 111.352 -170.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 66.7 mtm180 -132.23 140.73 48.78 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.178 -0.326 . . . . 1.14 111.163 -171.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 13.4 ttpt -111.51 123.66 50.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.265 -0.272 . . . . 0.35 110.265 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 20.1 ttmt -101.17 122.08 42.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.157 -0.312 . . . . 1.07 110.157 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' PRO . 5.3 p -76.67 100.82 5.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.497 -0.319 . . . . 0.33 110.977 175.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD12 HG22 ' A' ' 111' ' ' THR . 11.5 mt -68.71 -55.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.065 -1.457 . . . . 0.28 107.065 171.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.784 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 59.5 t -129.82 126.35 22.52 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 113.024 -1.898 . . . . 0.36 106.299 167.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 16.5 Cg_endo -104.48 60.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.832 2.355 . . . . 0.54 113.477 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.81 151.89 4.35 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.959 -0.564 . . . . 0.55 113.213 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 38.0 Cg_endo -68.39 163.28 37.12 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.176 1.918 . . . . 1.42 110.466 172.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.24 98.65 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.375 2.05 . . . . 2.04 112.009 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.04 51.37 2.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.134 -0.555 . . . . 0.98 112.674 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -83.09 -162.97 0.66 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 110.185 -0.302 . . . . 0.99 110.185 174.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 t -152.81 127.93 9.75 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.04 -0.726 . . . . 1.28 109.04 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.81 122.14 67.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.583 -0.447 . . . . 2.81 110.946 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.6 153.24 11.18 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.789 2.992 . . . . 0.3 114.13 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 23.7 t -100.08 155.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.004 -0.998 . . . . 0.88 109.449 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 95.4 mttt -64.34 106.86 1.19 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.386 0.613 . . . . 1.17 110.364 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 141.75 -24.73 2.44 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.28 -1.128 . . . . 0.42 110.28 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.652 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.01 137.72 34.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.282 -0.636 . . . . 0.59 109.282 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.5 m -81.05 133.54 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.064 -1.087 . . . . 1.22 108.064 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.2 m -127.8 143.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 116.022 -0.535 . . . . 0.25 110.92 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 45.9 p -94.11 112.61 24.44 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.309 -0.626 . . . . 0.29 109.309 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.59 HG21 HD21 ' A' ' 99' ' ' LEU . 19.6 m -110.15 143.41 20.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.901 -0.72 . . . . 0.19 109.849 174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.596 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.7 t-160 -102.33 116.11 31.95 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.824 -1.547 . . . . 0.19 106.824 169.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 83' ' ' GLU . 1.2 pt? -122.5 137.95 54.71 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.462 -0.895 . . . . 0.39 110.83 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.11 114.31 13.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.277 -2.12 . . . . 0.27 105.277 166.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.654 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 71.0 m -105.04 129.69 53.42 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.6 -1.182 . . . . 0.19 111.016 -166.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.993 ' HB3' ' SG ' ' A' ' 139' ' ' CYS . 4.7 t -104.38 172.51 6.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.268 -0.878 . . . . 1.06 108.884 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 80' ' ' VAL . 12.3 mt -101.48 165.54 11.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.517 -0.765 . . . . 0.84 109.178 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.18 -23.35 34.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.1 0.476 . . . . 1.14 110.492 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -89.28 -8.49 53.28 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.776 -0.647 . . . . 2.14 111.492 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.39 10.56 44.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.259 -0.972 . . . . 0.51 113.568 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 92.1 m -98.64 113.0 24.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.311 0.555 . . . . 0.46 112.332 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.894 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 47.4 mtt180 -69.91 125.56 27.12 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.47 110.363 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.012 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 30.2 m -108.89 -20.17 6.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.004 -0.998 . . . . 0.27 112.295 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.654 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -146.99 124.3 11.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.421 -0.354 . . . . 0.59 110.242 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -118.41 118.0 30.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.31 0.576 . . . . 1.34 109.964 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.563 ' HB3' HD23 ' A' ' 70' ' ' LEU . 6.4 tp10 -135.8 107.58 9.85 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.589 -0.732 . . . . 2.59 110.814 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.596 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 14.3 Cg_exo -68.12 -19.83 44.6 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.056 2.504 . . . . 0.5 112.952 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -164.22 113.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.025 0.917 . . . . 1.37 112.567 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.08 110.31 16.08 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.772 -1.558 . . . . 0.38 108.763 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.8 p -100.17 137.03 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 38.3 p90 -159.45 157.64 30.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 0.23 110.426 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 24.4 m -76.87 119.13 20.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.527 -0.546 . . . . 0.42 109.527 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.915 HD11 ' HD3' ' A' ' 104' ' ' PRO . 17.4 tp -62.19 133.22 54.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 0.6 110.544 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.71 -4.91 80.84 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 0.37 111.844 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 12.8 t70 -83.77 -15.06 49.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.165 -0.68 . . . . 0.93 109.165 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.0 m 62.65 30.1 16.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.863 -1.062 . . . . 0.62 109.414 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 13.7 t70 -62.55 -26.36 68.53 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 122.367 1.079 . . . . 1.33 108.45 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 15.1 m -114.46 -158.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 113.341 -1.754 . . . . 0.23 110.834 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 33.7 pt -84.34 139.85 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.81 -1.182 . . . . 0.29 107.81 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.512 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -60.17 -27.34 67.04 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.449 -0.341 . . . . 0.4 110.966 -173.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -56.39 -42.95 78.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.324 0.583 . . . . 0.2 110.286 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 68' ' ' VAL . 53.0 tp -78.53 -40.49 34.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.131 -0.941 . . . . 0.22 110.377 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HB3' HE21 ' A' ' 97' ' ' GLN . 20.1 t70 -61.97 -29.72 70.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.794 -1.094 . . . . 0.26 109.973 -174.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 57.6 mt -90.66 -33.64 15.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.44 -0.8 . . . . 0.25 111.959 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.5 t -65.63 -34.54 78.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 1.01 110.769 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.7 t -63.56 -53.29 52.78 Favored Pre-proline 0 C--O 1.22 -0.492 0 N-CA-C 113.129 0.789 . . . . 0.21 113.129 -177.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.915 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.7 Cg_endo -62.03 -22.15 73.71 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.988 1.792 . . . . 0.27 111.945 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' A' ' 39' ' ' ILE . 9.5 mt -83.82 -11.98 56.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.416 0.627 . . . . 0.64 110.991 172.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.771 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 34.8 ttm -98.28 140.36 32.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.969 -1.014 . . . . 0.78 111.635 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.13 153.11 19.56 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.485 -0.561 . . . . 0.97 109.485 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.588 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.0 t -62.0 124.98 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 0.8 110.65 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.51 12.95 52.98 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.28 112.723 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.784 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.6 pt-20 -105.43 168.63 8.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.478 0.639 . . . . 0.41 110.432 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.49 HG22 HD12 ' A' ' 50' ' ' LEU . 24.4 m -132.83 119.8 20.72 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.402 -0.962 . . . . 0.22 108.402 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.68 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -117.54 137.45 52.57 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.483 -0.781 . . . . 0.18 110.718 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 ttt -96.85 116.03 28.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.872 -1.529 . . . . 1.32 106.872 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.506 HG22 ' HG3' ' A' ' 47' ' ' LYS . 3.4 t -113.34 132.96 60.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.53 -0.545 . . . . 0.18 109.53 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.525 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 63.0 m -110.7 114.43 27.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.629 -0.828 . . . . 0.21 109.36 171.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.99 53.83 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.896 -1.502 . . . . 0.15 109.813 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.576 ' CG ' ' HG2' ' A' ' 119' ' ' LYS . 9.3 t70 -52.47 147.24 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.981 -0.748 . . . . 0.58 108.981 173.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.627 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.1 t -55.78 -28.32 55.45 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.068 0.461 . . . . 0.82 110.086 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.58 ' HG3' ' CD1' ' A' ' 120' ' ' TYR . 15.6 ptpt -55.48 -31.44 62.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.629 -0.259 . . . . 0.81 111.634 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.58 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 78.5 m-85 -95.2 -1.55 51.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.147 0.499 . . . . 0.42 109.839 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 65.6 m -117.14 -93.47 0.51 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.061 -0.972 . . . . 0.18 110.371 -177.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.609 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.8 m-85 -140.78 39.71 1.83 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.207 -0.597 . . . . 0.24 112.091 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -45.59 -83.03 0.02 OUTLIER Glycine 0 C--N 1.344 0.99 0 N-CA-C 114.242 0.457 . . . . 0.25 114.242 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.4 13.93 2.53 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.393 2.062 . . . . 0.58 110.77 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 35.9 mt-30 -104.65 -49.28 3.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.978 -1.01 . . . . 0.65 110.498 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 131' ' ' TYR . . . 81.83 142.2 3.76 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 114.544 -1.207 . . . . 0.3 112.622 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.609 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 30.4 t -91.93 165.99 12.94 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.091 0.404 . . . . 0.33 112.091 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.579 ' HG3' ' N ' ' A' ' 129' ' ' SER . 6.9 ptp180 -52.87 -49.88 64.95 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.728 -0.669 . . . . 3.17 112.219 -171.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.986 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 13.0 m -87.78 -62.72 0.22 Allowed Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.704 -0.48 . . . . 1.23 109.704 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.012 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 8.9 Cg_endo -101.08 127.7 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.592 2.195 . . . . 0.37 111.707 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.44 ' HA ' ' CA ' ' A' ' 126' ' ' GLY . 9.6 t80 -57.43 97.35 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.938 -1.504 . . . . 1.14 106.938 159.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -64.87 124.66 87.13 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 107.965 -1.124 . . . . 0.39 107.965 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.22 141.19 31.91 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.499 2.133 . . . . 0.61 112.301 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 55.0 Cg_exo -52.37 132.32 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.582 2.188 . . . . 0.52 112.156 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.515 ' H ' ' HB3' ' A' ' 118' ' ' SER . 1.4 m-70 72.35 9.22 5.83 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.069 -0.969 . . . . 2.38 113.015 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -74.09 123.84 25.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.162 -0.681 . . . . 0.26 109.162 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.82 112.28 9.79 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.351 0.596 . . . . 0.22 109.643 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 121' ' ' CYS . 2.0 tp -88.76 131.87 34.86 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.549 -0.751 . . . . 0.22 110.586 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.993 ' SG ' ' HB3' ' A' ' 73' ' ' SER . 24.7 p -116.73 100.29 7.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.795 0.807 . . . . 1.2 110.501 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -109.66 133.64 52.89 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.323 -0.853 . . . . 0.32 111.491 -172.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.537 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.1 tt0 -98.33 109.09 21.9 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.508 -0.769 . . . . 1.05 109.212 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.654 HG23 ' HE1' ' A' ' 106' ' ' MET . 0.8 OUTLIER -113.35 116.46 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.463 0.649 . . . . 0.19 112.39 -174.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 9.5 m -89.2 113.72 24.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 0.28 111.034 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.771 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -84.8 93.55 8.51 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.773 -0.825 . . . . 0.15 108.773 172.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -86.45 -32.61 20.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.111 -0.95 . . . . 1.08 110.799 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 6.3 m -150.71 147.31 27.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.309 -0.405 . . . . 0.37 111.197 -173.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -134.22 128.31 33.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.156 -0.683 . . . . 0.25 109.156 171.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.83 125.39 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 110.063 -0.347 . . . . 0.92 110.063 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.454 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 2.3 p-10 -70.67 117.15 11.83 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 120.335 -0.546 . . . . 2.27 109.961 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.59 25.07 1.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.492 -0.777 . . . . 1.97 109.168 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER -92.06 116.26 28.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.07 -0.715 . . . . 2.14 109.07 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -134.92 74.81 1.54 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.108 -0.701 . . . . 5.79 109.108 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -51.97 110.57 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.699 -1.137 . . . . 7.48 111.57 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -136.43 -65.99 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.952 -0.759 . . . . 8.46 108.952 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -157.4 25.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.752 0.787 . . . . 8.83 109.472 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 61.0 t-80 -130.09 53.36 1.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.932 -1.507 . . . . 12.17 106.932 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 33.6 m170 . . . . . 0 C--O 1.24 0.595 0 CA-C-N 114.483 -1.235 . . . . 13.46 109.082 -163.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.167 -0.309 . . . . 50.23 110.167 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.73 -173.0 36.4 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.481 -0.648 . . . . 47.99 111.481 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.729 ' HA ' HE21 ' A' ' 3' ' ' GLN . 0.1 OUTLIER -145.04 98.83 4.69 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 109.791 -0.448 . . . . 46.26 109.791 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.07 134.45 42.87 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.711 2.274 . . . . 44.8 111.443 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.79 123.82 14.68 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.126 2.551 . . . . 44.02 113.19 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.87 82.39 2.0 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.435 -0.802 . . . . 42.5 109.001 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.693 ' HG3' ' H ' ' A' ' 8' ' ' GLU . 5.3 pt-20 -153.35 -69.79 0.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.714 -0.675 . . . . 41.5 111.496 -170.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.693 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 41.4 tt0 64.11 89.82 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.701 0.625 . . . . 40.33 110.164 -175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.91 -168.82 0.14 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.574 -0.739 . . . . 39.09 110.893 -176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.92 -44.12 5.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.192 -0.458 . . . . 38.82 110.774 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -151.06 106.14 3.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 38.16 111.186 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.27 154.19 61.58 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.239 2.626 . . . . 36.7 111.85 175.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.81 -138.92 2.52 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.843 -0.694 . . . . 35.61 112.682 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 73.02 -64.55 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.024 0.93 . . . . 35.03 111.967 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.4 tt -94.09 133.24 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.418 -0.355 . . . . 34.01 110.344 -174.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 135.59 9.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 32.89 110.377 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -144.04 163.01 34.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.358 -0.383 . . . . 31.94 110.477 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HB3' ' H ' ' A' ' 21' ' ' ALA . 42.2 mt-10 -92.61 115.49 28.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.979 0.419 . . . . 31.24 110.754 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -85.82 0.94 51.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.151 -0.477 . . . . 31.24 110.429 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 21' ' ' ALA . 1.4 pp -129.09 -20.65 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 29.85 111.659 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 57.36 90.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.995 0.518 . . . . 28.2 111.858 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.5 10.62 3.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.981 0.419 . . . . 26.78 111.734 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.52 2.71 56.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.154 -0.476 . . . . 27.47 110.621 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.604 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 9.8 tp10 -81.56 -47.55 1.04 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.816 -0.629 . . . . 24.41 111.465 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 36.5 Cg_exo -62.72 -169.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.353 2.035 . . . . 21.63 112.777 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.466 ' OE2' ' HD2' ' A' ' 27' ' ' PRO . 10.0 tp10 -58.54 119.7 38.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 20.67 110.596 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HD2' ' OE2' ' A' ' 26' ' ' GLU . 28.5 Cg_endo -63.41 131.64 32.73 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.759 2.306 . . . . 18.02 112.957 -176.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.85 153.78 37.59 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.689 -0.687 . . . . 14.93 109.564 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.11 128.22 27.94 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.416 2.077 . . . . 13.81 112.525 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -144.68 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.701 -0.681 . . . . 10.76 110.311 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 17.1 Cg_exo -68.19 132.15 25.31 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.924 1.749 . . . . 9.77 110.502 170.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.22 148.06 35.87 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 121.023 -0.271 . . . . 5.86 110.863 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.33 -19.57 65.72 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.384 2.056 . . . . 4.47 111.251 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.39 -54.21 3.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.351 -0.84 . . . . 4.13 109.848 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 34.9 mm-40 -97.44 99.2 10.62 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.399 -0.364 . . . . 2.45 110.113 176.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.686 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -83.18 -158.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.81 -0.632 . . . . 0.53 110.995 -175.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.75 110.99 5.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.654 -0.703 . . . . 0.5 110.398 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.676 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -66.59 103.2 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.546 -0.752 . . . . 2.51 110.963 175.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.742 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.2 mt -53.88 -48.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.66 -1.155 . . . . 0.46 111.522 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 45' ' ' LEU . 52.0 mt -105.68 12.79 30.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 0.72 110.712 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.676 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 69.08 6.83 55.07 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.331 -0.849 . . . . 0.52 113.332 175.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -99.27 -12.76 20.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.676 0.275 . . . . 0.95 111.468 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.32 -19.11 37.35 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.382 -0.913 . . . . 0.72 112.832 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.5 mp -75.33 -24.47 57.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 122.039 0.923 . . . . 1.56 109.151 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.7 tp -119.13 113.84 21.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.911 -1.495 . . . . 0.32 110.145 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' A' ' 35' ' ' GLU . 43.4 mtm180 -142.86 133.44 25.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.35 0.5 . . . . 1.14 112.35 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB2' HD11 ' A' ' 39' ' ' ILE . 12.8 ttpt -109.97 125.04 52.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.35 109.976 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.686 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 26.5 ttpp -114.4 121.6 44.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.146 0.498 . . . . 1.07 111.046 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.612 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.3 p -74.68 103.45 4.97 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.198 -0.91 . . . . 0.33 111.713 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.09 -56.41 7.8 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.67 -1.604 . . . . 0.28 106.67 171.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 56.0 t -131.97 123.89 19.28 Favored Pre-proline 0 CA--C 1.502 -0.9 0 CA-C-N 112.726 -2.034 . . . . 0.36 106.719 168.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.708 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 73.5 Cg_endo -107.92 66.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 122.563 2.175 . . . . 0.54 114.055 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.48 157.68 5.58 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.435 -0.802 . . . . 0.55 113.394 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 97.0 Cg_endo -78.75 161.0 27.71 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.536 2.157 . . . . 1.42 110.927 172.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.38 98.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.176 1.917 . . . . 2.04 111.865 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.0 47.15 0.97 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.599 -0.81 . . . . 0.98 112.153 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.1 p -90.34 -165.81 1.44 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.108 0.48 . . . . 0.99 110.601 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -149.82 147.21 27.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.912 -0.773 . . . . 1.28 108.912 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 85.2 mtt180 -96.24 116.37 66.13 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 120.578 -0.449 . . . . 2.81 110.116 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.801 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.5 Cg_endo -49.47 144.48 18.42 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.756 2.971 . . . . 0.3 112.975 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 9.0 t -89.25 145.68 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.18 -0.463 . . . . 0.88 110.031 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.902 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 97.9 mttt -65.72 104.42 1.05 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.639 0.733 . . . . 1.17 109.788 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 142.12 -29.92 2.16 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 114.394 -1.276 . . . . 0.42 109.948 -174.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.663 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -74.83 136.16 41.6 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.363 -0.977 . . . . 0.59 108.363 175.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.3 m -84.16 115.23 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.951 -1.129 . . . . 1.22 107.951 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -109.65 146.93 14.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.95 -1.023 . . . . 0.25 110.853 -171.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.797 ' HB ' ' OE1' ' A' ' 85' ' ' GLU . 78.9 p -91.12 112.46 24.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.289 0.566 . . . . 0.29 109.725 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.739 HG21 HD21 ' A' ' 99' ' ' LEU . 26.8 m -111.04 142.39 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 119.907 -0.717 . . . . 0.19 109.319 170.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.4 t-160 -102.41 116.7 33.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.529 -1.656 . . . . 0.19 106.529 169.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -116.86 135.15 53.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.98 -1.088 . . . . 0.39 110.781 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.715 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -130.49 114.23 15.25 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.427 -2.064 . . . . 0.27 105.427 167.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.563 ' CG2' ' HG ' ' A' ' 138' ' ' LEU . 86.8 m -106.43 127.27 53.16 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.229 -1.35 . . . . 0.19 111.145 -166.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.789 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -107.1 153.22 22.95 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.21 -0.905 . . . . 1.06 109.335 -178.246 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.449 ' HG ' HG13 ' A' ' 80' ' ' VAL . 9.7 mt -78.6 164.79 24.36 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.488 -0.778 . . . . 0.84 109.293 174.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HG3' HD22 ' A' ' 76' ' ' ASN . 6.4 pt-20 -58.37 -14.21 7.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.436 0.636 . . . . 1.14 110.507 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -87.25 -14.77 40.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.242 -0.89 . . . . 2.14 109.895 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.33 -6.68 46.34 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.851 -0.613 . . . . 0.51 111.763 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -81.42 110.05 16.47 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.926 0.343 . . . . 0.46 111.926 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 37.5 mtt180 -74.11 116.75 15.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.511 0.672 . . . . 0.47 110.394 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.1 m -99.33 -12.91 8.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.27 112.314 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.536 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 28.9 pt20 -156.61 136.07 12.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.224 -0.444 . . . . 0.59 110.385 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 33.1 tt0 -135.13 116.54 14.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.962 -0.563 . . . . 1.34 109.652 174.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 86' ' ' LEU . 5.2 tt0 -129.5 109.59 17.55 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.29 -0.868 . . . . 2.59 109.795 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 16.5 Cg_exo -68.34 -13.57 38.02 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.736 2.957 . . . . 0.5 113.256 -172.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OE1' ' HB ' ' A' ' 67' ' ' THR . 2.9 tp10 -157.96 101.94 1.8 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.037 0.923 . . . . 1.37 110.711 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.478 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 28.1 tp -116.92 106.46 13.46 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.986 -1.461 . . . . 0.38 108.65 174.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 8.5 p -101.97 132.08 48.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.7 p90 -153.8 156.16 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.852 0.358 . . . . 0.23 110.824 -174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 5.3 m -75.32 112.03 11.2 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.674 -0.693 . . . . 0.42 109.66 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.902 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 15.8 tp -60.18 137.7 58.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.037 -0.528 . . . . 0.6 110.21 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA3' ' HB3' ' A' ' 62' ' ' LYS . . . 77.61 5.98 86.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.37 112.264 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 29.5 t70 -103.3 -5.6 22.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.952 0.406 . . . . 0.93 110.044 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 47.5 m 59.99 32.91 21.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.48 -0.782 . . . . 0.62 109.095 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 18.6 t70 -70.16 -16.52 63.1 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.424 1.107 . . . . 1.33 108.758 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.76 -150.28 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 113.537 -1.665 . . . . 0.23 110.253 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.6 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.1 pt -87.5 139.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.649 -1.241 . . . . 0.29 107.649 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -58.68 -29.18 66.41 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 123.264 0.352 . . . . 0.4 110.916 -173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -55.36 -48.34 74.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.362 0.601 . . . . 0.2 110.664 174.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 HG21 ' A' ' 68' ' ' VAL . 56.5 tp -75.6 -36.22 60.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.443 -0.799 . . . . 0.22 110.604 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -62.29 -30.63 71.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 0.26 109.594 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 0.25 112.296 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.6 t -63.75 -36.65 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 1.01 110.959 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.554 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 77.2 t -62.97 -54.88 42.76 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.059 0.763 . . . . 0.21 113.059 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.838 ' HD3' HD11 ' A' ' 90' ' ' LEU . 22.6 Cg_endo -62.54 -20.83 71.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.282 1.988 . . . . 0.27 111.721 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.584 ' CD1' HG23 ' A' ' 39' ' ' ILE . 10.8 mt -83.96 -12.69 54.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.64 111.29 173.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -106.98 155.94 19.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.268 -0.424 . . . . 0.78 110.887 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.98 153.17 17.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.995 0.426 . . . . 0.97 110.825 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.801 HG23 ' HD3' ' A' ' 60' ' ' PRO . 1.7 t -60.4 125.4 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.118 0.485 . . . . 0.8 110.403 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 18.58 41.98 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.103 -0.953 . . . . 0.28 112.499 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.774 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.0 pt-20 -107.57 167.3 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.418 0.628 . . . . 0.41 110.992 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 m -130.54 117.46 19.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.957 -1.127 . . . . 0.22 107.957 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.28 138.89 52.06 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.115 0.483 . . . . 0.18 110.736 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.0 ttp -100.03 117.45 34.32 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.079 -1.452 . . . . 1.32 107.079 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 47' ' ' LYS . 9.8 t -114.74 131.0 68.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.764 -0.458 . . . . 0.18 109.764 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.516 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 86.0 m -107.49 113.5 26.88 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.658 -0.867 . . . . 0.21 108.658 173.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.55 135.8 53.45 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.263 -1.335 . . . . 0.15 109.354 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.614 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 11.4 t70 -53.82 149.86 8.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.818 -0.808 . . . . 0.58 108.818 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.633 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.3 t -56.66 -28.01 59.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.202 0.525 . . . . 0.82 110.059 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 17.9 ptpt -56.43 -31.94 64.41 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.902 -0.499 . . . . 0.81 111.779 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.593 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.3 m-85 -94.87 4.22 54.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.42 109.632 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 66.8 m -123.16 -92.76 0.53 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.067 -0.97 . . . . 0.18 110.489 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 6.5 m-85 -142.0 39.77 1.64 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 119.041 -0.504 . . . . 0.24 112.135 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.16 -88.7 0.01 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 114.09 0.396 . . . . 0.25 114.09 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.96 10.63 3.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.015 1.81 . . . . 0.58 111.434 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -103.49 -49.4 3.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.567 -0.742 . . . . 0.65 109.924 -173.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.515 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 81.72 145.42 4.96 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.758 -1.11 . . . . 0.3 111.698 -173.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.687 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.5 t -90.49 162.54 15.01 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.405 -0.398 . . . . 0.33 110.925 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -51.63 -58.74 5.49 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.892 0.745 . . . . 3.17 110.733 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.849 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 59.6 m -77.48 -61.34 0.65 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.897 -0.592 . . . . 1.23 110.411 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.849 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.8 Cg_endo -106.04 125.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.09 1.86 . . . . 0.37 112.619 174.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.14 96.48 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.514 -0.921 . . . . 1.14 108.514 164.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.573 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.9 123.87 87.2 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.536 -0.757 . . . . 0.39 109.717 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.88 136.93 43.76 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.841 2.361 . . . . 0.61 112.459 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.672 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 Cg_endo -55.44 128.71 31.55 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.159 1.906 . . . . 0.52 111.998 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.593 ' H ' ' HB3' ' A' ' 118' ' ' SER . 62.7 m170 74.13 12.97 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.98 -1.009 . . . . 2.38 112.397 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -76.33 121.1 22.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.554 -0.906 . . . . 0.26 108.554 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -72.95 113.11 9.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.22 109.754 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.563 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.2 tp -88.45 131.45 34.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.572 -0.74 . . . . 0.22 110.566 -175.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.4 100.68 8.05 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.301 -1.0 . . . . 1.2 108.301 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.536 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.1 pp -115.22 136.54 53.0 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.058 -0.519 . . . . 0.32 111.734 -171.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.715 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 40.0 tt0 -102.71 117.14 34.01 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.479 -0.934 . . . . 1.05 108.479 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 99' ' ' LEU . 3.5 m -117.93 116.7 52.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.535 0.683 . . . . 0.19 112.785 -174.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -89.73 108.77 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 0.28 110.576 173.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.652 HD21 ' HG3' ' A' ' 60' ' ' PRO . 57.6 tp -85.44 97.78 10.21 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.379 -0.971 . . . . 0.15 108.379 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 143' ' ' THR . 19.7 mtmm -103.39 -18.17 14.94 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.08 110.702 -168.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m -156.16 145.36 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.913 -0.585 . . . . 0.37 110.913 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.531 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.62 127.26 32.64 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.641 -0.874 . . . . 0.25 108.641 169.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 65' ' ' VAL . 20.4 m -131.29 137.87 54.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.203 -0.599 . . . . 0.92 110.436 -178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.527 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 7.6 t70 -79.61 117.96 21.01 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.918 -0.583 . . . . 2.27 110.04 -176.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.9 5.3 3.08 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.808 -0.633 . . . . 1.97 109.764 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -85.68 85.78 7.39 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.522 0.677 . . . . 2.14 110.194 -175.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.07 79.02 1.45 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.538 -1.21 . . . . 5.79 108.407 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -52.02 143.52 13.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.611 -1.177 . . . . 7.48 110.539 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -45.27 7.88 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.476 0.917 . . . . 8.46 113.476 -166.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -116.08 32.65 5.97 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.533 -0.467 . . . . 8.83 111.826 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 42.1 m80 63.35 -90.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.537 0.523 . . . . 12.17 110.978 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.136 -0.935 . . . . 13.46 109.38 179.833 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.633 0.254 . . . . 50.23 110.515 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.53 -43.69 2.62 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.717 -0.754 . . . . 47.99 111.363 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -89.91 122.52 67.79 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.24 -0.652 . . . . 46.26 109.24 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.598 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 72.3 Cg_exo -47.49 -51.72 9.17 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.284 2.656 . . . . 44.8 114.5 -174.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 1.8 Cg_endo -83.65 120.61 2.79 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.346 1.364 . . . . 44.02 112.025 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.8 -0.96 2.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.605 -0.725 . . . . 42.5 110.217 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -132.83 148.03 52.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.343 -0.844 . . . . 41.5 109.938 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -122.18 107.97 12.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.116 -0.493 . . . . 40.33 109.689 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.29 -65.41 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.093 0.87 . . . . 39.09 111.27 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 179.07 -59.35 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.222 0.534 . . . . 38.82 110.022 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.14 76.74 0.44 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.805 -1.089 . . . . 38.16 109.978 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -95.8 -172.17 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.232 2.621 . . . . 36.7 112.1 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.52 -25.92 3.95 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.628 -0.796 . . . . 35.61 112.591 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.19 79.23 9.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.728 0.299 . . . . 35.03 110.562 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.0 tp 67.04 167.06 0.23 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.243 -0.89 . . . . 34.01 110.197 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 54.59 68.43 0.86 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.431 0.634 . . . . 32.89 110.601 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -76.49 24.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.584 -0.735 . . . . 31.94 112.523 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 54.86 74.63 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.061 0.458 . . . . 31.24 109.824 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.551 ' HD2' ' HG ' ' A' ' 20' ' ' LEU . 39.0 t80 -163.44 -60.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.097 0.475 . . . . 31.24 110.128 -177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 19' ' ' PHE . 96.1 mt -121.29 163.21 18.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 29.85 110.479 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.02 170.25 8.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.09 -0.505 . . . . 28.2 110.302 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.11 99.45 9.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 26.78 111.063 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 52.5 tpp -105.14 79.56 1.51 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.072 -0.714 . . . . 27.47 109.072 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 18.6 mm-40 -105.64 121.11 47.08 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.673 -0.694 . . . . 24.41 110.933 -174.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 3.9 Cg_exo -78.05 111.4 3.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.717 2.278 . . . . 21.63 111.485 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 40.8 mt-10 -70.99 145.34 91.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 20.67 110.438 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 37.0 Cg_exo -57.82 96.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.479 2.786 . . . . 18.02 113.925 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -120.61 142.16 33.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.61 . . . . 14.93 110.114 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 3.7 Cg_exo -80.84 163.29 20.88 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.994 2.463 . . . . 13.81 111.542 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.15 67.98 1.76 Allowed Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 123.961 0.788 . . . . 10.76 110.9 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.37 67.58 6.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.184 2.589 . . . . 9.77 110.963 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 145.38 73.29 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.526 -0.761 . . . . 5.86 110.402 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.89 -25.11 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.325 2.017 . . . . 4.47 112.374 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.15 122.51 19.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 4.13 111.186 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -93.08 103.63 15.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.886 -0.597 . . . . 2.45 109.575 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.565 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 1.0 OUTLIER -87.99 -170.41 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.53 109.864 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.3 tp -73.76 111.47 8.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.851 -0.613 . . . . 0.5 110.3 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.797 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 11.0 t70 -75.14 126.65 31.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.779 -0.768 . . . . 2.51 109.795 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 105' ' ' LEU . 5.0 mt -59.47 -30.22 43.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.46 110.771 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.6 mt -113.21 -5.58 13.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.577 -0.738 . . . . 0.72 110.572 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.676 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 66.71 21.8 71.32 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.428 -0.806 . . . . 0.52 111.675 -174.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.509 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -103.18 -20.27 14.21 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.078 0.769 . . . . 0.95 113.078 -175.137 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.491 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 125.79 -26.43 5.38 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.036 -1.078 . . . . 0.72 114.827 166.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -106.17 -11.47 16.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.124 0.787 . . . . 1.56 113.124 -171.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 26.7 tp -123.11 100.99 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.505 -0.122 . . . . 0.32 111.108 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.797 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 83.7 mtm180 -140.88 145.46 36.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.551 0.574 . . . . 1.14 112.551 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.652 ' HG3' HG22 ' A' ' 114' ' ' VAL . 16.7 ttpt -116.29 131.39 56.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.218 -0.447 . . . . 0.35 110.259 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 4.2 ttmm -111.85 125.75 54.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.626 0.251 . . . . 1.07 110.511 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 p -80.18 100.22 8.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.376 -0.375 . . . . 0.33 111.434 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.464 HD12 HG22 ' A' ' 111' ' ' THR . 11.8 mt -63.94 -53.15 54.78 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.943 -1.503 . . . . 0.28 106.943 170.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.8 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.9 t -136.35 129.36 17.72 Favored Pre-proline 0 CA--C 1.503 -0.844 0 CA-C-N 112.753 -2.021 . . . . 0.36 106.638 170.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 38.7 Cg_endo -103.91 56.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 122.812 2.342 . . . . 0.54 113.671 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.42 170.71 44.25 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.303 -0.862 . . . . 0.55 113.062 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.4 172.41 14.58 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.655 2.237 . . . . 1.42 110.93 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.56 103.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.362 2.041 . . . . 2.04 112.254 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.89 56.68 1.59 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.023 -0.608 . . . . 0.98 112.51 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.61 -173.85 4.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.5 0.667 . . . . 0.99 111.566 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -136.42 140.93 43.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.527 -0.916 . . . . 1.28 108.527 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 97.7 mtt180 -101.13 114.1 65.79 Favored Pre-proline 0 C--N 1.311 -1.097 0 C-N-CA 120.786 -0.366 . . . . 2.81 110.539 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.685 ' HD3' HG23 ' A' ' 108' ' ' VAL . 6.6 Cg_endo -47.29 142.1 12.77 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.875 3.05 . . . . 0.3 113.735 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.69 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.1 t -95.67 152.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.486 -0.779 . . . . 0.88 109.564 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HD3' ' CA ' ' A' ' 91' ' ' GLY . 40.4 mttp -66.51 106.92 1.9 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.569 0.699 . . . . 1.17 110.488 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.2 -23.14 2.57 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.96 -1.018 . . . . 0.42 110.756 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -85.25 139.13 31.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.803 -0.814 . . . . 0.59 108.803 177.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 HD11 ' A' ' 150' ' ' LEU . 10.7 m -87.28 129.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.677 -0.861 . . . . 1.22 108.677 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 24.9 m -123.15 149.64 26.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.928 -1.033 . . . . 0.25 110.502 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 20.2 p -97.82 112.85 24.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.748 -0.66 . . . . 0.29 110.218 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG21 HD21 ' A' ' 99' ' ' LEU . 24.4 m -110.93 147.01 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 C-N-CA 120.376 -0.53 . . . . 0.19 110.375 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.611 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.78 114.84 29.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.988 -1.486 . . . . 0.19 106.988 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.9 OUTLIER -120.33 138.16 53.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.387 -0.925 . . . . 0.39 111.194 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.732 HE22 ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -133.27 114.83 14.22 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.127 -1.805 . . . . 0.27 106.127 167.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.675 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 32.6 m -103.14 118.99 38.02 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.867 -1.06 . . . . 0.19 111.848 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -105.65 135.05 47.75 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.477 -0.783 . . . . 1.06 109.248 176.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.531 HD13 ' CG1' ' A' ' 80' ' ' VAL . 4.2 mp -58.46 165.29 2.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.562 0.22 . . . . 0.84 111.26 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 8.1 pt-20 -52.45 -20.48 2.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.374 0.607 . . . . 1.14 111.267 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -87.46 -14.73 39.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.706 -0.679 . . . . 2.14 111.15 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.66 -10.57 38.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.35 -0.452 . . . . 0.51 112.249 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -72.27 108.97 5.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.995 0.426 . . . . 0.46 111.552 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 18.1 mtt180 -73.33 128.47 35.57 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.472 0.653 . . . . 0.47 110.367 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.851 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 35.2 m -115.6 -8.17 12.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.683 -1.144 . . . . 0.27 111.501 -171.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.675 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 10.7 pt20 -162.69 130.74 3.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.697 -0.683 . . . . 0.59 109.334 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 25.9 tt0 -141.84 105.92 4.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 1.34 110.258 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 6.4 mm-40 -125.84 126.82 24.88 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.743 -0.662 . . . . 2.59 109.754 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.492 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 10.9 Cg_exo -70.94 -17.06 32.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.424 2.083 . . . . 0.5 112.639 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -159.66 122.9 3.6 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.99 0.9 . . . . 1.37 111.923 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.6 tp -132.82 113.15 12.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.519 -1.673 . . . . 0.38 108.774 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.9 p -104.94 132.58 51.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.6 p90 -153.16 156.29 38.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.651 0.262 . . . . 0.23 110.638 -176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -75.86 112.06 11.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.42 110.172 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.84 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.5 tp -60.26 135.38 57.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.6 110.427 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.573 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 81.01 5.43 90.16 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.708 -0.758 . . . . 0.37 112.069 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.82 -13.13 19.35 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.852 -0.425 . . . . 0.93 109.852 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.7 m 62.32 35.04 15.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.556 -0.905 . . . . 0.62 108.556 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.27 -6.34 49.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.55 1.167 . . . . 1.33 108.431 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 7.8 m -131.13 -156.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 113.375 -1.739 . . . . 0.23 110.021 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -80.08 137.36 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 107.482 -1.303 . . . . 0.29 107.482 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.507 HE21 ' HB3' ' A' ' 100' ' ' ASP . 8.0 tp60 -58.04 -29.16 65.13 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.583 -0.28 . . . . 0.4 110.891 -173.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.0 -46.91 78.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.2 110.802 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.565 ' H ' HG13 ' A' ' 96' ' ' ILE . 51.4 tp -72.51 -41.34 66.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.372 -0.831 . . . . 0.22 110.503 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.507 ' HB3' HE21 ' A' ' 97' ' ' GLN . 15.7 t70 -61.11 -30.22 70.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.26 109.911 -174.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.8 mt -90.14 -33.77 16.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.25 112.196 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.7 t -68.91 -29.11 67.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.593 -0.276 . . . . 1.01 111.111 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.602 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.5 t -66.31 -55.11 21.34 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.659 0.615 . . . . 0.21 112.659 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.84 ' HD3' HD11 ' A' ' 90' ' ' LEU . 20.7 Cg_endo -62.45 -23.62 75.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.921 1.747 . . . . 0.27 111.818 176.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 39' ' ' ILE . 20.2 mt -73.75 -26.12 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.738 -0.664 . . . . 0.64 111.015 172.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.767 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -95.72 156.52 16.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.09 -0.505 . . . . 0.78 111.082 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.03 151.54 21.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.055 0.455 . . . . 0.97 110.923 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.685 HG23 ' HD3' ' A' ' 60' ' ' PRO . 1.3 t -60.07 125.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.461 0.648 . . . . 0.8 110.22 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.39 56.74 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.865 -1.061 . . . . 0.28 112.803 177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.8 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.0 pt-20 -103.14 167.93 9.51 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.41 111.096 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.464 HG22 HD12 ' A' ' 50' ' ' LEU . 7.2 m -129.41 117.19 20.16 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.716 -1.216 . . . . 0.22 107.716 175.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -120.74 134.35 55.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.049 -0.523 . . . . 0.18 110.717 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.4 ttp -98.39 117.93 33.9 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.759 -1.2 . . . . 1.32 107.759 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.652 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.1 t -111.92 135.21 51.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.689 -0.687 . . . . 0.18 109.431 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.565 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 87.8 m -114.32 113.68 24.89 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.616 -0.834 . . . . 0.21 108.795 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.64 54.94 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.18 -1.373 . . . . 0.15 109.796 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.706 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.9 t70 -52.79 148.79 6.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.004 -0.739 . . . . 0.58 109.004 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.596 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.3 t -55.23 -28.5 53.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.116 0.484 . . . . 0.82 110.489 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.706 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.5 ptpt -54.77 -32.88 60.63 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.448 -0.342 . . . . 0.81 111.535 175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.636 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 98.3 m-85 -97.25 7.8 45.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.059 0.456 . . . . 0.42 110.04 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.667 ' HB3' HD22 ' A' ' 138' ' ' LEU . 61.4 m -123.7 -91.74 0.54 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.118 -0.946 . . . . 0.18 110.115 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 127' ' ' SER . 4.1 m-85 -144.56 41.57 1.34 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 119.272 -0.394 . . . . 0.24 111.985 175.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.692 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.49 -84.01 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 121.449 -0.405 . . . . 0.25 113.836 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.76 12.07 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.32 2.013 . . . . 0.58 111.088 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -104.45 -51.52 3.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.499 -0.773 . . . . 0.65 110.176 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.558 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 83.27 142.46 4.77 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 114.606 -1.179 . . . . 0.3 111.982 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.618 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 18.7 t -92.65 164.23 13.48 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.176 -0.512 . . . . 0.33 112.074 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 128' ' ' ARG . 44.6 mtm180 -50.59 -62.64 1.47 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.905 -1.043 . . . . 3.17 111.905 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.939 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 30.9 t -72.09 -63.68 1.21 Allowed Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 1.23 110.067 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.9 Cg_endo -107.22 127.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 122.653 2.235 . . . . 0.37 112.315 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.558 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 42.1 t80 -55.97 98.6 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.861 -1.163 . . . . 1.14 107.861 162.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.612 HG12 ' CB ' ' A' ' 127' ' ' SER . 27.2 mm -66.44 128.82 94.05 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-N 115.713 -0.676 . . . . 0.39 109.484 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.25 145.52 65.69 Favored 'Trans proline' 0 C--O 1.238 0.522 0 C-N-CA 122.656 2.237 . . . . 0.61 111.839 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.692 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 34.8 Cg_endo -63.85 139.39 68.14 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.922 1.748 . . . . 0.52 111.783 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.565 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 1.4 m80 68.75 6.97 5.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.129 -0.941 . . . . 2.38 112.558 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -72.4 120.65 18.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.283 -0.636 . . . . 0.26 109.283 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -73.45 113.2 10.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.355 0.598 . . . . 0.22 109.904 -172.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 121' ' ' CYS . 0.9 OUTLIER -87.95 131.32 34.65 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.567 -0.742 . . . . 0.22 110.663 -177.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.8 t -115.73 99.94 7.67 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.901 -0.778 . . . . 1.2 108.901 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.514 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.2 pp -115.23 134.32 55.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.116 -0.493 . . . . 0.32 111.325 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.732 ' HB3' HE22 ' A' ' 71' ' ' GLN . 34.0 tt0 -98.86 122.04 41.59 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.223 -0.658 . . . . 1.05 109.223 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.8 m -117.69 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.476 0.655 . . . . 0.19 112.342 -177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 6.8 m -95.08 111.01 22.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.102 -0.954 . . . . 0.28 110.06 172.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.619 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 51.8 tp -83.6 99.19 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.66 -0.867 . . . . 0.15 108.66 173.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.424 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 21.4 mtmt -94.69 -32.28 13.44 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.052 -0.976 . . . . 1.08 110.598 -170.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.463 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 9.9 m -152.44 151.69 31.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.144 -0.48 . . . . 0.37 111.019 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -139.25 129.35 25.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.249 -0.648 . . . . 0.25 109.249 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.55 128.73 63.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.385 0.612 . . . . 0.92 110.534 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.47 125.57 34.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.644 -0.707 . . . . 2.27 110.615 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.63 HD11 HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.2 -1.24 1.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.674 -0.694 . . . . 1.97 110.514 178.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.82 98.15 7.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.745 -0.661 . . . . 2.14 109.796 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 70.24 -1.53 2.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.56 -0.745 . . . . 5.79 111.022 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 69.72 137.78 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.71 0.804 . . . . 7.48 112.421 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -46.6 115.14 0.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.967 -1.015 . . . . 8.46 111.597 171.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -91.98 -12.03 34.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.486 -0.561 . . . . 8.83 109.486 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -76.74 87.64 3.37 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.593 -0.891 . . . . 12.17 108.593 167.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.6 m170 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 114.995 -1.002 . . . . 13.46 110.203 -174.472 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.134 -0.321 . . . . 50.23 110.134 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.65 -159.82 9.25 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.153 -0.779 . . . . 47.99 111.153 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -117.2 137.76 24.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.996 0.398 . . . . 46.26 110.092 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 31.9 Cg_exo -60.11 144.34 99.49 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.276 1.984 . . . . 44.8 111.441 172.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 23.6 Cg_exo -64.02 127.37 19.24 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.577 2.185 . . . . 44.02 112.214 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.86 -168.44 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 42.5 110.517 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 59.83 88.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.844 -0.798 . . . . 41.5 108.844 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 8' ' ' GLU . 1.3 pm0 -68.81 135.29 50.95 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.275 0.843 . . . . 40.33 113.275 -166.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.25 5.55 12.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.917 -1.038 . . . . 39.09 109.746 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -90.01 -63.89 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.524 -0.762 . . . . 38.82 109.519 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.83 86.35 43.93 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.031 -0.531 . . . . 38.16 109.909 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -86.19 -177.27 2.39 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.779 2.32 . . . . 36.7 111.407 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.79 70.45 0.68 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.174 -1.012 . . . . 35.61 112.319 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.05 95.4 2.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.024 0.44 . . . . 35.03 110.468 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.9 -53.64 3.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.941 -0.572 . . . . 34.01 110.241 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.79 77.83 6.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.046 -0.524 . . . . 32.89 110.622 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -87.88 -7.12 57.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 31.94 111.351 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 70.74 114.79 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.789 0.68 . . . . 31.24 111.117 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.673 ' HD2' ' HG ' ' A' ' 20' ' ' LEU . 26.5 p90 -164.09 164.59 22.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 31.24 110.712 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HG ' ' HD2' ' A' ' 19' ' ' PHE . 67.1 mt 66.44 71.61 0.39 Allowed 'General case' 0 C--O 1.239 0.512 0 O-C-N 124.143 0.902 . . . . 29.85 111.311 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.01 -110.82 0.56 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.864 -1.062 . . . . 28.2 110.987 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.81 -48.44 2.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.803 0.335 . . . . 26.78 110.403 175.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.4 mtm -138.34 16.42 2.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.35 . . . . 27.47 111.673 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 57.45 98.85 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.685 0.616 . . . . 24.41 110.895 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.78 101.09 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.58 2.186 . . . . 21.63 112.797 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.92 149.56 42.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.021 -0.536 . . . . 20.67 109.77 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.59 122.66 11.61 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.734 2.29 . . . . 18.02 111.984 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.19 155.98 92.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 14.93 110.515 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.06 134.96 51.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.845 2.363 . . . . 13.81 112.576 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -73.81 -52.85 4.45 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.102 -0.499 . . . . 10.76 111.176 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 5.5 Cg_exo -78.8 115.52 3.6 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.063 1.842 . . . . 9.77 111.343 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.5 112.63 6.88 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.452 -0.34 . . . . 5.86 111.242 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -93.04 29.69 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.116 2.544 . . . . 4.47 111.965 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 65.68 41.87 3.81 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.438 -0.801 . . . . 4.13 110.617 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -84.79 92.97 8.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.085 -1.08 . . . . 2.45 108.085 171.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.523 ' HZ3' ' N ' ' A' ' 115' ' ' THR . 2.0 m0 -72.56 -161.21 0.08 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.238 0.542 . . . . 0.53 110.334 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 49.0 tp -80.04 109.99 15.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.17 0.51 . . . . 0.5 110.661 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.713 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 2.8 p-10 -63.06 97.71 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.089 -0.959 . . . . 2.51 110.696 171.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.817 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 12.0 mt -51.14 -49.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.021 -0.99 . . . . 0.46 111.986 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 45' ' ' LEU . 55.2 mt -102.33 3.84 38.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.72 110.99 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.713 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 75.61 8.5 84.23 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.466 -0.788 . . . . 0.52 112.314 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.687 HD22 ' N ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -98.12 -15.85 19.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.224 0.453 . . . . 0.95 112.224 -177.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.687 ' N ' HD22 ' A' ' 42' ' ' ASN . . . 86.14 -26.87 5.86 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.72 112.623 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.6 mp -69.15 -23.74 63.99 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 122.018 0.913 . . . . 1.56 109.033 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.817 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 4.9 tp -120.24 112.39 19.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.133 -1.394 . . . . 0.32 110.486 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 57.2 mtm180 -142.45 140.76 32.04 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 122.962 0.164 . . . . 1.14 111.229 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HG3' HG22 ' A' ' 114' ' ' VAL . 15.9 ttpt -115.53 127.04 54.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.801 -0.444 . . . . 0.35 109.801 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' NE1' ' A' ' 36' ' ' TRP . 15.0 ttmt -107.16 122.42 46.47 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 110.216 -0.29 . . . . 1.07 110.216 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 3.0 p -79.05 99.6 6.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.896 0.379 . . . . 0.33 111.063 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.524 HD12 HG22 ' A' ' 111' ' ' THR . 9.3 mt -67.8 -52.5 36.32 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 106.724 -1.584 . . . . 0.28 106.724 173.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.819 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 58.3 t -134.68 126.66 18.15 Favored Pre-proline 0 CA--C 1.502 -0.88 0 CA-C-N 113.039 -1.891 . . . . 0.36 106.196 168.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 65.7 Cg_endo -107.01 54.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 123.013 2.476 . . . . 0.54 114.474 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 54' ' ' PRO . . . 87.43 140.73 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.849 -0.691 . . . . 0.55 113.206 173.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 14.3 Cg_exo -69.0 153.73 71.93 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.76 2.307 . . . . 1.42 110.695 173.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -50.31 108.69 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.593 2.195 . . . . 2.04 112.469 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.81 43.47 2.87 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.827 -0.701 . . . . 0.98 112.205 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -87.11 -172.23 3.87 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.163 0.506 . . . . 0.99 111.095 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.2 t -146.21 143.58 29.34 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.929 -0.767 . . . . 1.28 108.929 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 69.1 mtm180 -94.16 116.84 66.92 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 120.449 -0.5 . . . . 2.81 109.756 176.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.778 ' HD3' HG23 ' A' ' 108' ' ' VAL . 7.4 Cg_endo -49.05 148.02 10.07 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.51 2.807 . . . . 0.3 113.077 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 10.6 t -92.73 150.24 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.195 -0.669 . . . . 0.88 109.195 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 66.1 mttt -71.33 120.26 16.65 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.709 0.766 . . . . 1.17 109.862 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.85 -26.8 4.74 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 114.175 -1.375 . . . . 0.42 110.103 -172.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.686 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.1 135.88 35.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.86 -0.793 . . . . 0.59 108.86 177.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 11.4 m -82.63 118.47 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.524 -0.917 . . . . 1.22 108.524 174.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.6 m -112.96 146.06 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.249 -0.887 . . . . 0.25 110.513 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 35.0 p -97.05 113.1 24.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.946 -0.57 . . . . 0.29 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.446 HG21 HD21 ' A' ' 99' ' ' LEU . 27.1 m -111.05 150.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.767 -0.651 . . . . 0.19 110.187 174.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.734 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.7 t-160 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.52 -1.659 . . . . 0.19 106.52 167.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 1.8 pt? -125.0 141.62 52.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.901 0.858 . . . . 0.39 110.88 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.639 HE22 ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -139.28 120.03 14.26 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.464 -2.05 . . . . 0.27 105.464 167.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 43.3 m -112.26 121.66 45.55 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.382 -0.826 . . . . 0.19 111.808 -165.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -103.59 148.7 25.68 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.885 -0.598 . . . . 1.06 109.515 175.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD23 HD21 ' A' ' 76' ' ' ASN . 3.4 mp -71.56 165.6 23.56 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.955 -0.566 . . . . 0.84 111.067 170.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.34 -18.95 12.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.416 0.627 . . . . 1.14 110.08 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.496 HD21 HD23 ' A' ' 74' ' ' LEU . 29.5 p30 -92.44 -5.07 52.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.366 -0.833 . . . . 2.14 111.133 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.49 -10.74 53.89 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.248 -0.501 . . . . 0.51 113.577 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.6 m -78.49 110.45 13.58 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 122.74 -0.27 . . . . 0.46 111.697 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 33.9 mtt180 -71.19 122.25 19.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.476 0.655 . . . . 0.47 110.253 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.735 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 32.8 m -108.18 -10.13 10.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.976 -1.011 . . . . 0.27 111.625 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 29.4 pt20 -159.96 145.58 15.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.889 -0.596 . . . . 0.59 109.501 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 43.8 tt0 -148.96 105.57 3.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.195 0.521 . . . . 1.34 109.902 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HB2' HD23 ' A' ' 70' ' ' LEU . 7.1 mm-40 -122.27 117.57 29.28 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.693 -0.685 . . . . 2.59 109.435 -175.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -66.5 -19.18 55.02 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.705 2.27 . . . . 0.5 112.182 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -159.54 118.67 2.89 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.269 1.033 . . . . 1.37 111.685 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.3 tp -126.07 99.65 6.0 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.174 -1.83 . . . . 0.38 108.423 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.0 p -89.57 134.42 28.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.949 -0.76 . . . . 1.0 108.949 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.5 p90 -153.56 162.7 41.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.11 0.481 . . . . 0.23 111.168 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 5.1 m -84.09 108.27 16.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.249 -0.887 . . . . 0.42 110.063 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.859 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.7 tp -59.24 132.52 54.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.6 110.152 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.692 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 86.93 4.9 81.67 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.498 -0.858 . . . . 0.37 112.376 175.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 31.4 t70 -117.8 9.3 12.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.692 -0.485 . . . . 0.93 109.692 -176.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.3 p 43.9 42.45 4.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.145 -0.934 . . . . 0.62 110.296 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 48.9 t0 -71.41 -12.29 61.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.766 1.27 . . . . 1.33 108.166 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.471 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 4.1 m -123.48 -153.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 113.168 -1.833 . . . . 0.23 109.558 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.682 HG13 ' H ' ' A' ' 99' ' ' LEU . 38.9 pt -81.67 142.85 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 107.541 -1.281 . . . . 0.29 107.541 170.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.494 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 9.0 tp60 -59.96 -34.85 73.84 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.619 -0.264 . . . . 0.4 111.08 -173.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -53.18 -48.79 67.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.204 0.526 . . . . 0.2 110.759 175.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.682 ' H ' HG13 ' A' ' 96' ' ' ILE . 57.8 tp -67.68 -41.91 82.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.184 -0.916 . . . . 0.22 110.534 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' HB3' HE21 ' A' ' 97' ' ' GLN . 10.8 t70 -60.54 -28.01 68.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.923 -1.035 . . . . 0.26 109.913 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 87.0 mt -89.66 -34.86 16.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.246 -0.888 . . . . 0.25 111.893 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.477 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 60.3 p -70.82 -27.11 63.63 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.635 0.255 . . . . 1.01 110.768 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.613 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.1 t -66.05 -55.33 21.92 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 112.48 0.548 . . . . 0.21 112.48 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.676 ' HD3' HD11 ' A' ' 90' ' ' LEU . 21.9 Cg_endo -61.39 -24.64 78.84 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.806 1.67 . . . . 0.27 112.112 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.9 mt -77.98 -13.25 59.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.64 111.213 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.799 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -106.9 155.03 20.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.849 -0.614 . . . . 0.78 111.077 178.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.74 155.61 16.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.711 0.291 . . . . 0.97 110.619 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.778 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.1 t -60.5 125.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.381 0.61 . . . . 0.8 110.659 177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.01 5.86 56.19 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.201 -0.909 . . . . 0.28 112.499 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 5.5 pt-20 -98.45 168.29 10.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.466 0.65 . . . . 0.41 111.139 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.524 HG22 HD12 ' A' ' 50' ' ' LEU . 31.6 m -132.69 117.42 17.85 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.995 -1.002 . . . . 0.22 108.479 174.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -118.54 140.15 50.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.917 -0.583 . . . . 0.18 110.564 -176.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 ttm -97.92 117.16 31.63 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.263 -1.384 . . . . 1.32 107.263 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.476 HG22 ' HG3' ' A' ' 47' ' ' LYS . 4.2 t -113.29 132.81 61.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.424 -0.584 . . . . 0.18 109.424 -175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 79.4 m -112.71 113.75 26.01 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.133 0.968 . . . . 0.21 109.072 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -124.46 135.36 53.17 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.434 -1.712 . . . . 0.15 109.693 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.75 ' OD1' ' HA ' ' A' ' 135' ' ' HIS . 10.6 t70 -52.33 147.28 8.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.789 -0.819 . . . . 0.58 108.789 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.639 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -55.8 -27.92 53.6 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 120.993 0.425 . . . . 0.82 110.234 -178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.599 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 17.6 ptpt -56.29 -29.28 60.99 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.894 -0.504 . . . . 0.81 111.455 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.593 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 85.0 m-85 -97.35 1.72 49.74 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.196 0.522 . . . . 0.42 109.9 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.639 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.1 m -122.02 -90.71 0.57 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.954 -1.021 . . . . 0.18 110.66 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.659 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 8.1 m-85 -142.9 41.62 1.55 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.587 -0.445 . . . . 0.24 111.921 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.44 -80.82 0.06 OUTLIER Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.09 -0.576 . . . . 0.25 113.4 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -87.26 10.36 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.478 2.119 . . . . 0.58 111.003 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.659 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.2 mt-30 -102.83 -46.45 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.756 -1.111 . . . . 0.65 109.876 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.571 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 79.21 142.58 2.42 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.181 -0.918 . . . . 0.3 112.634 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.607 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 11.7 t -90.53 164.57 14.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.218 -0.491 . . . . 0.33 111.558 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -56.16 -50.22 71.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.651 -0.704 . . . . 3.17 112.065 -173.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.895 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 51.1 m -80.91 -62.4 0.36 Allowed Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.214 -0.594 . . . . 1.23 109.998 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.895 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 22.1 Cg_endo -107.19 127.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.892 2.395 . . . . 0.37 112.541 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.543 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 41.2 t80 -55.97 98.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.863 -1.162 . . . . 1.14 107.863 162.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.589 HG12 ' CB ' ' A' ' 127' ' ' SER . 34.2 mm -64.74 133.0 95.59 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.767 . . . . 0.39 110.196 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 146.05 37.55 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.622 2.215 . . . . 0.61 112.14 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 36.3 Cg_endo -63.74 135.57 49.31 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.296 1.998 . . . . 0.52 112.387 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.75 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER 70.75 -0.42 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.915 -1.038 . . . . 2.38 112.744 178.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -61.12 118.97 7.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.129 -0.693 . . . . 0.26 109.129 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.92 113.09 10.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.422 0.63 . . . . 0.22 109.685 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 115' ' ' THR . 0.9 OUTLIER -88.83 131.07 35.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.307 -0.86 . . . . 0.22 110.982 -173.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 3.2 t -114.64 100.38 8.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.57 -0.9 . . . . 1.2 108.57 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.571 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.0 OUTLIER -121.32 135.46 55.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.008 -0.542 . . . . 0.32 111.816 -174.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.639 ' HG2' HE22 ' A' ' 71' ' ' GLN . 4.8 tt0 -98.0 125.97 43.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.511 -0.768 . . . . 1.05 109.482 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 3.4 m -124.42 117.14 49.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.31 0.576 . . . . 0.19 112.053 -177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 24.4 m -89.25 114.8 26.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.365 -0.834 . . . . 0.28 110.391 170.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.697 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 62.0 tp -84.57 100.35 11.35 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.238 -0.653 . . . . 0.15 109.238 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 25.8 mtmt -95.08 -25.8 16.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.528 -0.76 . . . . 1.08 110.88 -170.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.536 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 14.2 m -157.37 155.25 30.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.115 0.413 . . . . 0.37 112.115 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.564 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -140.49 127.9 21.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.28 -0.637 . . . . 0.25 109.28 171.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 17.8 m -136.32 142.44 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.423 . . . . 0.92 110.412 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.513 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.9 t0 -79.85 118.66 21.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.242 0.544 . . . . 2.27 110.335 -176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.446 ' HB3' HG13 ' A' ' 65' ' ' VAL . 12.6 tp -137.07 16.36 3.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.532 -0.914 . . . . 1.97 108.532 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.83 -47.04 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.535 -1.212 . . . . 2.14 108.198 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -90.11 62.07 5.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.904 -1.044 . . . . 5.79 110.122 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -61.54 159.73 12.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.669 -1.15 . . . . 7.48 110.932 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -72.03 145.79 48.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.423 -0.353 . . . . 8.46 110.267 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.3 t60 66.29 107.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 O-C-N 124.0 0.812 . . . . 8.83 111.679 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -107.99 175.88 5.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.062 -0.517 . . . . 12.17 110.616 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 C--O 1.244 0.804 0 N-CA-C 108.196 -1.039 . . . . 13.46 108.196 172.134 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.425 -0.213 . . . . 50.23 110.425 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.38 6.76 55.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 47.99 112.743 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -132.64 121.98 17.54 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 122.531 -0.394 . . . . 46.26 110.681 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 13.8 Cg_exo -70.52 146.7 56.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.721 2.28 . . . . 44.8 111.394 173.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 27.9 Cg_exo -62.27 150.24 87.71 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.019 2.479 . . . . 44.02 112.488 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.1 98.5 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 42.5 110.927 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.5 129.65 47.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.003 0.43 . . . . 41.5 110.307 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -95.27 164.71 12.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 40.33 111.091 -171.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.72 143.33 26.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.186 -0.461 . . . . 39.09 110.713 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.13 -11.05 60.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 38.82 110.617 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.99 97.58 26.16 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 121.361 0.6 . . . . 38.16 110.084 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.46 -33.1 30.32 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.956 2.437 . . . . 36.7 113.164 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.65 -31.12 3.65 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.614 -0.803 . . . . 35.61 112.847 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.88 -152.03 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.44 -0.207 . . . . 35.03 110.44 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.11 94.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.985 0.421 . . . . 34.01 110.353 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.13 94.83 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 32.89 111.03 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -100.74 150.09 23.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.593 -0.73 . . . . 31.94 109.041 172.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -104.83 160.42 15.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.794 0.807 . . . . 31.24 111.417 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -144.81 20.51 1.64 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.46 -1.245 . . . . 31.24 108.374 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.01 -51.95 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.565 -1.198 . . . . 29.85 110.592 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.8 -64.16 1.33 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.851 -0.613 . . . . 28.2 109.802 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . . . 56.53 11.6 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.571 -0.74 . . . . 26.78 112.4 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 66.1 mtt 58.26 24.77 11.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.148 0.579 . . . . 27.47 111.296 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 46.7 mt-10 -77.86 -53.26 1.49 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.334 -0.393 . . . . 24.41 111.611 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 24' ' ' GLU . 11.4 Cg_endo -54.93 129.06 33.21 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.474 2.116 . . . . 21.63 112.332 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.73 145.94 90.26 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.036 -0.529 . . . . 20.67 111.322 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.72 165.88 30.62 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.962 2.441 . . . . 18.02 112.9 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.16 139.34 20.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 14.93 110.311 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.788 ' HG2' ' HB2' ' A' ' 32' ' ' ALA . 13.2 Cg_endo -60.38 157.27 36.68 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.513 2.142 . . . . 13.81 112.738 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -72.44 -48.46 9.49 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.151 -0.477 . . . . 10.76 112.219 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 6.3 Cg_exo -80.27 42.63 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.212 1.941 . . . . 9.77 112.179 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.788 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . . . -101.75 148.94 35.99 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 5.86 110.55 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 22.0 Cg_exo -65.34 -31.17 53.09 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.568 2.178 . . . . 4.47 112.053 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 73.07 168.19 0.31 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.079 0.862 . . . . 4.13 111.089 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.489 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 2.0 mp0 -83.74 104.41 13.83 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.853 -0.612 . . . . 2.45 110.011 176.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 46' ' ' ARG . 3.8 m0 -74.65 -170.0 0.96 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.124 -0.489 . . . . 0.53 109.765 174.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.5 tp -70.07 109.58 4.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.304 -0.628 . . . . 0.5 109.304 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.645 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.2 t70 -78.53 127.19 31.8 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.166 -0.614 . . . . 2.51 109.852 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 45' ' ' LEU . 3.3 mt -61.68 -31.1 49.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.702 -1.136 . . . . 0.46 110.531 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -115.45 0.54 13.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.9 -0.591 . . . . 0.72 110.546 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.645 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.2 25.27 64.36 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.522 -0.763 . . . . 0.52 111.552 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -96.03 -26.56 15.49 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.936 0.347 . . . . 0.95 111.936 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 105.45 0.86 40.54 Favored Glycine 0 CA--C 1.512 -0.122 0 C-N-CA 120.847 -0.692 . . . . 0.72 111.871 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 8.1 mp -105.49 -32.73 8.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.037 0.446 . . . . 1.56 110.873 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 39' ' ' ILE . 19.0 tp -123.12 101.55 7.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 0.32 111.572 -169.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 36' ' ' TRP . 66.4 mtm180 -137.35 148.31 46.18 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.152 -0.342 . . . . 1.14 111.449 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HG3' HG22 ' A' ' 114' ' ' VAL . 25.3 ttpt -113.75 132.16 55.93 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.435 -0.209 . . . . 0.35 110.435 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.6 ttpt -115.92 129.9 56.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.719 0.295 . . . . 1.07 110.219 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.466 HG22 ' OE1' ' A' ' 110' ' ' GLU . 5.9 p -82.43 107.67 15.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.163 -0.471 . . . . 0.33 111.549 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.486 HD12 HG22 ' A' ' 111' ' ' THR . 6.7 mt -76.04 -54.76 6.37 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.344 -1.354 . . . . 0.28 107.344 172.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.814 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 97.7 t -127.24 124.57 23.79 Favored Pre-proline 0 CA--C 1.501 -0.923 0 CA-C-N 113.06 -1.882 . . . . 0.36 106.879 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 40.0 Cg_endo -111.56 88.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.932 2.421 . . . . 0.54 114.252 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' A' ' 110' ' ' GLU . . . 50.48 76.95 0.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.387 -0.37 . . . . 0.55 113.446 174.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 51.6 Cg_exo -50.93 -59.33 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.455 2.77 . . . . 1.42 115.439 -170.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 12.5 Cg_endo -91.65 -4.2 4.11 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.48 2.12 . . . . 2.04 114.248 -170.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.82 90.35 0.91 Allowed Glycine 0 CA--C 1.509 -0.336 0 C-N-CA 120.479 -0.867 . . . . 0.98 111.107 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 2.1 p -96.58 -171.87 2.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.055 0.761 . . . . 0.99 113.055 -170.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -150.0 143.94 25.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.48 -1.304 . . . . 1.28 107.48 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 6.8 mtm-85 -91.15 115.38 64.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 120.484 -0.486 . . . . 2.81 110.638 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.79 ' HD3' HG23 ' A' ' 108' ' ' VAL . 9.4 Cg_endo -51.23 140.26 42.25 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.98 2.453 . . . . 0.3 113.598 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.711 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.3 t -90.91 156.99 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.531 -0.759 . . . . 0.88 109.845 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -66.26 107.89 2.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.408 0.623 . . . . 1.17 110.399 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.04 -27.12 2.56 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 110.534 -1.027 . . . . 0.42 110.534 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.711 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -74.45 140.14 44.43 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.465 -0.569 . . . . 0.59 109.465 178.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.531 HG23 HD11 ' A' ' 150' ' ' LEU . 69.8 t -86.03 124.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.896 -0.779 . . . . 1.22 108.896 174.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 34.6 m -127.79 146.82 32.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 112.296 0.48 . . . . 0.25 112.296 -170.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.0 p -96.46 113.83 25.44 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.767 -0.651 . . . . 0.29 110.008 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 99' ' ' LEU . 24.5 m -110.68 142.05 24.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 120.071 -0.652 . . . . 0.19 109.803 172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.6 t-160 -101.34 112.43 24.94 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.981 -1.859 . . . . 0.19 105.981 170.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -119.21 133.69 55.62 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 122.318 1.056 . . . . 0.39 111.097 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.667 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -129.09 114.12 15.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.109 -2.182 . . . . 0.27 105.109 167.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.61 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 80.4 m -106.04 126.41 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.745 -1.116 . . . . 0.19 111.279 -166.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.8 t -106.89 157.21 17.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.341 -0.845 . . . . 1.06 109.504 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.38 167.12 15.02 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.613 -0.722 . . . . 0.84 110.65 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' OE1' ' HB1' ' A' ' 136' ' ' ALA . 4.6 pm0 -50.81 -24.97 3.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.106 -0.952 . . . . 1.14 111.371 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -93.55 -10.25 35.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.036 -0.529 . . . . 2.14 111.371 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.48 20.08 20.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.327 -0.94 . . . . 0.51 112.492 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.1 m -96.29 109.6 22.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.628 0.251 . . . . 0.46 110.72 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.9 mtt180 -76.03 109.94 10.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.736 0.779 . . . . 0.47 110.004 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.744 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -95.1 -9.02 9.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.36 -1.291 . . . . 0.27 111.833 -169.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.61 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 11.7 pt20 -159.69 148.65 17.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.59 109.597 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 71' ' ' GLN . 28.7 tt0 -152.65 105.78 3.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.087 0.47 . . . . 1.34 110.172 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -124.77 117.15 26.17 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.697 -0.683 . . . . 2.59 110.072 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 30.0 Cg_endo -63.97 -17.96 61.85 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.592 2.194 . . . . 0.5 112.103 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.74 106.72 2.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.161 0.982 . . . . 1.37 111.699 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.4 tp -115.72 111.84 21.17 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.473 -1.694 . . . . 0.38 107.635 170.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 9.3 p -109.17 131.05 61.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 110.041 -0.355 . . . . 1.0 110.041 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 31.0 p90 -154.17 163.26 40.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.601 -0.272 . . . . 0.23 110.917 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.6 m -82.91 117.75 22.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.915 -0.584 . . . . 0.42 109.628 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.945 HD11 ' HD3' ' A' ' 104' ' ' PRO . 13.8 tp -61.45 138.08 58.26 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.6 110.843 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.29 -7.2 61.34 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.015 -0.612 . . . . 0.37 112.162 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.18 -9.14 55.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.491 . . . . 0.93 109.761 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.2 m 60.2 30.31 19.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.178 -0.919 . . . . 0.62 109.54 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.19 -20.63 63.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.542 1.163 . . . . 1.33 108.302 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 m -112.88 -158.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 113.279 -1.782 . . . . 0.23 110.38 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.654 HG13 ' H ' ' A' ' 99' ' ' LEU . 36.8 pt -79.51 140.29 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.689 -1.226 . . . . 0.29 107.689 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.521 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 5.9 tp60 -59.88 -30.97 69.36 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.267 0.355 . . . . 0.4 110.821 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -54.16 -49.88 68.28 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.373 0.606 . . . . 0.2 110.544 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.654 ' H ' HG13 ' A' ' 96' ' ' ILE . 58.4 tp -69.87 -41.68 74.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.832 -1.076 . . . . 0.22 110.294 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.443 ' HB3' HE21 ' A' ' 97' ' ' GLN . 19.9 t70 -60.72 -28.42 68.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.831 -1.077 . . . . 0.26 109.963 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 80.9 mt -90.84 -34.81 15.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.394 -0.821 . . . . 0.25 112.256 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 99' ' ' LEU . 79.4 p -70.86 -24.63 62.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.538 -0.301 . . . . 1.01 111.143 -173.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.581 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 53.3 t -72.42 -50.27 8.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 112.793 0.664 . . . . 0.21 112.793 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.945 ' HD3' HD11 ' A' ' 90' ' ' LEU . 30.8 Cg_endo -65.01 -20.96 64.08 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 121.553 1.502 . . . . 0.27 111.61 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.454 HD11 HG23 ' A' ' 39' ' ' ILE . 15.9 mt -80.94 -18.62 46.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.64 110.541 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.724 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 31.8 ttm -90.09 149.84 22.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.951 -1.022 . . . . 0.78 111.104 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -94.37 147.45 23.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.97 110.39 176.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.79 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.7 t -60.44 123.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.328 0.585 . . . . 0.8 110.68 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.27 56.89 Favored Glycine 0 C--N 1.314 -0.679 0 C-N-CA 120.784 -0.722 . . . . 0.28 113.017 175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.814 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.7 pt-20 -99.68 168.78 9.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.253 0.549 . . . . 0.41 110.674 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.486 HG22 HD12 ' A' ' 50' ' ' LEU . 11.5 m -127.68 116.87 20.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.461 -1.311 . . . . 0.22 107.461 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.53 139.56 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.076 -0.511 . . . . 0.18 110.494 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 ttm -98.44 117.02 31.91 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.328 -1.36 . . . . 1.32 107.328 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.683 HG22 ' HG3' ' A' ' 47' ' ' LYS . 11.3 t -113.19 131.34 65.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 109.078 -0.712 . . . . 0.18 109.078 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.542 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 41.6 m -115.81 113.93 24.06 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 119.278 -0.969 . . . . 0.21 109.068 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -126.42 139.03 53.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.038 -1.892 . . . . 0.15 109.739 -176.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 10.1 t70 -53.93 150.8 7.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.407 -0.59 . . . . 0.58 109.407 174.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.595 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 1.9 t -54.81 -30.02 56.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.82 110.341 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.639 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -55.53 -30.13 60.15 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 122.229 -0.294 . . . . 0.81 111.56 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.532 ' CD2' ' HG3' ' A' ' 119' ' ' LYS . 76.6 m-85 -95.87 2.03 53.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.231 0.538 . . . . 0.42 110.171 176.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.827 ' HB3' HD22 ' A' ' 138' ' ' LEU . 60.5 m -123.69 -91.05 0.56 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.156 -0.929 . . . . 0.18 110.654 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.803 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.9 m-85 -140.15 38.36 1.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.574 0.583 . . . . 0.24 112.574 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -48.48 -78.82 0.08 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.474 0.579 . . . . 0.25 113.628 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -89.64 13.79 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.367 2.044 . . . . 0.58 110.559 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.803 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 42.0 mt-30 -104.28 -49.02 3.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.97 -1.014 . . . . 0.65 110.464 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.586 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 76.93 142.75 1.48 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.996 -1.002 . . . . 0.3 112.905 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.608 ' CB ' HG12 ' A' ' 132' ' ' ILE . 10.3 t -90.68 159.62 16.28 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.042 -0.579 . . . . 0.33 112.376 -175.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -52.45 -48.83 65.57 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.016 -0.993 . . . . 3.17 111.968 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.966 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 34.6 m -80.59 -67.76 0.22 Allowed Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.453 -0.499 . . . . 1.23 109.946 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.966 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 19.4 Cg_endo -104.91 127.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.611 2.208 . . . . 0.37 112.091 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.586 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 39.4 t80 -55.67 99.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.194 -1.039 . . . . 1.14 108.194 163.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.608 HG12 ' CB ' ' A' ' 127' ' ' SER . 35.1 mm -65.63 129.58 94.37 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.282 -0.872 . . . . 0.39 109.726 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 9.4 Cg_endo -53.52 141.78 61.51 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.828 2.352 . . . . 0.61 112.499 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.645 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 35.3 Cg_exo -58.28 131.35 42.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.467 2.111 . . . . 0.52 112.52 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.595 ' H ' ' HB3' ' A' ' 118' ' ' SER . 32.2 m170 73.37 9.82 5.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.916 -1.038 . . . . 2.38 112.35 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -73.68 127.75 33.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.215 -0.661 . . . . 0.26 109.215 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.69 111.58 10.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.074 0.464 . . . . 0.22 110.533 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.827 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.8 tp -88.4 130.97 35.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.684 -0.689 . . . . 0.22 110.213 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.55 100.85 7.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.707 0.765 . . . . 1.2 110.085 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -109.58 136.7 48.53 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.96 -1.018 . . . . 0.32 112.067 -173.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.667 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 38.2 tt0 -101.14 118.19 36.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.74 -0.837 . . . . 1.05 108.74 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -121.43 118.15 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.092 0.775 . . . . 0.19 113.092 -173.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 2.9 m -90.75 109.31 20.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.709 -0.678 . . . . 0.28 110.539 172.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.724 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 38.3 tp -82.86 102.72 11.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.428 -0.952 . . . . 0.15 108.428 172.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -103.53 -19.93 14.21 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.452 -0.795 . . . . 1.08 110.901 -170.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 m -156.41 144.94 19.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.37 111.152 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -141.0 128.7 21.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.212 -0.662 . . . . 0.25 109.212 174.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 65' ' ' VAL . 18.3 m -124.37 127.31 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.478 -0.489 . . . . 0.92 110.7 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.534 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 7.5 t70 -87.43 121.67 30.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.416 -0.356 . . . . 2.27 110.751 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -144.37 -1.21 0.93 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.812 0.339 . . . . 1.97 111.428 176.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.99 -71.1 0.72 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 2.14 111.767 -172.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.33 122.07 11.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 5.79 111.299 -173.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -72.39 107.55 5.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 7.48 109.524 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -51.85 127.2 20.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.682 -0.69 . . . . 8.46 111.808 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -151.03 176.9 10.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.768 -0.651 . . . . 8.83 110.149 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 59.7 m-70 -110.9 118.21 35.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.09 0.404 . . . . 12.17 112.09 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 36.1 t60 . . . . . 0 C--O 1.243 0.715 0 CA-C-O 118.292 -0.861 . . . . 13.46 109.222 170.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.67 0.271 . . . . 50.23 110.362 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.66 128.71 1.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.003 -0.618 . . . . 47.99 111.865 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 36.8 mt-30 -82.9 129.23 62.52 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.484 0.183 . . . . 46.26 110.55 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 8' ' ' GLU . 3.8 Cg_exo -78.32 130.17 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.879 2.386 . . . . 44.8 111.569 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.73 141.74 43.37 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.923 2.416 . . . . 44.02 111.933 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.97 -82.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.956 0.785 . . . . 42.5 110.471 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.06 161.96 34.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.755 0.312 . . . . 41.5 110.315 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.536 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 35.0 tt0 -81.18 96.76 7.32 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.498 -0.927 . . . . 40.33 108.498 173.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.03 -166.99 1.31 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.811 -0.631 . . . . 39.09 111.765 -171.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 11' ' ' GLN . 12.8 pt-20 -129.73 -58.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.6 . . . . 38.82 112.322 -171.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 31.3 mm-40 65.76 74.91 0.36 Allowed Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 123.141 0.576 . . . . 38.16 110.235 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.05 128.54 18.83 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.112 2.541 . . . . 36.7 112.253 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.17 -170.28 35.5 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.677 -0.569 . . . . 35.61 111.677 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.36 95.11 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.981 0.42 . . . . 35.03 110.347 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -117.93 -10.49 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.866 -0.606 . . . . 34.01 110.286 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 72.34 -41.61 0.51 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.479 0.712 . . . . 32.89 110.901 -176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -85.68 96.6 9.75 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.423 -0.353 . . . . 31.94 110.394 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -76.46 -27.62 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.442 -0.577 . . . . 31.24 109.442 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.1 t80 71.37 120.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.801 -1.09 . . . . 31.24 112.337 177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.93 68.99 0.76 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.967 -1.015 . . . . 29.85 110.929 172.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.57 98.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.279 -0.873 . . . . 28.2 111.643 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.15 129.55 12.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.918 -0.313 . . . . 26.78 111.06 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 tpt -174.58 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.445 -0.946 . . . . 27.47 108.445 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 39.3 tt0 -103.74 120.06 52.63 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.579 -1.192 . . . . 24.41 108.816 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 19.8 Cg_exo -66.39 136.98 45.39 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.047 2.498 . . . . 21.63 112.947 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 12.4 pt-20 -91.92 136.68 25.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 20.67 110.199 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 8.3 Cg_exo -73.14 131.85 17.24 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.846 2.364 . . . . 18.02 111.843 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.84 147.42 70.54 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 14.93 110.39 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 162.99 40.39 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.499 2.132 . . . . 13.81 112.121 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.96 68.89 1.7 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.365 -0.834 . . . . 10.76 111.107 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.35 126.51 8.46 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.381 2.054 . . . . 9.77 112.724 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.4 134.96 94.63 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 5.86 110.764 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 57.6 Cg_endo -72.13 -13.14 28.47 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.859 2.372 . . . . 4.47 113.039 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mm-40 76.78 -7.18 1.89 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.628 0.771 . . . . 4.13 111.64 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 52.54 89.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.958 0.787 . . . . 2.45 111.74 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.676 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 1.1 m0 -85.89 -164.44 1.03 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.405 0.622 . . . . 0.53 110.663 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.75 110.91 17.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.684 -0.689 . . . . 0.5 110.012 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.665 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 9.3 t70 -73.83 123.73 24.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.264 -0.574 . . . . 2.51 110.086 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 105' ' ' LEU . 9.4 mt -54.51 -37.82 39.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.053 -0.976 . . . . 0.46 111.309 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -111.8 2.89 17.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.203 -0.453 . . . . 0.72 110.617 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 61.11 22.7 60.91 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.57 -0.741 . . . . 0.52 112.066 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -92.16 -27.8 17.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.146 0.424 . . . . 0.95 112.146 -176.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 106.52 2.69 37.76 Favored Glycine 0 N--CA 1.454 -0.136 0 C-N-CA 120.926 -0.655 . . . . 0.72 112.271 175.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 117' ' ' ASP . 3.8 mm? -112.72 -28.38 7.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.682 0.277 . . . . 1.56 110.969 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 39' ' ' ILE . 23.3 tp -122.06 100.33 6.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.32 110.989 -172.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -131.98 136.85 47.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.905 0.335 . . . . 1.14 111.905 -171.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HG3' HG22 ' A' ' 114' ' ' VAL . 12.8 ttpt -109.01 123.09 48.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.629 -0.508 . . . . 0.35 109.629 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.676 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 24.4 ttpp -105.46 110.79 23.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.666 0.269 . . . . 1.07 110.538 176.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -70.65 98.99 1.59 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.33 110.898 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 111' ' ' THR . 10.7 mt -66.06 -52.54 48.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.724 -1.584 . . . . 0.28 106.724 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.855 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 90.1 t -137.29 131.55 17.6 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 112.982 -1.917 . . . . 0.36 106.483 169.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 33.6 Cg_endo -105.65 52.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.704 2.269 . . . . 0.54 113.798 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.92 148.99 12.01 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.924 -0.655 . . . . 0.55 112.982 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.08 147.9 68.25 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.379 2.053 . . . . 1.42 110.484 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -48.77 107.35 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.869 2.379 . . . . 2.04 112.455 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.67 30.98 4.1 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.657 -0.701 . . . . 0.98 112.168 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -167.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.474 0.654 . . . . 0.99 111.173 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -153.22 137.52 16.6 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.944 -1.132 . . . . 1.28 107.944 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 106' ' ' MET . 40.3 mtm180 -91.67 110.61 44.57 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.696 -0.229 . . . . 2.81 110.451 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.842 ' HD3' HG23 ' A' ' 108' ' ' VAL . 12.1 Cg_endo -53.82 149.11 34.62 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.412 2.741 . . . . 0.3 112.8 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 2.2 m -102.99 157.94 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.204 -0.665 . . . . 0.88 109.204 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 56.6 mttp -62.97 119.85 10.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.246 0.546 . . . . 1.17 109.749 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.417 ' CA ' ' HG2' ' A' ' 151' ' ' GLU . . . 128.72 -26.75 4.5 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.49 -1.044 . . . . 0.42 110.49 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.656 ' OE1' ' HB2' ' A' ' 149' ' ' ASP . 3.1 mm-40 -83.88 127.14 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.884 -1.154 . . . . 0.59 107.884 174.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -80.37 126.75 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.18 -1.044 . . . . 1.22 108.18 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 147' ' ' ALA . 18.2 m -121.89 145.9 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.066 -0.97 . . . . 0.25 110.533 -171.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.675 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 54.4 p -96.92 112.99 24.5 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.29 109.778 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.754 HG21 HD21 ' A' ' 99' ' ' LEU . 17.1 m -110.91 145.6 17.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 C-N-CA 120.228 -0.589 . . . . 0.19 110.697 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.654 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 3.1 t-160 -102.03 114.87 29.37 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.014 -1.476 . . . . 0.19 107.014 169.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -121.21 133.5 55.17 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 122.218 1.008 . . . . 0.39 110.905 176.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.689 HE22 ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -128.79 113.59 15.5 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.372 -2.084 . . . . 0.27 105.372 168.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.635 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 40.1 m -104.4 127.69 52.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.953 -1.021 . . . . 0.19 111.724 -168.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.9 m -103.16 162.17 13.19 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.291 -0.868 . . . . 1.06 109.308 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.22 166.14 15.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.739 -1.119 . . . . 0.84 109.904 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 9.8 pt-20 -56.97 -21.88 33.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.187 0.518 . . . . 1.14 110.296 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.43 -4.47 55.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.909 -0.587 . . . . 2.14 111.29 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.98 -23.07 28.46 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.658 -0.782 . . . . 0.51 113.567 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 118.02 10.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.391 0.515 . . . . 0.46 112.391 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.0 mtt180 -76.38 125.25 28.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.74 0.781 . . . . 0.47 111.121 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.702 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 25.8 m -106.76 -9.09 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 0.27 111.886 -170.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.635 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 8.6 pt20 -160.91 145.95 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.828 -0.624 . . . . 0.59 109.399 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 71' ' ' GLN . 1.2 tm-20 -150.56 105.53 3.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.347 -0.612 . . . . 1.34 109.347 -177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -125.59 111.15 25.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 2.59 110.069 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 24.6 Cg_exo -63.12 -16.63 55.62 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.137 2.558 . . . . 0.5 113.192 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 67' ' ' THR . 11.6 tt0 -164.49 100.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.3 1.048 . . . . 1.37 111.682 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.0 tp -109.11 110.35 21.57 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 0.38 108.878 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.2 p -102.36 133.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.2 p90 -153.31 157.29 39.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.695 0.283 . . . . 0.23 110.622 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -76.67 110.85 11.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.711 -0.677 . . . . 0.42 109.646 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.874 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.3 tp -55.03 129.74 39.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.348 -0.387 . . . . 0.6 110.862 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.12 2.02 90.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.918 -0.658 . . . . 0.37 112.368 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.16 -7.16 52.27 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.387 -0.598 . . . . 0.93 109.387 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 34.8 m 60.65 28.77 18.48 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.207 -0.906 . . . . 0.62 110.019 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -63.87 -28.34 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.685 1.231 . . . . 1.33 108.633 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 16.0 m -110.15 -153.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 113.329 -1.76 . . . . 0.23 111.057 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 99' ' ' LEU . 35.3 pt -89.04 139.47 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.548 -1.279 . . . . 0.29 107.548 175.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 tp60 -59.23 -29.35 67.46 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.458 -0.337 . . . . 0.4 110.663 -174.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 120' ' ' TYR . . . -55.02 -47.48 74.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.212 0.53 . . . . 0.2 110.477 175.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.754 HD21 HG21 ' A' ' 68' ' ' VAL . 58.0 tp -78.04 -36.89 47.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.2 -0.909 . . . . 0.22 110.259 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.49 -30.45 71.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.223 -0.899 . . . . 0.26 109.588 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 65.2 mt -91.02 -33.32 15.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.418 -0.81 . . . . 0.25 112.214 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 106' ' ' MET . 34.1 t -67.2 -31.92 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.58 -0.282 . . . . 1.01 111.1 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.534 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.1 t -62.11 -55.45 40.57 Favored Pre-proline 0 C--O 1.219 -0.55 0 N-CA-C 112.309 0.485 . . . . 0.21 112.309 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.874 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.9 Cg_endo -62.57 -20.64 71.31 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 121.747 1.632 . . . . 0.27 111.75 176.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 39' ' ' ILE . 12.1 mt -82.14 -15.15 54.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.584 . . . . 0.64 111.299 173.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.759 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -107.41 146.41 31.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.925 -0.58 . . . . 0.78 111.095 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.96 157.5 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.18 0.514 . . . . 0.97 111.022 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.842 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.3 t -63.97 124.52 18.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.403 0.621 . . . . 0.8 110.169 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.68 16.39 45.81 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.067 -0.969 . . . . 0.28 112.342 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.855 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.5 pt-20 -105.28 167.98 9.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.334 0.588 . . . . 0.41 111.25 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 50' ' ' LEU . 17.8 m -132.98 118.46 18.88 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 173.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.13 140.19 52.84 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.885 -0.598 . . . . 0.18 110.327 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 39.6 ttp -100.61 118.26 36.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.506 -1.294 . . . . 1.32 107.506 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 47' ' ' LYS . 5.7 t -111.95 131.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.209 -0.45 . . . . 0.18 110.086 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 96.1 m -108.16 112.98 25.77 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.364 -0.976 . . . . 0.21 108.364 172.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.62 135.17 52.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.378 -1.283 . . . . 0.15 109.399 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.647 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.8 t70 -54.25 149.35 9.95 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.1 -0.704 . . . . 0.58 109.1 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.6 t -54.49 -28.49 45.25 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.407 0.442 . . . . 0.82 110.351 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.647 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.0 ptpt -54.68 -32.91 60.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.633 -0.258 . . . . 0.81 111.463 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.582 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 82.8 m-85 -95.39 1.68 54.31 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.01 0.434 . . . . 0.42 110.279 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 70.8 m -120.74 -89.8 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.215 -0.902 . . . . 0.18 110.6 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 10.0 m-85 -144.04 38.78 1.32 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.066 -0.396 . . . . 0.24 111.777 177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -51.03 -79.39 0.08 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.215 -0.517 . . . . 0.25 113.636 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -85.02 9.51 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.197 1.931 . . . . 0.58 111.044 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -104.0 -50.57 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.994 -1.003 . . . . 0.65 109.81 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 79.87 141.53 2.51 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.602 -1.181 . . . . 0.3 111.985 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.607 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 15.1 t -91.29 163.85 14.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.36 -0.42 . . . . 0.33 111.374 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -48.82 -69.05 0.13 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.899 0.749 . . . . 3.17 111.66 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.987 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 49.9 m -64.2 -66.37 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.759 0 CA-C-N 115.675 -0.693 . . . . 1.23 110.608 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.987 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 28.5 Cg_endo -106.94 127.24 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.5 2.133 . . . . 0.37 112.259 175.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.572 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 23.5 t80 -57.15 97.34 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.978 -1.119 . . . . 1.14 107.978 164.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.593 HG12 ' CB ' ' A' ' 127' ' ' SER . 31.8 mm -65.72 129.84 94.4 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 109.591 -0.522 . . . . 0.39 109.591 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.5 Cg_exo -53.76 140.88 66.61 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.59 2.194 . . . . 0.61 112.199 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.602 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 44.2 Cg_exo -57.8 131.28 43.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.234 1.956 . . . . 0.52 112.292 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.523 ' H ' ' HB3' ' A' ' 118' ' ' SER . 0.2 OUTLIER 75.15 4.68 4.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.14 -0.936 . . . . 2.38 112.356 177.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -70.05 123.3 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.281 -0.637 . . . . 0.26 109.281 176.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . . . -75.06 113.58 12.55 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.229 -0.588 . . . . 0.22 110.306 -172.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.614 ' HG ' ' CG2' ' A' ' 72' ' ' THR . 1.3 tp -90.87 132.81 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.779 -0.646 . . . . 0.22 110.918 -175.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.78 100.75 7.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.183 0.516 . . . . 1.2 109.696 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.583 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -116.19 136.16 53.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.138 -0.483 . . . . 0.32 111.836 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.689 ' HG2' HE22 ' A' ' 71' ' ' GLN . 6.4 tt0 -102.05 121.8 42.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.224 -0.658 . . . . 1.05 109.224 178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 99' ' ' LEU . 3.7 m -118.14 117.56 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.682 0.753 . . . . 0.19 112.52 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 145' ' ' LYS . 8.3 m -87.8 115.36 25.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.971 -1.013 . . . . 0.28 110.387 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.701 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 42.8 tp -88.87 100.73 13.4 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.223 -1.028 . . . . 0.15 108.223 170.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.622 ' HG3' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -93.75 -23.27 18.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.191 -0.913 . . . . 1.08 110.781 -173.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.675 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 94.7 m -159.84 144.91 15.22 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.763 -0.653 . . . . 0.37 111.494 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -136.44 126.92 26.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.144 -0.688 . . . . 0.25 109.144 170.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.0 m -135.41 131.07 51.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.126 0.489 . . . . 0.92 110.455 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.656 ' HB2' ' OE1' ' A' ' 64' ' ' GLN . 8.5 t70 -69.69 119.11 13.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.317 -0.401 . . . . 2.27 110.783 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.35 31.0 1.01 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.033 -0.728 . . . . 1.97 109.033 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.417 ' HG2' ' CA ' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -69.45 -62.08 1.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.578 -0.737 . . . . 2.14 109.756 -176.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -113.43 112.45 23.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.147 -0.478 . . . . 5.79 110.677 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -91.09 51.27 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.998 -0.742 . . . . 7.48 108.998 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -83.66 -15.75 47.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 8.46 110.541 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -66.59 153.17 43.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 8.83 110.876 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 67.47 27.61 7.93 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.972 0.795 . . . . 12.17 110.619 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.486 -0.769 . . . . 13.46 109.139 176.685 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.699 -0.482 . . . . 50.23 109.699 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.553 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . 62.91 54.36 33.93 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.13 -0.788 . . . . 47.99 111.13 -172.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -102.36 103.31 30.36 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.825 0.345 . . . . 46.26 111.618 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 2' ' ' GLY . 55.3 Cg_endo -95.2 117.86 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.006 2.471 . . . . 44.8 111.455 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 4' ' ' PRO . 19.1 Cg_endo -60.72 121.31 9.51 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.858 1.705 . . . . 44.02 111.269 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.88 -55.34 3.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 42.5 110.432 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -125.6 82.23 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.015 -0.539 . . . . 41.5 110.498 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.37 121.01 25.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.362 -0.607 . . . . 40.33 109.362 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.73 158.47 33.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 39.09 111.393 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -78.23 -32.79 49.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.494 -0.775 . . . . 38.82 109.623 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -124.56 92.29 48.17 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.225 -0.898 . . . . 38.16 111.3 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.01 114.83 3.89 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.446 2.097 . . . . 36.7 111.616 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.57 -21.08 4.3 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.528 -0.844 . . . . 35.61 112.389 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.56 -67.97 0.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.651 0.262 . . . . 35.03 110.34 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 tp 62.88 98.91 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.585 -0.734 . . . . 34.01 112.296 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.63 101.73 11.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.156 -0.683 . . . . 32.89 109.156 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HE ' ' C ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -98.19 162.92 12.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.324 0.49 . . . . 31.94 112.324 -174.13 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.41 173.25 7.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 31.24 109.179 171.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 26.0 p90 -155.12 159.15 39.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.028 -0.269 . . . . 31.24 110.719 -174.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 7.5 mt -173.41 -55.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.042 0.839 . . . . 29.85 109.516 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.41 102.49 4.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.016 -0.538 . . . . 28.2 109.831 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.68 -80.53 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.331 -0.395 . . . . 26.78 110.684 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ptm -120.04 -9.93 9.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.905 0.383 . . . . 27.47 111.108 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 6.5 tp10 -150.09 121.31 4.0 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.401 -0.363 . . . . 24.41 110.526 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 4.7 Cg_exo -76.49 -173.39 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.71 2.274 . . . . 21.63 110.834 173.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.59 131.09 22.1 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.797 -0.445 . . . . 20.67 109.797 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.05 115.1 1.83 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.033 2.489 . . . . 18.02 112.135 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -92.01 126.75 52.2 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 14.93 110.989 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 15.0 Cg_exo -70.71 129.29 16.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.953 2.436 . . . . 13.81 111.896 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -90.33 -52.59 0.32 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.395 -0.366 . . . . 10.76 111.888 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 4.3 Cg_exo -77.39 48.03 2.44 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.753 2.302 . . . . 9.77 112.156 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -100.26 140.89 21.81 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 5.86 110.41 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 19.2 Cg_exo -66.79 -24.94 46.41 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.873 2.382 . . . . 4.47 112.096 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 33' ' ' PRO . 45.1 tt0 80.17 144.53 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 124.308 1.005 . . . . 4.13 110.681 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 35' ' ' GLU . 1.0 OUTLIER -96.59 90.89 5.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.438 0.637 . . . . 2.45 110.162 178.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.702 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -73.73 -169.42 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.884 -1.053 . . . . 0.53 111.327 -176.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 tp -69.4 112.94 6.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.454 -0.794 . . . . 0.5 110.332 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.606 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 t70 -76.41 123.49 26.07 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.527 0.679 . . . . 2.51 109.999 176.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.582 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 4.8 mt -64.18 -30.13 49.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.794 -1.094 . . . . 0.46 110.667 -176.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.35 -8.43 19.23 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.72 110.05 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.49 25.3 68.55 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.209 -0.905 . . . . 0.52 111.654 -172.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.504 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -105.07 -26.95 11.91 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.359 0.503 . . . . 0.95 112.359 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.56 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 110.66 7.51 25.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.308 -0.948 . . . . 0.72 112.454 174.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.433 HD13 ' OD1' ' A' ' 42' ' ' ASN . 8.9 mp -110.2 -32.7 6.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.332 0.587 . . . . 1.56 110.578 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.582 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 19.4 tp -122.55 104.04 9.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.11 -0.95 . . . . 0.32 111.512 -170.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.572 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 77.9 mtm180 -134.63 144.91 48.14 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.942 -0.474 . . . . 1.14 112.197 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HG3' HG22 ' A' ' 114' ' ' VAL . 14.8 ttpt -115.34 129.08 56.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 110.271 -0.27 . . . . 0.35 110.271 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.702 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 38.9 ttpt -111.08 120.02 40.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.891 0.377 . . . . 1.07 111.109 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 p -72.91 101.03 3.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.747 -0.66 . . . . 0.33 111.647 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 111' ' ' THR . 10.9 mt -68.08 -51.39 47.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.895 -1.521 . . . . 0.28 106.895 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.849 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 69.0 t -136.58 130.46 17.94 Favored Pre-proline 0 CA--C 1.501 -0.927 0 CA-C-N 112.898 -1.956 . . . . 0.36 106.097 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 44.4 Cg_endo -104.21 56.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.743 2.295 . . . . 0.54 113.451 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.99 174.34 33.75 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.564 -0.744 . . . . 0.55 112.637 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.02 151.72 45.08 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.205 1.936 . . . . 1.42 110.685 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.21 97.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.448 2.098 . . . . 2.04 111.978 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.35 39.12 1.05 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.864 -0.607 . . . . 0.98 111.93 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -86.73 -168.78 2.36 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 120.941 0.4 . . . . 0.99 110.811 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.508 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 19.4 m -145.85 138.02 25.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.745 -0.465 . . . . 1.28 109.745 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 107' ' ' ASP . 85.2 mtt180 -92.14 116.2 66.05 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 2.81 109.626 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HG3' HD21 ' A' ' 144' ' ' LEU . 9.1 Cg_endo -52.19 155.35 9.28 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.552 2.834 . . . . 0.3 113.042 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.604 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 3.9 p -106.82 154.38 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.88 109.935 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.88 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 58.6 mttp -63.49 123.83 19.78 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.568 0.699 . . . . 1.17 109.54 178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 151' ' ' GLU . . . 118.24 -9.73 13.48 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 114.799 -1.091 . . . . 0.42 110.562 -170.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.705 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.45 136.32 34.88 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.948 -0.736 . . . . 0.59 109.698 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 4.2 p -82.87 115.7 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 108.445 -0.946 . . . . 1.22 108.445 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.3 m -117.81 148.76 20.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.595 -0.729 . . . . 0.25 111.156 -170.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.64 HG22 HG12 ' A' ' 87' ' ' VAL . 77.1 p -98.12 113.75 25.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.984 -0.553 . . . . 0.29 110.09 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.858 HG21 HD21 ' A' ' 99' ' ' LEU . 28.2 m -111.28 140.44 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 C-N-CA 119.641 -0.824 . . . . 0.19 110.762 172.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.599 ' ND1' ' HA ' ' A' ' 84' ' ' PRO . 1.8 t-160 -102.29 115.27 30.21 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.891 -1.522 . . . . 0.19 106.891 168.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.93 HD23 ' HB3' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -124.44 129.46 50.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 118.921 -1.112 . . . . 0.39 111.608 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -121.79 114.9 21.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.865 -1.902 . . . . 0.27 105.865 169.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.592 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 58.9 m -103.31 128.66 50.3 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.676 -1.147 . . . . 0.19 111.562 -167.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.711 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.8 m -103.51 156.8 17.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.129 -0.942 . . . . 1.06 108.869 176.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.69 165.34 19.02 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.199 -0.91 . . . . 0.84 109.431 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.06 -21.65 23.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.338 0.59 . . . . 1.14 110.482 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.94 -5.15 58.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.379 -0.828 . . . . 2.14 110.997 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.59 -6.4 57.39 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.979 -0.629 . . . . 0.51 112.878 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.8 m -81.04 112.95 18.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.786 0.327 . . . . 0.46 111.791 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 16.0 mtt180 -75.0 122.62 23.79 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.499 0.666 . . . . 0.47 110.747 176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.644 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.5 m -108.0 -9.93 10.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.695 -1.139 . . . . 0.27 112.1 -169.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.592 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 13.0 pt20 -158.88 133.3 7.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.449 -0.341 . . . . 0.59 110.439 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.55 107.11 12.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.309 0.576 . . . . 1.34 110.016 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.93 ' HB3' HD23 ' A' ' 70' ' ' LEU . 1.9 tp10 -111.29 105.68 57.0 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.237 -0.892 . . . . 2.59 110.332 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.599 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 12.7 Cg_exo -67.91 -22.32 42.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.904 1.736 . . . . 0.5 112.223 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.9 123.09 1.68 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.776 0.798 . . . . 1.37 111.09 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.622 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 40.8 tp -131.38 105.78 7.83 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.806 -1.543 . . . . 0.38 108.798 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 34.8 m -92.1 139.48 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-O 120.826 0.346 . . . . 1.0 110.492 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 33.8 p90 -158.36 159.63 36.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.098 -0.501 . . . . 0.23 110.567 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 92' ' ' ASP . 7.4 m -77.63 115.99 17.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.607 -0.516 . . . . 0.42 109.607 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.88 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . 13.3 tp -56.76 131.41 49.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.558 -0.292 . . . . 0.6 110.447 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.08 -3.66 86.85 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.908 -0.663 . . . . 0.37 112.55 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 12.6 t70 -86.34 -12.34 49.61 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.819 -0.438 . . . . 0.93 109.819 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 m 60.38 33.73 20.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.902 -0.777 . . . . 0.62 108.902 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 38.8 t70 -72.67 -11.9 60.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.341 1.067 . . . . 1.33 108.789 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.15 -158.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.502 -1.681 . . . . 0.23 110.487 -175.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 31.7 pt -81.76 137.62 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 107.914 -1.143 . . . . 0.29 107.914 175.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.527 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.0 tp60 -60.48 -28.78 68.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.829 -0.348 . . . . 0.4 111.095 -173.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.37 70.56 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.32 0.581 . . . . 0.2 110.472 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.858 HD21 HG21 ' A' ' 68' ' ' VAL . 56.1 tp -80.08 -40.78 26.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.406 -0.815 . . . . 0.22 110.941 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.527 ' HB3' HE21 ' A' ' 97' ' ' GLN . 16.3 t70 -60.58 -30.82 70.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.005 -0.998 . . . . 0.26 110.018 -174.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.84 -33.24 15.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.967 -1.015 . . . . 0.25 112.208 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.0 t -64.72 -35.32 80.66 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.76 0.314 . . . . 1.01 111.348 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.569 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 65.7 t -60.72 -55.17 47.49 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.507 0.558 . . . . 0.21 112.507 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.873 ' HD3' HD11 ' A' ' 90' ' ' LEU . 27.2 Cg_endo -64.51 -20.46 65.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.865 1.71 . . . . 0.27 112.143 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.87 -12.72 59.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.64 111.383 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 2.3 ptm -108.95 156.86 19.21 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 0.78 110.625 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.97 110.92 179.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 58' ' ' SER . 1.3 p -65.88 126.82 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.749 0.785 . . . . 0.8 110.29 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.37 7.4 62.04 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 114.75 -1.113 . . . . 0.28 112.723 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.849 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 3.9 pt-20 -95.44 167.75 11.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.483 0.659 . . . . 0.41 111.839 -176.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.431 HG22 HD12 ' A' ' 50' ' ' LEU . 5.3 m -126.06 116.96 22.22 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.838 -1.171 . . . . 0.22 107.838 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -119.9 134.97 55.07 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.123 0.487 . . . . 0.18 110.813 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.1 ttm -97.54 117.88 32.79 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.381 -1.34 . . . . 1.32 107.381 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 47' ' ' LYS . 7.8 t -112.85 130.31 66.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.417 -0.586 . . . . 0.18 109.417 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.569 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 78.9 m -110.29 112.75 24.9 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 119.146 -1.022 . . . . 0.21 108.365 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.23 135.04 52.16 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.963 -1.471 . . . . 0.15 109.91 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.625 ' OD1' ' HG2' ' A' ' 119' ' ' LYS . 9.6 t70 -52.36 147.94 7.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.819 -0.808 . . . . 0.58 108.819 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.637 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 2.9 t -56.35 -26.29 52.18 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.013 0.435 . . . . 0.82 110.218 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.625 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 15.4 ptpt -57.86 -29.96 65.43 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.762 -0.586 . . . . 0.81 111.394 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' HG3' ' A' ' 119' ' ' LYS . 81.9 m-85 -93.46 -2.11 54.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.543 0.687 . . . . 0.42 110.221 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.648 ' HB3' HD22 ' A' ' 138' ' ' LEU . 64.7 m -119.53 -90.95 0.56 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.725 -1.125 . . . . 0.18 110.416 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.645 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 6.1 m-85 -145.81 43.06 1.25 Allowed 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.337 -0.545 . . . . 0.24 112.266 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -54.42 -87.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.056 -0.593 . . . . 0.25 113.361 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.14 10.38 2.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.373 2.048 . . . . 0.58 111.046 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.645 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 37.5 mt-30 -103.47 -45.85 4.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.353 -0.839 . . . . 0.65 110.245 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.547 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 76.01 143.39 1.28 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.911 -1.041 . . . . 0.3 112.546 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.666 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 13.0 t -91.89 164.05 13.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.987 0.422 . . . . 0.33 111.639 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -58.14 -45.64 87.02 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.249 -0.887 . . . . 3.17 112.02 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.904 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 58.4 m -87.46 -60.26 0.26 Allowed Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 120.805 -0.358 . . . . 1.23 110.269 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 21.1 Cg_endo -107.58 126.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.541 2.161 . . . . 0.37 111.899 171.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 20.6 t80 -58.14 97.28 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.862 -1.162 . . . . 1.14 107.862 165.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.587 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.1 mm -64.3 127.88 92.59 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.756 -0.656 . . . . 0.39 110.013 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.0 Cg_endo -50.05 136.79 37.21 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.21 2.607 . . . . 0.61 111.87 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.567 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 31.2 Cg_exo -58.54 132.17 46.8 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.523 2.149 . . . . 0.52 112.08 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 30.2 m170 77.0 0.21 3.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.912 -1.04 . . . . 2.38 112.284 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -67.76 122.17 17.54 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 120.468 -0.493 . . . . 0.26 109.686 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.5 112.81 9.94 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.336 0.589 . . . . 0.22 109.634 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -88.05 132.32 34.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.605 -0.725 . . . . 0.22 110.552 -176.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 7.6 t -115.08 99.54 7.52 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.755 -0.832 . . . . 1.2 108.755 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.8 OUTLIER -113.95 134.12 55.04 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.289 0.566 . . . . 0.32 111.599 -173.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.516 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 57.6 tt0 -99.56 112.71 24.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 1.05 109.459 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.686 HG11 HD13 ' A' ' 99' ' ' LEU . 6.8 m -109.44 123.15 65.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.53 0.681 . . . . 0.19 111.86 -177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 4.3 m -96.59 111.01 23.31 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.126 -0.943 . . . . 0.28 110.167 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.65 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 58.1 tp -82.74 100.81 10.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.689 -0.856 . . . . 0.15 108.689 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -99.33 -21.38 16.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.631 -0.713 . . . . 1.08 110.653 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.8 m -158.12 147.02 19.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.848 -0.341 . . . . 0.37 111.408 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -133.74 127.68 33.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 0.25 109.225 169.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -124.12 147.57 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.307 -0.627 . . . . 0.92 109.307 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.617 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.8 p-10 -97.24 128.15 43.85 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 110.21 -0.293 . . . . 2.27 110.21 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 150' ' ' LEU . 1.3 tm? -135.13 -38.11 0.78 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.741 0.781 . . . . 1.97 110.21 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.614 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 4.8 tp10 -82.66 -34.89 27.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.468 -1.242 . . . . 2.14 111.593 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.61 ' CD2' ' HB2' ' A' ' 149' ' ' ASP . 0.1 OUTLIER -71.59 154.75 41.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 5.79 111.106 -173.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.7 t60 62.88 20.12 11.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.9 -0.591 . . . . 7.48 112.048 170.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -105.37 142.05 35.82 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.111 -0.329 . . . . 8.46 110.111 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 60.18 77.3 0.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.79 0.681 . . . . 8.83 111.277 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -112.5 128.92 56.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.119 -0.492 . . . . 12.17 110.683 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.167 -0.921 . . . . 13.46 109.267 175.434 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.449 0.166 . . . . 50.23 110.649 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.02 -17.65 5.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.207 -0.997 . . . . 47.99 113.365 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -137.91 121.93 11.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.091 0.445 . . . . 46.26 110.787 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.487 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.6 Cg_endo -76.96 150.45 30.02 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.682 2.255 . . . . 44.8 112.254 177.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 17.0 Cg_exo -68.67 123.41 10.42 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.543 2.162 . . . . 44.02 111.982 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.29 152.76 47.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.243 -0.435 . . . . 42.5 111.32 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.41 144.25 51.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.303 -0.629 . . . . 41.5 109.303 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -86.75 149.74 24.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.99 0.424 . . . . 40.33 110.8 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.33 137.36 53.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.106 -0.497 . . . . 39.09 111.305 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -126.6 -60.85 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 38.82 109.034 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -127.44 90.28 49.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.593 -0.731 . . . . 38.16 109.59 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.61 -64.88 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.753 2.302 . . . . 36.7 112.675 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.58 159.5 13.89 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.806 -0.712 . . . . 35.61 112.114 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.8 -53.54 7.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 35.03 110.568 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tt -125.35 103.71 8.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.577 -0.527 . . . . 34.01 109.577 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.02 124.91 50.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.572 . . . . 32.89 110.093 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -127.79 142.51 51.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.974 0.416 . . . . 31.94 111.313 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -77.76 -33.72 52.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.657 -0.701 . . . . 31.24 110.82 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -93.81 158.9 15.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.207 -0.452 . . . . 31.24 110.349 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.94 173.54 12.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.109 0.48 . . . . 29.85 111.352 -177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.8 94.02 9.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 28.2 110.455 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.62 152.63 33.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.619 . . . . 26.78 109.33 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -104.27 -64.66 1.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.579 0.228 . . . . 27.47 110.848 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . 37.4 tt0 -173.11 -49.76 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.43 0.529 . . . . 24.41 112.43 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 11.2 Cg_exo -72.18 52.68 1.92 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.45 2.1 . . . . 21.63 112.989 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 45.9 mt-10 -71.45 126.75 91.71 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.781 -0.645 . . . . 20.67 110.603 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 14.2 Cg_exo -69.2 146.66 64.41 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.595 2.196 . . . . 18.02 111.831 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.37 131.87 74.02 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 14.93 110.726 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.78 129.34 32.23 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.98 2.453 . . . . 13.81 112.039 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.581 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -149.91 -51.96 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.614 0.598 . . . . 10.76 112.614 -175.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 3.3 Cg_exo -81.83 173.03 11.57 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.659 2.239 . . . . 9.77 112.456 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -101.09 113.95 65.8 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.664 . . . . 5.86 109.822 176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.664 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 32.2 Cg_endo -93.56 -0.89 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.299 2.666 . . . . 4.47 114.4 -173.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.0 28.34 12.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.894 0.378 . . . . 4.13 110.633 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 33' ' ' PRO . 33.0 mt-10 -101.24 95.47 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.319 0.581 . . . . 2.45 110.03 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.531 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -81.16 -156.4 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.827 -1.079 . . . . 0.53 110.932 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.1 tp -70.47 111.83 6.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.506 -0.77 . . . . 0.5 110.621 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.592 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 10.7 t70 -73.06 131.88 42.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.586 0.708 . . . . 2.51 110.678 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 5.5 mt -65.25 -34.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.612 -1.176 . . . . 0.46 111.137 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.44 -2.35 20.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.503 0.668 . . . . 0.72 109.71 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 38' ' ' ASP . . . 63.88 24.26 68.21 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 114.879 -1.055 . . . . 0.52 111.986 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -100.11 -30.36 11.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.436 0.532 . . . . 0.95 112.436 -177.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 116.38 -0.98 20.62 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.717 -0.754 . . . . 0.72 112.303 172.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.433 HD23 ' HD2' ' A' ' 119' ' ' LYS . 6.7 mp -100.98 -36.52 8.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.592 0.711 . . . . 1.56 111.085 -175.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 116' ' ' ALA . 12.0 tp -122.22 104.82 9.71 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.838 -1.074 . . . . 0.32 111.112 -169.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 35' ' ' GLU . 15.1 mtm180 -132.16 138.65 48.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 1.14 111.856 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -112.19 126.32 55.09 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.645 -0.252 . . . . 0.35 110.54 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 39.0 ttpt -113.3 115.56 28.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 1.07 110.885 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 p -74.17 103.11 4.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.214 -0.448 . . . . 0.33 111.025 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD12 HG22 ' A' ' 111' ' ' THR . 7.6 mt -68.92 -56.08 8.99 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.656 -1.609 . . . . 0.28 106.656 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 64.8 t -128.85 125.81 23.06 Favored Pre-proline 0 CA--C 1.499 -1.013 0 CA-C-N 113.125 -1.852 . . . . 0.36 106.62 168.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 45.9 Cg_endo -105.02 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.949 2.433 . . . . 0.54 113.413 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 54' ' ' PRO . . . 71.32 149.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.55 113.328 177.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 27.2 Cg_exo -65.19 151.71 84.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.572 2.181 . . . . 1.42 110.591 169.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -51.97 109.58 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.352 2.035 . . . . 2.04 111.967 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 33.42 2.98 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.664 -0.698 . . . . 0.98 112.765 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m -85.18 178.74 7.41 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.177 0.513 . . . . 0.99 110.84 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.616 ' H ' HG12 ' A' ' 108' ' ' VAL . 23.7 m -135.62 127.17 28.8 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.004 -0.739 . . . . 1.28 109.004 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 4.0 ptt-85 -91.07 108.77 30.65 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-O 120.906 0.384 . . . . 2.81 109.991 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.2 Cg_endo -51.07 159.3 2.69 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.155 3.237 . . . . 0.3 114.571 -172.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.7 t -98.17 156.22 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.097 -0.956 . . . . 0.88 109.703 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.992 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 72.0 mttt -73.72 121.43 20.77 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.603 0.716 . . . . 1.17 109.632 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' CA ' ' HG2' ' A' ' 151' ' ' GLU . . . 127.71 -18.76 5.95 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.049 -1.221 . . . . 0.42 110.049 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.44 141.05 28.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.445 -0.946 . . . . 0.59 108.445 173.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG13 HD21 ' A' ' 150' ' ' LEU . 26.8 m -87.63 128.56 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.456 -0.898 . . . . 1.22 108.658 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 35.9 m -123.1 145.8 29.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.804 -1.089 . . . . 0.25 110.852 -173.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 66.9 p -89.84 115.81 27.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.013 0.435 . . . . 0.29 110.117 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 99' ' ' LEU . 18.1 m -109.36 144.06 18.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.597 -0.841 . . . . 0.19 109.283 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.693 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 2.0 t-160 -103.96 118.98 37.95 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.463 -1.68 . . . . 0.19 106.463 169.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 141' ' ' GLU . 0.8 OUTLIER -122.08 133.73 54.77 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 118.847 -1.141 . . . . 0.39 111.026 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.573 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -127.75 113.57 16.16 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.419 -2.067 . . . . 0.27 105.419 167.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.594 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 84.8 m -104.81 126.48 51.92 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.477 -1.238 . . . . 0.19 111.43 -166.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -107.24 147.71 29.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.147 -0.933 . . . . 1.06 109.511 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -72.71 165.79 24.09 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.732 -0.667 . . . . 0.84 110.013 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -55.89 -22.79 27.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 1.14 110.5 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -83.03 -8.33 59.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.242 -0.89 . . . . 2.14 110.884 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.38 60.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.959 -0.639 . . . . 0.51 112.089 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.5 m -81.33 110.14 16.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.72 0.295 . . . . 0.46 111.397 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 22.6 mtt180 -74.37 121.46 21.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.834 0.826 . . . . 0.47 110.82 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.752 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 27.7 m -105.22 -9.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.359 -1.291 . . . . 0.27 111.984 -169.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.594 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.4 pt20 -159.94 132.41 6.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.184 -0.462 . . . . 0.59 110.628 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 45.5 tt0 -127.78 109.52 11.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.484 . . . . 1.34 109.828 171.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -125.45 109.1 26.39 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.576 -0.738 . . . . 2.59 109.892 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.615 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 72.7 Cg_endo -68.19 -17.96 45.17 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.778 2.985 . . . . 0.5 113.454 -172.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.34 111.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.167 0.984 . . . . 1.37 111.04 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.9 tp -128.56 97.88 4.84 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.347 -1.751 . . . . 0.38 109.043 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.6 p -89.73 130.96 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.115 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.0 p90 -151.83 158.15 42.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.23 110.664 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.2 m -76.2 110.93 11.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.42 110.283 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.992 ' HG ' ' HG2' ' A' ' 62' ' ' LYS . 14.1 tp -58.18 128.58 37.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.955 -0.566 . . . . 0.6 110.382 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.638 ' CA ' ' HD3' ' A' ' 62' ' ' LYS . . . 84.68 7.92 83.61 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.716 -0.754 . . . . 0.37 112.419 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.6 6.0 23.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.577 -0.527 . . . . 0.93 109.577 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.52 32.98 20.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.136 -0.938 . . . . 0.62 110.385 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 26.0 t0 -75.49 -4.21 38.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.341 1.067 . . . . 1.33 109.335 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 10.2 m -135.24 -155.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.037 -1.438 . . . . 0.23 110.602 -175.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 34.4 pt -83.56 135.75 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 107.296 -1.372 . . . . 0.29 107.296 173.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.529 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 6.6 tp60 -59.22 -31.19 68.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.472 -0.331 . . . . 0.4 111.382 -171.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.87 74.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.23 0.538 . . . . 0.2 110.354 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 68' ' ' VAL . 58.6 tp -73.64 -41.41 62.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 0.22 110.496 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.528 ' HB3' HE21 ' A' ' 97' ' ' GLN . 12.7 t70 -61.95 -27.74 69.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.963 -1.017 . . . . 0.26 110.098 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 97' ' ' GLN . 64.8 mt -90.13 -36.41 14.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.194 -0.912 . . . . 0.25 111.91 176.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 t -63.01 -37.58 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 1.01 111.107 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.549 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 64.0 t -60.51 -55.79 41.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.0 0.741 . . . . 0.21 113.0 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.792 ' HD3' HD11 ' A' ' 90' ' ' LEU . 18.1 Cg_endo -61.69 -25.06 78.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.092 1.862 . . . . 0.27 111.849 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.0 mt -80.06 -11.89 59.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.64 111.593 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.664 ' HG3' ' HG2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -109.2 153.81 23.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.307 -0.406 . . . . 0.78 111.23 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.43 158.59 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 0.97 110.593 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 58' ' ' SER . 1.5 p -66.16 128.67 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.84 0.829 . . . . 0.8 110.378 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.4 4.62 59.49 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.909 -1.041 . . . . 0.28 112.15 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.821 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -98.06 165.12 12.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.383 0.611 . . . . 0.41 111.534 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.481 HG22 HD12 ' A' ' 50' ' ' LEU . 54.6 m -130.76 117.95 20.15 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.739 -1.119 . . . . 0.22 108.263 175.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.62 140.24 50.91 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.889 -0.596 . . . . 0.18 110.618 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.9 ttm -98.91 117.46 33.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.181 -1.415 . . . . 1.32 107.181 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.46 128.78 74.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.66 -0.496 . . . . 0.18 109.66 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.53 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 52.9 m -109.29 113.85 27.03 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 119.77 -0.772 . . . . 0.21 109.163 174.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -122.47 139.91 53.34 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.892 -1.504 . . . . 0.15 110.05 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 9.8 t70 -52.29 146.48 9.25 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.711 -0.848 . . . . 0.58 108.711 171.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.588 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 3.2 t -55.18 -26.98 42.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 0.82 110.171 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.3 ptpt -55.3 -32.26 62.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.554 -0.294 . . . . 0.81 111.426 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.554 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 90.7 m-85 -95.3 6.17 49.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.171 0.51 . . . . 0.42 110.196 176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 62.8 m -124.74 -90.82 0.55 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.831 -1.077 . . . . 0.18 110.489 -176.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.557 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 7.2 m-85 -143.75 37.72 1.33 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.978 0.353 . . . . 0.24 111.831 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -49.11 -78.51 0.09 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.471 -0.395 . . . . 0.25 113.83 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.48 8.68 4.45 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.15 1.9 . . . . 0.58 111.015 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -103.9 -50.12 3.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.435 -0.802 . . . . 0.65 110.135 -172.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . 80.28 143.53 3.27 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.571 -1.195 . . . . 0.3 111.753 -170.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 12.1 t -89.82 158.4 17.5 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.505 -0.348 . . . . 0.33 111.281 -177.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -58.81 -37.31 76.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.632 -0.713 . . . . 3.17 111.738 -170.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.937 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 7.0 m -91.44 -60.71 0.21 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 109.598 -0.519 . . . . 1.23 109.598 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.937 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 18.3 Cg_endo -107.41 126.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.808 2.339 . . . . 0.37 112.307 170.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CD1' ' HA3' ' A' ' 126' ' ' GLY . 64.6 t80 -57.61 97.5 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.361 -0.977 . . . . 1.14 108.361 164.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.592 HG12 ' CB ' ' A' ' 127' ' ' SER . 25.6 mm -66.43 128.36 93.81 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.441 -0.8 . . . . 0.39 109.522 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.7 Cg_exo -53.44 140.57 63.63 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.536 2.157 . . . . 0.61 112.286 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 33.9 Cg_exo -57.97 134.81 64.74 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.254 1.969 . . . . 0.52 112.079 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.435 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 18.6 m80 70.42 5.18 5.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.0 -1.0 . . . . 2.38 112.661 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -68.88 122.34 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.307 -0.627 . . . . 0.26 109.307 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.73 111.81 9.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.303 0.573 . . . . 0.22 109.583 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.66 131.32 36.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.834 -0.621 . . . . 0.22 111.063 -175.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.7 t -117.44 101.61 8.53 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.844 0.831 . . . . 1.2 109.55 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.534 ' HB3' HG23 ' A' ' 72' ' ' THR . 0.9 OUTLIER -114.05 136.6 52.74 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.84 -1.073 . . . . 0.32 111.702 -171.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.573 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 55.0 tt0 -101.28 117.11 34.32 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.082 -0.71 . . . . 1.05 109.082 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.777 HG11 HD13 ' A' ' 99' ' ' LEU . 5.5 m -116.15 121.95 68.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.367 0.603 . . . . 0.19 112.31 -175.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 5.9 m -96.71 114.47 26.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.28 111.281 173.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.65 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 52.0 tp -84.5 102.18 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.626 -0.879 . . . . 0.15 108.626 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HE3' ' O ' ' A' ' 84' ' ' PRO . 19.2 mtmm -105.06 -20.23 13.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.79 -0.641 . . . . 1.08 111.019 -169.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.401 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.7 m -156.51 148.73 23.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.767 -0.651 . . . . 0.37 110.599 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.518 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -145.61 128.47 16.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.761 -0.829 . . . . 0.25 108.761 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 20.6 m -134.35 133.77 55.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.86 -0.736 . . . . 0.92 111.715 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.517 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.9 p-10 -80.4 123.4 28.0 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.022 -0.99 . . . . 2.27 110.807 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 65' ' ' VAL . 1.5 pt? -153.11 13.14 0.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.319 -0.4 . . . . 1.97 110.986 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.459 ' HG2' ' CA ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -54.05 -72.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.624 0.577 . . . . 2.14 110.918 -172.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -122.06 101.23 7.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 5.79 112.188 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.475 ' H ' ' CD2' ' A' ' 153' ' ' HIS . 4.0 p80 -54.81 121.15 7.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.022 -0.99 . . . . 7.48 110.173 170.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -76.78 55.72 1.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.591 0.589 . . . . 8.46 112.591 -172.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 56.72 30.13 17.07 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.691 0.396 . . . . 8.83 111.508 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -134.73 156.33 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.975 0.417 . . . . 12.17 110.789 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m80 . . . . . 0 C--O 1.245 0.827 0 CA-C-N 115.508 -0.769 . . . . 13.46 109.466 173.576 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 mmt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.155 -0.683 . . . . 50.23 109.155 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.72 28.11 1.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.392 -0.908 . . . . 47.99 112.777 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 18.7 mm-40 -97.94 142.99 25.45 Favored Pre-proline 0 C--N 1.321 -0.645 0 O-C-N 122.748 -0.266 . . . . 46.26 110.336 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.631 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 64.4 Cg_exo -50.93 -48.09 22.51 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.726 2.284 . . . . 44.8 112.682 174.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 2.9 Cg_endo -82.94 122.33 3.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.825 1.683 . . . . 44.02 110.928 169.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.27 -21.66 15.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.873 0.368 . . . . 42.5 110.928 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 9' ' ' ALA . 10.6 tp10 -157.48 139.17 14.01 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 41.5 109.628 -177.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.44 -40.77 18.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.677 -0.49 . . . . 40.33 109.677 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HB2' ' HG3' ' A' ' 7' ' ' GLU . . . 51.66 39.85 26.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.37 -0.832 . . . . 39.09 112.156 174.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -88.84 -76.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.427 -0.352 . . . . 38.82 110.904 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 55.18 81.86 0.25 Allowed Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.658 -0.701 . . . . 38.16 110.08 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.06 -176.51 3.28 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.08 2.52 . . . . 36.7 113.643 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.08 -12.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.877 -0.677 . . . . 35.61 112.464 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.98 -84.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.361 0.664 . . . . 35.03 111.57 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -170.65 -70.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.307 . . . . 34.01 110.611 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 177.59 -60.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.618 0.723 . . . . 32.89 109.528 -174.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -120.96 -11.68 8.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.224 -0.898 . . . . 31.94 110.379 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 62.41 -84.68 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.865 0.728 . . . . 31.24 111.167 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -146.02 144.88 30.36 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.863 -0.421 . . . . 31.24 109.863 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.827 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.4 pt? -99.25 10.13 42.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 29.85 111.992 -172.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.79 87.3 6.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 28.2 110.39 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 -12.59 21.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.797 -0.638 . . . . 26.78 110.452 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 52.3 mtt -90.44 0.32 57.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 27.47 110.717 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -114.23 96.96 44.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.484 -0.561 . . . . 24.41 109.484 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -91.34 112.62 0.36 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.958 2.439 . . . . 21.63 113.018 -176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -100.26 150.02 36.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.723 -0.473 . . . . 20.67 109.723 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.53 126.82 22.48 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.595 2.196 . . . . 18.02 111.715 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.17 132.65 93.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 14.93 110.994 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.67 143.18 70.52 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.215 2.61 . . . . 13.81 113.319 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.08 65.16 18.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 10.76 110.355 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.8 166.26 19.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.775 2.317 . . . . 9.77 112.582 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.702 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . . . -111.13 142.71 26.89 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.293 -0.412 . . . . 5.86 110.552 176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 32' ' ' ALA . 22.4 Cg_exo -66.78 -24.0 47.6 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.215 2.61 . . . . 4.47 113.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -144.7 105.96 4.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.084 -0.71 . . . . 4.13 109.084 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.702 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 24.2 mt-10 -105.89 113.99 27.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.745 -0.661 . . . . 2.45 109.738 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.695 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -68.13 -166.85 0.07 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.066 -0.97 . . . . 0.53 112.422 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.7 tp -69.09 111.93 5.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.026 -0.988 . . . . 0.5 111.037 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.725 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -64.51 101.53 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.084 -0.962 . . . . 2.51 110.599 173.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.609 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 17.9 mt -54.07 -44.08 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.141 -0.936 . . . . 0.46 112.009 -174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.484 HD21 HD13 ' A' ' 101' ' ' LEU . 86.5 mt -109.84 12.64 23.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.72 110.525 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.725 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 70.66 0.12 30.49 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.52 113.02 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.597 ' H ' HD22 ' A' ' 42' ' ' ASN . 0.1 OUTLIER -81.06 -30.26 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.765 0.283 . . . . 0.95 111.765 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.19 63.69 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.72 112.311 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 2.3 mm? -79.04 -31.54 44.6 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.886 0.851 . . . . 1.56 109.06 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 39' ' ' ILE . 13.9 tp -119.31 114.01 21.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.087 -1.415 . . . . 0.32 110.13 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 mtm180 -140.51 140.8 35.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.675 -0.239 . . . . 1.14 111.37 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' HD11 ' A' ' 39' ' ' ILE . 11.1 ttpt -108.45 125.59 51.95 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.393 0.433 . . . . 0.35 110.462 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.695 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 36.1 ttpt -107.63 113.67 27.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.164 -0.309 . . . . 1.07 110.164 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 p -76.47 99.34 4.87 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.425 -0.352 . . . . 0.33 110.931 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD21 ' HE3' ' A' ' 48' ' ' LYS . 15.5 mt -63.84 -50.67 67.96 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.926 -1.509 . . . . 0.28 106.926 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.871 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 82.0 t -139.38 133.73 16.11 Favored Pre-proline 0 CA--C 1.502 -0.869 0 CA-C-N 113.303 -1.771 . . . . 0.36 106.389 169.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 42.7 Cg_endo -107.63 64.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.749 2.299 . . . . 0.54 113.446 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.89 142.13 1.77 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.53 -0.759 . . . . 0.55 112.504 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.48 145.94 96.52 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.943 1.762 . . . . 1.42 109.63 168.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -46.88 99.09 0.03 OUTLIER 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.686 2.257 . . . . 2.04 112.351 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.4 60.64 0.6 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.669 -0.696 . . . . 0.98 112.491 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m -116.57 -172.35 2.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.872 -0.788 . . . . 0.99 108.872 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 108' ' ' VAL . 17.9 t -128.22 -177.32 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.256 -1.016 . . . . 1.28 108.256 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 14.1 mtm180 -130.91 120.55 18.48 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.562 -0.533 . . . . 2.81 109.562 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 9.4 Cg_endo -51.15 138.08 45.06 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.247 2.631 . . . . 0.3 113.306 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.666 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 21.8 t -90.1 154.93 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.597 -0.729 . . . . 0.88 109.196 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.649 ' HD3' ' HA3' ' A' ' 91' ' ' GLY . 59.1 mttt -66.64 108.55 2.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.452 0.644 . . . . 1.17 111.037 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 140.44 -28.37 2.45 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.429 -1.259 . . . . 0.42 110.287 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -76.27 138.71 40.73 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.855 -0.795 . . . . 0.59 108.855 177.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 3.6 m -88.54 129.29 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.008 -1.108 . . . . 1.22 108.008 172.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.7 m -125.79 147.86 30.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.43 -0.804 . . . . 0.25 110.965 -171.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.509 ' OG1' ' HB ' ' A' ' 146' ' ' THR . 26.6 p -96.32 113.37 24.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.979 -0.555 . . . . 0.29 109.967 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.548 HG21 HD21 ' A' ' 99' ' ' LEU . 23.9 m -110.47 143.97 19.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.27 0.557 . . . . 0.19 110.336 174.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -102.58 112.1 24.7 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.106 -1.442 . . . . 0.19 107.106 169.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 83' ' ' GLU . 1.7 pt? -116.06 136.59 52.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.93 0.872 . . . . 0.39 110.808 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.21 116.58 14.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 105.702 -1.962 . . . . 0.27 105.702 169.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.602 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 62.6 m -109.28 123.67 49.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.876 -1.056 . . . . 0.19 111.418 -165.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.773 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -104.62 149.49 25.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.429 -0.805 . . . . 1.06 109.276 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.543 ' HG ' HG13 ' A' ' 80' ' ' VAL . 8.0 mt -77.53 166.83 22.57 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.749 -0.659 . . . . 0.84 110.804 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -54.35 -23.89 17.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.493 0.663 . . . . 1.14 110.4 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -82.55 -11.3 58.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.352 -0.84 . . . . 2.14 110.76 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.43 59.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.142 -0.551 . . . . 0.51 111.86 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 m -75.12 110.63 9.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.991 0.367 . . . . 0.46 111.991 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.773 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.5 mtt180 -73.1 117.57 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.47 110.804 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.686 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 26.7 m -98.96 -10.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.936 -1.029 . . . . 0.27 112.081 -171.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.602 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 12.6 pt20 -159.99 141.25 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.677 -0.692 . . . . 0.59 109.31 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' HG3' ' CG ' ' A' ' 71' ' ' GLN . 14.4 tt0 -145.56 103.89 3.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.367 0.603 . . . . 1.34 109.657 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.623 ' HB2' HD23 ' A' ' 70' ' ' LEU . 4.1 mm-40 -118.56 115.16 35.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.203 -0.908 . . . . 2.59 109.887 -173.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' HA ' ' ND1' ' A' ' 69' ' ' HIS . 47.1 Cg_endo -69.06 -14.51 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.377 2.051 . . . . 0.5 113.044 -176.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -166.98 114.86 0.82 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.861 0.839 . . . . 1.37 111.817 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.4 tp -123.97 112.18 16.89 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.604 -1.634 . . . . 0.38 108.802 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 12.4 p -103.23 128.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.6 -0.518 . . . . 1.0 109.6 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.785 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 47.2 p90 -148.75 159.83 43.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 0.23 111.698 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 92' ' ' ASP . 1.7 m -78.45 109.07 12.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.839 . . . . 0.42 110.546 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.816 HD11 ' HD3' ' A' ' 104' ' ' PRO . 15.4 tp -61.56 127.9 33.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.474 -0.33 . . . . 0.6 110.661 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.649 ' HA3' ' HD3' ' A' ' 62' ' ' LYS . . . 83.91 11.72 78.55 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.835 -0.698 . . . . 0.37 112.689 175.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 34.3 t70 -115.44 10.0 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.331 0.586 . . . . 0.93 109.605 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 54.5 m 54.39 39.15 30.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.62 109.438 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.785 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 7.9 t0 -70.63 -12.78 61.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.092 -1.077 . . . . 1.33 108.092 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' A' ' 96' ' ' ILE . 11.0 m -137.61 -159.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 113.758 -1.565 . . . . 0.23 110.578 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 32.7 pt -79.23 140.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.709 -1.219 . . . . 0.29 107.709 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.502 HE21 ' HB3' ' A' ' 100' ' ' ASP . 5.2 tp60 -59.66 -31.2 69.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.407 -0.361 . . . . 0.4 110.987 -173.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.96 -43.0 69.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.237 0.542 . . . . 0.2 110.422 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 142' ' ' VAL . 50.4 tp -78.01 -41.38 36.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.459 -0.791 . . . . 0.22 110.897 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' HB3' HE21 ' A' ' 97' ' ' GLN . 11.1 t70 -60.28 -29.67 68.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.328 -0.851 . . . . 0.26 110.123 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.484 HD13 HD21 ' A' ' 40' ' ' LEU . 73.3 mt -90.03 -33.3 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.414 -0.812 . . . . 0.25 111.92 176.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 106' ' ' MET . 40.0 t -66.28 -34.2 77.46 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.718 0.294 . . . . 1.01 110.888 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.609 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 54.3 t -64.0 -55.61 31.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.813 0.671 . . . . 0.21 112.813 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.816 ' HD3' HD11 ' A' ' 90' ' ' LEU . 17.8 Cg_endo -62.5 -22.39 73.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.91 1.74 . . . . 0.27 112.049 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 39' ' ' ILE . 11.5 mt -79.56 -16.89 55.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.64 111.275 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.574 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.8 ptm -104.43 157.24 17.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.095 -0.502 . . . . 0.78 111.315 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.5 m-20 -94.54 155.1 17.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.982 0.42 . . . . 0.97 111.17 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 58' ' ' SER . 40.0 t -60.89 125.16 16.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.581 0.705 . . . . 0.8 110.394 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.47 14.74 56.65 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 115.172 -0.922 . . . . 0.28 112.453 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.871 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 4.4 pt-20 -101.42 168.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.339 0.59 . . . . 0.41 111.433 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.442 HG22 HD12 ' A' ' 50' ' ' LEU . 9.4 m -130.59 117.24 19.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.066 -1.087 . . . . 0.22 108.066 173.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HB2' ' OE2' ' A' ' 110' ' ' GLU . . . -121.43 136.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.052 0.453 . . . . 0.18 110.653 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 ttm -99.49 116.86 32.61 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.528 -1.286 . . . . 1.32 107.528 173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.416 HG22 ' HG3' ' A' ' 47' ' ' LYS . 3.4 t -113.81 127.67 71.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.945 -0.761 . . . . 0.18 108.945 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.582 ' H ' ' HZ3' ' A' ' 36' ' ' TRP . 38.6 m -107.14 114.19 28.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.345 -0.942 . . . . 0.21 108.94 175.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 45' ' ' LEU . . . -122.14 136.43 54.91 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.749 -1.568 . . . . 0.15 109.93 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.715 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.3 t70 -53.33 149.33 7.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.792 -0.818 . . . . 0.58 108.792 172.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.63 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.8 t -55.0 -27.24 42.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.258 0.551 . . . . 0.82 110.549 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.715 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.9 ptpt -54.15 -35.95 62.8 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.293 -0.412 . . . . 0.81 111.515 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.553 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 99.2 m-85 -95.77 3.48 53.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.42 110.304 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.761 ' HB3' HD22 ' A' ' 138' ' ' LEU . 68.2 m -119.45 -91.03 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.033 -0.985 . . . . 0.18 110.572 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.685 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 7.6 m-85 -145.57 40.69 1.2 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.255 0.465 . . . . 0.24 112.255 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.5 -84.41 0.03 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-N 118.341 0.518 . . . . 0.25 113.647 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -81.84 11.12 3.22 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.364 2.043 . . . . 0.58 110.696 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.685 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 38.7 mt-30 -104.24 -50.19 3.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.203 -0.908 . . . . 0.65 110.125 -174.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.627 ' HA3' ' CD2' ' A' ' 131' ' ' TYR . . . 81.03 141.6 3.09 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.731 -1.122 . . . . 0.3 112.613 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' PRO . 14.0 t -92.28 165.38 13.13 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.232 -0.484 . . . . 0.33 111.373 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.709 ' HE ' ' HA ' ' A' ' 128' ' ' ARG . 2.6 mmp_? -54.79 -60.7 3.0 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.59 -0.732 . . . . 3.17 112.197 -176.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.843 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . 17.5 t -76.57 -58.06 1.19 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 116.142 -0.481 . . . . 1.23 109.871 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 129' ' ' SER . 20.4 Cg_endo -108.73 126.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.521 2.147 . . . . 0.37 112.25 171.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.627 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 44.9 t80 -57.0 99.37 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.59 -1.263 . . . . 1.14 107.59 163.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.606 HG12 ' CB ' ' A' ' 127' ' ' SER . 29.2 mm -65.61 128.54 93.88 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.39 110.188 -177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 50.0 Cg_exo -54.29 141.63 70.58 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.724 2.283 . . . . 0.61 112.051 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 Cg_exo -57.67 130.55 39.28 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.332 2.021 . . . . 0.52 112.068 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.552 ' H ' ' HB3' ' A' ' 118' ' ' SER . 13.6 m-70 74.1 7.79 4.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.831 -1.077 . . . . 2.38 113.105 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.48 ' N ' ' HB2' ' A' ' 118' ' ' SER . . . -68.9 120.59 15.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.503 -0.554 . . . . 0.26 109.503 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.32 113.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.171 0.51 . . . . 0.22 109.809 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.761 HD22 ' HB3' ' A' ' 121' ' ' CYS . 2.2 mp -90.87 129.81 36.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.847 -0.615 . . . . 0.22 111.009 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.47 ' SG ' HG23 ' A' ' 115' ' ' THR . 35.2 m -112.55 98.91 7.56 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.586 -0.894 . . . . 1.2 108.586 174.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -108.46 134.96 50.52 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.793 -0.639 . . . . 0.32 111.595 -174.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.575 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 43.2 tt0 -102.73 116.26 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.146 -0.687 . . . . 1.05 109.146 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.622 HG11 HD13 ' A' ' 99' ' ' LEU . 3.9 m -115.69 119.35 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.561 0.696 . . . . 0.19 112.758 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 3.7 m -90.32 110.48 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.28 110.271 171.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.574 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 61.7 tp -82.82 97.85 8.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.651 -0.87 . . . . 0.15 108.651 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 29.2 mtmt -94.57 -29.11 15.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 1.08 110.597 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.509 ' HB ' ' OG1' ' A' ' 67' ' ' THR . 17.9 m -153.53 149.31 27.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.466 -0.334 . . . . 0.37 111.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.496 ' CB ' HG12 ' A' ' 66' ' ' VAL . . . -140.12 127.99 21.98 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.27 -0.641 . . . . 0.25 109.27 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.12 140.35 49.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.44 0.638 . . . . 0.92 111.357 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.544 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 6.5 t70 -90.43 121.12 32.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 2.27 110.076 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 15.7 mt -153.65 15.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.052 -0.522 . . . . 1.97 110.765 -171.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.594 ' HG3' ' CD2' ' A' ' 152' ' ' HIS . 6.5 tp10 -97.13 -84.02 0.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 2.14 110.43 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.594 ' CD2' ' HG3' ' A' ' 151' ' ' GLU . 34.5 p80 -150.28 139.95 21.67 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.236 -0.586 . . . . 5.79 111.615 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -118.77 12.23 12.92 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.491 0.663 . . . . 7.48 109.243 169.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.87 127.15 33.63 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.864 -1.062 . . . . 8.46 109.061 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 64.23 -176.9 0.16 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.851 0.719 . . . . 8.83 111.682 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -115.22 11.73 16.31 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.44 -0.578 . . . . 12.17 109.44 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.402 -0.809 . . . . 13.46 109.53 -174.648 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.758 0.314 . . . . 50.23 110.821 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.93 134.59 6.86 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.733 -0.746 . . . . 47.99 112.123 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -111.22 158.78 35.08 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.405 -0.22 . . . . 46.26 110.405 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 29.4 Cg_endo -65.57 134.18 37.26 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.182 1.921 . . . . 44.8 110.809 169.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 33.5 Cg_exo -61.35 142.77 96.91 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.82 2.347 . . . . 44.02 112.771 -176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 73.14 -77.29 0.06 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.08 -0.963 . . . . 42.5 112.554 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.58 162.4 41.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.818 0.342 . . . . 41.5 111.426 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 9' ' ' ALA . 3.7 pt-20 -127.16 -31.57 2.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 40.33 110.711 173.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' A' ' 8' ' ' GLU . . . -166.21 105.35 0.66 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.889 0.376 . . . . 39.09 111.958 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -175.03 146.57 0.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.62 -0.882 . . . . 38.82 108.62 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 61.06 75.1 0.47 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.329 -0.619 . . . . 38.16 109.329 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.61 -18.98 58.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.19 2.593 . . . . 36.7 112.826 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.43 73.22 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.445 -0.883 . . . . 35.61 111.961 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.65 -21.53 66.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.259 . . . . 35.03 111.03 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt 66.82 -172.62 0.19 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.629 -0.714 . . . . 34.01 111.418 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.81 -81.04 0.06 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 32.89 109.748 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -103.08 -2.29 27.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.089 -0.505 . . . . 31.94 110.595 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 55.58 89.8 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.385 0.612 . . . . 31.24 110.84 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 10.13 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.285 -0.416 . . . . 31.24 111.971 -173.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp -144.8 17.2 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.719 0.295 . . . . 29.85 111.772 -177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.02 113.84 20.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.735 -0.211 . . . . 28.2 110.811 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.69 -179.78 0.23 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.041 0.838 . . . . 26.78 111.54 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.2 13.88 4.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 27.47 110.338 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 56.64 91.54 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 124.067 0.854 . . . . 24.41 110.95 -172.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.83 149.93 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.889 2.392 . . . . 21.63 112.456 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 24.1 mm-40 -62.91 132.94 95.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.856 -0.611 . . . . 20.67 110.066 175.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' GLU . 16.5 Cg_exo -68.08 131.89 24.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.571 2.181 . . . . 18.02 111.361 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 144.85 84.88 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 110.294 -0.262 . . . . 14.93 110.294 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 140.82 22.37 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 13.81 113.908 -174.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -97.67 -44.53 0.24 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.45 -0.795 . . . . 10.76 111.876 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 45.1 Cg_exo -57.96 128.22 28.07 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.821 1.681 . . . . 9.77 112.19 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . . . -111.01 112.48 55.52 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.272 -0.422 . . . . 5.86 110.481 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 32' ' ' ALA . 18.8 Cg_endo -61.22 -36.95 77.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.606 2.204 . . . . 4.47 112.035 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -168.83 110.4 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.392 -0.822 . . . . 4.13 109.093 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 2.3 pm0 -87.27 114.01 23.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.827 0.823 . . . . 2.45 111.592 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.631 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 0.9 OUTLIER -96.87 -163.52 1.06 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 0.53 109.087 173.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.44 109.99 7.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.894 0.378 . . . . 0.5 110.674 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.644 ' OD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 p-10 -64.9 96.77 0.2 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.652 -0.704 . . . . 2.51 111.499 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.732 ' HB ' ' HG ' ' A' ' 45' ' ' LEU . 15.1 mt -51.81 -53.08 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.46 110.38 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.885 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -78.71 -16.98 56.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.15 -1.386 . . . . 0.72 110.163 -176.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.644 ' HA2' ' OD2' ' A' ' 38' ' ' ASP . . . 72.37 8.34 70.48 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.404 -0.816 . . . . 0.52 111.674 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.515 ' ND2' ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -106.41 -9.14 16.84 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.568 0.223 . . . . 0.95 111.51 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.85 -22.38 28.76 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.346 -0.931 . . . . 0.72 113.238 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 4.2 mm? -80.09 -22.51 42.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.577 0.704 . . . . 1.56 109.235 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.885 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 26.3 tp -120.51 110.39 16.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.601 -1.181 . . . . 0.32 110.679 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.643 ' HG2' ' HA ' ' A' ' 38' ' ' ASP . 42.8 mtm105 -143.75 140.41 29.93 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 123.223 0.327 . . . . 1.14 111.544 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.754 ' HG3' HG22 ' A' ' 114' ' ' VAL . 7.3 ttpp -116.95 127.8 54.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.16 0.184 . . . . 0.35 110.553 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.631 ' HB2' ' CD2' ' A' ' 36' ' ' TRP . 35.9 ttpt -103.67 130.37 51.14 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.804 0.335 . . . . 1.07 110.986 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 52' ' ' PRO . 1.5 p -80.49 94.67 6.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.847 -0.615 . . . . 0.33 110.381 173.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 111' ' ' THR . 12.5 mt -63.78 -52.77 58.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.014 -1.476 . . . . 0.28 107.014 173.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.795 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 73.6 t -134.63 124.61 17.02 Favored Pre-proline 0 CA--C 1.494 -1.195 0 CA-C-N 113.362 -1.745 . . . . 0.36 106.599 168.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 68.3 Cg_endo -105.6 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 122.623 2.215 . . . . 0.54 113.593 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.533 ' HA3' ' OD2' ' A' ' 107' ' ' ASP . . . 60.71 173.93 1.05 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.201 -0.909 . . . . 0.55 114.207 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 57' ' ' SER . 71.9 Cg_endo -77.82 178.98 6.95 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.52 2.147 . . . . 1.42 109.475 164.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 54' ' ' PRO . 50.9 Cg_endo -71.22 36.52 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.922 1.748 . . . . 2.04 112.656 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 54' ' ' PRO . . . 177.4 53.35 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.275 -0.421 . . . . 0.98 112.073 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.83 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -95.66 -174.78 3.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.236 0.541 . . . . 0.99 111.639 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.25 -0.886 . . . . 1.28 108.791 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -91.06 119.14 68.89 Favored Pre-proline 0 C--N 1.319 -0.732 0 C-N-CA 120.792 -0.363 . . . . 2.81 110.59 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD3' HG23 ' A' ' 108' ' ' VAL . 11.3 Cg_endo -53.16 149.43 28.07 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.603 2.869 . . . . 0.3 113.318 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 14.6 t -100.02 151.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.974 -0.557 . . . . 0.88 109.737 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 90' ' ' LEU . 59.7 mttt -61.72 112.83 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.652 0.739 . . . . 1.17 110.875 177.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 151' ' ' GLU . . . 134.76 -30.0 2.91 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 114.165 -1.38 . . . . 0.42 110.186 -174.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.698 ' HA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -72.39 139.17 47.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.158 -0.617 . . . . 0.59 110.202 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.512 ' O ' HG22 ' A' ' 148' ' ' VAL . 40.9 t -80.81 117.14 26.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.503 -0.925 . . . . 1.22 108.503 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 30.6 m -125.47 150.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.782 0.66 . . . . 0.25 112.782 -170.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 145' ' ' LYS . 0.8 OUTLIER -98.43 121.8 40.81 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.696 -1.138 . . . . 0.29 110.41 174.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 99' ' ' LEU . 30.1 m -118.33 147.73 21.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.341 -0.543 . . . . 0.19 110.106 168.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.733 ' O ' ' HA ' ' A' ' 142' ' ' VAL . 1.9 t-160 -103.04 117.34 34.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 106.752 -1.573 . . . . 0.19 106.752 167.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -118.33 138.63 52.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.204 -0.999 . . . . 0.39 111.004 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.694 ' NE2' ' HB3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -135.77 113.91 11.39 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.194 -2.15 . . . . 0.27 105.194 165.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.618 ' HB ' ' HG2' ' A' ' 81' ' ' GLN . 72.0 m -102.73 127.3 49.93 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.738 -1.119 . . . . 0.19 111.076 -167.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.706 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 t -109.04 159.44 16.84 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.396 -0.82 . . . . 1.06 109.358 -177.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -84.74 164.53 18.49 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.694 -0.684 . . . . 0.84 109.303 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -52.19 -24.12 6.62 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.518 0.675 . . . . 1.14 110.58 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -94.46 -7.33 41.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.062 -0.972 . . . . 2.14 111.98 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.48 -8.72 37.86 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.83 -0.7 . . . . 0.51 113.981 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.3 m -75.55 110.69 10.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.448 0.624 . . . . 0.46 111.718 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 17.8 mtt180 -77.68 110.64 12.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.947 0.88 . . . . 0.47 110.298 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.522 ' HB ' ' HG2' ' A' ' 130' ' ' PRO . 34.2 m -91.36 -12.61 9.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.069 -1.423 . . . . 0.27 111.936 -169.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.618 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 9.2 pt20 -158.6 124.4 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.344 -0.389 . . . . 0.59 110.746 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.53 124.53 48.93 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.315 -0.624 . . . . 1.34 109.315 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 8.6 tt0 -144.61 107.28 4.7 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-O 121.879 0.847 . . . . 2.59 110.506 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 69' ' ' HIS . 53.1 Cg_endo -68.94 -19.2 40.43 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 123.35 2.7 . . . . 0.5 113.871 -171.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -158.74 99.76 1.57 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 122.0 0.905 . . . . 1.37 111.016 -174.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 37.4 tp -113.04 116.02 29.27 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.31 -1.768 . . . . 0.38 108.808 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 11.0 p -112.64 133.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 103' ' ' VAL . 24.3 p90 -154.86 164.74 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.884 0.373 . . . . 0.23 110.821 -172.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.402 ' HB ' ' CB ' ' A' ' 92' ' ' ASP . 2.7 m -83.38 112.46 19.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.634 -0.712 . . . . 0.42 109.495 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.974 HD11 ' HD3' ' A' ' 104' ' ' PRO . 14.2 tp -59.53 126.26 26.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.405 -0.361 . . . . 0.6 110.919 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.447 ' HA3' ' HG2' ' A' ' 62' ' ' LYS . . . 83.51 5.51 88.41 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.78 -0.724 . . . . 0.37 112.438 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' CB ' ' HB ' ' A' ' 89' ' ' THR . 30.6 t70 -90.33 -7.34 53.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.565 -1.272 . . . . 0.93 107.565 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 56.2 m 58.4 31.7 21.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.105 -1.407 . . . . 0.62 110.16 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.27 -18.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.256 1.026 . . . . 1.33 109.168 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.38 -155.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.069 -1.423 . . . . 0.23 110.454 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 120' ' ' TYR . 28.8 pt -82.75 137.27 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.296 -1.372 . . . . 0.29 107.296 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.601 HE21 ' HB3' ' A' ' 100' ' ' ASP . 12.4 tp60 -56.77 -30.03 63.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.468 -0.333 . . . . 0.4 110.96 -173.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.83 -44.77 78.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.163 0.506 . . . . 0.2 110.746 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.661 HD21 HG21 ' A' ' 68' ' ' VAL . 62.6 tp -77.88 -37.76 47.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.671 -0.695 . . . . 0.22 110.678 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.601 ' HB3' HE21 ' A' ' 97' ' ' GLN . 22.9 t70 -61.9 -29.51 70.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 0.26 109.59 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.3 -35.07 14.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.253 -0.885 . . . . 0.25 112.275 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 106' ' ' MET . 21.3 t -65.81 -32.83 74.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 1.01 111.479 -174.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.566 HG21 ' HZ ' ' A' ' 88' ' ' PHE . 53.5 t -66.92 -54.91 18.43 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.519 0.563 . . . . 0.21 112.519 -176.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.974 ' HD3' HD11 ' A' ' 90' ' ' LEU . 23.7 Cg_endo -63.76 -22.63 69.5 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.042 1.828 . . . . 0.27 111.921 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.51 ' CD1' HG23 ' A' ' 39' ' ' ILE . 4.2 mt -77.38 -31.15 54.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.64 111.336 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.703 ' SD ' ' HB2' ' A' ' 144' ' ' LEU . 1.3 ptm -88.52 157.23 18.69 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.936 -0.575 . . . . 0.78 109.68 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.533 ' OD2' ' HA3' ' A' ' 53' ' ' GLY . 8.3 p-10 -103.49 158.39 16.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.337 0.589 . . . . 0.97 111.713 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.647 HG23 ' HD3' ' A' ' 60' ' ' PRO . 2.8 t -61.37 125.82 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.524 -0.762 . . . . 0.8 111.464 -174.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.65 59.2 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 114.815 -1.084 . . . . 0.28 112.819 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.4 pt-20 -97.0 167.87 10.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.195 0.522 . . . . 0.41 110.625 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.533 HG22 HD12 ' A' ' 50' ' ' LEU . 21.5 m -128.07 117.4 21.58 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.048 -1.093 . . . . 0.22 108.048 173.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HB1' ' HG2' ' A' ' 47' ' ' LYS . . . -118.35 131.52 56.31 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.977 -0.556 . . . . 0.18 110.963 -173.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.2 ttp -98.44 117.99 34.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.994 -1.113 . . . . 1.32 107.994 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.754 HG22 ' HG3' ' A' ' 47' ' ' LYS . 12.7 t -109.1 137.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.878 -0.601 . . . . 0.18 109.583 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.598 ' N ' ' HZ3' ' A' ' 36' ' ' TRP . 89.6 m -110.66 113.07 25.39 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.241 -1.022 . . . . 0.21 108.241 170.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' LEU . . . -122.7 132.14 54.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.564 -1.198 . . . . 0.15 109.29 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.732 ' HB3' ' HG2' ' A' ' 119' ' ' LYS . 10.6 t70 -52.98 146.63 10.66 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.588 -0.893 . . . . 0.58 108.588 171.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.586 ' HA ' ' HB2' ' A' ' 121' ' ' CYS . 1.5 t -52.32 -26.78 13.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.131 0.491 . . . . 0.82 110.48 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.732 ' HG2' ' HB3' ' A' ' 117' ' ' ASP . 16.7 ptpt -54.33 -33.54 59.16 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 122.062 -0.399 . . . . 0.81 112.01 175.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' OH ' ' HG ' ' A' ' 40' ' ' LEU . 98.5 m-85 -96.4 3.08 53.11 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.352 0.596 . . . . 0.42 109.92 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 118' ' ' SER . 69.8 m -122.13 -90.46 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.034 . . . . 0.18 110.389 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 127' ' ' SER . 13.0 m-85 -144.39 39.62 1.3 Allowed 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.262 0.467 . . . . 0.24 112.262 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 134' ' ' PRO . . . -52.71 -83.26 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.188 -0.529 . . . . 0.25 113.744 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.74 7.66 4.72 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.405 2.07 . . . . 0.58 111.259 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 122' ' ' TYR . 34.0 mt-30 -104.45 -51.17 3.15 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.716 -0.674 . . . . 0.65 110.498 -173.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.559 ' C ' ' HB3' ' A' ' 122' ' ' TYR . . . 85.85 142.68 6.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.074 -0.966 . . . . 0.3 112.419 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.634 ' HB3' HG12 ' A' ' 132' ' ' ILE . 6.9 t -91.35 162.22 14.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.187 -0.506 . . . . 0.33 112.162 -175.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 83' ' ' GLU . 14.5 ptp180 -52.89 -51.37 61.42 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 115.151 -0.931 . . . . 3.17 112.238 -173.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.975 ' HB2' ' HD3' ' A' ' 130' ' ' PRO . 20.4 m -81.4 -64.7 0.27 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 120.606 -0.438 . . . . 1.23 110.36 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.975 ' HD3' ' HB2' ' A' ' 129' ' ' SER . 20.0 Cg_endo -105.24 126.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 122.401 2.067 . . . . 0.37 111.7 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.552 ' CD2' ' HA3' ' A' ' 126' ' ' GLY . 31.0 t80 -56.22 98.11 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.064 -1.087 . . . . 1.14 108.064 163.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 127' ' ' SER . 33.5 mm -65.35 128.99 94.27 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.893 -0.594 . . . . 0.39 109.639 -177.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 8.6 Cg_endo -52.38 139.14 55.72 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.659 2.239 . . . . 0.61 112.282 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.554 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 40.7 Cg_exo -57.55 129.05 31.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.528 2.152 . . . . 0.52 112.456 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.589 ' HA ' ' OD1' ' A' ' 117' ' ' ASP . 57.9 m80 75.36 12.16 3.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.936 -1.029 . . . . 2.38 112.289 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -75.76 127.14 32.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.235 -0.654 . . . . 0.26 109.235 173.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.48 113.08 11.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.521 -0.472 . . . . 0.22 110.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 121' ' ' CYS . 1.0 OUTLIER -90.14 132.87 35.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.072 -0.513 . . . . 0.22 110.97 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 5.2 t -118.11 100.07 7.29 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.605 ' HB3' HG23 ' A' ' 72' ' ' THR . 1.3 pp -109.5 136.71 48.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.651 -0.704 . . . . 0.32 111.586 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.694 ' HB3' ' NE2' ' A' ' 71' ' ' GLN . 50.8 tt0 -101.85 118.44 36.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.175 -0.676 . . . . 1.05 109.175 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 69' ' ' HIS . 4.2 m -119.67 123.3 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.435 0.636 . . . . 0.19 112.555 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 69' ' ' HIS . 42.9 m -92.79 118.54 31.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.645 -0.707 . . . . 0.28 109.362 170.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.703 ' HB2' ' SD ' ' A' ' 106' ' ' MET . 37.4 tp -80.82 99.01 8.07 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.481 -0.933 . . . . 0.15 108.481 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.625 ' HD3' ' HB ' ' A' ' 67' ' ' THR . 19.2 mtpt -79.91 -44.48 20.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.464 -1.244 . . . . 1.08 110.328 -168.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 m -158.48 160.0 36.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.969 -0.56 . . . . 0.37 110.526 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.534 ' HA ' HG12 ' A' ' 66' ' ' VAL . . . -137.32 128.05 27.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.165 -0.68 . . . . 0.25 109.165 170.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 65' ' ' VAL . 20.4 m -126.19 140.23 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.963 0.411 . . . . 0.92 110.06 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.491 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 7.7 t70 -86.36 117.76 25.36 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.509 -0.476 . . . . 2.27 110.55 -176.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.5 tp -136.25 6.9 3.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.878 -0.601 . . . . 1.97 109.793 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -109.07 117.87 35.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.496 -0.775 . . . . 2.14 109.198 -178.097 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -128.97 73.95 1.55 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.363 0.602 . . . . 5.79 109.745 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -71.29 120.57 17.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 7.48 110.897 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -84.34 -29.21 26.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.255 -0.884 . . . . 8.46 111.104 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -125.95 82.13 2.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.693 0.282 . . . . 8.83 110.999 -176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 20.0 m80 61.5 -89.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.695 -0.684 . . . . 12.17 111.385 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 . . . . . 0 C--O 1.244 0.798 0 N-CA-C 109.132 -0.692 . . . . 13.46 109.132 176.037 . . . . . . . . 0 0 . 1 stop_ save_